PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Preta, G; Lotti, V; Cronin, JG; Sheldon, IM				Preta, Giulio; Lotti, Virginia; Cronin, James G.; Sheldon, I. Martin			Protective role of the dynamin inhibitor Dynasore against the cholesterol-dependent cytolysin of Trueperella pyogenes	FASEB JOURNAL			English	Article						host-pathogen interaction; bacteria; mammalian cell survival; lipid rafts	PORE-FORMING TOXINS; LISTERIOLYSIN-O; LIPID RAFTS; BOVINE ENDOMETRIUM; INDUCED APOPTOSIS; PROTEIN TOXINS; STROMAL CELLS; IN-VITRO; ACTIVATION; AUTOPHAGY	The virulence of many Gram-positive bacteria depends on cholesterol-dependent cytolysins (CDCs), which form pores in eukaryotic cell plasma membranes. Pyolysin (PLO) from Trueperella pyogenes provided a unique opportunity to explore cellular responses to CDCs because it does not require thiol activation. Sublytic concentrations of PLO stimulated phosphorylation of MAPK ERK and p38 in primary stromal cells, and induced autophagy as determined by protein light-chain 3B cleavage. Although, inhibitors of MAPK or autophagy did not affect PLO-induced cytolysis. However, 10 mu M 3-hydroxynaphthalene-2-carboxylic acid-(3,4-dihydroxybenzylidene)- hydrazide (Dynasore), a dynamin guanosine 5'-triphosphatase inhibitor, protected stromal cells against PLO-induced cytolysis as determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay (85 +/- 17% versus 50 +/- 9% cell viability), measuring extra-cellular ATP, and kinetic assays. This was a generalized mechanism because Dynasore also protected HeLa cells against streptolysin O. Furthermore, the effect was reversible, with stromal cell sensitivity to PLO restored within 30 minutes of Dynasore removal. The protective effect of Dynasore was not conferred by dynamin inhibition, induction of ERK phosphorylation, or Dynasore binding to PLO. Rather, Dynasore reduced cellular cholesterol and disrupted plasma membrane lipid rafts, similar to positive control methyl-beta-cyclodextrin. Dynasore is a tractable tool to explore the complexity of cholesterol homeostasis in eukaryotic cells and to develop strategies to counter CDCs.	[Preta, Giulio; Lotti, Virginia; Cronin, James G.; Sheldon, I. Martin] Swansea Univ, Coll Med, Inst Life Sci, Swansea SA2 8PP, W Glam, Wales	Swansea University	Sheldon, IM (corresponding author), Swansea Univ, Coll Med, Inst Life Sci, Swansea SA2 8PP, W Glam, Wales.	m.sheldon@swansea.ac.uk	Preta, Giulio/AAW-6182-2021; Sheldon, I Martin/E-1567-2013; Preta, Giulio/N-7141-2016	Sheldon, I Martin/0000-0001-7902-5558; Preta, Giulio/0000-0002-8318-4698; Cronin, James/0000-0002-0590-9462	United Kingdom Biotechnology and Biological Sciences Research Council [BB/K006592/1]; BBSRC [BB/K006592/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K006592/1] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the United Kingdom Biotechnology and Biological Sciences Research Council (Grant BB/K006592/1).	Aguilar JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008076; Alouf JE, 2001, CURR TOP MICROBIOL, V257, P1; Amos MR, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115972; BANGHAM AD, 1965, J MOL BIOL, V13, P253, DOI 10.1016/S0022-2836(65)80094-8; Barrias ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0007764; Billington SJ, 1997, J BACTERIOL, V179, P6100, DOI 10.1128/jb.179.19.6100-6106.1997; Bischofberger M, 2009, CURR OPIN CELL BIOL, V21, P589, DOI 10.1016/j.ceb.2009.04.003; Cassidy SKB, 2013, TOXINS, V5, P618, DOI 10.3390/toxins5040618; Chen X, 2014, J BIOL CHEM, V289, P11162, DOI 10.1074/jbc.M113.531855; Cronin JG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092718; Davson H, 1936, BIOCHEM J, V30, P316, DOI 10.1042/bj0300316; DUNCAN JL, 1977, INFECT IMMUN, V18, P688, DOI 10.1128/IAI.18.3.688-693.1977; Gutierrez MG, 2007, P NATL ACAD SCI USA, V104, P1829, DOI 10.1073/pnas.0601437104; Ge MT, 1999, BIOPHYS J, V77, P925, DOI 10.1016/S0006-3495(99)76943-2; Gekara NO, 2005, CELL MICROBIOL, V7, P1345, DOI 10.1111/j.1462-5822.2005.00561.x; Gekara NO, 2004, BIOCHEM SOC T, V32, P712, DOI 10.1042/BST0320712; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Giddings KS, 2004, NAT STRUCT MOL BIOL, V11, P1173, DOI 10.1038/nsmb862; Gilbert RJC, 2002, CELL MOL LIFE SCI, V59, P832, DOI 10.1007/s00018-002-8471-1; Girard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029042; Golstein P, 2007, EMBO REP, V8, P829, DOI 10.1038/sj.embor.7401042; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Gonzalez MR, 2011, CELL MICROBIOL, V13, P1026, DOI 10.1111/j.1462-5822.2011.01600.x; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Harris JR, 2011, J STRUCT BIOL, V173, P38, DOI 10.1016/j.jsb.2010.07.010; Hotze EM, 2012, BBA-BIOMEMBRANES, V1818, P1028, DOI 10.1016/j.bbamem.2011.07.036; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Jost BH, 2005, ANTON LEEUW INT J G, V88, P87, DOI 10.1007/s10482-005-2316-5; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kao CY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001314; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kloft N, 2009, BIOCHEM BIOPH RES CO, V385, P503, DOI 10.1016/j.bbrc.2009.05.121; Lum M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084975; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Meyer-Morse N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008610; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mulherkar N, 2011, VIROLOGY, V419, P72, DOI 10.1016/j.virol.2011.08.009; Olsson S, 2006, MOL IMMUNOL, V43, P607, DOI 10.1016/j.molimm.2005.04.011; PAGE B, 1993, INT J ONCOL, V3, P473; Pavlovic D, 2000, EUR CYTOKINE NETW, V11, P267; Pokrajac L, 2012, BIOCHEM CELL BIOL, V90, P709, DOI [10.1139/O2012-029, 10.1139/o2012-029]; Porta H, 2011, PEPTIDES, V32, P601, DOI 10.1016/j.peptides.2010.06.012; Preta G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047328; Renshaw MW, 1997, EMBO J, V16, P5592, DOI 10.1093/emboj/16.18.5592; Rinaldi M, 2008, VET IMMUNOL IMMUNOP, V126, P199, DOI 10.1016/j.vetimm.2008.07.001; Robinet P, 2006, TRAFFIC, V7, P811, DOI 10.1111/j.1600-0854.2006.00435.x; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Sandvig K, 2002, FEBS LETT, V529, P49, DOI 10.1016/S0014-5793(02)03182-4; SANKARAM MB, 1990, BIOCHEMISTRY-US, V29, P10670, DOI 10.1021/bi00499a014; Sheldon IM, 2009, BIOL REPROD, V81, P1025, DOI 10.1095/biolreprod.109.077370; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Triantafilou M, 2002, J CELL SCI, V115, P2603; Turner ML, 2014, ENDOCRINOLOGY, V155, P1453, DOI 10.1210/en.2013-1822; Wang M, 2013, J NEURO-ONCOL, V115, P323, DOI 10.1007/s11060-013-1232-1; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200	60	40	41	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1516	1528		10.1096/fj.14-265207	http://dx.doi.org/10.1096/fj.14-265207			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25550455	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000354115000036
J	Bodman, JAR; Yang, Y; Logan, MR; Eitzen, G				Bodman, James A. R.; Yang, Yang; Logan, Michael R.; Eitzen, Gary			Yeast Translation Elongation Factor-1A Binds Vacuole-localized Rho1p to Facilitate Membrane Integrity through F-actin Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; FACTOR 1A; GTPASE ACTIVATION; HUMAN NEUTROPHILS; FACTOR 1-ALPHA; LIVE CELLS; CYTOSKELETON; PROTEIN; FUSION; EXOCYTOSIS	Rho GTPases are molecular switches that modulate a variety of cellular processes, most notably those involving actin dynamics. We have previously shown that yeast vacuolar membrane fusion requires re-organization of actin filaments mediated by two Rho GTPases, Rho1p and Cdc42p. Cdc42p initiates actin polymerization to facilitate membrane tethering; Rho1p has a role in the late stages of vacuolar fusion, but its mode of action is unknown. Here, we identified eEF1A as a vacuolar Rho1p-inter-acting protein. eEF1A (encoded by the TEF1 and TEF2 genes in yeast) is an aminoacyl-tRNA transferase needed during protein translation. eEF1A also has a second function that is independent of translation; it binds and organizes actin filaments into ordered cable structures. Here, we report that eEF1A interacts with Rho1p via a C-terminal subdomain. This interaction occurs predominantly when both proteins are in the GDP-bound state. Therefore, eEF1A is an atypical downstream effector of Rho1p. eEF1A does not promote vacuolar fusion; however, overexpression of the Rho1p-interacting subdomain affects vacuolar morphology. Vacuoles were destabilized and prone to leakage when treated with the eEF1A inhibitor narciclasine. We propose a model whereby eEF1A binds to Rho1p-GDP on the vacuolar membrane; it is released upon Rho1p activation and then bundles actin filaments to stabilize fused vacuoles. Therefore, the Rho1p-eEF1A complex acts to spatially localize a pool of eEF1A to vacuoles where it can readily organize F-actin.	[Bodman, James A. R.; Yang, Yang; Logan, Michael R.; Eitzen, Gary] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	University of Alberta	Eitzen, G (corresponding author), Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada.	gary.eitzen@ualberta.ca			Natural Sciences and Engineering Research Council of Canada [327237]; Queen Elizabeth II Scholarship from the Province of Alberta	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Queen Elizabeth II Scholarship from the Province of Alberta	This work was supported by Discovery Grant 327237 from the Natural Sciences and Engineering Research Council of Canada (to G. E.).; Supported by a Queen Elizabeth II Scholarship from the Province of Alberta.	Anand M, 2003, J BIOL CHEM, V278, P6985, DOI 10.1074/jbc.M209224200; Andersen GR, 2003, TRENDS BIOCHEM SCI, V28, P434, DOI 10.1016/S0968-0004(03)00162-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; BEKTAS M, 1994, FEBS LETT, V356, P89, DOI 10.1016/0014-5793(94)01239-3; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bunai F, 2006, J BIOCHEM, V140, P393, DOI 10.1093/jb/mvj169; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chiu TT, 2010, MOL BIOL CELL, V21, P3529, DOI 10.1091/mbc.E10-04-0316; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; de Kreuk BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073962; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Egea G, 2006, CURR OPIN CELL BIOL, V18, P168, DOI 10.1016/j.ceb.2006.02.007; Eitzen G, 2003, BBA-MOL CELL RES, V1641, P175, DOI 10.1016/S0167-4889(03)00087-9; Eitzen G, 2002, J CELL BIOL, V158, P669, DOI 10.1083/jcb.200204089; Eitzen G, 2001, EMBO J, V20, P5650, DOI 10.1093/emboj/20.20.5650; Eitzen G, 2012, METHODS MOL BIOL, V827, P369, DOI 10.1007/978-1-61779-442-1_24; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; Grant BJ, 2010, BIOPHYS J, V99, pL87, DOI 10.1016/j.bpj.2010.10.020; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Haas Albert, 1995, Methods in Cell Science, V17, P283, DOI 10.1007/BF00986234; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; Isgandarova S, 2007, J BIOL CHEM, V282, P30466, DOI 10.1074/jbc.M704117200; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; Jog NR, 2007, AM J PHYSIOL-CELL PH, V292, pC1690, DOI 10.1152/ajpcell.00384.2006; Johnson JL, 2012, MOL BIOL CELL, V23, P1902, DOI 10.1091/mbc.E11-12-1001; Jones L, 2010, J BIOL CHEM, V285, P4298, DOI 10.1074/jbc.M109.074609; Karunakaran S, 2012, J CELL SCI, V125, P1683, DOI 10.1242/jcs.091900; KINZY TG, 1994, NUCLEIC ACIDS RES, V22, P2703, DOI 10.1093/nar/22.13.2703; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Liebl D, 2009, J CELL SCI, V122, P2935, DOI 10.1242/jcs.048355; Liu G, 1996, J CELL BIOL, V135, P953, DOI 10.1083/jcb.135.4.953; Logan MR, 2010, BIOCHEM BIOPH RES CO, V394, P64, DOI 10.1016/j.bbrc.2010.02.102; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Merz AJ, 2004, J CELL BIOL, V164, P195, DOI 10.1083/jcb.200310105; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Mitchell T, 2008, AM J PHYSIOL-CELL PH, V295, pC1354, DOI 10.1152/ajpcell.00239.2008; Morita K, 2008, ZOOL SCI, V25, P22, DOI 10.2108/zsj.25.22; Munshi R, 2001, GENETICS, V157, P1425; Nightingale TD, 2011, J CELL BIOL, V194, P613, DOI 10.1083/jcb.201011119; OWEN CH, 1992, J STRUCT BIOL, V109, P248, DOI 10.1016/1047-8477(92)90037-B; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Pittman YR, 2009, J BIOL CHEM, V284, P4739, DOI 10.1074/jbc.M807945200; Porat-Shliom N, 2013, CELL MOL LIFE SCI, V70, P2099, DOI 10.1007/s00018-012-1156-5; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Soares DC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006315; Spector I., 1983, SCIENCE, V219, P492; Stockinger W, 2006, MOL BIOL CELL, V17, P1697, DOI 10.1091/mbc.E05-12-1140; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Toulmay A, 2013, J CELL BIOL, V202, P35, DOI 10.1083/jcb.201301039; Umikawa M, 1998, ONCOGENE, V16, P2011, DOI 10.1038/sj.onc.1201724; Van Goietsenoven G, 2010, FASEB J, V24, P4575, DOI 10.1096/fj.10-162263; Weisman LS, 2006, NAT REV MOL CELL BIO, V7, P243, DOI 10.1038/nrm1892; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131	59	10	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4705	4716		10.1074/jbc.M114.630764	http://dx.doi.org/10.1074/jbc.M114.630764			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25561732	Green Published, hybrid			2022-12-26	WOS:000350042000014
J	Ballesteros, A; Mentink-Kane, MM; Warren, J; Kaplan, GG; Dveksler, GS				Ballesteros, Angela; Mentink-Kane, Margaret M.; Warren, James; Kaplan, Gerardo G.; Dveksler, Gabriela S.			Induction and Activation of Latent Transforming Growth Factor-beta(1) Are Carried out by Two Distinct Domains of Pregnancy-specific Glycoprotein 1 (PSG1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; SWISS-MODEL; GROWTH-FACTOR-BETA-1; RECEPTOR; CELLS; MACROPHAGES; TGF-BETA-1; COMPLEX; FAMILY	Pregnancy-specific glycoproteins (PSGs) are a family of Ig-like proteins secreted by specialized placental cells. The PSG1 structure is composed of a single Ig variable region-like N-terminal domain and three Ig constant region-like domains termed A1, A2, and B2. Members of the human and murine PSG family have been shown to induce anti-inflammatory cytokines from monocytes and macrophages and to stimulate angiogenesis. We recently showed that recombinant forms of PSG1 (PSG1-Fc and PSG1-His) and PSG1 purified from the serum of pregnant women are associated with the immunoregulatory cytokine TGF-beta(1) and activated latent TGF-beta(1). Here, we sought to examine the requirement of specific PSG1 domains in the activation of latent TGF-beta(1). Plasmon surface resonance studies showed that PSG1 directly bound to the small latent complex and to the latency-associated peptide of TGF-beta(1) and that this binding was mediated through the B2 domain. Furthermore, the B2 domain alone was sufficient for activating the small latent complex. In separate experiments, we found that the PSG1-mediated induction of TGF-beta(1) secretion in macrophages was dependent on the N-terminal domain. Mutagenesis analysis revealed that four amino acids (LYHY) of the CC' loop of the N-terminal domain were required for induction of latent TGF-beta(1) secretion. Together, our results show that two distinct domains of PSG1 are involved in the regulation of TGF-beta(1) and provide a mechanistic framework for how PSGs modulate the immunoregulatory environment at the maternal-fetal interface for successful pregnancy outcome.	[Ballesteros, Angela; Kaplan, Gerardo G.] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; [Mentink-Kane, Margaret M.; Warren, James; Dveksler, Gabriela S.] Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA	US Food & Drug Administration (FDA); Uniformed Services University of the Health Sciences - USA	Dveksler, GS (corresponding author), Uniformed Serv Hlth Sci, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	gabriela.dveksler@usuhs.edu		Ballesteros Morcillo, Angela/0000-0001-5796-6875; kaplan, gerardo/0000-0003-3303-7259	National Institutes of Health from NIAID [R21AI101979]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101979] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Award R21AI101979 from NIAID.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Alcaraz LB, 2014, J CELL BIOL, V205, P409, DOI 10.1083/jcb.201308031; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bailly S, 1997, J BIOL CHEM, V272, P16329, DOI 10.1074/jbc.272.26.16329; Bhattacharya D, 2013, PROTEINS, V81, P119, DOI 10.1002/prot.24167; Blois SM, 2014, MUCOSAL IMMUNOL, V7, P348, DOI 10.1038/mi.2013.53; DVEKSLER GS, 1993, J VIROL, V67, P1; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fardini Y, 2010, INFECT IMMUN, V78, P1789, DOI 10.1128/IAI.01395-09; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE JN, 1979, BRIT J OBSTET GYNAEC, V86, P888, DOI 10.1111/j.1471-0528.1979.tb10717.x; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lisboa FA, 2011, J BIOL CHEM, V286, P7577, DOI 10.1074/jbc.M110.161810; Martinez FF, 2012, EUR J IMMUNOL, V42, P1573, DOI 10.1002/eji.201142140; McLellan AS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-4; Motran CC, 2002, J LEUKOCYTE BIOL, V72, P512; OHNO M, 1995, J CLIN INVEST, V95, P1363, DOI 10.1172/JCI117787; OSBORNE JC, 1982, BIOCHEMISTRY-US, V21, P5523, DOI 10.1021/bi00265a022; Pihl K, 2009, PRENATAL DIAG, V29, P1256, DOI 10.1002/pd.2408; Radaev S, 2010, J BIOL CHEM, V285, P14806, DOI 10.1074/jbc.M109.079921; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; Shanley DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057491; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Snyder SK, 2001, AM J REPROD IMMUNOL, V45, P205, DOI 10.1111/j.8755-8920.2001.450403.x; Sulkowski GN, 2011, PLACENTA, V32, P603, DOI 10.1016/j.placenta.2011.05.008; Tangeras LH, 2014, J REPROD IMMUNOL, V106, P89, DOI 10.1016/j.jri.2014.04.004; TEGLUND S, 1994, GENOMICS, V23, P669, DOI 10.1006/geno.1994.1556; Toossi Z, 1996, J IMMUNOL, V156, P3461; TOOSSI Z, 1995, INFECT IMMUN, V63, P224, DOI 10.1128/IAI.63.1.224-228.1995; Waterhouse R, 2002, J EXP MED, V195, P277, DOI 10.1084/jem.20011741; Xiong WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072772; Zhou GQ, 1997, PLACENTA, V18, P491, DOI 10.1016/0143-4004(77)90002-9; Zhou GQ, 2001, BIOL REPROD, V64, P90, DOI 10.1095/biolreprod64.1.90	39	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4422	4431		10.1074/jbc.M114.597518	http://dx.doi.org/10.1074/jbc.M114.597518			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25548275	Green Published, hybrid			2022-12-26	WOS:000349458400049
J	Thomas, MA; Buelow, BJ; Nevins, AM; Jones, SE; Peterson, FC; Gundry, RL; Grayson, MH; Volkman, BF				Thomas, Monica A.; Buelow, Becky J.; Nevins, Amanda M.; Jones, Stephanie E.; Peterson, Francis C.; Gundry, Rebekah L.; Grayson, Mitchell H.; Volkman, Brian F.			Structure-Function Analysis of CCL28 in the Development of Post-viral Asthma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR CHEMICAL-SHIFTS; CC-CHEMOKINE; AIRWAY HYPERREACTIVITY; IMPROVED SENSITIVITY; VIRAL-INFECTION; DISULFIDE BOND; T-CELLS; INFLAMMATION; PROTEIN; CCR10	CCL28 is a human chemokine constitutively expressed by epithelial cells in diverse mucosal tissues and is known to attract a variety of immune cell types including T-cell subsets and eosinophils. Elevated levels of CCL28 have been found in the airways of individuals with asthma, and previous studies have indicated that CCL28 plays a vital role in the acute development of post-viral asthma. Our study builds on this, demonstrating that CCL28 is also important in the chronic post-viral asthma phenotype. In the absence of a viral infection, we also demonstrate that CCL28 is both necessary and sufficient for induction of asthma pathology. Additionally, we present the first effort aimed at elucidating the structural features of CCL28. Chemokines are defined by a conserved tertiary structure composed of a three-stranded beta-sheet and a C-terminal alpha-helix constrained by two disulfide bonds. In addition to the four disulfide bondforming cysteine residues that define the traditional chemokine fold, CCL28 possesses two additional cysteine residues that form a third disulfide bond. If all disulfide bonds are disrupted, recombinant human CCL28 is no longer able to drive mouse CD4+ T-cell chemotaxis or in vivo airway hyper-reactivity, indicating that the conserved chemokine fold is necessary for its biologic activity. Due to the intimate relationship between CCL28 and asthma pathology, it is clear that CCL28 presents a novel target for the development of alternative asthma therapeutics.	[Thomas, Monica A.; Nevins, Amanda M.; Peterson, Francis C.; Gundry, Rebekah L.; Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Buelow, Becky J.; Jones, Stephanie E.; Grayson, Mitchell H.] Med Coll Wisconsin, Dept Pediat, Sect Allergy & Immunol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Grayson, MH (corresponding author), Med Coll Wisconsin, Dept Pediat, Sect Allergy & Immunol, MFRC 5064,8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	wheeze@allergist.com; bvolkman@mcw.edu	Volkman, Brian F./ABE-7312-2020; Gundry, Rebekah/K-6080-2019; Grayson, Mitchell/AAX-3674-2020; Grayson, Mitchell H/A-3693-2008; Volkman, Brian F./ABE-7306-2020	Volkman, Brian F./0000-0002-6681-5179; Grayson, Mitchell/0000-0002-4673-2122; Grayson, Mitchell H/0000-0002-4673-2122; Volkman, Brian F./0000-0002-6681-5179; Thomas, Monica/0000-0003-2513-3371; Gundry, Rebekah L./0000-0002-9263-833X	National Institutes of Health [R01 GM097381, R56 AI112519]; Children's Research Institute of the Children's Hospital of Wisconsin; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL072483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058072, R56AI112519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Research Institute of the Children's Hospital of Wisconsin; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM097381 (to B. F. V.) and R56 AI112519 (to B. F. V. and M. H. G.) and by the Children's Research Institute of the Children's Hospital of Wisconsin.	BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Cheung DS, 2010, ANN ALLERG ASTHMA IM, V105, P437, DOI 10.1016/j.anai.2010.09.010; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P71, DOI 10.1007/s10858-005-5705-1; English K, 2006, IMMUNOL LETT, V103, P92, DOI 10.1016/j.imlet.2005.09.011; Ezzat M H M, 2009, Indian J Dermatol, V54, P229, DOI 10.4103/0019-5154.55630; Fanta CH, 2009, NEW ENGL J MED, V360, P1002, DOI 10.1056/NEJMra0804579; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Grayson MH, 2007, J EXP MED, V204, P2759, DOI 10.1084/jem.20070360; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Hansbro NG, 2008, PHARMACOL THERAPEUT, V117, P313, DOI 10.1016/j.pharmthera.2007.11.002; John AE, 2005, AM J PATHOL, V166, P345, DOI 10.1016/S0002-9440(10)62258-4; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Keizer DW, 2000, BIOCHEMISTRY-US, V39, P6053, DOI 10.1021/bi000089l; Khan SH, 2008, CLIN THER, V30, P1017, DOI 10.1016/j.clinthera.2008.06.002; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kumar A, 2009, ANN ALLERG ASTHMA IM, V103, P181, DOI 10.1016/S1081-1206(10)60178-0; Laing KJ, 2004, DEV COMP IMMUNOL, V28, P443, DOI 10.1016/j.dci.2003.09.006; Lofgren JLS, 2006, J APPL PHYSIOL, V101, P1495, DOI 10.1152/japplphysiol.00464.2006; Love M, 2012, BIOCHEMISTRY-US, V51, P733, DOI 10.1021/bi201601k; Meng YY, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110312; Meyer EH, 2006, P NATL ACAD SCI USA, V103, P2782, DOI 10.1073/pnas.0510282103; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Muhandiram D. R., 1999, J MAGN RESON SER B, V103, P203; National Health and Medical Research Council, 2013, AUSTR COD PRACT CAR, P1; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Pan JL, 2000, J IMMUNOL, V165, P2943, DOI 10.4049/jimmunol.165.6.2943; Rajarathnam K, 2001, J BIOL CHEM, V276, P4909, DOI 10.1074/jbc.M005085200; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Sticht H, 1999, BIOCHEMISTRY-US, V38, P5995, DOI 10.1021/bi990065i; Takekoshi T, 2012, MOL CANCER THER, V11, P2516, DOI 10.1158/1535-7163.MCT-12-0494; Wang W, 2000, J BIOL CHEM, V275, P22313, DOI 10.1074/jbc.M001461200	35	15	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4528	4536		10.1074/jbc.M114.627786	http://dx.doi.org/10.1074/jbc.M114.627786			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25556652	Green Published, hybrid			2022-12-26	WOS:000349458400057
J	Huang, JH; Savini, G; Chen, H; Bao, FJ; Li, YG; Chen, HS; Lu, WC; Yu, Y; Wang, QM				Huang, Jinhai; Savini, Giacomo; Chen, Hao; Bao, Fangjun; Li, Yuanguang; Chen, Haisi; Lu, Weicong; Yu, Ye; Wang, Qinmei			Precision and Agreement of Corneal Power Measurements Obtained Using a New Corneal Topographer OphthaTOP	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; CATARACT-SURGERY; REPEATABILITY; PENTACAM; REPRODUCIBILITY; VIDEOKERATOGRAPHY; PERFORMANCE; CURVATURE; EYES; KERATOMETRY	Purpose: To evaluate repeatability and reproducibility of anterior corneal power measurements obtained with a new corneal topographer OphthaTOP (Hummel AG, Germany) and agreement with measurements by a rotating Scheimpflug camera (Pentacam HR, Oculus, Germany) and an automated keratometer (IOLMaster, Carl Zeiss Meditec, Germany). Methods: The right eyes of 79 healthy subjects were prospectively measured three times with all three devices. Another examiner performed three additional scans with the OphthaTOP in the same session. Within one week, the first examiner repeated the measurements using the OphthaTOP. The flat simulated keratometry (Kf), steep K (Ks), mean K (Km), J(0), and J(45) were noted. Repeatability and reproducibility of measurements were assessed by within-subject standard deviation (Sw), repeatability (2.77 Sw), coefficient of variation (CoV), and intraclass correlation coefficient (ICC). Agreement between devices was assessed using 95% limits of agreement (LoA). Results: Intraobserver repeatability and interobserver and intersession reproducibility of all measured parameters showed a 2.77 Sw of 0.29 diopter or less, a CoV of less than 0.24%, and an ICC of more than 0.906. Statistically significant differences (P<0.001) were found between the parameters analyzed by the three devices, except J(0) and J(45). The mean differences between OphthaTOP and the other two devices were small, and the 95% LoA was narrow for all results. Conclusions: The OphthaTOP showed excellent intraobserver repeatability and interobserver and intersession reproducibility of corneal power measurements. Good agreements with the other two devices in these parameters were found in healthy eyes.	[Huang, Jinhai; Savini, Giacomo; Chen, Hao; Bao, Fangjun; Li, Yuanguang; Chen, Haisi; Lu, Weicong; Yu, Ye; Wang, Qinmei] Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China; [Huang, Jinhai; Savini, Giacomo; Chen, Hao; Bao, Fangjun; Li, Yuanguang; Chen, Haisi; Lu, Weicong; Yu, Ye; Wang, Qinmei] Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China; [Huang, Jinhai; Bao, Fangjun; Yu, Ye; Wang, Qinmei] Minist Hlth, Key Lab Vis Sci, Wenzhou, Zhejiang, Peoples R China; [Savini, Giacomo] Studio Oculist Azeglio, Bologna, Italy	Wenzhou Medical University; Wenzhou Medical University	Wang, QM (corresponding author), Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China.	wqm6@mail.eye.ac.cn	Huang, Jinhai/ABH-4519-2020; Savini, Giacomo/J-9196-2018	Savini, Giacomo/0000-0003-0075-3582; Huang, Jinhai/0000-0001-9952-3175	Foundation of Wenzhou City Science & Technology Bureau [Y20110045, Y20120176]; Natural Science Foundation of China [81300807]; National Science and Technology Ministry [2012BAI08B04]; health Bureau of Zhejiang Province [2012KYB135]; Scientific Research Fund of Zhejiang Provincial Education Department [Y201223147]	Foundation of Wenzhou City Science & Technology Bureau; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Ministry; health Bureau of Zhejiang Province; Scientific Research Fund of Zhejiang Provincial Education Department	This study was supported in part by the Foundation of Wenzhou City Science & Technology Bureau (Y20110045, Y20120176; www.wzkj.gov.cn); the Natural Science Foundation of China (81300807; www.nsfc.gov.cn); the National Science and Technology Ministry (2012BAI08B04; www.most.gov.cn); the health Bureau of Zhejiang Province (2012KYB135; www.zjmed.org.cn); and the Scientific Research Fund of Zhejiang Provincial Education Department (Y201223147; www.zjedu.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation.	Aristodemou P, 2011, J CATARACT REFR SURG, V37, P63, DOI 10.1016/j.jcrs.2010.07.032; Bland JM, 1996, BRIT MED J, V313, P744; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chen D, 2007, J CATARACT REFR SURG, V33, P448, DOI 10.1016/j.jcrs.2006.11.008; Chen WH, 2012, J CATARACT REFR SURG, V38, P1626, DOI 10.1016/j.jcrs.2012.04.031; Cho P, 2002, OPTOMETRY VISION SCI, V79, P175, DOI 10.1097/00006324-200203000-00012; Chui WS, 2005, OPTOMETRY VISION SCI, V82, P420, DOI 10.1097/01.OPX.0000162642.24885.71; Collins MJ, 2006, ACTA OPHTHALMOL SCAN, V84, P216, DOI 10.1111/j.1600-0420.2005.00547.x; Delrivo M, 2014, J REFRACT SURG, V30, P49, DOI 10.3928/1081597X-20131217-06; Elbaz U, 2007, AM J OPHTHALMOL, V143, P48, DOI 10.1016/j.ajo.2006.08.031; Frings A, 2014, J CATARACT REFR SURG, V40, P232, DOI 10.1016/j.jcrs.2013.11.015; Gatinel D, 2002, J FR OPHTALMOL, V25, P81; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; Huynh SC, 2006, CORNEA, V25, P383, DOI 10.1097/01.ico.0000214203.84081.ec; Institution BS, 1994, 5725 BS ISO 1; Jeandervin M, 1998, OPTOMETRY VISION SCI, V75, P663, DOI 10.1097/00006324-199809000-00021; Kamiya K, 2014, BR J OPHTHALMOL; Kawamorita T, 2009, J REFRACT SURG, V25, P539, DOI 10.3928/1081597X-20090512-08; Kawamorita T, 2009, J CATARACT REFR SURG, V35, P127, DOI 10.1016/j.jcrs.2008.10.019; KRAMER MS, 1981, CLIN PHARMACOL THER, V29, P111, DOI 10.1038/clpt.1981.18; Ladas JG, 2001, AM J OPHTHALMOL, V132, P254, DOI 10.1016/S0002-9394(01)00894-7; Liu Z, 2001, Zhonghua Yan Ke Za Zhi, V37, P125; Mao XJ, 2013, J CATARACT REFR SURG, V39, P1561, DOI 10.1016/j.jcrs.2013.04.029; McAlinden C, 2011, INVEST OPHTH VIS SCI, V52, P7731, DOI 10.1167/iovs.10-7093; McKernan AL, 2014, CONTACT LENS ANTERIO, V37, P31, DOI 10.1016/j.clae.2013.07.014; Mehravaran S, 2014, INT OPHTHALMOL; Mihaltz K, 2009, CORNEA, V28, P976, DOI 10.1097/ICO.0b013e31819e34de; Moura RCMR, 1998, CORNEA, V17, P522; Muller LJ, 2001, BRIT J OPHTHALMOL, V85, P437, DOI 10.1136/bjo.85.4.437; MULLER R, 1994, STAT MED, V13, P2465, DOI 10.1002/sim.4780132310; PEREZ JG, 2004, EYE CONTACT LENS, V30, P74; Rao SN, 2002, OPHTHALMOLOGY, V109, P1642, DOI 10.1016/S0161-6420(02)01121-1; Read SA, 2006, INVEST OPHTH VIS SCI, V47, P1404, DOI 10.1167/iovs.05-1181; Read SA, 2009, J CATARACT REFR SURG, V35, P1072, DOI 10.1016/j.jcrs.2009.01.020; Parede TRR, 2013, ARQ BRAS OFTALMOL, V76, P386, DOI 10.1590/S0004-27492013000600016; Santodomingo-Rubido J, 2002, BRIT J OPHTHALMOL, V86, P458, DOI 10.1136/bjo.86.4.458; Savini G, 2009, J REFRACT SURG, V25, P534, DOI 10.3928/1081597X-20090512-07; Tang ML, 2006, J CATARACT REFR SURG, V32, P1843, DOI 10.1016/j.jcrs.2006.04.046; Tang W, 2000, OPTOMETRY VISION SCI, V77, P483, DOI 10.1097/00006324-200009000-00009; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; Varssano D, 1997, J CATARACT REFR SURG, V23, P419, DOI 10.1016/S0886-3350(97)80187-3	41	9	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e109414	10.1371/journal.pone.0109414	http://dx.doi.org/10.1371/journal.pone.0109414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559203	Green Published, Green Submitted, gold			2022-12-26	WOS:000348102200001
J	Acuna-Marrero, D; Jimenez, J; Smith, F; Doherty, PF; Hearn, A; Green, JR; Paredes-Jarrin, J; Salinas-de-Leon, P				Acuna-Marrero, David; Jimenez, Jesus; Smith, Franz; Doherty, Paul F., Jr.; Hearn, Alex; Green, Jonathan R.; Paredes-Jarrin, Jules; Salinas-de-Leon, Pelayo			Whale Shark (Rhincodon typus) Seasonal Presence, Residence Time and Habitat Use at Darwin Island, Galapagos Marine Reserve	PLOS ONE			English	Article							GULF-OF-CALIFORNIA; NINGALOO REEF; POPULATION-SIZE; MOVEMENTS; FISH; PATTERNS; PROGRAM; ECOLOGY; BIOLOGY; OCEAN	The life history of the whale shark (Rhincodon typus), including its reproductive ecology, still remains largely unknown. Here, we present results from the first whale shark population study around Darwin Island, Galapagos Marine Reserve. Following a diversified approach we characterized seasonal occurrence, population structure and size, and described habitat use of whale sharks based on fine scale movements around the island. Whale shark presence at Darwin Island was negatively correlated with Sea Surface Temperature (SST), with highest abundance corresponding to a cool season between July and December over six years of monitoring. From 2011 to 2013 we photo-identified 82 whale sharks ranging from 4 to 13.1 m Total Length (TL). Size distribution was bimodal, with a great majority (91.5%) of adult female individuals averaging 11.35 m +/- 0.12 m (TL +/- SE), all but one showing signs of a potential pregnancy. Population dynamics models for apparently pregnant sharks estimated the presence of 3.76 +/- 0.90 (mean +/- SE) sharks in the study area per day with an individual residence time of 2.09 +/- 0.51 (mean +/- SE) days. Movement patterns analysis of four apparently pregnant individuals tracked with acoustic tags at Darwin Island revealed an intense use of Darwin's Arch, where no feeding or specific behavior has been recorded, together with periodic excursions around the island's vicinity. Sharks showed a preference for intermediate depths (20-30 m) with occasional dives mostly to mid-water, remaining the majority of their time at water temperatures between 24-25 degrees C. All of our results point to Darwin Island as an important stopover in a migration, possibly with reproductive purposes, rather than an aggregation site. Current studies carried out in this area to investigate regional scale movement patterns may provide essential information about possible pupping grounds for this enigmatic species.	[Acuna-Marrero, David; Jimenez, Jesus; Smith, Franz; Green, Jonathan R.; Salinas-de-Leon, Pelayo] Charles Darwin Res Stn, Puerto Ayora, Galapagos Islan, Ecuador; [Doherty, Paul F., Jr.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Hearn, Alex] Turtle Isl Restorat Network, Olema, CA USA; [Paredes-Jarrin, Jules] Galapagos Natl Pk Directorate, Puerto Ayora, Galapagos Islan, Ecuador	Colorado State University	Acuna-Marrero, D (corresponding author), Charles Darwin Res Stn, Puerto Ayora, Galapagos Islan, Ecuador.	david.acuna@fcdarwin.org.ec	Hearn, Alex/AAK-6461-2020		Rapier Family Trust; Galapagos Conservancy; Lindblad Expeditions/National Geographic Funds; IWC Schaffhausen	Rapier Family Trust; Galapagos Conservancy; Lindblad Expeditions/National Geographic Funds; IWC Schaffhausen	This study has been funded by: Rapier Family Trust (www.rapiertrust.com), Galapagos Conservancy (www.galapagos.org), Lindblad Expeditions/National Geographic Funds (www.expeditions.com), IWC Schaffhausen (www.iwc.com). The funders provided funds to cover field trips to collect data.	Aca EQ, 2011, ASIA LIFE SCI, V20, P361; Acuna-Marrero David, 2013, Marine Biodiversity Records, V6, pe74, DOI 10.1017/S1755267213000456; Arnason AN, 1999, BIRD STUDY, V46, P157; ARNBOM T, 1988, NOTICIAS GALAPAGOS, V46, P3; Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; Banks SJ., 2002, RESERVA MARINA GAL P, P22; Beebe W, 1926, ARCTURUS ADVENTURE; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Colman JG, 1997, J FISH BIOL, V51, P1219, DOI 10.1111/j.1095-8649.1997.tb01138.x; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Edgar G.J., 2002, RESERVA MARINA GALAP, P68; Fox S, 2013, J FISH BIOL, V83, P574, DOI 10.1111/jfb.12195; Gleiss AC, 2011, FUNCT ECOL, V25, P595, DOI 10.1111/j.1365-2435.2010.01801.x; Graham RT, 2007, FISH RES, V84, P71, DOI 10.1016/j.fishres.2006.11.026; GUDGER E. W., 1927, SCIENCE, V65, P545, DOI 10.1126/science.65.1692.545; Gudger EW, 1933, NATURE, V132, P569, DOI 10.1038/132569a0; Gunn JS, 1999, MAR BIOL, V135, P553, DOI 10.1007/s002270050656; Hearn A, 2010, MAR BIOL, V157, P1899, DOI 10.1007/s00227-010-1460-2; Hearn AR, 2013, ANIMAL BIOTELEMETRY, V1, P1, DOI DOI 10.1186/2050-3385-1-11; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; Holmberg Jason, 2009, Endangered Species Research, V7, P39, DOI 10.3354/esr00186; Hueter RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071883; Kasteleyn H, 1986, NOTIC GALAPAGOS, P43; Kendall WL, 2001, BIOMETRICS, V57, P1113, DOI 10.1111/j.0006-341X.2001.01113.x; Ketchum JT, 2014, MAR BIOL, V161, P755, DOI 10.1007/s00227-013-2375-5; Ketchum JT, 2013, ENVIRON BIOL FISH, V96, P779, DOI 10.1007/s10641-012-0071-9; Klimley AP, 2005, ENVIRON BIOL FISH, V74, P79, DOI 10.1007/s10641-005-3997-3; Martin RA, 2007, FISH RES, V84, P10, DOI 10.1016/j.fishres.2006.11.010; Meekan MG, 2006, MAR ECOL PROG SER, V319, P275, DOI 10.3354/meps319275; Norman B, 2004, REV CURRENT CONSERVA; Norman B, 2005, IUCN 2013 IUCN RED L; Palacios DM, 2004, DEEP-SEA RES PT II, V51, P43, DOI 10.1016/j.dsr2.2003.08.001; Penaherrera C, 2013, RAPID SEAFLOOR MAPPI, V68; Pierce S, 2008, 2 INT WHAL SHARK C H; Ramirez-Macias D, 2012, J FISH BIOL, V80, P1401, DOI 10.1111/j.1095-8649.2012.03258.x; Ramirez-Macias D, 2007, FISH RES, V84, P87, DOI 10.1016/j.fishres.2006.11.038; Ramirez-Macias Deni, 2012, Endangered Species Research, V18, P115, DOI 10.3354/esr00437; Rohner CA, 2011, J FISH BIOL, V78, P378, DOI 10.1111/j.1095-8649.2010.02861.x; Rowat D, 2007, FISH RES, V84, P32, DOI 10.1016/j.fishres.2006.11.009; Rowat D, 2012, J FISH BIOL, V80, P1019, DOI 10.1111/j.1095-8649.2012.03252.x; Rowat D, 2011, MAR FRESHWATER RES, V62, P621, DOI 10.1071/MF10135; Schmidt Jennifer V., 2010, Endangered Species Research, V12, P117, DOI 10.3354/esr00300; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; Schwarz CJ, 2009, GENTLE INTRO MARK, P53; Sequeira AMM, 2013, J FISH BIOL, V82, P367, DOI 10.1111/jfb.12017; Silverman B. W., 1986, DENSITY ESTIMATION S, V26; Snell HM, 1996, J BIOGEOGR, V23, P619, DOI 10.1111/j.1365-2699.1996.tb00022.x; Van Tienhoven AM, 2007, J APPL ECOL, V44, P273, DOI 10.1111/j.1365-2664.2006.01273.x; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilson SG, 2006, MAR BIOL, V148, P1157, DOI 10.1007/s00227-005-0153-8; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	53	40	41	4	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115946	10.1371/journal.pone.0115946	http://dx.doi.org/10.1371/journal.pone.0115946			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551553	Green Published, gold, Green Submitted			2022-12-26	WOS:000347119100080
J	Covo, S; Chiou, E; Gordenin, DA; Resnick, MA				Covo, Shay; Chiou, Eric; Gordenin, Dmitry A.; Resnick, Michael A.			Suppression of Allelic Recombination and Aneuploidy by Cohesin Is Independent of Chk1 in Saccharomyces cerevisiae	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; S-PHASE; REPAIR; ECO1; AMPLIFICATION; ESTABLISHMENT; CONDENSATION; CHECKPOINT	Sister chromatid cohesion (SCC), which is established during DNA replication, ensures genome stability. Establishment of SCC is inhibited in G2. However, this inhibition is relived and SCC is established as a response to DNA damage, a process known as Damage Induced Cohesion (DIC). In yeast, Chk1, which is a kinase that functions in DNA damage signal transduction, is considered an activator of SCC through DIC. Nonetheless, here we show that, unlike SCC mutations, loss of CHK1 did not increase spontaneous or damage-induced allelic recombination or aneuploidy. We suggest that Chk1 has a redundant role in the control of DIC or that DIC is redundant for maintaining genome stability.	[Covo, Shay; Chiou, Eric; Gordenin, Dmitry A.; Resnick, Michael A.] NIEHS, Mol Genet Lab, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Covo, S (corresponding author), Hebrew Univ Jerusalem, Dept Plant Pathol & Microbiol, Robert H Smith Fac Agr, IL-76100 Rehovot, Israel.	shay.covo@mail.huji.ac.il	Covo, Shay/GRJ-0608-2022; Dmitry, Gordenin/C-3907-2018; resnick, Michael/F-1668-2019	Dmitry, Gordenin/0000-0002-8399-1836; resnick, Michael/0000-0002-8473-7506	Intramural Research Program of the National Institute of Environmental Health Sciences (NIEHS NIH, DHHS) [1Z01ES065073]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES021016, Z01ES065073] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Environmental Health Sciences (NIEHS NIH, DHHS); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the National Institute of Environmental Health Sciences (NIEHS NIH, DHHS) under project 1Z01ES065073 to MAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Covo S, 2014, GENETICS, V196, P373, DOI 10.1534/genetics.113.159202; Covo S, 2012, CELL CYCLE, V11, P3937, DOI 10.4161/cc.21945; Covo S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001006; Fasullo M, 2008, CELL CYCLE, V7, P2418, DOI 10.4161/cc.6411; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Heidinger-Pauli JM, 2008, MOL CELL, V31, P47, DOI 10.1016/j.molcel.2008.06.005; Heidinger-Pauli JM, 2010, CURR BIOL, V20, P957, DOI 10.1016/j.cub.2010.04.018; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; Lundin C, 2005, NUCLEIC ACIDS RES, V33, P3799, DOI 10.1093/nar/gki681; Narayanan V, 2006, CELL, V125, P1283, DOI 10.1016/j.cell.2006.04.042; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Putnam CD, 2009, DNA REPAIR, V8, P974, DOI 10.1016/j.dnarep.2009.04.021; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Sjogren C, 2010, EXP CELL RES, V316, P1445, DOI 10.1016/j.yexcr.2009.12.018; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Strom L, 2010, CELL CYCLE, V9, P3644, DOI 10.4161/cc.9.18.13182; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Theis JF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001227; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Westmoreland J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000656; Xiong B, 2010, ANNU REV BIOCHEM, V79, P131, DOI 10.1146/annurev-biochem-061708-092640	27	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e113435	10.1371/journal.pone.0113435	http://dx.doi.org/10.1371/journal.pone.0113435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551702	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100006
J	Cruz-Izquierdo, A; Pico, EA; Lopez, C; Serra, JL; Llama, MJ				Cruz-Izquierdo, Alvaro; Pico, Enrique A.; Lopez, Carmen; Serra, Juan L.; Llama, Maria J.			Magnetic Cross-Linked Enzyme Aggregates (mCLEAs) of Candida antarctica Lipase: An Efficient and Stable Biocatalyst for Biodiesel Synthesis	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; ENANTIOSELECTIVE HYDROLYSIS; COVALENT IMMOBILIZATION; POTENTIAL APPLICATIONS; CATALYTIC-PROPERTIES; FE3O4 NANOPARTICLES; STABILIZATION; PERFORMANCE; TRANSESTERIFICATION; OPTIMIZATION	Enzyme-catalyzed production of biodiesel is the object of extensive research due to the global shortage of fossil fuels and increased environmental concerns. Herein we report the preparation and main characteristics of a novel biocatalyst consisting of Cross-Linked Enzyme Aggregates (CLEAs) of Candida antarctica lipase B (CALB) which are covalently bound to magnetic nanoparticles, and tackle its use for the synthesis of biodiesel from non-edible vegetable and waste frying oils. For this purpose, insolubilized CALB was covalently cross-linked to magnetic nanoparticles of magnetite which the surface was functionalized with -NH2 groups. The resulting biocatalyst combines the relevant catalytic properties of CLEAs (as great stability and feasibility for their reutilization) and the magnetic character, and thus the final product (mCLEAs) are superparamagnetic particles of a robust catalyst which is more stable than the free enzyme, easily recoverable from the reaction medium and reusable for new catalytic cycles. We have studied the main properties of this biocatalyst and we have assessed its utility to catalyze transesterification reactions to obtain biodiesel from non-edible vegetable oils including unrefined soybean, jatropha and cameline, as well as waste frying oil. Using 1% mCLEAs (w/w of oil) conversions near 80% were routinely obtained at 30 degrees C after 24 h of reaction, this value rising to 92% after 72 h. Moreover, the magnetic biocatalyst can be easily recovered from the reaction mixture and reused for at least ten consecutive cycles of 24 h without apparent loss of activity. The obtained results suggest that mCLEAs prepared from CALB can become a powerful biocatalyst for application at industrial scale with better performance than those currently available.	[Cruz-Izquierdo, Alvaro; Pico, Enrique A.; Lopez, Carmen; Serra, Juan L.; Llama, Maria J.] Univ Basque Country UPV EHU, Dept Biochem & Mol Biol, Bilbao, Spain; [Lopez, Carmen] Basque Fdn Sci, Ikerbasque, Bilbao, Spain	University of Basque Country; Basque Foundation for Science	Lopez, C (corresponding author), Univ Politecn Madrid, Dept Chem & Food Technol, Madrid, Spain.	carmen.lopez@ehu.es	López, Carmen/K-2934-2017	López, Carmen/0000-0003-1417-3087; Pico, Enrique A./0000-0001-6681-3862; Cruz-Izquierdo, Alvaro/0000-0003-4212-8822	University of the Basque Country (UPV/EHU) [GIU11/25]; Spanish Ministry of Economy and Competitiveness [CTQ2011-25052]; Basque Government [SAIOTEK S-PE12UN041]; Ikerbasque; Basque Foundation for Science; European Union (project Energreen) [POCTEFA EFA217/11]	University of the Basque Country (UPV/EHU); Spanish Ministry of Economy and Competitiveness(Spanish Government); Basque Government(Basque Government); Ikerbasque; Basque Foundation for Science; European Union (project Energreen)	This work was supported by grants from the University of the Basque Country (UPV/EHU, project GIU11/25 and scholarship for AC-I, http://www.ehu.es), the Spanish Ministry of Economy and Competitiveness (project CTQ2011-25052, http://www.mineco.es), the Basque Government (project SAIOTEK S-PE12UN041, http://www.euskadi.net), Ikerbasque, the Basque Foundation for Science (fellowship for CL, www.ikerbasque.net) and European Union (project Energreen, POCTEFA EFA217/11, http://www.poctefa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2012, J PHYS CHEM LETT, V3, P1142, DOI 10.1021/jz201675m; Azocar L, 2010, J BIOSCI BIOENG, V109, P609, DOI 10.1016/j.jbiosc.2009.12.001; Bajaj A, 2010, J MOL CATAL B-ENZYM, V62, P9, DOI 10.1016/j.molcatb.2009.09.018; Bayramoglu G, 2008, BIOCHEM ENG J, V38, P180, DOI 10.1016/j.bej.2007.06.018; Bisen PS, 2010, BIOTECHNOL LETT, V32, P1019, DOI 10.1007/s10529-010-0275-z; Charpe TW, 2011, WASTE MANAGE, V31, P85, DOI 10.1016/j.wasman.2010.09.003; Contesini FJ, 2013, INT J MOL SCI, V14, P1335, DOI 10.3390/ijms14011335; Cruz-Izquierdo A, 2012, NEW BIOTECHNOL, V29, pS100, DOI 10.1016/j.nbt.2012.08.283; del Campo A, 2005, J MAGN MAGN MATER, V293, P33, DOI 10.1016/j.jmmm.2005.01.040; Devi BLAP, 2009, J AM OIL CHEM SOC, V86, P637, DOI 10.1007/s11746-009-1401-8; Dizge N, 2008, BIOMASS BIOENERG, V32, P1274, DOI 10.1016/j.biombioe.2008.03.005; Fernandez-Lorente G, 2007, BIOTECHNOL BIOENG, V97, P242, DOI 10.1002/bit.21230; Fernandez-Lorente G, 2006, BIOMACROMOLECULES, V7, P2610, DOI 10.1021/bm060408+; Gao L, 2004, J IND MICROBIOL BIOT, V31, P525, DOI 10.1007/s10295-004-0182-1; Gupta P, 2009, BIORESOURCE TECHNOL, V100, P4074, DOI 10.1016/j.biortech.2009.03.076; Han JY, 2011, J MICROBIOL BIOTECHN, V21, P1159, DOI 10.4014/jmb.1106.06048; Harris LA, 2003, CHEM MATER, V15, P1367, DOI 10.1021/cm020994n; Holcapek M, 1999, J CHROMATOGR A, V858, P13; Huang SH, 2003, BIOTECHNOL PROGR, V19, P1095, DOI 10.1021/bp025587v; Idris A, 2012, BIOTECHNOL ADV, V30, P550, DOI 10.1016/j.biotechadv.2011.10.002; Iso M, 2001, J MOL CATAL B-ENZYM, V16, P53, DOI 10.1016/S1381-1177(01)00045-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai JQ, 2012, PROCESS BIOCHEM, V47, P2058, DOI 10.1016/j.procbio.2012.07.024; Lee J, 2009, J MATER CHEM, V19, P7864, DOI 10.1039/b909109b; Leung DYC, 2010, APPL ENERG, V87, P1083, DOI 10.1016/j.apenergy.2009.10.006; Liu YY, 2000, J MOL CATAL B-ENZYM, V10, P523, DOI 10.1016/S1381-1177(00)00093-X; Liu ZL, 2002, J MATER SYNTH PROCES, V10, P83, DOI 10.1023/A:1021231527095; Lopez C, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00072; Lopez-Serrano P, 2002, BIOTECHNOL LETT, V24, P1379, DOI 10.1023/A:1019863314646; Maity D, 2007, J MAGN MAGN MATER, V308, P46, DOI 10.1016/j.jmmm.2006.05.001; Mateo C, 2000, BIOMACROMOLECULES, V1, P739, DOI 10.1021/bm000071q; Mendes AA, 2011, J MOL CATAL B-ENZYM, V68, P109, DOI 10.1016/j.molcatb.2010.10.002; Morales MP, 1999, CHEM MATER, V11, P3058, DOI 10.1021/cm991018f; NAKAMURA K, 1984, ANAL BIOCHEM, V142, P406, DOI 10.1016/0003-2697(84)90484-6; Netto CGCM, 2013, J MOL CATAL B-ENZYM, V85-86, P71, DOI 10.1016/j.molcatb.2012.08.010; Netto CGCM, 2009, TETRAHEDRON-ASYMMETR, V20, P2299, DOI 10.1016/j.tetasy.2009.08.022; Ngo TPN, 2013, BIORESOURCE TECHNOL, V145, P233, DOI 10.1016/j.biortech.2012.12.053; Ramirez LP, 2003, MACROMOL CHEM PHYSIC, V204, P22, DOI 10.1002/macp.200290052; Ren YH, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-63; Sahoo Y, 2005, J PHYS CHEM B, V109, P3879, DOI 10.1021/jp045402y; Samukawa T, 2000, J BIOSCI BIOENG, V90, P180, DOI 10.1016/S1389-1723(00)80107-3; Schoevaart R, 2004, BIOTECHNOL BIOENG, V87, P754, DOI 10.1002/bit.20184; Sheldon RA, 2007, BIOCHEM SOC T, V35, P1583, DOI 10.1042/BST0351583; Sheldon RA, 2013, CHEM SOC REV, V42, P6223, DOI 10.1039/c3cs60075k; Sheldon RA, 2011, APPL MICROBIOL BIOT, V92, P467, DOI 10.1007/s00253-011-3554-2; Shen XC, 2004, CHEM LETT, V33, P1468, DOI 10.1246/cl.2004.1468; Sohn OJ, 2008, BIOTECHNOL BIOPROC E, V13, P716, DOI 10.1007/s12257-008-0096-2; Talekar S, 2013, RSC ADV, V3, P12485, DOI 10.1039/c3ra40818c; Talekar S, 2012, BIORESOURCE TECHNOL, V123, P542, DOI 10.1016/j.biortech.2012.07.044; Tudorache M, 2013, RSC ADV, V3, P4052, DOI 10.1039/c3ra23222k; Verma ML, 2013, APPL MICROBIOL BIOT, V97, P23, DOI 10.1007/s00253-012-4535-9; Wang X, 2009, CHEMSUSCHEM, V2, P947, DOI 10.1002/cssc.200900174; Xie WL, 2010, BIOMASS BIOENERG, V34, P890, DOI 10.1016/j.biombioe.2010.01.034; Xie WL, 2009, ENERG FUEL, V23, P1347, DOI 10.1021/ef800648y; Yong Y, 2008, J MAGN MAGN MATER, V320, P2350, DOI 10.1016/j.jmmm.2008.04.158	55	58	59	3	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115202	10.1371/journal.pone.0115202	http://dx.doi.org/10.1371/journal.pone.0115202			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551445	gold, Green Published, Green Submitted			2022-12-26	WOS:000347119100031
J	An, R; Jia, Y; Wan, BH; Zhang, YF; Dong, P; Li, J; Liang, XG				An, Ran; Jia, Yu; Wan, Baihui; Zhang, Yanfang; Dong, Ping; Li, Jing; Liang, Xingguo			Non-Enzymatic Depurination of Nucleic Acids: Factors and Mechanisms	PLOS ONE			English	Article							CATALYZED HYDROLYSIS; DNA DEPURINATION; CHAIN BREAKAGE; NUCLEOSIDES; MUTAGENESIS; MUTATIONS; KINETICS; BOND	Depurination has attracted considerable attention since a long time for it is closely related to the damage and repair of nucleic acids. In the present study, depurination using a pool of 30-nt short DNA pieces with various sequences at diverse pH values was analyzed by High Performance Liquid Chromatography (HPLC). Kinetic analysis results showed that non-enzymatic depurination of oligodeoxynucleotides exhibited typical first-order kinetics, and its temperature dependence obeyed Arrhenius' law very well. Our results also clearly showed that the linear relationship between the logarithms of rate constants and pH values had a salient point around pH 2.5. Interestingly and unexpectedly, depurination depended greatly on the DNA sequences. The depurination of poly (dA) was found to be extremely slow, and thymine rich sequences depurinated faster than other sequences. These results could be explained to some extent by the protonation of nucleotide bases. Moreover, two equations were obtained based on our data for predicting the rate of depurination under various conditions. These results provide basic data for gene mutagenesis and nucleic acids metabolism in acidic gastric juice and some acidic organelles, and may also help to rectify some misconceptions about depurination.	[An, Ran; Jia, Yu; Wan, Baihui; Zhang, Yanfang; Dong, Ping; Li, Jing; Liang, Xingguo] Ocean Univ China, Coll Food Sci & Engn, Qingdao 266003, Peoples R China	Ocean University of China	Liang, XG (corresponding author), Ocean Univ China, Coll Food Sci & Engn, Qingdao 266003, Peoples R China.	liangxg@ouc.edu.cn	jia, yu/HHR-9047-2022		"Fund for Distinguished Young Scholars'' of Shandong province [JQ201204]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1188]; National Youth Qianren Plan	"Fund for Distinguished Young Scholars'' of Shandong province; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Youth Qianren Plan	This work was supported by "Fund for Distinguished Young Scholars'' of Shandong province [JQ201204], Program for Changjiang Scholars and Innovative Research Team in University [IRT1188], and "National Youth Qianren Plan.'' Funding for open access charge: "Fund for Distinguished Young Scholars'' of Shandong province [JQ201204]; http://www.sdnsf.gov.cn/portal/. XL is the author who received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amosova O, 2006, P NATL ACAD SCI USA, V103, P4392, DOI 10.1073/pnas.0508499103; Amosova O, 2011, J BIOL CHEM, V286, P36316, DOI 10.1074/jbc.M111.272047; Baik MH, 2002, J AM CHEM SOC, V124, P4495, DOI 10.1021/ja017588+; Cavalieri EL, 2000, THEOR CHEM ACC, V104, P235, DOI 10.1007/s002140000142; Cavalieri E, 2012, IUBMB LIFE, V64, P169, DOI 10.1002/iub.586; Chakravarti D, 2001, ONCOGENE, V20, P7945, DOI 10.1038/sj.onc.1204969; DEKKER CA, 1960, ANNU REV BIOCHEM, V29, P453, DOI 10.1146/annurev.bi.29.070160.002321; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; FRESCO JR, 2011, SITE SPECIFIC SELF C, P3; GARRETT ER, 1972, J AM CHEM SOC, V94, P8532, DOI 10.1021/ja00779a040; GARRETT ER, 1960, J AM CHEM SOC, V82, P827, DOI 10.1021/ja01489a018; GREER SHELDON, 1962, JOUR MOLECULAR BIOL, V4, P123; Gut IG, 1997, INT J MASS SPECTROM, V169, P313, DOI 10.1016/S0168-1176(97)00208-5; HEVESI L, 1972, J AM CHEM SOC, V94, P4715, DOI 10.1021/ja00768a046; Hotokka M, 1996, J MOL STRUC-THEOCHEM, V363, P191, DOI 10.1016/0166-1280(95)04440-X; LAWLEY PD, 1963, BIOCHEM J, V89, P127, DOI 10.1042/bj0890127; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3618, DOI 10.1021/bi00769a019; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; LYONS JW, 1965, J AM CHEM SOC, V87, P1781, DOI 10.1021/ja01086a030; Neidle S, 2010, PRINCIPLES NUCL ACID; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; OSBORNE M, 1985, CHEM-BIOL INTERACT, V53, P183, DOI 10.1016/S0009-2797(85)80095-8; Rios-Font R, 2007, J PHYS CHEM B, V111, P6071, DOI 10.1021/jp070822j; SCHAAPER RM, 1982, CANCER RES, V42, P3480; SCHAAPER RM, 1981, P NATL ACAD SCI-BIOL, V78, P1773, DOI 10.1073/pnas.78.3.1773; Sherchan J, 2009, B KOREAN CHEM SOC, V30, P2309; SUZUKI T, 1994, NUCLEIC ACIDS RES, V22, P4997, DOI 10.1093/nar/22.23.4997; TAMM C, 1952, J BIOL CHEM, V195, P49; TSUBOI M, 1962, BIOCHIM BIOPHYS ACTA, V55, P1; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; ZOLTEWICZ JA, 1970, J AM CHEM SOC, V92, P1741, DOI 10.1021/ja00709a055	34	61	65	9	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115950	10.1371/journal.pone.0115950	http://dx.doi.org/10.1371/journal.pone.0115950			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546310	Green Submitted, gold, Green Published			2022-12-26	WOS:000347120200084
J	Mariman, R; Tielen, F; Koning, F; Nagelkerken, L				Mariman, Rob; Tielen, Frans; Koning, Frits; Nagelkerken, Lex			The Probiotic Mixture VSL#3 Dampens LPS-Induced Chemokine Expression in Human Dendritic Cells by Inhibition of STAT-1 Phosphorylation	PLOS ONE			English	Article							GENE-EXPRESSION; SIGNAL-TRANSDUCTION; IMMUNE REGULATION; RESPONSES; MACROPHAGES; BACTERIA; RECEPTORS; PATHWAYS; HOMEOSTASIS; ACTIVATION	VSL#3, a mixture of 8 different probiotic bacteria, has successfully been used in the clinic to treat Ulcerative Colitis. We previously identified the modulation of chemokines as a major mechanism in the protective effect of the VSL#3 in a mouse model of colitis. This was supported by in vitro studies that implicated a role for VSL#3 in the suppression of LPS-induced chemokine production by mouse bone marrow-derived dendritic cells (DC). Herein, we validated these findings employing human monocyte-derived DC. Stimulation of human DC with LPS, VSL#3, or a combination of both resulted in their maturation, evident from enhanced expression of activation markers on the cell-surface, as well as the induction of various chemokines and cytokines. Interestingly, a set of LPS-induced chemokines was identified that were suppressed by VSL#3. These included CXCL9, CXCL10, CCL2, CCL7, and CCL8. In silico approaches identified STAT-1 as a dominant regulator of these chemokines, and this was confirmed by demonstrating that LPS-induced phosphorylation of this transcription factor was inhibited by VSL#3. This indicates that VSL#3 may contribute to the control of inflammation by selective suppression of STAT-1 induced chemokines.	[Mariman, Rob; Tielen, Frans; Nagelkerken, Lex] TNO, Dept Metab Hlth Res, Leiden, Netherlands; [Mariman, Rob; Koning, Frits] Leiden Univ, Dept Immunohematol & Bloodtransfus, Ctr Med, Leiden, Netherlands	Netherlands Organization Applied Science Research; Leiden University; Leiden University - Excl LUMC	Mariman, R (corresponding author), TNO, Dept Metab Hlth Res, Leiden, Netherlands.	r.m.mariman@gmail.com; lex.nagelkerken@xs4all.nl		Mariman, Rob/0000-0001-6405-1091; Koning, Frits/0000-0002-4007-5715	Dutch Top Institute Pharma project [D1-101]	Dutch Top Institute Pharma project	This study was performed in the framework of the Dutch Top Institute Pharma project D1-101. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2009, IMMUNOL REV, V227, P5, DOI 10.1111/j.1600-065X.2008.00739.x; Bandow K, 2012, FEBS LETT, V586, P1540, DOI 10.1016/j.febslet.2012.04.018; Boirivant M, 2007, CURR OPIN GASTROEN, V23, P679, DOI 10.1097/MOG.0b013e3282f0cffc; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Chung EY, 2011, J NUTR BIOCHEM, V22, P902, DOI 10.1016/j.jnutbio.2010.07.012; Chung EY, 2010, J PHARMACOL SCI, V112, P405, DOI 10.1254/jphs.09247FP; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Evrard B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018735; Fink LN, 2007, FEMS IMMUNOL MED MIC, V51, P535, DOI 10.1111/j.1574-695X.2007.00333.x; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gomez-Llorente C, 2010, P NUTR SOC, V69, P381, DOI 10.1017/S0029665110001527; Kagan JC, 2012, TRENDS IMMUNOL, V33, P442, DOI 10.1016/j.it.2012.06.005; Kayama H, 2012, INT IMMUNOL; Kelly D, 2012, NUTR REV, V70, pS18, DOI 10.1111/j.1753-4887.2012.00498.x; Latvala S, 2008, WORLD J GASTROENTERO, V14, P5570, DOI 10.3748/wjg.14.5570; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mariman R, 2014, BR J NUTR, P1; Mariman R, 2012, INFLAMM BOWEL DIS, V18, P1424, DOI 10.1002/ibd.22849; Mastrangeli G, 2009, INT ARCH ALLERGY IMM, V150, P133, DOI 10.1159/000218116; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Pamer EG, 2007, NAT IMMUNOL, V8, P1173, DOI 10.1038/ni1526; Powrie F, 2004, ANN NY ACAD SCI, V1029, P132, DOI 10.1196/annals.1309.030; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Siegemund S, 2012, NAT IMMUNOL, V13, P1031, DOI 10.1038/ni.2452; Soler C, 2003, BIOCHEM J, V375, P777, DOI 10.1042/BJ20030260; Staab J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069903; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; van Baarlen P, 2011, P NATL ACAD SCI USA, V108, P4562, DOI 10.1073/pnas.1000079107; Vanderpool C, 2008, INFLAMM BOWEL DIS, V14, P1585, DOI 10.1002/ibd.20525; Verbeek R, 2010, BENEF MICROBES, V1, P109, DOI 10.3920/BM2009.0026	33	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115676	10.1371/journal.pone.0115676	http://dx.doi.org/10.1371/journal.pone.0115676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546330	gold, Green Published, Green Submitted			2022-12-26	WOS:000347120200053
J	Zou, Y; Zhang, L; Rao, S; Zhu, XY; Ye, LL; Chen, WX; Li, XP				Zou, Yuan; Zhang, Lin; Rao, Shen; Zhu, Xiaoyang; Ye, Lanlan; Chen, Weixin; Li, Xueping			The Relationship between the Expression of Ethylene-Related Genes and Papaya Fruit Ripening Disorder Caused by Chilling Injury	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; MOLECULAR CHARACTERIZATION; FREEZING TOLERANCE; STRESS TREATMENTS; COLD-ACCLIMATION; FAMILY GENES; ARABIDOPSIS; TOMATO; BIOSYNTHESIS	Papaya (Carica papaya L.) is sensitive to low temperature and easy to be subjected to chilling injury, which causes fruit ripening disorder. This study aimed to investigate the relationship between the expression of genes related to ethylene and fruit ripening disorder caused by chilling injury. Papaya fruits were firstly stored at 7 degrees C and 12 degrees C for 25 and 30 days, respectively, then treated with exogenous ethylene and followed by ripening at 25 degrees C for 5 days. Chilling injury symptoms such as pulp water soaking were observed in fruit stored at 7 degrees C on 20 days, whereas the coloration and softening were completely blocked after 25 days, Large differences in the changes in the expression levels of twenty two genes involved in ethylene were seen during 7 degrees C-storage with chilling injury. Those genes with altered expression could be divided into three groups: the group of genes that were up-regulated, including ACS1/2/3, EIN2, EIN3s/EIL1, CTR1/2/ 3, and ERF1/3/4; the group of genes that were down-regulated, including ACO3, ETR1, CTR4, EBF2, and ERF2; and the group of genes that were un-regulated, including ACO1/2, ERS, and EBF1. The results also showed that pulp firmness had a significantly positive correlation with the expression of ACS2, ACO1, CTR1/ 4, EIN3a/b, and EBF1/2 in fruit without chilling injury. This positive correlation was changed to negative one in fruit after storage at 7 degrees C for 25 days with chilling injury. The coloring index displayed significantly negative correlations with the expression levels of ACS2, ACO1/2, CTR4, EIN3a/b, ERF3 in fruit without chilling injury, but these correlations were changed into the positive ones in fruit after storage at 7 degrees C for 25 days with chilling injury. All together, these results indicate that these genes may play important roles in the abnormal softening and coloration with chilling injury in papaya.	[Zou, Yuan; Zhang, Lin; Rao, Shen; Zhu, Xiaoyang; Ye, Lanlan; Chen, Weixin; Li, Xueping] South China Agr Univ, Coll Hort, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangdong Prov Key Lab Postharvest Sci & Technol, Guangzhou 510642, Guangdong, Peoples R China	South China Agricultural University	Li, XP (corresponding author), South China Agr Univ, Coll Hort, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangdong Prov Key Lab Postharvest Sci & Technol, Guangzhou 510642, Guangdong, Peoples R China.	lxp88@scau.edu.cn	Rao, Shen/GWV-1445-2022	Rao, Shen/0000-0001-5144-2878	National Natural Science Foundation of China [31372112]; National Key Technology R & D Program of China [2011BAD24B02-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R & D Program of China(National Key Technology R&D Program)	The research work was supported by National Natural Science Foundation of China (31372112), the National Key Technology R & D Program of China (2011BAD24B02-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RFd, 2005, REV BRAS FRUTIC, V27, P17; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Asensi-Fabado MA, 2012, J PLANT PHYSIOL, V169, P360, DOI 10.1016/j.jplph.2011.11.007; Antunes MDC, 2002, SCI HORTIC-AMSTERDAM, V92, P29, DOI 10.1016/S0304-4238(01)00278-3; Begheldo M, 2008, POSTHARVEST BIOL TEC, V48, P84, DOI 10.1016/j.postharvbio.2007.09.023; Binder BM, 2007, PLANT CELL, V19, P509, DOI 10.1105/tpc.106.048140; Blas AL, 2010, PLANT PHYSIOL, V152, P2013, DOI 10.1104/pp.109.152298; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; Chervin C, 2010, VITIS, V49, P129; Choudhury SR, 2008, J PLANT PHYSIOL, V165, P1865, DOI 10.1016/j.jplph.2008.04.012; Concellon A, 2005, FOOD CHEM, V92, P63, DOI 10.1016/j.foodchem.2004.04.048; El-Sharkawy I, 2003, J EXP BOT, V54, P1615, DOI 10.1093/jxb/erg158; El-Sharkawy I, 2009, J EXP BOT, V60, P907, DOI 10.1093/jxb/ern354; Fernandes FAN, 2006, FOOD RES INT, V39, P492, DOI 10.1016/j.foodres.2005.10.004; Ghasernnezhad M, 2008, POSTHARVEST BIOL TEC, V48, P364, DOI 10.1016/j.postharvbio.2007.09.014; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Hamilton AJ, 1990, ANTISENSE GENE INHIB; Hershkovitz V, 2009, J PLANT PHYSIOL, V166, P1855, DOI 10.1016/j.jplph.2009.05.012; Hiraga S, 2009, MOL GENET GENOMICS, V282, P517, DOI 10.1007/s00438-009-0483-1; Hu H- L, 2012, PLANT PHYSL BIOCH; Huang SZ, 2010, PLANT SCI, V178, P251, DOI 10.1016/j.plantsci.2010.01.005; Ireland HS, 2012, POSTHARVEST BIOL TEC, V72, P42, DOI 10.1016/j.postharvbio.2012.05.003; Katz E, 2004, PLANTA, V219, P243, DOI 10.1007/s00425-004-1228-3; Klee HJ, 2002, J EXP BOT, V53, P2057, DOI 10.1093/jxb/erf062; Kondo S, 2005, POSTHARVEST BIOL TEC, V36, P309, DOI 10.1016/j.postharvbio.2005.02.003; Konishi M, 2008, PLANT J, V55, P821, DOI 10.1111/j.1365-313X.2008.03551.x; Li M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058745, 10.1371/journal.pone.0078500, 10.1371/journal.pone.0059582, 10.1371/journal.pone.0079955]; Li X, 2013, PLANT PHYSL BIOCH; Li XP, 2013, PLANT PHYSIOL BIOCH, V70, P81, DOI 10.1016/j.plaphy.2013.05.020; Lin ZF, 2008, PLANT J, V54, P1083, DOI 10.1111/j.1365-313X.2008.03481.x; Lin ZF, 2009, J EXP BOT, V60, P3311, DOI 10.1093/jxb/erp204; Lopez-Gomez R, 2009, TRANSGENIC RES, V18, P89, DOI 10.1007/s11248-008-9197-0; Miller WR, 1999, HORTSCIENCE, V34, P1112, DOI 10.21273/HORTSCI.34.6.1112; Moussatche P, 2004, J BIOL CHEM, V279, P48734, DOI 10.1074/jbc.M403100200; Muller R, 2003, J HORTIC SCI BIOTECH, V78, P10; Nair S, 2003, J FOOD AGRIC ENVIRON, V1, P93; Novillo F, 2007, P NATL ACAD SCI USA, V104, P21002, DOI 10.1073/pnas.0705639105; Pang JH, 2007, POSTHARVEST BIOL TEC, V44, P195, DOI 10.1016/j.postharvbio.2006.12.017; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Savitch LV, 2005, PLANT CELL PHYSIOL, V46, P1525, DOI 10.1093/pcp/pci165; Sharma MK, 2010, MOL GENET GENOMICS, V284, P455, DOI 10.1007/s00438-010-0580-1; Shi YT, 2012, PLANT CELL, V24, P2578, DOI 10.1105/tpc.112.098640; Shibuya K, 2004, PLANT PHYSIOL, V136, P2900, DOI 10.1104/pp.104.046979; Szalai G, 2000, BIOL PLANTARUM, V43, P637, DOI 10.1023/A:1002824721597; Tian MS, 2002, PLANT GROWTH REGUL, V38, P249, DOI 10.1023/A:1021552002676; Tournier B, 2003, FEBS LETT, V550, P149, DOI 10.1016/S0014-5793(03)00757-9; Wang P, 2010, J EXP BOT, V61, P179, DOI 10.1093/jxb/erp302; Wong WS, 2001, PLANT SCI, V161, P969, DOI 10.1016/S0168-9452(01)00505-2; Wu LJ, 2007, PLANTA, V226, P815, DOI 10.1007/s00425-007-0528-9; Xu ZS, 2007, PLANT MOL BIOL, V65, P719, DOI 10.1007/s11103-007-9237-9; Yang XT, 2013, POSTHARVEST BIOL TEC, V78, P55, DOI 10.1016/j.postharvbio.2012.11.012; Yang YW, 2010, J EXP BOT, V61, P697, DOI 10.1093/jxb/erp332; Yin XR, 2010, PLANT PHYSIOL, V153, P1280, DOI 10.1104/pp.110.157081; Yin XR, 2009, POSTHARVEST BIOL TEC, V52, P9, DOI 10.1016/j.postharvbio.2008.09.016; Zhang ZJ, 2010, PLANT MOL BIOL, V73, P241, DOI 10.1007/s11103-010-9609-4; Zhong SL, 2008, J EXP BOT, V59, P965, DOI 10.1093/jxb/ern021; Zhou HW, 2001, J PLANT PHYSIOL, V158, P55, DOI 10.1078/0176-1617-00126; Zhou L, 2010, PLANT GROWTH REGUL, V62, P171, DOI 10.1007/s10725-010-9503-8; Zhu H, 2010, J HORTIC SCI BIOTECH, V85, P283, DOI 10.1080/14620316.2010.11512669; Zhu HL, 2006, J INTEGR PLANT BIOL, V48, P1478, DOI 10.1111/j.1744-7909.2006.00366.x; Zhu X, 2013, EUROPEAN FOOD RES TE, P1; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	63	18	19	7	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116002	10.1371/journal.pone.0116002	http://dx.doi.org/10.1371/journal.pone.0116002			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542021	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900126
J	Lund, J; Troeberg, L; Kjeldal, H; Olsen, OH; Nagase, H; Sorensen, ES; Stennicke, HR; Petersen, HH; Overgaard, MT				Lund, Jacob; Troeberg, Linda; Kjeldal, Henrik; Olsen, Ole H.; Nagase, Hideaki; Sorensen, Esben S.; Stennicke, Henning R.; Petersen, Helle H.; Overgaard, Michael T.			Evidence for Restricted Reactivity of ADAMDEC1 with Protein Substrates and Endogenous Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOLYTIC ACTIVITIES; CRYSTAL-STRUCTURE; CANDIDATE GENES; SNAKE-VENOM; EXPRESSION; METALLOPROTEASE; DECYSIN; ARCHITECTURE; SERRALYSINS; ASTACINS	ADAMDEC1 is a proteolytically active metzincin metalloprotease displaying rare active site architecture with a zinc-binding Asp residue (Asp-362). We previously demonstrated that substitution of Asp- :362 for a His residue, thereby reconstituting the canonical metzincin zinc-binding environment with three His zinc ligands, increases the proteolytic activity. The protease also has an atypically short domain structure with an odd number of Cys residues in the metalloprotease domain. Here, we investigated how these rare structural features in the ADAMDEC1 metalloprotease domain impact the proteolytic activity, the substrate specificity, and the effect of inhibitors. We identified carboxymethylated transferrin (Cm-TO as a new ADANIDEC1 substrate and determined the primary and secondary cleavage sites, which suggests a strong preference for Leu in the P1' position. Cys2, present in humans but only partially conserved within sequenced ADAMDEC1 orthologs, was found to be unpaired, and substitution of Cys392 for a Ser increased the reactivity with alpha(2)-macroglobulin but not with casein or Cm-Tf. Substitution of Asp(362) for His resulted in a general increase in proteolytic activity and a change in substrate specificity was observed with Cm-IT. ADAMDEC1 was inhibited by the small molecule inhibitor batimastat but not by tissue inhibitor of metalloproteases (TIMP)-1, TIMP-2, or the N-terminal inhibitory domain of TIMP-3 (N-1'IMP-3). However, N-TIMP-3 displayed profound inhibitory activity against the D362H variants with a reconstituted consensus metzincin zinc-binding environment. We hypothesize that these unique features of ADAMDEC1 may have evolved to escape from inhibition by endogenous metalloprotease inhibitors.	[Lund, Jacob; Kjeldal, Henrik; Overgaard, Michael T.] Aalborg Univ, Dept Chem & Biosci, DK-9220 Aalborg, Denmark; [Lund, Jacob; Olsen, Ole H.; Stennicke, Henning R.; Petersen, Helle H.] Novo Nordisk AS, Dept Haemophilia Biochem, DK-2760 Malov, Denmark; [Troeberg, Linda; Nagase, Hideaki] Univ Oxford, Kennedy Inst Rheumatol, Oxford OX3 7FY, England; [Sorensen, Esben S.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark	Aalborg University; Novo Nordisk; University of Oxford; Aarhus University	Overgaard, MT (corresponding author), Aalborg Univ, Dept Chem & Biosci, Frederik Bajers Vej 7H, DK-9220 Aalborg, Denmark.	mto@bio.aau.dk	Lund, Jacob/G-9885-2013; Overgaard, Michael Toft/E-1354-2011	Lund, Jacob/0000-0001-8627-7382; Overgaard, Michael Toft/0000-0002-1423-2481; /0000-0003-0939-4651; Sorensen, Esben Skipper/0000-0002-7050-3354	National Institutes of Health, NIAMS [AR40994]; Danish Ministry of Higher Education and Science; Arthritis Research UK Career Development Fellowship Grant [19466]; Centre for Osteoarthritis Pathogenesis Grant [20205]; Obelske Family Foundation; Novo Nordisk Foundation; Carlsberg Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER; Versus Arthritis [19466] Funding Source: researchfish	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Danish Ministry of Higher Education and Science; Arthritis Research UK Career Development Fellowship Grant(Versus Arthritis); Centre for Osteoarthritis Pathogenesis Grant(Versus Arthritis); Obelske Family Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Versus Arthritis(Versus Arthritis)	This work was supported, in whole or in part, by National Institutes of Health, NIAMS, Grant AR40994 (to H.N.).; Supported by the Danish Ministry of Higher Education and Science.; Supported by Arthritis Research UK Career Development Fellowship Grant 19466 and Centre for Osteoarthritis Pathogenesis Grant 20205.; Supported by the Obelske Family Foundation, the Novo Nordisk Foundation, and the Carlsberg Foundation.	Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Bates EEM, 2002, IMMUNOGENETICS, V54, P96, DOI 10.1007/s00251-002-0430-3; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Cerda-Costa N, 2014, PROTEIN SCI, V23, P123, DOI 10.1002/pro.2400; Crouser ED, 2009, AM J RESP CRIT CARE, V179, P929, DOI 10.1164/rccm.200803-490OC; Dommels YEM, 2007, GENES NUTR, V2, P209, DOI 10.1007/s12263-007-0051-4; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fritsche J, 2003, IMMUNOLOGY, V110, P450, DOI 10.1111/j.1365-2567.2003.01754.x; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; GOMISRUTH FX, 1993, EMBO J, V12, P4151, DOI 10.1002/j.1460-2075.1993.tb06099.x; Hall T, 2012, ACTA CRYSTALLOGR F, V68, P616, DOI 10.1107/S1744309112015618; Jacobsen J, 2008, BIOCHEMISTRY-US, V47, P537, DOI 10.1021/bi701629c; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Kurisu G, 2000, J INORG BIOCHEM, V82, P225, DOI 10.1016/S0162-0134(00)00136-7; Liu HL, 2009, J BIOL CHEM, V284, P29077, DOI 10.1074/jbc.M109.014258; Lucchesi W, 2008, J VIROL, V82, P7456, DOI 10.1128/JVI.00223-08; Lund J, 2013, J BIOL CHEM, V288, P21367, DOI 10.1074/jbc.M113.474536; Macartney-Coxson DP, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-187; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McClellan MJ, 2012, J VIROL, V86, P5165, DOI 10.1128/JVI.07161-11; Mueller CGF, 1997, J EXP MED, V186, P655, DOI 10.1084/jem.186.5.655; Mueller CGF, 2001, J IMMUNOL, V167, P5052, DOI 10.4049/jimmunol.167.9.5052; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; NAGASE H, 1995, METHOD ENZYMOL, V248, P449; Papaspyridonos M, 2006, ARTERIOSCL THROM VAS, V26, P1837, DOI 10.1161/01.ATV.0000229695.68416.76; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; STOCKER W, 1995, PROTEIN SCI, V4, P823; Tranchant I, 2014, CHEM BIOL, V21, P408, DOI 10.1016/j.chembiol.2014.01.008; Troeberg L, 2002, BIOCHEMISTRY-US, V41, P15025, DOI 10.1021/bi026454l; Wisniewska M, 2008, J MOL BIOL, V381, P1307, DOI 10.1016/j.jmb.2008.06.088; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Xu JG, 2012, NEUROL RES, V34, P701, DOI 10.1179/1743132812Y.0000000067	37	6	6	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6620	6629		10.1074/jbc.M114.601724	http://dx.doi.org/10.1074/jbc.M114.601724			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25564618	Green Published, hybrid			2022-12-26	WOS:000350732500063
J	Belman, JP; Bian, RR; Habtemichael, EN; Li, DT; Jurczak, MJ; Alcazar-Roman, A; McNally, LJ; Shulman, GI; Bogan, JS				Belman, Jonathan P.; Bian, Rachel R.; Habtemichael, Estifanos N.; Li, Don T.; Jurczak, Michael J.; Alcazar-Roman, Abel; McNally, Leah J.; Shulman, Gerald I.; Bogan, Jonathan S.			Acetylation of TUG Protein Promotes the Accumulation of GLUT4 Glucose Transporters in an Insulin-responsive Intracellular Compartment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; REGULATED AMINOPEPTIDASE; ENERGY-EXPENDITURE; GOLGI PROTEIN; ACYL-COENZYME; TRANSLOCATION; INTERACTS; VESICLES; 3T3-L1; CELLS	Insulin causes the exocytic translocation of GLUT4 glucose transporters to stimulate glucose uptake in fat and muscle. Previous results support a model in which TUG traps GLUT4 in intracellular, insulin-responsive vesicles termed GLUT4 storage vesicles (GSVs). Insulin triggers TUG cleavage to release the GSVs; GLUT4 then recycles through endosomes during ongoing insulin exposure. The TUG C terminus binds a GSV anchoring site comprising Golgin-160 and possibly other proteins. Here, we report that the TUG C terminus is acetylated. The TUG C-terminal peptide bound the Golgin-160-associated protein, ACBD3 (acyl-CoA-binding domain-containing 3), and acetylation reduced binding of TUG to ACBD3 but not to Golgin-160. Mutation of the acetylated residues impaired insulin-responsive GLUT4 trafficking in 3T3-L1 adipocytes. ACBD3 overexpression enhanced the translocation of GSV cargos, GLUT4 and insulin-regulated aminopeptidase (IRAP), and ACBD3 was required for intracellular retention of these cargos in unstimulated cells. Sirtuin 2 (SIRT2), a NAD(+)-dependent deacetylase, bound TUG and deacetylated the TUG peptide. SIRT2 overexpression reduced TUG acetylation and redistributed GLUT4 and IRAP to the plasma membrane in 3T3-L1 adipocytes. Mutation of the acetylated residues in TUG abrogated these effects. In mice, SIRT2 deletion increased TUG acetylation and proteolytic processing. During glucose tolerance tests, glucose disposal was enhanced in SIRT2 knock-out mice, compared with wild type controls, without any effect on insulin concentrations. Together, these data support a model in which TUG acetylation modulates its interaction with Golgi matrix proteins and is regulated by SIRT2. Moreover, acetylation of TUG enhances its function to trap GSVs within unstimulated cells and enhances insulin-stimulated glucose uptake.	[Belman, Jonathan P.; Bian, Rachel R.; Habtemichael, Estifanos N.; Li, Don T.; Jurczak, Michael J.; Alcazar-Roman, Abel; McNally, Leah J.; Shulman, Gerald I.; Bogan, Jonathan S.] Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, New Haven, CT 06520 USA; [Belman, Jonathan P.; Bogan, Jonathan S.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Bogan, JS (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, POB 208020, New Haven, CT 06520 USA.	jonathan.bogan@yale.edu	Bogan, Jonathan S/A-1575-2010; Shulman, Gerald I./P-7176-2019; Li, Don/F-5162-2018	Bogan, Jonathan S/0000-0001-6463-8466; Shulman, Gerald I./0000-0003-1529-5668; Alcazar-Roman, Abel R./0000-0003-1668-1886; Belman, Jonathan/0000-0002-1051-6938; Jurczak, Michael/0000-0002-6335-6915; Li, Don/0000-0001-7547-4022	National Institutes of Health [P30DK45735]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK093198, R01DK092661, T32DK007058, K01DK099402, P30DK045735, U24DK059635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG041383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Brad Rubin, Charisse Orme, Ali Nasiri, Jie Liu, Toren Finkel, Weimin Zhong, Carolyn Machamer, Frederick Alt, Eric Verdin, Thomas Melia, and Fred Gorelick for assistance, reagents, and advice. This work used the Cell Biology Core of the Yale Diabetes Endocrinology Research Center (supported by National Institutes of Health Grant P30DK45735) as well as services provided by the W. M. Keck Foundation Biotechnology Resource Laboratory at Yale University.	Arias EB, 2007, AM J PHYSIOL-ENDOC M, V292, pE1191, DOI 10.1152/ajpendo.00602.2006; Belman JP, 2014, REV ENDOCR METAB DIS, V15, P55, DOI 10.1007/s11154-013-9276-2; Blander G, 2005, J BIOL CHEM, V280, P9780, DOI 10.1074/jbc.M414080200; Bogan JS, 2012, J BIOL CHEM, V287, P23932, DOI 10.1074/jbc.M112.339457; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Camporez JPG, 2013, ENDOCRINOLOGY, V154, P3099, DOI 10.1210/en.2013-1191; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Castorena CM, 2014, DIABETES, V63, P2297, DOI 10.2337/db13-1686; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Cheah JH, 2006, NEURON, V51, P431, DOI 10.1016/j.neuron.2006.07.011; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chen Y.-S., 2012, B NETWORKING COMPUTI, V1, P1, DOI DOI 10.1039/C4CS00300D; Chen Y, 2013, J NEUROSCI, V33, P3582, DOI 10.1523/JNEUROSCI.1497-12.2013; Chen Y, 2012, J CELL BIOL, V198, P545, DOI 10.1083/jcb.201111091; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; de Oliveira RM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00082; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Fan JJ, 2010, PROG LIPID RES, V49, P218, DOI 10.1016/j.plipres.2009.12.003; Friedrichsen M, 2013, MOL CELL ENDOCRINOL, V366, P204, DOI 10.1016/j.mce.2012.06.013; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Goodpaster BH, 2014, DIABETES, V63, P1058, DOI 10.2337/db13-1249; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Greninger AL, 2012, J VIROL, V86, P3605, DOI 10.1128/JVI.06778-11; Guo HL, 2012, CELL RES, V22, P1246, DOI 10.1038/cr.2012.52; Hicks SW, 2005, J BIOL CHEM, V280, P28944, DOI 10.1074/jbc.M504937200; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Hosaka T, 2005, MOL BIOL CELL, V16, P2882, DOI 10.1091/mbc.E05-01-0072; Houtkooper RH, 2012, J CELL BIOL, V199, P205, DOI 10.1083/jcb.201207019; Huang G., 2010, THESIS BOSTON U; Huang GR, 2013, MOL BIOL CELL, V24, P3115, DOI 10.1091/mbc.E12-10-0765; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Johnson ES, 2012, CURR OPIN CELL BIOL, V24, P876, DOI 10.1016/j.ceb.2012.10.002; Kandror KV, 2011, TRAFFIC, V12, P665, DOI 10.1111/j.1600-0854.2011.01175.x; Katagiri H, 2002, MOL ENDOCRINOL, V16, P1049, DOI 10.1210/me.16.5.1049; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Koch-Nolte F, 2011, FEBS LETT, V585, P1651, DOI 10.1016/j.febslet.2011.03.045; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Loffler MG, 2013, J BIOL CHEM, V288, P20135, DOI 10.1074/jbc.M113.458075; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Ma JH, 2014, J BIOL CHEM, V289, P133, DOI [10.1074/jbc.M113.533240, 10.1074/jbc.A113.533240]; Maianu L, 2001, J CLIN ENDOCR METAB, V86, P5450, DOI 10.1210/jc.86.11.5450; Miller WL, 2013, MOL CELL ENDOCRINOL, V379, P62, DOI 10.1016/j.mce.2013.04.014; Muretta JM, 2008, J BIOL CHEM, V283, P311, DOI 10.1074/jbc.M705756200; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Orme CM, 2012, J BIOL CHEM, V287, P6679, DOI 10.1074/jbc.M111.284232; Rafaeloff-Phail R, 2004, J BIOL CHEM, V279, P52934, DOI 10.1074/jbc.M409574200; Ramakrishnan G, 2014, J BIOL CHEM, V289, P6054, DOI 10.1074/jbc.M113.537266; Rubin BR, 2009, VITAM HORM, V80, P155, DOI 10.1016/S0083-6729(08)00607-9; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sanders BD, 2007, MOL CELL, V25, P463, DOI 10.1016/j.molcel.2006.12.022; Sasaki J, 2012, EMBO J, V31, P754, DOI 10.1038/emboj.2011.429; Sbodio JI, 2007, J BIOL CHEM, V282, P29874, DOI 10.1074/jbc.M705794200; Sbodio JI, 2006, J BIOL CHEM, V281, P27924, DOI 10.1074/jbc.M603276200; Sbodio JI, 2013, CELL REP, V4, P890, DOI 10.1016/j.celrep.2013.08.001; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Sohda M, 2001, J BIOL CHEM, V276, P45298, DOI 10.1074/jbc.M108961200; Vassilopoulos S, 2009, SCIENCE, V324, P1192, DOI 10.1126/science.1171529; Wang F, 2009, MOL BIOL CELL, V20, P801, DOI 10.1091/mbc.E08-06-0647; Waters SB, 1997, J BIOL CHEM, V272, P23323, DOI 10.1074/jbc.272.37.23323; Williams D, 2006, MOL BIOL CELL, V17, P5346, DOI 10.1091/mbc.E06-05-0386; Xiong Y, 2012, J CELL BIOL, V198, P155, DOI 10.1083/jcb.201202056; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Xu Z, 2002, J BIOL CHEM, V277, P47972, DOI 10.1074/jbc.C200486200; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yeh TYJ, 2007, BIOCHEM J, V402, P279, DOI 10.1042/BJ20060793; Yeh TYJ, 2009, DIABETES, V58, P2476, DOI 10.2337/db08-1781; Yu CF, 2007, J BIOL CHEM, V282, P7710, DOI 10.1074/jbc.M610824200; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zhou Y, 2007, CELL, V129, P163, DOI 10.1016/j.cell.2007.02.037	78	41	43	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4447	4463		10.1074/jbc.M114.603977	http://dx.doi.org/10.1074/jbc.M114.603977			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25561724	hybrid, Green Published			2022-12-26	WOS:000349458400051
J	Li, Y; Li, Y; Meng, L; Zheng, LS				Li, Ying; Li, Yue; Meng, Lu; Zheng, LianShun			Association between Serum C-Peptide as a Risk Factor for Cardiovascular Disease and High-Density Lipoprotein Cholesterol Levels in Nondiabetic Individuals	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; INSULIN-RESISTANCE; METABOLIC SYNDROME; NEUROPATHY; CORONARY; CHEMOTAXIS; ADULTS; HEART	Objective: Objective: Although serum C-peptide has increasingly received attention as a new and important risk factor for cardiovascular disease (CVD), the potential mechanisms remain unclear. This study aimed to investigate the association between serum C-peptide as a risk factor for CVD and high-density lipoprotein cholesterol (HDL-C) levels. Methods: The present study included 13,185 participants aged >= 20 years. Serum C-peptide and HDL-C levels were measured according to a standard protocol. Stratified analysis of covariance was used to compare serum HDL-C levels between different quartiles of serum C-peptide levels. Logistic regression analysis was used to determine the association between serum C-peptide and HDL-C levels. Cox proportional hazard regression analysis was conducted to determine the hazard ratio of serum HDL-C for CVD-related mortality. Results: The results of the ANCOVA analysis showed a significant linear trend between the mean serum HDL-C level and the different quartiles of serum C-peptide. Compared to the first quartile (25th percentile), the second, third, and fourth quartiles had gradual reduction in serum HDL-C levels. Logistic regression analyses showed a strong negative association between serum C-peptide levels and HDL-C levels; the p value for the linear trend was <0.001. In men, compared with the lowest quartile of the serum C-peptide level, the relative risk was 1.75, 2.79, and 3.07 for the upper three quartiles of the serum C-peptide level. The relative risk was 1.60, 2.61, and 3.67 for women. The results of the survival analysis showed that serum HDL-C levels were negatively associated with CVD-related death in both men and women. Conclusion: Serum C-peptide as a risk factor for CVD was significantly and negatively associated with serum HDL-C levels in individuals without diabetes. These findings suggest that serum C-peptide levels association with CVD death can be caused, at least in part, by the low serum HDL-C level.	[Li, Ying; Meng, Lu] Zhejiang Univ, Sch Publ Hlth, Dept Social Med, Hangzhou, Zhejiang, Peoples R China; [Li, Yue; Zheng, LianShun] Zhejiang Univ, Sch Basic Med Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Li, Y (corresponding author), Zhejiang Univ, Sch Publ Hlth, Dept Social Med, Hangzhou, Zhejiang, Peoples R China.	ying_li@zju.edu.cn; zhenglianshun@zju.edu.cn			National Science Foundation of China (NSFC) [61375049]; Zhejiang Provincial Natural Science Foundation of China [Y14H260013]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported in part by National Science Foundation of China (NSFC 61375049), and in part by Zhejiang Provincial Natural Science Foundation of China (Y14H260013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, LAB PROCEDURES USED; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; *CDCP, 1994, VITAL HLTH STAT, V1; Chan WB, 2004, DIABETIC MED, V21, P349, DOI 10.1111/j.1464-5491.2004.01158.x; Chen CH, 1999, INT J CARDIOL, V68, P179, DOI 10.1016/S0167-5273(98)00366-0; Cotter MA, 2003, DIABETES, V52, P1812, DOI 10.2337/diabetes.52.7.1812; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Ekberg K, 2007, DIABETES CARE, V30, P71, DOI 10.2337/dc06-1274; Everson-Rose SA, 2005, ANNU REV PUBL HEALTH, V26, P469, DOI 10.1146/annurev.publhealth.26.021304.144542; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Genest J, 2008, J AM COLL CARDIOL, V51, P643, DOI 10.1016/j.jacc.2007.10.033; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Higashi Y, 2002, NEW ENGL J MED, V346, P1954, DOI 10.1056/NEJMoa013591; Johansson BL, 2000, DIABETIC MED, V17, P181, DOI 10.1046/j.1464-5491.2000.00274.x; Kamiya H, 2006, DIABETES, V55, P3581, DOI 10.2337/db06-0396; Li Y, 2014, J STROKE CEREBROVASC, V23, pE163, DOI 10.1016/j.jstrokecerebrovasdis.2013.09.013; Manolio T A, 1992, Ann Epidemiol, V2, P161, DOI 10.1016/1047-2797(92)90051-Q; Marx N, 2004, ARTERIOSCL THROM VAS, V24, P540, DOI 10.1161/01.ATV.0000116027.81513.68; Min JY, 2013, CAN MED ASSOC J, V185, pE402, DOI 10.1503/cmaj.121950; Patel N, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003152; Ramahi TM, 2010, ASIA-PAC J PUBLIC HE, V22, p83S, DOI 10.1177/1010539510373034; Reaven G, 2005, PANMINERVA MED, V47, P201; Reaven GM, 2011, MED CLIN N AM, V95, P875, DOI 10.1016/j.mcna.2011.06.002; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Shlipak MG, 2008, AM J MED, V121, P50, DOI 10.1016/j.amjmed.2007.06.030; STAMLER J, 1993, CARDIOLOGY, V82, P191, DOI 10.1159/000175868; Stevens MJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE497, DOI 10.1152/ajpendo.00048.2004; TOFFOLO G, 1995, DIABETES, V44, P845, DOI 10.2337/diabetes.44.7.845; Wahren J, 2007, DIABETOLOGIA, V50, P503, DOI 10.1007/s00125-006-0559-y; Walcher D, 2004, DIABETES, V53, P1664, DOI 10.2337/diabetes.53.7.1664; Wallerath T, 2003, NITRIC OXIDE-BIOL CH, V9, P95, DOI 10.1016/j.niox.2003.08.004; Williams RB, 2008, ANNU REV CLIN PSYCHO, V4, P349, DOI 10.1146/annurev.clinpsy.4.022007.141237; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	35	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e112281	10.1371/journal.pone.0112281	http://dx.doi.org/10.1371/journal.pone.0112281			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559358	Green Submitted, Green Published, gold			2022-12-26	WOS:000348102200004
J	Chen, YH; Robinson, EJH				Chen, Yi-Huei; Robinson, Elva J. H.			The Relationship between Canopy Cover and Colony Size of the Wood Ant Formica lugubris - Implications for the Thermal Effects on a Keystone Ant Species	PLOS ONE			English	Article							HYMENOPTERA-FORMICIDAE; FIRE ANT; FORAGING BEHAVIOR; POGONOMYRMEX-BADIUS; SOLENOPSIS-INVICTA; HARVESTER ANT; NEST MOUNDS; BODY-SIZE; CLIMATE; TEMPERATURE	Climate change may affect ecosystems and biodiversity through the impacts of rising temperature on species' body size. In terms of physiology and genetics, the colony is the unit of selection for ants so colony size can be considered the body size of a colony. For polydomous ant species, a colony is spread across several nests. This study aims to clarify how climate change may influence an ecologically significant ant species group by investigating thermal effects on wood ant colony size. The strong link between canopy cover and the local temperatures of wood ant's nesting location provides a feasible approach for our study. Our results showed that nests were larger in shadier areas where the thermal environment was colder and more stable compared to open areas. Colonies (sum of nests in a polydomous colony) also tended to be larger in shadier areas than in open areas. In addition to temperature, our results supported that food resource availability may be an additional factor mediating the relationship between canopy cover and nest size. The effects of canopy cover on total colony size may act at the nest level because of the positive relationship between total colony size and mean nest size, rather than at the colony level due to lack of link between canopy cover and number of nests per colony. Causal relationships between the environment and the life-history characteristics may suggest possible future impacts of climate change on these species.	[Chen, Yi-Huei; Robinson, Elva J. H.] Univ York, Dept Biol, York Ctr Complex Syst Anal, York YO10 5DD, N Yorkshire, England	University of York - UK	Chen, YH (corresponding author), Univ York, Dept Biol, York Ctr Complex Syst Anal, Wentworth Way, York YO10 5DD, N Yorkshire, England.	dennisyhchen@gmail.com	Robinson, Elva J H/AAC-9785-2019	Robinson, Elva/0000-0003-4914-9327	Studying Abroad Scholarship, Ministry of Education, Taiwan [SAS-100-1-16-1-UK-042]; Department of Biology at the University of York	Studying Abroad Scholarship, Ministry of Education, Taiwan; Department of Biology at the University of York	Funding was provided by the Studying Abroad Scholarship, Ministry of Education, Taiwan (SAS-100-1-16-1-UK-042) to YHC. Publication of this article was funded by the Department of Biology at the University of York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACIA, 2004, IMPACTS WARMING ARCT; Andrew NR, 2013, J INSECT PHYSIOL, V59, P870, DOI 10.1016/j.jinsphys.2013.06.003; Asano E, 2012, J THEOR BIOL, V305, P70, DOI 10.1016/j.jtbi.2012.03.011; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Bernasconi C, 2005, ANN ZOOL FENN, V42, P189; Bernasconi C, 2011, MYRMECOL NEWS, V14, P37; Bertelsmeier C, 2013, CONSERV BIOL, V27, P1458, DOI 10.1111/cobi.12093; Bertelsmeier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075438; Blanckenhorn WU, 2004, INTEGR COMP BIOL, V44, P413, DOI 10.1093/icb/44.6.413; BRANDT DC, 1980, NETH J ZOOL, V30, P326, DOI 10.1163/002829679X00449; Brown J. H., 1998, BIOGEOGRAPHY; Chen YH, 2013, INSECT SOC, V60, P351, DOI 10.1007/s00040-013-0300-z; Chen YH, 2008, INTEGR ZOOL, V3, P166, DOI 10.1111/j.1749-4877.2008.00095.x; COENENSTASS D, 1980, ECOLOGY, V61, P238, DOI 10.2307/1935180; Cotti G., 1996, Insect Social Life, V1, P133; Debout G, 2007, BIOL J LINN SOC, V90, P319, DOI 10.1111/j.1095-8312.2007.00728.x; Diamond SE, 2013, INTEGR COMP BIOL, V53, P965, DOI 10.1093/icb/ict085; Diamond SE, 2012, GLOBAL CHANGE BIOL, V18, P448, DOI 10.1111/j.1365-2486.2011.02542.x; Domisch T, 2008, BIOL FERT SOILS, V44, P539, DOI 10.1007/s00374-007-0248-0; ECKERT CD, 1994, OECOLOGIA, V97, P248, DOI 10.1007/BF00323157; Eeva T, 2004, ENVIRON POLLUT, V132, P533, DOI 10.1016/j.envpol.2004.05.004; Ellis S, 2014, INSECT SOC, V61, P111, DOI 10.1007/s00040-013-0337-z; Ellis S, 2014, BEHAV ECOL, V25, P1183, DOI 10.1093/beheco/aru108; Ellison AM, 2012, MYRMECOL NEWS, V17, P105; Forero-Medina G, 2011, CONSERV BIOL, V25, P163, DOI 10.1111/j.1523-1739.2010.01572.x; Frazer G.W., 1999, GAP LIGHT ANAL GLA V, P36; Frouz J, 2000, INSECT SOC, V47, P229, DOI 10.1007/PL00001708; Frouz J, 2007, INSECT SOC, V54, P251, DOI 10.1007/s00040-007-0939-4; Geiger R., 2009, CLIMATE NEAR GROUND; GORDON DM, 1992, ECOL ENTOMOL, V17, P114, DOI 10.1111/j.1365-2311.1992.tb01167.x; HAEMIG PD, 1992, OIKOS, V65, P479, DOI 10.2307/3545565; Herbers JM, 1996, ANIM BEHAV, V51, P141, DOI 10.1006/anbe.1996.0012; Huang SP, 2014, OECOLOGIA, V175, P25, DOI 10.1007/s00442-014-2882-1; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Hunt G, 2006, P NATL ACAD SCI USA, V103, P1347, DOI 10.1073/pnas.0510550103; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jurgensen MF, 2008, J APPL ENTOMOL, V132, P266, DOI 10.1111/j.1439-0418.2008.01280.x; KASPARI M, 1995, AM NAT, V145, P610, DOI 10.1086/285758; Kilpelainen J, 2005, ANN ZOOL FENN, V42, P243; Laakso J, 1997, OECOLOGIA, V111, P565, DOI 10.1007/s004420050272; Laakso J, 1998, OIKOS, V81, P266, DOI 10.2307/3547047; Maeder A, 2005, ANN ZOOL FENN, V42, P201; Morrison LW, 2005, DIVERS DISTRIB, V11, P199, DOI 10.1111/j.1366-9516.2005.00142.x; ODONNELL S, 1992, INSECT SOC, V39, P73, DOI 10.1007/BF01240532; Palmer TM, 2004, ANIM BEHAV, V68, P993, DOI 10.1016/j.anbehav.2004.02.005; PAMILO P, 1992, INSECT SOC, V39, P15, DOI 10.1007/BF01240528; Parmesan C, 1996, NATURE, V382, P765, DOI 10.1038/382765a0; Pelini SL, 2012, ECOL EVOL, V2, P3009, DOI 10.1002/ece3.407; PORTER SD, 1993, BEHAV ECOL SOCIOBIOL, V32, P321, DOI 10.1007/BF00183787; PUNTTILA P, 1994, ANN ZOOL FENN, V31, P131; Punttila P, 1996, OIKOS, V75, P291, DOI 10.2307/3546252; Punttila P, 2004, ANN ZOOL FENN, V41, P429; Punttila P, 2009, ANN ZOOL FENN, V46, P1, DOI 10.5735/086.046.0101; Robinson N.A., 2013, British Journal of Entomology and Natural History, V26, P67; Rodriguez-Garcia E, 2011, ANN FOREST SCI, V68, P337, DOI 10.1007/s13595-011-0039-5; Rolstad J, 2000, OECOLOGIA, V124, P116, DOI 10.1007/s004420050031; ROSENGREN R, 1991, ANT - PLANT INTERACTIONS, P80; ROSENGREN R, 1987, ANN ZOOL FENN, V24, P147; Roura-Pascual N, 2004, P ROY SOC B-BIOL SCI, V271, P2527, DOI 10.1098/rspb.2004.2898; SAVOLAINEN R, 1988, OIKOS, V51, P135, DOI 10.2307/3565636; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; SMITH R. L., 2003, ELEMENTS ECOLOGY; Sorvari J, 2005, ANN ZOOL FENN, V42, P259; Stuble KL, 2013, ECOL EVOL, V3, P482, DOI 10.1002/ece3.473; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; SUDD JH, 1981, BIOL CONSERV, V20, P133, DOI 10.1016/0006-3207(81)90024-0; SUDD JH, 1977, ECOL ENTOMOL, V2, P301, DOI 10.1111/j.1365-2311.1977.tb00895.x; Suggitt AJ, 2011, OIKOS, V120, P1, DOI 10.1111/j.1600-0706.2010.18270.x; TSCHINKEL WR, 1993, ECOL MONOGR, V63, P425, DOI 10.2307/2937154; Tschinkel WR, 1998, INSECT SOC, V45, P385, DOI 10.1007/s000400050097; Tschinkel WR, 1999, ECOL ENTOMOL, V24, P222, DOI 10.1046/j.1365-2311.1999.00184.x; van Gils HAJA, 2012, FLA ENTOMOL, V95, P914, DOI 10.1653/024.095.0414; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	73	20	20	4	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116113	10.1371/journal.pone.0116113	http://dx.doi.org/10.1371/journal.pone.0116113			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551636	Green Published, gold, Green Accepted			2022-12-26	WOS:000347119100095
J	Choi, JW; Cho, HJ; Park, JH; Baek, SY; Chung, JW; Kim, DD; Kim, HC				Choi, Jin Woo; Cho, Hyun-Jong; Park, Ju-Hwan; Baek, Song Yi; Chung, Jin Wook; Kim, Dae-Duk; Kim, Hyo-Cheol			Comparison of Drug Release and Pharmacokinetics after Transarterial Chemoembolization Using Diverse Lipiodol Emulsions and Drug-Eluting Beads	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; DELIVERY SYSTEM; IN-VITRO; DC BEAD; TOXICITY; CANCER; LIVER; MODEL; TACE	In many studies for chemoembolization of hepatocellular carcinoma, the Lipiodol emulsion preparation protocols, especially the mixing steps, were unclear or even unrevealed at all. However, doxorubicin (DOX) release may depend on the composition and volume ratio (Lipiodol to DOX solution) of a Lipiodol emulsion. Therefore, we conducted a preclinical study to compare in-vitro drug release and in-vivo pharmacokinetics of DOX from diverse Lipiodol emulsions and drug-eluting beads (DEBs) and to compare the tumor response in a rabbit VX2 carcinoma model. DOX release profiles of four types of Lipiodol emulsions with different media (normal saline or Pamiray as an iodinated contrast medium), volume ratio (Lipiodol to DOX solution), and DEBs were investigated in-vitro. For the in-vivo study, 15 rabbits bearing VX2 carcinoma in the liver were treated with 4:1 volume ratio Lipiodol emulsion (group A), 1:1 volume ratio Lipiodol emulsion (group B), and DEBs (group C) chemoembolization. Blood and tissue sampling was conducted to evaluate DOX concentration in plasma and tissues, histological changes, and liver toxicity. The most stable emulsion was formed with Pamiray (including DOX) at a 4:1 volume ratio. The AUC value of group A was significantly lower than that of group B (p=0.003) but comparable to that of group C (p=0.071). The C-max value of group A was significantly different compared with those of group B (p=0.004) and C (p=0.015). The tissue drug concentration in group A was comparable to that in group C (p=0.251). No viable tumor was detected in rabbits of group A and B. In group C, viable tumor less than 10% was seen in two of the five rabbits. There were no significant differences in liver enzyme levels after the procedure. In conclusion, DOX release and pharmacokinetics of presented emulsion systems depend substantially on their composition. Therefore, Lipiodol emulsion type should be considered when interpreting data and designing new studies dealing with chemoembolization.	[Choi, Jin Woo; Baek, Song Yi; Chung, Jin Wook; Kim, Hyo-Cheol] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Cho, Hyun-Jong] Kangwon Natl Univ, Coll Pharm, Chunchon, South Korea; [Park, Ju-Hwan; Kim, Dae-Duk] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Park, Ju-Hwan; Kim, Dae-Duk] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Kangwon National University; Seoul National University (SNU); Seoul National University (SNU)	Kim, DD (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul, South Korea.	ddkim@snu.ac.kr; angiointervention@gmail.com	Kim, Dae Duk/D-8864-2013	Chung, Jin Wook/0000-0002-1090-6872; Kim, Hyo-Cheol/0000-0002-6016-247X; Cho, Hyun-Jong/0000-0002-5070-9371	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013R1A1A2A10011007]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2013R1A1A2A10011007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Buijs M, 2008, RADIOLOGY, V249, P346, DOI 10.1148/radiol.2483071902; Chung GE, 2011, RADIOLOGY, V258, P627, DOI 10.1148/radiol.10101058; Chung JW, 1996, RADIOLOGY, V198, P33, DOI 10.1148/radiology.198.1.8539401; CHUNG JW, 1993, RADIOLOGY, V187, P689, DOI 10.1148/radiology.187.3.8388567; deBaere T, 1996, RADIOLOGY, V201, P731, DOI 10.1148/radiology.201.3.8939223; Dhanasekaran R, 2010, J SURG ONCOL, V101, P476, DOI 10.1002/jso.21522; HERESBACH D, 1989, GASTROEN CLIN BIOL, V13, P775; Hong K, 2006, CLIN CANCER RES, V12, P2563, DOI 10.1158/1078-0432.CCR-05-2225; Idee JM, 2013, CRIT REV ONCOL HEMAT, V88, P530, DOI 10.1016/j.critrevonc.2013.07.003; JOHNSON PJ, 1991, J HEPATOL, V13, P120, DOI 10.1016/0168-8278(91)90873-A; Kan ZX, 1997, ACAD RADIOL, V4, P275, DOI 10.1016/S1076-6332(97)80029-3; Kim HC, 2013, J VASC INTERV RADIOL, V24, P274, DOI 10.1016/j.jvir.2012.11.002; KONNO T, 1983, EUR J CANCER CLIN ON, V19, P1053, DOI 10.1016/0277-5379(83)90028-7; Lammer J, 2010, CARDIOVASC INTER RAD, V33, P41, DOI 10.1007/s00270-009-9711-7; Larson AC, 2008, RADIOLOGY, V246, P964, DOI 10.1148/radiol.2463070725; Lencioni R, 2012, CARDIOVASC INTER RAD, V35, P980, DOI 10.1007/s00270-011-0287-7; LEUNG WT, 1992, CANCER CHEMOTH PHARM, V29, P401, DOI 10.1007/BF00686011; Lewis AL, 2006, J VASC INTERV RADIOL, V17, P335, DOI 10.1097/01.RVI.0000195323.46152.B3; Lewis AL, 2006, J VASC INTERV RADIOL, V17, P1335, DOI 10.1097/01.RVI.0000228416.21560.7F; Malagari K, 2008, EXPERT REV ANTICANC, V8, P1643, DOI 10.1586/14737140.8.10.1643; Osuga K, 2012, INT J CLIN ONCOL, V17, P306, DOI 10.1007/s10147-012-0445-1; Park JH, 2014, J CONTROL RELEASE, V174, P98, DOI 10.1016/j.jconrel.2013.11.016; Sakaguchi H, 1991, Gan To Kagaku Ryoho, V18, P1349; Shin SW, 2009, KOREAN J RADIOL, V10, P425, DOI 10.3348/kjr.2009.10.5.425; Song MJ, 2012, J HEPATOL, V57, P1244, DOI 10.1016/j.jhep.2012.07.017; Varela M, 2007, J HEPATOL, V46, P474, DOI 10.1016/j.jhep.2006.10.020; Vogl TJ, 2011, AM J ROENTGENOL, V197, pW562, DOI 10.2214/AJR.10.4379	28	36	37	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115898	10.1371/journal.pone.0115898	http://dx.doi.org/10.1371/journal.pone.0115898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551760	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100075
J	Jiang, YL; Zhang, SH; Feng, SS; Sun, JS; Xu, P				Jiang, Yanliang; Zhang, Songhao; Feng, Shuaisheng; Sun, Jinsheng; Xu, Peng			Genome Wide Identification, Phylogeny and Expression of Zinc Transporter Genes in Common Carp	PLOS ONE			English	Article							MAMMALIAN ZINC; SLC30 FAMILY; DIETARY ZINC; FUNCTIONAL-CHARACTERIZATION; GROWTH-HORMONE; DUPLICATION; MICE; ZIP1; ZNT7	Background: Zinc is an essential trace element in organisms, which serves as a cofactor for hundreds of enzymes that are involved in many pivotal biological processes including growth, development, reproduction and immunity. Therefore, the homeostasis of zinc in the cell is fundamental. The zinc transporter gene family is a large gene family that encodes proteins which regulate the movement of zinc across cellular and intracellular membranes. However, studies on teleost zinc transporters are mainly limited to model species. Methodology/Principal Findings: We identified a set of 37 zinc transporters in common carp genome, including 17 from SLC30 family (ZnT), and 20 from SLC39 family (ZIP). Phylogenetic and syntenic analysis revealed that most of the zinc transporters are highly conserved, though recent gene duplication and gene losses do exist. Through examining the copy number of zinc transporter genes across several vertebrate genomes, thirteen zinc transporters in common carp are found to have undergone the gene duplications, including SLC30A1, SLC30A2, SLC30A5, SLC30A7, SLC30A9, SLC30A10, SLC39A1, SLC39A3, SLC39A4, SLC39A5, SLC39A6, SLC39A7 and SLC39A9. The expression patterns of all zinc transporters were established in various tissues, including blood, brain, gill, heart, intestine, liver, muscle, skin, spleen and kidney, and showed that most of the zinc transporters were ubiquitously expressed, indicating the critical role of zinc transporters in common carp. Conclusions: To some extent, examination of gene families with detailed phylogenetic or orthology analysis could verify the authenticity and accuracy of assembly and annotation of the recently published common carp whole genome sequences. The gene families are also considered as a unique source for evolutionary studies. Moreover, the whole set of common carp zinc transporters provides an important genomic resource for future biochemical, toxicological and physiological studies of zinc in teleost.	[Jiang, Yanliang; Zhang, Songhao; Feng, Shuaisheng; Xu, Peng] Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, CAFS Key Lab Aquat Genom, Beijing 100141, Peoples R China; [Jiang, Yanliang; Zhang, Songhao; Feng, Shuaisheng; Xu, Peng] Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing Key Lab Fishery Biotechnol, Beijing 100141, Peoples R China; [Zhang, Songhao; Sun, Jinsheng] Tianjin Normal Univ, Coll Life Sci, Tianjin 300387, Peoples R China	Chinese Academy of Fishery Sciences; Chinese Academy of Fishery Sciences; Tianjin Normal University	Xu, P (corresponding author), Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, CAFS Key Lab Aquat Genom, Beijing 100141, Peoples R China.	xupeng@cafs.ac.cn	Xu, Peng/J-4018-2012	Xu, Peng/0000-0002-1531-5078	National High-Technology Research and Development Program of China (863 program) [2011AA100401]; Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences [2014C011, 2013C010]	National High-Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences	This project was supported by the National High-Technology Research and Development Program of China (863 program; 2011AA100401) and Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences (2014C011 and 2013C010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews GK, 2004, GENESIS, V40, P74, DOI 10.1002/gene.20067; Aydemir TB, 2009, J LEUKOCYTE BIOL, V86, P337, DOI 10.1189/jlb.1208759; Chai FG, 1999, IMMUNOL CELL BIOL, V77, P272, DOI 10.1046/j.1440-1711.1999.00825.x; Christoffels A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S2; Cousins RJ, 2010, INT J VITAM NUTR RES, V80, P243, DOI 10.1024/0300-9831/a000030; David L, 2003, MOL BIOL EVOL, V20, P1425, DOI 10.1093/molbev/msg173; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dufner-Beattie J, 2004, J BIOL CHEM, V279, P49082, DOI 10.1074/jbc.M409962200; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; Feeney GP, 2005, BBA-GENE STRUCT EXPR, V1732, P88, DOI 10.1016/j.bbaexp.2005.12.002; FOSMIRE GJ, 1990, AM J CLIN NUTR, V51, P225, DOI 10.1093/ajcn/51.2.225; Fraker PJ, 2000, J NUTR, V130, p1399S, DOI 10.1093/jn/130.5.1399S; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; Geiser J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082149; Glasauer SM, 2014, MOL GENET GENOMICS, P1; Hambidge M, 2000, J NUTR, V130, p1344S, DOI 10.1093/jn/130.5.1344S; Haney CJ, 2005, J IND MICROBIOL BIOT, V32, P215, DOI 10.1007/s10295-005-0224-3; Hojyo S, 2014, P NATL ACAD SCI USA, V111, P11786, DOI 10.1073/pnas.1323557111; HOLLAND PWH, 1994, DEVELOPMENT, P125; Huang L, 2007, J BIOL CHEM, V282, P37053, DOI 10.1074/jbc.M706631200; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; Huang LP, 2002, J BIOL CHEM, V277, P26389, DOI 10.1074/jbc.M200462200; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; Inoue K, 2002, HUM MOL GENET, V11, P1775, DOI 10.1093/hmg/11.15.1775; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Jiang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108200; Kelleher SL, 2005, AM J PHYSIOL-CELL PH, V288, pC1042, DOI 10.1152/ajpcell.00471.2004; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Liu SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063895; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Liuzzi JP, 2001, J NUTR, V131, P46, DOI 10.1093/jn/131.1.46; Lopez V, 2009, BIOCHEM J, V422, P43, DOI 10.1042/BJ20081189; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Miletta MC, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/259189; Miyai T, 2014, P NATL ACAD SCI USA, V111, P11780, DOI 10.1073/pnas.1323549111; Ohno S., 1970, EVOLUTION GENE DUPLI; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Petkovic V, 2014, HORM RES PAEDIAT, V82, P245, DOI 10.1159/000365924; PILETZ JE, 1978, AM J CLIN NUTR, V31, P560, DOI 10.1093/ajcn/31.4.560; Pocanschi CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072446; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Seve M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-32; Sun P, 2013, BIOL TRACE ELEM RES, V155, P11, DOI 10.1007/s12011-013-9764-y; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wang JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-96; Xu J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-307; Xu P., 2014, NAT GENET; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-537; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-188; Yan G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042939; Yu YY, 2007, J HISTOCHEM CYTOCHEM, V55, P223, DOI 10.1369/jhc.6A7032.2006; Zhang X, 2012, MAR BIOTECHNOL NY, V15, P275; Zhao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063928; Zheng DL, 2008, PHYSIOL GENOMICS, V34, P205, DOI 10.1152/physiolgenomics.90206.2008	58	17	18	8	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116043	10.1371/journal.pone.0116043	http://dx.doi.org/10.1371/journal.pone.0116043			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551462	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100093
J	Johansson, G; Peng, PC; Huang, PY; Chien, HF; Hua, KT; Kuo, ML; Chen, CT; Lee, MJ				Johansson, Gunnar; Peng, Po-Chun; Huang, Po-Yuan; Chien, Hsiung-Fei; Hua, Kuo-Tai; Kuo, Min-Liang; Chen, Chin-Tin; Lee, Ming-Jen			Soluble AXL: A Possible Circulating Biomarker for Neurofibromatosis Type 1 Related Tumor Burden	PLOS ONE			English	Article							NERVE SHEATH TUMORS; RECEPTOR TYROSINE KINASE; GROWTH-FACTOR; SCHWANN-CELLS; PHOTODYNAMIC INACTIVATION; OVARIAN-CANCER; IN-VITRO; EXPRESSION; INVASION; GAS6	Neurofibromatosis type 1 (NF1) is the most common tumor predisposition disorder affecting 1/3500 worldwide. Patients are at risk of developing benign (neurofibromas) and malignant peripheral nerve sheath tumors (MPNST). The AXL receptor tyrosine kinase has been implicated in several kinds of cancers, but so far no studies have investigated the role of AXL in NF1 related tumorigenesis. Recently, the soluble fraction from the extracellular domain of AXL (sAXL) has been found in human plasma, and its level was correlated to poor prognosis in patients with renal cancer. Compared to normal human Schwann cells, a significantly high expression level of AXL was found in three of the four MPNST cell lines and two of the three primary MPNST tissues. Similarly, the level of sAXL in conditioned media corresponded to the protein and mRNA levels of AXL in the MPNST cell lines. Furthermore, in two different human MPNST xenograft models, the human sAXL could be detected in the mouse plasma. Its level was proportionate to the size of the xenograft tumors, while no human sAXL was detect prior to the formation of the tumors. Treatment with a newly developed photodynamic therapy, prevented further tumor growth and resulted in drastically reduced the levels of sAXL compared to that of the control group. Finally, the level of sAXL was significantly increased in patients with plexiform tumors compared to patients with only dermal neurofibromas, further supporting the role of sAXL as a marker for NF1 related tumor burden.	[Johansson, Gunnar; Huang, Po-Yuan; Lee, Ming-Jen] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Peng, Po-Chun; Chen, Chin-Tin] Inst Syst Biol, Seattle, WA USA; [Chien, Hsiung-Fei] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Hua, Kuo-Tai; Kuo, Min-Liang] Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei 10764, Taiwan; [Kuo, Min-Liang] Natl Taiwan Univ, Coll Life Sci, Inst Biochem Sci, Taipei 10764, Taiwan; [Lee, Ming-Jen] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; Institute for Systems Biology (ISB); National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Lee, MJ (corresponding author), Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan.	mjlee@ntu.edu.tw	Hsiao, Wei-Hung/B-9931-2013	Hua, Kuo-Tai/0000-0002-8468-4977; KUO, MIN-LIANG/0000-0002-7139-0144	Ministry of Science and Technology, Taiwan [NSC 99-3112-B-002-012]; National Taiwan University Hospital [NTUH 103-002464]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	The project was supported by the Ministry of Science and Technology, Taiwan (NSC 99-3112-B-002-012) and National Taiwan University Hospital (NTUH 103-002464), for Gunnar Johansson and Ming-Jen Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albritton KH, 2006, J CLIN ONCOL, V24, p524S; Ammoun S, 2014, ONCOGENE, V33, P336, DOI 10.1038/onc.2012.587; Aoki M, 2007, LAB INVEST, V87, P767, DOI 10.1038/labinvest.3700591; Badache A, 1998, J CELL PHYSIOL, V177, P334, DOI 10.1002/(SICI)1097-4652(199811)177:2<334::AID-JCP15>3.0.CO;2-9; Baron AT, 2003, CANCER EPIDEM BIOMAR, V12, P103; BARTLETT GR, 1959, J BIOL CHEM, V234, P459; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Costa M, 1996, J CELL PHYSIOL, V168, P737, DOI 10.1002/(SICI)1097-4652(199609)168:3<737::AID-JCP27>3.0.CO;2-U; DAHLBERG WK, 1993, INT J RADIAT BIOL, V63, P191, DOI 10.1080/09553009314550251; De Windt LJ, 2000, J BIOL CHEM, V275, P13571, DOI 10.1074/jbc.275.18.13571; DECLUE JE, 1992, CELL, V69, P265, DOI 10.1016/0092-8674(92)90407-4; DeClue JE, 2000, J CLIN INVEST, V105, P1233, DOI 10.1172/JCI7610; Ekman C, 2010, J THROMB HAEMOST, V8, P838, DOI 10.1111/j.1538-7836.2010.03752.x; Gustafsson A, 2009, CLIN CANCER RES, V15, P4742, DOI 10.1158/1078-0432.CCR-08-2514; Johansson G, 2008, MOL CANCER THER, V7, P1237, DOI 10.1158/1535-7163.MCT-07-2335; Korf BR, 1999, AM J MED GENET, V89, P31, DOI 10.1002/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-W; Li RH, 1996, J NEUROSCI, V16, P2012; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Mahadevan D, 2007, ONCOGENE, V26, P3909, DOI 10.1038/sj.onc.1210173; Mahller YY, 2008, CANCER RES, V68, P1170, DOI 10.1158/0008-5472.CAN-07-2734; Mantripragada KK, 2008, CLIN CANCER RES, V14, P1015, DOI 10.1158/1078-0432.CCR-07-1305; Miller SJ, 2006, CANCER RES, V66, P2584, DOI 10.1158/0008-5472.CAN-05-3330; Moon YH, 2009, ONCOL REP, V22, P1085, DOI 10.3892/or_00000540; Namiki Y, 2004, PHARMACOL RES, V50, P65, DOI 10.1016/j.phrs.2003.12.015; Nielsen-Preiss SM, 2007, ENDOCRINOLOGY, V148, P2806, DOI 10.1210/en.2007-0039; OBRYAN JP, 1995, J BIOL CHEM, V270, P551, DOI 10.1074/jbc.270.2.551; Rankin EB, 2010, CANCER RES, V70, P7570, DOI 10.1158/0008-5472.CAN-10-1267; Rao UNM, 1997, HUM PATHOL, V28, P1066, DOI 10.1016/S0046-8177(97)90060-5; Rasmussen SA, 2001, AM J HUM GENET, V68, P1110, DOI 10.1086/320121; Riccardi VM, 1999, NEUROFIBROMATOSIS PH; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Rosenbaum T, 2000, J NEUROSCI RES, V61, P524, DOI 10.1002/1097-4547(20000901)61:5<524::AID-JNR7>3.3.CO;2-Q; Su WP, 2004, GLIA, V45, P297, DOI 10.1002/glia.10340; TIESMAN J, 1993, J BIOL CHEM, V268, P9621; Tsai T, 2009, LASER SURG MED, V41, P316, DOI 10.1002/lsm.20754; WEINER TM, 1994, ANN SURG ONCOL, V1, P18, DOI 10.1007/BF02303537; Yang YT, 2013, LASER SURG MED, V45, P175, DOI 10.1002/lsm.22124	38	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115916	10.1371/journal.pone.0115916	http://dx.doi.org/10.1371/journal.pone.0115916			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551830	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100076
J	Li, G; Huan, D; Roehner, B; Xu, YJ; Zeng, L; Di, ZR; Han, ZG				Li, Geng; Huan, Di; Roehner, Bertrand; Xu, Yijuan; Zeng, Ling; Di, Zengru; Han, Zhangang			Symmetry Breaking on Density in Escaping Ants: Experiment and Alarm Pheromone Model	PLOS ONE			English	Article							TRANSITION; SYSTEM	The symmetry breaking observed in nature is fascinating. This symmetry breaking is observed in both human crowds and ant colonies. In such cases, when escaping from a closed space with two symmetrically located exits, one exit is used more often than the other. Group size and density have been reported as having no significant impact on symmetry breaking, and the alignment rule has been used to model symmetry breaking. Density usually plays important roles in collective behavior. However, density is not well-studied in symmetry breaking, which forms the major basis of this paper. The experiment described in this paper on an ant colony displays an increase then decrease of symmetry breaking versus ant density. This result suggests that a Vicsek-like model with an alignment rule may not be the correct model for escaping ants. Based on biological facts that ants use pheromones to communicate, rather than seeing how other individuals move, we propose a simple yet effective alarm pheromone model. The model results agree well with the experimental outcomes. As a measure, this paper redefines symmetry breaking as the collective asymmetry by deducing the random fluctuations. This research indicates that ants deposit and respond to the alarm pheromone, and the accumulation of this biased information sharing leads to symmetry breaking, which suggests true fundamental rules of collective escape behavior in ants.	[Li, Geng; Huan, Di; Di, Zengru; Han, Zhangang] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China; [Roehner, Bertrand] Univ Paris 06, Inst Theoret & High Energy Phys, F-75005 Paris, France; [Xu, Yijuan; Zeng, Ling] South China Agr Univ, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China	Beijing Normal University; UDICE-French Research Universities; Sorbonne Universite; South China Agricultural University	Han, ZG (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China.	zhan@bnu.edu.cn			China National Natural Science Foundation [61074116, 61374165, 31261160495]; Fundamental Research Funds for the Central Universities of China; BNU State Key Laboratory of ESPRE [2012-TDZY-21]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); BNU State Key Laboratory of ESPRE	This research is supported by China National Natural Science Foundation grants 61074116, 61374165 and 31261160495, as well as the Fundamental Research Funds for the Central Universities of China. This work was also supported by BNU State Key Laboratory of ESPRE grant 2012-TDZY-21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler E, 2005, AM NAT, V166, P643, DOI 10.1086/498139; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Becco C, 2006, PHYSICA A, V367, P487, DOI 10.1016/j.physa.2005.11.041; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Cavagna A, 2010, P NATL ACAD SCI USA, V105, P1232; Dombrowski C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098103; Dorigo M, 2006, IEEE COMPUT INTELL M, V1, P28, DOI 10.1109/MCI.2006.329691; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helfman GS, 2007, DIVERSITY FISHES; Herbert-Read JE, 2011, P NATL ACAD SCI USA, V108, P18726, DOI 10.1073/pnas.1109355108; Holldobler B., 1990, pi; Lalor PF, 2011, ANIM BEHAV, V10, P159; Makris NC, 2009, SCIENCE, V323, P1734, DOI 10.1126/science.1169441; Meer RKV, 2010, J CHEM ECOL, V36, P163, DOI 10.1007/s10886-010-9743-0; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Narayan V, 2007, SCIENCE, V317, P105, DOI 10.1126/science.1140414; Ordemann A, 2003, PHYSICA A, V325, P260, DOI 10.1016/S0378-4371(03)00204-8; POTTS WK, 1984, NATURE, V309, P344, DOI 10.1038/309344a0; REGNIER FE, 1968, J LIPID RES, V9, P541; Schaller V, 2010, NATURE, V467, P73, DOI 10.1038/nature09312; Sumpter DJT, 2007, INTRO COLLECTIVE ANI; Szabo B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.061908; Vander Meer R. K., 1998, PHEROMONE COMMUNICAT; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; WILSON EDWARD O., 1962, ANIMAL BEHAVIOUR, V10, P159, DOI 10.1016/0003-3472(62)90143-4; WILSON EO, 1963, RECENT PROG HORM RES, V19, P673; WILSON EO, 1971, AM NAT, V105, P279, DOI 10.1086/282724	28	14	17	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114517	10.1371/journal.pone.0114517	http://dx.doi.org/10.1371/journal.pone.0114517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551611	gold, Green Submitted, Green Published			2022-12-26	WOS:000347119100012
J	Pootakham, W; Shearman, JR; Ruang-areerate, P; Sonthirod, C; Sangsrakru, D; Jomchai, N; Yoocha, T; Triwitayakorn, K; Tragoonrung, S; Tangphatsornruang, S				Pootakham, Wirulda; Shearman, Jeremy R.; Ruang-areerate, Panthita; Sonthirod, Chutima; Sangsrakru, Duangjai; Jomchai, Nukoon; Yoocha, Thippawan; Triwitayakorn, Kanokporn; Tragoonrung, Somvong; Tangphatsornruang, Sithichoke			Large-Scale SNP Discovery through RNA Sequencing and SNP Genotyping by Targeted Enrichment Sequencing in Cassava (Manihot esculenta Crantz)	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; MOLECULAR-GENETIC MAP; ARABIDOPSIS-THALIANA; GENOME; IDENTIFICATION; DROSOPHILA; DIVERSITY; MARKERS; STARCH; SEQ	Cassava (Manihot esculenta Crantz) is one of the most important crop species being the main source of dietary energy in several countries. Marker-assisted selection has become an essential tool in plant breeding. Single nucleotide polymorphism (SNP) discovery via transcriptome sequencing is an attractive strategy for genome complexity reduction in organisms with large genomes. We sequenced the transcriptome of 16 cassava accessions using the Illumina HiSeq platform and identified 675,559 EST-derived SNP markers. A subset of those markers was subsequently genotyped by capture-based targeted enrichment sequencing in 100 F-1 progeny segregating for starch viscosity phenotypes. A total of 2,110 non-redundant SNP markers were used to construct a genetic map. This map encompasses 1,785 cM and consists of 19 linkage groups. A major quantitative trait locus (QTL) controlling starch pasting properties was identified and shown to coincide with the QTL previously reported for this trait. With a high-density SNP-based linkage map presented here, we also uncovered a novel QTL associated with starch pasting time on LG 10.	[Pootakham, Wirulda; Shearman, Jeremy R.; Ruang-areerate, Panthita; Sonthirod, Chutima; Sangsrakru, Duangjai; Jomchai, Nukoon; Yoocha, Thippawan; Tragoonrung, Somvong; Tangphatsornruang, Sithichoke] Natl Sci & Technol Dev Agcy NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand; [Triwitayakorn, Kanokporn] Mahidol Univ, Inst Mol Biosci, Nakhon Pathom, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University	Tangphatsornruang, S (corresponding author), Natl Sci & Technol Dev Agcy NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, 113 Thailand Sci Pk, Pathum Thani, Thailand.	sithichoke.tan@biotec.or.th	Pootakham, Wirulda/Q-9366-2019; Tangphatsornruang, Sithichoke/G-3633-2010; Pootakham, Wirulda/F-2358-2011; Shearman, Jeremy/F-1618-2010	Pootakham, Wirulda/0000-0001-6721-6453; Tangphatsornruang, Sithichoke/0000-0003-2673-0012; Pootakham, Wirulda/0000-0001-6721-6453; Triwitayakorn, Kanokporn/0000-0002-2179-1070	National Research Council of Thailand [P-12-00212]	National Research Council of Thailand(National Research Council of Thailand (NRCT))	This work was supported by the National Research Council of Thailand (http://en.nrct.go.th/en/home.aspx) grant number P-12-00212. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; AWOLEYE F, 1994, EUPHYTICA, V76, P195, DOI 10.1007/BF00022164; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Balat M, 2009, APPL ENERG, V86, P2273, DOI 10.1016/j.apenergy.2009.03.015; Barakat A, 1999, FEBS LETT, V463, P139, DOI 10.1016/S0014-5793(99)01587-2; Barakat A, 1998, P NATL ACAD SCI USA, V95, P10044, DOI 10.1073/pnas.95.17.10044; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Burrell MM, 2003, J EXP BOT, V54, P451, DOI 10.1093/jxb/erg049; Ceballos H, 2006, ACTA HORTIC, P63, DOI 10.17660/ActaHortic.2006.703.6; Chen X, 2010, PLANT MOL BIOL REP, V28, P676, DOI 10.1007/s11105-010-0198-9; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; CHURCHILL GA, 1994, GENETICS, V138, P963; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ferguson ME, 2012, THEOR APPL GENET, V124, P685, DOI 10.1007/s00122-011-1739-9; Fregene M, 1997, THEOR APPL GENET, V95, P431, DOI 10.1007/s001220050580; Giraut L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002354; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Gore MA, 2009, PLANT GENOME-US, V2, P121, DOI 10.3835/plantgenome2009.01.0002; Haseneyer G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-131; Hedges DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018595; Henderson IR, 2012, CURR OPIN PLANT BIOL, V15, P556, DOI 10.1016/j.pbi.2012.09.002; Hershey CH, 2012, ECOEFFICIENT INTERVE; Jabbari K, 2000, GENE, V247, P287, DOI 10.1016/S0378-1119(00)00128-1; Jimenez-Gomez JM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-85; Kawuki RS, 2009, MOL BREEDING, V23, P669, DOI 10.1007/s11032-009-9264-0; Kaya HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073674; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kunkeaw S, 2011, MOL BREEDING, V27, P67, DOI 10.1007/s11032-010-9414-4; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lopez C, 2005, THEOR APPL GENET, V110, P425, DOI 10.1007/s00122-004-1833-3; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moriyama EN, 1996, MOL BIOL EVOL, V13, P261, DOI 10.1093/oxfordjournals.molbev.a025563; Nuwamanya E., 2010, African Journal of Food Science, V4, P8; Okogbenin E, 2006, EUPHYTICA, V147, P433, DOI 10.1007/s10681-005-9042-y; Okogbenin E, 2003, THEOR APPL GENET, V107, P1452, DOI 10.1007/s00122-003-1383-0; Paritosh K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-463; Pegadaraju V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-556; Pootakham W, 2013, PLANT BREEDING, V132, P711, DOI 10.1111/pbr.12095; Pootakham W, 2011, AM J BOT, V98, pE337, DOI 10.3732/ajb.1100228; Prochnik S, 2012, TROP PLANT BIOL, V5, P88, DOI 10.1007/s12042-011-9088-z; Rabbi I, 2012, THEOR APPL GENET, V125, P329, DOI 10.1007/s00122-012-1836-4; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Sakurai T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074056; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Sraphet S, 2011, THEOR APPL GENET, V122, P1161, DOI 10.1007/s00122-010-1520-5; SUMNER AT, 1993, J MOL EVOL, V37, P117, DOI 10.1007/BF02407346; Thanyasiriwat T, 2014, PLANT BIOLOGY, V16, P197, DOI 10.1111/plb.12022; Turner EH, 2009, NAT METHODS, V6, P315, DOI 10.1038/nmeth.f.248; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; van Ooijen JW, 2002, MAPQTL 4 0 SOFTWARE; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Vidal RO, 2012, GENET MOL BIOL, V35, P331, DOI 10.1590/S1415-47572012000200014; Yin TF, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r77; Zhang XL, 2005, PLANT PHYSIOL, V138, P663, DOI 10.1104/pp.105.060319; Zheng Y, 2011, J BIOL CHEM, V286, P36108, DOI 10.1074/jbc.M111.275974	59	34	40	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116028	10.1371/journal.pone.0116028	http://dx.doi.org/10.1371/journal.pone.0116028			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551642	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100089
J	Razavi, MS; Shirani, E; Salimpour, MR; Kassab, GS				Razavi, Mohammad S.; Shirani, Ebrahim; Salimpour, Mohammad Reza; Kassab, Ghassan S.			Constructal Law of Vascular Trees for Facilitation of Flow	PLOS ONE			English	Article							CORONARY ARTERIAL TREE; BLOOD-FLOW; MORPHOMETRY; NETWORKS; DESIGN; RESISTANCE; EVOLUTION; TRANSPORT; PRESSURE; SYSTEMS	Diverse tree structures such as blood vessels, branches of a tree and river basins exist in nature. The constructal law states that the evolution of flow structures in nature has a tendency to facilitate flow. This study suggests a theoretical basis for evaluation of flow facilitation within vascular structure from the perspective of evolution. A novel evolution parameter (Ev) is proposed to quantify the flow capacity of vascular structures. Ev is defined as the ratio of the flow conductance of an evolving structure (configuration with imperfection) to the flow conductance of structure with least imperfection. Attaining higher Ev enables the structure to expedite flow circulation with less energy dissipation. For both Newtonian and non-Newtonian fluids, the evolution parameter was developed as a function of geometrical shape factors in laminar and turbulent fully developed flows. It was found that the non-Newtonian or Newtonian behavior of fluid as well as flow behavior such as laminar or turbulent behavior affects the evolution parameter. Using measured vascular morphometric data of various organs and species, the evolution parameter was calculated. The evolution parameter of the tree structures in biological systems was found to be in the range of 0.95 to 1. The conclusion is that various organs in various species have high capacity to facilitate flow within their respective vascular structures.	[Razavi, Mohammad S.; Salimpour, Mohammad Reza] Isfahan Univ Technol, Dept Mech Engn, Esfahan, Iran; [Shirani, Ebrahim] Foolad Inst Technol, Dept Engn, Fooladshahr, Isfahan, Iran; [Kassab, Ghassan S.] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Kassab, Ghassan S.] Indiana Univ Purdue Univ, Dept Surg, Indianapolis, IN 46202 USA; [Kassab, Ghassan S.] Indiana Univ Purdue Univ, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Isfahan University of Technology; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Kassab, GS (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.	gkassab@iupui.edu	Salimpour, Mohammad Reza/S-5314-2017; ANIKUZHIYIL, ANISH/Y-8609-2018; Shirani, Ebrahim/AAZ-6539-2021	Salimpour, Mohammad Reza/0000-0002-5871-8360; ANIKUZHIYIL, ANISH/0000-0001-9686-1283; Razavi Rizi, Mohammad/0000-0002-8991-6087				Bai C, 2010, J APPL PHYS, V108, DOI 10.1063/1.3486501; Bai C, 2009, J HEAT TRANS-T ASME, V131, DOI 10.1115/1.3155002; Bejan A, 1997, INT J HEAT MASS TRAN, V40, P799, DOI 10.1016/0017-9310(96)00175-5; Bejan A, 2004, INT J HEAT MASS TRAN, V47, P3203, DOI 10.1016/j.ijheatmasstransfer.2004.02.007; Bejan A, 2001, INT J HEAT MASS TRAN, V44, P699, DOI 10.1016/S0017-9310(00)00138-1; Bejan A., 2008, DESIGN CONSTRUCTAL T; Bejan A., 2000, SHAPE STRUCTURE ENG; Bejan A, 2013, J APPL PHYS, V113, DOI 10.1063/1.4798429; Bejan A, 2011, PHYS LIFE REV, V8, P209, DOI 10.1016/j.plrev.2011.05.010; Bejan A, 2010, PHILOS T R SOC B, V365, P1335, DOI 10.1098/rstb.2009.0302; Bejan A, 2006, J APPL PHYS, V100, DOI 10.1063/1.2221896; BERTUGLIA S, 1991, AM J PHYSIOL, V260, pH362, DOI 10.1152/ajpheart.1991.260.2.H362; Bieupoude P, 2012, COMPUT ENVIRON URBAN, V36, P434, DOI 10.1016/j.compenvurbsys.2012.03.007; CHILIAN WM, 1991, CIRC RES, V69, P561, DOI 10.1161/01.RES.69.3.561; ELLSWORTH ML, 1987, MICROVASC RES, V34, P168, DOI 10.1016/0026-2862(87)90051-3; Errera MR, 1998, FRACTALS, V6, P245, DOI 10.1142/S0218348X98000298; Fan J, 2010, INT J HEAT MASS TRAN, V53, P4238, DOI 10.1016/j.ijheatmasstransfer.2010.05.050; FENTON BM, 1981, ANN BIOMED ENG, V9, P303, DOI 10.1007/BF02364653; Finet G, 2010, EUROINTERVENTION, V6, pJ10, DOI 10.4244/EIJV6SUPJA3; GAN RZ, 1993, J APPL PHYSIOL, V75, P432, DOI 10.1152/jappl.1993.75.1.432; HORSFIELD K, 1981, LUNG, V159, P211, DOI 10.1007/BF02713917; Huang W, 1996, J APPL PHYSIOL, V81, P2123, DOI 10.1152/jappl.1996.81.5.2123; Huo YL, 2006, AM J PHYSIOL-HEART C, V291, pH1074, DOI 10.1152/ajpheart.00200.2006; Huo YL, 2012, J R SOC INTERFACE, V9, P190, DOI 10.1098/rsif.2011.0270; Huo YL, 2009, BIOPHYS J, V96, P339, DOI 10.1016/j.bpj.2008.09.038; Huo YL, 2009, BIOPHYS J, V96, P347, DOI 10.1016/j.bpj.2008.09.039; Jayaweera AR, 1999, AM J PHYSIOL-HEART C, V277, pH2363, DOI 10.1152/ajpheart.1999.277.6.H2363; JIANG ZL, 1994, J APPL PHYSIOL, V76, P882, DOI 10.1152/jappl.1994.76.2.882; Kaimovitz B, 2008, AM J PHYSIOL-HEART C, V294, pH714, DOI 10.1152/ajpheart.00818.2007; KANATSUKA H, 1991, CIRC RES, V68, P726, DOI 10.1161/01.RES.68.3.726; KASSAB GS, 1993, AM J PHYSIOL, V265, pH350, DOI 10.1152/ajpheart.1993.265.1.H350; Kassab GS, 1997, ANN BIOMED ENG, V25, P204, DOI 10.1007/BF02738551; Kleidon A, 2010, PHILOS T R SOC B, V365, P1297, DOI 10.1098/rstb.2010.0018; KOLLER A, 1987, AM J PHYSIOL, V253, pH154, DOI 10.1152/ajpheart.1987.253.1.H154; Ku DN, 1997, ANNU REV FLUID MECH, V29, P399, DOI 10.1146/annurev.fluid.29.1.399; LABARBERA M, 1990, SCIENCE, V249, P992, DOI 10.1126/science.2396104; LEY K, 1986, MICROVASC RES, V32, P315, DOI 10.1016/0026-2862(86)90068-3; McCulloh KA, 2003, NATURE, V421, P939, DOI 10.1038/nature01444; Miguel AF, 2010, J FLUID STRUCT, V26, P330, DOI 10.1016/j.jfluidstructs.2009.11.004; Mittal N, 2005, AM J PHYSIOL-HEART C, V289, pH439, DOI 10.1152/ajpheart.00730.2004; Price CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085420; Razavi MS, 2013, J BIOMECH, V46, P2303, DOI 10.1016/j.jbiomech.2013.06.005; Reddy BVK, 2008, INT J THERM SCI, V47, P1482, DOI 10.1016/j.ijthermalsci.2007.11.003; Sciacovelli A, 2011, INT J THERMODYNAMICS, V14; SINGHAL S, 1973, CIRC RES, V33, P190, DOI 10.1161/01.RES.33.2.190; TILLMANNS H, 1981, CIRC RES, V49, P1202, DOI 10.1161/01.RES.49.5.1202; VANBAVEL E, 1992, CIRC RES, V71, P1200, DOI 10.1161/01.RES.71.5.1200; Williams HR, 2008, J R SOC INTERFACE, V5, P55, DOI 10.1098/rsif.2007.1022; Wu F, 2009, CRYOGENICS, V49, P107, DOI 10.1016/j.cryogenics.2008.09.009; YEN RT, 1984, J BIOMECH ENG-T ASME, V106, P131, DOI 10.1115/1.3138469; YEN RT, 1983, J APPL PHYSIOL, V55, P236, DOI 10.1152/jappl.1983.55.1.236; ZAMIR M, 1983, J GEN PHYSIOL, V81, P325, DOI 10.1085/jgp.81.3.325; Zhou YF, 1999, PHYS MED BIOL, V44, P2929, DOI 10.1088/0031-9155/44/12/306	53	10	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116260	10.1371/journal.pone.0116260	http://dx.doi.org/10.1371/journal.pone.0116260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551617	Green Published, gold, Green Submitted			2022-12-26	WOS:000347119100116
J	Goyal, M; Chaudhuri, TK; Kuwajima, K				Goyal, Megha; Chaudhuri, Tapan K.; Kuwajima, Kunihiro			Irreversible Denaturation of Maltodextrin Glucosidase Studied by Differential Scanning Calorimetry, Circular Dichroism, and Turbidity Measurements	PLOS ONE			English	Article							PROTEIN KINETIC STABILITY; THERMAL-DENATURATION; ESCHERICHIA-COLI; HEAT DENATURATION; BETA-LACTOGLOBULIN; RESIDUAL STRUCTURE; GLOBULAR-PROTEINS; TRANSITION-STATE; LENTIL LECTIN; AGGREGATION	Thermal denaturation of Escherichia coli maltodextrin glucosidase was studied by differential scanning calorimetry, circular dichroism (230 nm), and UV-absorption measurements (340 nm), which were respectively used to monitor heat absorption, conformational unfolding, and the production of solution turbidity. The denaturation was irreversible, and the thermal transition recorded at scan rates of 0.5-1.5 K/min was significantly scan-rate dependent, indicating that the thermal denaturation was kinetically controlled. The absence of a protein-concentration effect on the thermal transition indicated that the denaturation was rate-limited by a mono-molecular process. From the analysis of the calorimetric thermograms, a one-step irreversible model well represented the thermal denaturation of the protein. The calorimetrically observed thermal transitions showed excellent coincidence with the turbidity transitions monitored by UV-absorption as well as with the unfolding transitions monitored by circular dichroism. The thermal denaturation of the protein was thus rate-limited by conformational unfolding, which was followed by a rapid irreversible formation of aggregates that produced the solution turbidity. It is thus important to note that the absence of the protein-concentration effect on the irreversible thermal denaturation does not necessarily means the absence of protein aggregation itself. The turbidity measurements together with differential scanning calorimetry in the irreversible thermal denaturation of the protein provided a very effective approach for understanding the mechanisms of the irreversible denaturation. The Arrhenius-equation parameters obtained from analysis of the thermal denaturation were compared with those of other proteins that have been reported to show the one-step irreversible thermal denaturation. Maltodextrin glucosidase had sufficiently high kinetic stability with a half-life of 68 days at a physiological temperature (37 degrees C).	[Goyal, Megha; Kuwajima, Kunihiro] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Goyal, Megha; Kuwajima, Kunihiro] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Goyal, Megha; Chaudhuri, Tapan K.] Indian Inst Technol, Sch Biol Sci, New Delhi 110016, India; [Kuwajima, Kunihiro] Grad Univ Adv Studies Sokendai, Sch Phys Sci, Dept Funct Mol Sci, Okazaki, Aichi 4448787, Japan; [Kuwajima, Kunihiro] Grad Univ Adv Studies Sokendai, CPIS, Hayama, Kanagawa 2400193, Japan; [Kuwajima, Kunihiro] Korea Inst Adv Study, Sch Computat Sci, Seoul 130722, South Korea	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Graduate University for Advanced Studies - Japan; Graduate University for Advanced Studies - Japan; Korea Institute for Advanced Study (KIAS)	Chaudhuri, TK (corresponding author), Indian Inst Technol, Sch Biol Sci, Hauz Khas, New Delhi 110016, India.	tkchaudhuri@bioschool.iitd.ernet.in; kuwajima_kunihiro@soken.ac.jp			Department of Science and Technology, Govt of India under Science and Engineering Board [SR/SO/BB-0040/2012]; Council of Scientific and Industrial Research, Govt. of India [37(1565)/12/EMR-II]; Ministry of Education, Culture, Sports, Science and Technology of Japan [20107009]; Japan Society for the Promotion of Science [25440075]	Department of Science and Technology, Govt of India under Science and Engineering Board; Council of Scientific and Industrial Research, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by funds to TKC from Department of Science and Technology, Govt of India under Science and Engineering Board, Grant No. SR/SO/BB-0040/2012, and by another grant from Council of Scientific and Industrial Research, Govt. of India, Grant No. 37(1565)/12/EMR-II. It was also supported by a Grant-in-Aid for Scientific Research on Innovative Areas to KK from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant number 20107009), and by a Grant-in-Aid for Scientific Research (C) to KK from the Japan Society for the Promotion of Science (grant number 25440075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHERN TJ, 1988, METHOD BIOCHEM ANAL, V33, P91; Amani M, 2007, BIOPHYS CHEM, V125, P254, DOI 10.1016/j.bpc.2006.08.006; Aymard P, 1996, J CHIM PHYS PCB, V93, P987, DOI 10.1051/jcp/1996930987; BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; Baussay K, 2004, INT J BIOL MACROMOL, V34, P21, DOI 10.1016/j.ijbiomac.2003.11.003; Benjwal S, 2006, PROTEIN SCI, V15, P635, DOI 10.1110/ps.051917406; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; CONEJEROLARA F, 1991, BIOCHEMISTRY-US, V30, P2067, DOI 10.1021/bi00222a010; Corley SC, 2011, BIOPHYS J, V100, P2946, DOI 10.1016/j.bpj.2011.05.015; Costas M, 2009, J MOL BIOL, V385, P924, DOI 10.1016/j.jmb.2008.10.056; Daniel RM, 1996, BIOCHEM J, V317, P1, DOI 10.1042/bj3170001; del Pino IMP, 2000, PROTEINS, V40, P58, DOI 10.1002/(SICI)1097-0134(20000701)40:1<58::AID-PROT80>3.0.CO;2-M; Durand D, 2002, PHYSICA A, V304, P253, DOI 10.1016/S0378-4371(01)00514-3; Duy C, 2005, J BIOL CHEM, V280, P37360, DOI 10.1074/jbc.M507530200; Dzwolak W, 2003, BIOCHEMISTRY-US, V42, P11347, DOI 10.1021/bi034879h; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Godoy-Ruiz R, 2006, J MOL BIOL, V362, P966, DOI 10.1016/j.jmb.2006.07.065; Golub N, 2007, FEBS LETT, V581, P4223, DOI 10.1016/j.febslet.2007.07.066; Guzzi R, 2008, BBA-PROTEINS PROTEOM, V1784, P1997, DOI 10.1016/j.bbapap.2008.07.005; Idakieva K, 2005, BBA-PROTEINS PROTEOM, V1748, P50, DOI 10.1016/j.bbapap.2004.12.004; Janis J, 2008, INT J BIOL MACROMOL, V42, P75, DOI 10.1016/j.ijbiomac.2007.09.012; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; Kedracka-Krok S, 2003, EUR J BIOCHEM, V270, P4564, DOI 10.1046/j.1432-1033.2003.03856.x; Khanova HA, 2005, BIOCHEMISTRY-US, V44, P15480, DOI 10.1021/bi051175u; Klimtchuk ES, 2010, BIOCHEMISTRY-US, V49, P9848, DOI 10.1021/bi101351c; Kurganov BI, 1997, BIOPHYS CHEM, V69, P125, DOI 10.1016/S0301-4622(97)80552-2; LOHNER K, 1991, BIOCHEMISTRY-US, V30, P6620, DOI 10.1021/bi00240a035; LUMRY R, 1954, J PHYS CHEM-US, V58, P110, DOI 10.1021/j150512a005; Lyubarev AE, 1999, BIOPHYS CHEM, V79, P199, DOI 10.1016/S0301-4622(99)00050-2; Lyubarev AE, 2000, J THERM ANAL CALORIM, V62, P51, DOI 10.1023/A:1010102525964; Marcos MJ, 1999, FEBS LETT, V443, P192, DOI 10.1016/S0014-5793(98)01708-6; Marcos MJ, 2000, EUR J BIOCHEM, V267, P2127, DOI 10.1046/j.1432-1327.2000.01233.x; Markossian KA, 2006, BIOCHEMISTRY-US, V45, P13375, DOI 10.1021/bi0610707; Nielsen AD, 2003, BBA-PROTEINS PROTEOM, V1652, P52, DOI 10.1016/j.bbapap.2003.08.002; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Paul S, 2007, FEBS J, V274, P6000, DOI 10.1111/j.1742-4658.2007.06122.x; Paul S, 2007, FASEB J, V21, P2874, DOI 10.1096/fj.06-7958com; Pey AL, 2013, BIOCHEMISTRY-US, V52, P1160, DOI 10.1021/bi301565m; Pey AL, 2011, AMINO ACIDS, V41, P1233, DOI 10.1007/s00726-010-0801-2; Pey AL, 2009, J BIOL INORG CHEM, V14, P521, DOI 10.1007/s00775-009-0467-y; Piatek R, 2009, BIOCHEMISTRY-US, V48, P11807, DOI 10.1021/bi900920k; Pina DG, 2001, EUR J BIOCHEM, V268, P120, DOI 10.1046/j.1432-1033.2001.01855.x; Potekhin SA, 1999, BIOCHEMISTRY-US, V38, P4121, DOI 10.1021/bi982789k; Potekhin SA, 1998, BIOPHYS CHEM, V73, P241, DOI 10.1016/S0301-4622(98)00149-5; Potekhin SA, 1998, BIOFIZIKA+, V43, P223; Potekhin SA, 2000, J THERM ANAL CALORIM, V62, P111, DOI 10.1023/A:1010114828690; Privalov P L, 1986, Methods Enzymol, V131, P4; Quesada-Soriano I, 2006, BBA-PROTEINS PROTEOM, V1764, P979, DOI 10.1016/j.bbapap.2006.03.002; Rodriguez A, 2002, EUR J BIOCHEM, V269, P2584, DOI 10.1046/j.1432-1033.2002.02930.x; Rodriguez-Larrea D, 2006, J MOL BIOL, V360, P715, DOI 10.1016/j.jmb.2006.05.009; Sanchez-Ruiz J M, 1995, Subcell Biochem, V24, P133; Sanchez-Ruiz JM, 2011, ANNU REV PHYS CHEM, V62, P231, DOI 10.1146/annurev-physchem-032210-103504; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; SANCHEZRUIZ JM, 1988, BIOCHEMISTRY-US, V27, P1648, DOI 10.1021/bi00405a039; Sandberg A, 2003, BIOCHEMISTRY-US, V42, P10301, DOI 10.1021/bi034371e; Sandberg A, 2002, BIOCHEMISTRY-US, V41, P1060, DOI 10.1021/bi0157621; Shnyrov VL, 1999, THERMOCHIM ACTA, V325, P143, DOI 10.1016/S0040-6031(98)00571-1; Song KM, 2010, BIOCHEM BIOPH RES CO, V397, P87, DOI 10.1016/j.bbrc.2010.05.073; Stirpe A, 2005, BBA-PROTEINS PROTEOM, V1752, P47, DOI 10.1016/j.bbapap.2005.07.004; Strucksberg KH, 2007, BBA-PROTEINS PROTEOM, V1774, P1591, DOI 10.1016/j.bbapap.2007.09.005; STURTEVANT JM, 1987, ANNU REV PHYS CHEM, V38, P463, DOI 10.1146/annurev.pc.38.100187.002335; TAPIO S, 1991, J BIOL CHEM, V266, P19450; Tur-Arlandis G, 2010, BIOPHYS J, V98, pL12, DOI 10.1016/j.bpj.2009.11.028; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; Weijers M, 2003, PROTEIN SCI, V12, P2693, DOI 10.1110/ps.03242803; Zamorano LS, 2008, BIOCHIMIE, V90, P1737, DOI 10.1016/j.biochi.2008.07.010; Zoldak G, 2004, J BIOL CHEM, V279, P47601, DOI 10.1074/jbc.M406883200	68	26	28	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115877	10.1371/journal.pone.0115877	http://dx.doi.org/10.1371/journal.pone.0115877			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548918	Green Published, gold, Green Submitted			2022-12-26	WOS:000347063500033
J	Li, L; Tan, HP; Gu, ZT; Liu, ZF; Geng, Y; Liu, YS; Tong, HS; Tang, YQ; Qiu, JM; Su, L				Li, Li; Tan, Hongping; Gu, Zhengtao; Liu, Zhifeng; Geng, Yan; Liu, Yunsong; Tong, Huasheng; Tang, Youqing; Qiu, Junmin; Su, Lei			Heat Stress Induces Apoptosis through a Ca2+-Mediated Mitochondrial Apoptotic Pathway in Human Umbilical Vein Endothelial Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; SARCOPLASMIC-RETICULUM; HEPATOCELLULAR INJURY; RYANODINE RECEPTOR; SMOOTH-MUSCLE; CA2+ RELEASE; HELA-CELLS; CALCIUM; HYPERTHERMIA	Background: Heat stress can be acutely cytotoxic, and heat stress-induced apoptosis is a prominent pathological feature of heat-related illnesses, although the precise mechanisms by which heat stress triggers apoptosis are poorly defined. Methods: The percentages of viability and cell death were assessed by WST-1 and LDH release assays. Apoptosis was assayed by DNA fragmentation and caspase activity. Expression of cleaved PARP, Apaf-1, phospho-PERK, Phospho-eIF2a, ATF4, XBP-1s, ATF6, GRP78, phospho-IP3R, RYR and SERCA was estimated by Western blot. The effect of calcium overload was determined using flow cytometric analysis with the fluorescent probe Fluo-3/AM. The generation of ROS (O-2(-), H2O2, NO) was labeled by confocal laser scanning microscopy images of fluorescently and flow cytometry. Results: In this study, we found that heat stress in HUVEC cells activated initiators of three major unfolded protein response (UPR) signaling transduction pathways: PERK-eIF2a-ATF4, IRE1-XBP-1S and ATF6 to protect against ER stress, although activation declined over time following cessation of heat stress. Furthermore, we show that intense heat stress may induce apoptosis in HUVEC cells through the calcium-mediated mitochondrial apoptotic pathway, as indicated by elevation of cytoplasmic Ca2+, expression of Apaf-1, activation of caspase-9 and caspase-3, PARP cleavage, and ultimately nucleosomal DNA fragmentation; Reactive oxygenspecies (ROS) appear to act upstream in this process. In addition, we provide evidence that IP3R upregulation may promote influx of Ca2+ into the cytoplasm after heat stress. Conclusion: Our findings describe a novel mechanism for heat stress-induced apoptosis in HUVEC cells: following elevation of cytoplasm Ca2+, activation of the mitochondrial apoptotic pathway via the IP3R upregulation, with ROS acting as an upstream regulator of the process.	[Li, Li; Liu, Zhifeng; Geng, Yan; Liu, Yunsong; Tong, Huasheng; Tang, Youqing; Qiu, Junmin; Su, Lei] PLA, Key Lab Trop Zone Trauma Care & Tissue Repair, Guangzhou Gen Hosp Guangzhou Mil Command, Dept Intens Care Unit, Guangzhou, Peoples R China; [Li, Li] Southern Med Univ, Guangzhou, Peoples R China; [Tan, Hongping] Guangdong Sanjiu Brain Hosp, Dept Epilepsy Surg, Guangzhou, Peoples R China; [Gu, Zhengtao] Southern Med Univ, Affiliated Hosp 3, Dept Intens Care Unit, Guangzhou, Peoples R China	Southern Theater Command General Hospital; Southern Medical University - China; Southern Medical University - China	Su, L (corresponding author), PLA, Key Lab Trop Zone Trauma Care & Tissue Repair, Guangzhou Gen Hosp Guangzhou Mil Command, Dept Intens Care Unit, Guangzhou, Peoples R China.	sulei_ICU@163.com			project team of the Natural Science Foundation of Guangdong Province [s2013030013217]; Project of Medical Research of PLA [BWS12J108]; Natural Science Fund of Guangdong Province [10151001002000001];  [81101467];  [81071529]	project team of the Natural Science Foundation of Guangdong Province; Project of Medical Research of PLA; Natural Science Fund of Guangdong Province(National Natural Science Foundation of Guangdong Province); ; 	This work was supported by China (No. 81101467, 81071529), the project team of the Natural Science Foundation of Guangdong Province (s2013030013217), the Project of Medical Research of PLA BWS12J108, and Natural Science Fund of Guangdong Province (No. 10151001002000001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2014, J CLIN BIOCHEM NUTR, V54, P129, DOI 10.3164/jcbn.13-46; Aubier M, 1998, EUR RESPIR J, V11, P758; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bhandary B, 2013, INT J MOL SCI, V14, P434, DOI 10.3390/ijms14010434; Bouchama A, 2005, J APPL PHYSIOL, V98, P697, DOI 10.1152/japplphysiol.00461.2004; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Breitwieser GE, 2006, CURR TOP DEV BIOL, V73, P85, DOI 10.1016/S0070-2153(05)73003-9; Brinton MR, 2012, INT J HYPERTHER, V28, P163, DOI 10.3109/02656736.2011.638963; BUCKLEY IK, 1972, LAB INVEST, V26, P201; Burdon R H, 1987, Free Radic Res Commun, V3, P129, DOI 10.3109/10715768709069778; Cao XH, 2011, CHEM-BIOL INTERACT, V190, P16, DOI 10.1016/j.cbi.2011.01.010; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; CDC (Centers for Disease Control and Prevention), 2000, MMWR-MORBID MORTAL W, V49, P470; Chang CK, 2007, PROG BRAIN RES, V162, P525, DOI 10.1016/S0079-6123(06)62025-6; Crompton M, 2002, BIOCHIMIE, V84, P143, DOI 10.1016/S0300-9084(02)01368-8; Glembotski CC, 2013, J MOL CELL CARDIOL; Gu ZT, 2014, SCI REP-UK, V4, DOI 10.1038/srep04469; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Hemon D, 2004, REV EPIDEMIOL SANTE, V52, P3, DOI 10.1016/S0398-7620(04)99017-7; Horimoto K, 2006, TOXICOLOGY, V225, P97, DOI 10.1016/j.tox.2006.05.004; Hsu YL, 2011, EXP EYE RES, V93, P405, DOI 10.1016/j.exer.2011.06.005; Hyun DH, 2007, J NEUROCHEM, V100, P1364, DOI 10.1111/j.1471-4159.2006.04411.x; Jaimovich E, 2005, FEBS LETT, V579, P2051, DOI 10.1016/j.febslet.2005.02.053; Laver DR, 2007, BIOPHYS J, V92, P3541, DOI 10.1529/biophysj.106.099028; Lee SJ, 2008, FREE RADICAL BIO MED, V45, P167, DOI 10.1016/j.freeradbiomed.2008.03.026; Lugo-Amador NM, 2004, EMERG MED CLIN N AM, V22, P315, DOI 10.1016/j.emc.2004.01.004; Lynch K, 2000, ENDOCRINOLOGY, V141, P4209, DOI 10.1210/en.141.11.4209; McAnulty SR, 2005, INT J SPORTS MED, V26, P188, DOI 10.1055/s-2004-820990; McCarron JG, 2008, J CELL SCI, V121, P86, DOI 10.1242/jcs.017541; Milleron RS, 2006, J BIOL CHEM, V281, P16991, DOI 10.1074/jbc.M512754200; Naranjo JR, 2012, J BIOL CHEM, V287, P31674, DOI 10.1074/jbc.R112.384982; NIXON GF, 1994, J MUSCLE RES CELL M, V15, P682, DOI 10.1007/BF00121075; Ortega-Camarillo C, 2006, MOL CELL BIOCHEM, V281, P163, DOI 10.1007/s11010-006-0829-5; OTSU K, 1990, J BIOL CHEM, V265, P13472; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pallepati P, 2010, ARCH BIOCHEM BIOPHYS, V495, P97, DOI 10.1016/j.abb.2009.12.014; Park CH, 2004, J INVEST DERMATOL, V123, P1012, DOI 10.1111/j.0022-202X.2004.23487.x; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Roberts GT, 2008, ARTERIOSCL THROM VAS, V28, P1130, DOI 10.1161/ATVBAHA.107.158709; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SAKAGUCHI Y, 1995, CANCER RES, V55, P5459; SKIBBA JL, 1991, INT J HYPERTHER, V7, P749, DOI 10.3109/02656739109056444; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tombal B, 1999, CELL CALCIUM, V25, P19, DOI 10.1054/ceca.1998.0005; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74; Wold LE, 2006, FREE RADICAL BIO MED, V40, P1419, DOI 10.1016/j.freeradbiomed.2005.12.009; Xu YF, 2009, CANCER LETT, V284, P229, DOI 10.1016/j.canlet.2009.04.028; Yamaguchi H, 2009, J BIOL CHEM, V284, P11171, DOI 10.1074/jbc.M809268200; Yeo Theresa Pluth, 2004, AACN Clin Issues, V15, P280, DOI 10.1097/00044067-200404000-00013	50	55	64	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e111083	10.1371/journal.pone.0111083	http://dx.doi.org/10.1371/journal.pone.0111083			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549352	Green Published, Green Submitted, gold			2022-12-26	WOS:000347063500002
J	Tian, H; Wang, LL; Cai, RQ; Zheng, L; Guo, L				Tian, Han; Wang, Leilei; Cai, Ruiqi; Zheng, Ling; Guo, Lin			Identification of Protein Network Alterations upon Retinal Ischemia-Reperfusion Injury by Quantitative Proteomics Using a Rattus norvegicus Model	PLOS ONE			English	Article							EXPRESSION; MECHANISMS; GLUTAMATE; CLASSIFICATION; INFLAMMATION; MTOR; TAU	Retinal ischemia is a common feature associated with several ocular diseases, including diabetic retinopathy. In this study, we investigated the effect of a retinal ischemia and reperfusion (I/R) injury on protein levels via a quantitative shotgun strategy using stable isotope dimethyl labeling combined with LC-MS/MS analysis. Based on the relative quantitation data of 1088 proteins, 234 proteins showed a greater than 1.5-fold change following I/R injury, 194 of which were up-regulated and 40 were down-regulated. Gene ontology analysis revealed that after I/R injury, there was an increase in the metabolic-process related proteins but a decline in cell communication, system process and transport-related proteins. A ribosome protein network and a secreted protein network consisting of many protease inhibitors were identified among the up-regulated proteins, despite a suppression of the mammalian target of rapamycin (mTOR) pathway following the I/R injury. A synaptic-related protein network was found to be significantly down-regulated, implicating a functional reduction of neurons following a retinal I/R injury. Our results provide new systems-biology clues for the study of retinal ischemia.	[Tian, Han; Wang, Leilei; Cai, Ruiqi; Zheng, Ling; Guo, Lin] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Zheng, L (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	lzheng@whu.edu.cn; guol@whu.edu.cn		Zheng, Ling/0000-0002-6545-4180	National Basic Research Program of China [2012CB524901]; Natural Science Foundation of China [31271370, 81100687]; Ministry of Science and Technology of China [2013CB911102]; 111 Project of China [B06018]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); 111 Project of China(Ministry of Education, China - 111 Project)	This work was supported by the National Basic Research Program of China (2012CB524901; http://www.973.gov.cn/AreaAppl.aspx), the Natural Science Foundation of China (no. 31271370 and 81100687; http://www.nsfc.gov.cn/), the Ministry of Science and Technology of China (2013CB911102; http://www.most.gov.cn/), and the 111 Project of China (B06018; http://www.dost.moe.edu.cn/dostmoe/) provided to Wuhan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Aoyagi T, 2012, AM J PHYSIOL-HEART C, V303, pH75, DOI 10.1152/ajpheart.00241.2012; Azuma M, 2008, SURV OPHTHALMOL, V53, P150, DOI 10.1016/j.survophthal.2007.12.006; Berntson AK, 2003, J VISION, V3, P274, DOI 10.1167/3.4.3; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bonne C, 1998, GEN PHARMACOL, V30, P275, DOI 10.1016/S0306-3623(97)00357-1; Chen FT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064262; Chen X, 2011, J CHROMATOGR B, V879, P25, DOI 10.1016/j.jchromb.2010.11.004; Dan C, 2008, ACTA HISTOCHEM CYTOC, V41, P173, DOI 10.1267/ahc.08034; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Dijk F, 2004, INVEST OPHTH VIS SCI, V45, P330, DOI 10.1167/iovs.03-0285; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; He MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084800; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Jiang M, 2010, AM J PATHOL, V176, P1181, DOI 10.2353/ajpath.2010.090594; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Liu G, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382549; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Neufeld AH, 2002, EXP EYE RES, V75, P521, DOI 10.1006/exer.2002.2042; Nucci C, 2005, NEUROTOXICOLOGY, V26, P935, DOI 10.1016/j.neuro.2005.06.002; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Portillo JAC, 2008, J IMMUNOL, V181, P8719, DOI 10.4049/jimmunol.181.12.8719; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; Stowell Cheri, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P148; Tanemura K, 2002, J NEUROSCI, V22, P133, DOI 10.1523/JNEUROSCI.22-01-00133.2002; Wang LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023194; Wu L, 2013, WORLD J DIABETES, V4, P290, DOI 10.4239/wjd.v4.i6.290; Ying Z, 2009, HUM MOL GENET, V18, P4268, DOI 10.1093/hmg/ddp380; Zhao X, 2014, J PROTEOME RES; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510; Zheng L, 2009, PROTEOMICS, V9, P1869, DOI 10.1002/pmic.200701071; Zhou LH, 2013, ACTA HISTOCHEM CYTOC, V46, P11, DOI 10.1267/ahc.12029	38	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116453	10.1371/journal.pone.0116453	http://dx.doi.org/10.1371/journal.pone.0116453			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549249	Green Published, Green Submitted, gold			2022-12-26	WOS:000347063500085
J	Aschenbrenner, D; Pippig, DA; Klamecka, K; Limmer, K; Leonhardt, H; Gaub, HE				Aschenbrenner, Daniela; Pippig, Diana A.; Klamecka, Kamila; Limmer, Katja; Leonhardt, Heinrich; Gaub, Hermann E.			Parallel Force Assay for Protein-Protein Interactions	PLOS ONE			English	Article							DNA; SFP; OLIGODEOXYNUCLEOTIDES; ARRAYS; BONDS; RNA	Quantitative proteome research is greatly promoted by high-resolution parallel format assays. A characterization of protein complexes based on binding forces offers an unparalleled dynamic range and allows for the effective discrimination of non-specific interactions. Here we present a DNA-based Molecular Force Assay to quantify protein-protein interactions, namely the bond between different variants of GFP and GFP-binding nanobodies. We present different strategies to adjust the maximum sensitivity window of the assay by influencing the binding strength of the DNA reference duplexes. The binding of the nanobody Enhancer to the different GFP constructs is compared at high sensitivity of the assay. Whereas the binding strength to wild type and enhanced GFP are equal within experimental error, stronger binding to superfolder GFP is observed. This difference in binding strength is attributed to alterations in the amino acids that form contacts according to the crystal structure of the initial wild type GFP-Enhancer complex. Moreover, we outline the potential for large-scale parallelization of the assay.	[Aschenbrenner, Daniela; Pippig, Diana A.; Klamecka, Kamila; Limmer, Katja; Gaub, Hermann E.] Univ Munich, Lehrstuhl Angew Phys, D-80799 Munich, Germany; [Aschenbrenner, Daniela; Pippig, Diana A.; Klamecka, Kamila; Limmer, Katja; Gaub, Hermann E.] Univ Munich, Ctr Nanosci CeNS, D-80799 Munich, Germany; [Klamecka, Kamila; Leonhardt, Heinrich] Univ Munich, Dept Biol 2, D-82152 Planegg Martinsried, Germany; [Klamecka, Kamila; Leonhardt, Heinrich] Univ Munich, Ctr Nanosci CeNS, D-82152 Planegg Martinsried, Germany; [Aschenbrenner, Daniela; Leonhardt, Heinrich] Munich Ctr Integrated Prot Sci CIPSM, D-81377 Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich; University of Munich	Pippig, DA (corresponding author), Univ Munich, Lehrstuhl Angew Phys, Amalienstr 54, D-80799 Munich, Germany.	diana.pippig@physik.uni-muenchen.de	Leonhardt, Heinrich/B-2791-2014		Deutsche Forschungsgemeinschaft [SFB 1032-A01, SPP 1623, LE 721/13-1]; European Research Council Advanced Grant; Elite Network of Bavaria (International Doctorate Program NanoBioTechnology); Nanosystems Initiative Munich	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council Advanced Grant(European Research Council (ERC)); Elite Network of Bavaria (International Doctorate Program NanoBioTechnology); Nanosystems Initiative Munich	Funding was provided by the Deutsche Forschungsgemeinschaft SFB 1032-A01 (HEG) and SPP 1623, LE 721/13-1 (HL) as well as a European Research Council Advanced Grant (HEG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KK and KL are grateful to the Elite Network of Bavaria (International Doctorate Program NanoBioTechnology) for doctoral fellowships. DA, KK and KL thank Nanosystems Initiative Munich for support.	Albrecht C, 2003, SCIENCE, V301, P367, DOI 10.1126/science.1084713; Albrecht CH, 2008, BIOPHYS J, V94, P4766, DOI 10.1529/biophysj.107.125427; Barnes TW, 2001, J AM CHEM SOC, V123, P4107, DOI 10.1021/ja003208t; Binnig G., 1986, PHYS REV LETT; Blank K, 2004, ANAL BIOANAL CHEM, V379, P974, DOI 10.1007/s00216-004-2607-0; Dervan P, 2003, CURR OPIN STRUCT BIO; Dervan P, 2005, TOP CURR CHEM; Dietz H, 2006, P NATL ACAD SCI USA, V103, P1244, DOI 10.1073/pnas.0509217103; Dose C, 2007, RECOGNITION MIRROR I; FROEHLER BC, 1992, TETRAHEDRON LETT, V33, P5307, DOI 10.1016/S0040-4039(00)79079-4; Gerber D, 2009, NAT METHODS, V6, P71, DOI [10.1038/NMETH.1289, 10.1038/nmeth.1289]; Heim R, 1995, NATURE; Hinterdorfer P, 2006, NATURE METHODS; Ho D, 2009, ANAL CHEM, V81, P3159, DOI 10.1021/ac802766j; Ho D, 2009, BIOPHYS J, V96, P4661, DOI 10.1016/j.bpj.2009.02.059; Jongsma MA, 2006, PROTEOMICS, V6, P2650, DOI 10.1002/pmic.200500654; Karlsson R, 2004, J MOL RECOGNITION; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Koch S, 2002, BIOPHYS J; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Kornreich M, 2013, CURRENT OPINION BIOT; Krautbauer R, 2003, NANO LETT, V3, P493, DOI 10.1021/nl034049p; Krautbauer R, 2002, SINGLE MOL; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Leckband D, 2000, ANNU REV BIOPH BIOM, V29, P1, DOI 10.1146/annurev.biophys.29.1.1; Lefebvre A, 1995, EUR J BIOCH; Limmer K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089626; Limmer K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1455; Lin S, 2005, CURRENT PROTEOMICS; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Manibog K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4941; Moffitt J, 2008, BIOCHEMISTRY; Morfill J, 2007, BIOPHYS J, V93, P2400, DOI 10.1529/biophysj.107.106112; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; Otten M, 2014, NATURE METHODS; Otten M, 2013, LAB CHIP, V13, P4198, DOI 10.1039/c3lc50830g; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pippig DA, 2014, ACS NANO; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Rakshit S, 2014, PHYS CHEM CHEM PHYS, V16, P2211, DOI 10.1039/c3cp53963f; Rief M, 1999, NAT STRUCT BIOL, V6, P346; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Severin P, 2011, NUCL ACIDS RES; Severin PMD, 2011, LAB CHIP, V11, P856, DOI [10.1039/c0lc00302f, 10.1039/c01c00302f]; Severin PMD, 2012, SMALL; Shen L, 2003, EVALUATION C 5 PROPY; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Stephanopoulos N, 2011, NAT CHEM BIOL, V7, P876, DOI [10.1038/NCHEMBIO.720, 10.1038/nchembio.720]; Strunz T, 1999, P NATL ACAD SCI US; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Terrazas M, 2009, NUCLEIC ACIDS RES, V37, P346, DOI 10.1093/nar/gkn958; Thomas W, 2002, CELL; Truong K, 2001, CURR OPIN STRUCT BIO; Tsien R, 1998, ANN REV BIOCH; Uetz P, 2000, NATURE; WAGNER RW, 1993, SCIENCE, V260, P1510, DOI 10.1126/science.7684856; Werther M, 2008, PROTEIN PROTEIN INTE; Wiegand G, 1998, APPL OPTICS, V37, P6892, DOI 10.1364/AO.37.006892; Wienken U, 2013, BIOPHYS J; Yin J, 2005, P NATL ACAD SCI USA, V102, P15815, DOI 10.1073/pnas.0507705102; Yin J, 2006, NAT PROTOC, V1, P280, DOI 10.1038/nprot.2006.43; Zhu H, 2003, ANNU REV BIOCHEM, V72, P783, DOI 10.1146/annurev.biochem.72.121801.161511	63	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115049	10.1371/journal.pone.0115049	http://dx.doi.org/10.1371/journal.pone.0115049			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546146	Green Published, gold, Green Submitted			2022-12-26	WOS:000347120200020
J	Tadimalla, S; Momot, KI				Tadimalla, Sirisha; Momot, Konstantin I.			Effect of Partial H2O-D2O Replacement on the Anisotropy of Transverse Proton Spin Relaxation in Bovine Articular Cartilage	PLOS ONE			English	Article							MAGNETIC-RESONANCE; MULTICOMPONENT T-2; PROTEIN SOLUTIONS; LONGITUDINAL RELAXATION; STRUCTURAL ADAPTATIONS; DYNAMIC PROCESSES; NMR-SPECTROSCOPY; BASIC SCIENCE; MU-MRI; COLLAGEN	Anisotropy of transverse proton spin relaxation in collagen-rich tissues like cartilage and tendon is a well-known phenomenon that manifests itself as the "magic-angle" effect in magnetic resonance images of these tissues. It is usually attributed to the non-zero averaging of intra-molecular dipolar interactions in water molecules bound to oriented collagen fibers. One way to manipulate the contributions of these interactions to spin relaxation is by partially replacing the water in the cartilage sample with deuterium oxide. It is known that dipolar interactions in deuterated solutions are weaker, resulting in a decrease in proton relaxation rates. In this work, we investigate the effects of deuteration on the longitudinal and the isotropic and anisotropic contributions to transverse relaxation of water protons in bovine articular cartilage. We demonstrate that the anisotropy of transverse proton spin relaxation in articular cartilage is independent of the degree of deuteration, bringing into question some of the assumptions currently held over the origins of relaxation anisotropy in oriented tissues.	[Tadimalla, Sirisha; Momot, Konstantin I.] Queensland Univ Technol, Sch Chem Phys & Mech Engn, Brisbane, Qld 4001, Australia; [Tadimalla, Sirisha; Momot, Konstantin I.] Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia	Queensland University of Technology (QUT)	Momot, KI (corresponding author), Queensland Univ Technol, Sch Chem Phys & Mech Engn, Brisbane, Qld 4001, Australia.	k.momot@qut.edu.au	Momot, Konstantin/A-5631-2008; Tadimalla, Sirisha/AAE-2576-2021	Momot, Konstantin/0000-0002-5695-153X; Tadimalla, Sirisha/0000-0003-2054-055X	Institute of Health and Biomedical Innovation (IHBI)	Institute of Health and Biomedical Innovation (IHBI)	Financial support for this study was provided by the Institute of Health and Biomedical Innovation (IHBI). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abragam A., 1961, PRINCIPLES NUCL MAGN; AKITT JW, 1989, J CHEM SOC FARAD T 1, V85, P2035, DOI 10.1039/f19898502035; Alhadlaq HA, 2004, OSTEOARTHR CARTILAGE, V12, P887, DOI 10.1016/j.joca.2004.07.006; BERENDSEN HJC, 1962, J CHEM PHYS, V36, P3297, DOI 10.1063/1.1732460; Bryant RG, 1996, ANNU REV BIOPH BIOM, V25, P29, DOI 10.1146/annurev.bb.25.060196.000333; BURSTEIN D, 1993, J ORTHOPAED RES, V11, P465, DOI 10.1002/jor.1100110402; Chen EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008565; Damion RA, 2012, OSTEOARTHR CARTILAGE, V20, P184, DOI 10.1016/j.joca.2011.12.005; de Visser SK, 2008, OSTEOARTHR CARTILAGE, V16, P689, DOI 10.1016/j.joca.2007.09.015; de Visser SK, 2008, OSTEOARTHR CARTILAGE, V16, P83, DOI 10.1016/j.joca.2007.05.013; Eliav U, 2002, J AM CHEM SOC, V124, P3125, DOI 10.1021/ja011791n; Eliav U, 1999, J MAGN RESON, V137, P295, DOI 10.1006/jmre.1998.1681; Fox AJS, 2009, SPORTS HEALTH, V1, P461, DOI 10.1177/1941738109350438; FULLERTON G D, 1982, Magnetic Resonance Imaging, V1, P209, DOI 10.1016/0730-725X(82)90172-2; Fullerton GD, 2007, J MAGN RESON IMAGING, V25, P345, DOI 10.1002/jmri.20808; FUNG BM, 1977, BIOPHYS J, V18, P235, DOI 10.1016/S0006-3495(77)85610-5; Galvis L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063518; Ghiassi-Nejad M, 2000, BIOMATERIALS, V21, P2089, DOI 10.1016/S0142-9612(00)00140-X; HENKELMAN RM, 1994, MAGNET RESON MED, V32, P592, DOI 10.1002/mrm.1910320508; HENKELMAN RM, 1993, MAGNET RESON MED, V29, P759, DOI 10.1002/mrm.1910290607; Jones CE, 2004, MAGN RESON IMAGING, V22, P211, DOI 10.1016/j.mri.2003.07.005; Keinan-Adamsky K, 2006, MAGN RESON MED, V55, P532, DOI 10.1002/mrm.20775; MIGCHELS.C, 1973, J CHEM PHYS, V59, P296, DOI 10.1063/1.1679805; Momot KI, 2012, BIOMED SPECTROSC IMA, V1, P27, DOI 10.3233/BSI-2012-0003; Momot KI, 2010, NMR BIOMED, V23, P313, DOI 10.1002/nbm.1466; Navon G, 2007, J MAGN RESON IMAGING, V25, P362, DOI 10.1002/jmri.20856; Navon G, 2001, NMR BIOMED, V14, P112, DOI 10.1002/nbm.687; Pearle AD, 2005, CLIN SPORT MED, V24, P1, DOI 10.1016/j.csm.2004.08.007; Pierce DM, 2010, ANN BIOMED ENG, V38, P2447, DOI 10.1007/s10439-010-9990-9; Raya JG, 2012, RADIOLOGY, V262, P550, DOI 10.1148/radiol.11110821; Reiter DA, 2009, MAGN RESON MED, V61, P803, DOI 10.1002/mrm.21926; Richter W, 2000, CONCEPT MAGNETIC RES, V12, P396, DOI 10.1002/1099-0534(2000)12:6<396::AID-CMR3>3.3.CO;2-P; SHERRY AD, 1973, ANAL BIOCHEM, V52, P415, DOI 10.1016/0003-2697(73)90044-4; Tsai PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076658; Wang N, 2013, J MAGN RESON IMAGING, V38, P625, DOI 10.1002/jmri.24012; Wang NA, 2011, J MAGN RESON, V212, P124, DOI 10.1016/j.jmr.2011.06.031; Wellard RM, 2014, SENSORS-BASEL, V14, P7940, DOI 10.3390/s140507940; Xia Y, 2000, INVEST RADIOL, V35, P602, DOI 10.1097/00004424-200010000-00007; Xia Y, 1998, MAGN RESON MED, V39, P941, DOI 10.1002/mrm.1910390612; Yusuf KQ, 2013, J MATER SCI-MATER M, V24, P1005, DOI 10.1007/s10856-013-4858-9; Zheng SK, 2010, CARTILAGE, V1, P55, DOI 10.1177/1947603509359784; Zheng SK, 2011, MAGN RESON MED, V65, P656, DOI 10.1002/mrm.22648; Zheng SK, 2009, J MAGN RESON, V198, P188, DOI 10.1016/j.jmr.2009.02.005; ZHONG JH, 1990, MAGNET RESON MED, V13, P192, DOI 10.1002/mrm.1910130203; ZHONG JH, 1989, MAGNET RESON MED, V11, P295, DOI 10.1002/mrm.1910110304; [No title captured], DOI DOI 10.1002/9780470034590; [No title captured], DOI DOI 10.1016/S0076-6879(01)39315-1.; [No title captured]	48	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115288	10.1371/journal.pone.0115288	http://dx.doi.org/10.1371/journal.pone.0115288			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545955	Green Published, gold, Green Submitted			2022-12-26	WOS:000347120200035
J	Pahlevaninezhad, H; Lee, AMD; Rosin, M; Sun, I; Zhang, LW; Hakimi, M; MacAulay, C; Lane, PM				Pahlevaninezhad, Hamid; Lee, Anthony M. D.; Rosin, Miriam; Sun, Ivan; Zhang, Lewei; Hakimi, Mehrnoush; MacAulay, Calum; Lane, Pierre M.			Optical Coherence Tomography and Autofluorescence Imaging of Human Tonsil	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SQUAMOUS-CELL CARCINOMA; LYMPH-NODE METASTASES; UNKNOWN PRIMARY HEAD; PERITONSILLAR ABSCESS; PALATINE TONSILS; FDG-PET/CT; HPV; ULTRASOUND; INTEGRATION	For the first time, we present co-registered autofluorescence imaging and optical coherence tomography (AF/OCT) of excised human palatine tonsils to evaluate the capabilities of OCT to visualize tonsil tissue components. Despite limited penetration depth, OCT can provide detailed structural information about tonsil tissue with much higher resolution than that of computed tomography, magnetic resonance imaging, and Ultrasound. Different tonsil tissue components such as epithelium, dense connective tissue, lymphoid nodules, and crypts can be visualized by OCT. The co-registered AF imaging can provide matching biochemical information. AF/OCT scans may provide a non-invasive tool for detecting tonsillar cancers and for studying the natural history of their development.	[Pahlevaninezhad, Hamid; Lee, Anthony M. D.; Rosin, Miriam; Sun, Ivan; Hakimi, Mehrnoush; MacAulay, Calum; Lane, Pierre M.] British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada; [Zhang, Lewei] Univ British Columbia, Dept Dent, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; University of British Columbia	Pahlevaninezhad, H (corresponding author), British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada.	hpahleva@bccrc.ca	MacAulay, Calum/K-1795-2016; Zhang, Lewei/AAP-4757-2021	Zhang, Lewei/0000-0003-3594-598X; Lane, Pierre/0000-0002-6370-4182; Lee, Anthony/0000-0001-6327-2351; MacAulay, Calum/0000-0003-4440-2792	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health and Research (CIHR); Canadian Cancer Society Institute [2012-701143]; NSERC; Michael Smith Foundation for Health and Research (MSFHR); Lotte & John Hecht Memorial Foundation	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health and Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Institute; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health and Research (MSFHR); Lotte & John Hecht Memorial Foundation	This work was supported through grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) and Canadian Institutes of Health and Research (CIHR). The collection of tonsil samples was supported by funding from Canadian Cancer Society Institute (Award #: 2012-701143). NSERC, the Michael Smith Foundation for Health and Research (MSFHR), and Lotte & John Hecht Memorial Foundation provided Postdoctoral fellowship for HP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ibraheem A, 2009, J ONCOL, V2009, DOI 10.1155/2009/208725; ASPESTRAND F, 1988, J COMPUT ASSIST TOMO, V12, P434, DOI 10.1097/00004728-198805010-00015; Begum S, 2005, CLIN CANCER RES, V11, P5694, DOI 10.1158/1078-0432.CCR-05-0587; Bhatia KSS, 2010, BRIT J RADIOL, V83, P753, DOI 10.1259/bjr/58331222; Blaivas M, 2003, AM J EMERG MED, V21, P155, DOI 10.1053/ajem.2003.50029; Chen XH, 2013, IRAN J RADIOL, V10, P148, DOI 10.5812/iranjradiol.9281; Donnelly LF, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.2.1790503; Fakhry C, 2014, ORAL ONCOL, V50, P640, DOI 10.1016/j.oraloncology.2014.03.015; Frisch M, 2000, CANCER CAUSE CONTROL, V11, P489, DOI 10.1023/A:1008918223334; Frisch M, 2000, CANCER-AM CANCER SOC, V88, P1464, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1464::AID-CNCR26>3.0.CO;2-O; FUJIMOTO JG, 1995, NAT MED, V1, P970, DOI 10.1038/nm0995-970; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Jumper JR, 2005, AM J NEURORADIOL, V26, P411; Kim SH, 2007, INT J CANCER, V120, P1418, DOI 10.1002/ijc.22464; King AD, 2001, BRIT J RADIOL, V74, P226, DOI 10.1259/bjr.74.879.740226; Koch WM, 2012, OTOLARYNG CLIN N AM, V45, P779, DOI 10.1016/j.otc.2012.04.004; Kreimer AR, 2011, CANCER PREV RES, V4, P1346, DOI 10.1158/1940-6207.CAPR-11-0379; Kwee TC, 2009, EUR RADIOL, V19, P731, DOI 10.1007/s00330-008-1194-4; Lingen MW, 2011, CANCER PREV RES, V4, P1350, DOI 10.1158/1940-6207.CAPR-11-0373; Lyon M, 2003, J ULTRAS MED, V22, P993, DOI 10.7863/jum.2003.22.9.993; Mannina Edward M, 2011, Int J Otolaryngol, V2011, P928240, DOI 10.1155/2011/928240; Miller FR, 2005, ARCH OTOLARYNGOL, V131, P626, DOI 10.1001/archotol.131.7.626; Monici M, 2005, BIOTECHNOL ANN REV, V11, P227, DOI 10.1016/S1387-2656(05)11007-2; Nabili V, 2007, AM J OTOLARYNG, V28, P153, DOI 10.1016/j.amjoto.2006.08.001; Pahlevaninezhad H, 2014, BIOMED OPT EXPRESS, V5, P2978, DOI 10.1364/BOE.5.002978; Pahlevaninezhad H, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.3.036022; Pai SI, 2009, ANNU REV PATHOL-MECH, V4, P49, DOI 10.1146/annurev.pathol.4.110807.092158; Park JJH, 2012, ACTA OTO-LARYNGOL, V132, P218, DOI 10.3109/00016489.2011.636377; Ruan LX, 2008, J INT MED RES, V36, P1140, DOI 10.1177/147323000803600536; Rusthoven KE, 2004, CANCER-AM CANCER SOC, V101, P2641, DOI 10.1002/cncr.20687; Shott SR, 2004, LARYNGOSCOPE, V114, P1724, DOI 10.1097/00005537-200410000-00009; Strojan P, 2013, HEAD NECK-J SCI SPEC, V35, P286, DOI 10.1002/hed.21899; Suzumoto M, 2006, ACTA OTO-LARYNGOL, V126, P1164, DOI 10.1080/00016480600681593; Tearney GJ, 1997, SCIENCE, V276, P2037, DOI 10.1126/science.276.5321.2037; Tsuboi M, 2005, LUNG CANCER, V49, P387, DOI 10.1016/j.lungcan.2005.04.007; Wang Xiao-Yi, 2010, Chin J Cancer, V29, P556; Westra WH, 2014, ORAL ONCOL, V50, P771, DOI 10.1016/j.oraloncology.2014.05.004	37	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115889	10.1371/journal.pone.0115889	http://dx.doi.org/10.1371/journal.pone.0115889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542010	Green Submitted, Green Published, gold			2022-12-26	WOS:000347239900105
J	Martinez-Bujidos, M; Rull, A; Gonzalez-Cura, B; Perez-Cuellar, M; Montoliu-Gaya, L; Villegas, S; Ordonez-Llanos, J; Sanchez-Quesada, JL				Martinez-Bujidos, Maria; Rull, Anna; Gonzalez-Cura, Beatriz; Perez-Cuellar, Montserrat; Montoliu-Gaya, Laia; Villegas, Sandra; Ordonez-Llanos, Jordi; Luis Sanchez-Quesada, Jose			Clusterin/apolipoprotein J binds to aggregated LDL in human plasma and plays a protective role against LDL aggregation	FASEB JOURNAL			English	Article						chaperones; electronegative LDL; atherosclerosis	LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; EXTRACELLULAR CHAPERONE CLUSTERIN; APOLIPOPROTEIN-J; ELECTRONEGATIVE LDL; PROTEOMIC ANALYSIS; PROTEINS; ATHEROSCLEROSIS; ACTIVATION; INDUCTION	Clusterin/apolipoprotein J (apoJ) is an extracellular chaperone involved in the quality control system against protein aggregation. A minor part of apoJ is transported in blood bound to LDLs, but its function is unknown. Our aim was to determine the role of apoJ bound to LDLs. Total LDL from human plasma was fractionated into native LDL [LDL(+)] and electronegative LDL [LDL(-)]. The latter was separated into nonaggregated [nagLDL(-)] and aggregated LDL(-) [agLDL(-)]. The content of apoJ was 6-fold higher in LDL(-) than in LDL(+) and 7-fold higher in agLDL(-) than in nagLDL(-). The proportion of LDL particles containing apoJ (LDL/J+) was 3-fold lower in LDL(+) than in LDL(-). LDL/J+ particles shared several characteristics with agLDL(-), including increased negative charge and aggregation. apoJ-depleted particles (LDL/J-) showed increased susceptibility to aggregation, whether spontaneous or induced by proteolysis or lipolysis, as was revealed by turbidimetric analysis, gel filtration chromatography, lipoprotein precipitation, native gradient gel electrophoresis, circular dichroism, and transmission electronic microscopy. The addition of purified apoJ to total LDL also prevented its aggregation induced by proteolysis or lipolysis. These findings point to apoJ as a key modulator of LDL aggregation and reveal a putative new therapeutic strategy against atherosclerosis.Martinez-Bujidos, M., Rull, A., Gonzalez-Cura, B., Perez-Cuellar, M., Montoliu-Gaya, L., Villegas, S., Ordonez-Llanos, J., Sanchez-Quesada, J. L. Clusterin/apolipoprotein J binds to aggregated LDL in human plasma and plays a protective role against LDL aggregation.	[Martinez-Bujidos, Maria; Rull, Anna; Gonzalez-Cura, Beatriz; Perez-Cuellar, Montserrat; Ordonez-Llanos, Jordi; Luis Sanchez-Quesada, Jose] Res Inst Hosp St Pau IIB St Pau, Cardiovasc Biochem Grp, Barcelona 08025, Spain; [Martinez-Bujidos, Maria; Ordonez-Llanos, Jordi] Univ Autonoma Barcelona, Biochem & Mol Biol Dept, Cerdanyola Del Valles, Spain; [Montoliu-Gaya, Laia; Villegas, Sandra] Univ Autonoma Barcelona, Biochem & Mol Biol Dept, Prot Folding & Stabil Grp, Cerdanyola Del Valles, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Sanchez-Quesada, JL (corresponding author), Res Inst Hosp St Pau IIB St Pau, Cardiovasc Biochem Grp, C Antoni Maria Claret 167, Barcelona 08025, Spain.	jsanchezq@santpau.cat	Villegas, Sandra/D-8789-2011; Villegas, Sandra/ABF-8206-2021; Rull, Anna/A-9438-2017; Ordonez-Llanos, Jorge/AAE-3088-2020; Ordonez-Llanos, Jorge/N-1126-2019	Villegas, Sandra/0000-0001-8644-4304; Villegas, Sandra/0000-0001-8644-4304; Rull, Anna/0000-0002-8907-7754; Ordonez-Llanos, Jorge/0000-0003-4896-5832; Ordonez-Llanos, Jorge/0000-0003-4896-5832; Sanchez-Quesada, Jose Luis/0000-0003-0224-591X	Spanish Ministry of Health (Instituto de Salud Carlos III/Fondo de Investigacion Sanitaria; ISCIII/FIS) [PI10/00265, PI10/00975, PI13/00364, PI13/01330]	Spanish Ministry of Health (Instituto de Salud Carlos III/Fondo de Investigacion Sanitaria; ISCIII/FIS)(Instituto de Salud Carlos IIISpanish Government)	The authors thank Carolyn Newey (Sant Pau Biomedical Research Institute; IIB Sant Pau) for editorial assistance. This work was supported by the Spanish Ministry of Health (Instituto de Salud Carlos III/Fondo de Investigacion Sanitaria; ISCIII/FIS) Grants PI10/00265, PI10/00975, PI13/00364, and PI13/01330. M.M.-B., A.R., M.P.-C., J.O.-L., and J.L.S.-Q. are members of the Quality Research Group 2009-SGR-1205 from Generalitat de Catalunya. L.M. and S.V. are members of the Quality Research Group 2014-SGR-00885 from Generalitat de Catalunya. M.M.-B., A.R., M.P.-C., J.O.-L., and J.L.S.-Q. are members of the Cardiovascular Research Network (Red de Investigacion Cardiovascular; RD12/0042/0043) from ISCIII. The authors declare no conflicts of interest.	Arrondo JR, 2003, J BACTERIOL, V185, P4226, DOI 10.1128/JB.185.14.4226-4232.2003; Bancells C, 2011, J BIOL CHEM, V286, P1125, DOI 10.1074/jbc.M110.175315; Bancells C, 2010, J LIPID RES, V51, P3508, DOI 10.1194/jlr.M009258; Bancells C, 2010, J BIOL CHEM, V285, P32425, DOI 10.1074/jbc.M110.139691; BANEULOS S, 1995, J BIOL CHEM, V270, P9192; Banfi C, 2009, PROTEOMICS, V9, P1344, DOI 10.1002/pmic.200800566; Benitez S, 2004, BIOCHEMISTRY-US, V43, P15863, DOI 10.1021/bi048825z; Bergmeier C, 2004, CLIN CHEM, V50, P2309, DOI 10.1373/clinchem.2004.034439; Camejo G, 1998, ATHEROSCLEROSIS, V139, P205, DOI 10.1016/S0021-9150(98)00107-5; DESILVA HV, 1990, J BIOL CHEM, V265, P13240; DESILVA HV, 1990, BIOCHEMISTRY-US, V29, P5380, DOI 10.1021/bi00474a025; Gelissen IC, 1998, BIOCHEM J, V331, P231, DOI 10.1042/bj3310231; Hevonoja T, 2000, BBA-MOL CELL BIOL L, V1488, P189, DOI 10.1016/S1388-1981(00)00123-2; Hochgrebe T, 2000, BIOCHEMISTRY-US, V39, P1411, DOI 10.1021/bi991581b; Hoofnagle AN, 2010, ARTERIOSCL THROM VAS, V30, P2528, DOI 10.1161/ATVBAHA.110.212894; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Ishii T, 2001, ATHEROSCLEROSIS, V158, P215, DOI 10.1016/S0021-9150(01)00416-6; Ishikawa Y, 1998, ARTERIOSCL THROM VAS, V18, P665, DOI 10.1161/01.ATV.18.4.665; Karlsson H, 2005, PROTEOMICS, V5, P551, DOI 10.1002/pmic.200300938; Karlsson H, 2006, J PROTEOME RES, V5, P2685, DOI 10.1021/pr060180x; Karlsson H, 2009, PROTEOM CLIN APPL, V3, P663, DOI 10.1002/prca.200800138; Kim HJ, 2009, ARTERIOSCL THROM VAS, V29, P1558, DOI 10.1161/ATVBAHA.109.190058; Kujiraoka T, 2006, J ATHEROSCLER THROMB, V13, P314, DOI 10.5551/jat.13.314; Navab M, 1997, J CLIN INVEST, V99, P2005, DOI 10.1172/JCI119369; Navab M, 2005, ARTERIOSCL THROM VAS, V25, P1932, DOI 10.1161/01.ATV.0000174589.70190.e2; Oorni K, 2000, J LIPID RES, V41, P1703; Parasassi T, 2008, FASEB J, V22, P2350, DOI 10.1096/fj.07-097774; Park S, 2014, REV ENDOCR METAB DIS, V15, P45, DOI 10.1007/s11154-013-9275-3; Pettersson C, 2011, J INTERN MED, V269, P306, DOI 10.1111/j.1365-2796.2010.02292.x; Poon S, 2002, FEBS LETT, V513, P259, DOI 10.1016/S0014-5793(02)02326-8; Poulakou MV, 2008, IN VIVO, V22, P537; Richardson MR, 2009, PROTEOMICS, V9, P2468, DOI 10.1002/pmic.200800613; Riwanto M, 2013, CIRCULATION, V127, P891, DOI 10.1161/CIRCULATIONAHA.112.108753; Rubinow KB, 2012, STEROIDS, V77, P454, DOI 10.1016/j.steroids.2012.01.002; Sanchez-Quesada JL, 2004, CURR OPIN LIPIDOL, V15, P329, DOI [10.1097/00041433-200406000-00014, 10.1097/01.mol.0000130093.54381.22]; Sanchez-Quesada JL, 2003, ATHEROSCLEROSIS, V166, P261, DOI 10.1016/S0021-9150(02)00374-X; Sanchez-Quesada JL, 2002, J LIPID RES, V43, P699; Schlatzer D, 2012, DIABETES CARE, V35, P549, DOI 10.2337/dc11-1491; Schwarz M, 2008, THROMB HAEMOSTASIS, V100, P110, DOI 10.1160/TH07-12-0737; Stahlman M, 2008, J LIPID RES, V49, P481, DOI 10.1194/jlr.D700025-JLR200; STUART WD, 1992, BIOCHEMISTRY-US, V31, P8552, DOI 10.1021/bi00151a024; Sun H. Y., 2009, CLIN CHIM ACTA; Swertfeger DK, 1996, AM J PATHOL, V148, P1971; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Trougakos IP, 2002, EXP GERONTOL, V37, P1175, DOI 10.1016/S0531-5565(02)00139-0; Trougakos IP, 2002, INT J BIOCHEM CELL B, V34, P1430, DOI 10.1016/S1357-2725(02)00041-9; Van Lenten BJ, 2001, CIRCULATION, V103, P2283; Vareka I, 2009, BIOMED PAP, V153, P117, DOI 10.5507/bp.2009.019; Vigano C, 2000, BIOPOLYMERS, V55, P373, DOI 10.1002/1097-0282(2000)55:5<373::AID-BIP1011>3.0.CO;2-U; WITTE DP, 1993, AM J PATHOL, V143, P763; Wyatt AR, 2010, J BIOL CHEM, V285, P3532, DOI 10.1074/jbc.M109.079566; Yerbury JJ, 2005, EMBO REP, V6, P1131, DOI 10.1038/sj.embor.7400586; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904	54	20	20	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1688	1700		10.1096/fj.14-264036	http://dx.doi.org/10.1096/fj.14-264036			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25550461				2022-12-26	WOS:000354114600008
J	Marchand, B; Arsenault, D; Raymond-Fleury, A; Boisvert, FM; Boucher, MJ				Marchand, Benoit; Arsenault, Dominique; Raymond-Fleury, Alexandre; Boisvert, Francois-Michel; Boucher, Marie-Josee			Glycogen Synthase Kinase-3 (GSK3) Inhibition Induces Prosurvival Autophagic Signals in Human Pancreatic Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; LYSOSOMAL BIOGENESIS; RAG GTPASES; TRANSCRIPTION; GEMCITABINE; MTORC1; SURVIVAL; BIOLOGY; GENE; TFEB	Glycogen synthase kinase-3 (GSK3) are ubiquitously expressed serine-threonine kinases involved in a plethora of functions ranging from the control of glycogen metabolism to transcriptional regulation. We recently demonstrated that GSK3 inhibition triggers JNK-cJUN-dependent apoptosis in human pancreatic cancer cells. However, the comprehensive picture of downstream GSK3-regulated pathways/functions remains elusive. Herein, counterbalancing the death signals, we show that GSK3 inhibition induces prosurvival signals through increased activity of the autophagy/lysosomal network. Our data also reveal a contribution of GSK3 in the regulation of the master transcriptional regulator of autophagy and lysosomal biogenesis, transcription factor EB (TFEB) in pancreatic cancer cells. Similarly to mammalian target of rapamycin (mTOR) inhibition, GSK3 inhibitors promote TFEB nuclear localization and leads to TFEB dephosphorylation through endogenous serine/threonine phosphatase action. However, GSK3 and mTOR inhibition impinge differently and independently on TFEB phosphorylation suggesting that TFEB is regulated by a panel of kinases and/or phosphatases. Despite their differential impact on TFEB phosphorylation, both GSK3 and mTOR inhibitors promote 14-3-3 dissociation and TFEB nuclear localization. Quantitative mass spectrometry analyses further reveal an increased association of TFEB with nuclear proteins upon GSK3 and mTOR inhibition suggesting a positive impact on TFEB transcriptional function. Finally, a predominant nuclear localization of TFEB is unveiled in fully fed pancreatic cancer cells, whereas a reduction in TFEB expression significantly impairs their capacity for growth in an anchorage-independent manner. In addition, TFEB-restricted cells are more sensitive to apoptosis upon GSK3 inhibition. Altogether, our data uncover new functions under the control of GSK3 in pancreatic cancer cells in addition to providing key insight into TFEB regulation.	[Marchand, Benoit; Arsenault, Dominique; Raymond-Fleury, Alexandre; Boucher, Marie-Josee] Univ Sherbrooke, Dept Med, Div Gastroenterol, Sherbrooke, PQ J1E 4K8, Canada; [Boisvert, Francois-Michel] Univ Sherbrooke, Dept Anat & Cell Biol, Fac Med & Sci Sante, Sherbrooke, PQ J1E 4K8, Canada	University of Sherbrooke; University of Sherbrooke	Boucher, MJ (corresponding author), Univ Sherbrooke, 3201 Rue Jean Mignault, Sherbrooke, PQ J1E 4K8, Canada.	marie-josee.boucher@usherbrooke.ca		Boucher, Marie-Josee/0000-0002-7615-3121; Marchand, Benoit/0000-0001-9302-6688	Natural Sciences and Engineering Research Council of Canada [NSERC 341809]; Canadian Institutes of Health Research [MOP-106456]; Fonds de Recherche Sante Quebec (FRQ-S)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche Sante Quebec (FRQ-S)	This work was supported in part by Natural Sciences and Engineering Research Council of Canada Grant NSERC 341809 and Canadian Institutes of Health Research Grant MOP-106456 (to M. J. B.).; Scholars from the Fonds de Recherche Sante Quebec (FRQ-S) and members of the FRQ-S-funded Centre de recherche du Centre hospitalier universitaire de Sherbrooke (CRCHUS).	Bang D, 2013, CANCER DISCOV, V3, P690, DOI 10.1158/2159-8290.CD-12-0541; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Billadeau DD, 2007, PANCREATOLOGY, V7, P398, DOI 10.1159/000108955; Boisvert F. M., 2012, PROTEOMICS, V11; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Chen RQ, 2009, CANCER RES, V69, P2663, DOI 10.1158/0008-5472.CAN-08-3222; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Donohue E, 2013, J CANCER, V4, P585, DOI 10.7150/jca.7030; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Furukawa T, 1996, AM J PATHOL, V148, P1763; Garcea G, 2007, CURR CANCER DRUG TAR, V7, P209, DOI 10.2174/156800907780618266; Guo JY, 2013, GENE DEV, V27, P1447, DOI 10.1101/gad.219642.113; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Haq R, 2011, J CLIN ONCOL, V29, P3474, DOI 10.1200/JCO.2010.32.6223; Hashimoto D, 2014, EUR J CANCER, V50, P1382, DOI 10.1016/j.ejca.2014.01.011; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Hong SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015793; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kitano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055289; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Papademetrio DL, 2014, TARGET ONCOL, V9, P123, DOI 10.1007/s11523-013-0278-5; Lee SJ, 2011, NAT REV NEPHROL, V7, P718, DOI 10.1038/nrneph.2011.150; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lin SY, 2012, SCIENCE, V336, P477, DOI 10.1126/science.1217032; Liu EY, 2012, J CELL SCI, V125, P2349, DOI 10.1242/jcs.093708; Maes H, 2013, TRENDS MOL MED, V19, P428, DOI 10.1016/j.molmed.2013.04.005; Mamaghani S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-132; Marchand B, 2012, CARCINOGENESIS, V33, P529, DOI 10.1093/carcin/bgr309; Martina JA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004754; Martina JA, 2013, J CELL BIOL, V200, P475, DOI 10.1083/jcb.201209135; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Martinez A, 2008, MED RES REV, V28, P773, DOI 10.1002/med.20119; Miyashita K, 2009, ANTI-CANCER AGENT ME, V9, P1114, DOI 10.2174/187152009789734982; Mukubou H, 2010, INT J ONCOL, V37, P821, DOI 10.3892/ijo_00000732; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pan S, 2014, J PROTEOME RES, V13, P1293, DOI 10.1021/pr4010184; Pardo R, 2010, PANCREATOLOGY, V10, P19, DOI 10.1159/000264680; Parr C, 2012, MOL CELL BIOL, V32, P4410, DOI 10.1128/MCB.00930-12; Petit CS, 2013, J CELL BIOL, V202, P1107, DOI 10.1083/jcb.201307084; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Schneider G, 2005, GASTROENTEROLOGY, V128, P1606, DOI 10.1053/j.gastro.2005.04.001; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Strohecker AM, 2014, AUTOPHAGY, V10, P384, DOI 10.4161/auto.27320; Wilson W, 2008, CANCER RES, V68, P8156, DOI 10.1158/0008-5472.CAN-08-1061; Yang J, 2010, J CELL SCI, V123, P861, DOI 10.1242/jcs.060475; Yang SH, 2011, AUTOPHAGY, V7, P912, DOI 10.4161/auto.7.8.15762; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang JS, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.102; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11	60	116	126	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5592	5605		10.1074/jbc.M114.616714	http://dx.doi.org/10.1074/jbc.M114.616714			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25561726	Green Published, hybrid			2022-12-26	WOS:000350044200030
J	Savolainen, MH; Yan, X; Myohanen, TT; Huttunen, HJ				Savolainen, Mari H.; Yan, Xu; Myohanen, Timo T.; Huttunen, Henri J.			Prolyl Oligopeptidase Enhances alpha-Synuclein Dimerization via Direct Protein-Protein Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEWY BODY DEMENTIA; PARKINSONS-DISEASE; FIBRIL FORMATION; MICROSCALE THERMOPHORESIS; MEMBRANE INTERACTIONS; TAU PHOSPHORYLATION; ALZHEIMERS-DISEASE; AGGREGATION; DOPAMINE; BINDING	Prolyl oligopeptidase (PREP) accelerates the aggregation of alpha-synuclein (aSyn), a key protein involved in development of Parkinson disease and other synucleinopathies. PREP inhibitors reduce aSyn aggregation, but the mechanism has remained unknown. We have now used protein-fragment complementation assays (PCA) and microscale thermophoresis in parallel to show that PREP interacts directly with aSyn in both intact cells and in a cell-free system. Using split luciferase-based PCA, we first showed that PREP enhances the formation of soluble aSyn dimers in live Neuro-2A neuroblastoma cells. APREP inhibitor, KYP-2047, reduced aSyn dimerization in PREP-expressing cells but not in cells lacking PREP expression. aSyn dimerization was also enhanced by PREP(S554A), an enzymatically inactive PREP mutant, but this was not affected by KYP-2047. PCA and microscale thermophoresis studies showed that aSyn interacts with both PREP and PREP(S554A) with low micromolar affinity. Neither the proline-rich, C-terminal domain of aSyn nor the hydrolytic activity of PREP was required for the interaction with PREP. Our results show that PREP binds directly to aSyn to enhance its dimerization and may thus serve as a nucleation point for aSyn aggregation. Native gel analysis showed that KYP-2047 shifts PREP to a compact monomeric form with reduced ability to promote aSyn nucleation. As PREP inhibition also enhances autophagic clearance of aSyn, PREP inhibitors may reduce accumulation of aSyn inclusions via a dual mechanism and are thus a novel therapeutic candidate for synucleinopathies. Our results also suggest that PREP has other cellular functions in addition to its peptidase activity.	[Savolainen, Mari H.; Myohanen, Timo T.] Univ Helsinki, Div Pharmacol & Pharmacotherapy, FI-00014 Helsinki, Finland; [Yan, Xu; Huttunen, Henri J.] Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki	Huttunen, HJ (corresponding author), Univ Helsinki, Ctr Neurosci, POB 56 Viikinkaari 4, FIN-00014 Helsinki, Finland.	Henri.Huttunen@helsinki.fi		Huttunen, Henri/0000-0002-9867-4438; Myohanen, Timo/0000-0002-9277-6687	Academy of Finland [218081, 263762, 267788, 2737991]; Brain and Mind doctoral program; Doctoral Program in Drug Research; University of Helsinki; Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation; Emil Aaltonen Foundation	Academy of Finland(Academy of Finland); Brain and Mind doctoral program; Doctoral Program in Drug Research; University of Helsinki; Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Emil Aaltonen Foundation	This work was supported by grants from the Academy of Finland (218081 and 263762 (to H. J. H.) and 267788 and 2737991 (to T. T. M.)), the Brain and Mind doctoral program (to X. Y.), the Doctoral Program in Drug Research (to M. S.), the University of Helsinki (to H. J. H. and T. T. M.), the Jane and Aatos Erkko Foundation (to T. T. M.), the Sigrid Juselius Foundation (to T. T. M.), and the Emil Aaltonen Foundation (to M. S.). H. J. H. is an employee and shareholder of Herantis Pharma plc.	Alim MA, 2002, J BIOL CHEM, V277, P2112, DOI 10.1074/jbc.M102981200; Arima K, 1998, ACTA NEUROPATHOL, V96, P439, DOI 10.1007/s004010050917; Bennett MC, 2005, PHARMACOL THERAPEUT, V105, P311, DOI 10.1016/j.pharmthera.2004.10.010; Bisaglia M, 2009, NEUROMOL MED, V11, P239, DOI 10.1007/s12017-009-8082-1; Bisaglia M, 2009, FASEB J, V23, P329, DOI 10.1096/fj.08-119784; Brandt I, 2008, PEPTIDES, V29, P1472, DOI 10.1016/j.peptides.2008.05.005; Brandt I, 2007, CLIN CHIM ACTA, V377, P50, DOI 10.1016/j.cca.2006.09.001; Cappai R, 2005, FASEB J, V19, P1377, DOI 10.1096/fj.04-3437fje; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Di Daniel E, 2009, MOL CELL NEUROSCI, V41, P373, DOI 10.1016/j.mcn.2009.03.003; Dokleja L, 2014, NEUROSCI LETT, V583, P37, DOI 10.1016/j.neulet.2014.09.026; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Garcia-Horsman JA, 2007, NEUROPEPTIDES, V41, P1, DOI 10.1016/j.npep.2006.10.004; Hannula MJ, 2013, NEUROSCIENCE, V242, P140, DOI 10.1016/j.neuroscience.2013.03.049; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Jalkanen AJ, 2012, NEUROCHEM INT, V60, P301, DOI 10.1016/j.neuint.2011.12.010; Jalkanen AJ, 2011, BASIC CLIN PHARMACOL, V109, P443, DOI 10.1111/j.1742-7843.2011.00747.x; Jarho EM, 2004, J MED CHEM, V47, P5605, DOI 10.1021/jm049503w; Jensen PH, 1997, BIOCHEM J, V323, P539, DOI 10.1042/bj3230539; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Kaszuba K, 2012, BIOCHIMIE, V94, P1398, DOI 10.1016/j.biochi.2012.03.012; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lai Y, 2014, BIOCHEMISTRY-US, V53, P3889, DOI 10.1021/bi5002536; Lambeir AM, 2011, CNS NEUROL DISORD-DR, V10, P349, DOI 10.2174/187152711794653878; Lee D, 2002, J NEUROCHEM, V82, P1007, DOI 10.1046/j.1471-4159.2002.01024.x; Lorenzen N, 2014, FEBS LETT, V588, P497, DOI 10.1016/j.febslet.2013.12.015; Mannisto PT, 2007, DRUG NEWS PERSPECT, V20, P293; Mantle D, 1996, CLIN CHIM ACTA, V249, P129, DOI 10.1016/0009-8981(96)06282-1; Meuvis J, 2010, BIOCHEMISTRY-US, V49, P9345, DOI 10.1021/bi1010927; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Myohanen TT, 2012, BRIT J PHARMACOL, V166, P1097, DOI 10.1111/j.1476-5381.2012.01846.x; Myohanen TT, 2008, HISTOCHEM CELL BIOL, V130, P993, DOI 10.1007/s00418-008-0468-x; Myohanen TT, 2009, J HISTOCHEM CYTOCHEM, V57, P831, DOI 10.1369/jhc.2009.953711; Nykanen NP, 2012, J BIOL CHEM, V287, P6743, DOI 10.1074/jbc.M111.309385; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Pfefferkorn CM, 2012, BBA-BIOMEMBRANES, V1818, P162, DOI 10.1016/j.bbamem.2011.07.032; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Savolainen MH, 2014, NEUROBIOL DIS, V68, P1, DOI 10.1016/j.nbd.2014.04.003; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Surguchov A, 2008, INT REV CEL MOL BIO, V270, P225, DOI 10.1016/S1937-6448(08)01406-8; Szeltner Z, 2013, BBA-PROTEINS PROTEOM, V1834, P98, DOI 10.1016/j.bbapap.2012.08.012; Szeltner Z, 2010, BBA-PROTEINS PROTEOM, V1804, P2162, DOI 10.1016/j.bbapap.2010.09.010; Tarrago T, 2009, FEBS LETT, V583, P3344, DOI 10.1016/j.febslet.2009.09.036; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Uversky VN, 2002, FEBS LETT, V515, P99, DOI 10.1016/S0014-5793(02)02446-8; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Venalainen JI, 2006, BIOCHEM PHARMACOL, V71, P683, DOI 10.1016/j.bcp.2005.11.029; WALTER R, 1971, SCIENCE, V173, P828, DOI 10.1126/science.173.3999.827; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	56	43	44	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5117	5126		10.1074/jbc.M114.592931	http://dx.doi.org/10.1074/jbc.M114.592931			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25555914	Green Published, hybrid			2022-12-26	WOS:000350042000051
J	von Stockum, S; Giorgio, V; Trevisan, E; Lippe, G; Glick, GD; Forte, MA; Da-Re, C; Checchetto, V; Mazzotta, G; Costa, R; Szabo, I; Bernardi, P				von Stockum, Sophia; Giorgio, Valentina; Trevisan, Elena; Lippe, Giovanna; Glick, Gary D.; Forte, Michael A.; Da-Re, Caterina; Checchetto, Vanessa; Mazzotta, Gabriella; Costa, Rodolfo; Szabo, Ildiko; Bernardi, Paolo			F-ATPase of Drosophila melanogaster Forms 53-Picosiemen (53-pS) Channels Responsible for Mitochondrial Ca2+-induced Ca2+ Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; C-SUBUNIT RING; CELL-DEATH; ESSENTIAL COMPONENT; UNCOUPLING CHANNEL; CASPASE ACTIVATION; MOLECULAR TARGET; CYTOCHROME-C; S2 CELLS; SYNTHASE	Mitochondria of Drosophila melanogaster undergo Ca2+-induced Ca2+ release through a putative channel (mCrC) that has several regulatory features of the permeability transition pore (PTP). The PTP is an inner membrane channel that forms from F-ATPase, possessing a conductance of 500 picosiemens (pS) in mammals and of 300 pS in yeast. In contrast to the PTP, the mCrC of Drosophila is not permeable to sucrose and appears to be selective for Ca2+ and H+. We show (i) that like the PTP, the mCrC is affected by the sense of rotation of F-ATPase, by Bz-423, and by Mg2+/ADP; (ii) that expression of human cyclophilin D in mitochondria of Drosophila S2R+ cells sensitizes the mCrC to Ca2+ but does not increase its apparent size; and (iii) that purified dimers of D. melanogaster F-ATPase reconstituted into lipid bilayers form 53-pS channels activated by Ca2+ and thiol oxidants and inhibited byMg(2+)/gamma-imino ATP. These findings indicate that the mCrC is the PTP of D. melanogaster and that the signature conductance of F-ATPase channels depends on unique structural features that may underscore specific roles in different species.	[von Stockum, Sophia; Giorgio, Valentina; Trevisan, Elena; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy; [Da-Re, Caterina; Checchetto, Vanessa; Mazzotta, Gabriella; Costa, Rodolfo; Szabo, Ildiko] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Lippe, Giovanna] Univ Udine, Dept Food Sci, I-33100 Udine, Italy; [Glick, Gary D.] Univ Michigan, Dept Chem, Grad Program Immunol, Ann Arbor, MI 48109 USA; [Forte, Michael A.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	University of Padua; University of Padua; University of Udine; University of Michigan System; University of Michigan; Oregon Health & Science University	Bernardi, P (corresponding author), Univ Padua, Dept Biomed Sci, Via Ugo Bassi 58-B, I-35121 Padua, Italy.	bernardi@bio.unipd.it	Giorgio, Valentina/O-1969-2015; checchetto, vanessa/ABI-6145-2020; Padova, Ildiko/K-5344-2016; Szabo, Ildiko/AAW-5972-2021; Bernardi, Paolo/C-3656-2008; Giorgio, Valentina/I-6110-2016	Giorgio, Valentina/0000-0002-4229-3054; checchetto, vanessa/0000-0001-8911-6146; Szabo, Ildiko/0000-0002-3637-3947; Bernardi, Paolo/0000-0001-9187-3736; MAZZOTTA, GABRIELLA MARGHERITA/0000-0001-5461-6837	AIRC [IG13392, IG11814]; PRIN Programs [20107Z8XBW, 2010CSJX4F]; National Institutes of Health-Public Health Service [1R01GM069883]; University of Padova Progetti Strategici di Ateneo Models of Mitochondrial Diseases; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069883] Funding Source: NIH RePORTER	AIRC(Fondazione AIRC per la ricerca sul cancro); PRIN Programs; National Institutes of Health-Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); University of Padova Progetti Strategici di Ateneo Models of Mitochondrial Diseases; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by AIRC Grants IG13392 (to P. B.) and IG11814 (to I. S.), PRIN Programs 20107Z8XBW (to P. B.) and 2010CSJX4F (to I. S.), National Institutes of Health-Public Health Service Grant 1R01GM069883 (to M. F. and P. B.), and the University of Padova Progetti Strategici di Ateneo Models of Mitochondrial Diseases (to P. B.).	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; ALTSCHULD RA, 1992, AM J PHYSIOL, V262, pH1699, DOI 10.1152/ajpheart.1992.262.6.H1699; Barsukova A, 2011, EUR J NEUROSCI, V33, P831, DOI 10.1111/j.1460-9568.2010.07576.x; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Basso E, 2008, J BIOL CHEM, V283, P26307, DOI 10.1074/jbc.C800132200; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; BERNARDI P, 1992, J BIOL CHEM, V267, P2934; BERNARDI P, 1983, EUR J BIOCHEM, V134, P377, DOI 10.1111/j.1432-1033.1983.tb07578.x; Bernardi P, 1996, J BIOENERG BIOMEMBR, V28, P131, DOI 10.1007/BF02110643; Bernardi P, 2015, J MOL CELL CARDIOL, V78, P100, DOI 10.1016/j.yjmcc.2014.09.023; Bernardi P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00095; Bernardi P, 2012, CELL CALCIUM, V52, P22, DOI 10.1016/j.ceca.2012.03.004; Bradshaw PC, 2013, YEAST, V30, P471, DOI 10.1002/yea.2984; Buzhynskyy N, 2007, BIOPHYS J, V93, P2870, DOI 10.1529/biophysj.107.109728; Carraro M, 2014, J BIOL CHEM, V289, P15980, DOI 10.1074/jbc.C114.559633; Chinopoulos C, 2014, FRONT ONCOL, V4, DOI [10.3389/fonc.2014.002350, 10.3389/fonc.2014.00235]; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; Da-Re C, 2014, J BIOL CHEM, V289, P29235, DOI 10.1074/jbc.M114.602938; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dorstyn L, 2004, J CELL BIOL, V167, P405, DOI 10.1083/jcb.200408054; EBLE KS, 1990, J BIOL CHEM, V265, P19434; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115; Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005; Iwaki T, 2003, BIOTECHNIQUES, V35, P482, DOI 10.2144/03353bm08; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Johnson KM, 2005, CHEM BIOL, V12, P485, DOI 10.1016/j.chembiol.2005.02.012; Jung DW, 1997, J BIOL CHEM, V272, P21104, DOI 10.1074/jbc.272.34.21104; KINNALLY KW, 1989, J BIOENERG BIOMEMBR, V21, P497, DOI 10.1007/BF00762521; Li B, 2012, BBA-BIOENERGETICS, V1817, P1628, DOI 10.1016/j.bbabio.2012.05.011; McGeoch J E, 2001, Eur J Paediatr Neurol, V5 Suppl A, P147, DOI 10.1053/ejpn.2000.0452; McGeoch JEM, 2000, BIOCHEM BIOPH RES CO, V274, P835, DOI 10.1006/bbrc.2000.3231; McGeoch JEM, 1997, BRAIN RES, V766, P188, DOI 10.1016/S0006-8993(97)00618-5; Means J, 2006, CELL DEATH DIFFER, V13, P1222, DOI 10.1038/sj.cdd.4401821; Oberst A, 2008, CELL DEATH DIFFER, V15, P1139, DOI 10.1038/cdd.2008.65; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Parone PA, 2013, J NEUROSCI, V33, P4657, DOI 10.1523/JNEUROSCI.1119-12.2013; Pemberton TJ, 2005, COMP FUNCT GENOM, V6, P277, DOI 10.1002/cfg.482; PETRONILLI V, 1989, FEBS LETT, V259, P137, DOI 10.1016/0014-5793(89)81513-3; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; Rasola A, 2014, CELL CALCIUM, V56, P437, DOI 10.1016/j.ceca.2014.10.003; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Scorrano L, 1997, MOL CELL BIOCHEM, V174, P181, DOI 10.1023/A:1006887921810; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Stelzer AC, 2010, BIOPOLYMERS, V93, P85, DOI 10.1002/bip.21306; SZABO I, 1992, J BIOL CHEM, V267, P2940; Szabo I, 2011, CELL DEATH DIFFER, V18, P427, DOI 10.1038/cdd.2010.112; SZABO I, 1991, J BIOL CHEM, V266, P3376; SZABO I, 1992, J BIOENERG BIOMEMBR, V24, P111, DOI 10.1007/BF00769537; von Stockum S, 2011, J BIOL CHEM, V286, P41163, DOI 10.1074/jbc.M111.268375; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Xu DB, 2009, FLY, V3, P78, DOI 10.4161/fly.3.1.7800; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	59	56	56	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4537	4544		10.1074/jbc.C114.629766	http://dx.doi.org/10.1074/jbc.C114.629766			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25550160	hybrid, Green Published			2022-12-26	WOS:000350042000001
J	Wang, A; Stout, CD; Zhang, QH; Johnson, EF				Wang, An; Stout, C. David; Zhang, Qinghai; Johnson, Eric F.			Contributions of Ionic Interactions and Protein Dynamics to Cytochrome P450 2D6 (CYP2D6) Substrate and Inhibitor Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PLASMA-LEVELS; HUMAN-LIVER; THIORIDAZINE; CRYSTALLOGRAPHY; PHARMACOPHORE; CONFORMATION; METABOLISM; P4502B4; MODEL	P450 2D6 contributes significantly to the metabolism of > 15% of the 200 most marketed drugs. Open and closed crystal structures of P450 2D6 thioridazine complexes were obtained using different crystallization conditions. The protonated piperidine moiety of thioridazine forms a charge-stabilized hydrogen bond with Asp-301 in the active sites of both complexes. The more open conformation exhibits a second molecule of thioridazine bound in an expanded substrate access channel antechamber with its piperidine moiety forming a charge-stabilized hydrogen bond with Glu-222. Incubation of the crystalline open thioridazine complex with alternative ligands, prinomastat, quinidine, quinine, or ajmalicine, displaced both thioridazines. Quinine and ajmalicine formed charge-stabilized hydrogen bonds with Glu-216, whereas the protonated nitrogen of quinidine is equidistant from Asp-301 and Glu-216 with protonated nitrogen H-bonded to a water molecule in the access channel. Prinomastat is not ionized. Adaptations of active site side-chain rotamers and polypeptide conformations were evident between the complexes, with the binding of ajmalicine eliciting a closure of the open structure reflecting in part the inward movement of Glu-216 to form a hydrogen bond with ajmalicine as well as sparse lattice restraints that would hinder adaptations. These results indicate that P450 2D6 exhibits sufficient elasticity within the crystal lattice to allow the passage of compounds between the active site and bulk solvent and to adopt a more closed form that adapts for binding alternative ligands with different degrees of closure. These crystals provide a means to characterize substrate and inhibitor binding to the enzyme after replacement of thioridazine with alternative compounds.	[Wang, An; Johnson, Eric F.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Stout, C. David; Zhang, Qinghai] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Johnson, EF (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd,MEM 255, La Jolla, CA 92037 USA.	johnson@scripps.edu			United States Department of Energy, Office of Biological and Environmental Research; National Center for Research Resources, Biomedical Technology Program; NIGMS of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098538, R01GM031001] Funding Source: NIH RePORTER	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the United States Department of Energy, Office of Biological and Environmental Research and by the National Center for Research Resources, Biomedical Technology Program, and NIGMS of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Annalora AJ, 2010, J MOL BIOL, V396, P441, DOI 10.1016/j.jmb.2009.11.057; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; de Groot MJ, 1999, J MED CHEM, V42, P1515, DOI 10.1021/jm981118h; DeVore NM, 2012, J BIOL CHEM, V287, P26576, DOI 10.1074/jbc.M112.372813; Eap CB, 1996, CLIN PHARMACOL THER, V59, P322, DOI 10.1016/S0009-9236(96)80010-5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FONNEPFISTER R, 1988, BIOCHEM PHARMACOL, V37, P3829, DOI 10.1016/0006-2952(88)90063-9; FROIMOWITZ M, 1993, J MED CHEM, V36, P2219, DOI 10.1021/jm00067a019; Headd JJ, 2012, ACTA CRYSTALLOGR D, V68, P381, DOI 10.1107/S0907444911047834; Hutzler JM, 2003, CHEM RES TOXICOL, V16, P450, DOI 10.1021/tx025674x; Johnson EF, 2014, DRUG METAB DISPOS, V42, P9, DOI 10.1124/dmd.113.054627; Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; KROEMER HK, 1995, LIFE SCI, V56, P2285, DOI 10.1016/0024-3205(95)00223-S; Lee SC, 2013, P NATL ACAD SCI USA, V110, pE1203, DOI 10.1073/pnas.1221442110; Masuda K, 2005, CHIRALITY, V17, P37, DOI 10.1002/chir.20092; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCDOWELL JJH, 1975, ACTA CRYSTALLOGR B, V31, P2256, DOI 10.1107/S0567740875007352; MEYER JW, 1990, EUR J CLIN PHARMACOL, V39, P613, DOI 10.1007/BF00316110; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; NIEDZWIECKI DM, 1984, J PHARMACOL EXP THER, V228, P636; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Obach RS, 2002, DRUG METAB DISPOS, V30, P831, DOI 10.1124/dmd.30.7.831; OMURA T, 1964, J BIOL CHEM, V239, P2379; OTTON SV, 1984, LIFE SCI, V34, P73, DOI 10.1016/0024-3205(84)90332-1; Rowland P, 2006, J BIOL CHEM, V281, P7614, DOI 10.1074/jbc.M511232200; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Sehnal D, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-39; Shah MB, 2012, BIOCHEMISTRY-US, V51, P7225, DOI 10.1021/bi300894z; Smart O. S., 2011, GRADE VERSION 1 101; STROBL GR, 1993, J MED CHEM, V36, P1136, DOI 10.1021/jm00061a004; VandenBrink BM, 2012, DRUG METAB DISPOS, V40, P47, DOI 10.1124/dmd.111.041210; VONBAHR C, 1991, CLIN PHARMACOL THER, V49, P234, DOI 10.1038/clpt.1991.22; Wang A, 2012, J BIOL CHEM, V287, P10834, DOI 10.1074/jbc.M111.307918; Wang B, 2009, DRUG METAB REV, V41, P573, DOI 10.1080/03602530903118729; Wen B, 2009, CHEM-BIOL INTERACT, V181, P220, DOI 10.1016/j.cbi.2009.05.014; Wojcikowski J, 2006, DRUG METAB DISPOS, V34, P471, DOI 10.1124/dmd.105.006445; Zhao B, 2012, J BIOL CHEM, V287, P10613, DOI 10.1074/jbc.M111.323501; Zhao YH, 2006, J BIOL CHEM, V281, P5973, DOI 10.1074/jbc.M511464200	42	65	66	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5092	5104		10.1074/jbc.M114.627661	http://dx.doi.org/10.1074/jbc.M114.627661			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25555909	Green Published, hybrid			2022-12-26	WOS:000350042000049
J	Arechederra, M; Priego, N; Vazquez-Carballo, A; Sequera, C; Gutierrez-Uzquiza, A; Cerezo-Guisado, MI; Ortiz-Rivero, S; Roncero, C; Cuenda, A; Guerrero, C; Porras, A				Arechederra, Maria; Priego, Neibla; Vazquez-Carballo, Ana; Sequera, Celia; Gutierrez-Uzquiza, Alvaro; Isabel Cerezo-Guisado, Maria; Ortiz-Rivero, Sara; Roncero, Cesareo; Cuenda, Ana; Guerrero, Carmen; Porras, Almudena			p38 MAPK Down-regulates Fibulin 3 Expression through Methylation of Gene Regulatory Sequences ROLE IN MIGRATION AND INVASION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PROMOTER METHYLATION; CELL PROLIFERATION; DNA METHYLATION; P38-ALPHA MAPK; BREAST-CANCER; MESSENGER-RNA; GROWTH; P38-DELTA; STRESS	p38 MAPKs regulate migration and invasion. However, the mechanisms involved are only partially known. We had previously identified fibulin 3, which plays a role in migration, invasion, and tumorigenesis, as a gene regulated by p38 alpha. We have characterized in detail how p38 MAPK regulates fibulin 3 expression and its role. We describe here for the first time that p38 alpha, p38 gamma, and p38 delta down-regulate fibulin 3 expression. p38 alpha has a stronger effect, and it does so through hypermethylation of CpG sites in the regulatory sequences of the gene. This would be mediated by the DNA methylase, DNMT3A, which is down-regulated in cells lacking p38 alpha, but once re-introduced represses Fibulin 3 expression. p38 alpha through HuR stabilizes dnmt3a mRNA leading to an increase in DNMT3A protein levels. Moreover, by knocking-down fibulin 3, we have found that Fibulin 3 inhibits migration and invasion in MEFs by mechanisms involving p38 alpha/beta inhibition. Hence, p38 alpha pro-migratory/invasive effect might be, at least in part, mediated by fibulin 3 down-regulation in MEFs. In contrast, in HCT116 cells, Fibulin 3 promotes migration and invasion through a mechanism dependent on p38 alpha and/or p38 beta activation. Furthermore, Fibulin 3 promotes in vitro and in vivo tumor growth of HCT116 cells through a mechanism dependent on p38 alpha, which surprisingly acts as a potent inducer of tumor growth. At the same time, p38 alpha limits fibulin 3 expression, which might represent a negative feed-back loop.	[Roncero, Cesareo; Porras, Almudena] Univ Complutense Madrid, Fac Farm, Dept Bioquim & Biol Mol 2, Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, E-28040 Madrid, Spain; [Isabel Cerezo-Guisado, Maria; Cuenda, Ana] Ctr Nacl Biotecnol CSIC, Dept Inmunol & Oncol, Madrid 28049, Spain; [Ortiz-Rivero, Sara; Guerrero, Carmen] Univ Salamanca, Fac Med, Inst Invest Biomed Salamanca IBSAL, Dept Med,IBMCC,Ctr Invest Canc, Salamanca 37007, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Guerrero, C (corresponding author), Ctr Invest Canc, Campus Unamuno S-N, Salamanca 37007, Spain.	cguerrero@usal.es; maporras@ucm.es	Porras, Almudena/N-2121-2015; Arechederra, Maria/F-4373-2016; Uzquiza, Alvaro Gutierrez/E-4073-2012; Ortiz-Rivero, Sara/A-4366-2017; Arechederra, María/L-9108-2019; Sequera, Celia/Y-6369-2019; Guerrero, Carmen/F-1776-2010; Roncero, Cesáreo/H-9039-2015	Porras, Almudena/0000-0002-6495-3308; Arechederra, Maria/0000-0002-4830-1924; Uzquiza, Alvaro Gutierrez/0000-0002-0446-4131; Arechederra, María/0000-0002-4830-1924; Sequera, Celia/0000-0001-6409-3910; Guerrero, Carmen/0000-0002-8747-6831; Roncero, Cesáreo/0000-0001-7608-8553	Spanish Ministry of Economy and Competitiveness [SAF2010-20918-C02-01, SAF2103-48210-C2-02, SAF2010-20918-C02-02, SAF2103-48210-C2-01]; Council of Health and Social Welfare; Council of Education from Junta de Castilla y Leon, Spain [SA157A12-1]; European FEDER Program; Spanish Ministry of Education; Spanish Ministry of Economy and Competitiveness	Spanish Ministry of Economy and Competitiveness(Spanish Government); Council of Health and Social Welfare; Council of Education from Junta de Castilla y Leon, Spain; European FEDER Program(European Commission); Spanish Ministry of Education(Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (SAF2010-20918-C02-01 and SAF2103-48210-C2-02 (to A.P.), SAF2010-20918-C02-02, SAF2103-48210-C2-01 (to C.G.)) and from the Council of Health and Social Welfare and the Council of Education from Junta de Castilla y Leon (SA157A12-1, to C.G.), Spain. All funding was cosponsored by the European FEDER Program. This work was also supported by the Spanish Ministry of Education (FPU fellowship) (to M.A. and N.P.) and the Spanish Ministry of Economy and Competitiveness (to A.V.).	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Barrantes ID, 2012, BIOCHEM SOC T, V40, P79, DOI 10.1042/BST20110676; Behren A, 2010, ONCOGENE, V29, P1519, DOI 10.1038/onc.2009.436; Blackburn J, 2003, INVEST OPHTH VIS SCI, V44, P4613, DOI 10.1167/iovs.03-0112; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Chen XJ, 2014, CARCINOGENESIS, V35, P1707, DOI 10.1093/carcin/bgu023; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; del Reino P, 2014, CANCER RES, V74, P6150, DOI 10.1158/0008-5472.CAN-14-0870; Denis H, 2011, EMBO REP, V12, P647, DOI 10.1038/embor.2011.110; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Farooq F, 2009, HUM MOL GENET, V18, P4035, DOI 10.1093/hmg/ddp352; Gallagher WM, 2005, TRENDS MOL MED, V11, P336, DOI 10.1016/j.molmed.2005.06.001; Gomes LR, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-26; Gupta J, 2014, CANCER CELL, V25, P484, DOI 10.1016/j.ccr.2014.02.019; Gutierrez-Uzquiza A, 2012, J BIOL CHEM, V287, P2632, DOI 10.1074/jbc.M111.323709; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hu B, 2012, CANCER RES, V72, P3873, DOI 10.1158/0008-5472.CAN-12-1060; Hu B, 2009, MOL CANCER RES, V7, P1756, DOI 10.1158/1541-7786.MCR-09-0207; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Cerezo-Guisado MI, 2011, CARCINOGENESIS, V32, P1093, DOI 10.1093/carcin/bgr079; Johansson N, 2000, J CELL SCI, V113, P227; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim EJ, 2012, INT J ONCOL, V40, P402, DOI 10.3892/ijo.2011.1191; Kim IG, 2013, ONCOGENE, V1, P1, DOI DOI 10.1128/JVI.01181-13; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Leelahavanichkul K, 2014, MOL ONCOL, V8, P105, DOI 10.1016/j.molonc.2013.10.003; de Silanes IL, 2009, NUCLEIC ACIDS RES, V37, P2658, DOI 10.1093/nar/gkp123; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; Miremadi A, 2007, HUM MOL GENET, V16, pR28, DOI 10.1093/hmg/ddm021; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Obaya AJ, 2012, CANCER LETT, V325, P132, DOI 10.1016/j.canlet.2012.06.019; Paradisi A, 2008, J BIOL CHEM, V283, P6005, DOI 10.1074/jbc.M707964200; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; Ricote M, 2006, J PATHOL, V208, P401, DOI 10.1002/path.1910; Rousseau S, 2006, CELL SIGNAL, V18, P1897, DOI 10.1016/j.cellsig.2006.02.006; Sadr-Nabavi A, 2009, INT J CANCER, V124, P1727, DOI 10.1002/ijc.24108; Schewe DM, 2008, P NATL ACAD SCI USA, V105, P10519, DOI 10.1073/pnas.0800939105; Schindler EM, 2009, CANCER RES, V69, P4648, DOI 10.1158/0008-5472.CAN-08-4455; Seeliger H, 2009, MOL CANCER RES, V7, P189, DOI 10.1158/1541-7786.MCR-08-0132; Suswam E, 2008, CANCER RES, V68, P674, DOI 10.1158/0008-5472.CAN-07-2751; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Tiedje C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002977; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Tong JD, 2011, NEOPLASMA, V58, P441, DOI 10.4149/neo_2011_05_441; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Xu S, 2014, ONCOL REP, V31, P79, DOI 10.3892/or.2013.2799; Zuluaga S, 2007, FEBS LETT, V581, P3819, DOI 10.1016/j.febslet.2007.06.078	53	19	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4383	4397		10.1074/jbc.M114.582239	http://dx.doi.org/10.1074/jbc.M114.582239			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25548290	Green Published, hybrid			2022-12-26	WOS:000349458400046
J	Baronio, D; Castro, K; Gonchoroski, T; de Melo, GM; Nunes, GD; Bambini, V; Gottfried, C; Riesgo, R				Baronio, Diego; Castro, Kamila; Gonchoroski, Taylor; de Melo, Gabriela Mueller; Della Flora Nunes, Gustavo; Bambini-Junior, Victorio; Gottfried, Carmem; Riesgo, Rudimar			Effects of an H3R Antagonist on the Animal Model of Autism Induced by Prenatal Exposure to Valproic Acid	PLOS ONE			English	Article							RECEPTOR ANTAGONISTS; WORKING-MEMORY; HISTAMINE; CHILDREN; ANTINOCICEPTION; SCHIZOPHRENIA; FAMOTIDINE; DISORDERS; DEFICITS; SENSITIZATION	Autism spectrum disorders (ASD) are a group of neurodevelopmental disorders primarily characterized by impaired social interaction and communication, and by restricted repetitive behaviors and interests. Ligands of histamine receptor 3 (H3R) are considered potential therapeutic agents for the treatment of different brain disorders and cognitive impairments. Considering this, the aim of the present study is to evaluate the actions of ciproxifan (CPX), an H3R antagonist, on the animal model of autism induced by prenatal exposure to valproic acid (VPA). Swiss mice were prenatally exposed to VPA on embryonic day 11 and assessed for social behavior, nociceptive threshold and repetitive behavior at 50 days of life. The treatment with CPX (3 mg/kg) or saline was administered 30 minutes before each behavioral test. The VPA group presented lower sociability index compared to VPA animals that were treated with CPX. Compared to the Control group, VPA animals presented a significantly higher nociceptive threshold, and treatment with CPX was not able to modify this parameter. In the marble burying test, the number of marbles buried by VPA animals was consistent with markedly repetitive behavior. VPA animals that received CPX buried a reduced amount of marbles. In summary, we report that an acute dose of CPX is able to attenuate sociability deficits and stereotypies present in the VPA model of autism. Our findings have the potential to help the investigations of both the molecular underpinnings of ASD and of possible treatments to ameliorate the ASD symptomatology, although more research is still necessary to corroborate and expand this initial data.	[Baronio, Diego; Castro, Kamila; Gonchoroski, Taylor; de Melo, Gabriela Mueller; Della Flora Nunes, Gustavo; Bambini-Junior, Victorio; Gottfried, Carmem; Riesgo, Rudimar] Univ Fed Rio Grande do Sul, Translat Res Grp Autism Spectrum Disorders, Porto Alegre, RS, Brazil; [Baronio, Diego; Castro, Kamila; Riesgo, Rudimar] Univ Fed Rio Grande do Sul, Postgrad Program Child & Adolescent Hlth, Porto Alegre, RS, Brazil; [Baronio, Diego; Castro, Kamila; Gonchoroski, Taylor; de Melo, Gabriela Mueller; Della Flora Nunes, Gustavo; Bambini-Junior, Victorio; Gottfried, Carmem; Riesgo, Rudimar] Univ Fed Rio Grande do Sul, Dept Biochem, Res Grp Neuroglial Plast, Porto Alegre, RS, Brazil; [Riesgo, Rudimar] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Child Neurol Unit, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Baronio, D (corresponding author), Univ Fed Rio Grande do Sul, Translat Res Grp Autism Spectrum Disorders, Porto Alegre, RS, Brazil.	diego@baronio.com.br	Riesgo, Rudimar/Q-3821-2016; Nunes, Gustavo Della-Flora/AAR-9617-2021; Bambini-Junior, Victorio/O-7563-2014; Grokoski, Kamila Castro/M-2068-2015; Gottfried, Carmem/AAG-2355-2019; Bambini-Junior, Victorio/AAO-7056-2021	Nunes, Gustavo Della-Flora/0000-0001-9323-3556; Gottfried, Carmem/0000-0001-8838-1300; Bambini-Junior, Victorio/0000-0002-8590-6770; Grokoski, Kamila Castro/0000-0003-0100-1788; Mueller de Melo, Gabriela/0000-0003-0429-2023	Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (FIPE-HCPA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (FIPE-HCPA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (FIPE-HCPA), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAMBINI V, 2014, PRENATAL EXPOSURE VA, P1779; da Silveira CKB, 2013, NEUROBIOL LEARN MEM, V103, P64, DOI 10.1016/j.nlm.2013.04.001; Brioni JD, 2011, J PHARMACOL EXP THER, V336, P38, DOI 10.1124/jpet.110.166876; Bromley RL, 2013, J NEUROL NEUROSUR PS, V84, P637, DOI 10.1136/jnnp-2012-304270; Brown JW, 2013, INT J NEUROPSYCHOPH, V16, P889, DOI 10.1017/S1461145712000739; Burban A, 2010, PSYCHOPHARMACOLOGY, V210, P591, DOI 10.1007/s00213-010-1863-2; Carroll LS, 2009, GENOME MED, V1, DOI 10.1186/gm102; CHRISTIANSON AL, 1994, DEV MED CHILD NEUROL, V36, P361; Ellenbroek BA, 2014, TRENDS NEUROSCI, V37, P191, DOI 10.1016/j.tins.2014.02.007; Farzin D, 2002, PHARMACOL BIOCHEM BE, V72, P751, DOI 10.1016/S0091-3057(02)00748-7; Ferstl R, 2012, FRONT BIOSCI-LANDMRK, V17, P40, DOI 10.2741/3914; Fox GB, 2005, J PHARMACOL EXP THER, V313, P176, DOI 10.1124/jpet.104.078402; GLICK SD, 1978, NATURE, V273, P547, DOI 10.1038/273547a0; Griebel G, 2012, PHARMACOL BIOCHEM BE, V102, P203, DOI 10.1016/j.pbb.2012.04.004; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Happe F, 2008, NEUROPSYCHOL REV, V18, P287, DOI 10.1007/s11065-008-9076-8; Huang L, 2007, REGION ANESTH PAIN M, V32, P124, DOI 10.1016/j.rapm.2006.11.009; Huguet G, 2013, ANNU REV GENOM HUM G, V14, P191, DOI 10.1146/annurev-genom-091212-153431; Ito C, 1997, PSYCHOPHARMACOLOGY, V130, P362, DOI 10.1007/s002130050251; JOSHI VV, 1981, EUR J PHARMACOL, V69, P499, DOI 10.1016/0014-2999(81)90456-8; KAMINSKY R, 1990, LANCET, V335, P1351, DOI 10.1016/0140-6736(90)91237-5; Konstantareas MM, 2001, J AUTISM DEV DISORD, V31, P19, DOI 10.1023/A:1005605528309; Linday LA, 1997, MED HYPOTHESES, V48, P381, DOI 10.1016/S0306-9877(97)90032-3; Linday LA, 2001, J NEURAL TRANSM, V108, P593, DOI 10.1007/s007020170059; MALMBERGAIELLO P, 1994, BRIT J PHARMACOL, V111, P1269, DOI 10.1111/j.1476-5381.1994.tb14883.x; Martin HGS, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00023; Motawaj M, 2011, EUR J NEUROSCI, V33, P1197, DOI 10.1111/j.1460-9568.2011.07618.x; NADDAFI F, 2013, AM J ALZHEIMERS DIS; Noland JS, 2010, DEVELOPMENTAL SCI, V13, P244, DOI 10.1111/j.1467-7687.2009.00882.x; Nuutinen S, 2011, NEUROPHARMACOLOGY, V60, P1193, DOI 10.1016/j.neuropharm.2010.10.027; OWEN SM, 1994, AGENTS ACTIONS, V41, pC62, DOI 10.1007/BF02007768; Paschou P, 2013, NEUROSCI BIOBEHAV R, V37, P1026, DOI 10.1016/j.neubiorev.2013.01.016; Passani MB, 2011, TRENDS PHARMACOL SCI, V32, P242, DOI 10.1016/j.tips.2011.01.003; Rodier PM, 1996, J COMP NEUROL, V370, P247, DOI 10.1002/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2; Rossi PG, 1999, J CHILD NEUROL, V14, P547, DOI 10.1177/088307389901400814; Roullet FI, 2010, NEUROSCIENCE, V170, P514, DOI 10.1016/j.neuroscience.2010.06.069; John A, 2013, AUTISM RES, V6, P69, DOI 10.1002/aur.1264; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Schwartz JC, 2011, BRIT J PHARMACOL, V163, P713, DOI 10.1111/j.1476-5381.2011.01286.x; Shan L, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.016; Silvestrin RB, 2013, BRAIN RES, V1495, P52, DOI 10.1016/j.brainres.2012.11.048; Steele SD, 2007, J AUTISM DEV DISORD, V37, P605, DOI 10.1007/s10803-006-0202-2; SUZUKI T, 1994, LIFE SCI, V54, P203, DOI 10.1016/0024-3205(94)00589-3; Tiligada E, 2011, CNS NEUROSCI THER, V17, P620, DOI 10.1111/j.1755-5949.2010.00212.x; Trofimiuk E, 2014, PSYCHOPHARMACOLOGY, V231, P209, DOI 10.1007/s00213-013-3227-1; Zhang DD, 2012, INFLAMM RES, V61, P1283, DOI 10.1007/s00011-012-0528-5	46	60	61	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e0116363	10.1371/journal.pone.0116363	http://dx.doi.org/10.1371/journal.pone.0116363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25560049	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000348102200015
J	Dumonceaux, TJ; Green, M; Hammond, C; Perez, E; Olivier, C				Dumonceaux, Tim J.; Green, Margaret; Hammond, Christine; Perez, Edel; Olivier, Chrystel			Molecular Diagnostic Tools for Detection and Differentiation of Phytoplasmas Based on Chaperonin-60 Reveal Differences in Host Plant Infection Patterns	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; FINER DIFFERENTIATION; SEQUENCE-ANALYSIS; GENE-SEQUENCES; GROEL GENE; IDENTIFICATION; CLASSIFICATION; AMPLIFICATION; YELLOWS; STRAINS	Phytoplasmas ('Candidatus Phytoplasma' spp.) are insect-vectored bacteria that infect a wide variety of plants, including many agriculturally important species. The infections can cause devastating yield losses by inducing morphological changes that dramatically alter inflorescence development. Detection of phytoplasma infection typically utilizes sequences located within the 16S-23S rRNA-encoding locus, and these sequences are necessary for strain identification by currently accepted standards for phytoplasma classification. However, these methods can generate PCR products >1400 bp that are less divergent in sequence than protein-encoding genes, limiting strain resolution in certain cases. We describe a method for accessing the chaperonin-60 (cpn60) gene sequence from a diverse array of 'Ca. Phytoplasma' spp. Two degenerate primer sets were designed based on the known sequence diversity of cpn60 from 'Ca. Phytoplasma' spp. and used to amplify cpn60 gene fragments from various reference samples and infected plant tissues. Forty three cpn60 sequences were thereby determined. The cpn60 PCR-gel electrophoresis method was highly sensitive compared to 16S-23S-targeted PCR-gel electrophoresis. The topology of a phylogenetic tree generated using cpn60 sequences was congruent with that reported for 16S rRNA-encoding genes. The cpn60 sequences were used to design a hybridization array using oligonucleotide-coupled fluorescent microspheres, providing rapid diagnosis and typing of phytoplasma infections. The oligonucleotide-coupled fluorescent microsphere assay revealed samples that were infected simultaneously with two subtypes of phytoplasma. These tools were applied to show that two host plants, Brassica napus and Camelina sativa, displayed different phytoplasma infection patterns.	[Dumonceaux, Tim J.; Hammond, Christine; Olivier, Chrystel] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada; [Dumonceaux, Tim J.] Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada; [Green, Margaret] Canadian Food Inspect Agcy, Ctr Plant Hlth, Sidney, BC, Canada; [Perez, Edel] Univ Veracruzana, Inst Biotecnol & Ecol Aplicada INBIOTECA, Xalapa 91000, Veracruz, Mexico	Agriculture & Agri Food Canada; University of Saskatchewan; Canadian Food Inspection Agency; Universidad Veracruzana	Dumonceaux, TJ (corresponding author), Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada.	tim.dumonceaux@agr.gc.ca	Olivier, chrystel/AAG-2673-2020; Dumonceaux, Tim/H-4751-2019; Pérez-López, Edel/B-2148-2016	Olivier, chrystel/0000-0002-5982-9775; Dumonceaux, Tim/0000-0001-5165-0343; Pérez-López, Edel/0000-0002-3708-8558	Genomics Research and Development Initiative for the shared priority project on quarantine and invasive species	Genomics Research and Development Initiative for the shared priority project on quarantine and invasive species	This work was supported by the Genomics Research and Development Initiative for the shared priority project on quarantine and invasive species. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini E, 2007, J MICROBIOL METH, V68, P613, DOI 10.1016/j.mimet.2006.11.015; Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmico1523, 10.1038/nrmicro1523]; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chaban B, 2009, APPL ENVIRON MICROB, V75, P3055, DOI 10.1128/AEM.00101-09; Chung WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062770; Clark GW, 2010, BIOCHEM CELL BIOL, V88, P185, DOI [10.1139/o09-157, 10.1139/O09-157]; Contaldo N, 2012, PHYTOPATHOL MEDITERR, V51, P607; Daire X, 1997, EUR J PLANT PATHOL, V103, P507, DOI 10.1023/A:1008641411025; DENG SJ, 1991, J MICROBIOL METH, V14, P53, DOI 10.1016/0167-7012(91)90007-D; DORSCH M, 1992, J MICROBIOL METH, V16, P271, DOI 10.1016/0167-7012(92)90017-X; Dumonceaux TJ, 2011, JOVE-J VIS EXP, DOI 10.3791/3344; Dumonceaux Tim J, 2009, J Clin Microbiol, V47, P4067, DOI 10.1128/JCM.00112-09; Dumonceaux TJ, 2006, J MICROBIOL METH, V64, P46, DOI 10.1016/j.mimet.2005.04.006; Firrao G, 2013, SYST APPL MICROBIOL, V36, P539, DOI 10.1016/j.syapm.2013.07.003; Gasparich GE, 2010, BIOLOGICALS, V38, P193, DOI 10.1016/j.biologicals.2009.11.007; Goh SH, 1996, J CLIN MICROBIOL, V34, P818, DOI 10.1128/JCM.34.4.818-823.1996; Goh SH, 2000, J CLIN MICROBIOL, V38, P3953, DOI 10.1128/JCM.38.11.3953-3959.2000; Hill JE, 2006, J MED MICROBIOL, V55, P393, DOI 10.1099/jmm.0.46282-0; Hill JE, 2006, ENVIRON MICROBIOL, V8, P741, DOI 10.1111/j.1462-2920.2005.00944.x; Hill JE, 2004, GENOME RES, V14, P1669, DOI 10.1101/gr.2649204; Hoorfar J, 2004, J CLIN MICROBIOL, V42, P1863, DOI 10.1128/JCM.42.5.1863-1868.2004; Jayaprakash TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043009; Lee IM, 2010, INT J SYST EVOL MICR, V60, P2887, DOI 10.1099/ijs.0.019695-0; Lee IM, 2006, MOL CELL PROBE, V20, P87, DOI 10.1016/j.mcp.2005.10.001; LEE IM, 1993, PHYTOPATHOLOGY, V83, P834, DOI 10.1094/Phyto-83-834; Lee IM, 1998, INT J SYST BACTERIOL, V48, P1153, DOI 10.1099/00207713-48-4-1153; Lee IM, 2000, ANNU REV MICROBIOL, V54, P221, DOI 10.1146/annurev.micro.54.1.221; Links MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049755; Maejima K, 2014, J GEN PLANT PATHOL, V80, P210, DOI 10.1007/s10327-014-0512-8; Makarova O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052092; Marcone C, 2000, INT J SYST EVOL MICR, V50, P1703, DOI 10.1099/00207713-50-5-1703; Martini M, 2007, INT J SYST EVOL MICR, V57, P2037, DOI 10.1099/ijs.0.65013-0; Mende DR, 2013, NAT METHODS, V10, P881, DOI [10.1038/NMETH.2575, 10.1038/nmeth.2575]; Mitrovic J, 2011, ANN APPL BIOL, V159, P41, DOI 10.1111/j.1744-7348.2011.00472.x; Mitrovic J, 2011, B INSECTOL, V64, pS17; Namba S, 2011, J GEN PLANT PATHOL, V77, P345, DOI 10.1007/s10327-011-0341-y; Nikolic P, 2010, MOL CELL PROBE, V24, P303, DOI 10.1016/j.mcp.2010.06.005; Olivier C, 2011, AM J PLANT SCI BIOTE, V141, P425; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Saccardo F, 2012, MICROBIOL-SGM, V158, P2805, DOI 10.1099/mic.0.061432-0; Schellenberg JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041217; Seemuller E, 2010, PHYTOPATHOLOGY, V100, P863, DOI 10.1094/PHYTO-100-9-0863; Smart CD, 1996, APPL ENVIRON MICROB, V62, P2988, DOI 10.1128/AEM.62.8.2988-2993.1996; Sugawara K, 2012, J GEN PLANT PATHOL, V78, P389, DOI 10.1007/s10327-012-0403-9; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valiunas D, 2013, INT J SYST EVOL MICR, V63, P3904, DOI 10.1099/ijs.0.051912-0; Wei W, 2007, INT J SYST EVOL MICR, V57, P1855, DOI 10.1099/ijs.0.65000-0; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039; Zeigler DR, 2003, INT J SYST EVOL MICR, V53, P1893, DOI 10.1099/ijs.0.02713-0; Zhao Y., 2014, GENOMICS PLANT ASS B, P235	52	28	28	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116039	10.1371/journal.pone.0116039	http://dx.doi.org/10.1371/journal.pone.0116039			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551224	Green Submitted, Green Published, gold			2022-12-26	WOS:000347119100091
J	Frerker, K; Sabo, A; Waller, D				Frerker, Katie; Sabo, Autumn; Waller, Donald			Long-Term Regional Shifts in Plant Community Composition Are Largely Explained by Local Deer Impact Experiments	PLOS ONE			English	Article							WHITE-TAILED DEER; ODOCOILEUS-VIRGINIANUS ZIMMERMAN; ALTERNATE STABLE STATES; GROUND-LAYER VEGETATION; GREAT-LAKES REGION; OLD-GROWTH FOREST; ECOLOGICAL RESEARCH; NORTHERN WISCONSIN; TREE REGENERATION; OVERABUNDANT DEER	The fact that herbivores and predators exert top-down effects to alter community composition and dynamics at lower trophic levels is no longer controversial, yet we still lack evidence of the full nature, extent, and longer-term effects of these impacts. Here, we use results from a set of replicated experiments on the local impacts of white-tailed deer to evaluate the extent to which such impacts could account for half-century shifts in forest plant communities across the upper Midwest, USA. We measured species' responses to deer at four sites using 10-20 year-old deer exclosures. Among common species, eight were more abundant outside the exclosures, seven were commoner inside, and 16 had similar abundances in-and outside. Deer herbivory greatly increased the abundance of ferns and graminoids and doubled the abundance of exotic plants. In contrast, deer greatly reduced tree regeneration, shrub cover (100200 fold in two species), plant height, plant reproduction, and the abundance of forbs. None of 36 focal species increased in reproduction or grew taller in the presence of deer, contrary to expectations. We compared these results to data on 50-year regional shifts in species abundances across 62 sites. The effects of herbivory by white-tailed deer accurately account for many of the long-term regional shifts observed in species' abundances (R-2=0.41). These results support the conjecture that deer impacts have driven many of the regional shifts in forest understory cover and composition observed in recent decades. Our ability to link results from shorter-term, local experiments to regional long-term studies of ecological change strengthens the inferences we can draw from both approaches.	[Frerker, Katie; Waller, Donald] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [Sabo, Autumn] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Waller, D (corresponding author), Univ Wisconsin, Dept Bot, Madison, WI 53706 USA.	dmwaller@wisc.edu			UW-Madison Botany Department; Friends of Peninsula State Park; McIntire-Stennis Program	UW-Madison Botany Department; Friends of Peninsula State Park; McIntire-Stennis Program	The authors thank the UW-Madison Botany Department (www.botany.wisc.edu/), Friends of Peninsula State Park (http://peninsulafriends.org/), and the McIntire-Stennis Program (http://www.csrees.usda.gov/business/awards/formula/mcintire_stennis.html) for funding portions of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allombert S, 2005, CONSERV BIOL, V19, P1917, DOI 10.1111/j.1523-1739.2005.00280.x; Alverson William S., 1997, P280; ALVERSON WS, 1988, CONSERV BIOL, V2, P348, DOI 10.1111/j.1523-1739.1988.tb00199.x; ANDERSON RC, 1994, ECOL APPL, V4, P104, DOI 10.2307/1942119; ANDERSON RC, 1993, BIOL CONSERV, V63, P203, DOI 10.1016/0006-3207(93)90713-B; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Augustine DJ, 1998, ECOL APPL, V8, P1260, DOI 10.1890/1051-0761(1998)008[1260:EFTASS]2.0.CO;2; Augustine DJ, 1998, CONSERV BIOL, V12, P995, DOI 10.1046/j.1523-1739.1998.97248.x; Augustine DJ, 1997, GRAZING PATTERNS IMP; BALGOOYEN CP, 1995, NAT AREA J, V15, P308; CALLAHAN JT, 1984, BIOSCIENCE, V34, P363, DOI 10.2307/1309727; Canterbury GE, 2000, CONSERV BIOL, V14, P544, DOI 10.1046/j.1523-1739.2000.98235.x; Cardinal E, 2012, CAN J ZOOL, V90, P704, DOI [10.1139/Z2012-037, 10.1139/z2012-037]; Cardinal E, 2012, ECOSCIENCE, V19, P38, DOI 10.2980/19-1-3441; Chollet S, 2015, BIOL INVASIONS, V17, P777, DOI 10.1007/s10530-014-0768-0; Chollet S, 2013, DIVERS DISTRIB, V19, P481, DOI 10.1111/ddi.12003; Christopher CC, 2012, AM MIDL NAT, V167, P256, DOI 10.1674/0003-0031-167.2.256; Collard A, 2010, FOREST ECOL MANAG, V260, P649, DOI 10.1016/j.foreco.2010.05.021; Cornett MW, 2000, BIOL CONSERV, V93, P359, DOI 10.1016/S0006-3207(99)00129-9; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Curtis JT, 1959, VEGETATION WISCONSIN; de la Cretaz AL, 2002, RESTOR ECOL, V10, P416, DOI 10.1046/j.1526-100X.2002.02037.x; Fletcher JD, 2001, NAT AREA J, V21, P172; Frerker K, 2012, COMP EVALUATION METH; Frerker KL, 2012, WHITE TAILED DEER OD; Hurley PM, 2012, BIOL CONSERV, V146, P62, DOI 10.1016/j.biocon.2011.10.034; Lapointe L, 2010, AM J BOT, V97, P913, DOI 10.3732/ajb.0900200; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; MAGNUSON JJ, 1990, BIOSCIENCE, V40, P495, DOI 10.2307/1311317; Martin JL, 2010, BIOL INVASIONS, V12, P353, DOI 10.1007/s10530-009-9628-8; Martin JL, 2002, CAN J FOREST RES, V32, P1254, DOI [10.1139/x02-043, 10.1139/X02-043]; McGraw JB, 2005, SCIENCE, V307, P920, DOI 10.1126/science.1107036; McShea WJ, 2012, ANN NY ACAD SCI, V1249, P45, DOI 10.1111/j.1749-6632.2011.06376.x; McShea WJ, 1992, VIRGINIA J SCI, V43, P177; MILLER S C, 1992, Natural Areas Journal, V12, P67; MLADENOFF DJ, 1993, CONSERV BIOL, V7, P889, DOI 10.1046/j.1523-1739.1993.740889.x; Morecroft MD, 2001, FORESTRY, V74, P251, DOI 10.1093/forestry/74.3.251; Mudrak EL, 2009, NAT AREA J, V29, P167, DOI 10.3375/043.029.0209; Newson SE, 2012, J APPL ECOL, V49, P278, DOI 10.1111/j.1365-2664.2011.02077.x; Patel A, 2000, NAT AREA J, V20, P250; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Rogers DA, 2009, CONSERV BIOL, V23, P1497, DOI 10.1111/j.1523-1739.2009.01256.x; Rooney TP, 2009, PLANT ECOL, V202, P103, DOI 10.1007/s11258-008-9489-8; Rooney TP, 2004, CONSERV BIOL, V18, P787, DOI 10.1111/j.1523-1739.2004.00515.x; Rooney TP, 2003, FOREST ECOL MANAG, V181, P165, DOI 10.1016/S0378-1127(03)00130-0; Rooney TP, 1997, NAT AREA J, V17, P297; Rooney TP, 2001, FORESTRY, V74, P201, DOI 10.1093/forestry/74.3.201; Rooney TP, 1998, FOREST ECOL MANAG, V111, P211, DOI 10.1016/S0378-1127(98)00333-8; Royo AA, 2006, CAN J FOREST RES, V36, P1345, DOI 10.1139/X06-025; Royo AA, 2010, BIOL CONSERV, V143, P2425, DOI 10.1016/j.biocon.2010.05.020; Russell FL, 2001, AM MIDL NAT, V146, P1, DOI 10.1674/0003-0031(2001)146[0001:EOWTDO]2.0.CO;2; Stromayer KAK, 1997, WILDLIFE SOC B, V25, P227; Suominen O, 1999, OIKOS, V84, P215, DOI 10.2307/3546716; SWANSON FJ, 1990, BIOSCIENCE, V40, P502, DOI 10.2307/1311318; Tanentzap AJ, 2012, FOREST ECOL MANAG, V264, P159, DOI 10.1016/j.foreco.2011.10.005; Tanentzap AJ, 2009, J APPL ECOL, V46, P1064, DOI 10.1111/j.1365-2664.2009.01683.x; Trumbull V. L., 1989, Northern Journal of Applied Forestry, V6, P162; Urbanek RE, 2012, NAT AREA J, V32, P6, DOI 10.3375/043.032.0103; Waller DM, 2004, TRENDS ECOL EVOL, V19, P6, DOI 10.1016/j.tree.2003.10.011; Waller DM, 1997, WILDLIFE SOC B, V25, P217; Webster CR, 2005, BIOL CONSERV, V125, P297, DOI 10.1016/j.biocon.2005.03.027; White MA, 2012, FOREST ECOL MANAG, V269, P222, DOI 10.1016/j.foreco.2011.12.043; Wiegmann SM, 2006, BIOL CONSERV, V129, P109, DOI 10.1016/j.biocon.2005.10.027; Wisconsin Department of Natural Resources, 2014, DEER POP GOALS	64	53	53	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115843	10.1371/journal.pone.0115843	http://dx.doi.org/10.1371/journal.pone.0115843			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551827	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100069
J	Liu, B; Chen, HT; Xu, Y; An, CY; Zhong, LQ; Wang, XH; Zhang, Y; Chen, HQ; Zhang, JX; Wang, ZL				Liu, Bin; Chen, Haitian; Xu, Yun; An, Chongyou; Zhong, Lieqiang; Wang, Xiaohui; Zhang, Ying; Chen, Hanqing; Zhang, Jinxin; Wang, Zilian			Fetal Growth Is Associated with Maternal Fasting Plasma Glucose at First Prenatal Visit	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; ADVERSE PREGNANCY OUTCOMES; DEVELOPMENTAL ORIGINS; METABOLIC SYNDROME; RANDOMIZED-TRIAL; WEIGHT-GAIN; WOMEN; OVERWEIGHT; HYPERGLYCEMIA; MULTICENTER	Aims: Fasting plasma glucose (FPG) concentration measured at the first prenatal visit is a predictor of gestational diabetes mellitus (GDM); however, whether this test is indicative of fetal growth has not been clarified. Thus, the purpose of this study was to determine whether birth weight and birth length were related to FPG levels at the first prenatal visit. Materials and Methods: Research samples were collected from pregnant women who took an FPG test at their first prenatal visit (10-24 gestational weeks), received regular prenatal care, and delivered in our center. FPG value, maternal pre-gravid BMI, weight gain before FPG test, before and after Oral Glucose Tolerance Test (OGTT), neonatal birthweight, birth length, Ponderal Index and birthing method were recorded for analysis. Data were analyzed by independent sample t test, Pearson correlation, and Chi-square test, followed by partial correlation or logistic regression to confirm differences. Statistical significance level was alpha=0.05. Results: 2284 pregnant women, including 462 GDM and 1822 with normal glucose tolerance (NGT) were recruited for the present study. FPG concentration at the first prenatal visit was associated with neonatal birth weight (partial correlation coefficient r'=0.089, P< 0.001) and birth length (partial correlation coefficient r'=0.061, P=0.005), but not with Ponderal Index or birthing method. Maternal pregravid BMI was associated with FPG value (partial correlation coefficient r'=0.113, P< 0.001). FPG concentration at the first prenatal visit (OR=2.945, P< 0.001), weight gain before OGTT test (OR=1.039, P=0.010), and age (OR=1.107, P<0.001) were independent related factors of GDM. Conclusion: Fasting plasma glucose concentration at the first prenatal visit is associated with fetal growth. Maternal pre-gravid BMI and weight gain are related to glucose metabolism.	[Liu, Bin; Chen, Haitian; An, Chongyou; Zhong, Lieqiang; Wang, Xiaohui; Zhang, Ying; Chen, Hanqing; Wang, Zilian] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Yun] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Endocrinol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Jinxin] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhang, JX (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China.	zhjinx@mail.sysu.edu.cn; wzlsums@163.com			Sun Yat-Sen University Clinical Research 5010 Program	Sun Yat-Sen University Clinical Research 5010 Program	The present study is granted by Sun Yat-Sen University Clinical Research 5010 Program(to Zilian Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberico S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-23; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Clausen TD, 2009, J CLIN ENDOCR METAB, V94, P2464, DOI 10.1210/jc.2009-0305; Dodd JM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1285; Dong L, 2013, DIABETES RES CLIN PR, V102, P210, DOI 10.1016/j.diabres.2013.10.017; Egan AM, 2014, J CLIN ENDOCR METAB, V99, P212, DOI 10.1210/jc.2013-2684; Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187; Jovanovic L, 2001, JAMA-J AM MED ASSOC, V286, P2516, DOI 10.1001/jama.286.20.2516; Kim SY, 2011, EXP DIABETES RES, DOI 10.1155/2011/541308; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082310; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Morrison JL, 2010, PEDIATR NEPHROL, V25, P669, DOI 10.1007/s00467-009-1407-3; Negrato CA, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-41; PEDERSEN J, 1954, ACTA ENDOCRINOL-COP, V16, P330, DOI 10.1530/acta.0.0160330; Rattanatray L, 2010, ENDOCRINOLOGY, V151, P5195, DOI 10.1210/en.2010-0501; Riskin-Mashiah S, 2009, DIABETES CARE, V32, P1639, DOI 10.2337/dc09-0688; Solomon CG, 1997, JAMA-J AM MED ASSOC, V278, P1078, DOI 10.1001/jama.278.13.1078; Tomedi LE, 2013, MATERN CHILD HLTH J; Zhang S, 2011, PROG BIOPHYS MOL BIO, V106, P307, DOI 10.1016/j.pbiomolbio.2010.12.004; Zhang S, 2010, FASEB J, V24, P2772, DOI 10.1096/fj.09-154294; Zhu WW, 2012, DIABETES CARE	23	12	13	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116352	10.1371/journal.pone.0116352	http://dx.doi.org/10.1371/journal.pone.0116352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551824	Green Published, gold, Green Submitted			2022-12-26	WOS:000347119100132
J	Melia, U; Burgos, F; Vallverdu, M; Velickovski, F; Lluch-Ariet, M; Roca, J; Caminal, P				Melia, Umberto; Burgos, Felip; Vallverdu, Montserrat; Velickovski, Filip; Lluch-Ariet, Magi; Roca, Josep; Caminal, Pere			Algorithm for Automatic Forced Spirometry Quality Assessment: Technological Developments	PLOS ONE			English	Article							STANDARDIZATION	We hypothesized that the implementation of automatic real-time assessment of quality of forced spirometry (FS) may significantly enhance the potential for extensive deployment of a FS program in the community. Recent studies have demonstrated that the application of quality criteria defined by the ATS/ERS (American Thoracic Society/European Respiratory Society) in commercially available equipment with automatic quality assessment can be markedly improved. To this end, an algorithm for assessing quality of FS automatically was reported. The current research describes the mathematical developments of the algorithm. An innovative analysis of the shape of the spirometric curve, adding 23 new metrics to the traditional 4 recommended by ATS/ERS, was done. The algorithm was created through a two-step iterative process including: (1) an initial version using the standard FS curves recommended by the ATS; and, (2) a refined version using curves from patients. In each of these steps the results were assessed against one expert's opinion. Finally, an independent set of FS curves from 291 patients was used for validation purposes. The novel mathematical approach to characterize the FS curves led to appropriate FS classification with high specificity (95%) and sensitivity (96%). The results constitute the basis for a successful transfer of FS testing to non-specialized professionals in the community.	[Melia, Umberto; Vallverdu, Montserrat; Caminal, Pere] Univ Politecn Cataluna, Dept Engn Sistemes Automat & Informat Ind ESAII, CREB, CIBER BBN, Barcelona, Spain; [Burgos, Felip; Roca, Josep] Univ Barcelona, IDIBAPS, Dept Pulm Med, Hosp Clin Barcelona ICT, Barcelona, Spain; [Burgos, Felip; Roca, Josep] Ctr Invest Red Enfermedades Resp CibeRes, Palma De Mallorca, Spain; [Velickovski, Filip; Lluch-Ariet, Magi] Barcelona Digital Technol Ctr, Barcelona, Spain; [Velickovski, Filip; Lluch-Ariet, Magi] Univ Politecn Cataluna, Dept Engn Telemat ENTEL, Barcelona, Spain; [Velickovski, Filip] Univ Girona, ViCOROB, Girona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universitat Politecnica de Catalunya; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Universitat Politecnica de Catalunya; Universitat de Girona	Melia, U (corresponding author), Univ Politecn Cataluna, Dept Engn Sistemes Automat & Informat Ind ESAII, CREB, CIBER BBN, Barcelona, Spain.	umberto.melia@upc.edu	Roca, Josep/J-2583-2015; LLUCH-ARIET, Magí/E-2233-2017; Burgos, Felip/E-5734-2015	Roca, Josep/0000-0003-4768-8722; LLUCH-ARIET, Magí/0000-0001-6926-7190; Burgos, Felip/0000-0002-4938-4581; Melia, Umberto/0000-0003-3033-0505	Inforegio (AGAUR); NEXES (Supporting Healthier and Independent Living for Chronic Patients and Elderly) [CIP-ICT-PSP-2007-225025]; FIS [PI09/90634]; Servicios Innovadores de Atencion Integrada para Pacientes Cronicos [PITES- ISCIII 2010-12]; EC-FP7 Programme, Synergy-COPD, GA [270086]; Catalan Master Plan of Respiratory Diseases (PDMAR); TAMESIS (Spanish Government) [TEC2011-22746]	Inforegio (AGAUR); NEXES (Supporting Healthier and Independent Living for Chronic Patients and Elderly); FIS(Instituto de Salud Carlos III); Servicios Innovadores de Atencion Integrada para Pacientes Cronicos; EC-FP7 Programme, Synergy-COPD, GA; Catalan Master Plan of Respiratory Diseases (PDMAR); TAMESIS (Spanish Government)	This work was supported by Inforegio (AGAUR) 2009; NEXES (Supporting Healthier and Independent Living for Chronic Patients and Elderly, CIP-ICT-PSP-2007-225025); FIS PI09/90634; Servicios Innovadores de Atencion Integrada para Pacientes Cronicos - PITES- ISCIII 2010-12; EC-FP7 Programme, Synergy-COPD, GA no 270086; Catalan Master Plan of Respiratory Diseases (PDMAR); and TAMESIS (TEC2011-22746, Spanish Government). CIBER of Bioengineering, Biomaterials and Nanomedicine is an initiative of ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Bellia V, 2000, AM J RESP CRIT CARE, V161, P1094, DOI 10.1164/ajrccm.161.4.9810093; Burgos F, 2013, BUYERS GUIDE RESP CA, V14, P11; Burgos F., 2013, THESIS U BARCELONA; Burgos F, 2012, EUR RESPIR J, V39, P1313, DOI 10.1183/09031936.00168010; de Oca MM, 2008, RESP MED, V102, P642, DOI 10.1016/j.rmed.2007.12.025; de Oliveira Camargo-Brunetto Maria Angelica, 2013, Proceedings of the 6th International Conference on Health Informatics (HEALTHINF 2013), P207; Devi GM, 2013, INT J SCI TECHNOLOGY, V3, P74; Enright Paul L, 2003, Respir Care, V48, P773; Enright PL, 2010, RESP CARE, V55, P303; GARDNER RM, 1988, J OCCUP ENVIRON MED, V30, P272; Janssens W, 2013, RESP MED, V25; LAMBERT R K, 1989, Journal of Biomechanical Engineering, V111, P200, DOI 10.1115/1.3168366; Masa JF, 2011, EUR RESPIR J, V37, P911, DOI 10.1183/09031936.00011510; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Muller-Brandes C, 2014, EUR RESPIR J, V43, P1347, DOI 10.1183/09031936.00058813; PARDAENS J, 1975, J APPL PHYSIOL, V39, P191, DOI 10.1152/jappl.1975.39.2.191; Perez-Padilla R, 2008, RESP CARE, V53, P1019; Polak AG, 1998, COMPUT BIOL MED, V28, P613, DOI 10.1016/S0010-4825(98)00041-9; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Salas T, 2011, ARCH BRONCONEUMOL, V47, P466, DOI 10.1016/j.arbres.2011.06.005; Sankar AB, 2013, SADHANA-ACAD P ENG S, V38, P377, DOI 10.1007/s12046-013-0140-6; Spirometry Monitoring Technology - SPIROLA, NIOSH SPIR OCC MED	23	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116238	10.1371/journal.pone.0116238	http://dx.doi.org/10.1371/journal.pone.0116238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551213	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100112
J	Yu, PF; Ye, L; Wang, HB; Du, GY; Zhang, JZ; Zuo, YH; Zhang, JH; Tian, JW				Yu, Pengfei; Ye, Liang; Wang, Hongbo; Du, Guangying; Zhang, Jianzhao; Zuo, Yanhua; Zhang, Jinghai; Tian, Jingwei			NSK-01105, a Novel Sorafenib Derivative, Inhibits Human Prostate Tumor Growth via Suppression of VEGFR2/EGFR-Mediated Angiogenesis	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; CELL LUNG-CANCER; PHASE-II TRIAL; FACTOR RECEPTOR; ANTITUMOR-ACTIVITY; POTENT INHIBITOR; VEGF; DESIGN; PROGRESSION; MANAGEMENT	The purpose of this study is to investigate the anti-angiogenic activities of NSK01105, a novel sorafenib derivative, in in vitro, ex vivo and in vivo models, and explore the potential mechanisms. NSK-01105 significantly inhibited vascular endothelial growth factor (VEGF)-induced migration and tube formation of human umbilical vein endothelial cells at non-cytotoxic concentrations as shown by wound-healing, transwell migration and endothelial cell tube formation assays, respectively. Cell viability and invasion of LNCaP and PC-3 cells were significantly inhibited by cytotoxicity assay and matrigel invasion assay. Furthermore, NSK01105 also inhibited ex vivo angiogenesis in matrigel plug assay. Western blot analysis showed that NSK-01105 down-regulated VEGF-induced phosphorylation of VEGF receptor 2 (VEGFR2) and the activation of epidermal growth factor receptor (EGFR). Tumor volumes were significantly reduced by NSK-01105 at 60 mg/kg/day in both xenograft models. Immunohistochemical staining demonstrated a close association between inhibition of tumor growth and neovascularization. Collectively, our results suggest a role of NSK-01105 in treatment for human prostate tumors, and one of the potential mechanisms may be attributed to anti-angiogenic activities.	[Yu, Pengfei; Zhang, Jinghai] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang 110016, Liaoning, Peoples R China; [Ye, Liang; Wang, Hongbo; Du, Guangying; Zhang, Jianzhao; Tian, Jingwei] Luye Pharma Grp Ltd, Nonclin Res Dept, State Key Lab Long Acting & Targeting Drug Delive, Yantai 264003, Shandong, Peoples R China; [Wang, Hongbo; Du, Guangying; Tian, Jingwei] Yantai Univ, Sch Pharm, Yantai 264005, Shandong, Peoples R China; [Ye, Liang] Binzhou Med Univ, Sch Pharmaceut Sci, Yantai 264005, Shandong, Peoples R China; [Ye, Liang] Binzhou Med Univ, Inst Mat Med, Yantai 264005, Shandong, Peoples R China; [Zuo, Yanhua] Qingdao Univ, Coll Med, Affiliated Hosp, Qingdao 266001, Shandong, Peoples R China	Shenyang Pharmaceutical University; Yantai University; Binzhou Medical University; Binzhou Medical University; Qingdao University	Zhang, JH (corresponding author), Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang 110016, Liaoning, Peoples R China.	hazacar.2012@gmail.com; tianjingwei@luye.cn	王, 洪波/A-6767-2019; Wang, Hongbo/AHC-7831-2022; Tian, Jingwei/GPJ-9819-2022	王, 洪波/0000-0001-8530-2339; Wang, Hongbo/0000-0001-8530-2339; 	National Natural Science Foundation of China [81473188, 81202038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China No. 81473188 (JT) and National Natural Science Foundation of China No. 81202038 (HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzid K, 2008, BIOORGAN MED CHEM, V16, P7543, DOI 10.1016/j.bmc.2008.07.038; Adams J, 2002, CURR OPIN CHEM BIOL, V6, P486, DOI 10.1016/S1367-5931(02)00357-5; Carlomagno F, 2006, JNCI-J NATL CANCER I, V98, P326, DOI 10.1093/jnci/djj069; Chan JM, 2005, J CLIN ONCOL, V23, P8152, DOI 10.1200/JCO.2005.03.1492; Chi KN, 2008, ANN ONCOL, V19, P746, DOI 10.1093/annonc/mdm554; Ciocca DR, 2010, INT J HYPERTHER, V26, P737, DOI 10.3109/02656731003776968; Ciraolo E, 2011, CURR MED CHEM, V18, P2674, DOI 10.2174/092986711796011193; Dahut WL, 2008, CLIN CANCER RES, V14, P209, DOI 10.1158/1078-0432.CCR-07-1355; Deslandres M, 2008, ANN DERMATOL VENER, P16, DOI 10.1016/S0151-9638(08)70093-0; Du GY, 2013, EUR J PHARMACOL, V700, P173, DOI 10.1016/j.ejphar.2012.12.013; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fu JJ, 2007, CANCER LETT, V248, P153, DOI 10.1016/j.canlet.2006.06.012; Gravis G, 2008, ANN ONCOL, V19, P1624, DOI 10.1093/annonc/mdn174; Hartmann JT, 2009, CURR DRUG METAB, V10, P470, DOI 10.2174/138920009788897975; Jiang N, 2012, MOLECULES, V17, P5870, DOI 10.3390/molecules17055870; Joensuu G, 2010, INT J RADIAT ONCOL, V78, P42, DOI 10.1016/j.ijrobp.2009.07.1731; Joseph IBJK, 1997, CANCER RES, V57, P1054; Kafousi M, 2012, PATHOL ONCOL RES, V18, P33, DOI 10.1007/s12253-011-9413-8; Kohli M, 2010, MAYO CLIN PROC, V85, P77, DOI 10.4065/mcp.2009.0442; Koistinen P, 2001, LEUKEMIA, V15, P1433, DOI 10.1038/sj.leu.2402217; Laird AD, 2003, EXPERT OPIN INV DRUG, V12, P51, DOI 10.1517/eoid.12.1.51.21253; Lin C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031708; Matsurnori Y, 2006, ONCOL RES, V16, P15, DOI 10.3727/000000006783981260; McMahon G, 2000, Oncologist, V5 Suppl 1, P3; Oh SJ, 2012, ENDOCR-RELAT CANCER, V19, P305, DOI 10.1530/ERC-11-0298; Pal HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077270; Patan S, 2004, CANC TREAT, V117, P3; Peraldo-Neia C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-31; Pratheeshkumar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052279; Qi JH, 2001, EXP CELL RES, V263, P173, DOI 10.1006/excr.2000.5102; Randi AM, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.060; Small EJ, 2007, BJU INT, V100, P765, DOI 10.1111/j.1464-410X.2007.07121.x; Steinbild S, 2007, BRIT J CANCER, V97, P1480, DOI 10.1038/sj.bjc.6604064; Trojan L, 2005, ANTICANCER RES, V25, P551; Vishnu P, 2010, ONCOTARGETS THER, V3, P39; Vulky J, 2009, CANCER, V115, P784, DOI 10.1002/cncr.24092; Wallace TJ, 2014, J CANCER, V5, P3, DOI 10.7150/jca.7709; Wedge SR, 2002, CANCER RES, V62, P4645; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wolk A, 2005, ACTA ONCOL, V44, P277, DOI 10.1080/02841860510029572; Wood JM, 2000, CANCER RES, V60, P2178; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Zhang S, 2011, CLIN CANCER RES, V17, P4439, DOI 10.1158/1078-0432.CCR-10-3109	43	9	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115041	10.1371/journal.pone.0115041	http://dx.doi.org/10.1371/journal.pone.0115041			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551444	Green Published, gold, Green Submitted			2022-12-26	WOS:000347119100024
J	Lee, LC; Chen, CM; Wang, PR; Su, MT; Lee-Chen, GJ; Chang, CY				Lee, Li-Ching; Chen, Chiung-Mei; Wang, Pin-Rong; Su, Ming-Tsan; Lee-Chen, Guey-Jen; Chang, Chun-Yen			Role of High Mobility Group Box 1 (HMGB1) in SCA17 Pathogenesis	PLOS ONE			English	Article							TATA-BINDING PROTEIN; POLYGLUTAMINE DISEASES; EXPANDED POLYGLUTAMINE; TRANSCRIPTION FACTOR; DNA-BINDING; AUTOPHAGY; TOXICITY; DOMAIN; ATAXIA; ACTIVATION	Spinocerebellar ataxia type 17 (SCA17) involves the expression of a polyglutamine (polyQ) expanded TATA-binding protein (TBP), a general transcription initiation factor. TBP interacts with other protein factors, including high mobility group box 1 (HMGB1), to regulate gene expression. Previously, our proteomic analysis of soluble proteins prepared from mutant TBP (TBP/Q(61)) expressing cells revealed a reduced concentration of HMGB1. Here, we show that HMGB1 can be incorporated into mutant TBP aggregates, which leads to reduced soluble HMGB1 levels in TBP/Q(61 similar to 79) expressing cells. HMGB1 overexpression reduced mutant TBP aggregation. HMGB1 cDNA and siRNA co-transfection, as well as an HSPA5 immunoblot and luciferase reporter assay demonstrated the important role of HMGB1 in the regulation of HSPA5 transcription. In starvation-stressed TBP/Q(36) and TBP/Q(79) cells, increased reactive oxygen species generation accelerated the cytoplasmic translocation of HMGB1, which accompanied autophagy activation. However, TBP/Q(79) cells displayed a decrease in autophagy activation as a result of the reduction in the cytoplasmic HMGB1 level. In neuronal SH-SY5Y cells with induced TBP/Q(61 similar to 79) expression, HMGB1 expression was reduced and accompanied by a significant reduction in the total outgrowth and branches in the TBP/Q(61 similar to 79) expressing cells compared with the non-induced cells. The decreased soluble HMGB1 and impaired starvation-induced autophagy in cells suggest that HMGB1 may be a critical modulator of polyQ disease pathology and may represent a target for drug development.	[Lee, Li-Ching; Wang, Pin-Rong; Su, Ming-Tsan; Lee-Chen, Guey-Jen] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Chen, Chiung-Mei] Chang Gung Univ, Coll Med, Dept Neurol, Chang Gung Mem Hosp, Taipei, Taiwan; [Chang, Chun-Yen] Natl Taiwan Normal Univ, Sci Educ Ctr, Taipei, Taiwan	National Taiwan Normal University; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan Normal University	Lee-Chen, GJ (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	t43019@ntnu.edu.tw; chunyenc@gmail.com	Chang, Chun-Yen/B-1307-2008; Chen, Chiung-Mei/AAL-6260-2020	Chang, Chun-Yen/0000-0003-2373-2004; 	Ministry of Science and Technology [NSC102-2325-B-003-002]; Chang Gung Memorial Hospital [CMRPG3D0091, CMRPG3D005]; Aim for the Top University Project of National Taiwan Normal University, Taipei, Taiwan	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Aim for the Top University Project of National Taiwan Normal University, Taipei, Taiwan	This work was supported by grants NSC102-2325-B-003-002 from the Ministry of Science and Technology, CMRPG3D0091 and CMRPG3D005 from Chang Gung Memorial Hospital, and Aim for the Top University Project of National Taiwan Normal University, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Chen CM, 2010, CLIN CHIM ACTA, V411, P375, DOI 10.1016/j.cca.2009.12.002; Das D, 2001, J BIOL CHEM, V276, P32597, DOI 10.1074/jbc.M011792200; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; GE H, 1994, J BIOL CHEM, V269, P17136; GOSTOUT B, 1993, AM J HUM GENET, V52, P1182; HORIKOSHI M, 1990, CELL, V61, P1171, DOI 10.1016/0092-8674(90)90681-4; Huang SS, 2011, BRAIN, V134, P1943, DOI 10.1093/brain/awr146; Jimenez-Sanchez M, 2012, PROG NEUROBIOL, V97, P67, DOI 10.1016/j.pneurobio.2011.08.013; Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047; LANDSMAN D, 1993, BIOESSAYS, V15, P539, DOI 10.1002/bies.950150807; Lee LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035302; Lee LC, 2009, CLIN CHIM ACTA, V400, P56, DOI 10.1016/j.cca.2008.10.013; LESCURE A, 1994, EMBO J, V13, P1166, DOI 10.1002/j.1460-2075.1994.tb06366.x; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Maltecca F, 2003, NEUROLOGY, V61, P1441, DOI 10.1212/01.WNL.0000094123.09098.A0; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Menzies FM, 2010, BRAIN, V133, P93, DOI 10.1093/brain/awp292; Min HJ, 2013, J IMMUNOL, V190, P1797, DOI 10.4049/jimmunol.1202472; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Qi ML, 2007, NAT CELL BIOL, V9, P402, DOI 10.1038/ncb1553; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Shimohata T, 2000, NEUROPATHOLOGY, V20, P326, DOI 10.1046/j.1440-1789.2000.00350.x; Silveira I, 2002, ARCH NEUROL-CHICAGO, V59, P623, DOI 10.1001/archneur.59.4.623; Stros M, 2009, NUCLEIC ACIDS RES, V37, P2070, DOI 10.1093/nar/gkp067; Sutrias-Grau M, 1999, J BIOL CHEM, V274, P1628, DOI 10.1074/jbc.274.3.1628; Takahashi T, 2010, J MOL CELL BIOL, V2, P180, DOI 10.1093/jmcb/mjq005; Tang DL, 2011, ANTIOXID REDOX SIGN, V15, P2185, DOI 10.1089/ars.2010.3666; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Zappavigna V, 1996, EMBO J, V15, P4981, DOI 10.1002/j.1460-2075.1996.tb00878.x	37	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115809	10.1371/journal.pone.0115809	http://dx.doi.org/10.1371/journal.pone.0115809			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549101	Green Submitted, Green Published, gold			2022-12-26	WOS:000347063500029
J	Chen, YX; Xu, FQ				Chen, Yi-Xiang; Xu, Fang-Qian			Higher Dimensional Gaussian-Type Solitons of Nonlinear Schrodinger Equation with Cubic and Power-Law Nonlinearities in PT-Symmetric Potentials	PLOS ONE			English	Article							WAVES	Two families of Gaussian-type soliton solutions of the (n+1)-dimensional Schrodinger equation with cubic and power-law nonlinearities in PT-symmetric potentials are analytically derived. As an example, we discuss some dynamical behaviors of two dimensional soliton solutions. Their phase switches, powers and transverse power-flow densities are discussed. Results imply that the powers flow and exchange from the gain toward the loss regions in the PT cell. Moreover, the linear stability analysis and the direct numerical simulation are carried out, which indicates that spatial Gaussian-type soliton solutions are stable below some thresholds for the imaginary part of PT-symmetric potentials in the defocusing cubic and focusing power-law nonlinear medium, while they are always unstable for all parameters in other media.	[Chen, Yi-Xiang; Xu, Fang-Qian] Zhejiang Univ Media & Commun, Sch Elect Informat, Hangzhou 310018, Zhejiang, Peoples R China	Communication University of Zhejiang	Chen, YX (corresponding author), Zhejiang Univ Media & Commun, Sch Elect Informat, Hangzhou 310018, Zhejiang, Peoples R China.	chenyix1979@126.com			Zhejiang Province welfare project [2014C32006]; Special Foundation for theoretical physics Research Program of China [11447124]	Zhejiang Province welfare project; Special Foundation for theoretical physics Research Program of China	This work was supported by Zhejiang Province welfare project (Grant No. 2014C32006) and the Special Foundation for theoretical physics Research Program of China (Grant No. 11447124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender CM, 1998, PHYS REV LETT, V80, P5243, DOI 10.1103/PhysRevLett.80.5243; Biswas A, 2013, NONLINEAR DYNAM, V73, P2191, DOI 10.1007/s11071-013-0933-5; Bronski JC, 2001, PHYS REV LETT, V86, P1402, DOI 10.1103/PhysRevLett.86.1402; Dai CQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100484; Dai CQ, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.013834; Dai CQ, 2014, OPT COMMUN, V315, P303, DOI 10.1016/j.optcom.2013.11.030; Dai CQ, 2014, ANN PHYS-NEW YORK, V341, P142, DOI 10.1016/j.aop.2013.11.015; Dai CQ, 2013, J OPT SOC AM B, V30, P3291, DOI 10.1364/JOSAB.30.003291; Dai CQ, 2012, NONLINEAR DYNAM, V70, P189, DOI 10.1007/s11071-012-0441-z; Dai CQ, 2010, OPT LETT, V35, P1437, DOI 10.1364/OL.35.001437; El-Ganainy R, 2007, OPT LETT, V32, P2632, DOI 10.1364/OL.32.002632; Guo A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.093902; Lederer F, 2008, PHYS REP, V463, P1, DOI 10.1016/j.physrep.2008.04.004; Liu WJ, 2013, LASER PHYS, V23, DOI 10.1088/1054-660X/23/9/095401; Makris KG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.103904; Midya B, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.045803; Musslimani ZH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.030402; Naher H., 2012, APPL MATH, V3, P1144, DOI [10.4236/am.2012.310168, DOI 10.4236/AM.2012.310168]; Naher H., 2012, APPL MATH SCI, V6, P5495; Naher H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064618; Naher H, 2013, AIP ADV, V3, DOI 10.1063/1.4794947; Serkin VN, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.074102; Wang YY, 2013, NONLINEAR DYNAM, V74, P429, DOI 10.1007/s11071-013-0980-y; Weise LD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021934; Yang J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021128, 10.1371/journal.pone.0024111]; Zhong WP, 2012, NONLINEAR DYNAM, V70, P2027, DOI 10.1007/s11071-012-0594-9; Zhu HP, 2013, NONLINEAR DYNAM, V72, P873, DOI 10.1007/s11071-013-0759-1	27	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115935	10.1371/journal.pone.0115935	http://dx.doi.org/10.1371/journal.pone.0115935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542020	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900111
J	da Costa, PB; Granada, CE; Ambrosini, A; Moreira, F; de Souza, R; dos Passos, JFM; Arruda, L; Passaglia, LMP				da Costa, Pedro Beschoren; Granada, Camille E.; Ambrosini, Adriana; Moreira, Fernanda; de Souza, Rocheli; dos Passos, Joao Frederico M.; Arruda, Leticia; Passaglia, Luciane M. P.			A Model to Explain Plant Growth Promotion Traits: A Multivariate Analysis of 2,211 Bacterial Isolates	PLOS ONE			English	Article							PHOSPHATE SOLUBILIZATION; SOIL; NITROGEN; RHIZOBACTERIA; RHIZOSPHERE; DIVERSITY; SIDEROPHORES; PHOSPHORUS; ACID; BIOSYNTHESIS	Plant growth-promoting bacteria can greatly assist sustainable farming by improving plant health and biomass while reducing fertilizer use. The plantmicroorganism- environment interaction is an open and complex system, and despite the active research in the area, patterns in root ecology are elusive. Here, we simultaneously analyzed the plant growth-promoting bacteria datasets from seven independent studies that shared a methodology for bioprospection and phenotype screening. The soil richness of the isolate's origin was classified by a Principal Component Analysis. A Categorical Principal Component Analysis was used to classify the soil richness according to isolate's indolic compound production, siderophores production and phosphate solubilization abilities, and bacterial genera composition. Multiple patterns and relationships were found and verified with nonparametric hypothesis testing. Including niche colonization in the analysis, we proposed a model to explain the expression of bacterial plant growthpromoting traits according to the soil nutritional status. Our model shows that plants favor interaction with growth hormone producers under rich nutrient conditions but favor nutrient solubilizers under poor conditions. We also performed several comparisons among the different genera, highlighting interesting ecological interactions and limitations. Our model could be used to direct plant growthpromoting bacteria bioprospection and metagenomic sampling.	[da Costa, Pedro Beschoren; Ambrosini, Adriana; Moreira, Fernanda; de Souza, Rocheli; dos Passos, Joao Frederico M.; Arruda, Leticia; Passaglia, Luciane M. P.] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil; [Granada, Camille E.] UNIVATES, Lajeado, RS, Brazil; [dos Passos, Joao Frederico M.] Empresa Pesquisa & Extensao Agr Santa Catarina EP, Lages, SC, Brazil	Universidade Federal do Rio Grande do Sul; Universidade do Vale do Taquari	Passaglia, LMP (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil.	luciane.passaglia@ufrgs.br	Ambrosini, Adriana/I-9140-2016; Granada, Camille E./N-6088-2018; Passaglia, Luciane M. P./L-1542-2015	Ambrosini, Adriana/0000-0003-2545-3332; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/ Brazil); Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior (CAPES/Brazil); Instituto Nacional de Ciencia e Tecnologia (INCT) da Fixacao Biologica do Nitrogenio (Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/ Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior (CAPES/Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Nacional de Ciencia e Tecnologia (INCT) da Fixacao Biologica do Nitrogenio (Brazil)	This work was financed by a grant and fellowships from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/ Brazil), Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior (CAPES/Brazil) and Instituto Nacional de Ciencia e Tecnologia (INCT) da Fixacao Biologica do Nitrogenio (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesemoye AO, 2009, APPL MICROBIOL BIOT, V85, P1, DOI 10.1007/s00253-009-2196-0; Ahemad Munees, 2014, Journal of King Saud University Science, V26, P1, DOI 10.1016/j.jksus.2013.05.001; Ambrosini A, 2012, PLANT SOIL, V356, P245, DOI 10.1007/s11104-011-1079-1; Anandham R, 2008, RES MICROBIOL, V159, P579, DOI 10.1016/j.resmic.2008.08.007; Arruda L, 2013, APPL SOIL ECOL, V63, P15, DOI 10.1016/j.apsoil.2012.09.001; BAATH E, 1989, WATER AIR SOIL POLL, V47, P335, DOI 10.1007/BF00279331; Babalola OO, 2010, BIOTECHNOL LETT, V32, P1559, DOI 10.1007/s10529-010-0347-0; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Baptista IIR, 2008, BIOTECHNOL BIOENG, V99, P68, DOI 10.1002/bit.21576; Barraquio WL, 2000, QUEST NITROGEN FIXAT, P93; Bashan Y, 2013, BIOL FERT SOILS, V49, P465, DOI 10.1007/s00374-012-0737-7; Bellenger JP, 2008, NAT GEOSCI, V1, P243, DOI 10.1038/ngeo161; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bianco C, 2010, APPL ENVIRON MICROB, V76, P4626, DOI 10.1128/AEM.02756-09; Boddey RM, 2003, PLANT SOIL, V252, P139, DOI 10.1023/A:1024152126541; Chaiharn M, 2011, CURR MICROBIOL, V62, P173, DOI 10.1007/s00284-010-9674-6; Chen CY, 2009, J HAZARD MATER, V172, P1439, DOI 10.1016/j.jhazmat.2009.08.009; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; da Costa PB, 2013, PLANT SOIL, V368, P267, DOI 10.1007/s11104-012-1513-z; de Souza R, 2013, PLANT SOIL, V366, P585, DOI 10.1007/s11104-012-1430-1; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; DOBEREINER J, 1988, PLANT SOIL, V110, P207, DOI 10.1007/BF02226800; dos Passos JFM, 2014, GENET MOL BIOL, V37, P560, DOI 10.1590/S1415-47572014000400013; Emmerling C, 2002, J PLANT NUTR SOIL SC, V165, P408, DOI 10.1002/1522-2624(200208)165:4<408::AID-JPLN408>3.0.CO;2-3; Estrada GA, 2013, PLANT SOIL, V369, P115, DOI 10.1007/s11104-012-1550-7; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; Good AG, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001124; Granada C, 2013, PLANT SOIL, V373, P339, DOI 10.1007/s11104-013-1796-8; Gray EJ, 2005, SOIL BIOL BIOCHEM, V37, P395, DOI 10.1016/j.soilbio.2004.08.030; GUERINOT ML, 1994, ANNU REV MICROBIOL, V48, P743, DOI 10.1146/annurev.micro.48.1.743; Han-Jen RE, 2013, SENSORS-BASEL, V13, P14121, DOI 10.3390/s131014121; Hartmann A, 2009, PLANT SOIL, V321, P235, DOI 10.1007/s11104-008-9814-y; Hayat R, 2010, ANN MICROBIOL, V60, P579, DOI 10.1007/s13213-010-0117-1; He ZL, 2010, ECOL LETT, V13, P564, DOI 10.1111/j.1461-0248.2010.01453.x; Hernlem BJ, 1999, WATER RES, V33, P951, DOI 10.1016/S0043-1354(98)00293-0; Hu JL, 2009, PEDOBIOLOGIA, V53, P49, DOI 10.1016/j.pedobi.2009.02.002; Jakobsen I., 2005, Phosphorus: agriculture and the environment, P437; JAYACHANDRAN K, 1989, SOIL SCI SOC AM J, V53, P1701, DOI 10.2136/sssaj1989.03615995005300060015x; Khalid A, 2004, AUST J SOIL RES, V42, P921, DOI 10.1071/SR04019; Kidd PS, 2008, PLANT SOIL, V302, P233, DOI 10.1007/s11104-007-9475-2; Kraepiel AML, 2009, BIOMETALS, V22, P573, DOI 10.1007/s10534-009-9222-7; Kuklinsky-Sobral J, 2004, ENVIRON MICROBIOL, V6, P1244, DOI 10.1111/j.1462-2920.2004.00658.x; Kunito T, 2012, ANN MICROBIOL, V62, P1339, DOI 10.1007/s13213-011-0393-4; Kuo S., 1996, Methods of soil analysis. Part 3 - chemical methods., P869; Lin TF, 2006, BIORESOURCE TECHNOL, V97, P957, DOI 10.1016/j.biortech.2005.02.017; Marasco R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048479; Marinari S, 2006, ECOL INDIC, V6, P701, DOI 10.1016/j.ecolind.2005.08.029; Mark GL, 2005, P NATL ACAD SCI USA, V102, P17454, DOI 10.1073/pnas.0506407102; Martinez-Viveros O, 2010, J SOIL SCI PLANT NUT, V10, P293, DOI 10.4067/S0718-95162010000100006; Matsuoka H, 2013, CURR MICROBIOL, V66, P314, DOI 10.1007/s00284-012-0276-3; Miransari M, 2011, APPL MICROBIOL BIOT, V92, P875, DOI 10.1007/s00253-011-3521-y; Neubauer U, 2000, ENVIRON SCI TECHNOL, V34, P2749, DOI 10.1021/es990495w; Nusslein K, 1999, APPL ENVIRON MICROB, V65, P3622; Ona O, 2005, FEMS MICROBIOL LETT, V246, P125, DOI 10.1016/j.femsle.2005.03.048; Parke JL, 2001, ANNU REV PHYTOPATHOL, V39, P225, DOI 10.1146/annurev.phyto.39.1.225; Rajkumar M, 2010, TRENDS BIOTECHNOL, V28, P142, DOI 10.1016/j.tibtech.2009.12.002; Rajkumar M, 2009, CHEMOSPHERE, V77, P153, DOI 10.1016/j.chemosphere.2009.06.047; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Ramette A, 2009, ENV MICROBIOL REP, V1, P3, DOI 10.1111/j.1758-2229.2008.00010.x; Richardson AE, 2009, PLANT SOIL, V321, P305, DOI 10.1007/s11104-009-9895-2; Schalk IJ, 2011, ENVIRON MICROBIOL, V13, P2844, DOI 10.1111/j.1462-2920.2011.02556.x; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sergeeva E, 2007, PLANT SOIL, V297, P1, DOI 10.1007/s11104-007-9314-5; Simpson RJ, 2011, PLANT SOIL, V349, P89, DOI 10.1007/s11104-011-0880-1; Singh JS, 2011, AGR ECOSYST ENVIRON, V140, P339, DOI 10.1016/j.agee.2011.01.017; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Spaepen Stijn, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a001438; SYLVESTER-BRADLEY R, 1982, Acta Amazonica, V12, P15; Wakelin SA, 2004, BIOL FERT SOILS, V40, P36, DOI 10.1007/s00374-004-0750-6; Wakelin SA, 2009, PEDOBIOLOGIA, V52, P237, DOI 10.1016/j.pedobi.2008.10.001; Weyens N, 2009, TRENDS BIOTECHNOL, V27, P591, DOI 10.1016/j.tibtech.2009.07.006; Young LS, 2013, APPL SOIL ECOL, V66, P40, DOI 10.1016/j.apsoil.2013.02.001; Zar J.H., 1996, BIOSTAT ANAL	73	34	36	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e0116020	10.1371/journal.pone.0116020	http://dx.doi.org/10.1371/journal.pone.0116020			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542031	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900129
J	Li, ZL; Cai, L; Liang, XL; Du, ZM; Chen, YH; An, SL; Tan, N; Xu, LX; Li, RZ; Li, LW; Shi, W				Li, Zhilian; Cai, Lu; Liang, Xinling; Du, Zhiming; Chen, Yuanhan; An, Shengli; Tan, Ning; Xu, Lixia; Li, Ruizhao; Li, Liwen; Shi, Wei			Identification and Predicting Short-Term Prognosis of Early Cardiorenal Syndrome Type 1: KDIGO Is Superior to RIFLE or AKIN	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; DECOMPENSATED HEART-FAILURE; WORSENING RENAL-FUNCTION; SERUM CREATININE; CONSENSUS CONFERENCE; OUTCOMES; CLASSIFICATION; IMPACT; DEFINITIONS; MORTALITY	Objective: Acute kidney injury (AKI) in patients hospitalized for acute heart failure (AHF) is usually type 1 of the cardiorenal syndrome (CRS) and has been associated with increased morbidity and mortality. Early recognition of AKI is critical. This study was to determine if the new KDIGO criteria (Kidney Disease: Improving Global Outcomes) for identification and short-term prognosis of early CRS type 1 was superior to the previous RIFLE and AKIN criteria. Methods: The association between AKI diagnosed by KDIGO but not by RIFLE or AKIN and in-hospital mortality was retrospectively evaluated in 1005 Chinese adult patients with AHF between July 2008 and May 2012. AKI was defined as RIFLE, AKIN and KDIGO criteria, respectively. Cox regression was used for multivariate analysis of in-hospital mortality. Results: Within 7 days on admission, the incidence of CRS type 1 was 38.9% by KDIGO criteria, 34.7% by AKIN, and 32.1% by RIFLE. A total of 110 (10.9%) cases were additional diagnosed by KDIGO criteria but not by RIFLE or AKIN. 89.1% of them were in Stage 1 (AKIN) or Stage Risk (RIFLE). They accounted for 18.4% (25 cases) of the overall death. After adjustment, this proportion remained an independent risk factor for in-hospital mortality [odds ratios (OR) 3.24, 95% confidence interval(95% CI) 1.97-5.35]. Kaplan-Meier curve showed AKI patients by RIFLE, AKIN, KDIGO and [K(+) R(-)+K(+)A(-)] had lower hospital survival than non-AKI patients (Log Rank P<0.001). Conclusion: KDIGO criteria identified significantly more CRS type 1 episodes than RIFLE or AKIN. AKI missed diagnosed by RIFLE or AKIN criteria was an independent risk factor for in-hospital mortality, indicating the new KDIGO criteria was superior to RIFLE and AKIN in predicting short-term outcomes in early CRS type 1.	[Li, Zhilian; Liang, Xinling; Chen, Yuanhan; Xu, Lixia; Li, Ruizhao; Shi, Wei] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Cai, Lu] Huzhou Cent Hosp, Dept Nephrol, Huzhou, Peoples R China; [Liang, Xinling; An, Shengli] Southern Med Univ, Dept Biostat, Guangzhou, Guangdong, Peoples R China; [Du, Zhiming] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China; [Tan, Ning; Li, Liwen] Guangdong Cardiovasc Inst, Guangdong Gen Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Huzhou University; Southern Medical University - China; Sun Yat Sen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Liang, XL (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Nephrol, Guangzhou, Guangdong, Peoples R China.	xinlingliang_ggh@163.com		liang, Xinling/0000-0002-6764-9571	National Natural Science Foundation [81170683, 81200544]; Science and Technique Project of Guangzhou City [2013J4100064]; National Key Technology RD Program [2011BAI10B08]; National Clinical Key Specialty Construction Preparatory Projects, China	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technique Project of Guangzhou City; National Key Technology RD Program(National Key Technology R&D Program); National Clinical Key Specialty Construction Preparatory Projects, China	This study was supported by grants from the National Natural Science Foundation (81170683 and 81200544), the Science and Technique Project of Guangzhou City (2013J4100064), the National Key Technology R&D Program (2011BAI10B08), and the National Clinical Key Specialty Construction Preparatory Projects, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagshaw SM, 2009, NEPHROL DIAL TRANSPL, V24, P2739, DOI 10.1093/ndt/gfp159; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Belziti CA, 2010, REV ESP CARDIOL, V63, P294, DOI 10.1016/S0300-8932(10)70088-9; Chen YC, 2009, SHOCK, V31, P139, DOI 10.1097/SHK.0b013e31817d419e; Cowie MR, 2006, EUR HEART J, V27, P1216, DOI 10.1093/eurheartj/ehi859; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Goldberg A, 2005, AM HEART J, V150, P330, DOI 10.1016/j.ahj.2004.09.055; Haase M, 2013, CONTRIB NEPHROL, V182, P99, DOI 10.1159/000349969; Haase M, 2009, J THORAC CARDIOV SUR, V138, P1370, DOI 10.1016/j.jtcvs.2009.07.007; Hata N, 2010, EUR J HEART FAIL, V12, P32, DOI 10.1093/eurjhf/hfp169; Hsu CY, 2007, KIDNEY INT, V72, P208, DOI 10.1038/sj.ki.5002297; Ismail Y, 2012, SEMIN NEPHROL, V32, P18, DOI 10.1016/j.semnephrol.2011.11.003; Joannidis M, 2009, INTENS CARE MED, V35, P1692, DOI 10.1007/s00134-009-1530-4; Lafrance JP, 2010, AM J KIDNEY DIS, V56, P651, DOI 10.1053/j.ajkd.2010.05.011; Lameire Norbert, 2013, Arab J Nephrol Transplant, V6, P145; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lopes JA, 2008, CRIT CARE, V12, DOI 10.1186/cc6997; McAlister FA, 2004, CIRCULATION, V109, P1004, DOI 10.1161/01.CIR.0000116764.53225.A9; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Metra M, 2008, EUR J HEART FAIL, V10, P188, DOI 10.1016/j.ejheart.2008.01.011; Nohria A, 2008, J AM COLL CARDIOL, V51, P1268, DOI 10.1016/j.jacc.2007.08.072; Ostermann M, 2011, QJM-INT J MED, V104, P237, DOI 10.1093/qjmed/hcq185; Parikh CR, 2008, ARCH INTERN MED, V168, P987, DOI 10.1001/archinte.168.9.987; Praught ML, 2005, CURR OPIN NEPHROL HY, V14, P265, DOI 10.1097/01.mnh.0000165894.90748.72; Rodrigues FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069998; Ronco C, 2013, LANCET, V382, P939, DOI 10.1016/S0140-6736(13)61932-7; Ronco C, 2012, J AM COLL CARDIOL, V60, P1031, DOI 10.1016/j.jacc.2012.01.077; Roy AK, 2013, CARDIORENAL MED, V3, P26, DOI 10.1159/000347037; Sampaio MC, 2013, ARQ BRAS CARDIOL, V101, P18, DOI 10.5935/abc.20130115; Shirakabe A, 2012, INT HEART J, V53, P313, DOI 10.1536/ihj.53.313; Siew ED, 2012, CLIN J AM SOC NEPHRO, V7, P712, DOI 10.2215/CJN.10821011; Siew ED, 2010, KIDNEY INT, V77, P536, DOI 10.1038/ki.2009.479; Zeng XX, 2014, CLIN J AM SOC NEPHRO, V9, P12, DOI 10.2215/CJN.02730313; Zhou QG, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-51	36	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e114369	10.1371/journal.pone.0114369	http://dx.doi.org/10.1371/journal.pone.0114369			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542014	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900009
J	Song, YW; Jiang, J; Vermeren, S; Tong, W				Song, Yiwen; Jiang, Jing; Vermeren, Sonja; Tong, Wei			ARAP3 Functions in Hematopoietic Stem Cells	PLOS ONE			English	Article							ACTIVATING PROTEIN ARAP3; RHO-GTPASES; BONE-MARROW; ARF GAPS; DEPENDENT PROCESSES; ACTIN CYTOSKELETON; PHOSPHATASE SHIP2; LINEAGE ANALYSIS; RAC GTPASES; SAM DOMAIN	ARAP3 is a GTPase-activating protein (GAP) that inactivates Arf6 and RhoA small GTPases. ARAP3 deficiency in mice causes a sprouting angiogenic defect resulting in embryonic lethality by E11. Mice with an ARAP3 R302,303A mutation (Arap3(KI/KI)) that prevents activation by phosphoinositide-3-kinase (PI3K) have a similar angiogenic phenotype, although some animals survive to adulthood. Here, we report that hematopoietic stem cells (HSCs) from rare adult Arap3(KI/KI) bone marrow are compromised in their ability to reconstitute recipient mice and to selfrenew. To elucidate the potential cell-autonomous and non-cell-autonomous roles of ARAP3 in hematopoiesis, we conditionally deleted Arap3 in hematopoietic cells and in several cell types within the HSC niche. Excision of Arap3 in hematopoietic cells using Vav1-Cre does not alter the ability of ARAP3-deficient progenitor cells to proliferate and differentiate in vitro or ARAP3-deficient HSCs to provide multilineage reconstitution and to undergo self-renewal in vivo. Thus, our data suggest that ARAP3 does not play a cell-autonomous role in HSPCs. Deletion of Arap3 in osteoblasts and mesenchymal stromal cells using Prx1-Cre resulted in no discernable phenotypes in hematopoietic development or HSC homeostasis in adult mice. In contrast, deletion of Arap3 using vascular endothelial cadherin (VEC or Cdh5)-driven Cre resulted in embryonic lethality, however HSCs from surviving adult mice were largely normal. Reverse transplantations into VEC-driven Arap3 conditional knockout mice revealed no discernable difference in HSC frequencies or function in comparison to control mice. Taken together, our investigation suggests that despite a critical role for ARAP3 in embryonic vascular development, its loss in endothelial cells minimally impacts HSCs in adult bone marrow.	[Song, Yiwen; Tong, Wei] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Song, Yiwen; Jiang, Jing; Tong, Wei] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Vermeren, Sonja] Univ Edinburgh, MRC Ctr Inflammat Res, Queens Med Res Inst, Edinburgh EH8 9YL, Midlothian, Scotland	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Edinburgh	Tong, W (corresponding author), Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.	tongw@email.chop.edu	Vermeren, Sonja/AAK-7442-2020	Vermeren, Sonja/0000-0002-8460-0884; Tong, Wei/0000-0001-9951-2273	National Institutes of Health (NIH) [R01HL095675, R01HL110806, T32-DK007780-09]; Myeloproliferative Neoplasm Research Foundation; Gabrielle's Angel Foundation; Leukemia Lymphoma Society (LLS) Scholar; Biotechnology and Biological Sciences Research Council [BB/C520712]; BBSRC [BBS/E/B/0000M221, BB/C520712/1] Funding Source: UKRI; MRC [G0700740] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C520712/1, BBS/E/B/0000M221] Funding Source: researchfish; Medical Research Council [G0700740] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095675, R01HL110806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007780] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Myeloproliferative Neoplasm Research Foundation; Gabrielle's Angel Foundation; Leukemia Lymphoma Society (LLS) Scholar; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	WT is supported by National Institutes of Health (NIH) grants R01HL095675 and R01HL110806. WT received a New Investigator Award from the Myeloproliferative Neoplasm Research Foundation and Gabrielle's Angel Foundation for Cancer Research, and is a Leukemia Lymphoma Society (LLS) Scholar. YS is supported by NIH training grant T32-DK007780-09. SV is supported by the Biotechnology and Biological Sciences Research Council (BB/C520712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Bersenev A, 2008, J CLIN INVEST, V118, P2832, DOI 10.1172/JCI35808; Bersenev A, 2012, AGING CELL, V11, P949, DOI 10.1111/j.1474-9726.2012.00862.x; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Cancelas JA, 2006, EXP HEMATOL, V34, P976, DOI 10.1016/j.exphem.2006.03.016; Chae HD, 2008, BLOOD, V111, P2597, DOI 10.1182/blood-2007-06-093237; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Choi W, 2006, BLOOD, V107, P3145, DOI 10.1182/blood-2005-09-3563; Craig HE, 2010, CELL SIGNAL, V22, P257, DOI 10.1016/j.cellsig.2009.09.025; Cuthbert EJ, 2008, AM J PHYSIOL-CELL PH, V294, pC263, DOI 10.1152/ajpcell.00292.2007; del Pozo MA, 1999, EUR J IMMUNOL, V29, P3609; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007; Gambardella L, 2013, J IMMUNOL, V190, P381, DOI 10.4049/jimmunol.1201330; Gambardella L, 2011, BLOOD, V118, P1087, DOI 10.1182/blood-2010-10-312959; Gambardella L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001026; Ghiaur G, 2006, BLOOD, V108, P2087, DOI 10.1182/blood-2006-02-001560; Gottig S, 2006, EUR J IMMUNOL, V36, P180, DOI 10.1002/eji.200525607; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Guo FK, 2009, BLOOD, V114, P2909, DOI 10.1182/blood-2009-04-214676; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Iurlaro M, 2003, J CELL SCI, V116, P3635, DOI 10.1242/jcs.00629; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jeon CY, 2010, J CELL PHYSIOL, V224, P786, DOI 10.1002/jcp.22184; Kalfa TA, 2010, HAEMATOL-HEMATOL J, V95, P27, DOI 10.3324/haematol.2009.006239; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Kartopawiro J, 2014, HUM MOL GENET, V23, P1286, DOI 10.1093/hmg/ddt518; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Knizhnik AV, 2012, J CELL BIOCHEM, V113, P360, DOI 10.1002/jcb.23362; Kowanetz K, 2004, MOL BIOL CELL, V15, P3155, DOI 10.1091/mbc.E03-09-0683; Krugmann S, 2006, METHOD ENZYMOL, V406, P91, DOI 10.1016/S0076-6879(06)06008-3; Krugmann S, 2006, J CELL SCI, V119, P425, DOI 10.1242/jcs.02755; Krugmann S, 2004, CURR BIOL, V14, P1380, DOI 10.1016/j.cub.2004.07.058; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lazer G, 2011, CELL SIGNAL, V23, P969, DOI 10.1016/j.cellsig.2010.10.022; Leko V, 2012, BLOOD, V119, P1856, DOI 10.1182/blood-2011-09-377077; Leone M, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-59; Lu Q, 2004, P NATL ACAD SCI USA, V101, P17246, DOI 10.1073/pnas.0407794101; Mercurio FA, 2013, CHEMBIOCHEM, V14, P100, DOI 10.1002/cbic.201200592; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Mulloy JC, 2010, BLOOD, V115, P936, DOI 10.1182/blood-2009-09-198127; Nandy D, 2010, J CELL MOL MED, V14, P1396, DOI 10.1111/j.1582-4934.2009.00900.x; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Pesesse X, 1998, FEBS LETT, V437, P301, DOI 10.1016/S0014-5793(98)01255-1; Raaijmakers JH, 2007, CELL SIGNAL, V19, P1249, DOI 10.1016/j.cellsig.2006.12.015; Raman R, 2013, LEUKEMIA, V27, P2209, DOI 10.1038/leu.2013.103; Randazzo P A, 2000, Sci STKE, V2000, pre1, DOI 10.1126/stke.2000.59.re1; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Schweitzer JK, 2005, EXP CELL RES, V311, P74, DOI 10.1016/j.yexcr.2005.07.033; Singh SK, 2013, J EXP MED, V210, P987, DOI 10.1084/jem.20121608; Stacey TTI, 2004, J CELL SCI, V117, P6071, DOI 10.1242/jcs.01526; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Tong JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064817; Tossidou I, 2012, MOL CELL BIOL, V32, P1068, DOI 10.1128/MCB.06106-11; Troeger A, 2013, EXP CELL RES, V319, P2375, DOI 10.1016/j.yexcr.2013.07.002; Wang L, 2006, BLOOD, V107, P98, DOI 10.1182/blood-2005-05-2171; Wu B, 2012, J STRUCT BIOL, V180, P84, DOI 10.1016/j.jsb.2012.06.011; Xu HM, 2009, BLOOD, V114, P3557, DOI 10.1182/blood-2009-02-205815; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yagi R, 2011, ONCOGENE, V30, P1413, DOI 10.1038/onc.2010.522; Yang L, 2007, BLOOD, V110, P3853, DOI 10.1182/blood-2007-03-079582; Yoon HY, 2006, J CELL SCI, V119, P4650, DOI 10.1242/jcs.03237; Zhang SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033773; Zheng XD, 2014, BMC BIOCHEM, V15, DOI 10.1186/1471-2091-15-13; Zhou X, 2013, J EXP MED, V210, P2371, DOI 10.1084/jem.20122348	76	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116107	10.1371/journal.pone.0116107	http://dx.doi.org/10.1371/journal.pone.0116107			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542002	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900144
J	Faust, JE; Desai, T; Verma, A; Ulengin, I; Sun, TL; Moss, TJ; Betancourt-Solis, MA; Huang, HW; Lee, T; McNew, JA				Faust, Joseph E.; Desai, Tanvi; Verma, Avani; Ulengin, Idil; Sun, Tzu-Lin; Moss, Tyler J.; Betancourt-Solis, Miguel A.; Huang, Huey W.; Lee, Tina; McNew, James A.			The Atlastin C-terminal Tail Is an Amphipathic Helix That Perturbs the Bilayer Structure during Endoplasmic Reticulum Homotypic Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER NETWORK FORMATION; MEMBRANE-FUSION; GTPASE ATLASTIN; REQUIRES; PROTEIN; RECONSTITUTION; DIMERIZATION; MECHANISMS; EXOCYTOSIS; LIPOSOMES	Fusion of tubular membranes is required to form three-way junctions found in reticular subdomains of the endoplasmic reticulum. The large GTPase Atlastin has recently been shown to drive endoplasmic reticulum membrane fusion and three-way junction formation. The mechanism of Atlastin-mediated membrane fusion is distinct from SNARE-mediated membrane fusion, and many details remain unclear. In particular, the role of the amphipathic C-terminal tail of Atlastin is still unknown. We found that a peptide corresponding to the Atlastin C-terminal tail binds to membranes as a parallel alpha helix, induces bilayer thinning, and increases acyl chain disorder. The function of the C-terminal tail is conserved in human Atlastin. Mutations in the C-terminal tail decrease fusion activity in vitro, but not GTPase activity, and impair Atlastin function in vivo. In the context of unstable lipid bilayers, the requirement for the C-terminal tail is abrogated. These data suggest that the C-terminal tail of Atlastin locally destabilizes bilayers to facilitate membrane fusion.	[Faust, Joseph E.; Desai, Tanvi; Verma, Avani; Moss, Tyler J.; Betancourt-Solis, Miguel A.; McNew, James A.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; [Ulengin, Idil; Lee, Tina] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Sun, Tzu-Lin; Huang, Huey W.] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA	Rice University; Carnegie Mellon University; Rice University	McNew, JA (corresponding author), Rice Univ, Dept Biochem & Cell Biol, 6100 Main St Rice Univ,MS601, Houston, TX 77005 USA.	mcnew@rice.edu	McNew, James/AAV-4911-2020; Desai, Tanvi/AAH-7038-2021; McNew, James/ABD-8081-2020	McNew, James/0000-0001-8459-3664; Betancourt-Solis, Miguel Alberto/0000-0001-8041-4120; Desai, Tanvi/0000-0003-2571-5910; Faust, Joseph/0000-0002-2183-8529	National Institutes of Health [GM55203, GM107285, GM101377]; Robert A. Welch Foundation [C-0991]; Virginia and L. E. Simmons Family Foundation; Hamill Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101377, R01GM055203, R01GM107285] Funding Source: NIH RePORTER; Direct For Education and Human Resources [0966303] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Virginia and L. E. Simmons Family Foundation; Hamill Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	Supported by National Institutes of Health Grant GM55203 and Robert A. Welch Foundation Grant C-0991.; Supported by National Institutes of Health Grant GM107285.; Supported by National Institutes of Health Grant GM101377, by The Virginia and L. E. Simmons Family Foundation, and by The Hamill Foundation. To whom correspondence should be addressed: Dept. of Biochemistry and Cell Biology, Rice University, 6100 Main St. Rice University, MS601, Houston, TX 77005. Tel.: 713-348-3133; E-mail: mcnew@rice.edu.	Barr FA, 2013, J CELL BIOL, V202, P191, DOI 10.1083/jcb.201306010; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Brugger B, 2014, ANNU REV BIOCHEM, V83, P79, DOI 10.1146/annurev-biochem-060713-035324; Byrnes LJ, 2013, EMBO J, V32, P369, DOI 10.1038/emboj.2012.353; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; Chen SL, 2012, NAT CELL BIOL, V14, P707, DOI 10.1038/ncb2523; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; English AR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013227; Evans K, 2006, P NATL ACAD SCI USA, V103, P10666, DOI 10.1073/pnas.0510863103; Goyal U, 2013, BBA-MOL CELL RES, V1833, P2492, DOI 10.1016/j.bbamcr.2013.04.009; Graf ER, 2012, J NEUROSCI, V32, P16586, DOI 10.1523/JNEUROSCI.0965-12.2012; Hoff KG, 2009, CHEM BIOL, V16, P1299, DOI 10.1016/j.chembiol.2009.11.011; Hoppins S, 2009, BBA-MOL CELL RES, V1793, P20, DOI 10.1016/j.bbamcr.2008.07.005; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Liu TY, 2012, P NATL ACAD SCI USA, V109, pE2146, DOI 10.1073/pnas.1208385109; Mcnew JA, 2008, CHEM REV, V108, P1669, DOI 10.1021/cr0782325; McNew JA, 2013, ANNU REV CELL DEV BI, V29, P529, DOI 10.1146/annurev-cellbio-101512-122328; Morin-Leisk J, 2011, J CELL BIOL, V195, P605, DOI 10.1083/jcb.201105006; Moss TJ, 2011, P NATL ACAD SCI USA, V108, P11133, DOI 10.1073/pnas.1105056108; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Pendin D, 2011, P NATL ACAD SCI USA, V108, P16283, DOI 10.1073/pnas.1106421108; Podbilewicz B, 2014, ANNU REV CELL DEV BI, V30, P111, DOI 10.1146/annurev-cellbio-101512-122422; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Skehel JJ, 2001, BIOCHEM SOC T, V29, P623, DOI 10.1042/BST0290623; Sun TL, 2013, BIOPHYS J, V104, P1923, DOI 10.1016/j.bpj.2013.03.039; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; WU Y, 1990, BIOPHYS J, V57, P797, DOI 10.1016/S0006-3495(90)82599-6	31	37	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4772	4783		10.1074/jbc.M114.601823	http://dx.doi.org/10.1074/jbc.M114.601823			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25555915	Green Published, hybrid			2022-12-26	WOS:000350042000020
J	Tan, FZ; Qian, C; Tang, K; Abd-Allah, SM; Jing, NH				Tan, Fangzhi; Qian, Cheng; Tang, Ke; Abd-Allah, Saber Mohamed; Jing, Naihe			Inhibition of Transforming Growth Factor beta (TGF-beta) Signaling can Substitute for Oct4 Protein in Reprogramming and Maintain Pluripotency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; MOUSE SOMATIC-CELLS; GROUND-STATE; EXTRACELLULAR-MATRIX; PRIMITIVE ENDODERM; INDUCTION; EPIBLAST; DIFFERENTIATION; FIBROBLASTS; PATHWAY	Mouse pluripotent stem cells (PSCs), such as ES cells and induced PSCs (iPSCs), are an excellent system to investigate the molecular and cellular mechanisms involved in early embryonic development. The signaling pathways orchestrated by leukemia inhibitor factor/STAT3, Wnt/beta-catenin, and FGF/MEK/ERK play key roles in the generation of pluripotency. However, the function of TGF-beta signaling in this process remains elusive. Here we show that inhibiting TGF-beta signaling with its inhibitor SB431542 can substitute for Oct4 during reprogramming. Moreover, inhibiting TGF-beta signaling can sustain the pluripotency of iPSCs and ES cells through modulating FGF/MEK/ERK signaling. Therefore, this study reveals a novel function of TGF-beta signaling inhibition in the generation and maintenance of PSCs.	[Tan, Fangzhi; Qian, Cheng; Jing, Naihe] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Tang, Ke] Nanchang Univ, Inst Life Sci, Nanchang 330031, Jiangxi, Peoples R China; [Abd-Allah, Saber Mohamed] Beni Suef Univ, Fac Vet Med, Dept Theriogenol, Bani Suwayf 62511, Egypt	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanchang University; Egyptian Knowledge Bank (EKB); Beni Suef University	Jing, NH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	njing@sibcb.ac.cn			Chinese Academy of Sciences [XDA01010201]; National Key Basic Research and Development Program of China [2014CB964804, 2015CB964500]; National Natural Science Foundation of China [91219303, 31430058]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Basic Research and Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDA01010201, by National Key Basic Research and Development Program of China Grants 2014CB964804 and 2015CB964500, and by National Natural Science Foundation of China Grants 91219303 and 31430058.	Barrett SD, 2008, BIOORG MED CHEM LETT, V18, P6501, DOI 10.1016/j.bmcl.2008.10.054; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; Du J, 2014, CELL SIGNAL, V26, P2107, DOI 10.1016/j.cellsig.2014.06.002; Fei T, 2010, CELL RES, V20, P1306, DOI 10.1038/cr.2010.158; Galvin KE, 2010, J BIOL CHEM, V285, P19747, DOI 10.1074/jbc.M109.077347; Gao X, 2001, BIOCHEM BIOPH RES CO, V284, P1098, DOI 10.1006/bbrc.2001.5089; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Hassani SN, 2014, STEM CELL REV REP, V10, P16, DOI 10.1007/s12015-013-9473-0; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jiao J, 2013, STEM CELLS, V31, P729, DOI 10.1002/stem.1318; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lee KL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002130; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li ZW, 2012, CELL STEM CELL, V10, P171, DOI 10.1016/j.stem.2011.12.016; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Morgani SM, 2013, CELL REP, V3, P1945, DOI 10.1016/j.celrep.2013.04.034; Moustakas A, 2001, J CELL SCI, V114, P4359; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Pangas SA, 2000, TRENDS ENDOCRIN MET, V11, P309, DOI 10.1016/S1043-2760(00)00294-0; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Xia CH, 2007, DIFFERENTIATION, V75, P912, DOI 10.1111/j.1432-0436.2007.00188.x; Yamanaka Y, 2010, DEVELOPMENT, V137, P715, DOI 10.1242/dev.043471; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494; Zhang T, 2013, J BIOL CHEM, V288, P6166, DOI 10.1074/jbc.M112.418376	52	31	34	4	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4500	4511		10.1074/jbc.M114.609016	http://dx.doi.org/10.1074/jbc.M114.609016			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25548277	Green Published, hybrid			2022-12-26	WOS:000349458400055
J	Porcal, P; Kopacek, J; Tomkova, I				Porcal, Petr; Kopacek, Jiri; Tomkova, Iva			Seasonal Photochemical Transformations of Nitrogen Species in a Forest Stream and Lake	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; BIOLOGICALLY AVAILABLE NITROGEN; INORGANIC NITROGEN; BOHEMIAN FOREST; ACIDIFICATION; DYNAMICS; AMMONIUM; NITRATE; WATERS; CARBON	The photochemical release of inorganic nitrogen from dissolved organic matter is an important source of bio-available nitrogen (N) in N-limited aquatic ecosystems. We conducted photochemical experiments and used mathematical models based on pseudo-first-order reaction kinetics to quantify the photochemical transformations of individual N species and their seasonal effects on N cycling in a mountain forest stream and lake (Plesne Lake, Czech Republic). Results from laboratory experiments on photochemical changes in N speciation were compared to measured lake N budgets. Concentrations of organic nitrogen (N-org; 40-58 mu mol L-1) decreased from 3 to 26% during 48-hour laboratory irradiation (an equivalent of 4-5 days of natural solar insolation) due to photochemical mineralization to ammonium (NH4+) and other N forms (N-x; possibly N oxides and N-2). In addition to N-org mineralization, N-x also originated from photochemical nitrate (NO3-) reduction. Laboratory exposure of a first-order forest stream water samples showed a high amount of seasonality, with the maximum rates of N-org mineralization and NH4+ production in winter and spring, and the maximum NO3- reduction occurring in summer. These photochemical changes could have an ecologically significant effect on NH4+ concentrations in streams (doubling their terrestrial fluxes from soils) and on concentrations of dissolved N-org in the lake. In contrast, photochemical reactions reduced NO3- fluxes by a negligible (<1%) amount and had a negligible effect on the aquatic cycle of this N form.	[Porcal, Petr; Kopacek, Jiri] Acad Sci Czech Republ, Inst Hydrobiol, Ctr Biol, Ceske Budejovice, Czech Republic; [Tomkova, Iva] Univ South Bohemia Ceske Budejovice, Fac Sci, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Porcal, P (corresponding author), Acad Sci Czech Republ, Inst Hydrobiol, Ctr Biol, Ceske Budejovice, Czech Republic.	porcal@hbu.cas.cz	Kopacek, Jiri/A-7373-2014; Porcal, Petr/A-7350-2014; Porcal, Petr/R-4687-2019	Kopacek, Jiri/0000-0002-4409-4032; Porcal, Petr/0000-0002-7787-4924; 	Czech Science Foundation [P503/12/0781]	Czech Science Foundation(Grant Agency of the Czech Republic)	This study was supported by the Czech Science Foundation, project number P503/12/0781 (www.gacr.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnos H, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2010JG001633; Anastasio C, 2000, AEROSOL SCI TECH, V32, P106, DOI 10.1080/027868200303812; Bertilsson S, 1999, AQUAT MICROB ECOL, V19, P47, DOI 10.3354/ame019047; Bevington P. R., 2003, DATA REDUCTION ERROR, DOI 10.2307/2284752; Brezonik PL, 1998, ENVIRON SCI TECHNOL, V32, P3004, DOI 10.1021/es9802908; Brooks PD, 1998, BIOGEOCHEMISTRY, V43, P1, DOI 10.1023/A:1005947511910; Bushaw KL, 1996, NATURE, V381, P404, DOI 10.1038/381404a0; Bushaw-Newton KL, 1999, AQUAT MICROB ECOL, V18, P285, DOI 10.3354/ame018285; CNI, 2014, 751400 CNI CSN CZECH; Edwards KA, 2006, SOIL BIOL BIOCHEM, V38, P2843, DOI 10.1016/j.soilbio.2006.04.042; Fanning JC, 2000, COORDIN CHEM REV, V199, P159, DOI 10.1016/S0010-8545(99)00143-5; Gao HZ, 1998, ENVIRON SCI TECHNOL, V32, P2940, DOI 10.1021/es9803660; Gardner WS, 1998, LIMNOL OCEANOGR, V43, P1814; Helms JR, 2008, LIMNOL OCEANOGR, V53, P955, DOI 10.4319/lo.2008.53.3.0955; Jones DL, 2004, SOIL BIOL BIOCHEM, V36, P749, DOI 10.1016/j.soilbio.2004.01.003; Kieber DJ, 2003, COMP SER PHOTOCHEM, V1, P251; Kieber RJ, 1999, ENVIRON SCI TECHNOL, V33, P993, DOI 10.1021/es980188a; Kitidis V, 2008, DEEP SEA RES 2, V53, P1666; Koopmans DJ, 2002, AQUAT MICROB ECOL, V26, P295, DOI 10.3354/ame026295; Kopacek J, 2004, LIMNOL OCEANOGR, V49, P1202; KOPACEK J, 1993, INT J ENVIRON AN CH, V53, P243, DOI 10.1080/03067319308045993; Kopacek J, 2006, BIOLOGIA, V61, pS427, DOI 10.2478/s11756-007-0067-7; Lipson DA, 2000, SOIL BIOL BIOCHEM, V32, P441, DOI 10.1016/S0038-0717(99)00068-1; Majer V, 2003, HYDROL EARTH SYST SC, V7, P494, DOI 10.5194/hess-7-494-2003; Porcal P, 2013, BIOGEOSCIENCES, V10, P5533, DOI 10.5194/bg-10-5533-2013; Porcal P, 2013, AQUAT SCI, V75, P469, DOI 10.1007/s00027-013-0293-8; Porcal P, 2009, J ENVIRON MONITOR, V11, P1064, DOI 10.1039/b812330f; Spokes LJ, 1996, MAR CHEM, V54, P1, DOI 10.1016/0304-4203(96)00033-3; Stedmon CA, 2007, MAR CHEM, V104, P227, DOI 10.1016/j.marchem.2006.11.005; Stevenson F.J, 1982, NITROGEN AGR SOILS, DOI DOI 10.2134/AGRONMONOGR22.C17; Stone A., 1990, AQUATIC CHEM KINETIC, V2, P1; Takeda K, 2004, ANAL SCI, V20, P153, DOI 10.2116/analsci.20.153; Tranvik LJ, 2001, ECOL LETT, V4, P458, DOI 10.1046/j.1461-0248.2001.00245.x; Vahatalo AV, 2007, LIMNOL OCEANOGR, V52, P132; Vahatalo AV, 2003, ARCH HYDROBIOL, V156, P287, DOI 10.1127/0003-9136/2003/0156-0287; Van der Perk M, 2006, SOIL WATER CONTAMINA; Vione D, 2006, ENVIRON SCI TECHNOL, V40, P3775, DOI 10.1021/es052206b; Voelker BM, 1996, ENVIRON SCI TECHNOL, V30, P1106, DOI 10.1021/es9502132; Vrba J, 2003, SCI TOTAL ENVIRON, V310, P73, DOI 10.1016/S0048-9697(02)00624-1; Wang WW, 2000, AQUAT GEOCHEM, V6, P275, DOI 10.1023/A:1009679730079; Wiegner TN, 2001, AQUAT MICROB ECOL, V24, P27, DOI 10.3354/ame024027	41	10	10	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116364	10.1371/journal.pone.0116364	http://dx.doi.org/10.1371/journal.pone.0116364			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551441	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100135
J	Carneiro, BR; Pernambuco, PCA; Mesquita, APD; da Silva, DS; Pinhal, MAS; Nader, HB; Lopes, CC				Carneiro, Bruna Ribeiro; Pernambuco Filho, Paulo Castanho A.; de Sousa Mesquita, Ana Paula; da Silva, Douglas Santos; Pinhal, Maria Aparecida S.; Nader, Helena B.; Lopes, Carla Cristina			Acquisition of Anoikis Resistance Up-Regulates Syndecan-4 Expression in Endothelial Cells	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; FIBROBLAST-GROWTH-FACTOR; PROTEIN-KINASE-C; BREAST-CANCER; TISSUE TRANSGLUTAMINASE; MAMMALIAN HEPARANASE; TUMOR PROGRESSION; ADHESION; SURFACE; SURVIVAL	Anoikis is a programmed cell death induced upon cell detachment from extracellular matrix, behaving as a critical mechanism in preventing adherent-independent cell growth and attachment to an inappropriate matrix, thus avoiding colonization of distant organs. Cell adhesion plays an important role in neoplastic transformation. Tumors produce several molecules that facilitate their proliferation, invasion and maintenance, especially proteoglycans. The syndecan-4, a heparan sulfate proteoglycan, can act as a co-receptor of growth factors and proteins of the extracellular matrix by increasing the affinity of adhesion molecules to their specific receptors. It participates together with integrins in cell adhesion at focal contacts connecting the extracellular matrix to the cytoskeleton. Changes in the expression of syndecan-4 have been observed in tumor cells, indicating its involvement in cancer. This study investigates the role of syndecan-4 in the process of anoikis and cell transformation. Endothelial cells were submitted to sequential cycles of forced anchorage impediment and distinct lineages were obtained. Anoikis-resistant endothelial cells display morphological alterations, high rate of proliferation, poor adhesion to fibronectin, laminin and collagen IV and deregulation of the cell cycle, becoming less serum-dependent. Furthermore, anoikis-resistant cell lines display a high invasive potential and a low rate of apoptosis. This is accompanied by an increase in the levels of heparan sulfate and chondroitin sulfate as well as by changes in the expression of syndecan-4 and heparanase. These results indicate that syndecan-4 plays a important role in acquisition of anoikis resistance and that the conferral of anoikis resistance may suffice to transform endothelial cells.	[Carneiro, Bruna Ribeiro; Pernambuco Filho, Paulo Castanho A.; de Sousa Mesquita, Ana Paula; da Silva, Douglas Santos; Lopes, Carla Cristina] Univ Fed Sao Paulo, Dept Ciencias Biol, Diadema, SP, Brazil; [Carneiro, Bruna Ribeiro; Pernambuco Filho, Paulo Castanho A.; de Sousa Mesquita, Ana Paula; da Silva, Douglas Santos; Pinhal, Maria Aparecida S.; Nader, Helena B.; Lopes, Carla Cristina] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Lopes, CC (corresponding author), Univ Fed Sao Paulo, Dept Ciencias Biol, Diadema, SP, Brazil.	lopesazevedo.bioq@epm.br	Lopes, Carla C/D-6236-2013; Nader, Helena Bonciani/D-9253-2012; Pinhal, Maria Aparecida Silva/J-1797-2012; Azevedo, Carla/GRF-0374-2022	Lopes, Carla C/0000-0002-0840-5702; Pinhal, Maria Aparecida Silva/0000-0003-4001-1663; NADER, HELENA/0000-0002-7569-2166	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Equipamentos Multiusuario (EMU - FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES); Financiadora de Estudos e Projetos (FINEP), Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Equipamentos Multiusuario (EMU - FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Financiadora de Estudos e Projetos (FINEP), Brazil(Financiadora de Inovacao e Pesquisa (Finep))	Supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Equipamentos Multiusuario (EMU - FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES) and Financiadora de Estudos e Projetos (FINEP), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACIU PC, 1995, MOL BIOL CELL, V6, P1503, DOI 10.1091/mbc.6.11.1503; Batista LTEA, 2012, INT J UROL, V19, P1036, DOI 10.1111/j.1442-2042.2012.03086.x; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Beauvais DM, 2003, EXP CELL RES, V286, P219, DOI 10.1016/S0014-4827(03)00126-5; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Bianchi-Smiraglia A, 2013, ONCOGENE, V32, P3049, DOI 10.1038/onc.2012.320; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; BUONASSISI V, 1976, P NATL ACAD SCI USA, V73, P1612, DOI 10.1073/pnas.73.5.1612; Carey DJ, 1997, BIOCHEM J, V327, P1; Caseli L, 2012, BBA-BIOMEMBRANES, V1818, P1211, DOI 10.1016/j.bbamem.2012.01.012; CASTELLOT JJ, 1984, J CELL PHYSIOL, V120, P315, DOI 10.1002/jcp.1041200309; Chiarugi P, 2008, IUBMB LIFE, V60, P301, DOI 10.1002/iub.45; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Chiodoni C, 2010, CANCER METAST REV, V29, P295, DOI 10.1007/s10555-010-9221-8; Choi Y, 2011, MATRIX BIOL, V30, P93, DOI 10.1016/j.matbio.2010.10.006; Clasper S, 1999, J BIOL CHEM, V274, P24113, DOI 10.1074/jbc.274.34.24113; Coombe DR, 2005, CELL MOL LIFE SCI, V62, P410, DOI 10.1007/s00018-004-4293-7; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; DIETRICH CP, 1977, BIOCHEM BIOPH RES CO, V75, P329, DOI 10.1016/0006-291X(77)91046-4; DIETRICH CP, 1984, BRAZ J MED BIOL RES, V17, P5; DIETRICH CP, 1983, BIOCHEM BIOPH RES CO, V111, P865, DOI 10.1016/0006-291X(83)91379-7; Eble JA, 2006, CURR CANCER DRUG TAR, V6, P89, DOI 10.2174/156800906776056518; Elkin M, 2001, FASEB J, V15, P1661, DOI 10.1096/fj.00-0895fje; Erdem M, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2012.08.022; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fiore MM, 2001, BIOCHEM BIOPH RES CO, V284, P384, DOI 10.1006/bbrc.2001.4978; Fjeldstad K, 2005, CURR DRUG TARGETS, V6, P665, DOI 10.2174/1389450054863662; GAMBARINI AG, 1993, MOL CELL BIOCHEM, V124, P121, DOI 10.1007/BF00929204; Gengrinovitch S, 1999, J BIOL CHEM, V274, P10816, DOI 10.1074/jbc.274.16.10816; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Gulyas M, 2003, J PATHOL, V199, P479, DOI 10.1002/path.1312; Hay E. D., 1981, CELL BIOL EXTRACELLU; Horowitz A, 2002, J CELL BIOL, V157, P715, DOI 10.1083/jcb.200112145; HYATT SL, 1990, MOL CARCINOGEN, V3, P45, DOI 10.1002/mc.2940030202; Hynes RO, 1990, FIBRONECTINS; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kotsakis P, 2007, AMINO ACIDS, V33, P373, DOI 10.1007/s00726-007-0516-1; KRAEMER PM, 1972, J CELL BIOL, V55, P713, DOI 10.1083/jcb.55.3.713; Kram V, 2006, J CELL PHYSIOL, V207, P784, DOI 10.1002/jcp.20625; Labropoulou VT, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/214864; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Liotta LA, 2004, NATURE, V430, P973, DOI 10.1038/430973a; Liu DF, 2002, SEMIN THROMB HEMOST, V28, P67, DOI 10.1055/s-2002-20565; Lopes CC, 2006, BIOCHIMIE, V88, P1493, DOI 10.1016/j.biochi.2006.04.009; Lopes CC, 2006, BRAZ J MED BIOL RES, V39, P157, DOI 10.1590/S0100-879X2006000200001; Matsuda K, 2001, CANCER RES, V61, P5562; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Mundhenke C, 2002, AM J PATHOL, V160, P185, DOI 10.1016/S0002-9440(10)64362-3; Na KY, 2012, PATHOLOGY, V44, P325, DOI 10.1097/PAT.0b013e328353447b; Nader HB, 2004, CURR PHARM DESIGN, V10, P951, DOI 10.2174/1381612043452758; NADER HB, 1987, P NATL ACAD SCI USA, V84, P3565, DOI 10.1073/pnas.84.11.3565; NADER HB, 1989, J CELL PHYSIOL, V140, P305, DOI 10.1002/jcp.1041400216; Oba-Shinjo SM, 2006, NEOPLASIA, V8, P231, DOI 10.1593/neo.05781; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; Oh ES, 1997, J BIOL CHEM, V272, P8133, DOI 10.1074/jbc.272.13.8133; Pazos MDC, 2007, INT J BIOCHEM CELL B, V39, P1130, DOI 10.1016/j.biocel.2007.02.008; Porcionatto MA, 1998, J CELL BIOCHEM, V70, P563, DOI 10.1002/(SICI)1097-4644(19980915)70:4<563::AID-JCB12>3.0.CO;2-I; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Rennebeck G, 2005, CANCER RES, V65, P11230, DOI 10.1158/0008-5472.CAN-05-2763; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; Roskams T, 1998, J PATHOL, V185, P290, DOI 10.1002/(SICI)1096-9896(199807)185:3<290::AID-PATH91>3.0.CO;2-I; Sanderson RD, 2001, SEMIN CELL DEV BIOL, V12, P89, DOI 10.1006/scdb.2000.0241; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Sastry SK, 1993, CURR OPIN CELL BIOL, V5, P819, DOI 10.1016/0955-0674(93)90031-K; Shimazu A, 1999, J DENT RES, V78, P1791, DOI 10.1177/00220345990780120501; Stupack DG, 2002, SCI STKE, V2002, ppe7; Sudhalter J, 1996, GLIA, V17, P28, DOI 10.1002/(SICI)1098-1136(199605)17:1<28::AID-GLIA3>3.0.CO;2-3; Theodoro TR, 2007, NEOPLASIA, V9, P504, DOI 10.1593/neo.07241; THOMPSON JA, 1988, SCIENCE, V241, P1349, DOI 10.1126/science.2457952; Valentijn AJ, 2004, BIOCHEM SOC T, V32, P421, DOI 10.1042/BST0320421; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; VLODAVSKY I, 1993, BASEMENT MEMBRANES C, P327; Wang LH, 2004, MT SINAI J MED, V71, P361; Wang Z, 2011, EXP CELL RES, V317, P367, DOI 10.1016/j.yexcr.2010.10.015; Wiedlocha A, 2004, CURR TOP MICROBIOL, V286, P45; WOODS A, 1994, MOL BIOL CELL, V5, P183, DOI 10.1091/mbc.5.2.183; Woods A, 2001, CURR OPIN CELL BIOL, V13, P578, DOI 10.1016/S0955-0674(00)00254-4; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Zhang YF, 2003, AM J PHYSIOL-HEART C, V284, pH2078, DOI 10.1152/ajpheart.00942.2001	86	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116001	10.1371/journal.pone.0116001	http://dx.doi.org/10.1371/journal.pone.0116001			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549223	Green Published, gold, Green Submitted			2022-12-26	WOS:000347063500045
J	Ferraro, A; Boni, T; Pintzas, A				Ferraro, Angelo; Boni, Themis; Pintzas, Alexander			EZH2 Regulates Cofilin Activity and Colon Cancer Cell Migration by Targeting ITGA2 Gene	PLOS ONE			English	Article							ACTIN REORGANIZATION; ALPHA(2)BETA(1) INTEGRIN; METASTASIS SUPPRESSOR; BREAST-CARCINOMA; PROTEIN EZH2; INVASION; PHOSPHORYLATION; ADF/COFILIN; REPRESSION; TRANSFORMATION	Reorganization of cytoskeleton via actin remodeling is a basic step of cell locomotion. Although cell migration of normal and cancer cells can be stimulated by a variety of intra-and extra-cellular factors, all paths ultimate on the regulation of cofilin activity. Cofilin is a small actin-binding protein able to bind both forms of actin, globular and filament, and is regulated by phosphorylation at Serine 3. Following phosphorylation at serine 3 cofilin is inactive, therefore cannot bind actin molecules and cytoskeleton remodeling is impaired. The histone methyltransferase EZH2 is frequently over expressed in many tumour types including colorectal cancer (CRC). EZH2 over activity, which results in epigenetic gene-silencing, has been associated with many tumour properties including invasion, angiogenesis and metastasis but little is known about the underneath molecular mechanisms. Herein, we report that EZH2 is able to control cofilin activity and consequently cell locomotion of CRC cell lines through a non-conventional novel axis that involves integrin signaling. Indeed, we show how genetic and pharmacological inhibition (DZNep and GSK343) of EZH2 function produces hyper phosphorylation of cofilin and reduces cell migration. We previously demonstrated by chromatin immuno-precipitation that Integrin alpha 2 (ITG alpha 2) expression is regulated by EZH2. In the present study we provide evidence that in EZH2-silenced cells the signaling activity of the derepressed ITG alpha 2 is able to increase cofilin phosphorylation, which in turn reduces cell migration. This study also proposes novel mechanisms that might provide new anti-metastatic strategies for CRC treatment based on the inhibition of the epigenetic factor EZH2 and/or its target gene.	[Ferraro, Angelo; Boni, Themis; Pintzas, Alexander] Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Lab Signal Mediated Gene Express, Athens 11635, Greece	National Hellenic Research Foundation	Pintzas, A (corresponding author), Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Lab Signal Mediated Gene Express, 48 Vas Constantinou Ave, Athens 11635, Greece.	apint@eie.gr	Ferraro, Angelo/H-3193-2019	Ferraro, Angelo/0000-0002-2044-7569	EU [FP7-241783]	EU(European Commission)	This work was supported by the EU FP7 grant FP7-241783 EpiDiaCan to AP.	AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bernstein BW, 2000, CELL MOTIL CYTOSKEL, V47, P319, DOI 10.1002/1097-0169(200012)47:4<319::AID-CM6>3.0.CO;2-I; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Ellinger-Ziegelbauer H, 1999, MOL CELL BIOL, V19, P3857; Ferraro A, 2013, INT J BIOCHEM CELL B, V45, P243, DOI 10.1016/j.biocel.2012.10.009; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Gonzalez ME, 2009, ONCOGENE, V28, P843, DOI 10.1038/onc.2008.433; Huttenlocher A, 1998, J CELL BIOL, V141, P515, DOI 10.1083/jcb.141.2.515; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; LaLonde DP, 2005, J BIOL CHEM, V280, P21680, DOI 10.1074/jbc.m500752200; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Madak-Erdogan Z, 2014, MOL CANCER RES, V12, P714, DOI 10.1158/1541-7786.MCR-13-0588; Makrodouli E, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-118; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Ramirez NE, 2011, J CLIN INVEST, V121, P226, DOI 10.1172/JCI42328; Rao ZY, 2010, CARCINOGENESIS, V31, P1576, DOI 10.1093/carcin/bgq150; Ren G, 2012, CANCER RES, V72, P3091, DOI 10.1158/0008-5472.CAN-11-3546; Shaikhibrahim Z, 2011, INT J MOL MED, V28, P605, DOI 10.3892/ijmm.2011.746; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; van Rheenen J, 2009, J CELL SCI, V122, P305, DOI 10.1242/jcs.031146; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Verma SK, 2012, ACS MED CHEM LETT, V3, P1091, DOI 10.1021/ml3003346; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; ZUTTER MM, 1995, P NATL ACAD SCI USA, V92, P7411, DOI 10.1073/pnas.92.16.7411	38	46	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115276	10.1371/journal.pone.0115276	http://dx.doi.org/10.1371/journal.pone.0115276			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549357	Green Submitted, Green Published, gold			2022-12-26	WOS:000347063500012
J	Zheng, LF; Zhang, ZL; Khazaie, K; Saha, S; Lewandowski, RJ; Zhang, GX; Larson, AC				Zheng, Linfeng; Zhang, Zhuoli; Khazaie, Khashayarsha; Saha, Saurabh; Lewandowski, Robert J.; Zhang, Guixiang; Larson, Andrew C.			MRI-Monitored Intra-Tumoral Injection of Iron-Oxide Labeled Clostridium novyi-NT Anaerobes in Pancreatic Carcinoma Mouse Model	PLOS ONE			English	Article							BACTERIOLYTIC THERAPY; SALMONELLA-TYPHIMURIUM; TRACKING; CELLS; CANCER; PARTICLES; DELIVERY; SPORES	Objectives: To validate the feasibility of labeling Clostridium novyi-NT (C.novyi-NT) anaerobes with iron-oxide nanoparticles for magnetic resonance imaging (MRI) and demonstrate the potential to use MRI to visualize intra-tumoral delivery of these iron-oxide labeled C. novyi-NT during percutaneous injection procedures. Materials and Methods: All studies were approved by IACUC. C. novyi-NT were labeled with hybrid iron-oxide Texas red nanoparticles. Growth of labeled and control samples were evaluated with optical density. Labeling was confirmed with confocal fluorescence and transmission electron microscopy (TEM). MRI were performed using a 7 Tesla scanner with T2*-weighted (T2*W) sequence. Contrast-to-noise ratio (CNR) measurements were performed for phantoms and signal-to-noise ratio (SNR) measurements performed in C57BL/6 mice (n=12) with Panc02 xenografts before and after percutaneous injection of iron-oxide labeled C. novyi-NT. MRI was repeated 3 and 7 days post-injection. Hematoxylin-eosin (HE), Prussian blue and Gram staining of tumor specimens were performed for confirmation of intra-tumoral delivery. Results: Iron-oxide labeling had no influence upon C. novyi-NT growth. The signal intensity (SI) within T2*W images was significantly decreased for iron-oxide labeled C. novyi-NT phantoms compared to unlabeled controls. Under confocal fluorescence microscopy, the iron-oxide labeled C. novyi-NT exhibited a uniform red fluorescence consistent with observed regions of DAPI staining and overall labeling efficiency was 100% (all DAPI stained C. novyi-NT exhibited red fluorescence). Within TEM images, a large number iron granules were observed within the iron-oxide labeled C.novyi-NT; these were not observed within unlabeled controls. Intra-procedural MRI measurements permitted in vivo visualization of the intra-tumoral distribution of iron-oxide labeled C.novyi-NT following percutaneous injection (depicted as punctate regions of SI reductions within T2*-weighted images); tumor SNR decreased significantly following intra-tumoral injection of C.novyi-NT (p<0.05); these SNR reductions were maintained at 3 and 7 day follow-up intervals. Prussian blue and Gram staining confirmed presence of the iron-oxide labeled anaerobes. Conclusions: C.novyi-NT can be labeled with iron-oxide nanoparticles for MRI visualization of intra-tumoral deposition following percutaneous injection during bacteriolytic therapy.	[Zheng, Linfeng; Zhang, Guixiang] Shanghai Jiao Tong Univ, Peoples Hosp 1, Dept Radiol, Shanghai 200030, Peoples R China; [Zheng, Linfeng; Zhang, Zhuoli; Lewandowski, Robert J.; Larson, Andrew C.] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60208 USA; [Zhang, Zhuoli; Larson, Andrew C.] Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA; [Khazaie, Khashayarsha] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN USA; [Saha, Saurabh] BioMed Valley Discoveries, Kansas City, MO USA	Shanghai Jiao Tong University; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Robert H. Lurie Comprehensive Cancer Center; Mayo Clinic	Larson, AC (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60208 USA.	a-larson@northwestern.edu			National Cancer Institute [R01CA159178, RO1CA141047, R21CA173491]; State Scholarship Fund by China Scholarship Council; Shanghai First People's Hospital, Shanghai Jiao Tong University; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA141047, R21CA173491, R01CA159178] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); State Scholarship Fund by China Scholarship Council; Shanghai First People's Hospital, Shanghai Jiao Tong University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants (R01CA159178, RO1CA141047 and R21CA173491) from the National Cancer Institute, the State Scholarship Fund by China Scholarship Council (for LZ), the award for the best youth medical scholars by Shanghai First People's Hospital, Shanghai Jiao Tong University (for LZ). This work was also supported by the Center for Translational Imaging at Northwestern University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Agrawal N, 2004, P NATL ACAD SCI USA, V101, P15172, DOI 10.1073/pnas.0406242101; Ahrens ET, 2013, NAT REV IMMUNOL, V13, P755, DOI 10.1038/nri3531; Benincasa M, 2009, ANTIMICROB AGENTS CH, V53, P3501, DOI 10.1128/AAC.01620-08; Benoit MR, 2009, CLIN CANCER RES, V15, P5170, DOI 10.1158/1078-0432.CCR-08-3206; Bettegowda C, 2003, P NATL ACAD SCI USA, V100, P15083, DOI 10.1073/pnas.2036598100; Bulte JWM, 2013, RADIOLOGY, V269, P1, DOI 10.1148/radiol.13131753; Daldrup-Link HE, 2005, RADIOLOGY, V234, P197, DOI 10.1148/radiol.2341031236; Dang LH, 2001, P NATL ACAD SCI USA, V98, P15155, DOI 10.1073/pnas.251543698; Elbing KL, 2001, CURR PROTOC PROTEIN; Fleige G, 2002, INVEST RADIOL, V37, P482, DOI 10.1097/00004424-200209000-00002; Gupta T, 2008, RADIOLOGY, V249, P845, DOI 10.1148/radiol.2491072027; Hayashi K, 2009, J CELL BIOCHEM, V106, P992, DOI 10.1002/jcb.22078; Hill PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025409; Hoerr V, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-63; Husain K, 2013, CANCER PREV RES, V6, P1074, DOI 10.1158/1940-6207.CAPR-13-0157; Khurana A, 2013, RADIOLOGY, V269, P186, DOI 10.1148/radiol.13130858; Killock David, 2014, Nat Rev Clin Oncol, V11, P562, DOI 10.1038/nrclinonc.2014.151; Krick EL, 2012, AM J VET RES, V73, P112, DOI 10.2460/ajvr.73.1.112; Liu GS, 2013, MAGN RESON MED, V70, P1690, DOI 10.1002/mrm.24955; Maletzki C, 2008, GUT, V57, P483, DOI 10.1136/gut.2007.125419; Maletzki C, 2010, WORLD J GASTROENTERO, V16, P3546, DOI 10.3748/wjg.v16.i28.3546; Meng YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031137; Plomp M, 2007, J BACTERIOL, V189, P6457, DOI 10.1128/JB.00757-07; Roberts NJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008982; Sheu AY, 2013, INVEST RADIOL, V48, P492, DOI 10.1097/RLI.0b013e31827994e5; Torres MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080580; Wagner M, 2011, J MAGN RESON IMAGING, V34, P816, DOI 10.1002/jmri.22683; Zhang Z, 2014, RADIOLOGY; Zhang ZL, 2013, J IMMUNOL METHODS, V400, P23, DOI 10.1016/j.jim.2013.06.013; Zhang ZL, 2009, MOL IMAGING, V8, P148, DOI 10.2310/7290.2009.00008; Zhang ZL, 2004, MAGN RESON MATER PHY, V17, P201, DOI 10.1007/s10334-004-0054-8; Zhao M, 2005, P NATL ACAD SCI USA, V102, P755, DOI 10.1073/pnas.0408422102	32	9	9	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116204	10.1371/journal.pone.0116204	http://dx.doi.org/10.1371/journal.pone.0116204			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549324	gold, Green Submitted, Green Published			2022-12-26	WOS:000347063500061
J	Andersson, IM; Christensson, K; Gemzell-Danielsson, K				Andersson, Inga-Maj; Christensson, Kyllike; Gemzell-Danielsson, Kristina			Experiences, Feelings and Thoughts of Women Undergoing Second Trimester Medical Termination of Pregnancy	PLOS ONE			English	Article							SURGICAL TERMINATION; INDUCED-ABORTION; PERCEPTIONS; DISTRESS; CARE	Main Objective: The objective of this study was to explore women's expectations and experiences of undergoing second trimester abortion. Methods: This is a cross-sectional study using a screening questionnaire and semi-structured interviews for data collection. Thirty-one women filled out the questionnaire and 23 of them were later interviewed. The questionnaires were analyzed by descriptive statistics. The interviews were recorded, transcribed verbatim and analyzed with qualitative content analysis. Most Important Findings: Indications for the abortion were fetal malformation or unintended pregnancy. The women expressed similar feelings and these were irrespective for the reason for having an abortion. Both physical and mental pain was experienced during the abortion process and described by the women. Taking the mifepristone-pill was experienced as especially emotionally difficult for many participants. Professional support from the staff together with support from the partner, a friend or relative helped in transforming the worries related to something unknown to feelings of coping with a new and hard experience. Prior to the abortion most women stated that they did not want to view the fetus but women who chose to view the fetus described this as a way of confronting the reality and an opportunity to say farewell to the pregnancy/fetus. The analysis of the interview transcripts revealed five themes mirroring the women's experiences, thoughts and feelings related to the abortion. Conclusions: The decision to undergo second trimester abortion sometimes exposes women to strong and conflicting emotions which are irrespective for the reason for having an abortion. Despite this women do not regret their decision to terminate the pregnancy. This analysis shows that their rational thinking outweighs their emotionally difficult feelings. It is important for the attending staff to be responsive to the needs of each individual woman whatever the indication is for the abortion.	[Andersson, Inga-Maj] Stockholm South Gen Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Christensson, Kyllike] Karolinska Inst, Dept Womens & Childrens Hlth, Div Reprod Hlth, Stockholm, Sweden; [Gemzell-Danielsson, Kristina] Karolinska Univ Hosp, Karolinska Inst, WHO Ctr, Dept Womens & Childrens Hlth,Div Obstet & Gynecol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Andersson, IM (corresponding author), Stockholm South Gen Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	Inga-Maj.Andersson@ki.se			Swedish Research Council [0855]; ALF (Karolinska Institutet - Stockholm County Council); Karolinska Institutet; Stockholm South General Hospital	Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF (Karolinska Institutet - Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Stockholm South General Hospital	The study was supported by grants from the Swedish Research Council (grant no 0855), ALF (Karolinska Institutet - Stockholm County Council, Agreement on Medical Research and Training) funding, the Karolinska Institutet, and Stockholm South General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex L, 2004, SCAND J CARING SCI, V18, P160, DOI 10.1111/j.1471-6712.2004.00257.x; Andersson IM, 2014, CONTRACEPTION, V89, P460, DOI 10.1016/j.contraception.2014.01.012; Becker S, 2008, CONTRACEPTION, V78, P424, DOI 10.1016/j.contraception.2008.06.011; Benute GRG, 2012, MIDWIFERY, V28, P472, DOI 10.1016/j.midw.2011.06.011; Cheng L, 2008, SURG VERSUS MED METH; Escott D, 2004, MIDWIFERY, V20, P144, DOI 10.1016/j.midw.2003.11.001; Fergusson DM, 2009, BRIT J PSYCHIAT, V195, P420, DOI 10.1192/bjp.bp.109.066068; Geerinck-Vercammen CR, 2003, PRENATAL DIAG, V23, P543, DOI 10.1002/pd.636; Gewell-Danielsson K, 2008, REPROD HEALTH MATTER, V16, P162, DOI 10.1016/S0968-8080(08)31371-8; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Grossman D, 2008, REPROD HEALTH MATTER, V16, P173, DOI 10.1016/S0968-8080(08)31379-2; Hallden BM, 2009, SCAND J CARING SCI, V23, P243, DOI 10.1111/j.1471-6712.2008.00612.x; HAMARK B, 1995, ACTA OBSTET GYN SCAN, V74, P302, DOI 10.3109/00016349509024454; Hamoda H, 2005, HUM REPROD, V20, P2348, DOI 10.1093/humrep/dei037; Kelly T, 2010, BJOG-INT J OBSTET GY, V117, P1512, DOI 10.1111/j.1471-0528.2010.02712.x; Kero A, 2001, SOC SCI MED, V53, P1481, DOI 10.1016/S0277-9536(00)00436-6; Kimport K, 2013, CONTRACEPTION, V88, P666, DOI 10.1016/j.contraception.2013.07.006; Lafarge C, 2013, QUAL HEALTH RES, V23, P924, DOI 10.1177/1049732313484198; Lauzon P, 2000, CAN FAM PHYSICIAN, V46, P2033; Lee E, 2010, BEST PRACT RES CL OB, V24, P479, DOI 10.1016/j.bpobgyn.2010.02.005; LORENZEN J, 1995, FETAL DIAGN THER, V10, P147, DOI 10.1159/000264225; Lowenstein L, 2006, GEN HOSP PSYCHIAT, V28, P43, DOI 10.1016/j.genhosppsych.2005.07.006; Mukkavaara I, 2012, MIDWIFERY, V28, pE720, DOI 10.1016/j.midw.2011.07.011; Powell J, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1600; Price B, 2002, J ADV NURS, V37, P273, DOI 10.1046/j.1365-2648.2002.02086.x; Purcell C, 2014, PERSPECT SEX REPRO H, V46, P101, DOI 10.1363/46e1214; Sandelowski M, 2003, QUAL HEALTH RES, V13, P905, DOI 10.1177/1049732303253488; Sihvo S, 1998, ACTA OBSTET GYN SCAN, V77, P210, DOI 10.1034/j.1600-0412.1998.770216.x; Slade P, 2001, J FAM PLAN REPROD H, V27, P72, DOI 10.1783/147118901101195281; Sloan EP, 2008, JOGNN-J OBST GYN NEO, V37, P395, DOI 10.1111/j.1552-6909.2008.00260.x; Stalhandske ML, 2011, J PSYCHOSOM OBST GYN, V32, P35, DOI 10.3109/0167482X.2010.545457; Stalhandske ML, 2012, J PSYCHOSOM OBST GYN, V33, P53, DOI 10.3109/0167482X.2012.677877; Taylor D, 2013, AM J MED QUAL, V28, P510, DOI 10.1177/1062860613484295; Vandamme J, 2013, EUR J CONTRACEP REPR, V18, P309, DOI 10.3109/13625187.2013.796586; Wiebe ER, 2009, CONTRACEPTION, V80, P575, DOI 10.1016/j.contraception.2009.07.005; Wiebe ER, 2009, EUR J CONTRACEP REPR, V14, P97, DOI 10.1080/13625180902745130; Woodcock S, 2011, BIOETHICS, V25, P495, DOI 10.1111/j.1467-8519.2009.01798.x; World Health Organization, 2014, CLIN PRACT HDB SAF A	38	29	31	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115957	10.1371/journal.pone.0115957	http://dx.doi.org/10.1371/journal.pone.0115957			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UN	25546416	Green Published, gold, Green Submitted			2022-12-26	WOS:000347120200086
J	de Hollander, G; Wagenmakers, EJ; Waldorp, L; Forstmann, B				de Hollander, Gilles; Wagenmakers, Eric-Jan; Waldorp, Lourens; Forstmann, Birte			An Antidote to the Imager's Fallacy, or How to Identify Brain Areas That Are in Limbo	PLOS ONE			English	Article							DECISION-MAKING; FMRI; NEUROSCIENCE	Traditionally, fMRI data are analyzed using statistical parametric mapping approaches. Regardless of the precise thresholding procedure, these approaches ultimately divide the brain in regions that do or do not differ significantly across experimental conditions. This binary classification scheme fosters the so-called imager's fallacy, where researchers prematurely conclude that region A is selectively involved in a certain cognitive task because activity in that region reaches statistical significance and activity in region B does not. For such a conclusion to be statistically valid, however, a test on the differences in activation across these two regions is required. Here we propose a simple GLM-based method that defines an "in-between" category of brain regions that are neither significantly active nor inactive, but rather "in limbo". For regions that are in limbo, the activation pattern is inconclusive: it does not differ significantly from baseline, but neither does it differ significantly from regions that do show significant changes from baseline. This pattern indicates that measurement was insufficiently precise. By directly testing differences in activation, our procedure helps reduce the impact of the imager's fallacy. The method is illustrated using concrete examples.	[de Hollander, Gilles; Forstmann, Birte] Univ Amsterdam, ABC, Amsterdam, Netherlands; [de Hollander, Gilles; Wagenmakers, Eric-Jan; Waldorp, Lourens; Forstmann, Birte] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	de Hollander, G (corresponding author), Univ Amsterdam, ABC, Amsterdam, Netherlands.	Gilles.de.Hollander@gmail.com	Forstmann, Birte/AAS-8515-2020; Wagenmakers, Eric-Jan/AAH-7065-2019	Wagenmakers, Eric-Jan/0000-0003-1596-1034; de Hollander, Gilles/0000-0003-1988-5091	Netherlands Organization for Scientific Research (NWO; Vidi-grant); European Research Council	Netherlands Organization for Scientific Research (NWO; Vidi-grant)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission)	This work was supported by The Netherlands Organization for Scientific Research (NWO; Vidi-grant "When the brain takes a break: A model-based cognitive neuroscience account of task unrelated thoughts'', BUF) and the European Research Council (Starting Grant "speeded decision-making in the basal ganglia: An integrative model-based approach'', BUF and GH, and the starting grant "Bayes or bust: sensible hypothesis tests for social scientists.'' EJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Friston K., 2007, STAT PARAMETRIC MAPP, DOI [10.1016/B978-0-12-372560-8.X5000-1, DOI 10.1016/B978-0-12-372560-8.X5000-1]; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gelman A, 2006, AM STAT, V60, P328, DOI 10.1198/000313006X152649; Gonzalez-Castillo J, 2012, P NATL ACAD SCI USA, V109, P5487, DOI 10.1073/pnas.1121049109; Gorgolewski  K., 2011, FRONTIERS NEUROINFOR, V5; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Henson R, 2005, Q J EXP PSYCHOL-A, V58, P193, DOI 10.1080/02724980443000502; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Mumford JA, 2007, SOC COGN AFFECT NEUR, V2, P251, DOI 10.1093/scan/nsm019; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; O'Reilly JX, 2012, SOC COGN AFFECT NEUR, V7, P604, DOI 10.1093/scan/nss055; Poldrack RA, 2011, HDB FUNCTIONAL MRI D; Poldrack RA, 2008, NEUROIMAGE, V40, P409, DOI 10.1016/j.neuroimage.2007.11.048; Waldorp L, 2009, INT J BIOMEDICAL IMA, V2009, P1; Welvaert M, 2011, BERL WORKSH STAT NEU; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023	21	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115700	10.1371/journal.pone.0115700	http://dx.doi.org/10.1371/journal.pone.0115700			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546581	Green Published, gold, Green Submitted			2022-12-26	WOS:000347120200056
J	Mugasha, C; Kigozi, J; Kiragga, A; Muganzi, A; Sewankambo, N; Coutinho, A; Nakanjako, D				Mugasha, Christine; Kigozi, Joanita; Kiragga, Agnes; Muganzi, Alex; Sewankambo, Nelson; Coutinho, Alex; Nakanjako, Damalie			Intra-Facility Linkage of HIV-Positive Mothers and HIV-Exposed Babies into HIV Chronic Care: Rural and Urban Experience in a Resource Limited Setting	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; FOLLOW-UP; PREVENTION; PROGRAM; PMTCT; ATTENDANCE; ADHERENCE; UGANDA; MALAWI	Introduction: Linkage of HIV-infected pregnant women to HIV care remains critical for improvement of maternal and child outcomes through prevention of maternal-to-child transmission of HIV (PMTCT) and subsequent chronic HIV care. This study determined proportions and factors associated with intra-facility linkage to HIV care and Early Infant Diagnosis care (EID) to inform strategic scale up of PMTCT programs. Methods: A cross-sectional review of records was done at 2 urban and 3 rural public health care facilities supported by the Infectious Diseases Institute (IDI). HIV-infected pregnant mothers, identified through routine antenatal care (ANC) and HIV-exposed babies were evaluated for enrollment in HIV clinics by 6 weeks post-delivery. Results: Overall, 1,025 HIV-infected pregnant mothers were identified during ANC between January and June, 2012; 267/1,025 (26%) in rural and 743/1,025 (74%) in urban facilities. Of these 375/1,025 (37%) were linked to HIV clinics [67/267(25%) rural and 308/758(41%) urban]. Of 636 HIV-exposed babies, 193 (30%) were linked to EID. Linkage of mother-baby pairs to HIV chronic care and EID was 16% (101/636); 8/179 (4.5%)] in rural and 93/457(20.3%) in urban health facilities. Within rural facilities, ANC registration <28 weeks-of-gestation was associated with mothers' linkage to HIV chronic care [AoR, 2.0 95% CI, 1.1-3.7, p=0.019] and mothers' multi-parity was associated with baby's linkage to EID; AoR 4.4 (1.3-15.1), p=0.023. Stigma, long distance to health facilities and vertical PMTCT services affected linkage in rural facilities, while peer mothers, infant feeding services, long patient queues and limited privacy hindered linkage to HIV care in urban settings. Conclusion: Post-natal linkage of HIV-infected mothers to chronic HIV care and HIV-exposed babies to EID programs was low. Barriers to linkage to HIV care vary in urban and rural settings. We recommend targeted interventions to rapidly improve linkage to antiretroviral therapy for elimination of MTCT.	[Mugasha, Christine; Kigozi, Joanita; Muganzi, Alex; Coutinho, Alex; Nakanjako, Damalie] Infect Dis Inst, Kampala, Uganda; [Kiragga, Agnes; Sewankambo, Nelson; Nakanjako, Damalie] Makerere Univ Coll Hlth Sci, Kampala, Uganda	Makerere University	Nakanjako, D (corresponding author), Infect Dis Inst, Kampala, Uganda.	dnakanjako@gmail.com		Nakanjako, Damalie/0000-0002-0935-2112; Sewankambo, Nelson/0000-0001-9362-053X	NIH Office of AIDS Research; Fogarty International Center [R24TW008907-01S1]; FOGARTY INTERNATIONAL CENTER [R24TW008907, R25TW009343] Funding Source: NIH RePORTER	NIH Office of AIDS Research; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The authors acknowledge funding by NIH Office of AIDS Research and Fogarty International Center, grant # R24TW008907-01S1, that supported Christine Mugasha to conduct this study during her Afya Bora Consortium Fellowship in Global Health Leadership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluisio A, 2011, JAIDS-J ACQ IMM DEF, V56, P76, DOI 10.1097/QAI.0b013e3181fdb4c4; [Anonymous], PROGR REP 2011 GLOB; [Anonymous], 2017, 2013 UNAIDS REP GLOB; AVERT, 2012, AV HIV AIDS AIDS SUB; Bajunirwe Francis, 2005, AIDS Res Ther, V2, P10, DOI 10.1186/1742-6405-2-10; Bwirire LD, 2008, T ROY SOC TROP MED H, V102, P1195, DOI 10.1016/j.trstmh.2008.04.002; Cook RE, 2011, JAIDS-J ACQ IMM DEF, V56, pE104, DOI 10.1097/QAI.0b013e318207a535; Ediau M, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-189; Esiru G, 2013, 20 C RETR OPP INF CR; Hardon A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-26; JOFFE H, 2003, RES METHODS CLIN HLT; Larsson EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037590; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; Mbonye AK, 2010, J BIOSOC SCI, V42, P271, DOI 10.1017/S002193200999040X; Mepham S, 2011, AIDS CARE, V23, P741, DOI 10.1080/09540121.2010.516341; Nakanjako D, 2013, SCALING HIV AIDS CAR, P249; Nassali M, 2009, AIDS CARE, V21, P1124, DOI 10.1080/09540120802707467; Uganda AIDS commission, 2011, NAT PRIOR ACT PLAN 2; Uganda aids Commission, 2012, GLOB AIDS RESP PROGR; Ujiji OA, 2011, CULT HEALTH SEX, V13, P829, DOI 10.1080/13691058.2011.583682; UNAIDS, 2012, GLOBAL REPORT UNAIDS; UNAIDS, 2010, UN ACC SCAL PRIOR HI; UNAIDS, 2012, TOG WE WILL END AIDS; UNAIDS, 2011, UNAIDS 2011 WORLD AI	24	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115171	10.1371/journal.pone.0115171	http://dx.doi.org/10.1371/journal.pone.0115171			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UN	25546453	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200025
J	Xu, X; Kang, CY; Guo, TM				Xu, Xu; Kang, Chunyan; Guo, Taomei			The Effects of Gender and Self-Insight on Early Semantic Processing	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; EMOTIONAL WORDS; SEX-DIFFERENCES; ERP EVIDENCE; CONCRETE; CONTEXT; COMPREHENSION; NETWORKS	This event-related potential (ERP) study explored individual differences associated with gender and level of self-insight in early semantic processing. Forty-eight Chinese native speakers completed a semantic judgment task with three different categories of words: abstract neutral words (e.g., logic, effect), concrete neutral words (e.g., teapot, table), and emotion words (e.g., despair, guilt). They then assessed their levels of self-insight. Results showed that women engaged in greater processing than did men. Gender differences also manifested in the relationship between level of self-insight and word processing. For women, level of self-insight was associated with level of semantic activation for emotion words and abstract neutral words, but not for concrete neutral words. For men, level of self-insight was related to processing speed, particularly in response to abstract and concrete neutral words. These findings provide electrophysiological evidence for the effects of gender and self-insight on semantic processing and highlight the need to take into consideration subject variables in related research.	[Xu, Xu] Penn State Univ Harrisburg, Sch Behav Sci & Educ, Middletown, PA USA; [Kang, Chunyan; Guo, Taomei] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Kang, Chunyan; Guo, Taomei] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Guo, Taomei] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing 100875, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Beijing Normal University; Beijing Normal University; Beijing Normal University	Guo, TM (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	guotm@bnu.edu.cn	Kang, Chunyan/AAF-5698-2019		National Natural Science Foundation of China [31170970]; National Key Basic Research Program of China [2014CB846102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	The study was supported by the National Natural Science Foundation of China (31170970) and the National Key Basic Research Program of China (2014CB846102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarriba J, 2004, AM J PSYCHOL, V117, P389, DOI 10.2307/4149007; Altarriba J, 1999, BEHAV RES METH INS C, V31, P578, DOI 10.3758/BF03200738; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Citron FMM, 2012, BRAIN LANG, V122, P211, DOI 10.1016/j.bandl.2011.12.007; Daltrozzo J, 2007, ARCH SEX BEHAV, V36, P555, DOI 10.1007/s10508-006-9161-0; Else-Quest NM, 2012, PSYCHOL BULL, V138, P947, DOI 10.1037/a0027930; Grant AM, 2002, SOC BEHAV PERSONAL, V30, P821, DOI 10.2224/sbp.2002.30.8.821; Hinojosa JA, 2001, BRAIN LANG, V78, P128, DOI 10.1006/brln.2001.2455; Hinojosa JA, 2010, PSYCHOPHYSIOLOGY, V47, P748, DOI 10.1111/j.1469-8986.2010.00982.x; Iglesias A, 2004, INT J PSYCHOPHYSIOL, V52, P169, DOI 10.1016/j.ijpsycho.2003.06.003; Kaltwasser L, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00168; Kanske P, 2007, BRAIN RES, V1148, P138, DOI 10.1016/j.brainres.2007.02.044; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Kissler J, 2006, PROG BRAIN RES, V156, P147, DOI 10.1016/S0079-6123(06)56008-X; KOUNIOS J, 1994, J EXP PSYCHOL LEARN, V20, P804, DOI 10.1037/0278-7393.20.4.804; Kousta ST, 2011, J EXP PSYCHOL GEN, V140, P14, DOI 10.1037/a0021446; Martin-Loeches M, 2004, SCHIZOPHR RES, V71, P393, DOI 10.1016/j.schres.2004.02.009; Martin-Loeches M, 2001, NEUROPSYCHOLOGIA, V39, P1086, DOI 10.1016/S0028-3932(01)00033-1; Martin-Loeches M, 2007, BRAIN RES REV, V53, P89, DOI 10.1016/j.brainresrev.2006.07.001; MEYERSLEVY J, 1991, J CONSUM RES, V18, P63, DOI 10.1086/209241; PAIVIO A, 1971, PERCEPT PSYCHOPHYS, V10, P408, DOI 10.3758/BF03210323; Palazova M, 2013, BRAIN LANG, V125, P264, DOI 10.1016/j.bandl.2013.02.008; Potts GF, 2001, COGNITIVE BRAIN RES, V11, P147, DOI 10.1016/S0926-6410(00)00075-6; Pu J, 2005, COGNITIVE BRAIN RES, V25, P273, DOI 10.1016/j.cogbrainres.2005.06.001; RUDELL AP, 1991, INT J NEUROSCI, V60, P85, DOI 10.3109/00207459109082040; Rudell AP, 1997, J EXP PSYCHOL HUMAN, V23, P1170; RUDELL AP, 1992, ELECTROEN CLIN NEURO, V83, P77, DOI 10.1016/0013-4694(92)90135-5; Sass SM, 2010, PSYCHOPHYSIOLOGY, V47, P247, DOI 10.1111/j.1469-8986.2009.00926.x; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; SCHWANENFLUGEL PJ, 1983, J EXP PSYCHOL LEARN, V9, P82, DOI 10.1037/0278-7393.9.1.82; Van Hell J.G., 1998, BILING LANG CONGN, V1, P193, DOI [10.1017/S1366728998000352, DOI 10.1017/S1366728998000352]; Vigliocco G, 2014, CEREB CORTEX, V24, P1767, DOI 10.1093/cercor/bht025; WATTENMAKER WD, 1987, J EXP PSYCHOL LEARN, V13, P140, DOI 10.1037/0278-7393.13.1.140; West WC, 2000, J COGNITIVE NEUROSCI, V12, P1024, DOI 10.1162/08989290051137558; Wiemer-Hastings K, 2005, COGNITIVE SCI, V29, P719, DOI 10.1207/s15516709cog0000_33; Wirth M, 2007, CEREB CORTEX, V17, P1987, DOI 10.1093/cercor/bhl121; Zhang Y, 2009, NEUROSCI LETT, V454, P86, DOI 10.1016/j.neulet.2009.02.047	39	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e114421	10.1371/journal.pone.0114421	http://dx.doi.org/10.1371/journal.pone.0114421			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UN	25545394	Green Published, gold			2022-12-26	WOS:000347120200013
J	Tusi, BK; Deng, CW; Salz, T; Zeumer, L; Li, YQ; So, CWE; Morel, LM; Qiu, Y; Huang, SM				Tusi, Betsabeh Khoramian; Deng, Changwang; Salz, Tal; Zeumer, Leilani; Li, Yangqiu; So, Chi Wai Eric; Morel, Laurence M.; Qiu, Yi; Huang, Suming			Setd1a regulates progenitor B-cell-to-precursor B-cell development through histone H3 lysine 4 trimethylation and Ig heavy-chain rearrangement	FASEB JOURNAL			English	Article						promoter H3K4me3; Setd1a KO mice; B-cell differentiation; long-range chromatin loops; transcriptional regulation	MIXED-LINEAGE-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; COMPASS FAMILY; MICE LACKING; 3D STRUCTURE; TRANSCRIPTION; LOCUS; GENE; METHYLATION; MLL1	SETD1A is a member of trithorax-related histone methyltransferases that methylate lysine 4 at histone H3 (H3K4). We showed previously that Setd1a is required for mesoderm specification and hematopoietic lineage differentiation in vitro. However, it remains unknown whether or not Setd1a controls specific hematopoietic lineage commitment and differentiation during animal development. Here, we reported that homozygous Setd1a knockout (KO) mice are embryonic lethal. Loss of the Setd1a gene in the hematopoietic compartment resulted in a blockage of the progenitor B-cell-to-precursor B-cell development in bone marrow (BM) and B-cell maturation in spleen. The Setd1a-cKO (conditional knockout) mice exhibited an enlarged spleen with disrupted spleen architecture and leukocytopenia. Mechanistically, Setd1a deficiency in BM reduced the levels of H3K4me3 at critical B-cell gene loci, including Pax5 and Rag1/2, which are critical for the IgH (Ig heavy-chain) locus contractions and rearrangement. Subsequently, the differential long-range looped interactions of the enhancer Em with proximal 59 DH region and 39 regulatory regions as well as with Pax5-activated intergenic repeat elements and 59 distal V-H genes were compromised by the Setd1a-cKO. Together, our findings revealed a critical role of Setd1a and its mediated epigenetic modifications in regulating the IgH rearrangement and B-cell development.	[Tusi, Betsabeh Khoramian; Deng, Changwang; Salz, Tal; Huang, Suming] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Zeumer, Leilani; Morel, Laurence M.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; [Qiu, Yi] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Li, Yangqiu] Jinan Univ, Coll Med, Inst Hematol, Guangzhou, Guangdong, Peoples R China; [So, Chi Wai Eric] Kings Coll London, Dept Haematol Med, London, England	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Jinan University; University of London; King's College London	Qiu, Y (corresponding author), Univ Florida, Coll Med, Dept Anat & Cell Biol, 2033 Mowry Rd,CGRC 356, Gainesville, FL 32610 USA.	qiuy@ufl.edu; sumingh@ufl.edu		Khoramian Tusi, Betsabeh/0000-0001-7072-2162; , Yi/0000-0002-3282-6072	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [R01HL091929, R01HL090589, R01HL095674]; Cancer Research UK [16753] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091929, R01HL095674, R01HL090589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058150] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cancer Research UK(Cancer Research UK); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are grateful to members of the S.H. and Y.Q. laboratories for their suggestions and comments. The authors thank Ms. Nga Tran for providing technical support during the revision. This work was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants R01HL091929 and R01HL090589 (to S.H.), and R01HL095674 (to Y.Q.). The authors declare no conflicts of interest.	Ardehali MB, 2011, EMBO J, V30, P2817, DOI 10.1038/emboj.2011.194; Artinger EL, 2013, P NATL ACAD SCI USA, V110, P12000, DOI 10.1073/pnas.1301278110; Bartholdy B, 2004, GENE, V327, P1, DOI 10.1016/j.gene.2003.11.008; Bertrand FE, 2001, BLOOD, V98, P3398, DOI 10.1182/blood.V98.12.3398; Bledau AS, 2014, DEVELOPMENT, V141, P1022, DOI 10.1242/dev.098152; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Degner-Leisso SC, 2010, SEMIN IMMUNOL, V22, P346, DOI 10.1016/j.smim.2010.08.002; Deng CW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003524; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Ebert A, 2011, IMMUNITY, V34, P175, DOI 10.1016/j.immuni.2011.02.005; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Ernst P, 2004, DEV CELL, V6, P437, DOI 10.1016/S1534-5807(04)00061-9; Gan T, 2010, LEUKEMIA, V24, P1732, DOI 10.1038/leu.2010.171; Guo CY, 2011, CELL, V147, P332, DOI 10.1016/j.cell.2011.08.049; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Heuser M, 2009, BLOOD, V113, P1432, DOI [10.1182/blood-2008-02-162263, 10.1182/blood-2008-06-162263]; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Huang HT, 2013, NAT CELL BIOL, V15, P1516, DOI 10.1038/ncb2870; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Li BE, 2013, BLOOD, V122, P2039, DOI 10.1182/blood-2013-03-486647; Li XG, 2011, BLOOD, V118, P1386, DOI 10.1182/blood-2010-11-319111; Li XG, 2010, BLOOD, V115, P2028, DOI 10.1182/blood-2009-07-236059; Madan V, 2009, BLOOD, V113, P1444, DOI 10.1182/blood-2008-02-142638; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; Mohan M, 2010, NAT REV CANCER, V10, P720, DOI 10.1038/nrc2915; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morgan MA, 2013, MOL CELL BIOL, V33, P1698, DOI 10.1128/MCB.00203-13; Muntean AG, 2012, ANNU REV PATHOL-MECH, V7, P283, DOI 10.1146/annurev-pathol-011811-132434; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Patel B, 2014, LEUKEMIA, V28, P349, DOI 10.1038/leu.2013.158; Salz T, 2014, MOL CANC RES; Salz T, 2014, CANCER RES, V74, P775, DOI 10.1158/0008-5472.CAN-13-1400; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Verma-Gaur J, 2012, P NATL ACAD SCI USA, V109, P17004, DOI 10.1073/pnas.1208398109; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2	43	21	21	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1505	1515		10.1096/fj.14-263061	http://dx.doi.org/10.1096/fj.14-263061			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25550471	Bronze, Green Published			2022-12-26	WOS:000354115000035
J	Lurick, A; Kuhlee, A; Brocker, C; Kummel, D; Raunser, S; Ungermann, C				Luerick, Anna; Kuhlee, Anne; Broecker, Cornelia; Kuemmel, Daniel; Raunser, Stefan; Ungermann, Christian			The H-abc Domain of the SNARE Vam3 Interacts with the HOPS Tethering Complex to Facilitate Vacuole Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL PEPTIDE; RAB INTERACTIONS; STRUCTURAL BASIS; YEAST VACUOLE; PROTEIN VPS33; MEMBRANE; DOCKING; PHOSPHOINOSITIDES; RECRUITMENT; ENDOSOME	Membrane fusion at vacuoles requires a consecutive action of the HOPS tethering complex, which is recruited by the Rab GTPase Ypt7, and vacuolar SNAREs to drive membrane fusion. It is assumed that the Sec1/Munc18-like Vps33 within the HOPS complex is largely responsible for SNARE chaperoning. Here, we present direct evidence for HOPS binding to SNAREs and the H-abc domain of the Vam3 SNARE protein, which may explain its function during fusion. We show that HOPS interacts strongly with the Vam3 H-abc domain, assembled Q-SNAREs, and the R-SNARE Ykt6, but not the Q-SNARE Vti1 or the Vam3 SNARE domain. Electron microscopy combined with Nanogold labeling reveals that the binding sites for vacuolar SNAREs and the H-abc domain are located in the large head of the HOPS complex, where Vps16 and Vps33 have been identified before. Competition experiments suggest that HOPS bound to the H-abc domain can still interact with assembled Q-SNAREs, whereas Q-SNARE binding prevents recognition of the H-abc domain. In agreement, membranes carrying Vam(3)Delta H-abc fuse poorly unless an excess of HOPS is provided. These data suggest that the H-abc domain of Vam3 facilitates the assembly of the HOPS/SNARE machinery at fusion sites and thus supports efficient membrane fusion.	[Luerick, Anna; Broecker, Cornelia; Ungermann, Christian] Univ Osnabruck, Dept Biol Chem, Biochem Sect, D-49076 Osnabruck, Germany; [Kuemmel, Daniel] Univ Osnabruck, Dept Biol Chem, D-49076 Osnabruck, Germany; [Kuhlee, Anne; Raunser, Stefan] Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany	University Osnabruck; University Osnabruck; Max Planck Society	Ungermann, C (corresponding author), Dept Biol Chem, Biochem Sect, Barbarastr 13, D-49076 Osnabruck, Germany.	cu@uos.de	Raunser, Stefan/AHE-1573-2022	Raunser, Stefan/0000-0001-9373-3016	Deutsche Forschungsgemeinschaft [UN111/5-3, KU2531/2-1]; Hans-Muhlenhoff foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hans-Muhlenhoff foundation	This work was supported by Deutsche Forschungsgemeinschaft Grants UN111/5-3 (to C. U. and S.R.) and KU2531/2-1 (to D. K.) and by funds from the Hans-Muhlenhoff foundation (to C. U.).	Baker RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067409; Balderhaar HJK, 2013, J CELL SCI, V126, P1307, DOI 10.1242/jcs.107805; Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098; Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; Collins RN, 2003, MOL CELL, V12, P1064, DOI 10.1016/S1097-2765(03)00445-3; Dulubova I, 2002, EMBO J, V21, P3620, DOI 10.1093/emboj/cdf381; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; Fratti RA, 2007, J BIOL CHEM, V282, P13133, DOI 10.1074/jbc.M700584200; Furgason MLM, 2009, P NATL ACAD SCI USA, V106, P14303, DOI 10.1073/pnas.0902976106; Graham SC, 2013, P NATL ACAD SCI USA, V110, P13345, DOI 10.1073/pnas.1307074110; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jun Y, 2007, P NATL ACAD SCI USA, V104, P13010, DOI 10.1073/pnas.0700970104; Kramer L, 2011, MOL BIOL CELL, V22, P2601, DOI 10.1091/mbc.E11-02-0104; Kummel D, 2014, CURR OPIN CELL BIOL, V29, P61, DOI 10.1016/j.ceb.2014.04.007; Laage R, 2001, MOL BIOL CELL, V12, P3375, DOI 10.1091/mbc.12.11.3375; Lobingier BT, 2014, ELIFE, V3, DOI 10.7554/eLife.02272; Lobingier BT, 2012, MOL BIOL CELL, V23, P4611, DOI 10.1091/mbc.E12-05-0343; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Mima J, 2009, J BIOL CHEM, V284, P27114, DOI 10.1074/jbc.M109.010223; Mima J, 2009, P NATL ACAD SCI USA, V106, P16191, DOI 10.1073/pnas.0908694106; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; Ostrowicz CW, 2010, TRAFFIC, V11, P1334, DOI 10.1111/j.1600-0854.2010.01097.x; Pieren M, 2010, NAT STRUCT MOL BIOL, V17, P710, DOI 10.1038/nsmb.1809; Plemel RL, 2011, MOL BIOL CELL, V22, P1353, DOI 10.1091/mbc.E10-03-0260; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Starai VJ, 2007, P NATL ACAD SCI USA, V104, P13551, DOI 10.1073/pnas.0704741104; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Xu H, 2010, EMBO J, V29, P1948, DOI 10.1038/emboj.2010.97	34	24	25	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5405	5413		10.1074/jbc.M114.631465	http://dx.doi.org/10.1074/jbc.M114.631465			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25564619	Green Published, hybrid			2022-12-26	WOS:000350044200014
J	Sun, XH; Zakharian, E				Sun, Xiaohui; Zakharian, Eleonora			Regulation of the Temperature-dependent Activation of Transient Receptor Potential Vanilloid 1 (TRPV1) by Phospholipids in Planar Lipid Bilayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSAICIN RECEPTOR; ION-CHANNEL; TRPM8 CHANNELS; NOXIOUS HEAT; MEMBRANE; PHOSPHOINOSITIDES; NEURONS; RAT	TRPV1 (transient receptor potential vanilloid 1) proteins are heat-activated nonselective cation channels. TRPV1 channels are polymodal in their function and exhibit multifaceted regulation with various molecular compounds. In this regard, phosphoinositides, particularly phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 4-phosphate, are important channel regulators. However, their effects on TRPV1 channel activity have not been conclusively determined. To characterize temperature-induced activation of TRPV1 in the presence of different phospholipids, we purified the TRPV1 protein from HEK-293 cells and incorporated it into planar lipid bilayers. In the presence of 2.5 mu M phosphatidylinositol 4,5-bisphosphate, TRPV1 channels demonstrated rapid activation at 33-39 degrees C and achieved full channel opening at 42 degrees C. At this temperature range, TRPV1 heat activation exhibited steep temperature dependence (temperature coefficient (Q(10)) of 18), and the channel openings were accompanied by large changes in entropy and enthalpy, suggesting a substantial conformation change. At a similar temperature range, another phosphoinositide, phosphatidylinositol 4-phosphate, also potentiated heat activation of TRPV1, but with much lower efficiency. Negatively charged phosphatidylglycerol could also induce heat activation of TRPV1 channels, although with a small-conductance state. Our data demonstrate that phospholipids, specifically phosphoinositides, are important regulators of TRPV1 and are required for heat-induced channel activity.	[Sun, Xiaohui; Zakharian, Eleonora] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61605 USA	University of Illinois System; University of Illinois Peoria	Zakharian, E (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, 1 Illini Dr, Peoria, IL 61605 USA.	zakharel@uic.edu	Sun, Xiaohui/G-5146-2013	Sun, Xiaohui/0000-0003-0294-6855	National Institutes of Health [R01GM098052]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098052] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM098052 (to E. Z.).	Cao CK, 2013, CELL REP, V4, P302, DOI 10.1016/j.celrep.2013.06.022; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Liu BY, 2003, BIOPHYS J, V85, P2988, DOI 10.1016/S0006-3495(03)74719-5; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Lukacs V, 2013, J BIOL CHEM, V288, P35003, DOI 10.1074/jbc.M113.520288; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Raisinghani M, 2005, J PHYSIOL-LONDON, V567, P771, DOI 10.1113/jphysiol.2005.087874; Senning EN, 2014, J BIOL CHEM, V289, P10999, DOI 10.1074/jbc.M114.553180; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Vlachova V, 2001, J PHYSIOL-LONDON, V533, P717, DOI 10.1111/j.1469-7793.2001.t01-1-00717.x; Vyklicky L, 1999, J PHYSIOL-LONDON, V517, P181, DOI 10.1111/j.1469-7793.1999.0181z.x; Zakharian Eleonora, 2013, Methods Mol Biol, V998, P109, DOI 10.1007/978-1-62703-351-0_8; Zakharian E, 2010, J NEUROSCI, V30, P12526, DOI 10.1523/JNEUROSCI.3189-10.2010; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404	19	20	20	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4741	4747		10.1074/jbc.M114.611459	http://dx.doi.org/10.1074/jbc.M114.611459			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25561742	Green Published, hybrid			2022-12-26	WOS:000350042000017
J	Tutunea-Fatan, E; Caetano, FA; Gros, R; Ferguson, SSG				Tutunea-Fatan, Elena; Caetano, Fabiana A.; Gros, Robert; Ferguson, Stephen S. G.			GRK2 Targeted Knock-down Results in Spontaneous Hypertension, and Altered Vascular GPCR Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR KINASE 2; ACTIVATED PROTEIN-KINASE; SMOOTH-MUSCLE-CELLS; BLOOD-PRESSURE; BETA-ARRESTIN; EXPRESSION; MICE; OVEREXPRESSION; PROLIFERATION; INHIBITION	Hypertension, elevated arterial pressure, occurs as the consequence of increased peripheral resistance. G protein-coupled receptors (GPCRs) contribute to the regulation of vasodilator and vasoconstrictor responses, and their activity is regulated by a family of GPCR kinases (GRKs). GRK2 expression is increased in hypertension and this facilitates the development of the hypertensive state by increasing the desensitization of GPCRs important for vasodilation. We demonstrate here, that genetic knockdown of GRK2 using a small hairpin (sh) RNA results in altered vascular reactivity and the development of hypertension between 8-12 weeks of age in shGRK2 mice due to enhanced G alpha(q/11) signaling. Vascular smooth muscle cells (VSMCs) cultured from shGRK2 knockdown mice show increases in GPCR-mediated G alpha(s) and G alpha(q/11) signaling, as the consequence of reduced GRK2-mediated desensitization. In addition, agonists and biased agonists exhibited age-dependent alterations in ERK1/2 and Akt signaling, as well as cell proliferation and migration responses in shGRK2 knockdown VSMCs when cultured from mice that are either 3 months or 6 months of age. Changes in angiotensin II-stimulated ERK1/2 phosphorylation are observed in VSMCs derived from 6-week-old shGRK2 mice prior to the development of the hypertensive phenotype. Thus, our findings indicate that the balance between mechanisms regulating vascular tone are shifted to favor vasoconstriction in the absence of GRK2 expression and that this leads to the age-dependent development of hypertension, as a consequence of global alterations in GPCR signaling. Consequently, therapeutic strategies that target GRK2 activity, not expression, may be more effective for the treatment of hypertension.	[Tutunea-Fatan, Elena; Caetano, Fabiana A.; Gros, Robert; Ferguson, Stephen S. G.] Univ Western Ontario, Robarts Res Inst, J Allyn Taylor Ctr Cell Biol, London, ON N6A 5K8, Canada; [Gros, Robert] Univ Western Ontario, Robarts Res Inst, Vasc Biol Grp, London, ON N6A 5K8, Canada; [Gros, Robert] Univ Western Ontario, Dept Med, London, ON N6A 5K8, Canada; [Tutunea-Fatan, Elena; Gros, Robert; Ferguson, Stephen S. G.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5K8, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Gros, R (corresponding author), Univ Western Ontario, Robarts Res Inst, 100 Perth Dr, London, ON N6A 5K8, Canada.	rgros@robarts.ca; ferguson@robarts.ca	Gros, Robert/AAV-2237-2020; Gros, Robert/A-3010-2009	Gros, Robert/0000-0002-3667-8011; Gros, Robert/0000-0002-3667-8011	Canadian Institutes of Health Research [MOP 111093, MOP 82756]; Canadian Institutes of Health Research Strategic Training Program in Vascular Research; New Investigator Award from the Heart and Stroke Foundation of Canada; Heart and Stroke Foundation of Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Strategic Training Program in Vascular Research(Canadian Institutes of Health Research (CIHR)); New Investigator Award from the Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This study was supported by grants from the Canadian Institutes of Health Research MOP 111093 (to S. S. G. F.) and MOP 82756 (to R. G.).; Supported in part through funding provided by Canadian Institutes of Health Research Strategic Training Program in Vascular Research.; Supported by a New Investigator Award from the Heart and Stroke Foundation of Canada. To whom correspondence may be addressed: Robarts Research Institute, University of Western Ontario, 100 Perth Dr., London, Ontario N6A 5K8, Canada. Tel.: 519-663-5777, Ext. 24429; Fax: 519-931-5252; E-mail: rgros@robarts.ca.; Recipient of a Tier I Canada Research Chair and Career Investigator Award from the Heart and Stroke Foundation of Ontario. To whom correspondence may be addressed: Robarts Research Institute, University of Western Ontario, 100 Perth Dr., London, Ontario N6A 5K8, Canada. Tel.: 519-931-5706; Fax: 519-931-5252; E-mail: ferguson@robarts.ca.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Avendano MS, 2014, HYPERTENSION, V63, P369, DOI 10.1161/HYPERTENSIONAHA.113.01991; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Brinks HL, 2010, BBA-MOL BASIS DIS, V1802, P1268, DOI 10.1016/j.bbadis.2010.01.005; Carotenuto A, 2013, EUR J MED CHEM, V69, P384, DOI 10.1016/j.ejmech.2013.08.039; Cohn HI, 2009, HYPERTENSION, V54, P71, DOI 10.1161/HYPERTENSIONAHA.108.125955; Cohn HI, 2008, AM J PHYSIOL-HEART C, V295, pH1695, DOI 10.1152/ajpheart.00564.2008; Dessy C, 1998, AM J PHYSIOL-CELL PH, V275, pC1081, DOI 10.1152/ajpcell.1998.275.4.C1081; Eckhart AD, 2002, MOL PHARMACOL, V61, P749, DOI 10.1124/mol.61.4.749; Feldman RD, 1998, TRENDS CARDIOVAS MED, V8, P297, DOI 10.1016/S1050-1738(98)00022-X; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; Ferguson SSG, 2014, CAN J CARDIOL, V30, pS3, DOI 10.1016/j.cjca.2014.01.017; Gros R, 2003, ENDOCRINOLOGY, V144, P2242, DOI 10.1210/en.2003-0007; Gros R, 2002, AM J PHYSIOL-HEART C, V282, pH380, DOI 10.1152/ajpheart.2002.282.1.H380; Gros R, 1999, CLIN PHARMACOL THER, V65, P545, DOI 10.1016/S0009-9236(99)70074-3; Gros R, 2000, HYPERTENSION, V35, P38, DOI 10.1161/01.HYP.35.1.38; Gros R, 1997, J CLIN INVEST, V99, P2087, DOI 10.1172/JCI119381; Gros R, 2006, CIRC RES, V99, P845, DOI 10.1161/01.RES.0000245189.21703.c0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Harris DM, 2007, AM J PHYSIOL-HEART C, V293, pH3072, DOI 10.1152/ajpheart.00880.2007; Izzo R, 2008, CTS-CLIN TRANSL SCI, V1, P215, DOI 10.1111/j.1752-8062.2008.00050.x; Kim J, 2005, EUR J PHARMACOL, V514, P209, DOI 10.1016/j.ejphar.2005.03.030; Kim J, 2008, CIRC RES, V103, P70, DOI 10.1161/CIRCRESAHA.108.172338; Lafarga V, 2012, CELL ADHES MIGR, V6, P495, DOI 10.4161/cam.21585; Lefkowitz RJ, 2013, PROG MOL BIOL TRANSL, V118, P3, DOI 10.1016/B978-0-12-394440-5.00001-2; Liu XW, 2012, NAT IMMUNOL, V13, P457, DOI 10.1038/ni.2258; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Luttrell LM, 2011, METHODS MOL BIOL, V756, P3, DOI 10.1007/978-1-61779-160-4_1; Metaye T, 2008, J ENDOCRINOL, V198, P101, DOI 10.1677/JOE-07-0562; Mii S, 1996, AM J PHYSIOL-HEART C, V270, pH142, DOI 10.1152/ajpheart.1996.270.1.H142; Morris GE, 2010, CARDIOVASC RES, V85, P424, DOI 10.1093/cvr/cvp310; Napolitano R, 2012, AM J HYPERTENS, V25, P366, DOI 10.1038/ajh.2011.211; Peppel K, 2000, CIRCULATION, V102, P793, DOI 10.1161/01.CIR.102.7.793; Ribeiro FM, 2010, J NEUROSCI, V30, P316, DOI 10.1523/JNEUROSCI.4974-09.2010; Roy A, 2013, FASEB J, V27, P5072, DOI 10.1096/fj.13-238279; Touyz RM, 2002, J HYPERTENS, V20, P1127, DOI 10.1097/00004872-200206000-00024; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wei ZY, 2012, J CELL PHYSIOL, V227, P2371, DOI 10.1002/jcp.22972; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Zhang J, 1997, RECEPTOR CHANNEL, V5, P193; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106	41	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5141	5155		10.1074/jbc.M114.615658	http://dx.doi.org/10.1074/jbc.M114.615658			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25561731	Green Published, hybrid			2022-12-26	WOS:000350042000053
J	Lu, XX; Zhang, TL; Xu, Z; Liu, SS; Zhao, B; Lan, WX; Wang, CX; Ding, JP; Cao, CY				Lu, Xiuxiu; Zhang, Tianlong; Xu, Zeng; Liu, Shanshan; Zhao, Bin; Lan, Wenxian; Wang, Chunxi; Ding, Jianping; Cao, Chunyang			Crystal Structure of DNA Cytidine Deaminase ABOBEC3G Catalytic Deamination Domain Suggests a Binding Mode of Full-length Enzyme to Single-stranded DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS-MODEL; CBF-BETA; HIV-1 VIRIONS; APOBEC3G; VIF; RESTRICTION; HYPERMUTATION; EVOLUTION; DETERMINANTS; SPECIFICITY	APOBEC3G (A3G) is a DNA cytidine deaminase (CD) that demonstrates antiviral activity against human immunodeficiency virus 1 (HIV-1) and other pathogenic virus. It has an inactive N-terminal CD1 virus infectivity factor (Vif) protein binding domain (A3G-CD1) and an actively catalytic C-terminal CD2 deamination domain (A3G-CD2). Although many studies on the structure of A3G-CD2 and enzymatic properties of full-length A3G have been reported, the mechanism of how A3G interacts with HIV-1 single-stranded DNA (ssDNA) is still not well characterized. Here, we reported a crystal structure of a novel A3G-CD2 head-to-tail dimer (in which the N terminus of the monomer H (head) interacts with the C terminus of monomer T (tail)), where a continuous DNA binding groove was observed. By constructing the A3G-CD1 structural model, we found that its overall fold was almost identical to that of A3G-CD2. We mutated the residues located in or along the groove in monomer H and the residues in A3G-CD1 that correspond to those seated in or along the groove in monomer T. Then, by performing enzymatic assays, we confirmed the reported key elements and the residues in A3G necessary to the catalytic deamination. Moreover, we identified more than 10 residues in A3G essential to DNA binding and deamination reaction. Therefore, this dimer structure may represent a structural model of full-length A3G, which indicates a possible binding mode of A3G to HIV-1 ssDNA.	[Lu, Xiuxiu; Xu, Zeng; Liu, Shanshan; Zhao, Bin; Lan, Wenxian; Wang, Chunxi; Cao, Chunyang] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Zhang, Tianlong; Ding, Jianping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Cao, CY (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 345 Lingling Rd, Shanghai 200032, Peoples R China.	ccao@mail.sioc.ac.cn		ding, jian ping/0000-0001-7029-7346	Ministry of Science and Technology of China [2011CB966300]; National Natural Science Foundation of China [21472229, 20902103, 21272261]; Science and Technology Commission of Shanghai Municipality [15ZR1449300]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Ministry of Science and Technology of China Grant 2011CB966300; National Natural Science Foundation of China Grants 21472229, 20902103, and 21272261; and Science and Technology Commission of Shanghai Municipality Grant 15ZR1449300.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bach D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-54; Bennett RP, 2008, J BIOL CHEM, V283, P33329, DOI 10.1074/jbc.M803726200; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bogerd HP, 2008, RNA, V14, P1228, DOI 10.1261/rna.964708; Bohn MF, 2013, STRUCTURE, V21, P1042, DOI 10.1016/j.str.2013.04.010; Byeon IJL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2883; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Chiu YL, 2009, PHILOS T R SOC B, V364, P689, DOI 10.1098/rstb.2008.0193; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Douaisi M, 2004, BIOCHEM BIOPH RES CO, V321, P566, DOI 10.1016/j.bbrc.2004.07.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furukawa A, 2009, EMBO J, V28, P440, DOI 10.1038/emboj.2008.290; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Guo YY, 2014, NATURE, V505, P229, DOI 10.1038/nature12884; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Khan MN, 2007, SURFACTANT SCI SER, V133, P1; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kitamura S, 2012, NAT STRUCT MOL BIOL, V19, P1005, DOI 10.1038/nsmb.2378; Larue RS, 2009, J VIROL, V83, P494, DOI 10.1128/JVI.01976-08; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Li M, 2012, ACS CHEM BIOL, V7, P506, DOI 10.1021/cb200440y; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mitra M, 2014, NUCLEIC ACIDS RES, V42, P1095, DOI 10.1093/nar/gkt945; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Siu KK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3593; Strebel K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-55; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang JZ, 2004, HUM MOL GENET, V13, P1785, DOI 10.1093/hmg/ddh183; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000378; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718	57	42	42	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4010	4021		10.1074/jbc.M114.624262	http://dx.doi.org/10.1074/jbc.M114.624262			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25542899	hybrid, Green Published			2022-12-26	WOS:000349458400014
J	Sun, LP; Huang, Y; Wei, Q; Tong, XM; Cai, R; Nalepa, G; Ye, X				Sun, Liping; Huang, Yan; Wei, Qian; Tong, Xiaomei; Cai, Rong; Nalepa, Grzegorz; Ye, Xin			Cyclin E-CDK2 Protein Phosphorylates Plant Homeodomain Finger Protein 8 (PHF8) and Regulates Its Function in the Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED MENTAL-RETARDATION; HISTONE DEMETHYLASE PHF8; RIBOSOMAL-RNA SYNTHESIS; S-PHASE PROGRESSION; DEPENDENT KINASE 2; GENE-TRANSCRIPTION; E/CDK2 SUBSTRATE; RECRUITMENT; TRANSITION; BINDING	Cyclin E-CDK2 is a key regulator in G1/S transition. Previously, we identified a number of CDK2-interacting proteins, including PHF8 (plant homeodomain finger protein 8). In this report, we confirmed that PHF8 is a novel cyclin E-CDK2 substrate. By taking the approach of mass spectrometry, we identified that PHF8 Ser-844 is phosphorylated by cyclin E-CDK2. Immunoblotting analysis indicated that WT PHF8 demethylates histone H3K9me2 more efficiently than the cyclin E-CDK2 phosphorylation-deficient PHF8-S844A mutant. Furthermore, flow cytometry analysis showed that WT PHF8 promotes S phase progression more robustly than PHF8-S844A. Real-time PCR results demonstrated that PHF8 increases transcription of cyclin E, E2F3, and E2F7 to significantly higher levels compared with PHF8-S844A. Further analysis by ChIP assay indicated that PHF8binds to the cyclin E promoter stronger than PHF8-S844A and reduces the H3K9me2 level at the cyclin E promoter more efficiently than PHF8-S844A. In addition, we found that cyclin E-CDK2-mediated phosphorylation of PHF8 Ser-844 promotes PHF8-dependent rRNA transcription in luciferase reporter assays and real-time PCR. Taken together, these results indicate that cyclin E-CDK2 phosphorylates PHF8 to stimulate its demethylase activity to promote rRNA transcription and cell cycle progression.	[Sun, Liping; Huang, Yan; Wei, Qian; Tong, Xiaomei; Cai, Rong; Ye, Xin] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Sun, Liping; Huang, Yan; Wei, Qian; Cai, Rong] Univ Chinese Acad Sci, Beijing 100101, Peoples R China; [Nalepa, Grzegorz] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Nalepa, Grzegorz] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Div Pediat Hematol Oncol, Indianapolis, IN 46202 USA; [Nalepa, Grzegorz] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Ye, X (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, 1 Beichen West Rd, Beijing 100101, Peoples R China.	yex@im.ac.cn		Lab, Nalepa/0000-0002-7560-1906; Nalepa, Grzegorz/0000-0002-5779-9103	National Natural Science Foundation of China [81272272]; Ministry of Science and Technology of China [2013ZX10004611, 2012CB519003, 2011CB504705]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068371] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Natural Science Foundation of China Grant 81272272 and by Ministry of Science and Technology of China Grants 2013ZX10004611, 2012CB519003, and 2011CB504705.	Adams PD, 1996, MOL CELL BIOL, V16, P6623; Ait-Si-Ali S, 2000, ONCOGENE, V19, P2430, DOI 10.1038/sj.onc.1203562; Arteaga MF, 2013, CANCER CELL, V23, P376, DOI 10.1016/j.ccr.2013.02.014; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Cooley A, 2010, CELL CYCLE, V9, P4900, DOI 10.4161/cc.9.24.14158; Deng M, 2009, J BIOL CHEM, V284, P7875, DOI 10.1074/jbc.M807827200; Deran M, 2008, MOL CELL BIOL, V28, P435, DOI 10.1128/MCB.00607-07; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Fortschegger K, 2011, EPIGENETICS-US, V6, P4, DOI 10.4161/epi.6.1.13297; Fortschegger K, 2010, MOL CELL BIOL, V30, P3286, DOI 10.1128/MCB.01520-09; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Hall C, 2001, MOL CELL BIOL, V21, P1854, DOI 10.1128/MCB.21.5.1854-1865.2001; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Krishnan S, 2011, CHEMBIOCHEM, V12, P254, DOI 10.1002/cbic.201000545; Laumonnier F, 2005, J MED GENET, V42, P780, DOI 10.1136/jmg.2004.029439; Li JH, 2011, J BIOL CHEM, V286, P39776, DOI 10.1074/jbc.M111.226464; Lim HJ, 2013, MOL CELL BIOL, V33, P4166, DOI 10.1128/MCB.00689-13; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; Morris L, 2000, NAT CELL BIOL, V2, P232, DOI 10.1038/35008660; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Qiu JH, 2010, CELL RES, V20, P908, DOI 10.1038/cr.2010.81; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Wang JD, 2013, J BIOL CHEM, V288, P3174, DOI 10.1074/jbc.M112.414839; Wei Q, 2013, J BIOL CHEM, V288, P19715, DOI 10.1074/jbc.M112.449652; Wei Y, 2003, MOL CELL BIOL, V23, P3669, DOI 10.1128/MCB.23.10.3669-3680.2003; Westendorp B, 2012, NUCLEIC ACIDS RES, V40, P3511, DOI 10.1093/nar/gkr1203; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zhu ZQ, 2010, CELL RES, V20, P794, DOI 10.1038/cr.2010.75	35	18	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4075	4085		10.1074/jbc.M114.602532	http://dx.doi.org/10.1074/jbc.M114.602532			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25548279	Green Published, hybrid			2022-12-26	WOS:000349458400019
J	Peacock, E; Sonsthagen, SA; Obbard, ME; Boltunov, A; Regehr, EV; Ovsyanikov, N; Aars, J; Atkinson, SN; Sage, GK; Hope, AG; Zeyl, E; Bachmann, L; Ehrich, D; Scribner, KT; Amstrup, SC; Belikov, S; Born, EW; Derocher, AE; Stirling, I; Taylor, MK; Wiig, O; Paetkau, D; Talbot, SL				Peacock, Elizabeth; Sonsthagen, Sarah A.; Obbard, Martyn E.; Boltunov, Andrei; Regehr, Eric V.; Ovsyanikov, Nikita; Aars, Jon; Atkinson, Stephen N.; Sage, George K.; Hope, Andrew G.; Zeyl, Eve; Bachmann, Lutz; Ehrich, Dorothee; Scribner, Kim T.; Amstrup, Steven C.; Belikov, Stanislav; Born, Erik W.; Derocher, Andrew E.; Stirling, Ian; Taylor, Mitchell K.; Wiig, Oystein; Paetkau, David; Talbot, Sandra L.			Implications of the Circumpolar Genetic Structure of Polar Bears for Their Conservation in a Rapidly Warming Arctic	PLOS ONE			English	Article							GENOMIC SEQUENCES REVEAL; MAXIMUM-LIKELIHOOD-ESTIMATION; URSUS-MARITIMUS; MITOCHONDRIAL-DNA; BROWN BEARS; POPULATION-GROWTH; HUDSON-BAY; COMPREHENSIVE ANALYSIS; BAYESIAN-INFERENCE; MIGRATION RATES	We provide an expansive analysis of polar bear (Ursus maritimus) circumpolar genetic variation during the last two decades of decline in their sea-ice habitat. We sought to evaluate whether their genetic diversity and structure have changed over this period of habitat decline, how their current genetic patterns compare with past patterns, and how genetic demography changed with ancient fluctuations in climate. Characterizing their circumpolar genetic structure using microsatellite data, we defined four clusters that largely correspond to current ecological and oceanographic factors: Eastern Polar Basin, Western Polar Basin, Canadian Archipelago and Southern Canada. We document evidence for recent (ca. last 1-3 generations) directional gene flow from Southern Canada and the Eastern Polar Basin towards the Canadian Archipelago, an area hypothesized to be a future refugium for polar bears as climate-induced habitat decline continues. Our data provide empirical evidence in support of this hypothesis. The direction of current gene flow differs from earlier patterns of gene flow in the Holocene. From analyses of mitochondrial DNA, the Canadian Archipelago cluster and the Barents Sea subpopulation within the Eastern Polar Basin cluster did not show signals of population expansion, suggesting these areas may have served also as past interglacial refugia. Mismatch analyses of mitochondrial DNA data from polar and the paraphyletic brown bear (U. arctos) uncovered offset signals in timing of population expansion between the two species, that are attributed to differential demographic responses to past climate cycling. Mitogenomic structure of polar bears was shallow and developed recently, in contrast to the multiple clades of brown bears. We found no genetic signatures of recent hybridization between the species in our large, circumpolar sample, suggesting that recently observed hybrids represent localized events. Documenting changes in subpopulation connectivity will allow polar nations to proactively adjust conservation actions to continuing decline in sea-ice habitat.	[Peacock, Elizabeth; Sonsthagen, Sarah A.; Sage, George K.; Hope, Andrew G.; Talbot, Sandra L.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [Peacock, Elizabeth; Atkinson, Stephen N.] Govt Nunavut, Dept Environm, Igloolik, NU, Canada; [Obbard, Martyn E.] Ontario Minist Nat Resources & Forestry, Peterborough, ON, Canada; [Boltunov, Andrei; Belikov, Stanislav] All Russian Res Inst Nat Protect, Moscow, Russia; [Regehr, Eric V.] US Fish & Wildlife Serv, Anchorage, AK USA; [Ovsyanikov, Nikita] Wrangel Isl State Nat Reserve, Moscow, Russia; [Aars, Jon] Norwegian Polar Res Inst, Tromso, Norway; [Zeyl, Eve; Bachmann, Lutz; Ehrich, Dorothee; Wiig, Oystein] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Scribner, Kim T.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Amstrup, Steven C.] Polar Bears Int, Bozeman, MT USA; [Born, Erik W.] Greenland Inst Nat Resources, Copenhagen, Denmark; [Derocher, Andrew E.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Stirling, Ian] Environm Canada, Sci & Technol Branch, Edmonton, AB, Canada; [Taylor, Mitchell K.] Lakehead Univ, Fac Sci & Environm Studies, Thunder Bay, ON P7B 5E1, Canada; [Paetkau, David] Wildlife Genet Int, Nelson, BC, Canada	United States Department of the Interior; United States Geological Survey; Ministry of Natural Resources & Forestry; United States Department of the Interior; US Fish & Wildlife Service; Norwegian Polar Institute; University of Oslo; Michigan State University; Greenland Institute of Natural Resources; University of Alberta; Environment & Climate Change Canada; Lakehead University	Peacock, E (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA.	lpeacock@usgs.gov	aars, jon/AAB-3076-2021; Wiig, Øystein/AAT-9518-2020; Derocher, Andrew/J-4469-2012; /AAD-5814-2021; Ehrich, Dorothee/F-6492-2015; Belikov, Stanislav/AAU-9597-2021; Wiig, Øystein/J-8383-2012; Obbard, Martyn/AFU-0326-2022	aars, jon/0000-0002-0574-6712; Wiig, Øystein/0000-0003-0395-5251; Derocher, Andrew/0000-0002-1104-7774; /0000-0002-6858-1978; Ehrich, Dorothee/0000-0002-3028-9488; Wiig, Øystein/0000-0003-0395-5251; Obbard, Martyn/0000-0003-2064-0155; Sonsthagen, Sarah/0000-0001-6215-5874	U.S. Geological Survey's Changing Arctic Ecosystem Initiative; Wildlife Program of the USGS Ecosystem Mission Area; US Fish and Wildlife Service; Ontario Ministry of Natural Resources; Toronto Zoo Endangered Species Fund; Government of Nunavut; Nunavut Wildlife Management Board; Makivik Corporation; Polar Continental Shelf Program; Norwegian Polar Institute; World Wildlife Fund; Natural Sciences and Engineering Research Council of Canada; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103395] Funding Source: NIH RePORTER	U.S. Geological Survey's Changing Arctic Ecosystem Initiative; Wildlife Program of the USGS Ecosystem Mission Area; US Fish and Wildlife Service(US Fish & Wildlife Service); Ontario Ministry of Natural Resources; Toronto Zoo Endangered Species Fund; Government of Nunavut; Nunavut Wildlife Management Board; Makivik Corporation; Polar Continental Shelf Program; Norwegian Polar Institute; World Wildlife Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for collection and analysis of new samples was provided by the U.S. Geological Survey's Changing Arctic Ecosystem Initiative and is supported by funding from the Wildlife Program of the USGS Ecosystem Mission Area, US Fish and Wildlife Service, Ontario Ministry of Natural Resources, Toronto Zoo Endangered Species Fund, Government of Nunavut, Nunavut Wildlife Management Board, Makivik Corporation, Polar Continental Shelf Program, Norwegian Polar Institute, World Wildlife Fund, and Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author D. Paetkau is an owner of the Canadian company, Wildlife Genetics International. Wildlife Genetics International provided support in the form of salary for author DP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Amstrup SC, 2004, WILDLIFE SOC B, V32, P661, DOI 10.2193/0091-7648(2004)032[0661:USRDTD]2.0.CO;2; Amstrup SC, 2001, CAN J ZOOL, V79, P2147, DOI 10.1139/cjz-79-12-2147; Amstrup SC, 2010, NATURE, V468, P955, DOI 10.1038/nature09653; Amstrup SC, 2008, GEOPHYS MONOGR SER, V180, P213, DOI 10.1029/180GM14; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bidon T, 2014, MOL BIOL EVOL, V31, P1353, DOI 10.1093/molbev/msu109; Cahill JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003345; Cherry SG, 2013, J ANIM ECOL, V82, P912, DOI 10.1111/1365-2656.12050; COLONY R, 1984, J GEOPHYS RES-OCEANS, V89, P623, DOI 10.1029/JC089iC06p10623; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Crompton AE, 2008, BIOL CONSERV, V141, P2528, DOI 10.1016/j.biocon.2008.07.018; CRONIN MA, 1991, CAN J ZOOL, V69, P2985, DOI 10.1139/z91-421; Cronin MA, 2014, J HERED, V105, P312, DOI 10.1093/jhered/est133; Cronin MA, 2012, J HERED, V103, P873, DOI 10.1093/jhered/ess090; Davison J, 2011, QUATERNARY SCI REV, V30, P418, DOI 10.1016/j.quascirev.2010.11.023; Dawson NG, 2013, J BIOGEOGR, V40, P415; Derocher AE, 2004, INTEGR COMP BIOL, V44, P163, DOI 10.1093/icb/44.2.163; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Durner GM, 2009, ECOL MONOGR, V79, P25, DOI 10.1890/07-2089.1; Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058; Elliot HW, 1875, HARPERS WEEKLY  0501, P1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu YX, 1997, GENETICS, V147, P915; Gillett NP, 2008, NAT GEOSCI, V1, P750, DOI 10.1038/ngeo338; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hailer F, 2013, SCIENCE, V339, DOI 10.1126/science.1228066; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; HARPENDING HC, 1994, HUM BIOL, V66, P591; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hope AG, 2014, EVOLUTION, V68, P2689, DOI 10.1111/evo.12469; Hope AG, 2013, NAT CLIM CHANGE, V3, P931, DOI 10.1038/NCLIMATE1926; Iverson SJ, 2006, CONSERV BIOL SER, P98, DOI 10.1017/CBO9780511541964.008; Jackson JV, 2008, CAN J ZOOL, V86, P756, DOI 10.1139/Z08-043; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Laidre KL, 2012, P BIOL SCI, V280; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindqvist C, 2010, P NATL ACAD SCI USA, V107, P5053, DOI 10.1073/pnas.0914266107; Liu S, 2014, CELL, V157, P1; Lone K, 2013, POLAR BIOL, V36, P27, DOI 10.1007/s00300-012-1235-y; Lorenzen ED, 2011, NATURE, V479, P359, DOI 10.1038/nature10574; Mauritzen M, 2002, J APPL ECOL, V39, P79, DOI 10.1046/j.1365-2664.2002.00690.x; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109; Molnar PK, 2010, BIOL CONSERV, V143, P1612, DOI 10.1016/j.biocon.2010.04.004; Mourier T, 2012, MOL BIOL EVOL, V29, P2241, DOI 10.1093/molbev/mss094; Nakagome S, 2013, SCIENCE, V339, DOI 10.1126/science.1227339; Nei M., 1987, MOL EVOLUTIONARY GEN; Obbard M.E., 2010, P 15 WORK M IUCN SSC; Obbard ME, 2012, URSUS, V23, P134, DOI 10.2192/URSUS-D-11-00030.1; Overland JE, 2013, GEOPHYS RES LETT, V40, P2097, DOI 10.1002/grl.50316; Packard AS, 1886, AM NAT, V20, P655; Paetkau D, 1999, MOL ECOL, V8, P1571, DOI 10.1046/j.1365-294x.1999.00733.x; Parks SDE, 2001, TRYPANOTOLERANCE W A; Peacock E, 2011, CAN J ZOOL, V89, P371, DOI [10.1139/z11-021, 10.1139/Z11-021]; Peacock E, 2010, LITTLE LESS ARCTIC: TOP PREDATORS IN THE WORLDS LARGEST NORTHERN INLAND SEA, HUDSON BAY, P93, DOI 10.1007/978-90-481-9121-5_5; Peacock E, 2013, J WILDLIFE MANAGE, V77, P463, DOI 10.1002/jwmg.489; Peacock E, 2012, ARCTIC, V65, P391; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Post E, 2013, SCIENCE, V341, P519, DOI 10.1126/science.1235225; Pritchard JK, 2000, GENETICS, V155, P945; Prost S, 2013, GLOBAL CHANGE BIOL, V19, P1854, DOI 10.1111/gcb.12157; Rausch R., 1954, Murrelet, V34, P18, DOI 10.2307/3535866; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Regehr EV, 2007, J WILDLIFE MANAGE, V71, P2673, DOI 10.2193/2006-180; Regehr EV, 2010, J ANIM ECOL, V79, P117, DOI 10.1111/j.1365-2656.2009.01603.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rode KD, 2014, GLOBAL CHANGE BIOL, V20, P76, DOI 10.1111/gcb.12339; Rode KD, 2012, POPUL ECOL, V54, P3, DOI 10.1007/s10144-011-0299-9; Rode KD, 2010, ECOL APPL, V20, P768, DOI 10.1890/08-1036.1; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Saarma U, 2007, MOL ECOL, V16, P401, DOI 10.1111/j.1365-294X.2006.03130.x; Sahanatien V, 2012, ANIM CONSERV, V15, P397, DOI 10.1111/j.1469-1795.2012.00529.x; Smith P, 1975, PROGR NOTES, V53; STIRLING I, 1993, ARCTIC, V46, P240; Stirling I, 1999, ARCTIC, V52, P294; Stirling I, 1980, 44 CAN WILDL SERV; Stirling I., 2011, POLAR BEARS NATURAL; Stirling I, 2006, ARCTIC, V59, P261; Stirling I, 2011, ECOL APPL, V21, P859, DOI 10.1890/10-0849.1; Stirling Ian, 1993, Polar Record, V29, P13; Stroeve J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029703; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; SWOFFORD DL, 1981, J HERED, V72, P281, DOI 10.1093/oxfordjournals.jhered.a109497; TAJIMA F, 1989, GENETICS, V123, P585; Talbot SL, 1996, MOL PHYLOGENET EVOL, V5, P567, DOI 10.1006/mpev.1996.0051; Talbot SL, 1996, MOL PHYLOGENET EVOL, V5, P477, DOI 10.1006/mpev.1996.0044; TAYLOR M, 1995, ARCTIC, V48, P147; Taylor MK, 2001, CAN J ZOOL, V79, P690, DOI 10.1139/cjz-79-4-690; Thiemann GW, 2008, ORYX, V42, P504, DOI 10.1017/S0030605308001877; Vongraven Dag, 2012, Ursus Monograph Series, V5, P1; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson GA, 2003, GENETICS, V163, P1177; Zeyl E, 2009, MOL ECOL, V18, P735, DOI 10.1111/j.1365-294X.2008.04049.x; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	101	35	36	1	234	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2015	10	1							e112021	10.1371/journal.pone.0112021	http://dx.doi.org/10.1371/journal.pone.0112021			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3YO	25562525	Green Published, gold, Green Submitted			2022-12-26	WOS:000348160000001
J	Cooper, EA; Garlick, J; Featherstone, E; Voon, V; Singer, T; Critchley, HD; Harrison, NA				Cooper, Ella A.; Garlick, John; Featherstone, Eric; Voon, Valerie; Singer, Tania; Critchley, Hugo D.; Harrison, Neil A.			You Turn Me Cold: Evidence for Temperature Contagion	PLOS ONE			English	Article							SKIN TEMPERATURE; PERIPHERAL TEMPERATURE; INDIVIDUAL-DIFFERENCES; PREMOTOR CORTEX; EMPATHY; PAIN; BIOFEEDBACK; PERCEPTION; OWNERSHIP; NEURONS	Introduction: During social interactions, our own physiological responses influence those of others. Synchronization of physiological (and behavioural) responses can facilitate emotional understanding and group coherence through inter-subjectivity. Here we investigate if observing cues indicating a change in another's body temperature results in a corresponding temperature change in the observer. Methods: Thirty-six healthy participants (age; 22.9+/-3.1 yrs) each observed, then rated, eight purpose-made videos (3 min duration) that depicted actors with either their right or left hand in visibly warm (warm videos) or cold water (cold videos). Four control videos with the actors' hand in front of the water were also shown. Temperature of participant observers' right and left hands was concurrently measured using a thermistor within a Wheatstone bridge with a theoretical temperature sensitivity of <0.0001 degrees C. Temperature data were analysed in a repeated measures ANOVA (temperature 6 actor's hand 6 observer's hand). Results: Participants rated the videos showing hands immersed in cold water as being significantly cooler than hands immersed in warm water, F-(1,F-34)=256.67, p<0.001. Participants' own hands also showed a significant temperature-dependent effect: hands were significantly colder when observing cold vs. warm videos F-(1,F-34)=13.83, p = 0.001 with post-hoc t-test demonstrating a significant reduction in participants' own left (t((35))=-3.54, p=0.001) and right (t((35))=-2.33, p=0.026) hand temperature during observation of cold videos but no change to warm videos (p>0.1). There was however no evidence of left-right mirroring of these temperature effects p>0.1). Sensitivity to temperature contagion was also predicted by inter-individual differences in self-report empathy. Conclusions: We illustrate physiological contagion of temperature in healthy individuals, suggesting that empathetic understanding for primary low-level physiological challenges (as well as more complex emotions) are grounded in somatic simulation.	[Cooper, Ella A.; Critchley, Hugo D.; Harrison, Neil A.] Univ Sussex, Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Garlick, John; Singer, Tania; Critchley, Hugo D.; Harrison, Neil A.] UCL, Inst Cognit Neurosci, London, England; [Featherstone, Eric] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Voon, Valerie] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Singer, Tania] Max Planck Inst Human Cognit & Brain Sci, Dept Social Neurosci, Leipzig, Germany; [Critchley, Hugo D.; Harrison, Neil A.] Univ Sussex, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England; [Critchley, Hugo D.; Harrison, Neil A.] Sussex Partnership NHS Trust, Brighton, E Sussex, England	University of Brighton; University of Sussex; University of London; University College London; University of London; University College London; University of Cambridge; Max Planck Society; University of Sussex	Harrison, NA (corresponding author), Univ Sussex, Brighton & Sussex Med Sch, Brighton, E Sussex, England.	n.harrison@bsms.ac.uk	Voon, Valerie/O-7038-2017; critchley, hugo d/G-9267-2011	Voon, Valerie/0000-0001-6790-1776; critchley, hugo d/0000-0002-2445-9284; Harrison, Neil/0000-0002-9584-3769	Wellcome Trust Intermediate Clinical Fellowships; European Research Council; Medical Research Council [G1000183B, G0001354B, G0001354] Funding Source: researchfish	Wellcome Trust Intermediate Clinical Fellowships(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust Intermediate Clinical Fellowships awarded to NAH; Wellcome Trust Intermediate Clinical Fellowships awarded to VV; and European Research Council support to HDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew D, 2001, J PHYSIOL-LONDON, V537, P489, DOI 10.1111/j.1469-7793.2001.00489.x; Blakemore SJ, 2005, BRAIN, V128, P1571, DOI 10.1093/brain/awh500; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Chong TW, 2004, SCHIZOPHR RES, V69, P149, DOI 10.1016/S0920-9964(03)00222-6; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2001, J NEUROPHYSIOL, V86, P1459, DOI 10.1152/jn.2001.86.3.1459; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Critchley HD, 2013, NEURON, V77, P624, DOI 10.1016/j.neuron.2013.02.008; Davis M. H, 1980, MULTIDIMENSIONAL APP; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Loarte MD, 2009, J NEUROL, V256, P127, DOI 10.1007/s00415-009-0821-6; DIKEL W, 1980, PEDIATRICS, V66, P335; DIMASCIO A, 1957, PSYCHOSOM MED, V19, P99, DOI 10.1097/00006842-195703000-00002; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; DUGAN M, 1976, PERCEPT MOTOR SKILL, V42, P14, DOI 10.2466/pms.1976.42.1.14; Ebisch SJ, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00060; Ebisch SJ, 2012, BIOL PSYCHOL, V89, P123, DOI 10.1016/j.biopsycho.2011.09.018; Ebisch SJH, 2008, J COGNITIVE NEUROSCI, V20, P1611, DOI 10.1162/jocn.2008.20111; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; EKMAN P, 1983, SCIENCE, V221, P1208, DOI 10.1126/science.6612338; Engert V, 2014, PSYCHONEUROENDOCRINO, V45, P192, DOI 10.1016/j.psyneuen.2014.04.005; Fan Y, 2011, NEUROSCI BIOBEHAV R, V35, P903, DOI 10.1016/j.neubiorev.2010.10.009; Hadfield JA, 1920, LANCET, V2, P68; Harrison NA, 2007, EMOTION, V7, P724, DOI 10.1037/1528-3542.7.4.724; Harrison NA, 2006, SOC COGN AFFECT NEUR, V1, P5, DOI 10.1093/scan/nsl006; Hatfield E., 1994, REV PERSONALITY SOCI; HORI T, 1986, BRAIN RES BULL, V17, P75, DOI 10.1016/0361-9230(86)90163-2; Jabbi M, 2007, NEUROIMAGE, V34, P1744, DOI 10.1016/j.neuroimage.2006.10.032; JACOBSON AM, 1979, AM J PSYCHIAT, V136, P844; JACOBSON AM, 1973, JAMA-J AM MED ASSOC, V225, P739, DOI 10.1001/jama.225.7.739; Janowski V, 2013, SOC COGN AFFECT NEUR, V8, P201, DOI 10.1093/scan/nsr086; Keefe F J, 1978, J Behav Med, V1, P383, DOI 10.1007/BF00846694; KENDON A, 1970, ACTA PSYCHOL, V32, P100; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; KING NJ, 1980, PSYCHOL BULL, V88, P738; KING NJ, 1980, BIOL PSYCHOL, V10, P139, DOI 10.1016/0301-0511(80)90034-4; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; MASLACH C, 1972, PSYCHOPHYSIOLOGY, V9, P600, DOI 10.1111/j.1469-8986.1972.tb00769.x; Matarazzo J.D., 1972, INTERVIEW RES ITS AN; McAllen RM, 2010, EUR J APPL PHYSIOL, V109, P27, DOI 10.1007/s00421-009-1295-z; Mehrabian A, 1997, J PSYCHOL, V131, P101, DOI 10.1080/00223989709603508; Mobbs D, 2009, SCIENCE, V324, P900, DOI 10.1126/science.1170539; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Moseley GL, 2012, BRAIN, V135, P3676, DOI 10.1093/brain/aws297; Nakamura K, 2011, AM J PHYSIOL-REG I, V301, pR1207, DOI 10.1152/ajpregu.00109.2011; Nakamura K, 2010, P NATL ACAD SCI USA, V107, P8848, DOI 10.1073/pnas.0913358107; Nakayama K, 2005, PHYSIOL BEHAV, V84, P783, DOI 10.1016/j.physbeh.2005.03.009; Ootsuka Y, 2006, AM J PHYSIOL-REG I, V291, pR589, DOI 10.1152/ajpregu.00850.2005; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; ROBERTS AH, 1973, J ABNORM PSYCHOL, V82, P163, DOI 10.1037/h0034852; ROBERTS AH, 1975, J ABNORM PSYCHOL, V84, P272, DOI 10.1037/h0076655; Salomon R, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00065; Satoshi T, 2000, J KYORIN MED SOC, V31, P357; Silani G, 2013, J NEUROSCI, V33, P15466, DOI 10.1523/JNEUROSCI.1488-13.2013; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Sonnby-Borgstrom M, 2002, SCAND J PSYCHOL, V43, P433, DOI 10.1111/1467-9450.00312; TAUB E, 1976, BIOFEEDBACK SELF-REG, V1, P147, DOI 10.1007/BF00998583; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Wigley FM, 2000, ARCH INTERN MED, V160, P1101	64	13	13	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116126	10.1371/journal.pone.0116126	http://dx.doi.org/10.1371/journal.pone.0116126			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UC	25551826	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000347119100097
J	Lapi, D; Federighi, G; Fantozzi, MP; del Seppia, C; Ghione, S; Colantuoni, A; Scuri, R				Lapi, Dominga; Federighi, Giuseppe; Fantozzi, M. Paola; del Seppia, Cristina; Ghione, Sergio; Colantuoni, Antonio; Scuri, Rossana			Trigeminocardiac Reflex by Mandibular Extension on Rat Pial Microcirculation: Role of Nitric Oxide	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; CARDIAC REFLEX; ELECTRICAL-STIMULATION; KNOWLEDGE; MODEL	In the present study we have extended our previous findings about the effects of 10 minutes of passive mandibular extension in anesthetized Wistar rats. By prolonging the observation time to 3 hours, we showed that 10 minutes mandibular extension caused a significant reduction of the mean arterial blood pressure and heart rate respect to baseline values, which persisted up to 160 minutes after mandibular extension. These effects were accompanied by a characteristic biphasic response of pial arterioles: during mandibular extension, pial arterioles constricted and after mandibular extension dilated for the whole observation period. Interestingly, the administration of the opioid receptor antagonist naloxone abolished the vasoconstriction observed during mandibular extension, while the administration of N-omega-Nitro-L-arginine methyl ester, a nitric oxide synthase inhibitor, abolished the vasodilation observed after mandibular extension. Either drug did not affect the reduction of mean arterial blood pressure and heart rate induced by mandibular extension. By qRT-PCR, we also showed that neuronal nitric oxide synthase gene expression was significantly increased compared with baseline conditions during and after mandibular extension and endothelial nitric oxide synthase gene expression markedly increased at 2 hours after mandibular extension. Finally, western blotting detected a significant increase in neuronal and endothelial nitric oxide synthase protein expression. In conclusion mandibular extension caused complex effects on pial microcirculation involving opioid receptor activation and nitric oxide release by both neurons and endothelial vascular cells at different times.	[Lapi, Dominga; Colantuoni, Antonio] Univ Naples Federico II, Sch Med, Dept Clin Med & Surg, Naples, Italy; [Federighi, Giuseppe; Fantozzi, M. Paola; Scuri, Rossana] Univ Pisa, Dept Translat Res New Technol Med & Surg, Pisa, Italy; [del Seppia, Cristina; Ghione, Sergio] Natl Council Res CNR, Inst Clin Physiol, Pisa, Italy; [Ghione, Sergio] Fdn Toscana Gabriele Monasterio Med & Publ Hlth R, Pisa, Italy	University of Naples Federico II; University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Scuri, R (corresponding author), Univ Pisa, Dept Translat Res New Technol Med & Surg, Pisa, Italy.	r.scuri@dsf.unipi.it	Tramonti Fantozzi, Maria Paola/AAB-5912-2022	Tramonti Fantozzi, Maria Paola/0000-0001-5146-4997; Colantuoni, Antonio/0000-0003-1152-5630; DELSEPPIA, CRISTINA/0000-0001-7459-8680	ATENEO Pisa	ATENEO Pisa	This work was supported by a grant from ATENEO Pisa, 2013-14. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Atochin DN, 2011, CURR PHARM BIOTECHNO, V12, P1334; Brunelli M, 2012, ARCH ITAL BIOL, V150, P231, DOI 10.4449/aib.v150i4.1420; Capuano A, 2010, NEUROPHARMACOLOGY, V58, P784, DOI 10.1016/j.neuropharm.2009.12.012; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Cornelius JF, 2010, EXPERT REV CARDIOVAS, V8, P895, DOI [10.1586/erc.10.74, 10.1586/ERC.10.74]; FLORENCE G, 1992, J CEREBR BLOOD F MET, V12, P674, DOI 10.1038/jcbfm.1992.92; Gong L, 2004, CURR OPIN HEMATOL, V11, P7, DOI 10.1097/00062752-200401000-00003; KASSAB GS, 1993, AM J PHYSIOL, V265, pH350, DOI 10.1152/ajpheart.1993.265.1.H350; KUMADA M, 1977, BRAIN RES, V119, P305, DOI 10.1016/0006-8993(77)90313-4; Lambert GA, 1997, CLIN EXP PHARMACOL P, V24, P377, DOI 10.1111/j.1440-1681.1997.tb01206.x; Lapi D, 2008, J VASC RES, V45, P69, DOI 10.1159/000109078; Lapi D, 2013, ARCH ITAL BIOL, V151, P11, DOI 10.4449/aib.v151i1.1470; Lee H, 2013, ANESTHESIOLOGY, V64, P257; Lindauer U, 1999, AM J PHYSIOL-HEART C, V277, pH799, DOI 10.1152/ajpheart.1999.277.2.H799; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCulloch PF, 1999, BRAIN RES, V830, P24, DOI 10.1016/S0006-8993(99)01374-8; Mchedlishvili G I, 1980, Usp Fiziol Nauk, V11, P3; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; NGAI AC, 1988, AM J PHYSIOL, V254, pH133, DOI 10.1152/ajpheart.1988.254.1.H133; Oriji GK, 1999, PROSTAG LEUKOTR ESS, V61, P45, DOI 10.1054/plef.1999.0072; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; Sandu N, 2010, THESCIENTIFICWORLDJO, V10, P1416, DOI 10.1100/tsw.2010.136; Sandu N, 2010, THESCIENTIFICWORLDJO, V10, P811, DOI 10.1100/tsw.2010.71; Sandu N, 2010, ARCH MED SCI, V6, P138, DOI 10.5114/aoms.2010.13523; Schaller B, 2004, J NEUROL, V251, P658, DOI 10.1007/s00415-004-0458-4; Schaller B, 2009, ACTA NEUROCHIR, V151, P1727, DOI 10.1007/s00701-009-0390-6; Schaller B, 2009, J NEUROSURG ANESTH, V21, P187, DOI 10.1097/ANA.0b013e3181a2bf22; Schaller BJ, 2007, J NEUROSURG, V107, P243, DOI 10.3171/JNS-07/07/0243; Toda N, 2009, PHARMACOL REV, V61, P62, DOI 10.1124/pr.108.000547; WEIJS WA, 1975, J MORPHOL, V146, P1, DOI 10.1002/jmor.1051460102	31	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115767	10.1371/journal.pone.0115767	http://dx.doi.org/10.1371/journal.pone.0115767			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551566	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100060
J	Protopopova, A; Mehrkam, LR; Boggess, MM; Wynne, CDL				Protopopova, Alexandra; Mehrkam, Lindsay Renee; Boggess, May Meredith; Wynne, Clive David Lawrence			In-Kennel Behavior Predicts Length of Stay in Shelter Dogs	PLOS ONE			English	Article							ENVIRONMENTAL ENRICHMENT; HOUSING CONDITIONS; ADOPTION SUCCESS; DOMESTIC DOGS; INDICATORS; WELFARE; NOISE	Previous empirical evaluations of training programs aimed at improving dog adoption rates assume that dogs exhibiting certain behaviors are more adoptable. However, no systematic data are available to indicate that the spontaneous behavior of shelter dogs has an effect on adopter preference. The aim of the present study was to determine whether any behaviors that dogs exhibit spontaneously in the presence of potential adopters were associated with the dogs' length of stay in the shelter. A sample of 289 dogs was videotaped for 1 min daily throughout their stay at a county shelter. To account for differences in adopter behavior, experimenters varied from solitary passive observers to pairs of interactive observers. Dogs behaved more attentively to active observers. To account for adopter preference for morphology, dogs were divided into "morphologically preferred" and "non-preferred" groups. Morphologically preferred dogs were small, long coated, ratters, herders, and lap dogs. No theoretically significant differences in behavior were observed between the two different dog morphologies. When accounting for morphological preference, three behaviors were found to have a significant effect on length of stay in all dogs: leaning or rubbing on the enclosure wall (increased median length of stay by 30 days), facing away from the front of the enclosure (increased by 15 days), and standing (increased by 7 days). When combinations of behaviors were assessed, back and forth motion was found to predict a longer stay (increased by 24 days). No consistent behavioral changes were observed due to time spent at the shelter. These findings will allow shelters to focus behavioral modification efforts only on behaviors likely to influence adopters' choices.	[Protopopova, Alexandra; Mehrkam, Lindsay Renee] Univ Florida, Dept Psychol, Gainesville, FL 32611 USA; [Boggess, May Meredith] Arizona State Univ, Sch Math & Stat Sci, Tempe, AZ 85281 USA; [Boggess, May Meredith] Univ Newcastle, Fac Hlth & Med, Callaghan, NSW 2308, Australia; [Wynne, Clive David Lawrence] Arizona State Univ, Dept Psychol, Tempe, AZ 85281 USA	State University System of Florida; University of Florida; Arizona State University; Arizona State University-Tempe; University of Newcastle; Arizona State University; Arizona State University-Tempe	Protopopova, A (corresponding author), Univ Florida, Dept Psychol, Room 114,Psychol Bldg,POB 112250, Gainesville, FL 32611 USA.	aprotopo@ufl.edu						Beerda B, 2000, ANIM WELFARE, V9, P49; Bollen K, 2012, ORAL PRESENTATION AT; Braun G., 2011, J VET BEHAV, V6, P100, DOI [DOI 10.1016/J.JVEB.2010.08.004, https://doi.org/10.1016/j.jveb.2010.08.004]; Brown WP, 2013, J APPL ANIM WELF SCI, V16, P2, DOI 10.1080/10888705.2013.740967; Clevenger J, 2003, J VET MED EDUC, V30, P372, DOI 10.3138/jvme.30.4.372; Coppola Crista L., 2006, Journal of Applied Animal Welfare Science, V9, P1, DOI 10.1207/s15327604jaws0901_1; Fox MW, 1978, THE DOG ITS DOMESTIC; Graham L, 2005, APPL ANIM BEHAV SCI, V91, P143, DOI 10.1016/j.applanim.2004.08.024; Herron ME, 2014, JAVMA-J AM VET MED A, V244, P687, DOI 10.2460/javma.244.6.687; HETTS S, 1992, APPL ANIM BEHAV SCI, V34, P137, DOI 10.1016/S0168-1591(05)80063-2; HUBRECHT RC, 1992, APPL ANIM BEHAV SCI, V34, P365, DOI 10.1016/S0168-1591(05)80096-6; Lepper Merry, 2002, Journal of Applied Animal Welfare Science, V5, P29, DOI 10.1207/S15327604JAWS0501_3; Lord K, 2012, POSTER SESSION PRESE; LORE RK, 1986, APPL ANIM BEHAV SCI, V15, P261, DOI 10.1016/0168-1591(86)90096-1; Luescher AU, 2009, APPL ANIM BEHAV SCI, V117, P63, DOI 10.1016/j.applanim.2008.11.001; LUESCHER UA, 1993, CAN VET J, V34, P368; Mehrkam LR, 2014, APPL ANIM BEHAV SCI, V155, P12, DOI 10.1016/j.applanim.2014.03.005; Protopopova A, 2014, APPL ANIM BEHAV SCI, V157, P109, DOI 10.1016/j.applanim.2014.04.007; Protopopova A, 2012, APPL ANIM BEHAV SCI, V142, P61, DOI 10.1016/j.applanim.2012.09.009; Rehn T, 2011, APPL ANIM BEHAV SCI, V129, P129, DOI 10.1016/j.applanim.2010.11.015; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; Sales G, 1997, APPL ANIM BEHAV SCI, V52, P321, DOI 10.1016/S0168-1591(96)01132-X; Schipper LL, 2008, APPL ANIM BEHAV SCI, V114, P182, DOI 10.1016/j.applanim.2008.01.001; Stephen Jacqueline M., 2005, Journal of Applied Animal Welfare Science, V8, P79, DOI 10.1207/s15327604jaws0802_1; The American Society for the Prevention of Cruelty to Animals, 2011, PET STATISTICS; Vas J, 2005, APPL ANIM BEHAV SCI, V94, P99, DOI 10.1016/j.applanim.2005.02.001; Voith VL, 2009, J APPL ANIM WELF SCI, V12, P253, DOI 10.1080/10888700902956151; Waller BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082686; Weiss E., 2012, ANIMALS, V2, P1; Wells D, 1992, ANIM WELFARE, V1, P171; Wells DL, 1999, APPL ANIM BEHAV SCI, V61, P341, DOI 10.1016/S0168-1591(98)00202-0; Wells DL, 2004, APPL ANIM BEHAV SCI, V85, P307, DOI 10.1016/j.applanim.2003.11.005; Wells DL, 2001, ANTHROZOOS, V14, P12, DOI 10.2752/089279301786999661	33	38	38	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114319	10.1371/journal.pone.0114319	http://dx.doi.org/10.1371/journal.pone.0114319			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551460	Green Published, gold			2022-12-26	WOS:000347119100010
J	Rishworth, GM; Tremblay, Y; Green, DB; Connan, M; Pistorius, PA				Rishworth, Gavin M.; Tremblay, Yann; Green, David B.; Connan, Maelle; Pistorius, Pierre A.			Drivers of Time-Activity Budget Variability during Breeding in a Pelagic Seabird	PLOS ONE			English	Article							INTRA-SPECIFIC COMPETITION; GANNETS MORUS-CAPENSIS; FORAGING BEHAVIOR; PROVISIONING BEHAVIOR; MONOMORPHIC SEABIRD; WANDERING ALBATROSSES; BIRD ISLAND; FOOD; COLONY; ALLOCATION	During breeding, animal behaviour is particularly sensitive to environmental and food resource availability. Additionally, factors such as sex, body condition, and offspring developmental stage can influence behaviour. Amongst seabirds, behaviour is generally predictably affected by local foraging conditions and has therefore been suggested as a potentially useful proxy to indicate prey state. However, besides prey availability and distribution, a range of other variables also influence seabird behavior, and these need to be accounted for to increase the signal-to-noise ratio when assessing specific characteristics of the environment based on behavioural attributes. The aim of this study was to use continuous, fine-scale time-activity budget data from a pelagic seabird (Cape gannet, Morus capensis) to determine the influence of intrinsic (sex and body condition) and extrinsic (offspring and time) variables on parent behaviour during breeding. Foraging trip duration and chick provisioning rates were clearly sex-specific and associated with chick developmental stage. Females made fewer, longer foraging trips and spent less time at the nest during chick provisioning. These sex-specific differences became increasingly apparent with chick development. Additionally, parents in better body condition spent longer periods at their nests and those which returned later in the day had longer overall nest attendance bouts. Using recent technological advances, this study provides new insights into the foraging behaviour of breeding seabirds, particularly during the post-guarding phase. The biparental strategy of chick provisioning revealed in this study appears to be an example where the costs of egg development to the female are balanced by paternal-dominated chick provisioning particularly as the chick nears fledging.	[Rishworth, Gavin M.; Green, David B.; Connan, Maelle; Pistorius, Pierre A.] Nelson Mandela Metropolitan Univ, Dept Zool, Percy FitzPatrick Inst, DST NRF Ctr Excellence, Summerstrand, South Africa; [Tremblay, Yann] Ctr Rech Halieut Mediterraneenne & Trop, UMR EME Exploited Marine Ecosyst 212, Inst Rech Dev, Sete, France; [Tremblay, Yann] Inst Mar Peru IMARPE, Chucuito Callao, Peru	National Research Foundation - South Africa; Nelson Mandela University; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Instituto del Mar del Peru	Rishworth, GM (corresponding author), Nelson Mandela Metropolitan Univ, Dept Zool, Percy FitzPatrick Inst, DST NRF Ctr Excellence, Summerstrand, South Africa.	gavin.rishworth@gmail.com	Green, David/U-5570-2019	Green, David/0000-0002-0346-3129; Connan, Maelle/0000-0002-1308-9118; Tremblay, Yann/0000-0002-4653-9269; Pistorius, Pierre/0000-0001-6561-7069	National Research Foundation (NRF) of South Africa	National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa)	This research was funded by the National Research Foundation (NRF) of South Africa, who also provided a bursary to GMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS NJ, 1991, MAR ECOL PROG SER, V70, P1, DOI 10.3354/meps070001; BATCHELOR AL, 1984, OSTRICH, V55, P45, DOI 10.1080/00306525.1984.9634757; BELL G, 1980, AM NAT, V116, P45, DOI 10.1086/283611; Bijleveld AI, 2009, BEHAV ECOL, V20, P736, DOI 10.1093/beheco/arp054; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Burger A.E., 1990, Studies in Avian Biology, P71; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CAIRNS D K, 1987, Biological Oceanography, V5, P261; CAIRNS DK, 1987, AUK, V104, P218, DOI 10.1093/auk/104.2.218; Carey MJ, 2009, NEW ZEAL J ZOOL, V36, P367, DOI 10.1080/03014220909510161; Catry P., 2006, SEXUAL SEGREGATION V, P351, DOI DOI 10.1017/CBO9780511525629.019; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Crawford RJM, 2007, ICES J MAR SCI, V64, P169, DOI 10.1093/icesjms/fsl011; Cuthill Innes C., 1997, P97; Dall'Antonia L, 2001, CONDOR, V103, P469, DOI 10.1650/0010-5422(2001)103[0469:TAAFPO]2.0.CO;2; Durant JM, 2009, CLIM RES, V39, P115, DOI 10.3354/cr00798; Elliott KH, 2010, BEHAV ECOL, V21, P1024, DOI 10.1093/beheco/arq076; FURNESS RW, 1984, NATURE, V311, P655, DOI 10.1038/311655a0; Garthe S, 2003, CAN J ZOOL, V81, P453, DOI 10.1139/Z03-027; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; Gremillet D, 2010, ECOL APPL, V20, P1498, DOI 10.1890/09-1586.1; Harding AMA, 2004, IBIS, V146, P642, DOI 10.1111/j.1474-919x.2004.00297.x; HATCH SA, 1990, ORNIS SCAND, V21, P89, DOI 10.2307/3676803; Jarvis MJF, 1971, ETHOLOGY ECOLOGY S A; Jonsson KI, 1997, OIKOS, V78, P57, DOI 10.2307/3545800; Kadin M, 2012, MAR ECOL PROG SER, V444, P239, DOI 10.3354/meps09417; KLAGES NTW, 1992, S AFR J MARINE SCI, V12, P761; KLAGES NTW, 1994, OSTRICH, V65, P218, DOI 10.1080/00306525.1994.9639685; LEMAHO Y, 1993, MAR ECOL PROG SER, V95, P1, DOI 10.3354/meps095001; Lewis S, 2006, OECOLOGIA, V147, P606, DOI 10.1007/s00442-005-0321-z; Lewis S, 2005, IBIS, V147, P408, DOI 10.1111/j.1474-919x.2005.00428.x; Lewis S, 2004, ANIM BEHAV, V68, P1331, DOI 10.1016/j.anbehav.2004.04.007; Lewis S, 2004, BEHAV ECOL SOCIOBIOL, V56, P81, DOI 10.1007/s00265-004-0762-0; Lewis S, 2002, P ROY SOC B-BIOL SCI, V269, P1687, DOI 10.1098/rspb.2002.2083; Lewis S, 2001, NATURE, V412, P816, DOI 10.1038/35090566; Litzow MA, 2003, J AVIAN BIOL, V34, P54, DOI 10.1034/j.1600-048X.2003.02995.x; McNamara JM, 2009, TRENDS ECOL EVOL, V24, P670, DOI 10.1016/j.tree.2009.05.011; Monaghan P, 1997, TRENDS ECOL EVOL, V12, P270, DOI 10.1016/S0169-5347(97)01094-X; Monaghan P, 1996, OIKOS, V77, P227, DOI 10.2307/3546061; Moseley C, 2012, J EXP MAR BIOL ECOL, V422, P29, DOI 10.1016/j.jembe.2012.04.002; Mullers Ralf H. E., 2010, Endangered Species Research, V12, P193, DOI 10.3354/esr00306; Mullers RHE, 2009, ICES J MAR SCI, V66, P2244, DOI 10.1093/icesjms/fsp210; Mullers RHE, 2009, ARDEA, V97, P89, DOI 10.5253/078.097.0111; Mullers RHE, 2007, BREEDING DYNAMIC SYS, P155; Nelson JB, 1978, SULIDAE GANNETS BOOB, P231; NEVITT GA, 1995, NATURE, V376, P680, DOI 10.1038/376680ao; Orians G.H., 1979, P155; Phillips RA, 2004, P ROY SOC B-BIOL SCI, V271, P1283, DOI 10.1098/rspb.2004.2718; Piatt JF, 2007, MAR ECOL PROG SER, V352, P199, DOI 10.3354/meps07070; Pichegru L, 2007, MAR ECOL PROG SER, V350, P127, DOI 10.3354/meps07128; Pinaud D, 2002, OIKOS, V99, P141, DOI 10.1034/j.1600-0706.2002.990114.x; Pinet P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027663; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Reynolds AM, 2012, ANIM BEHAV, V83, P1225, DOI 10.1016/j.anbehav.2012.02.014; Rishworth GM, 2014, METHODS ECOL EVOL, V5, P854, DOI 10.1111/2041-210X.12213; Rishworth GM, 2014, AFR ZOOL, V49, P107, DOI 10.3377/004.049.0115; Ropert-Coudert Y, 2004, ANIM BEHAV, V67, P985, DOI 10.1016/j.anbehav.2003.09.010; Sandberg R, 1996, OIKOS, V77, P577, DOI 10.2307/3545949; Shaffer SA, 2003, FUNCT ECOL, V17, P66, DOI 10.1046/j.1365-2435.2003.00705.x; Sommerfeld J, 2013, J AVIAN BIOL, V44, P531, DOI 10.1111/j.1600-048X.2013.00135.x; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Thaxter CB, 2009, J AVIAN BIOL, V40, P75, DOI 10.1111/j.1600-048X.2008.04507.x; Thiebault A, 2014, BEHAV ECOL, V25, P1302, DOI 10.1093/beheco/aru132; Thiebault A, 2014, AUK, V131, P595, DOI 10.1642/AUK-13-209.1; Thiebault A, 2013, BEHAV ECOL SOCIOBIOL, V67, P1013, DOI 10.1007/s00265-013-1546-1; Tremblay Y, 2003, MAR ECOL PROG SER, V251, P279, DOI 10.3354/meps251279; Tremblay Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088424; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Wakefield ED, 2013, SCIENCE, V341, P68, DOI 10.1126/science.1236077; Weimerskirch H, 2000, POLAR BIOL, V23, P733, DOI 10.1007/s003000000144; WEIMERSKIRCH H, 1992, MAR ECOL PROG SER, V86, P297, DOI 10.3354/meps086297; Weimerskirch H, 1998, J ANIM ECOL, V67, P99, DOI 10.1046/j.1365-2656.1998.00180.x; Weimerskirch H, 1997, ECOLOGY, V78, P2051; Welcker J, 2009, IBIS, V151, P502, DOI 10.1111/j.1474-919X.2009.00931.x; Zuur Alain F., 2009, P1	75	23	23	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116544	10.1371/journal.pone.0116544	http://dx.doi.org/10.1371/journal.pone.0116544			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551620	Green Published, gold, Green Submitted			2022-12-26	WOS:000347119100144
J	Sato, F; Miyaoka, Y; Miyajima, A; Tanaka, M				Sato, Fumi; Miyaoka, Yuichiro; Miyajima, Atsushi; Tanaka, Minoru			Oncostatin M Maintains the Hematopoietic Microenvironment in the Bone Marrow by Modulating Adipogenesis and Osteogenesis	PLOS ONE			English	Article							STEM-CELL NICHE; SELF-RENEWAL; STROMAL CELLS; PROGENITORS; DIFFERENTIATION; ENGRAFTMENT; ADIPOCYTES; INDUCTION; REGULATOR	The bone marrow (BM) is an essential organ for hematopoiesis in adult, in which proliferation and differentiation of hematopoietic stem/progenitor cells (HSPC) is orchestrated by various stromal cells. Alterations of BM hematopoietic environment lead to various hematopoietic disorders as exemplified by the linking of fatty marrow with increased adipogenesis to anemia or pancytopenia. Therefore, the composition of mesenchymal stromal cell (MSC)-derived cells in the BM could be crucial for proper hematopoiesis, but the mechanisms underlying the MSC differentiation for hematopoiesis remain poorly understood. In this study, we show that Oncostatin M (OSM) knock out mice exhibited pancytopenia advancing fatty marrow with age. OSM strongly inhibited adipogenesis from BM MSC in vitro, whereas it enhanced their osteogenesis but suppressed the terminal differentiation. Intriguingly, OSM allowed the MSC-derived cells to support the ex vivo expansion of HSPC effectively as feeder cells. Furthermore, the administration of OSM in lethally irradiated wild-type mice blocked fatty marrow and enhanced the recovery of HSPC number in the BM and peripheral blood cells after engraftment of HSPC. Collectively, OSM plays multiple critical roles in the maintenance and development of the hematopoietic microenvironment in the BM at a steady state as well as after injury.	[Sato, Fumi; Miyaoka, Yuichiro; Miyajima, Atsushi] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Cell Growth & Differentiat, Tokyo, Japan; [Tanaka, Minoru] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Stem Cell Regulat, Tokyo, Japan; [Tanaka, Minoru] Natl Ctr Global Hlth & Med, Res Inst, Dept Regenerat Med, Tokyo, Japan	University of Tokyo; University of Tokyo; National Center for Global Health & Medicine - Japan	Tanaka, M (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Stem Cell Regulat, Tokyo, Japan.	tanaka@iam.u-tokyo.ac.jp		Miyaoka, Yuichiro/0000-0002-8874-4738	Japan Society for the Promotion of Science, Japan [22118006]	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas 22118006 from the Japan Society for the Promotion of Science, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Asada N, 2013, CELL STEM CELL, V12, P737, DOI 10.1016/j.stem.2013.05.001; Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10622; BROWN TJ, 1987, J IMMUNOL, V139, P2977; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Gimble JM, 1996, BONE, V19, P421, DOI 10.1016/S8756-3282(96)00258-X; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Guihard P, 2012, STEM CELLS, V30, P762, DOI 10.1002/stem.1040; Haase VH, 2013, BLOOD REV, V27, P41, DOI 10.1016/j.blre.2012.12.003; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001; LEBOY PS, 1991, J CELL PHYSIOL, V146, P370, DOI 10.1002/jcp.1041460306; MALIK N, 1989, MOL CELL BIOL, V9, P2847, DOI 10.1128/MCB.9.7.2847; MCMANUS PM, 1984, BLOOD, V64, P1036; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Minehata K, 2006, INT J HEMATOL, V84, P319, DOI 10.1532/IJH97.06090; Miyaoka Y, 2006, J BIOL CHEM, V281, P37913, DOI 10.1074/jbc.M606089200; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Mukouyama YS, 1998, IMMUNITY, V8, P105, DOI 10.1016/S1074-7613(00)80463-X; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Perry JM, 2011, GENE DEV, V25, P1928, DOI 10.1101/gad.17421911; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Porter RM, 2003, J CELL BIOCHEM, V90, P13, DOI 10.1002/jcb.10592; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Scheinberg P, 2012, HEMATOL-AM SOC HEMAT, P292, DOI 10.1182/asheducation-2012.1.292; Shen Y, 2012, CURR OPIN HEMATOL, V19, P250, DOI 10.1097/MOH.0b013e328353c714; Song HY, 2007, J CELL BIOCHEM, V101, P1238, DOI 10.1002/jcb.21245; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Takeuchi M, 2002, BLOOD, V99, P1190, DOI 10.1182/blood.V99.4.1190; Tanaka M, 2004, REV PHYSIOL BIOCH P, V149, P39, DOI 10.1007/s10254-003-0013-1; Tanaka M, 2003, BLOOD, V102, P3154, DOI 10.1182/blood-2003-02-0367; Tansey JT, 2004, IUBMB LIFE, V56, P379, DOI 10.1080/15216540400009968; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Yoshimi A, 2008, BIOL BLOOD MARROW TR, V14, P1057, DOI 10.1016/j.bbmt.2008.07.003; Yoshimura A, 1996, EMBO J, V15, P1055, DOI 10.1002/j.1460-2075.1996.tb00443.x; Young NS, 1997, NEW ENGL J MED, V336, P1365, DOI 10.1056/NEJM199705083361906; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	50	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116209	10.1371/journal.pone.0116209	http://dx.doi.org/10.1371/journal.pone.0116209			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551451	Green Submitted, Green Published, gold			2022-12-26	WOS:000347119100107
J	Uhrig-Schmidt, S; Geiger, M; Luippold, G; Birk, G; Mennerich, D; Neubauer, H; Grimm, D; Wolfrum, C; Kreuz, S				Uhrig-Schmidt, Silke; Geiger, Matthias; Luippold, Gerd; Birk, Gerald; Mennerich, Detlev; Neubauer, Heike; Grimm, Dirk; Wolfrum, Christian; Kreuz, Sebastian			Gene Delivery to Adipose Tissue Using Transcriptionally Targeted rAAV8 Vectors	PLOS ONE			English	Article							EXPRESSION; OBESITY; STRATEGIES; TROPISM; FAMILY; MOUSE; WHITE	In recent years, the increasing prevalence of obesity and obesity-related co-morbidities fostered intensive research in the field of adipose tissue biology. To further unravel molecular mechanisms of adipose tissue function, genetic tools enabling functional studies in vitro and in vivo are essential. While the use of transgenic animals is well established, attempts using viral and non-viral vectors to genetically modify adipocytes in vivo are rare. Therefore, we here characterized recombinant Adeno-associated virus (rAAV) vectors regarding their potency as gene transfer vehicles for adipose tissue. Our results demonstrate that a single dose of systemically applied rAAV8-CMV-eGFP can give rise to remarkable transgene expression in murine adipose tissues. Upon transcriptional targeting of the rAAV8 vector to adipocytes using a 2.2 kb fragment of the murine adiponectin (mAP2.2) promoter, eGFP expression was significantly decreased in off-target tissues while efficient transduction was maintained in subcutaneous and visceral fat depots. Moreover, rAAV8-mAP2.2-mediated expression of perilipin A - a lipid-droplet-associated protein - resulted in significant changes in metabolic parameters only three weeks post vector administration. Taken together, our findings indicate that rAAV vector technology is applicable as a flexible tool to genetically modify adipocytes for functional proof-of-concept studies and the assessment of putative therapeutic targets in vivo.	[Uhrig-Schmidt, Silke; Luippold, Gerd; Birk, Gerald; Mennerich, Detlev; Neubauer, Heike; Kreuz, Sebastian] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; [Geiger, Matthias; Wolfrum, Christian] Swiss Fed Inst Technol, Swiss Fed Inst Technol, SLA C92, Inst Food Nutr & Hlth, Schwerzenbach, Switzerland; [Grimm, Dirk] Univ Heidelberg Hosp, Ctr Infect Dis Virol, Heidelberg, Germany; [Grimm, Dirk] Heidelberg Univ, Cluster Excellence CellNetworks, Heidelberg, Germany	Boehringer Ingelheim; Swiss Federal Institutes of Technology Domain; ETH Zurich; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Kreuz, S (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany.	sebastian.kreuz@boehringer-ingelheim.com		Wolfrum, Christian/0000-0002-3862-6805	Boehringer Ingelheim; Swiss National Fund; FP7 DIABAT Project of the European Union; Cluster of Excellence CellNetworks DFG EXC81	Boehringer Ingelheim(Boehringer Ingelheim); Swiss National Fund(Swiss National Science Foundation (SNSF)); FP7 DIABAT Project of the European Union; Cluster of Excellence CellNetworks DFG EXC81	The research described was funded by Boehringer Ingelheim (SUS, GL, GB, DM, HN, SK), by the Swiss National Fund and the FP7 DIABAT Project of the European Union (MG, CW) and by the Cluster of Excellence CellNetworks DFG EXC81 (SUS, DG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Asokan A, 2010, NAT BIOTECHNOL, V28, P79, DOI 10.1038/nbt.1599; Barness LA, 2007, AM J MED GENET A, V143A, P3016, DOI 10.1002/ajmg.a.32035; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; Buning H, 2008, J GENE MED, V10, P717, DOI 10.1002/jgm.1205; Casteilla L, 2008, CURR GENE THER, V8, P79, DOI 10.2174/156652308784049354; Coughlan L, 2010, VIRUSES-BASEL, V2, P2290, DOI 10.3390/v2102290; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Enerback S, 2009, NEW ENGL J MED, V360, P2021, DOI 10.1056/NEJMcibr0809610; Geisler A, 2011, GENE THER, V18, P199, DOI 10.1038/gt.2010.141; Grimm D, 2003, MOL THER, V7, P839, DOI 10.1016/S1525-0016(03)00095-9; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Halder S, 2012, FUTURE VIROL, V7, P253, DOI 10.2217/FVL.12.12; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Jimenez V, 2013, DIABETES, V62, P4012, DOI 10.2337/db13-0311; Koshfishi C, 2008, GENE, V424, P141, DOI 10.1016/j.gene.2008.07.039; Liu Q, 2003, GENE THER, V10, P935, DOI 10.1038/sj.gt.3302036; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Mizukami H, 2006, HUM GENE THER, V17, P921, DOI 10.1089/hum.2006.17.921; Moullier P, 2008, MOL THER, V16, P1185, DOI 10.1038/mt.2008.125; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nguyen T, 2012, CAN J CARDIOL, V28, P326, DOI 10.1016/j.cjca.2012.01.001; O'Neill SM, 2014, GENE THER, V21, P653, DOI 10.1038/gt.2014.38; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Rabinowitz JE, 2002, J VIROL, V76, P791, DOI 10.1128/JVI.76.2.791-801.2002; Raupp C, 2012, J VIROL, V86, P9396, DOI 10.1128/JVI.00209-12; Rauschhuber C, 2012, EUR J CELL BIOL, V91, P2, DOI 10.1016/j.ejcb.2011.01.006; Richardson VR, 2013, IMMUNOBIOLOGY, V218, P1497, DOI 10.1016/j.imbio.2013.05.002; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Schagen FHE, 2004, CRIT REV ONCOL HEMAT, V50, P51, DOI 10.1016/S1040-8428(03)00172-0; Schievenbusch S, 2010, MOL THER, V18, P1302, DOI 10.1038/mt.2010.71; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; SRIVASTAVA A, 1983, J VIROL, V45, P555, DOI 10.1128/JVI.45.2.555-564.1983; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Urabe M, 2002, HUM GENE THER, V13, P1935, DOI 10.1089/10430340260355347; Xie J, 2011, MOL THER, V19, P526, DOI 10.1038/mt.2010.279; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	39	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116288	10.1371/journal.pone.0116288	http://dx.doi.org/10.1371/journal.pone.0116288			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551639	Green Published, gold, Green Submitted			2022-12-26	WOS:000347119100124
J	Barbosa, TM; Phelan, RW; Leong, D; Morrissey, JP; Adams, C; Dobson, ADW; O'Gara, F				Barbosa, Teresa M.; Phelan, Robert W.; Leong, Dara; Morrissey, John P.; Adams, Claire; Dobson, Alan D. W.; O'Gara, Fergal			A Novel Erythromycin Resistance Plasmid from Bacillus Sp Strain HS24, Isolated from the Marine Sponge Haliclona Simulans	PLOS ONE			English	Article							SUBTILIS TRANSFORMATION SYSTEM; STAPHYLOCOCCUS-AUREUS ST398; ANTIBIOTIC-RESISTANCE; BACTERIAL PLASMIDS; BORNE ERM(T); HUMAN HEALTH; GENES; STREPTOCOCCUS; IDENTIFICATION; DIVERSITY	A better understanding of the origin and natural reservoirs of resistance determinants is fundamental to efficiently tackle antibiotic resistance. This paper reports the identification of a novel 5.8 kb erythromycin resistance plasmid, from Bacillus sp. HS24 isolated from the marine sponge Haliclona simulans. pBHS24B has a mosaic structure and carries the erythromycin resistance gene erm(T). This is the first report of an erythromycin resistance plasmid from a sponge associated bacteria and of the Erm(T) determinant in the genus Bacillus.	[Barbosa, Teresa M.] Natl Univ Ireland Univ Coll Cork, Sch Pharm, Cork, Ireland; [Phelan, Robert W.; Leong, Dara; Morrissey, John P.; Adams, Claire; Dobson, Alan D. W.; O'Gara, Fergal] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Phelan, Robert W.; Adams, Claire; O'Gara, Fergal] Natl Univ Ireland Univ Coll Cork, Biomerit Res Ctr, Cork, Ireland; [Morrissey, John P.; Dobson, Alan D. W.; O'Gara, Fergal] Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Ctr Marine Biotechnol, Cork, Ireland; [O'Gara, Fergal] Curtin Univ, Sch Biomed Sci, Perth, WA 6845, Australia	University College Cork; University College Cork; University College Cork; University College Cork; Curtin University	Barbosa, TM (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Pharm, Cork, Ireland.	t.barbosa@ucc.ie; f.ogara@ucc.ie	Morrissey, John/AAD-2255-2019; Dobson, Alan D W/M-7844-2017	Dobson, Alan D W/0000-0002-7713-5574; Leong, Dara/0000-0002-2269-8927; O'Gara, Fergal/0000-0002-2659-0673; Barbosa, Teresa M./0000-0001-7151-3418; Morrissey, John/0000-0001-7960-2001	Science Foundation of Ireland [SSPC2 12/RC/2275, 13-TIDA-B2625, 07/IN.1/B948, 12/TIDA/B2411, 12/TIDA/B2405, 09/RFP/BMT 2350]; Department of Agriculture, Fisheries and Food (FIRM/RSF/CoFoRD) [DAFF11/F/009 MabS, FIRM 08/RDC/629]; Environmental Protection Agency (EPA) [2008-PhD/S-2]; Irish Research Council for Science, Engineering and Technology [PD/2011/2414, RS/2010/2413]; European Commission (FP7-PEOPLE-ITN) [607786]; European Commission (OCEAN) [287589]; European Commission (FP7-KBBE-6) [CP-TP 311975]; European Commission (Marie Curie) [256596]; Marine Institute [C2CRA 2007/082]; Teagasc; Health Research Board [HRA/2009/146]	Science Foundation of Ireland(Science Foundation Ireland); Department of Agriculture, Fisheries and Food (FIRM/RSF/CoFoRD); Environmental Protection Agency (EPA)(United States Environmental Protection Agency); Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and Technology); European Commission (FP7-PEOPLE-ITN); European Commission (OCEAN); European Commission (FP7-KBBE-6); European Commission (Marie Curie)(European CommissionEuropean Commission Joint Research Centre); Marine Institute; Teagasc; Health Research Board	This research was supported in parts by grants awarded to FOG by the Science Foundation of Ireland (SSPC2 12/RC/2275, 13-TIDA-B2625, 07/IN.1/B948, 12/TIDA/B2411, 12/TIDA/B2405, 09/RFP/BMT 2350); the Department of Agriculture, Fisheries and Food (DAFF11/F/009 MabS, FIRM/RSF/CoFoRD; FIRM 08/RDC/629); the Environmental Protection Agency (EPA 2008-PhD/S-2), the Irish Research Council for Science, Engineering and Technology (PD/2011/2414; RS/2010/2413), the European Commission (FP7-PEOPLE-2013-ITN, 607786; OCEAN2012, 287589; FP7-KBBE-2012-6, CP-TP 311975; FP7-KBBE-2012-6, CP-TP-312184; Marie Curie 256596); and the Marine Institute (Beaufort award C2CRA 2007/082); Teagasc (Walsh Fellowship 2013) and the Health Research Board (HRA/2009/146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimpong DB, 2012, APPL ENVIRON MICROB, V78, P7903, DOI 10.1128/AEM.00730-12; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aminov RI, 2009, ENVIRON MICROBIOL, V11, P2970, DOI 10.1111/j.1462-2920.2009.01972.x; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Barbosa TM, 2005, APPL ENVIRON MICROB, V71, P968, DOI 10.1128/AEM.71.2.968-978.2005; Barbosa TM, 2000, DRUG RESIST UPDATE, V3, P303, DOI 10.1054/drup.2000.0167; Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; Bories G, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.732; BOTT KF, 1967, J BACTERIOL, V94, P562, DOI 10.1128/JB.94.3.562-570.1967; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Cabello FC, 2013, ENVIRON MICROBIOL, V15, P1917, DOI 10.1111/1462-2920.12134; Chen J, 2007, APPL ENVIRON MICROB, V73, P4407, DOI 10.1128/AEM.02799-06; Chen YG, 2011, INT J SYST EVOL MICR, V61, P2095, DOI 10.1099/ijs.0.026286-0; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; DiPersio LP, 2011, DIAGN MICR INFEC DIS, V71, P217, DOI 10.1016/j.diagmicrobio.2011.07.010; Duitman EH, 2007, APPL ENVIRON MICROB, V73, P3490, DOI 10.1128/AEM.02751-06; Esposito A, 2007, ANTIMICROB AGENTS CH, V51, P1043, DOI 10.1128/AAC.01002-06; Feld L, 2009, PLASMID, V61, P159, DOI 10.1016/j.plasmid.2009.01.002; Francia MV, 2004, FEMS MICROBIOL REV, V28, P79, DOI 10.1016/j.femsre.2003.09.001; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Gomez-Sanz E, 2013, ANTIMICROB AGENTS CH, V57, P3275, DOI 10.1128/AAC.00171-13; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; IMANAKA T, 1984, J GEN MICROBIOL, V130, P1399; Jackson SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084438; Kadlec K, 2010, ANTIMICROB AGENTS CH, V54, P915, DOI 10.1128/AAC.01091-09; Kennedy J, 2008, ENVIRON MICROBIOL, V10, P1888, DOI 10.1111/j.1462-2920.2008.01614.x; Kennedy J, 2010, MAR DRUGS, V8, P608, DOI 10.3390/md8030608; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Osborn AM, 2000, MICROBIOL-UK, V146, P2267, DOI 10.1099/00221287-146-9-2267; PERKINS JB, 1983, J BACTERIOL, V155, P607, DOI 10.1128/JB.155.2.607-615.1983; Phelan RW, 2012, J APPL MICROBIOL, V112, P65, DOI 10.1111/j.1365-2672.2011.05173.x; Phelan RW, 2013, MAR DRUGS, V11, P1878, DOI 10.3390/md11061878; Phelan RW, 2011, APPL ENVIRON MICROB, V77, P327, DOI 10.1128/AEM.01239-10; Rolain JM, 2012, CLIN MICROBIOL INFEC, V18, P615, DOI 10.1111/j.1469-0691.2012.03902.x; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Sanchez C, 2003, PLASMID, V49, P118, DOI 10.1016/S0147-619X(03)00013-1; Selvin J, 2009, MICROBIOL RES, V164, P352, DOI 10.1016/j.micres.2007.05.005; Sprincova A, 2005, PLASMID, V54, P39, DOI 10.1016/j.plasmid.2004.11.004; TANNOCK GW, 1994, PLASMID, V31, P60, DOI 10.1006/plas.1994.1007; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Teng LJ, 2001, ANTIMICROB AGENTS CH, V45, P3362, DOI 10.1128/AAC.45.12.3362-3365.2001; Whitehead TR, 2001, CURR MICROBIOL, V43, P17, DOI 10.1007/s002840010253; WILSON GA, 1968, J BACTERIOL, V95, P1439, DOI 10.1128/JB.95.4.1439-1449.1968; Woodbury RL, 2008, ANTIMICROB AGENTS CH, V52, P1140, DOI 10.1128/AAC.01352-07; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	49	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115583	10.1371/journal.pone.0115583	http://dx.doi.org/10.1371/journal.pone.0115583			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548909	gold, Green Published			2022-12-26	WOS:000347063500018
J	Singh, S; Guttula, PK; Guruprasad, L				Singh, Swati; Guttula, Praveen Kumar; Guruprasad, Lalitha			Structure Based Annotation of Helicobacter pylori Strain 26695 Proteome	PLOS ONE			English	Article							2-NITROPROPANE DIOXYGENASE; STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; CATALYTIC BASE; SERVER; FOLD; INFECTION; CLASSIFICATION; PATHOGENESIS; RECOGNITION	The availability of complete genome sequences of H. pylori 26695 has provided a wealth of information enabling us to carry out in silico studies to identify new molecular targets for pharmaceutical treatment. In order to construe the structural and functional information of complete proteome, use of computational methods are more relevant since these methods are reliable and provide a solution to the time consuming and expensive experimental methods. Out of 1590 predicted protein coding genes in H. pylori, experimentally determined structures are available for only 145 proteins in the PDB. In the absence of experimental structures, computational studies on the three dimensional (3D) structural organization would help in deciphering the protein fold, structure and active site. Functional annotation of each protein was carried out based on structural fold and binding site based ligand association. Most of these proteins are uncharacterized in this proteome and through our annotation pipeline we were able to annotate most of them. We could assign structural folds to 464 uncharacterized proteins from an initial list of 557 sequences. Of the 1195 known structural folds present in the SCOP database, 411 (34% of all known folds) are observed in the whole H. pylori 26695 proteome, with greater inclination for domains belonging to alpha/beta class (36.63%). Top folds include P-loop containing nucleoside triphosphate hydrolases (22.6%), TIM barrel (16.7%), transmembrane helix hairpin (16.05%), alpha-alpha superhelix (11.1%) and S-adenosyl-L-methionine-dependent methyltransferases (10.7%).	[Singh, Swati; Guttula, Praveen Kumar; Guruprasad, Lalitha] Univ Hyderabad, Sch Chem, Hyderabad 500046, Andhra Pradesh, India	University of Hyderabad	Guruprasad, L (corresponding author), Univ Hyderabad, Sch Chem, Hyderabad 500046, Andhra Pradesh, India.	lgpsc@uohyd.enet.in	Guttula, Praveen Kumar/AAG-2456-2019		CSIR, New Delhi, India; DST, New Delhi, India [SR/S5/MBD-05/2207]	CSIR, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); DST, New Delhi, India(Department of Science & Technology (India))	SS thanks CSIR, New Delhi, India, for the senior research fellowship. LGP thanks DST, New Delhi, India, for research funding (Ref. No. SR/S5/MBD-05/2207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGOS P, 1983, J BIOL CHEM, V258, P6450; Boneca IG, 2003, NUCLEIC ACIDS RES, V31, P1704, DOI 10.1093/nar/gkg250; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chow CS, 2007, ACS CHEM BIOL, V2, P610, DOI 10.1021/cb7001494; Cover TL, 1996, ADV INTERNAL MED, V41, P85; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Dutta Shuchismita, 2008, V426, P81, DOI 10.1007/978-1-60327-058-8_5; Eramian D, 2006, PROTEIN SCI, V15, P1653, DOI 10.1110/ps.062095806; Francis K, 2006, BIOCHEMISTRY-US, V45, P13889, DOI 10.1021/bi060566l; Gorlatova N, 1998, APPL ENVIRON MICROB, V64, P1029; Ha JY, 2006, J BIOL CHEM, V281, P18660, DOI 10.1074/jbc.M601658200; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOVEJENSEN B, 1986, J BIOL CHEM, V261, P6765; Hunt RH, 1996, SCAND J GASTROENTERO, V31, P3, DOI 10.3109/00365529609094743; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KIKUCHI S, 1995, CANCER, V75, P2789, DOI 10.1002/1097-0142(19950615)75:12<2789::AID-CNCR2820751202>3.0.CO;2-4; Kukimoto-Niino M, 2005, PROTEIN SCI, V14, P823, DOI 10.1110/ps.041229405; Labigne A, 1996, INFECT AGENT DIS, V5, P191; Lehoux IE, 1999, BIOCHEMISTRY-US, V38, P9948, DOI 10.1021/bi9907532; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Mandal RS, 2014, J BIOMOL STRUCT DYN, P1; McColl KEL, 1997, GASTROENTEROLOGY, V113, pS158, DOI 10.1016/S0016-5085(97)80031-5; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meurer LN, 2002, AM FAM PHYSICIAN, V65, P1327; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Pearson WR, 2013, CURR PROTOC BIOINFOR, V42, DOI 10.1002/0471250953.bi0301s42; Peek RM, 2005, SPRINGER SEMIN IMMUN, V27, P197, DOI 10.1007/s00281-005-0204-8; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Qian J, 2001, J MOL BIOL, V313, P673, DOI 10.1006/jmbi.2001.5079; RAea Laskowski, 1993, J APPL CRYST, V26; Resende T, 2013, J INTEGR BIOINFORMAT, V10, DOI 10.2390/biecoll-jib-2013-233; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schramm VL, 2004, PROG NUCLEIC ACID RE, V78, P261, DOI 10.1016/S0079-6603(04)78007-1; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Smith JL, 1995, CURR OPIN STRUC BIOL, V5, P752, DOI 10.1016/0959-440X(95)80007-7; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; WARREN JR, 1983, LANCET, V1, P1273; Yang JM, 2006, NUCLEIC ACIDS RES, V34, P3646, DOI 10.1093/nar/gkl395; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	43	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115020	10.1371/journal.pone.0115020	http://dx.doi.org/10.1371/journal.pone.0115020			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549250	Green Published, gold, Green Submitted			2022-12-26	WOS:000347063500010
J	Cheng, FHC; Aguda, BD; Tsai, JC; Kochanczyk, M; Lin, JMJ; Chen, GCW; Lai, HC; Nephew, KP; Hwang, TW; Chan, MWY				Cheng, Frank H. C.; Aguda, Baltazar D.; Tsai, Je-Chiang; Kochanczyk, Marek; Lin, Jora M. J.; Chen, Gary C. W.; Lai, Hung-Cheng; Nephew, Kenneth P.; Hwang, Tzy-Wei; Chan, Michael W. Y.			A Mathematical Model of Bimodal Epigenetic Control of miR-193a in Ovarian Cancer Stem Cells	PLOS ONE			English	Article							HORMONE-THERAPY; DNA METHYLATION; MICRORNAS; PROLIFERATION; EXPRESSION; RISK; GENE	Accumulating data indicate that cancer stem cells contribute to tumor chemoresistance and their persistence alters clinical outcome. Our previous study has shown that ovarian cancer may be initiated by ovarian cancer initiating cells (OCIC) characterized by surface antigen CD44 and c-KIT (CD117). It has been experimentally demonstrated that a microRNA, namely miR-193a, targets c-KIT mRNA for degradation and could play a crucial role in ovarian cancer development. How miR-193a is regulated is poorly understood and the emerging picture is complex. To unravel this complexity, we propose a mathematical model to explore how estrogen-mediated up-regulation of another target of miR-193a, namely E2F6, can attenuate the function of miR-193a in two ways, one through a competition of E2F6 and c-KIT transcripts for miR-193a, and second by binding of E2F6 protein, in association with a polycomb complex, to the promoter of miR-193a to downregulate its transcription. Our model predicts that this bimodal control increases the expression of c-KITand that the second mode of epigenetic regulation is required to generate a switching behavior in c-KIT and E2F6 expressions. Additional analysis of the TCGA ovarian cancer dataset demonstrates that ovarian cancer patients with low expression of EZH2, a polycomb-group family protein, show positive correlation between E2F6 and c-KIT. We conjecture that a simultaneous EZH2 inhibition and anti-estrogen therapy can constitute an effective combined therapeutic strategy against ovarian cancer.	[Cheng, Frank H. C.; Lin, Jora M. J.; Chen, Gary C. W.; Chan, Michael W. Y.] Natl Chung Cheng Univ, Dept Life Sci, Chiayi, Taiwan; [Cheng, Frank H. C.; Lin, Jora M. J.; Chen, Gary C. W.; Chan, Michael W. Y.] Natl Chung Cheng Univ, Inst Mol Biol, Chiayi, Taiwan; [Tsai, Je-Chiang; Hwang, Tzy-Wei] Natl Chung Cheng Univ, Dept Math, Chiayi, Taiwan; [Aguda, Baltazar D.] DiseasePathways LLC, Bethesda, MD USA; [Kochanczyk, Marek] Polish Acad Sci, Inst Fundamental Technol Res, Warsaw, Poland; [Lai, Hung-Cheng] Taipei Med Univ, Coll Med, Sch Med, Dept Obstet & Gynecol, Taipei, Taiwan; [Lai, Hung-Cheng] Taipei Med Univ, Shuang Ho Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Lai, Hung-Cheng] Cent South Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha, Hunan, Peoples R China; [Lai, Hung-Cheng] Cent South Univ, Inst Clin Pharmacol, Changsha, Hunan, Peoples R China; [Lai, Hung-Cheng] Hunan Key Lab Pharmacogenet, Changsha, Hunan, Peoples R China; [Nephew, Kenneth P.] Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Bloomington, IN USA	National Chung Cheng University; National Chung Cheng University; National Chung Cheng University; Polish Academy of Sciences; Institute of Fundamental Technological Research of the Polish Academy of Sciences; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Central South University; Central South University; Indiana University System; Indiana University Bloomington	Hwang, TW (corresponding author), Natl Chung Cheng Univ, Dept Math, Chiayi, Taiwan.	twhwang@math.ccu.edu.tw; biowyc@ccu.edu.tw	Kochanczyk, Marek/D-7825-2011; Chan, Michael/F-9615-2018	Kochanczyk, Marek/0000-0003-1215-3920; Chan, Michael/0000-0003-1431-322X; Chan, Michael/0000-0003-0314-2437	Ministry of Science and Technology, Taiwan [NSC102-2320-B-194-006, NSC102-2115-M-194-007-MY2, MOST103-2911-I-194- 504, MOST103-2320-B-194-002]; National Center for Theoretical Sciences (NCTS); National Chung Cheng University (NCCU Interdisciplinary Science), Taiwan [103-03]; DiseasePathways LLC	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Center for Theoretical Sciences (NCTS); National Chung Cheng University (NCCU Interdisciplinary Science), Taiwan; DiseasePathways LLC	This study was supported by the research grants from the Ministry of Science and Technology, Taiwan (NSC102-2320-B-194-006, NSC102-2115-M-194-007-MY2, MOST103-2911-I-194- 504 and MOST103-2320-B-194-002), National Center for Theoretical Sciences (NCTS), and National Chung Cheng University (NCCU Interdisciplinary Science grant 103-03), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Baltazar D. Aguda is employed by DiseasePathways LLC. DiseasePathways LLC provided support in the form of salary for author BDA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions'' section.	Attwooll C, 2005, J BIOL CHEM, V280, P1199, DOI 10.1074/jbc.M412509200; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Beral V, 2007, LANCET, V369, P1703, DOI 10.1016/S0140-6736(07)60534-0; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chau WK, 2013, ONCOGENE, V32, P2767, DOI 10.1038/onc.2012.290; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Cunat S, 2004, GYNECOL ONCOL, V94, P25, DOI 10.1016/j.ygyno.2004.03.026; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fung-Kee-Fung M, 2007, Curr Oncol, V14, P195; Gao XN, 2011, ONCOGENE, V30, P3416, DOI 10.1038/onc.2011.62; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Glud E, 2004, ARCH INTERN MED, V164, P2253, DOI 10.1001/archinte.164.20.2253; Heller G, 2012, CLIN CANCER RES, V18, P1619, DOI 10.1158/1078-0432.CCR-11-2450; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Lacey JV, 2006, JNCI-J NATL CANCER I, V98, P1397, DOI 10.1093/jnci/djj375; Li H, 2010, MOL CANCER RES, V8, P1610, DOI 10.1158/1541-7786.MCR-10-0398; Li YH, 2013, BLOOD, V121, P499, DOI 10.1182/blood-2012-07-444729; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Makar AP, 2000, ENDOCR-RELAT CANCER, V7, P85, DOI 10.1677/erc.0.0070085; Nossov V, 2008, AM J OBSTET GYNECOL, V199, P215, DOI 10.1016/j.ajog.2008.04.009; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Smyth JF, 2007, CLIN CANCER RES, V13, P3617, DOI 10.1158/1078-0432.CCR-06-2878; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; Velasco G, 2010, P NATL ACAD SCI USA, V107, P9281, DOI 10.1073/pnas.1000473107; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; WEISS NS, 1982, J NATL CANCER I, V68, P95; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	35	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116050	10.1371/journal.pone.0116050	http://dx.doi.org/10.1371/journal.pone.0116050			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545504	Green Published, gold			2022-12-26	WOS:000347120200093
J	Kuhn, M; Hoger, N; Feige, B; Blechert, J; Normann, C; Nissen, C				Kuhn, Marion; Hoeger, Nora; Feige, Bernd; Blechert, Jens; Normann, Claus; Nissen, Christoph			Fear Extinction as a Model for Synaptic Plasticity in Major Depressive Disorder	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; CONDITIONED FEAR; POTENTIATED STARTLE; HIPPOCAMPAL VOLUME; SPONTANEOUS-RECOVERY; UNIPOLAR DEPRESSION; DELAYED EXTINCTION; EMOTION PERCEPTION; CONTEXTUAL CONTROL; ANXIETY DISORDERS	Background: The neuroplasticity hypothesis of major depressive disorder proposes that a dysfunction of synaptic plasticity represents a basic pathomechanism of the disorder. Animal models of depression indicate enhanced plasticity in a ventral emotional network, comprising the amygdala. Here, we investigated fear extinction learning as a non-invasive probe for amygdala-dependent synaptic plasticity in patients with major depressive disorder and healthy controls. Methods: Differential fear conditioning was measured in 37 inpatients with severe unipolar depression (International Classification of Diseases, 10th revision, criteria) and 40 healthy controls. The eye-blink startle response, a subcortical output signal that is modulated by local synaptic plasticity in the amygdala in fear acquisition and extinction learning, was recorded as the primary outcome parameter. Results: After robust and similar fear acquisition in both groups, patients with major depressive disorder showed significantly enhanced fear extinction learning in comparison to healthy controls, as indicated by startle responses to conditioned stimuli. The strength of extinction learning was positively correlated with the total illness duration. Conclusions: The finding of enhanced fear extinction learning in major depressive disorder is consistent with the concept that the disorder is characterized by enhanced synaptic plasticity in the amygdala and the ventral emotional network. Clinically, the observation emphasizes the potential of successful extinction learning, the basis of exposure therapy, in anxiety-related disorders despite the frequent comorbidity of major depressive disorder.	[Kuhn, Marion; Hoeger, Nora; Feige, Bernd; Normann, Claus; Nissen, Christoph] Univ Med Ctr Freiburg, Dept Psychiat & Psychotherapy, Freiburg, Germany; [Blechert, Jens] Salzburg Univ, Div Clin Psychol Psychotherapy & Hlth Psychol, Dept Psychol, A-5020 Salzburg, Austria	University of Freiburg; Salzburg University	Nissen, C (corresponding author), Univ Med Ctr Freiburg, Dept Psychiat & Psychotherapy, Freiburg, Germany.	christoph.nissen@uniklinik-freiburg.de	Blechert, Jens/X-4040-2019; Nissen, Christoph/C-7642-2015; Feige, Bernd/C-6690-2012	Blechert, Jens/0000-0002-3820-109X; Nissen, Christoph/0000-0001-9809-0275; Feige, Bernd/0000-0002-9436-1258	FAZIT Stiftung; Albert Ludwigs University Freiburg	FAZIT Stiftung; Albert Ludwigs University Freiburg	The work was supported by the FAZIT Stiftung (PhD grant to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg.	Angrilli A, 1996, BRAIN, V119, P1991, DOI 10.1093/brain/119.6.1991; Arce E, 2008, PSYCHOPHARMACOLOGY, V196, P661, DOI 10.1007/s00213-007-1004-8; BECHARA A, 2002, SO NEUROSCI SER, P149; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; Blechert J, 2007, BEHAV RES THER, V45, P2019, DOI 10.1016/j.brat.2007.02.012; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; BOUTON ME, 1979, J EXP PSYCHOL ANIM B, V5, P368, DOI 10.1037/0097-7403.5.4.368; BOUTON ME, 1979, LEARN MOTIV, V10, P445, DOI 10.1016/0023-9690(79)90057-2; BOUTON ME, 1983, J EXP PSYCHOL ANIM B, V9, P248, DOI 10.1037/0097-7403.9.3.248; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; BROOKS DC, 1993, J EXP PSYCHOL ANIM B, V19, P77, DOI 10.1037/0097-7403.19.1.77; Burghardt NS, 2013, NEUROSCIENCE, V247, P253, DOI 10.1016/j.neuroscience.2013.05.050; Burghardt NS, 2013, BIOL PSYCHIAT, V73, P1078, DOI 10.1016/j.biopsych.2012.10.012; Burghardt NS, 2004, BIOL PSYCHIAT, V55, P1171, DOI 10.1016/j.biopsych.2004.02.029; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Camp MC, 2012, NEUROPSYCHOPHARMACOL, V37, P1534, DOI 10.1038/npp.2011.340; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Castren E, 2005, NAT REV NEUROSCI, V6, P241, DOI 10.1038/nrn1629; Castren E, 2013, JAMA PSYCHIAT, V70, P983, DOI 10.1001/jamapsychiatry.2013.1; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; DREVETS WC, 1992, J NEUROSCI, V12, P3628; FALLS WA, 1992, J NEUROSCI, V12, P854; Feige B., 1996, OSCILLATORY BRAIN AC; Fitzgerald PJ, 2013, BRAIN RES B; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frodl T, 2002, BIOL PSYCHIAT, V51, P708, DOI 10.1016/S0006-3223(01)01359-2; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Garcia R, 2002, REV NEUROSCIENCE, V13, P195; Grillon C, 2003, CLIN NEUROPHYSIOL, V114, P1557, DOI 10.1016/S1388-2457(03)00202-5; Grillon C, 2002, BIOL PSYCHIAT, V52, P958, DOI 10.1016/S0006-3223(02)01665-7; Hartley CA, 2010, NEUROPSYCHOPHARMACOL, V35, P136, DOI 10.1038/npp.2009.121; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; HITCHCOCK J, 1986, BEHAV NEUROSCI, V100, P11, DOI 10.1037/0735-7044.100.1.11; Holderbach R, 2007, BIOL PSYCHIAT, V62, P92, DOI 10.1016/j.biopsych.2006.07.007; Huff NC, 2009, BEHAV NEUROSCI, V123, P834, DOI 10.1037/a0016511; Karpova NN, 2011, SCIENCE, V334, P1731, DOI 10.1126/science.1214592; Keller SM, 2014, J CONSULT CLIN PSYCH, V82, P102, DOI 10.1037/a0035286; Kim JJ, 1996, P NATL ACAD SCI USA, V93, P4750, DOI 10.1073/pnas.93.10.4750; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; LABAR KS, 1995, J NEUROSCI, V15, P6846; LaBar KS, 1998, PSYCHOL SCI, V9, P490, DOI 10.1111/1467-9280.00090; Lange C, 2004, PSYCHOL MED, V34, P1059, DOI 10.1017/S0033291703001806; Ledgerwood L, 2003, BEHAV NEUROSCI, V117, P341, DOI 10.1037/0735-7044.117.2.341; Li XB, 2001, EUR J PHARMACOL, V425, P43, DOI 10.1016/S0014-2999(01)01159-1; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; MacQueen G, 2011, MOL PSYCHIATR, V16, P252, DOI 10.1038/mp.2010.80; Maier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050120; Mann JJ, 2005, NEW ENGL J MED, V353, P1819, DOI 10.1056/NEJMra050730; Maren S, 2003, ANN NY ACAD SCI, V985, P106; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Maren S., 2013, NEUROBIOLOGY LEARNIN; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; MAYBERG HS, 1994, J NUCL MED, V35, P929; McEwen BS, 2005, METABOLISM, V54, P20, DOI 10.1016/j.metabol.2005.01.008; Michael T, 2007, J ABNORM PSYCHOL, V116, P612, DOI 10.1037/0021-843X.116.3.612; Myers KM, 2006, LEARN MEMORY, V13, P216, DOI 10.1101/lm.119806; Nissen C, 2010, BIOL PSYCHIAT, V68, P544, DOI 10.1016/j.biopsych.2010.05.026; Normann C, 2007, BIOL PSYCHIAT, V62, P373, DOI 10.1016/j.biopsych.2006.10.006; Norrholm SD, 2008, BEHAV NEUROSCI, V122, P1016, DOI 10.1037/a0012604; Pavlides C, 2002, HIPPOCAMPUS, V12, P245, DOI 10.1002/hipo.1116; Pavlov I.P., 1927, CONDITIONED REFLEXES; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Rescorla RA, 2004, LEARN MEMORY, V11, P501, DOI 10.1101/lm.77504; Rescorla RA, 1975, J EXPT PSYCHOL ANIMA, V1, P88, DOI DOI 10.1037/0097-7403.1.1.88; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Schwab M, 2012, NATURE, V483, P267, DOI 10.1038/483267a; Senn V, 2014, NEURON, V81, P428, DOI 10.1016/j.neuron.2013.11.006; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Sheline YI, 1999, J NEUROSCI, V19, P5034; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Sotres-Bayon F, 2007, NEUROPSYCHOPHARMACOL, V32, P1929, DOI 10.1038/sj.npp.1301316; Spedding M, 2003, CURR OPIN PHARMACOL, V3, P33, DOI 10.1016/S1471-4892(02)00008-5; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Stockmeier CA, 2004, BIOL PSYCHIAT, V56, P640, DOI 10.1016/j.biopsych.2004.08.022; Suvrathan A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0151; The National Institute for Health and Care Excellence (NICE), 2005, POSTTRAUM STRESS DIS; Vriends N, 2011, J BEHAV THER EXP PSY, V42, P46, DOI 10.1016/j.jbtep.2010.09.001; Vyas A, 2002, J NEUROSCI, V22, P6810; Walker DL, 2002, PSYCHOPHARMACOLOGY, V164, P318, DOI 10.1007/s00213-002-1213-0; Walker DL, 2002, J NEUROSCI, V22, P2343, DOI 10.1523/JNEUROSCI.22-06-02343.2002; Walker DL, 2002, PHARMACOL BIOCHEM BE, V71, P379, DOI 10.1016/S0091-3057(01)00698-0; Welberg L, 2014, NAT REV NEUROSCI, V15, DOI 10.1038/nrn3698	86	21	29	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115280	10.1371/journal.pone.0115280	http://dx.doi.org/10.1371/journal.pone.0115280			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545818	Green Published, gold, Green Submitted			2022-12-26	WOS:000347120200034
J	Lieven, O; Dronka, J; Burmuhl, S; Ruther, U				Lieven, Oliver; Dronka, Julia; Burmuehl, Stephan; Ruether, Ulrich			Differential Binding of Lef1 and Msx1/2 Transcription Factors to Dkk1 CNEs Correlates with Reporter Gene Expression In Vivo	PLOS ONE			English	Article							WNT ANTAGONIST DICKKOPF-1; BETA-CATENIN; EYE; TARGET; MOUSE; INTERACT; PROTEINS; MORPHOGENESIS; ORGANIZATION; MAINTENANCE	Besides the active Wnt signalling itself, the extracellular inhibition by Dkk1 is important for various embryonic developmental processes, such as optic vesicle differentiation and facial outgrowth. Although a feedback crosstalk of the active Wnt/beta-catenin signaling and Dkk1 regulation has been suggested, the control of Dkk1 transcription by the Tcf/Lef1 mediated Wnt signalling and its connection to additional signalling factors has not been elucidated in vivo. Here, we used a combination of transgenic mouse approaches and biochemical analyses to unravel the direct Dkk1 transcriptional regulation via Tcf/Lefs. By using site directed mutagenesis, we tested several conserved Tcf/Lef1 binding sites within Dkk1 conserved non-coding elements (CNEs) and found that these are required for tissue specific reporter expression. In addition a conserved Msx1/2 binding site is required for retinal reporter expression and Msx2 but not Msx1 binds its conserved binding site within CNE195 in the optic cups. Within craniofacial expression domains, Lef1 interferes with Dkk1 directly via two conserved Tcf/Lef1 binding sites in the craniofacial enhancer CNE114, both of which are required for the general craniofacial Dkk1 reporter activation. Furthermore, these Tcf/Lef1 sites are commonly bound in the whisker hair bud mesenchyme but specifically Tcf/Lef1 (no. 2) is required for mandibular activation and repression of maxillar Dkk1 activation. Lastly, we tested the Tcf/Lef1 binding capacities of the Dkk1 promoter and found that although Lef1 binds the Dkk1 promoter, these sites are not sufficient for tissue specific Dkk1 activation. Together, we here present the importance of conserved Tcf/Lef1 and Msx1/2 sites that are required for differential Dkk1 transcriptional reporter activation in vivo. This requirement directly correlates with Lef1 and Msx1/2 interaction with these genomic loci.	[Lieven, Oliver] Univ Copenhagen, Danish Stem Cell Ctr, DK-2200 Copenhagen N, Denmark; [Dronka, Julia; Burmuehl, Stephan; Ruether, Ulrich] Univ Dusseldorf, Inst Anim Dev & Mol Biol, D-40225 Dusseldorf, Germany	University of Copenhagen; Heinrich Heine University Dusseldorf	Lieven, O (corresponding author), Univ Copenhagen, Danish Stem Cell Ctr, Blegdamsvej 3B,Bldg 6,4th Floor, DK-2200 Copenhagen N, Denmark.	oliver.lieven@sund.ku.dk			strategic research fonds (SFF) of the Heinrich-Heine University Dusseldorf	strategic research fonds (SFF) of the Heinrich-Heine University Dusseldorf	This work was supported by the strategic research fonds (SFF) of the Heinrich-Heine University Dusseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamska M, 2004, DEV BIOL, V272, P134, DOI 10.1016/j.ydbio.2004.04.026; Ang SJ, 2004, GENE EXPR PATTERNS, V4, P289, DOI 10.1016/j.modgep.2003.11.002; Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Baeg GH, 2001, DEVELOPMENT, V128, P87; Brugmann SA, 2007, DEVELOPMENT, V134, P3283, DOI 10.1242/dev.005132; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cain S, 2008, DEV BIOL, V321, P420, DOI 10.1016/j.ydbio.2008.07.002; Catron KM, 1996, MECH DEVELOP, V55, P185, DOI 10.1016/0925-4773(96)00503-5; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Chen YJ, 2004, INT J DEV BIOL, V48, P867, DOI 10.1387/ijdb.041882yc; Chen YJ, 2008, DEV BIOL, V324, P161, DOI 10.1016/j.ydbio.2008.09.002; de Iongh RU, 2006, FRONT BIOSCI-LANDMRK, V11, P2442, DOI 10.2741/1982; Diep DB, 2004, DEV BRAIN RES, V153, P261, DOI 10.1016/j.devbrainres.2004.09.008; Fjeld K, 2005, DEV DYNAM, V233, P161, DOI 10.1002/dvdy.20285; FoerstPotts L, 1997, DEV DYNAM, V209, P70, DOI 10.1002/(SICI)1097-0177(199705)209:1<70::AID-AJA7>3.0.CO;2-U; Fokina VM, 2006, DEV DYNAM, V235, P496, DOI 10.1002/dvdy.20621; Fuhrmann S, 2003, GENE EXPR PATTERNS, V3, P659, DOI 10.1016/S1567-133X(03)00107-8; Galceran J, 2001, P NATL ACAD SCI USA, V98, P8668, DOI 10.1073/pnas.151258098; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; GORDON JW, 1981, SCIENCE, V214, P1244, DOI 10.1126/science.6272397; Grotewold L, 2002, EMBO J, V21, P966, DOI 10.1093/emboj/21.5.966; Hussein SM, 2003, J BIOL CHEM, V278, P48805, DOI 10.1074/jbc.M305472200; Jasoni C, 1999, DEV DYNAM, V215, P215, DOI 10.1002/(SICI)1097-0177(199907)215:3<215::AID-AJA4>3.0.CO;2-W; Jin EJ, 2002, MECH DEVELOP, V116, P173, DOI 10.1016/S0925-4773(02)00128-4; Lewis SL, 2008, DEVELOPMENT, V135, P1791, DOI 10.1242/dev.018853; Lieven O, 2011, DEV BIOL, V355, P124, DOI 10.1016/j.ydbio.2011.04.023; Lieven O, 2010, DEV BIOL, V340, P256, DOI 10.1016/j.ydbio.2010.01.037; Liu CQ, 2008, DEVELOPMENT, V135, P3567, DOI 10.1242/dev.028076; Liu H, 2003, DEV DYNAM, V227, P323, DOI 10.1002/dvdy.10315; Liu H, 2006, INVEST OPHTH VIS SCI, V47, P5088, DOI 10.1167/iovs.06-0403; Liu ZT, 2011, J BIOL CHEM, V286, P28520, DOI 10.1074/jbc.M111.236307; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; MacDonald BT, 2004, DEVELOPMENT, V131, P2543, DOI 10.1242/dev.01126; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Nie XG, 2005, J MOL HISTOL, V36, P367, DOI 10.1007/s10735-005-9008-3; Nie XG, 2005, J MOL HISTOL, V36, P419, DOI 10.1007/s10735-005-9014-5; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; OOSTERWEGEL M, 1993, DEVELOPMENT, V118, P439; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Song LY, 2009, DEVELOPMENT, V136, P3161, DOI 10.1242/dev.037440; Stump RJW, 2003, DEV BIOL, V259, P48, DOI 10.1016/S0012-1606(03)00179-9; Theil T, 1999, DEVELOPMENT, V126, P3561; Van Raay TJ, 2004, DEV NEUROSCI-BASEL, V26, P352, DOI 10.1159/000082277; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Veien ES, 2008, DEVELOPMENT, V135, P4101, DOI 10.1242/dev.027367; Wehrli M, 2001, NATURE, V410, P847, DOI 10.1038/35071131; Wu LY, 2003, INVEST OPHTH VIS SCI, V44, P2404, DOI 10.1167/iovs.02-0317; Zhao JY, 2012, AM J PATHOL, V180, P2230, DOI 10.1016/j.ajpath.2012.02.017; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	57	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115442	10.1371/journal.pone.0115442	http://dx.doi.org/10.1371/journal.pone.0115442			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545010	Green Published, gold, Green Submitted			2022-12-26	WOS:000347120200042
J	Reemann, P; Reimann, E; Ilmjarv, S; Porosaar, O; Silm, H; Jaks, V; Vasar, E; Kingo, K; Koks, S				Reemann, Paula; Reimann, Ene; Ilmjaerv, Sten; Porosaar, Orm; Silm, Helgi; Jaks, Viljar; Vasar, Eero; Kingo, Kuelli; Koks, Sulev			Melanocytes in the Skin - Comparative Whole Transcriptome Analysis of Main Skin Cell Types	PLOS ONE			English	Article							GENE-EXPRESSION; STEM-CELLS; OXIDATIVE STRESS; ULTRAVIOLET-B; CANCER; MELANOMA; PROTEIN; DIFFERENTIATION; KERATINOCYTES; MELANOGENESIS	Melanocytes possess several functions besides a role in pigment synthesis, but detailed characteristics of the cells are still unclear. We used whole transcriptome sequencing (RNA- Seq) to assess differential gene expression of cultivated normal human melanocytes with respect to keratinocytes, fibroblasts and whole skin. The present results reveal cultivated melanocytes as highly proliferative cells with possible stem cell-like properties. The enhanced readiness to regenerate makes melanocytes the most vulnerable cells in the skin and explains their high risk of developing into malignant melanoma.	[Reemann, Paula; Ilmjaerv, Sten; Vasar, Eero] Univ Tartu, Dept Physiol, Inst Biomed & Translat Med, EE-50090 Tartu, Estonia; [Reimann, Ene] Univ Tartu, Core Facil Clin Genom, Dept Pathophysiol, Dept Biomed,Inst Biomed & Translat Med, EE-50090 Tartu, Estonia; [Reimann, Ene; Koks, Sulev] Estonian Univ Life Sci, Inst Vet Med & Anim Sci, Competence Ctr Reprod Med & Biol, Tartu, Estonia; [Ilmjaerv, Sten] Quretec Ltd, Tartu, Estonia; [Porosaar, Orm] Tallinn Childrens Hosp, Dept Pediat Surg, Tallinn, Estonia; [Silm, Helgi; Kingo, Kuelli] Univ Tartu, Dermatol Clin, Tartu Univ Hosp, Dept Dermatol, EE-50090 Tartu, Estonia; [Jaks, Viljar] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Vasar, Eero; Koks, Sulev] Univ Tartu, Ctr Translat Med, EE-50090 Tartu, Estonia; [Koks, Sulev] Univ Tartu, Dept Pathophysiol, Inst Biomed & Translat Med, EE-50090 Tartu, Estonia	University of Tartu; University of Tartu; Estonian University of Life Sciences; University of Tartu; University of Tartu; University of Tartu; University of Tartu	Reemann, P (corresponding author), Univ Tartu, Dept Physiol, Inst Biomed & Translat Med, Ulikooli 18, EE-50090 Tartu, Estonia.	paula.reemann@ut.ee	Jaks, Viljar/H-2467-2012; Kingo, Külli/H-3603-2012; Vasar, Eero/H-4490-2015; Koks, Sulev/H-3655-2015; Reimann, Ene/M-9912-2017	Jaks, Viljar/0000-0002-2221-6262; Koks, Sulev/0000-0001-6087-6643; Kingo, Kulli/0000-0001-6301-9612; Vasar, Eero/0000-0001-5226-345X; Reimann, Ene/0000-0002-5410-4433	European Union through the European Regional Development Fund via project of Centre of Excellence for Translational Medicine; Estonian Ministry of Education and Research [PUT177, PUT4, ETF8139]; Centre of Translational Genomics of University of Tartu; European Molecular Biology Organization Integration Grant; European Social Fund's Doctoral Studies Internationalization Programme DoRa;  [IUT20-46]	European Union through the European Regional Development Fund via project of Centre of Excellence for Translational Medicine; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Centre of Translational Genomics of University of Tartu; European Molecular Biology Organization Integration Grant; European Social Fund's Doctoral Studies Internationalization Programme DoRa; 	This study was financially supported by the European Union through the European Regional Development Fund via project of Centre of Excellence for Translational Medicine (http:// biomedicum.ut.ee/cetm/) (EV, PR); by the institutional research funding grant (IUT20-46) and by personal research funding grants (PUT177 (KK, HS, PR), PUT4, ETF8139 (VJ)) of the Estonian Ministry of Education and Research (http://www.etag.ee/en/); by the Centre of Translational Genomics of University of Tartu (http://www.ctg.ut. ee) (SP1GVARENG) (SK, ER); by the European Molecular Biology Organization Integration Grant (http://www.embo.org) (VJ) and by the European Social Fund's Doctoral Studies Internationalization Programme DoRa carried out by Archimedes Foundation (http://adm.archimedes.ee/ stipendiumid/en/programm-dora/t3/) (SI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed IA, 2010, CANCER GENET CYTOGEN, V199, P96, DOI 10.1016/j.cancergencyto.2010.02.007; Akaneya Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012486; Auge JM, 2005, ANTICANCER RES, V25, P1779; Bair EL, 2005, NEOPLASIA, V7, P380, DOI 10.1593/neo.04619; Cantaert T, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3150; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Chakrabarty K, 2012, BIOL OPEN, V1, P693, DOI 10.1242/bio.20121230; Chakraborty AK, 1996, BBA-MOL CELL RES, V1313, P130, DOI 10.1016/0167-4889(96)00063-8; Chen JD, 2003, CANCER CELL, V4, P405, DOI 10.1016/S1535-6108(03)00269-1; Chen YK, 2012, J NEUROSCI, V32, P1043, DOI 10.1523/JNEUROSCI.4405-11.2012; Chen ZX, 2014, CANCER DISCOV, V4, P434, DOI 10.1158/2159-8290.CD-13-0362; Cichorek M, 2013, POSTEP DERM ALERGOL, V30, P30, DOI 10.5114/pdia.2013.33376; Costin GE, 2007, FASEB J, V21, P976, DOI 10.1096/fj.06-6649rev; de Souza CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044800; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7; Ekblom P, 2003, MATRIX BIOL, V22, P35, DOI 10.1016/S0945-053X(03)00015-5; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Fang CC, 2013, CARDIOVASC RES, V99, P146, DOI 10.1093/cvr/cvt060; Foltz G, 2006, CANCER RES, V66, P6665, DOI 10.1158/0008-5472.CAN-05-4453; Freinkel, 2001, BIOL SKIN; Funasaka Y, 1998, BRIT J DERMATOL, V139, P216; Garcia-Areas R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00017; Gillis JS, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-27; Goldsmith LA, 2012, FITZPATRICKS DERMATO; HILL KK, 1995, GENETICS, V141, P595; Hoath SB, 2003, J INVEST DERMATOL, V121, P1440, DOI 10.1046/j.1523-1747.2003.12606.x; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hotta K, 2009, J ENDOCRINOL, V202, P111, DOI 10.1677/JOE-08-0531; Hou L, 2008, CELL RES, V18, P1163, DOI 10.1038/cr.2008.303; Itsui Y, 2006, J VIRAL HEPATITIS, V13, P690, DOI 10.1111/j.1365-2893.2006.00732.x; Jiao Y, 2005, GENETICS, V171, P1239, DOI 10.1534/genetics.105.044487; Jimenez-Cervantes C, 2001, J CELL SCI, V114, P2335; Kawakami Akinori, 2011, J Invest Dermatol, V131, pE2, DOI 10.1038/skinbio.2011.2; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koga Y, 2009, GENOME RES, V19, P1462, DOI 10.1101/gr.091447.109; Kos R, 2001, DEVELOPMENT, V128, P1467; Kumari K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-42; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JS, 2013, ANN DERMATOL, V25, P36, DOI 10.5021/ad.2013.25.1.36; LEE ST, 1995, GENOMICS, V26, P354, DOI 10.1016/0888-7543(95)80220-G; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Liu WT, 2013, PEERJ, V1, DOI 10.7717/peerj.49; Louro R, 2004, BIOCHEM BIOPH RES CO, V316, P618, DOI 10.1016/j.bbrc.2004.02.091; Marzook H, 2012, J BIOL CHEM, V287, P5615, DOI 10.1074/jbc.M111.314088; Miller CC, 2003, EXP DERMATOL, V12, P403, DOI 10.1034/j.1600-0625.2003.00023.x; Neufeld G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006718; Padmanabhan R, 2012, STEM CELLS, V30, P2175, DOI 10.1002/stem.1195; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Randolph RK, 1998, J INVEST DERMATOL, V111, P478, DOI 10.1046/j.1523-1747.1998.00307.x; Reemann P, 2013, ACTA DERM VENEREOL; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Roberts DW, 2006, PIGM CELL RES, V19, P76, DOI 10.1111/j.1600-0749.2005.00286.x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenblum MD, 2004, BLOOD, V103, P2691, DOI 10.1182/blood-2003-09-3184; Slominski A, 2009, EXP DERMATOL, V18, P760, DOI 10.1111/j.1600-0625.2009.00892.x; Stark JL, 2014, BIOCHEMISTRY-US, V53, P1360, DOI 10.1021/bi401329a; Szatanik M, 2008, NEUROGENETICS, V9, P237, DOI 10.1007/s10048-008-0136-2; Thingnes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040377; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Videira PA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-357; Wajant H, 2009, RESULTS PROBL CELL D, V49, P1, DOI 10.1007/400_2008_26; Wang K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.50; White RM, 2008, CELL STEM CELL, V3, P242, DOI 10.1016/j.stem.2008.08.005; Wu S, 2012, CANCER MED-US, V1, P306, DOI 10.1002/cam4.28; Wu Z, J IMMUNOL, V191, P5885; Yeo H, 2013, EMBO J, V32, P2589, DOI 10.1038/emboj.2013.186; Yim YS, 2013, P NATL ACAD SCI USA, V110, P4057, DOI 10.1073/pnas.1209881110; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470; Zhang XF, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-244	73	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115717	10.1371/journal.pone.0115717	http://dx.doi.org/10.1371/journal.pone.0115717			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545474	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200061
J	Sinues, PML; Tarokh, L; Li, X; Kohler, M; Brown, SA; Zenobi, R; Dallmann, R				Sinues, Pablo Martinez-Lozano; Tarokh, Leila; Li, Xue; Kohler, Malcolm; Brown, Steven A.; Zenobi, Renato; Dallmann, Robert			Circadian Variation of the Human Metabolome Captured by Real-Time Breath Analysis	PLOS ONE			English	Article							IONIZATION MASS-SPECTROMETRY; ELECTROSPRAY-IONIZATION; BODY TIME; DISRUPTION; EXPRESSION; VOLATILES; RESPONSES; INSIGHTS; VAPORS; MOUSE	Circadian clocks play a significant role in the correct timing of physiological metabolism, and clock disruption might lead to pathological changes of metabolism. One interesting method to assess the current state of metabolism is metabolomics. Metabolomics tries to capture the entirety of small molecules, i.e. the building blocks of metabolism, in a given matrix, such as blood, saliva or urine. Using mass spectrometric approaches we and others have shown that a significant portion of the human metabolome in saliva and blood exhibits circadian modulation; independent of food intake or sleep/wake rhythms. Recent advances in mass spectrometry techniques have introduced completely non-invasive breathprinting; a method to instantaneously assess small metabolites in human breath. In this proof-of-principle study, we extend these findings about the impact of circadian clocks on metabolomics to exhaled breath. As previously established, our method allows for real-time analysis of a rich matrix during frequent non-invasive sampling. We sampled the breath of three healthy, non-smoking human volunteers in hourly intervals for 24 hours during total sleep deprivation, and found 111 features in the breath of all individuals, 36-49% of which showed significant circadian variation in at least one individual. Our data suggest that real-time mass spectrometric "breathprinting" has high potential to become a useful tool to understand circadian metabolism, and develop new biomarkers to easily and in real-time assess circadian clock phase and function in experimental and clinical settings.	[Sinues, Pablo Martinez-Lozano; Li, Xue; Zenobi, Renato] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Zurich, Switzerland; [Tarokh, Leila; Brown, Steven A.; Dallmann, Robert] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Tarokh, Leila] Univ Bern, Univ Hosp Child & Adolescent Psychiat & Psychothe, Bern, Switzerland; [Kohler, Malcolm] Univ Zurich Hosp, Div Pulm, Zurich, Switzerland; [Kohler, Malcolm] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Bern; University Hospital of Bern; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Zenobi, R (corresponding author), Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Zurich, Switzerland.	zenobi@org.chem.ethz.ch; dallmann@pharma.uzh.ch	Sinues, Pablo/A-9576-2014; Dallmann, Bob/AAA-4929-2022; Sinues, Pablo/X-2311-2019	Sinues, Pablo/0000-0001-5602-2880; Sinues, Pablo/0000-0001-5602-2880; Dallmann, Robert/0000-0002-7490-0218; Tarokh, Leila/0000-0003-4014-428X	Marie Curie European Reintegration Grant within the 7th European Community Framework Programme [276860]	Marie Curie European Reintegration Grant within the 7th European Community Framework Programme	Marie Curie European Reintegration Grant within the 7th European Community Framework Programme No. 276860 to PMLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann A, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/3/034001; Ang JE, 2012, CHRONOBIOL INT, V29, P868, DOI 10.3109/07420528.2012.699122; Archer SN, 2014, P NATL ACAD SCI US; Bean HD, 2011, JOVE-J VIS EXP, DOI 10.3791/2664; BENOIT FM, 1985, INT ARCH OCC ENV HEA, V55, P113, DOI 10.1007/BF00378373; BENOIT FM, 1983, ANAL CHEM, V55, P805, DOI 10.1021/ac00255a053; Berchtold C, 2013, METABOLOMICS, P1; Bhatti P, 2014, OCCUP ENV MED; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chua ECP, 2013, P NATL ACAD SCI USA, V110, P14468, DOI 10.1073/pnas.1222647110; Costello BD, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/1/014001; Dallmann R, 2014, ANNU REV PHARMACOL, V54, P339, DOI 10.1146/annurev-pharmtox-011613-135923; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; Davies SK, 2014, P NATL ACAD SCI US; Dillon LA, 2010, ANALYST, V135, P306, DOI 10.1039/b918899a; Diskin AM, 2003, PHYSIOL MEAS, V24, P107, DOI 10.1088/0967-3334/24/1/308; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Filipski E, 2009, MUTAT RES; Foster RG, 2008, CURR BIOL, V18, pR784, DOI 10.1016/j.cub.2008.07.003; Fuerstenau S, 1994, AGGREGATION FRAGMENT; Fuerstenau S, 1999, ESIMS ANAL TRACE SPE; Hidalgo MP, 2009, PSYCHIAT CLIN NEUROS, V63, P283, DOI 10.1111/j.1440-1819.2009.01965.x; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Innominato PF, 2010, ADV DRUG DELIVER REV, V62, P979, DOI 10.1016/j.addr.2010.06.002; Jiangjiang Z., 2013, J BREATH RES, V7; Jiangjiang Z., 2013, J BREATH RES, V7; Kasukawa T, 2012, P NATL ACAD SCI USA, V109, P15036, DOI 10.1073/pnas.1207768109; Keller BO, 2008, ANAL CHIM ACTA, V627, P71, DOI 10.1016/j.aca.2008.04.043; King J, 2012, PHYSIOL MEAS, V33, P413, DOI 10.1088/0967-3334/33/3/413; Kiselev P, 2001, ESIMS ANAL VAPORS TR; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; Lee CY, 1998, ANAL CHEM, V70, P2757, DOI 10.1021/ac971325+; LOVETT AM, 1979, BIOMED MASS SPECTROM, V6, P91, DOI 10.1002/bms.1200060302; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Martinez-Lozano P, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/1/016002; Martinez-Lozano P, 2008, ANAL CHEM, V80, P8210, DOI 10.1021/ac801185e; Martinez-Lozano P, 2009, J AM SOC MASS SPECTR, V20, P287, DOI 10.1016/j.jasms.2008.10.006; Minami Y, 2009, P NATL ACAD SCI USA, V106, P9890, DOI 10.1073/pnas.0900617106; Moller-Levet CS, 2013, P NATL ACAD SCI; Oliver PL, 2012, CURR BIOL, V22, P314, DOI 10.1016/j.cub.2011.12.051; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Roenneberg T, 2007, COLD SPRING HARB SYM, V72, P293, DOI 10.1101/sqb.2007.72.043; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Sinues PML, 2014, RESPIRATION, V87, P301, DOI 10.1159/000357785; Sinues PML, 2013, CHEST, V144, P746, DOI 10.1378/chest.13-1106; Sinues PML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059909; Sinues PML, 2013, ANAL CHEM, V85, P369, DOI 10.1021/ac3029097; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Smith D, 1999, J APPL PHYSIOL, V87, P1584, DOI 10.1152/jappl.1999.87.5.1584; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2004, P NATL ACAD SCI USA, V101, P11227, DOI 10.1073/pnas.0401882101; Weaver D. R., 2013, FUNDAMENTAL NEUROSCI, P819; Whitehouse CM, 1986, FURTHER ADVENTURES E; Wu C, 2000, ANAL CHEM, V72, P396, DOI 10.1021/ac9907235; Wulff K, 2012, BRIT J PSYCHIAT, V200, P308, DOI 10.1192/bjp.bp.111.096321; Yong M, 2012, ARH HIG RADA TOKSIKO, V63, P153, DOI 10.2478/10004-1254-63-2012-2209; Zhu J, 2013, J APPL PHYSL; Zhu JJ, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/1/016003; Zhu JJ, 2010, J CLIN MICROBIOL, V48, P4426, DOI 10.1128/JCM.00392-10	67	53	53	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e114422	10.1371/journal.pone.0114422	http://dx.doi.org/10.1371/journal.pone.0114422			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545545	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000347120200014
J	Romero-Aguirregomezcorta, J; Santa, AP; Garcia-Vazquez, FA; Coy, P; Matas, C				Romero-Aguirregomezcorta, Jon; Patricia Santa, Angela; Alberto Garcia-Vazquez, Francisco; Coy, Pilar; Matas, Carmen			Nitric Oxide Synthase (NOS) Inhibition during Porcine In Vitro Maturation Modifies Oocyte Protein S-Nitrosylation and In Vitro Fertilization	PLOS ONE			English	Article							MEIOTIC MATURATION; SIGNALING PATHWAYS; EMBRYO DEVELOPMENT; REACTIVE OXYGEN; MOUSE OOCYTES; EXPRESSION; COMPLEXES; CELLS; RESUMPTION; SPERM	Nitric oxide (NO) is a molecule involved in many reproductive processes. Its importance during oocyte in vitro maturation (IVM) has been demonstrated in various species although sometimes with contradictory results. The objective of this study was to determine the effect of NO during IVM of cumulus oocyte complexes and its subsequent impact on gamete interaction in porcine species. For this purpose, IVM media were supplemented with three NOS inhibitors: NG-nitro-L-arginine methyl ester (L-NAME), NG-monomethyl-L-arginine (L-NMMA) and aminoguanidine (AG). A NO donor, S-nitrosoglutathione (GSNO), was also used. The effects on the cumulus cell expansion, meiotic resumption, zona pellucida digestion time (ZPdt) and, finally, on in vitro fertilization (IVF) parameters were evaluated. The oocyte S-nitrosoproteins were also studied by in situ nitrosylation. The results showed that after 42 h of IVM, AG, L-NAME and L-NMMA had an inhibitory effect on cumulus cell expansion. Meiotic resumption was suppressed only when AG was added, with 78.7% of the oocytes arrested at the germinal vesicle state (P<0.05). Supplementation of the IVM medium with NOS inhibitors or NO donor did not enhance the efficiency of IVF, but revealed the importance of NO in maturation and subsequent fertilization. Furthermore, protein S-nitrosylation is reported for the first time as a pathway through which NO exerts its effect on porcine IVM; therefore, it would be important to determine which proteins are nitrosylated in the oocyte and their functions, in order to throw light on the mechanism of action of NO in oocyte maturation and subsequent fertilization.	[Romero-Aguirregomezcorta, Jon; Patricia Santa, Angela; Alberto Garcia-Vazquez, Francisco; Coy, Pilar; Matas, Carmen] Univ Murcia, Fac Vet, Dept Physiol, Int Excellence Campus Higher Educ & Res, Murcia, Spain; [Romero-Aguirregomezcorta, Jon; Alberto Garcia-Vazquez, Francisco; Coy, Pilar; Matas, Carmen] Inst Biomed Res Murcia IMIB, Murcia, Spain	University of Murcia	Matas, C (corresponding author), Univ Murcia, Fac Vet, Dept Physiol, Int Excellence Campus Higher Educ & Res, Murcia, Spain.	cmatas@um.es	Romero-Aguirregomezcorta, Jon/H-9277-2015; VAZQUEZ, FRANCISCO A GARCIA/H-1524-2015; Coy, Pilar/G-6811-2015	Romero-Aguirregomezcorta, Jon/0000-0001-7779-6869; VAZQUEZ, FRANCISCO A GARCIA/0000-0001-7665-3858; Coy, Pilar/0000-0002-3943-1890; Matas, Carmen/0000-0002-8252-120X	Spanish Ministry of Economy and Competitiveness; European Regional Development Fund [AGL2012-40180-C03-01];  [BES-2010-029858]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund(European Commission); 	Funding: This study was supported by the Spanish Ministry of Economy and Competitiveness and the European Regional Development Fund, Grant AGL2012-40180-C03-01. JR-A received scholarship Formacion Personal Investigador (FPI), BES-2010-029858. JR-A, FAG-V, PC, and CM are members of the European Cooperation in Science and Technology (COST) Action FA1201 (EPICONCEPT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amale MH, 2011, CZECH J ANIM SCI, V56, P284, DOI 10.17221/1284-CJAS; Barroso RP, 1998, MOL HUM REPROD, V4, P503, DOI 10.1093/molehr/4.5.503; Bilodeaul-Goeseels S, 2007, THERIOGENOLOGY, V68, P693, DOI 10.1016/j.theriogenology.2007.05.063; Bu SM, 2003, MOL CELL ENDOCRINOL, V207, P21, DOI 10.1016/S0303-7207(03)00213-2; CAMPBELL G, 1985, J AM STAT ASSOC, V80, P998, DOI 10.2307/2288566; Chmelikova E, 2009, CZECH J ANIM SCI, V54, P137, DOI 10.17221/1742-CJAS; Chmelikova E, 2010, ZYGOTE, V18, P235, DOI 10.1017/S0967199409990268; Coy P, 2008, BIOL REPROD, V667; Coy P, 2008, P NATL ACAD SCI USA, V105, P15809, DOI 10.1073/pnas.0804422105; Coy P, 2010, BIOL REV, V85, P593, DOI 10.1111/j.1469-185X.2009.00117.x; Forrester MT, 2009, FREE RADICAL BIO MED, V46, P119, DOI 10.1016/j.freeradbiomed.2008.09.034; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Friebe A, 2003, CIRC RES, V93, P96, DOI 10.1161/01.RES.0000082524.34487.31; Goud PT, 2008, FREE RADICAL BIO MED, V45, P453, DOI 10.1016/j.freeradbiomed.2008.04.035; Goud PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098720; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; GROSS SS, 1991, BIOCHEM BIOPH RES CO, V178, P823, DOI 10.1016/0006-291X(91)90965-A; Grupen CG, 2014, THERIOGENOLOGY, V81, P24, DOI 10.1016/j.theriogenology.2013.09.022; Hartig SM, 2013, CURR PROTOC MOL BIOL, V14; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jablonka-Shariff A, 1999, J SOC GYNECOL INVEST, V6, P95, DOI 10.1177/107155769900600208; Jablonka-Shariff A, 1998, ENDOCRINOLOGY, V139, P2944, DOI 10.1210/en.139.6.2944; Jablonka-Shariff A, 2000, MOL REPROD DEV, V55, P412, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;412::AID-MRD9&gt;3.0.CO;2-W; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Ji YB, 1999, ARCH BIOCHEM BIOPHYS, V362, P67, DOI 10.1006/abbi.1998.1013; Kimura N, 2002, BIOL REPROD, V66, P707, DOI 10.1095/biolreprod66.3.707; Kuo RK, 2000, NATURE, V406, P633, DOI 10.1038/35020577; KWON NS, 1990, J BIOL CHEM, V265, P13442; LAMAS S, 1992, P NATL ACAD SCI USA, V89, P6348, DOI 10.1073/pnas.89.14.6348; LAMBERT LE, 1992, EUR J PHARMACOL, V216, P131, DOI 10.1016/0014-2999(92)90221-O; Lee TH, 2013, J ASSIST REPROD GEN, V30, P1063, DOI 10.1007/s10815-013-0045-7; Lefievre L, 2007, PROTEOMICS, V7, P3066, DOI 10.1002/pmic.200700254; Abbasi M, 2009, DARU, V17, P48; Matta SGC, 2009, ANIM REPROD SCI, V111, P189, DOI 10.1016/j.anireprosci.2008.03.002; MCCALL TB, 1991, BRIT J PHARMACOL, V102, P234, DOI 10.1111/j.1476-5381.1991.tb12159.x; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; MONCADA S, 1991, PHARMACOL REV, V43, P109; MORRIS SM, 1994, AM J PHYSIOL, V266, pE829, DOI 10.1152/ajpendo.1994.266.6.E829; Oliveira-Paula GH, 2014, CURR DRUG TARGETS, V15, P164, DOI 10.2174/13894501113146660227; Oropeza A, 2004, BIOL REPROD, V70, P1634, DOI 10.1095/biolreprod.103.025494; Pandey AN, 2010, J CELL BIOCHEM, V111, P521, DOI 10.1002/jcb.22736; PETTERS RM, 1993, J REPROD FERTIL, P61; PURSEL VG, 1975, J ANIM SCI, V40, P99, DOI 10.2527/jas1975.40199x; Rath D, 1999, J ANIM SCI, V77, P3346; Schwarz KRL, 2008, REPROD FERT DEVELOP, V20, P529, DOI 10.1071/RD07209; Stricker SA, 2012, REPRODUCTION, V143, P261, DOI 10.1530/REP-11-0358; Takesue K, 2003, J REPROD DEVELOP, V49, P135, DOI 10.1262/jrd.49.135; Takesue K, 2001, J MOL ENDOCRINOL, V26, P259, DOI 10.1677/jme.0.0260259; Tang DW, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111302; Tao Y, 2005, ZYGOTE, V13, P1, DOI 10.1017/S0967199404002953; Tao Y, 2004, MOL CELL ENDOCRINOL, V222, P93, DOI 10.1016/j.mce.2004.04.014; Tatemoto H, 2004, BIOL REPROD, V71, P1150, DOI 10.1095/biolreprod.104.029264; Tichovska H, 2011, ANIMAL, V5, P1398, DOI 10.1017/S1751731111000565; VANVOORHIS BJ, 1994, ENDOCRINOLOGY, V135, P1799, DOI 10.1210/en.135.5.1799; Yamashita Y, 2011, BIOL REPROD, V85, P1073, DOI 10.1095/biolreprod.110.090092; Yamauchi J, 1997, ENDOCRINOLOGY, V138, P3630, DOI 10.1210/en.138.9.3630; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016	57	11	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115044	10.1371/journal.pone.0115044	http://dx.doi.org/10.1371/journal.pone.0115044			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542028	Green Submitted, Green Published, gold			2022-12-26	WOS:000347239900021
J	Wegener, E; Brendel, C; Fischer, A; Hulsmann, S; Gartner, J; Huppke, P				Wegener, Eike; Brendel, Cornelia; Fischer, Andre; Huelsmann, Swen; Gaertner, Jutta; Huppke, Peter			Characterization of the MeCP2(R168X) Knockin Mouse Model for Rett Syndrome	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; MUTANT MICE; RESPIRATORY PHENOTYPES; SUBSTANCE-P; MECP2; MUTATIONS; ABNORMALITIES; DEFICIENCY; EXPRESSION; REVERSAL	Rett syndrome, one of the most common causes of mental retardation in females, is caused by mutations in the X chromosomal gene MECP2. Mice deficient for MeCP2 recapitulate some of the symptoms seen in patients with Rett syndrome. It has been shown that reactivation of silent MECP2 alleles can reverse some of the symptoms in these mice. We have generated a knockin mouse model for translational research that carries the most common nonsense mutation in Rett syndrome, R168X. In this article we describe the phenotype of this mouse model. In male MeCP2(R168X) mice life span was reduced to 12-14 weeks and bodyweight was significantly lower than in wild type littermates. First symptoms including tremor, hind limb clasping and inactivity occurred at age 27 days. At age 6 weeks nest building, rotarod, open-field and elevated plus maze experiments showed impaired motor performance, reduced activity and decreased anxiety-like behavior. Plethysmography at the same time showed apneas and irregular breathing with reduced frequency. Female MeCP2R168X mice showed no significant abnormalities except decreased performance on the rotarod at age 9 months. In conclusion we show that the male MeCP2R168X mice have a phenotype similar to that seen in MECP2 knockout mouse models and are therefore well suited for translational research. The female mice, however, have a much milder and less constant phenotype making such research with this mouse model more challenging.	[Wegener, Eike; Brendel, Cornelia; Gaertner, Jutta; Huppke, Peter] Univ Med Ctr Gottingen, Dept Child & Adolescent Hlth, Div Neuropediat, Gottingen, Germany; [Fischer, Andre] German Ctr Neurodegenerat Dis, Gottingen, Germany; [Fischer, Andre] Univ Med Ctr Gottingen, Dept Psychiat & Psychotherapy, Gottingen, Germany; [Huelsmann, Swen] Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, Gottingen, Germany	University of Gottingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Gottingen	Huppke, P (corresponding author), Univ Med Ctr Gottingen, Dept Child & Adolescent Hlth, Div Neuropediat, Gottingen, Germany.	phuppke@med.uni-goettingen.de	Hülsmann, Swen/F-7169-2010; Fischer, Andre/AAU-7487-2021	Hülsmann, Swen/0000-0001-5042-8724; Wegener, Jan Eike/0000-0003-3712-8748; Fischer, Andre/0000-0001-8546-1161	German Research Foundation [HU 941/2-1]; German-Israel Foundation (GIF) [1048/2009]; Open Access Publication Funds of the Gottingen University	German Research Foundation(German Research Foundation (DFG)); German-Israel Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); Open Access Publication Funds of the Gottingen University	Funding: The authors acknowledge support by the German Research Foundation grant HU 941/2-1 to P.H., the German-Israel Foundation (GIF) grant 1048/2009 to P.H. and the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala AP, 2013, AM J RESP CELL MOL B; Alvarez-Saavedra M, HUM MOL GENET, V19, P2177; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Barthe JY, 1997, EXP BRAIN RES, V115, P485, DOI 10.1007/PL00005718; Bissonnete JM, 2006, PEDIATR RES, V59, P513, DOI 10.1203/01.pdr.0000203157.31924.4a; Bissonnette JM, 2014, NEUROSCIENCE, V267, P166, DOI 10.1016/j.neuroscience.2014.02.043; Brendel C, 2011, J MOL MED, V89, P389, DOI 10.1007/s00109-010-0704-4; Brendel C, 2009, PEDIATR RES, V65, P520, DOI 10.1203/PDR.0b013e31819d9ebc; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; De Filippis B, GENES BRAIN BEHAV, V9, P213; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; DRORBAUGH JE, 1955, PEDIATRICS, V16, P81; Goffin D, 2012, NAT NEUROSCI, V15, P274, DOI 10.1038/nn.2997; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; HAGBERG B, 1995, ACTA PAEDIATR, V84, P971, DOI 10.1111/j.1651-2227.1995.tb13809.x; Katz DM, 2012, DIS MODEL MECH, V5, P733, DOI 10.1242/dmm.011007; Kerr AM, 1999, ARCH DIS CHILD, V80, P384, DOI 10.1136/adc.80.4.384; Lawson-Yuen A, 2007, BRAIN RES, V1180, P1, DOI 10.1016/j.brainres.2007.08.039; Levitt ES, 2013, J APPL PHYSIOL, V115, P1626, DOI 10.1152/japplphysiol.00889.2013; Lonetti G, BIOL PSYCHIAT, V67, P657; LUGARESI E, 1985, BRAIN DEV-JPN, V7, P329, DOI 10.1016/S0387-7604(85)80039-5; McGraw CM, 2011, SCIENCE, V333, P186, DOI 10.1126/science.1206593; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Mount RH, 2002, J CHILD PSYCHOL PSYC, V43, P1099, DOI 10.1111/1469-7610.00236; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; Ramirez JM, 2013, RESP PHYSIOL NEUROBI, V189, P280, DOI 10.1016/j.resp.2013.06.022; Rett A, 1966, Wien Med Wochenschr, V116, P723; Ricceri L, 2013, NEUROPHARMACOLOGY, V68, P106, DOI 10.1016/j.neuropharm.2012.08.010; Robinson L, 2012, BRAIN, V135, P2699, DOI 10.1093/brain/aws096; Samaco RC, 2008, HUM MOL GENET, V17, P1718, DOI 10.1093/hmg/ddn062; Schaevitz LR, 2013, GENES BRAIN BEHAV, V12, P732, DOI 10.1111/gbb.12070; Shahbazian MD, 2002, AM J HUM GENET, V71, P1259, DOI 10.1086/345360; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Stearns NA, 2007, NEUROSCIENCE, V146, P907, DOI 10.1016/j.neuroscience.2007.02.009; Stettner GM, 2007, J PHYSIOL-LONDON, V579, P863, DOI 10.1113/jphysiol.2006.119966; Telgkamp P, 2002, J NEUROPHYSIOL, V88, P206, DOI 10.1152/jn.2002.88.1.206; VandeWeerd HA, 1997, LAB ANIM, V31, P133, DOI 10.1258/002367797780600152; Voituron N, 2009, RESP PHYSIOL NEUROBI, V168, P109, DOI 10.1016/j.resp.2009.05.013	41	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115444	10.1371/journal.pone.0115444	http://dx.doi.org/10.1371/journal.pone.0115444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541993	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900045
J	Zhang, N; Wang, L; Chai, ZT; Zhu, ZM; Zhu, XD; Ma, DN; Zhang, QB; Zhao, YM; Wang, M; Ao, JY; Ren, ZG; Gao, DM; Sun, HC; Tang, ZY				Zhang, Ning; Wang, Lu; Chai, Zong-Tao; Zhu, Zi-Man; Zhu, Xiao-Dong; Ma, De-Ning; Zhang, Qiang-Bo; Zhao, Yi-Ming; Wang, Miao; Ao, Jian-Yang; Ren, Zheng-Gang; Gao, Dong-Mei; Sun, Hui-Chuan; Tang, Zhao-You			Incomplete Radiofrequency Ablation Enhances Invasiveness and Metastasis of Residual Cancer of Hepatocellular Carcinoma Cell HCCLM3 via Activating beta-Catenin Signaling	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NUDE-MICE; NONSURGICAL TREATMENT; RAPID PROGRESSION; THERMAL ABLATION; TUMOR-GROWTH; IN-VIVO; MODEL; THERAPY; MANAGEMENT	Background: Radiofrequency ablation (RFA) is one of the curative therapies for hepatocellular carcinoma (HCC), however, accelerated progression of residual HCC after incomplete RFA has been reported more frequently. The underlying molecular mechanism of this phenomenon remains to be elucidated. In this study, we used an incomplete RFA orthotopic HCC nude mouse model to study the invasive and metastatic potential of residual cancer as well as the correlated mechanism. Methods: The incomplete RFA orthotopic nude mouse models were established using high metastatic potential HCC cell line HCCLM3 and low metastatic potential HCC cell line HepG2, respectively. The changes in cellular morphology, motility, metastasis and epithelial-mesenchymal transition (EMT), and HCC cell molecular markers after in vitro and in vivo incomplete RFA intervention were observed. Results: Pulmonary and intraperitoneal metastasis were observed in an in vivo study. The underlying pro-invasive mechanism of incomplete RFA appeared to be associated with promoting EMT, including down-regulation of E-cadherin and up-regulation of N-cadherin and vimentin. These results were in accordance with the in vitro response of HCC cells to heat intervention. Further studies demonstrated that beta-catenin was a pivotal factor during this course and blocking beta-catenin reduced metastasis and EMT phenotype changes in heat-treated HCCLM3 cells in vitro. Conclusion: Incomplete RFA enhanced the invasive and metastatic potential of residual cancer, accompanying with EMT-like phenotype changes by activating beta-catenin signaling in HCCLM3 cells.	[Zhang, Ning; Wang, Lu; Chai, Zong-Tao; Zhu, Xiao-Dong; Ma, De-Ning; Zhao, Yi-Ming; Wang, Miao; Ao, Jian-Yang; Ren, Zheng-Gang; Gao, Dong-Mei; Sun, Hui-Chuan; Tang, Zhao-You] Fudan Univ, Liver Canc Inst, Shanghai 200032, Peoples R China; [Zhang, Ning; Wang, Lu; Chai, Zong-Tao; Zhu, Xiao-Dong; Ma, De-Ning; Zhao, Yi-Ming; Wang, Miao; Ao, Jian-Yang; Ren, Zheng-Gang; Gao, Dong-Mei; Sun, Hui-Chuan; Tang, Zhao-You] Fudan Univ, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas, Chinese Minist Educ, Shanghai 200032, Peoples R China; [Zhu, Zi-Man] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Hepatobiliary Surg, Beijing, Peoples R China; [Zhang, Qiang-Bo] Shandong Univ, Qilu Hosp, Dept Gen Surg, Jinan 250100, Peoples R China	Fudan University; Fudan University; Chinese People's Liberation Army General Hospital; Shandong University	Tang, ZY (corresponding author), Fudan Univ, Liver Canc Inst, Shanghai 200032, Peoples R China.	zytang88@163.com	Zhu, Xiao-Dong/A-8197-2010	Zhu, Xiao-Dong/0000-0001-9864-6763; Sun, Hui-Chuan/0000-0003-3761-7058	National Natural Science Foundation of China [81372314]; Shanghai Natural Science Fund for Youth Scholars [12ZR1442300]; National Key Project for Infectious Diseases [2012ZX10002012-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Fund for Youth Scholars; National Key Project for Infectious Diseases	This work was supported by National Natural Science Foundation of China (grant number: 81372314); Shanghai Natural Science Fund for Youth Scholars (12ZR1442300); the National Key Project for Infectious Diseases (2012ZX10002012-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arii S, 2000, HEPATOLOGY, V32, P1224, DOI 10.1053/jhep.2000.20456; Bu W, 1998, HEPATO-GASTROENTEROL, V45, P1056; Curley SA, 2000, ANN SURG, V232, P381, DOI 10.1097/00000658-200009000-00010; Dahmani R, 2011, CLIN RES HEPATOL GAS, V35, P709, DOI 10.1016/j.clinre.2011.05.010; Devereux TR, 1999, ONCOGENE, V18, P4726, DOI 10.1038/sj.onc.1202858; Firrincieli D, 2010, GASTROEN CLIN BIOL, V34, P523, DOI 10.1016/j.gcb.2010.04.017; Hu TH, 2014, CANC LETT, V20; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kasugai H, 2007, ONCOLOGY-BASEL, V72, P72, DOI 10.1159/000111710; Ke S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-73; Komorizono Y, 2003, CANCER-AM CANCER SOC, V97, P1253, DOI 10.1002/cncr.11168; Kong J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-230; Kong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037266; Kroeze SGC, 2012, BJU INT, V110, pE281, DOI 10.1111/j.1464-410X.2012.11261.x; Lau WY, 2009, ANN SURG, V249, P20, DOI 10.1097/SLA.0b013e31818eec29; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; Liang XH, 2014, CANCER SCI, V105, P660, DOI 10.1111/cas.12404; Liu LA, 2010, CLIN CANCER RES, V16, P2740, DOI 10.1158/1078-0432.CCR-09-2610; Liu L, 2010, CANCER SCI, V101, P120, DOI 10.1111/j.1349-7006.2009.01363.x; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Miao LF, 2014, CANCER GENET-NY, V207, P75, DOI 10.1016/j.cancergen.2014.02.008; Miyoshi H, 2009, CANCER SCI, V100, P2046, DOI 10.1111/j.1349-7006.2009.01284.x; Nakagawa H, 2014, CANCER IMMUNOL IMMUN, V63, P347, DOI 10.1007/s00262-013-1514-7; Oh SJ, 2013, J PATHOL, V231, P210, DOI 10.1002/path.4224; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ruzzenente A, 2004, WORLD J GASTROENTERO, V10, P1137; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Shiina S, 2002, ONCOLOGY-BASEL, V62, P64, DOI 10.1159/000048278; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; Song TJ, 2004, GASTROENTEROLOGY, V127, pS248, DOI 10.1053/j.gastro.2004.09.039; Sun FX, 1996, INT J CANCER, V66, P239, DOI 10.1002/(SICI)1097-0215(19960410)66:2<239::AID-IJC17>3.3.CO;2-G; Tajima H, 2010, ONCOL LETT, V1, P91, DOI 10.3892/ol_00000016; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tian J, 1999, BRIT J CANCER, V81, P814, DOI 10.1038/sj.bjc.6690769; van Zijl F, 2009, FUTURE ONCOL, V5, P1169, DOI [10.2217/fon.09.91, 10.2217/FON.09.91]; Villanueva A, 2007, SEMIN LIVER DIS, V27, P55, DOI 10.1055/s-2006-960171; Wang L, 2000, HEPATOLOGY, V32, P43, DOI 10.1053/jhep.2000.8525; Wang YY, 2005, P NATL ACAD SCI USA, V102, P1104, DOI 10.1073/pnas.0408831102; Wong CCL, 2009, HEPATOLOGY, V49, P1583, DOI 10.1002/hep.22836; Xu M, 2013, ACTA RADIOL, V54, P199, DOI 10.1258/ar.2012.120249; Yang BW, 2008, EUR J GASTROEN HEPAT, V20, P1077, DOI 10.1097/MEG.0b013e3283050a67; Yang JD, 2010, INFECT DIS CLIN N AM, V24, P899, DOI 10.1016/j.idc.2010.07.004; Yang N, 2014, TUMOR BIOL, V35, P7965, DOI 10.1007/s13277-014-2045-3; Yoshida S, 2013, HEPATOLOGY, V58, P1667, DOI 10.1002/hep.26526; Zavaglia C, 2008, EUR J GASTROEN HEPAT, V20, P196, DOI 10.1097/MEG.0b013e3282f1cc4a; Zhang W, 2010, CLIN CANCER RES, V16, P3420, DOI 10.1158/1078-0432.CCR-09-2904; Zhao JH, 2011, CANCER INVEST, V29, P377, DOI 10.3109/07357907.2010.512595	50	37	43	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115949	10.1371/journal.pone.0115949	http://dx.doi.org/10.1371/journal.pone.0115949			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542041	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900114
J	Zmyslowska, A; Malkowski, B; Fendler, W; Borowiec, M; Antosik, K; Gnys, P; Baranska, D; Mlynarski, W				Zmyslowska, Agnieszka; Malkowski, Bogdan; Fendler, Wojciech; Borowiec, Maciej; Antosik, Karolina; Gnys, Piotr; Baranska, Dobromila; Mlynarski, Wojciech			Central Nervous System PET-CT Imaging Reveals Regional Impairments in Pediatric Patients with Wolfram Syndrome	PLOS ONE			English	Article							GENOTYPE-PHENOTYPE CORRELATION; HYPOGLYCEMIA UNAWARENESS; GLUCOSE-METABOLISM; DIDMOAD SYNDROME; DISEASE; MRI; MEN	Wolfram syndrome (WFS) is inherited as an autosomal recessive disease with main clinical features of diabetes mellitus, optic atrophy, diabetes insipidus and deafness. However, various neurological defects may also be detected. The aim of this study was to evaluate aspects of brain structure and function using PET-CT (positron emission tomography and computed tomography) and MRI (magnetic resonance imaging) in pediatric patients with WFS. Regional changes in brain glucose metabolism were measured using standardized uptake values (SUVs) based on images of (F-18) fluorodeoxyglucose (FDG) uptake in 7 WFS patients aged 10.1-16.0 years (mean 12.9 +/- 2.4) and in 20 healthy children aged 3-17.9 years (mean 12.8 +/- 4.1). In all patients the diagnosis of WFS was confirmed by DNA sequencing of the WFS1 gene. Hierarchical clustering showed remarkable similarities of glucose uptake patterns among WFS patients and their differences from the control group. SUV data were subsequently standardized for age groups, <13 years old and >13 years old to account for developmental differences. Reduced SUVs in WFS patients as compared to the control group for the bilateral brain regions such as occipital lobe (-1.24 +/- 1.20 vs. -0.13 +/- 1.05; p=0.028) and cerebellum (-1.11 +/- 0.69 vs. -0.204 +/- 1.00; p=0.036) were observed and the same tendency for cingulate (-1.13 +/- 1.05 vs. -0.15 +/- 1.12; p=0.056), temporal lobe (-1.10 +/- 0.98 vs. -0.15 +/- 1.10; p=0.057), parietal lobe (-1.06 +/- 1.20 vs. -0.08 +/- 1.08; p=0.058), central region (-1.01 +/- 1.04 vs. -0.09 +/- 1.06; p=0.060), basal ganglia (-1.05 +/- 0.74 vs. -0.20 +/- 1.07; p=0.066) and mesial temporal lobe (-1.06 +/- 0.82 vs. -0.26 +/- 1.08; p=0.087) was also noticed. After adjusting for multiple hypothesis testing, the differences in glucose uptake were non-significant. For the first time, regional differences in brain glucose metabolism among patients with WFS were shown using PET-CT imaging.	[Zmyslowska, Agnieszka; Fendler, Wojciech; Gnys, Piotr; Mlynarski, Wojciech] Med Univ Lodz, Dept Pediat Oncol Hematol & Diabetol, Lodz, Poland; [Malkowski, Bogdan] Ctr Oncol, Dept Nucl Med, Bydgoszcz, Poland; [Borowiec, Maciej; Antosik, Karolina] Med Univ Lodz, Dept Clin Genet, Lodz, Poland; [Baranska, Dobromila] Clin Hosp 4, Dept Radiol, Lodz, Poland	Medical University Lodz; Medical University Lodz	Mlynarski, W (corresponding author), Med Univ Lodz, Dept Pediat Oncol Hematol & Diabetol, Lodz, Poland.	wojciech.mlynarski@umed.lodz.pl	Fendler, Wojciech Maksymilian/S-9592-2016; Fendler, Wojciech/AAG-7020-2019; Borowiec, Maciej/S-9220-2016	Fendler, Wojciech Maksymilian/0000-0002-5083-9168; Fendler, Wojciech/0000-0002-5083-9168; Malkowski, Bogdan/0000-0003-1421-4694; Borowiec, Maciej/0000-0003-2812-5676; Antosik, Karolina/0000-0002-0471-5826; Zmyslowska, Agnieszka/0000-0001-8781-4469; Mlynarski, Wojciech/0000-0003-2714-5851	Polish Ministry of Science and Higher Education [N 407 100040]; EURO-WABB Project; National Science Center [2012/05/E/NZ5/02130]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); EURO-WABB Project; National Science Center(National Science Centre, Poland)	Funding: This study was supported by the Polish Ministry of Science and Higher Education (grant no. N 407 100040) and EURO-WABB Project. Wojciech Fendler received financial support from the National Science Center (grant no. 2012/05/E/NZ5/02130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett TG, 1997, J MED GENET, V34, P838, DOI 10.1136/jmg.34.10.838; BARRETT TG, 1995, LANCET, V346, P1458, DOI 10.1016/S0140-6736(95)92473-6; Bingham EM, 2005, DIABETOLOGIA, V48, P2080, DOI 10.1007/s00125-005-1900-6; Chaussenot A, 2011, ANN NEUROL, V69, P501, DOI 10.1002/ana.22160; Cranston I, 2001, DIABETES, V50, P2329, DOI 10.2337/diabetes.50.10.2329; D'Annunzio G, 2008, DIABETES CARE, V31, P1743, DOI 10.2337/dc08-0178; Dunn JT, 2007, DIABETES, V56, P2766, DOI 10.2337/db07-0666; Fonseca SG, 2010, J CLIN INVEST, V120, P744, DOI 10.1172/JCI39678; Galluzzi P, 1999, NEURORADIOLOGY, V41, P729, DOI 10.1007/s002340050832; Genis D, 1997, ACTA NEUROPATHOL, V93, P426, DOI 10.1007/s004010050635; Hadidy AM, 2004, SAUDI MED J, V25, P638; Hershey T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040604; Hilson JB, 2009, ACTA NEUROPATHOL, V118, P415, DOI 10.1007/s00401-009-0546-8; Imabayashi E, 2013, BRAIN BEHAV, V3, P487, DOI 10.1002/brb3.146; Ito S, 2007, AM J NEURORADIOL, V28, P305; KINSLEY BT, 1995, DIABETES CARE, V18, P1566, DOI 10.2337/diacare.18.12.1566; LEIVASANTANA C, 1993, REV NEUROL, V149, P26; London K, 2014, EUR J NUCL MED MOL I, V41, P723, DOI 10.1007/s00259-013-2639-9; Marshall BA, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-64; Mathis S, 2007, REV NEUROL-FRANCE, V163, P197, DOI 10.1016/S0035-3787(07)90391-4; Pakdemirli E, 2005, Australas Radiol, V49, P189, DOI 10.1111/j.1440-1673.2005.01420.x; RANDO TA, 1992, NEUROLOGY, V42, P1220, DOI 10.1212/WNL.42.6.1220; Shan ZYY, 2014, HUM BRAIN MAPP, V35, P2297, DOI 10.1002/hbm.22328; Shannon P, 1999, ACTA NEUROPATHOL, V98, P304, DOI 10.1007/s004010051084; Waschbisch A, 2011, J NEUROL SCI, V300, P191, DOI 10.1016/j.jns.2010.08.044; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081; Yamane T., 2013, AJNR AM J NEURORADIO; Yang MS, 2005, J FORMOS MED ASSOC, V104, P129; Zmyslowska A, 2014, EXP CLIN ENDOCR DIAB, V122, P35, DOI 10.1055/s-0033-1357160; Zmyslowska A, 2011, CLIN ENDOCRINOL, V75, P636, DOI 10.1111/j.1365-2265.2011.04102.x	30	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115605	10.1371/journal.pone.0115605	http://dx.doi.org/10.1371/journal.pone.0115605			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542043	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900057
J	Salminen, A; Astrom, P; Metso, J; Soliymani, R; Salo, T; Jauhiainen, M; Pussinen, PJ; Sorsa, T				Salminen, Aino; Astrom, Pirjo; Metso, Jari; Soliymani, Rabah; Salo, Tuula; Jauhiainen, Matti; Pussinen, Pirkko J.; Sorsa, Timo			Matrix metalloproteinase 8 degrades apolipoprotein A-I and reduces its cholesterol efflux capacity	FASEB JOURNAL			English	Article						atherosclerosis; cholesterol metabolism; high-density lipoprotein; proteolytic enzyme	HIGH-DENSITY-LIPOPROTEIN; GINGIVAL CREVICULAR FLUID; C-TERMINAL DOMAIN; DOSE DOXYCYCLINE; LIPID EFFLUX; SERUM; BINDING; SUSCEPTIBILITY; COLLAGENASE; INHIBITION	Various cell types in atherosclerotic lesions express matrix metalloproteinase (MMP)-8. We investigated whether MMP-8 affects the structure and antiatherogenic function of apolipoprotein (apo) A-I, the main protein component of HDL particles. Furthermore, we studied serum lipid profiles and cholesterol efflux capacity in MMP-8-deficient mouse model. Incubation of apoA-I (28 kDa) with activated MMP-8 yielded 22 kDa and 25 kDa apoA-I fragments. Mass spectrometric analyses revealed that apoA-I was cleaved at its carboxyl-terminal part. Treatment of apoA-I and HDL with MMP-8 resulted in significant reduction (up to 84%, P < 0.001) in their ability to facilitate cholesterol efflux from cholesterol-loaded THP-1 macrophages. The cleavage of apoA-I by MMP- 8 and the reduction in its cholesterol efflux capacity was inhibited by doxycycline. MMP-8-deficient mice had significantly lower serum triglyceride (TG) levels (P = 0.003) and larger HDL particles compared with wild-type (WT) mice. However, no differences were observed in the apoA-I levels or serum cholesterol efflux capacities between the mouse groups. Proteolytic modification of apoA-I by MMP- 8 may impair the first steps of reverse cholesterol transport, leading to increased accumulation of cholesterol in the vessel walls. Eventually, inhibition of MMPs by doxycycline may reduce the risk for atherosclerotic vascular diseases.	[Salminen, Aino; Pussinen, Pirkko J.; Sorsa, Timo] Univ Helsinki, Inst Dent, FIN-00014 Helsinki, Finland; [Salminen, Aino; Sorsa, Timo] Helsinki Univ Cent Hosp, Dept Oral & Maxillofacial Dis, Helsinki, Finland; [Astrom, Pirjo; Salo, Tuula] Univ Oulu, Oulu Univ Hosp, Inst Dent, Dept Diagnost & Oral Med, Oulu, Finland; [Astrom, Pirjo; Salo, Tuula] Univ Oulu, Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Metso, Jari; Jauhiainen, Matti] Biomedicum, Publ Hlth Genom Unit, Natl Inst Hlth & Welf, Helsinki, Finland; [Soliymani, Rabah] Univ Helsinki, Biomedicum Helsinki, Dept Biochem & Dev Biol, Meilahti Clin Prote Core Unit,Inst Biomed, FIN-00014 Helsinki, Finland; [Sorsa, Timo] Karolinska Inst, Dept Dent Med, Div Periodontol, Huddinge, Sweden	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Karolinska Institutet	Salminen, A (corresponding author), Univ Helsinki, POB 63, FIN-00014 Helsinki, Finland.	aino.m.salminen@helsinki.fi	, tuula/ABG-2051-2021	Pussinen, Pirkko/0000-0003-3563-1876; Astrom, Pirjo/0000-0001-7150-2508; Salminen, Aino/0000-0001-7576-090X; Salo, Tuula/0000-0001-6039-0088; Soliymani, Rabah/0000-0003-0184-3352	Academy of Finland [1266053]; Helsinki University Central Hospital Research Foundation; Finnish Dental Society Apollonia; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Helsinki University Central Hospital Research Foundation; Finnish Dental Society Apollonia; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	The authors thank Ms. Sanna Juntunen for technical assistance, and Prof. Carlos Lopez-Otin for providing the MMP8-/- mice. This work was supported by the Academy of Finland (1266053), the Helsinki University Central Hospital Research Foundation, the Finnish Dental Society Apollonia, and the Sigrid Juselius Foundation.	Axisa B, 2002, STROKE, V33, P2858, DOI 10.1161/01.STR.0000038098.04291.F6; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Bench TJ, 2011, PHARMACOL RES, V64, P561, DOI 10.1016/j.phrs.2011.05.002; Bendeck MP, 2002, AM J PATHOL, V160, P1089, DOI 10.1016/S0002-9440(10)64929-2; Burgess JW, 1999, BIOCHEMISTRY-US, V38, P14524, DOI 10.1021/bi990930z; BURSTEIN M, 1970, J LIPID RES, V11, P583; CHEN CH, 1982, J LIPID RES, V23, P680; Chroni A, 2003, J BIOL CHEM, V278, P6719, DOI 10.1074/jbc.M205232200; Favari E, 2002, BIOCHEM BIOPH RES CO, V299, P801, DOI 10.1016/S0006-291X(02)02745-6; FIELDING CJ, 1995, J LIPID RES, V36, P211; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Golub L M, 1998, Adv Dent Res, V12, P12; Golub LM, 2008, J PERIODONTOL, V79, P1409, DOI [10.1902/jop.2008.070623, 10.1902/jop.2008.070623 ]; Halade GV, 2013, PHARMACOL THERAPEUT, V139, P32, DOI 10.1016/j.pharmthera.2013.03.009; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Herman MP, 2001, CIRCULATION, V104, P1899, DOI 10.1161/hc4101.097419; Jauhiainen M, 2005, METHODS, V36, P97, DOI 10.1016/j.ymeth.2004.11.006; JI Y, 1995, J BIOL CHEM, V270, P11290, DOI 10.1074/jbc.270.19.11290; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Kleemola P, 2002, ATHEROSCLEROSIS, V160, P425, DOI 10.1016/S0021-9150(01)00594-9; KNAUPER V, 1991, FEBS LETT, V290, P99, DOI 10.1016/0014-5793(91)81235-Z; Kormi I, 2014, INFLAMM RES, V63, P329, DOI 10.1007/s00011-013-0704-2; KUNITAKE ST, 1990, ARTERIOSCLEROSIS, V10, P25, DOI 10.1161/01.ATV.10.1.25; Laxton RC, 2009, CIRC RES, V105, P921, DOI 10.1161/CIRCRESAHA.109.200279; Lindstedt L, 1999, J BIOL CHEM, V274, P22627, DOI 10.1074/jbc.274.32.22627; Madan M, 2007, ATHEROSCLEROSIS, V190, P62, DOI 10.1016/j.atherosclerosis.2006.02.026; MATZ CE, 1982, J BIOL CHEM, V257, P4535; Natarajan P, 2004, J BIOL CHEM, V279, P24044, DOI 10.1074/jbc.M400561200; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Palgunachari MN, 1996, ARTERIOSCL THROM VAS, V16, P328, DOI 10.1161/01.ATV.16.2.328; Panagotopulos SE, 2002, J BIOL CHEM, V277, P39477, DOI 10.1074/jbc.M207005200; Park JH, 2011, BIOCHEM BIOPH RES CO, V409, P58, DOI 10.1016/j.bbrc.2011.04.105; Prall AK, 2002, J VASC SURG, V35, P923, DOI 10.1067/mva.2002.123757; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Salminen A, 2013, INFLAMM RES, V62, P711, DOI 10.1007/s00011-013-0626-z; SAMMALKORPI K, 1988, METABOLISM, V37, P859, DOI 10.1016/0026-0495(88)90120-5; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Siggins S, 2003, J LIPID RES, V44, P1698, DOI 10.1194/jlr.M300059-JLR200; SUOMALAINEN K, 1992, DRUG EXP CLIN RES, V18, P99; Tuter G, 2007, J CLIN PERIODONTOL, V34, P673, DOI 10.1111/j.1600-051X.2007.01104.x; Tuomainen AM, 2007, ARTERIOSCL THROM VAS, V27, P2722, DOI 10.1161/ATVBAHA.107.154831; Tuomainen AM, 2014, EUR J PREV CARDIOL, V21, P806, DOI 10.1177/2047487312465524; Turu MM, 2006, ATHEROSCLEROSIS, V187, P161, DOI 10.1016/j.atherosclerosis.2005.08.039; Turunen SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034910; Van den Steen PE, 2003, BIOCHEM BIOPH RES CO, V310, P889, DOI 10.1016/j.bbrc.2003.09.098; Van Lint P, 2006, CYTOKINE GROWTH F R, V17, P217, DOI 10.1016/j.cytogfr.2006.04.001	46	14	14	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1435	1445		10.1096/fj.14-262956	http://dx.doi.org/10.1096/fj.14-262956			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25550459				2022-12-26	WOS:000354115000029
J	Narusaka, M; Minami, T; Iwabuchi, C; Hamasaki, T; Takasaki, S; Kawamura, K; Narusaka, Y				Narusaka, Mari; Minami, Taichi; Iwabuchi, Chikako; Hamasaki, Takashi; Takasaki, Satoko; Kawamura, Kimito; Narusaka, Yoshihiro			Yeast Cell Wall Extract Induces Disease Resistance against Bacterial and Fungal Pathogens in Arabidopsis thaliana and Brassica Crop	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; MICROBE INTERACTIONS; DEFENSE RESPONSES; GENE-EXPRESSION; SALICYLIC-ACID; PLANT; GROWTH; SUPPRESSORS; ACTIVATION; PATHWAYS	Housaku Monogatari (HM) is a plant activator prepared from a yeast cell wall extract. We examined the efficacy of HM application and observed that HM treatment increased the resistance of Arabidopsis thaliana and Brassica rapa leaves to bacterial and fungal infections. HM reduced the severity of bacterial leaf spot and anthracnose on A. thaliana and Brassica crop leaves with protective effects. In addition, gene expression analysis of A. thaliana plants after treatment with HM indicated increased expression of several plant defense-related genes. HM treatment appears to induce early activation of jasmonate/ethylene and late activation of salicylic acid (SA) pathways. Analysis using signaling mutants revealed that HM required SA accumulation and SA signaling to facilitate resistance to the bacterial pathogen Pseudomonas syringae pv. maculicola and the fungal pathogen Colletotrichum higginsianum. In addition, HM-induced resistance conferred chitin-independent disease resistance to bacterial pathogens in A. thaliana. These results suggest that HM contains multiple microbe-associated molecular patterns that activate defense responses in plants. These findings suggest that the application of HM is a useful tool that may facilitate new disease control methods.	[Narusaka, Mari; Narusaka, Yoshihiro] Res Inst Biol Sci Okayama, Okayama, Japan; [Minami, Taichi; Iwabuchi, Chikako; Hamasaki, Takashi; Takasaki, Satoko; Kawamura, Kimito] Asahi Grp Holdings Ltd, Res & Dev Labs Sustainable Value Creat, Ibaraki, Japan	Asahi Group Holdings Ltd.	Narusaka, Y (corresponding author), Res Inst Biol Sci Okayama, Okayama, Japan.	yo_narusaka@bio-ribs.com			Industrial Technology Research Grant Program from New Energy and Industrial Technology Development Organization (NEDO) of Japan; Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [24580071, 25450523]	Industrial Technology Research Grant Program from New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Japan Society for the Promotion of Science (JSPS) KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Industrial Technology Research Grant Program in 2004 and 2009 from the New Energy and Industrial Technology Development Organization (NEDO) of Japan to YN, and by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 24580071 to YN and 25450523 to MN. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. TM, CI, TH, ST and KK are employed by Asahi Group Holdings, Ltd. Asahi Group Holdings, Ltd. provided support in the form of salaries for authors TM, CI, TH, ST and KK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aguilar-Uscanga B, 2003, LETT APPL MICROBIOL, V37, P268, DOI 10.1046/j.1472-765X.2003.01394.x; BASSE CW, 1993, J BIOL CHEM, V268, P14724; Bull CT, 2010, SYST APPL MICROBIOL, V33, P105, DOI 10.1016/j.syapm.2010.02.001; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; de Torres M, 2003, PLANT J, V33, P665, DOI 10.1046/j.1365-313X.2003.01653.x; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Dewdney J, 2000, PLANT J, V24, P205, DOI 10.1046/j.1365-313x.2000.00870.x; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; He P, 2007, CELL MICROBIOL, V9, P1385, DOI 10.1111/j.1462-5822.2007.00944.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Lawton KA, 1996, PLANT J, V10, P71, DOI 10.1046/j.1365-313X.1996.10010071.x; Minami T, 2011, PLANT BIOTECHNOL-NAR, V28, P481, DOI 10.5511/plantbiotechnology.11.1020a; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Narusaka M, 2011, J GEN PLANT PATHOL, V77, P75, DOI 10.1007/s10327-011-0298-x; Narusaka M, 2010, J GEN PLANT PATHOL, V76, P1, DOI 10.1007/s10327-009-0211-z; Narusaka M, 2009, PLANT J, V60, P218, DOI 10.1111/j.1365-313X.2009.03949.x; Narusaka Y, 2009, PLANT BIOTECHNOL, V26, P345, DOI 10.5511/plantbiotechnology.26.345; Obara N., 2007, Japanese Journal of Phytopathology, V73, P94, DOI 10.3186/jjphytopath.73.94; Penninckx IAMA, 1996, PLANT CELL, V8, P2309, DOI 10.1105/tpc.8.12.2309; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Sano H, 1996, PLANT CELL PHYSIOL, V37, P762, DOI 10.1093/oxfordjournals.pcp.a029011; Shibuya N, 2001, PHYSIOL MOL PLANT P, V59, P223, DOI 10.1006/pmpp.2001.0364; Silipo A, 2010, GLYCOBIOLOGY, V20, P406, DOI 10.1093/glycob/cwp201; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Yasuda M, 2008, PLANT CELL, V20, P1678, DOI 10.1105/tpc.107.054296; Zimmerli L, 2000, P NATL ACAD SCI USA, V97, P12920, DOI 10.1073/pnas.230416897; Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	36	29	30	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2015	10	1							e0115864	10.1371/journal.pone.0115864	http://dx.doi.org/10.1371/journal.pone.0115864			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BS	25565273	Green Published, Green Submitted, gold			2022-12-26	WOS:000348167900002
J	Laffont, C; Rey, T; Andre, O; Novero, M; Kazmierczak, T; Debelle, F; Bonfante, P; Jacquet, C; Frugier, F				Laffont, Carole; Rey, Thomas; Andre, Olivier; Novero, Mara; Kazmierczak, Theophile; Debelle, Frederic; Bonfante, Paola; Jacquet, Christophe; Frugier, Florian			The CRE1 Cytokinin Pathway Is Differentially Recruited Depending on Medicago truncatula Root Environments and Negatively Regulates Resistance to a Pathogen	PLOS ONE			English	Article							NOD FACTOR PERCEPTION; ABSCISIC-ACID; SALT STRESS; ARBUSCULAR MYCORRHIZA; HORMONE INTERACTIONS; SIGNALING PATHWAY; PLANT IMMUNITY; FOUNDER CELLS; ARABIDOPSIS; GENE	Cytokinins are phytohormones that regulate many developmental and environmental responses. The Medicago truncatula cytokinin receptor MtCRE1 (Cytokinin Response 1) is required for the nitrogen-fixing symbiosis with rhizobia. As several cytokinin signaling genes are modulated in roots depending on different biotic and abiotic conditions, we assessed potential involvement of this pathway in various root environmental responses. Phenotyping of cre1 mutant roots infected by the Gigaspora margarita arbuscular mycorrhizal (AM) symbiotic fungus, the Aphanomyces euteiches root oomycete, or subjected to an abiotic stress (salt), were carried out. Detailed histological analysis and quantification of cre1 mycorrhized roots did not reveal any detrimental phenotype, suggesting that MtCRE1 does not belong to the ancestral common symbiotic pathway shared by rhizobial and AM symbioses. cre1 mutants formed an increased number of emerged lateral roots compared to wild-type plants, a phenotype which was also observed under non-stressed conditions. In response to A. euteiches, cre1 mutants showed reduced disease symptoms and an increased plant survival rate, correlated to an enhanced formation of lateral roots, a feature previously linked to Aphanomyces resistance. Overall, we showed that the cytokinin CRE1 pathway is not only required for symbiotic nodule organogenesis but also affects both root development and resistance to abiotic and biotic environmental stresses.	[Laffont, Carole; Kazmierczak, Theophile; Frugier, Florian] CNRS, ISV, F-91198 Gif Sur Yvette, France; [Rey, Thomas; Andre, Olivier; Jacquet, Christophe] Univ Toulouse, UPS, Lab Rech Sci Vegetales, F-31326 Castanet Tolosan, France; [Rey, Thomas; Andre, Olivier; Jacquet, Christophe] CNRS, Lab Rech Sci Vegetales, F-31326 Castanet Tolosan, France; [Novero, Mara; Bonfante, Paola] Univ Turin, Dipartimento Sci Vita & Biol Sistemi, I-10125 Turin, Italy; [Debelle, Frederic] INRA, LIPM, UMR441, F-31326 Castanet Tolosan, France; [Debelle, Frederic] CNRS, LIPM, UMR2594, F-31326 Castanet Tolosan, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Turin; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse	Frugier, F (corresponding author), CNRS, ISV, Ave Terrasse, F-91198 Gif Sur Yvette, France.	frugier@isv.cnrs-gif.fr	jacquet, Christophe/B-2563-2009; Rey, Thomas/AAF-4454-2019; Rey, Thomas/K-8969-2019; Bonfante, Paola/ABE-6733-2020	jacquet, Christophe/0000-0002-7377-5638; Rey, Thomas/0000-0002-9454-074X; Bonfante, Paola/0000-0003-3576-8530	LEGUROOT French ANR project; CNRS; Ministere de l'Enseignement Supeieur et de la Recherche; Universite Paul Sabatier; "Immunit-Ae" French ANR project [ANR-10-GENM-0007]; Italian project PROROOT	LEGUROOT French ANR project(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Enseignement Supeieur et de la Recherche; Universite Paul Sabatier; "Immunit-Ae" French ANR project(French National Research Agency (ANR)); Italian project PROROOT	Work in F.F.'s laboratory was supported by the LEGUROOT French ANR project, CNRS, and the "Ministere de l'Enseignement Supeieur et de la Recherche" (PhD grant to T.K.). Work in C.J.'s laboratory (LRSV) was funded by the "Universite Paul Sabatier", CNRS, and the "Immunit-Ae" French ANR project (ANR-10-GENM-0007; PhD grant to O.A.). Work in P.B.'s laboratory was funded by the Italian project PROROOT (Call Prin 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argueso CT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002448; Argueso CT, 2009, PLANT CELL ENVIRON, V32, P1147, DOI 10.1111/j.1365-3040.2009.01940.x; Ariel F, 2010, PLANT CELL, V22, P2171, DOI 10.1105/tpc.110.074823; Badreddine I, 2008, EUKARYOT CELL, V7, P1980, DOI 10.1128/EC.00091-08; BECARD G, 1988, NEW PHYTOL, V108, P211, DOI 10.1111/j.1469-8137.1988.tb03698.x; Benkova E, 2009, PLANT MOL BIOL, V69, P383, DOI 10.1007/s11103-008-9393-6; BERTA G, 1990, NEW PHYTOL, V114, P207, DOI 10.1111/j.1469-8137.1990.tb00392.x; Bonfante P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1046; Bonhomme M, 2014, NEW PHYTOL, V201, P1328, DOI 10.1111/nph.12611; Choi J, 2011, TRENDS PLANT SCI, V16, P388, DOI 10.1016/j.tplants.2011.03.003; Choi J, 2010, DEV CELL, V19, P284, DOI 10.1016/j.devcel.2010.07.011; COSTACURTA A, 1995, CRIT REV MICROBIOL, V21, P1, DOI 10.3109/10408419509113531; de Lorenzo L, 2007, PLANT PHYSIOL, V145, P1521, DOI 10.1104/pp.107.106146; de Zelicourt A, 2012, PLANT J, V70, P220, DOI 10.1111/j.1365-313X.2011.04859.x; Del Bianco M, 2013, NEW PHYTOL, V199, P324, DOI 10.1111/nph.12338; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; den Camp RHMO, 2011, PLANT PHYSIOL, V157, P2013, DOI 10.1104/pp.111.187526; Djebali N, 2011, EUR J PLANT PATHOL, V131, P559, DOI 10.1007/s10658-011-9831-1; Djebali N, 2009, MOL PLANT MICROBE IN, V22, P1043, DOI 10.1094/MPMI-22-9-1043; DUC G, 1989, PLANT SCI, V60, P215, DOI 10.1016/0168-9452(89)90169-6; Evangelisti E, 2014, CURR OPIN PLANT BIOL, V20, P118, DOI 10.1016/j.pbi.2014.05.014; Frugier F, 2008, TRENDS PLANT SCI, V13, P115, DOI 10.1016/j.tplants.2008.01.003; Fukaki H, 2009, PLANT MOL BIOL, V69, P437, DOI 10.1007/s11103-008-9417-2; Giron D, 2014, J CHEM ECOL, V40, P826, DOI 10.1007/s10886-014-0466-5; Gomez SK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-10; Gonzalez-Rizzo S, 2006, PLANT CELL, V18, P2680, DOI 10.1105/tpc.106.043778; Gough C, 2013, TRENDS PLANT SCI, V18, P566, DOI 10.1016/j.tplants.2013.06.001; Gough C, 2011, MOL PLANT MICROBE IN, V24, P867, DOI 10.1094/MPMI-01-11-0019; Gutjahr C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00204; Havlova M, 2008, PLANT CELL ENVIRON, V31, P341, DOI 10.1111/j.1365-3040.2007.01766.x; Heyl A, 2013, PLANT PHYSIOL, V161, P1063, DOI 10.1104/pp.112.213207; Truong HN, 2015, PLANT CELL ENVIRON, V38, P73, DOI 10.1111/pce.12370; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Jeon J, 2010, J BIOL CHEM, V285, P23369, DOI 10.1074/jbc.M109.096644; Kaiser W, 2010, P ROY SOC B-BIOL SCI, V277, P2311, DOI 10.1098/rspb.2010.0214; Kiba T, 2011, J EXP BOT, V62, P1399, DOI 10.1093/jxb/erq410; KOCH B, 1966, PLANT PHYSIOL, V41, P1748, DOI 10.1104/pp.41.10.1748; Laplaze L, 2007, PLANT CELL, V19, P3889, DOI 10.1105/tpc.107.055863; Le Signor C., 2005, Plant Genetic Resources Characterization and Utilization, V3, P59, DOI 10.1079/PGR200562; Li DF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-517; Li X, 2006, PLANT CELL PHYSIOL, V47, P1112, DOI 10.1093/pcp/pcj082; Lohar DP, 2006, PLANT PHYSIOL, V140, P221, DOI 10.1104/pp.105.070326; Ludwig-Muller J, 2010, ARBUSCULAR MYCORRHIZAS: PHYSIOLOGY AND FUNCTION, P169, DOI 10.1007/978-90-481-9489-6_8; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Mason MG, 2005, PLANT CELL, V17, P3007, DOI 10.1105/tpc.105.035451; Mason MG, 2010, PLANT J, V64, P753, DOI 10.1111/j.1365-313X.2010.04366.x; Merchan F, 2007, PLANT J, V51, P1, DOI 10.1111/j.1365-313X.2007.03117.x; Moreau S, 2014, NEW PHYTOL, V201, P1343, DOI 10.1111/nph.12636; Murray JD, 2007, SCIENCE, V315, P101, DOI 10.1126/science.1132514; Nishiyama R, 2013, P NATL ACAD SCI USA, V110, P4840, DOI 10.1073/pnas.1302265110; Nishiyama R, 2011, PLANT CELL, V23, P2169, DOI 10.1105/tpc.111.087395; Novero M, 2002, NEW PHYTOL, V154, P741, DOI 10.1046/j.1469-8137.2002.00424.x; Olah B, 2005, PLANT J, V44, P195, DOI 10.1111/j.1365-313X.2005.02522.x; Ortu G, 2012, MOL PLANT, V5, P951, DOI 10.1093/mp/sss027; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Penmetsa RV, 2008, PLANT J, V55, P580, DOI 10.1111/j.1365-313X.2008.03531.x; Pepper AN, 2007, ANN BOT-LONDON, V99, P765, DOI 10.1093/aob/mcm013; Pertry I, 2009, P NATL ACAD SCI USA, V106, P929, DOI 10.1073/pnas.0811683106; Plet J, 2011, PLANT J, V65, P622, DOI 10.1111/j.1365-313X.2010.04447.x; Rey T, 2013, NEW PHYTOL, V198, P875, DOI 10.1111/nph.12198; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Saur IML, 2011, NEW PHYTOL, V190, P865, DOI 10.1111/j.1469-8137.2011.03738.x; Stes E, 2011, ANNU REV PHYTOPATHOL, V49, P69, DOI 10.1146/annurev-phyto-072910-095217; Tirichine L, 2007, SCIENCE, V315, P104, DOI 10.1126/science.1132397; Tran LSP, 2007, P NATL ACAD SCI USA, V104, P20623, DOI 10.1073/pnas.0706547105; Trouvelot A., 1986, MYCORRHIZAE PHYSL GE, V1986, P217, DOI DOI 10.1177/004057368303900411; Truernit E, 2008, PLANT CELL, V20, P1494, DOI 10.1105/tpc.107.056069; Uppalapati SR, 2009, MOL PLANT MICROBE IN, V22, P7, DOI 10.1094/MPMI-22-1-0007; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Werner T, 2010, PLANT CELL, V22, P3905, DOI 10.1105/tpc.109.072694; Werner T, 2009, CURR OPIN PLANT BIOL, V12, P527, DOI 10.1016/j.pbi.2009.07.002; Zahaf O, 2012, MOL PLANT, V5, P1068, DOI 10.1093/mp/sss009	72	28	29	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2015	10	1							0116819	10.1371/journal.pone.0116819	http://dx.doi.org/10.1371/journal.pone.0116819			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3YO	25562779	Green Published, Green Submitted, gold			2022-12-26	WOS:000348160000004
J	Almeida, H; Meurs, MJ; Kosseim, L; Butler, G; Tsang, A				Almeida, Hayda; Meurs, Marie-Jean; Kosseim, Leila; Butler, Greg; Tsang, Adrian			Machine Learning for Biomedical Literature Triage	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; IMBALANCED DATA; TEXT	This paper presents a machine learning system for supporting the first task of the biological literature manual curation process, called triage. We compare the performance of various classification models, by experimenting with dataset sampling factors and a set of features, as well as three different machine learning algorithms (Naive Bayes, Support Vector Machine and Logistic Model Trees). The results show that the most fitting model to handle the imbalanced datasets of the triage classification task is obtained by using domain relevant features, an under-sampling technique, and the Logistic Model Trees algorithm.	[Almeida, Hayda; Kosseim, Leila; Butler, Greg] Concordia Univ, Dept Comp Sci & Software Engn, Montreal, PQ, Canada; [Meurs, Marie-Jean; Butler, Greg; Tsang, Adrian] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada	Concordia University - Canada; Concordia University - Canada	Meurs, MJ (corresponding author), Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada.	marie-jean.meurs@concordia.ca			Genome Canada; Genome Quebec; Genome Alberta	Genome Canada(Genome Canada); Genome Quebec; Genome Alberta	This work was supported by funding from Genome Canada (http://www.genomecanada.ca), Genome Quebec (http://www.genomequebec.com/), and Genome Alberta (http://genomealberta.ca/), to AT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbani R, 2004, LECT NOTES COMPUT SC, V3201, P39, DOI 10.1007/978-3-540-30115-8_7; Antonie Maria-Luiza, 2001, P 2 INT WORKSH MULT, P94; Aronson AR, 2001, J AM MED INFORM ASSN, P17; Bolton RJ, 2002, STAT SCI, V17, P235; Borrajo L, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-176; Charton E, 2013, INFORMATICS, V2014, P32; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Cohen G, 2006, ARTIF INTELL MED, V37, P7, DOI 10.1016/j.artmed.2005.03.002; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hirschman L, 2012, DATABASE J BIOL DATA; Howe D, 2008, NATURE, V455, P47, DOI 10.1038/455047a; Hunter L, 2006, MOL CELL, V21, P589, DOI 10.1016/j.molcel.2006.02.012; Landwehr N, 2005, MACH LEARN, V59, P161, DOI 10.1007/s10994-005-0466-3; Liu Y, 2006, COMPUT SPEECH LANG, V20, P468, DOI 10.1016/j.csl.2005.06.002; Maloof MA, 2003, ICML 2003 WORKSH LEA, V2; Marsland S, 2009, CH CRC MACH LEARN PA, P1; Meurs MJ, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-S1-S5; Morris BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065848; Mountassir A, 2012, IEEE SYS MAN CYBERN, P3298, DOI 10.1109/ICSMC.2012.6378300; Mudunuri US, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080503; Murphy C, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar020; National Center for Biotechnology Information, 2005, PUBMED; Quan CQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102039; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Raskutti B., 2004, SIGKDD EXPLOR NEWSL, V6, P60, DOI [10.1145/1007730.1007739, DOI 10.1145/1007730.1007739]; Ruch P, 2006, BIOINFORMATICS, V22, P658, DOI 10.1093/bioinformatics/bti783; Tang YC, 2005, ARTIF INTELL MED, V35, P121, DOI 10.1016/j.artmed.2005.02.003; Tang YC, 2009, IEEE T SYST MAN CY B, V39, P281, DOI 10.1109/TSMCB.2008.2002909; Vapnik V., 2013, NATURE STAT LAERNING; Wang MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091315; Weiss Gary M., 2007, Proceedings of the International Conference on Data Mining. DMIN 2007, P35; Weiss G. M., 2001, MLTR44 RUTG U	33	18	18	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115892	10.1371/journal.pone.0115892	http://dx.doi.org/10.1371/journal.pone.0115892			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551575	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000347119100073
J	McDonald, JS; Adibi, M; Clifford, CWG; Arabzadeh, E				McDonald, James S.; Adibi, Mehdi; Clifford, Colin W. G.; Arabzadeh, Ehsan			Sampling Time and Performance in Rat Whisker Sensory System	PLOS ONE			English	Article							FREQUENCY DISCRIMINATION; BEHAVIORAL DETECTION; SPEED; VIBRATION; ACCURACY; NEURONS; PERCEPTION; STIMULI	We designed a behavioural paradigm for vibro-tactile detection to characterise the sampling time and performance in the rat whisker sensory system. Rats initiated a trial by nose-poking into an aperture where their whiskers came into contact with two meshes. A continuous nose-poke for a random duration triggered stimulus presentation. Stimuli were a sequence of discrete Gaussian deflections of the mesh that increased in amplitude over time - across 5 conditions, time to maximum amplitude varied from 0.5 to 8 seconds. Rats indicated the detected stimulus by choosing between two reward spouts. Two rats completed more than 500 trials per condition. Rats' stimulus sampling duration increased and performance dropped with increasing task difficulty. For all conditions the median reaction time was longer for correct trials than incorrect trials. Higher rates of increment in stimulus amplitude resulted in faster rise in performance as a function of stimulus sampling duration. Rats' behaviour indicated a dynamic stimulus sampling whereby nose-poke was maintained until a stimulus was correctly identified or the rat experienced a false alarm. The perception was then manifested in behaviour after a motor delay. We thus modelled the results with 3 parameters: signal detection, false alarm, and motor delay. The model captured the main features of the data and produced parameter estimates that were biologically plausible and highly similar across the two rats.	[McDonald, James S.; Clifford, Colin W. G.; Arabzadeh, Ehsan] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Adibi, Mehdi; Arabzadeh, Ehsan] Australian Natl Univ, John Curtin Sch Med Res, Eccles Inst Neurosci, Canberra, ACT 2601, Australia; [Adibi, Mehdi; Arabzadeh, Ehsan] Australian Natl Univ Node, ARC Ctr Excellence Integrat Brain Funct, Canberra, ACT, Australia	University of New South Wales Sydney; Australian National University; John Curtin School of Medical Research; Australian National University	McDonald, JS (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	jamesscottmcdonald@gmail.com	Adibi, Mehdi/L-9276-2016; Adibi, Mehdi/AAL-7760-2020	Adibi, Mehdi/0000-0001-8874-3586; Adibi, Mehdi/0000-0001-8874-3586; Mcdonald, James/0000-0003-1362-1095; Arabzadeh, Ehsan/0000-0001-9632-0735	Australian Research Council Centre of Excellence for Integrative Brain Function (ARC Centre) [CE140100007]; Australian Research Council Centre of Excellence for Integrative Brain Function [DP130101364]; Australian National Health & Medical Research Council [1028670]; Australian Research Council	Australian Research Council Centre of Excellence for Integrative Brain Function (ARC Centre)(Australian Research Council); Australian Research Council Centre of Excellence for Integrative Brain Function(Australian Research Council); Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council Centre of Excellence for Integrative Brain Function (ARC Centre Grant CE140100007), Discovery Project DP130101364, and the Australian National Health & Medical Research Council Project Grant 1028670. EA and CC are supported by Future Fellowships from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Adibi M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003415; Adibi M, 2013, J NEUROSCI, V33, P2108, DOI 10.1523/JNEUROSCI.3449-12.2013; Adibi M, 2012, P NATL ACAD SCI USA, V109, P971, DOI 10.1073/pnas.1116726109; Adibi M, 2011, J NEUROPHYSIOL, V105, P356, DOI 10.1152/jn.00794.2010; Arabzadeh E, 2004, J NEUROSCI, V24, P6011, DOI 10.1523/JNEUROSCI.1389-04.2004; Arabzadeh E, 2003, J NEUROSCI, V23, P9146; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Diamond ME, 2013, PROG NEUROBIOL, V103, P28, DOI 10.1016/j.pneurobio.2012.05.013; Diamond ME, 2008, PLOS BIOL, V6, P1627, DOI 10.1371/journal.pbio.0060220; Fassihi A, 2014, P NATL ACAD SCI USA, V111, P2331, DOI 10.1073/pnas.1315171111; Gerdjikov TV, 2010, NEURON, V65, P530, DOI 10.1016/j.neuron.2010.02.007; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; KALASKA JF, 1992, SCIENCE, V255, P1517, DOI 10.1126/science.1549781; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Mayrhofer JM, 2013, J NEUROPHYSIOL, V109, P273, DOI 10.1152/jn.00488.2012; Miyashita T, 2013, CEREB CORTEX, V23, P1655, DOI 10.1093/cercor/bhs155; Musall S, 2014, NAT NEUROSCI, V17, P1567, DOI 10.1038/nn.3821; Reinagel P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068505; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Roitman JD, 2002, J NEUROSCI, V22, P9475; Schiller PH, 2004, EXP BRAIN RES, V154, P154, DOI 10.1007/s00221-003-1653-8; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Stanford TR, 2010, NAT NEUROSCI, V13, P379, DOI 10.1038/nn.2485; Stuttgen MC, 2008, J NEUROPHYSIOL, V100, P1879, DOI 10.1152/jn.90511.2008; Stuttgen MC, 2010, J NEUROSCI, V30, P2060, DOI 10.1523/JNEUROSCI.3943-09.2010; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; WAIBLINGER C, 2013, CEREBRAL CORTEX	31	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116357	10.1371/journal.pone.0116357	http://dx.doi.org/10.1371/journal.pone.0116357			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551373	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100134
J	Pasquier, C; Clement, M; Dombrovsky, A; Penaud, S; Da Rocha, M; Rancurel, C; Ledger, N; Capovilla, M; Robichon, A				Pasquier, Claude; Clement, Mathilde; Dombrovsky, Aviv; Penaud, Stephanie; Da Rocha, Martine; Rancurel, Corinne; Ledger, Neil; Capovilla, Maria; Robichon, Alain			Environmentally Selected Aphid Variants in Clonality Context Display Differential Patterns of Methylation in the Genome	PLOS ONE			English	Article							DNA METHYLATION; EPIGENETIC VARIATION; GENE-EXPRESSION; PEA APHID; STABILITY; SYMBIONTS; ONTOLOGY; SITES; LOCUS	Heritability of acquired phenotypic traits is an adaptive evolutionary process that appears more complex than the basic allele selection guided by environmental pressure. In insects, the trans-generational transmission of epigenetic marks in clonal and/or sexual species is poorly documented. Aphids were used as a model to explore this feature because their asexual phase generates a stochastic and/or environment-oriented repertoire of variants. The a priori unchanged genome in clonal individuals prompts us to hypothesize whether covalent methyl DNA marks might be associated to the phenotypic variability and fitness selection. The full differential transcriptome between two environmentally selected clonal variants that originated from the same founder mother was mapped on the entire genomic scaffolds, in parallel with the methyl cytosine distribution. Data suggest that the assortments of heavily methylated DNA sites are distinct in these two clonal phenotypes. This might constitute an epigenetic mechanism that confers the robust adaptation of insect species to various environments involving clonal reproduction.	[Clement, Mathilde; Dombrovsky, Aviv; Da Rocha, Martine; Rancurel, Corinne; Ledger, Neil; Capovilla, Maria; Robichon, Alain] Univ Nice Sophia Antipolis, Inst Sophia Agrobiotech, INRA CNRS UNS, Sophia Antipolis, France; [Dombrovsky, Aviv] Volcani Ctr, Inst Plant Protect, Rehovot, Israel; [Pasquier, Claude] Univ Nice Sophia Antipolis, CNRS, Inst Dev Biol & Canc, Sophia Antipolis, France; [Penaud, Stephanie] Beckman Coulter Genom SA, Grenoble, France	INRAE; UDICE-French Research Universities; Universite Cote d'Azur; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Beckman Coulter Inc.	Robichon, A (corresponding author), Univ Nice Sophia Antipolis, Inst Sophia Agrobiotech, INRA CNRS UNS, Sophia Antipolis, France.	Alain.Robichon@sophia.inra.fr	Capovilla, Maria/O-8483-2016; Pasquier, Claude/C-6163-2008	Pasquier, Claude/0000-0001-7498-395X; Rancurel, Corinne/0000-0001-9355-5491; Capovilla, Maria/0000-0002-1308-7964; robichon, alain/0000-0003-1075-9646	ANR "Exdisum''; grant PEPS CNRS; ANR "Methylclonome''; French National Research Agency (ANR) through the "Investments for the Future'' LABEX SIGNALIFE [ANR-11-LABX-0028-01]	ANR "Exdisum''(French National Research Agency (ANR)); grant PEPS CNRS; ANR "Methylclonome''(French National Research Agency (ANR)); French National Research Agency (ANR) through the "Investments for the Future'' LABEX SIGNALIFE(French National Research Agency (ANR))	The authors were supported by ANR "Exdisum'' 2006-2009, grant PEPS CNRS 2010 and ANR "Methylclonome'' 2011-2015. The authors are thankful for the support of the French National Research Agency (ANR) for PhD students through the "Investments for the Future'' LABEX SIGNALIFE (#ANR-11-LABX-0028-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; BHAGWAT AS, 1986, J BACTERIOL, V166, P751, DOI 10.1128/jb.166.3.751-755.1986; Bird A, 2004, COLD SPRING HARB SYM, V69, P113, DOI 10.1101/sqb.2004.69.113; Braendle C, 2003, PLOS BIOL, V1, P70, DOI 10.1371/journal.pbio.0000021; Cohen HM, 2002, NUCLEIC ACIDS RES, V30, P3880, DOI 10.1093/nar/gkf507; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; Degnan PH, 2008, APPL ENVIRON MICROB, V74, P6782, DOI 10.1128/AEM.01285-08; Dixon AF G, 1998, APHID ECOLOGY; Dixon AFG, 1973, STUDIES BIOL; Dombrovsky A, 2009, GENOME RES, V19, P2052, DOI 10.1101/gr.091611.109; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Hilliou F, 2013, P INT C BIOINF MOD M, DOI [10.5220/0004312002020211, DOI 10.5220/0004312002020211]; Hunt BG, 2010, GENOME BIOL EVOL, V2, P719, DOI 10.1093/gbe/evq057; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; LANGE C, 1991, GENE, V100, P213, DOI 10.1016/0378-1119(91)90369-M; Lyko F, 2011, TRENDS GENET, V27, P127, DOI 10.1016/j.tig.2011.01.003; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Miura T, 2003, J EXP ZOOL PART B, V295B, P59, DOI 10.1002/jez.b.00003; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Reinders J, 2009, EPIGENETICS-US, V4, P557, DOI 10.4161/epi.4.8.10347; Reinders J, 2009, GENE DEV, V23, P939, DOI 10.1101/gad.524609; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Schumann J, 1996, J MOL BIOL, V257, P949, DOI 10.1006/jmbi.1996.0214; Shen HS, 2012, PLANT CELL, V24, P875, DOI 10.1105/tpc.111.094870; TERSCHUREN PA, 1987, J GEN MICROBIOL, V133, P945; Tsuchida T, 2010, SCIENCE, V330, P1102, DOI 10.1126/science.1195463; Valmalette JC, 2012, LIGHT INDUCED ELECT; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weese D, 2009, GENOME RES, V19, P1646, DOI 10.1101/gr.088823.108; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	50	12	12	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115022	10.1371/journal.pone.0115022	http://dx.doi.org/10.1371/journal.pone.0115022			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551225	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100022
J	Zhou, QY; Chen, TJ; Bozkanat, M; Ibe, JCF; Christman, JW; Raj, JU; Zhou, GF				Zhou, Qiyuan; Chen, Tianji; Bozkanat, Melike; Ibe, Joyce Christina F.; Christman, John W.; Raj, J. Usha; Zhou, Guofei			Intratracheal Instillation of High Dose Adenoviral Vectors Is Sufficient to Induce Lung Injury and Fibrosis in Mice	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; MEDIATED GENE-TRANSFER; HIPPEL-LINDAU-PROTEIN; IN-VIVO; ANIMAL-MODELS; EXPRESSION; DISEASE; MATRIX; PATHOGENESIS; ACTIVATION	Rationale: Replication deficient adenoviruses (Ad) vectors are common tools in gene therapy. Since Ad vectors are known to activate innate and adaptive immunity, we investigated whether intratracheal administration of Ad vectors alone is sufficient to induce lung injury and pulmonary fibrosis. Methods: We instilled Ad viruses ranging from 10(7) to 1.625 x 10(9) ifu/mouse as well as the same volume of PBS and bleomycin. 14 and 21 days after administration, we collected bronchoalveolar lavage fluid (BALF) and mouse lung tissues. We measured the protein concentration, total and differential cell counts, and TGF-beta 1 production, performed Trichrome staining and Sircol assay, determined gene and protein levels of profibrotic cytokines, MMPs, and Wnt signaling proteins, and conducted TUNEL staining and co-immunofluorescence for GFP and alpha-SMA staining. Results: Instillation of high dose Ad vectors (1.6256109 ifu/mouse) into mouse lungs induced high levels of protein content, inflammatory cells, and TGF-beta 1 in BALF, comparable to those in bleomycin-instilled lungs. The collagen content and mRNA levels of Col1a1, Col1a2, PCNA, and alpha-SMA were also increased in the lungs. Instillation of both bleomycin and Ad vectors increased expression levels of TNF alpha and IL-1 beta but not IL-10. Instillation of bleomycin but not Ad increased the expression of IL-1 alpha, IL-13 and IL-16. Treatment with bleomycin or Ad vectors increased expression levels of integrin alpha 1, alpha 5, and alpha v, MMP9, whereas treatment with bleomycin but not Ad vectors induced MMP2 expression levels. Both bleomycin and Ad vectors induced mRNA levels of Wnt2, 2b, 5b, and Lrp6. Intratracheal instillation of Ad viruses also induced DNA damages and Ad viral infection-mediated fibrosis is not limited to the infection sites. Conclusions: Our results suggest that administration of Ad vectors induces an inflammatory response, lung injury, and pulmonary fibrosis in a dose dependent manner.	[Zhou, Qiyuan; Chen, Tianji; Bozkanat, Melike; Ibe, Joyce Christina F.; Raj, J. Usha; Zhou, Guofei] Univ Illinois, Dept Pediat, Chicago, IL 60607 USA; [Ibe, Joyce Christina F.; Raj, J. Usha] Childrens Hosp Univ Illinois, Chicago, IL USA; [Christman, John W.] Ohio State Univ, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Zhou, Guofei] Univ Illinois, Ctr Canc, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Ohio State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zhou, GF (corresponding author), Univ Illinois, Dept Pediat, Chicago, IL 60607 USA.	guofei@uic.edu		Bozkanat, Kubra Melike/0000-0001-7623-6288	American Lung Association Biomedical Research Grant [RG-266090-N]; University of Illinois at Chicago Faculty Scholarship Support Program; University of Illinois Cancer Center Pilot Subsidy Program; UIC Center for Clinical and Translational Science [UL1RR029879]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075557] Funding Source: NIH RePORTER	American Lung Association Biomedical Research Grant; University of Illinois at Chicago Faculty Scholarship Support Program; University of Illinois Cancer Center Pilot Subsidy Program; UIC Center for Clinical and Translational Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported in part by an American Lung Association Biomedical Research Grant (RG-266090-N) (GZ), the University of Illinois at Chicago Faculty Scholarship Support Program (GZ), the University of Illinois Cancer Center Pilot Subsidy Program (GZ), and supplemental funding from the UIC Center for Clinical and Translational Science (UL1RR029879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumiller V, 2013, AM J RESP CELL MOL, V49, P96, DOI 10.1165/rcmb.2012-0524OC; Belperio JA, 2002, AM J RESP CELL MOL, V27, P419, DOI 10.1165/rcmb.2002-0009OC; Budinger GRS, 2006, P NATL ACAD SCI USA, V103, P4604, DOI 10.1073/pnas.0507604103; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Degryse AL, 2011, AM J MED SCI, V341, P444, DOI 10.1097/MAJ.0b013e31821aa000; Degryse AL, 2010, AM J PHYSIOL-LUNG C, V299, pL442, DOI 10.1152/ajplung.00026.2010; Di Paolo NC, 2009, IMMUNITY, V31, P110, DOI 10.1016/j.immuni.2009.04.015; Dumasius V, 2003, VIROLOGY, V308, P243, DOI 10.1016/S0042-6822(02)00138-1; Fitzgerald KA, 2009, IMMUNITY, V31, P7, DOI 10.1016/j.immuni.2009.07.001; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Garcia-Alvarez J, 2006, SARCOIDOSIS VASC DIF, V23, P13; Garcia-Prieto E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013242; Gasse P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023185; Gharaee-Kermani M, 2005, AM J PATHOL, V166, P1593, DOI 10.1016/S0002-9440(10)62470-4; Glass WG, 2009, CYTOKINE, V46, P17, DOI 10.1016/j.cyto.2008.11.007; Hoshino T, 2009, AM J RESP CELL MOL, V41, P661, DOI 10.1165/rcmb.2008-0182OC; Hunninghake Gary W, 2007, Proc Am Thorac Soc, V4, P449, DOI 10.1513/pats.200702-036MS; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Kuwano K, 1997, EUR RESPIR J, V10, P1445, DOI 10.1183/09031936.97.10071445; Lagares D, 2012, AM J RESP CELL MOL, V47, P834, DOI 10.1165/rcmb.2011-0446OC; Lam AP, 2011, AM J RESP CELL MOL, V45, P915, DOI 10.1165/rcmb.2010-0113OC; Lasaro MO, 2009, MOL THER, V17, P1333, DOI 10.1038/mt.2009.130; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Liu Q, 2003, GENE THER, V10, P935, DOI 10.1038/sj.gt.3302036; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; McManus TE, 2007, RESP MED, V101, P2084, DOI 10.1016/j.rmed.2007.05.015; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Moore BB, 2013, AM J RESP CELL MOL, V49, P167, DOI 10.1165/rcmb.2013-0094TR; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Oikonomou N, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000108; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Pardo Annie, 2006, Proc Am Thorac Soc, V3, P383, DOI 10.1513/pats.200601-012TK; PIGUET PF, 1989, J EXP MED, V170, P655, DOI 10.1084/jem.170.3.655; Ramirez G, 2011, LAB INVEST, V91, P1206, DOI 10.1038/labinvest.2011.80; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Saito F, 2008, AM J RESP CELL MOL, V38, P566, DOI 10.1165/rcmb.2007-0299OC; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; Selman M, 2008, PLOS MED, V5, P373, DOI 10.1371/journal.pmed.0050062; Sheppard D, 2004, CURR OPIN CELL BIOL, V16, P552, DOI 10.1016/j.ceb.2004.06.017; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yang IV, 2007, AM J RESP CRIT CARE, V175, P45, DOI 10.1164/rccm.200601-062OC; Zhou G, 2008, FASEB J, V22, P1335, DOI 10.1096/fj.07-8369com; Zhou QY, 2011, FASEB J, V25, P3032, DOI 10.1096/fj.10-177824; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; Ziegler RJ, 2002, HUM GENE THER, V13, P935, DOI 10.1089/10430340252939041; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099	50	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116142	10.1371/journal.pone.0116142	http://dx.doi.org/10.1371/journal.pone.0116142			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551570	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100101
J	Toots, M; Mannik, A; Kivi, G; Ustav, M; Ustav, E; Ustav, M				Toots, Mart; Maennik, Andres; Kivi, Gaily; Ustav, Mart, Jr.; Ustav, Ene; Ustav, Mart			The Transcription Map of Human Papillomavirus Type 18 during Genome Replication in U2OS Cells	PLOS ONE			English	Article							EPITHELIAL RAFT CULTURES; MESSENGER-RNA; IN-VITRO; VIRAL TRANSCRIPTION; TRANSFORMED CELLS; E2 TRANSACTIVATOR; GENE-EXPRESSION; TERMINAL DOMAIN; EARLY REGION; LIFE-CYCLE	The human osteosarcoma cell line U2OS is useful for studying genome replication of human papillomavirus (HPVs) subtypes that belong to different phylogenetic genera. In this study, we defined the HPV18 transcription map in U2OS cells during transient replication, stable maintenance and vegetative amplification by identifying viral promoter regions, transcription polyadenylation and splicing sites during HPV18 genome replication. Mapping of the HPV18 transcription start sites in U2OS cells revealed five distinct promoter regions (P-102, P-520, P-811, P-1193 and P-3000). With the exception of P-3000, all of these regions have been previously identified during productive HPV18 infection. Collectively, the data suggest that U2OS cells are suitable for studying the replication and transcription properties of HPVs and to serve as a platform for conducting high-throughput drug screens to identify HPV replication inhibitors. In addition, we have identified mRNA species that are initiated from the promoter region P-3000, which can encode two E2C regulator proteins that contain only the C-terminal hinge and DNA-binding and dimerization domains of E2. We show that these proteins regulate the initial amplification of HPV18 by modulating viral transcription. Moreover, we show that one of these proteins can act as a transcriptional activator of promoter P-102.	[Toots, Mart; Kivi, Gaily; Ustav, Mart, Jr.; Ustav, Mart] Univ Tartu, Inst Technol, EE-50090 Tartu, Tartumaa, Estonia; [Maennik, Andres; Kivi, Gaily; Ustav, Mart] Icosagen Cell Factory OU, Tartumaa, Estonia; [Ustav, Ene] Estonian Bioctr, Tartu, Tartumaa, Estonia; [Ustav, Mart] Estonian Acad Sci, EE-200103 Tallinn, Harjumaa, Estonia	University of Tartu; Estonian Biocentre; Estonian Academy of Sciences	Ustav, M (corresponding author), Univ Tartu, Inst Technol, Ulikooli 18, EE-50090 Tartu, Tartumaa, Estonia.	mart.ustav@ut.ee	Ustav, Mart/G-6484-2017		Estonian Research Council [SF0180175A, SF0180175B]; Center of Excellence in Chemical Biology - European Regional Development Fund [3.2.0101.08-0017]; Estonian Science Foundation [9385, 9467]; Enterprise Estonia (EAS) Project [EU42266]	Estonian Research Council; Center of Excellence in Chemical Biology - European Regional Development Fund; Estonian Science Foundation; Enterprise Estonia (EAS) Project	This work was supported by targeted financing to projects SF0180175A and SF0180175B by the Estonian Research Council; by the Center of Excellence in Chemical Biology (3.2.0101.08-0017) financed by the European Regional Development Fund; by research grants 9385 and 9467 from the Estonian Science Foundation; and by Enterprise Estonia (EAS) Project EU42266. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Firoz, 2009, In Silico Biology, V9, P135, DOI 10.3233/ISB-2009-0395; Akgul B, 2006, J PATHOL, V208, P165, DOI 10.1002/path.1893; Andrei G, 2010, ANTIVIR RES, V85, P431, DOI 10.1016/j.antiviral.2009.10.019; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Braunstein TH, 1999, J GEN VIROL, V80, P3241, DOI 10.1099/0022-1317-80-12-3241; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; CHOE J, 1989, J VIROL, V63, P1743, DOI 10.1128/JVI.63.4.1743-1755.1989; Chow LT, 1997, CLIN DERMATOL, V15, P217, DOI 10.1016/S0738-081X(97)00069-2; DOLLARD SC, 1992, GENE DEV, V6, P1131, DOI 10.1101/gad.6.7.1131; DOORBAR J, 1990, VIROLOGY, V178, P254, DOI 10.1016/0042-6822(90)90401-C; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Flores ER, 1999, VIROLOGY, V262, P344, DOI 10.1006/viro.1999.9868; Frattini MG, 1997, J VIROL, V71, P7068, DOI 10.1128/JVI.71.9.7068-7072.1997; Geimanen J, 2011, J VIROL, V85, P3315, DOI 10.1128/JVI.01985-10; Grassmann K, 1996, J VIROL, V70, P2339, DOI 10.1128/JVI.70.4.2339-2349.1996; Gray E, 2010, CANCER RES, V70, P4081, DOI 10.1158/0008-5472.CAN-09-3335; Howett MK, 1997, CLIN DERMATOL, V15, P229; HUBBERT NL, 1988, P NATL ACAD SCI USA, V85, P5864, DOI 10.1073/pnas.85.16.5864; HUMMEL M, 1992, J VIROL, V66, P6070, DOI 10.1128/JVI.66.10.6070-6080.1992; Kadaja M, 2009, VIROLOGY, V384, P360, DOI 10.1016/j.virol.2008.11.032; Karagas MR, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c2986; KARLEN S, 1993, J VIROL, V67, P4296, DOI 10.1128/JVI.67.7.4296-4306.1993; Kay MA, 2010, NAT BIOTECHNOL, V28, P1287, DOI 10.1038/nbt.1708; KIYONO T, 1989, VIROLOGY, V173, P551, DOI 10.1016/0042-6822(89)90567-9; Kurg R, 2010, VIROLOGY, V408, P159, DOI 10.1016/j.virol.2010.09.010; Lace MJ, 2008, J VIROL, V82, P10841, DOI 10.1128/JVI.01481-08; Lace MJ, 2012, VIROLOGY, V429, P99, DOI 10.1016/j.virol.2012.03.020; LAMBERT PF, 1990, J VIROL, V64, P950, DOI 10.1128/JVI.64.2.950-956.1990; LAMBERT PF, 1987, CELL, V50, P69, DOI 10.1016/0092-8674(87)90663-5; LAMBERT PF, 1989, J VIROL, V63, P3151, DOI 10.1128/JVI.63.7.3151-3154.1989; LIU JS, 1995, J BIOL CHEM, V270, P27283, DOI 10.1074/jbc.270.45.27283; Malik H, 2014, ARCH VIROL, V159, P199, DOI 10.1007/s00705-013-1827-z; MCBRIDE AA, 1989, P NATL ACAD SCI USA, V86, P510, DOI 10.1073/pnas.86.2.510; Mighty KK, 2014, RECENT RESULTS CANC, V193, P135, DOI 10.1007/978-3-642-38965-8_8; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; MUNGAL S, 1992, J VIROL, V66, P3220, DOI 10.1128/JVI.66.5.3220-3224.1992; Nindl I, 2007, DIS MARKERS, V23, P247, DOI 10.1155/2007/942650; Ozbun MA, 1997, J VIROL, V71, P5161, DOI 10.1128/JVI.71.7.5161-5172.1997; PALERMODILTS DA, 1990, J VIROL, V64, P3144, DOI 10.1128/JVI.64.6.3144-3149.1990; Reinson T, 2013, J VIROL, V87, P951, DOI 10.1128/JVI.01943-12; Remm M, 1999, J VIROL, V73, P3062, DOI 10.1128/JVI.73.4.3062-3070.1999; Renaud KJ, 1996, VIROLOGY, V220, P177, DOI 10.1006/viro.1996.0298; ROHLFS M, 1991, VIROLOGY, V183, P331, DOI 10.1016/0042-6822(91)90146-3; ROMANCZUK H, 1990, J VIROL, V64, P2849, DOI 10.1128/JVI.64.6.2849-2859.1990; ROTENBERG MO, 1989, VIROLOGY, V172, P468, DOI 10.1016/0042-6822(89)90189-X; Sankovski E, 2014, J VIROL, V88, P961, DOI 10.1128/JVI.01841-13; SCHNEIDERGADICKE A, 1986, EMBO J, V5, P2285, DOI 10.1002/j.1460-2075.1986.tb04496.x; SNIJDERS PJF, 1992, J VIROL, V66, P3172, DOI 10.1128/JVI.66.5.3172-3178.1992; Steger G, 1996, METHOD ENZYMOL, V274, P173; Stubenrauch F, 2000, J VIROL, V74, P1178, DOI 10.1128/JVI.74.3.1178-1186.2000; Tan CL, 2012, VIROLOGY, V429, P47, DOI 10.1016/j.virol.2012.03.023; THIERRY F, 1987, J VIROL, V61, P134, DOI 10.1128/JVI.61.1.134-142.1987; VAILLANCOURT P, 1990, J VIROL, V64, P3927, DOI 10.1128/JVI.64.8.3927-3937.1990; Wang HK, 2009, GENE DEV, V23, P181, DOI 10.1101/gad.1735109; Wang XH, 2011, J VIROL, V85, P8080, DOI 10.1128/JVI.00670-11	56	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116151	10.1371/journal.pone.0116151	http://dx.doi.org/10.1371/journal.pone.0116151			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548925	Green Submitted, gold, Green Published			2022-12-26	WOS:000347063500053
J	Kon, S; Nakayama, Y; Matsumoto, N; Ito, K; Kanayama, M; Kimura, C; Kouro, H; Ashitomi, D; Matsuda, T; Uede, T				Kon, Shigeyuki; Nakayama, Yosuke; Matsumoto, Naoki; Ito, Koyu; Kanayama, Masashi; Kimura, Chiemi; Kouro, Hitomi; Ashitomi, Dai; Matsuda, Tadashi; Uede, Toshimitsu			A Novel Cryptic Binding Motif, LRSKSRSFQVSDEQY, in the C-Terminal Fragment of MMP-3/7-Cleaved Osteopontin as a Novel Ligand for alpha 9b1 Integrin Is Involved in the Anti-Type II Collagen Antibody-Induced Arthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; THROMBIN-CLEAVAGE; ADHESIVE; DOMAIN; INFLAMMATION; ACTIVATION; EXPRESSION; RECEPTORS; MIGRATION; PEPTIDES	Osteopontin (OPN) is a multifunctional protein that has been linked to various intractable inflammatory diseases. One way by which OPN induces inflammation is the production of various functional fragments by enzyme cleavage. It has been well appreciated that OPN is cleaved by thrombin, and/or matrix metalloproteinase-3 and -7 (MMP-3/7). Although the function of thrombin-cleaved OPN is well characterized, little is known about the function of MMP-3/7-cleaved OPN. In this study, we found a novel motif, LRSKSRSFQVSDEQY, in the C-terminal fragment of MMP-3/7-cleaved mouse OPN binds to alpha 9b1 integrin. Importantly, this novel motif is involved in the development of anti-type II collagen antibody-induced arthritis (CAIA). This study provides the first in vitro and in vivo evidence that OPN cleavage by MMP-3/7 is an important regulatory mechanism for CAIA.	[Kon, Shigeyuki; Nakayama, Yosuke; Ito, Koyu; Kanayama, Masashi; Kimura, Chiemi; Uede, Toshimitsu] Hokkaido Univ, Inst Med Genet, Div Mol Immunol, Sapporo, Hokkaido, Japan; [Kon, Shigeyuki; Matsumoto, Naoki; Kouro, Hitomi; Ashitomi, Dai; Matsuda, Tadashi] Hokkaido Univ, Fac Pharmaceut Sci, Dept Immunol, Sapporo, Hokkaido 060, Japan	Hokkaido University; Hokkaido University	Kon, S (corresponding author), Hokkaido Univ, Inst Med Genet, Div Mol Immunol, Sapporo, Hokkaido, Japan.	kon@pharm.hokudai.ac.jp; uedetoshimitsu@icloud.com	Matsuda, Tadashi/A-3835-2012; Ito, Koyu/CAH-5669-2022	Matsuda, Tadashi/0000-0002-3089-3757; Kanayama, Masashi/0000-0001-8366-5275	JSPS KAKENHI [24590072]; Akiyama Life Science Foundation; Suzuken Memorial Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Akiyama Life Science Foundation; Suzuken Memorial Foundation	This work was supported in part by research grant from JSPS KAKENHI, Grant Number 24590072, the Akiyama Life Science Foundation, and Suzuken Memorial Foundation to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Barry ST, 2000, EXP CELL RES, V258, P342, DOI 10.1006/excr.2000.4941; Barry ST, 2000, BIOCHEM BIOPH RES CO, V267, P764, DOI 10.1006/bbrc.1999.2032; Bayless KJ, 2001, J BIOL CHEM, V276, P13483, DOI 10.1074/jbc.M011392200; BUCK CA, 1987, J CELL SCI, P231; BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; GAILIT J, 1988, J BIOL CHEM, V263, P12927; Gao YA, 2004, MATRIX BIOL, V23, P457, DOI 10.1016/j.matbio.2004.09.003; GIACHELLI CM, 1995, ANN NY ACAD SCI, V760, P109, DOI 10.1111/j.1749-6632.1995.tb44624.x; Green PM, 2001, FEBS LETT, V503, P75, DOI 10.1016/S0014-5793(01)02690-4; Helluin O, 2000, J BIOL CHEM, V275, P18337, DOI 10.1074/jbc.M001529200; Ito K, 2009, MATRIX BIOL, V28, P11, DOI 10.1016/j.matbio.2008.10.002; Kaartinen MT, 2002, J BONE MINER RES, V17, P2161, DOI 10.1359/jbmr.2002.17.12.2161; Kanayama M, 2009, J IMMUNOL, V182, P8015, DOI 10.4049/jimmunol.0900725; Kim SY, 2006, FRONT BIOSCI-LANDMRK, V11, P3026, DOI 10.2741/2030; Kon S, 2000, J CELL BIOCHEM, V77, P487; Kon S, 2008, J EXP MED, V205, P25, DOI 10.1084/jem.20071324; Nishimichi N, 2011, J BIOL CHEM, V286, P11170, DOI 10.1074/jbc.M110.189258; Nishimichi N, 2009, J BIOL CHEM, V284, P14769, DOI 10.1074/jbc.M901515200; O'Regan AW, 1999, J IMMUNOL, V162, P1024; Senger DR, 1996, BBA-MOL CELL RES, V1314, P13, DOI 10.1016/S0167-4889(96)00067-5; SENGER DR, 1994, MOL BIOL CELL, V5, P565, DOI 10.1091/mbc.5.5.565; Sharif SA, 2009, ARTHRITIS RHEUM-US, V60, P2902, DOI 10.1002/art.24814; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; Uede T, 1997, MICROBIOL IMMUNOL, V41, P641, DOI 10.1111/j.1348-0421.1997.tb01906.x; Weber Georg F., 1996, Cytokine and Growth Factor Reviews, V7, P241, DOI 10.1016/S1359-6101(96)00030-5; Weber GF, 2002, J LEUKOCYTE BIOL, V72, P752; Yamamoto N, 2003, J CLIN INVEST, V112, P181, DOI 10.1172/JCI200317778; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328	31	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e0116210	10.1371/journal.pone.0116210	http://dx.doi.org/10.1371/journal.pone.0116210			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545242	Green Published, gold			2022-12-26	WOS:000347120200107
J	Luo, Q; Sun, LN; Hu, XM; Zhou, RR				Luo, Qing; Sun, Lina; Hu, Xiaomin; Zhou, Ruiren			The Variation of Root Exudates from the Hyperaccumulator Sedum alfredii under Cadmium Stress: Metabonomics Analysis	PLOS ONE			English	Article							WEIGHT ORGANIC-ACIDS; DISCOVERED CD-HYPERACCUMULATOR; QUANTITATIVE-ANALYSIS; METAL ACCUMULATION; CONTAMINATED SOILS; PLANT; PHYTOREMEDIATION; MAIZE; ZINC; L.	Hydroponic experiments were conducted to investigate the variation of root exudates from the hyperaccumulator Sedum alfredii under the stress of cadmium (Cd). S. alfredii was cultured for 4 days in the nutrient solution spiked with CdCl2 at concentrations of 0, 5, 10, 40, and 400 mu M Cd after the pre-culture. The root exudates were collected and analyzed by GC-MS, and 62 compounds were identified. Of these compounds, the orthogonal partial least-squares discrimination analysis (OPLS-DA) showed that there were a distinct difference among the root exudates with different Cd treatments and 20 compounds resulting in this difference were found out. Changing tendencies in the relative content of these 20 compounds under the different Cd treatments were analyzed. These results indicated that trehalose, erythritol, naphthalene, d-pinitol and n-octacosane might be closely related to the Cd stabilization, phosphoric acid, tetradecanoic acid, oxalic acid, threonic acid and glycine could be attributed to the Cd mobilization, and mannitol, oleic acid, 3-hydroxybutanoic acid, fructose, octacosanol and ribitol could copy well with the Cd stress.	[Luo, Qing; Hu, Xiaomin] Northeast Univ, Sch Resources & Civil Engn, Shenyang, Peoples R China; [Luo, Qing; Sun, Lina] Shenyang Agr Univ, Key Lab Reg Environm & Ecoremediat, Minist Educ, Shenyang 110161, Peoples R China; [Zhou, Ruiren] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Northeastern University - China; Shenyang Agricultural University; Nankai University	Sun, LN (corresponding author), Shenyang Agr Univ, Key Lab Reg Environm & Ecoremediat, Minist Educ, Shenyang 110161, Peoples R China.	sln629@163.com	Hu, Xiaomin/GRY-1539-2022; Luo, Qing/ABD-4148-2020	Luo, Qing/0000-0002-4306-6283	National Natural Science Foundation of China [21037002, 41071304, 21107075]; Program for the Innovative Research Team in Liaoning Province [LT2011017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for the Innovative Research Team in Liaoning Province	The authors are thankful for the financial support from the National Natural Science Foundation of China (no. 21037002, 41071304, and 21107075) and Program for the Innovative Research Team in Liaoning Province (LT2011017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnon, 1950, WATER CULTURE METHOD, V347, DOI DOI 10.1073/PNAS.1211132109; Asemaneh T, 2006, PLANTA, V225, P193, DOI 10.1007/s00425-006-0340-y; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Blaylock MJ, 2000, PHYTOREMEDIATION OF TOXIC METALS, P53; Chiang PN, 2011, SOIL SCI, V176, P33, DOI 10.1097/SS.0b013e318202fdc9; Cieslinski G, 1998, PLANT SOIL, V203, P109, DOI 10.1023/A:1004325817420; CUNNINGHAM SD, 1995, TRENDS BIOTECHNOL, V13, P393, DOI 10.1016/S0167-7799(00)88987-8; CURL EA, 1986, RHIZOSPHERE, P288, DOI DOI 10.1007/978-3-642-70722-3; Dakora FD, 2002, PLANT SOIL, V245, P35, DOI 10.1023/A:1020809400075; Dong J, 2007, PLANT SOIL ENVIRON, V53, P193, DOI 10.17221/2205-PSE; Fan TWM, 2001, PHYTOCHEMISTRY, V57, P209, DOI 10.1016/S0031-9422(01)00007-3; Gransee A, 2000, J PLANT NUTR SOIL SC, V163, P381, DOI 10.1002/1522-2624(200008)163:4<381::AID-JPLN381>3.0.CO;2-7; Groleau-Renaud V, 2000, J PLANT NUTR, V23, P1283, DOI 10.1080/01904160009382100; Guo GL, 2006, ENVIRON MONIT ASSESS, V116, P513, DOI 10.1007/s10661-006-7668-4; Han F, 2006, PLANT SOIL, V289, P355, DOI 10.1007/s11104-006-9145-9; Jiang CA, 2013, J ENVIRON SCI-CHINA, V25, P1890, DOI 10.1016/S1001-0742(12)60213-7; Johansson EM, 2008, PLANT SOIL, V313, P39, DOI 10.1007/s11104-008-9678-1; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Kim S, 2010, J BIOSCI BIOENG, V109, P47, DOI 10.1016/j.jbiosc.2009.06.018; Kramer U, 2000, PLANT PHYSIOL, V122, P1343, DOI 10.1104/pp.122.4.1343; Kupper H, 2001, J EXP BOT, V52, P2291, DOI 10.1093/jexbot/52.365.2291; Li TQ, 2011, J HAZARD MATER, V192, P1616, DOI 10.1016/j.jhazmat.2011.06.086; Li TQ, 2005, J ENVIRON SCI HEAL A, V40, P1081, DOI 10.1081/ESE-200056163; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu D, 2008, J HAZARD MATER, V153, P114, DOI 10.1016/j.jhazmat.2007.08.026; Liu WT, 2011, J AGR FOOD CHEM, V59, P8324, DOI 10.1021/jf201454w; [龙新宪 Long Xinxian], 2002, [植物营养与肥料学报, Plant nutrition and fertitizer science], V8, P467; Luo CL, 2008, WATER AIR SOIL POLL, V193, P147, DOI 10.1007/s11270-008-9678-z; Marschner H., 1995, MARSCHNERS MINERAL N, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Nigam R, 2001, PLANT SOIL, V230, P107, DOI 10.1023/A:1004865811529; Prasad MNV, 2003, ELECTRON J BIOTECHN, V6, P285, DOI 10.2225/vol6-issue3-fulltext-6; Quartacci MF, 2009, ENVIRON POLLUT, V157, P2697, DOI 10.1016/j.envpol.2009.04.035; Selvakumar G., 2012, BACTERIAL MEDIATED A, P205; Sheng PH., 2001, POLLUTION ECOLOGY; Sun RL, 2007, ENVIRON EXP BOT, V60, P468, DOI 10.1016/j.envexpbot.2007.01.004; Sun RL, 2006, PLANT SOIL, V285, P125, DOI 10.1007/s11104-006-0064-6; Sun RuiLian, 2005, Acta Phytoecologica Sinica, V29, P497; Sun YB, 2009, GEODERMA, V150, P106, DOI 10.1016/j.geoderma.2009.01.016; Sun YB, 2009, J HAZARD MATER, V161, P808, DOI 10.1016/j.jhazmat.2008.04.030; Suzuki K, 2009, SOIL SCI PLANT NUTR, V55, P505, DOI 10.1111/j.1747-0765.2009.00390.x; Wei SH, 2005, CHINESE SCI BULL, V50, P33, DOI 10.1360/982004-292; Wei SH, 2004, PROG NAT SCI-MATER, V14, P495, DOI 10.1080/10020070412331343851; Wei SH, 2006, ENVIRON SCI POLLUT R, V13, P151, DOI 10.1065/espr2005.06.269; Wiltse CC, 1998, J ENVIRON QUAL, V27, P169, DOI 10.2134/jeq1998.00472425002700010024x; Yang X, 2002, CHINESE SCI BULL, V47, P1634, DOI 10.1360/02tb9359; Yang X, 1996, J PLANT NUTR, V19, P643, DOI 10.1080/01904169609365148; Yang X, 2014, J INTEGR AGR, V13, P105, DOI 10.1016/S2095-3119(13)60495-5; Zhao FJ, 2001, NEW PHYTOL, V151, P613, DOI 10.1046/j.0028-646x.2001.00213.x; Zhou Q., 1995, ECOLOGY COMBINED POL; Zhou Q.X., 2006, ECOLOGICAL REMEDIATI; Zhou QX., 2004, PRINCIPLES METHODS C	51	42	46	8	178	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115581	10.1371/journal.pone.0115581	http://dx.doi.org/10.1371/journal.pone.0115581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545686	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200048
J	Ormos, M; Zibriczky, D				Ormos, Mihaly; Zibriczky, David			Entropy-Based Financial Asset Pricing	PLOS ONE			English	Article							SELECTION	We investigate entropy as a financial risk measure. Entropy explains the equity premium of securities and portfolios in a simpler way and, at the same time, with higher explanatory power than the beta parameter of the capital asset pricing model. For asset pricing we define the continuous entropy as an alternative measure of risk. Our results show that entropy decreases in the function of the number of securities involved in a portfolio in a similar way to the standard deviation, and that efficient portfolios are situated on a hyperbola in the expected return - entropy system. For empirical investigation we use daily returns of 150 randomly selected securities for a period of 27 years. Our regression results show that entropy has a higher explanatory power for the expected return than the capital asset pricing model beta. Furthermore we show the time varying behavior of the beta along with entropy.	[Ormos, Mihaly; Zibriczky, David] Budapest Univ Technol & Econ, Dept Finance, H-1117 Budapest, Hungary	Budapest University of Technology & Economics	Ormos, M (corresponding author), Budapest Univ Technol & Econ, Dept Finance, Magyar Tudosok Krt 2, H-1117 Budapest, Hungary.	ormos@finance.bme.hu	Ormos, Mihály/E-1051-2011	Ormos, Mihály/0000-0002-3224-7636				Andor G, 2013, ENG ECON, V58, P3, DOI 10.1080/0013791X.2012.742607; Boltzmann L., 2012, WEITERE STUDIEN WARM, P316, DOI [10.1017/CBO9781139381420.023, DOI 10.1017/CBO9781139381420.023]; Clausius R., 1870, LONDON EDINB DUBLIN, V40, P122, DOI DOI 10.1080/14786447008640370; Dionisio A, 2006, EUR PHYS J B, V50, P161, DOI 10.1140/epjb/e2006-00113-2; Erdos P, 2009, ACTA OECON, V59, P391, DOI 10.1556/AOecon.59.2009.4.2; Erdos P, 2011, ECON MODEL, V28, P1150, DOI 10.1016/j.econmod.2010.12.008; FREEDMAN D, 1981, Z WAHRSCHEINLICHKEIT, V57, P453, DOI 10.1007/BF01025868; Gyorfi L., 1997, INT J MATH STAT SCI, V6, P17; HARDLE W., 2012, NONPARAMETRIC SEMIPA, DOI [10.1007/978-3-642-17146-8, DOI 10.1007/978-3-642-17146-8]; JENSEN MC, 1968, J FINANC, V23, P389, DOI 10.2307/2325404; Maasoumi E, 2002, J ECONOMETRICS, V107, P291, DOI 10.1016/S0304-4076(01)00125-7; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; NAWROCKI DN, 1986, APPL ECON, V18, P411, DOI 10.1080/00036848600000038; PHILIPPATOS GC, 1972, APPL ECON, V4, P209, DOI 10.1080/00036847200000017; Renyi A, 1961, P 4 BERK S MATH STAT, V1; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHARPE WF, 1964, J FINANC, V19, P425, DOI 10.2307/2977928; Silverman BW, 1986, MONOGRAPHS STAT APPL, DOI [DOI 10.1371/journal.pone.0064841, 10.1007/978-1-4899-3324-9, DOI 10.1007/978-1-4899-3324-9]; Turlach B.A., 1993, BANDWIDTH SELECTION; Wachowiak MP, 2005, PATTERN ANAL APPL, V8, P95, DOI 10.1007/s10044-005-0247-4; Zunckel C., 2011, ARXIV11024722	22	38	40	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115742	10.1371/journal.pone.0115742	http://dx.doi.org/10.1371/journal.pone.0115742			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UN	25545668	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200063
J	Alvarez-Castaneda, ST; Murphy, RW				Alvarez-Castananeda, Sergio Ticul; Murphy, Robert W.			The Endemic Insular and Peninsular Species Chaetodipus spinatus (Mammalia, Heteromyidae) Breaks Patterns for Baja California	PLOS ONE			English	Article							DNA-SEQUENCE DATA; POPULATION-GROWTH; GENETIC-STRUCTURE; EVOLUTION; DIVERSIFICATION; PHYLOGEOGRAPHY; BIOGEOGRAPHY; OSCILLATIONS; SYSTEMATICS; PEROMYSCUS	The Baja California peninsula is the second longest, most geographically isolated peninsula on Earth. Its physiography and the presence of many surrounding islands has facilitated studies of the underlying patterns and drivers of genetic structuring for a wide spectrum of organisms. Chaetodipus spinatus is endemic to the region and occurs on 12 associated islands, including 10 in the Gulf of California and two in the Pacific Ocean. This distribution makes it a model species for evaluating natural historical barriers. We test hypotheses associated with the relationship between the range of the species, patterns in other species, and its relationship to Pleistocene-Holocene climatic changes. We analyzed sequence data from mtDNA genes encoding cytochrome b (Cytb) and cytochrome c oxidase subunits I (COI) and III (COIII) in 26 populations including all 12 islands. The matrilineal genealogy, statistical parsimony network and Bayesian skyline plot indicated an origin of C. spinatus in the southern part of the peninsula. Our analyses detected several differences from the common pattern of peninsular animals: no mid-peninsula break exists, Isla Carmen hosts the most divergent population, the population on an ancient southern Midriff island does not differ from peninsular populations, and a mtDNA peninsular discordance occurs near Loreto.	[Alvarez-Castananeda, Sergio Ticul] Inst Politecn Nacl 195, Ctr Invest Biol Noroeste, La Paz, Baja California, Mexico; [Murphy, Robert W.] Royal Ontario Museum, Ctr Biodivers & Conservat Biol, Toronto, ON M5S 2C6, Canada	CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA; Royal Ontario Museum	Alvarez-Castaneda, ST (corresponding author), Inst Politecn Nacl 195, Ctr Invest Biol Noroeste, La Paz, Baja California, Mexico.	sticul@cibnor.mx			Consejo Nacional de Ciencia y Tecnologia (CONACYT) [39467Q, 151189, SEMARNAP-2002-COL-019]; University of California (UC-MEXUS-CONACYT)	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of California (UC-MEXUS-CONACYT)	Financial support (grant 39467Q, 151189, SEMARNAP-2002-COL-019) was provided by the Consejo Nacional de Ciencia y Tecnologia (CONACYT) and University of California (UC-MEXUS-CONACYT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre G, 1999, HERPETOLOGICA, V55, P369; Alexander LF, 2005, J MAMMAL, V86, P366, DOI 10.1644/BER-120.1; ALVAREZ T, 1974, ESCENARIO GEOGRAFICO; Alvarez-Castaneda ST, 2004, MOL ECOL, V13, P2287, DOI 10.1111/j.1365-294X.2004.02243.x; Blair C, 2009, ZOOTAXA, P28, DOI 10.11646/zootaxa.2027.1.2; BRATTSTROM BAYARD H., 1956, CONDER, V58, P107, DOI 10.2307/1364977; BRATTSTROM BH, 1990, J BIOGEOGR, V17, P177, DOI 10.2307/2845325; Brattstrom BH, 1963, PACIFIC BASIN BIOGEO; Canon C, 2010, J MAMMAL, V91, P1449, DOI 10.1644/10-MAMM-A-027.1; Capra L, 1998, J VOLCANOL GEOTH RES, V80, P239, DOI 10.1016/S0377-0273(97)00049-8; Carreno AL, 2002, NEW ISLAND BIOGEOGRA; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Davy CM, 2011, J BIOGEOGR, V38, P272, DOI 10.1111/j.1365-2699.2010.02422.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Fu YX, 1997, GENETICS, V147, P915; Gao Y, 2012, J BIOGEOGR, V39, P2264, DOI 10.1111/j.1365-2699.2012.02755.x; Gastil G, 1983, ISLAND BIOGEOGRAPHY; GRIsMER L. L., 2002, TUCSON HERPETOLOGICA; Hafner DJ, 2005, BIODIVERSITY ECOSYST; Hafner DJ, 2011, PALEOGEOGRAPHY PALEO; Hall E. R., 1981, MAMMALS N AM; Helenes J, 1999, J S AM EARTH SCI, V12, P589, DOI 10.1016/S0895-9811(99)00042-5; Herbert TD, 2001, SCIENCE, V293, P71, DOI 10.1126/science.1059209; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Holt JW, 2000, GEOL SOC AM BULL, V112, P540, DOI 10.1130/0016-7606(2000)112<540:AACOGO>2.0.CO;2; Huey L. M., 1960, Transactions of the San Diego Society for Natural History, V12, P409; HUEY LAURENCE M., 1964, TRANS SAN DIEGO SOC NAT HIST, V13, P85; HUEY LAURENCE M., 1930, TRANS SAN DIEGO SOC NAT HIST, V6, P231; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; IVES RL, 1962, GEOL SOC AM BULL, V73, P647, DOI 10.1130/0016-7606(1962)73[647:DOTEOT]2.0.CO;2; Lackey J.A., 1991, Mammalian Species, P1; Lawlor TE, 2002, NEW ISLAND BIOGEOGRA; Leache AD, 2007, BIOL LETTERS, V3, P646, DOI 10.1098/rsbl.2007.0368; Ledesma-Vazquez J, 2002, REV MEXICANA CIENCIA, V19, P143; Lindell J, 2005, MOL PHYLOGENET EVOL, V36, P682, DOI 10.1016/j.ympev.2005.04.031; Lindell J, 2008, MOL ECOL RESOUR, V8, P66, DOI 10.1111/j.1471-8286.2007.01894.x; Lindell J, 2006, J BIOGEOGR, V33, P1327, DOI 10.1111/j.1365-2699.2006.01532.x; Lorenzo C, 2010, WEST N AM NATURALIST, V70, P249, DOI 10.3398/064.070.0214; MOORE DG, 1973, GEOL SOC AM BULL, V84, P1883, DOI 10.1130/0016-7606(1973)84<1883:PDACGG>2.0.CO;2; Murphy RW, 2010, CONSERVATION MESOAME; Murphy RW., 2002, NEW ISLAND BIOGEOGRA; MURPHY RW, 1983, OCCAS PAP CALIF ACAD, V137, P1; Nabhan G. P., 2003, SINGING TURTLES SEA; Nei M, 1987, MOL EVOLUTION GENETI; Nylander J.A.A., 2004, MRMODELTEST V2 2 PRO; Patton JL, 1999, MAMIFEROS NOROESTE M; Pichaud N, 2012, EVOLUTION, V66, P3189, DOI 10.1111/j.1558-5646.2012.01683.x; Posada D, 2004, COLLAPSE VERSION 1 1; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Radtkey RR, 1997, P NATL ACAD SCI USA, V94, P9740, DOI 10.1073/pnas.94.18.9740; Riddle BR, 2000, MOL PHYLOGENET EVOL, V17, P161, DOI 10.1006/mpev.2000.0842; RIDDLE BR, 1995, J MAMMAL, V76, P283, DOI 10.2307/1382342; Riddle BR, 2000, PNAS, V26, P14443; Rodriguez-Robles JA, 2000, MOL PHYLOGENET EVOL, V14, P35, DOI 10.1006/mpev.1999.0698; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAVAGE JM, 1960, SYST ZOOL, V9, P184, DOI 10.2307/2411967; Schmidly JD, 1993, SPECIAL PUBLICATIONS, V10; Schmitt AK, 2010, QUAT GEOCHRONOL, V5, P503, DOI 10.1016/j.quageo.2010.02.004; Schneider S., 2000, ARLEQUIN VERSION 20; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Smith MF, 1998, MOL PHYLOGENET EVOL, V9, P1, DOI 10.1006/mpev.1997.0459; SMITH MF, 1993, BIOL J LINN SOC, V50, P149, DOI 10.1111/j.1095-8312.1993.tb00924.x; SOULE MICHAEL, 1966, TRANS SAN DIEGO SOC NATUR HIST, V14, P137; Swofford DL., 2001, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; TEMPLETON AR, 1992, GENETICS, V132, P619; Alvarez-Castaneda ST, 2007, J MAMMAL, V88, P1160, DOI 10.1644/06-MAMM-A-065R3.1; Alvarez-Castaneda ST, 2009, J MAMMAL, V90, P992, DOI 10.1644/07-MAMM-A-398.1; Upton DE, 1997, MOL PHYLOGENET EVOL, V8, P104, DOI 10.1006/mpev.1996.0392; WEBB T, 1992, ANNU REV ECOL SYST, V23, P141, DOI 10.1146/annurev.es.23.110192.001041; Whorley JR, 2004, MOL ECOL, V13, P2709, DOI 10.1111/j.1365-294X.2004.02257.x; Williams DF, 1993, SPECIAL PUBLICATION, V10; Zhang FF, 2013, GENOME BIOL EVOL, V5, P1781, DOI 10.1093/gbe/evt129; Zheng XG, 2003, MOL ECOL, V12, P711, DOI 10.1046/j.1365-294X.2003.01770.x	77	11	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116146	10.1371/journal.pone.0116146	http://dx.doi.org/10.1371/journal.pone.0116146			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542029	gold, Green Published, Green Submitted			2022-12-26	WOS:000347239900150
J	Lee, YD; Yoon, SH; Park, CK; Lee, J; Lee, ZH; Kim, HH				Lee, Yong Deok; Yoon, Soo-Hyun; Park, Cheol Kyu; Lee, Jiyeon; Lee, Zang Hee; Kim, Hong-Hee			Caveolin-1 Regulates Osteoclastogenesis and Bone Metabolism in a Sex-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ESTROGEN-RECEPTOR-ALPHA; LIPID RAFTS; ENDOTHELIAL-CELLS; FAS LIGAND; IN-VITRO; ER-ALPHA; ACTIVATION; DIFFERENTIATION; OSTEOBLASTS	Lipid raft microdomains have important roles in various cellular responses. Caveolae are a specialized type of lipid rafts that are stabilized by oligomers of caveolin proteins. Here, we show that caveolin-1 (Cav-1) plays a crucial role in the regulation of osteoclastogenesis. We found that caveolin-1 was dramatically up-regulated by receptor activator of nuclear.factor kappa B ligand (RANKI,), the osteoclast differentiation factor. Knockdown of Cav- I reduced osteodastogenesis and induction of NFATcl, the master transcription factor for osteoclastogenesis, by RANKL. Consistent with the in vitro results, injection of caveolin-1 siRNA onto mice calvariae showed reduction in RANK!,induced bone resorption and osteoclast formation. Moreover, Cav-1(-/-) female mice had higher bone volume and lower osteodast number compared with wild type mice. However, Cav-1(-/-) male mice had both osteoclast and osteoblast numbers higher than wild type mice with no difference in bone volume. The sex dependence in the effect of Cav- I deficiency was partly attributed to decreased receptor activator of nuclear factor kappa B and increased cFms expression in osteoclast precursors of female and male mice, respectively. Taken together, these data demonstrate that Cav-1 has a complicated but critical role for osteodastogenesis.	[Kim, Hong-Hee] Seoul Natl Univ, Dept Cell & Dev Biol, BK21 Program, Seoul 110749, South Korea; Seoul Natl Univ, Dent Res Inst, Seoul 110749, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, HH (corresponding author), Seoul Natl Univ, Dept Cell & Dev Biol, BK21 Program, 28 Yeongon Dong, Seoul 110749, South Korea.	hhbkim@snu.ac.kr			Korean MSIP/KRF via Science Research Center [2014001895]; Korean Ministry of Health and Welfare [A111787]	Korean MSIP/KRF via Science Research Center; Korean Ministry of Health and Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Korean MSIP/KRF via Science Research Center Grant 2014001895 and by Korean Ministry of Health and Welfare Grant A111787.	Abulrob A, 2004, ONCOGENE, V23, P6967, DOI 10.1038/sj.onc.1207911; Almeida M, 2010, J BONE MINER RES, V25, P769, DOI 10.1359/jbmr.091017; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Buitrago C, 2010, J STEROID BIOCHEM, V121, P169, DOI 10.1016/j.jsbmb.2010.03.002; Chang EJ, 2008, NAT MED, V14, P966, DOI 10.1038/nm.1860; CHOW J, 1992, J CLIN INVEST, V89, P74, DOI 10.1172/JCI115588; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Fielding CJ, 1997, P NATL ACAD SCI USA, V94, P3753, DOI 10.1073/pnas.94.8.3753; Frank PG, 2004, ARTERIOSCL THROM VAS, V24, P98, DOI 10.1161/01.ATV.0000101182.89118.E5; Frank PG, 2007, CURR PHARM DESIGN, V13, P1761, DOI 10.2174/138161207780831202; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Gohel A, 1999, ENDOCRINOLOGY, V140, P5339, DOI 10.1210/en.140.11.5339; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hada N, 2012, BONE, V50, P226, DOI 10.1016/j.bone.2011.10.028; Jiao H, 2013, J IMMUNOL, V191, P6191, DOI 10.4049/jimmunol.1300873; Kameda T, 1997, J EXP MED, V186, P489, DOI 10.1084/jem.186.4.489; Krum SA, 2008, EMBO J, V27, P535, DOI 10.1038/sj.emboj.7601984; Kwiatek AM, 2006, MOL PHARMACOL, V70, P1174, DOI 10.1124/mol.105.021741; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Mirza MK, 2010, AM J PATHOL, V176, P2344, DOI 10.2353/ajpath.2010.091088; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nystrom FH, 1999, MOL ENDOCRINOL, V13, P2013, DOI 10.1210/me.13.12.2013; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Qu Q, 1998, BONE, V22, P201, DOI 10.1016/S8756-3282(97)00276-7; Racine C, 1999, BIOCHEM BIOPH RES CO, V255, P580, DOI 10.1006/bbrc.1999.0236; Razandi M, 2002, MOL ENDOCRINOL, V16, P100, DOI 10.1210/me.16.1.100; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Rubin J, 2007, J BONE MINER RES, V22, P1408, DOI 10.1359/jbmr.070601; Saintier D, 2006, J STEROID BIOCHEM, V99, P165, DOI 10.1016/j.jsbmb.2006.01.009; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Schlegel A, 1999, J BIOL CHEM, V274, P33551, DOI 10.1074/jbc.274.47.33551; Schwencke C, 2006, CARDIOVASC RES, V70, P42, DOI 10.1016/j.cardiores.2005.11.029; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Srivastava S, 2001, J BIOL CHEM, V276, P8836, DOI 10.1074/jbc.M010764200; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2005, J MOL MED, V83, P170, DOI 10.1007/s00109-004-0612-6; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Tomassian T, 2011, J IMMUNOL, V187, P2993, DOI 10.4049/jimmunol.1101447; TRAVIS J, 1993, SCIENCE, V262, P1208, DOI 10.1126/science.8235646	41	18	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6522	6530		10.1074/jbc.M114.598581	http://dx.doi.org/10.1074/jbc.M114.598581			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25561739	Green Published, hybrid			2022-12-26	WOS:000350732500055
J	Salem, D; Subang, R; Okazaki, Y; Laplante, P; Levine, JS; Kuwana, M; Rauch, J				Salem, David; Subang, Rebecca; Okazaki, Yuka; Laplante, Patrick; Levine, Jerrold S.; Kuwana, Masataka; Rauch, Joyce			beta(2)-Glycoprotein I-specific T Cells Are Associated with Epitope Spread to Lupus-related Autoantibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIPHOSPHOLIPID SYNDROME; BINDING; BETA-2-GLYCOPROTEIN-I; ANTIBODIES; ATHEROSCLEROSIS; ANTICARDIOLIPIN; ERYTHEMATOSUS; CLEARANCE; RECEPTOR; ONSET	Systemic lupus erythematosus (SLE) is a prototypic model for B cell epitope spread in autoimmunity. Autoantibodies to numerous and molecularly distinct self-antigens emerge in a sequential manner over several years, leading to disease manifestations. Among the earliest autoantibodies to appear are those targeting the apoptotic cell-binding protein beta(2)-glycoprotein I (beta(2)GPI). Notably, mice immunized with beta(2)GPI and LPS display a remarkably similar pattern of autoantibody emergence to that seen in human SLL. Here, we used this model to investigate whether epitope spread to SLE-related autoantibodies is associated with a unique or limited AAWI-specific T cell response. We ask whether MHC class II haplotype and its associated T cell epitope restriction impact epitope spread to SLE-related autoantibodies. We found that beta(2)GPI/LPS-immunized mice produced similar SLE-related autoantibody profiles regardless of their beta(2)GPI T cell epitope specificity or MHC class II haplotype. Although beta(2)GPI T cell epitope specificity was clearly determined by MHC class II haplotype, a number of different beta(2)GP IT cell epitopes were associated with epitope spread to SLE-related autoantibodies. Notably, one beta(2)GPI T cell epitope (peptide 23, NTGFYLNGADSAKCT) was also recognized by T cells from an HLA-DRB1*0403(+) autoimmune patient. These data suggest that the generation of a beta(2)GPI-reacfive T cell response is associated with epitope spread to SLE-related autoantibodies, independent of epitope specificity or MHC class II restriction. On the basis of these findings, we propose that factors enabling a beta(2)GPI-reactive T cell response may predispose individuals to the development of SLE-related autoantibodies independent of their MHC class II haplotype.	[Salem, David; Subang, Rebecca; Laplante, Patrick; Rauch, Joyce] McGill Univ, Ctr Hlth, Res Inst, Div Rheumatol,Dept Med, Montreal, PQ H3G 1A4, Canada; [Okazaki, Yuka; Kuwana, Masataka] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo 1608582, Japan; [Levine, Jerrold S.] Univ Illinois, Dept Med, Nephrol Sect, Chicago, IL 60612 USA; [Levine, Jerrold S.] Jesse Brown Vet Affairs Med Ctr, Dept Med, Nephrol Sect, Chicago, IL 60612 USA	McGill University; Keio University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Rauch, J (corresponding author), Montreal Gen Hosp, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	joyce.rauch@mcgill.ca			Canadian Institutes of Health Research (CIHR)/Institute of Musculoskeletal Health and Arthritis (IMHA)/Arthritis Society [MOP-42391]; CIHR [MOP-67101, MOP-97916]; CIHR/IMHA [MUS-67101]; Japanese Ministry of Health, Labor and Welfare; Arthritis Society/Canadian Arthritis Network; Research Institute of the McGill University Health Centre; Section of Nephrology, University of Illinois at Chicago	Canadian Institutes of Health Research (CIHR)/Institute of Musculoskeletal Health and Arthritis (IMHA)/Arthritis Society(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); CIHR/IMHA(Canadian Institutes of Health Research (CIHR)); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Arthritis Society/Canadian Arthritis Network; Research Institute of the McGill University Health Centre; Section of Nephrology, University of Illinois at Chicago	This was supported in part by Canadian Institutes of Health Research (CIHR)/Institute of Musculoskeletal Health and Arthritis (IMHA)/Arthritis Society Grant MOP-42391, CIHR Grants MOP-67101 and MOP-97916, and CIHR/IMHA (Fall 2008 Priority Announcement) Grant MUS-67101 (to J. R.); and a research grant on intractable diseases from the Japanese Ministry of Health, Labor and Welfare (to M. K.).; Supported by postdoctoral fellowships from The Arthritis Society/Canadian Arthritis Network and the Research Institute of the McGill University Health Centre. Present address: Centre Hospitaller de l'Universite de Montreal Research Center, 900 St-Denis, Montreal, Quebec H2X 0A9, Canada.; Supported by institutional funds from Dr. Jose A. Arruda and the Section of Nephrology, University of Illinois at Chicago.	Arai T, 2001, BLOOD, V98, P1889, DOI 10.1182/blood.V98.6.1889; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Balasubramanian K, 1997, J BIOL CHEM, V272, P31113, DOI 10.1074/jbc.272.49.31113; Behar SM, 1999, J IMMUNOL, V162, P161; Blank M, 1998, J IMMUNOL, V161, P5303; Buttari B, 2011, BLOOD, V117, P6152, DOI 10.1182/blood-2010-12-325514; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Conti F, 2014, ARTERIOSCL THROM VAS, V34, P661, DOI 10.1161/ATVBAHA.113.302680; Galeazzi M, 2000, LUPUS, V9, P47, DOI 10.1177/096120330000900109; George J, 2000, CIRCULATION, V102, P1822; Hattori N, 2000, ARTHRITIS RHEUM-US, V43, P65, DOI 10.1002/1529-0131(200001)43:1<65::AID-ANR9>3.0.CO;2-I; HUNT JE, 1993, P NATL ACAD SCI USA, V90, P2141, DOI 10.1073/pnas.90.6.2141; Ito H, 2000, HUM IMMUNOL, V61, P366, DOI 10.1016/S0198-8859(99)00184-6; Kaburaki J, 1996, INTERNAL MED, V35, P105, DOI 10.2169/internalmedicine.35.105; Levine JS, 2014, LUPUS, V23, P752, DOI 10.1177/0961203314525676; Levine JS, 2006, J IMMUNOL, V177, P6504, DOI 10.4049/jimmunol.177.9.6504; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; McClain MT, 2004, ARTHRITIS RHEUM-US, V50, P1226, DOI 10.1002/art.20120; MCRAE BL, 1992, J NEUROIMMUNOL, V38, P229, DOI 10.1016/0165-5728(92)90016-E; Price BE, 1996, J IMMUNOL, V157, P2201; Qian Y, 2004, J IMMUNOL, V172, P625, DOI 10.4049/jimmunol.172.1.625; Reed JH, 2009, ARTHRITIS RHEUM-US, V60, P860, DOI 10.1002/art.24361; Tolomeo T, 2009, AUTOIMMUNITY, V42, P292, DOI 10.1080/08916930902828254; Visvanathan S, 1999, J IMMUNOL, V162, P6919	24	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5543	5554		10.1074/jbc.M114.619817	http://dx.doi.org/10.1074/jbc.M114.619817			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25555913	Green Published, hybrid			2022-12-26	WOS:000350044200026
J	Danies, G; Myers, K; Mideros, MF; Restrepo, S; Martin, FN; Cooke, DEL; Smart, CD; Ristaino, JB; Seaman, AJ; Gugino, BK; Grunwald, NJ; Fry, WE				Danies, Giovanna; Myers, Kevin; Mideros, Maria F.; Restrepo, Silvia; Martin, Frank N.; Cooke, David E. L.; Smart, Christine D.; Ristaino, Jean B.; Seaman, Abby J.; Gugino, Beth K.; Gruenwald, Niklaus J.; Fry, William E.			An Ephemeral Sexual Population of Phytophthora infestans in the Northeastern United States and Canada	PLOS ONE			English	Article							RECENT CLONAL LINEAGES; LATE BLIGHT; TOLUCA VALLEY; POTATO; GENOTYPES; OOSPORES; MEXICO; METALAXYL; INFERENCE; SOFTWARE	Phytophthora infestans, the causal agent of late blight disease, has been reported in North America since the mid-nineteenth century. In the United States the lack of or very limited sexual reproduction has resulted in largely clonal populations of P. infestans. In 2010 and 2011, but not in 2012 or 2013, 20 rare and diverse genotypes of P. infestans were detected in a region that centered around central New York State. The ratio of A1 to A2 mating types among these genotypes was close to the 50: 50 ratio expected for sexual recombination. These genotypes were diverse at the glucose-6-phosphate isomerase locus, differed in their microsatellite profiles, showed different banding patterns in a restriction fragment length polymorphism assay using a moderately repetitive and highly polymorphic probe (RG57), were polymorphic for four different nuclear genes and differed in their sensitivity to the systemic fungicide mefenoxam. The null hypothesis of linkage equilibrium was not rejected, which suggests the population could be sexual. These new genotypes were monomorphic in their mitochondrial haplotype that was the same as US-22. Through parentage exclusion testing using microsatellite data and sequences of four nuclear genes, recent dominant lineages US-8, US-11, US-23, and US-24 were excluded as possible parents for these genotypes. Further analyses indicated that US-22 could not be eliminated as a possible parent for 14 of the 20 genotypes. We conclude that US-22 could be a parent of some, but not all, of the new genotypes found in 2010 and 2011. There were at least two other parents for this population and the genotypic characteristics of the other parents were identified.	[Danies, Giovanna; Myers, Kevin; Fry, William E.] Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Ithaca, NY 14850 USA; [Mideros, Maria F.; Restrepo, Silvia] Univ Los Andes, Dept Biol Sci, Bogota, Colombia; [Martin, Frank N.] ARS, USDA, Salinas, CA USA; [Cooke, David E. L.] Invergowrie, James Hutton Inst, Dundee, Scotland; [Smart, Christine D.] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Geneva, NY USA; [Ristaino, Jean B.] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [Seaman, Abby J.] Cornell Cooperat Extens, New York State Integrated Pest Management Program, Geneva, NY USA; [Gugino, Beth K.] Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA; [Gruenwald, Niklaus J.] ARS, Hort Crops Res Lab, USDA, Corvallis, OR USA; [Gruenwald, Niklaus J.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Gruenwald, Niklaus J.] Oregon State Univ, Ctr Genome Biol & Biocomp, Corvallis, OR 97331 USA	Cornell University; Universidad de los Andes (Colombia); United States Department of Agriculture (USDA); James Hutton Institute; Cornell University; University of North Carolina; North Carolina State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Agriculture (USDA); Oregon State University; Oregon State University	Fry, WE (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Ithaca, NY 14850 USA.	wef1@cornell.edu	Grunwald, Niklaus` J/K-6041-2013; Cooke, David/D-1933-2012; MIDEROS, MARIA F/C-9932-2016; Myers, Kevin/GZK-8865-2022; MIDEROS, MARIA FERNANDA/GPG-1874-2022; Ristaino, Jean Beagle/N-3616-2018	Grunwald, Niklaus` J/0000-0003-1656-7602; Cooke, David/0000-0002-9154-7954; Ristaino, Jean Beagle/0000-0002-9458-0514; Smart, Christine/0000-0003-4162-9502	Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture [2011-68004-30154]; USDA Sustainable Agriculture Research and Education [SARE GNE13-056]; College of Agriculture and Life Sciences at Cornell University; ARS [ARS-0426096] Funding Source: Federal RePORTER	Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture; USDA Sustainable Agriculture Research and Education; College of Agriculture and Life Sciences at Cornell University; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the Agriculture and Food Research Initiative Competitive Grants Program Grant 2011-68004-30154 from the USDA National Institute of Food and Agriculture, by the USDA Sustainable Agriculture Research and Education (SARE GNE13-056), and by the College of Agriculture and Life Sciences at Cornell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Blair JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037003; CATEN CE, 1968, CAN J BOTANY, V46, P329, DOI 10.1139/b68-055; Cooke DEL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002940; Danies G, 2013, PLANT DIS, V97, P873, DOI 10.1094/PDIS-07-12-0682-RE; DRENTH A, 1995, PLANT PATHOL, V44, P86, DOI 10.1111/j.1365-3059.1995.tb02719.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fernandez-Pavia SP, 2004, PLANT DIS, V88, P29, DOI 10.1094/PDIS.2004.88.1.29; Flier WG, 2001, MYCOL RES, V105, P998, DOI 10.1016/S0953-7562(08)61958-9; Fry WE, 2013, PLANT DIS, V97, P296, DOI 10.1094/PDIS-08-12-0791-FE; Fry WE, 1997, PLANT DIS, V81, P1349, DOI 10.1094/PDIS.1997.81.12.1349; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Gavino PD, 2000, PLANT DIS, V84, P731, DOI 10.1094/PDIS.2000.84.7.731; GOODWIN SB, 1995, PLANT DIS, V79, P1181, DOI 10.1094/PD-79-1181; GOODWIN SB, 1995, PHYTOPATHOLOGY, V85, P669, DOI 10.1094/Phyto-85-669; Goodwin SB, 1996, PHYTOPATHOLOGY, V86, P793, DOI 10.1094/Phyto-86-793; Goodwin SB, 1997, PHYTOPATHOLOGY, V87, P462, DOI 10.1094/PHYTO.1997.87.4.462; GOODWIN SB, 1994, PHYTOPATHOLOGY, V84, P553, DOI 10.1094/Phyto-84-553; GOODWIN SB, 1994, P NATL ACAD SCI USA, V91, P11591, DOI 10.1073/pnas.91.24.11591; GOODWIN SB, 1992, CURR GENET, V22, P107, DOI 10.1007/BF00351469; Goss EM, 2014, P NATL ACAD SCI USA, V111, P8791, DOI 10.1073/pnas.1401884111; Grunwald NJ, 2012, TRENDS MICROBIOL, V20, P131, DOI 10.1016/j.tim.2011.12.006; Grunwald NJ, 2005, ANNU REV PHYTOPATHOL, V43, P171, DOI 10.1146/annurev.phyto.43.040204.135906; Grunwald NJ, 2001, PHYTOPATHOLOGY, V91, P882, DOI 10.1094/PHYTO.2001.91.9.882; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hu CH, 2012, PLANT DIS, V96, P1323, DOI 10.1094/PDIS-03-11-0156-RE; Jaime-Garcia R, 2000, PHYTOPATHOLOGY, V90, P1188, DOI 10.1094/PHYTO.2000.90.11.1188; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; KARLOVSKY P, 1991, GENE, V109, P161, DOI 10.1016/0378-1119(91)90603-9; Lambert DH, 1997, AM POTATO J, V74, P39, DOI 10.1007/BF02849171; LEGARD DE, 1995, PHYTOPATHOLOGY, V85, P1356, DOI 10.1094/Phyto-85-1356; Li Y, 2013, J MICROBIOL METH, V92, P316, DOI 10.1016/j.mimet.2012.11.021; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MARTIN FN, 2012, PHYTOPATHOLOGY S4, V102, P76; Miller JS, 1998, PHYTOPATHOLOGY, V88, P190, DOI 10.1094/PHYTO.1998.88.3.190; Miller M.A., 2010, P GAT COMP ENV WORKS; Myers K, 2011, PHYTOPATHOLOGY, V101, pS261; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Small IM, 2012, PHYTOPATHOLOGY, V102, P110; TAJIMA F, 1989, GENETICS, V123, P585; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; THERRIEN CD, 1993, MYCOL RES, V97, P945, DOI 10.1016/S0953-7562(09)80860-5; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Yuen JE, 2013, PLANT PATHOL, V62, P485, DOI 10.1111/j.1365-3059.2012.02685.x	52	28	30	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116354	10.1371/journal.pone.0116354	http://dx.doi.org/10.1371/journal.pone.0116354			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551215	gold, Green Submitted, Green Published			2022-12-26	WOS:000347119100133
J	Isensee, J; Wenzel, C; Buschow, R; Weissmann, R; Kuss, AW; Hucho, T				Isensee, Joerg; Wenzel, Carsten; Buschow, Rene; Weissmann, Robert; Kuss, Andreas W.; Hucho, Tim			Subgroup-Elimination Transcriptomics Identifies Signaling Proteins that Define Subclasses of TRPV1-Positive Neurons and a Novel Paracrine Circuit	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; GENE-RELATED PEPTIDE; PROSTATIC ACID-PHOSPHATASE; PERIPHERAL SENSORY NEURONS; PRIMARY AFFERENT NEURONS; CAPSAICIN RECEPTOR; INFLAMMATORY PAIN; KINASE-II; VANILLOID RECEPTOR-1; MOLECULAR-MECHANISMS	Normal and painful stimuli are detected by specialized subgroups of peripheral sensory neurons. The understanding of the functional differences of each neuronal subgroup would be strongly enhanced by knowledge of the respective subgroup transcriptome. The separation of the subgroup of interest, however, has proven challenging as they can hardly be enriched. Instead of enriching, we now rapidly eliminated the subgroup of neurons expressing the heat-gated cation channel TRPV1 from dissociated rat sensory ganglia. Elimination was accomplished by brief treatment with TRPV1 agonists followed by the removal of compromised TRPV1(+) neurons using density centrifugation. By differential microarray and sequencing (RNA-Seq) based expression profiling we compared the transcriptome of all cells within sensory ganglia versus the same cells lacking TRPV1 expressing neurons, which revealed 240 differentially expressed genes (adj. p<.05, fold-change >1.5). Corroborating the specificity of the approach, many of these genes have been reported to be involved in noxious heat or pain sensitization. Beyond the expected enrichment of ion channels, we found the TRPV1 transcriptome to be enriched for GPCRs and other signaling proteins involved in adenosine, calcium, and phosphatidylinositol signaling. Quantitative population analysis using a recent High Content Screening (HCS) microscopy approach identified substantial heterogeneity of expressed target proteins even within TRPV1-positive neurons. Signaling components defined distinct further subgroups within the population of TRPV1-positive neurons. Analysis of one such signaling system showed that the pain sensitizing prostaglandin PGD2 activates DP1 receptors expressed predominantly on TRPV1(+) neurons. In contrast, we found the PGD2 producing prostaglandin D synthase to be expressed exclusively in myelinated large-diameter neurons lacking TRPV1, which suggests a novel paracrine neuron-neuron communication. Thus, subgroup analysis based on the elimination rather than enrichment of the subgroup of interest revealed proteins that define subclasses of TRPV1-positive neurons and suggests a novel paracrine circuit.	[Isensee, Joerg; Hucho, Tim] Univ Hosp, Dept Anesthesiol & Intens Care Med, Cologne, Germany; [Isensee, Joerg; Wenzel, Carsten; Buschow, Rene; Hucho, Tim] Max Planck Inst Mol Genet, Dept Human Mol Genet, D-14195 Berlin, Germany; [Weissmann, Robert; Kuss, Andreas W.] Univ Med Greifswald, Dept Human Genet, Greifswald, Germany; [Weissmann, Robert; Kuss, Andreas W.] Ernst Moritz Arndt Univ Greifswald, Interfaculty Inst Genet & Funct Gen, Greifswald, Germany	University of Cologne; Max Planck Society; Greifswald Medical School; Ernst Moritz Arndt Universitat Greifswald	Isensee, J (corresponding author), Univ Hosp, Dept Anesthesiol & Intens Care Med, Cologne, Germany.	joerg.isensee@uk-koeln.de	Isensee, Joerg/C-4745-2019; Hucho, Tim/Q-5218-2018; Buschow, René/AAZ-5533-2021	Isensee, Joerg/0000-0002-3390-0051; Hucho, Tim/0000-0002-4147-9308; Buschow, René/0000-0002-9800-2578; Kuss, Andreas/0000-0002-9401-4627	project 'Modelling pain switches (MoPS)' - Federal Ministry of Education and Research, Germany [FKZ0315449D]; project NoPain - Federal Ministry of Education and Research, Germany [FKZ0316177A, FKZ0316177FF]	project 'Modelling pain switches (MoPS)' - Federal Ministry of Education and Research, Germany; project NoPain - Federal Ministry of Education and Research, Germany	This work was supported by the projects 'Modelling pain switches (MoPS)' (FKZ0315449D) and NoPain (FKZ0316177A, FKZ0316177FF) funded by the Federal Ministry of Education and Research, Germany (http://www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Alloui A, 2006, EMBO J, V25, P2368, DOI 10.1038/sj.emboj.7601116; Amaya F, 2004, EUR J NEUROSCI, V20, P2303, DOI 10.1111/j.1460-9568.2004.03701.x; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andres C, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-98; Bali KK, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-48; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Brown DC, 2005, ANESTHESIOLOGY, V103, P1052, DOI 10.1097/00000542-200511000-00020; Bruggemann I, 2000, MOL BRAIN RES, V85, P239, DOI 10.1016/S0169-328X(00)00265-5; Carlton SM, 2002, J COMP NEUROL, V448, P102, DOI 10.1002/cne.10250; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Chen LH, 2013, PROSTAG OTH LIPID M, V104, P58, DOI 10.1016/j.prostaglandins.2012.08.006; Chiu HY, 2010, REGUL PEPTIDES, V164, P90, DOI 10.1016/j.regpep.2010.05.012; Chiu HY, 2009, REGUL PEPTIDES, V158, P77, DOI 10.1016/j.regpep.2009.07.012; Choi SS, 2006, BRAIN RES, V1108, P28, DOI 10.1016/j.brainres.2006.06.048; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Dhaka A, 2009, J NEUROSCI, V29, P153, DOI 10.1523/JNEUROSCI.4901-08.2009; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ebersberger A, 2011, PAIN, V152, P1114, DOI 10.1016/j.pain.2011.01.033; Enyedi P, 2012, MOL CELL ENDOCRINOL, V353, P75, DOI 10.1016/j.mce.2011.11.009; Fink CC, 2002, CURR OPIN NEUROBIOL, V12, P293, DOI 10.1016/S0959-4388(02)00327-6; Goswami C, 2007, J NEUROCHEM, V101, P250, DOI 10.1111/j.1471-4159.2006.04338.x; Goswami C, 2011, J NEUROCHEM; Goswami SC, 2014, J PAIN; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Huang CW, 2007, MOL CELL NEUROSCI, V36, P195, DOI 10.1016/j.mcn.2007.06.010; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang F, 2013, NAT NEUROSCI, V16, P1284, DOI 10.1038/nn.3468; Hucho T, 2007, NEURON, V55, P365, DOI 10.1016/j.neuron.2007.07.008; Iadarola MJ, 2011, CURR TOP MED CHEM, V11, P2171; Isensee J, 2014, J CELL SCI, V127, P216, DOI 10.1242/jcs.136580; Ivanusic JJ, 2012, NEUROPEPTIDES, V46, P55, DOI 10.1016/j.npep.2011.09.002; JEFTINIJA S, 1992, REGUL PEPTIDES, V39, P123, DOI 10.1016/0167-0115(92)90534-2; Jenkins DW, 2001, BRIT J PHARMACOL, V134, P1296, DOI 10.1038/sj.bjp.0704357; Jeske NA, 2011, J NEUROSCI, V31, P8681, DOI 10.1523/JNEUROSCI.0020-11.2011; Jimenez-Andrade JM, 2004, PAIN, V110, P10, DOI 10.1016/j.pain.2004.02.032; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kan KKW, 2004, EUR J PHARMACOL, V491, P37, DOI 10.1016/j.ejphar.2004.02.058; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Kesingland AC, 2000, PAIN, V86, P113, DOI 10.1016/S0304-3959(00)00233-5; Kojundzic SL, 2010, J COMP NEUROL, V518, P64, DOI 10.1002/cne.22209; Kozsurek M, 2007, EUR J NEUROSCI, V26, P1624, DOI 10.1111/j.1460-9568.2007.05789.x; Kozsurek M, 2009, EUR J NEUROSCI, V29, P2375, DOI 10.1111/j.1460-9568.2009.06773.x; Ku GM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002449; LaCroix-Fralish ML, 2007, PAIN, V131, DOI 10.1016/j.pain.2007.04.041; Landry M, 2000, EXP NEUROL, V162, P361, DOI 10.1006/exnr.1999.7329; Leipold E, 2013, NAT GENET, V45, P1399, DOI 10.1038/ng.2767; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005705; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Lu RR, 2014, PAIN, V155, P556, DOI 10.1016/j.pain.2013.12.005; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Luo F, 2008, J PHARMACOL EXP THER, V325, P267, DOI 10.1124/jpet.107.132167; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; Mandadi S, 2006, PAIN, V123, P106, DOI 10.1016/j.pain.2006.02.016; Manteniotis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079523; Matsumoto M, 2005, MOL BRAIN RES, V138, P58, DOI 10.1016/j.molbrainres.2005.04.002; McMahon SB, 2013, WALL MELZACKS TXB PA, P1; Mishra SK, 2012, J NEUROSCI, V32, P8686, DOI 10.1523/JNEUROSCI.1533-12.2012; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; Mishra SK, 2010, MOL CELL NEUROSCI, V43, P157, DOI 10.1016/j.mcn.2009.10.006; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murakami Y, 2003, ARTHRITIS RHEUM, V48, P2931, DOI 10.1002/art.11271; Neely GG, 2010, CELL, V143, P628, DOI 10.1016/j.cell.2010.09.047; Neely GG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003071; Nuwer MO, 2010, J NEUROSCI, V30, P14165, DOI 10.1523/JNEUROSCI.3150-10.2010; Oka S, 2010, BIOCHEM BIOPH RES CO, V395, P232, DOI 10.1016/j.bbrc.2010.03.169; Olah Z, 2001, J BIOL CHEM, V276, P11021, DOI 10.1074/jbc.M008392200; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Pattinson D, 2006, MOL CELL NEUROSCI, V33, P88, DOI 10.1016/j.mcn.2006.06.010; Peeters PJ, 2006, PHYSIOL GENOMICS, V24, P252, DOI 10.1152/physiolgenomics.00169.2005; Perkins JR, 2013, PAIN, V154, DOI 10.1016/j.pain.2013.09.003; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Price TJ, 2007, J PAIN, V8, P263, DOI 10.1016/j.jpain.2006.09.005; Quick K, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120068; R Development Core Team, 2021, R PROJECT STAT COMPU; Rasband W., 2006, IMAGEJ; Rau KK, 2009, J NEUROSCI, V29, P8612, DOI 10.1523/JNEUROSCI.1057-09.2009; Reichling DB, 2013, PAIN, V154, pS2, DOI 10.1016/j.pain.2013.05.037; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Rogge G, 2008, NAT REV NEUROSCI, V9, P747, DOI 10.1038/nrn2493; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; RUEFF A, 1993, AGENTS ACTIONS, V38, pC13, DOI 10.1007/BF01991122; RUSSELL LC, 1984, BRAIN RES REV, V8, P165, DOI 10.1016/0165-0173(84)90005-5; Schmidtko A, 2009, TRENDS NEUROSCI, V32, P339, DOI 10.1016/j.tins.2009.01.010; Schnizler K, 2008, J NEUROSCI, V28, P4904, DOI 10.1523/JNEUROSCI.0233-08.2008; Shinohara T, 2004, J BIOL CHEM, V279, P23559, DOI 10.1074/jbc.M314240200; Simonetti M, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-11; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; SZALLASI A, 1989, NEUROSCIENCE, V30, P515, DOI 10.1016/0306-4522(89)90269-8; SZALLASI A, 1989, BRAIN RES, V503, P68, DOI 10.1016/0006-8993(89)91705-8; Taylor-Blake B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008674; Tender GC, 2005, J NEUROSURG, V102, P522, DOI 10.3171/jns.2005.102.3.0522; Tomassy GS, 2014, SCIENCE, V344, P319, DOI 10.1126/science.1249766; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Traynor J, 2010, ANN NY ACAD SCI, V1187, P341, DOI 10.1111/j.1749-6632.2009.05150.x; Traynor JR, 1998, BRIT J ANAESTH, V81, P69, DOI 10.1093/bja/81.1.69; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vay L, 2012, BRIT J PHARMACOL, V165, P787, DOI 10.1111/j.1476-5381.2011.01601.x; WAKISAKA S, 1991, NEUROSCI LETT, V124, P200, DOI 10.1016/0304-3940(91)90093-9; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Wei F, 2002, NAT NEUROSCI, V5, P573, DOI 10.1038/nn0602-855; Westlund KN, 2014, NEUROSCIENCE, V262, P165, DOI 10.1016/j.neuroscience.2013.12.043; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Woodbury CJ, 2004, J NEUROSCI, V24, P6410, DOI 10.1523/JNEUROSCI.1421-04.2004; Xu XJ, 2010, EXPERIENTIA SUPPL, V102, P39, DOI 10.1007/978-3-0346-0228-0_4; Yu L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-61; Zayed N, 2008, ARTHRITIS RHEUM-US, V58, P3530, DOI 10.1002/art.23958; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhao PW, 2010, MOL PHARMACOL, V78, P560, DOI 10.1124/mol.110.066746; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024	120	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115731	10.1371/journal.pone.0115731	http://dx.doi.org/10.1371/journal.pone.0115731			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551770	Green Submitted, Green Published, gold			2022-12-26	WOS:000347119100056
J	Scalfi, M; Mosca, E; Di Pierro, EA; Troggio, M; Vendramin, GG; Sperisen, C; La Porta, N; Neale, DB				Scalfi, Marta; Mosca, Elena; Di Pierro, Erica Adele; Troggio, Michela; Vendramin, Giovanni Giuseppe; Sperisen, Christoph; La Porta, Nicola; Neale, David B.			Micro- and Macro-Geographic Scale Effect on the Molecular Imprint of Selection and Adaptation in Norway Spruce	PLOS ONE			English	Article							PINE PINUS-TAEDA; GENETIC-STRUCTURE; PICEA-ABIES; LOCAL ADAPTATION; POPULATION DIFFERENTIATION; CLIMATE; MITOCHONDRIAL; DIVERSITY; GENOME; L.	Forest tree species of temperate and boreal regions have undergone a long history of demographic changes and evolutionary adaptations. The main objective of this study was to detect signals of selection in Norway spruce (Picea abies [L.] Karst), at different sampling-scales and to investigate, accounting for population structure, the effect of environment on species genetic diversity. A total of 384 single nucleotide polymorphisms (SNPs) representing 290 genes were genotyped at two geographic scales: across 12 populations distributed along two altitudinal-transects in the Alps (micro-geographic scale), and across 27 populations belonging to the range of Norway spruce in central and south-east Europe (macro-geographic scale). At the macrogeographic scale, principal component analysis combined with Bayesian clustering revealed three major clusters, corresponding to the main areas of southern spruce occurrence, i.e. the Alps, Carpathians, and Hercynia. The populations along the altitudinal transects were not differentiated. To assess the role of selection in structuring genetic variation, we applied a Bayesian and coalescent-based F-ST-outlier method and tested for correlations between allele frequencies and climatic variables using regression analyses. At the macrogeographic scale, the F-ST-outlier methods detected together 11 F-ST-outliers. Six outliers were detected when the same analyses were carried out taking into account the genetic structure. Regression analyses with population structure correction resulted in the identification of two (micro-geographic scale) and 38 SNPs (macro-geographic scale) significantly correlated with temperature and/or precipitation. Six of these loci overlapped with F-ST-outliers, among them two loci encoding an enzyme involved in riboflavin biosynthesis and a sucrose synthase. The results of this study indicate a strong relationship between genetic and environmental variation at both geographic scales. It also suggests that an integrative approach combining different outlier detection methods and population sampling at different geographic scales is useful to identify loci potentially involved in adaptation.	[Scalfi, Marta; Mosca, Elena; Di Pierro, Erica Adele; Troggio, Michela; La Porta, Nicola; Neale, David B.] Fdn Edmund Mach FEM, Res & Innovat Ctr, Trento, Italy; [Vendramin, Giovanni Giuseppe] CNR, Inst Biosci & Bioresources, Florence, Italy; [Sperisen, Christoph] Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland; [Neale, David B.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	Fondazione Edmund Mach; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of California System; University of California Davis	Mosca, E (corresponding author), Fdn Edmund Mach FEM, Res & Innovat Ctr, Trento, Italy.	elena.mosca@fmach.it	La Porta, Nicola/G-8461-2011; Di Pierro, Erica A/AAI-8868-2020; Sperisen, Christoph/S-1383-2019; Vendramin, Giovanni G/K-9731-2014	La Porta, Nicola/0000-0002-7080-3349; Sperisen, Christoph/0000-0003-1241-5636; Vendramin, Giovanni G/0000-0001-9921-7872; Mosca, Elena/0000-0001-6575-053X; Di Pierro, Erica Adele/0000-0002-3394-3190	project "PECC-Genetic and molecular analysis of Picea abies: Variability and adaptive evolution of the species under conditions of global change''; Autonomous Province of Trento (Italy) [23]; ACE-SAP project "Alpine Ecosystems in a Changing Environment: Biodiversity Sensitivity and Adaptive Potential" - Autonomous Province of Trento (Italy) [23]; European Commission through the FP7-project FORGER, "Towards the Sustainable Management of Forest Genetic Resources in Europe'' [KBBE-289119]	project "PECC-Genetic and molecular analysis of Picea abies: Variability and adaptive evolution of the species under conditions of global change''; Autonomous Province of Trento (Italy)(Autonomous Province of Trento); ACE-SAP project "Alpine Ecosystems in a Changing Environment: Biodiversity Sensitivity and Adaptive Potential" - Autonomous Province of Trento (Italy); European Commission through the FP7-project FORGER, "Towards the Sustainable Management of Forest Genetic Resources in Europe''	MS's study was financed by the project "PECC-Genetic and molecular analysis of Picea abies: Variability and adaptive evolution of the species under conditions of global change'', funded by the Autonomous Province of Trento (Italy), with the regulation N. 23, 2007. EM and EADP were supported by the ACE-SAP project "Alpine Ecosystems in a Changing Environment: Biodiversity Sensitivity and Adaptive Potential" partially funded by the Autonomous Province of Trento (Italy), with the regulation No. 23, June 12, 2008. GGV was supported by a grant of the European Commission through the FP7-project FORGER, "Towards the Sustainable Management of Forest Genetic Resources in Europe'' (KBBE-289119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto FJ, 2013, GLOBAL CHANGE BIOL, V19, P1645, DOI 10.1111/gcb.12181; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bedon F, 2010, J EXP BOT, V61, P3847, DOI 10.1093/jxb/erq196; Bucci G, 2000, MOL ECOL, V9, P923, DOI 10.1046/j.1365-294x.2000.00946.x; Cheddadi R, 2006, GLOBAL ECOL BIOGEOGR, V15, P271, DOI [10.1111/j.1466-822x.2006.00226.x, 10.1111/j.1466-822X.2006.00226.x]; Chen J, 2012, GENETICS, V191, P865, DOI 10.1534/genetics.112.140749; Collignon AM, 2002, CAN J FOREST RES, V32, P266, DOI [10.1139/x01-198, 10.1139/X01-198]; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; DABNEY A, 2012, QVALUE Q VALUE ESTIM; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Eckert AJ, 2010, GENETICS, V185, P969, DOI 10.1534/genetics.110.115543; Eckert AJ, 2010, MOL ECOL, V19, P3789, DOI 10.1111/j.1365-294X.2010.04698.x; Eckert AJ, 2009, GENETICS, V183, P289, DOI 10.1534/genetics.109.103895; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Gomory D, 2012, EUR J FOREST RES, V131, P401, DOI 10.1007/s10342-011-0512-6; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Grivet D, 2011, MOL BIOL EVOL, V28, P101, DOI 10.1093/molbev/msq190; Heuertz M, 2006, GENETICS, V174, P2095, DOI 10.1534/genetics.106.065102; Keller SR, 2012, MOL BIOL EVOL, V29, P3143, DOI 10.1093/molbev/mss121; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Korves TM, 2007, AM NAT, V169, pE141, DOI 10.1086/513111; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Krutzsch P., 1974, Silvae Genetica, V23, P58; LAGERCRANTZ U, 1990, EVOLUTION, V44, P38, DOI 10.1111/j.1558-5646.1990.tb04278.x; Latalowa M, 2006, QUATERNARY SCI REV, V25, P2780, DOI 10.1016/j.quascirev.2006.06.007; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Lockwood JD, 2013, MOL PHYLOGENET EVOL, V69, P717, DOI 10.1016/j.ympev.2013.07.004; Loopstra CA, 2004, PINUS HALEPENS UNPUB; Maghuly F, 2006, FOREST ECOL MANAG, V222, P266, DOI 10.1016/j.foreco.2005.10.025; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Mosca E, 2012, MOL ECOL, V21, P5530, DOI 10.1111/mec.12043; Mosca E, 2014, NEW PHYTOL, V201, P180, DOI 10.1111/nph.12476; Namroud MC, 2008, MOL ECOL, V17, P3599, DOI 10.1111/j.1365-294X.2008.03840.x; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; NEI M, 1975, GENETICS, V80, P395; Nielsen R, 2009, GENOME RES, V19, P838, DOI 10.1101/gr.088336.108; Olsson C, 2013, ECOL MODEL, V266, P103, DOI 10.1016/j.ecolmodel.2013.06.026; Piotti A, 2009, HEREDITY, V103, P136, DOI 10.1038/hdy.2009.42; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Prunier J, 2012, MOL ECOL, V21, P4270, DOI 10.1111/j.1365-294X.2012.05691.x; Prunier J, 2011, MOL ECOL, V20, P1702, DOI 10.1111/j.1365-294X.2011.05045.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruan YL, 2010, MOL PLANT, V3, P942, DOI 10.1093/mp/ssq044; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Sboarina C., 2004, 33 CTR EC ALP; Schmidt-Vogt H., 1974, Allgemeine Forst- und Jagdzeitung, V145, P185; Schmidt-Vogt H., 1974, DIE FICHTE; SKROPPA T, 1993, SILVAE GENET, V42, P111; Sogaard G, 2008, TREE PHYSIOL, V28, P311, DOI 10.1093/treephys/28.2.311; Sperisen C, 2001, MOL ECOL, V10, P257, DOI 10.1046/j.1365-294X.2001.01180.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tollefsrud MM, 2009, HEREDITY, V102, P549, DOI 10.1038/hdy.2009.16; Tollefsrud MM, 2008, MOL ECOL, V17, P4134, DOI 10.1111/j.1365-294X.2008.03893.x; Wang TL, 2010, ECOL APPL, V20, P153, DOI 10.1890/08-2257.1; Wegrzyn JL, 2009, BIOINFORMATICS, V25, P2609, DOI 10.1093/bioinformatics/btp477; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yang RC, 1998, EVOLUTION, V52, P950, DOI 10.1111/j.1558-5646.1998.tb01824.x; Zhang SJ, 2009, J INTEGR PLANT BIOL, V51, P167, DOI 10.1111/j.1744-7909.2008.00763.x	64	25	25	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115499	10.1371/journal.pone.0115499	http://dx.doi.org/10.1371/journal.pone.0115499			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551624	Green Published, gold, Green Submitted			2022-12-26	WOS:000347119100040
J	Shebl, FM; Hsing, AW; Park, Y; Hollenbeck, AR; Chu, LW; Meyer, TE; Koshiol, J				Shebl, Fatma M.; Hsing, Ann W.; Park, Yikyung; Hollenbeck, Albert R.; Chu, Lisa W.; Meyer, Tamra E.; Koshiol, Jill			Non-Steroidal Anti-Inflammatory Drugs Use Is Associated with Reduced Risk of Inflammation-Associated Cancers: NIH-AARP Study	PLOS ONE			English	Article							LONG-TERM USE; LARGE COHORT; ASPIRIN USE; COLORECTAL-CANCER; GASTRIC-CANCER; NSAID USE; INVERSE ASSOCIATION; ESOPHAGEAL CANCER; ACETAMINOPHEN USE; RANDOMIZED-TRIAL	Background: Chronic inflammation has been linked to cancers, and use of nonsteroidal anti-inflammatory drugs (NSAIDs) has been associated with reduced risk of several cancers. To further refine the magnitude of NSAID-related associations, in particular for cancers related to inflammation, such as alcohol-, infection-, obesity-, and smoking-related cancers, as well as for less common cancers, we evaluated the use of NSAIDs and cancer risk in a very large cohort. We used propensity scores to account for potential selection bias and hypothesized that NSAID use is associated with decreased cancer incidence. Methods: We conducted a prospective study among 314,522 participants in the NIH-AARP Diet and Health Study. Individuals who completed the lifestyle questionnaire, which included NSAID use, in 1996-1997 were followed through 2006. Information on cancer incidence was ascertained by linking to cancer registries and vital status databases. Findings: During 2,715,994 person-years of follow-up (median 10.1 person-years), there were 51,894 incident cancers. Compared with non-users of NSAIDs, individuals who reported use in the 12 months prior to interview had a significantly lower risk of all inflammation-related cancer, alcohol-related, infection-related, obesity-related, and smoking-related cancers [hazard ratio (HR) (95% CI)) 0.90 (0.87-0.93), 0.80 (0.74-0.85), 0.82 (0.78-0.87), 0.88 (0.84-0.92), and 0.88 (0.85-0.92) respectively)]. Conclusions: After accounting for potential selection bias, our data showed an inverse association between NSAID use and alcohol-related, infection-related, obesity-related, and smoking-related cancers and support the hypothesis that inflammation is related to an increased risk of certain cancers.	[Shebl, Fatma M.; Hsing, Ann W.; Park, Yikyung; Meyer, Tamra E.; Koshiol, Jill] NCI, Div Canc Epidemiol & Genet, NIH, Dept Human Hlth & Serv, Rockville, MD USA; [Hollenbeck, Albert R.] AARP, Washington, DC USA; [Chu, Lisa W.] Canc Prevent Inst Calif, Fremont, CA USA; [Chu, Lisa W.] Stanford Canc Inst, Palo Alto, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Association of Retired Persons (AARP); Cancer Prevention Institute of California; Stanford Cancer Institute	Shebl, FM (corresponding author), Yale Univ, Dept Chron Dis Epidemiol, Sch Publ Hlth, New Haven, CT 06520 USA.	fatma.shebl@yale.edu	Hollenbeck, Albert/AAG-9461-2020; koshiol, Jill/L-8686-2014	koshiol, Jill/0000-0002-3832-6204	Intramural Research Program of the NIH, National Cancer Institute	Intramural Research Program of the NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, CURR OPIN GENET DEV, V18, P3, DOI 10.1016/j.gde.2008.01.003; Anderson KE, 2002, J NATL CANCER I, V94, P1168, DOI 10.1093/jnci/94.15.1168; [Anonymous], 2010, IARC MONOGRAPHS EVAL; Asgari MM, 2008, J NATL CANCER I, V100, P967, DOI 10.1093/jnci/djn154; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Bardou M, 2004, CLIN GASTROENTEROL H, V2, P880, DOI 10.1016/S1542-3565(04)00389-1; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Bodelon C, 2009, AM J EPIDEMIOL, V170, P1512, DOI 10.1093/aje/kwp321; Bosetti C, 2003, BRIT J CANCER, V88, P672, DOI 10.1038/sj.bjc.6600820; Bosetti C, 2006, CANCER CAUSE CONTROL, V17, P871, DOI 10.1007/s10552-006-0033-7; Bosetti C, 2009, RECENT RESULTS CANC, V181, P231; Burn J, 2011, CANCER PREV RES, V4, P655, DOI 10.1158/1940-6207.CAPR-11-0106; Chan AT, 2008, GASTROENTEROLOGY, V134, P21, DOI 10.1053/j.gastro.2007.09.035; Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914; Chan AT, 2011, CANC PREV RES; Chang ET, 2010, CANCER EPIDEM BIOMAR, V19, P59, DOI 10.1158/1055-9965.EPI-09-0909; Cole BF, 2009, J NATL CANCER I, V101, P256, DOI 10.1093/jnci/djn485; Coogan PF, 2010, PHARMACOEPIDEM DR S, V19, P752, DOI 10.1002/pds.1970; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Corley DA, 2003, GASTROENTEROLOGY, V124, P47, DOI 10.1053/gast.2003.50008; Curiel-Lewandrowski C, 2011, J INVEST DERMATOL, V131, P1460, DOI 10.1038/jid.2011.58; Danforth KN, 2009, CANCER PREV RES, V2, P466, DOI 10.1158/1940-6207.CAPR-08-0239; Daugherty SE, 2011, CANCER PREV RES, V4, P2027, DOI 10.1158/1940-6207.CAPR-11-0274; Daugherty SE, 2011, AM J EPIDEMIOL, V173, P721, DOI 10.1093/aje/kwq437; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; FUNKHOUSER EM, 1995, CANCER-AM CANCER SOC, V76, P1116, DOI 10.1002/1097-0142(19951001)76:7<1116::AID-CNCR2820760703>3.0.CO;2-I; Gallicchio L, 2007, INT J CANCER, V121, P211, DOI 10.1002/ijc.22656; Gao JC, 2004, CANCER SCI, V95, P901, DOI 10.1111/j.1349-7006.2004.tb02200.x; Gonzalez-Perez A, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-28; Greenspan EJ, 2011, CANCER PREV RES, V4, P161, DOI 10.1158/1940-6207.CAPR-10-0021; Grosch S, 2006, JNCI-J NATL CANCER I, V98, P736, DOI 10.1093/jnci/djj206; Haas M, 2011, VIRCHOWS ARCH, V458, P403, DOI 10.1007/s00428-011-1058-1; Harris RE, 2001, ONCOL REP, V8, P655; Hernandez-Diaz S, 2007, INT J CANCER, V120, P1565, DOI 10.1002/ijc.22514; Hossain MA, 2012, INT J ONCOL, V40, P1298, DOI 10.3892/ijo.2011.1304; Jacobs EJ, 2005, JNCI-J NATL CANCER I, V97, P975, DOI 10.1093/jnci/dji173; Jacobs EJ, 2007, JNCI-J NATL CANCER I, V99, P608, DOI 10.1093/jnci/djk132; Janssen A, 2006, EUR J PHARMACOL, V540, P24, DOI 10.1016/j.ejphar.2006.04.030; Jayaprakash V, 2006, ARCH OTOLARYNGOL, V132, P1231, DOI 10.1001/archotol.132.11.1231; Jeter JM, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/598571; Johannesdottir SA, 2012, CANCER; Joosse A, 2009, J INVEST DERMATOL, V129, P2620, DOI 10.1038/jid.2009.201; Kasum CM, 2003, CANCER EPIDEM BIOMAR, V12, P534; Khan Z, 2011, CURR DRUG TARGETS, V12, P1082, DOI 10.2174/138945011795677764; Legge F, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-214; Li GQ, 2008, HELICOBACTER, V13, P20, DOI 10.1111/j.1523-5378.2008.00585.x; Luo T, 2011, BREAST CANC RES TREA; Macfarlane TV, 2012, ANN ONCOL, V23, P1053, DOI 10.1093/annonc/mdr335; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; Mantovani A, 2008, CANCER LETT, V267, P180, DOI 10.1016/j.canlet.2008.05.003; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McCormack VA, 2011, CANCER CAUSE CONTROL, V22, P1709, DOI 10.1007/s10552-011-9847-z; Michaud D, 2005, J REGISTRY MANAGE, V2, P70; Moysich KB, 2005, CANCER EPIDEM BIOMAR, V14, P2923, DOI 10.1158/1055-9965.EPI-05-0457; National Cancer Institute, 2013, FACT SHEET ALC CANC; Prizment AE, 2010, CANCER EPIDEM BIOMAR, V19, P435, DOI 10.1158/1055-9965.EPI-09-0976; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Ross JA, 2011, CANCER EPIDEM BIOMAR, V20, P1741, DOI 10.1158/1055-9965.EPI-11-0411; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Ruder EH, 2011, AM J GASTROENTEROL, V106, P1340, DOI 10.1038/ajg.2011.38; Sahasrabuddhe VV, 2012, JNCI-J NATL CANCER I, V104, P1808, DOI 10.1093/jnci/djs452; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; SCHREINEMACHERS DM, 1994, EPIDEMIOLOGY, V5, P138, DOI 10.1097/00001648-199403000-00003; Schror K, 2011, BEST PRACT RES CL GA, V25, P473, DOI 10.1016/j.bpg.2011.10.016; Singh R, 2011, APOPTOSIS, V16, P889, DOI 10.1007/s10495-011-0624-y; Sorensen HT, 2003, BRIT J CANCER, V88, P1687, DOI 10.1038/sj.bjc.6600945; Sudbo J, 2005, LANCET, V366, P1359, DOI 10.1016/S0140-6736(05)67488-0; Suh N, 2011, CANCER PREV RES, V4, P1895, DOI 10.1158/1940-6207.CAPR-11-0222; Sun L, 2011, DIS ESOPHAGUS, V24, P544, DOI 10.1111/j.1442-2050.2011.01198.x; Tsan YT, 2013, J CLIN ONCOL; Van Dyke AL, 2008, CANCER EPIDEM BIOMAR, V17, P148, DOI 10.1158/1055-9965.EPI-07-0517; Vaughan TL, 2005, LANCET ONCOL, V6, P945, DOI 10.1016/S1470-2045(05)70431-9; Viswanathan AN, 2008, CANCER RES, V68, P2507, DOI 10.1158/0008-5472.CAN-07-6257; Wang WH, 2003, JNCI-J NATL CANCER I, V95, P1784, DOI 10.1093/jnci/djg106; Wernli KJ, 2008, BRIT J CANCER, V98, P1781, DOI 10.1038/sj.bjc.6604392; Wilson JC, 2011, CANCER CAUSE CONTROL, V22, P803, DOI 10.1007/s10552-011-9751-6; Wu CY, 2010, J CLIN ONCOL, V28, P2952, DOI 10.1200/JCO.2009.26.0695; Xu J, 2011, CLIN LUNG CANC; Yang P, 2010, DIGEST DIS SCI, V55, P1533, DOI 10.1007/s10620-009-0915-0; Zaric J, 2011, ONCOGENE	84	37	37	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114633	10.1371/journal.pone.0114633	http://dx.doi.org/10.1371/journal.pone.0114633			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551641	Green Published, gold, Green Submitted			2022-12-26	WOS:000347119100013
J	Kuo, AJ; Su, LH; Shu, JC; Wang, JT; Wang, JH; Fung, CP; Chia, JH; Lu, JJ; Wu, TL				Kuo, An-Jing; Su, Lin-Hui; Shu, Jwu-Ching; Wang, Jann-Tay; Wang, Jen-Hsien; Fung, Chang-Phone; Chia, Ju-Hsin; Lu, Jang-Jih; Wu, Tsu-Lan			National Surveillance on Vancomycin-Resistant Enterococcus faecium in Taiwan: Emergence and Widespread of ST414 and a Tn1546-Like Element with Simultaneous Insertion of IS1251-like and IS1678	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; GLYCOPEPTIDE RESISTANCE; VANA; DIVERSITY; HUMANS; FAECALIS; SEQUENCE; SPREAD; EPIDEMIOLOGY; BACTEREMIA	Cases of bacteremia caused by vancomycin-resistant E. faecium (VRE-fm) increased significantly in Taiwan. The present multicenter surveillance study was performed to reveal the associated epidemiological characteristics. In 2012, 134 non-repetitive VRE-fm isolates were prospectively collected from 12 hospitals in Taiwan. Antimicrobial susceptibility, pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST), and analysis of van genes and Tn1546 structures were investigated. Two isolates carried vanB genes, while all the remaining isolates carried vanA genes. Three isolates demonstrated a specific vanA genotype-vanB phenotype. Nine (6.7%) isolates demonstrated tigecycline resistance, and all were susceptible to daptomycin and linezolid. Molecular typing revealed 58 pulsotypes and 13 sequence types (STs), all belonged to three major lineages 17, 18, and 78. The most frequent STs were ST17 (n=48, 35.8%), ST414 (n=22, 16.4%), and ST78 (n=16, 11.9%). Among the vanA harboring isolates, eight structure types of the Tn1546-like element were demonstrated. Type I (a partial deletion in the orf1 and insertion of IS1251-like between the vanS-vanH genes) and Type II (Type I with an additional insertion of IS1678 between orf2-vanS genes) were the most predominant, consisted of 60 (45.5%) and 62 (47.0%) isolates, respectively. The increase of VRE-fm bacteremia in Taiwan may be associated with the inter-and intra-hospital spread of some major STs and horizontal transfer of vanA genes mostly carried on two efficient Tn1546-like elements. The prevailing ST414 and widespread of the Type II Tn1546-like elements are an emerging problem that requires continuous monitoring.	[Kuo, An-Jing; Su, Lin-Hui; Chia, Ju-Hsin; Lu, Jang-Jih; Wu, Tsu-Lan] Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan; [Kuo, An-Jing; Su, Lin-Hui; Shu, Jwu-Ching; Chia, Ju-Hsin; Lu, Jang-Jih; Wu, Tsu-Lan] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Shu, Jwu-Ching] Chang Gung Univ, Res Ctr Pathogen Bacteria, Taoyuan, Taiwan; [Wang, Jann-Tay] Natl Taiwan Univ Hosp, Dept Med, Div Infect Dis, Taipei, Taiwan; [Wang, Jen-Hsien] China Med Univ Hosp, Dept Internal Med, Div Infect Dis, Taichung, Taiwan; [Fung, Chang-Phone] Natl Yan Ming Univ, Taipei Vet Gen Hosp, Dept Med, Infect Dis Sect, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taipei Veterans General Hospital	Wu, TL (corresponding author), Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan.	wutsulan@adm.cgmh.org.tw		WANG, JANN-TAY/0000-0002-0924-3469; Shu, Jwu-Ching/0000-0003-4862-6056	National Surveillance Program of Taiwan Centers for Disease Control [DOH101-DC-1204]	National Surveillance Program of Taiwan Centers for Disease Control	This work was supported by the grant DOH101-DC-1204 from the National Surveillance Program of Taiwan Centers for Disease Control to TLW, JTW, and CPF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; ARTHUR M, 1993, J BACTERIOL, V175, P117, DOI 10.1128/JB.175.1.117-127.1993; Ben RJ, 1996, J FORMOS MED ASSOC, V95, P946; Cattoir V, 2013, J ANTIMICROB CHEMOTH, V68, P731, DOI 10.1093/jac/dks469; Cha JO, 2013, J APPL MICROBIOL, V115, P969, DOI 10.1111/jam.12300; Chang CM, 2010, J HOSP INFECT, V74, P377, DOI 10.1016/j.jhin.2009.10.025; Cheng VCC, 2012, CHINESE MED J-PEKING, V125, P3450, DOI 10.3760/cma.j.issn.0366-6999.2012.19.017; Chiang Ping-Cherng, 2007, Chang Gung Med J, V30, P493; Clinical and Laboratory Standards Institute, 2012, M100S22 CLIN LAB STA; European Committee on Antimicrobial Susceptibility Testing, 2013, BREAKP TABL INT MICS; Fallico L, 2011, INFECTION, V39, P127, DOI 10.1007/s15010-011-0086-8; Freitas AR, 2009, APPL ENVIRON MICROB, V75, P4904, DOI 10.1128/AEM.02945-08; GOERING RV, 1992, J CLIN MICROBIOL, V30, P577, DOI 10.1128/JCM.30.3.577-580.1992; HANDWERGER S, 1995, ANTIMICROB AGENTS CH, V39, P362, DOI 10.1128/AAC.39.2.362; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Homan WL, 2002, J CLIN MICROBIOL, V40, P1963, DOI 10.1128/JCM.40.6.1963-1971.2002; Hsieh YC, 2010, EUR J CLIN MICROBIOL, V29, P25, DOI 10.1007/s10096-009-0810-9; Hsieh YC, 2009, J MICROBIOL IMMUNOL, V42, P63; Hsueh PR, 1999, J FORMOS MED ASSOC, V98, P45; Jung WK, 2005, ANTIMICROB AGENTS CH, V49, P1666, DOI 10.1128/AAC.49.4.1666-1667.2005; Khan MA, 2010, CLIN MICROBIOL INFEC, V16, P624, DOI 10.1111/j.1469-0691.2009.02898.x; Ko KS, 2005, J CLIN MICROBIOL, V43, P2303, DOI 10.1128/JCM.43.5.2303-2306.2005; Lauderdale TL, 2002, ANTIMICROB AGENTS CH, V46, P525, DOI 10.1128/AAC.46.2.525-527.2002; LECLERCQ R, 1988, NEW ENGL J MED, V319, P157, DOI 10.1056/NEJM198807213190307; Lee SC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-163; Liu YM, 2011, MICROB DRUG RESIST, V17, P449, DOI 10.1089/mdr.2011.0025; Lu CL, 2012, J ANTIMICROB CHEMOTH, V67, P2243, DOI 10.1093/jac/dks181; Lu JJ, 2001, EPIDEMIOL INFECT, V126, P357, DOI 10.1017/S0950268801005453; McCracken M, 2013, J ANTIMICROB CHEMOTH, V68, P1505, DOI 10.1093/jac/dkt054; Oh JY, 2007, J MICROBIOL, V45, P466; da Silva LPP, 2012, DIAGN MICR INFEC DIS, V74, P267, DOI 10.1016/j.diagmicrobio.2012.07.012; Putnam SD, 2010, DIAGN MICR INFEC DIS, V67, P359, DOI 10.1016/j.diagmicrobio.2010.03.009; Rathnayake IU, 2011, J CLIN MICROBIOL, V49, P367, DOI 10.1128/JCM.01120-10; Sadowy E, 2013, EUR J CLIN MICROBIOL, V32, P1193, DOI 10.1007/s10096-013-1868-y; UTTLEY AHC, 1988, LANCET, V1, P57; Wang JT, 2013, DIAGN MICR INFEC DIS, V75, P406, DOI 10.1016/j.diagmicrobio.2013.01.004; Willems RJL, 1999, ANTIMICROB AGENTS CH, V43, P483, DOI 10.1128/AAC.43.3.483; Willems RJL, 2005, EMERG INFECT DIS, V11, P821, DOI 10.3201/1106.041204; Willems RJL, 2012, MBIO, V3, DOI 10.1128/mBio.00151-12; Woodford N, 1998, ANTIMICROB AGENTS CH, V42, P502, DOI 10.1128/AAC.42.3.502; Xu HT, 2011, CHINESE MED J-PEKING, V124, P498, DOI 10.3760/cma.j.issn.0366-6999.2011.04.003	41	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115555	10.1371/journal.pone.0115555	http://dx.doi.org/10.1371/journal.pone.0115555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549328	Green Published, gold, Green Submitted			2022-12-26	WOS:000347063500016
J	Barbi, F; Bragalini, C; Vallon, L; Prudent, E; Dubost, A; Fraissinet-Tachet, L; Marmeisse, R; Luis, P				Barbi, Florian; Bragalini, Claudia; Vallon, Laurent; Prudent, Elsa; Dubost, Audrey; Fraissinet-Tachet, Laurence; Marmeisse, Roland; Luis, Patricia			PCR Primers to Study the Diversity of Expressed Fungal Genes Encoding Lignocellulolytic Enzymes in Soils Using High-Throughput Sequencing	PLOS ONE			English	Article							ELEVATED ATMOSPHERIC CO2; LITTER DECOMPOSITION; LACCASE GENES; LEAF-LITTER; FOREST SOILS; COMMUNITIES; ECTOMYCORRHIZAL; EVOLUTION; PERFORMANCE; RESPONSES	Plant biomass degradation in soil is one of the key steps of carbon cycling in terrestrial ecosystems. Fungal saprotrophic communities play an essential role in this process by producing hydrolytic enzymes active on the main components of plant organic matter. Open questions in this field regard the diversity of the species involved, the major biochemical pathways implicated and how these are affected by external factors such as litter quality or climate changes. This can be tackled by environmental genomic approaches involving the systematic sequencing of key enzyme-coding gene families using soil-extracted RNA as material. Such an approach necessitates the design and evaluation of gene family-specific PCR primers producing sequence fragments compatible with high-throughput sequencing approaches. In the present study, we developed and evaluated PCR primers for the specific amplification of fungal CAZy Glycoside Hydrolase gene families GH5 (subfamily 5) and GH11 encoding endo-beta-1,4-glucanases and endo beta-1,4-xylanases respectively as well as Basidiomycota class II peroxidases, corresponding to the CAZy Auxiliary Activity family 2 (AA2), active on lignin. These primers were experimentally validated using DNA extracted from a wide range of Ascomycota and Basidiomycota species including 27 with sequenced genomes. Along with the published primers for Glycoside Hydrolase GH7 encoding enzymes active on cellulose, the newly design primers were shown to be compatible with the Illumina MiSeq sequencing technology. Sequences obtained from RNA extracted from beech or spruce forest soils showed a high diversity and were uniformly distributed in gene trees featuring the global diversity of these gene families. This high-throughput sequencing approach using several degenerate primers	[Barbi, Florian; Bragalini, Claudia; Vallon, Laurent; Prudent, Elsa; Dubost, Audrey; Fraissinet-Tachet, Laurence; Marmeisse, Roland; Luis, Patricia] Univ Lyon 1, USC INRA 1364, UMR CNRS 5557, F-69622 Villeurbanne, France; [Bragalini, Claudia] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; University of Turin	Luis, P (corresponding author), Univ Lyon 1, USC INRA 1364, UMR CNRS 5557, F-69622 Villeurbanne, France.	patricia.luis@univ-lyon1.fr		Marmeisse, Roland/0000-0003-1653-3517; Barbi, Florian/0000-0002-5547-935X; DUBOST, Audrey/0000-0003-0572-7834; Luis, Patricia/0000-0001-7002-6212	French ''Ministere de l'Enseignement Superieur et de la Recherche''; University of Turin (Italy); CMIRA; French county Rhone-Alpes; French Research foundation CNRS-INSU	French ''Ministere de l'Enseignement Superieur et de la Recherche''; University of Turin (Italy); CMIRA(Region Auvergne-Rhone-Alpes); French county Rhone-Alpes(Region Auvergne-Rhone-Alpes); French Research foundation CNRS-INSU	Funding: Florian Barbi was supported by a PhD grant from the French ''Ministere de l'Enseignement Superieur et de la Recherche''. Claudia Bragalini was supported by a PhD grant from the University of Turin (Italy) and a CMIRA (Cooperation et Mobilite 'Internationales Rhone-Alpes) fellowship from the French county Rhone-Alpes. The work was financed by the French Research foundation CNRS-INSU (Centre National de la Recherche Scientifique -Institut National des Sciences de l'Univers) through an ''Ecosphere Continentale et Cotiere'' program (EC2CO MicrobiEn 2013) and an `` Agence Nationale de la Recherche'' project (ANR 09-GENM-033-001/ Eumetasol). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Austin AT, 2010, P NATL ACAD SCI USA, V107, P4618, DOI 10.1073/pnas.0909396107; Bailly J, 2007, ISME J, V1, P632, DOI 10.1038/ismej.2007.68; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Baldrian P, 2011, PLANT SOIL, V338, P111, DOI 10.1007/s11104-010-0324-3; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bodeker ITM, 2014, NEW PHYTOL, V203, P245, DOI 10.1111/nph.12791; Bodeker ITM, 2009, ISME J, V3, P1387, DOI 10.1038/ismej.2009.77; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Buee M, 2011, FUNGAL ECOL, V4, P22, DOI 10.1016/j.funeco.2010.07.003; Damon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028967; Damon C, 2010, FEMS MICROBIOL ECOL, V74, P693, DOI 10.1111/j.1574-6941.2010.00983.x; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwards IP, 2008, APPL ENVIRON MICROB, V74, P3481, DOI 10.1128/AEM.02893-07; Edwards IP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020421; Fawal N, 2013, NUCLEIC ACIDS RES, V41, pD441, DOI 10.1093/nar/gks1083; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Gifford RM, 2003, FUNCT PLANT BIOL, V30, P171, DOI 10.1071/FP02083; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hadziavdic K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087624; Hao JJ, 2006, J EUKARYOT MICROBIOL, V53, P193, DOI 10.1111/j.1550-7408.2006.00093.x; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Herculano PN, 2011, CURR MICROBIOL, V62, P1416, DOI 10.1007/s00284-011-9879-3; Kellner H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095557; Kellner H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010971; Kellner H, 2009, SOIL BIOL BIOCHEM, V41, P1380, DOI 10.1016/j.soilbio.2009.03.012; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Levasseur A, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-32; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luis P, 2005, MICROB ECOL, V50, P570, DOI 10.1007/s00248-005-5047-2; Luis P, 2004, SOIL BIOL BIOCHEM, V36, P1025, DOI 10.1016/j.soilbio.2004.02.017; MacDonald J, 2011, APPL ENVIRON MICROB, V77, P3211, DOI 10.1128/AEM.02490-10; Manzoni S, 2012, ECOLOGY, V93, P930, DOI 10.1890/11-0026.1; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Osono T, 2006, MYCOLOGIA, V98, P172, DOI 10.3852/mycologia.98.2.172; Palomares-Rius JE, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-69; RANGER J, 2004, EFFET SUBSTITUTIONS; Richard F, 2011, ANN FOREST SCI, V68, P57, DOI 10.1007/s13595-010-0007-5; Sarkar P, 2009, J EXP BOT, V60, P3615, DOI 10.1093/jxb/erp245; Schadel C, 2010, PLANT PHYSIOL BIOCH, V48, P1, DOI 10.1016/j.plaphy.2009.09.008; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt PA, 2013, SOIL BIOL BIOCHEM, V65, P128, DOI 10.1016/j.soilbio.2013.05.014; Schneider T, 2012, ISME J, V6, P1749, DOI 10.1038/ismej.2012.11; Sinsabaugh RL, 2002, BOOK SOIL P, P249; Sinsabaugh RL, 2010, SOIL BIOL BIOCHEM, V42, P391, DOI 10.1016/j.soilbio.2009.10.014; Snajdr J, 2008, SOIL BIOL BIOCHEM, V40, P2068, DOI 10.1016/j.soilbio.2008.01.015; Snajdr J, 2011, FEMS MICROBIOL ECOL, V75, P291, DOI 10.1111/j.1574-6941.2010.00999.x; Tedersoo L, 2008, NEW PHYTOL, V180, P479, DOI 10.1111/j.1469-8137.2008.02561.x; Trap J, 2011, SOIL BIOL BIOCHEM, V43, P1553, DOI 10.1016/j.soilbio.2011.04.005; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Valaskova V, 2007, SOIL BIOL BIOCHEM, V39, P2651, DOI 10.1016/j.soilbio.2007.05.023; von Lutzow M, 2006, EUR J SOIL SCI, V57, P426, DOI 10.1111/j.1365-2389.2006.00809.x; Voriskova J, 2013, ISME J, V7, P477, DOI 10.1038/ismej.2012.116; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Weber CF, 2012, APPL ENVIRON MICROB, V78, P3950, DOI 10.1128/AEM.08018-11; Weber CF, 2011, ENVIRON MICROBIOL, V13, P2778, DOI 10.1111/j.1462-2920.2011.02548.x; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wolfe BE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039597; Wubet T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047500; Yoon JJ, 2008, BIOTECHNOL LETT, V30, P1373, DOI 10.1007/s10529-008-9715-4; Zhang DQ, 2008, J PLANT ECOL, V1, P85, DOI 10.1093/jpe/rtn002; Zhou DQ, 2001, MYCOL RES, V105, P1449, DOI 10.1017/S0953756201004713	70	22	25	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e0116264	10.1371/journal.pone.0116264	http://dx.doi.org/10.1371/journal.pone.0116264			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545363	gold, Green Published, Green Submitted			2022-12-26	WOS:000347120200108
J	Hasegawa, H; Ishibashi, K; Kubota, S; Yamaguchi, C; Yuki, R; Nakajo, H; Eckner, R; Yamaguchi, N; Yokoyama, KK; Yamaguchi, N				Hasegawa, Hitomi; Ishibashi, Kenichi; Kubota, Shoichi; Yamaguchi, Chihiro; Yuki, Ryuzaburo; Nakajo, Haruna; Eckner, Richard; Yamaguchi, Noritaka; Yokoyama, Kazunari K.; Yamaguchi, Naoto			Cdk1-Mediated Phosphorylation of Human ATF7 at Thr-51 and Thr-53 Promotes Cell-Cycle Progression into M Phase	PLOS ONE			English	Article							JUN DIMERIZATION PROTEIN-2; ACTIVATING TRANSCRIPTION FACTOR-2; AURORA-A KINASE; HISTONE H3; MITOTIC PHOSPHORYLATION; TYROSINE KINASES; C-SRC; COMPLEX; ROLES; SPINDLE	Activating transcription factor 2 (ATF2) and its homolog ATF7 are phosphorylated at Thr-69/Thr-71 and at Thr-51/Thr-53, respectively, by stress-activated MAPKs regulating their transcriptional functions in G1 and S phases. However, little is known about the role of ATF2 and ATF7 in G2/M phase. Here, we show that Cdk1-cyclin B1 phosphorylates ATF2 at Thr-69/Thr-71 and ATF7 at Thr-51/Thr-53 from early prophase to anaphase in the absence of any stress stimulation. Knockdown of ATF2 or ATF7 decreases the rate of cell proliferation and the number of cells in M-phase. In particular, the knockdown of ATF7 severely inhibits cell proliferation and G2/M progression. The inducible expression of a mitotically nonphosphorylatable version of ATF7 inhibits G2/M progression despite the presence of endogenous ATF7. We also show that mitotic phosphorylation of ATF7 promotes the activation of Aurora kinases, which are key enzymes for early mitotic events. These results suggest that the Cdk1-mediated phosphorylation of ATF7 facilitates G2/M progression, at least in part, by enabling Aurora signaling.	[Hasegawa, Hitomi; Ishibashi, Kenichi; Kubota, Shoichi; Yamaguchi, Chihiro; Yuki, Ryuzaburo; Nakajo, Haruna; Yamaguchi, Noritaka; Yamaguchi, Naoto] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cell Biol, Chiba, Japan; [Eckner, Richard] Rutgers State Univ, Rutgers New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07102 USA; [Yokoyama, Kazunari K.] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan	Chiba University; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Kaohsiung Medical University	Yokoyama, KK (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan.	kazu@kmu.edu.tw; nyama@faculty.chiba-u.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology; G-COE Research Assistants;  [NSC-101-2320-B-037-047-My3];  [NSC-101-2314-B-037-004-My2];  [NHRI-Ex102-10109BI];  [NHRI-102A1-PDCO-0310201];  [KMU-DT103001]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); G-COE Research Assistants; ; ; ; ; 	This work was supported by Grants-in-aid for Scientific Research and the Global COE Program (G-COE, Global Center for Education and Research in Immune Regulation and Treatment) from the Japanese Ministry of Education, Culture, Sports, Science and Technology; Grants from Taiwan (NSC-101-2320-B-037-047-My3; NSC-101-2314-B-037-004-My2; NHRI-Ex102-10109BI; NHRI-102A1-PDCO-0310201; KMU-DT103001); G-COE Research Assistants (HH KI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva C, 2006, J CELL SCI, V119, P2401, DOI 10.1242/jcs.02937; Aoyama K, 2013, EXP CELL RES, V319, P3251, DOI 10.1016/j.yexcr.2013.09.003; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; BENBROOK DM, 1990, ONCOGENE, V5, P295; Bhoumik A, 2005, MOL CELL, V18, P577, DOI 10.1016/j.molcel.2005.04.015; Bhoumik A, 2007, PIGM CELL RES, V20, P498, DOI 10.1111/j.1600-0749.2007.00414.x; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; Camuzeaux B, 2008, J MOL BIOL, V384, P980, DOI 10.1016/j.jmb.2008.10.008; CHATTON B, 1993, MOL CELL BIOL, V13, P561, DOI 10.1128/MCB.13.1.561; Chow JPH, 2003, J BIOL CHEM, V278, P40815, DOI 10.1074/jbc.M306683200; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; De Graeve F, 1999, ONCOGENE, V18, P3491, DOI 10.1038/sj.onc.1202723; Diring J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023351; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fuchs SY, 1999, MOL CELL BIOL, V19, P3289; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Goetz J, 1996, J BIOL CHEM, V271, P29589, DOI 10.1074/jbc.271.47.29589; Gozdecka M, 2012, BIOCHEM SOC T, V40, P230, DOI 10.1042/BST20110630; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hamard PJ, 2005, ONCOGENE, V24, P3472, DOI 10.1038/sj.onc.1208565; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Ishibashi K, 2013, J CELL SCI, V126, P625, DOI 10.1242/jcs.116277; Jin CY, 2001, FEBS LETT, V489, P34, DOI 10.1016/S0014-5793(00)02387-5; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kasahara K, 2007, J BIOL CHEM, V282, P5327, DOI 10.1074/jbc.M608396200; Kawasaki H, 1998, GENE DEV, V12, P233, DOI 10.1101/gad.12.2.233; KNEHR M, 1995, EXP CELL RES, V217, P546, DOI 10.1006/excr.1995.1121; Kubota S, 2013, J BIOL CHEM, V288, P17871, DOI 10.1074/jbc.M112.437756; Kubota S, 2014, J BIOL CHEM, V289, P5730, DOI 10.1074/jbc.M113.546655; Kuga T, 2007, ARCH BIOCHEM BIOPHYS, V466, P116, DOI 10.1016/j.abb.2007.07.002; Lau E, 2012, J CELL SCI, V125, P2815, DOI 10.1242/jcs.095000; Lau E, 2012, CELL, V148, P543, DOI 10.1016/j.cell.2012.01.016; Li XY, 1996, GENE DEV, V10, P517, DOI 10.1101/gad.10.5.517; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Maekawa T, 1999, J BIOL CHEM, V274, P17813, DOI 10.1074/jbc.274.25.17813; Maekawa T, 2010, EMBO J, V29, P184, DOI 10.1038/emboj.2009.318; Marumoto T, 2002, GENES CELLS, V7, P1173, DOI 10.1046/j.1365-2443.2002.00592.x; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Matsui Y, 2012, EUR J CELL BIOL, V91, P413, DOI 10.1016/j.ejcb.2011.12.008; Morton S, 2004, FEBS LETT, V572, P177, DOI 10.1016/j.febslet.2004.07.031; Nakayama Y, 2012, J BIOL CHEM, V287, P24905, DOI 10.1074/jbc.M112.341578; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Pan J, 2010, ONCOGENE, V29, P6245, DOI 10.1038/onc.2010.355; Perez de Castro I, 2008, CURR OPIN PHARMACOL, V8, P375, DOI 10.1016/j.coph.2008.06.013; Pines J, 2001, NAT CELL BIOL, V3, pE3, DOI 10.1038/35050676; Reimold AM, 1996, NATURE, V379, P262, DOI 10.1038/379262a0; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Song B, 2011, NEUROSCI LETT, V505, P76, DOI 10.1016/j.neulet.2011.09.060; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; TAKEDA J, 1991, ONCOGENE, V6, P1009; Tanigawa S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.448; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Walczynski J, 2014, ONCOGENE, V33, P1027, DOI 10.1038/onc.2013.28; Yamasaki T, 2009, J BIOL CHEM, V284, P8567, DOI 10.1074/jbc.M808719200; Yuan ZM, 2009, MOL CELL BIOL, V29, P2431, DOI 10.1128/MCB.01344-08	64	14	14	0	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116048	10.1371/journal.pone.0116048	http://dx.doi.org/10.1371/journal.pone.0116048			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545367	gold, Green Published, Green Submitted			2022-12-26	WOS:000347120200092
J	Matsuda, S; Matsumoto, H; Furubayashi, T; Fukuda, H; Emoto, M; Hanajima, R; Tsuji, S; Ugawa, Y; Terao, Y				Matsuda, Shunichi; Matsumoto, Hideyuki; Furubayashi, Toshiaki; Fukuda, Hideki; Emoto, Masaki; Hanajima, Ritsuko; Tsuji, Shoji; Ugawa, Yoshikazu; Terao, Yasuo			Top-Down but Not Bottom-Up Visual Scanning is Affected in Hereditary Pure Cerebellar Ataxia	PLOS ONE			English	Article							EYE-MOVEMENTS; SACCADIC DYSMETRIA; FASTIGIAL NUCLEUS; COVERT SHIFTS; ATTENTION; LESIONS; SEARCH; INTEGRATION; NYSTAGMUS; FEATURES	The aim of this study was to clarify the nature of visual processing deficits caused by cerebellar disorders. We studied the performance of two types of visual search (top-down visual scanning and bottom-up visual scanning) in 18 patients with pure cerebellar types of spinocerebellar degeneration (SCA6: 11; SCA31: 7). The gaze fixation position was recorded with an eye-tracking device while the subjects performed two visual search tasks in which they looked for a target Landolt figure among distractors. In the serial search task, the target was similar to the distractors and the subject had to search for the target by processing each item with top-down visual scanning. In the pop-out search task, the target and distractor were clearly discernible and the visual salience of the target allowed the subjects to detect it by bottom-up visual scanning. The saliency maps clearly showed that the serial search task required top-down visual attention and the pop-out search task required bottom-up visual attention. In the serial search task, the search time to detect the target was significantly longer in SCA patients than in normal subjects, whereas the search time in the pop-out search task was comparable between the two groups. These findings suggested that SCA patients cannot efficiently scan a target using a top-down attentional process, whereas scanning with a bottom-up attentional process is not affected. In the serial search task, the amplitude of saccades was significantly smaller in SCA patients than in normal subjects. The variability of saccade amplitude (saccadic dysmetria), number of re-fixations, and unstable fixation (nystagmus) were larger in SCA patients than in normal subjects, accounting for a substantial proportion of scattered fixations around the items. Saccadic dysmetria, re-fixation, and nystagmus may play important roles in the impaired top-down visual scanning in SCA, hampering precise visual processing of individual items.	[Matsuda, Shunichi; Matsumoto, Hideyuki; Hanajima, Ritsuko; Tsuji, Shoji; Terao, Yasuo] Univ Tokyo, Dept Neurol, Tokyo, Japan; [Furubayashi, Toshiaki; Ugawa, Yoshikazu] Fukushima Med Univ, Sch Med, Dept Neurol, Fukushima, Japan; [Fukuda, Hideki] Segawa Neurol Clin Children, Tokyo, Japan; [Emoto, Masaki] Univ Tokyo, Interfac Initiat Informat Studies, Tokyo, Japan	University of Tokyo; Fukushima Medical University; University of Tokyo	Matsumoto, H (corresponding author), Univ Tokyo, Dept Neurol, Tokyo, Japan.	hideyukimatsumoto.jp@gmail.com	Ugawa, Yoshikazu/AAM-2052-2020	Ugawa, Yoshikazu/0000-0002-8016-152X	Committee of the Study of Human Exposure; Ministry of Public Management, Home Affairs, Post and Telecommunications	Committee of the Study of Human Exposure; Ministry of Public Management, Home Affairs, Post and Telecommunications	Dr. Hanajima was supported by a Research Project Grant- in- Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and Research, and Dainippon Sumitomo Pharma. Co., Ltd; and has received a speaker's honorarium from Kyowa Hakko Kilin Co., Ltd. Dr. Ugawa was supported by a Research Project Grant- in- Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; by grants for the Research Committee on degenerative ataxia from the Ministry of Health and Welfare of Japan; by the Research Committee on insomnia in Parkinson's disease from the Ministry of Health and Welfare of Japan; by a grant from the Committee of the Study of Human Exposure to EMF from the Ministry of Public Management, Home Affairs, Post and Telecommunications; and by a grant from the Uehara Memorial Foundation. Dr. Terao was supported by a Research Project Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research, by grants from GlaxoSmithKline and Boehringer Ingelheim, and has received a speaker's honorarium from Boehringer Ingelheim. The other authors have no disclosures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre MF, 2013, CEREBELLUM, V12, P396, DOI 10.1007/s12311-012-0433-z; Andreasen NC, 1996, P NATL ACAD SCI USA, V93, P9985, DOI 10.1073/pnas.93.18.9985; Barash S, 1999, J NEUROSCI, V19, P10931, DOI 10.1523/JNEUROSCI.19-24-10931.1999; BURR DC, 1982, VISION RES, V22, P479, DOI 10.1016/0042-6989(82)90196-1; BUTTNER U, 1995, J NEUROL, V242, P384, DOI 10.1007/BF00868394; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Eckstein M. P., 2011, J VIS, V11; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foulsham T, 2008, J VISION, V8, DOI 10.1167/8.2.6; Foulsham T, 2009, NEUROPSYCHOLOGIA, V47, P1994, DOI 10.1016/j.neuropsychologia.2009.03.013; Frings M, 2007, CEREBELLUM, V6, P328, DOI 10.1080/14734220701200063; Golla H, 2005, BRAIN, V128, P1525, DOI 10.1093/brain/awh523; Gomez CM, 1997, ANN NEUROL, V42, P933, DOI 10.1002/ana.410420616; Haarmeier T, 2007, CEREBELLUM, V6, P177, DOI 10.1080/14734220701286187; Harel J, 2006, P NEURAL INFORM P SY; Harel J., SALIENCY IMPLEMENTAT; Ignashchenkova A, 2009, J NEUROPHYSIOL, V102, P3156, DOI 10.1152/jn.00659.2009; Ishikawa K, 1999, J NEUROL NEUROSUR PS, V67, P86, DOI 10.1136/jnnp.67.1.86; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; JACOBS RJ, 1979, VISION RES, V19, P1187, DOI 10.1016/0042-6989(79)90183-4; Kawai Y, 2008, J NEUROL SCI, V271, P68, DOI 10.1016/j.jns.2008.03.018; Kelly RM, 2003, J NEUROSCI, V23, P8432; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Land MF, 2009, VISUAL NEUROSCI, V26, P51, DOI 10.1017/S0952523808080899; Ludwig CJH, 2002, J EXP PSYCHOL HUMAN, V28, P902, DOI 10.1037//0096-1523.28.4.902; Machner B, 2005, NEUROREPORT, V16, P1507, DOI 10.1097/01.wnr.0000177015.75096.b6; Matsuda S, 2014, CEREBELLUM; Matsumoto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028928; Matsumoto H, 2011, MOVEMENT DISORD, V26, P1619, DOI 10.1002/mds.23683; NODA H, 1988, J NEUROPHYSIOL, V60, P1036, DOI 10.1152/jn.1988.60.3.1036; NOTHDURFT HC, 1993, VISION RES, V33, P1937, DOI 10.1016/0042-6989(93)90020-W; Owada K, 2005, NEUROLOGY, V65, P629, DOI 10.1212/01.wnl.0000173065.75680.e2; Ramnani N, 2006, NAT REV NEUROSCI, V7, P511, DOI 10.1038/nrn1953; ROBINSON FR, 1993, J NEUROPHYSIOL, V70, P1741, DOI 10.1152/jn.1993.70.5.1741; Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; SCHMAHMANN JD, 1991, ARCH NEUROL-CHICAGO, V48, P1178, DOI 10.1001/archneur.1991.00530230086029; Suenaga M, 2008, J NEUROL NEUROSUR PS, V79, P496, DOI 10.1136/jnnp.2007.119883; Suzuki Y, 2003, JPN J OPHTHALMOL, V47, P535, DOI 10.1016/S0021-5155(03)00144-8; Takagi M, 1998, J NEUROPHYSIOL, V80, P1911, DOI 10.1152/jn.1998.80.4.1911; TREISMAN A, 1991, J EXP PSYCHOL HUMAN, V17, P652, DOI 10.1037/0096-1523.17.3.652; TREISMAN A, 1988, Q J EXP PSYCHOL-A, V40, P201, DOI 10.1080/02724988843000104; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Trouillas P, 1997, J NEUROL SCI, V145, P205, DOI 10.1016/S0022-510X(96)00231-6; van Zoest W, 2004, PERCEPTION, V33, P927, DOI 10.1068/p5158; VILIS T, 1981, J NEUROPHYSIOL, V46, P828, DOI 10.1152/jn.1981.46.4.828; WAESPE W, 1990, BRAIN, V113, P821, DOI 10.1093/brain/113.3.821; Yabe I, 2003, J NEUROL, V250, P440, DOI 10.1007/s00415-003-1020-5; ZEE DS, 1976, BRAIN, V99, P207, DOI 10.1093/brain/99.2.207	51	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e0116181	10.1371/journal.pone.0116181	http://dx.doi.org/10.1371/journal.pone.0116181			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545148	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200106
J	Muniz, JAPC; de Athaide, LM; Gomes, BD; Finlay, BL; Silveira, LCD				Pereira Carneiro Muniz, Jose Augusto; de Athaide, Luana Modesto; Gomes, Bruno Duarte; Finlay, Barbara L.; de Lima Silveira, Luiz Carlos			Ganglion Cell and Displaced Amacrine Cell Density Distribution in the Retina of the Howler Monkey (Alouatta caraya)	PLOS ONE			English	Article							NEW-WORLD MONKEY; CORTICAL MAGNIFICATION FACTOR; OPTIC-NERVE; COLOR-VISION; HORIZONTAL CELLS; RHESUS-MONKEY; OWL MONKEY; STEREOLOGIC ANALYSIS; CAPUCHIN MONKEY; PRIMATE RETINA	Unlike all other New World (platyrrine) monkeys, both male and female howler monkeys (Alouatta sp.) are obligatory trichromats. In all other platyrrines, only females can be trichromats, while males are always dichromats, as determined by multiple behavioral, electrophysiological, and genetic studies. In addition to obligatory trichromacy, Alouatta has an unusual fovea, with substantially higher peak cone density in the foveal pit than every other diurnal anthropoid monkey (both platyrrhines and catarrhines) and great ape yet examined, including humans. In addition to documenting the general organization of the retinal ganglion cell layer in Alouatta, the distribution of cones is compared to retinal ganglion cells, to explore possible relationships between their atypical trichromacy and foveal specialization. The number and distribution of retinal ganglion cells and displaced amacrine cells were determined in six flat-mounted retinas from five Alouatta caraya. Ganglion cell density peaked at 0.5 mm between the fovea and optic nerve head, reaching 40,700-45,200 cells/mm(2). Displaced amacrine cell density distribution peaked between 0.5-1.75 mm from the fovea, reaching mean values between 2,050-3,100 cells/mm2. The mean number of ganglion cells was 1,133,000 +/- 79,000 cells and the mean number of displaced amacrine cells was 537,000 +/- 61,800 cells, in retinas of mean area 641 +/- 62 mm(2). Ganglion cell and displaced amacrine cell density distribution in the Alouatta retina was consistent with that observed among several species of diurnal Anthropoidea, both platyrrhines and catarrhines. The principal alteration in the Alouatta retina appears not to be in the number of any retinal cell class, but rather a marked gradient in cone density within the fovea, which could potentially support high chromatic acuity in a restricted central region.	[Pereira Carneiro Muniz, Jose Augusto] Ctr Nacl Primatas, Ananindeua, Para, Brazil; [de Athaide, Luana Modesto] Fed Univ Para, Inst Tecnol, BR-66059 Belem, Para, Brazil; [Gomes, Bruno Duarte; de Lima Silveira, Luiz Carlos] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Finlay, Barbara L.] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA; [de Lima Silveira, Luiz Carlos] Fed Univ Para, Nucleo Med Trop, BR-66059 Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para; Cornell University; Universidade Federal do Para	Silveira, LCD (corresponding author), Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.	luiz@ufpa.br	Gomes, Bruno Duarte/I-4499-2013		CNPq-PRONEX/FAPESPA/UFPA/FADESP [2268]; CNPq-PRONEX/FAPESPA [316799/2009]; CNPq [476744/2009-1, 479500/2011-8]; NSF [0130789]; FINEP/UFPA/FADESP [1723]	CNPq-PRONEX/FAPESPA/UFPA/FADESP; CNPq-PRONEX/FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NSF(National Science Foundation (NSF)); FINEP/UFPA/FADESP	This research was supported by the following grants: CNPq-PRONEX/FAPESPA/UFPA/FADESP #2268, CNPq-PRONEX/FAPESPA #316799/2009, CNPq #476744/2009-1 and #479500/2011-8, NSF #0130789, and FINEP/UFPA/FADESP #1723 (IBN Net). LCLS is a CNPq research fellow. The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1977, VISUAL SYSTEM VERTEB, DOI [DOI 10.1007/978-3-642-66468-7, 10.1007/978-3-642-66468-7_11, DOI 10.1007/978-3-642-66468-7_11]; Araujo AC, 2008, VISUAL NEUROSCI, V25, P243, DOI 10.1017/S0952523808080292; Arey LB, 1935, ANAT REC S, V61, P3; AYRES M., 2007, BIOESTAT; BALAZSI AG, 1984, AM J OPHTHALMOL, V97, P760, DOI 10.1016/0002-9394(84)90509-9; BOYCOTT BB, 1991, EUR J NEUROSCI, V3, P1069, DOI 10.1111/j.1460-9568.1991.tb00043.x; Bruesch SR, 1942, J COMP NEUROL, V77, P631, DOI 10.1002/cne.900770310; Chan TL, 2001, J COMP NEUROL, V437, P219, DOI 10.1002/cne.1280; Coimbra JP, 2013, J COMP NEUROL, V521, P2042, DOI 10.1002/cne.23271; Collin SP, 2012, BRAIN BEHAV EVOLUT, V80, P80, DOI 10.1159/000339870; CONRADI N, 1993, GRAEF ARCH CLIN EXP, V231, P169, DOI 10.1007/BF00920942; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; De Lima SMA, 2005, VISUAL NEUROSCI, V22, P707, DOI 10.1017/S0952523805226032; DEMONASTERIO FM, 1975, J PHYSIOL-LONDON, V251, P217, DOI 10.1113/jphysiol.1975.sp011088; DEMONASTERIO FM, 1975, J PHYSIOL-LONDON, V251, P197, DOI 10.1113/jphysiol.1975.sp011087; DEMONASTERIO FM, 1975, J PHYSIOL-LONDON, V251, P167, DOI 10.1113/jphysiol.1975.sp011086; Doi E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003761; Dos Reis JWL, 2002, J COMP NEUROL, V443, P105, DOI 10.1002/cne.10105; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; Dyer MA, 2009, P NATL ACAD SCI USA, V106, P8963, DOI 10.1073/pnas.0901484106; Finlay BL, 2008, VISUAL NEUROSCI, V25, P289, DOI 10.1017/S0952523808080371; Finlay BL, 2008, BRAIN RES, V1192, P5, DOI 10.1016/j.brainres.2007.07.005; Finlay BL, 2005, PRIMATE VISUAL SYSTEM: A COMPARATIVE APPROACH, P37; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; FISCHER QS, 1991, BRAIN BEHAV EVOLUT, V37, P189, DOI 10.1159/000114358; Fleagle JG, 1988, PRIMATE ADAPTATION E; Franco ECS, 2000, BRAIN BEHAV EVOLUT, V56, P276, DOI 10.1159/000047211; Ghosh KK, 1996, J COMP NEUROL, V366, P76, DOI 10.1002/(SICI)1096-9861(19960226)366:1<76::AID-CNE6>3.0.CO;2-H; Ghosh KK, 1999, J COMP NEUROL, V413, P417, DOI 10.1002/(SICI)1096-9861(19991025)413:3<417::AID-CNE5>3.0.CO;2-H; Ghosh KK, 1997, J COMP NEUROL, V379, P211; Gomes FL, 2005, BRAZ J MED BIOL RES, V38, P915, DOI 10.1590/S0100-879X2005000600014; Harman A, 2000, ANAT REC, V260, P124; HENDRICKSON AE, 1994, INVEST OPHTH VIS SCI, V35, P3129; Herbin M, 1997, J COMP NEUROL, V383, P459, DOI 10.1002/(SICI)1096-9861(19970714)383:4<459::AID-CNE5>3.0.CO;2-1; Hess RF, 2003, J PHYSIOL-PARIS, V97, P105, DOI 10.1016/j.jphysparis.2003.09.013; HUGHES A, 1971, DOC OPHTHALMOL, V30, P33, DOI 10.1007/BF00142518; Hunt DM, 1998, VISION RES, V38, P3299, DOI 10.1016/S0042-6989(97)00443-4; IBBOTSON RE, 1992, P ROY SOC B-BIOL SCI, V247, P145, DOI 10.1098/rspb.1992.0021; Jacobs GH, 2007, INT J PRIMATOL, V28, P729, DOI 10.1007/s10764-007-9168-y; Jacobs GH, 1996, NATURE, V382, P156, DOI 10.1038/382156a0; Jacobs GH, 1996, P ROY SOC B-BIOL SCI, V263, P705, DOI 10.1098/rspb.1996.0105; JOHNSON BM, 1987, AGE, V10, P5, DOI 10.1007/BF02431765; JONAS JB, 1992, INVEST OPHTH VIS SCI, V33, P2012; Kremers Jan, 1999, P123; KUPFER C, 1967, J ANAT, V101, P393; LAVAIL MM, 1991, J COMP NEUROL, V309, P86, DOI 10.1002/cne.903090107; Lee Barry B., 1996, Revista Brasileira de Biologia, V56, P323; LEE BB, 1989, J PHYSIOL-LONDON, V414, P223, DOI 10.1113/jphysiol.1989.sp017685; LEE BB, 1989, J PHYSIOL-LONDON, V414, P245, DOI 10.1113/jphysiol.1989.sp017686; Lee BB, 2000, J PHYSIOL-LONDON, V528, P573, DOI 10.1111/j.1469-7793.2000.00573.x; LEE BB, 1988, J PHYSIOL-LONDON, V404, P323, DOI 10.1113/jphysiol.1988.sp017292; Lima SMA, 1996, J COMP NEUROL, V368, P538; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Moran RJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003422; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; OGDEN TE, 1966, VISION RES, V6, P485, DOI 10.1016/0042-6989(66)90108-8; Oppel O, 1967, Albrecht Von Graefes Arch Klin Exp Ophthalmol, V172, P1, DOI 10.1007/BF00577151; PERRY VH, 1985, VISION RES, V25, P1795, DOI 10.1016/0042-6989(85)90004-5; PERRY VH, 1988, NEUROSCIENCE, V25, P225, DOI 10.1016/0306-4522(88)90021-8; PICANCODINIZ CW, 1992, BRAZ J MED BIOL RES, V25, P57; Polyak S. L., 1941, RETINA-J RET VIT DIS; POTTS AM, 1972, INVEST OPHTH VISUAL, V11, P980; QUIGLEY HA, 1982, ARCH OPHTHALMOL-CHIC, V100, P135, DOI 10.1001/archopht.1982.01030030137016; RAKIC P, 1983, SCIENCE, V219, P1441, DOI 10.1126/science.6828871; REPKA MX, 1989, OPHTHALMOLOGY, V96, P26; SCHEIN SJ, 1988, J COMP NEUROL, V269, P479, DOI 10.1002/cne.902690403; Silveira LCD, 2004, METH NE FRO NEUROSCI, P29; SILVEIRA LCL, 1989, VISUAL NEUROSCI, V2, P221, DOI 10.1017/S0952523800001140; Silveira LCL, 1999, VISUAL NEUROSCI, V16, P333, DOI 10.1017/S0952523899162138; SILVEIRA LCL, 1993, VISUAL NEUROSCI, V10, P887, DOI 10.1017/S095252380000609X; SILVEIRA LCL, 1989, VISUAL NEUROSCI, V3, P483, DOI 10.1017/S0952523800005988; SILVEIRA LCL, 1994, NEUROREPORT, V5, P2077; SILVEIRA LCL, 1989, VISION RES, V29, P1471, DOI 10.1016/0042-6989(89)90131-4; Silveira LCL, 1998, VISION RES, V38, P3329, DOI 10.1016/S0042-6989(97)00335-0; SJOSTRAND J, 1994, GRAEF ARCH CLIN EXP, V232, P432, DOI 10.1007/BF00186586; Sjostrand J, 1999, VISION RES, V39, P2987, DOI 10.1016/S0042-6989(99)00030-9; Sjostrand J, 1999, GRAEF ARCH CLIN EXP, V237, P1014, DOI 10.1007/s004170050338; Springer AD, 2004, VISUAL NEUROSCI, V21, P53, DOI 10.1017/S0952523804041057; STONE J, 1981, J COMP NEUROL, V196, P205, DOI 10.1002/cne.901960204; Stone J., 1983, PARALLEL PROCESSING, DOI DOI 10.1007/978-1-4684-4433-9; TROILO D, 1993, VISION RES, V33, P1301, DOI 10.1016/0042-6989(93)90038-X; WASSLE H, 1989, NATURE, V341, P643, DOI 10.1038/341643a0; WASSLE H, 1990, VISION RES, V30, P1897, DOI 10.1016/0042-6989(90)90166-I; Wassle H, 2000, VISUAL NEUROSCI, V17, P591, DOI 10.1017/S0952523800174097; WEBB SV, 1976, VISION RES, V16, P1247, DOI 10.1016/0042-6989(76)90049-3; Wikler KC, 1996, PERSPECT DEV NEUROBI, V3, P161; WIKLER KC, 1990, J NEUROSCI, V10, P3390; Wilder HD, 1996, VISUAL NEUROSCI, V13, P335, DOI 10.1017/S0952523800007586; Williams AL, 2002, J COMP NEUROL, V445, P269, DOI 10.1002/cne.10171; Yamada Elizabeth S., 1996, Revista Brasileira de Biologia, V56, P381; Yamada ES, 1996, VISUAL NEUROSCI, V13, P1011, DOI 10.1017/S0952523800007677; Yamada ES, 2001, VISION RES, V41, P119, DOI 10.1016/S0042-6989(00)00244-3	93	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115291	10.1371/journal.pone.0115291	http://dx.doi.org/10.1371/journal.pone.0115291			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546077	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200036
J	Price, JS; Shear, P; Lisdahl, KM				Price, Jenessa S.; Shear, Paula; Lisdahl, Krista M.			Ecstasy Exposure & Gender: Examining Components of Verbal Memory Functioning	PLOS ONE			English	Article							SEROTONIN TRANSPORTER AVAILABILITY; MONOAMINE METABOLITE CONCENTRATIONS; LONG-TERM ABSTENTION; MDMA ECSTASY; WORKING-MEMORY; HIPPOCAMPAL DYSFUNCTION; MINIMAL EXPOSURE; SUBSTANCE USE; NEUROPSYCHOLOGICAL EVIDENCE; COGNITIVE PERFORMANCE	Objective: Studies have demonstrated verbal memory deficits associated with past year ecstasy use, although specific underlying components of these deficits are less understood. Further, prior research suggests potential gender differences in ecstasy-induced serotonergic changes. Therefore, the current study investigated whether gender moderated the relationship between ecstasy exposure and components of verbal memory after controlling for polydrug use and confounding variables. Method: Data were collected from 65 polydrug users with a wide range of ecstasy exposure (ages 18-35; 48 ecstasy and 17 marijuana users; 0-2310 ecstasy tablets). Participants completed a verbal learning and memory task, psychological questionnaires, and a drug use interview. Results: Increased past year ecstasy exposure predicted poorer short and long delayed free and cued recalls, retention, and recall discrimination. Male ecstasy users were more susceptible to dose-dependent deficits in retention than female users. Conclusion: Past year ecstasy consumption was associated with verbal memory retrieval, retention, and discrimination deficits in a dose-dependent manner in a sample of healthy young adult polydrug users. Male ecstasy users were at particular risk for deficits in retention following a long delay. Gender difference may be reflective of different patterns of polydrug use as well as increased hippocampal sensitivity. Future research examining neuronal correlates of verbal memory deficits in ecstasy users are needed.	[Price, Jenessa S.] Harvard Univ, McLean Hosp, Sch Med, Belmont, MA USA; [Shear, Paula] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Lisdahl, Krista M.] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA	Harvard University; McLean Hospital; University of Cincinnati; University of Wisconsin System; University of Wisconsin Milwaukee	Lisdahl, KM (corresponding author), Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA.	krista.medina@gmail.com	Lisdahl, Krista/P-8470-2019	Lisdahl, Krista/0000-0001-9515-1335	University of Cincinnati University Research Council (URC) faculty grant; URC Summer Graduate Student Research Fellowship Program; NIDA [R03 DA027457-01, 2T32DA015036]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030354, R03DA027457, T32DA015036] Funding Source: NIH RePORTER	University of Cincinnati University Research Council (URC) faculty grant; URC Summer Graduate Student Research Fellowship Program; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this research was provided by the University of Cincinnati University Research Council (URC) faculty grant (Co-PIs: Lisdahl, Shear) and URC Summer Graduate Student Research Fellowship Program (Price, Mentor: Lisdahl). Drs. Lisdahl and Price were supported by NIDA during manuscript preparation (R03 DA027457-01; PI: Lisdahl; 2T32DA015036, PI: Scott E. Lukas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allott K, 2007, NEUROSCI BIOBEHAV R, V31, P327, DOI 10.1016/j.neubiorev.2006.09.009; Benningfield MM, 2013, NEUROPSYCHOPHARMACOL, V38, P253, DOI 10.1038/npp.2012.178; Biezonski DK, 2011, CURR NEUROPHARMACOL, V9, P84, DOI 10.2174/157015911795017146; Bolla KI, 1998, NEUROLOGY, V51, P1532, DOI 10.1212/WNL.51.6.1532; Bosch OG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061234; Brennan KA, 2006, PSYCHOPHARMACOLOGY, V184, P239, DOI 10.1007/s00213-005-0278-y; Brezun JM, 1999, NEUROSCIENCE, V89, P999, DOI 10.1016/S0306-4522(98)00693-9; Brezun JM, 2000, EUR J NEUROSCI, V12, P391, DOI 10.1046/j.1460-9568.2000.00932.x; Cohen J., 2003, APPL MULTIPLE REGRES; CONSROE P, 1979, PSYCHOPHARMACOLOGY, V66, P45, DOI 10.1007/BF00431988; Croft RJ, 2001, PSYCHOPHARMACOLOGY, V153, P373, DOI 10.1007/s002130000591; Curran HV, 2003, PSYCHOPHARMACOLOGY, V169, P91, DOI 10.1007/s00213-003-1463-5; Daumann J, 2005, PSYCHOPHARMACOLOGY, V180, P607, DOI 10.1007/s00213-004-2002-8; Daumann J, 2003, NEUROREPORT, V14, P1983, DOI 10.1097/00001756-200310270-00021; Daumann J, 2003, COGNITIVE BRAIN RES, V16, P479, DOI 10.1016/S0926-6410(03)00075-2; Debassio WA, 1996, BRAIN RES BULL, V41, P379, DOI 10.1016/S0361-9230(96)00214-6; Delis DC, 2001, CALIFORNIA VERBAL LE; Disney ER, 1999, AM J PSYCHIAT, V156, P1515, DOI 10.1176/ajp.156.10.1515; DOUDET D, 1995, AM J PSYCHIAT, V152, P1782; Fals-Stewart W, 2000, J CONSULT CLIN PSYCH, V68, P134, DOI 10.1037/0022-006X.68.1.134; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; First MB, 2002, STRUCTURED CLIN INTE; Fisk JE, 2011, HUM PSYCHOPHARM CLIN, V26, P313, DOI 10.1002/hup.1207; Foster TC, 1999, BRAIN RES REV, V30, P236, DOI 10.1016/S0165-0173(99)00017-X; Fox HC, 2002, PSYCHOPHARMACOLOGY, V162, P203, DOI 10.1007/s00213-002-1071-9; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gould E, 1999, NEUROPSYCHOPHARMACOL, V21, pS46, DOI 10.1016/S0893-133X(99)00045-7; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Gould RW, 2011, NEUROPHARMACOLOGY, V61, P245, DOI 10.1016/j.neuropharm.2011.04.007; Gouzoulis-Mayfrank E, 2000, J NEUROL NEUROSUR PS, V68, P719, DOI 10.1136/jnnp.68.6.719; Gouzoulis-Mayfrank E, 2003, PROG NEURO-PSYCHOPH, V27, P819, DOI 10.1016/S0278-5846(03)00114-3; Gudelsky GA, 2008, PHARMACOL BIOCHEM BE, V90, P198, DOI 10.1016/j.pbb.2007.10.003; Halpern JH, 2004, DRUG ALCOHOL DEPEN, V75, P135, DOI 10.1016/j.drugalcdep.2004.02.008; Halpern JH, 2011, ADDICTION, V106, P777, DOI 10.1111/j.1360-0443.2010.03252.x; Hanson KL, 2004, PSYCHOL MED, V34, P229, DOI 10.1017/S0033291703001132; Hillman CH, 2003, INT J PSYCHOPHYSIOL, V48, P307, DOI 10.1016/S0167-8760(03)00080-1; Hjorthoj CR, 2012, ADDICT BEHAV, V37, P225, DOI 10.1016/j.addbeh.2011.11.025; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; Izco M, 2007, PSYCHOPHARMACOLOGY, V189, P459, DOI 10.1007/s00213-006-0602-1; Jacobsen LK, 2004, PSYCHOPHARMACOLOGY, V173, P383, DOI 10.1007/s00213-003-1679-4; Johnston L. D., 2014, MONITORING FUTURE NA; Jonsson EG, 1998, PSYCHIAT RES, V79, P1, DOI 10.1016/S0165-1781(98)00027-4; Jonsson EG, 2000, J PSYCHIAT RES, V34, P239, DOI 10.1016/S0022-3956(00)00013-3; Keyes KM, 2008, DRUG ALCOHOL DEPEN, V97, P139, DOI 10.1016/j.drugalcdep.2008.04.001; Klugman A, 1999, LANCET, V353, P1269, DOI 10.1016/S0140-6736(05)66942-5; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Laws KR, 2007, HUM PSYCHOPHARM CLIN, V22, P381, DOI 10.1002/hup.857; Liechti ME, 2000, J PSYCHOPHARMACOL, V14, P269, DOI 10.1177/026988110001400313; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; McCann UD, 2005, NEUROPSYCHOPHARMACOL, V30, P1741, DOI 10.1038/sj.npp.1300736; McCann UD, 1998, LANCET, V352, P1433, DOI 10.1016/S0140-6736(98)04329-3; McCann UD, 2008, POSITRON EMISSION TO; McCardle K, 2004, PSYCHOPHARMACOLOGY, V173, P434, DOI 10.1007/s00213-004-1791-0; MEDINA KL, 2005, J INT NEUROPSYCH SOC, V11, P1; Medina KL, 2007, DRUG ALCOHOL DEPEN, V87, P303, DOI 10.1016/j.drugalcdep.2006.09.003; Morgan MJ, 1999, PSYCHOPHARMACOLOGY, V141, P30, DOI 10.1007/s002130050803; Morgan MJ, 2002, PSYCHOPHARMACOLOGY, V159, P294, DOI 10.1007/s002130100907; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; O'Shea E, 1998, NEUROPHARMACOLOGY, V37, P919, DOI 10.1016/S0028-3908(98)00029-X; Parrott AC, 2001, HUM PSYCHOPHARM CLIN, V16, P557, DOI 10.1002/hup.351; Pezawas L, 2008, MOL PSYCHIATR, V13, P709, DOI 10.1038/mp.2008.32; Quednow BB, 2006, J PSYCHOPHARMACOL, V20, P373, DOI 10.1177/0269881106061200; Reneman L, 2001, LANCET, V358, P1864, DOI 10.1016/S0140-6736(01)06888-X; Rodgers J, 2000, PSYCHOPHARMACOLOGY, V151, P19, DOI 10.1007/s002130000467; Roiser JP, 2006, PSYCHOPHARMACOLOGY, V188, P213, DOI 10.1007/s00213-006-0495-z; SAVITZ DA, 1995, AM J EPIDEMIOL, V142, P904, DOI 10.1093/oxfordjournals.aje.a117737; SCHEFFEL U, 1992, NEUROPHARMACOLOGY, V31, P881, DOI 10.1016/0028-3908(92)90126-A; Schilt T, 2007, ARCH GEN PSYCHIAT, V64, P728, DOI 10.1001/archpsyc.64.6.728; SHARKEY J, 1991, PSYCHOPHARMACOLOGY, V105, P113, DOI 10.1007/BF02316872; SOBELL LC, 1979, BEHAV RES THER, V17, P157, DOI 10.1016/0005-7967(79)90025-1; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Sprague JE, 1993, PHYSIOL BEHAV, V79, P1281; STANLEY M, 1985, LIFE SCI, V37, P1279, DOI 10.1016/0024-3205(85)90242-5; Substance Abuse and Mental Health Services Administration, 2011, NSDUH SER H; Tapert SF, 2000, ADDICTION, V95, P1043, DOI 10.1046/j.1360-0443.2000.95710436.x; Tapert SF, 2002, J INT NEUROPSYCH SOC, V8, P873, DOI 10.1017/S1355617702870011; Thomasius R, 2006, J PSYCHOPHARMACOL, V20, P211, DOI 10.1177/0269881106059486; Thomasius R, 2003, PSYCHOPHARMACOLOGY, V167, P85, DOI 10.1007/s00213-002-1383-9; Urban NBL, 2012, NEUROPSYCHOPHARMACOL, V37, P1465, DOI 10.1038/npp.2011.332; Verbaten MN, 2003, HUM PSYCHOPHARM, V167, P85; Verrico CD, 2007, PSYCHOPHARMACOLOGY, V189, P489, DOI 10.1007/s00213-005-0174-5; Wang GJ, 2008, OBESITY, V16, pS88, DOI 10.1038/oby.2008.469; Wareing M, 2005, HUM PSYCHOPHARM CLIN, V20, P115, DOI 10.1002/hup.670; Wilkinson G.S, 1993, WIDE RANGE ACHIEVEME; Williams RB, 2003, NEUROPSYCHOPHARMACOL, V28, P533, DOI 10.1038/sj.npp.1300054; Wilson J J, 2001, Curr Psychiatry Rep, V3, P497, DOI 10.1007/s11920-001-0044-8; YOUNG SN, 1980, J NEUROL NEUROSUR PS, V43, P438, DOI 10.1136/jnnp.43.5.438; Zakzanis KK, 2001, NEUROLOGY, V56, P966, DOI 10.1212/WNL.56.7.966; Zakzanis KK, 2007, HUM PSYCHOPHARM CLIN, V22, P427, DOI 10.1002/hup.873	93	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115645	10.1371/journal.pone.0115645	http://dx.doi.org/10.1371/journal.pone.0115645			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545890	gold, Green Published, Green Submitted			2022-12-26	WOS:000347120200050
J	Williamson, DH; Ceccarelli, DM; Evans, RD; Hill, JK; Russ, GR				Williamson, David H.; Ceccarelli, Daniela M.; Evans, Richard D.; Hill, Jos K.; Russ, Garry R.			Derelict Fishing Line Provides a Useful Proxy for Estimating Levels of Non-Compliance with No-Take Marine Reserves	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CORAL TROUT; IMPACTS; GEAR; BIOMASS; DEBRIS; SIZE; LOST; ENFORCEMENT; NETWORKS	No-take marine reserves (NTMRs) are increasingly being established to conserve or restore biodiversity and to enhance the sustainability of fisheries. Although effectively designed and protected NTMR networks can yield conservation and fishery benefits, reserve effects often fail to manifest in systems where there are high levels of non-compliance by fishers (poaching). Obtaining reliable estimates of NTMR non-compliance can be expensive and logistically challenging, particularly in areas with limited or non-existent resources for conducting surveillance and enforcement. Here we assess the utility of density estimates and re-accumulation rates of derelict (lost and abandoned) fishing line as a proxy for fishing effort and NTMR non-compliance on fringing coral reefs in three island groups of the Great Barrier Reef Marine Park (GBRMP), Australia. Densities of derelict fishing line were consistently lower on reefs within old (> 20 year) NTMRs than on non-NTMR reefs (significantly in the Palm and Whitsunday Islands), whereas line densities did not differ significantly between reefs in new NTMRs (5 years of protection) and non-NTMR reefs. A manipulative experiment in which derelict fishing lines were removed from a subset of the monitoring sites demonstrated that lines re-accumulated on NTMR reefs at approximately one third (32.4%) of the rate observed on non-NTMR reefs over a thirty-two month period. Although these inshore NTMRs have long been considered some of the best protected within the GBRMP, evidence presented here suggests that the level of non-compliance with NTMR regulations is higher than previously assumed.	[Williamson, David H.; Ceccarelli, Daniela M.; Russ, Garry R.] Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Russ, Garry R.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Evans, Richard D.] Dept Pk & Wildlife, Perth, WA 6151, Australia; [Evans, Richard D.] Univ Western Australia, Oceans Inst, Sch Plant Biol, Crawley, WA 6009, Australia; [Hill, Jos K.] Olazul, San Francisco, CA 94108 USA	James Cook University; University of Western Australia	Williamson, DH (corresponding author), Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	david.williamson@jcu.edu.au	Ceccarelli, Daniela/AGO-7628-2022; Evans, Richard D./O-3559-2019; Ceccarelli, Daniela/AAN-3577-2020	Evans, Richard D./0000-0003-4364-4810; Williamson, David/0000-0001-8447-039X	Australian Department of Environment through the Marine and Tropical Sciences Research Facility (MTSRF); Landcare Australia; George Alexander Foundation; PADI Project Aware	Australian Department of Environment through the Marine and Tropical Sciences Research Facility (MTSRF)(Australian Government); Landcare Australia; George Alexander Foundation; PADI Project Aware	Funding for this work was provided by the Australian Department of Environment (previously; Department of Sustainability, Environment, Water, Population and Communities) through the Marine and Tropical Sciences Research Facility (MTSRF) (http://www.environment.gov.au/topics/science-and-research/cerf/marine-and-tropicalsciences-research-facility). Reef Check funding was provided by Landcare Australia (http://www.landcareonline.com.au/), The George Alexander Foundation (http://www.georgealexander.org.au/) and PADI Project Aware (http://www.projectaware.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Alder J, 1996, ENVIRON MANAGE, V20, P541, DOI 10.1007/BF01474654; Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Almany GR, 2013, CURR BIOL, V23, P626, DOI 10.1016/j.cub.2013.03.006; Arias A, 2013, ECOL SOC, V18, DOI 10.5751/ES-05872-180418; Asoh K, 2004, CONSERV BIOL, V18, P1645, DOI 10.1111/j.1523-1739.2004.00122.x; Ayling A.M., 2008, ABUNDANCE PATTERNS R; Ban NC, 2011, CONSERV LETT, V4, P241, DOI 10.1111/j.1755-263X.2011.00171.x; Bauer LJ, 2008, MAR POLLUT BULL, V56, P402, DOI 10.1016/j.marpolbul.2007.11.001; Bergseth BJ, 2015, FISH FISH, V16, P240, DOI 10.1111/faf.12051; Brainard RE, 2000, ORIGINS TYPES MAGNIT; Byers JE, 2007, ECOL APPL, V17, P1851, DOI 10.1890/07-0067.1; Chiappone M, 2005, BIOL CONSERV, V121, P221, DOI 10.1016/j.biocon.2004.04.023; Chiappone M, 2004, CARIBB J SCI, V40, P312; Chiappone M, 2002, MAR POLLUT BULL, V44, P597, DOI 10.1016/S0025-326X(01)00290-9; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Davis KLF, 2004, COAST MANAGE, V32, P373, DOI 10.1080/08920750490487223; Donohue MJ, 2001, MAR POLLUT BULL, V42, P1301, DOI 10.1016/S0025-326X(01)00139-4; Evans RD, 2004, AQUAT CONSERV, V14, P505, DOI 10.1002/aqc.631; GBRMPA, 2003, GREAT BARR REEF MAR, P220; Goni R, 2010, MAR ECOL PROG SER, V400, P233, DOI 10.3354/meps08419; Gorley C.K., 2006, GETTING STARTED PRIM; Graham NAJ, 2011, OCEANOGR MAR BIOL, V49, P105; Gribble NA, 1998, J ENVIRON MANAGE, V52, P53, DOI 10.1006/jema.1997.0160; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Ishida T, 2001, ENV MONITORING BIODI, P79; Jennings S, 1996, AMBIO, V25, P44; Kerwath SE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3347; Laist David W., 1997, P99; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Little LR, 2005, FISHERIES MANAG ECOL, V12, P177, DOI 10.1111/j.1365-2400.2005.00440.x; Lubchenco J, 2003, ECOL APPL, V13, pS3; Mangi SC, 2006, MAR POLLUT BULL, V52, P1646, DOI 10.1016/j.marpolbul.2006.06.006; Mapstone BD, 2003, EFFECTS LINE FISHING, P205; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; McIntosh N, 2000, 2000 6 11 AUG 2000 H, P364; Miller I, 2012, MAR ENVIRON RES, V79, P167, DOI 10.1016/j.marenvres.2012.05.008; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Roberts CM, 2005, PHILOS T R SOC B, V360, P123, DOI 10.1098/rstb.2004.1578; Roberts CM, 2000, B MAR SCI, V66, P581; Russ GR, 2008, CURR BIOL, V18, pR514, DOI 10.1016/j.cub.2008.04.016; Russ GR, 2011, ECOL APPL, V21, P241, DOI 10.1890/09-1197.1; Russ GR, 2010, OECOLOGIA, V163, P1103, DOI 10.1007/s00442-010-1692-3; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Russ GR, 2003, ECOL APPL, V13, P1553, DOI 10.1890/01-5341; Spengler A, 2008, MAR POLLUT BULL, V56, P226, DOI 10.1016/j.marpolbul.2007.09.040; Taylor S, 2012, STATEWIDE RECREATION, P93; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Watson J, 2010, PALM ISLAND LONG LEN, P212; Williamson DH, 2014, ECOL EVOL, V4, P337, DOI 10.1002/ece3.934; Williamson DH, 2004, ENVIRON CONSERV, V31, P149, DOI 10.1017/S0376892904001262; Yoshikawa T, 2004, BIOL CONSERV, V117, P557, DOI 10.1016/j.biocon.2003.09.025	58	18	18	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e114395	10.1371/journal.pone.0114395	http://dx.doi.org/10.1371/journal.pone.0114395			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545154	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000347120200011
J	Zhang, YX; Zhang, S; Ma, KM; Fu, BJ; Anand, M				Zhang, Yuxin; Zhang, Shuang; Ma, Keming; Fu, Bojie; Anand, Madhur			Woody Species Diversity in Forest Plantations in a Mountainous Region of Beijing, China: Effects of Sampling Scale and Species Selection	PLOS ONE			English	Article							PLANT DIVERSITY; BETA-DIVERSITY; SPATIAL SCALES; ALPHA-DIVERSITY; BIODIVERSITY; CONSERVATION; PATTERN	The role of forest plantations in biodiversity conservation has gained more attention in recent years. However, most work on evaluating the diversity of forest plantations focuses only on one spatial scale; thus, we examined the effects of sampling scale on diversity in forest plantations. We designed a hierarchical sampling strategy to collect data on woody species diversity in planted pine (Pinus tabuliformis Carr.), planted larch (Larix principis-rupprechtii Mayr.), and natural secondary deciduous broadleaf forests in a mountainous region of Beijing, China. Additive diversity partition analysis showed that, compared to natural forests, the planted pine forests had a different woody species diversity partitioning pattern at multi-scales (except the Simpson diversity in the regeneration layer), while the larch plantations did not show multi-scale diversity partitioning patterns that were obviously different from those in the natural secondary broadleaf forest. Compare to the natural secondary broadleaf forests, the effects of planted pine forests on woody species diversity are dependent on the sampling scale and layers selected for analysis. Diversity in the planted larch forest, however, was not significantly different from that in the natural forest for all diversity components at all sampling levels. Our work demonstrated that the species selected for afforestation and the sampling scales selected for data analysis alter the conclusions on the levels of diversity supported by plantations. We suggest that a wide range of scales should be considered in the evaluation of the role of forest plantations on biodiversity conservation.	[Zhang, Yuxin; Zhang, Shuang; Ma, Keming; Fu, Bojie] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing 100085, Peoples R China; [Anand, Madhur] Univ Guelph, Sch Environm Sci, Global Ecol Change Lab, Guelph, ON N1G 2W1, Canada	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); University of Guelph	Ma, KM (corresponding author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing 100085, Peoples R China.	mkm@rcees.ac.cn	Fu, Bojie/B-1493-2009		Innovation Project of the State Key Laboratory of Urban and Regional Ecology of China [SKLURE2013-1-02]; National Natural Science Foundation of China [31370451]	Innovation Project of the State Key Laboratory of Urban and Regional Ecology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the Innovation Project of the State Key Laboratory of Urban and Regional Ecology of China (SKLURE2013-1-02) and National Natural Science Foundation of China (31370451). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1981, OIKOS, V37, P199, DOI 10.2307/3544465; ALLAN JD, 1975, OECOLOGIA, V18, P359, DOI 10.1007/BF00345855; Bremer LL, 2010, BIODIVERS CONSERV, V19, P3893, DOI 10.1007/s10531-010-9936-4; Bretz F., 2010, MULTIPLE COMP USING; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Brockerhoff EG, 2013, FOREST ECOL MANAG, V301, P43, DOI 10.1016/j.foreco.2012.09.018; Chandy S, 2006, J APPL ECOL, V43, P792, DOI 10.1111/j.1365-2664.2006.01178.x; Chazdon R.L., 2008, INTROPICAL FORESTCOM, P384; Chen L.Z, 1997, STUDY STRUCTURE FUNC, P1; Concepcion ED, 2012, ECOL APPL, V22, P972, DOI 10.1890/11-1471.1; Crawley M.J., 2007, R BOOK; Crawley MJ, 2001, SCIENCE, V291, P864, DOI 10.1126/science.291.5505.864; Crist TO, 2006, ECOL LETT, V9, P923, DOI 10.1111/j.1461-0248.2006.00941.x; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Ellison AM, 2010, ECOLOGY, V91, P1962, DOI 10.1890/09-1692.1; Eycott AE, 2006, J APPL ECOL, V43, P1160, DOI 10.1111/j.1365-2664.2006.01235.x; FAO, 2012, STAT WORLDS FOR 2012; FAO-UNESCO, 1988, 60 FAOUNESCO WORLD S; Finegan B, 1996, TRENDS ECOL EVOL, V11, P119, DOI 10.1016/0169-5347(96)81090-1; Fu BJ, 2004, PLANT SOIL, V261, P47, DOI 10.1023/B:PLSO.0000035567.97093.48; Gabriel D, 2006, ECOL APPL, V16, P2011, DOI 10.1890/1051-0761(2006)016[2011:BDADSS]2.0.CO;2; Gabriel D, 2010, ECOL LETT, V13, P858, DOI 10.1111/j.1461-0248.2010.01481.x; Gering JC, 2003, CONSERV BIOL, V17, P488, DOI 10.1046/j.1523-1739.2003.01465.x; Golodets C, 2011, J APPL ECOL, V48, P1260, DOI 10.1111/j.1365-2664.2011.02031.x; Hartmann H, 2010, FOREST CHRON, V86, P354, DOI 10.5558/tfc86354-3; Hassan R., 2005, ECOSYSTEMS HUMAN WEL; HORNBECK JW, 1992, ECOL APPL, V2, P238, DOI 10.2307/1941858; Irwin S, 2014, BIODIVERS CONSERV, V23, P697, DOI 10.1007/s10531-014-0627-4; Kuznetsova A., 2014, IMERTEST TESTS RANDO; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Ma KP, 1997, STUDY STRUCTURE FUNC, P56; MACARTHUR R, 1966, AM NAT, V100, P319, DOI 10.1086/282425; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Oxbrough A, 2014, FOREST ECOL MANAG, V321, P1, DOI 10.1016/j.foreco.2013.09.038; Parrotta JA, 1997, FOREST ECOL MANAG, V99, P1, DOI 10.1016/S0378-1127(97)00190-4; Pawson SM, 2013, BIODIVERS CONSERV, V22, P1203, DOI 10.1007/s10531-013-0458-8; R Core Team, 2021, R LANGUAGE ENV STAT; Ricotta C, 2010, ECOLOGY, V91, P1981, DOI 10.1890/09-0126.1; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Smart SM, 2006, P ROY SOC B-BIOL SCI, V273, P2659, DOI 10.1098/rspb.2006.3630; UNEP, 2001, ASS STAT WORLDS REM; Veech JA, 2002, OIKOS, V99, P3, DOI 10.1034/j.1600-0706.2002.990101.x; Veech JA, 2010, ECOLOGY, V91, P1988, DOI 10.1890/09-1140.1; Verstraeten G, 2013, FOREST ECOL MANAG, V289, P363, DOI 10.1016/j.foreco.2012.10.049; Wagner HH, 2000, LANDSCAPE ECOL, V15, P219, DOI 10.1023/A:1008114117913; Zuur Alain F., 2009, P1	49	5	5	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115038	10.1371/journal.pone.0115038	http://dx.doi.org/10.1371/journal.pone.0115038			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545860	Green Published, gold, Green Submitted			2022-12-26	WOS:000347120200018
J	Zhao, H; Chen, D; Tang, JY; Jia, G; Long, DB; Liu, GM; Chen, XL; Shang, HY				Zhao, Hua; Chen, Dan; Tang, Jiayong; Jia, Gang; Long, Dingbiao; Liu, Guangmang; Chen, Xiaoling; Shang, Haiying			Partial Optimization of the 5-Terminal Codon Increased a Recombination Porcine Pancreatic Lipase (opPPL) Expression in Pichia pastoris	PLOS ONE			English	Article							HIGH-LEVEL EXPRESSION; COVALENT IMMOBILIZATION; TRIACYLGLYCEROL LIPASE; GENE-EXPRESSION; PURIFICATION; ENZYMES; PIGLETS; PIGS; STOMACH; CLONING	Pancreatic lipase plays a key role in intestinal digestion of feed fat, and is often deficient in young animals such as weaning piglets. The objective of this study was to express and characterize a partial codon optimized porcine pancreatic lipase (opPPL). A 537 bp cDNA fragment encoding N-terminus amino acid residue of the mature porcine pancreatic lipase was synthesized according to the codon bias of Pichia pastoris and ligated to the full-length porcine pancreatic lipase cDNA fragment. The codon optimized PPL was cloned into the pPICZ alpha A (Invitrogen, Beijing, China) vector. After the resultant opPPL/pPICZ alpha A plasmid was transformed into P. pastoris, the over-expressed extracellular opPPL containing a His-tag to the C terminus was purified using Ni Sepharose affinity column (GE Healthcare, Piscataway, NJ, USA), and was characterized against the native enzyme (commercial PPL from porcine pancreas, Sigma). The opPPL exhibited a molecular mass of approximately 52 kDa, and showed optimal temperature (40 degrees C), optimal pH (8.0), K-m (0.041 mM), and V-max (2.008 mu mol.mg protein(-1).min(-1)) similar to those of the commercial enzyme with p-NPP as the substrate. The recombinant enzyme was stable at 60 degrees C, but lost 80% (P<0.05) of its activity after exposure to heat >= 60 degrees C for 20 min. The codon optimization increased opPPL yield for ca 4 folds (146 mg.L-1 vs 36 mg.L-1) and total enzyme activity increased about 5 folds (1900 IU.L-1 vs 367 IU.L-1) compared with those native naPPL/pPICZ alpha A tranformant. Comparison of gene copies and mRNA profiles between the two strains indicated the increased rePPL yields may partly be ascribed to the increased protein translational efficiency after codon optimization. In conclusion, we successfully optimized 5-terminal of porcine pancreatic lipase encoding gene and over-expressed the gene in P. pastoris as an extracellular, functional enzyme. The recombination enzyme demonstrates a potential for future use as an animal feed additive for animal improvement.	[Zhao, Hua; Chen, Dan; Tang, Jiayong; Jia, Gang; Liu, Guangmang; Chen, Xiaoling; Shang, Haiying] Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Sichuan, Peoples R China; [Long, Dingbiao] Chongqing Acad Anim Sci, Chongqing 402460, Peoples R China	Sichuan Agricultural University	Zhao, H (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Sichuan, Peoples R China.	zhua666@126.com			National Natural Science Foundation of China [31272468]; Special Research Funding for Discipline Construction in Sichuan Agricultural University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Research Funding for Discipline Construction in Sichuan Agricultural University	This work was supported in part by the National Natural Science Foundation of China (No. 31272468) and by the Special Research Funding for Discipline Construction in Sichuan Agricultural University (to H. Zhao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MB, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-24; Bai YX, 2006, J BIOTECHNOL, V125, P574, DOI 10.1016/j.jbiotec.2006.04.003; Bai YX, 2006, PROCESS BIOCHEM, V41, P770, DOI 10.1016/j.procbio.2005.09.012; Boettner M, 2007, J BIOTECHNOL, V130, P1, DOI 10.1016/j.jbiotec.2007.02.019; Borgstrom Bengt, 1993, P475; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carvalho NB, 2008, APPL BIOCHEM BIOTECH, V150, P25, DOI 10.1007/s12010-008-8194-3; CHWALIBOG A, 1994, J ANIM PHYSIOL AN N, V72, P80, DOI 10.1111/j.1439-0396.1994.tb00374.x; CLARE JJ, 1991, BIO-TECHNOL, V9, P455, DOI 10.1038/nbt0591-455; De Caro J, 1981, BIOCHIM BIOPHYS ACTA, V671, P29; Dheeman DS, 2010, J IND MICROBIOL BIOT, V37, P1, DOI 10.1007/s10295-009-0643-7; DINTZIS FR, 1995, J ANIM SCI, V73, P1138; Freitas L, 2007, WORLD J MICROB BIOT, V23, P1725, DOI 10.1007/s11274-007-9421-8; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Gvritishvili AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015056; Hasan F, 2009, BIOTECHNOL ADV, V27, P782, DOI 10.1016/j.biotechadv.2009.06.001; Hedemann MS, 2004, ARCH ANIM NUTR, V58, P47, DOI 10.1080/00039420310001656677; Hopkins SA, 1992, PHARM ENG, V12, P48; Huang H, 2008, APPL MICROBIOL BIOT, V78, P95, DOI 10.1007/s00253-007-1290-4; Jacobsen EE, 2013, J MOL CATAL B-ENZYM, V85-86, P134, DOI 10.1016/j.molcatb.2012.09.007; Jensen MS, 1997, J ANIM SCI, V75, P437; Jia HY, 2012, J MOL CATAL B-ENZYM, V78, P72, DOI 10.1016/j.molcatb.2012.02.009; Kim T, 2006, APPL ENVIRON MICROB, V72, P4397, DOI 10.1128/AEM.02612-05; Lin L, 2001, CHINESE J BIOCH MOL, V18, P32; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Liu FC, 2010, J AGR FOOD CHEM, V58, P3322, DOI 10.1021/jf903439q; Liu Y, 2011, BIORESOURCE TECHNOL, V102, P10414, DOI 10.1016/j.biortech.2011.08.056; Mendes AA, 2012, J MOL CATAL B-ENZYM, V78, P119, DOI 10.1016/j.molcatb.2012.03.004; Pierzynowski S, 2012, J ANIM SCI, V90, P439, DOI 10.2527/jas.53868; Pierzynowski S, 2012, J ANIM SCI, V90, P324, DOI 10.2527/jas.53872; Richter S, 2006, BIOTECHNOL BIOENG, V93, P1017, DOI 10.1002/bit.20705; ROMANOS M, 1995, CURR OPIN BIOTECH, V6, P527, DOI 10.1016/0958-1669(95)80087-5; Sebban-Kreuzer C, 2006, PROTEIN EXPRES PURIF, V49, P284, DOI 10.1016/j.pep.2006.06.001; Simons JWFA, 1998, EUR J BIOCHEM, V253, P675, DOI 10.1046/j.1432-1327.1998.2530675.x; Slupecka M, 2012, J ANIM SCI, V90, P311, DOI [10.2527/jas.53921, 10.2527/jas53921]; Svihus B, 2011, ANIM PROD SCI, V51, P590, DOI 10.1071/AN11004; Tang SJ, 2001, ARCH BIOCHEM BIOPHYS, V387, P93, DOI 10.1006/abbi.2000.2235; Vakhlu J, 2006, ELECTRON J BIOTECHN, V9, P69, DOI 10.2225/vol9-issue1-fulltext-9; VERGER R, 1969, BIOCHIM BIOPHYS ACTA, V188, P272, DOI 10.1016/0005-2795(69)90075-0; WINKLER UK, 1979, J BACTERIOL, V138, P663, DOI 10.1128/JB.138.3.663-670.1979; Xie XL, 2011, THESIS SICHUAN AGR U; Yu MR, 2007, PROTEIN EXPRES PURIF, V53, P255, DOI 10.1016/j.pep.2006.10.018; Zheng JH, 2012, J MOL MICROB BIOTECH, V22, P300, DOI 10.1159/000343819; Zhou JC, 2009, J NUTR, V139, P1061, DOI 10.3945/jn.109.104901	44	6	7	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e114385	10.1371/journal.pone.0114385	http://dx.doi.org/10.1371/journal.pone.0114385			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25544987	gold, Green Published, Green Submitted			2022-12-26	WOS:000347120200010
J	Liu, D; Hu, K; Stork, S; Herrmann, S; Kramer, B; Cikes, M; Gaudron, PD; Knop, S; Ertl, G; Bijnens, B; Weidemann, F				Liu, Dan; Hu, Kai; Stoerk, Stefan; Herrmann, Sebastian; Kramer, Bastian; Cikes, Maja; Gaudron, Philipp Daniel; Knop, Stefan; Ertl, Georg; Bijnens, Bart; Weidemann, Frank			Predictive Value of Assessing Diastolic Strain Rate on Survival in Cardiac Amyloidosis Patients with Preserved Ejection Fraction	PLOS ONE			English	Article							LIGHT-CHAIN AMYLOIDOSIS; SPECKLE-TRACKING ECHOCARDIOGRAPHY; LEFT-VENTRICULAR FUNCTION; SYSTEMIC AMYLOIDOSIS; DOPPLER-ECHOCARDIOGRAPHY; PROGNOSTIC-SIGNIFICANCE; AL AMYLOIDOSIS; INVOLVEMENT; FEATURES; RECOMMENDATIONS	Objectives: Since diastolic abnormalities are typical findings of cardiac amyloidosis (CA), we hypothesized that speckle-tracking-imaging (STI) derived longitudinal early diastolic strain rate (LSRdias) could predict outcome in CA patients with preserved left ventricular ejection fraction (LVEF >50%). Background: Diastolic abnormalities including altered early filling are typical findings and are related to outcome in CA patients. Reduced longitudinal systolic strain (LSsys) assessed by STI predicts increased mortality in CA patients. It remains unknown if LSRdias also related to outcome in these patients. Methods: Conventional echocardiography and STI were performed in 41 CA patients with preserved LVEF (25 male; mean age 65 +/- 9 years). Global and segmental LSsys and LSRdias were obtained in six LV segments from apical 4-chamber views. Results: Nineteen (46%) out of 41 CA patients died during a median of 16 months (quartiles 5-35 months) follow-up. Baseline mitral annular plane systolic excursion (MAPSE, 6 +/- 2 vs. 8 +/- 3 mm), global LSRdias and basal-septal LSRdias were significantly lower in non-survivors than in survivors (all p< 0.05). NYHA class, number of non-cardiac organs involved, MAPSE, mid-septal LSsys, global LSRdias, basal-septal LSRdias and E/LSRdias were the univariable predictors of all-cause death. Multivariable analysis showed that number of non-cardiac organs involved hazard ratio [HR] =1.96, 95% confidence interval [CI] 1.17-3.26, P=0.010), global LSRdias (HR=7.30, 95% CI 2.08-25.65, P=0.002), and E/LSRdias (HR=2.98, 95% CI 1.54-5.79, P=0.001) remained independently predictive of increased mortality risk. The prognostic performance of global LSRdias was optimal at a cutoff value of 0.85 S-1 (sensitivity 68%, specificity 67%). Global LSRdias,0.85 S21 predicted a 4-fold increased mortality in CA patients with preserved LVEF. Conclusions: STI-derived early diastolic strain rate is a powerful independent predictor of survival in CA patients with preserved LVEF.	[Liu, Dan; Hu, Kai; Stoerk, Stefan; Herrmann, Sebastian; Kramer, Bastian; Gaudron, Philipp Daniel; Ertl, Georg; Weidemann, Frank] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany; [Liu, Dan; Hu, Kai; Stoerk, Stefan; Herrmann, Sebastian; Kramer, Bastian; Gaudron, Philipp Daniel; Ertl, Georg; Weidemann, Frank] Univ Hosp Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany; [Cikes, Maja] Univ Hosp Ctr Zagreb, Dept Cardiovasc Dis, Zagreb, Croatia; [Cikes, Maja] Univ Zagreb, Sch Med, Zagreb 41001, Croatia; [Knop, Stefan] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany; [Bijnens, Bart] Univ Pompeu Fabra, ICREA, Barcelona, Spain; [Bijnens, Bart] Katholieke Univ Leuven, Dept Cardiovasc Dis, Leuven, Belgium	University of Wurzburg; University of Wurzburg; University of Zagreb; University of Zagreb; University of Wurzburg; ICREA; Pompeu Fabra University; KU Leuven	Weidemann, F (corresponding author), Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany.	Weidemann_F@ukw.de	Bijnens, Bart/AAE-7186-2021; Stork, Stefan/AAR-4182-2020; Bijnens, Bart H/C-2955-2008	Bijnens, Bart/0000-0003-3130-6937; Stork, Stefan/0000-0002-1771-7249; Bijnens, Bart H/0000-0003-3130-6937	Bundesministerium fur Bildung und Forschung, Germany [BMBF01 EO1004]; ICREA Funding Source: Custom	Bundesministerium fur Bildung und Forschung, Germany(Federal Ministry of Education & Research (BMBF)); ICREA(ICREA)	This work was supported by grants from the Bundesministerium fur Bildung und Forschung (BMBF01 EO1004), Germany (http://.bmbf.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zahrani GB, 2009, J AM SOC ECHOCARDIOG, V22, P290, DOI 10.1016/j.echo.2008.11.013; APPLETON CP, 1988, J AM COLL CARDIOL, V12, P426, DOI 10.1016/0735-1097(88)90416-0; Baccouche H, 2012, ECHOCARDIOGR-J CARD, V29, P668, DOI 10.1111/j.1540-8175.2012.01680.x; Bellavia D, 2008, AM J CARDIOL, V101, P1039, DOI 10.1016/j.amjcard.2007.11.047; Bellavia D, 2010, J AM SOC ECHOCARDIOG, V23, P643, DOI 10.1016/j.echo.2010.03.027; Blessberger H, 2010, HEART, V96, P2032, DOI 10.1136/hrt.2010.199885; Buss SJ, 2012, J AM COLL CARDIOL, V60, P1067, DOI 10.1016/j.jacc.2012.04.043; CUETOGARCIA L, 1985, J AM COLL CARDIOL, V6, P737, DOI 10.1016/S0735-1097(85)80475-7; Dong SJ, 2001, AM J PHYSIOL-HEART C, V281, pH2002, DOI 10.1152/ajpheart.2001.281.5.H2002; Ersboll M, 2014, EUR HEART J, V35, P648, DOI 10.1093/eurheartj/eht179; Falk RH, 2005, CIRCULATION, V112, P2047, DOI 10.1161/CIRCULATIONAHA.104.489187; FALK RH, 1987, AM J CARDIOL, V59, P418, DOI 10.1016/0002-9149(87)90948-9; Gertz MA, 2005, AM J HEMATOL, V79, P319, DOI 10.1002/ajh.20381; Hu K, 2013, EUR HEART J-CARD IMG, V14, P205, DOI 10.1093/ehjci/jes240; Jasaityte R, 2013, J AM SOC ECHOCARDIOG, V26, P15, DOI 10.1016/j.echo.2012.10.005; Kadish AH, 2001, CIRCULATION, V104, P3169; Kasner M, 2010, EUR J ECHOCARDIOGR, V11, P743, DOI 10.1093/ejechocard/jeq060; Kim H, 2008, HEART VESSELS, V23, P271, DOI 10.1007/s00380-008-1042-0; KLEIN AL, 1991, CIRCULATION, V83, P808, DOI 10.1161/01.CIR.83.3.808; KLEIN AL, 1989, J AM COLL CARDIOL, V13, P1017, DOI 10.1016/0735-1097(89)90254-4; KLEIN AL, 1990, J AM COLL CARDIOL, V16, P1135, DOI 10.1016/0735-1097(90)90545-Z; Koyama J, 2010, JACC-CARDIOVASC IMAG, V3, P333, DOI 10.1016/j.jcmg.2009.11.013; Kristen AV, 2007, EUR J HEART FAIL, V9, P617, DOI 10.1016/j.ejheart.2007.01.012; Kristen AV, 2010, BLOOD, V116, P2455, DOI 10.1182/blood-2010-02-267708; KROEKER CAG, 1995, CIRCULATION, V92, P130, DOI 10.1161/01.CIR.92.1.130; KYLE RA, 1995, SEMIN HEMATOL, V32, P45; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Liu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056923; Liu D, 2011, AM J CARDIOL, V108, P591, DOI 10.1016/j.amjcard.2011.03.092; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Palka P, 2002, J AM SOC ECHOCARDIOG, V15, P1353, DOI 10.1067/mje.2002.125285; Palladini G, 2003, CIRCULATION, V107, P2440, DOI 10.1161/01.CIR.0000068314.02595.B2; Perry R, 2008, EUR J ECHOCARDIOGR, V9, P791, DOI 10.1093/ejechocard/jen148; Phelan D, 2012, HEART, V98, P1442, DOI 10.1136/heartjnl-2012-302353; SUTTON MGS, 1982, CIRCULATION, V66, P790, DOI 10.1161/01.CIR.66.4.790; Wang JW, 2007, CIRCULATION, V115, P1376, DOI 10.1161/CIRCULATIONAHA.106.662882	36	39	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115910	10.1371/journal.pone.0115910	http://dx.doi.org/10.1371/journal.pone.0115910			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542015	Green Published, gold			2022-12-26	WOS:000347239900108
J	O'Connell, BC; O'Callaghan, K; Tillotson, B; Douglas, M; Hafeez, N; West, KA; Stern, H; Ali, JA; Changelian, P; Fritz, CC; Palombella, VJ; McGovern, K; Kutok, JL				O'Connell, Brenda C.; O'Callaghan, Katie; Tillotson, Bonnie; Douglas, Mark; Hafeez, Nafeeza; West, Kip A.; Stern, Howard; Ali, Janid A.; Changelian, Paul; Fritz, Christian C.; Palombella, Vito J.; McGovern, Karen; Kutok, Jeffery L.			HSP90 Inhibition Enhances Antimitotic Drug-Induced Mitotic Arrest and Cell Death in Preclinical Models of Non-Small Cell Lung Cancer	PLOS ONE			English	Article							PROTEIN 90 INHIBITOR; CHECKPOINT; IPI-504; DESTRUCTION; DEGRADATION; MITOSIS; PHOSPHORYLATION; COMBINATION; INDUCTION; APOPTOSIS	HSP90 inhibitors are currently undergoing clinical evaluation in combination with antimitotic drugs in non-small cell lung cancer (NSCLC), but little is known about the cellular effects of this novel drug combination. Therefore, we investigated the molecular mechanism of action of IPI-504 (retaspimycin HCl), a potent and selective inhibitor of HSP90, in combination with the microtubule targeting agent (MTA) docetaxel, in preclinical models of NSCLC. We identified a subset of NSCLC cell lines in which these drugs act in synergy to enhance cell death. Xenograft models of NSCLC demonstrated tumor growth inhibition, and in some cases, regression in response to combination treatment. Treatment with IPI-504 enhanced the antimitotic effects of docetaxel leading to the hypothesis that the mitotic checkpoint is required for the response to drug combination. Supporting this hypothesis, overriding the checkpoint with an Aurora kinase inhibitor diminished the cell death synergy of IPI-504 and docetaxel. To investigate the molecular basis of synergy, an unbiased stable isotope labeling by amino acids in cell culture (SILAC) proteomic approach was employed. Several mitotic regulators, including components of the ubiquitin ligase, anaphase promoting complex (APC/C), were specifically down-regulated in response to combination treatment. Loss of APC/C by RNAi sensitized cells to docetaxel and enhanced its antimitotic effects. Treatment with a PLK1 inhibitor (BI2536) also sensitized cells to IPI-504, indicating that combination effects may be broadly applicable to other classes of mitotic inhibitors. Our data provide a preclinical rationale for testing the combination of IPI-504 and docetaxel in NSCLC.	[O'Connell, Brenda C.; O'Callaghan, Katie; Tillotson, Bonnie; Douglas, Mark; Hafeez, Nafeeza; West, Kip A.; Stern, Howard; Ali, Janid A.; Changelian, Paul; Fritz, Christian C.; Palombella, Vito J.; McGovern, Karen; Kutok, Jeffery L.] Infin Pharmaceut Inc, Cambridge, MA 02139 USA		O'Connell, BC (corresponding author), Infin Pharmaceut Inc, Cambridge, MA 02139 USA.	brenda.oconnell@infi.com						Agarwal R, 2002, GENE DEV, V16, P1371, DOI 10.1101/gad.971402; Bagatell R, 2000, CLIN CANCER RES, V6, P3312; Beck Alain, 2012, MAbs, V4, P637, DOI 10.4161/mabs.21697; Blagg BSJ, 2006, MED RES REV, V26, P310, DOI 10.1002/med.20052; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Chan KS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.148; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; de Carcer G, 2004, CANCER RES, V64, P5106, DOI 10.1158/0008-5472.CAN-03-2214; de Carcer G, 2001, EMBO J, V20, P2878, DOI 10.1093/emboj/20.11.2878; Dewaele B, 2008, CLIN CANCER RES, V14, P5749, DOI 10.1158/1078-0432.CCR-08-0533; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Harley ME, 2010, EMBO J, V29, P2407, DOI 10.1038/emboj.2010.112; Hernandez-Vargas H, 2007, CELL CYCLE, V6, P780, DOI 10.4161/cc.6.7.4050; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Leow CC, 2009, MOL CANCER THER, V8, P2131, DOI 10.1158/1535-7163.MCT-08-1038; Masuda A, 2003, AM J PATHOL, V163, P1109, DOI 10.1016/S0002-9440(10)63470-0; Min MW, 2012, SEMIN CELL DEV BIOL, V23, P482, DOI 10.1016/j.semcdb.2012.01.015; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; Normant E, 2011, ONCOGENE, V30, P2581, DOI 10.1038/onc.2010.625; Orth JD, 2008, MOL CANCER THER, V7, P3480, DOI 10.1158/1535-7163.MCT-08-0684; Peng C, 2007, BLOOD, V110, P678, DOI 10.1182/blood-2006-10-054098; Pratt WB, 2006, HANDB EXP PHARM, V172, P111; Proia DA, 2012, INVEST NEW DRUG, V30, P2201, DOI 10.1007/s10637-011-9790-6; ROWINSKY EK, 1993, SEMIN ONCOL, V20, P1; Song D, 2008, MOL CANCER THER, V7, P3275, DOI 10.1158/1535-7163.MCT-08-0508; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Topham CH, 2013, CURR OPIN CELL BIOL, V25, P780, DOI 10.1016/j.ceb.2013.07.003; Torres K, 1998, CANCER RES, V58, P3620; Wu JY, 2014, EXP THER MED, V8, P893, DOI 10.3892/etm.2014.1800; Yamada HY, 2006, MOL CANCER THER, V5, P2963, DOI 10.1158/1535-7163.MCT-06-0319	33	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115228	10.1371/journal.pone.0115228	http://dx.doi.org/10.1371/journal.pone.0115228			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542032	Green Submitted, gold, Green Published			2022-12-26	WOS:000347239900027
J	Tsuji, R; Koizumi, H; Aoki, D; Watanabe, Y; Sugihara, Y; Matsushita, Y; Fukushima, K; Fujiwara, D				Tsuji, Ryohei; Koizumi, Hideki; Aoki, Dan; Watanabe, Yuta; Sugihara, Yoshihiko; Matsushita, Yasuyuki; Fukushima, Kazuhiko; Fujiwara, Daisuke			Lignin-rich Enzyme Lignin (LREL), a Cellulase-treated Lignin-Carbohydrate Derived from Plants, Activates Myeloid Dendritic Cells via Toll-like Receptor 4 (TLR4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROXYCINNAMIC ACIDS; GENE-EXPRESSION; BARLEY; EXTRACT; COMPLEX; INDUCTION; ANTITUMOR; SYRINGYL; PROTEIN; WHEAT	Lignin-carbohydrates, one of the major cell wall components, are believed to be the structures that form chemical linkage between lignin and cell wall polysaccharides. Due to the molecular complexity of lignin-containing substances, their isolation and the assignment of their biological activities have so far remained a difficult task. Here, we extracted two lignin-containing carbohydrates, lignin-rich enzyme lignin (LREL) and pure enzyme lignin (PEL), from barley husk and demonstrated that they act as immune stimulators of dendritic cells (DCs), which are particularly important in linking innate and adaptive immunity. Thioacidolysis, acid hydrolysis, and mild alkali hydrolysis of both LREL and PEL revealed that their immunostimulatory activities depended on the lignin structure and/or content, neutral sugar content (especially the characteristic distribution of galactose and mannose), and presence of an ester bond. Furthermore, we showed that the immunostimulatory potency of the lignin-carbohydrate depended on its molecular weight and degree of polymerization. We also demonstrated that the LREL-induced activation of DCs was mediated via TLR4. Thus, LREL-induced increases in the expression levels of several cell surface marker proteins, production of inflammatory cytokines IL-12p40 and TNF-alpha, and activation and nuclear translocation of transcription factors, as was observed in the WT DCs, were completely abrogated in DCs derived from the TLR4(-/-) mice but not in DCs derived from the TLR2(-/-), TLR7(-/-), and TLR9(-/-) mice. We further demonstrated that LRELs isolated from other plant tissues also activated DCs. These immunostimulatory activities of lignin-carbohydrates, extracted from edible plant tissues, could have potential relevance in anti-infectious immunity and vaccine adjuvants.	[Tsuji, Ryohei; Koizumi, Hideki; Watanabe, Yuta; Sugihara, Yoshihiko; Fujiwara, Daisuke] Kirin Co Ltd, Cent Labs Key Technol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Aoki, Dan; Matsushita, Yasuyuki; Fukushima, Kazuhiko] Nagoya Univ, Div Biol Mat Sci, Dept Biosphere Resources Sci, Grad Sch Bioagr Sci,Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Tsuji, R (corresponding author), Kirin Co Ltd, Cent Labs Key Technol, Kanazawa Ku, 1-13-5 Fukuura, Yokohama, Kanagawa 2360004, Japan.	Ryohei_Tsuji@kirin.co.jp	Matsushita, Yasuyuki/I-6924-2014; Aoki, Dan/I-6926-2014; Matsushita, Yasuyuki/AFN-3168-2022	Matsushita, Yasuyuki/0000-0003-1357-3927; Aoki, Dan/0000-0003-3696-4103				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; BACIC A, 1981, AUST J PLANT PHYSIOL, V8, P475, DOI 10.1071/PP9810475; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baucher M, 1998, CRIT REV PLANT SCI, V17, P125, DOI 10.1016/S0735-2689(98)00360-8; Bjorkman A., 1957, Svensk Papperstidning, V60, P243; Bjorkman A., 1956, SVEN PAPPERSTIDN, V59, P477, DOI DOI 10.1016/J.CHROMA.2003.08.046; Campbell MM, 1996, PLANT PHYSIOL, V110, P3, DOI 10.1104/pp.110.1.3; Choi EM, 2005, J MED FOOD, V8, P446, DOI 10.1089/jmf.2005.8.446; Davin LB, 1997, SCIENCE, V275, P362, DOI 10.1126/science.275.5298.362; FINCHER GB, 1975, J I BREWING, V81, P116, DOI 10.1002/j.2050-0416.1975.tb03672.x; Fu SL, 2006, BIOCHEM BIOPH RES CO, V339, P137, DOI 10.1016/j.bbrc.2005.11.005; Fujiwara D, 2008, J IMMUNOL, V180, P5843, DOI 10.4049/jimmunol.180.9.5843; Helm R. F., 1999, LIGNIN HIST BIOL MAT, P161; Hernanz D, 2001, J AGR FOOD CHEM, V49, P4884, DOI 10.1021/jf010530u; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; IIYAMA K, 1990, PHYTOCHEMISTRY, V29, P733, DOI 10.1016/0031-9422(90)80009-6; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawano M, 2010, IN VIVO, V24, P543; Kawano M, 2010, ANTICANCER RES, V30, P2567; Kelly G S, 1999, Altern Med Rev, V4, P96; Kishimoto T, 2010, J AGR FOOD CHEM, V58, P895, DOI 10.1021/jf9035172; Kushida T, 2011, ANTICANCER RES, V31, P1241; Leung MYK, 2004, GLYCOBIOLOGY, V14, P501, DOI 10.1093/glycob/cwh050; LUNDQUIST K, 1992, METHODS LIGNIN CHEM, P65; Miron J, 2001, J DAIRY SCI, V84, P1294, DOI 10.3168/jds.S0022-0302(01)70159-2; Okamoto M, 2004, CLIN DIAGN LAB IMMUN, V11, P483, DOI 10.1128/CDLI.11.3.483-495.2004; Olkku J, 2005, J AM SOC BREW CHEM, V63, P17, DOI 10.1094/ASBCJ-63-0017; Oscarsson M, 1996, J CEREAL SCI, V24, P161, DOI 10.1006/jcrs.1996.0049; Pitkanen L, 2008, J AGR FOOD CHEM, V56, P5069, DOI 10.1021/jf800315q; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Reale S, 2004, MASS SPECTROM REV, V23, P87, DOI 10.1002/mas.10072; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Rolando C., 1992, METHODS LIGNIN CHEM, P334, DOI DOI 10.1007/978-3-642-74065-7_23; Russell JB, 2009, FEMS MICROBIOL ECOL, V67, P183, DOI 10.1111/j.1574-6941.2008.00633.x; Saito K, 2012, PLANT J, V69, P542, DOI 10.1111/j.1365-313X.2011.04811.x; Sakagami H, 2005, PHYTOCHEMISTRY, V66, P2108, DOI 10.1016/j.phytochem.2005.05.013; SAKAGAMI H, 1989, ANTICANCER RES, V9, P1593; Sakagami H., 2012, COMPENDIUM ESSAYS AL, DOI [10.5772/30449, DOI 10.5772/30449]; Sakagami H, 2010, PHARMACOL THERAPEUT, V128, P91, DOI 10.1016/j.pharmthera.2010.05.004; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Srimal S, 1996, BIOCHEM J, V315, P679, DOI 10.1042/bj3150679; Sun RC, 2002, IND CROP PROD, V15, P179, DOI 10.1016/S0926-6690(01)00112-1; Sun RC, 2001, J AGR FOOD CHEM, V49, P5122, DOI 10.1021/jf010500r; Sun RC, 1998, J AGR FOOD CHEM, V46, P718, DOI 10.1021/jf9705532; SUZUKI H, 1990, AGR BIOL CHEM TOKYO, V54, P479, DOI 10.1080/00021369.1990.10869950; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Vailhe MAB, 2000, J AGR FOOD CHEM, V48, P618, DOI 10.1021/jf9906329; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Whitmire JK, 2011, VIROLOGY, V411, P216, DOI 10.1016/j.virol.2010.12.015; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; Yue FX, 2012, J AGR FOOD CHEM, V60, P922, DOI 10.1021/jf204481x; Zhong B, 2006, VIROLOGY, V352, P14, DOI 10.1016/j.virol.2006.04.029	55	12	15	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4410	4421		10.1074/jbc.M114.593673	http://dx.doi.org/10.1074/jbc.M114.593673			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25548274	Green Published, hybrid			2022-12-26	WOS:000349458400048
J	Hengartner, NE; Fiedler, J; Schrezenmeier, H; Huber-Lang, M; Brenner, RE				Hengartner, Nina-Emily; Fiedler, Joerg; Schrezenmeier, Hubert; Huber-Lang, Markus; Brenner, Rolf E.			Crucial Role of IL1beta and C3a in the In Vitro-Response of Multipotent Mesenchymal Stromal Cells to Inflammatory Mediators of Polytrauma	PLOS ONE			English	Article							MULTIPLE ORGAN FAILURE; ANTIINFLAMMATORY PROTEIN TSG-6; RESPIRATORY-DISTRESS-SYNDROME; HUMAN ADIPOSE-TISSUE; STEM-CELLS; PROGENITOR CELLS; OSTEOARTHRITIC CARTILAGE; MYOCARDIAL-INFARCTION; COMPLEMENT ACTIVATION; INJURY SEVERITY	Multipotent mesenchymal stromal cells (MSC) exert immune-modulatory effects and support tissue regeneration in various local trauma models. In case of a polytrauma, high amounts of danger-associated molecular patterns are released, leading to a systemic increase of inflammatory mediators. The influence of such a complex inflammatory microenvironment on human MSC is mainly unknown so far. Therefore, we investigated the effects of a defined serum-free polytrauma "cocktail" containing IL beta, IL6, IL8 and the anaphylatoxins C3a and C5a, in concentrations corresponding to those measured in the blood of polytrauma patients, on human MSC in vitro. The polytrauma cocktail induced directed migration of MSC with C3a representing its major soluble chemoattractive agent. Furthermore, the polytrauma cocktail and IL1beta upregulated the expression of MMP1 indicating a potential role of IL1beta to enhance MSC migration in the tissue context. COX2, PTGES and TSG6 were also found to be upregulated upon stimulation with the polytrauma cocktail or IL1beta, but not through other single factors of the polytrauma cocktail in pathophysiologically relevant concentrations. An RNA expression array of 84 inflammation-related genes revealed that both the polytrauma cocktail and IL1beta induced C3, CSF1, TLR3 and various chemokines without major qualitative or quantitative differences. These results indicate that IL1beta is a crucial mediator of the polytrauma cocktail in terms of immune-modulation and MMP1 expression. Thus, upon encountering the primary sterile, inflammatory milieu of a polytrauma, endogenous or systemically transfused MSC might be able to migrate to sites of injury, secrete TSG6 and PGE2 and to influence macrophage biology as observed in local trauma models.	[Hengartner, Nina-Emily; Fiedler, Joerg; Brenner, Rolf E.] Univ Ulm, Dept Orthoped, Div Biochem Joint & Connect Tissue Dis, D-89069 Ulm, Germany; [Schrezenmeier, Hubert] German Red Cross Blood Transfus Serv Baden Wurtt, Inst Clin Transfus Med & Immunogenet Ulm, Ulm, Germany; [Schrezenmeier, Hubert] Univ Ulm, Univ Hosp Ulm, D-89069 Ulm, Germany; [Huber-Lang, Markus] Univ Ulm, Dept Orthoped Trauma Hand Plast & Reconstruct Sur, D-89069 Ulm, Germany	Ulm University; Ulm University; Ulm University	Brenner, RE (corresponding author), Univ Ulm, Dept Orthoped, Div Biochem Joint & Connect Tissue Dis, D-89069 Ulm, Germany.	rolf.brenner@uni-ulm.de	Huber-Lang, Markus/AAJ-2209-2020	Fiedler, Jorg/0000-0002-5834-3730	Center of Musculoskeletal Research Ulm; State of Baden-Wurttember (Perspektivfoderung)	Center of Musculoskeletal Research Ulm; State of Baden-Wurttember (Perspektivfoderung)	The study was funded in part by the Center of Musculoskeletal Research Ulm and the State of Baden-Wurttember (Perspektivfoderung). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm JJ, 2010, J ORTHOP RES, V28, P1634, DOI 10.1002/jor.21167; Ames RS, 2001, J IMMUNOL, V166, P6341, DOI 10.4049/jimmunol.166.10.6341; Bartosh TJ, 2013, STEM CELLS, V31, P2443, DOI 10.1002/stem.1499; Bogner V, 2009, EUR J MED RES, V14, P284, DOI 10.1186/2047-783X-14-7-284; Burk AM, 2012, SHOCK, V37, P348, DOI 10.1097/SHK.0b013e3182471795; Carrero R, 2012, STEM CELL REV REP, V8, P905, DOI 10.1007/s12015-012-9364-9; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Crop MJ, 2010, CLIN EXP IMMUNOL, V162, P474, DOI 10.1111/j.1365-2249.2010.04256.x; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Devine MJ, 2002, J ORTHOP RES, V20, P1232, DOI 10.1016/S0736-0266(02)00051-7; Fickert S, 2004, ARTHRITIS RES THER, V6, pR422, DOI 10.1186/ar1210; Fiedler J, 2005, BIOCHEM BIOPH RES CO, V334, P561, DOI 10.1016/j.bbrc.2005.06.116; Fiedler J, 2004, J CELL BIOCHEM, V93, P990, DOI 10.1002/jcb.20219; Fiedler J, 2006, BIOCHEM BIOPH RES CO, V345, P1177, DOI 10.1016/j.bbrc.2006.05.034; Foraker JE, 2011, J NEUROCHEM, V119, P1052, DOI 10.1111/j.1471-4159.2011.07511.x; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; Ganter MT, 2007, SHOCK, V28, P29, DOI 10.1097/shk.0b013e3180342439; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Giannoudis PV, 1998, ACTA ORTHOP SCAND, V69, P184, DOI 10.3109/17453679809117625; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hecke F, 1997, CRIT CARE MED, V25, P2015, DOI 10.1097/00003246-199712000-00019; Hengartner NE, 2013, MOL MED, V19, P36, DOI 10.2119/molmed.2012.00058; Hensler T, 2003, SHOCK, V20, P497, DOI 10.1097/01.shk.0000095058.62263.1f; Ignatius A, 2011, J TRAUMA, V71, P952, DOI 10.1097/TA.0b013e3181f8aa2d; Joos H, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4299; Kohl J, 2006, IMMUNOL RES, V34, P157, DOI 10.1385/IR:34:2:157; Kraitchman DL, 2005, CIRCULATION, V112, P1451, DOI 10.1161/CIRCULATIONAHA.105.537480; Krumina G, 2013, J TRAUMA ACUTE CARE, V74, P785, DOI 10.1097/TA.0b013e31827e1879; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Liang J, 2010, ANN RHEUM DIS, V69, P1423, DOI 10.1136/ard.2009.123463; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Lucia A, 2009, BRIT J SPORT MED, V43, P221, DOI 10.1136/bjsm.2007.044693; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; Matthes G, 2001, ZBL CHIR, V126, P995, DOI 10.1055/s-2001-19658; Mishima Y, 2008, J ORTHOP RES, V26, P1407, DOI 10.1002/jor.20668; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Qi Y, 2014, J INVEST DERMATOL, V134, P526, DOI 10.1038/jid.2013.328; Raffaghello L, 2008, STEM CELLS, V26, P151, DOI 10.1634/stemcells.2007-0416; Ramirez M, 2006, BRIT J SPORT MED, V40, P719, DOI 10.1136/bjsm.2006.028639; Rattigan Y, 2010, EXP CELL RES, V316, P3417, DOI 10.1016/j.yexcr.2010.07.002; Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060; Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; Schmidt A, 2006, STEM CELLS, V24, P1750, DOI 10.1634/stemcells.2005-0191; Schraufstatter IU, 2009, J IMMUNOL, V182, P3827, DOI 10.4049/jimmunol.0803055; Tu ZD, 2010, STEM CELLS DEV, V19, P1803, DOI 10.1089/scd.2009.0418; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Weckbach S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/890816; Williams JT, 1999, AM SURGEON, V65, P22; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; Ylostalo JH, 2012, STEM CELLS, V30, P2283, DOI 10.1002/stem.1191; Yukawa H, 2012, BIOMATERIALS, V33, P2177, DOI 10.1016/j.biomaterials.2011.12.009; Zhang QZ, 2010, STEM CELLS, V28, P1856, DOI 10.1002/stem.503; ZILOW G, 1990, CLIN EXP IMMUNOL, V79, P151; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	59	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2015	10	1							e0116772	10.1371/journal.pone.0116772	http://dx.doi.org/10.1371/journal.pone.0116772			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3YO	25562599	Green Published, gold, Green Submitted			2022-12-26	WOS:000348160000002
J	Krychowiak, M; Grinholc, M; Banasiuk, R; Krauze-Baranowska, M; Glod, D; Kawiak, A; Krolicka, A				Krychowiak, Marta; Grinholc, Mariusz; Banasiuk, Rafal; Krauze-Baranowska, Miroslawa; Glod, Daniel; Kawiak, Anna; Krolicka, Aleksandra			Combination of Silver Nanoparticles and Drosera binata Extract as a Possible Alternative for Antibiotic Treatment of Burn Wound Infections Caused by Resistant Staphylococcus aureus	PLOS ONE			English	Article							IN-VITRO; NAPHTHOQUINONES; PLUMBAGIN; BACTERIA; SYNERGY; PLANTS; MODEL	Staphylococcus aureus is the most common infectious agent involved in the development of skin infections that are associated with antibiotic resistance, such as burn wounds. As drug resistance is a growing problem it is essential to establish novel antimicrobials. Currently, antibiotic resistance in bacteria is successfully controlled by multi-drug therapies. Here we demonstrate that secondary metabolites present in the extract obtained from Drosera binata in vitro cultures are effective antibacterial agents against S. aureus grown in planktonic culture and in biofilm. Moreover, this is the first report demonstrating the synergistic interaction between the D. binata extract and silver nanoparticles (AgNPs), which results in the spectacular enhancement of the observed bactericidal activity, while having no cytotoxic effects on human keratinocytes. Simultaneous use of these two agents in significantly reduced quantities produces the same effect, i.e. by killing 99.9% of bacteria in inoculum or eradicating the staphylococcal biofilm, as higher amounts of the agents used individually. Our data indicates that combining AgNPs with either the D. binata extract or with its pure compound (3-chloroplumbagin) may provide a safe and highly effective alternative to commonly used antibiotics, which are ineffective towards the antibiotic-resistant S. aureus.	[Krychowiak, Marta; Banasiuk, Rafal; Krolicka, Aleksandra] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Biotechnol, Lab Biol Act Cpds, PL-80952 Gdansk, Poland; [Krychowiak, Marta; Grinholc, Mariusz; Banasiuk, Rafal; Kawiak, Anna; Krolicka, Aleksandra] Med Univ Gdansk, Gdansk, Poland; [Grinholc, Mariusz] Univ Gdansk, Dept Biotechnol, Lab Mol Diagnost, IFB, Gdansk, Poland; [Krauze-Baranowska, Miroslawa; Glod, Daniel] Med Univ Gdansk, Dept Pharmacognosy Med Plant Garden, Gdansk, Poland; [Kawiak, Anna] Univ Gdansk, Dept Biotechnol, Lab Plant Protect & Biotechnol, IFB, Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; University of Gdansk	Krolicka, A (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Biotechnol, Lab Biol Act Cpds, PL-80952 Gdansk, Poland.	aleksandra.krolicka@biotech.ug.edu.pl	Królicka, Aleksandra/J-4170-2014; Krychowiak-Masnicka, Marta/ABB-2956-2021; Krychowiak-Masnicka, Marta/AAI-3977-2020; Kawiak, Anna/L-6060-2014; Krolicka, Aleksandra/AAC-3958-2019; Grinholc, Mariusz/F-5962-2011; Grinholc, Mariusz/N-8726-2019	Krychowiak-Masnicka, Marta/0000-0002-3617-6572; Krychowiak-Masnicka, Marta/0000-0002-3617-6572; Kawiak, Anna/0000-0001-8105-2555; Krolicka, Aleksandra/0000-0001-5231-283X; Grinholc, Mariusz/0000-0003-4041-0891; Banasiuk, Rafal/0000-0002-3774-1545; Krauze-Baranowska, Miroslawa/0000-0002-0344-7401	National Centre for Research and Development [LIDER/32/36/L-2/10/NCRiR/2011]; EU FP7 project MOBI4Health [GA. 316094]	National Centre for Research and Development(National Centre for Research & Development, Poland); EU FP7 project MOBI4Health	The research was supported by the National Centre for Research and Development (project LIDER/32/36/L-2/10/NCRiR/2011). Publication costs were covered by the EU FP7 project MOBI4Health, GA. 316094. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaker RP, 2014, INT J ANTIMICROB AG, V43, P95, DOI 10.1016/j.ijantimicag.2013.11.002; BEHRMAN EJ, 1995, J CHEM RES-S, P164; BENDZ G, 1968, ACTA CHEM SCAND, V22, P2722, DOI 10.3891/acta.chem.scand.22-2722; BERENBAUM MC, 1978, J INFECT DIS, V137, P122, DOI 10.1093/infdis/137.2.122; Bringmann G, 2000, PHYTOCHEMISTRY, V53, P339, DOI 10.1016/S0031-9422(99)00543-9; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Clinical and Laboratory Standards Institute (CLSI), 2014, CLIN LAB STANDARDS I; Daglia M, 2012, CURR OPIN BIOTECH, V23, P174, DOI 10.1016/j.copbio.2011.08.007; Davis SC, 2008, WOUND REPAIR REGEN, V16, P23, DOI 10.1111/j.1524-475X.2007.00303.x; ENGVILD KC, 1986, PHYTOCHEMISTRY, V25, P781, DOI 10.1016/0031-9422(86)80002-4; Garcia-Barrasa J, 2011, CENT EUR J CHEM, V9, P7, DOI 10.2478/s11532-010-0124-x; Harrison JJ, 2010, NAT PROTOC, V5, P1236, DOI 10.1038/nprot.2010.71; Hernandez-Munoz LS, 2009, ORG BIOMOL CHEM, V7, P1896, DOI 10.1039/b822684a; Higa M, 1998, CHEM PHARM BULL, V46, P1189, DOI 10.1248/cpb.46.1189; Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014; Kawiak A, 2003, PLANT CELL TISS ORG, V75, P175, DOI 10.1023/A:1025023800304; KREHER B, 1990, PHYTOCHEMISTRY, V29, P605, DOI 10.1016/0031-9422(90)85125-Y; KRISHNAN.V, 1969, PHYTOCHEMISTRY, V8, P1591, DOI 10.1016/S0031-9422(00)85936-1; Krolicka A, 2008, ENZYME MICROB TECH, V42, P216, DOI 10.1016/j.enzmictec.2007.09.011; Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478; LAKSHMI VV, 1987, CURR MICROBIOL, V16, P159; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Machado TB, 2003, INT J ANTIMICROB AG, V21, P279, DOI 10.1016/S0924-8579(02)00349-7; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murray CK, 2007, J TRAUMA, V62, pS73, DOI 10.1097/TA.0b013e318065af1a; NAIR A G R, 1990, Fitoterapia, V61, P85; RAZZAKOVA DM, 1973, KHIM PRIRODNYK SOEDI, P206; SIDHU GS, 1971, TETRAHEDRON LETT, P2385; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; THORNSBERRY C, 1991, ANN OTO RHINOL LARYN, V100, P7, DOI 10.1177/00034894911000S904; Tsymbal A, 2005, LECT NOTES COMPUTER; Wagner H, 2009, PHYTOMEDICINE, V16, P97, DOI 10.1016/j.phymed.2008.12.018; Wikler M.A., 2012, CLIN LAB STANDARDS I, V26, pM07; Williamson EM, 2001, PHYTOMEDICINE, V8, P401, DOI 10.1078/0944-7113-00060; Zehl M, 2011, ANAL BIOANAL CHEM, V400, P2565, DOI 10.1007/s00216-011-4690-3	36	44	45	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115727	10.1371/journal.pone.0115727	http://dx.doi.org/10.1371/journal.pone.0115727			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551660	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100055
J	Mirzaei, MK; Eriksson, H; Kasuga, K; Haggard-Ljungquist, E; Nilsson, AS				Mirzaei, Mohammadali Khan; Eriksson, Harald; Kasuga, Kie; Haggard-Ljungquist, Elisabeth; Nilsson, Anders S.			Genomic, Proteomic, Morphological, and Phylogenetic Analyses of vB_EcoP_SU10, a Podoviridae Phage with C3 Morphology	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTERIOPHAGES; SEQUENCE; FREQUENCY; GENES; DNA	A recently isolated phage, vB_EcoP_SU10 (SU10), with the unusual elongated C3 morphotype, can infect a wide range of Escherichia coli strains. We have sequenced the genome of this phage and characterized it further by mass spectrometry based proteomics, transmission electron microscopy (TEM), scanning electron microscopy (SEM), and ultra-thin section electron microscopy. The genome size is 77,327 base pairs and its genes, and genome architecture, show high similarity to the phiEco32 phage genes and genome. The TEM images reveal that SU10 have a quite long tail for being a Podoviridae phage, and that the tail also changes conformation upon infection. The ultra-thin section electron microscopy images of phages at the stage of replication within the host cell show that the phages form a honeycomb-like structure under packaging of genomes and assembly of mature capsids. This implies a tight link between the replication and cutting of the concatemeric genome, genome packaging, and capsid assembly. We have also performed a phylogenetic analysis of the structural genes common between Podoviridae phages of the C1 and C3 morphotypes. The result shows that the structural genes have coevolved, and that they form two distinct groups linked to their morphotypes. The structural genes of C1 and C3 phages appear to have diverged around 280 million years ago applying a molecular clock calibrated according to the presumed split between the Escherichia - Salmonella genera.	[Mirzaei, Mohammadali Khan; Eriksson, Harald; Haggard-Ljungquist, Elisabeth; Nilsson, Anders S.] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, SE-10691 Stockholm, Sweden; [Kasuga, Kie] Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, SE-17121 Solna, Sweden	Stockholm University; Karolinska Institutet	Nilsson, AS (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, SE-10691 Stockholm, Sweden.	anders.s.nilsson@su.se	Khan Mirzaei, Mohammadali/ABB-9778-2021; Kasuga, Kie/D-2308-2013	Khan Mirzaei, Mohammadali/0000-0003-2801-4474; Kasuga, Kie/0000-0003-0489-194X	Olle Enqvist foundation	Olle Enqvist foundation	This work was funded by the Olle Enqvist foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN.HW, 1974, J VIROL, V13, P706, DOI 10.1128/JVI.13.3.706-711.1974; Ackermann HW, 1996, ARCH VIROL, V141, P209, DOI 10.1007/BF01718394; Ackermann HW, 2001, ARCH VIROL, V146, P843, DOI 10.1007/s007050170120; Biomatters, 2013, GEN 6 1 2; Chopin A, 2007, VIROLOGY, V365, P1, DOI 10.1016/j.virol.2007.03.044; CHUNG YB, 1990, J MOL BIOL, V216, P911, DOI 10.1016/S0022-2836(99)80010-2; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Hendrix RW, 2003, CURR OPIN MICROBIOL, V6, P506, DOI 10.1016/j.mib.2003.09.004; Kropinski AM, 2011, ARCH VIROL, V156, P149, DOI 10.1007/s00705-010-0835-5; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Li YZ, 2012, J VIROL, V86, P13874, DOI 10.1128/JVI.02727-12; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mahadevan Padmanabhan, 2009, BMC Res Notes, V2, P168, DOI 10.1186/1756-0500-2-168; Matsushita K, 2009, FEMS MICROBIOL LETT, V291, P201, DOI 10.1111/j.1574-6968.2008.01455.x; Molineux IJ, 2006, BACTERIOPHAGES, P277; Nho SW, 2012, J VIROL, V86, P12439, DOI 10.1128/JVI.02141-12; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Pavlova O, 2012, J MOL BIOL, V416, P389, DOI 10.1016/j.jmb.2012.01.002; Qimron U., 2010, MICROBE MAG, V5, P117; Sambrook J., 2001, MOL CLONING LAB MANU; Savalia D, 2008, J MOL BIOL, V377, P774, DOI 10.1016/j.jmb.2007.12.077; SAXELIN ML, 1979, CAN J MICROBIOL, V25, P1182, DOI 10.1139/m79-183; SAXELIN ML, 1986, APPL ENVIRON MICROB, V52, P771, DOI 10.1128/AEM.52.4.771-777.1986; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Solovjev V, 2011, METAGENOMICITAPP, P61; TAJIMA F, 1993, GENETICS, V135, P599; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	32	25	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116294	10.1371/journal.pone.0116294	http://dx.doi.org/10.1371/journal.pone.0116294			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551446	Green Published, gold			2022-12-26	WOS:000347119100128
J	Goncalves-Souza, T; Romero, GQ; Cottenie, K				Goncalves-Souza, Thiago; Romero, Gustavo Q.; Cottenie, Karl			Metacommunity versus Biogeography: A Case Study of Two Groups of Neotropical Vegetation-Dwelling Arthropods	PLOS ONE			English	Article							COMPREHENSIVE FRAMEWORK; ATLANTIC FOREST; DISTANCE DECAY; COMMUNITY; DIVERSITY; HABITAT; CLIMATE; SCALE; DISPERSAL; DETERMINANTS	Biogeography and metacommunity ecology provide two different perspectives on species diversity. Both are spatial in nature but their spatial scales do not necessarily match. With recent boom of metacommunity studies, we see an increasing need for clear discrimination of spatial scales relevant for both perspectives. This discrimination is a necessary prerequisite for improved understanding of ecological phenomena across scales. Here we provide a case study to illustrate some spatial scale-dependent concepts in recent metacommunity studies and identify potential pitfalls. We presented here the diversity patterns of Neotropical lepidopterans and spiders viewed both from metacommunity and biogeographical perspectives. Specifically, we investigated how the relative importance of niche-and dispersal-based processes for community assembly change at two spatial scales: metacommunity scale, i.e. within a locality, and biogeographical scale, i.e. among localities widely scattered along a macroclimatic gradient. As expected, niche-based processes dominated the community assembly at metacommunity scale, while dispersal-based processes played a major role at biogeographical scale for both taxonomical groups. However, we also observed small but significant spatial effects at metacommunity scale and environmental effects at biogeographical scale. We also observed differences in diversity patterns between the two taxonomical groups corresponding to differences in their dispersal modes. Our results thus support the idea of continuity of processes interactively shaping diversity patterns across scales and emphasize the necessity of integration of metacommunity and biogeographical perspectives.	[Goncalves-Souza, Thiago] Univ Estadual Paulista, UNESP, Dept Zool & Bot, Programa Posgrad Biol Anim,IBILCE, Sao Jose Do Rio Preto, SP, Brazil; [Romero, Gustavo Q.] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Biol Anim, Campinas, SP, Brazil; [Cottenie, Karl] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas; University of Guelph	Goncalves-Souza, T (corresponding author), Univ Estadual Paulista, UNESP, Dept Zool & Bot, Programa Posgrad Biol Anim,IBILCE, Sao Jose Do Rio Preto, SP, Brazil.	tgoncalves.souza@gmail.com	Souza, Thiago Gonçalves/E-3813-2012; Romero, Gustavo Q/N-1896-2019; Romero, Gustavo Q/H-8974-2012	Souza, Thiago Gonçalves/0000-0001-8471-7479; Romero, Gustavo Q/0000-0003-3736-4759; Romero, Gustavo Q/0000-0003-3736-4759; Cottenie, Karl/0000-0001-9498-8483	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [proc. 2008/11530-2, proc. 2010/51636-4]; State University of Campinas (FAEPEX/UNICAMP) [solic. 825/10]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [proc. 309815/2009-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); State University of Campinas (FAEPEX/UNICAMP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	TG-S was supported by a fellowship from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, proc. 2008/11530-2). GQR was supported by research grants from the State University of Campinas (FAEPEX/UNICAMP, solic. 825/10), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, proc. 2010/51636-4), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, proc. 309815/2009-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astorga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P365, DOI 10.1111/j.1466-8238.2011.00681.x; Bell JR, 2005, B ENTOMOL RES, V95, P69, DOI 10.1079/BER2004350; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brown KS, 2000, BIOTROPICA, V32, P934, DOI 10.1646/0006-3606(2000)032[0934:AFBIFL]2.0.CO;2; Carvalho JC, 2011, DIVERS DISTRIB, V17, P225, DOI 10.1111/j.1472-4642.2010.00731.x; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Cofre H, 1999, BIOL CONSERV, V88, P53, DOI 10.1016/S0006-3207(98)00090-1; Cornell HV, 2013, OIKOS, V122, P288, DOI 10.1111/j.1600-0706.2012.20691.x; CORNELL HV, 1992, J ANIM ECOL, V61, P1, DOI 10.2307/5503; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Assis André M. de, 2004, Braz. J. Bot., V27, P349, DOI 10.1590/S0100-84042004000200014; Declerck SAJ, 2011, ECOGRAPHY, V34, P296, DOI 10.1111/j.1600-0587.2010.06462.x; Dray S, 2012, ECOL MONOGR, V82, P257, DOI 10.1890/11-1183.1; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Entling MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045875; Entling W, 2007, GLOBAL ECOL BIOGEOGR, V16, P440, DOI 10.1111/j.1466-8238.2006.00305.x; Goncalves-Souza T, 2011, AUSTRAL ECOL, V36, P476, DOI 10.1111/j.1442-9993.2010.02177.x; Goncalves-Souza T, 2010, J ARACHNOL, V38, P270, DOI 10.1636/P09-58.1; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Hajek M, 2011, J BIOGEOGR, V38, P1683, DOI 10.1111/j.1365-2699.2011.02503.x; Harrison S, 2008, ECOL LETT, V11, P969, DOI 10.1111/j.1461-0248.2008.01210.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Holt R, 1993, SPECIES DIVERSITY EC; Hortal J, 2011, ECOL LETT, V14, P741, DOI 10.1111/j.1461-0248.2011.01634.x; Hubbell Stephen P., 2001, V32, pi; Jimenez-Valverde A, 2007, ECOL ENTOMOL, V32, P113, DOI 10.1111/j.1365-2311.2006.00848.x; Jocque M, 2010, GLOBAL ECOL BIOGEOGR, V19, P244, DOI 10.1111/j.1466-8238.2009.00510.x; LAWTON JH, 1983, ANNU REV ENTOMOL, V28, P23, DOI 10.1146/annurev.en.28.010183.000323; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lenoir J, 2012, GLOBAL ECOL BIOGEOGR, V21, P851, DOI 10.1111/j.1466-8238.2011.00733.x; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; MacArthur R. H., 1984, GEOGRAPHICAL ECOLOGY; Marquez JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054580; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Ng ISY, 2009, HYDROBIOLOGIA, V619, P133, DOI 10.1007/s10750-008-9605-8; Novotny V, 2002, P ROY SOC B-BIOL SCI, V269, P2337, DOI 10.1098/rspb.2002.2166; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Purves DW, 2010, J ANIM ECOL, V79, P1215, DOI 10.1111/j.1365-2656.2010.01738.x; Quinn R, 2002, EXPT DESIGN DATA ANA; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ricklefs R.E., 1993, J EVOLUTION BIOL, DOI DOI 10.1046/J.1420-9101.1993.6020171.X; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; ROBINSON JV, 1981, ECOLOGY, V62, P73, DOI 10.2307/1936670; Samu F, 1999, J ARACHNOL, V27, P325; Scarano FR, 2002, ANN BOT-LONDON, V90, P517, DOI 10.1093/aob/mcf189; Schaffers AP, 2008, ECOLOGY, V89, P782, DOI 10.1890/07-0361.1; Summerville KS, 2003, ECOL ENTOMOL, V28, P747, DOI 10.1111/j.1365-2311.2003.00561.x; Thome MTC, 2010, MOL PHYLOGENET EVOL, V55, P1018, DOI 10.1016/j.ympev.2010.02.003; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; von Humboldt A., 1807, ESSAY GEOGRAPHY PLAN; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056; Willis J.C., 1922, AGE AREA STUDY GEOGR; World Wide Fund for Nature WWF, 2001, ATL COAST REST NT010	61	22	23	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115137	10.1371/journal.pone.0115137	http://dx.doi.org/10.1371/journal.pone.0115137			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549332	Green Published, Green Submitted, gold			2022-12-26	WOS:000347063500011
J	Wang, BH; Song, N; Yu, T; Zhou, LY; Zhang, HL; Duan, L; He, WS; Zhu, YH; Bai, YF; Zhu, MA				Wang, Baohua; Song, Ning; Yu, Tong; Zhou, Lianya; Zhang, Helin; Duan, Lin; He, Wenshu; Zhu, Yihua; Bai, Yunfei; Zhu, Miao			Expression of Tumor Necrosis Factor-Alpha-Mediated Genes Predicts Recurrence-Free Survival in Lung Cancer	PLOS ONE			English	Article							TNF-ALPHA; CARCINOMA; RECEPTOR; TRANSACTIVATION; IDENTIFICATION; METASTASIS; PROMOTION; BIOMARKER; CYTOKINE; GROWTH	In this study, we conducted a meta-analysis on high-throughput gene expression data to identify TNF-alpha-mediated genes implicated in lung cancer. We first investigated the gene expression profiles of two independent TNF-alpha/TNFR KO murine models. The EGF receptor signaling pathway was the top pathway associated with genes mediated by TNF-alpha. After matching the TNF-alpha-mediated mouse genes to their human orthologs, we compared the expression patterns of the TNF-alpha-mediated genes in normal and tumor lung tissues obtained from humans. Based on the TNF-alpha-mediated genes that were dysregulated in lung tumors, we developed a prognostic gene signature that effectively predicted recurrence-free survival in lung cancer in two validation cohorts. Resampling tests suggested that the prognostic power of the gene signature was not by chance, and multivariate analysis suggested that this gene signature was independent of the traditional clinical factors and enhanced the identification of lung cancer patients at greater risk for recurrence.	[Wang, Baohua; Zhou, Lianya; Zhang, Helin] HeBei Med Univ, Hosp 2, Dept Thorac Surg, Shijiazhuang 050000, Peoples R China; [Song, Ning; Duan, Lin; He, Wenshu] HeBei Med Univ, Hosp 2, Dept Resp Med, Shijiazhuang 050000, Peoples R China; [Yu, Tong; Zhu, Miao] Nanjing Decode Genom Biotechnol Co Ltd, Nanjing 210019, Jiangsu, Peoples R China; [Zhu, Yihua; Bai, Yunfei] Southeast Univ, Sch Biol Sci & Med Engn, Nanjing 210096, Jiangsu, Peoples R China; [Zhu, Yihua] Nanjing Agr Univ, Coll Informat Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China	Hebei Medical University; Hebei Medical University; Southeast University - China; Nanjing Agricultural University	Wang, BH (corresponding author), HeBei Med Univ, Hosp 2, Dept Thorac Surg, Shijiazhuang 050000, Peoples R China.	xwkbh1972@sina.com; zm@decodegenomics.com			National Natural Science Foundation of China [61271054]; Fundamental Research Funds for the Central Universities [KYZ201320]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by project 61271054 of the National Natural Science Foundation of China and was also supported by project KYZ201320 of the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argast GM, 2004, J BIOL CHEM, V279, P34530, DOI 10.1074/jbc.M405703200; Arnott CH, 2002, ONCOGENE, V21, P4728, DOI 10.1038/sj.onc.1205588; Arnott CH, 2004, ONCOGENE, V23, P1902, DOI 10.1038/sj.onc.1207317; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Botling J, 2013, CLIN CANCER RES, V19, P194, DOI 10.1158/1078-0432.CCR-12-1139; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Huang B, 2010, INT J MOL MED, V25, P687, DOI 10.3892/ijmm_00000392; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ko JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086569; Ko JH, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-106; Koscielny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000313; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Lee CW, 2007, AM J PHYSIOL-LUNG C, V292, pL799, DOI 10.1152/ajplung.00311.2006; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Li AM, 2013, BIOCHEM BIOPH RES CO, V436, P486, DOI 10.1016/j.bbrc.2013.05.131; Lu TP, 2010, CANCER EPIDEM BIOMAR, V19, P2590, DOI 10.1158/1055-9965.EPI-10-0332; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Murray J, 1997, BLOOD, V90, P2772, DOI 10.1182/blood.V90.7.2772.2772_2772_2783; Obama K, 2006, CLIN CANCER RES, V12, P70, DOI 10.1158/1078-0432.CCR-05-0588; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Pitroda SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046104; Prevost-Blondel A, 2000, J IMMUNOL, V164, P3645, DOI 10.4049/jimmunol.164.7.3645; Rink L, 1996, INT ARCH ALLERGY IMM, V111, P199, DOI 10.1159/000237369; Sanchez-Palencia A, 2011, INT J CANCER, V129, P355, DOI 10.1002/ijc.25704; Scott KA, 2003, MOL CANCER THER, V2, P445; Smyth MJ, 2004, IMMUNOL REV, V202, P275, DOI 10.1111/j.0105-2896.2004.00199.x; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Tse BC, 2012, PROSTATE CANCER, V2012, DOI 10.1155/2012/128965; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Wang PP, 2014, MOL CELL, V54, P378, DOI 10.1016/j.molcel.2014.03.007; WATANABE N, 1988, IMMUNOPHARM IMMUNOT, V10, P109, DOI 10.3109/08923978809014405; WATANABE N, 1988, CANCER RES, V48, P2179; Waters JP, 2013, J PATHOL, V230, P241, DOI 10.1002/path.4188; Westbrook L, 2007, CANCER RES, V67, P11393, DOI 10.1158/0008-5472.CAN-06-4173; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yamaoka T, 2008, P NATL ACAD SCI USA, V105, P11772, DOI 10.1073/pnas.0801463105; Yoo J, 2012, AM J PHYSIOL-GASTR L, V302, pG805, DOI 10.1152/ajpgi.00522.2011; Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278; Zhou T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094325; Zhou ZJ, 2014, CANCER RES, V74, P2750, DOI 10.1158/0008-5472.CAN-13-2509	43	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115945	10.1371/journal.pone.0115945	http://dx.doi.org/10.1371/journal.pone.0115945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548907	Green Submitted, Green Published, gold			2022-12-26	WOS:000347063500043
J	Lahesaare, A; Moor, H; Kivisaar, M; Teras, R				Lahesaare, Andrio; Moor, Hanna; Kivisaar, Maia; Teras, Riho			Pseudomonas putida Fis Binds to the lapF Promoter In Vitro and Represses the Expression of LapF	PLOS ONE			English	Article							ESCHERICHIA-COLI; BIOFILM FORMATION; TOL PLASMID; PROTEIN; DNA; SIGMA(S); IDENTIFICATION; TRANSCRIPTION; COLONIZATION; DERIVATIVES	The biofilm matrix of the rhizospheric bacterium Pseudomonas putida consists mainly of a proteinaceous component. The two largest P. putida proteins, adhesins LapA and LapF, are involved in biofilm development but prevail in different developmental stages of the biofilm matrix. LapA is abundant in the initial stage of biofilm formation whereas LapF is found in the mature biofilm. Although the transcriptional regulation of the adhesins is not exhaustively studied, some factors that can be involved in their regulation have been described. For example, RpoS, the major stress response sigma factor, activates, and Fis represses LapF expression. This study focused on the LapF expression control by Fis. Indeed, using DNase I footprint analysis a Fis binding site Fis-F2 was located 150 bp upstream of the lapF gene coding sequence. The mapped 59 end of the lapF mRNA localized the promoter to the same region, overlapping with the Fis binding site Fi-sF2. Monitoring the lapF promoter activity by a beta-galactosidase assay revealed that Fis overexpression causes a 4-fold decrease in the transcriptional activity. Furthermore, mutations that diminished Fis binding to the Fis-F2 site abolished the repression of the lapF promoter. Thus, these data suggest that Fis is involved in the biofilm regulation via repression of LapF expression.	[Lahesaare, Andrio; Moor, Hanna; Kivisaar, Maia; Teras, Riho] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia	University of Tartu	Teras, R (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	riho.teras@ut.ee	Teras, Riho/ABA-8761-2021	Ainelo, Hanna/0000-0003-3340-9120	Estonian Ministry of Education and Research [SF0180031s08, IUT20-19]	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	This work was supported by funding of Targeted Financing Project SF0180031s08 and Institutional Research Funding IUT20-19 from Estonian Ministry of Education and Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertani I, 2003, ARCH MICROBIOL, V180, P264, DOI 10.1007/s00203-003-0586-8; Browning DF, 2010, CURR OPIN MICROBIOL, V13, P773, DOI 10.1016/j.mib.2010.09.013; Canosa I, 1999, J BACTERIOL, V181, P1748, DOI 10.1128/JB.181.6.1748-1754.1999; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Czeczulin JR, 1997, INFECT IMMUN, V65, P4135, DOI 10.1128/IAI.65.10.4135-4145.1997; DELORENZO V, 1993, J BACTERIOL, V175, P6902, DOI 10.1128/jb.175.21.6902-6907.1993; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Dorman CJ, 2009, ADV APPL MICROBIOLOG; Espinosa-Urgel M, 2000, J BACTERIOL, V182, P2363, DOI 10.1128/JB.182.9.2363-2369.2000; FINKEL SE, 1992, MOL MICROBIOL, V6, P3257, DOI 10.1111/j.1365-2958.1992.tb02193.x; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Fuqua C, 2010, MOL MICROBIOL, V77, P533, DOI 10.1111/j.1365-2958.2010.07250.x; Gama-Castro S., NUCL ACIDS RES, V39, pD98; Gjermansen M, 2010, MOL MICROBIOL, V75, P815, DOI 10.1111/j.1365-2958.2009.06793.x; Hinsa SM, 2003, MOL MICROBIOL, V49, P905, DOI 10.1046/j.1365-2958.2003.03615.x; Jahn A, 1999, BIOFOULING, V14, P49, DOI 10.1080/08927019909378396; Jakovleva J, 2012, MICROBIOL-SGM, V158, P708, DOI 10.1099/mic.0.053355-0; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; LANG HN, 1993, MOL MICROBIOL, V10, P891, DOI 10.1111/j.1365-2958.1993.tb00960.x; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Marques S, 1995, MOL MICROBIOL, V18, P851, DOI 10.1111/j.1365-2958.1995.18050851.x; Martinez-Gil M, 2014, J BACTERIOL, V196, P1484, DOI 10.1128/JB.01287-13; Martinez-Gil M, 2010, MOL MICROBIOL, V77, P549, DOI 10.1111/j.1365-2958.2010.07249.x; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Miura K, 1998, MOL GEN GENET, V259, P72, DOI 10.1007/s004380050790; Moor H, 2014, MICROBIOLOGY; Prigent-Combaret C, 2012, MOL MICROBIOL, V86, P172, DOI 10.1111/j.1365-2958.2012.08182.x; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Saldana Z, 2009, ENVIRON MICROBIOL, V11, P992, DOI 10.1111/j.1462-2920.2008.01824.x; Sambrook J., 2001, MOL CLONING LAB MANU; Shao YP, 2008, J MOL BIOL, V376, P771, DOI 10.1016/j.jmb.2007.11.101; Sharma RC, 1996, BIOTECHNIQUES, V20, P42; Sheikh J, 2001, MOL MICROBIOL, V41, P983, DOI 10.1046/j.1365-2958.2001.02512.x; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Tavita K, 2012, MUTAT RES-FUND MOL M, V737, P12, DOI 10.1016/j.mrfmmm.2012.07.004; Teras R, 2000, J BACTERIOL, V182, P589, DOI 10.1128/JB.182.3.589-598.2000; Teras R, 2009, MICROBIOL-SGM, V155, P1203, DOI 10.1099/mic.0.022830-0; Typas A, 2007, MOL MICROBIOL, V63, P1296, DOI 10.1111/j.1365-2958.2007.05601.x; Waite RD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-162; Yousef-Coronado F, 2008, FEMS MICROBIOL LETT, V288, P118, DOI 10.1111/j.1574-6968.2008.01339.x; Yuste L, 2006, ENVIRON MICROBIOL, V8, P165, DOI 10.1111/j.1462-2920.2005.00890.x	41	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115901	10.1371/journal.pone.0115901	http://dx.doi.org/10.1371/journal.pone.0115901			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545773	gold, Green Published, Green Submitted			2022-12-26	WOS:000347120200080
J	O'Loughlin, J; Sylvestre, MP; Labbe, A; Low, NC; Roy-Gagnon, MH; Dugas, EN; Karp, I; Engert, JC				O'Loughlin, Jennifer; Sylvestre, Marie-Pierre; Labbe, Aurelie; Low, Nancy C.; Roy-Gagnon, Marie-Helene; Dugas, Erika N.; Karp, Igor; Engert, James C.			Genetic Variants and Early Cigarette Smoking and Nicotine Dependence Phenotypes in Adolescents	PLOS ONE			English	Article							DOPAMINE TRANSPORTER GENE; RECEPTOR DRD2 GENE; FUNCTIONAL POLYMORPHISM; GENOME-WIDE; RISK-FACTOR; ASSOCIATION; BEHAVIOR; SMOKERS; METAANALYSIS; HAPLOTYPE	Background: While the heritability of cigarette smoking and nicotine dependence (ND) is well-documented, the contribution of specific genetic variants to specific phenotypes has not been closely examined. The objectives of this study were to test the associations between 321 tagging single-nucleotide polymorphisms (SNPs) that capture common genetic variation in 24 genes, and early smoking and ND phenotypes in novice adolescent smokers, and to assess if genetic predictors differ across these phenotypes. Methods: In a prospective study of 1294 adolescents aged 12-13 years recruited from ten Montreal-area secondary schools, 544 participants who had smoked at least once during the 7-8 year follow-up provided DNA. 321 single-nucleotide polymorphisms (SNPs) in 24 candidate genes were tested for an association with number of cigarettes smoked in the past 3 months, and with five ND phenotypes (a modified version of the Fagerstrom Tolerance Questionnaire, the ICD-10 and three clusters of ND symptoms representing withdrawal symptoms, use of nicotine for self-medication, and a general ND/craving symptom indicator). Results: The pattern of SNP-gene associations differed across phenotypes. Sixteen SNPs in seven genes (ANKK1, CHRNA7, DDC, DRD2, COMT, OPRM1, SLC6A3 (also known as DAT1)) were associated with at least one phenotype with a p-value <0.01 using linear mixed models. After permutation and FDR adjustment, none of the associations remained statistically significant, although the p-values for the association between rs557748 in OPRM1 and the ND/craving and self-medication phenotypes were both 0.076. Conclusions: Because the genetic predictors differ, specific cigarette smoking and ND phenotypes should be distinguished in genetic studies in adolescents. Fifteen of the 16 top-ranked SNPs identified in this study were from loci involved in dopaminergic pathways (ANKK1/DRD2, DDC, COMT, OPRM1, and SLC6A3). Impact: Dopaminergic pathways may be salient during early smoking and the development of ND.	[O'Loughlin, Jennifer; Sylvestre, Marie-Pierre; Dugas, Erika N.; Karp, Igor] Ctr Rech CHUM, Montreal, PQ, Canada; [O'Loughlin, Jennifer; Sylvestre, Marie-Pierre; Karp, Igor] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada; [O'Loughlin, Jennifer] Inst Natl Sante Publ Quebec, Montreal, PQ, Canada; [Labbe, Aurelie] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada; [Low, Nancy C.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Roy-Gagnon, Marie-Helene] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Karp, Igor] Univ Western Ontario, Dept Epidemiol & Biostat, Schulich Sch Med & Dent, London, ON, Canada; [Engert, James C.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Engert, James C.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Engert, James C.] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Institut national de sante publique du Quebec (INSPQ); McGill University; McGill University; University of Ottawa; Western University (University of Western Ontario); McGill University; McGill University; McGill University	O'Loughlin, J (corresponding author), Ctr Rech CHUM, Montreal, PQ, Canada.	jennifer.oloughlin@umontreal.ca	Sylvestre, Marie-Pierre/CAF-5219-2022; Dugas, Erika/AAH-7550-2020	Sylvestre, Marie-Pierre/0000-0001-5803-4615; Roy-Gagnon, Marie-Helene/0000-0001-8747-0846; Engert, James/0000-0001-8411-4790	Canadian Cancer Society [010271, 017435]	Canadian Cancer Society(Canadian Cancer Society (CCS))	J O'Loughlin holds a Canada Research Chair in the Early Determinants of Adult Chronic Disease. I Karp is a Fonds de la Recherche en Sante du Quebec Junior 1 Scholar and Canadian Institutes of Health Research New Investigator. This work was supported by Canadian Cancer Society grant numbers 010271 and 017435 awarded to J O'Loughlin (http://www.cancer.ca/en/?region=qc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Audrain-McGovern J, 2004, AM J PSYCHIAT, V161, P1224, DOI 10.1176/appi.ajp.161.7.1224; Baker TB, 2009, NICOTINE TOB RES, V11, P785, DOI 10.1093/ntr/ntp064; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bates D, 2014, LME4 LINEAR MIXED EF; Batra A, 2000, ADDICT BIOL, V5, P429, DOI 10.1111/j.1369-1600.2000.tb00212.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENOWITZ NL, 1988, NEW ENGL J MED, V319, P1318; Bergen AW, 2009, NEUROPSYCHOPHARMACOL, V34, P2252, DOI 10.1038/npp.2009.52; Breitling LP, 2009, PHARMACOGENET GENOM, V19, P657, DOI 10.1097/FPC.0b013e32832fabf3; Caporaso N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004653; Carpenter CM, 2007, ADDICTION, V102, P136, DOI 10.1111/j.1360-0443.2006.01649.x; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P386; Chen YT, 2013, J HUM GENET, V58, P84, DOI 10.1038/jhg.2012.139; Comings DE, 1996, PHARMACOGENETICS, V6, P73, DOI 10.1097/00008571-199602000-00006; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DiFranza JR, 2007, ARCH PEDIAT ADOL MED, V161, P704, DOI 10.1001/archpedi.161.7.704; Doran N, 2013, SUBST USE MISUSE, V48, P106, DOI 10.3109/10826084.2012.733791; Ducci F, 2011, BIOL PSYCHIAT, V69, P650, DOI 10.1016/j.biopsych.2010.09.055; Eppel A, 2006, ADDICT BEHAV, V31, P1700, DOI 10.1016/j.addbeh.2005.11.006; Erblich J, 2004, PHARMACOGENOMICS J, V4, P102, DOI 10.1038/sj.tpj.6500227; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gelernter J, 2006, HUM MOL GENET, V15, P3498, DOI 10.1093/hmg/ddl426; Goeman JJ, 2014, STAT MED, V33, P1946, DOI 10.1002/sim.6082; Han SZ, 2010, BIOL PSYCHIAT, V67, P12, DOI 10.1016/j.biopsych.2009.08.028; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hiemstra M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086497; Hiemstra M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061673; Huang SW, 2005, PHARMACOGENET GENOM, V15, P839, DOI 10.1097/01213011-200512000-00002; Huang WH, 2009, NEUROPSYCHOPHARMACOL, V34, P319, DOI 10.1038/npp.2008.37; Jorm AF, 2000, AM J MED GENET, V96, P331, DOI 10.1002/1096-8628(20000612)96:3<331::AID-AJMG19>3.0.CO;2-0; Keskitalo-Vuokko K, 2011, NICOTINE TOB RES, V13, P686, DOI 10.1093/ntr/ntr059; Laucht M, 2008, J AM ACAD CHILD PSY, V47, P673, DOI 10.1097/CHI.0b013e31816bff77; Leonard S, 2001, Nicotine Tob Res, V3, P203; Lerman CE, 2007, AM J PREV MED, V33, pS398, DOI 10.1016/j.amepre.2007.09.006; Li DL, 2011, AM J EPIDEMIOL, V173, P1039, DOI 10.1093/aje/kwq471; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Li MD, 2004, CLIN GENET, V66, P382, DOI 10.1111/j.1399-0004.2004.00302.x; Ling DJ, 2004, J HUM GENET, V49, P35, DOI 10.1007/s10038-003-0104-5; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Lobo DSS, 2012, WORLD J BIOL PSYCHIA, V13, P232, DOI 10.3109/15622975.2011.598560; Ma JZ, 2005, HUM MOL GENET, V14, P1691, DOI 10.1093/hmg/ddi177; Munafo MR, 2008, ADDICTION, V103, P893, DOI 10.1111/j.1360-0443.2007.02071.x; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Munafo MR, 2004, NICOTINE TOB RES, V6, P583, DOI 10.1080/14622200410001734030; National Cancer Institute, 2009, NIH PUBLICATION; Nestler EJ, 2002, NAT NEUROSCI, V5, P1076, DOI 10.1038/nn945; O'Loughlin J, 2002, TOB CONTROL, V11, P354, DOI 10.1136/tc.11.4.354; O'Loughlin J, 2002, NICTOB RES, V4, P20; O'Loughlin J., 2014, INT J EPIDE IN PRESS; O'Loughlin J, 2009, AM J PUBLIC HEALTH, V99, P499, DOI 10.2105/AJPH.2007.128629; Omidvar M, 2009, PHARMACOGENET GENOM, V19, P45, DOI 10.1097/FPC.0b013e328317f3f8; Pedneault M, 2014, ADDICT BEHAV, V39, P316, DOI 10.1016/j.addbeh.2013.08.033; Perkins KA, 2008, BEHAV PHARMACOL, V19, P641, DOI 10.1097/FBP.0b013e32830c367c; Radwan GN, 2007, NICOTINE TOB RES, V9, P1325, DOI 10.1080/14622200701704889; Ray R, 2011, P NATL ACAD SCI USA, V108, P9268, DOI 10.1073/pnas.1018699108; Rojas NL, 1998, ARCH PEDIAT ADOL MED, V152, P151, DOI 10.1001/archpedi.152.2.151; Saccone NL, 2010, GENES BRAIN BEHAV, V9, P741, DOI 10.1111/j.1601-183X.2010.00608.x; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Sherva R, 2008, ADDICTION, V103, P1544, DOI 10.1111/j.1360-0443.2008.02279.x; Shield AJ, 2004, MOL PSYCHIATR, V9, P151, DOI 10.1038/sj.mp.4001386; SHIPPENBERG TS, 1992, ANN NY ACAD SCI, V654, P347, DOI 10.1111/j.1749-6632.1992.tb25980.x; Singleton AB, 1998, PHARMACOGENETICS, V8, P125, DOI 10.1097/00008571-199804000-00005; Stapleton JA, 2007, ADDICT BIOL, V12, P221, DOI 10.1111/j.1369-1600.2007.00058.x; Stephens SH, 2013, GENET EPIDEMIOL, V37, P846, DOI 10.1002/gepi.21760; Sullivan P F, 1999, Nicotine Tob Res, V1 Suppl 2, pS51; Sullivan P.F., 1999, NICOTINE TOB RES S2, V1, pS69; Tammimaki AE, 2010, PHARMACOGENET GENOM, V20, P717, DOI 10.1097/FPC.0b013e328340bdf2; TENHUNEN J, 1994, EUR J BIOCHEM, V223, P1049, DOI 10.1111/j.1432-1033.1994.tb19083.x; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Timberlake DS, 2006, HEALTH PSYCHOL, V25, P190, DOI 10.1037/0278-6133.25.2.190; *US DEP HHS, 1994, PREV TOB US YOUNG PE; Vandenbergh David J, 2002, Nicotine Tob Res, V4, P333, DOI 10.1080/14622200210142689; Voisey J, 2012, PSYCHIAT RES, V196, P285, DOI 10.1016/j.psychres.2011.09.024; Wernicke C, 2009, PHARMACOPSYCHIATRY, V42, P41, DOI 10.1055/s-0028-1085444; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wheeler KC, 2004, J ADOLESCENT HEALTH, V35, P225, DOI 10.1016/j.jadohealth.2003.10.004; Wong SL, 2012, HEALTH REP, V23, P47; World Health Organization, 1992, INT STAT CLASS DIS R; Yi Y, 2006, HUM MOL GENET, V15, P2192, DOI 10.1093/hmg/ddl144; Zhang Lan, 2006, Behav Brain Funct, V2, P28, DOI 10.1186/1744-9081-2-28	82	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115716	10.1371/journal.pone.0115716	http://dx.doi.org/10.1371/journal.pone.0115716			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545355	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200060
J	Malejko, K; Weydt, P; Sussmuth, SD; Gron, G; Landwehrmeyer, BG; Abler, B				Malejko, Kathrin; Weydt, Patrick; Suessmuth, Sigurd D.; Groen, Georg; Landwehrmeyer, Bernhard G.; Abler, Birgit			Prodromal Huntington Disease as a Model for Functional Compensation of Early Neurodegeneration	PLOS ONE			English	Article							REWARD SYSTEM ACTIVATION; ALZHEIMERS-DISEASE; BRAIN ACTIVATION; DYSFUNCTION; PREDICTION; FMRI; PREMANIFEST; OLANZAPINE; DIAGNOSIS; STRIATUM	Functional compensation demonstrated as mechanism to offset neuronal loss in early Alzheimer disease may also occur in other adult-onset neurodegenerative diseases, particularly Huntington disease (HD) with its genetic determination and gradual changes in structural integrity. In HD, neurodegeneration typically initiates in the dorsal striatum, successively affecting ventral striatal areas. Investigating carriers of the HD mutation with evident dorsal, but only minimal or no ventral striatal atrophy, we expected to find evidence for compensation of ventral striatal functioning. We investigated 14 pre-or early symptomatic carriers of the mutation leading to HD and 18 matched healthy controls. Participants underwent structural T1 magnetic resonance imaging (MRI) and functional MRI during a reward task that probes ventral striatal functioning. Motor functioning and attention were assessed with reaction time (RT) tasks. Structural images confirmed a specific decrease of dorsal striatal but only marginal ventral striatal volume in HD relative to control subjects, paralleling prolonged RT in the motor response tasks. While behavioral performance in the reward task during fMRI scanning was unimpaired, reward-related fMRI signaling in the HD group was differentially enhanced in the bilateral ventral striatum and in bilateral orbitofrontal cortex/anterior insula, as another region sensitive to reward processing. We provide evidence for the concept of functional compensation in premanifest HD which may suggest a defense mechanism in neurodegeneration. Given the so far inevitable course of HD with its genetically determined endpoint, this disease may provide another model to study the different aspects of the concept of functional compensation.	[Malejko, Kathrin; Groen, Georg; Abler, Birgit] Univ Ulm, Dept Psychiat, D-89522 Ulm, Germany; [Suessmuth, Sigurd D.; Landwehrmeyer, Bernhard G.] Univ Ulm, Dept Neurol, D-89081 Ulm, Germany	Ulm University; Ulm University	Abler, B (corresponding author), Univ Ulm, Dept Psychiat, Leimgrubenweg 12-14, D-89522 Ulm, Germany.	birgit.abler@uni-ulm.de	Landwehrmeyer, Georg Bernhard/AHB-4443-2022; Weydt, Patrick/F-5114-2015	Landwehrmeyer, Georg Bernhard/0000-0003-3375-790X; Weydt, Patrick/0000-0003-2344-5662; Gron, Georg/0000-0002-0282-3575	European Huntington's Disease Network (EHDN); PREDICT HD; Ulm University	European Huntington's Disease Network (EHDN); PREDICT HD; Ulm University	This study was supported by the European Huntington's Disease Network (EHDN) and by PREDICT HD. The study was sponsored by departmental funds from Ulm University. K.M., P.W., G.G. and B.A. report no disclosures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2008, NEUROPSYCHOPHARMACOL, V33, P2217, DOI 10.1038/sj.npp.1301620; Abler B, 2007, PSYCHOPHARMACOLOGY, V191, P823, DOI 10.1007/s00213-006-0690-y; Abler B, 2006, NEUROIMAGE, V31, P790, DOI 10.1016/j.neuroimage.2006.01.001; Abler B, 2009, BRAIN, V132, P2396, DOI 10.1093/brain/awp170; APA, 1994, DIAGN STAT MAN MENT; Beauducel A, 2003, DIAGNOSTICA, V49, P61, DOI 10.1026//0012-1924.49.2.61; Benjamini Y, 2001, ANN STAT, V29, P1165; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Dekosky ST, 2003, SCIENCE, V302, P830, DOI 10.1126/science.1090349; Douaud G, 2006, NEUROIMAGE, V32, P1562, DOI 10.1016/j.neuroimage.2006.05.057; Enzi B, 2012, EXP NEUROL, V235, P256, DOI 10.1016/j.expneurol.2012.02.003; Hautzinger M., 1993, ALLGEMEINE DEPRESSIO; Juckel G, 2006, NEUROIMAGE, V29, P409, DOI 10.1016/j.neuroimage.2005.07.051; Kalbe E, 2004, INT J GERIATR PSYCH, V19, P136, DOI 10.1002/gps.1042; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; Lappin JM, 2009, J CEREBR BLOOD F MET, V29, P554, DOI 10.1038/jcbfm.2008.146; Palminteri S, 2012, NEURON, V76, P998, DOI 10.1016/j.neuron.2012.10.017; Paulsen JS, 2008, J NEUROL NEUROSUR PS, V79, P874, DOI 10.1136/jnnp.2007.128728; Paulsen JS, 2004, AM J NEURORADIOL, V25, P1715; Politis M, 2008, BRAIN, V131, P2860, DOI 10.1093/brain/awn244; Politis M, 2011, HUM BRAIN MAPP, V32, P258, DOI 10.1002/hbm.21008; Quiroz YT, 2010, ANN NEUROL, V68, P865, DOI 10.1002/ana.22105; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Schlagenhauf F, 2008, PSYCHOPHARMACOLOGY, V196, P673, DOI 10.1007/s00213-007-1016-4; Tabrizi SJ, 2012, LANCET NEUROL, V11, P42, DOI 10.1016/S1474-4422(11)70263-0; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Vonsattel JPG, 2011, HDB CLIN NEUROLOGY H; Wishart HA, 2006, AM J PSYCHIAT, V163, P1603, DOI 10.1176/appi.ajp.163.9.1603; Wolf RC, 2007, BRAIN, V130, P2845, DOI 10.1093/brain/awm210; Zuckerman M, 1996, PERS INDIV DIFFER, V21, P283, DOI 10.1016/0191-8869(96)00042-6; Zuckerman M., 1994, BEHAV EXPRESSIONS BI	31	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e114569	10.1371/journal.pone.0114569	http://dx.doi.org/10.1371/journal.pone.0114569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541992	gold, Green Published, Green Submitted			2022-12-26	WOS:000347239900012
J	Tange, S; Oktyabri, D; Terashima, M; Ishimura, A; Suzuki, T				Tange, Shoichiro; Oktyabri, Dulamsuren; Terashima, Minoru; Ishimura, Akihiko; Suzuki, Takeshi			JARID2 Is Involved in Transforming Growth Factor-Beta-Induced Epithelial-Mesenchymal Transition of Lung and Colon Cancer Cell Lines	PLOS ONE			English	Article							GROUP PROTEIN EZH2; GENE-EXPRESSION; MIR-200 FAMILY; STEM-CELLS; E-CADHERIN; HISTONE; PRC2; PROGRESSION; SNAIL; METHYLATION	Histone methylation plays a crucial role in various biological and pathological processes including cancer development. In this study, we discovered that JARID2, an interacting component of Polycomb repressive complex-2 (PRC2) that catalyzes methylation of lysine 27 of histone H3 (H3K27), was involved in Transforming Growth Factor-beta (TGF-beta)-induced epithelial-mesenchymal transition (EMT) of A549 lung cancer cell line and HT29 colon cancer cell line. The expression of JARID2 was increased during TGF-beta-induced EMT of these cell lines and knockdown of JARID2 inhibited TGF-beta-induced morphological conversion of the cells associated with EMT. JARID2 knockdown itself had no effect in the expression of EMT-related genes but antagonized TGF-beta-dependent expression changes of EMT-related genes such as CDH1, ZEB family and microRNA-200 family. Chromatin immunoprecipitation assays showed that JARID2 was implicated in TGF-beta-induced transcriptional repression of CDH1 and microRNA-200 family genes through the regulation of histone H3 methylation and EZH2 occupancies on their regulatory regions. Our study demonstrated a novel role of JARID2 protein, which may control PRC2 recruitment and histone methylation during TGF-beta-induced EMT of lung and colon cancer cell lines.	[Tange, Shoichiro; Oktyabri, Dulamsuren; Terashima, Minoru; Ishimura, Akihiko; Suzuki, Takeshi] Kanazawa Univ, Canc Res Inst, Div Funct Genom, Kanazawa, Ishikawa 920, Japan	Kanazawa University	Suzuki, T (corresponding author), Kanazawa Univ, Canc Res Inst, Div Funct Genom, Kanazawa, Ishikawa 920, Japan.	suzuki-t@staff.kanazawa-u.ac.jp	Tange, Shoichiro/AAJ-5265-2020; Terashima, Minoru/D-8462-2015	Tange, Shoichiro/0000-0002-2126-6938; Suzuki, Takeshi/0000-0002-1737-0900	Ministry of Education, Culture, Sports, Science and Technology of Japan [24590346, 22112010]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research C (grant number 24590346 to T.S.) and Scientific Research on Innovative Areas (grant number 22112010 to T.S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cao Q, 2011, CANCER CELL, V20, P187, DOI 10.1016/j.ccr.2011.06.016; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Cifuentes-Rojas C, 2014, MOL CELL; da Rocha ST, 2014, MOL CELL, V53, P301, DOI 10.1016/j.molcel.2014.01.002; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Enkhbaatar Z, 2013, CELL CYCLE, V12, P2100, DOI 10.4161/cc.25142; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Herz HM, 2010, GENE DEV, V24, P857, DOI 10.1101/gad.1921610; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Ke XS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-669; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Miyazono K, 2012, UPSALA J MED SCI, V117, P143, DOI 10.3109/03009734.2011.638729; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Puda A, 2012, AM J HEMATOL, V87, P245, DOI 10.1002/ajh.22257; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Siemens H, 2011, CELL CYCLE, V10, P4256, DOI 10.4161/cc.10.24.18552; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Suzuki T, 2006, EMBO J, V25, P3422, DOI 10.1038/sj.emboj.7601215; Suzuki T, 2013, CANCER SCI, V104, P795, DOI 10.1111/cas.12169; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Walters ZS, 2014, ONCOGENE, V33, P1148, DOI 10.1038/onc.2013.46; Wu CY, 2012, TRENDS GENET; Yoshida M, 2011, BIOCHEM J, V437, P555, DOI 10.1042/BJ20110343	36	49	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115684	10.1371/journal.pone.0115684	http://dx.doi.org/10.1371/journal.pone.0115684			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542019	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900069
J	Jia, D; Huang, L; Bischoff, J; Moses, MA				Jia, Di; Huang, Lan; Bischoff, Joyce; Moses, Marsha A.			The endogenous zinc finger transcription factor, ZNF24, modulates the angiogenic potential of human microvascular endothelial cells	FASEB JOURNAL			English	Article						angiogenesis; transcriptional regulation; VEGF repression	GROWTH-FACTOR RECEPTOR-2; BREAST-TUMOR GROWTH; EMBRYONIC-DEVELOPMENT; TISSUE INHIBITOR; CANCER-PATIENTS; IV COLLAGENASE; GELATINASE-A; LIPOCALIN 2; IN-VIVO; EXPRESSION	We have previously identified a zinc finger transcription factor, ZNF24 (zinc finger protein 24), as a novel inhibitor of tumor angiogenesis and have demonstrated that ZNF24 exerts this effect by repressing the transcription of VEGF in breast cancer cells. Here we focused on the role of ZNF24 in modulating the angiogenic potential of the endothelial compartment. Knockdown of ZNF24 by siRNA in human primary microvascular endothelial cells (ECs) led to significantly decreased cell migration and invasion compared with control siRNA. ZNF24 knockdown consistently led to significantly impaired VEGF receptor 2 (VEGFR2) signaling and decreased levels of matrix metalloproteinase-2 (MMP-2), with no effect on levels of major regulators of MMP-2 activity such as the tissue inhibitors of metalloproteinases and MMP-14. Moreover, silencing ZNF24 in these cells led to significantly decreased EC proliferation. Quantitative PCR array analyses identified multiple cell cycle regulators as potential ZNF24 downstream targets which may be responsible for the decreased proliferation in ECs. In vivo, knockdown of ZNF24 specifically in microvascular ECs led to significantly decreased formation of functional vascular networks. Taken together, these results demonstrate that ZNF24 plays an essential role in modulating the angiogenic potential of microvascular ECs by regulating the proliferation, migration, and invasion of these cells.	[Jia, Di; Huang, Lan; Bischoff, Joyce; Moses, Marsha A.] Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Jia, Di; Huang, Lan; Bischoff, Joyce; Moses, Marsha A.] Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Jia, Di; Huang, Lan; Bischoff, Joyce; Moses, Marsha A.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Moses, MA (corresponding author), Boston Childrens Hosp, Vasc Biol Program, Karp Family Res Bldg,300 Longwood Ave, Boston, MA 02115 USA.	marsha.moses@childrens.harvard.edu	BISCHOFF, JOYCE/K-3354-2019	BISCHOFF, JOYCE/0000-0002-6367-1974	Breast Cancer Research Foundation (New York, NY, USA); Advanced Medical Research Foundation (Brookline, MA, USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096384] Funding Source: NIH RePORTER	Breast Cancer Research Foundation (New York, NY, USA); Advanced Medical Research Foundation (Brookline, MA, USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this study was supported by the Breast Cancer Research Foundation (New York, NY, USA) and the Advanced Medical Research Foundation (Brookline, MA, USA).	Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; Albanese V, 2001, HUM MOL GENET, V10, P1785, DOI 10.1093/hmg/10.17.1785; Arvey A, 2012, GENOME RES, V22, P1723, DOI 10.1101/gr.127712.111; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Coticchia CM, 2011, GYNECOL ONCOL, V123, P295, DOI 10.1016/j.ygyno.2011.07.034; Dib H, 2012, PROTEOMICS, V12, P2547, DOI 10.1002/pmic.201200060; Edelstein LC, 2005, GENE, V359, P1, DOI 10.1016/j.gene.2005.06.022; EMMERTBUCK MR, 1995, FEBS LETT, V364, P28, DOI 10.1016/0014-5793(95)00345-A; Fang LH, 2013, NATURE, V498, P118, DOI 10.1038/nature12166; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; Fernandez CA, 2003, J BIOL CHEM, V278, P40989, DOI 10.1074/jbc.M306176200; Fernandez CA, 2006, BIOCHEM BIOPH RES CO, V345, P523, DOI 10.1016/j.bbrc.2006.04.083; Fernandez CA, 2010, J BIOL CHEM, V285, P41886, DOI 10.1074/jbc.M110.166439; Foradori MJ, 2014, J BIOL CHEM, V289, P14301, DOI 10.1074/jbc.M113.529982; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Han ZG, 1999, J BIOL CHEM, V274, P35741, DOI 10.1074/jbc.274.50.35741; Harper J, 2006, EXP SUPPL, V96, P223; Harper J, 2007, CANCER RES, V67, P8736, DOI 10.1158/0008-5472.CAN-07-1617; HERRON GS, 1986, J BIOL CHEM, V261, P2810; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Howng SYB, 2010, GENE DEV, V24, P301, DOI 10.1101/gad.1864510; Hutchins AP, 2013, NUCLEIC ACIDS RES, V41, P2155, DOI 10.1093/nar/gks1300; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Jia D, 2013, BLOOD, V121, P707, DOI 10.1182/blood-2012-05-433045; Khalfallah O, 2008, GENE EXPR PATTERNS, V8, P148, DOI 10.1016/j.gep.2007.11.002; Khalfallah O, 2009, STEM CELLS, V27, P1643, DOI 10.1002/stem.88; Labrecque L, 2003, MOL BIOL CELL, V14, P334, DOI 10.1091/mbc.E02-07-0379; Li JZ, 2006, EXP CELL RES, V312, P3990, DOI 10.1016/j.yexcr.2006.08.020; Liu GY, 2012, HEPATOLOGY, V55, P1830, DOI 10.1002/hep.25564; Lozito TP, 2014, MATRIX BIOL, V34, P132, DOI 10.1016/j.matbio.2013.10.003; Lv L, 2014, J VASC SURG, V59, P500, DOI 10.1016/j.jvs.2013.03.049; Ma YF, 2013, DEVELOPMENT, V140, P2203, DOI 10.1242/dev.089789; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Moses MA, 1998, CANCER RES, V58, P1395; MOSES MA, 1990, SCIENCE, V248, P1408, DOI 10.1126/science.1694043; Noghero A, 2012, ARTERIOSCL THROM VAS, V32, P2280, DOI 10.1161/ATVBAHA.112.250621; Ohno-Matsui K, 2003, INVEST OPHTH VIS SCI, V44, P5370, DOI 10.1167/iovs.03-0249; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pories SE, 2008, CANCER EPIDEM BIOMAR, V17, P1034, DOI 10.1158/1055-9965.EPI-07-0365; Prost JF, 1999, BBA-GENE STRUCT EXPR, V1447, P278, DOI 10.1016/S0167-4781(99)00157-8; Rodrigues M, 2013, DIABETES, V62, P3863, DOI 10.2337/db13-0014; Roy R, 2006, EXP CELL RES, V312, P608, DOI 10.1016/j.yexcr.2005.11.022; Roy R, 2008, CLIN CANCER RES, V14, P6610, DOI 10.1158/1078-0432.CCR-08-1136; Roy R, 2011, J BIOL CHEM, V286, P20758, DOI 10.1074/jbc.M110.216036; Roy R, 2012, BREAST CANCER RES TR, V131, P731, DOI 10.1007/s10549-011-1431-4; Sanda T, 2010, BLOOD, V115, P1735, DOI 10.1182/blood-2009-07-235143; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Smith ER, 2008, CLIN CANCER RES, V14, P2378, DOI 10.1158/1078-0432.CCR-07-1253; Stanton H, 1998, J CELL SCI, V111, P2789; STETLERSTEVENSON WG, 1989, J BIOL CHEM, V264, P1353; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Theret N, 1999, HEPATOLOGY, V30, P462, DOI 10.1002/hep.510300236; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Wang HY, 2008, ACTA BIOCH BIOPH SIN, V40, P704, DOI 10.1111/j.1745-7270.2008.00450.x; Xie JJ, 2005, BIOCHEM BIOPH RES CO, V337, P355, DOI 10.1016/j.bbrc.2005.09.055; Yang J, 2013, FASEB J, V27, P45, DOI 10.1096/fj.12-211730; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106	60	14	14	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1371	1382		10.1096/fj.14-258947	http://dx.doi.org/10.1096/fj.14-258947			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25550468	Green Published			2022-12-26	WOS:000354115000023
J	Gupte, TM; Haque, F; Gangadharan, B; Sunitha, MS; Mukherjee, S; Anandhan, S; Rani, DS; Mukundan, N; Jambekar, A; Thangaraj, K; Sowdhamini, R; Sommese, RF; Nag, S; Spudich, JA; Mercer, JA				Gupte, Tejas M.; Haque, Farah; Gangadharan, Binnu; Sunitha, Margaret S.; Mukherjee, Souhrid; Anandhan, Swetha; Rani, Deepa Selvi; Mukundan, Namita; Jambekar, Amruta; Thangaraj, Kumarasanny; Sowdhamini, Ramanathan; Sommese, Ruth F.; Nag, Suman; Spudich, James A.; Mercer, John A.			Mechanistic Heterogeneity in Contractile Properties of alpha-Tropomyosin (TPM1) Mutants Associated with Inherited Cardiomyopathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL DILATED CARDIOMYOPATHY; THIN FILAMENT MUTATIONS; HYPERTROPHIC CARDIOMYOPATHY; CARDIAC TROPONIN; FORCE GENERATION; STRUCTURAL BASIS; BINDING-SITES; CA2+ BINDING; MUSCLE; MYOSIN	The most frequent known causes of primary cardiomyopathies are mutations in the genes encoding sarcomeric proteins. Among those are 30 single-residue mutations in TPM1, the gene encoding a-tropomyosin. We examined seven mutant tropomyosins, E62Q, D84N, I172T, L185R, S215L, D230N, and M281T, that were chosen based on their clinical severity and locations along the molecule. The goal of our study was to determine how the biochemical characteristics of each of these mutant proteins are altered, which in turn could provide a structural rationale for treatment of the cardiomyopathies they produce. Measurements of Ca2+ sensitivity of human beta-cardiac myosin ATPase activity are consistent with the hypothesis that hypertrophic cardiomyopathies are hypersensitive to Ca2+ activation, and dilated cardiomyopathies are hyposensitive. We also report correlations between ATPase activity at maximum Ca2+ concentrations and conformational changes in TnC measured using a fluorescent probe, which provide evidence that different substitutions perturb the structure of the regulatory complex in different ways. Moreover, we observed changes in protein stability and protein-protein interactions in these mutants. Our results suggest multiple mechanistic pathways to hypertrophic and dilated cardiomyopathies. Finally, we examined a computationally designed mutant, E181K, that is hypersensitive, confirming predictions derived from in silico structural analysis.	[Gupte, Tejas M.; Haque, Farah; Gangadharan, Binnu; Sunitha, Margaret S.; Mukherjee, Souhrid; Anandhan, Swetha; Jambekar, Amruta; Spudich, James A.; Mercer, John A.] Inst Stem Cell Biol & Regenerat Med, Bangalore 560065, Karnataka, India; [Haque, Farah; Sunitha, Margaret S.; Mukundan, Namita; Jambekar, Amruta; Sowdhamini, Ramanathan] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; [Gangadharan, Binnu] Manipal Univ, Manipal 576104, Karnataka, India; [Rani, Deepa Selvi; Thangaraj, Kumarasanny] Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India; [Sommese, Ruth F.; Nag, Suman; Spudich, James A.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Mercer, John A.] McLaughlin Res Inst, Great Falls, MT 59405 USA	Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Manipal Academy of Higher Education (MAHE); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Stanford University; McLaughlin Research Institute for Biomedical Sciences, Inc.	Mercer, JA (corresponding author), InStem NCBS TIFR, GKVK Post, Bellary Rd, Bangalore 560065, Karnataka, India.	jam@instem.res.in	Jambekar, Amruta/J-5939-2019; Haque, Farah/ABA-3956-2020	Jambekar, Amruta/0000-0002-0781-6104; Haque, Farah/0000-0002-5492-3164; Gupte, Tejas/0000-0001-7422-016X; GANGADHARAN, BINNU/0000-0002-5126-1089; Mercer, John/0000-0003-0307-4438; Anandhan, Swetha/0000-0001-9187-7921; Thangaraj, Kumarasamy/0000-0002-0075-0106; , Margaret Sunitha S/0000-0002-2751-9254	National Institutes of Health [GM33289, HL117138]; inStem (Department of Biotechnology, Government of India); Shanta Wadhwani Centre for Cardiac and Neural Research; Human Frontiers Science Program [RGP0054/2009-C]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); inStem (Department of Biotechnology, Government of India); Shanta Wadhwani Centre for Cardiac and Neural Research; Human Frontiers Science Program(Human Frontier Science Program); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM33289 and HL117138 (to J. A. S.). This work was also supported by intramural grants from inStem (Department of Biotechnology, Government of India), the Shanta Wadhwani Centre for Cardiac and Neural Research, and program Grant RGP0054/2009-C from the Human Frontiers Science Program (to R. S. and J. A. S.).	Alves ML, 2010, J MOL CELL CARDIOL, V48, P834, DOI 10.1016/j.yjmcc.2010.01.003; Bai F, 2011, BIOPHYS J, V100, P1014, DOI 10.1016/j.bpj.2011.01.001; Barua B, 2011, P NATL ACAD SCI USA, V108, P10150, DOI 10.1073/pnas.1101221108; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; Bing W, 2000, J MOL CELL CARDIOL, V32, P1489, DOI 10.1006/jmcc.2000.1182; Borovikov YS, 2009, BIOCHEM BIOPH RES CO, V381, P403, DOI 10.1016/j.bbrc.2009.02.054; Chang AN, 2005, J BIOL CHEM, V280, P34343, DOI 10.1074/jbc.M505014200; COME PC, 1977, CIRCULATION, V55, P901, DOI 10.1161/01.CIR.55.6.901; Correa F, 2007, BIOPHYS J, V92, P2463, DOI 10.1529/biophysj.106.098541; Coulton AT, 2008, BIOCHEMISTRY-US, V47, P388, DOI 10.1021/bi701144g; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; Debold EP, 2007, AM J PHYSIOL-HEART C, V293, pH284, DOI 10.1152/ajpheart.00128.2007; Desai R, 2015, J BIOL CHEM, V290, P1915, DOI 10.1074/jbc.M114.609743; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Dyer EC, 2009, CIRC-HEART FAIL, V2, P456, DOI 10.1161/CIRCHEARTFAILURE.108.818237; Golitsina N, 1997, BIOCHEMISTRY-US, V36, P4637, DOI 10.1021/bi962970y; Gomes AV, 2002, J BIOL CHEM, V277, P35341, DOI 10.1074/jbc.M204118200; Greenfield NJ, 2002, BIOPHYS J, V83, P2754, DOI 10.1016/S0006-3495(02)75285-5; Harvey PA, 2011, J CELL BIOL, V194, P355, DOI 10.1083/jcb.201101100; Hitchcock-DeGregori SE, 2010, J STRUCT BIOL, V170, P319, DOI 10.1016/j.jsb.2009.12.013; Hitchcock-DeGregori SE, 2002, BIOCHEMISTRY-US, V41, P15036, DOI 10.1021/bi026519k; Hodges RS, 2009, J MOL BIOL, V392, P747, DOI 10.1016/j.jmb.2009.07.039; Janco M, 2012, BIOCHEMISTRY-US, V51, P9880, DOI 10.1021/bi301323n; Jarraya M, 2012, NEUROMUSCULAR DISORD, V22, pS137, DOI 10.1016/j.nmd.2012.06.347; JOHNSON JD, 1980, J BIOL CHEM, V255, P9635; Jongbloed RJ, 2003, J AM COLL CARDIOL, V41, P981, DOI 10.1016/S0735-1097(02)03005-X; Kalyva A, 2012, BIOCHEMISTRY-US, V51, P6388, DOI 10.1021/bi300340r; Kintses B, 2007, EMBO J, V26, P265, DOI 10.1038/sj.emboj.7601482; Kraft T, 2005, P NATL ACAD SCI USA, V102, P13861, DOI 10.1073/pnas.0504026102; Lakdawala NK, 2010, J AM COLL CARDIOL, V55, P320, DOI 10.1016/j.jacc.2009.11.017; Lehrer SS, 1998, J MOL BIOL, V277, P1081, DOI 10.1006/jmbi.1998.1654; Li XC, 2012, BIOCHEM BIOPH RES CO, V424, P493, DOI 10.1016/j.bbrc.2012.06.141; Makhoul M, 2011, PEDIATR CARDIOL, V32, P215, DOI 10.1007/s00246-010-9843-1; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; MARON BJ, 1984, AM J CARDIOL, V53, P1087, DOI 10.1016/0002-9149(84)90643-X; Marston S, 2013, HUM MOL GENET, V22, P4978, DOI 10.1093/hmg/ddt345; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Michele DE, 1999, NAT MED, V5, P1413; Michele DE, 2002, PHYSIOL GENOMICS, V9, P103, DOI 10.1152/physiolgenomics.00099.2001; Mirza M, 2007, J BIOL CHEM, V282, P13487, DOI 10.1074/jbc.M701071200; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; Murakami K, 2008, P NATL ACAD SCI USA, V105, P7200, DOI 10.1073/pnas.0801950105; Murphy CT, 2001, NAT CELL BIOL, V3, P311, DOI 10.1038/35060110; Nallari P, 2010, ENVIRON MOL MUTAGEN, V51, P722; Ochala J, 2012, HUM MOL GENET, V21, P4473, DOI 10.1093/hmg/dds289; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Rao VS, 2011, J BIOL CHEM, V286, P24135, DOI 10.1074/jbc.M110.167957; Redwood C, 2013, J MUSCLE RES CELL M, V34, P285, DOI 10.1007/s10974-013-9358-5; Resnicow DI, 2010, P NATL ACAD SCI USA, V107, P1053, DOI 10.1073/pnas.0913527107; Rieck DC, 2013, ARCH BIOCHEM BIOPHYS, V537, P198, DOI 10.1016/j.abb.2013.07.013; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Sanoudou D, 2005, PHYSIOL GENOMICS, V21, P131, DOI 10.1152/physiolgenomics.00259.2004; Sheehan KA, 2011, J MOL CELL CARDIOL, V50, P442, DOI 10.1016/j.yjmcc.2010.10.032; SHENG ZL, 1992, J BIOL CHEM, V267, P25407; Smith L, 2009, BIOPHYS J, V96, P3692, DOI 10.1016/j.bpj.2009.02.018; Sommese RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083403; Sommese RF, 2013, P NATL ACAD SCI USA, V110, P12607, DOI 10.1073/pnas.1309493110; Margaret SM, 2012, BIOINFORM BIOL INSIG, V6, P203, DOI 10.4137/BBI.S9798; Szczesna D, 1996, J BIOL CHEM, V271, P8381, DOI 10.1074/jbc.271.14.8381; Tardiff JC, 2011, CIRC RES, V108, P765, DOI 10.1161/CIRCRESAHA.110.224170; Tobacman LS, 2000, J BIOL CHEM, V275, P27587; Trybus KM, 2000, METHODS, V22, P327, DOI 10.1006/meth.2000.1085; van de Meerakker JBA, 2013, BBA-MOL CELL RES, V1833, P833, DOI 10.1016/j.bbamcr.2012.11.003; Van Driest SL, 2003, CIRCULATION, V108, P445, DOI 10.1161/01.CIR.0000080896.52003.DF; Van Driest SL, 2002, AM J CARDIOL, V90, P1123, DOI 10.1016/S0002-9149(02)02780-7; Watkins H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMra0902923; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Yar S, 2013, J BIOL CHEM, V288, P16235, DOI 10.1074/jbc.M113.458695; Zhou ZQ, 2012, J BIOL CHEM, V287, P7661, DOI 10.1074/jbc.M111.281600	70	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7003	7015		10.1074/jbc.M114.596676	http://dx.doi.org/10.1074/jbc.M114.596676			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25548289	Green Published, hybrid			2022-12-26	WOS:000350991500034
J	Sommerfeld, A; Reinehr, R; Haussinger, D				Sommerfeld, Annika; Reinehr, Roland; Haeussinger, Dieter			Free Fatty Acids Shift Insulin-induced Hepatocyte Proliferation towards CD95-dependent Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; HEPATIC STELLATE CELLS; LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; MEDIATED PHOSPHORYLATION; AUTOPHAGIC PROTEOLYSIS; SIGNAL-TRANSDUCTION; NADPH OXIDASE; CD95 LIGAND; ACTIVATION	Insulin is known to induce hepatocyte swelling, which triggers via integrins and c-Src kinase an activation of the epidermal growth factor receptor (EGFR) and subsequent cell proliferation (1). Free fatty acids (FFAs) are known to induce lipoapoptosis in liver cells in a c-Jun-NH2-terminal kinase (JNK)-dependent, but death receptor-independent way (2). As non-alcoholic steatohepatitis (NASH) is associated with hyperinsulinemia and increased FFA-blood levels, the interplay between insulin and FFA was studied with regard to hepatocyte proliferation and apoptosis in isolated rat and mouse hepatocytes. Saturated long chain FFAs induced apoptosis and JNK activation in primary rat hepatocytes, but did not activate the CD95 (Fas, APO-1) system, whereas insulin triggered EGFR activation and hepatocyte proliferation. Coadministration of insulin and FFAs, however, abolished hepatocyte proliferation and triggered CD95-dependent apoptosis due to a JNK-dependent association of the activated EGFR with CD95, subsequent CD95 tyrosine phosphorylation and formation of the death-inducing signaling complex (DISC). JNK inhibition restored the proliferative insulin effect in presence of FFAs and prevented EGFR/CD95 association, CD95 tyrosine phosphorylation and DISC formation. Likewise, in presence of FFAs insulin increased apoptosis in hepatocytes from wild type but not from Alb-Cre-FAS(fl/fl) mice, which lack functional CD95. It is concluded that FFAs can shift insulin-induced hepatocyte proliferation toward hepatocyte apoptosis by triggering a JNK signal, which allows activated EGFR to associate with CD95 and to trigger CD95-dependent apoptosis. Such phenomena may contribute to the pathogenesis of NASH.	[Sommerfeld, Annika; Reinehr, Roland; Haeussinger, Dieter] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Haussinger, D (corresponding author), Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, Moorenstr 5, D-40225 Dusseldorf, Germany.	haeussin@uni-duesseldorf.de	Reinehr, Roland/G-6118-2016		Deutsche Forschungsgemeinschaft through Collaborative Research Center 974 (Dusseldorf) "Communication and System Relevance in Liver Injury and Regeneration"	Deutsche Forschungsgemeinschaft through Collaborative Research Center 974 (Dusseldorf) "Communication and System Relevance in Liver Injury and Regeneration"	This work was supported by Deutsche Forschungsgemeinschaft through Collaborative Research Center 974 (Dusseldorf) "Communication and System Relevance in Liver Injury and Regeneration."	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Akbar DH, 2006, MED SCI MONITOR, V12, pRA23; Angulo P, 2002, J GASTROEN HEPATOL, V17, pS186, DOI 10.1046/j.1440-1746.17.s1.10.x; Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Boerner JL, 2005, MOL CARCINOGEN, V44, P262, DOI 10.1002/mc.20138; Cazanave SC, 2009, J BIOL CHEM, V284, P26591, DOI 10.1074/jbc.M109.022491; Clark JM, 2003, JAMA-J AM MED ASSOC, V289, P3000, DOI 10.1001/jama.289.22.3000; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Diehl AM, 1996, FASEB J, V10, P215, DOI 10.1096/fasebj.10.2.8641555; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Eberle A, 2005, HEPATOLOGY, V41, P315, DOI 10.1002/hep.20564; Egnatchik RA, 2014, METABOLISM, V63, P283, DOI 10.1016/j.metabol.2013.10.009; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Haussinger D, 2011, CELL PHYSIOL BIOCHEM, V28, P1089, DOI 10.1159/000335845; Hao ZY, 2004, J EXP MED, V199, P1355, DOI 10.1084/jem.20032196; HAUSSINGER D, 1992, TRENDS PHARMACOL SCI, V13, P371, DOI 10.1016/0165-6147(92)90114-L; Haussinger D, 2003, GASTROENTEROLOGY, V124, P1476, DOI 10.1016/S0016-5085(03)00274-9; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Hunter T, 1997, CELL, V88, P333, DOI 10.1016/S0092-8674(00)81872-3; Kong JY, 2000, BBA-MOL CELL BIOL L, V1485, P45, DOI 10.1016/S1388-1981(00)00028-7; Kordes C, 2007, BIOCHEM BIOPH RES CO, V352, P410, DOI 10.1016/j.bbrc.2006.11.029; Kordes C, 2014, J CLIN INVEST, V124, P5503, DOI 10.1172/JCI74119; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; MEIJER AJ, 1975, J BIOL CHEM, V250, P7728; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Nystrom FH, 1999, CELL SIGNAL, V11, P563, DOI 10.1016/S0898-6568(99)00025-X; Pereira S, 2014, AM J PHYSIOL-ENDOC M, V307, pE34, DOI 10.1152/ajpendo.00436.2013; Poppleton HM, 1999, ARCH BIOCHEM BIOPHYS, V363, P227, DOI 10.1006/abbi.1998.1095; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Reinehr R, 2004, J BIOL CHEM, V279, P10364, DOI 10.1074/jbc.M311997200; Reinehr R, 2008, GASTROENTEROLOGY, V134, P1494, DOI 10.1053/j.gastro.2008.02.021; Reinehr R, 2012, ARCH BIOCHEM BIOPHYS, V518, P2, DOI 10.1016/j.abb.2011.12.004; Reinehr R, 2010, J BIOL CHEM, V285, P25904, DOI 10.1074/jbc.M110.125781; Ribeiro PS, 2004, AM J GASTROENTEROL, V99, P1708, DOI 10.1111/j.1572-0241.2004.40009.x; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Schliess F, 2004, J BIOL CHEM, V279, P21294, DOI 10.1074/jbc.M313901200; Schliess F, 2001, BIOL CHEM, V382, P1063, DOI 10.1515/BC.2001.133; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Sommerfeld A, 2009, J BIOL CHEM, V284, P22173, DOI 10.1074/jbc.M109.005355; Susca M, 2001, DIGEST LIVER DIS, V33, P768, DOI 10.1016/S1590-8658(01)80694-0; Taha C, 1999, J MEMBRANE BIOL, V169, P1, DOI 10.1007/PL00005896; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Volkmann X, 2007, HEPATOLOGY, V46, P1498, DOI 10.1002/hep.21846; vom Dahl S, 2003, J BIOL CHEM, V278, P27088, DOI 10.1074/jbc.M210699200; Wang Y, 2008, J NUTR, V138, P1866, DOI 10.1093/jn/138.10.1866; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Zafrani ES, 2004, VIRCHOWS ARCH, V444, P3, DOI 10.1007/s00428-003-0943-7	57	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4398	4409		10.1074/jbc.M114.617035	http://dx.doi.org/10.1074/jbc.M114.617035			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25548285	Green Published, hybrid			2022-12-26	WOS:000349458400047
J	de Almeida, SA; Claudio, ERG; Mengal, VF; de Oliveira, SG; Merlo, E; Podratz, PL; Gouvea, SA; Graceli, JB; de Abreu, GR				de Almeida, Simone Alves; Goncalves Claudio, Erick Roberto; Mengal, Vinicius Franskoviaky; de Oliveira, Suelen Guedes; Merlo, Eduardo; Podratz, Priscila Lang; Gouvea, Sonia Alves; Graceli, Jones Bernardes; de Abreu, Glaucia Rodrigues			Exercise Training Reduces Cardiac Dysfunction and Remodeling in Ovariectomized Rats Submitted to Myocardial Infarction	PLOS ONE			English	Article							ANGIOTENSIN-II RECEPTORS; HEART-FAILURE; NADPH OXIDASE; ESTROGEN; SYSTEM; PATHOPHYSIOLOGY; CONTRACTILITY; ACTIVATION; REDUCTION; GENDER	The aim of this study was to evaluate whether exercise training (ET) prevents or minimizes cardiac dysfunction and pathological ventricular remodeling in ovariectomized rats subjected to myocardial infarction (MI) and to examine the possible mechanisms involved in this process. Ovariectomized Wistar rats were subjected to either MI or fictitious surgery (Sham) and randomly divided into the following groups: Control, OVX+SHAM(SED), OVX+SHAM(ET), OVX+MISED and OVX+MIET. ET was performed on a motorized treadmill (5x/wk, 60 min/day, 8 weeks). Cardiac function was assessed by ventricular catheterization and Dihydroethidium fluorescence (DHE) was evaluated to analyze cardiac oxidative stress. Histological analyses were made to assess collagen deposition, myocyte hypertrophy and infarct size. Western Blotting was performed to analyze the protein expression of catalase and SOD-2, as well as Gp91phox and AT1 receptor (AT1R). MI-trained rats had significantly increased in +dP/dt and decreased left ventricular end-diastolic pressure compared with MI-sedentary rats. Moreover, oxidative stress and collagen deposition was reduced, as was myocyte hypertrophy. These effects occurred in parallel with a reduction in both AT1R and Gp91phox expression and an increase in catalase expression. SOD-2 expression was not altered. These results indicate that ET improves the functional cardiac parameters associated with attenuation of cardiac remodeling in ovariectomized rats subjected to MI. The mechanism seems to be related to a reduction in the expression of both the AT1 receptor and Gp91phox as well as an increase in the antioxidant enzyme catalase, which contributes to a reduction in oxidative stress. Therefore, ET may be an important therapeutic target for the prevention of heart failure in postmenopausal women affected by MI.	[de Almeida, Simone Alves; Goncalves Claudio, Erick Roberto; Mengal, Vinicius Franskoviaky; de Oliveira, Suelen Guedes; Gouvea, Sonia Alves; de Abreu, Glaucia Rodrigues] Univ Fed Espirito Santo, Ctr Ciencias Saude, Dept Ciencias Fisiol, Vitoria, ES, Brazil; [Merlo, Eduardo; Podratz, Priscila Lang; Graceli, Jones Bernardes] Univ Fed Espirito Santo, Ctr Ciencias Saude, Dept Morfol, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo	de Almeida, SA (corresponding author), Univ Fed Espirito Santo, Ctr Ciencias Saude, Dept Ciencias Fisiol, Vitoria, ES, Brazil.	simoalves@yahoo.com.br	Bernardes Graceli, Jones/ABC-7439-2021	Merlo, Eduardo/0000-0003-0155-1472; Goncalves Claudio, Erick Roberto/0000-0001-7030-3558				ALP PR, 1976, BIOCHEM J, V154, P689, DOI 10.1042/bj1540689; Barbosa VA, 2012, INT J CARDIOL, V157, P422, DOI 10.1016/j.ijcard.2012.03.153; Bianchi PR, 2006, LIFE SCI, V78, P875, DOI 10.1016/j.lfs.2005.05.086; Braith RW, 1999, J AM COLL CARDIOL, V34, P1170, DOI 10.1016/S0735-1097(99)00339-3; Brower GL, 2006, EUR J CARDIO-THORAC, V30, P604, DOI 10.1016/j.ejcts.2006.07.006; Cabanelas LA, 2010, REV BRAS GINECOL OBS, V34, P447, DOI 10.1590/S0100-72032012001000003; Campos JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052764; Cavasin MA, 2004, LIFE SCI, V75, P2181, DOI 10.1016/j.lfs.2004.04.024; Claudio ERG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064806; CRABOS M, 1994, J CLIN INVEST, V93, P2372, DOI 10.1172/JCI117243; de Tombe PP, 2010, J MOL CELL CARDIOL, V48, P851, DOI 10.1016/j.yjmcc.2009.12.017; Dimitrios N. T., 2003, HELL J CARDIOL, V44, P195; Distefano G, 2012, ITAL J PEDIATR, V38, DOI 10.1186/1824-7288-38-41; Dostal DE, 1997, J MOL CELL CARDIOL, V29, P2893, DOI 10.1006/jmcc.1997.0524; Dubach P, 2001, SWISS MED WKLY, V131, P510; Flores LJ, 2010, MENOPAUSE, V17, P712, DOI 10.1097/gme.0b013e3181cdebc9; Forechi L, 2012, PHARMACOL REP, V64, P643, DOI 10.1016/S1734-1140(12)70860-5; Giuberti K, 2007, ARCH MED RES, V38, P170, DOI 10.1016/j.arcmed.2006.09.015; Hafstad AD, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0359-8; Hingtgen SD, 2006, PHYSIOL GENOMICS, V26, P180, DOI 10.1152/physiolgenomics.00029.2005; Johar S, 2006, FASEB J, V20, P1546, DOI 10.1096/fj.05-4642fje; Ju HS, 1997, CARDIOVASC RES, V35, P223, DOI 10.1016/S0008-6363(97)00130-2; Kim JK, 2006, J BIOL CHEM, V281, P6760, DOI 10.1074/jbc.M511024200; Komajda M, 1998, HEART, V79, pS17, DOI 10.1136/hrt.79.2008.17S; Komukai K, 2010, FUND CLIN PHARMACOL, V24, P687, DOI 10.1111/j.1472-8206.2010.00854.x; Kraljevic J, 2013, CARDIOVASC RES, V99, P55, DOI 10.1093/cvr/cvt080; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Looi YH, 2008, HYPERTENSION, V51, P319, DOI 10.1161/HYPERTENSIONAHA.107.101980; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Bozi LHM, 2013, CLINICS, V68, P549, DOI 10.6061/clinics/2013(04)18; MEGGS LG, 1993, CIRC RES, V72, P1149, DOI 10.1161/01.RES.72.6.1149; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Negrao CE, 2008, J APPL PHYSIOL, V104, P577, DOI 10.1152/japplphysiol.01368.2007; Pedram A, 2010, MOL ENDOCRINOL, V24, P2152, DOI 10.1210/me.2010-0154; PFEFFER JM, 1984, AM J MED, V76, P99, DOI 10.1016/0002-9343(84)90894-5; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Pinho CA, 2012, LIFE SCI, V90, P553, DOI 10.1016/j.lfs.2012.01.018; Piro M, 2010, J AM COLL CARDIOL, V55, P1057, DOI 10.1016/j.jacc.2009.09.065; Shlipak MG, 2001, CIRCULATION, V104, P2300, DOI 10.1161/hc4401.98414; Smith PJW, 2000, CIRCULATION, V102, P2983; Strehlow K, 2003, CIRC RES, V93, P170, DOI 10.1161/01.RES.0000082334.17947.11; Stupka N, 2001, J APPL PHYSIOL, V91, P1828, DOI 10.1152/jappl.2001.91.4.1828; Sun Y, 2009, CARDIOVASC RES, V81, P482, DOI 10.1093/cvr/cvn333; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Touyz RM, 2004, BRAZ J MED BIOL RES, V37, P1263, DOI 10.1590/S0100-879X2004000800018; Wan WH, 2007, AM J MED SCI, V334, P265, DOI 10.1097/MAJ.0b013e318068b5ed; Wilson P, 2009, CLIN SCI, V116, P731, DOI 10.1042/CS20080247; Wisloff U, 2002, CARDIOVASC RES, V54, P162, DOI 10.1016/S0008-6363(01)00565-X; Yung LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017437; Zornoff LAM, 2009, ARQ BRAS CARDIOL, V92, P157, DOI 10.1590/S0066-782X2009000200013	50	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115970	10.1371/journal.pone.0115970	http://dx.doi.org/10.1371/journal.pone.0115970			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551214	Green Published, gold			2022-12-26	WOS:000347119100084
J	Haffner-Luntzer, M; Heilmann, A; Rapp, AE; Beie, S; Schinke, T; Amling, M; Ignatius, A; Liedert, A				Haffner-Luntzer, Melanie; Heilmann, Aline; Rapp, Anna Elise; Beie, Simon; Schinke, Thorsten; Amling, Michael; Ignatius, Anita; Liedert, Astrid			Midkine-Deficiency Delays Chondrogenesis during the Early Phase of Fracture Healing in Mice	PLOS ONE			English	Article							GROWTH-FACTOR MIDKINE; COMPUTED TOMOGRAPHY; BONE; EXPRESSION; DIFFERENTIATION; ANGIOGENESIS; CHONDROCYTES; INHIBITION; CYTOKINE; PROTEIN	The growth and differentiation factor midkine (Mdk) plays an important role in bone development and remodeling. Mdk-deficient mice display a high bone mass phenotype when aged 12 and 18 months. Furthermore, Mdk has been identified as a negative regulator of mechanically induced bone formation and it induces prochondrogenic, pro-angiogenic and pro-inflammatory effects. Together with the finding that Mdk is expressed in chondrocytes during fracture healing, we hypothesized that Mdk could play a complex role in endochondral ossification during the bone healing process. Femoral osteotomies stabilized using an external fixator were created in wildtype and Mdk-deficient mice. Fracture healing was evaluated 4, 10, 21 and 28 days after surgery using 3-point-bending, micro-computed tomography, histology and immunohistology. We demonstrated that Mdk-deficient mice displayed delayed chondrogenesis during the early phase of fracture healing as well as significantly decreased flexural rigidity and moment of inertia of the fracture callus 21 days after fracture. Mdk-deficiency diminished beta-catenin expression in chondrocytes and delayed presence of macrophages during early fracture healing. We also investigated the impact of Mdk knockdown using siRNA on ATDC5 chondroprogenitor cells in vitro. Knockdown of Mdk expression resulted in a decrease of beta-catenin and chondrogenic differentiation-related matrix proteins, suggesting that delayed chondrogenesis during fracture healing in Mdk-deficient mice may be due to a cell-autonomous mechanism involving reduced beta-catenin signaling. Our results demonstrated that Mdk plays a crucial role in the early inflammation phase and during the development of cartilaginous callus in the fracture healing process.	[Haffner-Luntzer, Melanie; Heilmann, Aline; Rapp, Anna Elise; Beie, Simon; Ignatius, Anita; Liedert, Astrid] Univ Med Ctr Ulm, Inst Orthopaed Res & Biomech, Ulm, Germany; [Schinke, Thorsten; Amling, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany	Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Liedert, A (corresponding author), Univ Med Ctr Ulm, Inst Orthopaed Res & Biomech, Ulm, Germany.	astrid.liedert@uni-ulm.de	Ignatius, Anita/M-6012-2013; Rapp, Anna/L-8807-2016; Haffner-Luntzer, Melanie/L-3562-2019	Ignatius, Anita/0000-0002-4782-1979; Rapp, Anna/0000-0001-5122-765X; Haffner-Luntzer, Melanie/0000-0002-3333-2613	German Research Foundation [IG 18-3/3, AM103/10-3]	German Research Foundation(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation (IG 18-3/3 and AM103/10-3) (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chen M, 2008, J CELL SCI, V121, P1455, DOI 10.1242/jcs.020362; Dao DY, 2010, J ORTHOP RES, V28, P89, DOI 10.1002/jor.20954; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Heilmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084232; Heilmann A, 2013, J ORTHOP RES, V31, P1845, DOI 10.1002/jor.22426; Horiba M, 2000, J CLIN INVEST, V105, P489, DOI 10.1172/JCI7208; Huang Y, 2012, J ORTHOP RES, V30, P304, DOI 10.1002/jor.21505; Ikutomo M, 2014, ACTA HISTOCHEM, V116, P319, DOI 10.1016/j.acthis.2013.08.009; Johnson K, 2003, J BONE MINER RES, V18, P994, DOI 10.1359/jbmr.2003.18.6.994; KADOMATSU K, 1990, J CELL BIOL, V110, P607, DOI 10.1083/jcb.110.3.607; Kadomatsu K, 2013, J BIOCHEM, V153, P511, DOI 10.1093/jb/mvt035; Komatsu DE, 2010, J ORTHOP RES, V28, P928, DOI 10.1002/jor.21078; Kosugi T, 2007, LAB INVEST, V87, P903, DOI 10.1038/labinvest.3700599; Liedert A, 2014, BRIT J PHARMACOL, V171, P870, DOI 10.1111/bph.12412; Liedert A, 2011, BONE, V48, P945, DOI 10.1016/j.bone.2010.12.019; Ling YF, 2005, J BONE MINER RES, V20, P2169, DOI 10.1359/JBMR.050815; Lu CY, 2011, J ORTHOP TRAUMA, V25, P494, DOI 10.1097/BOT.0b013e31822511e0; Morgan EF, 2009, BONE, V44, P335, DOI 10.1016/j.bone.2008.10.039; Nakamura E, 1998, GENES CELLS, V3, P811, DOI 10.1046/j.1365-2443.1998.00231.x; Nam HK, 2011, J BIOL CHEM, V286, P39059, DOI 10.1074/jbc.M111.221689; Neunaber C, 2010, J BONE MINER RES, V25, P1724, DOI 10.1002/jbmr.75; Ohta S, 1999, J BONE MINER RES, V14, P1132, DOI 10.1359/jbmr.1999.14.7.1132; Ominsky MS, 2011, J BONE MINER RES, V26, P1012, DOI 10.1002/jbmr.307; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rontgen V, 2010, J ORTHOP RES, V28, P1456, DOI 10.1002/jor.21148; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Takada T, 1997, J BIOCHEM-TOKYO, V122, P453; Tian J, 2014, TUMOUR BIOL; Toyosawa S, 2004, BONE, V35, P553, DOI 10.1016/j.bone.2004.03.030; Weckbach LT, 2012, AM J PHYSIOL-HEART C, V303, pH429, DOI 10.1152/ajpheart.00934.2011; Wehrle E, 2014, J ORTHOP RES, V32, P1006, DOI 10.1002/jor.22629; Xing ZQ, 2010, DIS MODEL MECH, V3, P451, DOI 10.1242/dmm.003186; Zhang ZH, 2010, CELL PROLIFERAT, V43, P184, DOI 10.1111/j.1365-2184.2010.00668.x	35	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116282	10.1371/journal.pone.0116282	http://dx.doi.org/10.1371/journal.pone.0116282			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551381	Green Published, gold, Green Submitted			2022-12-26	WOS:000347119100120
J	Salyer, A; Bennett, GW; Buczkowski, GA				Salyer, Adam; Bennett, Gary W.; Buczkowski, Grzegorz A.			Odorous House Ants (Tapinoma sessile) as Back-Seat Drivers of Localized Ant Decline in Urban Habitats	PLOS ONE			English	Article							HYMENOPTERA-FORMICIDAE; LINEPITHEMA-HUMILE; BIOLOGICAL INVASIONS; ECOLOGICAL CHANGE; FUNCTIONAL-GROUPS; ARGENTINE ANTS; NATIVE ANTS; COMMUNITIES; URBANIZATION; SUCCESS	Invasive species and habitat disturbance threaten biodiversity worldwide by modifying ecosystem performance and displacing native organisms. Similar homogenization impacts manifest locally when urbanization forces native species to relocate or reinvade perpetually altered habitat. This study investigated correlations between ant richness and abundance in response to urbanization and the nearby presence of invasive ant species, odorous house ants (Tapinoma sessile), within its native region. Surveying localized ant composition within natural, semi-natural, and urban habitat supported efforts to determine whether T. sessile appear to be primary (drivers) threats as instigators or secondary (passengers) threats as inheritors of indigenous ant decline. Sampling 180 sites, evenly split between all habitats with and without T. sessile present, yielded 45 total species. Although urbanization and T. sessile presence factors were significantly linked to ant decline, their interaction correlated to the greatest reduction of total ant richness (74%) and abundance (81%). Total richness appeared to decrease from 27 species to 18 when natural habitat is urbanized and from 18 species to 7 with T. sessile present in urban plots. Odorous house ant presence minimally influenced ant communities within natural and semi-natural habitat, highlighting the importance of habitat alteration and T. sessile presence interactions. Results suggest urbanization releases T. sessile from unknown constraints by decreasing ant richness and competition. Within urban environment, T. sessile are pre-adapted to quickly exploit new resources and grow to supercolony strength wherein T. sessile drive adjacent biodiversity loss. Odorous house ants act as passengers and drivers of ecological change throughout different phases of urban 'invasion'. This progression through surviving habitat alteration, exploiting new resources, thriving, and further reducing interspecific competition supports a "back-seat driver" role and affects pest management strategies. As demonstrated by T. sessile, this article concludes native species can become back-seat drivers of biodiversity loss and potentially thrive as "metro-invasive" species.	[Salyer, Adam; Bennett, Gary W.; Buczkowski, Grzegorz A.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Salyer, A (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	asalyer@purdue.edu			Industrial Affiliates Program at Purdue University	Industrial Affiliates Program at Purdue University	The authors were supported by the Industrial Affiliates Program at Purdue University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN AN, 1995, J BIOGEOGR, V22, P15, DOI 10.2307/2846070; Bauer JT, 2012, BIOL INVASIONS, V14, P1295, DOI 10.1007/s10530-011-0165-x; Berman M, 2013, BIOL INVASIONS, V15, P2311, DOI 10.1007/s10530-013-0455-6; Bolton B., 1994, Identification guide to the ant genera of the world.; BOLTON B., 2007, BOLTONS CATALOGUE AN; Bolton B, 1995, NEW GEN CATALOGUE AN, P504; Buczkowski G, 2009, INSECT SOC, V56, P185, DOI 10.1007/s00040-009-0011-7; Buczkowski G, 2008, ECOL ENTOMOL, V33, P780, DOI 10.1111/j.1365-2311.2008.01034.x; Buczkowski G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041729; Buczkowski G, 2012, MYRMECOL NEWS, V16, P61; Buczkowski G, 2010, BIOL INVASIONS, V12, P3343, DOI 10.1007/s10530-010-9727-6; Carney SE, 2003, OECOLOGIA, V135, P576, DOI 10.1007/s00442-003-1200-0; Cover, 2007, ANTS N AM GUIDE GENE, P145; Covert GA, 2005, ANTS OHIO HYMENOPTER, P196; Didham RK, 2005, TRENDS ECOL EVOL, V20, P470, DOI 10.1016/j.tree.2005.07.006; FELLERS JH, 1987, ECOLOGY, V68, P1466, DOI 10.2307/1939230; Friedrich R, 2009, ENVIRON ENTOMOL, V38, P600, DOI 10.1603/022.038.0311; Gibb H, 2004, BIOL CONSERV, V106, P91; Goodisman MAD, 2007, BIOL INVASIONS, V9, P571, DOI 10.1007/s10530-006-9059-8; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Heterick BE, 2013, URBAN ECOSYST, V16, P145, DOI 10.1007/s11252-012-0257-0; Hoffmann BD, 2003, AUSTRAL ECOL, V28, P444, DOI 10.1046/j.1442-9993.2003.01301.x; Holway DA, 1998, SCIENCE, V282, P949, DOI 10.1126/science.282.5390.949; Holway DA, 2006, BIOL CONSERV, V127, P319, DOI 10.1016/j.biocon.2005.05.016; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Human KG, 1996, OECOLOGIA, V105, P405, DOI 10.1007/BF00328744; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; King JR, 2008, P NATL ACAD SCI USA, V105, P20339, DOI 10.1073/pnas.0809423105; Laeger Thomas, 2005, Myrmecologische Nachrichten, V7, P17; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; Lopez-Moreno IR, 2003, SOCIOBIOLOGY, V42, P605; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MAJER J D, 1986, Journal of the Royal Society of Western Australia, V69, P13; McGlynn TP, 1999, J BIOGEOGR, V26, P535, DOI 10.1046/j.1365-2699.1999.00310.x; Menke SB, 2011, URBAN ECOSYST, V14, P135, DOI 10.1007/s11252-010-0150-7; Menke SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009194; Milford ER, 1999, SOUTHWEST NAT, V44, P278; Oliver TH, 2008, INSECT CONSERV DIVER, V1, P208, DOI 10.1111/j.1752-4598.2008.00026.x; Pacheco R, 2007, LANDSCAPE URBAN PLAN, V81, P193, DOI 10.1016/j.landurbplan.2006.11.004; PASSERA L, 1994, WESTV STUD, P23; PORTER SD, 1990, ECOLOGY, V71, P2095, DOI 10.2307/1938623; Ricciardi A, 2004, TRENDS ECOL EVOL, V19, P619, DOI 10.1016/j.tree.2004.09.021; Sanford MP, 2009, CONSERV BIOL, V23, P131, DOI 10.1111/j.1523-1739.2008.01040.x; SEIFERT B, 1990, Entomologische Nachrichten und Berichte, V34, P21; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Suarez AV, 2001, P NATL ACAD SCI USA, V98, P1095, DOI 10.1073/pnas.98.3.1095; Taylor BW, 2004, P NATL ACAD SCI USA, V101, P17725, DOI 10.1073/pnas.0405176101; THOMPSON CR, 1990, WESTV STUD, P51; Toennisson TA, 2011, ENVIRON ENTOMOL, V40, P1397, DOI 10.1603/EN11110; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Vepsalainen K, 2000, ANN ZOOL FENN, V37, P135; Vitousek PM, 1996, AM SCI, V84, P468; Wheeler GC, 1986, ANTS NEVADA, P138; Wilder SM, 2011, P NATL ACAD SCI USA, V108, P20639, DOI 10.1073/pnas.1115263108; Witt A. B. R., 2006, African Plant Protection, V12, P60; Yamaguchi T, 2004, ECOL RES, V19, P209, DOI 10.1111/j.1440-1703.2003.00625.x	58	11	13	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e113878	10.1371/journal.pone.0113878	http://dx.doi.org/10.1371/journal.pone.0113878			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551819	gold, Green Published, Green Submitted			2022-12-26	WOS:000347119100007
J	Chang, HC; Gaur, P; Chou, YH; Chu, ML; Chen, NK				Chang, Hing-Chiu; Gaur, Pooja; Chou, Ying-hui; Chu, Mei-Lan; Chen, Nan-kuei			Interleaved EPI Based fMRI Improved by Multiplexed Sensitivity Encoding (MUSE) and Simultaneous Multi-Band Imaging	PLOS ONE			English	Article							ECHO; MRI; RECONSTRUCTION; ACCELERATION; DISTORTIONS; ACQUISITION; ARTIFACTS; IMAGES	Functional magnetic resonance imaging (fMRI) is a non-invasive and powerful imaging tool for detecting brain activities. The majority of fMRI studies are performed with single-shot echo-planar imaging (EPI) due to its high temporal resolution. Recent studies have demonstrated that, by increasing the spatial-resolution of fMRI, previously unidentified neuronal networks can be measured. However, it is challenging to improve the spatial resolution of conventional single-shot EPI based fMRI. Although multi-shot interleaved EPI is superior to single-shot EPI in terms of the improved spatial-resolution, reduced geometric distortions, and sharper point spread function (PSF), interleaved EPI based fMRI has two main limitations: 1) the imaging throughput is lower in interleaved EPI; 2) the magnitude and phase signal variations among EPI segments (due to physiological noise, subject motion, and B-0 drift) are translated to significant in-plane aliasing artifact across the field of view (FOV). Here we report a method that integrates multiple approaches to address the technical limitations of interleaved EPI-based fMRI. Firstly, the multiplexed sensitivity-encoding (MUSE) post-processing algorithm is used to suppress in-plane aliasing artifacts resulting from time-domain signal instabilities during dynamic scans. Secondly, a simultaneous multi-band interleaved EPI pulse sequence, with a controlled aliasing scheme incorporated, is implemented to increase the imaging throughput. Thirdly, the MUSE algorithm is then generalized to accommodate fMRI data obtained with our multi-band interleaved EPI pulse sequence, suppressing both in-plane and through-plane aliasing artifacts. The blood-oxygenation-level-dependent (BOLD) signal detectability and the scan throughput can be significantly improved for interleaved EPI-based fMRI. Our human fMRI data obtained from 3 Tesla systems demonstrate the effectiveness of the developed methods. It is expected that future fMRI studies requiring high spatial-resolvability and fidelity will largely benefit from the reported techniques.	[Chang, Hing-Chiu; Chou, Ying-hui; Chu, Mei-Lan; Chen, Nan-kuei] Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC 27708 USA; [Gaur, Pooja] Vanderbilt Univ, Dept Chem & Phys Biol, Nashville, TN 37235 USA; [Gaur, Pooja] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37235 USA; [Chou, Ying-hui] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Chu, Mei-Lan] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan	Duke University; Vanderbilt University; Vanderbilt University; Duke University; National Taiwan University	Chen, NK (corresponding author), Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC 27708 USA.	nankuei.chen@duke.edu	Chen, Nan-Kuei/E-7791-2016; Chou, Ying-hui/GPT-0971-2022	Chen, Nan-Kuei/0000-0001-6564-4219; Gaur, Pooja/0000-0003-0433-975X; Chang, Hing-Chiu/0000-0001-8634-328X	NIH [R01 NS-074045]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074045] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by NIH R01 NS-074045. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bammer P, 1999, RADIOLOGY, V211, P799, DOI 10.1148/radiology.211.3.r99jn15799; Breuer FA, 2005, MAGNET RESON MED, V53, P684, DOI 10.1002/mrm.20401; Chen NK, 2008, MAGN RESON MED, V59, P916, DOI 10.1002/mrm.21529; Chen NK, 2013, NEUROIMAGE, V72, P41, DOI 10.1016/j.neuroimage.2013.01.038; Chen NK, 2011, MAGN RESON MED, V66, P1057, DOI 10.1002/mrm.22896; Chen NK, 1999, MAGNET RESON MED, V41, P1206, DOI 10.1002/(SICI)1522-2594(199906)41:6<1206::AID-MRM17>3.0.CO;2-L; Chou MC, 2007, AM J NEURORADIOL, V28, P1099, DOI 10.3174/ajnr.A0532; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Hyde JS, 2001, MAGN RESON MED, V46, P114, DOI 10.1002/mrm.1166; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; KWONG KK, 1995, MAGN RESON QUART, V11, P1; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Larkman DJ, 2001, J MAGN RESON IMAGING, V13, P313, DOI 10.1002/1522-2586(200102)13:2<313::AID-JMRI1045>3.0.CO;2-W; Madore B, 1999, MAGNET RESON MED, V42, P813, DOI 10.1002/(SICI)1522-2594(199911)42:5<813::AID-MRM1>3.0.CO;2-S; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Setsompop K, 2012, NEUROIMAGE, V63, P569, DOI 10.1016/j.neuroimage.2012.06.033; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; WEAVER JB, 1988, MAGNET RESON MED, V8, P275, DOI 10.1002/mrm.1910080305; Yun SD, 2013, NEUROIMAGE, V73, P135, DOI 10.1016/j.neuroimage.2013.01.070	20	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116378	10.1371/journal.pone.0116378	http://dx.doi.org/10.1371/journal.pone.0116378			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549271	gold, Green Published, Green Submitted			2022-12-26	WOS:000347063500080
J	Machado, JD; Chatkin, JM; Zimmer, AR; Goulart, APS; Thiesen, FV				Machado, Julia de Barros; Chatkin, Jose Miguel; Zimmer, Aline Rigon; Goulart, Ana Paula Szezepaniak; Thiesen, Flavia Valladao			Cotinine and Polycyclic Aromatic Hydrocarbons Levels in the Amniotic Fluid and Fetal Cord at Birth and in the Urine from Pregnant Smokers	PLOS ONE			English	Article							AMBIENT AIR-POLLUTION; SELF-REPORTED SMOKING; PRENATAL EXPOSURE; TOBACCO-SMOKE; DNA-ADDUCTS; OCCUPATIONAL-EXPOSURE; DETERMINING NICOTINE; GROWTH RESTRICTION; CIGARETTE-SMOKING; MATERNAL EXPOSURE	Cigarette smoking during pregnancy has several impacts on fetal development, including teratogenic effects. The objective of this study was to assess whether the toxic substances (cotinine and polycyclic aromatic hydrocarbons) found in pregnant smokers are transmitted to their fetuses. The outcomes were analyzed measuring cotinine and 1-hydroxypyrene in the amniotic fluid and maternal urine, benzopyrene and cotinine in the umbilical cord blood. Through a controlled cross-sectional design, 125 pregnant women were selected and classified according to their smoking status: 37 current smokers, 25 passive smokers and 63 non-smokers (controls). We performed high-performance liquid chromatography to measure substances' concentrations. A post-hoc Tukey's test was used to analyze the differences between the groups. All variables were significantly different between controls and smokers. The mean ratios between the concentration of cotinine in smokers compared to controls were as follows: 5.9 [2.5-13.5], p<0.001 in the urine; 25 [11.9-52.9], p<0.001 in the amniotic fluid; and 2.6 [1.0-6.8], p=0.044 in the umbilical cord blood. The mean ratios of 1-hydroxypyrene concentration between smokers and controls were 7.3 [1.6-29.6], p=0.003 in the urine and 1.3 [1.0-1.7], p=0.012 in the amniotic fluid, and of benzopyrene in umbilical cord blood was 2.9 [1.7-4.7], p<0.001. There were no significant differences between controls and passive smokers. When comparing the three groups together, there were statistical differences between all variables. Thus, the fetuses of pregnant smokers are exposed to toxic and carcinogens substances. To our knowledge, this is the first study to measure 1-hydroxypyrene in the amniotic fluid and benzopyrene in umbilical cord blood by high-performance liquid chromatography when considering pregnant women in relation to smoking exposure only.	[Machado, Julia de Barros; Chatkin, Jose Miguel; Goulart, Ana Paula Szezepaniak] Pontificia Univ Catolica, Sch Med, Porto Alegre, RS, Brazil; [Zimmer, Aline Rigon; Thiesen, Flavia Valladao] Pontificia Univ Catolica, Sch Pharm, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Machado, JD (corresponding author), Pontificia Univ Catolica, Sch Med, Porto Alegre, RS, Brazil.	juliamachado@terra.com.br	Chatkin, Jose M/Q-3925-2016; Zimmer, Aline R/A-3330-2016; thiesen, flavia/A-3470-2017	Chatkin, Jose M/0000-0002-4343-025X; Zimmer, Aline R/0000-0002-8309-7068; thiesen, flavia/0000-0003-4907-6789				Ananth CV, 1999, OBSTET GYNECOL, V93, P622, DOI 10.1016/S0029-7844(98)00408-6; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P297; [Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P1232; Benowitz NL, 1996, EPIDEMIOL REV, V18, P188, DOI 10.1093/oxfordjournals.epirev.a017925; Binnie V, 2004, ORAL DIS, V10, P287, DOI 10.1111/j.1601-0825.2004.01018.x; Bocskay KA, 2005, CANCER EPIDEM BIOMAR, V14, P506, DOI 10.1158/1055-9965.EPI-04-0566; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; BUCHET JP, 1992, BRIT J IND MED, V49, P761; Cattaneo RAAP, 2007, BRAZILIAN J TOXICOLO, V19, P6; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P54; Choi H, 2008, ENVIRON HEALTH PERSP, V116, P658, DOI 10.1289/ehp.10958; Dejmek J, 2000, ENVIRON HEALTH PERSP, V108, P1159, DOI 10.2307/3434828; Dolinoy DC, 2007, REPROD TOXICOL, V23, P297, DOI 10.1016/j.reprotox.2006.08.012; Dwyer Jennifer B., 2008, Birth Defects Research, V84, P30, DOI 10.1002/bdrc.20118; Edwards SC, 2010, ENVIRON HEALTH PERSP, V118, P1326, DOI 10.1289/ehp.0901070; Gilboa SM, 2005, AM J EPIDEMIOL, V162, P238, DOI 10.1093/aje/kwi189; HALEY NJ, 1989, AM J PUBLIC HEALTH, V79, P1046, DOI 10.2105/AJPH.79.8.1046; Harmonization ICot, 2005, VAL AN PROC TEXT MET; Hellstrom-Lindahl E, 2002, RESPIRATION, V69, P289, DOI 10.1159/000063261; Jedrychowski W, 2012, NUTRITION, V28, P372, DOI 10.1016/j.nut.2011.07.020; Jongeneelen FJ, 2001, ANN OCCUP HYG, V45, P3, DOI 10.1016/S0003-4878(00)00009-0; Jules GE, 2012, TOXICOLOGY, V295, P56, DOI 10.1016/j.tox.2012.01.017; Kim H, 2011, EUR J CLIN NUTR, V65, P1118, DOI 10.1038/ejcn.2011.77; Klebanoff MA, 1998, AM J EPIDEMIOL, V148, P259; Kohler E, 2007, HUM EXP TOXICOL, V26, P535, DOI 10.1177/0960327107072391; Kohler E, 2001, HUM EXP TOXICOL, V20, P1, DOI 10.1191/096032701669841404; Kriek E, 1998, MUTAT RES-FUND MOL M, V400, P215, DOI 10.1016/S0027-5107(98)00065-7; Langlois PH, 2013, CLEFT PALATE-CRAN J, V50, P337, DOI 10.1597/12-104; Leem JH, 2006, ENVIRON HEALTH PERSP, V114, P905, DOI 10.1289/ehp.8733; Liu SL, 2007, J EXPO SCI ENV EPID, V17, P426, DOI 10.1038/sj.jes.7500503; Llop S, 2008, SCI TOTAL ENVIRON, V407, P97, DOI 10.1016/j.scitotenv.2008.07.070; Machado JD, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-24; Mannes T, 2005, OCCUP ENVIRON MED, V62, P524, DOI 10.1136/oem.2004.014282; Maritz Gert S., 2008, Birth Defects Research, V84, P45, DOI 10.1002/bdrc.20116; Obolenskaya MY, 2010, TOXICOL LETT, V196, P80, DOI 10.1016/j.toxlet.2010.03.1115; OSTREA EM, 1994, J PEDIATR-US, V124, P471, DOI 10.1016/S0022-3476(94)70378-7; Perera F, 2005, CANCER EPIDEM BIOMAR, V14, P709, DOI 10.1158/1055-9965.EPI-04-0457; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Perera FP, 2009, PEDIATRICS, V124, pE195, DOI 10.1542/peds.2008-3506; Petersen GO, 2010, J SEP SCI, V33, P516, DOI 10.1002/jssc.200900575; Pichini S, 2000, ENVIRON HEALTH PERSP, V108, P1079, DOI 10.2307/3434962; Polanska K, 2011, INT J OCCUP MED ENV, V24, P8, DOI 10.2478/s13382-011-0003-5; Ramesh A, 2004, INT J TOXICOL, V23, P301, DOI 10.1080/10915810490517063; Ritz B, 2007, AM J EPIDEMIOL, V166, P1045, DOI 10.1093/aje/kwm181; Rogers JM, 2009, REPROD TOXICOL, V28, P152, DOI 10.1016/j.reprotox.2009.03.012; Rossner P, 2009, MUTAT RES-FUND MOL M, V669, P20, DOI 10.1016/j.mrfmmm.2009.04.010; Rundle A, 2012, AM J EPIDEMIOL, V175, P1163, DOI 10.1093/aje/kwr455; Santos S, 2008, PNEUMOLOGIA PAULISTA, V21; Sasco AJ, 1999, HUM EXP TOXICOL, V18, P192, DOI 10.1191/096032799678839905; Shi Min, 2008, Birth Defects Research, V84, P16, DOI 10.1002/bdrc.20117; Stejskalova L, 2011, CURR PHARM BIOTECHNO, V12, P715, DOI 10.2174/138920111795470994; Suzuki Y, 2010, ENVIRON INT, V36, P699, DOI 10.1016/j.envint.2010.05.003; Wang Lei, 2008, Birth Defects Research, V84, P54, DOI 10.1002/bdrc.20114; WHO, 2011, CENT EUR J PUBL HEAL, V19, P151; WHO urges more countries to require large, 2011, CENT EUR J PUBL HEAL, V19, P133; WHO (World Health Organization), 1998, SEL NONH POL AR HYDR; Whyatt RM, 1998, CARCINOGENESIS, V19, P1389, DOI 10.1093/carcin/19.8.1389; Wilhelm M, 2005, ENVIRON HEALTH PERSP, V113, P1212, DOI 10.1289/ehp.7751; World Health Organization, 2011, IMPL TOB CONTR; World Health Organization, 2013, REP GLOB TOB EP ENF; Ziaei S, 2005, PAEDIATR PERINAT EP, V19, P27, DOI 10.1111/j.1365-3016.2004.00619.x	61	11	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116293	10.1371/journal.pone.0116293	http://dx.doi.org/10.1371/journal.pone.0116293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549364	Green Published, gold, Green Submitted			2022-12-26	WOS:000347063500072
J	Tijet, N; Sheth, PM; Lastovetska, O; Chung, C; Patel, SN; Melano, RG				Tijet, Nathalie; Sheth, Prameet M.; Lastovetska, Olga; Chung, Catherine; Patel, Samir N.; Melano, Roberto G.			Molecular Characterization of Klebsiella pneumoniae Carbapenemase (KPC)-Producing Enterobacteriaceae in Ontario, Canada, 2008-2011	PLOS ONE			English	Article							BETA-LACTAMASE; SEQUENCE; PLASMIDS; OUTBREAK; DISSEMINATION; EPIDEMIOLOGY; KPC; PLANTICOLA; EXPANSION; CLOACAE	Due to the lack of detailed reports of Klebsiella pneumoniae carbapenemase (KPC)-producing enterobacteria in Ontario, Canada, we perform a molecular characterization of KPC-producing Enterobacteriaceae submitted to the provincial reference laboratory from 2008 to 2011. Susceptibility profiles were accessed by E-test. Molecular types of isolates were determined by pulse-field gel electrophoresis (PFGE) and multilocus sequence typing. Screening of beta-lactamase genes was performed by multiplex PCR and alleles were identified by DNA sequencing. The genetic platform of bla(KPC) gene was analyzed by PCR. Plasmid replicons were typed using PCR-based typing approach. KPC-plasmids were also evaluated by S1 nuclease-PFGE and Southern blot. Thirty unique clinical isolates (26 Klebsiella pneumoniae, 2 Enterobacter cloacae, 1 Citrobacter freundii and 1 Raoultella ornithinolytica) were identified as blaKPC positive: 4 in 2008, 3 in 2009, 10 in 2010 and 13 in 2011. The majority exhibited resistance to carbapenems, cephalosporins and fluoroquinolones and two isolates were also resistant to colistin. The isolates harbored bla(KPC-2) (n=23) or bla(KPC-3) (n=7). bla(TEM-1) (n=27) was commonly detected and occasionally bla(OXA-1) (n=3) and bla(CTX-M-15) (n=1). As expected, all K. pneumoniae isolates carried bla(SHV-11). blaKPC genes were identified on Tn4401a (n=20) or b (n=10) isoforms, on plasmids of different sizes belonging to the incompatibility groups IncFIIA (n=19), IncN (n=3), IncI2 (n=3), IncFrep (n=2) and IncA/C (n=1). The occurrence of KPC beta-lactamase in Ontario was mainly associated with the spread of the K. pneumoniae clone ST258.	[Tijet, Nathalie; Lastovetska, Olga; Chung, Catherine; Patel, Samir N.; Melano, Roberto G.] Publ Hlth Ontario Labs, Toronto, ON, Canada; [Sheth, Prameet M.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Patel, Samir N.; Melano, Roberto G.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Melano, Roberto G.] Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada	McMaster University; Queens University - Canada; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Melano, RG (corresponding author), Publ Hlth Ontario Labs, Toronto, ON, Canada.	roberto.melano@oahpp.ca			Public Health Ontario	Public Health Ontario	This work was supported by Public Health Ontario internal funding. The authors received no specific funding for this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade LN, 2011, ANTIMICROB AGENTS CH, V55, P3579, DOI 10.1128/AAC.01783-10; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Bennett JW, 2009, ANTIMICROB AGENTS CH, V53, P292, DOI 10.1128/AAC.00931-08; Borgia S, 2012, CLIN INFECT DIS, V55, pE109, DOI 10.1093/cid/cis737; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2013, INT J MED MICROBIOL, V303, P298, DOI 10.1016/j.ijmm.2013.02.001; Castanheira M, 2009, J CLIN MICROBIOL, V47, P4129, DOI 10.1128/JCM.01502-09; Chan WW, 2013, DIAGN MICR INFEC DIS, V75, P317, DOI 10.1016/j.diagmicrobio.2012.12.003; Chen L, 2013, ANTIMICROB AGENTS CH, V57, P5019, DOI 10.1128/AAC.01397-13; Clinical and Laboratory Standards Institute, 2014, M100S24 CLSI; Cuzon G, 2010, EMERG INFECT DIS, V16, P1349, DOI 10.3201/eid1609.091389; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Deleo FR, 2014, P NATL ACAD SCI USA, V111, P4988, DOI 10.1073/pnas.1321364111; Denisuik AJ, 2013, J ANTIMICROB CHEMOTH, V68, pi57, DOI 10.1093/jac/dkt027; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Drancourt M, 2001, INT J SYST EVOL MICR, V51, P925, DOI 10.1099/00207713-51-3-925; Goldfarb D, 2009, J CLIN MICROBIOL, V47, P1920, DOI 10.1128/JCM.00098-09; Gomez SA, 2011, CLIN MICROBIOL INFEC, V17, P1520, DOI 10.1111/j.1469-0691.2011.03600.x; Haraoui LP, 2013, J CLIN MICROBIOL, V51, P2406, DOI 10.1128/JCM.02480-12; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; Kitchel B, 2009, ANTIMICROB AGENTS CH, V53, P3365, DOI 10.1128/AAC.00126-09; Leung V, 2012, CAN J INFECT DIS MED, V23, P117, DOI 10.1155/2012/725151; Mataseje LF, 2012, J ANTIMICROB CHEMOTH, V67, P1359, DOI 10.1093/jac/dks046; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Naas T, 2008, ANTIMICROB AGENTS CH, V52, P1257, DOI 10.1128/AAC.01451-07; Nordberg V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076597; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Osborn AM, 2000, MICROBIOL-UK, V146, P2267, DOI 10.1099/00221287-146-9-2267; Osterblad M, 2012, J ANTIMICROB CHEMOTH, V67, P2860, DOI 10.1093/jac/dks299; Oteo J, 2013, ANTIMICROB AGENTS CH, V57, P6344, DOI 10.1128/AAC.01513-13; Peirano G, 2014, J CLIN MICROBIOL, V52, P1575, DOI 10.1128/JCM.00162-14; Pillai DR, 2009, EMERG INFECT DIS, V15, P827, DOI 10.3201/eid1505.081536; Robledo IE, 2010, ANTIMICROB AGENTS CH, V54, P1354, DOI 10.1128/AAC.00899-09; Sanchez-Romero I, 2012, ANTIMICROB AGENTS CH, V56, P420, DOI 10.1128/AAC.05036-11; Tanne JH, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1646; Tijet N, 2011, EMERG INFECT DIS, V17, P306, DOI 10.3201/eid1702.101561; Tijet N, 2011, ANTIMICROB AGENTS CH, V55, P904, DOI 10.1128/AAC.00962-10; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Walckenaer E, 2004, ANTIMICROB AGENTS CH, V48, P305, DOI 10.1128/AAC.48.1.305-312.2004; Walsh TR, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/S0924-8579(10)70004-2; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001	42	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116421	10.1371/journal.pone.0116421	http://dx.doi.org/10.1371/journal.pone.0116421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549365	Green Submitted, Green Published, gold			2022-12-26	WOS:000347063500082
J	Wilson, ACC; Delgado, RN; Vorburger, C				Wilson, Alex C. C.; Delgado, Ryan N.; Vorburger, Christoph			Biased Transmission of Sex Chromosomes in the Aphid Myzus persicae Is Not Associated with Reproductive Mode	PLOS ONE			English	Article							PEACH-POTATO APHID; X-CHROMOSOME; SULZER HEMIPTERA; RECOMBINATION; SITOBION	Commonly, a single aphid species exhibits a wide range of reproductive strategies including cyclical parthenogenesis and obligate parthenogenesis. Sex determination in aphids is chromosomal; females have two X chromosomes, while males have one. X chromosome elimination at male production is generally random, resulting in equal representation of both X chromosomes in sons. However, two studies have demonstrated deviations from randomness in some lineages. One hypothesis to account for such deviations is that recessive deleterious mutations accumulate during bouts of asexual reproduction and affect male viability, resulting in overrepresentation of males with the least deleterious of the two maternal X chromosomes. This hypothesis results in a testable prediction: X chromosome transmission bias will increase with time spent in the asexual phase and should therefore be most extreme in the least sexual aphid life cycle class. Here we test this prediction in Myzus persicae. We used multiple heterozygous X-linked microsatellite markers to screen 1085 males from 95 lines of known life cycle. We found significant deviations from equal representation of X chromosomes in 15 lines; however, these lines included representatives of all life cycles. Our results are inconsistent with the hypothesis that deviations from randomness are attributable to mutation accumulation.	[Wilson, Alex C. C.; Delgado, Ryan N.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Vorburger, Christoph] ETH, Inst Integrat Biol, Zurich, Switzerland; [Vorburger, Christoph] Swiss Fed Inst Aquat Sci & Technol, Eawag, Dubendorf, Switzerland	University of Arizona; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Wilson, ACC (corresponding author), Univ Miami, Dept Biol, Coral Gables, FL 33124 USA.	acwilson@bio.miami.edu	Vorburger, Christoph/A-1650-2008	Vorburger, Christoph/0000-0002-3627-0841	National Institutes of Health Training Grant [1 K12 Gm00708]; Swiss National Science Foundation; Faculty of Science, Technology and Engineering, La Trobe University [104084]; National Science Foundation [0313737, 1121847]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Faculty of Science, Technology and Engineering, La Trobe University; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Training Grant #1 K12 Gm00708 to the Center for Insect Science, University of Arizona, Swiss National Science Foundation Fellowship to Christoph Vorburger, Small Grant (104084) from the Faculty of Science, Technology and Engineering, La Trobe University to Paul Sunnucks, National Science Foundation 0313737 funds to Nancy Moran, and National Science Foundation Award 1121847 to Alex Wilson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], APHIDS THEIR BIOL NA; Blackman RL, 1996, CHROMOSOME RES, V4, P314, DOI 10.1007/BF02263684; Blackman RL, 2000, HEREDITY, V84, P254, DOI 10.1046/j.1365-2540.2000.00667.x; Frantz A, 2005, GENET RES, V85, P111, DOI 10.1017/S0016672305007482; Frantz A, 2010, B ENTOMOL RES, V100, P59, DOI 10.1017/S0007485309006750; Hales DF, 2002, GENET RES, V79, P203, DOI 10.1017/S0016672302005657; Hales DF, 2002, GENET RES, V79, P119, DOI 10.1017/S001667230100550X; Jaenike J, 2001, ANNU REV ECOL SYST, V32, P25, DOI 10.1146/annurev.ecolsys.32.081501.113958; Jaquiery J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003690; Jiggins FM, 1999, AM NAT, V154, P481, DOI 10.1086/303251; Mandrioli M, 1999, CHROMOSOME RES, V7, P157, DOI 10.1023/A:1009215721904; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; RCore Team, 2020, R LANG ENV STAT COMP; SANDLER L, 1957, AM NAT, V91, P105, DOI 10.1086/281969; Sloane MA, 2001, GENET RES, V77, P251, DOI 10.1017/S0016672301005018; Sokal R.R., 2012, BIOMETRY; Vorburger C, 2003, MOL ECOL, V12, P3493, DOI 10.1046/j.1365-294X.2003.01998.x; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL; Wilson ACC, 2004, MOL ECOL NOTES, V4, P104, DOI 10.1046/j.1471-8286.2004.00584.x; Wilson ACC, 2003, BIOL J LINN SOC, V79, P115, DOI 10.1046/j.1095-8312.2003.00176.x; Wilson ACC, 1997, GENET RES, V69, P233, DOI 10.1017/S0016672397002747; Wilson ACC, 2000, REPROD STRATEGY GENE; Wilson ACC, 2006, GENET RES, V87, P175, DOI 10.1017/S0016672306008202	23	2	2	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116348	10.1371/journal.pone.0116348	http://dx.doi.org/10.1371/journal.pone.0116348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548924	gold, Green Published, Green Submitted			2022-12-26	WOS:000347063500078
J	Chen, CC; Hung, TH; Lee, CY; Wang, LF; Wu, CH; Ke, CH; Chen, SF				Chen, Chien-Cheng; Hung, Tai-Ho; Lee, Chao Yu; Wang, Liang-Fei; Wu, Chun-Hu; Ke, Chia-Hua; Chen, Szu-Fu			Berberine Protects against Neuronal Damage via Suppression of Glia-Mediated Inflammation in Traumatic Brain Injury	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; COPTIDIS-RHIZOMA EXTRACT; CEREBRAL-ISCHEMIA; INTESTINAL INJURY; TYROSINE KINASE; NERVOUS-SYSTEM; NITRIC-OXIDE; IN-VITRO; MICROGLIA; MICE	Traumatic brain injury (TBI) triggers a series of neuroinflammatory processes that contribute to evolution of neuronal injury. The present study investigated the neuroprotective effects and anti-inflammatory actions of berberine, an isoquinoline alkaloid, in both in vitro and in vivo TBI models. Mice subjected to controlled cortical impact injury were injected with berberine (10 mg.kg(-1)) or vehicle 10 min after injury. In addition to behavioral studies and histology analysis, blood-brain barrier (BBB) permeability and brain water content were determined. Expression of PI3K/Akt and Erk signaling and inflammatory mediators were also analyzed. The protective effect of berberine was also investigated in cultured neurons either subjected to stretch injury or exposed to conditioned media with activated microglia. Berberine significantly attenuated functional deficits and brain damage associated with TBI up to day 28 post-injury. Berberine also reduced neuronal death, apoptosis, BBB permeability, and brain edema at day 1 post-injury. These changes coincided with a marked reduction in leukocyte infiltration, microglial activation, matrix metalloproteinase-9 activity, and expression of inflammatory mediators. Berberine had no effect on Akt or Erk 1/2 phosphorylation. In mixed glial cultures, berberine reduced TLR4/MyD88/NF-kappa B signaling. Berberine also attenuated neuronal death induced by microglial conditioned media; however, it did not directly protect cultured neurons subjected to stretch injury. Moreover, administration of berberine at 3 h post-injury also reduced TBI-induced neuronal damage, apoptosis and inflammation in vivo. Berberine reduces TBI-induced brain damage by limiting the production of inflammatory mediators by glial cells, rather than by a direct neuroprotective effect.	[Chen, Chien-Cheng; Lee, Chao Yu; Ke, Chia-Hua; Chen, Szu-Fu] Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Hung, Tai-Ho] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taipei 10591, Taiwan; [Hung, Tai-Ho] Chang Gung Univ, Coll Med, Taipei, Taiwan; [Wang, Liang-Fei; Wu, Chun-Hu; Ke, Chia-Hua; Chen, Szu-Fu] Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan; [Wang, Liang-Fei; Wu, Chun-Hu; Ke, Chia-Hua; Chen, Szu-Fu] Natl Def Med Ctr, Dept Biophys, Taipei, Taiwan; [Wang, Liang-Fei; Wu, Chun-Hu] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan	Cheng Hsin General Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center	Chen, SF (corresponding author), Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.	szufuchen@yahoo.com.tw	Hung, Tai-Ho/ABD-1800-2020; Hung, Tai-Ho/C-7584-2011; WU, CHUN-HU/P-3958-2018	Hung, Tai-Ho/0000-0003-2354-7060; WU, CHUN-HU/0000-0001-6851-7936	National Science Council of Taiwan, R.O.C. (NSC) [101-2314-B-350-001-MY3]; Cheng Hsin General Hospital	National Science Council of Taiwan, R.O.C. (NSC)(Ministry of Science and Technology, Taiwan); Cheng Hsin General Hospital	This work was supported by 1. SFC: Grants from the National Science Council of Taiwan, R.O.C. (NSC 101-2314-B-350-001-MY3); 2. SFC and CCC: Cheng Hsin General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; Carson MJ, 1998, GLIA, V22, P72, DOI 10.1002/(SICI)1098-1136(199801)22:1<72::AID-GLIA7>3.0.CO;2-A; Chai YS, 2013, EUR J PHARMACOL, V708, P44, DOI 10.1016/j.ejphar.2013.02.041; Chang CF, 2011, AM J PATHOL, V178, P1749, DOI 10.1016/j.ajpath.2010.12.023; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045763; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Downes CE, 2010, BRIT J PHARMACOL, V160, P1872, DOI 10.1111/j.1476-5381.2010.00864.x; Durairajan SSK, 2012, NEUROBIOL AGING, V33, P2903, DOI 10.1016/j.neurobiolaging.2012.02.016; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; Haase G, 2008, CURR OPIN NEUROBIOL, V18, P284, DOI 10.1016/j.conb.2008.07.013; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hu J, 2012, EUR J PHARMACOL, V674, P132, DOI 10.1016/j.ejphar.2011.11.014; Jara JH, 2007, J NEUROCHEM, V100, P1407, DOI 10.1111/j.1471-4159.2006.04330.x; Jia LY, 2012, J PHARM PHARMACOL, V64, P1510, DOI 10.1111/j.2042-7158.2012.01529.x; Jiang-Shieh YF, 2005, J NEUROSCI RES, V82, P515, DOI 10.1002/jnr.20663; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kong LY, 1996, BRAIN RES, V729, P102, DOI 10.1016/0006-8993(96)00417-9; Koshinaga M, 2007, HISTOL HISTOPATHOL, V22, P129, DOI 10.14670/HH-22.129; Kulkarni SK, 2010, PHYTOTHER RES, V24, P317, DOI 10.1002/ptr.2968; Li HM, 2011, ACTA PHARMACOL SIN, V32, P1364, DOI 10.1038/aps.2011.102; Liao YJ, 2013, NEW ENGL J MED, V368, P2014, DOI 10.1056/NEJMicm1205007; Lu DY, 2010, J CELL BIOCHEM, V110, P697, DOI 10.1002/jcb.22580; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Ma YY, 2004, NAT IMMUNOL, V5, P380, DOI 10.1038/ni1054; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Nag S, 2009, ACTA NEUROPATHOL, V118, P197, DOI 10.1007/s00401-009-0541-0; Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Singhal A, 2002, J NEUROTRAUM, V19, P929, DOI 10.1089/089771502320317087; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Song B, 2012, CELL IMMUNOL, V276, P91, DOI 10.1016/j.cellimm.2012.04.006; Tan XS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077969; Truettner JS, 2007, J NEUROTRAUM, V24, P599, DOI 10.1089/neu.2006.0186; Wang XL, 2005, AM J CHINESE MED, V33, P935, DOI 10.1142/S0192415X05003557; Wang XL, 2005, LIFE SCI, V77, P3058, DOI 10.1016/j.lfs.2005.02.033; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Wang YQ, 2009, CARDIOVASC RES, V82, P484, DOI 10.1093/cvr/cvp078; Zhang QA, 2011, FOOD CHEM TOXICOL, V49, P61, DOI 10.1016/j.fct.2010.09.032; Zhang XL, 2012, BRAIN RES, V1459, P61, DOI 10.1016/j.brainres.2012.03.065; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008; Zhou XQ, 2008, NEUROSCI LETT, V447, P31, DOI 10.1016/j.neulet.2008.09.064; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	54	42	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115694	10.1371/journal.pone.0115694	http://dx.doi.org/10.1371/journal.pone.0115694			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546475	Green Submitted, Green Published, gold			2022-12-26	WOS:000347120200055
J	Geng, RX; Chen, ZY; Zhao, XY; Qiu, LX; Liu, X; Liu, RJ; Guo, WJ; He, G; Li, J; Zhu, XD				Geng, Ruixuan; Chen, Zhiyu; Zhao, Xiaoying; Qiu, Lixin; Liu, Xin; Liu, Rujiao; Guo, Weijian; He, Guang; Li, Jin; Zhu, Xiaodong			Oxidative Stress-Related Genetic Polymorphisms Are Associated with the Prognosis of Metastatic Gastric Cancer Patients Treated with Epirubicin, Oxaliplatin and 5-Fluorouracil Combination Chemotherapy	PLOS ONE			English	Article							DISEASE-FREE SURVIVAL; BREAST-CANCER; NITRIC-OXIDE; PARAOXONASE; SUSCEPTIBILITY; TOXICITY; RISK; NQO1	Background: Oxidative stress genes are related to cancer development and treatment response. In this study, we aimed to determine the predictive and prognostic roles of oxidative stress-related genetic polymorphisms in metastatic gastric cancer (MGC) patients treated with chemotherapy. Methods: In this retrospective study, we genotyped nine oxidative stress-related single nucleotide polymorphisms (SNPs) in NQO1, SOD2, SOD3, PON1, GSTP1, GSTT1, and NOS3 (rs1800566, rs10517, rs4880, rs1799895, rs662, rs854560, rs1695, rs2266637, rs1799983, respectively) in 108 consecutive MGC patients treated with epirubicin, oxaliplatin, and 5-fluorouracil (EOF) regimen as the first-line chemotherapy and analyzed the association between the genotypes and the disease control rate (DCR), progression-free survival (PFS), and overall survival (OS). Results: We found that, in addition to a lower pathological grade (p50.017), NQO1 rs1800566 CT/TT genotype was an independent predictive factor of poor PFS (hazard ratio [HR] = 1.97, 95% confidence interval [CI] = 1.23-3.16; p = 0.005). PON1 rs662 AA/AG genotype was significantly associated with poor OS HR=1.95, 95% CI=1.07-3.54; p=0.029). No associations were detected between the nine SNPs and DCR. Conclusions: NQO1 rs1800566 is an independent predictive factor of PFS for MGC patients treated with EOF chemotherapy, and PON1 rs662 is a noteworthy prognostic factor of OS. Information on oxidative stress-related genetic variants may facilitate optimization of individualized chemotherapy in clinical practice.	[Geng, Ruixuan; Chen, Zhiyu; Zhao, Xiaoying; Qiu, Lixin; Liu, Xin; Liu, Rujiao; Guo, Weijian; Li, Jin; Zhu, Xiaodong] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China; [Geng, Ruixuan; Chen, Zhiyu; Zhao, Xiaoying; Qiu, Lixin; Liu, Xin; Liu, Rujiao; Guo, Weijian; Li, Jin; Zhu, Xiaodong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [He, Guang] Shanghai Jiao Tong Univ, BioX Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University	Li, J (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China.	fudanlijin@163.com; xddr@netease.com			Natural Science Foundation of Shanghai [13ZR1408200]	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	The project is supported by the Natural Science Foundation of Shanghai (Grant No. 13ZR1408200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Atay A E, 2014, Clin Ter, V165, pe1, DOI 10.7471/CT.2014.1663; Bag A, 2008, CANCER EPIDEM BIOMAR, V17, P3298, DOI 10.1158/1055-9965.EPI-08-0235; Barragan E, 2007, LEUKEMIA RES, V31, P947, DOI 10.1016/j.leukres.2006.10.002; Chen S, 2000, FREE RADICAL BIO MED, V29, P276, DOI 10.1016/S0891-5849(00)00308-7; Choi JY, 2009, CLIN CANCER RES, V15, P5258, DOI 10.1158/1078-0432.CCR-09-0685; Conklin Kenneth A, 2004, Integr Cancer Ther, V3, P294, DOI 10.1177/1534735404270335; Fagerholm R, 2008, NAT GENET, V40, P844, DOI 10.1038/ng.155; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Glimelius B, 1997, ANN ONCOL, V8, P163, DOI 10.1023/A:1008243606668; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; HUMBERT R, 1993, NAT GENET, V3, P73, DOI 10.1038/ng0193-73; Hwang IT, 2007, BIOCHEM BIOPH RES CO, V359, P304, DOI 10.1016/j.bbrc.2007.05.088; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Jang MJ, 2013, GENE, V512, P275, DOI 10.1016/j.gene.2012.10.032; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jungwirth U, 2011, ANTIOXID REDOX SIGN, V15, P1085, DOI 10.1089/ars.2010.3663; Krzystek-Korpacka M, 2008, CLIN BIOCHEM, V41, P804, DOI 10.1016/j.clinbiochem.2008.03.012; Lajin B, 2013, BRIT J CANCER, V109, P1325, DOI 10.1038/bjc.2013.357; Leviev I, 2001, J LIPID RES, V42, P528; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lurie G, 2008, CANCER EPIDEM BIOMAR, V17, P2070, DOI 10.1158/1055-9965.EPI-08-0145; Menzel HJ, 2004, BRIT J CANCER, V90, P1989, DOI 10.1038/sj.bjc.6601779; Ruzzo A, 2006, J CLIN ONCOL, V24, P1883, DOI 10.1200/JCO.2005.04.8322; Saadat M, 2012, CANCER EPIDEMIOL, V36, pE101, DOI 10.1016/j.canep.2011.10.015; SANDSTROM J, 1994, J BIOL CHEM, V269, P19163; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Simunek T, 2009, PHARMACOL REP, V61, P154; Tian G, 2014, CELL BIOCH BIOPHYS; Tulsyan S, 2013, MOL DIAGN THER, V17, P371, DOI 10.1007/s40291-013-0045-4; Verim L, 2013, ASIAN PAC J CANCER P, V14, P665, DOI 10.7314/APJCP.2013.14.2.665; Wagner AD, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub3; Yao S, 2010, BREAST CANCER RES TR, V124, P433, DOI 10.1007/s10549-010-0840-0	34	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116027	10.1371/journal.pone.0116027	http://dx.doi.org/10.1371/journal.pone.0116027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545243	Green Submitted, Green Published, gold			2022-12-26	WOS:000347120200091
J	Greferath, U; Vessey, KA; Jobling, AI; Mills, SA; Bui, BV; He, Z; Nag, N; Ohtsu, H; Fletcher, EL				Greferath, Ursula; Vessey, Kirstan A.; Jobling, Andrew I.; Mills, Samuel A.; Bui, Bang V.; He, Zheng; Nag, Nupur; Ohtsu, Hiroshi; Fletcher, Erica L.			The Role of Histamine in the Retina: Studies on the Hdc Knockout Mouse	PLOS ONE			English	Article							NERVOUS-SYSTEM; RAT RETINA; VERTEBRATE RETINA; MAMMALIAN RETINA; CONE RESPONSES; GANGLION-CELLS; RABBIT RETINA; MICE; MODEL; BRAIN	The role of histamine in the retina is not well understood, despite it regulating a number of functions within the brain, including sleep, feeding, energy balance, and anxiety. In this study we characterized the structure and function of the retina in mice that lacked expression of the rate limiting enzyme in the formation of histamine, histidine decarboxylase (Hdc(-/-) mouse). Using laser capture microdissection, Hdc mRNA expression was assessed in the inner and outer nuclear layers of adult C57BI6J wildtype (WT) and Hdc(-/-)-retinae. In adult WTand Hdc(-/-)-mice, retinal fundi were imaged, retinal structure was assessed using immunocytochemistry and function was probed by electroretinography. Blood flow velocity was assessed by quantifying temporal changes in the dynamic fluorescein angiography in arterioles and venules. In WT retinae, Hdc gene expression was detected in the outer nuclear layer, but not the inner nuclear layer, while the lack of Hdc expression was confirmed in the Hdc(-/-) retina. Preliminary examination of the fundus and retinal structure of the widely used Hdc(-/-) mouse strain revealed discrete lesions across the retina that corresponded to areas of photoreceptor abnormality reminiscent of the rd8 (Crb1) mutation. This was confirmed after genotyping and the strain designated Hd(crd8/rd8). In order to determine the effect of the lack of Hdc-alone on the retina, Hdc(-/-) mice free of the Crb1 mutation were bred. Retinal fundi appeared normal in these animals and there was no difference in retinal structure, macrogliosis, nor any change in microglial characteristics in Hdc(-/-) compared to wildtype retinae. In addition, retinal function and retinal blood flow dynamics showed no alterations in the Hdc(-/-) retina. Overall, these results suggest that histamine plays little role in modulating retinal structure and function.	[Greferath, Ursula; Vessey, Kirstan A.; Jobling, Andrew I.; Mills, Samuel A.; Nag, Nupur; Fletcher, Erica L.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia; [Bui, Bang V.; He, Zheng] Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3052, Australia; [Ohtsu, Hiroshi] Tohoku Univ, Sch Med, Dept Engn, Sendai, Miyagi 980, Japan	University of Melbourne; University of Melbourne; Tohoku University	Fletcher, EL (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia.	elf@unimelb.edu.au	Bui, Bang/AAD-2679-2021; Fletcher, Erica/E-6364-2012; Jobling, Andrew/C-8221-2015	Bui, Bang/0000-0001-7298-1352; Fletcher, Erica/0000-0001-9412-9523; Greferath, Ursula/0000-0003-1028-648X; Vessey, Kirstan/0000-0003-1031-1964; Nag, Nupur/0000-0002-0271-0781; Jobling, Andrew/0000-0002-7827-3135; He, Zheng/0000-0001-6496-3971	National Health and Medical Research Council (Australia) [APP1021918]; Retina Australia	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Retina Australia	Funding provided by Grant #APP1021918 from the National Health and Medical Research Council (Australia) to ELF, UG and a grant from Retina Australia to ELF, UG. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AIRAKSINEN MS, 1988, J COMP NEUROL, V273, P163, DOI 10.1002/cne.902730204; Akimov NP, 2010, INVEST OPHTH VIS SCI, V51, P3825, DOI 10.1167/iovs.09-4806; Aleman TS, 2011, INVEST OPHTH VIS SCI, V52, P6898, DOI 10.1167/iovs.11-7701; Baldan LC, 2014, NEURON, V81, P77, DOI 10.1016/j.neuron.2013.10.052; BENEDITO S, 1991, INVEST OPHTH VIS SCI, V32, P32; Casini G, 2002, NEUROSCIENCE, V115, P1309, DOI 10.1016/S0306-4522(02)00408-6; den Hollander AI, 2004, HUM MUTAT, V24, P355, DOI 10.1002/humu.20093; den Hollander AI, 2002, MECH DEVELOP, V110, P203, DOI 10.1016/S0925-4773(01)00568-8; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Dmitrieva NA, 2001, VISUAL NEUROSCI, V18, P93, DOI 10.1017/S0952523801181083; Fletcher EL, 2000, J COMP NEUROL, V420, P98; Frazao R, 2011, INVEST OPHTH VIS SCI, V52, P3083, DOI 10.1167/iovs.10-6160; Gastinger MJ, 2006, J COMP NEUROL, V495, P658, DOI 10.1002/cne.20902; Gastinger MJ, 2004, VISUAL NEUROSCI, V21, P935, DOI 10.1017/S0952523804216133; Gastinger MJ, 1999, INVEST OPHTH VIS SCI, V40, P487; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; Greferath U, 2009, NEUROSCIENCE, V158, P932, DOI 10.1016/j.neuroscience.2008.10.034; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Ho T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029892; Hui FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111330; Jobling AI, 2013, INVEST OPHTH VIS SCI, V54, P3350, DOI 10.1167/iovs.13-11831; John J, 2013, ANN NEUROL, V74, P786, DOI 10.1002/ana.23968; Kalloniatis M, 1999, PROG RETIN EYE RES, V18, P811, DOI 10.1016/S1350-9462(98)00036-6; Kaneko H, 2014, BR J PHARM; KARTEN HJ, 1983, VISION RES, V23, P1197, DOI 10.1016/0042-6989(83)90033-0; Ly A, 2011, INVEST OPHTH VIS SCI, V52, P9316, DOI 10.1167/iovs.11-7879; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Melzig J, 1998, J NEUROSCI, V18, P7160; Melzig J, 1996, J COMP PHYSIOL A, V179, P763, DOI 10.1007/BF00207355; Nixon PJ, 2001, CLIN EXP OPHTHALMOL, V29, P193, DOI 10.1046/j.1442-9071.2001.00402.x; Oh SJ, 2002, J COMP NEUROL, V446, P219, DOI 10.1002/cne.10184; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Ohtsu H, 2002, EUR J IMMUNOL, V32, P1698, DOI 10.1002/1521-4141(200206)32:6<1698::AID-IMMU1698>3.0.CO;2-7; Opie NL, 2012, INVEST OPHTH VIS SCI, V53, P7802, DOI 10.1167/iovs.12-10600; PANULA P, 1989, NEUROSCIENCE, V28, P585, DOI 10.1016/0306-4522(89)90007-9; Panula P, 2013, NAT REV NEUROSCI, V14, P472, DOI 10.1038/nrn3526; Parmentier R, 2002, J NEUROSCI, V22, P7695; Plithussery T, 2007, NEUROSCIENCE, V146, P403, DOI 10.1016/j.neuroscience.2007.01.055; Schmetterer L, 1997, CEPHALALGIA, V17, P175, DOI 10.1046/j.1468-2982.1997.1703175.x; van de Pavert SA, 2004, J CELL SCI, V117, P4169, DOI 10.1242/jcs.01301; Vaney D.I., 1990, PROGR RETINAL RES, V9, P49, DOI [10.1016/0278-4327(90)90004-2, DOI 10.1016/0278-4327(90)90004-2]; VERSAUXBOTTERI C, 1986, J COMP NEUROL, V243, P422, DOI 10.1002/cne.902430311; Vessey KA, 2011, J COMP NEUROL, V519, P506, DOI 10.1002/cne.22530; Vessey KA, 2014, J COMP NEUROL; Vessey KA, 2012, INVEST OPHTH VIS SCI, V53, P7833, DOI 10.1167/iovs.12-10650; Vila A, 2012, J COMP NEUROL, V520, P528, DOI 10.1002/cne.22731; Weigert G, 2006, INVEST OPHTH VIS SCI, V47, P1096, DOI 10.1167/iovs.05-1174; Weymouth AE, 2008, PROG RETIN EYE RES, V27, P1, DOI 10.1016/j.preteyeres.2007.09.003; Zawinka C, 2004, INVEST OPHTH VIS SCI, V45, P2337, DOI 10.1167/iovs.03-1235	50	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116025	10.1371/journal.pone.0116025	http://dx.doi.org/10.1371/journal.pone.0116025			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545149	Green Published, gold			2022-12-26	WOS:000347120200090
J	Nie, P; Yang, GJ; Wang, XM; Duan, YH; Xu, WJ; Li, HO; Cao, T; Liu, XJ; Ji, XP; Cheng, ZP; Wang, AB				Nie, Pei; Yang, Guangjie; Wang, Ximing; Duan, Yanhua; Xu, Wenjian; Li, Haiou; Cao, Ting; Liu, Xuejun; Ji, Xiaopeng; Cheng, Zhaoping; Wang, Anbiao			Application of Prospective ECG-Gated High-Pitch 128-Slice Dual-Source CT Angiography in the Diagnosis of Congenital Extracardiac Vascular Anomalies in Infants and Children	PLOS ONE			English	Article							HEART-DISEASE; MULTIDETECTOR CT; ABNORMALITIES; MULTISLICE; ANATOMY; AORTA	Purpose: To investigate the value of prospective ECG-gated high-pitch 128-slice dual-source CT (DSCT) angiography in the diagnosis of congenital extracardiac vascular anomalies in infants and children in comparison with transthoracic echocardiography (TTE). Methods: Eighty consecutive infants or children clinically diagnosed of congenital heart disease and suspected with extracardiac vascular anomaly were enrolled, and 75 patients were finally included in this prospective study. All patients underwent prospective ECG-gated high-pitch DSCT angiography after TTE with an interval of 1-7 days. The diagnostic accuracy and sensitivity of high-pitch DSCT angiography and TTE were compared according to the surgical/CCA findings. The image quality of DSCT was assessed using a five-point scale. The effective radiation dose (ED) was calculated. Results: A total of 17 congenital heart diseases and 162 separate extracardiac vascular anomalies were confirmed by surgical/CCA findings in 75 patients. The diagnostic accuracy of high-pitch DSCT angiography and TTE was 99.67% and 97.89%, respectively. The sensitivity of high-pitch DSCT angiography and TTE was 97.53% and 79.62%, respectively. There was significant difference regarding to the diagnostic accuracy and the sensitivity between high-pitch DSCT angiography and TTE (chi(2) = 23.561 and 28.013, P<0.05). The agreement on the image quality scoring of DSCT between the two observers was excellent (kappa=0.81), and the mean score of image quality was 4.1 +/- 0.7. The mean ED of DSCT was 0.29 +/- 0.08 mSv. Conclusions: Prospective ECG-gated high-pitch 128-slice DSCT angiography with low radiation dose and high diagnostic accuracy has higher sensitivity compared to TTE in the detection of congenital extracardiac vascular anomalies in infants and children.	[Nie, Pei; Xu, Wenjian; Liu, Xuejun] Qingdao Univ, Dept Radiol, Affiliated Hosp, Qingdao 266071, Shandong, Peoples R China; [Yang, Guangjie] Shandong Univ, Dept Nucl Med, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Wang, Ximing; Duan, Yanhua; Li, Haiou; Cao, Ting; Ji, Xiaopeng; Cheng, Zhaoping] Shandong Med Imaging Res Inst, Shandong Prov Key Lab Diag & Treatment Cardiocere, Jinan, Shandong, Peoples R China; [Wang, Anbiao] Shandong Prov Hosp, Dept Cardiovasc Surg, Jinan, Shandong, Peoples R China	Qingdao University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences	Wang, XM (corresponding author), Shandong Med Imaging Res Inst, Shandong Prov Key Lab Diag & Treatment Cardiocere, Jinan, Shandong, Peoples R China.	Wangximing369@hotmail.com		Cheng, Zhaoping/0000-0001-7217-7284	Natural Science Foundation of Shandong Province [ZR2011HQ022]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was supported by grants from the Natural Science Foundation of Shandong Province (Liu X, ZR2011HQ022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach S, 2011, JACC-CARDIOVASC IMAG, V4, P328, DOI 10.1016/j.jcmg.2011.01.012; Ben Saad M, 2009, PEDIATR RADIOL, V39, P668, DOI 10.1007/s00247-009-1209-6; Chandrashekhar G, 2012, EUR J RADIOL, V81, P4211, DOI 10.1016/j.ejrad.2012.08.010; Cheng ZP, 2010, EUR RADIOL, V20, P2503, DOI 10.1007/s00330-010-1822-7; Chung Jonathan H, 2009, J Cardiovasc Comput Tomogr, V3, pS35, DOI 10.1016/j.jcct.2008.11.005; Flohr TG, 2009, MED PHYS, V36, P5641, DOI 10.1118/1.3259739; Goetti R, 2010, AM J ROENTGENOL, V194, P938, DOI 10.2214/AJR.09.3482; Goo HW, 2003, RADIOGRAPHICS, V23, pS147, DOI 10.1148/rg.23si035501; Goo HW, 2010, KOREAN J RADIOL, V11, P4, DOI 10.3348/kjr.2010.11.1.4; Greil GF, 2006, PEDIATR RADIOL, V36, P502, DOI 10.1007/s00247-006-0143-0; Hughes D, 2010, RADIOL CLIN N AM, V48, P817, DOI 10.1016/j.rcl.2010.04.005; Kim JE, 2010, AM J ROENTGENOL, V194, P1188, DOI 10.2214/AJR.09.3726; Kimura-Hayama ET, 2010, RADIOGRAPHICS, V30, P79, DOI 10.1148/rg.301095061; Krishnamurthy R, 2010, PEDIATR RADIOL, V40, P518, DOI 10.1007/s00247-010-1549-2; Krishnamurthy Rajesh, 2009, Pediatr Radiol, V39 Suppl 2, pS196, DOI 10.1007/s00247-009-1166-0; Lell M, 2009, EUR RADIOL, V19, P2576, DOI 10.1007/s00330-009-1558-4; Long YG, 2010, PEDIATR NEONATOL, V51, P227, DOI 10.1016/S1875-9572(10)60043-5; Maldonado JA, 2010, RADIOL CLIN N AM, V48, P85, DOI 10.1016/j.rcl.2009.09.004; Nie P, 2012, CLIN RADIOL, V67, P738, DOI 10.1016/j.crad.2011.12.007; Nie P, 2012, EUR RADIOL, V22, P2057, DOI 10.1007/s00330-012-2479-1; Oguz B, 2007, BRIT J RADIOL, V80, P376, DOI 10.1259/bjr/47124005; Pache G, 2011, EUR J RADIOL, V80, pE440, DOI 10.1016/j.ejrad.2011.01.032; Paul JF, 2011, PEDIATR RADIOL, V41, P244, DOI 10.1007/s00247-010-1804-6; Paul JF, 2010, PEDIATR RADIOL, V40, P869, DOI 10.1007/s00247-010-1614-x; Tsai IC, 2008, PEDIATR RADIOL, V38, P438, DOI 10.1007/s00247-008-0761-9; Vyas HV, 2012, RADIOGRAPHICS, V32, P87, DOI 10.1148/rg.321105764; Wolf F, 2010, EUR RADIOL, V20, P2084, DOI 10.1007/s00330-010-1792-9; Yang DH, 2008, PEDIATR RADIOL, V38, P89, DOI 10.1007/s00247-007-0662-3; Young C, 2011, EUR RADIOL, V21, P518, DOI 10.1007/s00330-010-2036-8	29	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115793	10.1371/journal.pone.0115793	http://dx.doi.org/10.1371/journal.pone.0115793			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546178	Green Published, gold, Green Submitted			2022-12-26	WOS:000347120200068
J	Tian, YP; Hepojoki, J; Ranki, H; Lankinen, H; Valkonen, JPT				Tian, Yan-Ping; Hepojoki, Jussi; Ranki, Harri; Lankinen, Hilkka; Valkonen, Jari P. T.			Analysis of Potato virus Y Coat Protein Epitopes Recognized by Three Commercial Monoclonal Antibodies	PLOS ONE			English	Article							HELPER COMPONENT-PROTEINASE; MOLECULAR CHARACTERIZATION; STRAIN DIFFERENTIATION; APHID TRANSMISSION; GENOME SEQUENCE; TERMINAL REGION; PVY; POTYVIRUS; RESISTANCE; GENES	Background: Potato virus Y (PVY, genus Potyvirus) causes substantial economic losses in solanaceous plants. Routine screening for PVY is an essential part of seed potato certification, and serological assays are often used. The commercial, commonly used monoclonal antibodies, MAb1128, MAb1129, and MAb1130, recognize the viral coat protein (CP) of PVY and distinguish PVYN strains from PVYO and PVYC strains, or detect all PVY strains, respectively. However, the minimal epitopes recognized by these antibodies have not been identified. Methodology/Principal Findings: SPOT peptide array was used to map the epitopes in CP recognized by MAb1128, MAb1129, and MAb1130. Then alanine replacement as well as N-and C-terminal deletion analysis of the identified peptide epitopes was done to determine critical amino acids for antibody recognition and the respective minimal epitopes. The epitopes of all antibodies were located within the 30 N-terminal-most residues. The minimal epitope of MAb1128 was (NLNKEK30)-N-25. Replacement of N-25 or N-27 with alanine weakened the recognition by MAb1128, and replacement of L-26, E-29, or K-30 nearly precluded recognition. The minimal epitope for MAb1129 was (16)RPEQGSIQSNP(26) and the most critical residues for recognition were I-22 and (23)Q. The epitope of MAb1130 was defined by residues (5)IDAGGS(10). Mutation of residue D-6 abrogated and mutation of (9)G strongly reduced recognition of the peptide by MAb1130. Amino acid sequence alignment demonstrated that these epitopes are relatively conserved among PVY strains. Finally, recombinant CPs were produced to demonstrate that mutations in the variable positions of the epitope regions can affect detection with the MAbs. Conclusions/Significance: The epitope data acquired can be compared with data on PVY CP-encoding sequences produced by laboratories worldwide and utilized to monitor how widely the new variants of PVY can be detected with current seed potato certification schemes or during the inspection of imported seed potatoes as conducted with these MAbs.	[Tian, Yan-Ping; Valkonen, Jari P. T.] Univ Helsinki, Dept Agr Sci, Plant Pathol Lab, Helsinki, Finland; [Hepojoki, Jussi; Ranki, Harri; Lankinen, Hilkka] Univ Helsinki, Haartman Inst, Infect Biol Res Program, Dept Virol,Peptide & Prot Lab, Helsinki, Finland	University of Helsinki; University of Helsinki	Valkonen, JPT (corresponding author), Univ Helsinki, Dept Agr Sci, Plant Pathol Lab, Helsinki, Finland.	jari.valkonen@helsinki.fi	Hepojoki, Jussi/W-4667-2017; Tian, Yanping/F-3403-2010	Hepojoki, Jussi/0000-0001-5699-214X; Tian, Yanping/0000-0002-3452-2013; Valkonen, Jari/0000-0002-3704-9911	Academy of Finland [1253126]; Ministry of Agriculture and Forestry [2383/312]	Academy of Finland(Academy of Finland); Ministry of Agriculture and Forestry	Financial support from the Academy of Finland (grant 1253126) and the Ministry of Agriculture and Forestry (grant 2383/312) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M.J., 2012, VIRUS TAXONOMY, P1069; Adams MJ, 2006, NUCLEIC ACIDS RES, V34, pD382, DOI 10.1093/nar/gkj023; Ali MC, 2008, J PHYTOPATHOL, V156, P413, DOI 10.1111/j.1439-0434.2007.01377.x; Ali MC, 2007, VIRUS GENES, V35, P359, DOI 10.1007/s11262-007-0115-y; ANDREEVA L, 1994, ANN APPL BIOL, V125, P337, DOI 10.1111/j.1744-7348.1994.tb04974.x; Andrejeva J, 1999, J GEN VIROL, V80, P1133, DOI 10.1099/0022-1317-80-5-1133; Bakker E, 2011, THEOR APPL GENET, V123, P493, DOI 10.1007/s00122-011-1602-z; Baratova LA, 2001, J VIROL, V75, P9696, DOI 10.1128/JVI.75.20.9696-9702.2001; Barker H, 2009, AM J POTATO RES, V86, P227, DOI 10.1007/s12230-009-9076-0; Blanc S, 1997, VIROLOGY, V231, P141, DOI 10.1006/viro.1997.8521; Bolotova YV, 2009, AM J POTATO RES, V86, P265, DOI 10.1007/s12230-009-9079-x; BOONEKAMP PM, 1991, ACTA BOT NEERL, V40, P41, DOI 10.1111/j.1438-8677.1991.tb01512.x; Boonham N, 1998, J VIROL METHODS, V74, P193, DOI 10.1016/S0166-0934(98)00097-4; Candresse T, 2011, PHYTOPATHOLOGY, V101, P611, DOI 10.1094/PHYTO-10-10-0274; CANTO T, 1995, PLANT DIS, V79, P234, DOI 10.1094/PD-79-0234; Chikh-Ali M, 2013, PLANT DIS, V97, P1370, DOI 10.1094/PDIS-02-13-0161-SR; Chung BYW, 2008, P NATL ACAD SCI USA, V105, P5897, DOI 10.1073/pnas.0800468105; CLARK MF, 1977, J GEN VIROL, V34, P475, DOI 10.1099/0022-1317-34-3-475; COCKERHAM G, 1970, HEREDITY, V25, P309, DOI 10.1038/hdy.1970.35; Dhar AK, 1997, CAN J MICROBIOL, V43, P677, DOI 10.1139/m97-096; Ellis P, 1996, CAN J PLANT PATHOL, V18, P64, DOI 10.1080/07060669609500657; Faurez F, 2012, MOL PLANT PATHOL, V13, P948, DOI 10.1111/j.1364-3703.2012.00803.x; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Gebhardt C, 2006, THEOR APPL GENET, V112, P1458, DOI 10.1007/s00122-006-0248-8; Glais L, 2002, ARCH VIROL, V147, P363, DOI 10.1007/s705-002-8325-0; GOVIER DA, 1977, VIROLOGY, V78, P306, DOI 10.1016/0042-6822(77)90101-5; GUGERLI P, 1983, J GEN VIROL, V64, P2471, DOI 10.1099/0022-1317-64-11-2471; Gutierrez-Aguirre I, 2014, ANAL BIOCHEM, V447, P74, DOI 10.1016/j.ab.2013.10.032; HIDAKA M, 1992, NUCLEIC ACIDS RES, V20, P3515, DOI 10.1093/nar/20.13.3515; Huhnlein A, 2013, J PLANT DIS PROTECT, V120, P57; Jakab G, 1997, J GEN VIROL, V78, P3141, DOI 10.1099/0022-1317-78-12-3141; Jayaram C, 1998, VIRUS RES, V58, P1, DOI 10.1016/S0168-1702(98)00091-4; JONES RAC, 1990, ANN APPL BIOL, V117, P93, DOI 10.1111/j.1744-7348.1990.tb04198.x; Kaikkonen L, 1999, J CLIN MICROBIOL, V37, P3952, DOI 10.1128/JCM.37.12.3952-3956.1999; Karasev AV, 2013, ANNU REV PHYTOPATHOL, V51, P571, DOI 10.1146/annurev-phyto-082712-102332; Karasev AV, 2010, AM J POTATO RES, V87, P1, DOI 10.1007/s12230-009-9110-2; Keller H, 2005, EUR J PLANT PATHOL, V111, P391, DOI 10.1007/s10658-004-6892-4; Kirchner SM, 2014, POTATO RES IN PRESS; Mallik I, 2012, AM J POTATO RES, V89, P184, DOI 10.1007/s12230-012-9241-8; MCDONALD JG, 1993, PLANT DIS, V77, P87, DOI 10.1094/PD-77-0087; Mink GI, 1999, ARCH VIROL, V144, P1173, DOI 10.1007/s007050050577; Moury B, 2011, MOL PLANT MICROBE IN, V24, P787, DOI 10.1094/MPMI-10-10-0246; Nikolaeva OV, 2012, AM J POTATO RES, V89, P121, DOI 10.1007/s12230-012-9233-8; OHSHIMA K, 1992, J VIROL METHODS, V40, P265, DOI 10.1016/0166-0934(92)90085-R; Oruetxebarria I, 2001, VIRUS GENES, V22, P335, DOI 10.1023/A:1011174509453; Ounouna H, 2002, PLANT PATHOL, V51, P487, DOI 10.1046/j.1365-3059.2002.00734.x; PAPPU HR, 1993, P NATL ACAD SCI USA, V90, P3641, DOI 10.1073/pnas.90.8.3641; PEREIRA LG, 1994, VIROLOGY, V203, P277, DOI 10.1006/viro.1994.1485; Rajamaki M, 1998, PHYTOPATHOLOGY, V88, P311, DOI 10.1094/PHYTO.1998.88.4.311; Regenmortel MHW, 1993, PLANT VIRUS DIS, P165; Romero A, 2001, VIRUS RES, V79, P71, DOI 10.1016/S0168-1702(01)00300-8; ROSE DG, 1986, ANN APPL BIOL, V109, P317, DOI 10.1111/j.1744-7348.1986.tb05323.x; Roudet-Tavert G, 2002, J GEN VIROL, V83, P1765, DOI 10.1099/0022-1317-83-7-1765; Rupar M, 2013, J VIROL METHODS, V189, P93, DOI 10.1016/j.jviromet.2013.01.013; Schubert J, 2007, J VIROL METHODS, V140, P66, DOI 10.1016/j.jviromet.2006.10.017; Seo JK, 2010, MOL PLANT PATHOL, V11, P265, DOI 10.1111/j.1364-3703.2009.00603.x; Singh RP, 2008, ARCH VIROL, V153, P1, DOI 10.1007/s00705-007-1059-1; Soto MJ, 1994, ANN APPL BIOL, V124, P31; Sudarsono, 1993, ARCH VIROL, V132, P161; Tian YP, 2011, PHYTOPATHOLOGY, V101, P377, DOI 10.1094/PHYTO-02-10-0055; Tian YP, 2013, MOL PLANT MICROBE IN, V26, P297, DOI 10.1094/MPMI-09-12-0219-R; Valkonen Jari P. T., 2007, P619; VALKONEN JPT, 1994, PLANT BREEDING, V112, P1, DOI 10.1111/j.1439-0523.1994.tb01270.x; VANDERVLUGT RAA, 1993, ARCH VIROL, V131, P361, DOI 10.1007/BF01378638; VUENTO M, 1993, BIOCHIM BIOPHYS ACTA, V1162, P155, DOI 10.1016/0167-4838(93)90142-E	65	5	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115766	10.1371/journal.pone.0115766	http://dx.doi.org/10.1371/journal.pone.0115766			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542005	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900081
J	Wu, M; Cao, ML; He, YQ; Liu, YW; Yang, CX; Du, Y; Wang, WJ; Gao, F				Wu, Man; Cao, Manlin; He, Yiqing; Liu, Yiwen; Yang, Cuixia; Du, Yan; Wang, Wenjuan; Gao, Feng			A novel role of low molecular weight hyaluronan in breast cancer metastasis	FASEB JOURNAL			English	Article						mammary carcinoma; lymphatic invasion; biomarker; LMW-HA; prognosis	ANGIOGENIC OLIGOSACCHARIDES; HYAL1 HYALURONIDASE; PROSTATE-CANCER; CD44 CLEAVAGE; UP-REGULATION; EXPRESSION; ACID; CELLS; SERUM; FRAGMENTS	Low molecular weight hyaluronan (LMWHA), a degradation fragment of the extracellular matrix component hyaluronan (HA), has been proven to play a crucial role in cancer progression. However, no systematic clinical study of breast cancer has been performed to correlate LMW-HA levels with metastasis. In the present study, we analyzed 176 serum specimens and found for the first time that the serum LMW-HA (but not total HA) level significantly correlated with lymph node metastasis, suggesting that serum LMW-HA represents a better prognostic indicator of breast cancer progression than HA. Similarly, we found that breast cancer cell lines displaying higher invasive potential had a higher LMW-HA concentration than less-invasive cell lines. This higher LMW-HA level was accompanied by the overexpression of hyaluronan synthase (HAS2) and hyaluronidase (both HYAL1 and HYAL2). Of great importance, decreasing LMW-HA production significantly inhibited breast cancer cell migration and invasion. Overall, our results suggest that during cancer progression, cancer cells may actively remodel their microenvironment via an autocrine/paracrine-like process, resulting in elevated LMW-HA levels, which in turn may facilitate cancer progression by promoting the migration and invasion of cancer cells. Therefore, cancer-associated LMW-HA may be a more promising molecular biomarker than total HA for detecting metastasis and may have further applications inbreast cancer treatment.	[Wu, Man; He, Yiqing; Liu, Yiwen; Yang, Cuixia; Du, Yan; Wang, Wenjuan] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Mol Biol, Shanghai 20233, Peoples R China; [Cao, Manlin] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Rehabil Med, Shanghai 20233, Peoples R China; [Gao, Feng] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Mol Biol & Clin Lab, 600 Yishan Rd, Shanghai 20233, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gao, F (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Mol Biol & Clin Lab, 600 Yishan Rd, Shanghai 20233, Peoples R China.	gao3507@126.com	liu, yi/GXE-9662-2022; Wu, Man/AAH-6253-2020		National Natural Science Foundation of China [81071814, 81172027, 81272479]; Shanghai Committee of Science and Technology [10411950500, 12ZR1447400, 14YF1412200]; Program of Shanghai Leading Talents [038]; program of the Shanghai Shen-Kang Hospital Development Center [SHDC22014004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Program of Shanghai Leading Talents; program of the Shanghai Shen-Kang Hospital Development Center	This work was supported by the National Natural Science Foundation of China (81071814, 81172027, and 81272479), the Shanghai Committee of Science and Technology (10411950500, 12ZR1447400, and 14YF1412200), the Program of Shanghai Leading Talents (038), and the program of the Shanghai Shen-Kang Hospital Development Center (SHDC22014004).	Adamia Sophia, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P3, DOI 10.2174/1568006053005056; AFIFY AM, 1993, ARCH BIOCHEM BIOPHYS, V305, P434, DOI 10.1006/abbi.1993.1443; Al'Qteishat A, 2006, BRAIN, V129, P2158, DOI 10.1093/brain/awl139; Bertrand P, 1997, INT J CANCER, V73, P327, DOI 10.1002/(SICI)1097-0215(19971104)73:3<327::AID-IJC4>3.0.CO;2-1; BERTRAND P, 1992, INT J CANCER, V52, P1, DOI 10.1002/ijc.2910520102; BOYLAND E, 1957, BRIT J CANCER, V11, P578, DOI 10.1038/bjc.1957.71; DAHL IMS, 1988, CANCER-AM CANCER SOC, V62, P326, DOI 10.1002/1097-0142(19880715)62:2<326::AID-CNCR2820620217>3.0.CO;2-Y; Deed R, 1997, INT J CANCER, V71, P251, DOI 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J; DELPECH B, 1990, INT J CANCER, V46, P388, DOI 10.1002/ijc.2910460309; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; FISHER B, 1983, CANCER-AM CANCER SOC, V52, P1551, DOI 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3; Fujisaki T, 1999, CANCER RES, V59, P4427; Gao F, 2006, J BIOMED MATER RES B, V78B, P385, DOI 10.1002/jbm.b.30499; Itano N, 2004, J BIOL CHEM, V279, P18679, DOI 10.1074/jbc.M313178200; KUMAR S, 1989, INT J CANCER, V44, P445, DOI 10.1002/ijc.2910440311; Kung CI, 2012, ONCOL REP, V28, P1808, DOI 10.3892/or.2012.1993; Lokeshwar VB, 2005, CANCER RES, V65, P2243, DOI 10.1158/0008-5472.CAN-04-2805; Lokeshwar VB, 2001, J BIOL CHEM, V276, P11922, DOI 10.1074/jbc.M008432200; Lokeshwar VB, 1996, CANCER RES, V56, P651; Mahoney DJ, 2001, GLYCOBIOLOGY, V11, P1025, DOI 10.1093/glycob/11.12.1025; Matou-Nasri S, 2009, INT J ONCOL, V35, P761, DOI 10.3892/ijo_00000389; Nykopp TK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-512; PONTING J, 1992, INT J CANCER, V52, P873, DOI 10.1002/ijc.2910520607; ROONEY P, 1995, INT J CANCER, V60, P632, DOI 10.1002/ijc.2910600511; Slevin M, 2004, INT J CANCER, V109, P793, DOI 10.1002/ijc.20059; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; Slomiany MG, 2009, CANCER RES, V69, P4992, DOI 10.1158/0008-5472.CAN-09-0143; STERN M, 1992, MATRIX, V12, P397, DOI 10.1016/S0934-8832(11)80036-3; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Sugahara KN, 2006, J BIOL CHEM, V281, P5861, DOI 10.1074/jbc.M506740200; Tan JX, 2011, INT J CANCER, V128, P1303, DOI 10.1002/ijc.25460; Tempel C, 2000, BIOL REPROD, V63, P134, DOI 10.1095/biolreprod63.1.134; TENGBLAD A, 1980, BIOCHEM J, V185, P101, DOI 10.1042/bj1850101; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; Udabage L, 2003, GLYCOCONJUGATE J, V20, P461, DOI 10.1023/B:GLYC.0000038292.71098.35; Veiseh M, 2011, INTEGR BIOL-UK, V3, P304, DOI 10.1039/c0ib00096e; Voelcker V, 2008, EXP DERMATOL, V17, P100, DOI 10.1111/j.1600-0625.2007.00638.x; Weiss I, 2012, INT J MOL SCI, V13, P12925, DOI 10.3390/ijms131012925; Wu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092857; Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209	41	127	129	2	42	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1290	1298		10.1096/fj.14-259978	http://dx.doi.org/10.1096/fj.14-259978			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25550464				2022-12-26	WOS:000354115000017
J	Marcano-Velazquez, JG; Batey, RT				Marcano-Velazquez, Joan G.; Batey, Robert T.			Structure-guided Mutational Analysis of Gene Regulation by the Bacillus subtilis pbuE Adenine-responsive Riboswitch in a Cellular Context	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; PURINE RIBOSWITCH; S-ADENOSYLMETHIONINE; IN-VITRO; RNA; APTAMER; TRANSCRIPTION; KINETICS; EXPRESSION; STABILITY	Riboswitches are a broadly distributed form of RNA-based gene regulation in Bacteria and, more rarely, Archaea and Eukarya. Most often found in the 5'-leader sequence of bacterial mRNAs, they are generally composed of two functional domains: a receptor (aptamer) domain that binds an effector molecule and a regulatory domain (or expression platform) that instructs the expression machinery. One of the most studied riboswitches is the Bacillus subtilis adenine-responsive pbuE riboswitch, which regulates gene expression at the transcriptional level, up-regulating expression in response to increased intracellular effector concentrations. In this work, we analyzed sequence and structural elements that contribute to efficient ligand-dependent regulatory activity in a co-transcriptional and cellular context. Unexpectedly, we found that the P1 helix, which acts as the antitermination element of the switch in this RNA, supported ligand-dependent activation of a reporter gene over a broad spectrum of lengths from 3 to 10 bp. This same trend was also observed using a minimal in vitro single-turnover transcription assay, revealing that this behavior is intrinsic to the RNA sequence. We also found that the sequences at the distal tip of the terminator not directly involved in alternative secondary structure formation are highly important for efficient regulation. These data strongly support a model in which the switch is highly localized to the P1 helix adjacent to the ligand-binding pocket that likely presents a local kinetic block to invasion of the aptamer by the terminator.	[Marcano-Velazquez, Joan G.; Batey, Robert T.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Batey, RT (corresponding author), Univ Colorado, Dept Chem & Biochem, UCB 596, Boulder, CO 80309 USA.	robert.batey@colorado.edu	Batey, Robert/A-8265-2009	Batey, Robert/0000-0002-1384-6625	National Institutes of Health [GM073850, T32 GM065103]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073850, T32GM065103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM073850 (to R. T. B.) and Biophysics Training Grant T32 GM065103 (to J. G. M.-V.).	Artsimovitch I, 2009, METHODS, V47, P37, DOI 10.1016/j.ymeth.2008.10.006; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Blose JM, 2009, J AM CHEM SOC, V131, P8474, DOI 10.1021/ja900065e; Blouin S, 2011, NUCLEIC ACIDS RES, V39, P3373, DOI 10.1093/nar/gkq1247; Ceres P, 2013, NUCLEIC ACIDS RES, V41, P10449, DOI 10.1093/nar/gkt787; Ceres P, 2013, ACS SYNTH BIOL, V2, P463, DOI 10.1021/sb4000096; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Edwards Andrea L., 2009, V535, P135, DOI 10.1007/978-1-59745-557-2_9; Frieda KL, 2012, SCIENCE, V338, P397, DOI 10.1126/science.1225722; Garst AD, 2012, J MOL BIOL, V423, P17, DOI 10.1016/j.jmb.2012.06.038; Gilbert SD, 2007, BIOCHEMISTRY-US, V46, P13297, DOI 10.1021/bi700410g; Gilbert SD, 2006, J MOL BIOL, V359, P754, DOI 10.1016/j.jmb.2006.04.003; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Lemay JF, 2007, RNA, V13, P339, DOI 10.1261/rna.142007; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Lemay JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001278; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Mahen EM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000307; Mahen EM, 2005, MOL CELL, V19, P27, DOI 10.1016/j.molcel.2005.05.025; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; McDaniel BAM, 2003, P NATL ACAD SCI USA, V100, P3083, DOI 10.1073/pnas.0630422100; Mulhbacher J, 2007, NUCLEIC ACIDS RES, V35, P5568, DOI 10.1093/nar/gkm572; Nagel JHA, 2006, NUCLEIC ACIDS RES, V34, P3568, DOI 10.1093/nar/gkl445; Noeske J, 2007, NUCLEIC ACIDS RES, V35, P572, DOI 10.1093/nar/gkl1094; Nozinovic S, 2014, RNA BIOL, V11, P655, DOI 10.4161/rna.29439; Porter EB, 2014, BBA-GENE REGUL MECH, V1839, P919, DOI 10.1016/j.bbagrm.2014.02.014; Sambrook J., 2001, MOL CLONING LAB MANU; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Stoddard CD, 2008, RNA, V14, P675, DOI 10.1261/rna.736908; Stoddard CD, 2013, J MOL BIOL, V425, P1596, DOI 10.1016/j.jmb.2013.02.023; Strulson CA, 2014, RNA, V20, P331, DOI 10.1261/rna.042747.113; Strulson CA, 2013, BIOCHEMISTRY-US, V52, P8187, DOI 10.1021/bi400816s; Tomsic J, 2008, J BACTERIOL, V190, P823, DOI 10.1128/JB.01034-07; Trausch JJ, 2011, STRUCTURE, V19, P1413, DOI 10.1016/j.str.2011.06.019; Tyrrell J, 2013, BIOCHEMISTRY-US, V52, P8777, DOI 10.1021/bi401207q; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wickiser JK, 2005, BIOCHEMISTRY-US, V44, P13404, DOI 10.1021/bi051008u; Zakataeva NP, 2007, RES MICROBIOL, V158, P659, DOI 10.1016/j.resmic.2007.08.003; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	42	18	19	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4464	4475		10.1074/jbc.M114.613497	http://dx.doi.org/10.1074/jbc.M114.613497			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25550163	Green Published, hybrid			2022-12-26	WOS:000349458400052
J	Sridharan, V; Park, H; Ryu, H; Azuma, Y				Sridharan, Vinidhra; Park, Hyewon; Ryu, Hyunju; Azuma, Yoshiaki			SUMOylation Regulates Polo-like Kinase 1-interacting Checkpoint Helicase (PICH) during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMINE-DNA GLYCOSYLASE; TOPOISOMERASE-II; SUMO-1 MODIFICATION; CHROMOSOME SEGREGATION; MITOTIC CHROMOSOMES; UBIQUITIN; CONJUGATION; PROTEINS; BINDING; MOTIF	Mitotic SUMOylation has an essential role in faithful chromosome segregation in eukaryotes, although its molecular consequences are not yet fully understood. In Xenopus egg extract assays, we showed that poly(ADP-ribose) polymerase 1 (PARP1) is modified by SUMO2/3 at mitotic centromeres and that its enzymatic activity could be regulated by SUMOylation. To determine the molecular consequence of mitotic SUMOylation, we analyzed SUMOylated PARP1-specific binding proteins. We identified Polo-like kinase 1-interacting checkpoint helicase (PICH) as an interaction partner of SUMOylated PARP1 in Xenopus egg extract. Interestingly, PICH also bound to SUMOylated topoisomerase II alpha (TopoII alpha), a major centromeric small ubiquitin-like modifier (SUMO) substrate. Purified recombinant human PICH interacted with SUMOylated substrates, indicating that PICH directly interacts with SUMO, and this interaction is conserved among species. Further analysis of mitotic chromosomes revealed that PICH localized to the centromere independent of mitotic SUMOylation. Additionally, we found that PICH is modified by SUMO2/3 on mitotic chromosomes and in vitro. PICH SUMOylation is highly dependent on protein inhibitor of activated STAT, PIASy, consistent with other mitotic chromosomal SUMO substrates. Finally, the SUMOylation of PICH significantly reduced its DNA binding capability, indicating that SUMOylation might regulate its DNA-dependent ATPase activity. Collectively, our findings suggest a novel SUMO-mediated regulation of the function of PICH at mitotic centromeres.	[Sridharan, Vinidhra; Park, Hyewon; Ryu, Hyunju; Azuma, Yoshiaki] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Azuma, Y (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave,Haworth Hall Rm 3037, Lawrence, KS 66045 USA.	azumay@ku.edu			National Institutes of Health through the NIGMS [GM80278]; University of Kansas; University of Kansas [2301743]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080278] Funding Source: NIH RePORTER	National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Kansas; University of Kansas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM80278 through the NIGMS (to Y. A.) and is currently supported by bridge funding from the University of Kansas and in part by a general research fund (Grant 2301743) from the University of Kansas.	Agostinho M, 2008, CANCER RES, V68, P2409, DOI 10.1158/0008-5472.CAN-07-2092; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Azuma Y, 2005, EMBO J, V24, P2172, DOI 10.1038/sj.emboj.7600700; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Biebricher A, 2013, MOL CELL, V51, P691, DOI 10.1016/j.molcel.2013.07.016; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Cubenas-Potts C, 2013, MOL BIOL CELL, V24, P3483, DOI 10.1091/mbc.E13-05-0230; Dasso M, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-5; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; Kaulich M, 2012, CHROMOSOMA, V121, P395, DOI 10.1007/s00412-012-0370-0; Ke YW, 2011, EMBO J, V30, P3309, DOI 10.1038/emboj.2011.226; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kornbluth Sally, 2006, Curr Protoc Cell Biol, VChapter 11, DOI 10.1002/0471143030.cb1111s29; Kurasawa Y, 2010, MOL BIOL CELL, V21, P1188, DOI 10.1091/mbc.E09-11-0950; Leng M, 2008, CELL CYCLE, V7, P1480, DOI 10.4161/cc.7.10.5951; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Nathan D, 2006, GENE DEV, V20, P966, DOI 10.1101/gad.1404206; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Porter ACG, 2004, CHROMOSOME RES, V12, P569, DOI 10.1023/B:CHRO.0000036608.91085.d1; Ryu H, 2010, J CELL BIOL, V191, P783, DOI 10.1083/jcb.201004033; Ryu H, 2010, J BIOL CHEM, V285, P32576, DOI 10.1074/jbc.M110.153817; Ryu H, 2010, J BIOL CHEM, V285, P14415, DOI 10.1074/jbc.M109.074583; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Steinacher R, 2005, CURR BIOL, V15, P616, DOI 10.1016/j.cub.2005.02.054; Wang LHC, 2008, CHROMOSOMA, V117, P123, DOI 10.1007/s00412-007-0131-7; Watts FZ, 2007, CHROMOSOMA, V116, P15, DOI 10.1007/s00412-006-0079-z; Ying SM, 2011, INT J HEMATOL, V93, P440, DOI 10.1007/s12185-011-0818-7	39	19	19	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3269	3276		10.1074/jbc.C114.601906	http://dx.doi.org/10.1074/jbc.C114.601906			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25564610	hybrid, Green Published			2022-12-26	WOS:000349456000007
J	Zhou, XY; Li, LZ; Xiang, JH; Gao, GF; Xu, FX; Liu, AL; Zhang, XW; Peng, Y; Chen, XB; Wan, XY				Zhou, Xiaoyun; Li, Linzhi; Xiang, Jianhua; Gao, Guofu; Xu, Faxi; Liu, Ailing; Zhang, Xianwen; Peng, Yan; Chen, Xinbo; Wan, Xiangyuan			OsGL1-3 is Involved in Cuticular Wax Biosynthesis and Tolerance to Water Deficit in Rice	PLOS ONE			English	Article							ARABIDOPSIS ECERIFERUM1; ALKANE BIOSYNTHESIS; CUTICLE MEMBRANE; GENE; DROUGHT; OVEREXPRESSION; ACCUMULATION; EXPRESSION; COENZYME; ENCODES	Cuticular wax covers aerial organs of plants and functions as the outermost barrier against non-stomatal water loss. We reported here the functional characterization of the Glossy1(GL1)-homologous gene OsGL1-3 in rice using overexpression and RNAi transgenic rice plants. OsGL1-3 gene was ubiquitously expressed at different level in rice plants except root and its expression was up-regulated under ABA and PEG treatments. The transient expression of OsGL1-3-GFP fusion protein indicated that OsGL1-3 is mainly localized in the plasma membrane. Compared to the wild type, overexpression rice plants exhibited stunted growth, more wax crystallization on leaf surface, and significantly increased total cuticular wax load due to the prominent changes of C-30-C-32 aldehydes and C-30 primary alcohols. While the RNAi knockdown mutant of OsGL1-3 exhibited no significant difference in plant height, but less wax crystallization and decreased total cuticular wax accumulation on leaf surface. All these evidences, together with the effects of OsGL1-3 on the expression of some wax synthesis related genes, suggest that OsGL1-3 is involved in cuticular wax biosynthesis. Overexpression of OsGL1-3 decreased chlorophyll leaching and water loss rate whereas increased tolerance to water deficit at both seedling and late-tillering stages, suggesting an important role of OsGL1-3 in drought tolerance.	[Zhou, Xiaoyun; Li, Linzhi; Xiang, Jianhua; Gao, Guofu; Xu, Faxi; Liu, Ailing; Zhang, Xianwen; Peng, Yan; Chen, Xinbo; Wan, Xiangyuan] Hunan Agr Univ, Key Lab Crop Germplasm Innovat & Utilizat Hunan P, Changsha, Hunan, Peoples R China; [Zhou, Xiaoyun; Li, Linzhi; Xu, Faxi; Liu, Ailing; Zhang, Xianwen; Chen, Xinbo] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China; [Wan, Xiangyuan] State Key Lab Main Crop Germplasm Innovat, Beijing, Peoples R China; [Xiang, Jianhua] Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan, Peoples R China; [Gao, Guofu] Hunan Acad Agr Sci, Res Inst Sci & Technol Informat, Changsha, Hunan, Peoples R China	Hunan Agricultural University; Hunan Agricultural University; Hunan University of Science & Technology; Hunan Academy of Agricultural Sciences	Chen, XB (corresponding author), Hunan Agr Univ, Key Lab Crop Germplasm Innovat & Utilizat Hunan P, Changsha, Hunan, Peoples R China.	xinbochen@live.cn; wanxy2005@163.com	Wan, Xiangyuan/GRJ-1567-2022; Chen, Xinbo/J-6708-2012	Chen, Xinbo/0000-0002-8758-0591; Peng, Yan/0000-0003-3374-3209	Specialized Research Fund for the Doctoral Program of Higher Education of China [20124320110012]; Open Research Fund of the State Key Laboratory of Main Crop Germplasm Innovation, Key Science and Technology Project of Hunan Province [2014WK2004]; Construct Program of the Key Discipline in Hunan Province	Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Open Research Fund of the State Key Laboratory of Main Crop Germplasm Innovation, Key Science and Technology Project of Hunan Province; Construct Program of the Key Discipline in Hunan Province	This study was supported by Specialized Research Fund for the Doctoral Program of Higher Education of China (20124320110012), Open Research Fund of the State Key Laboratory of Main Crop Germplasm Innovation, Key Science and Technology Project of Hunan Province (2014WK2004), and Construct Program of the Key Discipline in Hunan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2004, PLANT CELL, V16, P2463, DOI 10.1105/tpc.104.022897; Bach L, 2008, P NATL ACAD SCI USA, V105, P14727, DOI 10.1073/pnas.0805089105; Beaudoin F, 2009, PLANT PHYSIOL, V150, P1174, DOI 10.1104/pp.109.137497; Bernard A, 2013, PROG LIPID RES, V52, P110, DOI 10.1016/j.plipres.2012.10.002; Bernard A, 2012, PLANT CELL, V24, P3106, DOI 10.1105/tpc.112.099796; Bourdenx B, 2011, PLANT PHYSIOL, V156, P29, DOI 10.1104/pp.111.172320; Cameron KD, 2006, PLANT PHYSIOL, V140, P176, DOI 10.1104/pp.105.069724; Chen XB, 2003, PLANT CELL, V15, P1170, DOI 10.1105/tpc.010926; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Greer S, 2007, PLANT PHYSIOL, V145, P653, DOI 10.1104/pp.107.107300; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; Haslam TM, 2012, PLANT PHYSIOL, V160, P1164, DOI 10.1104/pp.112.201640; Hooker TS, 2002, PLANT PHYSIOL, V129, P1568, DOI 10.1104/pp.003707; Islam MA, 2009, PLANT MOL BIOL, V70, P443, DOI 10.1007/s11103-009-9483-0; JENKS MA, 1995, PLANT PHYSIOL, V108, P369, DOI 10.1104/pp.108.1.369; Jung KH, 2006, PLANT CELL, V18, P3015, DOI 10.1105/tpc.106.042044; Kim J, 2013, PLANT PHYSIOL, V162, P567, DOI 10.1104/pp.112.210450; Kosma DK, 2009, PLANT PHYSIOL, V151, P1918, DOI 10.1104/pp.109.141911; Kunst L, 2009, CURR OPIN PLANT BIOL, V12, P721, DOI 10.1016/j.pbi.2009.09.009; Kurata T, 2003, PLANT J, V36, P55, DOI 10.1046/j.1365-313X.2003.01854.x; Lu SY, 2009, PLANT J, V59, P553, DOI 10.1111/j.1365-313X.2009.03892.x; Mao BG, 2012, PLANTA, V235, P39, DOI 10.1007/s00425-011-1481-1; PostBeittenmiller D, 1996, ANNU REV PLANT PHYS, V47, P405, DOI 10.1146/annurev.arplant.47.1.405; Qin BX, 2011, MOL PLANT, V4, P985, DOI 10.1093/mp/ssr028; Rowland O, 2007, FEBS LETT, V581, P3538, DOI 10.1016/j.febslet.2007.06.065; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Seo PJ, 2011, PLANT CELL, V23, P1138, DOI 10.1105/tpc.111.083485; Sturaro M, 2005, PLANT PHYSIOL, V138, P478, DOI 10.1104/pp.104.058164; Xu DQ, 2008, FEBS LETT, V582, P1037, DOI 10.1016/j.febslet.2008.02.052; Yeats TH, 2013, PLANT PHYSIOL, V163, P5, DOI 10.1104/pp.113.222737; Zheng HQ, 2005, PLANT CELL, V17, P1467, DOI 10.1105/tpc.104.030155; Zhou L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057382, 10.1371/journal.pone.0073724]; Zhou XY, 2014, PLANT MOL BIOL REP, V32, P719, DOI 10.1007/s11105-013-0687-8; Zhu XY, 2013, P NATL ACAD SCI USA, V110, P17790, DOI 10.1073/pnas.1316412110; Zou J, 2009, J PLANT PHYSIOL, V166, P851, DOI 10.1016/j.jplph.2008.11.007	36	18	20	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2015	10	1							e116676	10.1371/journal.pone.0116676	http://dx.doi.org/10.1371/journal.pone.0116676			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3XP	25555239	Green Published, gold, Green Submitted			2022-12-26	WOS:000348157400004
J	Iskandar, DT; Evans, BJ; McGuire, JA				Iskandar, Djoko T.; Evans, Ben J.; McGuire, Jimmy A.			A Novel Reproductive Mode in Frogs: A New Species of Fanged Frog with Internal Fertilization and Birth of Tadpoles	PLOS ONE			English	Article							ELEUTHERODACTYLUS-COQUI; EVOLUTION; LEPTODACTYLIDAE; SYSTEMATICS; AMPHIBIA; SULAWESI; BIOLOGY; ANURA	We describe a new species of fanged frog (Limnonectes larvaepartus) that is unique among anurans in having both internal fertilization and birth of tadpoles. The new species is endemic to Sulawesi Island, Indonesia. This is the fourth valid species of Limnonectes described from Sulawesi despite that the radiation includes at least 15 species and possibly many more. Fewer than a dozen of the 6455 species of frogs in the world are known to have internal fertilization, and of these, all but the new species either deposit fertilized eggs or give birth to froglets.	[Iskandar, Djoko T.] Inst Teknol Bandung, Sch Life Sci & Technol, Bandung, Indonesia; [Evans, Ben J.] McMaster Univ, Dept Biol, Ctr Environm Genom, Hamilton, ON, Canada; [McGuire, Jimmy A.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [McGuire, Jimmy A.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	Institute Technology of Bandung; McMaster University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	McGuire, JA (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	mcguirej@berkeley.edu	McGuire, Jimmy/N-7357-2019; Iskasndar, Djoko/AAD-2204-2021	Iskasndar, Djoko/0000-0002-8923-6081; Evans, Ben/0000-0002-9512-8845	United States National Science Foundation Division of Environmental Biology [DEB 0328700, DEB 0640967]; Natural Science and Engineering Research Council of Canada [RGPIN/283102-2012]; Indonesian Directorate General of Higher Education, Ministry of Education and Culture (Basic Science Grant) [60/P4M/DPPM/L-3311/MS/1993]	United States National Science Foundation Division of Environmental Biology; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Indonesian Directorate General of Higher Education, Ministry of Education and Culture (Basic Science Grant)	This research was funded by the United States National Science Foundation Division of Environmental Biology (DEB 0328700, DEB 0640967) to JAM, the Natural Science and Engineering Research Council of Canada (RGPIN/283102-2012) to BJE, and the Indonesian Directorate General of Higher Education, Ministry of Education and Culture (Basic Science Grant No. 60/P4M/DPPM/L-3311/MS/1993) to DTI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown RM, 2000, J HERPETOL, V34, P404, DOI 10.2307/1565364; Buckley CR, 2005, FUNCT ECOL, V19, P67, DOI 10.1111/j.0269-8463.2005.00931.x; Duellman W. E., 1986, BIOL AMPHIBIANS; Emerson SB, 2000, MOL PHYLOGENET EVOL, V16, P131, DOI 10.1006/mpev.2000.0778; Evans BJ, 2003, SYST BIOL, V52, P794, DOI 10.1080/10635150390251063; Gosner K. L., 1960, Herpetologica, V16, P183; Guayasamin JM, 2006, ZOOL J LINN SOC-LOND, V147, P489, DOI 10.1111/j.1096-3642.2006.00223.x; Haddad CFB, 2005, BIOSCIENCE, V55, P207, DOI 10.1641/0006-3568(2005)055[0207:RMIFAT]2.0.CO;2; Inger RF, 2001, J BIOGEOGR, V28, P863, DOI 10.1046/j.1365-2699.2001.00580.x; Iskandar Djoko T., 1996, P39; Kusrini MD, 2014, PLOS ONE IN PRESS, V10; LUTZ B, 1948, EVOLUTION, V2, P29, DOI 10.2307/2405613; Lynn W. Gardner, 1942, CARNEGIE INST WASHINGTON PUBL, V541, P27; McDiarmid R. W., 1999, TADPOLES BIOL ANURAN; McGuire JA, 2007, HERPETOL MONOGR, V21, P179, DOI 10.1655/07-012.1; Merker S, 2010, INT J PRIMATOL, V31, P1107, DOI 10.1007/s10764-010-9452-0; Setiadi MI, 2011, AM NAT, V178, P221, DOI 10.1086/660830; Tlibaudeau G, 1999, TADPOLES, P170; TOWNSEND DS, 1985, COPEIA, P423, DOI 10.2307/1444854; WAKE MH, 1980, COPEIA, P193; WAKE MH, 1978, J HERPETOL, V12, P121, DOI 10.2307/1563398; Wake MH, 2003, ANIM BIOL, V53, P209, DOI 10.1163/157075603322539426; Warkentin KM, 2011, INTEGR COMP BIOL, V51, P111, DOI 10.1093/icb/icr046; Wells KD., 2008, ECOLOGY BEHAV AMPHIB	24	36	36	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115884	10.1371/journal.pone.0115884	http://dx.doi.org/10.1371/journal.pone.0115884			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551466	gold, Green Published			2022-12-26	WOS:000347119100072
J	Mohamed, MF; Hammac, GK; Guptill, L; Seleem, MN				Mohamed, Mohamed F.; Hammac, G. Kenitra; Guptill, Lynn; Seleem, Mohamed N.			Antibacterial Activity of Novel Cationic Peptides against Clinical Isolates of Multi-Drug Resistant Staphylococcus pseudintermedius from Infected Dogs	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDES; ANTIMICROBIAL PEPTIDES; PSEUDOMONAS-AERUGINOSA; BACTERIA; AUREUS; MEMBRANE; MECHANISMS; SEQUENCE; DESIGN	Staphylococcus pseudintermedius is a major cause of skin and soft tissue infections in companion animals and has zoonotic potential. Additionally, methicillin-resistant S. pseudintermedius (MRSP) has emerged with resistance to virtually all classes of antimicrobials. Thus, novel treatment options with new modes of action are required. Here, we investigated the antimicrobial activity of six synthetic short peptides against clinical isolates of methicillin-susceptible and MRSP isolated from infected dogs. All six peptides demonstrated potent antistaphylococcal activity regardless of existing resistance phenotype. The most effective peptides were RRIKA (with modified C terminus to increase amphipathicity and hydrophobicity) and WR-12 (a-helical peptide consisting exclusively of arginine and tryptophan) with minimum inhibitory concentration(50) (MIC50) of 1 mu M and MIC90 of 2 mu M. RR (short anti-inflammatory peptide) and IK8 "D isoform" demonstrated good antimicrobial activity with MIC50 of 4 mu M and MIC90 of 8 mu M. Penetratin and (KFF) 3K (two cell penetrating peptides) were the least effective with MIC50 of 8 mu M and MIC90 of 16 mu M. Killing kinetics revealed a major advantage of peptides over conventional antibiotics, demonstrating potent bactericidal activity within minutes. Studies with propidium iodide and transmission electron microscopy revealed that peptides damaged the bacterial membrane leading to leakage of cytoplasmic contents and consequently, cell death. A potent synergistic increase in the antibacterial effect of the cell penetrating peptide (KFF) 3K was noticed when combined with other peptides and with antibiotics. In addition, all peptides displayed synergistic interactions when combined together. Furthermore, peptides demonstrated good therapeutic indices with minimal toxicity toward mammalian cells. Resistance to peptides did not evolve after 10 passages of S. pseudintermedius at sub-inhibitory concentration. However, the MICs of amikacin and ciprofloxacin increased 32 and 8 fold, respectively; under similar conditions. Taken together, these results support designing of peptide-based therapeutics for combating MRSP infections, particularly for topical application.	[Mohamed, Mohamed F.; Hammac, G. Kenitra; Seleem, Mohamed N.] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Guptill, Lynn] Purdue Univ, Dept Vet Clin Sci, Coll Vet Med, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Seleem, MN (corresponding author), Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.	mseleem@purdue.edu	Seleem, Mohamed/H-2774-2018; Guptill, Lynn/O-2881-2015	Seleem, Mohamed/0000-0003-0939-0458; Mohamed, Mohamed/0000-0003-1967-119X	Egyptian Cultural and Educational Bureau (ECEB) in Washington DC, USA	Egyptian Cultural and Educational Bureau (ECEB) in Washington DC, USA(Egyptian Cultural & Educational Bureau)	The authors received no specific funding for this work. Mohamed F. Mohamed is supported by a scholarship from the Egyptian Cultural and Educational Bureau (ECEB) in Washington DC, USA. ECEB had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZBRAVO J, 1994, BIOCHEM J, V302, P535, DOI 10.1042/bj3020535; Bahnsen JS, 2013, BBA-BIOMEMBRANES, V1828, P223, DOI 10.1016/j.bbamem.2012.10.010; Bond PJ, 2010, PROTEIN PEPTIDE LETT, V17, P1313; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chu HL, 2013, ANTIMICROB AGENTS CH, V57, P4050, DOI 10.1128/AAC.00252-13; CLSI, 2007, METH DIL ANT SUSC TE; Deslouches B, 2013, ANTIMICROB AGENTS CH, V57, P2511, DOI 10.1128/AAC.02218-12; Fazakerley J, 2010, VET DERMATOL, V21, P463, DOI 10.1111/j.1365-3164.2010.00893.x; FIDAI S, 1997, METH MOL B, V78, P187; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kuriakose J, 2013, ANGEW CHEM INT EDIT, V52, P9664, DOI 10.1002/anie.201302693; Laarhoven LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027788; Mohamed MF, 2014, DRUG DES DEV THER, V8, P1979, DOI 10.2147/DDDT.S72129; Mohamed MF, 2014, ANTIMICROB AGENTS CH, V58, P4113, DOI 10.1128/AAC.02578-14; Mohammad H, 2014, J ANTIBIOT TOKYO; Nagant C, 2012, ANTIMICROB AGENTS CH, V56, P5698, DOI 10.1128/AAC.00918-12; Ong ZY, 2014, BIOMATERIALS, V35, P1315, DOI 10.1016/j.biomaterials.2013.10.053; Papich MG, 2012, VET DERMATOL, V23, P352, DOI 10.1111/j.1365-3164.2011.01030.x; Perreten V, 2010, J ANTIMICROB CHEMOTH, V65, P1145, DOI 10.1093/jac/dkq078; PIERS KL, 1994, MOL MICROBIOL, V12, P951, DOI 10.1111/j.1365-2958.1994.tb01083.x; RUHR E, 1985, ANTIMICROB AGENTS CH, V27, P841, DOI 10.1128/AAC.27.5.841; Santoro D, 2014, VET DERMATOL, V25, P35, DOI 10.1111/vde.12091; Sasaki T, 2007, J CLIN MICROBIOL, V45, P1118, DOI 10.1128/JCM.02193-06; SHIMODA M, 1995, INFECT IMMUN, V63, P2886, DOI 10.1128/IAI.63.8.2886-2891.1995; Splith K, 2011, EUR BIOPHYS J BIOPHY, V40, P387, DOI 10.1007/s00249-011-0682-7; Stegmann R, 2010, J ANTIMICROB CHEMOTH, V65, P2047, DOI 10.1093/jac/dkq241; van Duijkeren E, 2011, J ANTIMICROB CHEMOTH, V66, P2705, DOI 10.1093/jac/dkr367; VANNUFFEL P, 1995, J CLIN MICROBIOL, V33, P2864, DOI 10.1128/JCM.33.11.2864-2867.1995; Wadhwani P, 2012, EUR BIOPHYS J BIOPHY, V41, P177, DOI 10.1007/s00249-011-0771-7; Walther B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035197; Ward B, 2009, J PEPT SCI, V15, P668, DOI 10.1002/psc.1168; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang LJ, 1999, BIOCHEMISTRY-US, V38, P8102, DOI 10.1021/bi9904104	38	34	35	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116259	10.1371/journal.pone.0116259	http://dx.doi.org/10.1371/journal.pone.0116259			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551573	gold, Green Published, Green Submitted			2022-12-26	WOS:000347119100115
J	Sharma, A; Wongkham, C; Prasongwattana, V; Boonnate, P; Thanan, R; Reungjui, S; Cha'on, U				Sharma, Amod; Wongkham, Chaisiri; Prasongwattana, Vitoon; Boonnate, Piyanard; Thanan, Raynoo; Reungjui, Sirirat; Cha'on, Ubon			Proteomic Analysis of Kidney in Rats Chronically Exposed to Monosodium Glutamate	PLOS ONE			English	Article							OXIDATIVE STRESS; DEHYDROGENASE; EXPRESSION; DECARBOXYLASE; CONTRIBUTES; TRYPTOPHAN; NEURONS; SERINE; DAMAGE; DIET	Background: Chronic monosodium glutamate (MSG) intake causes kidney dysfunction and renal oxidative stress in the animal model. To gain insight into the renal changes induced by MSG, proteomic analysis of the kidneys was performed. Methods: Six week old male Wistar rats were given drinking water with or without MSG (2 mg/g body weight, n=10 per group) for 9 months. Kidneys were removed, frozen, and stored at -75 degrees C. After protein extraction, 2-D gel electrophoresis was performed and renal proteome profiles were examined with Colloidal Coomassie Brilliant Blue staining. Statistically significant protein spots (ANOVA, p<0.05) with 1.2-fold difference were excised and analyzed by LC-MS. Proteomic data were confirmed by immunohistochemistry and Western blot analyses. Results: The differential image analysis showed 157 changed spots, of which 71 spots were higher and 86 spots were lower in the MSG-treated group compared with those in the control group. Eight statistically significant and differentially expressed proteins were identified: glutathione S-transferase class-pi, heat shock cognate 71 kDa, phosphoserine phosphatase, phosphoglycerate kinase, cytosolic glycerol-3-phosphate dehydrogenase, 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase, alpha-ketoglutarate dehydrogenase and succinyl-CoA ligase. Conclusion: The identified proteins are mainly related to oxidative stress and metabolism. They provide a valuable clue to explore the mechanism of renal handling and toxicity on chronic MSG intake.	[Sharma, Amod; Wongkham, Chaisiri; Prasongwattana, Vitoon; Boonnate, Piyanard; Thanan, Raynoo; Cha'on, Ubon] Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand; [Reungjui, Sirirat] Khon Kaen Univ, Dept Internal Med, Fac Med, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University	Cha'on, U (corresponding author), Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand.	ubocha@kku.ac.th	sharma, amod/ABT-8672-2022; Sharma, Amod/AAA-3679-2022	Sharma, Amod/0000-0002-2860-7790	Research and Technology affairs division, Khon Kaen University; Faculty of Medicine [I57137]	Research and Technology affairs division, Khon Kaen University; Faculty of Medicine	UC received the grants from the Research and Technology affairs division, Khon Kaen University, under incubation research project and the invitation research fund from the Faculty of Medicine (I57137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYLIS LL, 1991, PHYSIOL BEHAV, V49, P973, DOI 10.1016/0031-9384(91)90210-F; Bunik VI, 2009, BIOCHEM J, V422, P405, DOI 10.1042/BJ20090722; Colussi C, 2000, FASEB J, V14, P2266, DOI 10.1096/fj.00-0074com; Corthals GL, 2000, ELECTROPHORESIS, V21, P1104, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1104::AID-ELPS1104>3.3.CO;2-3; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; Diniz YS, 2004, FOOD CHEM TOXICOL, V42, P313, DOI 10.1016/j.fct.2003.09.006; Dixit SG, 2014, RENAL FAILURE, V36, P266, DOI 10.3109/0886022X.2013.846865; Farombi EO, 2006, HUM EXP TOXICOL, V25, P251, DOI 10.1191/0960327106ht621oa; Gill SS, 2001, TOXICOL PATHOL, V29, P208, DOI 10.1080/019262301317052486; Haugen E, 1999, BLOOD PURIFICAT, V17, P58, DOI 10.1159/000014377; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; IKEDA M, 1965, J BIOL CHEM, V240, P1395; Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3; Merrick B. Alex, 2009, V99, P367; Mracek T, 2013, BBA-BIOENERGETICS, V1827, P401, DOI 10.1016/j.bbabio.2012.11.014; NEUHAUS FC, 1958, BIOCHIM BIOPHYS ACTA, V28, P223, DOI 10.1016/0006-3002(58)90464-5; Ortiz GG, 2006, BIOMED PHARMACOTHER, V60, P86, DOI 10.1016/j.biopha.2005.07.012; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Paul MVS, 2012, TOXICOL MECH METHOD, V22, P625, DOI 10.3109/15376516.2012.714008; Pucci L, 2007, FEBS J, V274, P827, DOI 10.1111/j.1742-4658.2007.05635.x; Schroer KT, 2011, J ALLERGY CLIN IMMUN, V128, P539, DOI 10.1016/j.jaci.2011.04.018; Sharma A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075546; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Tanabe A, 2002, J NUTR, V132, P1153, DOI 10.1093/jn/132.6.1153; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; Zhang HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020862; Zundorf G, 2009, NEUROSCIENCE, V158, P610, DOI 10.1016/j.neuroscience.2008.10.015	27	22	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116233	10.1371/journal.pone.0116233	http://dx.doi.org/10.1371/journal.pone.0116233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551610	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100109
J	Sharma, GS; Kumar, T; Singh, LR				Sharma, Gurumayum Suraj; Kumar, Tarun; Singh, Laishram Rajendrakumar			N-Homocysteinylation Induces Different Structural and Functional Consequences on Acidic and Basic Proteins	PLOS ONE			English	Article							TRANSFER RNA-SYNTHETASE; PATHOLOGICAL CONSEQUENCES; POSSIBLE MECHANISM; ENDOTHELIAL-CELLS; MOLECULAR-BASIS; THIOLACTONE; PLASMA; METABOLISM; TOXICITY; FIBRILLATION	One of the proposed mechanisms of homocysteine toxicity in human is the modification of proteins by the metabolite of Hcy, homocysteine thilolactone (HTL). Incubation of proteins with HTL has earlier been shown to form covalent adducts with e-amino group of lysine residues of protein (called N-homocysteinylation). It has been believed that protein N-homocysteinylation is the pathological hallmark of cardiovascular and neurodegenerative disorders as homocysteinylation induces structural and functional alterations in proteins. In the present study, reactivity of HTL towards proteins with different physico-chemical properties and hence their structural and functional alterations were studied using different spectroscopic approaches. We found that N-homocysteinylation has opposite consequences on acidic and basic proteins suggesting that pI of the protein determines the extent of homocysteinylation, and the structural and functional consequences due to homocysteinylation. Mechanistically, pI of protein determines the extent of N-homocysteinylation and the associated structural and functional alterations. The study suggests the role of HTL primarily targeting acidic proteins in eliciting its toxicity that could yield mechanistic insights for the associated neurodegeneration.	[Sharma, Gurumayum Suraj; Kumar, Tarun; Singh, Laishram Rajendrakumar] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India	University of Delhi	Singh, LR (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India.	lairksingh@gmail.com		Sharma, Gurumayum Suraj/0000-0002-7924-2031				Arora B, 2014, J CHROMATOGR B, V944, P49, DOI 10.1016/j.jchromb.2013.11.011; BIGELOW C C, 1960, C R Trav Lab Carlsberg, V31, P305; Chwatko G, 2005, CLIN CHEM, V51, P408, DOI 10.1373/clinchem.2004.042531; Chwatko G, 2005, ANAL BIOCHEM, V337, P271, DOI 10.1016/j.ab.2004.11.035; CROOK EM, 1960, BIOCHEM J, V74, P234, DOI 10.1042/bj0740234; de Koning ABL, 2003, CLIN BIOCHEM, V36, P431, DOI 10.1016/S0009-9120(03)00062-6; Dodds L, 2008, CLIN CHEM, V54, P326, DOI 10.1373/clinchem.2007.097469; DUDMAN NPB, 1991, ARTERIOSCLER THROMB, V11, P663, DOI 10.1161/01.ATV.11.3.663; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Ferretti G, 2004, J CELL BIOCHEM, V92, P351, DOI 10.1002/jcb.20069; Gellekink Henkjan, 2005, Semin Vasc Med, V5, P98, DOI 10.1055/s-2005-872396; Glowacki R, 2004, J BIOL CHEM, V279, P10864, DOI 10.1074/jbc.M313268200; HAMAGUCHI K, 1963, J BIOCHEM-TOKYO, V54, P111; Hong L, 2007, J BIOL CHEM, V282, P34684, DOI 10.1074/jbc.M707231200; Hubmacher D, 2006, CURR TOP DEV BIOL, V75, P93, DOI 10.1016/S0070-2153(06)75004-9; Hubmacher D, 2010, J BIOL CHEM, V285, P1188, DOI 10.1074/jbc.M109.021246; JAKUBOWSKI H, 1993, FEBS LETT, V317, P237, DOI 10.1016/0014-5793(93)81283-6; Jakubowski H, 2000, J BIOL CHEM, V275, P3957, DOI 10.1074/jbc.275.6.3957; Jakubowski H, 2000, CIRC RES, V87, P45, DOI 10.1161/01.RES.87.1.45; Jakubowski H, 1997, J BIOL CHEM, V272, P1935; Jakubowski H, 2004, CELL MOL LIFE SCI, V61, P470, DOI 10.1007/s00018-003-3204-7; Jakubowski H, 2002, J BIOL CHEM, V277, P30425, DOI 10.1074/jbc.C200267200; Jakubowski H, 2003, CLIN CHEM LAB MED, V41, P1462, DOI 10.1515/CCLM.2003.224; Jakubowski H, 2002, ANAL BIOCHEM, V308, P112, DOI 10.1016/S0003-2697(02)00224-5; JAKUBOWSKI H, 1991, EMBO J, V10, P593, DOI 10.1002/j.1460-2075.1991.tb07986.x; Jakubowski H, 1999, FASEB J, V13, P2277, DOI 10.1096/fasebj.13.15.2277; Jakubowski H, 2000, J NUTR, V130, p377S, DOI 10.1093/jn/130.2.377S; Jakubowski H, 2007, CLIN CHEM LAB MED, V45, P1704, DOI 10.1515/CCLM.2007.338; Jakubowski H, 2006, J NUTR, V136, p1741S, DOI 10.1093/jn/136.6.1741S; Jalili S, 2011, PROTEIN J, V30, P299, DOI 10.1007/s10930-011-9333-1; Karima O, 2012, FEBS LETT, V586, P3914, DOI 10.1016/j.febslet.2012.09.024; Khazaei S, 2012, PROTEIN J, V31, P717, DOI 10.1007/s10930-012-9451-4; Khodadadi S, 2012, FEBS LETT, V586, P127, DOI 10.1016/j.febslet.2011.12.018; Kielty CM, 2005, ADV PROTEIN CHEM, V70, P405, DOI 10.1016/S0065-3233(04)70012-1; Mattson MP, 2003, TRENDS NEUROSCI, V26, P137, DOI 10.1016/S0166-2236(03)00032-8; MAUREL P, 1976, J MOL BIOL, V102, P253, DOI 10.1016/S0022-2836(76)80052-6; Obeid R, 2006, FEBS LETT, V580, P2994, DOI 10.1016/j.febslet.2006.04.088; Pace C N, 1986, Methods Enzymol, V131, P266; PANCHARUNITI N, 1994, AM J CLIN NUTR, V59, P940, DOI 10.1093/ajcn/59.4.940; Paoli P, 2010, J MOL BIOL, V400, P889, DOI 10.1016/j.jmb.2010.05.039; Perla-Kajan J, 2007, AMINO ACIDS, V32, P561, DOI 10.1007/s00726-006-0432-9; Perla-Kajan J, 2007, BIOCHEMISTRY-US, V46, P6225, DOI 10.1021/bi602463m; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Seshadri S, 2006, J ALZHEIMERS DIS, V9, P393; Sikora M, 2014, AMINO ACIDS, V46, P235, DOI 10.1007/s00726-013-1617-7; Sinha A, 2000, BIOCHEM J, V345, P711, DOI 10.1042/0264-6021:3450711; Sontag E, 2007, J NEUROSCI, V27, P2751, DOI 10.1523/JNEUROSCI.3316-06.2007; Spence JD, 2005, STROKE, V36, P2404, DOI 10.1161/01.STR.0000185929.38534.f3; Stroylova YY, 2012, ARCH BIOCHEM BIOPHYS, V526, P29, DOI 10.1016/j.abb.2012.06.008; Stroylova YY, 2011, BBA-PROTEINS PROTEOM, V1814, P1234, DOI 10.1016/j.bbapap.2011.05.017; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; SUGAI S, 1973, BIOCHIM BIOPHYS ACTA, V328, P35, DOI 10.1016/0005-2795(73)90327-9; Thorn DC, 2005, BIOCHEMISTRY-US, V44, P17027, DOI 10.1021/bi051352r; Topal G, 2004, FREE RADICAL BIO MED, V36, P1532, DOI 10.1016/j.freeradbiomed.2004.03.019; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Yazdanparast R, 2005, ARCH BIOCHEM BIOPHYS, V437, P178, DOI 10.1016/j.abb.2005.03.003; Yousefi R, 2012, INT J BIOL MACROMOL, V51, P291, DOI 10.1016/j.ijbiomac.2012.05.021; Zang TZ, 2009, ANAL CHEM, V81, P9065, DOI 10.1021/ac9017132; Zimny J, 2006, J BIOL CHEM, V281, P22485, DOI 10.1074/jbc.M603656200	59	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116386	10.1371/journal.pone.0116386	http://dx.doi.org/10.1371/journal.pone.0116386			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551634	gold, Green Published, Green Submitted			2022-12-26	WOS:000347119100138
J	Stathias, V; Pastori, C; Griffin, TZ; Komotar, R; Clarke, J; Zhang, M; Ayad, NG				Stathias, Vasileios; Pastori, Chiara; Griffin, Tess Z.; Komotar, Ricardo; Clarke, Jennifer; Zhang, Ming; Ayad, Nagi G.			Identifying Glioblastoma Gene Networks Based on Hypergeometric Test Analysis	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; RNA-SEQ; COEXPRESSION NETWORK; BIOLOGICAL NETWORKS; CANCER-CELLS; MICROARRAY; NORMALIZATION; INSIGHTS	Patient specific therapy is emerging as an important possibility for many cancer patients. However, to identify such therapies it is essential to determine the genomic and transcriptional alterations present in one tumor relative to control samples. This presents a challenge since use of a single sample precludes many standard statistical analysis techniques. We reasoned that one means of addressing this issue is by comparing transcriptional changes in one tumor with those observed in a large cohort of patients analyzed by The Cancer Genome Atlas (TCGA). To test this directly, we devised a bioinformatics pipeline to identify differentially expressed genes in tumors resected from patients suffering from the most common malignant adult brain tumor, glioblastoma (GBM). We performed RNA sequencing on tumors from individual GBM patients and filtered the results through the TCGA database in order to identify possible gene networks that are overrepresented in GBM samples relative to controls. Importantly, we demonstrate that hypergeometric-based analysis of gene pairs identifies gene networks that validate experimentally. These studies identify a putative workflow for uncovering differentially expressed patient specific genes and gene networks for GBM and other cancers.	[Stathias, Vasileios] Univ Miami, Miller Sch Med, Dept Human Genet & Genom, Miami, FL 33136 USA; [Stathias, Vasileios; Pastori, Chiara; Ayad, Nagi G.] Univ Miami, Miller Sch Med, Ctr Therapeut Innovat, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Griffin, Tess Z.; Zhang, Ming] Univ Georgia, Dept Epidemiol & Biostat, Athens, GA 30602 USA; [Griffin, Tess Z.; Zhang, Ming] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Komotar, Ricardo] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA; [Clarke, Jennifer] Univ Nebraska, Dept Stat, Dept Food Sci & Technol, Lincoln, NE 68588 USA	University of Miami; University of Miami; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Miami; University of Nebraska System; University of Nebraska Lincoln	Ayad, NG (corresponding author), Univ Miami, Miller Sch Med, Ctr Therapeut Innovat, Dept Psychiat & Behav Sci, Miami, FL 33136 USA.	nayad@med.miami.edu	Stathias, Vasileios/AAN-5323-2021	Clarke, Jennifer/0000-0002-2723-7249	National Institutes of Health, National Institutes of Neurological Disease and Stroke;  [1R01NS067289]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067289] Funding Source: NIH RePORTER	National Institutes of Health, National Institutes of Neurological Disease and Stroke; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	1R01NS067289. The funders (National Institutes of Health, National Institutes of Neurological Disease and Stroke)had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arzate-Mejia RG, 2011, IUBMB LIFE, V63, P881, DOI 10.1002/iub.557; Clarke J, 2013, EPIGENETICS-US, V8, P785, DOI 10.4161/epi.25440; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Erkan EP, 2013, ONCOGENE; Fanelli M, 2008, ONCOGENE, V27, P358, DOI 10.1038/sj.onc.1210642; Foltz G, 2009, ONCOGENE, V28, P2667, DOI 10.1038/onc.2009.122; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Guo Ya, 2013, PLOS ONE, V8; Haar CP, 2012, NEUROCHEM RES, V37, P1192, DOI 10.1007/s11064-011-0701-1; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hu HY, 2005, BIOINFORMATICS, V21, pI213, DOI 10.1093/bioinformatics/bti1049; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim HJ, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-39; Lei M, 2005, CURR CANCER DRUG TAR, V5, P365, DOI 10.2174/1568009054629654; Li J, 2010, PHARMACOGN PERS MED, V3, P111, DOI 10.2147/PGPM.S6852; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Pastori C, 2014, EPIGENETICS-US, V9, P611, DOI 10.4161/epi.27906; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Seyednasrollah F, 2013, BRIEF BIOINFORM; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vartanian A, 2014, NEUROONCOL; Xu X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S9-S1; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	34	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115842	10.1371/journal.pone.0115842	http://dx.doi.org/10.1371/journal.pone.0115842			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551752	Green Published, gold			2022-12-26	WOS:000347119100068
J	Xing, S; Martinon-Torres, M; de Castro, JMB; Zhang, YQ; Fan, XX; Zheng, LT; Huang, WB; Liu, W				Xing, Song; Martinon-Torres, Maria; Bermudez de Castro, Jose Maria; Zhang, Yingqi; Fan, Xiaoxiao; Zheng, Longting; Huang, Wanbo; Liu, Wu			Middle Pleistocene Hominin Teeth from Longtan Cave, Hexian, China	PLOS ONE			English	Article							GEOMETRIC MORPHOMETRIC-ANALYSIS; ENAMEL-DENTIN JUNCTION; HOMO-ERECTUS; MORPHOLOGICAL DESCRIPTION; TISSUE PROPORTIONS; FOSSIL HOMINIDS; HADAR FORMATION; REMAINS; SANGIRAN; MOLARS	Excavations at the Longtan Cave, Hexian, Anhui Province of Eastern China, have yielded several hominin fossils including crania, mandibular fragments, and teeth currently dated to 412 +/- 25 ka. While previous studies have focused on the cranial remains, there are no detailed analyses of the dental evidence. In this study, we provide metric and morphological descriptions and comparisons of ten teeth recovered from Hexian, including microcomputed tomography analyses. Our results indicate that the Hexian teeth are metrically and morphologically primitive and overlap with H. ergaster and East Asian Early and mid-Middle Pleistocene hominins in their large dimensions and occlusal complexities. However, the Hexian teeth differ from H. ergaster in features such as conspicuous vertical grooves on the labial/buccal surfaces of the central incisor and the upper premolar, the crown outline shapes of upper and lower molars and the numbers, shapes, and divergences of the roots. Despite their close geological ages, the Hexian teeth are also more primitive than Zhoukoudian specimens, and resemble Sangiran Early Pleistocene teeth. In addition, no typical Neanderthal features have been identified in the Hexian sample. Our study highlights the metrical and morphological primitive status of the Hexian sample in comparison to contemporaneous or even earlier populations of Asia. Based on this finding, we suggest that the primitive-derived gradients of the Asian hominins cannot be satisfactorily fitted along a chronological sequence, suggesting complex evolutionary scenarios with the coexistence and/or survival of different lineages in Eurasia. Hexian could represent the persistence in time of a H. erectus group that would have retained primitive features that were lost in other Asian populations such as Zhoukoudian or Panxian Dadong. Our study expands the metrical and morphological variations known for the East Asian hominins before the mid-Middle Pleistocene and warns about the possibility that the Asian hominin variability may have been taxonomically oversimplified.	[Xing, Song; Zhang, Yingqi; Liu, Wu] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Martinon-Torres, Maria; Bermudez de Castro, Jose Maria] Natl Res Ctr Human Evolut CENIEH, Burgos, Spain; [Fan, Xiaoxiao] Hexian Museum Anhui Prov, Hexian, Peoples R China; [Zheng, Longting] Anhui Museum, Hefei, Peoples R China; [Huang, Wanbo] China Three Gorges Museum, Chongqing Three Gorges Inst Paleoanthropol, Chongqing, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); Chongqing Three Gorges University	Martinon-Torres, M (corresponding author), Natl Res Ctr Human Evolut CENIEH, Burgos, Spain.	maria.martinon.torres@gmail.com	ZHANG, Yingqi/D-4350-2013	ZHANG, Yingqi/0000-0001-7783-8336; Bermudez de Castro, Jose Maria/0000-0003-1314-3273	Chinese Academy of Sciences [GJHZ201314, KZZD-EW03, XDA05130100]; National Natural Science Foundation of China [41302016, 41272034]; Direccion General de Investigacion of the Spanish Ministerio de Educacion y Ciencia [CGL2012-38434-C03-02, HF2007-0115]; Consejeria de Educacion de Junta de Castilla y Leon [CEN074A12-2]; Leakey Foundation	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Direccion General de Investigacion of the Spanish Ministerio de Educacion y Ciencia(Spanish Government); Consejeria de Educacion de Junta de Castilla y Leon; Leakey Foundation	This work has been supported by the grants from Chinese Academy of Sciences (GJHZ201314, KZZD-EW03, and XDA05130100), National Natural Science Foundation of China (41302016 and 41272034), Direccion General de Investigacion of the Spanish Ministerio de Educacion y Ciencia (CGL2012-38434-C03-02 and Accion Integrada Espana Francia HF2007-0115), Consejeria de Educacion de Junta de Castilla y Leon (CEN074A12-2), and Leakey Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton SC, 2003, YEARB PHYS ANTHROPOL, V46, P126, DOI 10.1002/ajpa.10399; Anton SC, 2002, AM J PHYS ANTHROPOL, V118, P301, DOI 10.1002/ajpa.10091; Asfaw B, 2002, NATURE, V416, P317, DOI 10.1038/416317a; Baba H, 2003, SCIENCE, V299, P1384, DOI 10.1126/science.1081676; Bailey SE, 2004, J HUM EVOL, V47, P183, DOI 10.1016/j.jhevol.2004.07.001; Bailey SE, 2011, AM J PHYS ANTHROPOL, V145, P505, DOI 10.1002/ajpa.21468; Bailey Shara E., 2002, Anatomical Record, V269, P148, DOI 10.1002/ar.10116; Bailey SE, 2010, QUATERN INT, V211, P14, DOI 10.1016/j.quaint.2009.01.008; Bettis EA, 2009, J HUM EVOL, V56, P11, DOI 10.1016/j.jhevol.2008.09.003; Brink JS, 2012, J HUM EVOL, V63, P527, DOI 10.1016/j.jhevol.2012.06.004; Carbonell E, 2005, P NATL ACAD SCI USA, V102, P5674, DOI 10.1073/pnas.0501841102; Carlsen O, 1987, DENTAL MORPHOLOGY; Chen T, 1987, ACTA ANTHR SINICA, V6, P249; [陈铁梅 CHEN Tie-mei], 2009, [人类学学报, Acta Anthropologica Sinica], V28, P285; de Castro JMB, 1999, J HUM EVOL, V37, P523, DOI 10.1006/jhev.1999.0323; DECASTRO JMB, 1988, J HUM EVOL, V17, P279; deCastro JMB, 1997, SCIENCE, V276, P1392; Dennell R, 2013, QUATERN INT, V300, P13, DOI 10.1016/j.quaint.2012.12.002; Dennell RW, 2013, QUATERN INT, V295, P223, DOI 10.1016/j.quaint.2012.02.012; Dennell RW, 2011, QUATERNARY SCI REV, V30, P1511, DOI 10.1016/j.quascirev.2009.11.027; Durband AC, 2005, ANTHROPOL SCI, V113, P147, DOI 10.1537/ase.040303; Etler DA, 1996, ANNU REV ANTHROPOL, V25, P275, DOI 10.1146/annurev.anthro.25.1.275; FRAYER DW, 1977, AM J PHYS ANTHROPOL, V46, P109, DOI 10.1002/ajpa.1330460114; Gabunia L, 2000, SCIENCE, V288, P1019, DOI 10.1126/science.288.5468.1019; Gomez-Robles A, 2007, J HUM EVOL, V53, P272, DOI 10.1016/j.jhevol.2007.02.002; Gomez-Robles A, 2008, J HUM EVOL, V55, P627, DOI 10.1016/j.jhevol.2008.03.011; Gomez-Robles A, 2012, J HUM EVOL, V63, P512, DOI 10.1016/j.jhevol.2012.06.002; Gomez-Robles A, 2011, J HUM EVOL, V61, P688, DOI 10.1016/j.jhevol.2011.09.004; Grine Frederick Edward, 1994, Courier Forschungsinstitut Senckenberg, V171, P75; Grun R, 1998, J HUM EVOL, V34, P555, DOI 10.1006/jhev.1997.0211; Grun R, 1997, J HUM EVOL, V32, P83; Hlusko LJ, 2004, J HUM EVOL, V46, P579, DOI 10.1016/j.jhevol.2004.03.003; Huang P, 1994, CHINESE SCI BULL, V40, P1318; Huang P, 1995, NUCL TECH, V18, P491; HUANG W, 1982, VERTEBRAT PALASIATIC, V20, P248; Huang W, 1981, CHINESE SCI BULL, V26, P1116; Huang WB, 2001, HEXIAN HOMINID SITE; HYODO M, 1993, ANTHROPOL SCI, V101, P157, DOI 10.1537/ase.101.157; Hyodo M, 2002, J HUM EVOL, V43, P27, DOI 10.1006/jhev.2002.0555; Hyodo M., 2001, SANGIRAN MAN CULTURE, P320; Hyodo M, 2011, P NATL ACAD SCI USA, V108, P19563, DOI 10.1073/pnas.1113106108; Irish JD, 2003, J HUM EVOL, V45, P113, DOI 10.1016/S0047-2484(03)00090-3; Irish JD, 1998, J HUM EVOL, V34, P81, DOI 10.1006/jhev.1997.0191; IRISH JD, 1993, THESIS ARIZONA STATE; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P545, DOI 10.1002/ajpa.1330570406; Kaifu Y, 2005, AM J PHYS ANTHROPOL, V128, P709, DOI 10.1002/ajpa.10425; Kaifu Y, 2005, AM J PHYS ANTHROPOL, V128, P497, DOI 10.1002/ajpa.10427; Kaifu Y, 2006, ANTHROPOL SCI, V114, P35, DOI 10.1537/ase.040729; Kaifu Y, 2011, J HUM EVOL, V61, P270, DOI 10.1016/j.jhevol.2011.04.002; Keith A, 1913, Proc R Soc Med, V6, P103; Kidder JH, 2004, J HUM EVOL, V46, P299, DOI 10.1016/j.jhevol.2003.12.003; Kupczik K, 2010, J HUM EVOL, V59, P525, DOI 10.1016/j.jhevol.2010.05.009; Larick R, 2001, P NATL ACAD SCI USA, V98, P4866, DOI 10.1073/pnas.081077298; LIEBERMAN DE, 1988, J HUM EVOL, V17, P503, DOI 10.1016/0047-2484(88)90039-5; Liu TS, 1999, QUATERNARY SCI REV, V18, P1205, DOI 10.1016/S0277-3791(98)00110-3; Liu W, 2005, AM J PHYS ANTHROPOL, V127, P253, DOI 10.1002/ajpa.20066; Liu W, 2013, J HUM EVOL, V64, P337, DOI 10.1016/j.jhevol.2012.10.012; MacDonald K, 2012, QUATERN INT, V271, P84, DOI 10.1016/j.quaint.2011.10.009; Martin-Frances L, 2014, CR PALEVOL, V13, P189, DOI 10.1016/j.crpv.2013.10.007; de Pinillos MM, 2014, CR PALEVOL, V13, P205, DOI 10.1016/j.crpv.2013.10.008; Martinon-~Torres M, 2006, THESIS U SANTIAGO CO; Martinon-Torres M, 2007, P NATL ACAD SCI USA, V104, P13279, DOI 10.1073/pnas.0706152104; Martinon-Torres M, 2006, J HUM EVOL, V50, P523, DOI 10.1016/j.jhevol.2005.12.004; Martinon-Torres M, 2008, J HUM EVOL, V55, P249, DOI 10.1016/j.jhevol.2007.12.008; Martinon-Torres M, 2014, CR PALEVOL, V13, P223, DOI 10.1016/j.crpv.2013.12.002; Martinon-Torres M, 2013, J ANAT, V223, P353, DOI 10.1111/joa.12090; Martinon-Torres M, 2012, J HUM EVOL, V62, P7, DOI 10.1016/j.jhevol.2011.08.007; Moggi-Cecchi J, 2006, J HUM EVOL, V50, P239, DOI 10.1016/j.jhevol.2005.08.012; MOLNAR S, 1971, AM J PHYS ANTHROPOL, V34, P175, DOI 10.1002/ajpa.1330340204; Olejniczak AJ, 2006, THESIS STONY BROOK U; Olejniczak AJ, 2008, J HUM EVOL, V55, P12, DOI 10.1016/j.jhevol.2007.11.004; Ortiz A, 2012, J HUM EVOL, V63, P586, DOI 10.1016/j.jhevol.2012.06.003; Quam R, 2009, J ANAT, V214, P655, DOI 10.1111/j.1469-7580.2009.01064.x; Rightmire G. Philip, 1992, Evolutionary Anthropology, V1, P43, DOI 10.1002/evan.1360010204; RIGHTMIRE GP, 1993, AM J PHYS ANTHROPOL, V90, P1, DOI 10.1002/ajpa.1330900102; Rukang W., 1982, ACTA ANTHR SIN, V1, P2; Scott G.R., 1997, ANTHR MODERN HUMAN T, DOI 10.1017/CBO9781316529843; Semah F, 2000, J ARCHAEOL SCI, V27, P763, DOI 10.1006/jasc.1999.0482; Shen GJ, 2001, J HUM EVOL, V41, P679, DOI 10.1006/jhev.2001.0516; Shen GJ, 2009, NATURE, V458, P198, DOI 10.1038/nature07741; Skinner MM, 2009, J HUM EVOL, V56, P76, DOI 10.1016/j.jhevol.2008.08.021; Smith TM, 2012, J HUM EVOL, V62, P395, DOI 10.1016/j.jhevol.2011.12.004; Suwa G, 2007, ANTHROPOL SCI, V115, P133, DOI 10.1537/ase.061203; Tobias P. V., 1991, SKULLS ENDOCASTS TEE, VIV; Turner C G 2nd, 1969, Am J Phys Anthropol, V30, P421; Turner II C. G., 1991, ADV DENT ANTHR, P13; von Koenigswald G.H.R., 1950, INT GEOL C REP 18 9, P59; Walker A., 1993, NARIOKOTOME HOMO ERE; WARD SC, 1982, AM J PHYS ANTHROPOL, V57, P605, DOI 10.1002/ajpa.1330570407; Weidenreich F., 1935, Bull Geol Soc Peiping, V14, P427; Weidenreich F., 1937, DENTITION SINANTHROP; WHITE TD, 1980, AM J PHYS ANTHROPOL, V53, P487, DOI 10.1002/ajpa.1330530405; WHITE TD, 1977, AM J PHYS ANTHROPOL, V46, P197, DOI 10.1002/ajpa.1330460203; Wolpoff M. H., 1999, PALEOANTHROPOLOGY; Wolpoff M. H., 1971, STUDIES ANTHR, V2; WOOD B, 1992, NATURE, V355, P397, DOI 10.1038/355397a0; Wood B., 1991, HOMINID CRANIAL REMA, V4; WOOD BA, 1988, J ANAT, V161, P1; Wu X, 2006, AM J PHYS ANTHROPOL, V26, P445; Wu X.Z., 1995, HUMAN EVOLUTION CHIN; Wu XJ, 2010, QUATERN INT, V211, P4, DOI 10.1016/j.quaint.2009.07.002; Wu XJ, 2010, P ROY SOC B-BIOL SCI, V277, P337, DOI 10.1098/rspb.2009.0149; Wu XZ, 2004, QUATERN INT, V117, P131, DOI 10.1016/S1040-6182(03)00123-X; Wu XZ, 2004, INT J PRIMATOL, V25, P1093, DOI 10.1023/B:IJOP.0000043353.24043.19; Xing S, 2012, THESIS CHINESE ACAD; Xing S, 2015, AM J PHYS ANTHROPOL, V156, P224, DOI 10.1002/ajpa.22641; Xing Song, 2012, Acta Anthropologica Sinica, V31, P250; Zanolli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067233; Zanolli C, 2010, CR PALEVOL, V9, P341, DOI 10.1016/j.crpv.2010.07.019; 黄培华, 1995, 人类学学报, V14, P262	110	45	52	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114265	10.1371/journal.pone.0114265	http://dx.doi.org/10.1371/journal.pone.0114265			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UC	25551383	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100009
J	Yuan, QY; Zhang, L; Xiao, D; Zhao, K; Lin, C; Si, LY				Yuan, Qiao-Ying; Zhang, Ling; Xiao, Dan; Zhao, Kun; Lin, Chun; Si, Liang-Yi			An Accurate, Flexible and Small Optical Fiber Sensor: A Novel Technological Breakthrough for Real-Time Analysis of Dynamic Blood Flow Data In Vivo	PLOS ONE			English	Article							PRESSURE SENSOR; MEMS PRESSURE; SPECTROSCOPY	Because of the limitations of existing methods and techniques for directly obtaining real-time blood data, no accurate microflow in vivo real-time analysis method exists. To establish a novel technical platform for real-time in vivo detection and to analyze average blood pressure and other blood flow parameters, a small, accurate, flexible, and nontoxic Fabry-Perot fiber sensor was designed. The carotid sheath was implanted through intubation of the rabbit carotid artery (n=8), and the blood pressure and other detection data were determined directly through the veins. The fiber detection results were compared with test results obtained using color Doppler ultrasound and a physiological pressure sensor recorder. Pairwise comparisons among the blood pressure results obtained using the three methods indicated that real-time blood pressure information obtained through the fiber sensor technique exhibited better correlation than the data obtained with the other techniques. The highest correlation (correlation coefficient of 0.86) was obtained between the fiber sensor and pressure sensor. The blood pressure values were positively related to the total cholesterol level, low-density lipoprotein level, number of red blood cells, and hemoglobin level, with correlation coefficients of 0.033, 0.129, 0.358, and 0.373, respectively. The blood pressure values had no obvious relationship with the number of white blood cells and high-density lipoprotein and had a negative relationship with triglyceride levels, with a correlation coefficient of -0.031. The average ambulatory blood pressure measured by the fiber sensor exhibited a negative correlation with the quantity of blood platelets (correlation coefficient of -0.839, P<0.05). The novel fiber sensor can thus obtain in vivo blood pressure data accurately, stably, and in real time; the sensor can also determine the content and status of the blood flow to some extent. Therefore, the fiber sensor can obtain partially real-time vascular rheology information and may thus enable the early diagnosis of blood rheology disorders and diseases.	[Yuan, Qiao-Ying; Xiao, Dan; Zhao, Kun; Si, Liang-Yi] Third Mil Med Univ, Dept Geriatr, Southwest Hosp, Chongqing, Peoples R China; [Zhang, Ling] Third Mil Med Univ, Southwest Hosp, Dept Outpatient Clin OPD, Chongqing, Peoples R China; [Lin, Chun] Xiamen Univ, Sch Phys & Mech & Elect Engn, Xiamen, Peoples R China	Army Medical University; Army Medical University; Xiamen University	Si, LY (corresponding author), Third Mil Med Univ, Dept Geriatr, Southwest Hosp, Chongqing, Peoples R China.	Liangyisi2014@163.com			National Natural Science Foundation of China (NSFC) [81271657]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC) Project No: 81271657. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiche YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092451; Abeysinghe DC, 2002, J MICROMECH MICROENG, V12, P229, DOI 10.1088/0960-1317/12/3/306; Abeysinghe DC, 2001, IEEE PHOTONIC TECH L, V13, P993, DOI 10.1109/68.942671; BELLEVILLE C, 2006, Patent No. 20060133715; Cibula E, 2005, APPL OPTICS, V44, P2736, DOI 10.1364/AO.44.002736; Cohen AE, 2000, SENSOR ACTUAT B-CHEM, V62, P23, DOI 10.1016/S0925-4005(99)00372-X; Hill GC, 2007, SENSOR ACTUAT A-PHYS, V138, P52, DOI 10.1016/j.sna.2007.04.047; Lim JKH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098393; Liu XD, 2006, PHYS MED BIOL, V51, P173, DOI 10.1088/0031-9155/51/1/013; MacPherson WN, 1999, REV SCI INSTRUM, V70, P1868, DOI 10.1063/1.1149682; Nesson S, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2967908; Neudel F, 2002, MED ENG PHYS, V24, P301, DOI 10.1016/S1350-4533(02)00012-7; OBERG PA, 1984, ACTA MED SCAND, P17; Olson ES, 1998, J ACOUST SOC AM, V103, P3445, DOI 10.1121/1.423083; SHERRER DW, 2002, Patent No. 20020003917; Skora A, 2004, TECHNOL HEALTH CARE, V12, P87; Spielman AJ, 2000, BRAIN RES, V866, P313, DOI 10.1016/S0006-8993(00)02320-9; Takeuchi A, 2010, J CLIN MONIT COMPUT, V24, P363, DOI 10.1007/s10877-010-9255-z; Totsu K, 2005, J MICROMECH MICROENG, V15, P71, DOI 10.1088/0960-1317/15/1/011; Urquiza SA, 2006, COMPUT METHOD APPL M, V195, P4002, DOI 10.1016/j.cma.2005.07.014; Wang X., 2005, 2005 Quantum Electronics and Laser Science Conference (QELS) (IEEE Cat. No. 05CH37696), P916; Wang XW, 2006, OPT LETT, V31, P885, DOI 10.1364/OL.31.000885; Watson S, 2006, APPL OPTICS, V45, P5590, DOI 10.1364/AO.45.005590	23	4	4	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114794	10.1371/journal.pone.0114794	http://dx.doi.org/10.1371/journal.pone.0114794			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551384	Green Submitted, Green Published, gold			2022-12-26	WOS:000347119100016
J	Adamowicz, MS; Stasulli, DM; Sobestanovich, EM; Bille, TW				Adamowicz, Michael S.; Stasulli, Dominique M.; Sobestanovich, Emily M.; Bille, Todd W.			Evaluation of Methods to Improve the Extraction and Recovery of DNA from Cotton Swabs for Forensic Analysis	PLOS ONE			English	Article							COLLECTION; SAMPLES; PROFILES; PCR; FINGERPRINTS; SENSITIVITY; TIME; SKIN	Samples for forensic DNA analysis are often collected from a wide variety of objects using cotton or nylon tipped swabs. Testing has shown that significant quantities of DNA are retained on the swab, however, and subsequently lost. When processing evidentiary samples, the recovery of the maximum amount of available DNA is critical, potentially dictating whether a usable profile can be derived from a piece of evidence or not. The QIAamp DNA Investigator extraction kit was used with its recommended protocol for swabs (one hour incubation at 56 degrees C) as a baseline. Results indicate that over 50% of the recoverable DNA may be retained on the cotton swab tip, or otherwise lost, for both blood and buccal cell samples when using this protocol. The protocol's incubation time and temperature were altered, as was incubating while shaking or stationary to test for increases in recovery efficiency. An additional step was then tested that included periodic re-suspension of the swab tip in the extraction buffer during incubation. Aliquots of liquid blood or a buccal cell suspension were deposited and dried on cotton swabs and compared with swab-less controls. The concentration of DNA in each extract was quantified and STR analysis was performed to assess the quality of the extracted DNA. Stationary incubations and those performed at 65 degrees C did not result in significant gains in DNA yield. Samples incubated for 24 hours yielded less DNA. Increased yields were observed with three and 18 hour incubation periods. Increases in DNA yields were also observed using a swab re-suspension method for both cell types. The swab re-suspension method yielded an average two-fold increase in recovered DNA yield with buccal cells and an average three-fold increase with blood cells. These findings demonstrate that more of the DNA collected on swabs can be recovered with specific protocol alterations.	[Adamowicz, Michael S.; Stasulli, Dominique M.; Sobestanovich, Emily M.] Univ New Haven, Henry C Lee Coll Criminal Justice & Forens Sci, Dept Forens Sci, West Haven, CT 06516 USA; [Bille, Todd W.] Bur Alcohol Tobacco Firearms & Explos, Natl Lab Ctr, Ammendale, MD USA	University New Haven	Adamowicz, MS (corresponding author), Univ New Haven, Henry C Lee Coll Criminal Justice & Forens Sci, Dept Forens Sci, West Haven, CT 06516 USA.	madamowicz@newhaven.edu		Bille, Todd/0000-0003-2976-5085	University of New Haven Summer Undergraduate Research Fellowship program	University of New Haven Summer Undergraduate Research Fellowship program	This work was supported by the University of New Haven Summer Undergraduate Research Fellowship program. MSA, DMS, and EMS received summer stipends; DMS and EMS also received summer housing. Limited funds were provided for reagents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, APPL BIOSYSTEMS LIFE; [Anonymous], 2010, QIAGEN QIAAMP DNA IN, P14; Benschop CCG, 2010, FORENSIC SCI INT-GEN, V4, P115, DOI 10.1016/j.fsigen.2009.07.003; Bille TW, 2009, J FORENSIC SCI, V54, P1059, DOI 10.1111/j.1556-4029.2009.01128.x; Brownlow RJ, 2012, J FORENSIC SCI, V57, P713, DOI 10.1111/j.1556-4029.2011.02022.x; Butler JM, 2012, ADV TOPICS FORENSIC, P311; Cook O, 2007, FORENSIC SCI INT-GEN, V1, P62, DOI 10.1016/j.fsigen.2006.10.009; de Bruin KG, 2012, FORENSIC SCI INT-GEN, V6, P219, DOI 10.1016/j.fsigen.2011.04.019; Dowlman EA, 2010, SCI JUSTICE, V50, P64, DOI 10.1016/j.scijus.2009.03.005; GILL P, 1985, NATURE, V318, P577, DOI 10.1038/318577a0; Hoffmann SG, 2012, J FORENSIC SCI, V57, P602, DOI 10.1111/j.1556-4029.2011.01982.x; Kopka J, 2011, J FORENSIC SCI, V56, P1235, DOI 10.1111/j.1556-4029.2011.01853.x; Leclair B, 2003, J FORENSIC SCI, V48, P1001; Lee HC, 1998, AM J FOREN MED PATH, V19, P10, DOI 10.1097/00000433-199803000-00002; Lee HC, 1991, J FORENSIC IDENTIF, V41, P344; Marshall PL, 2014, FORENSIC SCI INT-GEN, V12, P192, DOI 10.1016/j.fsigen.2014.05.014; Mulligan CM, 2011, J FORENSIC SCI, V56, P485, DOI 10.1111/j.1556-4029.2010.01659.x; Norris JV, 2007, J FORENSIC SCI, V52, P800, DOI 10.1111/j.1556-4029.2007.00453.x; Opel KL, 2010, J FORENSIC SCI, V55, P25, DOI 10.1111/j.1556-4029.2009.01245.x; Pang B. C. M., 2007, Legal Medicine, V9, P181, DOI 10.1016/j.legalmed.2006.12.003; Schiffner LA, 2005, CROAT MED J, V46, P578; Smith PJ, 2007, J FORENSIC SCI, V52, P820, DOI 10.1111/j.1556-4029.2007.00470.x; Sweet D, 1997, J FORENSIC SCI, V42, P320; Thomasma SM, 2013, J FORENSIC SCI, V58, P465, DOI 10.1111/1556-4029.12036; Verdon TJ, 2014, J FORENSIC SCI, V59, P1080, DOI 10.1111/1556-4029.12427; Verdon TJ, 2013, FORENSIC SCI INT-GEN, V7, P167, DOI 10.1016/j.fsigen.2012.09.004; Westen AA, 2009, J FORENSIC SCI, V54, P591, DOI 10.1111/j.1556-4029.2009.01022.x; Whitaker JP, 2001, FORENSIC SCI INT, V123, P215, DOI 10.1016/S0379-0738(01)00557-6; Zech WD, 2012, J FORENSIC SCI, V57, P1036, DOI 10.1111/j.1556-4029.2012.02105.x	29	36	36	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116351	10.1371/journal.pone.0116351	http://dx.doi.org/10.1371/journal.pone.0116351			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549111	Green Published, Green Submitted, gold			2022-12-26	WOS:000347063500079
J	Borin, TF; Zuccari, DAPC; Jardim-Perassi, BV; Ferreira, LC; Iskander, ASM; Varma, NRS; Shankar, A; Guo, AM; Scicli, G; Arbab, AS				Borin, Thaiz Ferraz; Zuccari, Debora A. P. C.; Jardim-Perassi, Bruna V.; Ferreira, Livia C.; Iskander, A. S. M.; Varma, Nadimpalli Ravi S.; Shankar, Adarsh; Guo, Austin M.; Scicli, Guillermo; Arbab, Ali S.			HET0016, a Selective Inhibitor of 20-HETE Synthesis, Decreases Pro-Angiogenic Factors and Inhibits Growth of Triple Negative Breast Cancer in Mice	PLOS ONE			English	Article							TUMOR ANGIOGENESIS; CELL-PROLIFERATION; DOWN-REGULATION; ANGIOSTATIN; METASTASIS; EXPRESSION; MANAGEMENT; REGULATOR; SURVIVAL; ENZYMES	A selective inhibitor of 20-HETE synthesis, HET0016, has been reported to inhibit angiogenesis. 20-HETE has been known as a second mitogenic messenger of angiogenesis inducing growth factors. HET0016 effects were analyzed on MDA-MB-231 derived breast cancer in mouse and in vitro cell line. MDA-MB-231 tumor cells were implanted in animals' right flank and randomly assigned to early (1 and 2), starting treatments on day 0, or delayed groups (3 and 4) on day 8 after implantation of tumor. Animals received HET0016 (10 mg/kg) treatment via intraperitoneal injection for 5 days/week for either 3 or 4 weeks. Control group received vehicle treatment. Tumor sizes were measured on days 7, 14, 21, and 28 and the animals were euthanized on day 22 and 29. Proteins were extracted from the whole tumor and from cells treated with 10 mM HET0016 for 4 and 24 hrs. Protein array kits of 20 different cytokines/factors were used. ELISA was performed to observe the HIF-1 alpha and MMP-2 protein expression. Other markers were confirmed by IHC. HET0016 significantly inhibited tumor growth in all treatment groups at all-time points compared to control (p<0.05). Tumor growth was completely inhibited on three of ten animals on early treatment group. Treatment groups showed significantly lower expression of pro-angiogenic factors compared to control at 21 days; however, there was no significant difference in HIF-1 alpha expression after treatments. Similar results were found in vitro at 24 hrs of HET0016 treatment. After 28 days, significant increase of angiogenin, angiopoietin-1/2, EGF-R and IGF-1 pro-angiogenic factors were found (p<0.05) compared to control, as well as an higher intensity of all factors were found when compared to that of 21 day's data, suggesting a treatment resistance. HET0016 inhibited tumor growth by reducing expression of different set of pro-angiogenic factors; however, a resistance to treatment seemed to happen after 21 days.	[Borin, Thaiz Ferraz; Zuccari, Debora A. P. C.; Jardim-Perassi, Bruna V.; Ferreira, Livia C.] Fac Med Sao Jose Rio Preto FAMERP, LIMC, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil; [Borin, Thaiz Ferraz; Iskander, A. S. M.; Varma, Nadimpalli Ravi S.; Shankar, Adarsh; Scicli, Guillermo; Arbab, Ali S.] Henry Ford Hosp, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA; [Guo, Austin M.] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA	Henry Ford Health System; Henry Ford Hospital; New York Medical College	Arbab, AS (corresponding author), Henry Ford Hosp, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA.	aarbab@gru.edu	Jardim-Perassi, Bruna V/H-8633-2014; Arbab, Ali/AAS-1933-2020; de Campos Zuccari, Debora Aparecida Pires/M-3560-2014; Borin, Thaiz Ferraz/E-8013-2012	de Campos Zuccari, Debora Aparecida Pires/0000-0002-0146-9041; Borin, Thaiz Ferraz/0000-0003-1464-9823	National Institutes of Health [R01CA160216]; FAPESP-BEPE [2012/12114-8]; NATIONAL CANCER INSTITUTE [R01CA172048, R01CA160216] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAPESP-BEPE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by grants from National Institutes of Health R01CA160216 and from FAPESP-BEPE 2012/12114-8. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexanian A, 2013, ONCOTARGETS THER, V6, P243, DOI 10.2147/OTT.S31586; Alexanian A, 2012, CANCER GENOM PROTEOM, V9, P163; Alexanian A, 2009, ANTICANCER RES, V29, P3819; Blankenberg FG, 2006, EUR J NUCL MED MOL I, V33, P841, DOI 10.1007/s00259-006-0099-1; Chen JC, 2013, INT J MOL SCI, V14, P88, DOI 10.3390/ijms14010088; Chen L, 2012, PROSTAG OTH LIPID M, V98, P63, DOI 10.1016/j.prostaglandins.2011.12.005; Chen P, 2005, AM J PATHOL, V166, P615, DOI 10.1016/S0002-9440(10)62282-1; Chung AWY, 2006, CIRC RES, V99, P140, DOI 10.1161/01.RES.0000232352.90786.fa; Cornelius LA, 1998, J IMMUNOL, V161, P6845; Dhanasekaran A, 2009, AM J PHYSIOL-HEART C, V296, pH777, DOI 10.1152/ajpheart.01087.2008; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Guo AM, 2007, J PHARMACOL EXP THER, V321, P18, DOI 10.1124/jpet.106.115360; Guo AM, 2011, J PHARMACOL EXP THER, V338, P421, DOI 10.1124/jpet.111.179036; Guo AM, 2009, AM J PHYSIOL-HEART C, V297, pH602, DOI 10.1152/ajpheart.00874.2008; Guo M, 2006, J PHARMACOL EXP THER, V317, P97, DOI 10.1124/jpet.105.097782; Guo M, 2005, J PHARMACOL EXP THER, V315, P526, DOI 10.1124/jpet.105.088567; Holash J, 1999, ONCOGENE, V18, P5356, DOI 10.1038/sj.onc.1203035; Janic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009173; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Laakkonen P, 2007, CANCER RES, V67, P593, DOI 10.1158/0008-5472.CAN-06-3567; Longatto A, 2010, J ONCOL, V2010, DOI 10.1155/2010/576384; Miyata N, 2001, BRIT J PHARMACOL, V133, P325, DOI 10.1038/sj.bjp.0704101; Nielsen DL, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2642; Orozco LD, 2013, J PHARMACOL EXP THER, V346, P67, DOI 10.1124/jpet.113.203844; Park F, 2008, J AM SOC NEPHROL, V19, P1929, DOI 10.1681/ASN.2007070771; Pozzi A, 2000, P NATL ACAD SCI USA, V97, P2202, DOI 10.1073/pnas.040378497; Pytel D, 2009, ANTI-CANCER AGENT ME, V9, P66, DOI 10.2174/187152009787047752; Saidi A, 2008, INT J CANCER, V122, P2187, DOI 10.1002/ijc.23313; Seki T, 2005, BIOL PHARM BULL, V28, P1651, DOI 10.1248/bpb.28.1651; Smith NR, 2010, CLIN CANCER RES, V16, P3548, DOI 10.1158/1078-0432.CCR-09-2797; Turner NC, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a540; Turner NC, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a421; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yu W, 2010, CANC CHEMOTHER PHARM; Yu W, 2012, TOXICOL APPL PHARM, V264, P73, DOI 10.1016/j.taap.2012.07.019; Zhang W, 2012, MOL THER, V20, P37, DOI 10.1038/mt.2011.187; Zheng H, 2014, TOXICOL APPL PHARM, V280, P10, DOI 10.1016/j.taap.2014.07.018	37	26	27	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116247	10.1371/journal.pone.0116247	http://dx.doi.org/10.1371/journal.pone.0116247			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549350	Green Published, Green Submitted, gold			2022-12-26	WOS:000347063500067
J	Gret-Regamey, A; Weibel, B; Bagstad, KJ; Ferrari, M; Geneletti, D; Klug, H; Schirpke, U; Tappeiner, U				Gret-Regamey, Adrienne; Weibel, Bettina; Bagstad, Kenneth J.; Ferrari, Marika; Geneletti, Davide; Klug, Hermann; Schirpke, Uta; Tappeiner, Ulrike			On the Effects of Scale for Ecosystem Services Mapping	PLOS ONE			English	Article							LANDSCAPE PATTERN-ANALYSIS; LAND-USE; SPATIAL AUTOCORRELATION; TRADE-OFFS; BIODIVERSITY; MULTISCALE; VALUATION; CONSERVATION; INDICATORS; SCENARIOS	Ecosystems provide life-sustaining services upon which human civilization depends, but their degradation largely continues unabated. Spatially explicit information on ecosystem services (ES) provision is required to better guide decision making, particularly for mountain systems, which are characterized by vertical gradients and isolation with high topographic complexity, making them particularly sensitive to global change. But while spatially explicit ES quantification and valuation allows the identification of areas of abundant or limited supply of and demand for ES, the accuracy and usefulness of the information varies considerably depending on the scale and methods used. Using four case studies from mountainous regions in Europe and the U.S., we quantify information gains and losses when mapping five ES -carbon sequestration, flood regulation, agricultural production, timber harvest, and scenic beauty - at coarse and fine resolution (250 m vs. 25 m in Europe and 300 m vs. 30 m in the U.S.). We analyze the effects of scale on ES estimates and their spatial pattern and show how these effects are related to different ES, terrain structure and model properties. ES estimates differ substantially between the fine and coarse resolution analyses in all case studies and across all services. This scale effect is not equally strong for all ES. We show that spatially explicit information about non-clustered, isolated ES tends to be lost at coarse resolution and against expectation, mainly in less rugged terrain, which calls for finer resolution assessments in such contexts. The effect of terrain ruggedness is also related to model properties such as dependency on land use-land cover data. We close with recommendations for mapping ES to make the resulting maps more comparable, and suggest a four-step approach to address the issue of scale when mapping ES that can deliver information to support ES-based decision making with greater accuracy and reliability.	[Gret-Regamey, Adrienne; Weibel, Bettina] ETH, Swiss Fed Inst Technol, CH-8093 Zurich, Switzerland; [Bagstad, Kenneth J.] US Geol Survey, Geosci & Environm Change Sci Ctr, Denver, CO 80225 USA; [Ferrari, Marika; Geneletti, Davide] Univ Trento, Dept Civil Environm & Mech Engn, I-38123 Trento, Italy; [Klug, Hermann] Salzburg Univ, Interfaculty Dept Geoinformat Z GIS, A-5020 Salzburg, Austria; [Schirpke, Uta; Tappeiner, Ulrike] EURAC Res, Inst Alpine Environm, I-39100 Bolzano, Italy; [Schirpke, Uta; Tappeiner, Ulrike] Univ Innsbruck, Inst Ecol, A-6020 Innsbruck, Austria	Swiss Federal Institutes of Technology Domain; ETH Zurich; United States Department of the Interior; United States Geological Survey; University of Trento; Salzburg University; European Academy of Bozen-Bolzano; University of Innsbruck	Gret-Regamey, A (corresponding author), ETH, Swiss Fed Inst Technol, Stefano Franscini Pl 5, CH-8093 Zurich, Switzerland.	gret@ethz.ch	Geneletti, Davide/AAH-5407-2019; BITOUN, RACHEL Elisabeth/AAC-9538-2021; Tappeiner, Ulrike/B-8727-2009; Geneletti, Davide/D-5266-2014; Klug, Hermann/C-3183-2011; Schirpke, Uta/AAF-5256-2020; Grêt-Regamey, Adrienne/AAZ-7546-2021	Geneletti, Davide/0000-0002-5528-3365; BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Tappeiner, Ulrike/0000-0002-0195-7459; Geneletti, Davide/0000-0002-5528-3365; Klug, Hermann/0000-0002-0545-9721; Schirpke, Uta/0000-0002-2075-6118; Grêt-Regamey, Adrienne/0000-0001-8156-9503; Bagstad, Kenneth/0000-0001-8857-5615	U.S. Geological Survey's Mendenhall Postdoctoral Research program; U.S. Geological Survey's Land Change Science program; Competence Center Environment and Sustainability of the Swiss Federal Institute of Technology, Mountland project	U.S. Geological Survey's Mendenhall Postdoctoral Research program(United States Geological Survey); U.S. Geological Survey's Land Change Science program; Competence Center Environment and Sustainability of the Swiss Federal Institute of Technology, Mountland project	We are grateful to the Mountain Research Initiative, which initiated this study in a workshop held 2012 in Switzerland. Partial support in the frame of the Puyallup case study was provided by the U.S. Geological Survey's Mendenhall Postdoctoral Research and Land Change Science programs. Zach Ancona, Gary Johnson, Ferdinando Villa, Brian Voigt, and Earth Economics assisted with data and model development and testing for the Puyallup case study. The Stubai case study was conducted on the LTER site 'Stubai Valley', a member of the Austrian LTSER Platform 'Tyrolean Alps'. We thank Dieter Stohr from the Forest Department of the Province of the Tyrol and Peter Frank from the Chamber of Agriculture Tyrol for the useful information and data. The Davos case study was supported by the Competence Center Environment and Sustainability of the Swiss Federal Institute of Technology as part of the Mountland project. The ASTER global digital elevation model GDEM V1 data product which is a product of METI and NASA was obtained through the online Data Pool at the NASA Land Processes Distributed Active Archive Center (LP DAAC), USGS/Earth Resources Observation and Science (EROS) Center, Sioux Falls, South Dakota (https://lpdaac.usgs.gov/data_access). Jay Diffendorfer, Miguel Villareal, and two anonymous reviewers provided constructive reviews of earlier drafts of this manuscript. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	Agarwal C., 2002, 297 NE DEP AGR FOR S, DOI 10.2737/NE-GTR-297; Anton C, 2010, BIODIVERS CONSERV, V19, P2979, DOI 10.1007/s10531-010-9853-6; Bagstad KJ, 2014, ECOL SOC, V19, DOI 10.5751/ES-06523-190264; Bagstad KJ, 2013, ECOSYST SERV, V5, pE40, DOI 10.1016/j.ecoser.2013.07.007; Bagstad KJ, 2013, ECOSYST SERV, V5, pE27, DOI 10.1016/j.ecoser.2013.07.004; Bagstad KJ, 2013, ECOSYST SERV, V4, P117, DOI 10.1016/j.ecoser.2012.07.012; Balmford A, 2011, ENVIRON RESOUR ECON, V48, P161, DOI 10.1007/s10640-010-9413-2; Bourassa SC, 2004, ENVIRON PLANN A, V36, P1427, DOI 10.1068/a36103; Bridgham SD, 2006, WETLANDS, V26, P889, DOI 10.1672/0277-5212(2006)26[889:TCBONA]2.0.CO;2; Burns I. S., 2007, AUTOMATED GEOSPATIAL; Capistrano D, 2005, ECOSYSTEMS HUMAN WEL; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Chapin FS, 2010, TRENDS ECOL EVOL, V25, P241, DOI 10.1016/j.tree.2009.10.008; Crossman ND, 2013, ECOSYST SERV, V4, P4, DOI 10.1016/j.ecoser.2013.02.001; Daily GC, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P3; Dale MRT, 2002, ECOGRAPHY, V25, P558, DOI 10.1034/j.1600-0587.2002.250506.x; de Groot R, 2006, LANDSCAPE URBAN PLAN, V75, P175, DOI 10.1016/j.landurbplan.2005.02.016; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; EC, 2011, OUR LIF INS OUR NAT; Egoh B., 2012, VIA ENRICO FERMI 274, DOI [10.2788/41823, DOI 10.2788/41823]; Eppink FV, 2012, GAIA, V21, P55, DOI 10.14512/gaia.21.1.14; Ferrari M, 2014, ANN BOT-ITALY, V4, P65, DOI 10.4462/annbotrm-11729; Ferrari M, 2014, THESIS U TRENTO; Folke C, 2007, ECOL SOC, V12; Fortin M-J, 2006, ENCY ENV; Fortin MJ, 1999, LANDSCAPE ECOLOGICAL ANALYSIS: ISSUES AND APPLICATIONS, P253; Getis A., 2010, HDB APPL SPATIAL ANA, P255, DOI [10.1007/978-3-642-03647-7_14, DOI 10.1007/978-3-642-03647-7_14, 10.1007/978-3-642-03647-7]; Gret-Regamey A, 2013, ECOL SOC, V18, DOI 10.5751/ES-05800-180334; Harflinger O, 1999, KLIMATOGRAPHIE 1; Heffernan JB, 2014, FRONT ECOL ENVIRON, V12, P5, DOI 10.1890/130017; Hein L, 2006, ECOL ECON, V57, P209, DOI 10.1016/j.ecolecon.2005.04.005; Huber U. M., 2005, Global change and mountain regions: an overview of current knowledge; Jelinski DE, 1996, LANDSCAPE ECOL, V11, P129, DOI 10.1007/BF02447512; Jose Martinez-Harms Maria, 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P17, DOI 10.1080/21513732.2012.663792; Kandziora M, 2013, ECOSYST SERV, V4, P47, DOI 10.1016/j.ecoser.2013.04.001; Klein JA, 2011, ADV GLOB CHANGE RES, V42, P423, DOI 10.1007/978-94-007-0567-8_31; Konarska KM, 2002, ECOL ECON, V41, P491, DOI 10.1016/S0921-8009(02)00096-4; Landesforstinspektion fur Tirol, 1979, WALDW JAHR 1978 BIS; Landesforstinspektion fur Tirol, 2004, WALDW AGR NEUST STUB; Leitinger G, 2010, J HYDROL, V385, P95, DOI 10.1016/j.jhydrol.2010.02.006; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Liu S, 2012, BASELINE PROJECTED F; LP DAAC, 2009, AST GDEM V1 DAT PROD; MA, 2005, ECOSYSTEMS HUMAN WEL; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Maes J., 2013, MAPPING ASSESSMENT E, DOI [10.2779/12398, DOI 10.2779/12398]; Maes J, 2012, ECOSYST SERV, V1, P31, DOI 10.1016/j.ecoser.2012.06.004; Martin-Lopez B, 2014, ECOL INDIC, V37, P220, DOI 10.1016/j.ecolind.2013.03.003; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; McKenzie E, 2011, NATURAL CAPITAL; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Moody A, 1995, PHOTOGRAMMETRIC ENG, V60; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Nedkov S, 2012, ECOL INDIC, V21, P67, DOI 10.1016/j.ecolind.2011.06.022; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; O'Neill RV, 1989, LANDSCAPE ECOL, V3, P193, DOI 10.1007/BF00131538; O'Neill R.V., 1991, HETEROGENEITY SPATIA, P85; OANDA corporation, 2013, HIST EXCH RAT; ONeill RV, 1996, LANDSCAPE ECOL, V11, P169, DOI 10.1007/BF02447515; Openshaw S., 1983, MODIFIABLE AREAL UNI; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Overmars KP, 2003, ECOL MODEL, V164, P257, DOI 10.1016/S0304-3800(03)00070-X; Palomo I, 2013, ECOSYST SERV, V4, P104, DOI 10.1016/j.ecoser.2012.09.001; PAT, 2010, PROV AUT TRENT SERV; Perry JN, 2002, ECOGRAPHY, V25, P578, DOI 10.1034/j.1600-0587.2002.250507.x; President's Council of Advisors on Science and Technology (PCAST), 2011, REP PRES SUST ENV CA; Province of Tyrol, 2013, HOLZM; PUP, 2008, PIAN URB PROV; Qi Y, 1996, LANDSCAPE ECOL, V11, P39, DOI 10.1007/BF02087112; Qiu JX, 2013, P NATL ACAD SCI USA, V110, P12149, DOI 10.1073/pnas.1310539110; R Core Team, 2021, R LANGUAGE ENV STAT; Raudsepp-Hearne C, 2010, Proc Natl Acad Sci U S A, V107, P5242, DOI 10.1073/pnas.0907284107; Riley S.J., 1999, INTERMOUNTAIN J SCI, V5, P23, DOI DOI 10.1016/j.geomorph.2010.11.003; Schagner JP, 2013, ECOSYST SERV, V4, P33, DOI 10.1016/j.ecoser.2013.02.003; Schirpke Uta, 2013, International Journal of Biodiversity Science Ecosystem Services & Management, V9, P123, DOI 10.1080/21513732.2012.751936; Schirpke U, 2013, LANDSCAPE URBAN PLAN, V111, P1, DOI 10.1016/j.landurbplan.2012.11.010; Scholes RJ, 2013, CURR OPIN ENV SUST, V5, P16, DOI 10.1016/j.cosust.2013.01.004; Seppelt R, 2013, CURR OPIN ENV SUST, V5, P458, DOI 10.1016/j.cosust.2013.05.002; Smith JE., 2006, METHODS CALCULATING; Syrbe RU, 2012, ECOL INDIC, V21, P80, DOI 10.1016/j.ecolind.2012.02.013; Tallis H, 2009, ANN NY ACAD SCI, V1162, P265, DOI 10.1111/j.1749-6632.2009.04152.x; Tappeiner U, 2008, ECOSYSTEMS, V11, P1383, DOI 10.1007/s10021-008-9195-3; Thurig E., 2008, Schweizerische Zeitschrift fur Forstwesen, V159, P31, DOI 10.3188/szf.2008.0031; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Tonolli S, 2008, INFOCARB INVENTARIO; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; Turner MG, 1989, LANDSCAPE ECOL, V3, P153, DOI 10.1007/BF00131534; U.S. Department of Agriculture,, 1986, URB HYDR SMALL WAT T, V2nd; USDA (U. S. Department of Agriculture), 2007, 2007 CENS AGR; Veldkamp A, 1996, ECOL MODEL, V91, P231, DOI 10.1016/0304-3800(95)00158-1; Villa F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091001; Washington Department of Natural Resources, 2012, EC REV FOR NOV 2012; Washington Department of Natural Resources, 2011, WASH TIMB HARV 2011; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; WSL, 2010, ORD DAT LAND LFI; Wu J., 2000, ANN GIS, V6, P6, DOI DOI 10.1080/10824000009480529; Wu JG, 2004, LANDSCAPE ECOL, V19, P125, DOI 10.1023/B:LAND.0000021711.40074.ae; Wu JG, 2002, LANDSCAPE ECOL, V17, P761, DOI 10.1023/A:1022995922992; Wu JG, 2002, LANDSCAPE ECOL, V17, P355, DOI 10.1023/A:1020561630963	101	89	91	1	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e112601	10.1371/journal.pone.0112601	http://dx.doi.org/10.1371/journal.pone.0112601			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549256	Green Submitted, Green Published, gold			2022-12-26	WOS:000347063500005
J	Guyochin, A; Maenner, S; Chu, ETJ; Hentati, A; Attia, M; Avner, P; Clerc, P				Guyochin, Aurelia; Maenner, Sylvain; Chu, Erin Tsi-Jia; Hentati, Asma; Attia, Mikael; Avner, Philip; Clerc, Philippe			Live Cell Imaging of the Nascent Inactive X Chromosome during the Early Differentiation Process of Naive ES Cells towards Epiblast Stem Cells	PLOS ONE			English	Article							COUNTING PROCESS; GROUND-STATE; XIST RNA; MOUSE; LINES; ESTABLISHMENT; PLURIPOTENCY; RECRUITMENT; METHYLATION; DERIVATION	Random X-chromosome inactivation ensures dosage compensation in mammals through the transcriptional silencing of one of the two X chromosomes present in each female cell. Silencing is initiated in the differentiating epiblast of the mouse female embryos through coating of the nascent inactive X chromosome by the noncoding RNA Xist, which subsequently recruits the Polycomb Complex PRC2 leading to histone H3-K27 methylation. Here we examined in mouse ES cells the early steps of the transition from naive ES cells towards epiblast stem cells as a model for inducing X chromosome inactivation in vitro. We show that these conditions efficiently induce random XCI. Importantly, in a transient phase of this differentiation pathway, both X chromosomes are coated with Xist RNA in up to 15% of the XX cells. In an attempt to determine the dynamics of this process, we designed a strategy aimed at visualizing the nascent inactive X-chromosome in live cells. We generated transgenic female XX ES cells expressing the PRC2 component Ezh2 fused to the fluorescent protein Venus. The fluorescent fusion protein was expressed at sub-physiological levels and located in nuclei of ES cells. Upon differentiation of ES cell towards epiblast stem cell fate, Venus-fluorescent territories appearing in interphase nuclei were identified as nascent inactive X chromosomes by their association with Xist RNA. Imaging of Ezh2-Venus for up to 24 hours during the differentiation process showed survival of some cells with two fluorescent domains and a surprising dynamics of the fluorescent territories across cell division and in the course of the differentiation process. Our data reveal a strategy for visualizing the nascent inactive X chromosome and suggests the possibility for a large plasticity of the nascent inactive X chromosome.	[Guyochin, Aurelia; Maenner, Sylvain; Chu, Erin Tsi-Jia; Hentati, Asma; Attia, Mikael; Avner, Philip; Clerc, Philippe] Inst Pasteur, CNRS, URA2578, Paris, France; [Avner, Philip] EMBL Monterotondo, Monterotondo, Italy; [Clerc, Philippe] Inst Pasteur, CNRS, Dept Dev Biol, URA2578, Paris, France; [Guyochin, Aurelia] Univ Technol Compiegne, Compiegne, France; [Hentati, Asma] Univ Blaise Pascal, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Picardie Universites; Universite de Technologie de Compiegne; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Clerc, P (corresponding author), Inst Pasteur, CNRS, URA2578, Paris, France.	pclerc@pasteur.fr			Institut Pasteur; Centre National pour la Recherche Scientifique; Agence Nationale pour la Recherche; Epigenome Network of Excellence, REVIVE Labex; Foundation Louis D. Institut de France	Institut Pasteur(European Commission); Centre National pour la Recherche Scientifique; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Epigenome Network of Excellence, REVIVE Labex; Foundation Louis D. Institut de France	AG, SM, ETC, MA, PA, and PC were supported by Institut Pasteur (www.pasteur.fr), Centre National pour la Recherche Scientifique (www.cnrs.fr), Agence Nationale pour la Recherche (www.agence-nationale-recherche.fr), Epigenome Network of Excellence, REVIVE Labex, (www.pasteur.fr/easysite/pasteur/en/research/labex/revive), and Foundation Louis D. Institut de France (http://www.institut-de-france.fr/institutions/prix-amp-fondations/fondations/fondation-louis-d-florence-dec). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augui S, 2007, SCIENCE, V318, P1632, DOI 10.1126/science.1149420; Bao SQ, 2005, EMBO REP, V6, P748, DOI 10.1038/sj.embor.7400461; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; Brockdorff N, 2013, RNA, V19, P429, DOI 10.1261/rna.037598.112; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Burgoyne PS, 1995, PHILOS T R SOC B, V350, P253, DOI 10.1098/rstb.1995.0159; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Escamilla-Del-Arenal M, 2011, HUM GENET, V130, P307, DOI 10.1007/s00439-011-1029-2; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Hofemeister H, 2011, METHODS, V53, P437, DOI 10.1016/j.ymeth.2010.12.026; JOHNSTON PG, 1981, GENET RES, V37, P151, DOI 10.1017/S0016672300020127; Kress C, 1998, MAMM GENOME, V9, P998, DOI 10.1007/s003359900914; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Maenner S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000276; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Minkovsky A, 2012, STEM CELLS, V30, P48, DOI 10.1002/stem.755; MITTWOCH U, 1993, HUM REPROD, V8, P1550, DOI 10.1093/oxfordjournals.humrep.a137889; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; Ng K, 2011, MOL BIOL CELL, V22, P2634, DOI 10.1091/mbc.E11-02-0146; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Okamoto I, 2000, DEVELOPMENT, V127, P4137; Okamoto I, 2006, CYTOGENET GENOME RES, V113, P318, DOI 10.1159/000090848; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Shin J., 2014, NATURE; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Soma A, 2013, GENESIS, V51, P259, DOI 10.1002/dvg.22369; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Vigneau S, 2006, P NATL ACAD SCI USA, V103, P7390, DOI 10.1073/pnas.0602381103; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, METHOD ENZYMOL, V365, P327	38	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116109	10.1371/journal.pone.0116109	http://dx.doi.org/10.1371/journal.pone.0116109			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546018	Green Published, gold, Green Submitted			2022-12-26	WOS:000347120200098
J	Huichalaf, C; Micheloni, S; Ferri, G; Caccia, R; Gabellini, D				Huichalaf, Claudia; Micheloni, Stefano; Ferri, Giulia; Caccia, Roberta; Gabellini, Davide			DNA Methylation Analysis of the Macrosatellite Repeat Associated with FSHD Muscular Dystrophy at Single Nucleotide Level	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; CANDIDATE GENE; D4Z4; BINDING; LOCUS; HYPOMETHYLATION; EXPRESSION; PROTEIN; CPG; LOCALIZATION	Facioscapulohumeral muscular dystrophy ( FSHD) is one of the most common inherited diseases of the skeletal muscle. It is characterized by asymmetric muscle weakness and variable penetrance. FSHD is linked to a reduction in copy number of the D4Z4 3.3 kb macrosatellite repeat, located in 4q35. This causes the epigenetic de-repression of FSHD candidate genes leading to disease. Nevertheless, the molecular mechanism responsible for silencing of FSHD candidate genes in healthy subjects is not fully understood. While a role for DNA methylation has been suggested, so far there is limited information regarding the methylation status of the 325 CpGs contained in each D4Z4 unit. Using a human/rodent monochromosomal hybrid cell line containing a single human chromosome 4, we performed an in depth analysis of DNA methylation for the majority of the CpGs inside D4Z4 at single nucleotide level. We found that D4Z4 is not uniformly methylated and that the level of DNA methylation does not correlate with the density of CpG dinucleotides. Moreover, in several D4Z4 regions characterized by near complete methylation, we found specific unmethylated CpGs. These elements are enriched in transcription factor binding sites that could be involved in muscle-specific D4Z4 activity. Our approach also detected differential methylation among different D4Z4 units, suggesting that the D4Z4 array is a mosaic of euchromatic and heterochromatic domains. Finally, we found that DNA methylation and histone deacetylation are required to maintain FSHD candidate genes repressed. Taken together, our data underscore new players involved in the epigenetic regulation of the FSHD locus that could be targeted for therapeutic purposes.	[Huichalaf, Claudia; Micheloni, Stefano; Ferri, Giulia; Caccia, Roberta; Gabellini, Davide] Ist Sci San Raffaele, Dulbecco Telethon Inst, Div Regenerat Med, DIBIT2, I-20132 Milan, Italy; [Huichalaf, Claudia; Ferri, Giulia] Univ Vita Salute San Raffaele, Milan, Italy	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Gabellini, D (corresponding author), Ist Sci San Raffaele, Dulbecco Telethon Inst, Div Regenerat Med, DIBIT2, 5A3,Via Olgettina 58, I-20132 Milan, Italy.	gabellini.davide@hsr.it	Gabellini, Davide/I-4551-2018; Caccia, Roberta/AAN-1851-2020	Gabellini, Davide/0000-0002-3811-4121; Caccia, Roberta/0000-0003-3212-3104	Association Francaise contre les Myopathies; ERA-Net for Research on Rare Diseases; European Research Council; Italian Epigenomics Flagship Project; Italian Ministry of Health; FSHD Global Research Foundation; Fondazione Telethon Funding Source: Custom	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); ERA-Net for Research on Rare Diseases; European Research Council(European Research Council (ERC)European Commission); Italian Epigenomics Flagship Project; Italian Ministry of Health(Ministry of Health, Italy); FSHD Global Research Foundation; Fondazione Telethon(Fondazione Telethon)	This work was supported by the Association Francaise contre les Myopathies (http://www.afm-telethon.com/); the ERA-Net for Research on Rare Diseases (http://www.erare.eu/); the European Research Council (http://erc.europa.eu/); the Italian Epigenomics Flagship Project (http://www.epigen.it/); the Italian Ministry of Health (http://www.salute.gov.it/) and the FSHD Global Research Foundation (http://fshdglobal.org/).	Ansseau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007482; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bodega B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-41; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Broucqsault N, 2013, HUMAN MOL GENETICS; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Cabianca DS, 2010, J CELL BIOL, V191, P1049, DOI 10.1083/jcb.201007028; Caruso N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003550; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Clapp J, 2007, AM J HUM GENET, V81, P264, DOI 10.1086/519311; Clark LN, 1996, CHROMOSOMA, V105, P180, DOI 10.1007/BF02509499; de Greef JC, 2007, NEUROLOGY, V69, P1018, DOI 10.1212/01.wnl.0000271391.44352.fe; de Greef JC, 2010, NEUROLOGY, V75, P1548, DOI 10.1212/WNL.0b013e3181f96175; de Greef JC, 2009, HUM MUTAT, V30, P1449, DOI 10.1002/humu.21091; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Do Kim J, 2009, NUCLEIC ACIDS RES, V37, P5656, DOI 10.1093/nar/gkp613; Flanigan KM, 2001, NEUROMUSCULAR DISORD, V11, P525, DOI 10.1016/S0960-8966(01)00201-2; Fraga ME, 2002, BIOTECHNIQUES, V33, P632, DOI 10.2144/02333rv01; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hartweck LM, 2013, NEUROLOGY, V80, P392, DOI 10.1212/WNL.0b013e31827f075c; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Hu SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00726; Jabbari K, 2004, GENE, V333, P143, DOI 10.1016/j.gene.2004.02.043; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kim J, 2003, HUM MOL GENET, V12, P233, DOI 10.1093/hmg/ddg028; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Laoudj-Chenivesse D, 2005, J MOL MED, V83, P216, DOI 10.1007/s00109-004-0583-7; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; LI LH, 1970, CANCER RES, V30, P2760; LUNT PW, 1989, J MED GENET, V26, P755, DOI 10.1136/jmg.26.12.755; LYLE R, 1995, GENOMICS, V28, P389, DOI 10.1006/geno.1995.1166; Marks PA, 2001, CURR OPIN ONCOL, V13, P477, DOI 10.1097/00001622-200111000-00010; Masny PS, 2004, HUM MOL GENET, V13, P1857, DOI 10.1093/hmg/ddh205; Meehan RR, 2005, EXP CELL RES, V309, P241, DOI 10.1016/j.yexcr.2005.06.023; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Neguembor MV, 2010, EPIGENOMICS-UK, V2, P271, DOI [10.2217/epi.10.8, 10.2217/EPI.10.8]; Ottaviani A, 2009, EMBO J, V28, P2428, DOI 10.1038/emboj.2009.201; Ottaviani A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000394; Rijkers T, 2004, J MED GENET, V41, P826, DOI 10.1136/jmg.2004.019364; Sekimata M, 2011, BIOCHEM BIOPH RES CO, V414, P767, DOI 10.1016/j.bbrc.2011.09.155; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Tam R, 2004, J CELL BIOL, V167, P269, DOI 10.1083/jcb.200403128; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; Tupler R, 2004, CELL MOL LIFE SCI, V61, P557, DOI 10.1007/s00018-003-3285-3; van Geel M, 2002, GENOMICS, V79, P210, DOI 10.1006/geno.2002.6690; van Overveld PGM, 2005, ANN NEUROL, V58, P569, DOI 10.1002/ana.20625; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; Vanhaecke T, 2004, CURR MED CHEM, V11, P1629, DOI 10.2174/0929867043365099; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559; Zhang Yingying, 2009, V507, P177, DOI 10.1007/978-1-59745-522-0_14	61	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115278	10.1371/journal.pone.0115278	http://dx.doi.org/10.1371/journal.pone.0115278			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545674	Green Submitted, gold, Green Published			2022-12-26	WOS:000347120200032
J	Langhans, SD; Tockner, K				Langhans, Simone D.; Tockner, Klement			Edge Effects Are Important in Supporting Beetle Biodiversity in a Gravel-Bed River Floodplain	PLOS ONE			English	Article							TAGLIAMENTO RIVER; GROUND BEETLE; BRAIDED-RIVER; COLEOPTERA; CARABIDAE; HABITAT; INVERTEBRATES; SEDIMENTS; ECOLOGY; FOREST	Understanding complex, dynamic, and diverse ecosystems is essential for developing sound management and conservation strategies. Gravel-bed river floodplains are composed of an interlinked mosaic of aquatic and terrestrial habitats hosting a diverse, specialized, and endangered fauna. Therefore, they serve as excellent models to investigate the biodiversity of multiple ecotones and related edge effects. In this study, we investigated the abundance, composition, richness, and conservation status of beetle assemblages at varying sediment depth (0, 0.1, 0.6 and 1.1 m), distance from the channel (1, 5, 20, and 60-100 m, and 5 m within the riparian forest), and time of the year (February-November) across a 200 m-wide gravel bar at the near-natural Tagliamento River (Italy), to detect edge effects in four floodplain ecotones: aquatic-terrestrial, forest-active floodplain, sediment-air, and sediment-groundwater. We used conventional pitfall traps and novel tube traps to sample beetles comparably on the sediment surface and within the unsaturated sediments. We found a total of 308 beetle species (including 87 of conservation concern) that showed multiple, significant positive edge effects across the floodplain ecotones, mainly driven by spatial heterogeneity: Total and red list beetle abundance and richness peaked on the sediment surface, at channel margins, and at the edge of the riparian forest. All ecotones possessed edge/habitat specialists. Most red list species occurred on the sediment surface, including five species previously considered extinct - yet two of these species occurred in higher densities in the unsaturated sediments. Conservation and management efforts along gravel-bed rivers must therefore promote a dynamic flow and sediment regime to create and maintain habitat heterogeneity and ecotone diversity, which support a unique and high biodiversity.	[Langhans, Simone D.] Swiss Fed Inst Aquat Sci & Technol, Eawag, CH-8600 Dubendorf, Switzerland; [Langhans, Simone D.] ETH Zrich, Inst Integrat Biol, CH-8092 Zurich, Switzerland; [Langhans, Simone D.; Tockner, Klement] Leibniz Inst Freshwater Ecol & Inland Fisheries, D-12587 Berlin, Germany; [Tockner, Klement] Free Univ Berlin, Inst Biol, Berlin, Germany	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Free University of Berlin	Langhans, SD (corresponding author), Swiss Fed Inst Aquat Sci & Technol, Eawag, Uberlandstr 133, CH-8600 Dubendorf, Switzerland.	langhans@igb-berlin.de	Tockner, Klement/G-9265-2011; Langhans, Simone D/A-5314-2019	Langhans, Simone Daniela/0000-0001-9581-3183; Tockner, Klement/0000-0002-0038-8151	European Commission; tempQsim-project [EVK1-CT-20020012]; Swiss State Secretariat for Education and Research (SBF) [02.0072]; Alexander von Humboldt-Foundation	European Commission(European CommissionEuropean Commission Joint Research Centre); tempQsim-project; Swiss State Secretariat for Education and Research (SBF); Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation)	This research was funded by the European Commission and supported through the tempQsim-project (contract no. EVK1-CT-20020012) and the Swiss State Secretariat for Education and Research (SBF no. 02.0072). S. D. Langhans was additionally supported by the Alexander von Humboldt-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoros C, 1996, FLUVIAL HYDROSYSTEMS, P184; ANDERSEN J, 1968, Norsk Entomologisk Tidsskrift, V15, P115; Andersen J, 2011, J INSECT CONSERV, V15, P799, DOI 10.1007/s10841-011-9378-7; BAARS MA, 1979, OECOLOGIA, V41, P25, DOI 10.1007/BF00344835; Bates AJ, 2006, OECOLOGIA, V150, P50, DOI 10.1007/s00442-006-0508-y; BAUER T, 1985, J INSECT PHYSIOL, V31, P593, DOI 10.1016/0022-1910(85)90057-5; Binot M., 1998, ROTE LISTE GEFAHRDET; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Cao Y, 1999, LIMNOL OCEANOGR, V44, P1841; Cao Y, 2001, J N AM BENTHOL SOC, V20, P144, DOI 10.2307/1468195; Cardenas AM, 2004, VIE MILIEU, V54, P47; Corti R, 2013, HYDROBIOLOGIA, V717, P13, DOI 10.1007/s10750-013-1563-0; Datry T, 2014, FRESHWATER BIOL, V59, P1308, DOI 10.1111/fwb.12350; Dieterich M, 1996, VERHANDLUNGEN DER GESELLSCHAFT FUR OKOLOGIE, VOL 26, P363; Ewers RM, 2008, P NATL ACAD SCI USA, V105, P5426, DOI 10.1073/pnas.0800460105; Ewers RM, 2006, J APPL ECOL, V43, P527, DOI 10.1111/j.1365-2664.2006.01151.x; Eyre MD, 2001, J INSECT CONSERV, V5, P173, DOI 10.1023/A:1017956927482; Hering D, 1997, OECOLOGIA, V111, P261, DOI 10.1007/s004420050234; Hering D, 1998, COLEOPTS BULL, V52, P161; Horvath R., 2002, Web Ecology, V3, P43; Imbeau L, 2003, ECOGRAPHY, V26, P514, DOI 10.1034/j.1600-0587.2003.03509.x; Johnson VE, 2013, P NATL ACAD SCI USA, V110, P19313, DOI 10.1073/pnas.1313476110; Kahlen M, 2003, GORTANIA, V24, P147; Kahlen Manfred, 2009, Gortania-Atti del Museo Friulano di Storia Naturale Botanica Zoologia, V31, P65; Karrenberg S, 2003, BASIC APPL ECOL, V4, P157, DOI 10.1078/1439-1791-00123; Langhans SD, 2014, GLOB ECOL CONSERV, V2, P129, DOI 10.1016/j.gecco.2014.08.009; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lovei GL, 2006, GLOBAL ECOL BIOGEOGR, V15, P283, DOI 10.1111/j.1466-8238.2005.00221.x; LUFF ML, 1975, OECOLOGIA, V19, P345, DOI 10.1007/BF00348110; Magura T., 2001, Web Ecology, V2, P7; Magura T, 2001, BIODIVERS CONSERV, V10, P287, DOI 10.1023/A:1008967230493; Molnar T, 2001, EUR J SOIL BIOL, V37, P297, DOI 10.1016/S1164-5563(01)01103-7; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Naiman R, 1990, ECOLOGY MANAGEMENT A; NAIMAN RJ, 1988, J N AM BENTHOL SOC, V7, P289, DOI 10.2307/1467295; Naiman RJ, 2005, RIPARIA ECOLOGY CONS; OKLAND RH, 1994, J VEG SCI, V5, P117, DOI 10.2307/3235645; Okland RH, 1999, J VEG SCI, V10, P131, DOI 10.2307/3237168; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Paetzold A, 2005, ECOSYSTEMS, V8, P748, DOI 10.1007/s10021-005-0004-y; Parris KM, 2004, ECOGRAPHY, V27, P392, DOI 10.1111/j.0906-7590.2004.03711.x; Pe'er G, 2008, ECOL MODEL, V213, P73, DOI 10.1016/j.ecolmodel.2007.11.020; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Petts GE, 2000, AQUAT CONSERV, V10, P249, DOI 10.1002/1099-0755(200007/08)10:4<249::AID-AQC410>3.0.CO;2-R; Poos MS, 2012, ECOL INDIC, V18, P82, DOI 10.1016/j.ecolind.2011.10.008; R Core Team, 2021, R LANGUAGE ENV STAT; Sadler JP, 2004, BIOL CONSERV, V118, P41, DOI 10.1016/j.biocon.2003.07.007; Sadler JP, 2000, W196 R D ENV AG; Smilauer, 1998, REFERENCE MANUAL USE; Stanley EH, 2010, J N AM BENTHOL SOC, V29, P67, DOI 10.1899/08-027.1; Steward AL, 2011, AQUAT SCI, V73, P551, DOI 10.1007/s00027-011-0217-4; Strayer DL, 2003, BIOSCIENCE, V53, P723, DOI 10.1641/0006-3568(2003)053[0723:ACOEB]2.0.CO;2; Thomas JA, 2001, P ROY SOC B-BIOL SCI, V268, P1791, DOI 10.1098/rspb.2001.1693; Tockner K, 2003, AQUAT SCI, V65, P239, DOI 10.1007/s00027-003-0699-9; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; Tockner K., 2006, BRAIDED RIVERS PROCE, DOI [10.1002/9781444304374.ch17, DOI 10.1002/9781444304374.CH17]; Tockner K, 2010, FRESHWATER BIOL, V55, P135, DOI 10.1111/j.1365-2427.2009.02371.x; van der Nat D, 2002, ECOSYSTEMS, V5, P636, DOI 10.1007/s10021-002-0170-0; Ward JV, 2002, FRESHWATER BIOL, V47, P517, DOI 10.1046/j.1365-2427.2002.00893.x; Ward JV, 1999, REGUL RIVER, V15, P125, DOI 10.1002/(SICI)1099-1646(199901/06)15:1/3&lt;125::AID-RRR523&gt;3.0.CO;2-E; West B. T., 2007, LINEAR MIXED MODELS; Wiens JA, 2002, FRESHWATER BIOL, V47, P501, DOI 10.1046/j.1365-2427.2002.00887.x	63	10	11	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e114415	10.1371/journal.pone.0114415	http://dx.doi.org/10.1371/journal.pone.0114415			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545280	Green Submitted, Green Published, gold			2022-12-26	WOS:000347120200012
J	Obry, A; Lequerre, T; Hardouin, J; Boyer, O; Fardellone, P; Philippe, P; Le Loet, X; Cosette, P; Vittecoq, O				Obry, Antoine; Lequerre, Thierry; Hardouin, Julie; Boyer, Olivier; Fardellone, Patrice; Philippe, Peggy; Le Loet, Xavier; Cosette, Pascal; Vittecoq, Olivier			Identification of S100A9 as Biomarker of Responsiveness to the Methotrexate/Etanercept Combination in Rheumatoid Arthritis Using a Proteomic Approach	PLOS ONE			English	Article							INFLAMMATORY JOINT DISEASES; MASS-SPECTROMETRY; SYNOVIAL-FLUID; SERUM-LEVELS; BLOOD-CELLS; PROTEINS; CALPROTECTIN; ETANERCEPT; THERAPY; INFLIXIMAB	Objectives: One way to optimize the drug prescription in rheumatoid arthritis (RA) is to identify predictive biomarkers of drug responsiveness. Here, we investigated the potential "theranostic" value of proteins of the S100 family by monitoring levels of both S100A8 and S100A9 in blood samples from RA patients. Design: For proteomic analysis, peripheral blood mononuclear cells (PBMC) and serum samples were collected in patients prior to initiation of the methotrexate/etanercept (MTX/ETA) combination. Firstly, relative mass spectrometry (MS) quantification focusing on S100A8 and S100A9 proteins was carried out from PBMCs samples to identify potential biomarkers. The same approach was also performed from serum samples from responder (R) and non responder (NR) patients. Finally, to confirm these results, an absolute quantification of S100A8, S100A9 proteins and calprotectin (heterodimer of S100A8/S100A9) was carried out on the serum samples using ELISA. Results: MS analyses revealed that both S100A8 and S100A9 proteins were significantly accumulated in PBMC from responders. In contrast to PBMC, only the S100A9 protein was significantly overexpressed in the serum of R patients. Absolute quantification by ELISA confirmed this result and pointed out a similar expression level of S100A8 protein and calprotectin in sera from both R and NR groups. Thus, the S100A9 protein revealed to be predictive of MTX/ETA responsiveness, contrarily to parameters of inflammation and auto-antibodies which did not allow significant discrimination. Conclusion: This is the first report of an overexpression of S100A9 protein in both PBMCs and serum of patients with subsequent response to the MTX/ETA combination. This protein thus represents an interesting biomarker candidate of therapeutic response in RA.	[Obry, Antoine; Lequerre, Thierry; Boyer, Olivier; Le Loet, Xavier; Vittecoq, Olivier] INSERM, U905, F-76000 Rouen, France; [Obry, Antoine; Hardouin, Julie; Cosette, Pascal] CNRS, UMR 6270, F-76821 Mont St Aignan, France; [Obry, Antoine; Hardouin, Julie; Cosette, Pascal] PISSARO Prote Facil, F-76821 Mont St Aignan, France; [Obry, Antoine; Lequerre, Thierry; Hardouin, Julie; Boyer, Olivier; Le Loet, Xavier; Vittecoq, Olivier] Normandy Univ, Inst Res & Innovat Biomed, F-76821 Mont St Aignan, France; [Lequerre, Thierry; Le Loet, Xavier; Vittecoq, Olivier] Rouen Univ Hosp, Dept Rheumatol, F-76000 Rouen, France; [Lequerre, Thierry; Vittecoq, Olivier] INSERM, Ctr Invest Clin 1404, F-76000 Rouen, France; [Boyer, Olivier] Rouen Univ Hosp, Dept Immunol, F-76000 Rouen, France; [Fardellone, Patrice] Amiens Univ Hosp, Dept Rheumatol, F-80000 Amiens 1, France; [Philippe, Peggy] Univ Hosp Lille, F-59037 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Universite de Lille - ISITE; CHU Lille	Cosette, P (corresponding author), CNRS, UMR 6270, F-76821 Mont St Aignan, France.	pascal.cosette@univ-rouen.fr	Boyer, Olivier/N-6552-2013	Boyer, Olivier/0000-0002-7591-307X; Cosette, Pascal/0000-0002-7588-0167; Hardouin, Julie/0000-0003-4588-9811	French Ministry of Health; European Regional Development Fund (FEDER program) [33267]; Interreg IVA PeReNE project [4230]	French Ministry of Health; European Regional Development Fund (FEDER program); Interreg IVA PeReNE project	This study was supported by the French Ministry of Health, European Regional Development Fund (FEDER program 33267) and the the Interreg IVA PeReNE project (project 4230). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baillet A, 2010, RHEUMATOLOGY, V49, P671, DOI 10.1093/rheumatology/kep452; BARTHE C, 1991, BIOCHIM BIOPHYS ACTA, V1096, P175, DOI 10.1016/0925-4439(91)90057-G; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; Benoit S, 2006, BRIT J DERMATOL, V155, P62, DOI 10.1111/j.1365-2133.2006.07198.x; Brennan FM, 1998, SPRINGER SEMIN IMMUN, V20, P133, DOI 10.1007/BF00832003; Cerezo LA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3426; de Seny D, 2005, ARTHRITIS RHEUM-US, V52, P3801, DOI 10.1002/art.21607; Drynda S, 2004, PATHOL RES PRACT, V200, P165, DOI 10.1016/j.prp.2004.02.011; Fabre S, 2008, CLIN EXP IMMUNOL, V153, P188, DOI 10.1111/j.1365-2249.2008.03691.x; Foell D, 2004, CLIN CHIM ACTA, V344, P37, DOI 10.1016/j.cccn.2004.02.023; HAGA HJ, 1993, LUPUS, V2, P47, DOI 10.1177/096120339300200108; Hammer HB, 2007, ANN RHEUM DIS, V66, P1093, DOI 10.1136/ard.2006.064741; Hammer HB, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3503; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Hueber W, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2706; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P353, DOI 10.1002/art.20019; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Lequerre T, 2007, RHEUMATOLOGY, V46, P446, DOI 10.1093/rheumatology/kel262; Lequerre T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1990; Liao H, 2004, ARTHRITIS RHEUM-US, V50, P3792, DOI 10.1002/art.20720; Lugering N, 1997, IMMUNOLOGY, V91, P130, DOI 10.1046/j.1365-2567.1997.00221.x; Meugnier E, 2011, PHYSIOL GENOMICS, V43, P365, DOI 10.1152/physiolgenomics.00127.2010; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Singh JA, 2009, CAN MED ASSOC J, V181, P787, DOI 10.1503/cmaj.091391; Sinz A, 2002, ELECTROPHORESIS, V23, P3445, DOI 10.1002/1522-2683(200210)23:19<3445::AID-ELPS3445>3.0.CO;2-J; Summerton CB, 2002, EUR J GASTROEN HEPAT, V14, P841, DOI 10.1097/00042737-200208000-00005; Sweet SP, 2001, ORAL MICROBIOL IMMUN, V16, P119, DOI 10.1034/j.1399-302x.2001.016002119.x; Uchida T, 2002, J PROTEOME RES, V1, P495, DOI 10.1021/pr025531w; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446	31	38	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115800	10.1371/journal.pone.0115800	http://dx.doi.org/10.1371/journal.pone.0115800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546405	Green Published, gold, Green Submitted			2022-12-26	WOS:000347120200070
J	Schrobback, P; Pascoe, S; Coglan, L				Schrobback, Peggy; Pascoe, Sean; Coglan, Louisa			Shape Up or Ship Out: Can We Enhance Productivity in Coastal Aquaculture to Compete with Other Uses?	PLOS ONE			English	Article							TECHNICAL EFFICIENCY; CAPACITY UTILIZATION; PRODUCTION FRONTIER; 2ND-STAGE DEA; MORETON BAY; OYSTERS; MANAGEMENT; FISHERIES; IMPACTS; QUALITY	Coastal resources are coming under increasing pressure from competition between recreational, commercial and conservation uses. This is particularly so in coastal areas adjacent to major population centres. Given high recreational and conservation values in such areas, economic activities need to be highly efficient in order to persist. Management of these industries must therefore also encourage efficient production and full utilisation of the areas available. In order to achieve this, managers must first understand the level and drivers of productivity, and how these can be influenced. In this study, by way of illustration, the focus was on the Sydney rock oyster industry within Queensland's Moreton Bay, a multiple use marine park with high recreational and conservation value adjacent to Australia's third largest city. Productivity of the oyster industry in Moreton Bay is currently low compared to historic levels, and management has an objective of reversing this trend. It is unclear whether this difference is due to oyster farmers' business choices and personal characteristics or whether varying environmental conditions in the Moreton Bay limit the capacity of the oyster industry. These require different management responses in order to enhance productivity. The study examined different productivity measures of the oyster industry using data envelopment analysis (DEA) to determine where productivity gains can be made and by how much. The findings suggest that the industry is operating at a high level of capacity utilisation, but a low level of efficiency. The results also suggest that both demographic and environmental conditions affect technical efficiency in the Bay, with water characteristics improvements and appropriate training potentially providing the greatest benefits to the industry. Methods used in this study are transferable to other industries and provide a means by which coastal aquaculture may be managed to ensure it remains competitive with other uses of coastal resources.	[Schrobback, Peggy; Coglan, Louisa] Queensland Univ Technol, Sch Econ & Finance, Brisbane, Qld 4001, Australia; [Pascoe, Sean] CSIRO Oceans & Atmospher Flagship, EcoSci Precinct, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Schrobback, P (corresponding author), Queensland Univ Technol, Sch Econ & Finance, Brisbane, Qld 4001, Australia.	p.schrobback@gmail.com	Coglan, Louisa/J-1113-2012; Coglan, Louisa/AAF-2356-2019; Schrobback, Peggy/X-4697-2019; Pascoe, Sean/D-9710-2011	Coglan, Louisa/0000-0001-5730-7845; Coglan, Louisa/0000-0001-5730-7845; Schrobback, Peggy/0000-0003-0526-1659; Pascoe, Sean/0000-0001-6581-2649	Fisheries Research Development Cooperation (FRDC) [2008/306]; Commonwealth Scientific and Industrial Research Organisation (CSIRO)	Fisheries Research Development Cooperation (FRDC)(Fisheries R&D Corp); Commonwealth Scientific and Industrial Research Organisation (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	The authors would like to acknowledge the financial support of the Fisheries Research Development Cooperation (FRDC) (www.frdc.com.au) under the FRDC-funded project 2008/306: "Building economic capability to improve the management of marine resources in Australia,'' and in-kind support of the Commonwealth Scientific and Industrial Research Organisation (CSIRO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABARES (Australian Bureau of Agricultural and Resource Economics and Sciences), 2013, AUSTR FISH STAT 2012; Ahmed N, 2011, AUST J AGR RESOUR EC, V55, P199, DOI 10.1111/j.1467-8489.2011.00535.x; Alam MF, 2011, AQUAC RES, V42, P1487, DOI 10.1111/j.1365-2109.2010.02741.x; [Anonymous], 2000, AQUACULT ECON MANAG, V4, P33, DOI [10.1080/13657300009380259, DOI 10.1080/13657300009380259]; [Anonymous], 1981, J ROYAL HIST SOC QUE; Australian Government, 2014, AUSTR RAMS WETL; Australian Taxation Office, 2013, TAX WITHH CALC IND N; Azizi H, 2010, COMPUT IND ENG, V59, P411, DOI 10.1016/j.cie.2010.05.013; BANKER RD, 1984, MANAGE SCI, V30, P1078, DOI 10.1287/mnsc.30.9.1078; Bayne BL, 1999, BIOL BULL-US, V197, P377, DOI 10.2307/1542792; Byron C, 2011, MAR POLICY, V35, P363, DOI 10.1016/j.marpol.2010.10.016; Chambers RG, 2011, AUST J AGR RESOUR EC, V55, P90, DOI 10.1111/j.1467-8489.2010.00517.x; Chapelle A, 2000, ECOL MODEL, V127, P161, DOI 10.1016/S0304-3800(99)00206-9; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; Chiang FS, 2004, AQUACULTURE, V230, P99, DOI 10.1016/j.aquaculture.2003.09.038; Coelli T, 2000, APPL ECON, V32, P1967, DOI 10.1080/00036840050155896; Coelli T. J., 2005, MEDICINE; de la Mare W, 2012, MAR POLLUT BULL, V64, P704, DOI 10.1016/j.marpolbul.2012.01.039; DOVE MC, 2003, THESIS U NEW S WALES; Dove MC, 2007, J SHELLFISH RES, V26, P939, DOI 10.2983/0730-8000(2007)26[939:SATTOS]2.0.CO;2; DPI NSW, 2013, AQUACULTURE PRODUCTI; Dupont DP, 2002, RESOUR ENERGY ECON, V24, P193, DOI 10.1016/S0928-7655(01)00050-1; FARE R, 1989, INT ECON REV, V30, P655, DOI 10.2307/2526781; FARE R, 1983, RESOUR ENERG, V5, P349, DOI 10.1016/0165-0572(83)90033-6; Fare R, 2000, J PROD ANAL, V13, P93, DOI 10.1023/A:1007844628920; Fare R, 2000, B EC RES, V52, P101, DOI DOI 10.1111/1467-8586.00097; Grant J, 1997, J MAR RES, V55, P965, DOI 10.1357/0022240973224193; GROSSKOPF S, 1995, EUR J OPER RES, V80, P575, DOI 10.1016/0377-2217(94)00138-3; Healthy Waterways Ltd, 2012, EST MAR DAT EC HLTH; Higgins CB, 2011, J ENVIRON QUAL, V40, P271, DOI 10.2134/jeq2010.0203; Hoff A, 2007, EUR J OPER RES, V181, P425, DOI 10.1016/j.ejor.2006.05.019; Holland DS, 2002, EUR J OPER RES, V137, P10, DOI 10.1016/S0377-2217(01)00087-X; Holliday JE, 1995, THESIS U TASMANIA; Humphreys J, 2014, AQUACULTURE, V428, P117, DOI 10.1016/j.aquaculture.2014.02.034; Iliyasu A, 2014, AQUACULT ECON MANAG, V18, P221, DOI 10.1080/13657305.2014.926464; Irz X., 2003, Aquaculture Economics & Management, V7, P195, DOI 10.1080/13657300309380340; Islam MS, 2004, MAR POLLUT BULL, V48, P624, DOI 10.1016/j.marpolbul.2003.12.004; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kellogg ML, 2013, MAR ECOL PROG SER, V480, P1, DOI 10.3354/meps10331; Kieschnick R, 2003, STAT MODEL, V3, P193, DOI 10.1191/1471082X03st053oa; Klein CJ, 2010, FRONT ECOL ENVIRON, V8, P349, DOI 10.1890/090047; Lampe HW, 2014, EUROPEAN J OPERATION; Lergessner JG, 2006, OYSTERERS MORETON BA; Mazor T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104489; McDonald J, 2009, EUR J OPER RES, V197, P792, DOI 10.1016/j.ejor.2008.07.039; Mugera AW, 2013, AUST J AGR RESOUR EC, V57, P501, DOI 10.1111/1467-8489.12008; O'Donnell CJ, 2005, J ECONOMETRICS, V126, P493, DOI 10.1016/j.jeconom.2004.05.011; Ogburn DM, 2007, COAST MANAGE, V35, P271, DOI 10.1080/08920750601169618; Onumah EE, 2010, J WORLD AQUACULT SOC, V41, P506, DOI 10.1111/j.1749-7345.2010.00391.x; Pantus FJ, 2005, ENVIRON MANAGE, V36, P757, DOI 10.1007/s00267-003-0110-6; Parker LM, 2011, MAR BIOL, V158, P689, DOI 10.1007/s00227-010-1592-4; Pascoe S, 2000, MAR POLICY, V24, P301, DOI 10.1016/S0308-597X(00)00006-3; Pascoe S., 2002, Aquaculture Economics & Management, V6, P295, DOI 10.1080/13657300209380320; Pascoe S, 2014, TOURISM MANAGE, V41, P53, DOI 10.1016/j.tourman.2013.08.015; Pascoe S, 2010, EUR REV AGRIC ECON, V37, P313, DOI 10.1093/erae/jbq022; QLD DPI, 2008, OYST IND MAN PLAN MO; QLD DPI&F, 2007, POL MAX ROCK OYST PR; QLD DPI&F, 2008, OYST IND MAN PLAN MO; Reid C, 2003, MAR POLICY, V27, P449, DOI 10.1016/S0308-597X(03)00065-4; Rubio Zuazo AM, 2008, THESIS AUSTR NATL U; Schrobback P, 2014, AQUACULT ECON MANAG, V18, P248, DOI 10.1080/13657305.2014.926465; Sharma K.R., 1998, MAR RESOUR ECON, V13, P259, DOI 10.1086/mre.13.4.42629241.; Sharma KR, 2000, AQUAC RES, V31, P937, DOI 10.1046/j.1365-2109.2000.00521.x; Singh K., 2009, AG EC RE REV, V22, P185; Smith G., 1985, QUEENSLAND OYSTER FI; Stewart RR, 2005, ENVIRON MODEL ASSESS, V10, P203, DOI 10.1007/s10666-005-9001-y; Tingley D, 2005, J AGR ECON, V56, P287, DOI 10.1111/j.1477-9552.2005.00005.x; Tingley D, 2005, FISH RES, V73, P363, DOI 10.1016/j.fishres.2005.01.008; Vestergaard N, 2003, FISH RES, V60, P357, DOI 10.1016/S0165-7836(02)00141-8; Whitmore M, 2005, SUSTAINABLE DEV MANA; Wingfield M, 2013, ANN SYDNEY ROCK OYST	71	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115912	10.1371/journal.pone.0115912	http://dx.doi.org/10.1371/journal.pone.0115912			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UN	25545861	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200081
J	Yu, HT; Tian, D; Wang, JY; Guo, CX; Li, Y; Wang, X; Li, D; Zhang, FM; Zhuang, M; Ling, H				Yu, Hao-Tong; Tian, Dan; Wang, Jia-Ye; Guo, Cai-Xia; Li, Yan; Wang, Xin; Li, Di; Zhang, Feng-Min; Zhuang, Min; Ling, Hong			An HIV-1 Envelope Immunogen with W427S Mutation in CD4 Binding Site Induced More T Follicular Helper Memory Cells and Reduced Non-Specific Antibody Responses	PLOS ONE			English	Article							VACCINE EFFICACY TRIAL; TEST-OF-CONCEPT; NEUTRALIZING ANTIBODIES; CD4-BINDING SITE; GERMINAL CENTER; DOUBLE-BLIND; B-CELLS; VIRUS; INFECTION; GLYCOPROTEIN	The CD4 binding site (CD4BS) of the HIV-1 envelope glycoprotein (Env) contains epitopes for broadly neutralizing antibody (nAb) and is the target for the vaccine development. However, the CD4BS core including residues 425-430 overlaps the B cell superantigen site and may be related to B cell exhaustion in HIV-1 infection. Furthermore, production of nAb and high-affinity plasma cells needs germinal center reaction and the help of T follicular helper (Tfh) cells. We believe that strengthening the ability of Env CD4BS in inducing Tfh response and decreasing the effects of the superantigen are the strategies for eliciting nAb and development of HIV-1 vaccine. We constructed a gp120 mutant W427S of an HIV-1 primary R5 strain and examined its ability in the elicitation of Ab and the production of Tfh by immunization of BALB/c mice. We found that the trimeric wild-type gp120 can induce more non-specific antibody-secreting plasma cells, higher serum IgG secretion, and more Tfh cells by splenocyte. The modified W427S gp120 elicits higher levels of specific binding antibodies as well as nAbs though it produces less Tfh cells. Furthermore, higher Tfh cell frequency does not correlate to the specific binding Abs or nAbs indicating that the wild-type gp120 induced some non-specific Tfh that did not contribute to the production of specific Abs. This gp120 mutant led to more memory Tfh production, especially, the effector memory Tfh cells. Taken together, W427S gp120 could induce higher level of specific binding and neutralizing Ab production that may be associated with the reduction of non-specific Tfh but strengthening of the memory Tfh.	[Yu, Hao-Tong; Tian, Dan; Wang, Jia-Ye; Guo, Cai-Xia; Li, Yan; Wang, Xin; Li, Di; Zhang, Feng-Min; Zhuang, Min; Ling, Hong] Harbin Med Univ, Dept Microbiol, Harbin, Peoples R China; [Wang, Jia-Ye; Li, Yan; Li, Di; Zhang, Feng-Min; Zhuang, Min; Ling, Hong] Key Lab Etiol Heilongjiang Prov Educ Bur, Heilongjiang Prov Key Lab Infect & Immun, Harbin, Peoples R China; [Ling, Hong] Harbin Med Univ, Dept Parasitol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Zhuang, M (corresponding author), Harbin Med Univ, Dept Microbiol, Harbin, Peoples R China.	zhuangm@ems.hrbmu.edu.cn; lingh@ems.hrbmu.edu.cn	Tian, Dan/AAR-4019-2020	Tian, Dan/0000-0002-6894-2673; ling, hong/0000-0002-1886-1242	Key Projects in the National Science & Technology Pillar Program [2012ZX10001009-002-003]; National Natural Science Foundation of China [30771910, 81271824, 81202364]	Key Projects in the National Science & Technology Pillar Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Key Projects in the National Science & Technology Pillar Program during the twelfth Five-Year Plan Period (2012ZX10001009-002-003), and The National Natural Science Foundation of China (30771910; 81271824; 81202364). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameri M, 2008, J MED ENTOMOL, V45, P94, DOI 10.1603/0022-2585(2008)45[94:AIBPAO]2.0.CO;2; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Bonsignori M, 2012, J VIROL, V86, P11521, DOI 10.1128/JVI.01023-12; Bouhdoud L, 2000, J VIROL, V74, P2121, DOI 10.1128/JVI.74.5.2121-2130.2000; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; BUERKI H, 1989, IMMUNOL LETT, V23, P87, DOI 10.1016/0165-2478(89)90118-1; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Carbonetti S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086905; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Deenick EK, 2011, IMMUNOLOGY, V134, P361, DOI 10.1111/j.1365-2567.2011.03487.x; Dosenovic P, 2009, J IMMUNOL, V183, P3373, DOI 10.4049/jimmunol.0900407; Euler Z, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00215; Feng Y, 2012, J BIOL CHEM, V287, P5673, DOI 10.1074/jbc.M111.317776; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Gray G, 2010, CURR OPIN HIV AIDS, V5, P357, DOI 10.1097/COH.0b013e32833d2d2b; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hioe CE, 2009, VACCINE, V28, P352, DOI 10.1016/j.vaccine.2009.10.040; Hollister K, 2014, HUM VACCIN IMMUNOTHE, V10; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Karray S, 1997, P NATL ACAD SCI USA, V94, P1356, DOI 10.1073/pnas.94.4.1356; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; LANDAU NR, 1988, NATURE, V334, P159, DOI 10.1038/334159a0; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Moir S, 2013, IMMUNOL REV, V254, P207, DOI 10.1111/imr.12067; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Narayan KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052732; Nishiyama Y, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00383; OLSHEVSKY U, 1990, J VIROL, V64, P5701, DOI 10.1128/JVI.64.12.5701-5707.1990; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Planque SA, 2012, J IMMUNOL, V189, P5367, DOI 10.4049/jimmunol.1200981; Ramiscal RR, 2013, IMMUNOL REV, V252, P146, DOI 10.1111/imr.12031; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; ROBEY WG, 1986, P NATL ACAD SCI USA, V83, P7023, DOI 10.1073/pnas.83.18.7023; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; SCHNITTMAN SM, 1986, SCIENCE, V233, P1084, DOI 10.1126/science.3016902; Silverman GJ, 2006, NAT REV IMMUNOL, V6, P465, DOI 10.1038/nri1853; Stamatatos L, 2012, CURR OPIN IMMUNOL, V24, P316, DOI 10.1016/j.coi.2012.04.006; Stephenson KE, 2013, IMMUNOL REV, V254, P295, DOI 10.1111/imr.12073; Sundling C, 2013, J INFECT DIS, V207, P426, DOI 10.1093/infdis/jis696; THALI M, 1992, J VIROL, V66, P5635, DOI 10.1128/JVI.66.9.5635-5641.1992; Townsley-Fuchs J, 1997, Int Rev Immunol, V14, P325, DOI 10.3109/08830189709116523; Van Regenmortel MHV, 2011, J MOL RECOGNIT, V24, P741, DOI 10.1002/jmr.1116; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang JY, 2011, APPL MICROBIOL BIOT, V91, P731, DOI 10.1007/s00253-011-3297-0; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Willinger T, 2005, J IMMUNOL, V175, P5895, DOI 10.4049/jimmunol.175.9.5895; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	63	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115047	10.1371/journal.pone.0115047	http://dx.doi.org/10.1371/journal.pone.0115047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546013	Green Submitted, Green Published, gold			2022-12-26	WOS:000347120200019
J	Yuki, K; Asaoka, R; Tsubota, K				Yuki, Kenya; Asaoka, Ryo; Tsubota, Kazuo			The Relationship between Central Visual Field Damage and Motor Vehicle Collisions in Primary Open-Angle Glaucoma Patients	PLOS ONE			English	Article							QUALITY-OF-LIFE; OLDER-ADULTS; EYE; RISK; QUESTIONNAIRE; ASSOCIATION; SENSITIVITY; INVOLVEMENT; STAGE	Purpose: To investigate the relationship between visual field (VF) damage and history of motor vehicle collisions (MVCs) in subjects with primary open-angle glaucoma (POAG). Methods: MVC history and driving habits were recorded using patient questionnaires in 247 POAG patients. Patients' driving attitudes (carefulness) were estimated using Rasch analysis. The relationship between MVC outcomes and 52 total deviation (TD) values of integrated binocular VF (IVF), better and worse visual acuities (VAs), age and gender was analyzed using principal component analysis and logistic regression. Results: 51 patients had the history of MVCs. Significant difference was observed between patients with and without history of MVCs only for: better VA, a single TD value in the superior-right VF, and the typical distance driven in a week (unpaired t-test, p=0.002, 0.015 and 0.006, respectively). There was not a significant relationship between MVCs and mean deviation (MD) of IVF (p=0.41, logistic regression). None of the principal components were significantly correlated with MVC outcome (p>0.05, polynomial logistic regression analysis). There was a significant relationship between IVF MD and Rasch derived Person parameter (R-2 = 0.023, p=0.0095). There was also a significant positive relationship between MVCs and the distance driven in a week (p=0.005, logistic regression). Conclusions: In this study of POAG patients, MVCs were not related to central binocular VF damage. These results suggest the relationship between visual function and driving is not straightforward, and careful consideration should be given when predicting patients' driving ability using their VF.	[Yuki, Kenya; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Asaoka, Ryo] Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan	Keio University; University of Tokyo	Asaoka, R (corresponding author), Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan.	rasaoka-tky@umin.ac.jp			Japan Science and Technology Agency (JST) CREST; KAKENHI Grant [26462679]	Japan Science and Technology Agency (JST) CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	RA (Japan Science and Technology Agency (JST) CREST and KAKENHI Grant 26462679). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora KS, 2013, OPHTHALMOLOGY, V120, P2476, DOI 10.1016/j.ophtha.2013.07.020; Asaoka R, 2013, BRIT J OPHTHALMOL, V97, P1355, DOI 10.1136/bjophthalmol-2013-303431; Asaoka R, 2013, GRAEF ARCH CLIN EXP, V251, P1335, DOI 10.1007/s00417-012-2214-2; Asaoka R, 2011, INVEST OPHTH VIS SCI, V52, P7007, DOI 10.1167/iovs.11-7643; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black AA, 2008, OPTOMETRY VISION SCI, V85, P489, DOI 10.1097/OPX.0b013e31817882db; Black AA, 2011, OPHTHAL PHYSL OPT, V31, P283, DOI 10.1111/j.1475-1313.2010.00811.x; Bond TG., 2020, APPL RASCH MODEL FUN; Bowers A, 2005, OPTOMETRY VISION SCI, V82, P657, DOI 10.1097/01.opx.0000175558.33268.b5; Bronstad PM, 2013, JAMA OPHTHALMOL, V131, P303, DOI 10.1001/jamaophthalmol.2013.1443; Burian MA, 1980, PHYSL SENSORIMOTOR C; Cochrane GM, 2011, INVEST OPHTH VIS SCI, V52, P1632, DOI 10.1167/iovs.10-6079; Coleman AL, 2009, J AM GERIATR SOC, V57, P1825, DOI 10.1111/j.1532-5415.2009.02432.x; Coleman AL, 2008, SURV OPHTHALMOL, V53, pS3, DOI 10.1016/j.survophthal.2008.08.006; Crabb DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009710; Crabb DP, 2005, GRAEF ARCH CLIN EXP, V243, P210, DOI 10.1007/s00417-004-0984-x; Crabb DP, 2004, BRIT J OPHTHALMOL, V88, P1191, DOI 10.1136/bjo.2003.035949; Crabb DP, 1998, BRIT J OPHTHALMOL, V82, P1236, DOI 10.1136/bjo.82.11.1236; FARRAR DE, 1967, REV ECON STAT, V49, P92, DOI 10.2307/1937887; Gothwal VK, 2013, QUAL LIFE RES, V22, P839, DOI 10.1007/s11136-012-0195-6; Hamel J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00339; Haymes SA, 2008, INVEST OPHTH VIS SCI, V49, P3035, DOI 10.1167/iovs.07-1609; Haymes SA, 2007, INVEST OPHTH VIS SCI, V48, P1149, DOI 10.1167/iovs.06-0886; JOHNSON CA, 1983, ARCH OPHTHALMOL-CHIC, V101, P371; Kasneci E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087470; Khadka J, 2011, INVEST OPHTH VIS SCI, V52, P6971, DOI 10.1167/iovs.11-7423; Khattree R., 2000, MULTIVARIATE DATA RE; Kotecha A, 2009, INVEST OPHTH VIS SCI, V50, P203, DOI 10.1167/iovs.08-2496; Labiris G, 2008, BMC OPHTHALMOL, V8, DOI 10.1186/1471-2415-8-4; Lachenmayr B J, 1995, Ger J Ophthalmol, V4, P175; Lappi O, 2013, J VISION, V13, DOI 10.1167/13.13.11; Linacre JM, 2000, RASCH MEAS T, V14, P743; Lisboa R, 2013, JAMA OPHTHALMOL, V131, P486, DOI 10.1001/jamaophthalmol.2013.2602; Mallinson T, 2007, OPTOMETRY VISION SCI, V84, P675, DOI 10.1097/OPX.0b013e3181339f44; Marottoli RA, 1997, J GERONTOL A-BIOL, V52, pM184, DOI 10.1093/gerona/52A.3.M184; McAlinden C, 2011, INVEST OPHTH VIS SCI, V52, P5685, DOI 10.1167/iovs.10-67951; McGwin G, 2005, INVEST OPHTH VIS SCI, V46, P4437, DOI 10.1167/iovs.05-0750; McGwin G, 2004, INVEST OPHTH VIS SCI, V45, P3934, DOI 10.1167/iovs.04-0524; McGwin G, 1998, ACCIDENT ANAL PREV, V30, P781, DOI 10.1016/S0001-4575(98)00031-1; Mills RP, 2006, AM J OPHTHALMOL, V141, P24, DOI 10.1016/j.ajo.2005.07.044; Murata H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058695; Nelson-Quigg JM, 2000, INVEST OPHTH VIS SCI, V41, P2212; Owsley C, 1999, J GERONTOL A-BIOL, V54, pM203, DOI 10.1093/gerona/54.4.M203; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pesudovs K, 2007, OPTOMETRY VISION SCI, V84, P663, DOI 10.1097/OPX.0b013e318141fe75; Pesudovs K, 2010, J CATARACT REFR SURG, V36, P718, DOI 10.1016/j.jcrs.2009.11.019; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Ramulu P, 2009, CURR OPIN OPHTHALMOL, V20, P92, DOI 10.1097/ICU.0b013e32832401a9; Rasch G., 1980, PROBABILISTIC MODELS; Smith Everett V Jr, 2002, J Appl Meas, V3, P205; SUZUKI Y, 1993, OPHTHALMOLOGY, V100, P69; Szlyk JP, 2005, J GLAUCOMA, V14, P145, DOI 10.1097/01.ijg.0000151686.89162.28; Tanabe S, 2011, INVEST OPHTH VIS SCI, V52, P4177, DOI 10.1167/iovs.10-6264; Transporation: Motor Vehicle Accidents and Fatalities, TRANSP MOT VEH ACC F; Vianya-Estopa M, 2010, INVEST OPHTH VIS SCI, V51, P2496, DOI 10.1167/iovs.09-4381; Viswanathan AC, 1999, ARCH OPHTHALMOL-CHIC, V117, P450; Wright BD, 1982, RATING SCALE ANAL; Wright BD, 1979, BEST TEST DESIGN RAS; ZEYEN TG, 1993, OPHTHALMOLOGY, V100, P518	59	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115572	10.1371/journal.pone.0115572	http://dx.doi.org/10.1371/journal.pone.0115572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545660	gold, Green Published, Green Submitted			2022-12-26	WOS:000347120200047
J	TenNapel, MJ; Lynch, CF; Burns, TL; Wallace, R; Smith, BJ; Button, A; Domann, FE				TenNapel, Mindi J.; Lynch, Charles F.; Burns, Trudy L.; Wallace, Robert; Smith, Brian J.; Button, Anna; Domann, Frederick E.			SIRT6 Minor Allele Genotype Is Associated with > 5-Year Decrease in Lifespan in an Aged Cohort	PLOS ONE			English	Article							IOWA ESTABLISHED POPULATIONS; HUMAN LONGEVITY; OXIDATIVE STRESS; APOLIPOPROTEIN-E; ELDERLY COHORT; OLDER-ADULTS; BODY-MASS; GENE; SURVIVAL; RISK	Aging is a natural process involving complex interplay between environment, metabolism, and genes. Sirtuin genes and their downstream targets have been associated with lifespan in numerous organisms from nematodes to humans. Several target proteins of the sirtuin genes are key sensors and/or effectors of oxidative stress pathways including FOXO3, SOD3, and AKT1. To examine the relationship between single nucleotide polymorphisms (SNP) at candidate genes in these pathways and human lifespan, we performed a molecular epidemiologic study of an elderly cohort (>= 65 years old.). Using age at death as a continuous outcome variable and assuming a co-dominant genetic model within the framework of multi-variable linear regression analysis, the genotype-specific adjusted mean age at death was estimated for individual SNP genotypes while controlling for age-related risk factors including smoking, body mass index, alcohol consumption and co-morbidity. Significant associations were detected between human lifespan and SNPs in genes SIRT3, SIRT5, SIRT6, FOXO3 and SOD3. Individuals with either the CC or CT genotype at rs107251 within SIRT6 displayed >5-year mean survival advantages compared to the TT genotype (5.5 and 5.9 years, respectively; q-value =0.012). Other SNPs revealed genotype-specific mean survival advantages ranging from 0.5 to 1.6 years. Gender also modified the effect of SNPs in SIRT3, SIRT5 and AKT1 on lifespan. Our novel findings highlight the impact of sirtuins and sirtuin-related genotypes on lifespan, the importance of evaluating gender and the advantage of using age as a continuous variable in analyses to report mean age at death.	[TenNapel, Mindi J.; Lynch, Charles F.; Burns, Trudy L.; Wallace, Robert; Smith, Brian J.; Button, Anna] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA 52242 USA; [Domann, Frederick E.] Univ Iowa, Dept Radiat Oncol, Free Radical & Radiat Biol Program, Iowa City, IA USA	University of Iowa; University of Iowa	TenNapel, MJ (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Epidemiol, 01620 PFPW,200 Hawkins Dr, Iowa City, IA 52242 USA.	mindi-tennapel@uiowa.edu		Smith, Brian/0000-0003-1250-1710; Domann, Frederick/0000-0002-0489-2179	University of Iowa from the Environmental Health Sciences Research Center (NIH) [P30 ES005605]; Holden Comprehensive Cancer Center at the University of Iowa (NIH) [P30 CA086862]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	University of Iowa from the Environmental Health Sciences Research Center (NIH); Holden Comprehensive Cancer Center at the University of Iowa (NIH); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding: This work was supported by pilot grants at the University of Iowa from the Environmental Health Sciences Research Center (NIH P30 ES005605) awarded to FED and the Holden Comprehensive Cancer Center at the University of Iowa (NIH P30 CA086862) awarded to BJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani D, 2014, AGE, V36, P469, DOI 10.1007/s11357-013-9559-2; Austad Steven N, 2006, Gend Med, V3, P79, DOI 10.1016/S1550-8579(06)80198-1; Avendano M, 2006, STROKE, V37, P1368, DOI 10.1161/01.STR.0000221702.75002.66; Beydoun MA, 2013, J AM GERIATR SOC, V61, P525, DOI 10.1111/jgs.12156; Beydoun MA, 2012, AM J CLIN NUTR, V95, P163, DOI 10.3945/ajcn.111.017137; Brooks-Wilson AR, 2013, HUM GENET, V132, P1323, DOI 10.1007/s00439-013-1342-z; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Cerhan JR, 1997, CANCER CAUSE CONTROL, V8, P229, DOI 10.1023/A:1018428531619; CORNONIHUNTLEY J, 1993, AGING-CLIN EXP RES, V5, P27; Crimmins EM, 2012, J GERONTOL A-BIOL, V67, P467, DOI 10.1093/gerona/gls101; Dresler CM, 2000, LUNG CANCER-J IASLC, V30, P153, DOI 10.1016/S0169-5002(00)00163-X; Dutta A, 2011, J AM GERIATR SOC, V59, P963, DOI 10.1111/j.1532-5415.2011.03451.x; Engelfriet PM, 2013, EPIDEMIOL REV, V35, P132, DOI 10.1093/epirev/mxs011; Eskes T, 2007, EUR J OBSTET GYN R B, V133, P126, DOI 10.1016/j.ejogrb.2007.01.006; Fallin MD, 2009, J GERONTOL A-BIOL, V64, P47, DOI 10.1093/gerona/gln021; Fillenbaum GG, 2000, J GERONTOL A-BIOL, V55, pM84; Glorioso C, 2011, NEUROBIOL DIS, V41, P279, DOI 10.1016/j.nbd.2010.09.016; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lescai F, 2009, EUR J HUM GENET, V17, P1515, DOI 10.1038/ejhg.2009.54; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mahlknecht U, 2006, INT J ONCOL, V28, P447; Malovini A, 2011, REJUV RES, V14, P283, DOI 10.1089/rej.2010.1114; Merksamer PI, 2013, AGING-US, V5, P144, DOI 10.18632/aging.100544; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Murabito JM, 2012, J GERONTOL A-BIOL, V67, P470, DOI 10.1093/gerona/gls089; Napolioni V, 2010, BIOGERONTOLOGY, V11, P457, DOI 10.1007/s10522-010-9266-7; Newman AB, 2013, EPIDEMIOL REV, V35, P181, DOI 10.1093/epirev/mxs013; Orsted DD, 2007, J EXP MED, V204, P1295, DOI 10.1084/jem.20062476; Purser JL, 2005, J AM GERIATR SOC, V53, P1966, DOI 10.1111/j.1532-5415.2005.53566.x; Roerecke M, 2012, CURR ATHEROSCLER REP, V14, P556, DOI 10.1007/s11883-012-0277-5; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Seripa D, 2006, J GERONTOL A-BIOL, V61, P918, DOI 10.1093/gerona/61.9.918; Simeoni F, 2013, SCI REP-UK, V3, DOI 10.1038/srep03085; SIMONSICK EM, 1993, AM J PUBLIC HEALTH, V83, P1443, DOI 10.2105/AJPH.83.10.1443; Soerensen M, 2013, AGE, V35, P487, DOI 10.1007/s11357-011-9373-7; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tremblay A, 2003, CHEST, V123, P1202, DOI 10.1378/chest.123.4.1202; Vina J, 2005, SCI AGING KNOWLEDGE, V2005, ppe17; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Yi NJ, 2010, GENET RES, V92, P443, DOI 10.1017/S0016672310000595; Zeng Y, 2010, J GERONTOL A-BIOL, V65, P1285, DOI 10.1093/gerona/glq156; Zhang B, 2013, AGE, V35, P2237, DOI 10.1007/s11357-013-9520-4; Zillikens MC, 2008, DIABETOLOGIA, V51, P2233, DOI 10.1007/s00125-008-1163-0	52	31	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115616	10.1371/journal.pone.0115616	http://dx.doi.org/10.1371/journal.pone.0115616			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541994	Green Submitted, Green Published, gold			2022-12-26	WOS:000347239900060
J	Hansson, ML; Albert, S; Somermeyer, LG; Peco, R; Mejia-Ramirez, E; Montserrat, N; Belmonte, JCI				Hansson, Magnus L.; Albert, Silvia; Gonzalez Somermeyer, Louisa; Peco, Ruben; Mejia-Ramirez, Eva; Montserrat, Nuria; Izpisua Belmonte, Juan Carlos			Efficient Delivery and Functional Expression of Transfected Modified mRNA in Human Embryonic Stem Cell-derived Retinal Pigmented Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECTED DIFFERENTIATION; INNATE IMMUNITY; MITF; ACTIVATION; RPE; TRANSPLANTATION; RECOGNITION; TFE3; FATE	Gene- and cell-based therapies are promising strategies for the treatment of degenerative retinal diseases such as age-related macular degeneration, Stargardt disease, and retinitis pigmentosa. Cellular engineering before transplantation may allow the delivery of cellular factors that can promote functional improvements, such as increased engraftment or survival of transplanted cells. A current challenge in traditional DNA-based vector transfection is to find a delivery system that is both safe and efficient, but using mRNA as an alternative to DNA can circumvent these major roadblocks. In this study, we show that both unmodified and modified mRNA can be delivered to retinal pigmented epithelial (RPE) cells with a high efficiency compared with conventional plasmid delivery systems. On the other hand, administration of unmodified mRNA induced a strong innate immune response that was almost absent when using modified mRNA. Importantly, transfection of mRNA encoding a key regulator of RPE gene expression, microphthalmia-associated transcription factor (MITE), confirmed the functionality of the delivered mRNA. Immunostaining showed that transfection with either type of mRNA led to the expression of roughly equal levels of MITE, primarily localized in the nucleus. Despite these findings, quantitative RT-PCR analyses showed that the activation of the expression of MITE target genes was higher following toransfection with modified mRNA compared with unmodified mRNA. Our findings, therefore, show that modified mRNA transfection can be applied to human embryonic stem cell-derived RPE cells and that the method is safe, efficient, and functional.	[Hansson, Magnus L.; Albert, Silvia; Gonzalez Somermeyer, Louisa; Peco, Ruben; Mejia-Ramirez, Eva; Montserrat, Nuria] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Gonzalez Somermeyer, Louisa] Univ Barcelona, E-08007 Barcelona, Spain; [Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; University of Barcelona; Salk Institute	Hansson, ML (corresponding author), Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	magnus.l.hansson@ki.se; belmonte@salk.edu	Albert, Silvia/P-8231-2015; Montserrat, Nuria/F-3136-2016	Albert, Silvia/0000-0002-6921-0351; Montserrat, Nuria/0000-0002-1603-1755; Mejia-Ramirez, EVA/0000-0003-1251-5223; Gonzalez Somermeyer, Louisa/0000-0001-9139-5383	PLE-MINECO [PLE2009-0164]; Moxie Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107442] Funding Source: NIH RePORTER	PLE-MINECO; Moxie Foundation; Leona M. and Harry B. Helmsley Charitable Trust; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by PLE-MINECO Grant PLE2009-0164, by the Moxie Foundation, by Leona M. and Harry B. Helmsley Charitable Trust Grant 2012-PG-MED002, and by the G. Harold and Leila Y. Mathers Charitable Foundation. To whom correspondence may be addressed: 10010 N. Torrey Pines Rd., La Jolla, CA 92037. Tel.: 858-453-4100; E-mail: belmonte@salk.edu.	Adijanto J, 2012, J BIOL CHEM, V287, P20491, DOI 10.1074/jbc.M112.354761; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Anderson BR, 2011, NUCLEIC ACIDS RES, V39, P9329, DOI 10.1093/nar/gkr586; ARONSON JF, 1983, IN VITRO CELL DEV B, V19, P642; Bharti K, 2008, DEVELOPMENT, V135, P1169, DOI 10.1242/dev.014142; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Capowski EE, 2014, HUM MOL GENET, V23, P6332, DOI 10.1093/hmg/ddu351; Carr AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008152; Chen HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036864; Falkner-Radler CI, 2011, BRIT J OPHTHALMOL, V95, P370, DOI 10.1136/bjo.2009.176305; Housset M, 2013, J NEUROSCI, V33, P9890, DOI 10.1523/JNEUROSCI.1099-13.2013; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Klimanskaya I, 2004, CLONING STEM CELLS, V6, P217, DOI 10.1089/clo.2004.6.217; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Kumar MV, 2004, J NEUROIMMUNOL, V153, P7, DOI 10.1016/j.jneuroim.2004.04.018; Liu Y., 2010, INVEST OPHTH VIS SCI, V51, P3172; Liu YQ, 2009, INVEST OPHTH VIS SCI, V50, P5080, DOI 10.1167/iovs.08-2911; Lu SY, 2010, HISTOCHEM CELL BIOL, V133, P651, DOI 10.1007/s00418-010-0703-0; Lui KO, 2013, CELL RES, V23, P1172, DOI 10.1038/cr.2013.112; Lund RD, 2006, CLONING STEM CELLS, V8, P189, DOI 10.1089/clo.2006.8.189; Martina JA, 2013, J CELL BIOL, V200, P475, DOI 10.1083/jcb.201209135; Maruotti J, 2012, PIGM CELL MELANOMA R, V25, P641, DOI 10.1111/j.1755-148X.2012.01033.x; Masuda T, 2014, J BIOL CHEM, V289, P12908, DOI 10.1074/jbc.M114.556738; Mays LE, 2013, J CLIN INVEST, V123, P1216, DOI 10.1172/JCI65351; Melville H, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-53; Miller AJ, 2005, J BIOL CHEM, V280, P146, DOI 10.1074/jbc.M411757200; Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436; Puras G, 2014, J CONTROL RELEASE, V174, P27, DOI 10.1016/j.jconrel.2013.11.004; Raya A, 2008, COLD SH Q B, V73, P127, DOI 10.1101/sqb.2008.73.038; Saika Shizuya, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P69, DOI 10.2174/187153008783928343; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Singh R, 2013, INVEST OPHTH VIS SCI, V54, P6767, DOI 10.1167/iovs.13-11943; Sparrrow JR, 2010, CURR MOL MED, V10, P802; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Sunshine JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037543; Tachibana M, 2000, PIGM CELL RES, V13, P230, DOI 10.1034/j.1600-0749.2000.130404.x; Tucker BA, 2014, HUM MOL GENET, V23, pR9, DOI 10.1093/hmg/ddu124; Vercammen E, 2008, CLIN MICROBIOL REV, V21, P13, DOI 10.1128/CMR.00022-07; Vercauteren D, 2011, BIOMATERIALS, V32, P3072, DOI 10.1016/j.biomaterials.2010.12.045; Wang YH, 2013, MOL THER, V21, P358, DOI 10.1038/mt.2012.250; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Weilbaecher KN, 2001, MOL CELL, V8, P749, DOI 10.1016/S1097-2765(01)00360-4; Xu WD, 2000, EXP CELL RES, V255, P135, DOI 10.1006/excr.2000.4803; Zangi L, 2013, NAT BIOTECHNOL, V31, P898, DOI 10.1038/nbt.2682; Zhang KJ, 2014, PROTEIN CELL, V5, P48, DOI 10.1007/s13238-013-0011-2	48	18	20	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5661	5672		10.1074/jbc.M114.618835	http://dx.doi.org/10.1074/jbc.M114.618835			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25555917	Green Published, hybrid			2022-12-26	WOS:000350044200035
J	Gordon, ON; Luis, PB; Sintim, HO; Schneider, C				Gordon, Odaine N.; Luis, Paula B.; Sintim, Herman O.; Schneider, Claus			Unraveling Curcumin Degradation AUTOXIDATION PROCEEDS THROUGH SPIROEPOXIDE AND VINYLETHER INTERMEDIATES EN ROUTE TO THE MAIN BICYCLOPENTADIONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA TOPOISOMERASE-II; KAPPA-B KINASE; ANTIOXIDANT MECHANISM; BIOLOGICAL-ACTIVITIES; DIETARY CURCUMIN; HEME OXYGENASE-1; FATTY-ACIDS; METABOLITES; PRODUCTS; CANCER	Curcumin is a dietary anti-inflammatory and chemopreventive agent consisting of two methoxyphenol rings connected by a conjugated heptadienedione chain. Curcumin is unstable at physiological pH and rapidly degrades in an autoxidation reaction to a major bicyclopentadione product in which the 7-carbon chain has undergone oxygenation and double cyclization. Early degradation products (but not the final bicyclopentadione) mediate topoisomerase poisoning and possibly many other activities of curcumin, but it is not known how many and what autoxidation products are formed, nor their mechanism of formation. Here, using [C-14(2)] curcumin as a tracer, seven novel autoxidation products, including two reaction intermediates, were isolated and identified using one-and two-dimensional NMR and mass spectrometry. The unusual spiroepoxide and vinylether reaction intermediates are precursors to the final bicyclopentadione product. A mechanism for the autoxidation of curcumin is proposed that accounts for the addition and exchange of oxygen that have been determined using O-18(2) and (H2O)-O-18. Several of the by-products are formed from an endoperoxide intermediate via reactions that are well precedented in lipid peroxidation. The electrophilic spiroepoxide intermediate formed a stable adduct with N-acetylcysteine, suggesting that oxidative transformation is required for biological effects mediated by covalent adduction to protein thiols. The spontaneous autoxidation distinguishes curcumin among natural polyphenolic compounds of therapeutic interest; the formation of chemically diverse reactive and electrophilic products provides a novel paradigm for understanding the polypharmacological effects of curcumin.	[Gordon, Odaine N.; Luis, Paula B.; Schneider, Claus] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA; [Gordon, Odaine N.; Luis, Paula B.; Schneider, Claus] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Sch Med, Nashville, TN 37232 USA; [Sintim, Herman O.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	Vanderbilt University; Vanderbilt University; University System of Maryland; University of Maryland College Park	Schneider, C (corresponding author), Vanderbilt Univ, Dept Pharmacol, Sch Med, 23rd Ave S Pierce, Nashville, TN 37232 USA.	claus.schneider@vanderbilt.edu	Sintim, Herman O./B-4475-2009	Sintim, Herman O./0000-0002-2280-9359	National Institutes of Health [CA159382, AT006896, GM076592]; NIGMS [2T32GM07628]; NCCAM [F31AT007287]; Camille Dreyfus Foundation; Vanderbilt Institute in Chemical Biology [P30DK058404]; Vanderbilt Digestive Diseases Research Center; NCI SPORE in GI Cancer Pilot Award [5P50CA095103]; NATIONAL CANCER INSTITUTE [P50CA095103, R03CA159382] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [F31AT007287] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT006896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076592, T32GM007628, R25GM062459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Camille Dreyfus Foundation; Vanderbilt Institute in Chemical Biology; Vanderbilt Digestive Diseases Research Center; NCI SPORE in GI Cancer Pilot Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA159382, AT006896, and GM076592 (to C. S.) and NIGMS Training Grant 2T32GM07628 and NCCAM Predoctoral Fellowship Award F31AT007287 (to O. N. G.). This work was also supported by the Camille Dreyfus Foundation (to H. O. S.), Pilot Award P30DK058404 from the Vanderbilt Institute in Chemical Biology, the Vanderbilt Digestive Diseases Research Center, and the NCI SPORE in GI Cancer Pilot Award 5P50CA095103.	Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Anand P, 2008, CANCER LETT, V267, P133, DOI 10.1016/j.canlet.2008.03.025; Ballatore C, 2011, J MED CHEM, V54, P6969, DOI 10.1021/jm200980u; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Barclay LRC, 2000, ORG LETT, V2, P2841, DOI 10.1021/ol000173t; Coban D, 2012, MOL NUTR FOOD RES, V56, P1270, DOI 10.1002/mnfr.201100818; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Dhillon N, 2009, CLIN CANCER RES, V15, P7108, DOI 10.1158/1078-0432.CCR-09-2362; Dinkova-Kostova AT, 2008, MOL NUTR FOOD RES, V52, pS128, DOI 10.1002/mnfr.200700195; Doerge DR, 1997, ANAL BIOCHEM, V250, P10, DOI 10.1006/abio.1997.2191; Esatbeyoglu T, 2012, ANGEW CHEM INT EDIT, V51, P5308, DOI 10.1002/anie.201107724; FORRESTER IT, 1988, BIOCHEM BIOPH RES CO, V157, P992, DOI 10.1016/S0006-291X(88)80972-0; Foti MC, 2007, J PHARM PHARMACOL, V59, P1673, DOI 10.1211/jpp.59.12.0010; Funk JL, 2010, J AGR FOOD CHEM, V58, P842, DOI 10.1021/jf9027206; Funk JL, 2006, J NAT PROD, V69, P351, DOI 10.1021/np050327j; Galano A, 2009, CHEM PHYS, V363, P13, DOI 10.1016/j.chemphys.2009.07.003; GIERER J, 1977, ACTA CHEM SCAND B, V31, P561, DOI 10.3891/acta.chem.scand.31b-0561; Gimenez-Bastida JA, 2012, MOL NUTR FOOD RES, V56, P784, DOI 10.1002/mnfr.201100677; Gordon ON, 2013, J LABELLED COMPD RAD, V56, P696, DOI 10.1002/jlcr.3102; Gordon ON, 2012, TRENDS MOL MED, V18, P361, DOI 10.1016/j.molmed.2012.04.011; Griesser M, 2011, J BIOL CHEM, V286, P1114, DOI 10.1074/jbc.M110.178806; HAMBERG M, 1967, J BIOL CHEM, V242, P5344; HUANG MT, 1994, CANCER RES, V54, P5841; Ireson C, 2001, CANCER RES, V61, P1058; Jahn U, 2008, ANGEW CHEM INT EDIT, V47, P5894, DOI 10.1002/anie.200705122; Ji C, 2001, J BIOL CHEM, V276, P18223, DOI 10.1074/jbc.M101266200; Jiao Y, 2009, BLOOD, V113, P462, DOI 10.1182/blood-2008-05-155952; Jovanovic SV, 1999, J AM CHEM SOC, V121, P9677, DOI 10.1021/ja991446m; Karhu M., 1981, J CHEM SOC PERK T, V1, P303; Ketron AC, 2013, BIOCHEMISTRY-US, V52, P221, DOI 10.1021/bi3014455; KORNBLUM N, 1951, J AM CHEM SOC, V73, P880, DOI 10.1021/ja01146a542; Lambert JD, 2007, MOL PHARMACEUT, V4, P819, DOI 10.1021/mp700075m; Liby K, 2005, CANCER RES, V65, P4789, DOI 10.1158/0008-5472.CAN-04-4539; Litwinienko G, 2004, J ORG CHEM, V69, P5888, DOI 10.1021/jo049254j; Litwinienko G, 2007, ACCOUNTS CHEM RES, V40, P222, DOI 10.1021/ar0682029; Lopez-Lazaro M, 2007, J NAT PROD, V70, P1884, DOI 10.1021/np070332i; Martin-Cordero C, 2003, J ENZYM INHIB MED CH, V18, P505, DOI 10.1080/14756360310001613085; Masuda T, 1999, J AGR FOOD CHEM, V47, P71, DOI 10.1021/jf9805348; Masuda T, 2001, J AGR FOOD CHEM, V49, P2539, DOI 10.1021/jf001442x; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; PABON HJJ, 1964, RECL TRAV CHIM PAY B, V83, P379; Pereira MA, 1996, CARCINOGENESIS, V17, P1305, DOI 10.1093/carcin/17.6.1305; PORTER NA, 1984, TETRAHEDRON LETT, V25, P807, DOI 10.1016/S0040-4039(01)80032-0; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Priyadarsini KI, 2003, FREE RADICAL BIO MED, V35, P475, DOI 10.1016/S0891-5849(03)00325-3; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Schneider C, 2004, J BIOL CHEM, V279, P4404, DOI 10.1074/jbc.M307431200; Schneider C, 1998, J MOL CATAL B-ENZYM, V4, P219, DOI 10.1016/S1381-1177(98)00002-2; Shen L, 2012, TRENDS MOL MED, V18, P138, DOI 10.1016/j.molmed.2012.01.004; Szewczuk LM, 2005, J NAT PROD, V68, P36, DOI 10.1021/np049702i; Szewczuk LM, 2004, J BIOL CHEM, V279, P22727, DOI 10.1074/jbc.M314302200; TAUROG A, 1992, ANAL BIOCHEM, V205, P271, DOI 10.1016/0003-2697(92)90434-9; Toth G, 2000, MAGN RESON CHEM, V38, P51, DOI 10.1002/(SICI)1097-458X(200001)38:1<51::AID-MRC593>3.3.CO;2-U; VEDERAS JC, 1980, J AM CHEM SOC, V102, P374, DOI 10.1021/ja00521a063; Wang YJ, 1997, J PHARMACEUT BIOMED, V15, P1867, DOI 10.1016/S0731-7085(96)02024-9; Wu JC, 2011, MOL NUTR FOOD RES, V55, P1646, DOI 10.1002/mnfr.201100454; Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z	57	108	111	4	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4817	4828		10.1074/jbc.M114.618785	http://dx.doi.org/10.1074/jbc.M114.618785			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25564617	hybrid, Green Published			2022-12-26	WOS:000350042000027
J	Blanco, A; Puertolas-Pascual, E; Marmi, J; Vila, B; Selles, AG				Blanco, Alejandro; Puertolas-Pascual, Eduardo; Marmi, Josep; Vila, Bernat; Selles, Albert G.			Allodaposuchus palustris sp nov from the Upper Cretaceous of Fumanya (South-Eastern Pyrenees, Iberian Peninsula): Systematics, Palaeoecology and Palaeobiogeography of the Enigmatic Allodaposuchian Crocodylians	PLOS ONE			English	Article							EUSUCHIA; EUROPE; ALLIGATOROIDEA; REASSESSMENT; DINOSAURS; PRECEDENS; HUNGARY; FRANCE; SPAIN; BASIN	The controversial European genus Allodaposuchus is currently composed of two species (A. precedens, A. subjuniperus) and it has been traditionally considered a basal eusuchian clade of crocodylomorphs. In the present work, the new species A. palustris is erected on the base of cranial and postcranial remains from the lower Maastrichtian of the southern Pyrenees. Phylogenetic analyses here including both cranial and postcranial data support the hypothesis that Allodaposuchus is included within Crocodylia. The studied specimen suggests little change in postcranial skeleton along the evolutionary history of crocodylians, except for some bone elements such as the axis, the first caudal vertebra and the ilium. The specimen was found in an organic mudstone corresponding to a coastal wetland environment. Thus, A. palustris from Fumanya is the first Allodaposuchus reported in lacustrine-palustrine settings that expand the ecological range for this genus. The S-DIVA palaeobiogeographic reconstruction of ancestral area suggests that early members of Crocodylia rapidly widespread for the Northern Hemisphere landmasses no later than the Campanian, leading the apparition of endemic groups. In that way "Allodaposuchia'' represents an endemic European clade probably originated in the Ibero-Armorican domain in the late Campanian and dispersed by the Southern European archipelago prior to the early Maastrichtian.	[Blanco, Alejandro; Marmi, Josep; Selles, Albert G.] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, E-08201 Sabadell, Spain; [Puertolas-Pascual, Eduardo; Vila, Bernat] Univ Zaragoza, Fac Ciencias, Area Paleontol, Grp Aragosaurus IUCA, E-50009 Zaragoza, Spain	Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); University of Zaragoza	Blanco, A (corresponding author), Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, C Escola Ind 23, E-08201 Sabadell, Spain.	alejandro.blanco@icp.cat	Pascual, Eduardo Puértolas/A-3309-2012; Blanco, Alejandro/I-7352-2015; VILA, BERNAT/AAA-7367-2021; Selles, Albert G./ACZ-6076-2022	Pascual, Eduardo Puértolas/0000-0003-0759-7105; Blanco, Alejandro/0000-0003-2527-932X; VILA, BERNAT/0000-0002-5935-1732; Selles, Albert G./0000-0002-4637-6084	Ministerio de Economia y Competitividad [CGL2011-30069-C02-01/BTE]; INTERREG III-A (European Council); FI AGAUR grant from DGR of Generalitat de Catalunya [2013FI_B 01059]; Ministerio de Ciencia e Innovacion (Subprograma Juan de la Cierva (MICINN-JDC))	Ministerio de Economia y Competitividad(Spanish Government); INTERREG III-A (European Council); FI AGAUR grant from DGR of Generalitat de Catalunya; Ministerio de Ciencia e Innovacion (Subprograma Juan de la Cierva (MICINN-JDC))(Ministry of Science and Innovation, Spain (MICINN))	The present work was funded by the project CGL2011-30069-C02-01/BTE (Ministerio de Economia y Competitividad) and INTERREG III-A (European Council). A. B. is supported by FI AGAUR grant from DGR of Generalitat de Catalunya (2013FI_B 01059). B. V. acknowledges support from the Ministerio de Ciencia e Innovacion (Subprograma Juan de la Cierva (MICINN-JDC) 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aepler R, 1967, THESIS FREIN U BERLI; Badiola A, 2009, PALAIOS, V24, P522, DOI 10.2110/palo.2008.p08-126r; Behrensmeyer Anna K., 1992, P15; Benton MJ, 2010, PALAEOGEOGR PALAEOCL, V293, P438, DOI 10.1016/j.palaeo.2010.01.026; Brochu C.A., 1997, THESIS U TEXAS; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Brochu CA, 2011, ZOOL J LINN SOC-LOND, V163, pS228, DOI 10.1111/j.1096-3642.2011.00716.x; Buscalioni AD, 2001, J VERTEBR PALEONTOL, V21, P74, DOI 10.1671/0272-4634(2001)021[0074:AROTCA]2.0.CO;2; Buscalioni AD, 1997, CR ACAD SCI II A, V325, P525, DOI 10.1016/S1251-8050(97)89872-2; Buscalioni Angela D., 2003, Coloquios de Paleontologia Volumen Extraordinario, V1, P77; Buscalioni AD, 2011, ZOOL J LINN SOC-LOND, V163, pS199, DOI 10.1111/j.1096-3642.2011.00718.x; Dalla Vecchia FM, 2009, J VERTEBR PALEONTOL, V29, P1100, DOI 10.1671/039.029.0428; Delfino M, 2008, PALAEONTOLOGY, V51, P1091, DOI 10.1111/j.1475-4983.2008.00800.x; Delfino M, 2008, J VERTEBR PALEONTOL, V28, P111, DOI 10.1671/0272-4634(2008)28[111:ACSOAP]2.0.CO;2; Erickson GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031781; Feist M., 1983, GEOLOGIE MEDITERRANE, V10, P303, DOI 10.3406/geolm.1983.1273; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Isaji Shinji, 2005, Bulletin of the Kitakyushu Museum of Natural History and Human History Series A Natural History, V3, P123; LELOEUFF J, 1991, CRETACEOUS RES, V12, P93, DOI 10.1016/S0195-6671(05)80019-9; Leymerie A., 1862, B SOC GEOLOGIQUE FRA, V19, P1091; Marmi J, 2009, CRETACEOUS RES, V30, P1307, DOI 10.1016/j.cretres.2009.07.008; Martin JE, 2008, ZOOL J LINN SOC-LOND, V152, P567, DOI 10.1111/j.1096-3642.2007.00358.x; Martin JE, 2010, PALAEOGEOGR PALAEOCL, V293, P406, DOI 10.1016/j.palaeo.2009.10.021; Martin JE, 2010, J VERTEBR PALEONTOL, V30, P756, DOI 10.1080/02724631003758318; Martin Jeremy Emiland, 2005, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V14, P33; Mey P.H.W., 1968, LEIDSE GEOL MEDED, V41, P221; Mook C, 1921, B AM MUS NAT HIST, VXLIV; Narvaez I, 2011, ACT 9 EJIP, P223; Narvaez I., 2013, 6 JORN INT PAL DIN E, P96; Narvaez I, 2012, FUNDAMENTAL, V20, P169; Nopcsa F, 1928, ACTA GEOL HUNGARIC P, V1, P75; Oms O, 2007, PALAEOGEOGR PALAEOCL, V255, P35, DOI 10.1016/j.palaeo.2007.02.039; Osi A, 2007, NEUES JAHRB GEOL P-A, V243, P169, DOI 10.1127/0077-7749/2007/0243-0169; Osi A, 2013, CRETACEOUS RES, V44, P58, DOI 10.1016/j.cretres.2013.03.006; Osi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044318; Osi A, 2010, CRETACEOUS RES, V31, P304, DOI 10.1016/j.cretres.2010.01.001; Osi A, 2010, NATURE, V465, P466, DOI 10.1038/nature09019; Owen R, 1874, PALAEONTOGR SOC M S6, V27; Pereda-Suberbiola X, 1999, ZUBIA, V17, P259; Puertolas E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020011; Puertolas-Pascual E, 2014, HIST BIOL, V26, P91, DOI 10.1080/08912963.2012.763034; Rosell J., 2001, REV SOC GEOLOGICA ES, V14, P47; Salisbury SW, 2006, P ROY SOC B-BIOL SCI, V273, P2439, DOI 10.1098/rspb.2006.3613; Salisbury SW, 1999, SPEC PAP PALAEONTOL, P121; Scotese CR, 1992, 200692 U TEX ARL DEP; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Verdade L. M., 2000, Revista Brasileira de Biologia, V60, P469; Vila B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057408; Villalba-Breva S, 2012, GEOL ACTA, V10, P189, DOI 10.1344/105.000001711; Villalba-Breva S, 2011, J PHYCOL, V47, P131, DOI 10.1111/j.1529-8817.2010.00947.x; Weishampel DB, 2010, PALAEOGEOGR PALAEOCL, V293, P419, DOI 10.1016/j.palaeo.2010.03.024; Yu Y., 2013, RASP RECONSTRUCT ANC; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011	53	35	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115837	10.1371/journal.pone.0115837	http://dx.doi.org/10.1371/journal.pone.0115837			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551630	Green Published, gold, Green Submitted			2022-12-26	WOS:000347119100067
J	Nemeth, M; Millesi, E; Wagner, KH; Wallner, B				Nemeth, Matthias; Millesi, Eva; Wagner, Karl-Heinz; Wallner, Bernard			Effects of Diets High in Unsaturated Fatty Acids on Socially Induced Stress Responses in Guinea Pigs	PLOS ONE			English	Article							PITUITARY-ADRENAL-AXIS; DOCOSAHEXAENOIC ACID; LOCOMOTOR-ACTIVITY; DEFICIENT DIET; BRAIN; CORTISOL; BEHAVIOR; N-3; METABOLISM; ALLOSTASIS	Unsaturated fatty acids (UFAs), such as omega-3 and omega-6 poly- and omega-9 monounsaturated fatty acids are important nutrients and major components of neuronal cell membranes. They play a major role in modulating brain functions and physiology and may therefore diminish behavioral and physiological stress reactions in corroboration with decreased cortisol concentrations. Functionally, cortisol itself can modulate several behaviors and also the fatty acid metabolism in the long term. But only little is known about the behavioral and physiological influences of dietary UFAs in a social group, where individuals are regularly exposed to stressful situations. Therefore, the aim of this study was to determine the effects of dietary UFAs on saliva cortisol concentrations and behavioral responses in socially confronted guinea pigs. Three groups of animals were additionally supplemented with 500 mg chia seeds (high in omega-3), walnuts (high in omega-6), or peanuts (high in omega-9) per kg bodyweight each day and compared to a control group. During social confrontation saliva cortisol concentrations significantly increased in all groups, which was accompanied by a loss in bodyweight. However, cortisol levels remained lower in the chia and walnut groups compared to controls. Additionally, the walnut group displayed significantly increased locomotion, while no differences between groups were detected in socio-positive, sexual, or aggressive behaviors. Total plasma omega-3, omega-6, and omega-9 fatty acids were significantly increased in the corresponding groups, due to the dietary supplementations. However, a significant decrease in plasma omega-3 and an increase in plasma n-6 fatty acids were detected in the chia group when comparing the measurements before and after social confrontation. We conclude that both omega-3 and omega-6 polyunsaturated fatty acids can diminish behavioral and physiological stress responses to the social environment, enabling individuals to cope with social stressors, but at the expense of plasma derived omega-3 fatty acids.	[Nemeth, Matthias; Millesi, Eva; Wallner, Bernard] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Wagner, Karl-Heinz] Univ Vienna, Dept Nutr Sci, Vienna, Austria; [Wallner, Bernard] Univ Vienna, Vienna, Austria	University of Vienna; University of Vienna; University of Vienna	Nemeth, M (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	matthias.nemeth@univie.ac.at	Wallner, Bernard/B-1089-2009; Wagner, Karl-Heinz/B-9098-2013	Wagner, Karl-Heinz/0000-0002-1683-7265; Millesi, Eva/0000-0003-0740-0413	dean's office of the faculty of life sciences, University of Vienna; Open Access Publishing Fund of the University of Vienna	dean's office of the faculty of life sciences, University of Vienna; Open Access Publishing Fund of the University of Vienna	This study was part of an "intrafaculty networks" research activity by the departments of Behavioural Biology, Anthropology, and Nutritional Sciences, funded by the dean's office of the faculty of life sciences, University of Vienna. This article was supported by the Open Access Publishing Fund of the University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], J NUTR HLTH AGING, V10, P386; Appleton KM, 2008, NUTR RES REV, V21, P13, DOI 10.1017/S0954422408998620; Augier S, 2003, BRAIN RES BULL, V60, P161, DOI 10.1016/S0361-9230(03)00029-7; Barbadoro P, 2013, MOL NUTR FOOD RES, V57, P1110, DOI 10.1002/mnfr.201200676; Barcelo-Coblijn G, 2009, PROG LIPID RES, V48, P355, DOI 10.1016/j.plipres.2009.07.002; Bauer B, 2008, GEN COMP ENDOCR, V155, P680, DOI 10.1016/j.ygcen.2007.09.015; BAYARD J, 1957, J COMP PHYSIOL PSYCH, V50, P130, DOI 10.1037/h0042304; Benatti P, 2004, J AM COLL NUTR, V23, P281, DOI 10.1080/07315724.2004.10719371; Bernardi JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062031; BEZARD J, 1994, REPROD NUTR DEV, V34, P539, DOI 10.1051/rnd:19940603; Blanchard RJ, 2001, PHYSIOL BEHAV, V73, P261, DOI 10.1016/S0031-9384(01)00449-8; Bourre J M, 2004, J Nutr Health Aging, V8, P163; Brenner RR, 2003, PROSTAG LEUKOTR ESS, V68, P151, DOI 10.1016/S0952-3278(02)00265-X; Chen HF, 2013, J NUTR BIOCHEM, V24, P70, DOI 10.1016/j.jnutbio.2012.02.006; Coiro V, 2007, CLIN ENDOCRINOL, V66, P740, DOI 10.1111/j.1365-2265.2007.02792.x; de Alaniz MJT, 2003, PROSTAG LEUKOTR ESS, V68, P163, DOI 10.1016/S0952-3278(02)00266-1; De Rosario-Martinez H, 2013, PHIA POST HOC INTERA; De Vriese SR, 2004, PROSTAG LEUKOTR ESS, V71, P13, DOI 10.1016/j.plefa.2003.12.002; DeMar JC, 2006, J LIPID RES, V47, P172, DOI 10.1194/jlr.M500362-JLR200; DeVries AC, 2002, HORM BEHAV, V41, P405, DOI 10.1006/hbeh.2002.1780; Du Bois TM, 2006, NEUROSCIENCE, V139, P1397, DOI 10.1016/j.neuroscience.2006.02.068; Fedorova I, 2006, PROSTAG LEUKOTR ESS, V75, P271, DOI 10.1016/j.plefa.2006.07.006; Fenske M, 1996, STEROIDS, V61, P647, DOI 10.1016/S0039-128X(96)00185-7; Fenske M, 1997, EXP CLIN ENDOCR DIAB, V105, P163, DOI 10.1055/s-0029-1211746; Ferraz AC, 2011, BEHAV BRAIN RES, V219, P116, DOI 10.1016/j.bbr.2010.12.028; Fu Z, 2000, LIPIDS, V35, P395, DOI 10.1007/s11745-000-537-7; Gamoh S, 2001, CLIN EXP PHARMACOL P, V28, P266, DOI 10.1046/j.1440-1681.2001.03437.x; Haider S, 2011, PLANT FOOD HUM NUTR, V66, P335, DOI 10.1007/s11130-011-0260-2; Hamazaki T, 2008, PROG LIPID RES, V47, P221, DOI 10.1016/j.plipres.2008.02.001; Hennebelle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042142; Hu FB, 2001, J AM COLL NUTR, V20, P5, DOI 10.1080/07315724.2001.10719008; KAPLAN JR, 1991, PSYCHOSOM MED, V53, P634, DOI 10.1097/00006842-199111000-00005; Kaplan JR, 1996, AM J PRIMATOL, V38, P333, DOI 10.1002/(SICI)1098-2345(1996)38:4<333::AID-AJP4>3.0.CO;2-#; Kien CL, 2013, AM J CLIN NUTR, V97, P689, DOI 10.3945/ajcn.112.051730; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Kuratko CN, 2009, PROSTAG LEUKOTR ESS, V81, P111, DOI 10.1016/j.plefa.2009.05.007; Laugero KD, 2011, PROSTAG LEUKOTR ESS, V84, P71, DOI 10.1016/j.plefa.2010.12.003; Lavialle M, 2008, J NUTR, V138, P1719, DOI 10.1093/jn/138.9.1719; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; Macfarlane DP, 2008, J ENDOCRINOL, V197, P189, DOI 10.1677/JOE-08-0054; Machatschke IH, 2004, ETHOLOGY, V110, P161, DOI 10.1111/j.1439-0310.2004.00966.x; Machatschke IH, 2008, BEHAV ECOL SOCIOBIOL, V62, P1341, DOI 10.1007/s00265-008-0562-z; Marin MT, 2007, PHYSIOL BEHAV, V90, P29, DOI 10.1016/j.physbeh.2006.08.021; MATTSON FH, 1985, J LIPID RES, V26, P194; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Nieuwenhuizen AG, 2008, PHYSIOL BEHAV, V94, P169, DOI 10.1016/j.physbeh.2007.12.011; PALME R, 1994, ADVANCES IN STEROID ANALYSIS '93, P111; Palme R, 1997, Z SAUGETIERKD, V62, P192; Pinheiro J, 2013, NLME LINEAR AND NONL; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rabinovitz S, 2004, PSYCHONEUROENDOCRINO, V29, P113, DOI 10.1016/S0306-4530(02)00149-X; Rapoport SI, 2001, J LIPID RES, V42, P678; Raygada M, 1998, J NUTR, V128, P2505; Re S, 2008, VET RES COMMUN, V32, P225, DOI 10.1007/s11259-007-9021-y; Rogers PJ, 2001, P NUTR SOC, V60, P135, DOI 10.1079/PNS200061; Romero LM, 2009, HORM BEHAV, V55, P375, DOI 10.1016/j.yhbeh.2008.12.009; Rood J.P., 1972, Animal Behav Monogr, V5, P1; Rui LY, 2013, REV ENDOCR METAB DIS, V14, P387, DOI 10.1007/s11154-013-9261-9; SACHSER N, 1986, BEHAVIOUR, V97, P252, DOI 10.1163/156853986X00630; SACHSER N, 1984, AGGRESSIVE BEHAV, V10, P285, DOI 10.1002/1098-2337(1984)10:4<285::AID-AB2480100402>3.0.CO;2-8; Sachser N, 1998, PSYCHONEUROENDOCRINO, V23, P891, DOI 10.1016/S0306-4530(98)00059-6; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sartorius T, 2012, DIABETES, V61, P1669, DOI 10.2337/db11-1521; Song C, 2003, J LIPID RES, V44, P1984, DOI 10.1194/jlr.M300217-JLR200; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Stillwell W, 2003, CHEM PHYS LIPIDS, V126, P1, DOI 10.1016/S0009-3084(03)00101-4; SVENNERHOLM L, 1968, J LIPID RES, V9, P570; Tu WC, 2013, PROSTAG LEUKOTR ESS, V88, P53, DOI 10.1016/j.plefa.2012.04.005; Vinot N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020491; Wagner KH, 2000, EUR FOOD RES TECHNOL, V210, P237, DOI 10.1007/s002179900080; Wallner B., 2009, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V4, P1, DOI 10.1079/PAVSNNR20094075; Wallner B, 2003, ACTA ETHOL, V5, P101, DOI DOI 10.1007/S10211-003-0076-7; Wallner B, 2009, PROG NEURO-PSYCHOPH, V33, P391, DOI 10.1016/j.pnpbp.2009.02.006; WEISINGER HS, 1995, LIPIDS, V30, P471, DOI 10.1007/BF02536307; WIDMAIER EP, 1995, PROSTAG LEUKOTR ESS, V52, P179, DOI 10.1016/0952-3278(95)90019-5; Yehuda S, 2003, WORLD REV NUTR DIET, V92, P37; Yehuda S, 2005, NEUROBIOL AGING, V26, pS98, DOI 10.1016/j.neurobiolaging.2005.09.013	78	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116292	10.1371/journal.pone.0116292	http://dx.doi.org/10.1371/journal.pone.0116292			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551380	gold, Green Published, Green Submitted			2022-12-26	WOS:000347119100127
J	Obishakin, E; Stijlemans, B; Santi-Rocca, J; Vandenberghe, I; Devreese, B; Muldermans, S; Bastin, P; Magez, S				Obishakin, Emmanuel; Stijlemans, Benoit; Santi-Rocca, Julien; Vandenberghe, Isabel; Devreese, Bart; Muldermans, Serge; Bastin, Philippe; Magez, Stefan			Generation of a Nanobody Targeting the Paraflagellar Rod Protein of Trypanosomes	PLOS ONE			English	Article							DETECTION ENZYME IMMUNOASSAYS; DOMAIN ANTIBODY FRAGMENTS; AFRICAN TRYPANOSOMIASIS; BRUCEI; INFECTIONS; CONGOLENSE; VIVAX; RNA; COMPONENTS; DIAGNOSIS	Trypanosomes are protozoan parasites that cause diseases in humans and livestock for which no vaccines are available. Disease eradication requires sensitive diagnostic tools and efficient treatment strategies. Immunodiagnostics based on antigen detection are preferable to antibody detection because the latter cannot differentiate between active infection and cure. Classical monoclonal antibodies are inaccessible to cryptic epitopes (based on their size-150 kDa), costly to produce and require cold chain maintenance, a condition that is difficult to achieve in trypanosomiasis endemic regions, which are mostly rural. Nanobodies are recombinant, heat-stable, small-sized (15 kDa), antigen-specific, single-domain, variable fragments derived from heavy chain-only antibodies in camelids. Because of numerous advantages over classical antibodies, we investigated the use of nanobodies for the targeting of trypanosome-specific antigens and diagnostic potential. An alpaca was immunized using lysates of Trypanosoma evansi. Using phage display and bio-panning techniques, a cross-reactive nanobody (Nb392) targeting all trypanosome species and isolates tested was selected. Imunoblotting, immunofluorescence microscopy, immunoprecipitation and mass spectrometry assays were combined to identify the target recognized. Nb392 targets paraflagellar rod protein (PFR1) of T. evansi, T. brucei, T. congolense and T. vivax. Two different RNAi mutants with defective PFR assembly (PFR2(RNAi) and KIF9B(RNAi)) were used to confirm its specificity. In conclusion, using a complex protein mixture for alpaca immunization, we generated a highly specific nanobody (Nb392) that targets a conserved trypanosome protein, i.e., PFR1 in the flagella of trypanosomes. Nb392 is an excellent marker for the PFR and can be useful in the diagnosis of trypanosomiasis. In addition, as demonstrated, Nb392 can be a useful research or PFR protein isolation tool.	[Obishakin, Emmanuel; Stijlemans, Benoit; Muldermans, Serge; Magez, Stefan] Vrije Univ Brussel, B-1050 Brussels, Belgium; [Obishakin, Emmanuel; Muldermans, Serge; Magez, Stefan] VIB Flanders Inst Biotechnol, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Stijlemans, Benoit] VIB, Lab Myeloid Cell Immunol, Flanders Inst Biotechnol, B-1050 Brussels, Belgium; [Vandenberghe, Isabel; Devreese, Bart] Univ Ghent, Dept Biochem & Microbiol, Lab Prot Biochem & Biomol Engn L ProBE, B-9000 Ghent, Belgium; [Santi-Rocca, Julien; Bastin, Philippe] Inst Pasteur, Trypanosome Cell Biol Unit, F-75015 Paris, France; [Santi-Rocca, Julien; Bastin, Philippe] CNRS, URA 2581, F-75015 Paris, France	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Ghent University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Obishakin, E (corresponding author), Vrije Univ Brussel, Pleinlaan 2, B-1050 Brussels, Belgium.	eobishak@vub.ac.be	Stijlemans, Benoit/AAD-9122-2021; Muyldermans, Serge V/C-6418-2016; Bastin, Philippe/E-6688-2017; Magez, Stefan/D-9497-2014; Bastin, Philippe/O-4230-2019; Magez, Stefan/AAC-5682-2021; Devreese, Bart/K-2841-2019; Devreese, Bart/B-2011-2009; Santi-Rocca, Julien/AAD-2448-2020	Stijlemans, Benoit/0000-0003-0082-9751; Muyldermans, Serge V/0000-0002-3678-3575; Magez, Stefan/0000-0003-3760-7968; Bastin, Philippe/0000-0002-3042-8679; Magez, Stefan/0000-0003-3760-7968; Devreese, Bart/0000-0002-9764-2581; Devreese, Bart/0000-0002-9764-2581; Santi-Rocca, Julien/0000-0002-9791-3521; OBISHAKIN, EMMANUEL/0000-0001-6026-492X	European Union/FP7 Nanotryp [FP7-HEALTH 2007-2.3.4-1]; Fund for Scientific Research Flanders (FWO); French Government Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases'' [ANR-10-LABX-62- IBEID]; Institut Carnot Maladies Infectieuses; Fondation pour la Recherche Medicale	European Union/FP7 Nanotryp; Fund for Scientific Research Flanders (FWO)(FWO); French Government Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases''(French National Research Agency (ANR)); Institut Carnot Maladies Infectieuses; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the European Union/FP7 Nanotryp (FP7-HEALTH 2007-2.3.4-1) and the Fund for Scientific Research Flanders (FWO). Work at the Institut Pasteur was funded by a French Government Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases'' (ANR-10-LABX-62- IBEID), the Institut Carnot Maladies Infectieuses and the Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbady AQ, 2011, VET IMMUNOL IMMUNOP, V142, P49, DOI 10.1016/j.vetimm.2011.04.004; Abdille MH, 2008, EXP PARASITOL, V120, P411, DOI 10.1016/j.exppara.2008.08.007; Baral TN, 2007, J INFECT DIS, V195, P1513, DOI 10.1086/515577; Baral TN, 2006, NAT MED, V12, P580, DOI 10.1038/nm1395; Bastin P, 1996, PARASITOL TODAY, V12, P302, DOI 10.1016/0169-4758(96)10031-4; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; Bastin P, 2000, J CELL SCI, V113, P3321; Bockstal V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002089; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Chamond N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000792; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Coustou V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000618; De Vooght L, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-23; DEFLORIN J, 1994, J BIOL CHEM, V269, P28745; Delespaux V, 2007, DRUG RESIST UPDATE, V10, P30, DOI 10.1016/j.drup.2007.02.004; Demonchy R, 2009, J CELL BIOL, V187, P615, DOI 10.1083/jcb.200903139; Desquesnes M, 2013, TRYPANOSOMA EVANSI S; Ditlev SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084981; Durand-Dubief M, 2003, MOL BIOCHEM PARASIT, V129, P11, DOI 10.1016/S0166-6851(03)00071-9; Gadelha C, 2005, EUKARYOT CELL, V4, P516, DOI 10.1128/EC.4.3.516-525.2005; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Griffiths S, 2007, EUKARYOT CELL, V6, P1248, DOI 10.1128/EC.00110-07; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; La Greca F, 2011, HUM VACCINES, V7, P1225, DOI 10.4161/hv.7.11.18203; Manual OT, 2008, TRYPANOSOMA EVANSI I; Michailowsky V, 2003, INFECT IMMUN, V71, P3165, DOI 10.1128/IAI.71.6.3165-3171.2003; Muyldermans S, 2013, ANN REV BIOCH; NANTULYA VM, 1987, PARASITE IMMUNOL, V9, P421, DOI 10.1111/j.1365-3024.1987.tb00520.x; NANTULYA VM, 1989, TROP MED PARASITOL, V40, P267; Njiru ZK, 2011, DIAGN MICR INFEC DIS, V69, P205, DOI 10.1016/j.diagmicrobio.2010.08.026; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; OLAHOMUKANI W, 1993, VET PARASITOL, V45, P231, DOI 10.1016/0304-4017(93)90078-2; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Portman N, 2010, INT J PARASITOL, V40, P135, DOI 10.1016/j.ijpara.2009.10.005; Portman N, 2009, J BIOL CHEM, V284, P5610, DOI 10.1074/jbc.M808859200; Pradel LC, 2006, J CELL SCI, V119, P1852, DOI 10.1242/jcs.02900; Reid SA, 2002, TRENDS PARASITOL, V18, P219, DOI 10.1016/S1471-4922(02)02250-X; Saerens D, 2008, J IMMUNOL METHODS, V329, P138, DOI 10.1016/j.jim.2007.10.005; SCHLAEPPI K, 1989, J CELL BIOL, V109, P1695, DOI 10.1083/jcb.109.4.1695; SCHNEIDER A, 1987, J CELL BIOL, V104, P431, DOI 10.1083/jcb.104.3.431; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; Stijlemans B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002072; Subota I, 2014, MOL CELL PROTEOMICS, V13, P1769, DOI 10.1074/mcp.M113.033357; Subota I, 2011, MOL BIOL CELL, V22, P4205, DOI 10.1091/mbc.E11-06-0511; Vaneycken I, 2011, FASEB J, V25, P2433, DOI 10.1096/fj.10-180331; Wrightsman RA, 2000, VACCINE, V18, P1419, DOI 10.1016/S0264-410X(99)00380-1	48	27	27	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115893	10.1371/journal.pone.0115893	http://dx.doi.org/10.1371/journal.pone.0115893			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551637	Green Submitted, Green Published, gold			2022-12-26	WOS:000347119100074
J	Shi, J; Mao, NF; Wang, L; Zhang, HB; Chen, Q; Liu, H; Tang, X; Jin, T; Zhu, CT; Li, FB; Sun, LH; Xu, XM; Xu, YQ				Shi, Jian; Mao, Ning-Fang; Wang, Li; Zhang, Han-Bo; Chen, Qian; Liu, Hua; Tang, Xun; Jin, Tao; Zhu, Chong-Tao; Li, Fu-Bing; Sun, Lin-Hui; Xu, Xin-Ming; Xu, Yong-Qing			Efficacy of Combined Vancomycin and Fosfomycin against Methicillin-Resistant Staphylococcus aureus in Biofilms In Vivo	PLOS ONE			English	Article							BACTERIAL BIOFILMS; VITRO EFFICACY; COMBINATION; MODEL; INFECTIONS; DAPTOMYCIN; RIFAMPIN; SUSCEPTIBILITY; ANTIBIOTICS; PENETRATION	Infection by methicillin-resistant Staphylococcus aureus (MRSA) is a life-threatening condition, and formation of biofilms can lead to treatment failure in a clinical setting. The aim of this study was to demonstrate the in vivo bactericidal effects of a combination of vancomycin (VAN) and fosfomycin (FOS) against MRSA in a rat carboxymethyl cellulose-pouch biofilm model. The results of the time-kill assay showed that the combination therapy was capable of killing at low minimal inhibitory concentrations (MIC) (1/2 x MIC VAN + 1 x MIC FOS and 1 x MIC VAN + 1 x MIC FOS). In the in vivo study, a synergistically bactericidal effect was observed when using the combination therapy on MRSA embedded in the mature biofilm model. In comparison with the untreated control group and the groups receiving either VAN or FOS alone, the rats treated with combination therapy had lower MRSA colony counts in exudates from the pouch, lower white blood cell and neutrophil counts, and C-reactive protein (CRP) in peripheral blood. Furthermore, histological analysis of the pouch wall indicated combination therapy resulted in disappearance of biofilm-like structures, marked decrease in necrosis, and formation of granular tissue. In conclusion, the combination of VAN with FOS had a synergistic bactericidal effect on chronic MRSA infection embedded in biofilm, providing an alternative approach to treating this condition.	[Shi, Jian; Liu, Hua; Tang, Xun; Jin, Tao; Zhu, Chong-Tao; Li, Fu-Bing; Sun, Lin-Hui; Xu, Xin-Ming; Xu, Yong-Qing] Kunming Gen Hosp Chengdu Mil Reg, Dept Orthoped, Kunming, Peoples R China; [Mao, Ning-Fang] Changhai Hosp, Dept Orthoped, Shanghai, Peoples R China; [Wang, Li] Kunming Gen Hosp Chengdu Mil Reg, Dept Pathol, Kunming, Peoples R China; [Zhang, Han-Bo] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Minist Educ, Kunming, Peoples R China; [Zhang, Han-Bo] Yunnan Univ, Key Lab Microbial Resources, Minist Educ, Kunming, Peoples R China; [Chen, Qian] Kunming Gen Hosp Chengdu Mil Reg, Dept Infect Control, Kunming, Peoples R China	Kunming General Hospital; Naval Medical University; Kunming General Hospital; Yunnan University; Yunnan University; Kunming General Hospital	Xu, YQ (corresponding author), Kunming Gen Hosp Chengdu Mil Reg, Dept Orthoped, Kunming, Peoples R China.	YongQingXu97@126.com			National Natural Science Foundation of China [81171734]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a research grant from National Natural Science Foundation of China (No. 81171734). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; HAMMES WP, 1974, ANTIMICROB AGENTS CH, V6, P722, DOI 10.1128/AAC.6.6.722; Jefferson KK, 2005, ANTIMICROB AGENTS CH, V49, P2467, DOI 10.1128/AAC.49.6.2467-2473.2005; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; LaPlante KL, 2009, ANTIMICROB AGENTS CH, V53, P3880, DOI 10.1128/AAC.00134-09; Masadeh MM, 2013, INFECT DRUG RESISTAN, V6, P27; McCaughey G, 2012, J CYST FIBROS, V11, P163, DOI 10.1016/j.jcf.2011.11.003; Morikawa K, 2005, INT J ANTIMICROB AG, V25, P44, DOI 10.1016/j.ijantimicag.2004.07.015; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; Pachon-Ibanez ME, 2011, EUR J CLIN MICROBIOL, V30, P89, DOI 10.1007/s10096-010-1058-0; Parra-Ruiz J, 2010, ANTIMICROB AGENTS CH, V54, P4329, DOI 10.1128/AAC.00455-10; Perlroth J, 2008, ARCH INTERN MED, V168, P805, DOI 10.1001/archinte.168.8.805; Pistella Eleonora, 2005, Infez Med, V13, P97; Raad I, 2007, ANTIMICROB AGENTS CH, V51, P1656, DOI 10.1128/AAC.00350-06; Rose WE, 2009, J ANTIMICROB CHEMOTH, V63, P485, DOI 10.1093/jac/dkn513; Roussos N, 2009, INT J ANTIMICROB AG, V34, P506, DOI 10.1016/j.ijantimicag.2009.08.013; Salem AH, 2011, J PHARM PHARMACOL, V63, P73, DOI 10.1111/j.2042-7158.2010.01183.x; Simoes M, 2011, CURR MED CHEM, V18, P2129, DOI 10.2174/092986711795656216; Singh R, 2010, J ANTIMICROB CHEMOTH, V65, P1955, DOI 10.1093/jac/dkq257; Steinkraus G, 2007, J ANTIMICROB CHEMOTH, V60, P788, DOI 10.1093/jac/dkm258; Tang HJ, 2012, J ANTIMICROB CHEMOTH, V67, P944, DOI 10.1093/jac/dkr535; Tang HJ, 2011, INT J ANTIMICROB AG, V38, P46, DOI 10.1016/j.ijantimicag.2011.02.013; TOMASZ A, 1986, REV INFECT DIS, V8, pS260; Tre-Hardy M, 2009, INT J ANTIMICROB AG, V33, P40, DOI 10.1016/j.ijantimicag.2008.07.012; Wayne PA, 2006, M7A7 CLIN LAB STAND; Wikler M.A., 2006, PERFORMANCE STANDARD; Yasuda H, 1999, METHOD ENZYMOL, V310, P577; Yoshiyama Y, 2001, J Infect Chemother, V7, P243, DOI 10.1007/s101560170020	30	21	24	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e113133	10.1371/journal.pone.0113133	http://dx.doi.org/10.1371/journal.pone.0113133			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551618	gold, Green Submitted, Green Published			2022-12-26	WOS:000347119100005
J	Delannoy, M; Schwarz, J; Fournier, A; Rychen, G; Feidt, C				Delannoy, Matthieu; Schwarz, Jessica; Fournier, Agnes; Rychen, Guido; Feidt, Cyril			Effects of Standard Humic Materials on Relative Bioavailability of NDL-PCBs in Juvenile Swine	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; SOIL ORGANIC-MATTER; POLYCHLORINATED-BIPHENYLS; SURFACE SOILS; LAYING HENS; SORPTION; EXPOSURE; ABSORPTION; CONTAMINANTS; MECHANISMS	Young children with their hand-to-mouth activity may be exposed to contaminated soils. However few studies assessing exposure of organic compounds sequestrated in soil were realized. The present study explores the impact of different organic matters on retention of NDL-PCBs during digestive processes using commercial humic substances in a close digestive model of children: the piglet. Six artificial soils were used. One standard soil, devoid of organic matter, and five amended versions of this standard soil with either fulvic acid, humic acid, Sphagnum peat, activated carbon or a mix of Sphagnum peat and activated carbon (95:5) (SPAC) were prepared. In order to compare the different treatments, we use spiked oil and negative control animals. Forty male piglets were randomly distributed in 7 contaminated and one control groups (n = 5 for each group). During 10 days, the piglets were fed artificial soil or a corn oil spiked with 19 200 ng of Aroclor 1254 per g of dry matter (6 000 ng.g(-1) of NDL-PCBs) to achieve an exposure dose of 1 200 ng NDL-PCBs.Kg(-1) of body weight per day. NDL-PCBs in adipose tissue were analyzed by GC-MS. Fulvic acid reduced slightly the bioavailability of NDL-PCBs compared to oil. Humic acid and Sphagnum peat reduced it significantly higher whereas activated carbon reduced the most. Piglets exposed to soil containing both activated carbon and Shagnum peat exhibited a lower reduction than soil with only activated carbon. Therefore, treatment groups are ordered by decreasing value of relative bioavailability as following: oil >= fulvic acid > Sphagnum peat >= Sphagnum peat and activated carbon >= Humic acid >> activated carbon. This suggests competition between Sphagnum peat and activated carbon. The present study highlights that quality of organic matter does have a significant effect on bioavailability of sequestrated organic compounds.	[Delannoy, Matthieu; Schwarz, Jessica; Fournier, Agnes; Rychen, Guido; Feidt, Cyril] Univ Lorraine, UR AFPA, Vandoeuvre Les Nancy, France; [Delannoy, Matthieu; Schwarz, Jessica; Fournier, Agnes; Rychen, Guido; Feidt, Cyril] INRA, UR AFPA, USC 340, Vandoeuvre Les Nancy, France	Universite de Lorraine; INRAE	Delannoy, M (corresponding author), Univ Lorraine, UR AFPA, Vandoeuvre Les Nancy, France.	matthieu.delannoy@univ-lorraine.fr	FEIDT, Cyril/AAY-6066-2020	Feidt, Cyril/0000-0003-3828-9543; Delannoy, Matthieu/0000-0002-9699-6513	French Ministry for Agriculture; Agence de l'Environnement et de la Maitrise de l'Energie (ADEME) (ADEME-university of Lorraine) [1072C0054]	French Ministry for Agriculture; Agence de l'Environnement et de la Maitrise de l'Energie (ADEME) (ADEME-university of Lorraine)	The authors are grateful to the French Ministry for Agriculture and Agence de l'Environnement et de la Maitrise de l'Energie (ADEME) for their financial support (contract ADEME-university of Lorraine, number: 1072C0054) (http://www2.ademe.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATSDR, 2000, TOXICOLOGICAL PROFIL; Boix J, 2010, NEUROSCIENCE, V167, P994, DOI 10.1016/j.neuroscience.2010.02.068; Boix J, 2011, NEUROCHEM INT, V58, P69, DOI 10.1016/j.neuint.2010.10.014; Bouveret C, 2013, J AGR FOOD CHEM, V61, P9269, DOI 10.1021/jf400697r; Budinsky RA, 2008, CHEMOSPHERE, V70, P1774, DOI 10.1016/j.chemosphere.2007.08.035; Casteel SW, 2006, ENVIRON HEALTH PERSP, V114, P1162, DOI 10.1289/ehp.8852; CHIOU CT, 1987, ENVIRON SCI TECHNOL, V21, P1231, DOI 10.1021/es00165a012; Corey DA, 1996, GROWTH DEVELOP AGING, V60, P131; Delannoy M, 2014, CHEMOSPHERE, V104, P105, DOI 10.1016/j.chemosphere.2013.10.072; Doick KJ, 2005, ENVIRON SCI TECHNOL, V39, P6575, DOI 10.1021/es050523c; Drouillard KG, 2000, ENVIRON TOXICOL CHEM, V19, P2707, DOI 10.1002/etc.5620191114; E.F.S. Authority, 2010, EFSA J, V8, P1701, DOI DOI 10.2903/J.EFSA.2010.1701; Elnar AA, 2012, TOXICOLOGY, V299, P44, DOI 10.1016/j.tox.2012.05.004; Fournier A, 2012, CHEMOSPHERE, V88, P300, DOI 10.1016/j.chemosphere.2012.02.041; Gomez-Eyles JL, 2013, ENVIRON SCI TECHNOL, V47, P13721, DOI 10.1021/es403712q; Graber ER, 1998, ENVIRON SCI TECHNOL, V32, P3286, DOI 10.1021/es9801238; Jondreville C, 2013, ENVIRON SCI POLLUT R, V20, P292, DOI 10.1007/s11356-012-1010-1; Jonker MTO, 2002, ENVIRON SCI TECHNOL, V36, P3725, DOI 10.1021/es020019x; Kelly BC, 2004, ENVIRON TOXICOL CHEM, V23, P2324, DOI 10.1897/03-545; Lesan HM, 2003, WATER RES, V37, P1644, DOI 10.1016/S0043-1354(02)00497-9; LILIENTHAL H, 1991, FUND APPL TOXICOL, V17, P368, DOI 10.1016/0272-0590(91)90226-T; Meijer SN, 2003, ENVIRON SCI TECHNOL, V37, P667, DOI 10.1021/es025809l; Mirza MA, 2011, SCI ADV MATER, V3, P223, DOI 10.1166/sam.2011.1149; Niederer C, 2007, ENVIRON SCI TECHNOL, V41, P6711, DOI 10.1021/es0709932; OECD, 1984, GUIDELINE FOR TESTIN; Oomen AG, 2004, ARCH ENVIRON CON TOX, V46, P183, DOI 10.1007/s00244-003-2138-2; Pignatello JJ, 1996, ENVIRON SCI TECHNOL, V30, P1, DOI 10.1021/es940683g; Pignatello JJ, 1998, ADV COLLOID INTERFAC, V76, P445, DOI 10.1016/S0001-8686(98)00055-4; Schantz SL, 2003, ENVIRON HEALTH PERSP, V111, P357, DOI 10.1289/ehp.5461; Schlummer M, 1998, TOXICOL APPL PHARM, V152, P128, DOI 10.1006/taap.1998.8487; Sharma B, 2009, ENVIRON ENG SCI, V26, P1371, DOI 10.1089/ees.2008.0231; Soares M, 2002, ANIM FEED SCI TECH, V95, P169, DOI 10.1016/S0377-8401(01)00324-8; Sutton R, 2005, ENVIRON SCI TECHNOL, V39, P9009, DOI 10.1021/es050778q; *US EPA, 2007, GUIDANCE AND TECHNIC; WILSON FA, 1974, BIOCHIM BIOPHYS ACTA, V363, P112, DOI 10.1016/0005-2736(74)90010-8; Wittsiepe J, 2007, CHEMOSPHERE, V67, pS355, DOI 10.1016/j.chemosphere.2006.05.129; Xing BS, 1996, ENVIRON TOXICOL CHEM, V15, P1282, DOI [10.1002/etc.5620150805, 10.1897/1551-5028(1996)015&lt;1282:TDISOO&gt;2.3.CO;2]; Yan MQ, 2012, CHEMOSPHERE, V87, P879, DOI 10.1016/j.chemosphere.2012.01.029; Yang Y, 2010, ENVIRON POLLUT, V158, P2170, DOI 10.1016/j.envpol.2010.02.019	39	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115759	10.1371/journal.pone.0115759	http://dx.doi.org/10.1371/journal.pone.0115759			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549096	Green Submitted, Green Published, gold			2022-12-26	WOS:000347063500024
J	Pereira, J; Johnson, WE; O'Brien, SJ; Jarvis, ED; Zhang, GJ; Gilbert, MTP; Vasconcelos, V; Antunes, A				Pereira, Joana; Johnson, Warren E.; O'Brien, Stephen J.; Jarvis, Erich D.; Zhang, Guojie; Gilbert, M. Thomas P.; Vasconcelos, Vitor; Antunes, Agostinho			Evolutionary Genomics and Adaptive Evolution of the Hedgehog Gene Family (Shh, Ihh and Dhh) in Vertebrates	PLOS ONE			English	Article							AMINO-ACID SITES; PROTEIN-STRUCTURE PREDICTION; SONIC-HEDGEHOG; I-TASSER; FUNCTIONAL DIVERGENCE; MAXIMUM-LIKELIHOOD; STRUCTURAL DIVERGENCE; PHYLOGENETIC ANALYSIS; POSITIVE SELECTION; SEQUENCE ALIGNMENT	The Hedgehog (Hh) gene family codes for a class of secreted proteins composed of two active domains that act as signalling molecules during embryo development, namely for the development of the nervous and skeletal systems and the formation of the testis cord. While only one Hh gene is found typically in invertebrate genomes, most vertebrates species have three (Sonic hedgehog - Shh; Indian hedgehog - Ihh; and Desert hedgehog - Dhh), each with different expression patterns and functions, which likely helped promote the increasing complexity of vertebrates and their successful diversification. In this study, we used comparative genomic and adaptive evolutionary analyses to characterize the evolution of the Hh genes in vertebrates following the two major whole genome duplication (WGD) events. To overcome the lack of Hh-coding sequences on avian publicly available databases, we used an extensive dataset of 45 avian and three non-avian reptilian genomes to show that birds have all three Hh paralogs. We find suggestions that following the WGD events, vertebrate Hh paralogous genes evolved independently within similar linkage groups and under different evolutionary rates, especially within the catalytic domain. The structural regions around the ion-binding site were identified to be under positive selection in the signaling domain. These findings contrast with those observed in invertebrates, where different lineages that experienced gene duplication retained similar selective constraints in the Hh orthologs. Our results provide new insights on the evolutionary history of the Hh gene family, the functional roles of these paralogs in vertebrate species, and on the location of mutational hotspots.	[Pereira, Joana; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, Interdisciplinary Ctr Marine & Environm Res, CIMAR, CIIMAR, P-4100 Oporto, Portugal; [Johnson, Warren E.] Smithsonian Conservat Biol Inst, Front Royal, VA USA; [O'Brien, Stephen J.] St Petersburg State Univ, Theodosius Dobzhansky Ctr Genome Bioinformat, St Petersburg 199034, Russia; [O'Brien, Stephen J.] Nova SE Univ, Oceanog Ctr, Ft Lauderdale, FL 33314 USA; [Zhang, Guojie] Beishan Ind Zoon, BGI Shenzhen, Shenzhen, Peoples R China; [Gilbert, M. Thomas P.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, Fac Sci, Dept Biol, P-4100 Oporto, Portugal	Universidade do Porto; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Saint Petersburg State University; Nova Southeastern University; Beijing Genomics Institute (BGI); University of Copenhagen; Universidade do Porto	Antunes, A (corresponding author), Univ Porto, Interdisciplinary Ctr Marine & Environm Res, CIMAR, CIIMAR, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	aantunes@ciimar.up.pt	Zhang, Guojie/J-7273-2019; OBRIEN, STEPHEN/ABD-1346-2020; Pereira, Joana/AAU-6247-2020; Gilbert, Marcus TP/A-8936-2013; Jarvis, Erich D/A-2319-2008; Vasconcelos, Vitor/A-8933-2008; Zhang, Guojie/B-6188-2014; Johnson, Warren/D-4149-2016	Zhang, Guojie/0000-0001-6860-1521; Pereira, Joana/0000-0002-5588-6588; Gilbert, Marcus TP/0000-0002-5805-7195; Jarvis, Erich D/0000-0001-8931-5049; Vasconcelos, Vitor/0000-0003-3585-2417; Zhang, Guojie/0000-0001-6860-1521; Antunes, Agostinho/0000-0002-1328-1732; OBRIEN, STEPHEN/0000-0001-7857-0757; Johnson, Warren/0000-0002-5954-186X	BII from Portuguese Foundation for Science and Technology (FCT) [CIIMAR/C2008/BII/01-25]; Russian Ministry of Science [11.G34.31.0068]; FCT [PEst-C/MAR/LA0015/2013, PTDC/BIA-BDE/69144/2006 (FCOMP-01-0124-FEDER-007065), PTDC/AAC-AMB/104983/2008 (FCOMP-01-0124-FEDER-008610), PTDC/AAC-AMB/121301/2010 (FCOMP-01-0124-FEDER-019490)]; HHMI; European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme	BII from Portuguese Foundation for Science and Technology (FCT); Russian Ministry of Science; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); HHMI(Howard Hughes Medical Institute); European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme	Joana Pereira was funded by a BII grant (CIIMAR/C2008/BII/01-25) from the Portuguese Foundation for Science and Technology (FCT). SJO was supported as Principal Investigator by Russian Ministry of Science Mega-grant no. 11.G34.31.0068. Erich D. Jarvis was funded by HHMI. Agostinho Antunes was partially supported by the European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme and national funds through FCT under the projects PEst-C/MAR/LA0015/2013 and PTDC/BIA-BDE/69144/2006 (FCOMP-01-0124-FEDER-007065), PTDC/AAC-AMB/ 104983/2008 (FCOMP-01-0124-FEDER-008610) and PTDC/AAC-AMB/121301/2010 (FCOMP-01-0124-FEDER-019490). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; [Anonymous], PYMOL MOL GRAPH SYST; Avaron F, 2006, DEV DYNAM, V235, P478, DOI 10.1002/dvdy.20619; Battey JND, 2007, PROTEINS, V69, P68, DOI 10.1002/prot.21761; Beachy PA, 1997, COLD SPRING HARB SYM, V62, P191; Beachy PA, 2010, GENE DEV, V24, P2001, DOI 10.1101/gad.1951710; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bingham S, 2001, GENESIS, V30, P170, DOI 10.1002/gene.1057; Burglin TR, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-241; Burglin TR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-127; Burt DW, 2002, CYTOGENET GENOME RES, V96, P97, DOI 10.1159/000063018; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chen X, 2011, J CELL BIOL, V192, P825, DOI 10.1083/jcb.201008090; Cozzetto D, 2009, PROTEINS, V77, P18, DOI 10.1002/prot.22561; da Fonseca RR, 2007, GENE, V387, P58, DOI 10.1016/j.gene.2006.08.017; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Davis JC, 2005, J MOL EVOL, V60, P774, DOI 10.1007/s00239-004-0241-2; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dessimoz C, 2010, GENOME BIOL, V11; DJABALI M, 1992, NAT GENET, V2, P113, DOI 10.1038/ng1092-113; Dutcher SK, 2001, CURR OPIN CELL BIOL, V13, P49, DOI 10.1016/S0955-0674(00)00173-3; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EKKER SC, 1995, DEVELOPMENT, V121, P2337; Eugster C, 2007, DEV CELL, V13, P57, DOI 10.1016/j.devcel.2007.04.019; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Fujita P. A., 2010, NUCL ACIDS RES; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Gu X, 2006, MOL BIOL EVOL, V23, P1937, DOI 10.1093/molbev/msl056; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Gunbin Konstantin V., 2007, In Silico Biology, V7, P333; Hadzhiev Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r106; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; Hao LM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-280; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Irimia M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00433; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Kano S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013332; Kinch L, 2011, PROTEINS, V79, P59, DOI 10.1002/prot.23181; KOONIN EV, 1995, TRENDS BIOCHEM SCI, V20, P141, DOI 10.1016/S0968-0004(00)88989-6; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar S, 1996, GENETICS, V142, P965; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Ladjali-Mohammedi K, 1999, CYTOGENET CELL GENET, V86, P271, DOI 10.1159/000015318; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Masabanda JS, 2004, GENETICS, V166, P1367, DOI 10.1534/genetics.166.3.1367; McClellan DA, 2005, MOL BIOL EVOL, V22, P437, DOI 10.1093/molbev/msi028; McClellan DA, 2001, MOL BIOL EVOL, V18, P917, DOI 10.1093/oxfordjournals.molbev.a003892; McKean PG, 2001, J CELL SCI, V114, P2723; McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Misawa H, 2000, INT J MOL MED, V6, P191; Morisson M, 2007, CYTOGENET GENOME RES, V117, P14, DOI 10.1159/000103160; Mortier GR, 2003, J MED GENET, V40, P201, DOI 10.1136/jmg.40.3.201; Muffato M, 2010, BIOINFORMATICS, V26, P1119, DOI 10.1093/bioinformatics/btq079; Murone M, 1999, EXP CELL RES, V253, P25, DOI 10.1006/excr.1999.4676; Nagase T, 2007, ANN NY ACAD SCI, V1101, P412, DOI 10.1196/annals.1389.029; Nanni L, 1999, HUM MOL GENET, V8, P2479, DOI 10.1093/hmg/8.13.2479; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Odent S, 1999, HUM MOL GENET, V8, P1683, DOI 10.1093/hmg/8.9.1683; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Porter ML, 2007, MOL BIOL EVOL, V24, P253, DOI 10.1093/molbev/msl152; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roux J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000311; Roy A, 2011, JOVE-J VIS EXP, DOI 10.3791/3259; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Sobrinho IS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-293; St John JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-415; Sun XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001499; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Takatori N, 2002, MECH DEVELOP, V116, P235, DOI 10.1016/S0925-4773(02)00150-8; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trukhina A V, 2010, Genetika, V46, P509; Umehara F, 2000, AM J HUM GENET, V67, P1302, DOI 10.1016/S0002-9297(07)62958-9; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang YF, 2001, GENETICS, V158, P1311; Woolley S, 2003, BIOINFORMATICS, V19, P671, DOI 10.1093/bioinformatics/btg043; Wu ST, 2011, STRUCTURE, V19, P1182, DOI 10.1016/j.str.2011.05.004; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2002, CURR OPIN GENET DEV, V12, P688, DOI 10.1016/S0959-437X(02)00348-9; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yao HHC, 2002, GENE DEV, V16, P1433, DOI 10.1101/gad.981202; Zardoya R, 1996, TRENDS GENET, V12, P496, DOI 10.1016/S0168-9525(96)20014-9; Zhan X, 2013, NAT GENET; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zhang Y, 2007, PROTEINS, V68, P1020, DOI 10.1002/prot.21643; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zheng XY, 2010, GENE DEV, V24, P57, DOI 10.1101/gad.1870310	112	31	33	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e74132	10.1371/journal.pone.0074132	http://dx.doi.org/10.1371/journal.pone.0074132			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549322	Green Published, gold, Green Submitted			2022-12-26	WOS:000347063500001
J	Coffeng, LE; Stolk, WA; Hoerauf, A; Habbema, D; Bakker, R; Hopkins, AD; de Vlas, SJ				Coffeng, Luc E.; Stolk, Wilma A.; Hoerauf, Achim; Habbema, Dik; Bakker, Roel; Hopkins, Adrian D.; de Vlas, Sake J.			Elimination of African Onchocerciasis: Modeling the Impact of Increasing the Frequency of Ivermectin Mass Treatment	PLOS ONE			English	Article							CONTROL PROGRAM; ENDEMIC FOCI; MULTIPLE TREATMENTS; TREATED POPULATION; SKIN MICROFILARIAE; ADULT PARASITES; VECTOR CONTROL; 1ST EVIDENCE; WEST-AFRICA; VOLVULUS	The African Programme for Onchocerciasis Control (APOC) is currently shifting its focus from morbidity control to elimination of infection. To enhance the likelihood of elimination and speed up its achievement, programs may consider to increase the frequency of ivermectin mass treatment from annual to 6-monthly or even higher. In a computer simulation study, we examined the potential impact of increasing the mass treatment frequency for different settings. With the ONCHOSIM model, we simulated 92,610 scenarios pertaining to different assumptions about transmission conditions, history of mass treatment, the future mass treatment strategy, and ivermectin efficacy. Simulation results were used to determine the minimum remaining program duration and number of treatment rounds required to achieve 99% probability of elimination. Doubling the frequency of treatment from yearly to 6-monthly or 3-monthly was predicted to reduce remaining program duration by about 40% or 60%, respectively. These reductions come at a cost of additional treatment rounds, especially in case of 3-monthly mass treatment. Also, aforementioned reductions are highly dependent on maintained coverage, and could be completely nullified if coverage of mass treatment were to fall in the future. In low coverage settings, increasing treatment coverage is almost just as effective as increasing treatment frequency. We conclude that 6-monthly mass treatment may only be worth the effort in situations where annual treatment is expected to take a long time to achieve elimination in spite of good treatment coverage, e. g. because of unfavorable transmission conditions or because mass treatment started recently.	[Coffeng, Luc E.; Stolk, Wilma A.; Habbema, Dik; Bakker, Roel; de Vlas, Sake J.] Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Hoerauf, Achim] Univ Hosp Bonn, Inst Med Microbiol Immunol & Parasitol, D-53105 Bonn, Germany; [Hopkins, Adrian D.] Mectizan Donat Program, Decatur, GA 30030 USA	Erasmus University Rotterdam; Erasmus MC; University of Bonn	Coffeng, LE (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	l.coffeng@erasmusmc.nl	Coffeng, Luc/AAL-6631-2021	Coffeng, Luc/0000-0002-4425-2264; de Vlas, Sake J./0000-0002-1830-5668; Stolk, Wilma/0000-0001-9509-1328	Mectizan Donation Program	Mectizan Donation Program	The study was funded by the Mectizan Donation Program. ADH is the director of the Mectizan Donation Program. The funder provided support in the form of salary for author ADH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	African Programme for Onchocerciasis Control and World Health Organization, 2010, CONC OP FRAM ONCH EL; ALLEY ES, 1994, T ROY SOC TROP MED H, V88, P581, DOI 10.1016/0035-9203(94)90172-4; Amazigo U, 2008, ANN TROP MED PARASIT, V102, P19, DOI 10.1179/136485908X337436; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P533; Awadzi K, 2004, ANN TROP MED PARASIT, V98, P359, DOI 10.1179/000349804225003442; Basanez MG, 2008, LANCET INFECT DIS, V8, P310, DOI 10.1016/S1473-3099(08)70099-9; Basanez MG, 2009, ADV PARASIT, V68, P263, DOI 10.1016/S0065-308X(08)00611-8; BASANEZ MG, 1995, PARASITOLOGY, V110, P409, DOI 10.1017/S0031182000064751; Bottomley C, 2008, PARASITOLOGY, V135, P1571, DOI 10.1017/S0031182008000425; CHAVASSE DC, 1993, TROP MED PARASITOL, V44, P155; Churcher TS, 2005, PARASITOLOGY, V131, P121, DOI 10.1017/S0031182005007341; Coffeng LE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002168; Coffeng LE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002032; Coulibaly Y, 2008, TROP MED INT HEALTH, V13, P1430, DOI 10.1111/j.1365-3156.2008.02174.x; Cupp EW, 2011, ACTA TROP, V120, pS100, DOI 10.1016/j.actatropica.2010.08.009; Cupp EW, 2005, AM J TROP MED HYG, V73, P1159, DOI 10.4269/ajtmh.2005.73.1159; Cupp EW, 2004, AM J TROP MED HYG, V71, P602; Dembele M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001574; Diawara L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000497; Duerr HP, 2011, INT J PARASITOL, V41, P581, DOI 10.1016/j.ijpara.2010.12.009; Duerr HP, 2004, INT J PARASITOL, V34, P463, DOI 10.1016/j.ijpara.2003.11.008; DUKE BOL, 1992, AM J TROP MED HYG, V46, P189, DOI 10.4269/ajtmh.1992.46.189; DUKE BOL, 1990, AM J TROP MED HYG, V43, P657, DOI 10.4269/ajtmh.1990.43.657; Duke BOL, 2005, PARASITOLOGY, V130, P447, DOI 10.1017/S0031182004006766; DUKE BOL, 1991, AM J TROP MED HYG, V45, P132, DOI 10.4269/ajtmh.1991.45.132; DUKE BOL, 1991, B WORLD HEALTH ORGAN, V69, P163; Gardon J, 2002, LANCET, V360, P203, DOI 10.1016/S0140-6736(02)09456-4; Habbema JDF, 1996, MODELS INFECT HUMAN, P360; KLAGER S, 1993, TROP MED PARASITOL, V44, P305; Klager SL, 1996, TROP MED INT HEALTH, V1, P581; Mwinzi PNM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-182; Nana-Djeunga HC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002824; Osei-Atweneboana MY, 2012, INT J PARASITOL-DRUG, V2, P20, DOI 10.1016/j.ijpddr.2012.01.005; Osei-Atweneboana MY, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000998; Pion SDS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002084; PLAISIER AP, 1995, J INFECT DIS, V172, P204, DOI 10.1093/infdis/172.1.204; Plaisier AP, 1997, B WORLD HEALTH ORGAN, V75, P237; PLAISIER AP, 1991, ACTA TROP, V48, P271, DOI 10.1016/0001-706X(91)90015-C; PLAISIER AP, 1990, COMPUT METH PROG BIO, V31, P43, DOI 10.1016/0169-2607(90)90030-D; PLAISIER AP, 1991, B WORLD HEALTH ORGAN, V69, P169; Sauerbrey M, 2008, ANN TROP MED PARASIT, V102, P25, DOI 10.1179/136485908X337454; Soumbey-Alley E, 2004, J MED ENTOMOL, V41, P83, DOI 10.1603/0022-2585-41.1.83; Stolk WA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001984; Tekle AH, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-28; Traore MO, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001825; Turner HC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002452; Turner HC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002169; WHO, 2012, ACC WORK OV GLOB IMP, P13; Winnen M, 2002, B WORLD HEALTH ORGAN, V80, P384	49	50	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115886	10.1371/journal.pone.0115886	http://dx.doi.org/10.1371/journal.pone.0115886			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545677	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200079
J	Pearson-Dennett, V; Flavel, SC; Wilcox, RA; Thewlis, D; Vogel, AP; White, JM; Todd, G				Pearson-Dennett, Verity; Flavel, Stanley C.; Wilcox, Robert A.; Thewlis, Dominic; Vogel, Adam P.; White, Jason M.; Todd, Gabrielle			Hand Function is Altered in Individuals with a History of Illicit Stimulant Use	PLOS ONE			English	Article							GRIP FORCE CONTROL; PARKINSONS-DISEASE; CLINICAL-PHARMACOLOGY; COGNITIVE IMPAIRMENT; OBJECT MANIPULATION; ECSTASY; AGE; PERFORMANCE; DISORDERS	Use of illicit stimulant drugs such as methamphetamine, cocaine, and ecstasy are a significant worldwide problem. However, little is known about the effect of these drugs on movement. The aim of the current study was to investigate hand function in adults with a history of illicit stimulant use. We hypothesized that prior use of illicit stimulant drugs is associated with abnormal manipulation of objects. The study involved 22 subjects with a history of illicit stimulant use (aged 29 +/- 8 yrs; time since last use: 1.8 +/- 4.0 yrs) and two control groups comprising 27 non-drug users (aged 25 +/- 8 yrs) and 17 cannabis users with no history of stimulant use (aged 22 +/- 5 yrs). Each subject completed screening tests (neuropsychological assessment, medical history questionnaire, lifetime drug history questionnaire, and urine drug screen) prior to gripping and lifting a light-weight object with the dominant right hand. Horizontal grip force, vertical lift force, acceleration, and first dorsal interosseus electromyographic (EMG) activity were recorded during three trials. In trial one, peak grip force was significantly greater in the stimulant group (12.8 +/- 3.9 N) than in the control groups (non-drug: 10.3 +/- 4.6 N; cannabis: 9.4 +/- 2.9 N, P<0.022). However, peak grip force did not differ between groups in trials two and three. The results suggest that individuals with a history of stimulant use overestimate the grip force required to manipulate a novel object but, are able to adapt grip force in subsequent lifts. The results suggest that movement dysfunction may be an unrecognized consequence of illicit stimulant use.	[Pearson-Dennett, Verity; Flavel, Stanley C.; White, Jason M.; Todd, Gabrielle] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Pearson-Dennett, Verity; Flavel, Stanley C.; Thewlis, Dominic; White, Jason M.; Todd, Gabrielle] Univ S Australia, Sansom Inst, Adelaide, SA 5001, Australia; [Wilcox, Robert A.] Flinders Med Ctr, Dept Neurol, Bedford Pk, SA, Australia; [Wilcox, Robert A.] Flinders Univ S Australia, Sch Med, Bedford Pk, SA, Australia; [Thewlis, Dominic] Univ S Australia, Sch Hlth Sci, Adelaide, SA 5001, Australia; [Vogel, Adam P.] Univ Melbourne, Speech Neurosci Unit, Melbourne, Vic 3010, Australia	University of South Australia; University of South Australia; Flinders Medical Centre; Flinders University South Australia; University of South Australia; University of Melbourne	Todd, G (corresponding author), Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia.	gabrielle.todd@unisa.edu.au	Todd, Gabrielle/K-7122-2012; Thewlis, Dominic/X-1184-2019; White, Jason M/A-2795-2011; Thewlis, Dominic/C-5686-2009; Vogel, Adam/ABD-7685-2020	Todd, Gabrielle/0000-0002-2465-6026; Thewlis, Dominic/0000-0001-6614-8663; White, Jason M/0000-0001-6750-1078; Thewlis, Dominic/0000-0001-6614-8663; Vogel, Adam/0000-0002-3505-2631; Wilcox, Robert/0000-0001-9911-8743; Pearson-Dennett, Verity/0000-0003-0971-2007	Ramaciotti Foundation [ID2974/2010]; National Health and Medical Research Council of Australia [627003]; APV holds an Early Career Research Fellowship [ID 1012302]; Australian Government; University of South Australia	Ramaciotti Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); APV holds an Early Career Research Fellowship; Australian Government(Australian GovernmentCGIAR); University of South Australia	This work was supported by the Ramaciotti Foundation (GT holds an Establishment Grant; ID2974/2010), National Health and Medical Research Council of Australia (GT holds a Career Development Award: ID 627003; APV holds an Early Career Research Fellowship: ID 1012302), Australian Government (VPD holds an Australian Postgraduate Award), and the University of South Australia (GT holds a Research SA Fellowship and Division of Health Sciences Research Grant, SCF held an Australian Postgraduate Award, and VPD holds a Top-up Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON GT, 1965, ERGONOMICS, V8, P237, DOI 10.1080/00140136508930795; AIHW, 2011, AIHW DRUG STAT SER, V22, P1; [Anonymous], 2012, WORLD DRUG REP 2012; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BENOWITZ NL, 1993, PHARMACOL TOXICOL, V72, P3, DOI 10.1111/j.1600-0773.1993.tb01331.x; Benton AL, 1983, MULTILINGUAL APHASIA; Bousman CA, 2010, J INT NEUROPSYCH SOC, V16, P1047, DOI 10.1017/S1355617710000846; Breen C, 2006, SUBST USE MISUSE, V41, P1095, DOI 10.1080/10826080500411528; Callaghan RC, 2010, MOVEMENT DISORD, V25, P2333, DOI 10.1002/mds.23263; CARDOSO F, 1993, NEUROL CLIN, V11, P625, DOI 10.1016/S0733-8619(18)30143-9; Claudino R, 2013, PERCEPT MOTOR SKILL, V116, P859, DOI 10.2466/10.06.PMS.116.3.859-871; Croft RJ, 2001, PSYCHOPHARMACOLOGY, V153, P373, DOI 10.1007/s002130000591; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fellows SJ, 2004, MOVEMENT DISORD, V19, P560, DOI 10.1002/mds.10710; Flanagan JR, 2006, CURR OPIN NEUROBIOL, V16, P650, DOI 10.1016/j.conb.2006.10.005; Flanagan JR, 1997, J NEUROSCI, V17, P1519; Flavel SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052025; Flavel SC, 2012, J APPL PHYSIOL, V113, P1486, DOI 10.1152/japplphysiol.00718.2012; GORDON AM, 1993, J NEUROPHYSIOL, V69, P1789, DOI 10.1152/jn.1993.69.6.1789; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; GRIGSBY J, 1995, PERCEPT MOTOR SKILL, V80, P732, DOI 10.2466/pms.1995.80.3.732; Hermsdorfer J, 2003, CLIN NEUROPHYSIOL, V114, P915, DOI 10.1016/S1388-2457(03)00042-7; Johansson RS, 1998, NOVART FDN SYMP, V218, P45; KEARCOLWELL JJ, 1978, J CLIN PSYCHOL, V34, P437, DOI 10.1002/1097-4679(197804)34:2<437::AID-JCLP2270340239>3.0.CO;2-K; King G, 2010, PSYCHOPHARMACOLOGY, V212, P243, DOI 10.1007/s00213-010-1949-x; Melega WP, 2007, NEUROREPORT, V18, P1741, DOI 10.1097/WNR.0b013e3282f0d4f4; Mrazik M, 2010, ARCH CLIN NEUROPSYCH, V25, P236, DOI 10.1093/arclin/acq006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; STEADWARD RD, 1975, MED SCI SPORT EXER, V7, P309; Thompson G.B., 1992, PSYCHOL ASSESSMENT, V4, P363; Todd G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056438; Todd G, 2010, EUR J NEUROSCI, V32, P1686, DOI 10.1111/j.1460-9568.2010.07444.x; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Yamamoto BK, 2010, ANN NY ACAD SCI, V1187, P101, DOI 10.1111/j.1749-6632.2009.05141.x	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115771	10.1371/journal.pone.0115771	http://dx.doi.org/10.1371/journal.pone.0115771			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545892	Green Published, Green Accepted, gold			2022-12-26	WOS:000347120200066
J	Toda, T; Ishida, K; Kiyama, H; Yamashita, T; Lee, S				Toda, Takuya; Ishida, Kazuto; Kiyama, Hiroshi; Yamashita, Toshihide; Lee, Sachiko			Down-Regulation of KCC2 Expression and Phosphorylation in Motoneurons, and Increases the Number of in Primary Afferent Projections to Motoneurons in Mice with Post-Stroke Spasticity	PLOS ONE			English	Article							SPINAL-CORD-INJURY; VESICULAR GLUTAMATE TRANSPORTERS; CHLORIDE COTRANSPORTER KCC2; DORSAL-ROOT GANGLIA; STROKE SURVIVORS; NEUROPATHIC PAIN; RAT; DEPRESSION; INHIBITION; ACTIVATION	Spasticity obstructs motor function recovery post-stroke, and has been reported to occur in spinal cord injury and electrophysiological studies. The purpose of the present study was to assess spinal cord circuit spasticity in post-stroke mice. At 3, 7, 21, and 42 d after photothrombotic ischemic cortical injury in C57BL/6J mice, we observed decreased rate-dependent depression (RDD) of the Hoffmann reflex (H reflex) in the affected forelimb of mice compared with the limbs of sham mice and the non-affected forelimb. This finding suggests a hyper-excitable stretch reflex in the affected forelimb. We then performed immunohistochemical and western blot analyses to examine the expression of the potassium-chloride cotransporter 2 (KCC2) and phosphorylation of the KCC2 serine residue, 940 (S940), since this is the main chloride extruder that affects neuronal excitability. We also performed immunohistochemical analyses on the number of vesicular glutamate transporter 1 (vGluT1)-positive boutons to count the number of la afferent fibers that connect to motoneurons. Western bolts revealed that, compared with sham mice, experimental mice had significantly reduced KCC2 expression at 7 d post-stroke, and dephosphorylated S940 at 3 and 7 d post-stroke in motoneuron plasma membranes. We also observed a lower density of KCC2-positive areas in the plasma membrane of motoneurons at 3 and 7 d post-stroke. However, western blot and immunohistochemical analyses revealed that there were no differences between groups 21 and 42 d post-stroke, respectively. In addition, at 7 and 42 d post-stroke, experimental mice exhibited a significant increase in vGluT1 boutons compared with sham mice. Our findings suggest that both the down-regulation of KCC2 and increases in la afferent fibers are involved in post-stroke spasticity.	[Toda, Takuya; Ishida, Kazuto; Lee, Sachiko] Nagoya Univ, Grad Sch Med, Dept Phys & Occupat Therapy, Nagoya, Aichi 4648601, Japan; [Kiyama, Hiroshi] Nagoya Univ, Grad Sch Med, Dept Funct Anat & Neurosci, Nagoya, Aichi 4648601, Japan; [Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Osaka, Japan	Nagoya University; Nagoya University; Osaka University	Lee, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Phys & Occupat Therapy, Nagoya, Aichi 4648601, Japan.	lee@met.nagoya-u.ac.jp	Kiyama, Hiroshi/M-8867-2014; Lee, Sachiko/I-6252-2014	Kiyama, Hiroshi/0000-0001-5963-046X; Yamashita, Toshihide/0000-0003-4559-7018	JSPS KAKENHI [23700598]; Hayashi Memorial Foundation for Female Nature Scientists; Grants-in-Aid for Scientific Research [25750201] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hayashi Memorial Foundation for Female Nature Scientists; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by the following: JSPS KAKENHI (Grant Number: 23700598, http://www.jsps.go.jp/english/index.html), and the Hayashi Memorial Foundation for Female Nature Scientists (http://www.smtb.jp/personal/entrustment/management/public/example/list.html).	Alvarez FJ, 2004, J COMP NEUROL, V472, P257, DOI 10.1002/cne.20012; Alvarez FJ, 2011, J NEUROPHYSIOL, V106, P2450, DOI 10.1152/jn.01095.2010; Bennett DJ, 2004, J NEUROPHYSIOL, V91, P2247, DOI 10.1152/jn.00946.2003; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Bos R, 2013, P NATL ACAD SCI USA, V110, P348, DOI 10.1073/pnas.1213680110; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Chamma I, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00005; Chen CF, 2002, NEURON, V33, P779, DOI 10.1016/S0896-6273(02)00611-6; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Crone C, 2003, BRAIN, V126, P495, DOI 10.1093/brain/awg036; Delpire E, 2010, J PHYSIOL-LONDON, V588, P3365, DOI 10.1113/jphysiol.2010.190769; DELWAIDE PJ, 1988, J NEUROL NEUROSUR PS, V51, P1546, DOI 10.1136/jnnp.51.12.1546; Du Beau A, 2012, NEUROSCIENCE, V227, P67, DOI 10.1016/j.neuroscience.2012.09.037; FAIST M, 1994, BRAIN, V117, P1449, DOI 10.1093/brain/117.6.1449; Foster KA, 2004, NEURON, V43, P119, DOI 10.1016/j.neuron.2004.06.022; Fuchs A, 2010, J NEUROPATH EXP NEUR, V69, P1057, DOI 10.1097/NEN.0b013e3181f4dcef; Fulton J. F., 1934, RES PUBL ASS NERV ME, V13, P158; Higashi T, 2001, ARCH PHYS MED REHAB, V82, P1604, DOI 10.1053/apmr.2001.25081; Hosoido T, 2011, NEUROSCI LETT, V505, P263, DOI 10.1016/j.neulet.2011.10.035; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Jaenisch N, 2010, STROKE, V41, pE151, DOI 10.1161/STROKEAHA.109.570424; Kahle KT, 2013, TRENDS NEUROSCI, V36, P726, DOI 10.1016/j.tins.2013.08.006; Khirug S, 2010, J NEUROSCI, V30, P12028, DOI 10.1523/JNEUROSCI.3154-10.2010; Lamy JC, 2009, BRAIN, V132, P734, DOI 10.1093/brain/awn310; Lee H, 2011, NAT NEUROSCI; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Lee S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.544; Li H, 2007, NEURON, V56, P1019, DOI 10.1016/j.neuron.2007.10.039; Li YR, 2004, J NEUROPHYSIOL, V91, P767, DOI 10.1152/jn.00788.2003; Malet M, 2013, NEUROSCIENCE, V248, P95, DOI 10.1016/j.neuroscience.2013.05.044; Mazzocchio R, 1997, BRAIN, V120, P991, DOI 10.1093/brain/120.6.991; McPherson JG, 2008, J NEUROPHYSIOL, V100, P3236, DOI 10.1152/jn.90563.2008; Mottram CJ, 2010, J NEUROPHYSIOL, V104, P3168, DOI 10.1152/jn.00463.2010; Mottram CJ, 2009, J NEUROPHYSIOL, V102, P2026, DOI 10.1152/jn.00151.2009; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Navarro X, 2009, INT REV NEUROBIOL, V87, P105, DOI 10.1016/S0074-7742(09)87006-2; Nielsen JB, 2007, ACTA PHYSIOL, V189, P171, DOI 10.1111/j.1748-1716.2006.01652.x; Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249; Pizzi A, 2005, ARCH PHYS MED REHAB, V86, P410, DOI 10.1016/j.apmr.2004.10.022; Puskarjov M, 2012, J NEUROSCI, V32, P11356, DOI 10.1523/JNEUROSCI.6265-11.2012; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Sheean G, 2002, EUR J NEUROL, V9, P3, DOI 10.1046/j.1468-1331.2002.0090s1003.x; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Tan AM, 2012, J NEUROSCI, V32, P12896, DOI 10.1523/JNEUROSCI.6451-11.2012; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Urban PP, 2010, STROKE, V41, P2016, DOI 10.1161/STROKEAHA.110.581991; Wissel J, 2010, J NEUROL, V257, P1067, DOI 10.1007/s00415-010-5463-1; Wong AYC, 2003, J NEUROSCI, V23, P4868; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Wu SX, 2004, BRAIN RES, V1011, P247, DOI 10.1016/brainres.2004.03.047; Xu JH, 2007, CURR OPIN NEUROBIOL, V17, P352, DOI 10.1016/j.conb.2007.04.005; Zhang LL, 2006, J COMP NEUROL, V499, P132, DOI 10.1002/cne.21100; Zhou HY, 2012, J BIOL CHEM, V287, P33853, DOI 10.1074/jbc.M112.395830	55	26	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e114328	10.1371/journal.pone.0114328	http://dx.doi.org/10.1371/journal.pone.0114328			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546454	gold, Green Submitted, Green Published			2022-12-26	WOS:000347120200009
J	Rasmussen, NR; Debebe, Z; Wright, TM; Brooks, SA; Sendor, AB; Brannon, AR; Hakimi, AA; Hsieh, JJ; Choueiri, TK; Tamboli, P; Maranchie, JK; Hinds, P; Wallen, EM; Simpson, C; Norris, JL; Janzen, WP; Rathmell, WK				Rasmussen, Neal R.; Debebe, Zufan; Wright, Tricia M.; Brooks, Samira A.; Sendor, Adam B.; Brannon, A. Rose; Hakimi, A. Ari; Hsieh, James J.; Choueiri, Toni K.; Tamboli, Pheroze; Maranchie, Jodi K.; Hinds, Peter; Wallen, Eric M.; Simpson, Catherine; Norris, Jacqueline L.; Janzen, William P.; Rathmell, W. Kimryn			Expression of Ror2 Mediates Invasive Phenotypes in Renal Cell Carcinoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; RECEPTOR TYROSINE KINASE; BRACHYDACTYLY TYPE-B; TUMOR; METALLOPROTEINASE; OSTEOSARCOMA; PSEUDOKINASE; MELANOMA; DISEASE; CANCER	Ror2 is a Wnt ligand receptor that is overexpressed in a variety of tumors including clear cell renal cell carcinoma (ccRCC). Here we demonstrate that expression of wild type Ror2 results in increased tumorigenic properties in in vitro cell culture and in vivo xenograft models. In addition, Ror2 expression produced positive changes in both cell migration and invasion, which were dependent on matrix metalloprotease 2 (MMP2) activity. Mutations in key regions of the kinase domain of Ror2 resulted in the abrogation of increased tumor growth, cell migration, and cell invasion observed with expression of wild-type Ror2. Finally, we examined Ror2 expression as a prognostic biomarker for ccRCC utilizing the TCGA ccRCC dataset. High expression of Ror2 showed a significant correlation with higher clinical stage, nuclear grade, and tumor stage. Furthermore, high expression of Ror2 in ccRCC patients correlated with significant lower overall survival, cancer specific survival, and recurrence free survival. Together, these findings suggest that Ror2 plays a central role in influencing the ccRCC phenotype, and can be considered as a negative prognostic biomarker and potential therapeutic target in this cancer.	[Rasmussen, Neal R.; Wright, Tricia M.; Brannon, A. Rose] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Rasmussen, Neal R.; Debebe, Zufan; Wright, Tricia M.; Brooks, Samira A.; Sendor, Adam B.; Brannon, A. Rose; Rathmell, W. Kimryn] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Brooks, Samira A.] Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC 27599 USA; [Brannon, A. Rose; Hakimi, A. Ari; Hsieh, James J.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Hakimi, A. Ari; Hsieh, James J.] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10065 USA; [Choueiri, Toni K.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Choueiri, Toni K.] Dana Farber Canc Inst, Kidney Canc Ctr, Boston, MA 02215 USA; [Tamboli, Pheroze] Univ Texas Houston, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Maranchie, Jodi K.; Hinds, Peter] Univ Pittsburgh, Med Ctr, Dept Urol Oncol, Pittsburgh, PA 15219 USA; [Wallen, Eric M.] Univ N Carolina, Dept Urol, Chapel Hill, NC 27599 USA; [Wallen, Eric M.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Simpson, Catherine; Norris, Jacqueline L.; Janzen, William P.] Univ N Carolina, Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC 27599 USA; [Rathmell, W. Kimryn] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Rathmell, W. Kimryn] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Rathmell, WK (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	Rathmell@med.unc.edu	Choueiri, Toni/K-5238-2019; , Pathology Services Core/CEZ-2246-2022; Maranchie, Jodi/AAG-1035-2020	Choueiri, Toni/0000-0002-9201-3217; Rasmussen, Neal/0000-0002-5343-9119; Maranchie, Jodi/0000-0002-8534-9468; Sendor, Adam/0000-0003-4958-4660	American Cancer Society Research Scholar [RSG-10-192-01]; National Heart, Lung, and Blood Institute [T32 HL069768-09]; National Cancer Institute [5T32CA160001]; NATIONAL CANCER INSTITUTE [T32CA160001] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007126] Funding Source: NIH RePORTER	American Cancer Society Research Scholar(American Cancer Society); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding provided by (www.cancer.org) American Cancer Society Research Scholar Grant RSG-10-192-01 (WKR), (www.nhlbi.nih.gov) National Heart, Lung, and Blood Institute T32 HL069768-09 (NR) and (www.cancer.gov) National Cancer Institute 5T32CA160001 (ARB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; [Anonymous], 2013, NATURE, V499, P43; Brannon A Rose, 2010, Genes Cancer, V1, P152; Brooks SA, 2014, EUROPEAN UROLOGY; Choi H, 2010, CANCER RES, V70, P10101, DOI 10.1158/0008-5472.CAN-10-0505; Edris B, 2012, J PATHOL, V227, P223, DOI 10.1002/path.3986; Eggener SE, 2006, J CLIN ONCOL, V24, P3101, DOI 10.1200/JCO.2005.04.8280; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Gentile A, 2011, CANCER RES, V71, P3132, DOI 10.1158/0008-5472.CAN-10-2662; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Kobayashi M, 2009, ORAL SURG ORAL MED O, V107, P398, DOI 10.1016/j.tripleo.2008.08.018; Kubo T, 2009, CARCINOGENESIS, V30, P1857, DOI 10.1093/carcin/bgp206; Lai SS, 2012, CANCER GENET-NY, V205, P552, DOI 10.1016/j.cancergen.2012.09.002; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li X, 2013, GENES CELLS, V18, P608, DOI 10.1111/gtc.12064; Liotta L A, 1990, Semin Cancer Biol, V1, P99; Lu BJ, 2012, MOL MED REP, V5, P1033, DOI 10.3892/mmr.2012.772; Mei H, 2014, BIOCH BIOPHYSICAL RE; Mendrola JM, 2013, BIOCHEM SOC T, V41, P1029, DOI 10.1042/BST20130104; Morioka K, 2009, CANC SCI; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; O'Connell MP, 2013, CANCER DISCOV, V3, P1378, DOI 10.1158/2159-8290.CD-13-0005; O'Connell MP, 2009, ONCOGENE; Ohta H, 2009, BRIT J CANCER, V100, P389, DOI 10.1038/sj.bjc.6604846; Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495; Rasmussen NR, 2013, J BIOL CHEM; Ren DY, 2011, GENES CELLS, V16, P304, DOI 10.1111/j.1365-2443.2011.01487.x; Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x; Wright TM, 2009, ONCOGENE, V28, P2513, DOI 10.1038/onc.2009.116; Yamagata K, 2012, J BIOL CHEM, V287, P1588, DOI 10.1074/jbc.M111.315127; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496	32	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116101	10.1371/journal.pone.0116101	http://dx.doi.org/10.1371/journal.pone.0116101			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542006	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900141
J	Tittel, J; Welz, T; Czogalla, A; Dietrich, S; Samol-Wolf, A; Schulte, M; Schwille, P; Weidemann, T; Kerkhoff, E				Tittel, Janine; Welz, Tobias; Czogalla, Aleksander; Dietrich, Susanne; Samol-Wolf, Annette; Schulte, Markos; Schwille, Petra; Weidemann, Thomas; Kerkhoff, Eugen			Membrane Targeting of the Spir.Formin Actin Nucleator Complex Requires a Sequential Handshake of Polar Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; CROSS-CORRELATION SPECTROSCOPY; FYVE DOMAIN; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; CELLULAR MEMBRANES; VESICLE TRANSPORT; CRYSTAL-STRUCTURE; KINASE FUNCTION; C-LOBE; PROTEIN	Spir and formin (FMN)-type actin nucleators initiate actin polymerization at vesicular membranes necessary for long range vesicular transport processes. Here we studied in detail the membrane binding properties and protein/protein interactions that govern the assembly of the membrane-associated SpirFMN complex. Using biomimetic membrane models we show that binding of the C-terminal Spir-2 FYVE-type zinc finger involves both the presence of negatively charged lipids and hydrophobic contributions from the turret loop that intrudes the lipid bilayer. In solution, we uncovered a yet unknown intramolecular interaction between the Spir-2 FYVE-type domain and the N-terminal kinase non-catalytic C-lobe domain (KIND) that could not be detected in the membrane-bound state. Interestingly, we found that the intramolecular Spir-2 FYVE/KIND and the trans-regulatory Fmn-2-FSI/Spir-2-KIND interactions are competitive. We therefore characterized co-expressed Spir-2 and Fmn-2 fluorescent protein fusions in living cells by fluorescence cross-correlation spectroscopy. The data corroborate a model according to which Spir-2 exists in two different states, a cytosolic monomeric conformation and a membrane-bound state in which the KIND domain is released and accessible for subsequent Fmn-2 recruitment. This sequence of interactions mechanistically couples membrane binding of Spir to the recruitment of FMN, a pivotal step for initiating actin nucleation at vesicular membranes.	[Tittel, Janine; Schwille, Petra; Weidemann, Thomas] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Tittel, Janine; Schwille, Petra; Weidemann, Thomas] Tech Univ TU Dresden, Biotechnol Ctr BIOTEC, Biophys Res Grp, D-01307 Dresden, Germany; [Czogalla, Aleksander] Tech Univ TU Dresden, Paul Langerhans Inst, D-01307 Dresden, Germany; [Welz, Tobias; Dietrich, Susanne; Samol-Wolf, Annette; Schulte, Markos; Kerkhoff, Eugen] Univ Hosp Regensburg, Dept Neurol, Mol Cell Biol Lab, D-93053 Regensburg, Germany; [Czogalla, Aleksander] German Ctr Diabet Res, D-85764 Neuherberg, Germany	Max Planck Society; Technische Universitat Dresden; Technische Universitat Dresden; University of Regensburg	Kerkhoff, E (corresponding author), Univ Hosp Regensburg, Dept Neurol, Mol Cell Biol Lab, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.	eugen.kerkhoff@klinik.uni-regensburg.de	Czogalla, Aleksander/M-8504-2019; Weidemann, Thomas/I-9798-2017; Schwille, Petra/A-4983-2010; Czogalla, Aleksander/A-9752-2014	Weidemann, Thomas/0000-0002-6694-1087; Czogalla, Aleksander/0000-0003-3035-059X	German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) [SPP 1464]; Bavarian Genorne Research Network (BayGene)	German Research Foundation (Deutsche Forschungsgemeinschaft (DFG))(German Research Foundation (DFG)); Bavarian Genorne Research Network (BayGene)	The work was supported by German Research Foundation (Deutsche Forschungsgemeinschaft (DFG), priority program SPP 1464) (to P. S. and E. K.) and the Bavarian Genorne Research Network (BayGene) (to E. K.).	ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Bacia K, 2012, CHEMPHYSCHEM, V13, P1221, DOI 10.1002/cphc.201100801; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Busse RA, 2013, AUTOPHAGY, V9, P770, DOI 10.4161/auto.23978; Ciccarelli FD, 2003, TRENDS BIOCHEM SCI, V28, P349, DOI 10.1016/S0968-0004(03)00116-6; Czogalla A, 2014, BBA-MOL CELL BIOL L, V1841, P1049, DOI 10.1016/j.bbalip.2013.12.012; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; Dietrich S, 2013, BIOL CHEM, V394, P1649, DOI 10.1515/hsz-2013-0176; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Gil JE, 2012, J BIOL CHEM, V287, P41268, DOI 10.1074/jbc.M112.419127; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Hofer CT, 2010, METHODS MOL BIOL, V606, P69, DOI 10.1007/978-1-60761-447-0_6; Holubcova Z, 2013, NAT CELL BIOL, V15, P937, DOI 10.1038/ncb2802; Huang J, 2007, J CELL BIOL, V179, P539, DOI 10.1083/jcb.200702036; Kapusta P., 2010, APPL NOTE; Kerkhoff E, 2001, CURR BIOL, V11, P1963, DOI 10.1016/S0960-9822(01)00602-9; Kolondra A, 2010, BBA-BIOMEMBRANES, V1798, P2084, DOI 10.1016/j.bbamem.2010.07.024; Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475; Kutateladze TG, 2006, BBA-MOL CELL BIOL L, V1761, P868, DOI 10.1016/j.bbalip.2006.03.011; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Misra S, 1999, CELL, V97, P657, DOI 10.1016/S0092-8674(00)80776-X; Montaville P, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001795; Montis C, 2014, SOFT MATTER, V10, P39, DOI 10.1039/c3sm52254g; Morel E, 2009, DEV CELL, V16, P445, DOI 10.1016/j.devcel.2009.01.007; Muller P, 2014, BIOINFORMATICS, V30, P2532, DOI 10.1093/bioinformatics/btu328; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Otto IM, 2000, CURR BIOL, V10, P345, DOI 10.1016/S0960-9822(00)00388-2; Pechlivanis M, 2009, J BIOL CHEM, V284, P25324, DOI 10.1074/jbc.M109.030320; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Pleiser S, 2014, EUR J CELL BIOL, V93, P225, DOI 10.1016/j.ejcb.2013.11.001; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Quinlan ME, 2013, DEVELOPMENT, V140, P4417, DOI 10.1242/dev.097337; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Schuh M, 2011, NAT CELL BIOL, V13, P1431, DOI 10.1038/ncb2353; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Shpetner H, 1996, J CELL BIOL, V132, P595, DOI 10.1083/jcb.132.4.595; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; UI M, 1995, TRENDS BIOCHEM SCI, V20, P303, DOI 10.1016/S0968-0004(00)89056-8; Vizcarra CL, 2011, P NATL ACAD SCI USA, V108, P11884, DOI 10.1073/pnas.1105703108; Weidemann T, 2013, METHOD ENZYMOL, V518, P43, DOI 10.1016/B978-0-12-388422-0.00003-0; Weidemann T, 2011, BIOPHYS J, V101, P2360, DOI 10.1016/j.bpj.2011.10.014; Welz T, 2014, TRENDS CELL BIOL, V24, P407, DOI 10.1016/j.tcb.2014.02.004; Wolny M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021538; ZAMBRANO F, 1975, BIOCHIM BIOPHYS ACTA, V380, P357, DOI 10.1016/0005-2760(75)90104-6; Zeth K, 2011, J BIOL CHEM, V286, P30732, DOI 10.1074/jbc.M111.257782	55	12	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6428	6444		10.1074/jbc.M114.602672	http://dx.doi.org/10.1074/jbc.M114.602672			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25564607	hybrid, Green Published			2022-12-26	WOS:000350732500047
J	Moon, MJ; Lee, YN; Park, S; Reyes-Alcaraz, A; Hwang, JI; Millar, RP; Choe, H; Seong, JY				Moon, Mi Jin; Lee, Yoo-Na; Park, Sumi; Reyes-Alcaraz, Arfaxad; Hwang, Jong-Ik; Millar, Robert Peter; Choe, Han; Seong, Jae Young			Ligand Binding Pocket Formed by Evolutionarily Conserved Residues in the Glucagon-like Peptide-1 (GLP-1) Receptor Core Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT INSULINOTROPIC POLYPEPTIDE; PROTEIN-COUPLED RECEPTOR; HORMONE GNRH RECEPTORS; MOLECULAR EVOLUTION; EXTRACELLULAR LOOP-3; CRYSTAL-STRUCTURE; MID-REGION; AGONIST; SELECTIVITY; CELL	Glucagon-like peptide-1 (GLP-1) plays a pivotal role in glucose homeostasis through its receptor GLP1R. Due to its multiple beneficial effects, GLP-1 has gained great attention for treatment of type 2 diabetes and obesity. However, little is known about the molecular mechanism underlying the interaction of GLP-1 with the heptahelical core domain of GLP1R conferring high affinity ligand binding and ligand-induced receptor activation. Here, using chimeric and point-mutated GLP1R, we determined that the evolutionarily conserved amino acid residue Are flanked by hydrophobic Leu(379) and Phe(381) in extracellular loop 3 (ECL3) may have an interaction with Asp(9) and Gly(4) of the GLP-1 peptide. The molecular modeling study showed that Ile(196) at transmembrane helix 2, Met(233) at ECL1 and Asn(302) at ECL2 of GLP1R have contacts with His' and Thr(7) of GLP-1 This study may shed light on the mechanism underlying high affinity interaction between the ligand and the binding pocket that is formed by these conserved residues in the GLP1R core domain.	[Moon, Mi Jin; Lee, Yoo-Na; Park, Sumi; Reyes-Alcaraz, Arfaxad; Hwang, Jong-Ik; Seong, Jae Young] Korea Univ, Grad Sch Med, Seoul 136705, South Korea; [Millar, Robert Peter] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0028 Pretoria, South Africa; [Millar, Robert Peter] Med Res Council Receptor Biol Unit, ZA-7925 Cape Town, South Africa; [Millar, Robert Peter] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Millar, Robert Peter] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH164TJ, Midlothian, Scotland; [Choe, Han] Univ Ulsan, Coll Med, Dept Physiol, Seoul 138736, South Korea; [Choe, Han] Univ Ulsan, Coll Med, Biomed Inst Technol, Seoul 138736, South Korea	Korea University; Korea University Medicine (KU Medicine); University of Pretoria; University of Cape Town; University of Edinburgh; University of Ulsan; University of Ulsan	Choe, H (corresponding author), Univ Ulsan, Coll Med, Dept Physiol, Seoul 138736, South Korea.	hchoe@ulsan.ac.kr; jyseong@korea.ac.kr	Seong, Jae Young/A-5794-2012	Seong, Jae Young/0000-0002-3312-6924; choe, han/0000-0003-4604-647X; Hwang, Jong-Ik/0000-0002-0729-1782; Millar, Robert P/0000-0003-3606-2708	National Research Foundation of Korea [2013R1A1A2010481]; Korea-South Africa Collaboration Program of the National Research Foundation of South Africa [2012K1A3A1A09033014]; Korea University	National Research Foundation of Korea(National Research Foundation of Korea); Korea-South Africa Collaboration Program of the National Research Foundation of South Africa; Korea University	This work was supported by grants from Basic Science Research Program (2013R1A1A2010481) of the National Research Foundation of Korea and Korea-South Africa Collaboration Program (2012K1A3A1A09033014) of the National Research Foundation of South Africa.; Supported by a research fellowship grant from Korea University.	Acharjee S, 2004, J BIOL CHEM, V279, P54445, DOI 10.1074/jbc.M408909200; ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Al-Sabah S, 2003, BRIT J PHARMACOL, V140, P339, DOI 10.1038/sj.bjp.0705453; Alana I, 2007, PROTEINS, V68, P92, DOI 10.1002/prot.21372; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Chen QA, 2010, J BIOL CHEM, V285, P24508, DOI 10.1074/jbc.M110.135749; Chen Q, 2009, J BIOL CHEM, V284, P34135, DOI 10.1074/jbc.M109.038109; Cho HJ, 2007, GEN COMP ENDOCR, V153, P98, DOI 10.1016/j.ygcen.2006.12.013; Coopman K, 2011, MOL ENDOCRINOL, V25, P1804, DOI 10.1210/me.2011-1160; DaCambra MP, 2000, BIOCHEMISTRY-US, V39, P8888, DOI 10.1021/bi000497p; de Maturana RL, 2003, J BIOL CHEM, V278, P10195, DOI 10.1074/jbc.M212147200; de Maturana RL, 2004, PROTEIN PEPTIDE LETT, V11, P15, DOI 10.2174/0929866043478491; de Maturana RL, 2002, FEBS LETT, V530, P244, DOI 10.1016/S0014-5793(02)03492-0; Dong MQ, 2003, J BIOL CHEM, V278, P48300, DOI 10.1074/jbc.M309166200; Drucker DJ, 2003, MOL ENDOCRINOL, V17, P161, DOI 10.1210/me.2002-0306; FEHMANN HC, 1995, ENDOCR REV, V16, P390, DOI 10.1210/er.16.3.390; GALLWITZ B, 1994, EUR J BIOCHEM, V225, P1151, DOI 10.1111/j.1432-1033.1994.1151b.x; Harmar AJ, 2001, GENOME BIOL, V2; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Hwang JI, 2014, J MOL ENDOCRINOL, V52, pT15, DOI 10.1530/JME-13-0137; Hwang JI, 2013, MOL BIOL EVOL, V30, P1119, DOI 10.1093/molbev/mst031; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; Kirkpatrick A, 2012, P NATL ACAD SCI USA, V109, P19988, DOI [10.1073/pnas.1218051109, 10.1073/pnas.12180511091]; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Koole C, 2012, J BIOL CHEM, V287, P3642, DOI 10.1074/jbc.M111.309328; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee YR, 2009, ENDOCRINOLOGY, V150, P2837, DOI 10.1210/en.2008-1679; Li JH, 2005, MOL PHARMACOL, V67, P1099, DOI 10.1124/mol.104.004887; Lin F, 2009, J MOL MODEL, V15, P53, DOI 10.1007/s00894-008-0372-2; List JF, 2004, AM J PHYSIOL-ENDOC M, V286, pE875, DOI 10.1152/ajpendo.00007.2004; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Miller LJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217901; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; MontroseRafizadeh C, 1997, J BIOL CHEM, V272, P21201, DOI 10.1074/jbc.272.34.21201; Moon Mi Jin, 2012, Front Endocrinol (Lausanne), V3, P141, DOI 10.3389/fendo.2012.00141; Moon MJ, 2012, J BIOL CHEM, V287, P3873, DOI 10.1074/jbc.M111.276808; Moon MJ, 2011, MOL CELLS, V32, P389, DOI 10.1007/s10059-011-0157-9; Moon MJ, 2010, MOL CELLS, V30, P149, DOI 10.1007/s10059-010-0100-5; Nauck MA, 2002, J CLIN ENDOCR METAB, V87, P1239, DOI 10.1210/jc.87.3.1239; Neidigh JW, 2001, BIOCHEMISTRY-US, V40, P13188, DOI 10.1021/bi010902s; Oh DY, 2006, INT REV CYTOL, V252, P163, DOI 10.1016/S0074-7696(06)52003-0; Park CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065420; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Perret J, 2002, BIOCHEM J, V362, P389, DOI 10.1042/0264-6021:3620389; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Runge S, 2003, J BIOL CHEM, V278, P28005, DOI 10.1074/jbc.M301085200; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; Tan YV, 2006, J BIOL CHEM, V281, P12792, DOI 10.1074/jbc.M513305200; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; Totrov M, 2001, BIOPOLYMERS, V60, P124, DOI 10.1002/1097-0282(2001)60:2<124::AID-BIP1008>3.0.CO;2-S; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Venneti KC, 2011, FEBS LETT, V585, P346, DOI 10.1016/j.febslet.2010.12.011; Wang CB, 2004, MOL ENDOCRINOL, V18, P105, DOI 10.1210/me.2003-0101; Wang YJ, 2012, ENDOCRINOLOGY, V153, P5247, DOI 10.1210/en.2012-1586; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7	62	23	23	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5696	5706		10.1074/jbc.M114.612606	http://dx.doi.org/10.1074/jbc.M114.612606			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25561730	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000350044200038
J	Prasad, H; Rao, R				Prasad, Hari; Rao, Rajini			The Na+/H+ Exchanger NHE6 Modulates Endosomal pH to Control Processing of Amyloid Precursor Protein in a Cell Culture Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SECRETASE CLEAVAGE; A-BETA; MENTAL-RETARDATION; GENE-EXPRESSION; INTRACELLULAR TRAFFICKING; SODIUM/PROTON EXCHANGER; BAFILOMYCIN A1; RETINOIC ACID; APP; ENDOCYTOSIS	Early intervention may be key to safe and effective therapies in patients with Alzheimer disease. Endosomal dysfunction is an early step in neurodegeneration. Endosomes are a major site of production of A beta peptide from the processing of amyloid precursor protein (APP) by clipping enzymes (beta- and gamma-secretases). The beta-secretase enzyme BACE1 requires acidic lumen pH for optimum function, and acid pH promotes A beta aggregation. The Na+/H+ exchanger NHE6 provides a leak pathway for protons, limiting luminal acidification by proton pumps. Like APP, NHE6 expression was induced upon differentiation of SH-SY5Y neuroblastoma cells and localized to an endosomal compartment. Therefore, we investigated whether NHE6 expression altered APP localization and processing in a stably transfected cell culture model of human APP expression. We show that co-expression with NHE6 or treatment with the Na+/H+ ionophore monensin shifted APP away from the trans-Golgi network into early and recycling endosomes in HEK293 cells. NHE6 alkalinized the endosomal lumen, similar to monensin, and significantly attenuated APP processing and A beta secretion. In contrast, A beta production was elevated upon NHE6 knockdown. We show that NHE6 transcript and protein levels are lowered in Alzheimer brains relative to control. These findings, taken together with emerging genetic evidence linking endosomal Na+/H+ exchangers with Alzheimer disease, suggest that proton leak pathways may regulate A beta generation and contribute to disease etiology.	[Prasad, Hari; Rao, Rajini] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University	Rao, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA.	rrao@jhmi.edu			National Institutes of Health [DK054214, GM62142]; International Fulbright Science and Technology Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Fulbright Science and Technology Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK054214 and GM62142 (to R. R.).; A Fulbright Fellow supported by the International Fulbright Science and Technology Award.	Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brett CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017619; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Brett CL, 2002, AM J PHYSIOL-CELL PH, V282, pC1031, DOI 10.1152/ajpcell.00420.2001; Caglayan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007747; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; Cataldo AM, 2008, AM J PATHOL, V173, P370, DOI 10.2353/ajpath.2008.071053; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; Christianson AL, 1999, J MED GENET, V36, P759, DOI 10.1136/jmg.36.10.759; Coelho Lucio, 2010, International Journal of Software Science and Computational Intelligence, V2, P60, DOI 10.4018/jssci.2010100105; Das U, 2013, NEURON, V79, P447, DOI 10.1016/j.neuron.2013.05.035; Deane EC, 2013, J NEUROSCI, V33, P595, DOI 10.1523/JNEUROSCI.2583-12.2013; Demars M, 2010, J NEUROSCI RES, V88, P2103, DOI 10.1002/jnr.22387; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Dunckley T, 2006, NEUROBIOL AGING, V27, P1359, DOI 10.1016/j.neurobiolaging.2005.08.013; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Frost B, 2015, TRENDS CELL BIOL, V25, P46, DOI 10.1016/j.tcb.2014.07.005; Funk K. E., 2012, INT J ALZHEIMERS DIS, V2012, DOI DOI 10.1155/2012/752894; Garbern JY, 2010, BRAIN, V133, P1391, DOI 10.1093/brain/awq071; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; HAASS C, 1995, J BIOL CHEM, V270, P6186, DOI 10.1074/jbc.270.11.6186; Hardy J, 2014, J INTERN MED, V275, P296, DOI 10.1111/joim.12192; Hauser MA, 2005, ARCH NEUROL-CHICAGO, V62, P917, DOI 10.1001/archneur.62.6.917; Itoh N, 2009, NEURODEGENER DIS, V6, P230, DOI 10.1159/000236902; Kanatsu K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4386; Karch CM, 2015, BIOL PSYCHIAT, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Kim MKH, 2011, ONCOGENE, V30, P832, DOI 10.1038/onc.2010.452; KNOPS J, 1995, J BIOL CHEM, V270, P2419, DOI 10.1074/jbc.270.6.2419; Kohn KW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099269; Kojetin DJ, 2003, FEBS LETT, V554, P231, DOI 10.1016/S0014-5793(03)01167-0; Kondapalli KC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00172; Kondapalli KC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3510; KONIG G, 1990, FEBS LETT, V269, P305, DOI 10.1016/0014-5793(90)81181-M; LAHIRI DK, 1994, CELL MOL NEUROBIOL, V14, P297, DOI 10.1007/BF02088713; Lee C, 2013, NATURE, V501, P573, DOI 10.1038/nature12484; Liang WS, 2007, PHYSIOL GENOMICS, V28, P311, DOI 10.1152/physiolgenomics.00208.2006; Lou XH, 2011, AM J PHYSIOL-CELL PH, V301, pC1431, DOI 10.1152/ajpcell.00154.2011; Malik M, 2013, J NEUROSCI, V33, P13320, DOI 10.1523/JNEUROSCI.1224-13.2013; Martinelli-Boneschi F, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.12.008; Meda SA, 2012, NEUROIMAGE, V60, P1608, DOI 10.1016/j.neuroimage.2011.12.076; Mitterreiter S, 2010, J NEUROSCI, V30, P8974, DOI 10.1523/JNEUROSCI.1199-10.2010; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Muro S, 2006, AM J PHYSIOL-LUNG C, V290, pL809, DOI 10.1152/ajplung.00311.2005; Nass R, 1998, J BIOL CHEM, V273, P21054, DOI 10.1074/jbc.273.33.21054; Naumova OY, 2012, DEV PSYCHOPATHOL, V24, P1427, DOI 10.1017/S0954579412000818; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Nyasae LK, 2014, TRAFFIC, V15, P1344, DOI 10.1111/tra.12229; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Olubiyi OO, 2012, J PHYS CHEM B, V116, P3280, DOI 10.1021/jp2076337; Ouyang Q, 2013, NEURON, V80, P97, DOI 10.1016/j.neuron.2013.07.043; Perez-Palma E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095413; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; SchraderFischer G, 1996, BRAIN RES, V716, P91, DOI 10.1016/0006-8993(96)00002-9; Schwede M, 2014, MOL PSYCHIATR, V19, P277, DOI 10.1038/mp.2013.28; Sokol DK, 2006, J CHILD NEUROL, V21, P444, DOI 10.1177/08830738060210062201; Stromme P, 2011, BRAIN, V134, P3369, DOI 10.1093/brain/awr250; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Urmoneit B, 1998, J MOL NEUROSCI, V11, P141, DOI 10.1385/JMN:11:2:141; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200; Vos SJB, 2013, LANCET NEUROL, V12, P957, DOI 10.1016/S1474-4422(13)70194-7; Wang ZL, 2012, CURR ALZHEIMER RES, V9, P217, DOI 10.2174/156720512799361691; Wegiel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035414; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; Wolfe DM, 2013, EUR J NEUROSCI, V37, P1949, DOI 10.1111/ejn.12169; WOLOZIN B, 1992, J NEUROSCI RES, V33, P163, DOI 10.1002/jnr.490330121; Wu J, 2011, CELL, V147, P615, DOI 10.1016/j.cell.2011.09.036; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	75	39	40	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5311	5327		10.1074/jbc.M114.602219	http://dx.doi.org/10.1074/jbc.M114.602219			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25561733	hybrid, Green Published			2022-12-26	WOS:000350044200007
J	Lamkin, E; Cheng, G; Calabro, A; Hascall, VC; Joo, EJ; Li, LY; Linhardt, RJ; Lauer, ME				Lamkin, Elliott; Cheng, Georgiana; Calabro, Anthony; Hascall, Vincent C.; Joo, Eun Ji; Li, Lingyun; Linhardt, Robert J.; Lauer, Mark E.			Heavy Chain Transfer by Tumor Necrosis Factor-stimulated Gene 6 to the Bikunin Proteoglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; ALPHA-TRYPSIN INHIBITOR; HYALURONAN COMPLEX; TSG-6; CD44; GLYCOSAMINOGLYCAN; ADHESION; BIND	We present data that hyaluronan (HA) polysaccharides, about 14-86 monosaccharides in length, are capable of accepting only a single heavy chain (HC) from inter-alpha-inhibitor via transfer by tumor necrosis factor-stimulated gene 6 (TSG-6) and that this transfer is irreversible. We propose that either the sulfate groups (or the sulfation pattern) at the reducing end of the chondroitin sulfate (CS) chain of bikunin, or the core protein itself, enables the bikunin proteoglycan (PG) to accept more than a single HC and permits TSG-6 to transfer these HCs from its relatively small CS chain to HA. To test these hypotheses, we investigated HC transfer to the intact CS chain of the bikunin PG, and to the free chain of bikunin. We observed that both the free CS chain and the intact bikunin PG were only able to accept a single HC from inter-alpha-inhibitor via transfer by TSG-6 and that HCs could be swapped from the bikunin PG and its free CS chain to HA. Furthermore, a significant portion of the bikunin PG was unable to accept a single heavy chain. We discuss explanations for these observations, including the intracellular assembly of inter-alpha-inhibitor. In summary, these data demonstrate that the sulfation of the CS chain of bikunin and/or its core protein promote HC transfer by TSG-6 to its relatively short CS chain, although they are insufficient to enable the CS chain of bikunin to accept more than one HC in the absence of other cofactors.	[Lamkin, Elliott; Calabro, Anthony; Hascall, Vincent C.; Lauer, Mark E.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Cheng, Georgiana] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44195 USA; [Joo, Eun Ji; Li, Lingyun; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Joo, Eun Ji; Li, Lingyun; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Joo, Eun Ji; Li, Lingyun; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biol, Troy, NY 12180 USA; [Joo, Eun Ji; Li, Lingyun; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biomed Engn, Troy, NY 12180 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Lauer, ME (corresponding author), Cleveland Clin, Dept Biomed Engn ND20, Cleveland, OH 44195 USA.	lauerm1@ccf.org			NHLBI/National Institutes of Health [HL107147, HL62244, HL113325, HL103453, HL081064]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113325, P01HL103453, P01HL081064, P01HL107147, R01HL062244] Funding Source: NIH RePORTER	NHLBI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI/National Institutes of Health Awards HL107147, HL62244, HL113325, HL103453, and HL081064.	Chi LL, 2008, J AM CHEM SOC, V130, P2617, DOI 10.1021/ja0778500; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Fries E, 2003, ACTA BIOCHIM POL, V50, P735; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Lauer ME, 2013, J BIOL CHEM, V288, P205, DOI 10.1074/jbc.M112.403998; Lauer ME, 2013, J BIOL CHEM, V288, P423, DOI 10.1074/jbc.M112.389882; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Lord MS, 2013, J BIOL CHEM, V288, P22930, DOI 10.1074/jbc.M112.404186; Ly M, 2011, NAT CHEM BIOL, V7, P827, DOI 10.1038/nchembio.673; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Sanggaard KW, 2005, J BIOL CHEM, V280, P11936, DOI 10.1074/jbc.M409016200; Wedes SH, 2011, J PEDIATR-US, V159, P248, DOI 10.1016/j.jpeds.2011.01.029; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	17	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5156	5166		10.1074/jbc.M114.636258	http://dx.doi.org/10.1074/jbc.M114.636258			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25561734	hybrid, Green Published			2022-12-26	WOS:000350042000054
J	Norden, R; Halim, A; Nystrom, K; Bennett, EP; Mandel, U; Olofsson, S; Nilsson, J; Larson, G				Norden, Rickard; Halim, Adnan; Nystrom, Kristina; Bennett, Eric P.; Mandel, Ulla; Olofsson, Sigvard; Nilsson, Jonas; Larson, Goran			O-Linked Glycosylation of the Mucin Domain of the Herpes Simplex Virus Type 1-specific Glycoprotein gC-1 Is Temporally Regulated in a Seed-and-spread Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; FUCOSYL-TRANSFERASE GENES; CELL-INDUCED DIFFERENCES; GALNAC-TRANSFERASE; T-CELLS; SUBSTRATE SPECIFICITIES; MONOCLONAL-ANTIBODIES; INFECTED CELLS; 3 MEMBERS; HOST	The herpes simplex virus type 1 (HSV-1) glycoprotein gC-1, participating in viral receptor interactions and immunity interference, harbors a mucin-like domain with multiple clustered O-linked glycans. Using HSV-1-infected diploid human fibroblasts, an authentic target for HSV-1 infection, and a protein immunoaffinity procedure, we enriched fully glycosylated gC-1 and a series of its biosynthetic intermediates. This fraction was subjected to trypsin digestion and a LC-MS/MS glycoproteomics approach. In parallel, we characterized the expression patterns of the 20 isoforms of human GalNAc transferases responsible for initiation of O-linked glycosylation. The gC-1 O-glycosylation was regulated in an orderly manner initiated by synchronous addition of one GalNAc unit each to Thr-87 and Thr-91 and one GalNAc unit to either Thr-99 or Thr-101, forming a core glycopeptide for subsequent additions of in all 11 GalNAc residues to selected Ser and Thr residues of the Thr-76-Lys-107 stretch of the mucin domain. The expression patterns of GalNAc transferases in the infected cells suggested that initial additions of GalNAc were carried out by initiating Gal-NActransferases, in particular GalNAc-T2, whereas subsequent GalNAc additions were carried out by followup transferases, in particular GalNAc-T10. Essentially all of the susceptible Ser or Thr residues had to acquire their GalNAc units before any elongation to longer O-linked glycans of the gC-1-associated GalNAc units was permitted. Because the GalNAc occupancy pattern is of relevance for receptor binding of gC-1, the data provide a model to delineate biosynthetic steps of O-linked gly-cosylation of the gC-1 mucin domain in HSV-1-infected target cells.	[Norden, Rickard; Nystrom, Kristina; Olofsson, Sigvard] Univ Gothenburg, Inst Biomed, Dept Infect Dis, SE-41345 Gothenburg, Sweden; [Halim, Adnan; Bennett, Eric P.; Mandel, Ulla] Univ Copenhagen, Copenhagen Ctr Glyc, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Halim, Adnan; Bennett, Eric P.; Mandel, Ulla] Univ Copenhagen, Copenhagen Ctr Glyc, Dept Odontol, DK-2200 Copenhagen, Denmark; [Halim, Adnan; Nilsson, Jonas] Univ Gothenburg, Dept Clin Chem & Transfus Med, SE-41345 Gothenburg, Sweden	University of Gothenburg; University of Copenhagen; University of Copenhagen; University of Gothenburg	Larson, G (corresponding author), Sahlgrens Univ Hosp, Dept Clin Chem & Transfus Med, Bruna Straket 16, SE-41345 Gothenburg, Sweden.	goran.larson@clinchem.gu.se	Bennett, Eric/AAG-6120-2020; Nordén, Rickard/AAQ-8843-2020; Larson, Göran/AAF-3404-2019; Nyström, Kristina/N-3125-2014	Bennett, Eric/0000-0002-4976-0647; Halim, Adnan/0000-0003-1629-187X; Mandel, Ulla/0000-0001-7012-9836; Nilsson, Jonas/0000-0001-5263-2454; Norden, Rickard/0000-0002-3866-7228	Swedish Research Council [8266, 15283]; Swedish Governmental Grants; Danish Research Councils; Danish National Research Foundation [DNRF 107]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Governmental Grants; Danish Research Councils(Det Frie Forskningsrad (DFF)); Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by grants from the Swedish Research Council (8266 and 15283), Swedish Governmental Grants to the Sahlgrenska University Hospital, and by the Danish Research Councils and the Danish National Research Foundation (DNRF 107).	Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Antoine TE, 2013, REV MED VIROL, V23, P194, DOI 10.1002/rmv.1740; Aubert M, 2009, J VIROL, V83, P6171, DOI 10.1128/JVI.02163-08; Bennett EP, 1998, J BIOL CHEM, V273, P30472, DOI 10.1074/jbc.273.46.30472; Bennett EP, 1999, J BIOL CHEM, V274, P25362, DOI 10.1074/jbc.274.36.25362; Bennett EP, 1999, FEBS LETT, V460, P226, DOI 10.1016/S0014-5793(99)01268-5; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; BERGSTROM T, 1992, MOL CELL PROBE, V6, P41, DOI 10.1016/0890-8508(92)90070-E; Biller M, 2000, GLYCOBIOLOGY, V10, P1259, DOI 10.1093/glycob/10.12.1259; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Cheng LM, 2002, FEBS LETT, V531, P115, DOI 10.1016/S0014-5793(02)03399-9; Clo E, 2012, J VIROL, V86, P6268, DOI 10.1128/JVI.00392-12; D'Arrigo I, 2013, GLYCOCONJUGATE J, V30, P633, DOI 10.1007/s10719-012-9465-3; DALLOLIO F, 1985, J VIROL, V56, P127, DOI 10.1128/JVI.56.1.127-134.1985; Eisenberg RJ, 2012, VIRUSES-BASEL, V4, P800, DOI 10.3390/v4050800; Ekbad M, 2007, VIROLOGY, V367, P244, DOI 10.1016/j.virol.2007.05.040; Friedman HM, 1996, J VIROL, V70, P4253, DOI 10.1128/JVI.70.7.4253-4260.1996; Gerken TA, 2013, J BIOL CHEM, V288, P19900, DOI 10.1074/jbc.M113.477877; Gerken TA, 2011, J BIOL CHEM, V286, P14493, DOI 10.1074/jbc.M111.218701; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; HEROLD BC, 1991, J VIROL, V65, P1090, DOI 10.1128/JVI.65.3.1090-1098.1991; Kennedy PGE, 2013, J NEUROVIROL, V19, P346, DOI 10.1007/s13365-013-0178-6; Kong Y, 2015, GLYCOBIOLOGY, V25, P55, DOI 10.1093/glycob/cwu089; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; LUNDSTROM M, 1987, VIROLOGY, V161, P395, DOI 10.1016/0042-6822(87)90132-2; LUNDSTROM M, 1987, VIROLOGY, V161, P385, DOI 10.1016/0042-6822(87)90131-0; LYCKE E, 1991, J GEN VIROL, V72, P1131, DOI 10.1099/0022-1317-72-5-1131; Machiels B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002387; Mandel U, 1999, GLYCOBIOLOGY, V9, P43, DOI 10.1093/glycob/9.1.43; Mardberg K, 2004, GLYCOBIOLOGY, V14, P571, DOI 10.1093/glycob/cwh075; MARSDEN HS, 1976, J GEN VIROL, V31, P347, DOI 10.1099/0022-1317-31-3-347; Namvar L, 2005, J CLIN MICROBIOL, V43, P2058, DOI 10.1128/JCM.43.5.2058-2064.2005; Norden R, 2013, APMIS, V121, P280, DOI 10.1111/j.1600-0463.2012.02967.x; Norden R, 2013, GLYCOBIOLOGY, V23, P310, DOI 10.1093/glycob/cws160; Norden R, 2009, GLYCOBIOLOGY, V19, P776, DOI 10.1093/glycob/cwp050; Nystrom K, 2004, J VIROL METHODS, V118, P83, DOI 10.1016/j.jviromet.2004.01.019; Nystrom K, 2007, GLYCOBIOLOGY, V17, P355, DOI 10.1093/glycob/cwl083; Nystrom K, 2009, GLYCOBIOLOGY, V19, P847, DOI 10.1093/glycob/cwp057; OLOFSSON S, 1983, J GEN VIROL, V64, P2735, DOI 10.1099/0022-1317-64-12-2735; OLOFSSON S, 1992, APMIS, V100, P84; Perrine CL, 2009, J BIOL CHEM, V284, P20387, DOI 10.1074/jbc.M109.017236; Pratt MR, 2004, CHEM BIOL, V11, P1009, DOI 10.1016/j.chembiol.2004.05.009; Puttur FK, 2010, J IMMUNOL, V185, P477, DOI 10.4049/jimmunol.0904106; Raman J, 2012, GLYCOBIOLOGY, V22, P768, DOI 10.1093/glycob/cwr183; Schjoldager KTBG, 2012, P NATL ACAD SCI USA, V109, P9893, DOI 10.1073/pnas.1203563109; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SJOBLOM I, 1992, APMIS, V100, P229; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503	51	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5078	5091		10.1074/jbc.M114.616409	http://dx.doi.org/10.1074/jbc.M114.616409			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25548287	hybrid, Green Published			2022-12-26	WOS:000350042000048
J	Wang, MY; Zhong, ZM; Zhong, YB; Zhang, W; Wang, H				Wang, Mingyong; Zhong, Zhaomin; Zhong, Yingbin; Zhang, Wei; Wang, Han			The Zebrafish Period2 Protein Positively Regulates the Circadian Clock through Mediation of Retinoic Acid Receptor (RAR)-related Orphan Receptor alpha (Ror alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR ANALYSIS; PINEAL-GLAND; MOUSE CLOCK; GENE; MUTATION; PHOSPHORYLATION; EXPRESSION; TRANSCRIPTION; COMPONENT; RHYTHMS	We report the characterization of a null mutant for zebrafish circadian clock gene period2 (per2) generated by transcription activator-like effector nuclease and a positive role of PER2 in vertebrate circadian regulation. Locomotor experiments showed that per2 mutant zebrafish display reduced activities under light-dark and 2-h phase delay under constant darkness, and quantitative real time PCR analyses showed up-regulation of cry1aa, cry1ba, cry1bb, and aanat2 but down-regulation of per1b, per3, and bmal1b in per2 mutant zebrafish, suggesting that Per2 is essential for the zebrafish circadian clock. Luciferase reporter assays demonstrated that Per2 represses aanat2 expression through E-box and enhances bmal1b expression through the Ror/Rev-erb response element, implicating that Per2 plays dual roles in the zebrafish circadian clock. Cell transfection and co-immunoprecipitation assays revealed that Per2 enhances bmal1b expression through binding to orphan nuclear receptor Ror alpha. The enhancing effect of mouse PER2 on Bmal1 transcription is also mediated by ROR alpha even though it binds to REV-ERB alpha. Moreover, zebrafish Per2 also appears to have tissue-specific regulatory roles in numerous peripheral organs. These findings help define the essential functions of Per2 in the zebrafish circadian clock and in particular provide strong evidence for a positive role of PER2 in the vertebrate circadian system.	Soochow Univ, Ctr Circadian Clocks, Coll Med, Suzhou 215123, Jiangsu, Peoples R China; Soochow Univ, Sch Biol & Basic Med Sci, Coll Med, Suzhou 215123, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Wang, H (corresponding author), Soochow Univ, Ctr Circadian Clocks, SIP, 199 Renai, Suzhou 215123, Jiangsu, Peoples R China.	han.wang88@gmail.com	Wang, Han/A-9774-2008	Wang, Han/0000-0003-2420-3147; Wang, Mingyong/0000-0002-5705-8145	National Basic Research Program of China (973 Program) [2012CB947600]; National Natural Science Foundation of China [31030062, 81070455]; National High Technology Research and Development Program of China (863 Program) [2011AA100402-2]; Jiangsu Distinguished Professorship Program [SR13400111]; Natural Science Foundation of Jiangsu Province [BK2012052]; Priority Academic Program Development of Jiangsu Higher Education Institutions [YX13400214]; High-Level Innovative Team of Jiangsu Province; Soochow University [Q4134918]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Jiangsu Distinguished Professorship Program; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions; High-Level Innovative Team of Jiangsu Province; Soochow University	This work was supported by National Basic Research Program of China (973 Program) Grant 2012CB947600, National Natural Science Foundation of China Grants 31030062 and 81070455, National High Technology Research and Development Program of China (863 Program) Grant 2011AA100402-2, Jiangsu Distinguished Professorship Program Grant SR13400111, Natural Science Foundation of Jiangsu Province Grant BK2012052, Priority Academic Program Development of Jiangsu Higher Education Institutions Grant YX13400214, the High-Level Innovative Team of Jiangsu Province, and Soochow University Startup Fund Grant Q4134918.	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Akashi M, 2014, CELL REP, V7, P1056, DOI 10.1016/j.celrep.2014.03.072; Appelbaum L, 2006, J MOL ENDOCRINOL, V36, P337, DOI 10.1677/jme.1.01893; Ben-Moshe Z, 2014, NUCLEIC ACIDS RES, V42, P3750, DOI 10.1093/nar/gkt1359; Ben-Shlomo R, 2002, CELL BIOCHEM BIOPHYS, V37, P141, DOI 10.1385/CBB:37:2:141; Blau J, 2001, SEMIN CELL DEV BIOL, V12, P287, DOI 10.1006/scdb.2001.0256; Brager AJ, 2013, BEHAV BRAIN RES, V243, P255, DOI 10.1016/j.bbr.2013.01.014; Cahill GM, 1996, BRAIN RES, V708, P177, DOI 10.1016/0006-8993(95)01365-2; Cahill GM, 2002, CELL TISSUE RES, V309, P27, DOI 10.1007/s00441-002-0570-7; Camacho F, 2001, FEBS LETT, V489, P159, DOI 10.1016/S0014-5793(00)02434-0; Cavallari N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001142; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Dekens MPS, 2008, EMBO J, V27, P2757, DOI 10.1038/emboj.2008.183; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Flores MV, 2007, GENE EXPR PATTERNS, V7, P535, DOI 10.1016/j.modgep.2007.02.001; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; GARDNER GF, 1980, GENETICS, V96, P877; Gavriouchkina D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012542; Gothilf Y, 1999, ENDOCRINOLOGY, V140, P4895, DOI 10.1210/en.140.10.4895; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HARDIN PE, 1992, EMBO J, V11, P1; Huang J., 2015, J NEUROSCI IN PRESS; Huang P, 2014, METHODS, V69, P67, DOI 10.1016/j.ymeth.2014.02.010; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hurd MW, 1998, PHYSIOL BEHAV, V65, P465, DOI 10.1016/S0031-9384(98)00183-8; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Ishikawa T, 2002, GENES CELLS, V7, P1073, DOI 10.1046/j.1365-2443.2002.00579.x; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kobayashi Y, 2000, GENES CELLS, V5, P725, DOI 10.1046/j.1365-2443.2000.00364.x; Liu C., 2015, SCI REP IN PRESS; Low-Zeddies SS, 2001, CELL, V105, P25, DOI 10.1016/S0092-8674(01)00294-X; Maywood ES, 2003, J NEUROENDOCRINOL, V15, P329, DOI 10.1046/j.1365-2826.2003.00971.x; Menet JS, 2010, GENE DEV, V24, P358, DOI 10.1101/gad.1883910; Morin LP, 2006, NEUROSCIENCE, V137, P1285, DOI 10.1016/j.neuroscience.2005.10.030; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Storz SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054189; Subramanian P., 2003, Indian Journal of Experimental Biology, V41, P797; Tamai TK, 2012, J BIOL RHYTHM, V27, P226, DOI 10.1177/0748730412440861; Tan Y, 2008, J NEUROGENET, V22, P149, DOI 10.1080/01677060802049738; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Triqueneaux G, 2004, J MOL ENDOCRINOL, V33, P585, DOI 10.1677/jme.1.01554; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; Uz T, 2001, J PINEAL RES, V30, P166, DOI 10.1034/j.1600-079X.2001.300305.x; Vanselow K, 2007, COLD SPRING HARB SYM, V72, P167, DOI 10.1101/sqb.2007.72.036; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; Vatine G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000223; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; Wang H, 2008, J MOL EVOL, V67, P29, DOI 10.1007/s00239-008-9121-5; Wang H, 2009, GENETICA, V136, P149, DOI 10.1007/s10709-008-9328-9; Wang J, 2014, ZEBRAFISH, V11, P115, DOI 10.1089/zeb.2013.0929; Wang Ming-Yong, 2012, Yichuan, V34, P1133, DOI 10.3724/SP.J.1005.2012.01133; Weger M, 2013, DEV BIOL, V380, P259, DOI 10.1016/j.ydbio.2013.04.035; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE, P11; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Xu KY, 2011, CELL METAB, V13, P639, DOI 10.1016/j.cmet.2011.05.001; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zhao J, 2003, CELL, V113, P755, DOI 10.1016/S0092-8674(03)00400-8; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Ziv L, 2006, CHRONOBIOL INT, V23, P101, DOI 10.1080/07420520500464551; Ziv L, 2006, P NATL ACAD SCI USA, V103, P4146, DOI 10.1073/pnas.0600571103; Ziv L, 2005, J NEUROENDOCRINOL, V17, P314, DOI 10.1111/j.1365-2826.2005.01315.x	80	28	31	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4367	4382		10.1074/jbc.M114.605022	http://dx.doi.org/10.1074/jbc.M114.605022			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25544291	hybrid, Green Published			2022-12-26	WOS:000349458400045
J	Tang, WM; Huan, XP; Zhang, Y; Mahapatra, T; Li, JJ; Liu, XY; Mahapatra, S; Yan, HJ; Fu, GF; Zhao, JK; Gu, CH; Detels, R				Tang, Weiming; Huan, Xiping; Zhang, Ye; Mahapatra, Tanmay; Li, Jianjun; Liu, Xiaoyan; Mahapatra, Sanchita; Yan, Hongjing; Fu, Gengfeng; Zhao, Jinkou; Gu, Chenghua; Detels, Roger			Factors Associated with Loss-to-Follow-Up during Behavioral Interventions and HIV Testing Cohort among Men Who Have Sex with Men in Nanjing, China	PLOS ONE			English	Article							RISK; PREVENTION; INFECTION; TRANSMISSION; POPULATION; PREVALENCE; SHANGHAI; SYPHILIS; METAANALYSIS; RETENTION	Background: Behavioral interventions (BIs) remained the cornerstone of HIV prevention in resource-limited settings. One of the major concerns for such efforts is the loss-to-follow-up (LTFU) that threatens almost every HIV control program involving high-risk population groups. Methods: To evaluate the factors associated with LTFU during BIs and HIV testing among men who have sex with men (MSM), 410 HIV sero-negatives MSM were recruited using respondent driven sampling (RDS) in Nanjing, China during 2008, they were further followed for 18 months. At baseline and each follow-up visits, each participant was counseled about various HIV risk-reductions BIs at a designated sexually transmitted infection (STI) clinic. Results: Among 410 participants recruited at baseline, altogether 221 (53.9%) were LTFU at the 18-month follow-up visit. Overall, 46 participants were found to be positive for syphilis infection at baseline while 13 participants were HIV seroconverted during the follow-up period. Increasing age was less (Adjusted Odds Ratio(aOR) of 0.90, 95% confidence Interval (CI) 0.86-0.94) and official residency of provinces other than Nanjing (AOR of 2.49, 95% CI 1.32-4.71), lower level of education (AOR of 2.01, 95% CI 1.10-3.66) and small social network size (AOR of 1.75, 95% CI 1.09-2.80) were more likely to be associated with higher odds of LTFU. Conclusion: To improve retention in the programs for HIV control, counseling and testing among MSM in Nanjing, focused intensified intervention targeting those who were more likely to be LTFU, especially the young, less educated, unofficial residents of Nanjing who had smaller social network size, might be helpful.	[Tang, Weiming; Zhang, Ye] Guangdong Prov Ctr Skin Dis & STI Control, Guangzhou 510095, Guangdong, Peoples R China; [Tang, Weiming; Huan, Xiping; Li, Jianjun; Liu, Xiaoyan; Yan, Hongjing; Fu, Gengfeng; Gu, Chenghua] Jiangsu Prov Cent Dis Control & Prevent, Nanjing 210009, Jiangsu, Peoples R China; [Tang, Weiming] Univ North Carolina Project China, Guangzhou 510095, Guangdong, Peoples R China; [Mahapatra, Sanchita; Detels, Roger] Sch Natl Inst Cholera & Enter Dis, Dept Epidemiol, Kolkata, W Bengal, India; [Zhao, Jinkou] Global Fund Fight AIDS TB & Malaria, Investment & Impact Div, Geneva, Switzerland	Jiangsu Provincial Center for Disease Control & Prevention; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Gu, CH (corresponding author), Jiangsu Prov Cent Dis Control & Prevent, Nanjing 210009, Jiangsu, Peoples R China.	guchenghua@jscdc.cn; detels@ucla.edu		Tang, Weiming/0000-0002-9026-707X; Zhao, Jinkou/0000-0001-9184-3385; Zhang, Ye/0000-0001-6159-7427	National Natural Science Foundation of China [81373125]; Jiangsu Provincial Technologies Research Program [BE2009685]; Jiangsu Province's Outstanding Medical Academic Leader Program [RC2011086, 2011087]; NIH program [1D43TW009532-01]; FOGARTY INTERNATIONAL CENTER [D43TW009532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Technologies Research Program; Jiangsu Province's Outstanding Medical Academic Leader Program; NIH program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Natural Science Foundation of China (grant no. 81373125), Jiangsu Provincial Technologies Research Program (BE2009685), Jiangsu Province's Outstanding Medical Academic Leader Program (RC2011086, 2011087) and NIH program (1D43TW009532-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AF, 2003, AIDS CARE, V15, P177, DOI 10.1080/0954012031000068326; [Anonymous], 2012, CHIN AIDS RESP PROGR; [Anonymous], UNAIDS WORLD AIDS DA; Auerbach JD, 2000, AM J PUBLIC HLTH, V90; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bull SS, 2004, AIDS CARE, V16, P931, DOI 10.1080/09540120412331292507; Centers for Disease Control and Prevention (CDC), 2013, EFF BEH INT HIV AIDS; Choi KH, 2006, AIDS EDUC PREV, V18, P33, DOI 10.1521/aeap.2006.18.1.33; Choi KH, 2002, AIDS BEHAV, V6, P255, DOI DOI 10.1023/A:1019895909291; Choi KH, 2007, JAIDS-J ACQ IMM DEF, V45, P77, DOI 10.1097/QAI.0b013e3180415dd7; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Dilley JW, 2007, JAIDS-J ACQ IMM DEF, V44, P569, DOI 10.1097/QAI.0b013e318033ffbd; Gao L, 2009, SEX TRANSM INFECT, V85, P354, DOI 10.1136/sti.2008.034702; Gao MY, 2007, AIDS CARE, V19, P799, DOI 10.1080/09540120601114832; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; He N, 2007, AIDS CARE, V19, P109, DOI 10.1080/09540120600888394; Herbst JH, 2005, JAIDS-J ACQ IMM DEF, V39, P228; Hightow LB, 2006, SEX TRANSM DIS, V33, P585, DOI 10.1097/01.olq.0000216031.93089.68; Huan XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069740; Institute S, 1996, SAS SYST WIND; Koblin B, 2004, LANCET, V364, P41, DOI 10.1016/S0140-6736(04)16588-4; Lau JTF, 2008, AIDS CARE, V20, P820, DOI 10.1080/09540120701694048; Lau JTF, 2011, PUBLIC HEALTH, V125, P260, DOI 10.1016/j.puhe.2011.01.007; Lauritsen J, 2003, EPIDATA VERSION 3 CO; Liu H, 2006, SEX TRANSM DIS, V33, P68, DOI 10.1097/01.olq.0000187266.29927.11; Liu HJ, 2009, AIDS BEHAV, V13, P652, DOI 10.1007/s10461-008-9475-0; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Meda N, 1999, AIDS, V13, P1397, DOI 10.1097/00002030-199907300-00018; Rojanapithayakorn W, 1996, AIDS, V10, P1, DOI 10.1097/00002030-199601000-00001; Ruan YH, 2009, JAIDS-J ACQ IMM DEF, V52, P604, DOI 10.1097/QAI.0b013e3181b31f5c; Segura M, 2007, AIDS RES HUM RETROV, V23, P1322, DOI 10.1089/aid.2007.0063; Shang H, 2012, NATURE, V485, P576, DOI 10.1038/485576a; Smith AMA, 2004, SEX TRANSM INFECT, V80, P455, DOI 10.1136/sti.2004.010355; Song Y, 2011, AIDS CARE, V23, P179, DOI 10.1080/09540121.2010.487088; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Tang W, 2013, AIDS BEHAV, P1; UNAIDS, 2001, HIV PREV NEEDS SUCC; Wong FY, 2008, AIDS CARE, V20, P170, DOI 10.1080/09540120701534707; Wong FY, 2009, AIDS EDUC PREV, V21, P430, DOI 10.1521/aeap.2009.21.5.430; World Health Organization, 2011, PREVENTION TREATMENT; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; Zhang HB, 2010, JAIDS-J ACQ IMM DEF, V53, pS88, DOI 10.1097/QAI.0b013e3181c7de63; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7	44	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e115691	10.1371/journal.pone.0115691	http://dx.doi.org/10.1371/journal.pone.0115691			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ3BG	25559678	Green Published, gold			2022-12-26	WOS:000348102200010
J	Both, J; Krijgsman, O; Bras, J; Schaap, GR; Baas, F; Ylstra, B; Hulsebos, TJM				Both, Joeri; Krijgsman, Oscar; Bras, Johannes; Schaap, Gerard R.; Baas, Frank; Ylstra, Bauke; Hulsebos, Theo J. M.			Focal Chromosomal Copy Number Aberrations Identify CMTM8 and GPR177 as New Candidate Driver Genes in Osteosarcoma	PLOS ONE			English	Article							HIGH-GRADE OSTEOSARCOMA; INTEGRATIVE ANALYSIS; ARRAY CGH; EXPRESSION; CANCER; GENOME; TUMORS; IDENTIFICATION; RECEPTOR; CD147	Osteosarcoma is an aggressive bone tumor that preferentially develops in adolescents. The tumor is characterized by an abundance of genomic aberrations, which hampers the identification of the driver genes involved in osteosarcoma tumorigenesis. Our study aims to identify these genes by the investigation of focal copy number aberrations (CNAs, <3 Mb). For this purpose, we subjected 26 primary tumors of osteosarcoma patients to high-resolution single nucleotide polymorphism array analyses and identified 139 somatic focal CNAs. Of these, 72 had at least one gene located within or overlapping the focal CNA, with a total of 94 genes. For 84 of these genes, the expression status in 31 osteosarcoma samples was determined by expression microarray analysis. This enabled us to identify the genes of which the over-or underexpression was in more than 35% of cases in accordance to their copy number status (gain or loss). These candidate genes were subsequently validated in an independent set and furthermore corroborated as driver genes by verifying their role in other tumor types. We identified CMTM8 as a new candidate tumor suppressor gene and GPR177 as a new candidate oncogene in osteosarcoma. In osteosarcoma, CMTM8 has been shown to suppress EGFR signaling. In other tumor types, CMTM8 is known to suppress the activity of the oncogenic protein c-Met and GPR177 is known as an overexpressed upstream regulator of the Wnt-pathway. Further studies are needed to determine whether these proteins also exert the latter functions in osteosarcoma tumorigenesis.	[Both, Joeri; Baas, Frank; Hulsebos, Theo J. M.] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands; [Krijgsman, Oscar; Ylstra, Bauke] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Bras, Johannes] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Schaap, Gerard R.] Univ Amsterdam, Acad Med Ctr, Dept Orthoped Surg, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Hulsebos, TJM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.j.hulsebos@amc.uva.nl	Baas, Frank/F-9574-2010; Ylstra, Bauke/D-2906-2012	Baas, Frank/0000-0003-3912-5428; Ylstra, Bauke/0000-0001-9479-3010	VUMC-CCA (Cancer Centre Amsterdam, VU medical centre); Dutch Cancer society [UVA 2006-3525]	VUMC-CCA (Cancer Centre Amsterdam, VU medical centre); Dutch Cancer society(KWF Kankerbestrijding)	OK is supported by VUMC-CCA (Cancer Centre Amsterdam, VU medical centre). J. Both is supported by the Dutch Cancer society, grant no. UVA 2006-3525. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astolfi A, 2010, LAB INVEST, V90, P1285, DOI 10.1038/labinvest.2010.110; Augustin I, 2012, EMBO MOL MED, V4, P38, DOI 10.1002/emmm.201100186; Bacci G, 2001, EUR J CANCER, V37, P2030, DOI 10.1016/S0959-8049(01)00229-5; Benayahu D, 2002, J CELL BIOCHEM, V84, P108, DOI 10.1002/jcb.1270; Both J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030907; Brazier H, 2006, J BONE MINER RES, V21, P1387, DOI 10.1359/JBMR.060613; Briccoli A, 2010, SURG ONCOL, V19, P193, DOI 10.1016/j.suronc.2009.05.002; Brosens RPM, 2010, J PATHOL, V221, P411, DOI 10.1002/path.2724; Cai YP, 2010, J PATHOL, V220, P24, DOI 10.1002/path.2628; Calicchio ML, 2009, AM J PATHOL, V174, P1638, DOI 10.2353/ajpath.2009.080517; Cappellari AR, 2012, MOL CELL BIOCHEM, V359, P315, DOI 10.1007/s11010-011-1025-9; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Di Sano F, 2007, J NEUROCHEM, V102, P345, DOI 10.1111/j.1471-4159.2007.04479.x; Du XL, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-450; Fazi B, 2010, NEUROBIOL DIS, V40, P634, DOI 10.1016/j.nbd.2010.08.007; Ferguson WS, 2001, CANCER INVEST, V19, P292, DOI 10.1081/CNV-100102557; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Freeman SS, 2008, CANCER-AM CANCER SOC, V113, P1453, DOI 10.1002/cncr.23782; Fujimoto Yoko, 2006, Journal of Medical and Dental Sciences, V53, P85; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Futreal PA, 2001, NATURE, V409, P850, DOI 10.1038/35057046; Horak CE, 2007, CANCER RES, V67, P7238, DOI 10.1158/0008-5472.CAN-07-0962; Iwaya K, 2003, CLIN EXP METASTAS, V20, P525, DOI 10.1023/A:1025821229013; Jin CN, 2007, J CELL PHYSIOL, V211, P112, DOI 10.1002/jcp.20914; Jin CN, 2005, FEBS LETT, V579, P6375, DOI 10.1016/j.febslet.2005.10.021; Kansara M, 2009, J CLIN INVEST, V119, P837, DOI 10.1172/JCI37175; Katoh M, 2002, INT J MOL MED, V10, P221; Kresse SH, 2009, GENE CHROMOSOME CANC, V48, P679, DOI 10.1002/gcc.20675; Krijgsman O, 2014, BBA-MOL CELL RES, V1843, P2698, DOI 10.1016/j.bbamcr.2014.08.001; Kuijjer ML, 2013, INT J CANCER, V133, P2512, DOI 10.1002/ijc.28124; Kuijjer ML, 2012, GENE CHROMOSOME CANC, V51, P696, DOI 10.1002/gcc.21956; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Lee JA, 2012, CANCER RES TREAT, V44, P202, DOI 10.4143/crt.2012.44.3.202; Li D, 2007, INT J BIOCHEM CELL B, V39, P2107, DOI 10.1016/j.biocel.2007.06.002; Li Q, 1999, MOL CELL BIOL, V19, P5339; Martin Jeff W., 2012, Sarcoma, V2012, P627254, DOI 10.1155/2012/627254; Maruyama EO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056644; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Nakamura K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-191; Omi Y, 2012, THYROID, V22, P383, DOI 10.1089/thy.2010.0426; Ottaviani G, 2009, CANCER TREAT RES, V152, P421, DOI 10.1007/978-1-4419-0284-9_2; Pan YQ, 2012, ONCOL REP, V27, P2003, DOI 10.3892/or.2012.1729; Radig K, 1998, PATHOL RES PRACT, V194, P669, DOI 10.1016/S0344-0338(98)80125-8; Rauch TA, 2012, TUMOR BIOL, V33, P287, DOI 10.1007/s13277-011-0282-2; Ritter J, 2010, ANN ONCOL, V21, P320, DOI 10.1093/annonc/mdq276; Sadikovic B, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-202; Salvi A, 2007, INT J ONCOL, V31, P451; Sandberg AA, 2003, CANCER GENET CYTOGEN, V140, P1, DOI 10.1016/S0165-4608(02)00848-8; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sweeny L, 2012, J CUTAN PATHOL, V39, P603, DOI 10.1111/j.1600-0560.2012.01912.x; Teicher BA, 2012, BIOCHEM PHARMACOL, V84, P1, DOI 10.1016/j.bcp.2012.02.009; van de Wiel MA, 2011, BRIEF BIOINFORM, V12, P10, DOI 10.1093/bib/bbq004; van Wieringen WN, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-80; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wang H, 2012, BRIT J CANCER, V106, P1446, DOI 10.1038/bjc.2012.95; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Zhang WJ, 2012, J BIOL CHEM, V287, P11850, DOI 10.1074/jbc.M111.258236; Zhong ZD, 2012, P NATL ACAD SCI USA, V109, pE2197, DOI 10.1073/pnas.1120407109; Zhu J, 2011, J CELL BIOCHEM, V112, P1749, DOI 10.1002/jcb.23094	59	27	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115835	10.1371/journal.pone.0115835	http://dx.doi.org/10.1371/journal.pone.0115835			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551557	Green Submitted, gold, Green Published			2022-12-26	WOS:000347119100066
J	Giordano, BL; Egermann, H; Bresin, R				Giordano, Bruno L.; Egermann, Hauke; Bresin, Roberto			The Production and Perception of Emotionally Expressive Walking Sounds: Similarities between Musical Performance and Everyday Motor Activity	PLOS ONE			English	Article							COMMUNICATION; MODEL; LOCOMOTION; BRAIN	Several studies have investigated the encoding and perception of emotional expressivity in music performance. A relevant question concerns how the ability to communicate emotions in music performance is acquired. In accordance with recent theories on the embodiment of emotion, we suggest here that both the expression and recognition of emotion in music might at least in part rely on knowledge about the sounds of expressive body movements. We test this hypothesis by drawing parallels between musical expression of emotions and expression of emotions in sounds associated with a non-musical motor activity: walking. In a combined production-perception design, two experiments were conducted, and expressive acoustical features were compared across modalities. An initial performance experiment tested for similar feature use in walking sounds and music performance, and revealed that strong similarities exist. Features related to sound intensity, tempo and tempo regularity were identified as been used similarly in both domains. Participants in a subsequent perception experiment were able to recognize both non-emotional and emotional properties of the sound-generating walkers. An analysis of the acoustical correlates of behavioral data revealed that variations in sound intensity, tempo, and tempo regularity were likely used to recognize expressed emotions. Taken together, these results lend support the motor origin hypothesis for the musical expression of emotions.	[Giordano, Bruno L.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Egermann, Hauke] Tech Univ Berlin, Audio Commun Grp, Berlin, Germany; [Bresin, Roberto] KTH Royal Inst Technol, Sound & Mus Comp Grp, Stockholm, Sweden	University of Glasgow; Technical University of Berlin; Royal Institute of Technology	Bresin, R (corresponding author), KTH Royal Inst Technol, Sound & Mus Comp Grp, Stockholm, Sweden.	roberto@kth.se	Bresin, Roberto/I-3458-2019; Giordano, Bruno L./A-4398-2008; Bresin, Roberto/J-4240-2012	Bresin, Roberto/0000-0002-3086-0322; Giordano, Bruno L./0000-0001-7002-0486; Bresin, Roberto/0000-0002-3086-0322	ConGAS COST Action [287]; EU [FP6-2004-NEST-PATH-028570]; Swedish Research Council [2010-4654]	ConGAS COST Action(European Cooperation in Science and Technology (COST)); EU(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Bruno L. Giordano was partially supported by the ConGAS COST Action 287. Roberto Bresin's work was supported by EU funded project Brain-Tuning FP6-2004-NEST-PATH-028570, EU funded FET-Open coordination action Sound to Sense, Sense to Sound, and by the Swedish Research Council, Grant Nr. 2010-4654. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangert M, 2006, NEUROIMAGE, V30, P917, DOI 10.1016/j.neuroimage.2005.10.044; Bangert M, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-26; Bigand E, 2005, COGNITION EMOTION, V19, P1113, DOI 10.1080/02699930500204250; Bresin R, 2000, COMPUT MUSIC J, V24, P44, DOI 10.1162/014892600559515; Bresin R, 2003, THE SOUNDING OBJECT, P111; Bresin R, 2011, CORTEX, V47, P1068, DOI 10.1016/j.cortex.2011.05.009; Cochrane T, 2010, AUSTRALAS J PHILOS, V88, P191, DOI 10.1080/00048400902941257; DAVIES S, 1980, MIND, V89, P67; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Friberg A, 1999, J ACOUST SOC AM, V105, P1469, DOI 10.1121/1.426687; Gabrielsson A., 1996, PSYCHOL MUSIC, V24, P68, DOI DOI 10.1177/0305735696241007; Gibson E. J., 2000, ECOLOGICAL APPROACH; HAJDA JM, 1997, PERCEPTION COGNITION, P253; Hartmann W. M., 1997, SIGNALS SOUND SENSAT; IMAN RL, 1979, TECHNOMETRICS, V21, P499, DOI 10.2307/1268289; Janata P, 2003, NAT NEUROSCI, V6, P682, DOI 10.1038/nn1081; Juslin PN, 2006, J EXP PSYCHOL-APPL, V12, P79, DOI 10.1037/1076-898X.12.2.79; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Juslin PN, 1997, MUSIC PERCEPT, V14, P383; Juslin PN., 1997, MUSIC SCI, V1, P225, DOI [10.1177/102986499700100205, DOI 10.1177/102986499700100205]; Keysers C, 2009, CURR OPIN NEUROBIOL, V19, P666, DOI 10.1016/j.conb.2009.10.006; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; LEMAN M, 2008, EMBODIED MUSIC COGNI; LI XF, 1991, J ACOUST SOC AM, V90, P3036, DOI 10.1121/1.401778; McAdams S, 2004, J ACOUST SOC AM, V115, P1306, DOI 10.1121/1.1645855; McKean JW, 2001, PSYCHOL REP, V89, P267, DOI 10.2466/PR0.89.6.267-273; Molnar-Szakacs I, 2006, SOC COGN AFFECT NEUR, V1, P235, DOI 10.1093/scan/nsl029; NILSSON J, 1989, ACTA PHYSIOL SCAND, V136, P217, DOI 10.1111/j.1748-1716.1989.tb08655.x; NILSSON J, 1987, ACTA PHYSIOL SCAND, V129, P107, DOI 10.1111/j.1748-1716.1987.tb08045.x; Pastore RE, 2008, PERCEPT PSYCHOPHYS, V70, P13, DOI 10.3758/PP.70.1.13; Peretz I, 1998, COGNITION, V68, P111, DOI 10.1016/S0010-0277(98)00043-2; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; SCHERER KR, 1986, PSYCHOL BULL, V99, P143, DOI 10.1037/0033-2909.99.2.143; SUNDBERG J, 1991, MUSIC PERCEPT, V9, P71; TUCKER LR, 1960, PSYCHOL SCALING THEO, P155; Varela FJ, 2017, EMBODIED MIND COGNIT; VONHAUSEGGER F, 1887, MUSIK ALS AUSDRUCK; Wallbott HG, 1998, EUR J SOC PSYCHOL, V28, P879, DOI 10.1002/(SICI)1099-0992(1998110)28:6<879::AID-EJSP901>3.0.CO;2-W; Williamon A., 2003, RES STUD MUSIC EDUC, V20, P23, DOI DOI 10.1177/1321103X030200010201	41	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115587	10.1371/journal.pone.0115587	http://dx.doi.org/10.1371/journal.pone.0115587			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AX7UC	25551392	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000347119100044
J	Maganga, GD; Bourgarel, M; Nkoghe, JO; N'Dilimabaka, N; Drosten, C; Paupy, C; Morand, S; Drexler, JF; Leroy, EM				Maganga, Gael D.; Bourgarel, Mathieu; Nkoghe, Judicael Obame; N'Dilimabaka, Nadine; Drosten, Christian; Paupy, Christophe; Morand, Serge; Drexler, Jan Felix; Leroy, Eric M.			Identification of an Unclassified Paramyxovirus in Coleura afra: A Potential Case of Host Specificity	PLOS ONE			English	Article							RESERVOIR HOSTS; VIRUS-INFECTION; HENDRA VIRUS; RISK-FACTORS; FRUIT BATS; ENCEPHALITIS; LYSSAVIRUS; GENOME	Bats are known to harbor multiple paramyxoviruses. Despite the creation of two new genera, Aquaparamyxovirus and Ferlavirus, to accommodate this increasing diversity, several recently isolated or characterized viruses remain unclassified beyond the subfamily level. In the present study, among 985 bats belonging to 6 species sampled in the Belinga caves of Gabon, RNA of an unclassified paramyxovirus (Belinga bat virus, BelPV) was discovered in 14 African sheathtailed bats (Coleura afra), one of which exhibited several hemorrhagic lesions at necropsy, and viral sequence was obtained in two animals. Phylogenetically, BelPV is related to J virus and Beilong virus (BeiPV), two other unclassified paramyxoviruses isolated from rodents. In the diseased BelPV-infected C. afra individual, high viral load was detected in the heart, and the lesions were consistent with those reported in wild rodents and mice experimentally infected by J virus. BelPV was not detected in other tested bat species sharing the same roosting sites and living in very close proximity with C. afra in the two caves sampled, suggesting that this virus may be host-specific for C. afra. The mode of transmission of this paramyxovirus in bat populations remains to be discovered.	[Maganga, Gael D.; Bourgarel, Mathieu; Nkoghe, Judicael Obame; N'Dilimabaka, Nadine; Paupy, Christophe; Leroy, Eric M.] Ctr Int Rech Med Franceville, Franceville, Gabon; [Maganga, Gael D.] Inst Natl Super Agron & Biotechnol, Franceville, Gabon; [Bourgarel, Mathieu; Morand, Serge] UPR AGIRs, Ctr Cooperat Int Rech Agron Dev CIRAD, Montpellier, France; [Bourgarel, Mathieu] UPR AGIRs, Ctr Cooperat Int Rech Agron Dev CIRAD, Harare, Zimbabwe; [Nkoghe, Judicael Obame; Paupy, Christophe; Leroy, Eric M.] Inst Rech Dev, UMR MIVEGEC 224, IRD CNRS UM1 UM2, Montpellier, France; [Drosten, Christian; Drexler, Jan Felix] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany; [Morand, Serge] Univ Montpellier 2, CNRS UM2, CC065, Montpellier, France	CIRAD; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Bonn; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Maganga, GD (corresponding author), Ctr Int Rech Med Franceville, BP 769, Franceville, Gabon.	gael_maganga@yahoo.fr	LEROY, Eric M/I-4347-2016; Morand, Serge/M-5433-2018; OBAME-NKOGHE, Judicaël/ABD-3456-2020; Paupy, Christophe/I-4847-2017; Bourgarel, Mathieu/F-1750-2017; Drexler, Jan Felix/GMW-5098-2022	LEROY, Eric M/0000-0003-0022-0890; Morand, Serge/0000-0003-3986-7659; Paupy, Christophe/0000-0002-7122-2079; Bourgarel, Mathieu/0000-0001-9774-7669; Drexler, Jan Felix/0000-0002-3509-0232	Global Viral Forecasting, a 'Fonds de Solidarite Prioritaire'' grant from the Ministere des Affaires Etrangeres de la France (FSP) [2002005700]; government of Gabon; Total-Fina-Elf Gabon; Ministere des Affaires Etrangeres de la France	Global Viral Forecasting, a 'Fonds de Solidarite Prioritaire'' grant from the Ministere des Affaires Etrangeres de la France (FSP); government of Gabon; Total-Fina-Elf Gabon; Ministere des Affaires Etrangeres de la France	This work was supported by Global Viral Forecasting, a 'Fonds de Solidarite Prioritaire'' grant from the Ministere des Affaires Etrangeres de la France (FSP no 2002005700). CIRMF is supported by the government of Gabon, Total-Fina-Elf Gabon, and the Ministere des Affaires Etrangeres de la France. This study was also made possible by the generous support of the American people through the United States Agency for International Development (USAID), Emerging Pandemic Threats PREDICT. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baer G.M., 1991, P341; Banyard AC, 2011, ADV VIRUS RES, V79, P239, DOI 10.1016/B978-0-12-387040-7.00012-3; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; CAMPBELL RW, 1977, SEARCH, V8, P435; Chu DKW, 2008, J VIROL, V82, P9107, DOI 10.1128/JVI.00857-08; Chu DKW, 2008, J GEN VIROL, V89, P1282, DOI 10.1099/vir.0.83605-0; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Duval L, 2012, INFECT GENET EVOL, V12, P1558, DOI 10.1016/j.meegid.2012.06.006; Frank G. H., 1981, Comparative diagnosis of viral diseases. Volume IV, part B, P187; Fraser GC, 1996, EMERG INFECT DIS, V2, P327, DOI 10.3201/eid0204.960408; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johnson N, 2006, J MED MICROBIOL, V55, P785, DOI 10.1099/jmm.0.46370-0; JUN MH, 1977, AUST J EXP BIOL MED, V55, P645, DOI 10.1038/icb.1977.63; Jun MH, 1976, THESIS JAMES COOK U; Kunz T.H., 2009, ECOLOGICAL BEHAV MET; LAMB R., 2001, FIELDS VIROLOGY, V1, P1305; LANDAU I, 1980, ANN PARASIT HUM COMP, V55, P271, DOI 10.1051/parasite/1980553271; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li Z, 2006, VIROLOGY, V346, P219, DOI 10.1016/j.virol.2005.10.039; Maganga GD, 2011, J INFECT DIS, V204, pS800, DOI 10.1093/infdis/jir358; McColl KA, 2002, AUST VET J, V80, P636, DOI 10.1111/j.1751-0813.2002.tb10973.x; Montgomery JM, 2008, EMERG INFECT DIS, V14, P1526, DOI 10.3201/eid1410.060507; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Renshaw RW, 2000, VIROLOGY, V270, P417, DOI 10.1006/viro.2000.0305; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tidona CA, 1999, VIROLOGY, V258, P425, DOI 10.1006/viro.1999.9693; TIKASING.ES, 1966, AM J TROP MED HYG, V15, P235, DOI 10.4269/ajtmh.1966.15.235; Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Woo PCY, 2011, J VIROL, V85, P13473, DOI 10.1128/JVI.06356-11	42	5	5	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115588	10.1371/journal.pone.0115588	http://dx.doi.org/10.1371/journal.pone.0115588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551455	Green Published, gold			2022-12-26	WOS:000347119100045
J	Yang, ZM; Chang, ZL; Sun, LH; Yu, JJ; Huang, BR				Yang, Zhimin; Chang, Zuoliang; Sun, Lihong; Yu, Jingjin; Huang, Bingru			Physiological and Metabolic Effects of 5-Aminolevulinic Acid for Mitigating Salinity Stress in Creeping Bentgrass	PLOS ONE			English	Article							PHOTOSYNTHETIC GAS-EXCHANGE; BRASSICA-NAPUS; SALT TOLERANCE; OILSEED RAPE; HEAT TOLERANCE; RESPONSES; DROUGHT; GROWTH; SEEDLINGS; TOXICITY	The objectives of this study were to determine whether foliar application of a chlorophyll precursor, 5-aminolevulinic acid (ALA), could mitigate salinity stress damages in perennial grass species by regulating photosynthetic activities, ion content, antioxidant metabolism, or metabolite accumulation. A salinity-sensitive perennial grass species, creeping bentgrass (Agrostis stolonifera), was irrigated daily with 200 mM NaCl for 28 d, which were foliar sprayed with water or ALA (0.5 mg L-1) weekly during the experiment in growth chamber. Foliar application of ALA was effective in mitigating physiological damage resulting from salinity stress, as manifested by increased turf quality, shoot growth rate, leaf relative water content, chlorophyll content, net photosynthetic rate, stomatal conductance and transpiration rate. Foliar application of ALA also alleviated membrane damages, as shown by lower membrane electrolyte leakage and lipid peroxidation, which was associated with increases in the activities of antioxidant enzymes. Leaf content of Na+ was reduced and the ratio of K+/Na+ was increased with ALA application under salinity stress. The positive effects of ALA for salinity tolerance were also associated with the accumulation of organic acids (alpha-ketoglutaric acid, succinic acid, and malic acid), amino acids (alanine, 5-oxoproline, aspartic acid, and gamma - aminobutyric acid), and sugars (glucose, fructose, galactose, lyxose, allose, xylose, sucrose, and maltose). ALA-mitigation of physiological damages by salinity could be due to suppression of Na+ accumulation and enhanced physiological and metabolic activities related to photosynthesis, respiration, osmotic regulation, and antioxidant defense.	[Yang, Zhimin; Chang, Zuoliang; Sun, Lihong; Yu, Jingjin] Nanjing Agr Univ, Coll Agrograssland Sci, Nanjing 210095, Jiangsu, Peoples R China; [Huang, Bingru] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08901 USA	Nanjing Agricultural University; Rutgers State University New Brunswick	Yang, ZM (corresponding author), Nanjing Agr Univ, Coll Agrograssland Sci, Nanjing 210095, Jiangsu, Peoples R China.	nauyzm@njau.edu.cn; huang@aesop.rutgers.edu						Ali B, 2014, IND CROP PROD, V52, P617, DOI 10.1016/j.indcrop.2013.11.033; Ali B, 2013, J PLANT GROWTH REGUL, V32, P604, DOI 10.1007/s00344-013-9328-6; [Anonymous], 1991, TURFGRASS MANAGEMENT; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Azevedo RA, 2006, AMINO ACIDS, V30, P143, DOI 10.1007/s00726-005-0245-2; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; CAKMAK I, 1994, J EXP BOT, V45, P1259, DOI 10.1093/jxb/45.9.1259; Carrow R.N., 1998, SALT AFFECTED TURFGR; Couee I, 2006, J EXP BOT, V57, P449, DOI 10.1093/jxb/erj027; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Du HM, 2011, PHYSIOL PLANTARUM, V141, P251, DOI 10.1111/j.1399-3054.2010.01432.x; FOUGERE F, 1991, PLANT PHYSIOL, V96, P1228, DOI 10.1104/pp.96.4.1228; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hotta Y, 1997, BIOSCI BIOTECH BIOCH, V61, P2025, DOI 10.1271/bbb.61.2025; Hotta Y, 2000, J JAPANESE SOC TURFG, V28, P97; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kinnersley AM, 2000, CRIT REV PLANT SCI, V19, P479, DOI 10.1016/S0735-2689(01)80006-X; Korkmaz A, 2012, ABIOTIC STRESS RESPONSES IN PLANTS: METABOLISM, PRODUCTIVITY AND SUSTAINABILITY, P215, DOI 10.1007/978-1-4614-0634-1_12; LAI FM, 1994, PLANT SCI, V103, P209, DOI 10.1016/0168-9452(94)90209-7; Liu D, 2013, ACTA PHYSIOL PLANT, V35, P2747, DOI 10.1007/s11738-013-1307-9; Liu H, 2006, J FRUIT SCI, V6, P15; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Merewitz EB, 2012, J EXP BOT, V63, P1315, DOI 10.1093/jxb/err372; Miyashita Y, 2007, PLANT J, V49, P1108, DOI 10.1111/j.1365-313X.2006.03023.x; Morales-Payan J. P., 2004, Proceedings of the Florida State Horticultural Society, V117, P282; MUNNS R, 1993, PLANT CELL ENVIRON, V16, P15, DOI 10.1111/j.1365-3040.1993.tb00840.x; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Naeem MS, 2011, ACTA PHYSIOL PLANT, V33, P517, DOI 10.1007/s11738-010-0575-x; Naeem MS, 2010, PLANT SOIL, V332, P405, DOI 10.1007/s11104-010-0306-5; Naeem MS, 2012, PLANT PHYSIOL BIOCH, V57, P84, DOI 10.1016/j.plaphy.2012.05.018; Nilsen ET, 1996, FIELD CROP RES, P192; Nishihara E, 2003, J PLANT PHYSIOL, V160, P1085, DOI 10.1078/0176-1617-00991; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Pessarakli M., 1999, HDB PLANT CROP STRES, P1; Qiu Y, 2007, ANAL CHIM ACTA, V583, P277, DOI 10.1016/j.aca.2006.10.025; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Sanchez DH, 2008, PHYSIOL PLANTARUM, V132, P209, DOI 10.1111/j.1399-3054.2007.00993.x; Sun YP, 2009, PHOTOSYNTHETICA, V47, P347, DOI 10.1007/s11099-009-0055-y; Urbonaviciute A, 2006, POL J ENVIRON STUD, V15, P921; Wang B., 1995, PLANT PHYSL COMMUN, V31, P50; Watanabe K, 2000, PLANT GROWTH REGUL, V32, P99, DOI 10.1023/A:1006369404273; Wongkantrakorn N, 2009, J PESTIC SCI, V34, P89, DOI 10.1584/jpestics.G08-43; Wu DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056624, 10.1371/journal.pone.0053932, 10.1371/journal.pone.0055431]; WU L, 1994, J PLANT NUTR, V17, P1905, DOI 10.1080/01904169409364854; Xu Y, 2013, CROP SCI, V53, P1626, DOI 10.2135/cropsci2013.01.0045; Youssef T, 2008, J PLANT GROWTH REGUL, V27, P1, DOI 10.1007/s00344-007-9025-4; Zhang CP, 2013, BOT STUD, V54, DOI 10.1186/1999-3110-54-18; Zhang JX, 1996, NEW PHYTOL, V132, P361, DOI 10.1111/j.1469-8137.1996.tb01856.x; Zhang WF, 2008, J PLANT GROWTH REGUL, V27, P159, DOI 10.1007/s00344-008-9042-y; Zhang ZJ, 2006, PLANT GROWTH REGUL, V49, P27, DOI 10.1007/s10725-006-0011-9; Zhen A, 2012, BIOL PLANTARUM, V56, P566, DOI 10.1007/s10535-012-0118-y	56	32	35	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116283	10.1371/journal.pone.0116283	http://dx.doi.org/10.1371/journal.pone.0116283			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551443	Green Submitted, Green Published, gold			2022-12-26	WOS:000347119100121
J	Casagrande, S; Pinxten, R; Zaid, E; Eens, M				Casagrande, Stefania; Pinxten, Rianne; Zaid, Erika; Eens, Marcel			Carotenoids, Birdsong and Oxidative Status: Administration of Dietary Lutein Is Associated with an Increase in Song Rate and Circulating Antioxidants (Albumin and Cholesterol) and a Decrease in Oxidative Damage	PLOS ONE			English	Article							OPEN-ENDED LEARNER; IMMUNE-RESPONSE; GREAT TITS; INFORMATION-CONTENT; SINGING BEHAVIOR; STRESS; TESTOSTERONE; SUPPLEMENTATION; ECOLOGY; SIGNALS	Despite the appealing hypothesis that carotenoid-based colouration signals oxidative status, evidence supporting the antioxidant function of these pigments is scarce. Recent studies have shown that lutein, the most common carotenoid used by birds, can enhance the expression of non-visual traits, such as birdsong. Nevertheless, the underlying physiological mechanisms remain unclear. In this study we hypothesized that male European starlings (Sturnus vulgaris) fed extra lutein increase their song rate as a consequence of an improved oxidative status. Although birdsong may be especially sensitive to the redox status, this has, to the best of our knowledge, never been tested. Together with the determination of circulating oxidative damage (ROMs, reactive oxygen metabolites), we quantified uric acid, albumin, total proteins, cholesterol, and testosterone, which are physiological parameters potentially sensitive to oxidation and/or related to both carotenoid functions and birdsong expression. We found that the birds fed extra lutein sang more frequently than control birds and showed an increase of albumin and cholesterol together with a decrease of oxidative damage. Moreover, we could show that song rate was associated with high levels of albumin and cholesterol and low levels of oxidative damage, independently from testosterone levels. Our study shows for the first time that song rate honestly signals the oxidative status of males and that dietary lutein is associated with the circulation of albumin and cholesterol in birds, providing a novel insight to the theoretical framework related to the honest signalling of carotenoid-based traits.	[Casagrande, Stefania; Pinxten, Rianne; Zaid, Erika; Eens, Marcel] Univ Antwerp, Dept Biol, Ethol Grp, B-2020 Antwerp, Belgium; [Pinxten, Rianne] Univ Antwerp, Res Unit Didact, Inst Educ & Informat Sci, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp	Casagrande, S (corresponding author), Univ Antwerp, Dept Biol, Ethol Grp, Campus Drie Eiken, B-2020 Antwerp, Belgium.	stefania.casagrande@uantwerpen.be	Casagrande, Stefania/I-3725-2019; Eens, Marcel/AAC-8466-2020	Casagrande, Stefania/0000-0002-4264-8062; Zaid, Erika/0000-0002-4637-6711	FWO postdoctoral Pegasus Marie Curie Fellowship [05-05-1.2.205.13N]; University of Antwerp (TOPBOF); FWO-Flanders; Erasmus Placement program	FWO postdoctoral Pegasus Marie Curie Fellowship; University of Antwerp (TOPBOF); FWO-Flanders(FWO); Erasmus Placement program	S.C. was supported by an FWO postdoctoral Pegasus Marie Curie Fellowship (grant 05-05-1.2.205.13N). RP and ME were supported by the University of Antwerp (TOPBOF) and FWO-Flanders. EZ was supported by an Erasmus Placement program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; Ball GF, 1998, AM PSYCHOL, V53, P37, DOI 10.1037/0003-066X.53.1.37; Ben-Dor A, 2005, MOL CANCER THER, V4, P177; Berthouly A, 2007, FUNCT ECOL, V21, P335, DOI 10.1111/j.1365-2435.2006.01236.x; Bertrand S, 2006, J EXP BIOL, V209, P4414, DOI 10.1242/jeb.02540; Blount JD, 2004, ARCH BIOCHEM BIOPHYS, V430, P10, DOI 10.1016/j.abb.2004.03.039; Boogert NJ, 2008, ANIM BEHAV, V76, P1735, DOI 10.1016/j.anbehav.2008.08.009; Brown AJ, 2010, EVOLUTION, V64, P2179, DOI 10.1111/j.1558-5646.2010.01011.x; Buchanan KL, 2013, TRENDS ECOL EVOL, V28, P290, DOI 10.1016/j.tree.2013.02.004; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Casagrande S, 2012, BEHAV ECOL SOCIOBIOL, V66, P1319, DOI 10.1007/s00265-012-1387-3; Casagrande S, 2011, COMP BIOCHEM PHYS A, V160, P16, DOI 10.1016/j.cbpa.2011.04.011; Cohen A, 2007, COMP BIOCHEM PHYS B, V147, P110, DOI 10.1016/j.cbpb.2006.12.015; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; Costantini D, 2011, METHODS ECOL EVOL, V2, P321, DOI 10.1111/j.2041-210X.2010.00080.x; Costantini D, 2009, COMP BIOCHEM PHYS A, V153, P339, DOI 10.1016/j.cbpa.2009.03.010; Costantini D, 2009, FUNCT ECOL, V23, P506, DOI 10.1111/j.1365-2435.2009.01546.x; Deng JM, 2013, FISH SHELLFISH IMMUN, V34, P324, DOI 10.1016/j.fsi.2012.11.008; EENS M, 1991, BEHAVIOUR, V116, P210, DOI 10.1163/156853991X00049; Eens M, 1997, ADV STUD BEHAV, V26, P355, DOI 10.1016/S0065-3454(08)60384-8; El-Agamey A, 2004, ARCH BIOCHEM BIOPHYS, V430, P37, DOI 10.1016/j.abb.2004.03.007; Ewen JG, 2006, COMP BIOCHEM PHYS A, V143, P149, DOI 10.1016/j.cbpa.2005.11.006; Ewen JG, 2009, P NATL ACAD SCI USA, V106, P12798, DOI 10.1073/pnas.0902575106; Farrell TM, 2012, BEHAV ECOL, V23, P101, DOI 10.1093/beheco/arr162; Fitze PS, 2007, AM NAT, V169, pS137, DOI 10.1086/510094; Freeman-Gallant CR, 2011, BIOL LETTERS, V7, P429, DOI 10.1098/rsbl.2010.1186; Garamszegi LZ, 2004, BRAIN RES REV, V44, P187, DOI 10.1016/j.brainresrev.2003.12.001; Garratt M, 2014, P NATL ACAD SCI USA, V111, P8119, DOI 10.1073/pnas.1322282111; Garratt M, 2012, P ROY SOC B-BIOL SCI, V279, P3121, DOI 10.1098/rspb.2012.0568; Geens A, 2009, COMP BIOCHEM PHYS C, V150, P155, DOI 10.1016/j.cbpc.2009.04.007; Gentner TQ, 2000, ANIM BEHAV, V59, P443, DOI 10.1006/anbe.1999.1313; Halliwell B., 2007, FREE RADICALS BIOL M; Harding CF, 2004, ANN NY ACAD SCI, V1016, P524, DOI 10.1196/annals.1298.030; Hartley RC, 2004, TRENDS ECOL EVOL, V19, P353, DOI 10.1016/j.tree.2004.04.002; HARVEY R, 2011, BIOCHEMISTRY-US, P219; Hasselquist D, 2008, J AVIAN BIOL, V39, P384, DOI 10.1111/j.0908-8857.2008.04427.x; Helfenstein F, 2010, ECOL LETT, V13, P213, DOI 10.1111/j.1461-0248.2009.01419.x; HILL EG, 1966, J NUTR, V89, P143, DOI 10.1093/jn/89.2.143; Hill GE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1314; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Horak P, 2010, FUNCT ECOL, V24, P960, DOI 10.1111/j.1365-2435.2010.01755.x; KAZUYOSHI T, 1995, BRAIN RES, V678, P1, DOI DOI 10.1016/0006-8993(95)00116-8; Kubli SP, 2014, AM NAT, V183, P660, DOI 10.1086/675757; MacDonald IF, 2006, P ROY SOC B-BIOL SCI, V273, P2559, DOI 10.1098/rspb.2006.3547; MANSON MM, 1992, ARCH TOXICOL, V66, P51, DOI 10.1007/BF02307270; McGraw KJ, 2006, ETHOLOGY, V112, P1209, DOI 10.1111/j.1439-0310.2006.01280.x; McGraw KJ, 2006, AUK, V123, P1161, DOI 10.1642/0004-8038(2006)123[1161:CIAICI]2.0.CO;2; McGraw KJ, 2006, PHYSIOL BEHAV, V87, P103, DOI 10.1016/j.physbeh.2005.09.001; McGraw KJ, 2003, AM NAT, V162, P704, DOI 10.1086/378904; Medina-Navarro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008971; Meitern R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067545; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Moreno J, 2013, ACTA ETHOL, V16, P65, DOI 10.1007/s10211-012-0138-9; Mortensen A, 2001, ARCH BIOCHEM BIOPHYS, V385, P13, DOI 10.1006/abbi.2000.2172; Muller W, 2009, HORM BEHAV, V55, P175, DOI 10.1016/j.yhbeh.2008.09.012; Navarro C, 2010, BEHAV ECOL SOCIOBIOL, V64, P1057, DOI 10.1007/s00265-010-0920-5; Ophir AG, 2010, J EVOLUTION BIOL, V23, P1564, DOI 10.1111/j.1420-9101.2010.02005.x; Pattison DI, 2009, CHEM RES TOXICOL, V22, P807, DOI 10.1021/tx800372d; Perez-Rodriguez L, 2009, BIOESSAYS, V31, P1116, DOI 10.1002/bies.200900070; Pinxten R, 2003, HORM BEHAV, V43, P394, DOI 10.1016/S0018-506X(03)00012-6; Pinxten R, 2002, HORM BEHAV, V42, P307, DOI 10.1006/hbeh.2002.1824; Remes V, 2007, FUNCT ECOL, V21, P776, DOI 10.1111/j.1365-2435.2007.01277.x; Riters LV, 2002, J COMP NEUROL, V444, P63, DOI 10.1002/cne.10131; Ritschard M, 2011, PHYSIOL BEHAV, V102, P30, DOI 10.1016/j.physbeh.2010.10.005; Roche M, 2008, FEBS LETT, V582, P1783, DOI 10.1016/j.febslet.2008.04.057; Sahin K, 2006, J THERM BIOL, V31, P307, DOI 10.1016/j.jtherbio.2005.12.006; Seifried HE, 2007, J NUTR BIOCHEM, V18, P567, DOI 10.1016/j.jnutbio.2006.10.007; Sewall KB, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0344; SMITH LL, 1991, FREE RADICAL BIO MED, V11, P47, DOI 10.1016/0891-5849(91)90187-8; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; Stier A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-37; STOCKER R, 1987, P NATL ACAD SCI USA, V84, P5918, DOI 10.1073/pnas.84.16.5918; Svensson PA, 2011, BEHAVIOUR, V148, P131, DOI 10.1163/000579510X548673; Taverna M, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-4; Thorogood R, 2008, FUNCT ECOL, V22, P1044, DOI 10.1111/j.1365-2435.2008.01455.x; Tummeleht L, 2006, COMP BIOCHEM PHYS C, V144, P166, DOI 10.1016/j.cbpc.2006.08.004; Turell L, 2013, FREE RADICAL BIO MED, V65, P244, DOI 10.1016/j.freeradbiomed.2013.05.050; Van Hout AJM, 2012, HORM BEHAV, V62, P563, DOI 10.1016/j.yhbeh.2012.09.008; Van Hout AJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036547; Van Hout AJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016326; Van Hout AJM, 2009, HORM BEHAV, V56, P564, DOI 10.1016/j.yhbeh.2009.09.010; Vinkler M, 2010, NATURWISSENSCHAFTEN, V97, P19, DOI 10.1007/s00114-009-0595-9; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; Ward S, 2004, BEHAV ECOL, V15, P477, DOI 10.1093/beheco/arh038; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; ZHANG LX, 1992, CANCER RES, V52, P5707; Zollinger SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023198	87	17	17	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115899	10.1371/journal.pone.0115899	http://dx.doi.org/10.1371/journal.pone.0115899			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549336	Green Submitted, Green Published, gold			2022-12-26	WOS:000347063500036
J	Fukui, S; Araki, KS				Fukui, Shin; Araki, Kiwako S.			Spatial Niche Facilitates Clonal Reproduction in Seed Plants under Temporal Disturbance	PLOS ONE			English	Article							ASEXUAL REPRODUCTION; DISPERSAL; POPULATION; DIVERSITY; CORAL; METAPOPULATION; MAINTENANCE; ADAPTATION; SIMULATION; ALLOCATION	The evolutionary origins and advantages of clonal reproduction relative to sexual reproduction have been discussed for several taxonomic groups. In particular, organisms with a sessile lifestyle are often exposed to spatial and temporal environmental fluctuations. Thus, clonal propagation may be advantageous in such fluctuating environments, for sessile species that can reproduce both sexually and clonally. Here we introduce the concept of niche to a lattice space that changes spatially and temporally, by incorporating the compatibility between the characteristics of a sessile clonal plant with its habitat into a spatially explicit individual-based model. We evaluate the impact of spatially and temporally heterogeneous environments on the evolution of reproductive strategies: the optimal balance between seed and clonal reproduction of a clonal plant. The spatial niche case with local habitats led to avoidance of specialization in reproductive strategy, whereas stable environments or intensive environmental change tended to result in specialization in either clonal or seed reproduction under neutral conditions. Furthermore, an increase in spatial niches made clonal reproduction advantageous, as a consequence of competition among several genets under disturbed conditions, because a ramet reached a favorable habitat through a rare long-distance dispersal event via seed production. Thus, the existence of spatial niches could explain the advantages of clonal propagation.	[Fukui, Shin; Araki, Kiwako S.] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Fukui, Shin] Natl Inst Agroenvironm Sci, Agrometeorol Div, Tsukuba, Ibaraki 305, Japan; [Araki, Kiwako S.] Ritsumeikan Univ, Fac Life Sci, Dept Biotechnol, Kusatsu, Shiga, Japan	Kyoto University; National Institute for Agro-Environmental Sciences (NIAES) Japan; Ritsumeikan University	Fukui, S (corresponding author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan.	fshin3@gmail.com			Japan Society for the Promotion of Science (JSPS) for Young Scientists [201100907]; JSPS through the "Funding Program for Next Generation World-Leading Researchers (NEXT Program) [GS013]; Global COE program (A06) of Kyoto University; Grants for Excellent Graduate Schools program of MEXT, Japan; Grants-in-Aid for Scientific Research [26840148] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS through the "Funding Program for Next Generation World-Leading Researchers (NEXT Program); Global COE program (A06) of Kyoto University; Grants for Excellent Graduate Schools program of MEXT, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by a research fellowship of the Japan Society for the Promotion of Science (JSPS) for Young Scientists (201100907 to KSA), JSPS through the "Funding Program for Next Generation World-Leading Researchers (NEXT Program, GS013)'' initiated by the Council for Science and Technology Policy (CSTP), Japan, Global COE program (A06) of Kyoto University, and the Grants for Excellent Graduate Schools program of MEXT, Japan. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Becks L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001317; Cain ML, 1997, J ECOL, V85, P883, DOI 10.2307/2960609; Coffroth MA, 1998, EVOLUTION, V52, P379, DOI 10.1111/j.1558-5646.1998.tb01639.x; CONNELL J H, 1971, P298; COOK RE, 1979, AM NAT, V113, P769, DOI 10.1086/283435; de Kroon J.M, 1990, CLONAL GROWTH PLANTS; Dietz H, 1999, OECOLOGIA, V120, P225, DOI 10.1007/s004420050852; ELLSTRAND NC, 1987, AM J BOT, V74, P123, DOI 10.2307/2444338; Eriksson O, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P211; EVANS JP, 1995, ECOLOGY, V76, P1147, DOI 10.2307/1940922; Fischer M, 2001, EVOL ECOL, V15, P565, DOI 10.1023/A:1016013721469; Foster NL, 2007, J ANIM ECOL, V76, P384, DOI 10.1111/j.1365-2656.2006.01207.x; Fournier D, 2005, NATURE, V435, P1230, DOI 10.1038/nature03705; Gruntman M, 2004, P NATL ACAD SCI USA, V101, P3863, DOI 10.1073/pnas.0306604101; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; Harada Y, 1997, J ECOL, V85, P591, DOI 10.2307/2960530; HICKS DJ, 1985, PHYSL ECOLOGY N AM P, P257, DOI DOI 10.1007/978-94-009-4830-3_12; Hiebeler D, 2004, THEOR POPUL BIOL, V66, P205, DOI 10.1016/j.tpb.2004.06.004; Hubbell Stephen P., 2001, V32, pi; Jackson J. B. C., 1985, POPULATION BIOL EVOL; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Karlson RH, 1996, ECOLOGY, V77, P1592, DOI 10.2307/2265554; King KC, 2009, CURR BIOL, V19, P1438, DOI 10.1016/j.cub.2009.06.062; Klimes L, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P1; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Lande R, 1996, EVOLUTION, V50, P434, DOI 10.2307/2410812; LIVELY CM, 1987, NATURE, V328, P519, DOI 10.1038/328519a0; Lovett-Doust L., 1988, PLANT REPROD ECOLOGY; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Nakamaru M, 2007, J THEOR BIOL, V248, P288, DOI 10.1016/j.jtbi.2007.05.012; Nishitani S, 1999, PLANT ECOL, V141, P179, DOI 10.1023/A:1009896111536; Ohkawara K, 2006, BIOL LETTERS, V2, P359, DOI 10.1098/rsbl.2006.0491; Pearcy M, 2011, P ROY SOC B-BIOL SCI, V278, P2677, DOI 10.1098/rspb.2010.2562; Reisch C, 2009, PLANT ECOL, V201, P699, DOI 10.1007/s11258-008-9458-2; Reusch TBH, 2006, MOL ECOL, V15, P277, DOI 10.1111/j.1365-294X.2005.02779.x; Roff Derek A., 1992; Skalova H, 1999, PLANT ECOL, V143, P129, DOI 10.1023/A:1009899803229; Skold HN, 2009, STEM CELLS IN MARINE ORGANISMS, P105, DOI 10.1007/978-90-481-2767-2_5; SMITH JM, 1971, J THEOR BIOL, V30, P319, DOI 10.1016/0022-5193(71)90058-0; Stearns S.C., 1992, pi; Stocklin J, 2004, EVOL ECOL, V18, P563, DOI 10.1007/s10682-004-5144-6; Tani T, 2001, ANN BOT-LONDON, V88, P393, DOI 10.1006/anbo.2001.1483; Travis JMJ, 1998, P ROY SOC B-BIOL SCI, V265, P17, DOI 10.1098/rspb.1998.0258; Tubay JM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02835; Van Groenendael J. M., 1997, P191; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; WATKINSON AR, 1993, J ECOL, V81, P707, DOI 10.2307/2261668; Winkler E, 2001, EVOL ECOL, V15, P281, DOI 10.1023/A:1016080714200; Wright S, 1943, GENETICS, V28, P114; Yanai RD, 2000, FOREST ECOL MANAG, V138, P273, DOI 10.1016/S0378-1127(00)00402-3	51	8	11	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116111	10.1371/journal.pone.0116111	http://dx.doi.org/10.1371/journal.pone.0116111			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549330	Green Published, gold, Green Submitted			2022-12-26	WOS:000347063500051
J	Guedj, K; Khallou-Laschet, J; Clement, M; Morvan, M; Delbosc, S; Gaston, AT; Andreata, F; Castier, Y; Deschildre, C; Michel, JB; Caligiuri, G; Nicoletti, A				Guedj, Kevin; Khallou-Laschet, Jamila; Clement, Marc; Morvan, Marion; Delbosc, Sandrine; Gaston, Anh-Thu; Andreata, Francesco; Castier, Yves; Deschildre, Catherine; Michel, Jean-Baptiste; Caligiuri, Giuseppina; Nicoletti, Antonino			Inflammatory Micro-Environmental Cues of Human Atherothrombotic Arteries Confer to Vascular Smooth Muscle Cells the Capacity to Trigger Lymphoid Neogenesis	PLOS ONE			English	Article							NF-KAPPA-B; RHEUMATOID-ARTHRITIS; CHRONIC REJECTION; ATHEROSCLEROSIS; TISSUE; MICE; EXPRESSION; RESPONSES; SYNOVIUM; DISEASES	Background: Experimental atherosclerosis is characterized by the formation of tertiary lymphoid structures (TLOs) within the adventitial layer, which involves the chemokine-expressing aortic smooth muscle cells (SMCs). TLOs have also been described around human atherothrombotic arteries but the mechanisms of their formation remain poorly investigated. Herein, we tested whether human vascular SMCs play the role of chemokine-expressing cells that would trigger the formation of TLOs in atherothrombotic arteries. Results: We first characterized, by flow cytometry and immunofluorescence analysis, the prevalence and cell composition of TLOs in human abdominal aneurysms of the aorta (AAAs), an evolutive form of atherothrombosis. Chemotaxis experiments revealed that the conditioned medium from AAA tissues recruited significantly more B and T lymphocytes than the conditioned medium from control (N-AAA) tissues. This was associated with an increase in the concentration of CXCL13, CXCL16, CCL19, CCL20, and CCL21 chemokines in the conditioned medium from AAA tissues. Immunofluorescence analysis of AAA cryosections revealed that alpha-SMA-positive SMCs were the main contributors to the chemokine production. These results were confirmed by RT-qPCR assays where we found that primary vascular SMCs from AAA tissues expressed significantly more chemokines than SMCs from N-AAA. Finally, in vitro experiments demonstrated that the inflammatory cytokines found to be increased in the conditioned medium from AAA were able to trigger the production of chemokines by primary SMCs. Conclusion: Together, these results suggest that human vascular SMCs in atherothrombotic arteries, in response to inflammatory signals, are converted into chemokine-expressing cells that trigger the recruitment of immune cells and the formation of aortic TLOs.	[Guedj, Kevin; Khallou-Laschet, Jamila; Clement, Marc; Morvan, Marion; Delbosc, Sandrine; Gaston, Anh-Thu; Andreata, Francesco; Castier, Yves; Deschildre, Catherine; Michel, Jean-Baptiste; Caligiuri, Giuseppina; Nicoletti, Antonino] Hop Xavier Bichat, INSERM, Unite 1148, Paris, France; [Guedj, Kevin; Khallou-Laschet, Jamila; Clement, Marc; Andreata, Francesco; Nicoletti, Antonino] Univ Paris 07, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Nicoletti, A (corresponding author), Hop Xavier Bichat, INSERM, Unite 1148, Paris, France.	antonino.nicoletti@inserm.fr	Nicoletti, Antonino/A-9460-2015; Caligiuri, Giuseppina/G-4810-2015; Michel, Jean-Baptiste/AAH-9336-2020; CLEMENT, Marc/GVS-8052-2022; DELBOSC, Sandrine/ABB-4618-2021	Nicoletti, Antonino/0000-0002-2623-0897; Caligiuri, Giuseppina/0000-0003-4973-2205; CLEMENT, Marc/0000-0002-6479-8360; Laschet, Jamila/0000-0002-5090-4417; Andreata, Francesco/0000-0002-5710-3671; Delbosc, Sandrine/0000-0001-8076-6927	Agence Nationale de la Recherche (ANR); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Paris 7 Denis Diderot; Fondation de France	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris 7 Denis Diderot; Fondation de France(Fondation de France)	This work was supported by Agence Nationale de la Recherche (ANR); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Paris 7 Denis Diderot and Fondation de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Baddoura FK, 2005, AM J TRANSPLANT, V5, P510, DOI 10.1111/j.1600-6143.2004.00714.x; Bilsborough J, 2006, J ALLERGY CLIN IMMUN, V117, P418, DOI 10.1016/j.jaci.2005.10.046; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Carrero R, 2012, STEM CELL REV REP, V8, P905, DOI 10.1007/s12015-012-9364-9; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Dutertre CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089983; Gao Q, 2010, J IMMUNOL, V185, P5820, DOI 10.4049/jimmunol.1000116; GERLIS LM, 1956, BRIT HEART J, V18, P166; Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Guedj K, 2013, CARDIOVASC RES; Guedj K, 2014, CARDIOVASC RES, V101, P434, DOI 10.1093/cvr/cvt263; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Hosokawa Y, 2007, CLIN EXP IMMUNOL, V149, P146, DOI 10.1111/j.1365-2249.2007.03398.x; Houtkamp MA, 2001, J PATHOL, V193, P263, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH774>3.0.CO;2-N; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Lotzer K, 2010, ARTERIOSCL THROM VAS, V30, P395, DOI 10.1161/ATVBAHA.109.191395; Lutgens E, 2000, P NATL ACAD SCI USA, V97, P7464, DOI 10.1073/pnas.97.13.7464; Mabuchi T, 2013, J INVEST DERMATOL, V133, P164, DOI 10.1038/jid.2012.260; McLaren JE, 2009, CYTOKINE GROWTH F R, V20, P125, DOI 10.1016/j.cytogfr.2008.11.003; Michel JB, 2007, ARTERIOSCL THROM VAS, V27, P1259, DOI 10.1161/ATVBAHA.106.137851; Pablos JL, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-6; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pickens SR, 2011, ARTHRITIS RHEUM-US, V63, P914, DOI 10.1002/art.30232; Pietila TE, 2007, J IMMUNOL, V178, P253, DOI 10.4049/jimmunol.178.1.253; SAPHIR O, 1950, ARCH PATHOL, V49, P418; Shahrara S, 2010, J IMMUNOL, V184, P4479, DOI 10.4049/jimmunol.0901942; STEERE AC, 1988, ARTHRITIS RHEUM, V31, P487, DOI 10.1002/art.1780310405; Stott DI, 1998, J CLIN INVEST, V102, P938, DOI 10.1172/JCI3234; Thaunat O, 2010, J IMMUNOL, V185, P717, DOI 10.4049/jimmunol.0903589	30	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116295	10.1371/journal.pone.0116295	http://dx.doi.org/10.1371/journal.pone.0116295			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548922	Green Submitted, Green Published, gold			2022-12-26	WOS:000347063500073
J	Yan, CZ; Wang, ZH; Luo, ZX				Yan, Changzhou; Wang, Zhenhong; Luo, Zhuanxi			Arsenic Efflux from Microcystis aeruginosa under Different Phosphate Regimes	PLOS ONE			English	Article							SPECIATION; FOOD; BIOTRANSFORMATION; BIOACCUMULATION; ACCUMULATION; TOXICITY; DYNAMICS; BIOMETHYLATION; TRANSFORMATION; INHIBITION	Phytoplankton plays an important role in arsenic speciation, distribution, and cycling in freshwater environments. Little information, however, is available on arsenic efflux from the cyanobacteria Microcystis aeruginosa under different phosphate regimes. This study investigated M. aeruginosa arsenic efflux and speciation by pre-exposing it to 10 mu M arsenate or arsenite for 24 h during limited (12 h) and extended (13 d) depuration periods under phosphate enriched (+P) and phosphate depleted (-P) treatments. Arsenate was the predominant species detected in algal cells throughout the depuration period while arsenite only accounted for no greater than 45% of intracellular arsenic. During the limited depuration period, arsenic efflux occurred rapidly and only arsenate was detected in solutions. During the extended depuration period, however, arsenate and dimethylarsinic acid (DMA) were found to be the two predominant arsenic species detected in solutions under -P treatments, but arsenate was the only species detected under +P treatments. Experimental results also suggest that phosphorus has a significant effect in accelerating arsenic efflux and promoting arsenite bio-oxidation in M. aeruginosa. Furthermore, phosphorus depletion can reduce arsenic efflux from algal cells as well as accelerate arsenic reduction and methylation. These findings can contribute to our understanding of arsenic biogeochemistry in aquatic environments and its potential environmental risks under different phosphorus levels.	[Yan, Changzhou; Wang, Zhenhong; Luo, Zhuanxi] Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen 361021, Peoples R China; [Wang, Zhenhong] Minnan Normal Univ, Coll Chem & Environm, Zhangzhou 363000, Peoples R China	Chinese Academy of Sciences; Institute of Urban Environment, CAS; MinNan Normal University	Yan, CZ (corresponding author), Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen 361021, Peoples R China.	czyan@iue.ac.cn	CAS, KLUEH/T-5743-2019; luo, Zhuanxi/B-8441-2009	luo, Zhuanxi/0000-0003-0164-4492	National Nature Science Foundation of China [21277136]; International Science & Technology Cooperation Program of China [2011DFB91710]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China	This work was jointly supported by the National Nature Science Foundation of China (Project No. 21277136), International Science & Technology Cooperation Program of China (2011DFB91710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali W, 2009, CELL MOL LIFE SCI, V66, P2329, DOI 10.1007/s00018-009-0021-7; Croteau MN, 2004, ENVIRON SCI TECHNOL, V38, P5002, DOI 10.1021/es049432q; Elias M, 2012, NATURE, V491, P134, DOI 10.1038/nature11517; Guo PR, 2011, ENVIRON TOXICOL CHEM, V30, P1754, DOI 10.1002/etc.567; Hasegawa H, 2001, CHEMOSPHERE, V43, P265, DOI 10.1016/S0045-6535(00)00137-5; Heikens A, 2007, REV ENVIRON CONTAM T, V189, P43, DOI 10.1007/978-0-387-35368-5_3; Hellweger FL, 2004, ENVIRON SCI TECHNOL, V38, P6716, DOI 10.1021/es049660k; Huang ZC, 2007, J ENVIRON SCI-CHINA, V19, P714, DOI 10.1016/S1001-0742(07)60119-3; Kaise T, 1997, APPL ORGANOMET CHEM, V11, P297, DOI 10.1002/(SICI)1099-0739(199704)11:4<297::AID-AOC584>3.0.CO;2-0; Khan FR, 2012, ENVIRON SCI TECHNOL, V46, P7621, DOI 10.1021/es301253s; Levy JL, 2005, ENVIRON TOXICOL CHEM, V24, P2630, DOI 10.1897/04-580R.1; Liu GJ, 2006, WA SCI TECHNOL, V6, P175, DOI 10.2166/ws.2006.954; Liu J, 2002, ENVIRON HEALTH PERSP, V110, P119, DOI 10.1289/ehp.02110119; Lloyd JR, 2006, ELEMENTS, V2, P85, DOI 10.2113/gselements.2.2.85; MAEDA S, 1992, APPL ORGANOMET CHEM, V6, P407, DOI 10.1002/aoc.590060416; Meharg AA, 2002, NEW PHYTOL, V154, P29, DOI 10.1046/j.1469-8137.2002.00363.x; MEHARG AA, 1994, PLANT CELL ENVIRON, V17, P989, DOI 10.1111/j.1365-3040.1994.tb02032.x; MORRIS RJ, 1984, MAR CHEM, V14, P259, DOI 10.1016/0304-4203(84)90046-X; Pigna M, 2010, J SOIL SCI PLANT NUT, V10, P428, DOI 10.4067/S0718-95162010000200004; Quaghebeur M, 2003, PLANT PHYSIOL, V132, P1600, DOI 10.1104/pp.103.021741; Quisel JD, 1996, PLANT PHYSIOL, V111, P839, DOI 10.1104/pp.111.3.839; Rahman MA, 2014, AQUAT TOXICOL, V146, P212, DOI 10.1016/j.aquatox.2013.11.009; Rahman MA, 2012, ENVIRON RES, V116, P118, DOI 10.1016/j.envres.2012.03.014; Rahman MA, 2012, APPL GEOCHEM, V27, P304, DOI 10.1016/j.apgeochem.2011.09.020; Ruttens A, 2012, J GEOCHEM EXPLOR, V121, P55, DOI 10.1016/j.gexplo.2012.07.003; SANDERS JG, 1980, ESTUAR COAST MAR SCI, V10, P555, DOI 10.1016/S0302-3524(80)80075-2; Sharma VK, 2009, ENVIRON INT, V35, P743, DOI 10.1016/j.envint.2009.01.005; Signes-Pastor A, 2007, GEODERMA, V137, P504, DOI 10.1016/j.geoderma.2006.10.012; Slaughter DC, 2012, MICROBIOL RES, V167, P151, DOI 10.1016/j.micres.2011.05.007; Wang LH, 2009, J ENVIRON SCI, V21, P346, DOI 10.1016/S1001-0742(08)62275-5; Wang NX, 2013, WATER RES, V47, P2497, DOI 10.1016/j.watres.2013.02.034; Wang ZH, 2013, ENVIRON SCI POLLUT R, V20, P7286, DOI 10.1007/s11356-013-1741-7; Xue PY, 2012, ENVIRON SCI POLLUT R, V19, P3969, DOI 10.1007/s11356-012-0856-6; Ye J, 2013, ENVIRON SCI TECHNOL, V47, P3893, DOI 10.1021/es304593c; Yin XX, 2012, WATER AIR SOIL POLL, V223, P1183, DOI 10.1007/s11270-011-0936-0; Yin XX, 2011, J ENVIRON SCI, V23, P1186, DOI 10.1016/S1001-0742(10)60492-5; Zhao FJ, 2010, ANNU REV PLANT BIOL, V61, P535, DOI 10.1146/annurev-arplant-042809-112152	37	16	18	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116099	10.1371/journal.pone.0116099	http://dx.doi.org/10.1371/journal.pone.0116099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549253	Green Published, Green Submitted, gold			2022-12-26	WOS:000347063500050
J	Kamp, MA; Dibue, M; Sommer, C; Steiger, HJ; Schneider, T; Hanggi, D				Kamp, Marcel A.; Dibue, Maxine; Sommer, Clemens; Steiger, Hans-Jakob; Schneider, Toni; Haenggi, Daniel			Evaluation of a Murine Single-Blood-Injection SAH Model	PLOS ONE			English	Article							EXPERIMENTAL SUBARACHNOID HEMORRHAGE; DELAYED CEREBRAL-ISCHEMIA; SPREADING DEPOLARIZATION; PERFUSION-PRESSURE; CONTINUOUS EEG; MOUSE MODEL; IN-VIVO; FLOW; VASOSPASM; BRAIN	The molecular pathways underlying the pathogenesis after subarachnoid haemorrhage (SAH) are poorly understood and continue to be a matter of debate. A valid murine SAH injection model is not yet available but would be the prerequisite for further transgenic studies assessing the mechanisms following SAH. Using the murine single injection model, we examined the effects of SAH on regional cerebral blood flow (rCBF) in the somatosensory (S1) and cerebellar cortex, neuro-behavioural and morphological integrity and changes in quantitative electrocorticographic and electrocardiographic parameters. Micro CT imaging verified successful blood delivery into the cisterna magna. An acute impairment of rCBF was observed immediately after injection in the SAH and after 6, 12 and 24 hours in the S1 and 6 and 12 hours after SAH in the cerebellum. Injection of blood into the foramen magnum reduced telemetric recorded total ECoG power by an average of 65%. Spectral analysis of ECoGs revealed significantly increased absolute delta power, i.e., slowing, cortical depolarisations and changes in ripples and fast ripple oscillations 12 hours and 24 hours after SAH. Therefore, murine single-blood-injection SAH model is suitable for pathophysiological and further molecular analysis following SAH.	[Kamp, Marcel A.; Dibue, Maxine; Steiger, Hans-Jakob; Haenggi, Daniel] Univ Dusseldorf, Fac Med, Dept Neurosurg, D-40225 Dusseldorf, Germany; [Kamp, Marcel A.; Dibue, Maxine; Schneider, Toni] Univ Cologne, Fac Med, Inst Neurophysiol, D-50931 Cologne, Germany; [Dibue, Maxine; Schneider, Toni] CMMC, D-50931 Cologne, Germany; [Sommer, Clemens] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neuropathol, D-55131 Mainz, Germany	Heinrich Heine University Dusseldorf; University of Cologne; University of Cologne; Johannes Gutenberg University of Mainz	Kamp, MA (corresponding author), Univ Dusseldorf, Fac Med, Dept Neurosurg, Moorenstr 5, D-40225 Dusseldorf, Germany.	marcelalexander.kamp@med.uni-duesseldorf.de	Steiger, Hans-Jakob/AAN-8307-2021	Steiger, Hans-Jakob/0000-0002-8249-2998; Kamp, Marcel/0000-0002-1252-2944				Badan I, 2003, J CEREBR BLOOD F MET, V23, P845, DOI 10.1097/01.WCB.0000071883.63724.A7; BEDERSON JB, 1995, STROKE, V26, P1086, DOI 10.1161/01.STR.26.6.1086; Bosche B, 2010, ANN NEUROL, V67, P607, DOI 10.1002/ana.21943; Chen S, 2014, PROG NEUROBIOL, V115, P64, DOI 10.1016/j.pneurobio.2013.09.002; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; DAVIDSON RJ, 1990, PSYCHOPHYSIOLOGY, V27, P528, DOI 10.1111/j.1469-8986.1990.tb01970.x; Dibue M, 2013, EPILEPSIA, V54, P1542, DOI 10.1111/epi.12250; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2001, J PHYSIOL-LONDON, V531, P515, DOI 10.1111/j.1469-7793.2001.0515i.x; Drenckhahn C, 2012, BRAIN, V135, P853, DOI 10.1093/brain/aws010; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Feiler S, 2010, J NEUROSCI METH, V190, P164, DOI 10.1016/j.jneumeth.2010.05.005; Frauenknecht K, 2010, J NEUROIMMUNOL, V227, P1, DOI 10.1016/j.jneuroim.2010.05.043; Friedrich B, 2012, J CEREBR BLOOD F MET, V32, P447, DOI 10.1038/jcbfm.2011.154; GASSER T, 1982, PSYCHOPHYSIOLOGY, V19, P237, DOI 10.1111/j.1469-8986.1982.tb02553.x; GASSER T, 1982, ELECTROEN CLIN NEURO, V53, P119, DOI 10.1016/0013-4694(82)90112-2; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Kamii H, 1999, STROKE, V30, P867, DOI 10.1161/01.STR.30.4.867; King JT, 1997, NEUROIMAG CLIN N AM, V7, P659; LABAR DR, 1991, ELECTROEN CLIN NEURO, V78, P325, DOI 10.1016/0013-4694(91)90094-K; LEWONTIN RC, 1966, GENETICS, V54, P595; Lin CL, 2003, J NEUROSCI METH, V123, P89, DOI 10.1016/S0165-0270(02)00344-8; Offenhauser N, 2011, ACTA NEUROCHIR SUPPL, V110, P119, DOI [10.1007/978-3-7091-0353-1_21, 10.1007/978-3-7091-0353-1_2l]; Parra A, 2002, NEUROL RES, V24, P510, DOI 10.1179/016164102101200276; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Prunell GF, 2005, J NEUROSURG, V102, P1046, DOI 10.3171/jns.2005.102.6.1046; Prunell GF, 2003, NEUROSURGERY, V52, P165, DOI 10.1097/00006123-200301000-00022; Prunell GF, 2004, NEUROSURGERY, V54, P426, DOI 10.1227/01.NEU.0000103670.09687.7A; Sabri M, 2012, NEUROSCIENCE, V224, P26, DOI 10.1016/j.neuroscience.2012.08.002; Sabri M, 2009, BRAIN RES, V1295, P179, DOI 10.1016/j.brainres.2009.08.021; Stuart RM, 2010, NEUROCRIT CARE, V13, P355, DOI 10.1007/s12028-010-9414-6; Vespa PM, 1997, ELECTROEN CLIN NEURO, V103, P607, DOI 10.1016/S0013-4694(97)00071-0; Weiergraber M, 2006, EPILEPSIA, V47, P839, DOI 10.1111/j.1528-1167.2006.00541.x; Weiergraber M, 2005, BRAIN RES PROTOC, V14, P154, DOI 10.1016/j.brainresprot.2004.12.006; Westermaier T, 2011, NEUROSURGERY, V68, P223, DOI 10.1227/NEU.0b013e3181fe23c1; Westermaier T, 2009, J NEUROSURG, V110, P996, DOI 10.3171/2008.8.JNS08591; Westermaier T, 2009, J CEREBR BLOOD F MET, V29, P771, DOI 10.1038/jcbfm.2008.169; Woitzik J, 2012, J CEREBR BLOOD F MET, V32, P203, DOI 10.1038/jcbfm.2011.169	40	15	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e114946	10.1371/journal.pone.0114946	http://dx.doi.org/10.1371/journal.pone.0114946			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545775	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200017
J	Le, QT; Lotfi-Emran, S; Min, HK; Schwartz, LB				Quang Trong Le; Lotfi-Emran, Sahar; Min, Hae-Ki; Schwartz, Lawrence B.			A Simple, Sensitive and Safe Method to Determine the Human alpha/beta-Tryptase Genotype	PLOS ONE			English	Article							GC-RICH DNA; PCR AMPLIFICATION; MESSENGER-RNA; BETA-TRYPTASE; CELL-LINE; GENES; ESTABLISHMENT; EXPRESSION; IMPROVES	The human tryptase locus on chromosome 16 contains one gene encoding only beta-tryptase and another encoding either b-tryptase or the homologous a-tryptase, providing alpha:beta gene ratios of 0:4, 1:3 or 2:2 in the diploid genome, these genotypes being of potential clinical relevance in severe atopy. Using an EcoRV restriction site in alpha-but not beta-tryptase, PCR products, spanning intron 1 to exon 5, were used to determine alpha/beta-tryptase gene ratios using non-radioactive labels, including ethidium bromide labeling of all PCR products, and either digoxigenin-primer or DY682-primer labeling of only the final PCR cycle products. Sensitivity increased similar to 60-fold with each final PCR cycle labeling technique. Ethidium bromide labeling underestimated amounts of alpha-tryptase, presumably because heteroduplexes of alpha/beta-tryptase amplimers, formed during annealing, were EcoRV resistant. In contrast, both final PCR cycle labeling techniques precisely quantified these gene ratios, because only homoduplexes were labeled. Using the DY682-primer was most efficient, because PCR/EcoRV products could be analyzed directly in the gel; while digoxigenin-labeled products required transfer to a nitrocellulose membrane followed by immunoblotting. This technique for determining the alpha/beta-tryptase genotype is sensitive, accurate, simple and safe, and should permit high-throughput screening to detect potential phenotype-genotype relations for alpha/beta-tryptases, and for other closely related alleles.	[Quang Trong Le; Lotfi-Emran, Sahar; Min, Hae-Ki; Schwartz, Lawrence B.] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23284 USA	Virginia Commonwealth University	Schwartz, LB (corresponding author), Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23284 USA.	lbschwar@vcu.edu	Lotfi-Emran, Sahar/AGY-2353-2022	Lotfi-Emran, Sahar/0000-0002-8650-6779	National Institutes of Health [AI27517, AI77435]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077435, R01AI027517] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (AI27517, AI77435 to L.B.S.).	Abdelmotelb AM, 2014, CLIN EXP ALLERGY, V44, P822, DOI 10.1111/cea.12259; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Caughey GH, 2000, J IMMUNOL, V164, P6566, DOI 10.4049/jimmunol.164.12.6566; Court M. H., 2008, SIMPLE HARDY WEINBER; Fukuoka Y, 2013, J IMMUNOL, V191, P1827, DOI 10.4049/jimmunol.1202889; Guida M, 2000, PHARMACOGENETICS, V10, P389, DOI 10.1097/00008571-200007000-00002; Henke W, 1997, NUCLEIC ACIDS RES, V25, P3957, DOI 10.1093/nar/25.19.3957; Huang CF, 1999, J BIOL CHEM, V274, P19670, DOI 10.1074/jbc.274.28.19670; Jensen MA, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011024, 10.1371/journal.pone.0012965]; Jogie-Brahim S, 2004, J ALLERGY CLIN IMMUN, V113, P1086, DOI 10.1016/j.jaci.2004.02.032; KOMMINOTH P, 1992, HISTOCHEMISTRY, V98, P217, DOI 10.1007/BF00271035; Le QT, 2011, J IMMUNOL, V186, P7136, DOI 10.4049/jimmunol.1001804; Marquardt U, 2002, J MOL BIOL, V321, P491, DOI 10.1016/S0022-2836(02)00625-3; Min HK, 2004, J ALLERGY CLIN IMMUN, V114, P48, DOI 10.1016/j.jaci.2004.04.008; Min HK, 2001, J ALLERGY CLIN IMMUN, V107, P315, DOI 10.1067/mai.2001.112130; MOXLEY G, 1990, NUCLEIC ACIDS RES, V18, P7197, DOI 10.1093/nar/18.23.7197-a; Onouchi Y, 2010, HUM MOL GENET, V19, P2898, DOI 10.1093/hmg/ddq176; Pallaoro M, 1999, J BIOL CHEM, V274, P3355, DOI 10.1074/jbc.274.6.3355; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; Schwartz LB, 2006, IMMUNOL ALLERGY CLIN, V26, P451, DOI 10.1016/j.iac.2006.05.010; Simonovic A, 2012, ARCH BIOL SCI, V64, P865, DOI 10.2298/ABS1203865S; Soto D, 2002, CLIN EXP ALLERGY, V32, P1000, DOI 10.1046/j.1365-2222.2002.01416.x; Trivedi NN, 2008, J ALLERGY CLIN IMMUN, V121, P1262, DOI 10.1016/j.jaci.2008.01.019; Trivedi NN, 2009, J ALLERGY CLIN IMMUN, V124, P1099, DOI 10.1016/j.jaci.2009.07.026; Wang HW, 2002, J IMMUNOL, V169, P5145, DOI 10.4049/jimmunol.169.9.5145; Wong GW, 2002, J BIOL CHEM; Ying BW, 2007, RNA, V13, P2042, DOI 10.1261/rna.637907; Zhang ZZ, 2009, BIOTECHNIQUES, V47, P775, DOI 10.2144/000113203; Zhou Y, 2001, EXP MOL PATHOL, V70, P281, DOI 10.1006/exmp.2001.2365; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	30	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e114944	10.1371/journal.pone.0114944	http://dx.doi.org/10.1371/journal.pone.0114944			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545679	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200016
J	Zhang, XM; Barberan, A; Zhu, XZ; Zhang, GM; Han, XG				Zhang, Ximei; Barberan, Albert; Zhu, Xunzhi; Zhang, Guangming; Han, Xingguo			Water Content Differences Have Stronger Effects than Plant Functional Groups on Soil Bacteria in a Steppe Ecosystem	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; RHIZOSPHERE MICROBIOME; CURRENT KNOWLEDGE; DIVERSITY; BIODIVERSITY; MICROORGANISMS; GRASSLAND; REDUNDANCY; RESISTANCE; IDENTITY	Many investigations across natural and artificial plant diversity gradients have reported that both soil physicochemical factors and plant community composition affect soil microbial communities. To test the effect of plant diversity loss on soil bacterial communities, we conducted a five-year plant functional group removal experiment in a steppe ecosystem in Inner Mongolia (China). We found that the number and composition type of plant functional groups had no effect on bacterial diversity and community composition, or on the relative abundance of major taxa. In contrast, bacterial community patterns were significantly structured by soil water content differences among plots. Our results support researches that suggest that water availability is the key factor structuring soil bacterial communities in this semiarid ecosystem.	[Zhang, Ximei; Han, Xingguo] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Barberan, Albert] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Zhu, Xunzhi] Jiangsu Univ Sci & Technol, Sch Biol & Chem Engn, Zhenjiang 212018, Jiangsu, Peoples R China; [Zhang, Guangming; Han, Xingguo] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing 100093, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University of Colorado System; University of Colorado Boulder; Jiangsu University of Science & Technology; Chinese Academy of Sciences; Institute of Botany, CAS	Zhang, GM (corresponding author), Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing 100093, Peoples R China.	zhanggm@ibcas.ac.cn; xghan@ibcas.ac.cn	Barberan, Albert/A-5319-2013; Han, Xingguo/K-7552-2016	Han, Xingguo/0000-0002-1836-975X; BARBERAN, ALBERT/0000-0002-3066-7530	State Key Laboratory of Forest and Soil Ecology [LFSE201315]; "Strategic Priority Research Program'' of Chinese Academy of Sciences [XDB15010404]; National Natural Science Foundation of China [31300431]	State Key Laboratory of Forest and Soil Ecology; "Strategic Priority Research Program'' of Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by State Key Laboratory of Forest and Soil Ecology (LFSE201315), "Strategic Priority Research Program'' of Chinese Academy of Sciences (XDB15010404), and National Natural Science Foundation (31300431) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; [Anonymous], 2010, R LANG ENV STAT COMP; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bardgett RD, 1998, SOIL BIOL BIOCHEM, V30, P1867, DOI 10.1016/S0038-0717(98)00069-8; Batten KM, 2006, BIOL INVASIONS, V8, P217, DOI 10.1007/s10530-004-3856-8; Belnap J, 2005, ECOLOGY, V86, P298, DOI 10.1890/03-0567; Benjamini Y, 1995, J R STAT SOC B, V57, P57, DOI DOI 10.2307/2346101; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Broughton LC, 2000, OECOLOGIA, V125, P420, DOI 10.1007/s004420000456; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eisenhauer N, 2010, ECOLOGY, V91, P485, DOI 10.1890/08-2338.1; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2003, MICROB ECOL, V45, P63, DOI 10.1007/s00248-002-1007-2; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Gastine A, 2003, APPL SOIL ECOL, V24, P101, DOI 10.1016/S0929-1393(02)00137-3; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hector A, 2007, FUNCT ECOL, V21, P998, DOI 10.1111/j.1365-2435.2007.01308.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Kong DL, 2011, PLANT SOIL, V346, P133, DOI 10.1007/s11104-011-0803-1; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lennon JT, 2012, ECOLOGY, V93, P1867, DOI 10.1890/11-1745.1; Li S, 1990, REPORTS INNER MONGOL, P207; Liu ZF, 2010, SOIL BIOL BIOCHEM, V42, P445, DOI 10.1016/j.soilbio.2009.11.027; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Loranger-Merciris G, 2006, SOIL BIOL BIOCHEM, V38, P2336, DOI 10.1016/j.soilbio.2006.02.009; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McLaren JR, 2010, GLOBAL CHANGE BIOL, V16, P3075, DOI 10.1111/j.1365-2486.2009.02151.x; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Oksanen J., 2016, R PACKAG; Rodriguez-Loinaz G, 2008, SOIL BIOL BIOCHEM, V40, P49, DOI 10.1016/j.soilbio.2007.04.015; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stachowicz JJ, 2002, ECOLOGY, V83, P2575; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Sun Y, 2010, SCI CHINA EARTH SCI, V53, P284, DOI 10.1007/s11430-009-0123-y; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Vogel A, 2013, GLOBAL CHANGE BIOL, V19, P2795, DOI 10.1111/gcb.12225; Wallenstein MD, 2012, BIOGEOCHEMISTRY, V109, P35, DOI 10.1007/s10533-011-9641-8; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zhang XM, 2014, SOIL BIOL BIOCHEM, V72, P26, DOI 10.1016/j.soilbio.2014.01.034; Zhang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084210; Zhang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078616; Zhang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076500	55	7	8	11	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115798	10.1371/journal.pone.0115798	http://dx.doi.org/10.1371/journal.pone.0115798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546333	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200069
J	Mir, SUR; George, NM; Zahoor, L; Harms, R; Guinn, Z; Sarvetnick, NE				Mir, Shakeel U. R.; George, Nicholas M.; Zahoor, Lubna; Harms, Robert; Guinn, Zachary; Sarvetnick, Nora E.			Inhibition of Autophagic Turnover in beta-Cells by Fatty Acids and Glucose Leads to Apoptotic Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ISLET AMYLOID POLYPEPTIDE; INSULIN-RESISTANCE; DISEASE; TYPE-2; SYSTEM; MICE; HYPERGLYCEMIA; ACCUMULATION; DEGRADATION	Autophagy, a cellular recycling process responsible for turnover of cytoplasmic contents, is critical for maintenance of health. Defects in this process have been linked to diabetes. Diabetes-associated glucotoxicity/lipotoxicity contribute to impaired beta-cell function and have been implicated as contributing factors to this disease. We tested the hypothesis that these two conditions affect beta-cell function by modulating autophagy. We report that exposure of beta-cell lines and human pancreatic islets to high levels of glucose and lipids blocks autophagic flux and leads to apoptotic cell death. EM analysis showed accumulation of autophagy intermediates (autophagosomes), with abundant engulfed cargo in palmitic acid (PA)-or glucose-treated cells, indicating suppressed autophagic turnover. EM studies also showed accumulation of damaged mitochondria, endoplasmic reticulum distention, and vacuolar changes in PA-treated cells. Pulse-chase experiments indicated decreased protein turnover in beta-cells treated with PA/glucose. Expression of mTORC1, an inhibitor of autophagy, was elevated in beta-cells treated with PA/glucose. mTORC1 inhibition, by treatment with rapamycin, reversed changes in autophagic flux, and cell death induced by glucose/PA. Our results indicate that nutrient toxicity-induced cell death occurs via impaired autophagy and is mediated by activation of mTORC1 in beta-cells, contributing to beta-cell failure in the presence of metabolic stress.	[Mir, Shakeel U. R.; George, Nicholas M.; Zahoor, Lubna; Harms, Robert; Guinn, Zachary; Sarvetnick, Nora E.] Univ Nebraska Med Ctr, Dept Surg, Omaha, NE 68198 USA; [Mir, Shakeel U. R.; George, Nicholas M.; Zahoor, Lubna; Harms, Robert; Guinn, Zachary; Sarvetnick, Nora E.] Univ Nebraska Med Ctr, Holland Regenerat Med Program, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Sarvetnick, NE (corresponding author), Univ Nebraska Med Ctr, Dept Surg, Holland Regenerat Med Project, Omaha, NE 68198 USA.	noras@unmc.edu			National Institutes of Health [1UO1AI102012-01, DK091991]; Kieckhefer Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI102012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kieckhefer Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1UO1AI102012-01 (to N. E. S.). This work was also supported by generous funding from the Kieckhefer Foundation (to N. E. S.).; Supported by National Institutes of Health Postdoctoral Fellowship DK091991.	Chavez JA, 2010, BBA-MOL CELL BIOL L, V1801, P252, DOI 10.1016/j.bbalip.2009.09.015; Bachar-Wikstrom E, 2013, DIABETES, V62, P1227, DOI 10.2337/db12-1474; Bartolome A, 2014, DIABETES, V63, P2996, DOI 10.2337/db13-0970; Bartolome A, 2012, AUTOPHAGY, V8, P1757, DOI 10.4161/auto.21994; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Choi SE, 2009, ENDOCRINOLOGY, V150, P126, DOI 10.1210/en.2008-0483; Cnop M, 2014, DIABETES, V63, P1978, DOI 10.2337/db13-1383; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Elghazi L, 2010, DIABETES, V59, P2390, DOI 10.2337/db09-0851; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; Gonzalez CD, 2011, AUTOPHAGY, V7, P2, DOI 10.4161/auto.7.1.13044; Grishko V, 2005, FREE RADICAL BIO MED, V38, P755, DOI 10.1016/j.freeradbiomed.2004.11.023; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Huang CJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1656, DOI 10.1152/ajpendo.00318.2007; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kim J, 2014, J CLIN INVEST, V124, P3311, DOI 10.1172/JCI69625; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Koyanagi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023238; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Las G, 2011, J BIOL CHEM, V286, P42534, DOI 10.1074/jbc.M111.242412; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; Mir SUR, 2012, INT J CANCER, V131, pE1, DOI 10.1002/ijc.26432; Mir SUR, 2012, J BIOL CHEM, V287, P14494, DOI 10.1074/jbc.M111.324921; Moscat J, 2011, CELL, V147, P724, DOI 10.1016/j.cell.2011.10.021; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Quan W, 2012, DIABETOLOGIA, V55, P392, DOI 10.1007/s00125-011-2350-y; Rivera JF, 2014, J CLIN INVEST, V124, P3489, DOI 10.1172/JCI71981; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Shibata M, 2010, BIOCHEM BIOPH RES CO, V393, P274, DOI 10.1016/j.bbrc.2010.01.121; Shigihara N, 2014, J CLIN INVEST, V124, P3634, DOI 10.1172/JCI69866; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Teutonico A, 2005, J AM SOC NEPHROL, V16, P3128, DOI 10.1681/ASN.2005050487; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	56	86	89	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6071	6085		10.1074/jbc.M114.605345	http://dx.doi.org/10.1074/jbc.M114.605345			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25548282	hybrid, Green Published			2022-12-26	WOS:000350732500018
J	Kelley, RA; Al-Ubaidi, MR; Naash, MI				Kelley, Ryan A.; Al-Ubaidi, Muayyad R.; Naash, Muna I.			Retbindin Is an Extracellular Riboflavin-binding Protein Found at the Photoreceptor/Retinal Pigment Epithelium Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XANTHINE-OXIDASE CATALYZES; FATTY ACYL DERIVATIVES; LIPID-PEROXIDATION; HUMAN RETINA; INTERPHOTORECEPTOR MATRIX; PHOTOCHEMICAL DEGRADATION; PERIPHERIN/RDS CAUSES; OXYGEN-CONSUMPTION; TRANSGENIC MICE; COENZYME-A	Retbindin is a novel retina-specific protein of unknown function. In this study, we have used various approaches to evaluate protein expression, localization, biochemical properties, and function. We find that retbindin is secreted by the rod photoreceptors into the inter-photoreceptor matrix where it is maintained via electrostatic forces. Retbindin is predominantly localized at the interface between photoreceptors and retinal pigment epithelium microvilli, a region critical for retinal function and homeostasis. Interestingly, although it is associated with photoreceptor outer segments, retbindin's expression is not dependent on their presence. In vitro, retbindin is capable of binding riboflavin, thus implicating the protein as a metabolite carrier between the retina and the retinal pigment epithelium. Altogether, our data show that retbindin is a novel photoreceptor-specific protein with a unique localization and function. We hypothesize that retbindin is an excellent candidate for binding retinal flavins and possibly participating in their transport from the extracellular space to the photoreceptors. Further investigations are warranted to determine the exact function of retbindin in retinal homeostasis and disease.	[Kelley, Ryan A.; Al-Ubaidi, Muayyad R.; Naash, Muna I.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Naash, MI (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	Muna-Naash@ouhsc.edu			National Institutes of Health from NEI [R01EY10609, R01EY018137, P30EY021725]; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [P30EY021725, R01EY018656, R01EY018137, R01EY010609] Funding Source: NIH RePORTER	National Institutes of Health from NEI; Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY10609 (to M. I. N.), R01EY018137 (to M. R. A.), and P30EY021725 from NEI. This work was also supported by the Foundation Fighting Blindness (to M. I. N. and M. R. A.).	ALDER VA, 1990, INVEST OPHTH VIS SCI, V31, P1029; BATEY DW, 1991, INVEST OPHTH VIS SCI, V32, P1981; BATEY DW, 1992, EXP EYE RES, V54, P605, DOI 10.1016/0014-4835(92)90139-J; BECVAR J, 1982, J BIOL CHEM, V257, P5607; BRAUN RD, 1995, INVEST OPHTH VIS SCI, V36, P542; CAIRNS WL, 1971, J AM CHEM SOC, V93, P2772; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Chakraborty D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098939; CRANE FL, 1956, J BIOL CHEM, V218, P701; CRANE FL, 1956, J BIOL CHEM, V218, P717; DELAPAZ M, 1992, INVEST OPHTH VIS SCI, V33, P3497; Ding XQ, 2004, HUM MOL GENET, V13, P2075, DOI 10.1093/hmg/ddh211; DONOSO LA, 1990, CURR EYE RES, V9, P343, DOI 10.3109/02713689008999622; Doonan S, 1996, Methods Mol Biol, V59, P1; ECKHERT CD, 1993, EXPERIENTIA, V49, P1084, DOI 10.1007/BF01929917; FEENEY L, 1973, DEV BIOL, V32, P115, DOI 10.1016/0012-1606(73)90224-8; FONG SL, 1984, J BIOL CHEM, V259, P6534; Fox NE, 1998, FREE RADICAL BIO MED, V24, P900, DOI 10.1016/S0891-5849(97)00369-9; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; FRIDOVICH I, 1958, J BIOL CHEM, V231, P899; FUTTERMAN S, 1959, J BIOL CHEM, V234, P723; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Gille C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-64; GOLDSMITH G A, 1975, P221; HAMAZUME Y, 1987, J BIOCHEM-TOKYO, V101, P217, DOI 10.1093/oxfordjournals.jbchem.a121894; Han ZC, 2012, J CLIN INVEST, V122, P3221, DOI 10.1172/JCI64833; Hollyfield JG, 1999, INVEST OPHTH VIS SCI, V40, P2767; Huvaere K, 2010, J PHYS CHEM B, V114, P5583, DOI 10.1021/jp9121744; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kopitz J, 2004, BIOCHIMIE, V86, P825, DOI 10.1016/j.biochi.2004.09.029; Kruse HD, 1940, PUBLIC HEALTH REP, V55, P157, DOI 10.2307/4583161; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Monaco HL, 1997, EMBO J, V16, P1475, DOI 10.1093/emboj/16.7.1475; Morre DJ, 2003, FREE RADICAL RES, V37, P795, DOI 10.1080/1071576031000083107; Njie-Mbye YF, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00366; OSTER G, 1962, EXPERIENTIA, V18, P249, DOI 10.1007/BF02148213; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; ROHLICH P, 1970, EXP EYE RES, V10, P80, DOI 10.1016/S0014-4835(70)80013-6; Said HM, 2005, J PHYSIOL-LONDON, V566, P369, DOI 10.1113/jphysiol.2005.085811; Sparrrow JR, 2010, CURR MOL MED, V10, P802; Stone J, 1999, PROG RETIN EYE RES, V18, P689, DOI 10.1016/S1350-9462(98)00032-9; Stricker HM, 2005, BIOCHEM J, V388, P605, DOI 10.1042/BJ20041960; Taibi G, 2001, J ENZYM INHIB, V16, P275, DOI 10.1080/14756360109162376; Taibi G, 2007, J ENZYM INHIB MED CH, V22, P471, DOI 10.1080/14756360701408739; Thompson CL, 2003, INVEST OPHTH VIS SCI, V44, P4515, DOI 10.1167/iovs.03-0303; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Tomitsuka E, 2003, J BIOCHEM, V134, P191, DOI 10.1093/jb/mvg144; TREADWELL GE, 1968, J CHROMATOGR, V35, P376, DOI 10.1016/S0021-9673(01)82399-2; WIEGAND RD, 1983, INVEST OPHTH VIS SCI, V24, P1433; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667; Wistow G, 2002, MOL VIS, V8, P196	54	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5041	5052		10.1074/jbc.M114.624189	http://dx.doi.org/10.1074/jbc.M114.624189			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25542898	Green Published, hybrid			2022-12-26	WOS:000350042000045
J	Allema, B; van der Werf, W; van Lenteren, JC; Hemerik, L; Rossing, WAH				Allema, Bas; van der Werf, Wopke; van Lenteren, Joop C.; Hemerik, Lia; Rossing, Walter A. H.			Movement Behaviour of the Carabid Beetle Pterostichus melanarius in Crops and at a Habitat Interface Explains Patterns of Population Redistribution in the Field	PLOS ONE			English	Article							COLEOPTERA CARABIDAE; GENERALIST PREDATORS; DISPERSAL; EDGES; DYNAMICS; DENSITY; MODELS	Animals may respond to habitat quality and habitat edges and these responses may affect their distribution between habitats. We studied the movement behaviour of a ground-dwelling generalist predator, the carabid beetle Pterostichus melanarius (Illiger). We performed a mark-recapture experiment in two adjacent habitats; a large plot with oilseed radish (Raphanus sativus) and a plot with rye (Secale cereale). We used model selection to identify a minimal model representing the mark-recapture data, and determine whether habitat-specific motility and boundary behaviour affected population redistribution. We determined movement characteristics of P. melanarius in laboratory arenas with the same plant species using video recording. Both the field and arena results showed preference behaviour of P. melanarius at the habitat interface. In the field, significantly more beetles moved from rye to oilseed radish than from radish to rye. In the arena, habitat entry was more frequent into oilseed radish than into rye. In the field, movement was best described by a Fokker-Planck diffusion model that contained preference behaviour at the interface and did not account for habitat specific motility. Likewise, motility calculated from movement data using the Patlak model was not different between habitats in the arena studies. Motility (m(2) d(-1)) calculated from behavioural data resulted in estimates that were similar to those determined in the field. Thus individual behaviour explained population redistribution in the field qualitatively as well as quantitatively. The findings provide a basis for evaluating movement within and across habitats in complex agricultural landscapes with multiple habitats and habitat interfaces.	[Allema, Bas; Hemerik, Lia; Rossing, Walter A. H.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Allema, Bas; van Lenteren, Joop C.] Wageningen Univ, Entomol Lab, NL-6700 AP Wageningen, Netherlands; [van der Werf, Wopke] Wageningen Univ, Ctr Crop Syst Anal, Crop & Weed Ecol Grp, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Rossing, WAH (corresponding author), Wageningen Univ, NL-6700 AP Wageningen, Netherlands.	walter.rossing@wur.nl	van Lenteren, Joop/J-1748-2014; van der Werf, Wopke/A-2557-2009	van Lenteren, Joop/0000-0003-3620-1392; van der Werf, Wopke/0000-0002-5506-4699; Hemerik, Lia/0000-0002-6892-2840	strategic research funds of the C.T. de Wit Graduate School for Production Ecology and Resource Conservation; strategic research program "Sustainable spatial development of ecosystems, landscapes, seas and regions'' - Dutch Ministry of Agriculture, Nature Conservation and Food Quality; Wageningen University and Research Centre [KB-01-008-024-ALT]	strategic research funds of the C.T. de Wit Graduate School for Production Ecology and Resource Conservation; strategic research program "Sustainable spatial development of ecosystems, landscapes, seas and regions'' - Dutch Ministry of Agriculture, Nature Conservation and Food Quality; Wageningen University and Research Centre	This project was financially supported by the strategic research funds of the C.T. de Wit Graduate School for Production Ecology and Resource Conservation (http://www.pe-rc.nl/) and the strategic research program "Sustainable spatial development of ecosystems, landscapes, seas and regions,'' which is funded by the Dutch Ministry of Agriculture, Nature Conservation and Food Quality, and carried out by Wageningen University and Research Centre (KB-01-008-024-ALT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allema AB, 2012, J APPL ENTOMOL, V136, P793, DOI 10.1111/j.1439-0418.2012.01728.x; Batschelet E, 1981, CIRCULAR STAT BIOL; Bohan DA, 2000, J ANIM ECOL, V69, P367, DOI 10.1046/j.1365-2656.2000.00399.x; Bolker B, 2008, ECOLOGICAL MODELS DA; Bommarco R, 2002, AGR FOREST ENTOMOL, V4, P21, DOI 10.1046/j.1461-9563.2002.00117.x; Cantrell RS, 1999, THEOR POPUL BIOL, V55, P189, DOI 10.1006/tpbi.1998.1397; Chapman PA, 1999, ENTOMOL EXP APPL, V91, P477, DOI 10.1023/A:1003779613048; CREED RP, 1990, EXPERIENTIA, V46, P758, DOI 10.1007/BF01939959; Fagan WE, 1999, AM NAT, V153, P165, DOI 10.1086/303162; Fournier E, 2002, AGR ECOSYST ENVIRON, V89, P253, DOI 10.1016/S0167-8809(01)00216-X; FRAMPTON GK, 1995, BIOL CONSERV, V71, P347, DOI 10.1016/0006-3207(94)00072-X; Garcia AF, 2000, ANN APPL BIOL, V137, P89, DOI 10.1111/j.1744-7348.2000.tb00040.x; Groot JCJ, 2012, COMPASS FRAMEWORK NA; Haynes KJ, 2003, ECOLOGY, V84, P2856, DOI 10.1890/02-0611; Hilborn Ray, 1997, V28; Kuczma M, 2009, INTODUCTION THEORY F; Maciel GA, 2013, AM NAT, V182, P42, DOI 10.1086/670661; MAUREMOOTO JR, 1995, AGR ECOSYST ENVIRON, V52, P141, DOI 10.1016/0167-8809(94)00548-S; Musgrave J, 2014, J MATH BIOL, V69, P617, DOI [10.1007/s00285-013-0714-2, 10.1007/s00285-013-0715-1]; Ovaskainen O, 2004, ECOLOGY, V85, P242, DOI 10.1890/02-0706; Ovaskainen O, 2003, J APPL PROBAB, V40, P557, DOI 10.1239/jap/1059060888; Ovaskainen O, 2008, AM NAT, V171, P610, DOI 10.1086/587070; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Rand TA, 2006, ECOL LETT, V9, P603, DOI 10.1111/j.1461-0248.2006.00911.x; Ries L, 2004, ECOLOGY, V85, P2917, DOI 10.1890/03-8021; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; Snyder WE, 2001, ECOLOGY, V82, P705, DOI 10.1890/0012-9658(2001)082[0705:GPDBCB]2.0.CO;2; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Symondson WOC, 1996, J APPL ECOL, V33, P741, DOI 10.2307/2404945; Trefas H, 2001, AGR FOREST ENTOMOL, V3, P71, DOI 10.1046/j.1461-9563.2001.00089.x; Trefas H, 2008, B INSECTOL, V61, P225; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Turchin Peter, 1998; Turin H, 2000, NEDERLANDSE LOOPKEVE; Winder L, 2005, J ANIM ECOL, V74, P443, DOI 10.1111/j.1365-2656.2005.00939.x	36	13	13	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115751	10.1371/journal.pone.0115751	http://dx.doi.org/10.1371/journal.pone.0115751			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551222	Green Submitted, gold, Green Published			2022-12-26	WOS:000347119100057
J	Facco, M; Nespeca, M; Simonato, M; Isak, I; Verlato, G; Ciambra, G; Giorgetti, C; Carnielli, VP; Cogo, PE				Facco, Maddalena; Nespeca, Matteo; Simonato, Manuela; Isak, Ilena; Verlato, Giovanna; Ciambra, Gianluca; Giorgetti, Chiara; Carnielli, Virgilio P.; Cogo, Paola E.			In Vivo Effect of Pneumonia on Surfactant Disaturated-Phosphatidylcholine Kinetics in Newborn Infants	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; POSITIVE-PRESSURE VENTILATION; ESCHERICHIA-COLI PNEUMONIA; INDUCED LUNG INJURY; PRETERM INFANTS; BRONCHOPULMONARY DYSPLASIA; PULMONARY INFLAMMATION; BOVINE SURFACTANT; STABLE-ISOTOPES; THERAPY	Background: Bacterial pneumonia in newborns often leads to surfactant deficiency or dysfunction, as surfactant is inactivated or its production/turnover impaired. No data are available in vivo in humans on the mechanism of surfactant depletion in neonatal pneumonia. We studied the kinetics of surfactant's major component, disaturated-phosphatidylcholine (DSPC), in neonatal pneumonia, and we compared our findings with those obtained from control newborn lungs. Methods: We studied thirty-one term or near-term newborns (gestational age 39.7 +/- 1.7 weeks, birth weight 3185 +/- 529 g) requiring mechanical ventilation. Fifteen newborns had pneumonia, while 16 newborns were on mechanical ventilation but had no lung disease. Infants received an intratracheal dose of C-13 labeled dipalmitoyl-phosphatidylcholine at the study start. We measured the amount and the isotopic enrichment of DSPC-palmitate from serial tracheal aspirates by gas chromatography and gas chromatography-mass spectrometry, respectively, and we calculated the DSPC half-life (HL) and pool size (PS) from the isotopic enrichment curves of surfactant DSPC-palmitate. Results: The mean DSPC amount obtained from all tracheal aspirates did not differ between the two groups. DSPC HL was 12.7 (6.5-20.2) h and 25.6 (17.9-60.6) h in infants with pneumonia compared with control infants (p=0.003). DSPC PS was 14.1 (6.6-30.9) mg/kg in infants with pneumonia and 34.1 (25.6-65.0) mg/kg in controls, p=0.042. Myeloperoxidase (MPO) activity, as a marker of lung inflammation, was 1322 (531-2821) mU/ml of Epithelial Lining Fluid (ELF) and 371(174-1080) mU/ml ELF in infants with pneumonia and in controls, p=0.047. In infants with pneumonia, DSPC PS and HL significantly and inversely correlated with mean Oxygenation Index (OI) during the study (DSPC PS vs. OI R=-0.710, p=0.004 and HL vs. OI R=-0.525, p=0.044, respectively). Conclusions: We demonstrated for the first time in vivo in humans that DSPC HL and PS were markedly impaired in neonatal pneumonia and that they inversely correlated with the degree of respiratory failure.	[Facco, Maddalena; Simonato, Manuela; Isak, Ilena; Verlato, Giovanna] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Nespeca, Matteo; Ciambra, Gianluca; Giorgetti, Chiara; Carnielli, Virgilio P.] Polytech Univ Marche, Salesi Childrens Hosp, Ancona, Italy; [Nespeca, Matteo; Ciambra, Gianluca; Giorgetti, Chiara; Carnielli, Virgilio P.] Univ Ancona, Ancona, Italy; [Cogo, Paola E.] Bambino Gesu Pediat Hosp, Pediat Cardiac Anesthesia Intens Care Unit, Dept Pediat Cardiol & Cardiac Surg, Rome, Italy	University of Padua; Marche Polytechnic University; Marche Polytechnic University; IRCCS Bambino Gesu	Facco, M (corresponding author), Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy.	maddalena.facco@unipd.it	Cogo, Paola P/J-6918-2018; Simonato, Manuela/AAX-5656-2020; Verlato, Giovanna/H-2202-2018	Cogo, Paola P/0000-0002-6235-140X; Simonato, Manuela/0000-0002-2745-7305; Verlato, Giovanna/0000-0003-4613-7427; Isak, Ilena/0000-0002-2462-4710				Bauer TT, 2006, CLIN INFECT DIS, V43, P748, DOI 10.1086/506430; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BREHMER U, 1993, KLIN PADIATR, V205, P78, DOI 10.1055/s-2008-1034532; Cogo PE, 2008, PEDIATR RES, V63, P433, DOI 10.1203/PDR.0b013e3181659759; Cogo PE, 2011, INTENS CARE MED, V37, P510, DOI 10.1007/s00134-010-2091-2; Cogo PE, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-13; Cogo PE, 2009, PEDIATRICS, V124, pE950, DOI 10.1542/peds.2009-0126; Cogo PE, 1999, PEDIATR RES, V45, P242, DOI 10.1203/00006450-199902000-00015; Cogo PE, 2003, CRIT CARE MED, V31, P1532, DOI 10.1097/01.CCM.0000063043.25167.99; Dargaville PA, 2005, DRUGS, V65, P2569, DOI 10.2165/00003495-200565180-00003; Dargaville PA, 1999, AM J RESP CRIT CARE, V160, P778, DOI 10.1164/ajrccm.160.3.9811049; El Shahed AI, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002054.pub2; GORTNER L, 1990, MONATSSCHR KINDERH, V138, P274; GRIESE M, 1995, AM J RESP CRIT CARE, V152, P1050, DOI 10.1164/ajrccm.152.3.7663782; Halbertsma FJJ, 2005, NETH J MED, V63, P382; HALLMAN M, 1986, PEDIATR RES, V20, P1228, DOI 10.1203/00006450-198612000-00008; HARMS K, 1994, RESPIRATION, V61, P348; Herting E, 1999, AM J RESP CRIT CARE, V159, P1862, DOI 10.1164/ajrccm.159.6.9810047; Herting E, 2000, PEDIATRICS, V106, P957, DOI 10.1542/peds.106.5.957; Herting E, 2002, ACTA PAEDIATR, V91, P1174, DOI 10.1080/080352502320777397; Hilgendorff Anne, 2008, BMC Pulm Med, V8, P10, DOI 10.1186/1471-2466-8-10; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Ikegami M, 2006, RESPIROLOGY, V11, pS24, DOI 10.1111/j.1440-1843.2006.00803.x; Lotze A, 1998, J PEDIATR-US, V132, P40, DOI 10.1016/S0022-3476(98)70482-2; Malloy JL, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-8; Plataki Maria, 2010, Expert Rev Respir Med, V4, P373, DOI 10.1586/ers.10.28; Quintero OA, 2002, AM J PHYSIOL-LUNG C, V282, pL330, DOI 10.1152/ajplung.00190.2001; Rudiger M, 2001, BIOL NEONATE, V79, P73, DOI 10.1159/000047070; Seger N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007836; Soll Roger F, 2009, Neonatology, V95, P368, DOI 10.1159/000209303; Song GW, 1996, ACTA ANAESTH SCAND, V40, P1154, DOI 10.1111/j.1399-6576.1996.tb05580.x; Stichtenoth G, 2010, PEDIATR RES, V67, P369, DOI 10.1203/PDR.0b013e3181d026f6; Tan K, 2012, COCHRANE DB SYST REV, V2; Torresin M, 2000, AM J RESP CRIT CARE, V161, P1584, DOI 10.1164/ajrccm.161.5.9905088; TOUCHSTONE JC, 1980, LIPIDS, V15, P61, DOI 10.1007/BF02534120; van Kaam AH, 2003, BIOL NEONATE, V83, P273, DOI 10.1159/000069482; van Kaam AH, 2003, PEDIATR RES, V53, P245, DOI 10.1203/01.PDR.0000047520.44168.22; Verlato G, 2003, ITAL J PEDIATR, V29, P414; Zuo YY, 2008, BBA-BIOMEMBRANES, V1778, P1947, DOI 10.1016/j.bbamem.2008.03.021	39	12	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e93612	10.1371/journal.pone.0093612	http://dx.doi.org/10.1371/journal.pone.0093612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551219	Green Submitted, gold, Green Published			2022-12-26	WOS:000347119100001
J	Kruger, S; Reid, T; Amar, A				Krueger, Sonja; Reid, Timothy; Amar, Arjun			Differential Range Use between Age Classes of Southern African Bearded Vultures Gypaetus barbatus	PLOS ONE			English	Article							SPANISH IMPERIAL EAGLES; HOME-RANGE; GYPS-FULVUS; BEHAVIOR; DISPERSAL; POPULATION; SELECTION; DENSITY; ESTIMATORS; DECLINE	Bearded Vulture Gypaetus barbatus movements were investigated in southern Africa to determine whether an individual's age, sex or breeding status influenced its ranging behaviour and to provide the information required to guide conservation activities. Data from satellite transmitters fitted to 18 individuals of four age classes were used to determine range size and use. Because of the nature of the movements of marked individuals, these data could be used to determine the overall foraging range of the entire population, which was estimated to be 51 767 km(2). Although juvenile, immature and sub-adult birds used different parts of the overall range, their combined foraging range was 65% (33 636 km(2)) of the overall range. Average adult home ranges (286 km(2)) were only around 1% the size of the average foraging ranges of non-adults (10 540 -25 985 km(2)), with those of breeding adults being even smaller (95 km(2)). Home ranges of breeding adults did not vary in size between seasons but adults utilized their home range more intensively whilst breeding, moving greater distances during the incubation and chick hatching period. Range size and use increased as non-adults aged. Immatures and sub-adults had larger range sizes during winter, but range use of non-adults did not vary seasonally. Range size and use did not differ between the sexes in any of the age classes. Information on home range size and use enables specific areas within the species' range to be targeted for management planning, education and conservation action.	[Krueger, Sonja; Reid, Timothy; Amar, Arjun] Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, DST NRF Ctr Excellence, ZA-7700 Rondebosch, South Africa; [Krueger, Sonja] Ezemvelo KZN Wildlife, Cascades, South Africa	National Research Foundation - South Africa; University of Cape Town	Kruger, S (corresponding author), Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, DST NRF Ctr Excellence, ZA-7700 Rondebosch, South Africa.	sonja.krueger@kznwildlife.com	Arjun, Amar/F-3815-2011; Amar, Arjun/L-4493-2019	Arjun, Amar/0000-0002-7405-1180; 	Maloti Drakensberg Transfrontier Programme; Wildlands Conservation Trust; Terra de Natura; Aspen Pharmaceuticals; McAdams family	Maloti Drakensberg Transfrontier Programme; Wildlands Conservation Trust; Terra de Natura; Aspen Pharmaceuticals; McAdams family	GPS satellite tags were funded by the Maloti Drakensberg Transfrontier Programme (12), the Wildlands Conservation Trust (3), Terra de Natura (1), Aspen Pharmaceuticals (1) and the McAdams family (1). Vulture capture related expenses were covered by Ezemvelo KwaZulu-Natal Wildlife and Sasol through the Endangered Wildlife Trust. In all cases the funding was received by SK. Ezemvelo KwaZulu-Natal Wildlife and the Maloti Drakensberg Transfrontier Programme approved the study design and data collection. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya R, 2010, FORKTAIL, P117; Bamford AJ, 2007, BIRD CONSERV INT, V17, P331, DOI 10.1017/S0959270907000846; BATES DM, 2012, CONSERVING BIRD DIVE, P105; Beissinger SR, 2000, P NATL ACAD SCI USA, V97, P11688, DOI 10.1073/pnas.97.22.11688; Garcia CB, 2009, EUR J WILDLIFE RES, V55, P309, DOI 10.1007/s10344-008-0239-y; Bell BD, 2002, CONSERV BIOL SER, V7, P105; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Bertran J, 2002, J FIELD ORNITHOL, V73, P86, DOI 10.1648/0273-8570-73.1.86; Beyer H. L, 2012, GEOSPATIAL MODELLING; Bivand R, 2013, RGDAL BINDINGS GEOSP; Boggie MA, 2014, LANDSCAPE URBAN PLAN, V124, P34, DOI 10.1016/j.landurbplan.2014.01.001; Boshoff Andre, 2011, Vulture News, V61, P4; Brown C. J., 1988, THESIS U NATAL PIETE; BROWN CJ, 1991, BIOL CONSERV, V57, P315, DOI 10.1016/0006-3207(91)90075-K; BROWN CJ, 1989, OSTRICH, V60, P165, DOI 10.1080/00306525.1989.9633751; Brown CJ, 1997, AFR J ECOL, V35, P53, DOI 10.1111/j.1365-2028.1997.048-89048.x; BROWN CJ, 1990, OSTRICH, V61, P24, DOI 10.1080/00306525.1990.9633934; BROWN CJ, 1992, OSTRICH, V63, P1, DOI 10.1080/00306525.1992.9634172; BROWN LH, 1982, BIRDS OF AFRICA, V1; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Calenge C., 2011, HOME RANGE ESTIMATIO; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Carrete M, 2006, ECOL APPL, V16, P1674, DOI 10.1890/1051-0761(2006)016[1674:DPDIPB]2.0.CO;2; Clark RG, 2004, CONDOR, V106, P717, DOI 10.1650/7644; Cumming GS, 2012, DIVERS DISTRIB, V18, P1057, DOI 10.1111/j.1472-4642.2012.00908.x; Donazar J.A., 1993, BUITRES IBERICOS BIO; Donazar JA, 2002, ECOL APPL, V12, P1445, DOI 10.1890/1051-0761(2002)012[1445:EOFAOL]2.0.CO;2; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; FERRER M, 1993, IBIS, V135, P132, DOI 10.1111/j.1474-919X.1993.tb02824.x; Ferrer M, 1997, J APPL ECOL, V34, P1359, DOI 10.2307/2405253; Fieberg J, 2007, ECOLOGY, V88, P1059, DOI 10.1890/06-0930; FREY H, 1996, MONOGRAFIAS SEO; Fuller MR, 1987, J RAPTOR RES, V21, P126; Garcia-Ripolles C, 2011, ACTA ORNITHOL, V46, P127, DOI 10.3161/000164511X625892; Gavashelishvili A, 2006, ANIM CONSERV, V9, P159, DOI 10.1111/j.1469-1795.2005.00017.x; Gil JA, 2010, JUVENILE DISPERSAL B; GIL JA, 2014, HOME RANGE IN PRESS; Gonzalez LM, 2006, ANIM CONSERV, V9, P85, DOI 10.1111/j.1469-1795.2005.00016.x; Hegglin D., 2004, SATELLITE TRACKING B, P52; HIRALDO F, 1979, MONOGRAFIAS ICONA; Kenward RE, 2001, ECOLOGY, V82, P1905, DOI 10.2307/2680056; Kenward RE, 2000, OIKOS, V91, P271, DOI 10.1034/j.1600-0706.2000.910207.x; Kruger SC, 2014, BIRD CONSERV INT, V24, P162, DOI 10.1017/S0959270913000440; KRUGER S, 2014, ESKOM RED D IN PRESS; KRUGER S, 2013, 37620 GOV GAZ; Lenth RV, 2013, USING ISMEANS PACKAG; Margalida A, 2005, ETHOL ECOL EVOL, V17, P51; Margalida A, 2000, IBIS, V142, P225, DOI 10.1111/j.1474-919X.2000.tb04862.x; Margalida A, 2008, BIRD CONSERV INT, V18, P1, DOI 10.1017/S0959270908000026; Margalida A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065857; Mingozzi T, 1997, BIOL CONSERV, V79, P155, DOI 10.1016/S0006-3207(96)00110-3; Morrison JL, 2009, J RAPTOR RES, V43, P81, DOI 10.3356/JRR-08-33.1; Mundy P., 1992, VULTURES AFRICA; Naidoo V, 2009, REGUL TOXICOL PHARM, V53, P205, DOI 10.1016/j.yrtph.2009.01.010; Newton I., 1979, POPULATION ECOLOGY R; Ogada DL, 2012, ANN NY ACAD SCI, V1249, P57, DOI 10.1111/j.1749-6632.2011.06293.x; Penteriani V, 2005, P ROY SOC B-BIOL SCI, V272, P1265, DOI 10.1098/rspb.2005.3075; Penteriani V, 2005, OIKOS, V108, P523, DOI 10.1111/j.0030-1299.2005.13514.x; Penteriani V, 2009, J RAPTOR RES, V43, P90, DOI 10.3356/JRR-08-39.1; Phipps WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052813; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; R Core Team, 2021, R LANGUAGE ENV STAT; Reed JM, 1999, CONSERV BIOL, V13, P232, DOI 10.1046/j.1523-1739.1999.013002232.x; REID T, 2014, SPATIAL ANA IN PRESS; Rushworth I, 2014, OSTRICH, V85, P13, DOI 10.2989/00306525.2014.913211; Serrano D, 2008, BASIC APPL ECOL, V9, P771, DOI 10.1016/j.baae.2007.08.013; Sycholt A., 2002, GUIDE DRAKENSBERG; TERRASSE J. F., 1961, ALAUDA, V29, P1; Tukey JW, 1977, EXPLORATORY DATA ANA; Urios V, 2010, ORNIS FENNICA, V87, P114; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; Virani MZ, 2011, BIOL CONSERV, V144, P746, DOI 10.1016/j.biocon.2010.10.024; Wand MP., 1994, KERNEL SMOOTHING; White C.M., 1994, NEW WORLD VULTURES G; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959	76	42	43	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114920	10.1371/journal.pone.0114920	http://dx.doi.org/10.1371/journal.pone.0114920			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551614	gold, Green Published, Green Submitted			2022-12-26	WOS:000347119100019
J	Lao, M; Caro, V; Thiberge, JM; Bounmany, P; Vongpayloth, K; Buchy, P; Duong, V; Vanhlasy, C; Hospied, JM; Thongsna, M; Choumlivong, K; Vongkhamchanh, P; Oudavong, B; Brey, PT; Grandadam, M				Lao, Malayvanh; Caro, Valerie; Thiberge, Jean-Michel; Bounmany, Phaitong; Vongpayloth, Khamsing; Buchy, Philippe; Duong, Veasna; Vanhlasy, Chansamone; Hospied, Jean-Marie; Thongsna, Manichanh; Choumlivong, Khamla; Vongkhamchanh, Phonesavanh; Oudavong, Bounleua; Brey, Paul T.; Grandadam, Marc			Co-Circulation of Dengue Virus Type 3 Genotypes in Vientiane Capital, Lao PDR	PLOS ONE			English	Article							SURVEILLANCE; CAMBODIA	During the 2012 epidemic of dengue in Vientiane capital, Lao PDR, a major serotype switch from dengue 1 to 3 was observed. A molecular epidemiology study demonstrated that dengue 3 remained the predominant serotype in 2013, but also revealed the co-circulation of two genotypes, supporting the hypothesis of multiple geographic origins of dengue 3 strains circulating in Vientiane capital.	[Lao, Malayvanh; Bounmany, Phaitong; Vongpayloth, Khamsing; Brey, Paul T.; Grandadam, Marc] Inst Pasteur Laos, Viangchan, Laos; [Caro, Valerie; Thiberge, Jean-Michel] Inst Pasteur, Paris, France; [Buchy, Philippe; Duong, Veasna] Inst Pasteur Cambodge, Phnom Penh, Cambodia; [Vanhlasy, Chansamone] Mil Hosp 103, Viangchan, Laos; [Hospied, Jean-Marie] Ctr Med Ambassade France, Viangchan, Laos; [Thongsna, Manichanh] Mittaphab Hosp, Viangchan, Laos; [Choumlivong, Khamla] Setthathirath Hosp, Viangchan, Laos; [Vongkhamchanh, Phonesavanh] 5 April Police Hosp, Viangchan, Laos; [Oudavong, Bounleua] Children Hosp, Viangchan, Laos	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia	Grandadam, M (corresponding author), Inst Pasteur Laos, Viangchan, Laos.	m.grandadam@pasteur.la	VONGPHAYLOTH, Khamsing/AAR-7293-2020; Veasna, Duong/I-9684-2014; GRANDADAM, Marc/GNP-7470-2022	Veasna, Duong/0000-0003-0353-1678; VONGPHAYLOTH, Khamsing/0000-0002-4844-8547; BUCHY, Philippe/0000-0003-1372-3008	Institut Pasteur's International Division [ACIP 2016-16]	Institut Pasteur's International Division	This work was supported by the Institut Pasteur's International Division (ACIP 2016-16). Diagnosis and surveillance activities benefitted the support of Institut Pasteur's International Division (Emergency fund) and donations from AusAID/WHO; ST Bank; Phongsavanh Bank; Exotissimo travel Co., ltd; Lao Brewery Co., LTD; Phu Bai Mining limited; and the Banque Franco-Lao ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dubot-Peres A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002360; Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166; Gupta E, 2012, J VECTOR DIS, V49, P82; Huy R, 2010, B WORLD HEALTH ORGAN, V88, P650, DOI 10.2471/BLT.09.073908; Ito M, 2004, J CLIN MICROBIOL, V42, P5935, DOI 10.1128/JCM.42.12.5935-5937.2004; Jiang T, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-125; Khampapongpane B, 2014, WEST PAC SURVEILL RE, V5, DOI [10.5365/wpsar.2014.5.1.001, 10.5365/WPSAR.2014.5.1.001]; Manakkadan A, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-37; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Undurraga EA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002056; Vong S, 2012, EPIDEMIOL INFECT, V140, P491, DOI 10.1017/S0950268811001191; Warrilow D, 2002, J MED VIROL, V66, P524, DOI 10.1002/jmv.2176; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Yamanaka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027322	14	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115569	10.1371/journal.pone.0115569	http://dx.doi.org/10.1371/journal.pone.0115569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551768	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100042
J	Wallmeier, L; Wiegrebe, L				Wallmeier, Ludwig; Wiegrebe, Lutz			Ranging in Human Sonar: Effects of Additional Early Reflections and Exploratory Head Movements	PLOS ONE			English	Article							AUDITORY DISTANCE PERCEPTION; SOUND LOCALIZATION; HUMAN ECHOLOCATION; SIGHTED SUBJECTS; ECHO PERCEPTION; BLIND HUMANS; TEST SCORE; LISTENERS; ABILITY; CUES	Many blind people rely on echoes from self-produced sounds to assess their environment. It has been shown that human subjects can use echolocation for directional localization and orientation in a room, but echo-acoustic distance perception - e.g. to determine one's position in a room - has received little scientific attention, and systematic studies on the influence of additional early reflections and exploratory head movements are lacking. This study investigates echo-acoustic distance discrimination in virtual echo-acoustic space, using the impulse responses of a real corridor. Six blindfolded sighted subjects and a blind echolocation expert had to discriminate between two positions in the virtual corridor, which differed by their distance to the front wall, but not to the lateral walls. To solve this task, participants evaluated echoes that were generated in real time from self-produced vocalizations. Across experimental conditions, we systematically varied the restrictions for head rotations, the subjects' orientation in virtual space and the reference position. Three key results were observed. First, all participants successfully solved the task with discrimination thresholds below 1 m for all reference distances (0.75-4 m). Performance was best for the smallest reference distance of 0.75 m, with thresholds around 20 cm. Second, distance discrimination performance was relatively robust against additional early reflections, compared to other echolocation tasks like directional localization. Third, free head rotations during echolocation can improve distance discrimination performance in complex environmental settings. However, head movements do not necessarily provide a benefit over static echolocation from an optimal single orientation. These results show that accurate distance discrimination through echolocation is possible over a wide range of reference distances and environmental conditions. This is an important functional benefit of human echolocation, which may also play a major role in the calibration of auditory space representations.	[Wallmeier, Ludwig; Wiegrebe, Lutz] Univ Munich, Grad Sch Syst Neurosci, Planegg Martinsried, Germany; [Wallmeier, Ludwig; Wiegrebe, Lutz] Univ Munich, Dept Biol, Div Neurobiol, Planegg Martinsried, Germany	University of Munich; University of Munich	Wiegrebe, L (corresponding author), Univ Munich, Grad Sch Syst Neurosci, Planegg Martinsried, Germany.	lutzw@lmu.de			DFG [wi1518/9]; Studienstiftung des Deutschen Volkes; Bernstein Center for Computational Neuroscience, Munich [B3]	DFG(German Research Foundation (DFG)); Studienstiftung des Deutschen Volkes; Bernstein Center for Computational Neuroscience, Munich	This work was supported by DFG wi1518/9 to Lutz Wiegrebe; Studienstiftung des Deutschen Volkes, Stipend to Ludwig Wallmeier; and Bernstein Center for Computational Neuroscience, Munich, Project B3 to Lutz Wiegrebe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashmead DH, 1998, J VISUAL IMPAIR BLIN, V92, P615, DOI 10.1177/0145482X9809200905; ASHMEAD DH, 1995, J EXP PSYCHOL HUMAN, V21, P239, DOI 10.1037/0096-1523.21.2.239; Au W. W., 1993, SONAR DOLPHINS; BASSETT IG, 1964, J ACOUST SOC AM, V36, P911, DOI 10.1121/1.1919117; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Crawford JR, 2010, COGNITIVE NEUROPHSYC, V1, P1; DeLong CM, 2007, J ACOUST SOC AM, V121, P605, DOI 10.1121/1.2400848; Dufour A, 2005, EXP BRAIN RES, V165, P515, DOI 10.1007/s00221-005-2329-3; Griffin DR, 1986, LISTENING DARK ACOUS; HAUSFELD S, 1982, PERCEPT MOTOR SKILL, V55, P623, DOI 10.2466/pms.1982.55.2.623; KELLOGG WN, 1962, SCIENCE, V137, P399, DOI 10.1126/science.137.3528.399; Kolarik AJ, 2014, HEARING RES, V310, P60, DOI 10.1016/j.heares.2014.01.010; Kolarik AJ, 2013, EXP BRAIN RES, V224, P623, DOI 10.1007/s00221-012-3340-0; Krumbholz K, 2004, J ACOUST SOC AM, V115, P1696, DOI 10.1121/1.1649334; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lewald J, 2002, NEUROPSYCHOLOGIA, V40, P1868, DOI 10.1016/S0028-3932(02)00071-4; Lewald J, 2013, NEUROPSYCHOLOGIA, V51, P181, DOI 10.1016/j.neuropsychologia.2012.11.017; Litovsky RY, 1999, J ACOUST SOC AM, V106, P1633, DOI 10.1121/1.427914; McDonald J.H., 2014, HDB BIOL STAT; Milne JL, 2014, ATTEN PERCEPT PSYCHO, DOI [10.3758/s13414-13014-10695-13412, DOI 10.3758/S13414-13014-10695-13412]; Moore, 2012, INTRO PSYCHOL HEARIN; Moore JM, 2008, HEARING RES, V238, P94, DOI 10.1016/j.heares.2007.11.006; Plack C.J., 2005, PITCH NEURAL CODING, DOI [10.1007/0-387-28958-5, DOI 10.1007/0-387-28958-5]; RICE CE, 1965, J EXP PSYCHOL, V70, P246, DOI 10.1037/h0022215; RICE CE, 1967, SCIENCE, V155, P656, DOI 10.1126/science.155.3763.656; RICE CE, 1969, PSYCHOL REC, V19, P1; RICE CE, 1965, SCIENCE, V148, P1107, DOI 10.1126/science.148.3673.1107; Rosenblum LD, 2000, ECOL PSYCHOL, V12, P181, DOI 10.1207/S15326969ECO1203_1; Rowan D, 2013, HEARING RES, V300, P56, DOI 10.1016/j.heares.2013.03.005; Schenkman BN, 2010, PERCEPTION, V39, P483, DOI 10.1068/p6473; Schornich S, 2012, JARO-J ASSOC RES OTO, V13, P673, DOI 10.1007/s10162-012-0338-z; Shinn-Cunningham B, 2003, P ICAD 2003, P21; Shinn-Cunningham BG, 2005, J ACOUST SOC AM, V117, P3100, DOI 10.1121/1.1872572; Speigle J. M., 1993, Proceedings IEEE 1993 Symposium on Research Frontiers in Virtual Reality (Cat. No.93TH0585-0), P92, DOI 10.1109/VRAIS.1993.378257; Stoffregen TA, 1995, ECOL PSYCHOL, V7, P181; Supa M, 1944, AM J PSYCHOL, V57, P133, DOI 10.2307/1416946; Teng S, 2012, EXP BRAIN RES, V216, P483, DOI 10.1007/s00221-011-2951-1; Teng S, 2011, J VISUAL IMPAIR BLIN, V105, P20, DOI 10.1177/0145482X1110500103; Thaler L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020162; Voss P, 2004, CURR BIOL, V14, P1734, DOI 10.1016/j.cub.2004.09.051; Wallach H, 1940, J EXP PSYCHOL, V27, P339, DOI 10.1037/h0054629; Wallmeier L, 2014, ROYAL SOC O IN PRESS; Wallmeier L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1428; Zahorik P, 2002, J ACOUST SOC AM, V111, P1832, DOI 10.1121/1.1458027; Zahorik P, 2005, ACTA ACUST UNITED AC, V91, P409	47	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115363	10.1371/journal.pone.0115363	http://dx.doi.org/10.1371/journal.pone.0115363			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UC	25551226	Green Submitted, Green Published, gold			2022-12-26	WOS:000347119100036
J	Li, H; Jiang, YM; Sun, YF; Li, P; Dang, RJ; Ning, HM; Li, YH; Zhang, YJ; Jiang, XX; Guo, XM; Wen, N; Han, Y; Mao, N; Chen, H; Zhang, Y				Li, Hong; Jiang, Yan-Ming; Sun, Yan-Feng; Li, Ping; Dang, Rui-Jie; Ning, Hong-Mei; Li, Yu-Hang; Zhang, Ying-Jie; Jiang, Xiao-Xia; Guo, Xi-Min; Wen, Ning; Han, Yan; Mao, Ning; Chen, Hu; Zhang, Yi			CCR7 Expressing Mesenchymal Stem Cells Potently Inhibit Graft-versus-Host Disease by Spoiling the Fourth Supplemental Billingham's Tenet	PLOS ONE			English	Article							REGULATORY T-CELLS; SECONDARY LYMPHOID ORGANS; HUMAN BONE-MARROW; IN-VITRO; IMMUNOSUPPRESSIVE ACTIVITY; AUTOIMMUNE-DISEASES; CHEMOKINE RECEPTORS; IMMUNE-RESPONSE; DENDRITIC CELLS; TRAFFICKING	The clinical acute graft-versus-host disease (GvHD)-therapy of mesenchymal stem cells (MSCs) is not as satisfactory as expected. Secondary lymphoid organs (SLOs) are the major niches serve to initiate immune responses or induce tolerance. Our previous study showed that CCR7 guide murine MSC line C3H10T1/2 migrating to SLOs. In this study, CCR7 gene was engineered into murine MSCs by lentivirus transfection system (MSCs/CCR7). The immunomodulatory mechanism of MSCs/CCR7 was further investigated. Provoked by inflammatory cytokines, MSCs/CCR7 increased the secretion of nitric oxide and calmed down the T cell immune response in vitro. Immunofluorescent staining results showed that transfused MSCs/CCR7 can migrate to and relocate at the appropriate T cell-rich zones within SLOs in vivo. MSCs/CCR7 displayed enhanced effect in prolonging the survival and alleviating the clinical scores of the GvHD mice than normal MSCs. Owing to the critical relocation sites, MSCs/CCR7 co-infusion potently made the T cells in SLOs more naive like, thus control T cells trafficking from SLOs to the target organs. Through spoiling the fourth supplemental Billingham's tenet, MSCs/CCR7 potently inhibited the development of GvHD. The study here provides a novel therapeutic strategy of MSCs/CCR7 infusion at a low dosage to give potent immunomodulatory effect for clinical immune disease therapy.	[Li, Hong; Jiang, Xiao-Xia; Guo, Xi-Min; Mao, Ning; Zhang, Yi] Inst Basic Med Sci, Dept Cell Biol, Beijing 100850, Peoples R China; [Li, Hong; Ning, Hong-Mei; Li, Yu-Hang; Chen, Hu] Acad Mil Med Sci, Affiliated Hosp, Dept Hematopoiet Stem Cell Transplantat, Beijing 100071, Peoples R China; [Jiang, Yan-Ming] Second Artillery Gen Hosp, Dept Ophthalmol, Beijing 100088, Peoples R China; [Sun, Yan-Feng] Gen Hosp Chinese Peoples Armed Police Forces, Dept Pediat, Beijing 100039, Peoples R China; [Li, Ping; Dang, Rui-Jie; Wen, Ning] Chinese Peoples Liberat Army Gen Hosp, Dept Stomatol, Beijing 100853, Peoples R China; [Zhang, Ying-Jie; Han, Yan] Chinese Peoples Liberat Army Gen Hosp, Dept Plast & Reconstruct Surg, Beijing 100853, Peoples R China	Academy of Military Medical Sciences - China; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Chen, H (corresponding author), Inst Basic Med Sci, Dept Cell Biol, Beijing 100850, Peoples R China.	msc_lihong@163.com; Chenhu217@aliyun.com; zhangyi0216@yeah.com	张, 西京/HIK-3273-2022; Zhang, Yingjie/HHM-3016-2022		National High-tech Research and Development Program of China [2011AA020114, 2010CB529904]; National Natural Science Foundation of China [30900568, 81170523, 31370916, 31170926, 81271936]; Clinical Feature and Application Research of Capital [Z111107058811107]	National High-tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Clinical Feature and Application Research of Capital	This study was supported by the National High-tech Research and Development Program of China (Grant no. 2011AA020114, 2010CB529904), the National Natural Science Foundation of China (Grant nos. 30900568, 81170523, 31370916, 31170926, 81271936), and Clinical Feature and Application Research of Capital (Grant no. Z111107058811107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; Beres AJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00163; Billingham R E, 1966, Harvey Lect, V62, P21; Blazar BR, 1998, BLOOD, V92, P3949, DOI 10.1182/blood.V92.10.3949.422k26_3949_3959; Brooke G, 2008, STEM CELLS DEV, V17, P929, DOI 10.1089/scd.2007.0156; Chamberlain G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002934; Chauhan SK, 2014, J IMMUNOL, V192, P817, DOI 10.4049/jimmunol.1203469; Coghill JM, 2010, BLOOD, V115, P4914, DOI 10.1182/blood-2009-08-239848; Duramad O, 2011, BIOL BLOOD MARROW TR, V17, P1154, DOI 10.1016/j.bbmt.2010.11.022; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Guo ZK, 2006, STEM CELLS, V24, P992, DOI 10.1634/stemcells.2005-0224; Haase D, 2012, IMMUNOL RES, V53, P200, DOI 10.1007/s12026-012-8267-9; Ho LP, 2013, J IMMUNOL, V191, P5603, DOI 10.4049/jimmunol.1301175; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Johnson LA, 2014, ANGIOGENESIS, V17, P335, DOI 10.1007/s10456-013-9407-0; Karakhanova S, 2006, J IMMUNOTHER, V29, P336, DOI 10.1097/01.cji.0000203080.43235.9e; Kataoka H, 2005, TRANSPL P, V37, P107, DOI 10.1016/j.transproceed.2004.12.287; Kim YM, 2003, J CLIN INVEST, V111, P659, DOI 10.1172/JCI200316950; Li H, 2014, STEM CELLS, V32, P1890, DOI 10.1002/stem.1656; Li W, 2012, CELL DEATH DIFFER, V19, P1505, DOI 10.1038/cdd.2012.26; Lin Y, 2011, ADV HEMATOL, V2011, DOI DOI 10.1155/2011/427863; Mafi R, 2011, Open Orthop J, V5 Suppl 2, P242, DOI 10.2174/1874325001105010242; Martin I, 2010, TISSUE ENG PT A, V16, P2419, DOI [10.1089/ten.tea.2010.0056, 10.1089/ten.TEA.2010.0056]; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Panoskaltsis-Mortari A, 2004, BLOOD, V103, P3590, DOI 10.1182/blood-2003-08-2827; Papatriantafyllou M, 2011, NAT REV IMMUNOL, V11, P644, DOI 10.1038/nri3068; Parmar S, 2014, CYTOTHERAPY, V16, P90, DOI 10.1016/j.jcyt.2013.07.009; Paunescu V, 2007, J CELL MOL MED, V11, P502, DOI 10.1111/j.1582-4934.2007.00041.x; Prockop DJ, 2012, J CELL BIOCHEM, V113, P1460, DOI 10.1002/jcb.24046; Ruddle NH, 2009, J IMMUNOL, V183, P2205, DOI 10.4049/jimmunol.0804324; Sackstein R, 2006, BIOL BLOOD MARROW TR, V12, P2, DOI 10.1016/j.bbmt.2005.09.015; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Su J, 2014, CELL DEATH DIFFER, V21, P388, DOI 10.1038/cdd.2013.149; Taylor PA, 2007, BLOOD, V110, P3480, DOI 10.1182/blood-2007-05-087940; Teschner D, 2014, BONE MARROW TRANSPL, V49, P138, DOI 10.1038/bmt.2013.114; Tran TC, 2011, J CELL PHYSIOL, V226, P224, DOI 10.1002/jcp.22329; Tyndall A, 2011, HEMATOL-AM SOC HEMAT, P280, DOI 10.1182/asheducation-2011.1.280; Tyndall A, 2010, ANN RHEUM DIS, V69, P1413, DOI 10.1136/ard.2010.132639; Unsoeld H, 2005, J VIROL, V79, P4510, DOI 10.1128/JVI.79.7.4510-4513.2005; van den Brink MRM, 2000, J IMMUNOL, V164, P469, DOI 10.4049/jimmunol.164.1.469; Verneris MR, 2013, HEMATOL-AM SOC HEMAT, P335, DOI 10.1182/asheducation-2013.1.335; Viola A, 2006, TRENDS IMMUNOL, V27, P421, DOI 10.1016/j.it.2006.07.004; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wolf D, 2005, J AM SOCNEPHROL, V2005; Worbs T, 2007, TRENDS IMMUNOL, V28, P274, DOI 10.1016/j.it.2007.04.002	52	2	3	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115720	10.1371/journal.pone.0115720	http://dx.doi.org/10.1371/journal.pone.0115720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549354	Green Published, Green Submitted, gold			2022-12-26	WOS:000347063500022
J	Frank, KL; Colomer-Winter, C; Grindle, SM; Lemos, JA; Schlievert, PM; Dunny, GM				Frank, Kristi L.; Colomer-Winter, Cristina; Grindle, Suzanne M.; Lemos, Jose A.; Schlievert, Patrick M.; Dunny, Gary M.			Transcriptome Analysis of Enterococcus faecalis during Mammalian Infection Shows Cells Undergo Adaptation and Exist in a Stringent Response State	PLOS ONE			English	Article							GENE-EXPRESSION; VIRULENCE DETERMINANTS; SURFACE-PROTEINS; VIBRIO-CHOLERAE; STRESS; IDENTIFICATION; STREPTOCOCCUS; ENDOCARDITIS; METABOLISM; GLS24	As both a commensal and a major cause of healthcare-associated infections in humans, Enterococcus faecalis is a remarkably adaptable organism. We investigated how E. faecalis adapts in a mammalian host as a pathogen by characterizing changes in the transcriptome during infection in a rabbit model of subdermal abscess formation using transcriptional microarrays. The microarray experiments detected 222 and 291 differentially regulated genes in E. faecalis OG1RF at two and eight hours after subdermal chamber inoculation, respectively. The profile of significantly regulated genes at two hours post-inoculation included genes involved in stress response, metabolism, nutrient acquisition, and cell surface components, suggesting genome-wide adaptation to growth in an altered environment. At eight hours post-inoculation, 88% of the differentially expressed genes were down-regulated and matched a transcriptional profile consistent with a (p) ppGpp-mediated stringent response. Subsequent subdermal abscess infections with E. faecalis mutants lacking the (p) ppGpp synthetase/hydrolase RSH, the small synthetase RelQ, or both enzymes, suggest that intracellular (p) ppGpp levels, but not stringent response activation, influence persistence in the model. The ability of cells to synthesize (p) ppGpp was also found to be important for growth in human serum and whole blood. The data presented in this report provide the first genome-wide insights on E. faecalis in vivo gene expression and regulation measured by transcriptional profiling during infection in a mammalian host and show that (p) ppGpp levels affect viability of E. faecalis in multiple conditions relevant to mammalian infection. The subdermal abscess model can serve as a novel experimental system for studying the E. faecalis stringent response in the context of the mammalian immune system.	[Frank, Kristi L.; Grindle, Suzanne M.; Schlievert, Patrick M.; Dunny, Gary M.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Colomer-Winter, Cristina; Lemos, Jose A.] Univ Rochester, Sch Med & Dent, Ctr Oral Biol, Rochester, NY USA; [Colomer-Winter, Cristina; Lemos, Jose A.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Rochester; University of Rochester	Frank, KL (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA.	fran0616@umn.edu		Lemos, Jose/0000-0003-0791-5863; Colomer Winter, Cristina/0000-0003-0103-4977; Schlievert, Patrick/0000-0001-8314-9369	National Institute of Allergy and Infectious Diseases [F32AI082881, R01AI58134]; National Institute of Dental and Craniofacial Research [T32DE007288]; American Heart Association [10POST3290026]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI082881, R01AI058134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by Award Number R01AI58134 from the National Institute of Allergy and Infectious Diseases to GMD. KLF was supported by Award Number F32AI082881 from the National Institute of Allergy and Infectious Diseases, Award Number T32DE007288 from the National Institute of Dental and Craniofacial Research, and Award Number 10POST3290026 from the American Heart Association. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases, the National Institute of Dental and Craniofacial Research, the National Institutes of Health, or the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2009, J BACTERIOL, V191, P2248, DOI 10.1128/JB.01726-08; Attia AS, 2013, PATHOG DIS; Benachour A, 2009, CAN J MICROBIOL, V55, P967, DOI [10.1139/W09-052, 10.1139/w09-052]; Bohle LA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-135; Chaffin DO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041329; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; COQUE TM, 1995, J INFECT DIS, V171, P1223, DOI 10.1093/infdis/171.5.1223; Creti R, 2004, J MED MICROBIOL, V53, P13, DOI 10.1099/jmm.0.05353-0; de Marques EB, 2004, J MED MICROBIOL, V53, P1069, DOI 10.1099/jmm.0.45654-0; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479; Dupre I, 2003, J MED MICROBIOL, V52, P491, DOI 10.1099/jmm.0.05038-0; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fabretti F, 2006, INFECT IMMUN, V74, P4164, DOI 10.1128/IAI.00111-06; Frank KL, 2012, INFECT IMMUN, V80, P539, DOI 10.1128/IAI.05964-11; Gaca AO, 2013, MBIO, V4, DOI 10.1128/mBio.00646-13; Gaca AO, 2012, MICROBIOL-SGM, V158, P1994, DOI 10.1099/mic.0.060236-0; Geiger T, 2014, J BACTERIOL, V196, P894, DOI 10.1128/JB.01201-13; Giard JC, 2000, J BACTERIOL, V182, P4512, DOI 10.1128/JB.182.16.4512-4520.2000; Graham MR, 2006, AM J PATHOL, V169, P927, DOI 10.2353/ajpath.2006.060112; Hanin A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011879; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Holt JF, 2014, INFECT IMMUN; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johansson D, 2013, MICROB PATHOGENESIS, V55, P28, DOI 10.1016/j.micpath.2012.09.009; Jorth P, 2013, J BACTERIOL, V195, P4991, DOI 10.1128/JB.00875-13; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Lasa I, 2011, P NATL ACAD SCI USA, V108, P20172, DOI 10.1073/pnas.1113521108; Le Jeune A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009658; Lebreton F., 2014, ENTEROCOCCI COMMENSA; Lindenstrauss AG, 2014, ARCH MICROBIOL, V196, P423, DOI 10.1007/s00203-014-0982-2; Lopez G, 2012, BIOMETALS, V25, P737, DOI 10.1007/s10534-012-9539-5; Maadani A, 2007, INFECT IMMUN, V75, P2634, DOI 10.1128/IAI.01372-06; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Mandlik A, 2011, CELL HOST MICROBE, V10, P165, DOI 10.1016/j.chom.2011.07.007; Mehra S, 2006, J IND MICROBIOL BIOT, V33, P159, DOI 10.1007/s10295-005-0034-7; de Oliveira NEM, 2011, MICROBIOL-SGM, V157, P656, DOI 10.1099/mic.0.041897-0; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; Nannini EC, 2005, INFECT IMMUN, V73, P7772, DOI 10.1128/IAI.73.11.7772-7774.2005; Nygaard P, 1996, J BACTERIOL, V178, P846, DOI 10.1128/jb.178.3.846-853.1996; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; Paganelli FL, 2012, TRENDS MICROBIOL, V20, P40, DOI 10.1016/j.tim.2011.11.001; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Priyadarshi A, 2009, BBA-PROTEINS PROTEOM, V1794, P1030, DOI 10.1016/j.bbapap.2009.03.006; Reffuveille F, 2011, MICROBIOL-SGM, V157, P3001, DOI 10.1099/mic.0.053314-0; ROE BA, 1996, DNA ISOLATION SEQUEN; Roggiani M, 2000, METH MOLEC MED, V36, P59, DOI 10.1385/1-59259-216-3:59; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P11766, DOI 10.1073/pnas.0601182103; Shah P, 2008, MICROB PATHOGENESIS, V45, P167, DOI 10.1016/j.micpath.2008.05.001; Shepard BD, 2002, INFECT IMMUN, V70, P4344, DOI 10.1128/IAI.70.8.4344-4352.2002; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Skvortsov TA, 2013, ACTA NATURAE, V5, P62, DOI 10.32607/20758251-2013-5-2-62-69; Solheim M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-194; Stintzi A, 2005, INFECT IMMUN, V73, P1797, DOI 10.1128/IAI.73.3.1797-1810.2005; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Tanenbaum DM, 2010, STAND GENOMIC SCI, V2, P229, DOI 10.4056/sigs.651139; Teng F, 2005, J INFECT DIS, V191, P472, DOI 10.1086/427191; TIGHT RR, 1975, ANTIMICROB AGENTS CH, V8, P495, DOI 10.1128/AAC.8.4.495; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Torrieri R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047436; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; Traxler MF, 2011, MOL MICROBIOL, V79, P830, DOI 10.1111/j.1365-2958.2010.07498.x; Vebo HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012489; Vebo HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007660; Xu Q, 2003, P NATL ACAD SCI USA, V100, P1286, DOI 10.1073/pnas.0337479100; Yan X, 2009, MICROBIOL-SGM, V155, P3226, DOI 10.1099/mic.0.026146-0; Yarwood JM, 2002, J BACTERIOL, V184, P1095, DOI 10.1128/jb.184.4.1095-1101.2002	71	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115839	10.1371/journal.pone.0115839	http://dx.doi.org/10.1371/journal.pone.0115839			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545155	gold, Green Published, Green Submitted			2022-12-26	WOS:000347120200074
J	Goodswen, SJ; Kennedy, PJ; Ellis, JT				Goodswen, Stephen J.; Kennedy, Paul J.; Ellis, John T.			Enhancing In Silico Protein-Based Vaccine Discovery for Eukaryotic Pathogens Using Predicted Peptide-MHC Binding and Peptide Conservation Scores	PLOS ONE			English	Article							T-CELL RESPONSES; TOXOPLASMA-GONDII; REVERSE VACCINOLOGY; PROTECTION; EPITOPES; ANTIGEN; MICE; IDENTIFICATION; ADJUVANTS; SELECTION	Given thousands of proteins constituting a eukaryotic pathogen, the principal objective for a high-throughput in silico vaccine discovery pipeline is to select those proteins worthy of laboratory validation. Accurate prediction of T-cell epitopes on protein antigens is one crucial piece of evidence that would aid in this selection. Prediction of peptides recognised by T-cell receptors have to date proved to be of insufficient accuracy. The in silico approach is consequently reliant on an indirect method, which involves the prediction of peptides binding to major histocompatibility complex (MHC) molecules. There is no guarantee nevertheless that predicted peptide-MHC complexes will be presented by antigen-presenting cells and/or recognised by cognate T-cell receptors. The aim of this study was to determine if predicted peptide-MHC binding scores could provide contributing evidence to establish a protein's potential as a vaccine. Using T-Cell MHC class I binding prediction tools provided by the Immune Epitope Database and Analysis Resource, peptide binding affinity to 76 common MHC I alleles were predicted for 160 Toxoplasma gondii proteins: 75 taken from published studies represented proteins known or expected to induce T-cell immune responses and 85 considered less likely vaccine candidates. The results show there is no universal set of rules that can be applied directly to binding scores to distinguish a vaccine from a non-vaccine candidate. We present, however, two proposed strategies exploiting binding scores that provide supporting evidence that a protein is likely to induce a T-cell immune response-one using random forest (a machine learning algorithm) with a 72% sensitivity and 82.4% specificity and the other, using amino acid conservation scores with a 74.6% sensitivity and 70.5% specificity when applied to the 160 benchmark proteins. More importantly, the binding score strategies are valuable evidence contributors to the overall in silico vaccine discovery pool of evidence.	[Goodswen, Stephen J.; Ellis, John T.] Univ Technol Sydney, Sch Med & Mol Sci, Ultimo, NSW, Australia; [Kennedy, Paul J.] Univ Technol Sydney, Sch Software, Fac Engn & Informat Technol, Ultimo, NSW, Australia; [Kennedy, Paul J.] Univ Technol Sydney, Ctr Quantum Computat & Intelligent Syst, Ultimo, NSW, Australia	University of Technology Sydney; University of Technology Sydney; University of Technology Sydney	Ellis, JT (corresponding author), Univ Technol Sydney, Sch Med & Mol Sci, Ultimo, NSW, Australia.	John.Ellis@uts.edu.au	Kennedy, Paul/GPC-6789-2022; Ellis, John T/L-6988-2016	Kennedy, Paul/0000-0001-7837-3171; Ellis, John T/0000-0001-7328-4831; Goodswen, Stephen/0000-0001-6184-3157	Zoetis (Pfizer) Animal Health	Zoetis (Pfizer) Animal Health	SJG gratefully acknowledges receipt of a PhD scholarship from Zoetis (Pfizer) Animal Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel N, 2002, INFECT IMMUN, V70, P6817, DOI 10.1128/IAI.70.12.6817-6827.2002; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bui HH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-361; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Che FY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000745; Cong H, 2008, VACCINE, V26, P3913, DOI 10.1016/j.vaccine.2008.04.046; Cong H, 2012, HUM IMMUNOL, V73, P1, DOI 10.1016/j.humimm.2011.10.006; Cong Hua, 2010, Immunome Res, V6, P12, DOI 10.1186/1745-7580-6-12; Cong H, 2011, VACCINE, V29, P754, DOI 10.1016/j.vaccine.2010.11.015; Deavin AJ, 1996, MOL IMMUNOL, V33, P145, DOI 10.1016/0161-5890(95)00120-4; Elsheikha HM, 2004, PARASITOL RES, V94, P452, DOI 10.1007/s00436-004-1237-y; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Escobar Andres J. Gutierrez, 2006, In Silico Biology, V6, P347; Fatoohi F, 2006, JPN J OPHTHALMOL, V50, P103, DOI 10.1007/s10384-005-0295-8; Flower Darren R, 2010, Immunome Res, V6 Suppl 2, pS1, DOI 10.1186/1745-7580-6-S2-S1; GODARD I, 1994, MOL IMMUNOL, V31, P1353, DOI 10.1016/0161-5890(94)90054-X; Goodswen SJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-315; Goodswen SJ, 2013, BRIEF BIOINFORM, V14, P753, DOI 10.1093/bib/bbs066; Guglietta S, 2007, MICROBES INFECT, V9, P127, DOI 10.1016/j.micinf.2006.10.017; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Johansson F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-388; Jordan KA, 2009, INFECT IMMUN, V77, P3894, DOI 10.1128/IAI.00024-09; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kelly DF, 2005, ADV EXP MED BIOL, V568, P217; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leuzzi R., 2006, HDB MENINGOCOCCAL DI, P391; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Montigiani S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Morrison DA, 2009, TRENDS PARASITOL, V25, P375, DOI 10.1016/j.pt.2009.05.010; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Nielsen HV, 1999, INFECT IMMUN, V67, P6358; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Platt JC, 2000, ADV NEUR IN, P61; Prigione I, 2006, MICROBES INFECT, V8, P552, DOI 10.1016/j.micinf.2005.08.008; Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5; Rappuoli R, 2007, CURR OPIN BIOTECH, V18, P521, DOI 10.1016/j.copbio.2007.11.001; Rappuoli R, 2007, NAT BIOTECHNOL, V25, P1361, DOI 10.1038/nbt1207-1361; Roos DS, 2005, SCIENCE, V309, P72, DOI 10.1126/science.1115252; Ross BC, 2001, VACCINE, V19, P4135, DOI 10.1016/S0264-410X(01)00173-6; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; Serino L, 2006, REVERSE VACCINOLOGY, P533; Serruto D, 2009, VACCINE, V27, P3245, DOI 10.1016/j.vaccine.2009.01.072; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2; Tan TG, 2010, VACCINE, V28, P3977, DOI 10.1016/j.vaccine.2010.03.028; Tong JC, 2007, BRIEF BIOINFORM, V8, P96, DOI 10.1093/bib/bbl038; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Valizadeh V, 2014, INFECT GENET EVOL, V21, P424, DOI 10.1016/j.meegid.2013.12.012; Vivona S, 2008, TRENDS BIOTECHNOL, V26, P190, DOI 10.1016/j.tibtech.2007.12.006; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Williams TM, 2001, J MOL DIAGN, V3, P98, DOI 10.1016/S1525-1578(10)60658-7; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001; Yano A, 1997, BIOCHEM BIOPH RES CO, V236, P257, DOI 10.1006/bbrc.1997.6904	61	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115745	10.1371/journal.pone.0115745	http://dx.doi.org/10.1371/journal.pone.0115745			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545691	Green Submitted, Green Published, gold			2022-12-26	WOS:000347120200064
J	Hotson, G; Fifer, MS; Acharya, S; Benz, HL; Anderson, WS; Thakor, NV; Crone, NE				Hotson, Guy; Fifer, Matthew S.; Acharya, Soumyadipta; Benz, Heather L.; Anderson, William S.; Thakor, Nitish V.; Crone, Nathan E.			Coarse Electrocorticographic Decoding of Ipsilateral Reach in Patients with Brain Lesions	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; HUMAN SENSORIMOTOR CORTEX; STEM-CELLS; CORTICAL REPRESENTATION; MOVEMENT TRAJECTORIES; COMPUTER INTERFACE; SPECTRAL-ANALYSIS; PREMOTOR CORTEX; ECOG-RECORDINGS; ARM MOVEMENTS	In patients with unilateral upper limb paralysis from strokes and other brain lesions, strategies for functional recovery may eventually include brain-machine interfaces (BMIs) using control signals from residual sensorimotor systems in the damaged hemisphere. When voluntary movements of the contralateral limb are not possible due to brain pathology, initial training of such a BMI may require use of the unaffected ipsilateral limb. We conducted an offline investigation of the feasibility of decoding ipsilateral upper limb movements from electrocorticographic (ECoG) recordings in three patients with different lesions of sensorimotor systems associated with upper limb control. We found that the first principal component (PC) of unconstrained, naturalistic reaching movements of the upper limb could be decoded from ipsilateral ECoG using a linear model. ECoG signal features yielding the best decoding accuracy were different across subjects. Performance saturated with very few input features. Decoding performances of 0.77, 0.73, and 0.66 (median Pearson's r between the predicted and actual first PC of movement using nine signal features) were achieved in the three subjects. The performance achieved here with small numbers of electrodes and computationally simple decoding algorithms suggests that it may be possible to control a BMI using ECoG recorded from damaged sensorimotor brain systems.	[Hotson, Guy] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; [Fifer, Matthew S.; Acharya, Soumyadipta; Benz, Heather L.; Thakor, Nitish V.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA; [Anderson, William S.] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD 21287 USA; [Crone, Nathan E.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Hotson, G (corresponding author), Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA.	ghotson1@jhu.edu	Thakor, Nitish/G-9110-2015; Thakor, Nitish V/A-5878-2008; Coish, Elizabeth/AAU-1245-2020	Thakor, Nitish/0000-0002-9981-9395; Fifer, Matthew/0000-0003-3425-7552; Anderson, William/0000-0003-0958-050X; Benz, Heather/0000-0002-6707-9695	National Institute of Neurological Disorders and Stroke [3R01NS0405956-09S1]; National Institute of Biomedical Imaging and Bioengineering [5T32EB003383-08]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB003383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040596] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the National Institute of Neurological Disorders and Stroke under grant 3R01NS0405956-09S1 (MSF, HLB) and by the National Institute of Biomedical Imaging and Bioengineering under grant 5T32EB003383-08 (GH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 2010, J NEURAL ENG, V7, DOI [10.1088/1741-2560/7/4/046002, 10.2202/1553-3840.1324]; Anderson NR, 2012, EXP BRAIN RES, V223, P1, DOI 10.1007/s00221-012-3226-1; Barnes S, 1901, BRAIN, V24; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Brown JA, 2006, NEUROSURGERY, V58, P464, DOI 10.1227/01.NEU.0000197100.63931.04; Bundy DT, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036011; Chapman H, 2002, EUR J NEUROSCI, V15, P2037, DOI 10.1046/j.1460-9568.2002.02021.x; Chen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083534; Cisek P, 2003, J NEUROPHYSIOL, V89, P922, DOI 10.1152/jn.00607.2002; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Crone NE, 1998, BRAIN, V121, P2271, DOI 10.1093/brain/121.12.2271; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Duncan JS, 2004, NEUROIMAGE, V23, pS34, DOI 10.1016/j.neuroimage.2004.07.027; Fifer M, 2013, IEEE T NEURAL SYST R; Filimon F, 2007, NEUROIMAGE, V37, P1315, DOI 10.1016/j.neuroimage.2007.06.008; Galletti C, 1997, EUR J NEUROSCI, V9, P410, DOI 10.1111/j.1460-9568.1997.tb01410.x; Ganguly K, 2009, J NEUROSCI, V29, P12948, DOI 10.1523/JNEUROSCI.2471-09.2009; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Gunduz A, 2009, I IEEE EMBS C NEUR E, P260; Hanlon RE, 1996, ARCH PHYS MED REHAB, V77, P811, DOI 10.1016/S0003-9993(96)90262-2; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Kleim JA, 2003, NEUROL RES, V25, P789, DOI 10.1179/016164103771953862; Kubanek J, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/066001; LEVINE DN, 1978, NEUROLOGY, V28, P556, DOI 10.1212/WNL.28.6.556; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; McFarland DJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036007; McFarland DJ, 1997, ELECTROEN CLIN NEURO, V103, P386, DOI 10.1016/S0013-4694(97)00022-2; McMullen DP, 2014, IEEE T NEUR SYS REH, V22, P784, DOI 10.1109/TNSRE.2013.2294685; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Nakanishi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072085; Ojakangas CL, 2006, J CLIN NEUROPHYSIOL, V23, P577, DOI 10.1097/01.wnp.0000233323.87127.14; Oki K, 2012, STEM CELLS, V30, P1120, DOI 10.1002/stem.1104; PFURTSCHELLER G, 1991, ELECTROEN CLIN NEURO, P58; Pineda JA, 2000, IEEE T REHABIL ENG, V8, P219, DOI 10.1109/86.847822; Pistohl T, 2008, J NEUROSCI METH, V167, P105, DOI 10.1016/j.jneumeth.2007.10.001; Reina GA, 2001, J NEUROPHYSIOL, V85, P2576, DOI 10.1152/jn.2001.85.6.2576; Schaechter JD, 2004, PROG NEUROBIOL, V73, P61, DOI 10.1016/j.pneurobio.2004.04.001; Schalk G, 2008, J NEURAL ENG, V5, P75, DOI 10.1088/1741-2560/5/1/008; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Suminski AJ, 2010, J NEUROSCI, V30, P16777, DOI 10.1523/JNEUROSCI.3967-10.2010; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Vargas-Irwin CE, 2010, J NEUROSCI, V30, P9659, DOI 10.1523/JNEUROSCI.5443-09.2010; Veizovic T, 2001, STROKE, V32, P1012, DOI 10.1161/01.STR.32.4.1012; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055344; Wisneski KJ, 2008, STROKE, V39, P3351, DOI 10.1161/STROKEAHA.108.518175; WOLPAW JR, 1991, ELECTROEN CLIN NEURO, V78, P252, DOI 10.1016/0013-4694(91)90040-B; Wu W, 2009, IEEE T NEUR SYS REH, V17, P370, DOI 10.1109/TNSRE.2009.2023307; Yanagisawa T, 2011, J NEUROSURG, V114, P1715, DOI 10.3171/2011.1.JNS101421; Yarosh CA, 2004, J NEUROPHYSIOL, V92, P3276, DOI 10.1152/jn.00549.2004	51	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115236	10.1371/journal.pone.0115236	http://dx.doi.org/10.1371/journal.pone.0115236			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545500	gold, Green Published, Green Submitted			2022-12-26	WOS:000347120200030
J	Yang, HJ; Huang, X; Zhou, ZH; Wang, HHX; Tong, XY; Wang, ZH; Wang, JJ; Lu, ZX				Yang, Huajie; Huang, Xiang; Zhou, Zhiheng; Wang, Harry H. X.; Tong, Xinyue; Wang, Zhihong; Wang, Jiaji; Lu, Zuxun			Determinants of Initial Utilization of Community Healthcare Services among Patients with Major Non-Communicable Chronic Diseases in South China	PLOS ONE			English	Article							WORKFORCE; PHYSICIAN; BURDEN; EUROPE	Background: Although expected to act as gate-keeping primary care providers, as community health service (CHS) facilities are severely under-utilized; Chinese people in both rural and urban areas used predominantly higher-tier facilities for primary care purpose, with significant financial and outcome consequences. This study intends to explore the determinants of initial utilization of CHS among patients with major non-communicable chronic diseases (NCDs) in order to understand the care-seeking behavior among urban and rural residents in South China. Methods: A multi-stage cluster random sampling methodology was adopted to create a sample of 19,466 adults with NCDs from 7,970 urban households and 32,035 adults with NCDs from 3,860 rural households in Guangdong, China. Interviews and physical examinations were conducted in 2010 to collect data on patient characteristics, medical conditions, and awareness and utilization of healthcare. Descriptive analysis and logistic regression analysis were performed to study utilization patterns and the factors associated with the patterns. Results: Prevalence of major NCDs in urban areas was significantly higher than that in rural areas (12.55% vs. 8.70%; p<0.001). Second-tier district hospitals were most preferred for initial consultation (46.05% in rural areas vs. 45.32% in urban areas; p<0.001), followed by tertiary general or specialized hospitals (28.39% in rural areas vs. 33.89% in urban areas; p<0.001). The proportion of patients who had initial use of CHS was relatively low (25.56% in rural areas vs. 20.79% in urban areas; p<0.001). Awareness of self-care and the presence of medical insurance were leading factors associated with first contact of CHS facilities in both urban and rural areas. Conclusion: The study suggests that CHS facilities are not often used as the first contact for patients in both rural and urban areas in south China. Much effect must be made to enhance the gatekeeper system and improve medical insurance coverage in future healthcare reforms.	[Yang, Huajie; Tong, Xinyue; Lu, Zuxun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Wuhan 430030, Peoples R China; [Huang, Xiang; Zhou, Zhiheng; Wang, Jiaji] Guangzhou Med Univ, Sch Publ Hlth, Guangzhou 510182, Guangdong, Peoples R China; [Wang, Harry H. X.] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Wang, Harry H. X.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 9LX, Lanark, Scotland; [Wang, Zhihong] Huazhong Univ Sci & Technol, Affiliated Liyuan Hosp, Tongji Med Coll, Wuhan 430077, Peoples R China	Huazhong University of Science & Technology; Guangzhou Medical University; Chinese University of Hong Kong; University of Glasgow; Huazhong University of Science & Technology	Wang, JJ (corresponding author), Guangzhou Med Univ, Sch Publ Hlth, Guangzhou 510182, Guangdong, Peoples R China.	wjiaji@163.com; zuxunlu@yahoo.com	zhou, zhiheng/AAC-1519-2019; Wang, Harry H.X./E-9027-2015; WANG, Jia Ji/E-9059-2015	Wang, Harry H.X./0000-0002-0361-6527; 	National Natural Science Foundation of China [71373090, 81172753]; Department of Education, Guangdong Province, P. R. China [BKZZ2011047]; Medical Research Fund, Chinese Medical Association, P. R. China; Guangdong Medical Doctor Association of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Education, Guangdong Province, P. R. China; Medical Research Fund, Chinese Medical Association, P. R. China; Guangdong Medical Doctor Association of China	This research was funded by National Natural Science Foundation of China (71373090, 81172753); Department of Education, Guangdong Province, P. R. China (BKZZ2011047); Medical Research Fund, Chinese Medical Association, P. R. China (2010-08-05); and Guangdong Medical Doctor Association of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, MANUAL COMMUNITY APP; Bodenheimer T, 2009, HEALTH AFFAIR, V28, P64, DOI 10.1377/hlthaff.28.1.64; Boerma WGW, 1998, SOC SCI MED, V47, P445, DOI 10.1016/S0277-9536(98)00074-4; Boerma WGW, 1997, BRIT J GEN PRACT, V47, P481; Chernew ME, 2009, HEALTH AFFAIR, V28, P1327, DOI 10.1377/hlthaff.28.5.1327; Collins SR, 2010, COMPREHENSIVE CONGRE; Delnoij DMJ, 1994, PHYS PAYMENT SYSTEMS; Department of diseases control MOH China CDC, 2006, REP CHRON DIS CHIN; Dongfen C, 2006, THESIS ZHEIIANG U; Dupuits FMHM, 1998, COMPUT METH PROG BIO, V55, P39, DOI 10.1016/S0169-2607(97)00046-1; Fleming DM, 1993, EUROPEAN STUDY REFER; Groenewegen PP, 1997, WAT ZOU NEDERLAND ZI; Harrington DW, 2012, HEALTH PLACE, V18, P814, DOI 10.1016/j.healthplace.2012.03.011; Institute of Social Science Survey ISSS, 2009, CHIN FAM DYN; Kong L.Z, 2012, CHINESE J PREVENTION, V20, P502; Kroneman MW, 2006, HEALTH POLICY, V76, P72, DOI 10.1016/j.healthpol.2005.05.003; LaVeist T, 2011, HEALTH AFFAIR, V30, P1880, DOI 10.1377/hlthaff.2011.0640; Li P, 2011, ANAL REPORTED INCIDE; Liu J, 2003, CHINESE HLTH EC, V11, P22; Longhua HJ, 2011, CHINESE HLTH RESOURC, V14, P124; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Majun Shanshan L, 2008, CHINESE J PUBLIC HLT, V24, P907; Mo T.J., 1993, POVERTY SOCIAL SECUR; Murray C., 1996, GLOBAL BURDEN DIS IN, V1; Ningxiu L, 2001, CHINESE HLTH SERVICE, V2, P101; Shi LY, 2012, J AMBUL CARE MANAG, V35, P60, DOI 10.1097/JAC.0b013e31823abf07; STARFIELD B, 1994, LANCET, V344, P1129, DOI 10.1016/S0140-6736(94)90634-3; United Nations, 2003, WORLD POPULATION PRO; Wang H H X, 2013, Malays Fam Physician, V8, P2; Wang HHX, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0188-0; Wang HHX, 2013, ANN FAM MED, V11, P517, DOI 10.1370/afm.1545; Wang HHX, 2015, BRIT J GEN IN PRESS; Wang Jian, 2006, CHINESE HLTH EC, V25, P45; Wang N, 2011, CHINESE GEN PRACTICE, V1; WHO, 2012, LAUNCH WHO PROGR INC; Wright DB, 2010, SOC SCI MED, V70, P2006, DOI 10.1016/j.socscimed.2010.02.043; Zurn P, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-8; 陈兆杰, 2009, [中国老年学杂志, Chinese Journal of Gerontology], V29, P2107	39	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116051	10.1371/journal.pone.0116051	http://dx.doi.org/10.1371/journal.pone.0116051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UN	25545636	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000347120200094
J	Duarte-Neto, P; Stoslc, B; Stoslc, T; Lessa, R; Milosevic, MV; Stanley, HE				Duarte-Neto, Paulo; Stosic, Borko; Stosic, Tatijana; Lessa, Rosangela; Milosevic, Milorad V.; Stanley, H. Eugene			Multifractal Properties of a Closed Contour: A Peek beyond the Shape Analysis	PLOS ONE			English	Article							FISH OTOLITHS; MATURITY; CLASSIFICATION; GROWTH; SIZE; AGE	In recent decades multifractal analysis has been successfully applied to characterize the complex temporal and spatial organization of such diverse natural phenomena as heartbeat dynamics, the dendritic shape of neurons, retinal vessels, rock fractures, and intricately shaped volcanic ash particles. The characterization of multifractal properties of closed contours has remained elusive because applying traditional methods to their quasi-one-dimensional nature yields ambiguous answers. Here we show that multifractal analysis can reveal meaningful and sometimes unexpected information about natural structures with a perimeter well-defined by a closed contour. To this end, we demonstrate how to apply multifractal detrended fluctuation analysis, originally developed for the analysis of time series, to an arbitrary shape of a given study object. In particular, we show the application of the method to fish otoliths, calcareous concretions located in fish's inner ear. Frequently referred to as the fish's "black box", they contain a wealth of information about the fish's life history and thus have recently attracted increasing attention. As an illustrative example, we show that a multifractal approach can uncover unexpected relationships between otolith contours and size and age of fish at maturity.	[Duarte-Neto, Paulo; Stosic, Borko; Stosic, Tatijana] Univ Fed Rural Pernambuco, Dept Estat & Informat, Recife, PE, Brazil; [Lessa, Rosangela] Univ Fed Rural Pernambuco, Dept Pesca & Aquicultura, Recife, PE, Brazil; [Duarte-Neto, Paulo; Milosevic, Milorad V.] Univ Antwerp, Dept Fys, Antwerp, Belgium; [Stanley, H. Eugene] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; [Stanley, H. Eugene] Boston Univ, Dept Phys, Boston, MA 02215 USA	Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal Rural de Pernambuco (UFRPE); University of Antwerp; Boston University; Boston University	Duarte-Neto, P (corresponding author), Univ Fed Rural Pernambuco, Dept Estat & Informat, Recife, PE, Brazil.	pjduarteneto@gmail.com	Stosic, Borko/B-5808-2014; LESSA, ROSANGELA PAULA TEIXEIRA/D-5043-2013; Stosic, Tatijana/J-3974-2013; Milosevic, Milorad V/H-9393-2012; Milosevic, Milorad/AAN-6233-2021; Duarte-Neto, Paulo J/J-5623-2016	Milosevic, Milorad V/0000-0002-5431-377X; Milosevic, Milorad/0000-0002-5431-377X; Duarte-Neto, Paulo J/0000-0002-2592-7297; Stanley, H./0000-0003-2800-4495; Stosic, Tatijana/0000-0002-5691-945X; Lessa, Rosangela/0000-0002-9217-1215; Stosic, Borko/0000-0001-5031-6968	CNPq, Brazil [201506/2011-4, 303251/2010-7, 306719/2012-6]; Flemish Science Foundation (FWO-Vlaanderen); CAPES PVE action [BEX1392/11-5]	CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Flemish Science Foundation (FWO-Vlaanderen)(FWO); CAPES PVE action(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding: This work was supported by CNPq, Brazil (Projects No. 201506/2011-4, No. 303251/2010-7, and No. 306719/2012-6). MVM acknowledges support from Flemish Science Foundation (FWO-Vlaanderen) and CAPES PVE action No. BEX1392/11-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand D, 2007, FISH OTOLITH CALCIFI, P291; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Costa LD, 2009, IMAGE PROCESS SER, P1; Dellino P, 2002, J VOLCANOL GEOTH RES, V113, P1, DOI 10.1016/S0377-0273(01)00247-5; Drolon H, 2000, PATTERN RECOGN LETT, V21, P473, DOI 10.1016/S0167-8655(00)00010-6; Duarte-Neto P, 2008, ICES J MAR SCI, V65, P1144, DOI 10.1093/icesjms/fsn090; Fablet R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027055; Fernandez E, 1999, J NEUROSCI METH, V89, P151, DOI 10.1016/S0165-0270(99)00066-7; Fontoura NF, 2009, NEOTROP ICHTHYOL, V7, P217, DOI 10.1590/S1679-62252009000200013; GILDEN DL, 1993, PSYCHOL REV, V100, P460, DOI 10.1037/0033-295X.100.3.460; Green BS, 2009, REV-METHODS TECHNOL, V11, P1, DOI 10.1007/978-1-4020-5775-5; HARTE D, 2001, MULTIFRACTALS THEORY; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; Kantelhardt JW, 2002, PHYSICA A, V316, P87, DOI 10.1016/S0378-4371(02)01383-3; Lecomte-Finiger Raymonde, 1999, Annee Biologique, V38, P107; Lestrel PE, 1997, INTRO OVERVIEW FOURI, P22; Lombarte A, 2006, SCI MAR, V70, P147, DOI 10.3989/scimar.2006.70n1147; Mellon-Duval C, 2010, ICES J MAR SCI, V67, P62, DOI 10.1093/icesjms/fsp215; MUGIYA Y, 1987, FISH B-NOAA, V85, P395; MUZY JF, 1991, PHYS REV LETT, V67, P3515, DOI 10.1103/PhysRevLett.67.3515; Nasreddinea K, 2010, FISHERY RES, V98, P8; Oswiecimka P, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016103; PANNELLA G, 1971, SCIENCE, V173, P1124, DOI 10.1126/science.173.4002.1124; Piera J, 2005, MAR FRESHWATER RES, V56, P805, DOI 10.1071/MF04163; Pineiro C, 2003, ICES J MAR SCI, V60, P1086, DOI 10.1016/S1054-3139(03)00086-9; Posadas AND, 2003, SOIL SCI SOC AM J, V67, P1361, DOI 10.2136/sssaj2003.1361; Recasens L, 2008, SCI MAR, V72, P721, DOI 10.3989/scimar.2008.72n4721; Santana FM, 2009, AQUAT BIOL, V7, P199, DOI 10.3354/ab00189; Sollner C, 2003, SCIENCE, V302, P282, DOI 10.1126/science.1088443; Stosic T, 2006, IEEE T MED IMAGING, V25, P1101, DOI 10.1109/TMI.2006.879316; TEL T, 1989, PHYSICA A, V159, P155, DOI 10.1016/0378-4371(89)90563-3; TRIPPEL EA, 1991, CAN J FISH AQUAT SCI, V48, P1446, DOI 10.1139/f91-172; Xie HP, 1999, INT J ROCK MECH MIN, V36, P19, DOI 10.1016/S0148-9062(98)00172-7; Xie S, 2010, NONLINEAR PROC GEOPH, V17, P319, DOI 10.5194/npg-17-319-2010	35	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115262	10.1371/journal.pone.0115262	http://dx.doi.org/10.1371/journal.pone.0115262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542025	Green Published, gold			2022-12-26	WOS:000347239900030
J	Shinsky, SA; Monteith, KE; Viggiano, S; Cosgrove, MS				Shinsky, Stephen A.; Monteith, Kelsey E.; Viggiano, Susan; Cosgrove, Michael S.			Biochemical Reconstitution and Phylogenetic Comparison of Human SET1 Family Core Complexes Involved in Histone Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H3K4 METHYLTRANSFERASE ACTIVITY; MULTIPLE LYSINE METHYLATION; MOLECULAR REGULATION; STRUCTURAL BASIS; 11Q23 TRANSLOCATIONS; TRITHORAX FAMILY; BINDING PROTEIN; DOMAIN; MLL1; GENE	Mixed lineage leukemia protein-1 (MLL1) is a member of the SET1 family of histone H3 lysine 4 (H3K4) methyltransferases that are required for metazoan development. MLL1 is the best characterized human SET1 family member, which includes MLL1-4 and SETd1A/B. MLL1 assembles with WDR5, RBBP5, ASH2L, DPY-30 (WRAD) to form the MLL1 core complex, which is required for H3K4 dimethylation and transcriptional activation. Because all SET1 family proteins interact with WRAD in vivo, it is hypothesized they are regulated by similar mechanisms. However, recent evidence suggests differences among family members that may reflect unique regulatory inputs in the cell. Missing is an understanding of the intrinsic enzymatic activities of different SET1 family complexes under standard conditions. In this investigation, we reconstituted each human SET1 family core complex and compared subunit assembly and enzymatic activities. We found that in the absence of WRAD, all but one SET domain catalyzes at least weak H3K4 monomethylation. In the presence of WRAD, all SET1 family members showed stimulated monomethyltransferase activity but differed in their di- and trimethylation activities. We found that these differences are correlated with evolutionary lineage, suggesting these enzyme complexes have evolved to accomplish unique tasks within metazoan genomes. To understand the structural basis for these differences, we employed a "phylogenetic scanning mutagenesis" assay and identified a cluster of amino acid substitutions that confer a WRAD-dependent gain-of-function dimethylation activity on complexes assembled with the MLL3 or Drosophila trithorax proteins. These results form the basis for understanding how WRAD differentially regulates SET1 family complexes in vivo.	[Shinsky, Stephen A.; Monteith, Kelsey E.; Viggiano, Susan; Cosgrove, Michael S.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Cosgrove, MS (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 East Adams St, Syracuse, NY 13210 USA.	cosgrovm@upstate.edu		Shinsky, Stephen/0000-0001-5437-1729	National Institutes of Health [1R01CA140522]; NATIONAL CANCER INSTITUTE [R01CA140522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01CA140522 (to M. S. C.).	Banka S, 2013, CLIN GENET, V83, P467, DOI 10.1111/j.1399-0004.2012.01955.x; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Cao F, 2014, MOL CELL, V53, P247, DOI 10.1016/j.molcel.2013.12.001; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Dharmarajan V, 2012, J BIOL CHEM, V287, P27275, DOI 10.1074/jbc.M112.364125; DJABALI M, 1992, NAT GENET, V2, P113, DOI 10.1038/ng1092-113; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Hubert A, 2013, EPIGENETICS-US, V8, P79, DOI 10.4161/epi.23211; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Jones WD, 2012, AM J HUM GENET, V91, P358, DOI 10.1016/j.ajhg.2012.06.008; Kim J, 2013, MOL CELL, V49, P1121, DOI 10.1016/j.molcel.2013.01.034; Kleefstra T, 2012, AM J HUM GENET, V91, P73, DOI 10.1016/j.ajhg.2012.05.003; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lee JH, 2008, MOL CELL BIOL, V28, P609, DOI 10.1128/MCB.01356-07; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Niedermeyer THJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044913; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Patel A, 2014, J BIOL CHEM, V289, P868, DOI 10.1074/jbc.M113.501064; Patel A, 2011, J BIOL CHEM, V286, P3359, DOI 10.1074/jbc.M110.174524; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Qian CM, 2006, J MOL BIOL, V359, P86, DOI 10.1016/j.jmb.2006.03.006; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shinsky SA, 2014, J MOL BIOL, V426, P2283, DOI 10.1016/j.jmb.2014.03.011; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Takahashi YH, 2009, MOL CELL BIOL, V29, P3478, DOI 10.1128/MCB.00013-09; Thornton JL, 2014, GENE DEV, V28, P115, DOI 10.1101/gad.232215.113; Tie F, 2014, DEVELOPMENT, V141, P1129, DOI 10.1242/dev.102392; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Trievel RC, 2003, NAT STRUCT BIOL, V10, P545, DOI 10.1038/nsb946; van Dijk K, 2005, PLANT CELL, V17, P2439, DOI 10.1105/tpc.105.034165; van Nuland R, 2013, MOL CELL BIOL, V33, P2067, DOI 10.1128/MCB.01742-12; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Wu LP, 2013, MOL CELL, V49, P1108, DOI 10.1016/j.molcel.2013.01.033; Wu M, 2008, MOL CELL BIOL, V28, P7337, DOI 10.1128/MCB.00976-08; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Yang YW, 2014, ELIFE, V3, DOI 10.7554/eLife.02046; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; ZIEMINVANDERPOEL S, 1991, P NATL ACAD SCI USA, V88, P10735, DOI 10.1073/pnas.88.23.10735	68	63	65	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6361	6375		10.1074/jbc.M114.627646	http://dx.doi.org/10.1074/jbc.M114.627646			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25561738	Green Published, hybrid			2022-12-26	WOS:000350732500041
J	Mori, T; Yang, DF; Matsui, T; Hashimoto, M; Morita, H; Fujii, I; Abe, I				Mori, Takahiro; Yang, Dengfeng; Matsui, Takashi; Hashimoto, Makoto; Morita, Hiroyuki; Fujii, Isao; Abe, Ikuro			Structural Basis for the Formation of Acylalkylpyrones from Two beta-Ketoacyl Units by the Fungal Type III Polyketide Synthase CsyB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHALCONE SYNTHASE; MOLECULAR-BASIS; BIOSYNTHESIS; SPECIFICITY	The acylalkylpyrone synthase CsyB from Aspergillus oryzae catalyzes the one-pot formation of the 3-acyl-4-hydroxy-6-alkyl-alpha-pyrone scaffold from acetoacetyl-CoA, fatty acyl-CoA, and malonyl-CoA. This is the first type III polyketide synthase that performs not only the polyketide chain elongation but also the condensation of two beta-ketoacyl units. The crystal structures of wild-type CsyB and its I375F and I375W mutants were solved at 1.7-, 2.3-, and 2.0-angstrom resolutions, respectively. The crystal structures revealed a unique active site architecture featuring a hitherto unidentified novel pocket for accommodation of the acetoacetyl-CoA starter in addition to the conventional elongation/cyclization pocket with the Cys-His-Asn catalytic triad and the long hydrophobic tunnel for binding the fatty acyl chain. The structures also indicated the presence of a putative nucleophilic water molecule activated by the hydrogen bond networks with His-377 and Cys-155 at the active site center. Furthermore, an in vitro enzyme reaction confirmed that the O-18 atom of the (H2O)-O-18 molecule is enzymatically incorporated into the final product. These observations suggested that the enzyme reaction is initiated by the loading of acetoacetyl-CoA onto Cys-155, and subsequent thioester bond cleavage by the nucleophilic water generates the beta-keto acid intermediate, which is placed within the novel pocket. The second beta-ketoacyl unit is then produced by polyketide chain elongation of fatty acyl-CoA with one molecule of malonyl-CoA, and the condensation with the beta-keto acid generates the final products. Indeed, steric modulation of the novel pocket by the structure-based I375F and I375W mutations resulted in altered specificities for the chain lengths of the substrates.	[Mori, Takahiro; Yang, Dengfeng; Abe, Ikuro] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Matsui, Takashi; Morita, Hiroyuki] Toyama Univ, Inst Nat Med, Dept Med Resources, Toyama 9300194, Japan; [Hashimoto, Makoto; Fujii, Isao] Iwate Med Univ, Sch Pharm, Yahaba, Iwate 0283694, Japan	University of Tokyo; University of Toyama; Iwate Medical University	Morita, H (corresponding author), Toyama Univ, Inst Nat Med, Dept Med Resources, 2630 Sugitani, Toyama 9300194, Japan.	hmorita@inm.u-toyama.ac.jp; ifujii@iwate-med.ac.jp; abei@mol.f.u-tokyo.ac.jp	Abe, Ikuro/E-4449-2010	Abe, Ikuro/0000-0002-3640-888X; Matsui, Takashi/0000-0002-4496-2389; Hashimoto, Makoto/0000-0002-8716-4985	Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [26282210, 25108722] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to T. M., H. M., and I. A.).	Abe I, 2010, NAT PROD REP, V27, P809, DOI 10.1039/b909988n; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Austin MB, 2004, J BIOL CHEM, V279, P45162, DOI 10.1074/jbc.M406567200; Austin MB, 2004, CHEM BIOL, V11, P1179, DOI 10.1016/j.chembiol.2004.05.024; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Brachmann AO, 2013, NAT CHEM BIOL, V9, P573, DOI [10.1038/NCHEMBIO.1295, 10.1038/nchembio.1295]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erol O, 2010, CHEMBIOCHEM, V11, P1253, DOI 10.1002/cbic.201000085; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Fuchs SW, 2013, ANGEW CHEM INT EDIT, V52, P4108, DOI 10.1002/anie.201210116; GILBERT IH, 1995, BIOORG MED CHEM LETT, V5, P1587, DOI 10.1016/0960-894X(95)00276-Y; Goyal A, 2008, J STRUCT BIOL, V162, P411, DOI 10.1016/j.jsb.2008.02.009; Hashimoto M, 2014, NAT PROD REP, V31, P1306, DOI 10.1039/c4np00096j; Hashimoto M, 2014, J BIOL CHEM, V289, P19976, DOI 10.1074/jbc.M114.569095; Hashimoto M, 2013, BIOORG MED CHEM LETT, V23, P5637, DOI 10.1016/j.bmcl.2013.08.036; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; Katsuyama Y, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P147; Mori T, 2013, J BIOL CHEM, V288, P28845, DOI 10.1074/jbc.M113.493155; Morita H, 2007, CHEM BIOL, V14, P359, DOI 10.1016/j.chembiol.2007.02.003; Morita H, 2011, P NATL ACAD SCI USA, V108, P13504, DOI 10.1073/pnas.1107782108; Morita H, 2010, P NATL ACAD SCI USA, V107, P19778, DOI 10.1073/pnas.1011499107; Morita H, 2010, P NATL ACAD SCI USA, V107, P669, DOI 10.1073/pnas.0909982107; Oguro S, 2004, BIOCHEM BIOPH RES CO, V325, P561, DOI 10.1016/j.bbrc.2004.10.057; Sankaranarayanan R, 2004, NAT STRUCT MOL BIOL, V11, P894, DOI 10.1038/nsmb809; Seshime Y, 2010, BIOORGAN MED CHEM, V18, P4542, DOI 10.1016/j.bmc.2010.04.058; Sucipto H, 2013, CHEMBIOCHEM, V14, P1581, DOI 10.1002/cbic.201300289; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang DF, 2014, ACTA CRYSTALLOGR F, V70, P730, DOI 10.1107/S2053230X14008516	30	14	16	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5214	5225		10.1074/jbc.M114.626416	http://dx.doi.org/10.1074/jbc.M114.626416			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25564614	Green Published, hybrid			2022-12-26	WOS:000350042000059
J	Juliao, GR; Venticinque, EM; Fernandes, GW; Price, PW				Juliao, Genimar R.; Venticinque, Eduardo M.; Wilson Fernandes, G.; Price, Peter W.			Unexpected High Diversity of Galling Insects in the Amazonian Upper Canopy: The Savanna Out There	PLOS ONE			English	Article							SPECIES RICHNESS; VERTICAL STRATIFICATION; RAINFALL GRADIENT; SOIL FERTILITY; VARZEA FORESTS; LEAF; PATTERNS; VEGETATION; HERBIVORY; TRAITS	A relatively large number of studies reassert the strong relationship between galling insect diversity and extreme hydric and thermal status in some habitats, and an overall pattern of a greater number of galling species in the understory of scleromorphic vegetation. We compared galling insect diversity in the forest canopy and its relationship with tree richness among upland terra firme, varzea, and igapo floodplains in Amazonia, Brazil. The soils of these forest types have highly different hydric and nutritional status. Overall, we examined the upper layer of 1,091 tree crowns. Galling species richness and abundance were higher in terra firme forests compared to varzea and igapo forests. GLM-ANCOVA models revealed that the number of tree species sampled in each forest type was determinant in the gall-forming insect diversity. The ratio between galling insect richness and number of tree species sampled (GIR/TSS ratio) was higher in the terra firme forest and in seasonally flooded igapo, while the varzea presented the lowest GIR/TSS ratio. In this study, we recorded unprecedented values of galling species diversity and abundance per sampling point. The GIR/TSS ratio from varzea was approximately 2.5 times higher than the highest value of this ratio ever reported in the literature. Based on this fact, we ascertained that varzea and igapo floodplain forests (with lower GIA and GIR), together with the speciose terra firme galling community emerge as the gall diversity apex landscape among all biogeographic regions already investigated. Contrary to expectation, our results also support the "harsh environment hypothesis", and unveil the Amazonian upper canopy as similar to Mediterranean vegetation habitats, hygrothermically stressed environments with leaf temperature at lethal limits and high levels of leaf sclerophylly.	[Juliao, Genimar R.] Inst Nacl Pesquisa Amazonia INPA, Manaus, Amazonas, Brazil; [Juliao, Genimar R.] Fiocruz Rondonia, Lab Entomol, Porto Velho, Rondonia, Brazil; [Venticinque, Eduardo M.] CB Univ Fed Rio Grande Norte, Dept Ecol, Natal, RN, Brazil; [Wilson Fernandes, G.] ICB Univ Fed Minas Gerais UFMG, Ecol Evolut & Biodiversidade DBG, Belo Horizonte, MG, Brazil; [Price, Peter W.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA	Institute Nacional de Pesquisas da Amazonia; Fundacao Oswaldo Cruz; Universidade Federal do Rio Grande do Norte; Northern Arizona University	Fernandes, GW (corresponding author), ICB Univ Fed Minas Gerais UFMG, Ecol Evolut & Biodiversidade DBG, CP 486, Belo Horizonte, MG, Brazil.	gw.fernandes@gmail.com	Fernandes, Geraldo/AAN-5602-2021; Venticinque, Eduardo M/G-8961-2015; Juliao, Genimar R/K-7872-2012	Fernandes, Geraldo/0000-0003-1559-6049; Venticinque, Eduardo M/0000-0002-3455-9107; Reboucas Juliao, Genimar/0000-0002-3850-9182	Mamiraua Sustainable Development Institute; Mamiraua Civil Society; Biological Dynamics of Forest Fragment Project (INPA/Smithsonian Institution); CNPq [141415/2003-7, 30 3352/2010-8, 403781/2012-4, 457519/2012-6, 309458/2013-7]; Fapemig [APQ-04105-10]	Mamiraua Sustainable Development Institute; Mamiraua Civil Society; Biological Dynamics of Forest Fragment Project (INPA/Smithsonian Institution); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fapemig(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Funds were provided by the Mamiraua Sustainable Development Institute, Mamiraua Civil Society, and Biological Dynamics of Forest Fragment Project (INPA/Smithsonian Institution). G. R. Juliao was a PhD grant holder supported by CNPq (Process Number: 141415/2003-7); GWF acknowledges the support provided by CNPq (30 3352/2010-8, 403781/2012-4, 457519/2012-6) and Fapemig (APQ-04105-10); and EMV acknowledges the support provided by CNPq no309458/2013-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell AD, 1999, BIOL J LINN SOC, V66, P481, DOI 10.1111/j.1095-8312.1999.tb01922.x; BLANCHE KR, 1995, ECOLOGY, V76, P2334, DOI 10.2307/1941706; Blanche KR, 2000, AUSTRAL ECOL, V25, P311, DOI 10.1046/j.1442-9993.2000.01040.x; Blanche KR, 2001, AM MIDL NAT, V145, P219, DOI 10.1674/0003-0031(2001)145[0219:SROGII]2.0.CO;2; Camargo MAB, 2012, REV ARVORE, V36, P7, DOI 10.1590/S0100-67622012000100002; Carvalho-Fernandes SP, 2010, THESIS I NACL PESQUI; Crawley M.J., 2007, R BOOK; Cuevas-Reyes P, 2004, OIKOS, V107, P181, DOI 10.1111/j.0030-1299.2004.13263.x; De Oliveira AA, 1999, BIODIVERS CONSERV, V8, P1219, DOI 10.1023/A:1008908615271; de Souza Mendonça Jr. Milton, 2007, Bol. Soc. Argent. Bot., V42, P347; Doughty CE, 2008, J GEOPHYS RES-BIOGEO, V113, DOI [10.1029/2007JG000632, 10.1029/2007JG000590]; Espirito-Santo MM, 2007, ANN ENTOMOL SOC AM, V100, P95, DOI 10.1603/0013-8746(2007)100[95:HMSOGI]2.0.CO;2; Fagundes M, 2005, ECOL ENTOMOL, V30, P28, DOI 10.1111/j.0307-6946.2005.00668.x; Fernandes G. Wilson, 1997, Naturalia (Rio Claro), V22, P221; Fernandes G. Wilson, 1993, Biodiversity Letters, V1, P186, DOI 10.2307/2999743; Fernandes Geraldo Wilson, 2005, P693; FERNANDES GW, 1988, OECOLOGIA, V76, P161, DOI 10.1007/BF00379948; FERNANDES GW, 1992, OECOLOGIA, V90, P14, DOI 10.1007/BF00317803; FERNANDES GW, 1992, GLOBAL ECOL BIOGEOGR, V2, P71, DOI 10.2307/2997508; Fernandes GW, 1991, PLANT ANIMAL INTERAC, P91; Franklin Elizabeth, 1997, Ecological Studies, V126, P331; Gonçalves José Francisco de C., 2005, Acta Amaz., V35, P23, DOI 10.1590/S0044-59672005000100004; Groom PK, 1999, ECOSCIENCE, V6, P471, DOI 10.1080/11956860.1999.11682537; Haugaasen Torbjørn, 2006, Acta Amaz., V36, P25, DOI 10.1590/S0044-59672006000100005; Hill RS, 1998, AUST SYST BOT, V11, P391, DOI 10.1071/SB97016; Hofer Hubert, 1997, Ecological Studies, V126, P373; Juliao GR, 2005, UAKARI, V1, P39; Junk W.J., 1989, TROPICAL FORESTS BOT, P47, DOI [DOI 10.1016/B978-0-12-353550-4.50012-5, 10.1016/b978-0-12-353550-4.50012-5]; Junk W.J., 2010, AMAZONIAN FLOODPLAIN, V210, P511, DOI [10.1007/978-90-481-8725-6_24, DOI 10.1007/978-90-481-8725-6_24]; Junk W. J., 1983, AMAZONIA DESENVOLVIM, P45; Junk WJ, 1984, AMAZON LIMNOLOGY LAN, P215; KUBITZKI K, 1989, PLANT SYST EVOL, V162, P285, DOI 10.1007/BF00936922; Lara ACF, 2002, TROP ZOOL, V15, P219, DOI 10.1080/03946975.2002.10531176; Lara Angela Christina F., 1996, Biodiversity Letters, V3, P111, DOI 10.2307/2999724; MALCOLM JR, 1991, J MAMMAL, V72, P188, DOI 10.2307/1381995; Marenco RA, 2001, TREE PHYSIOL, V21, P1311, DOI 10.1093/treephys/21.18.1311; MEDIANERO E, 2001, SCIENTIA PANAMA, V16, P17; Medianero Enrique, 2003, Acta Zool. Mex, P153; Medianero E, 2010, NEOTROP ENTOMOL, V39, P365, DOI 10.1590/S1519-566X2010000300009; MONTEIRO R.F, 2002, ARQUIVOS MUSEU NACL, V61, P31; Paniagua MR, 2009, ECOL ENTOMOL, V34, P310, DOI 10.1111/j.1365-2311.2008.01079.x; Pires JM, 1985, KEY ENV AMAZONIA, P83; Powers JS, 2005, NEW PHYTOL, V165, P913, DOI 10.1111/j.1469-8137.2004.01279.x; PRANCE GT, 1979, BRITTONIA, V31, P26, DOI 10.2307/2806669; PRANCE GT, 1989, TROPICAL RAIN FOREST, P99; Price P.W., 1991, P51; Price PW, 1998, J BIOGEOGR, V25, P581, DOI 10.1046/j.1365-2699.1998.2530581.x; Pereira MJR, 2010, CURR ZOOL, V56, P469, DOI 10.1093/czoolo/56.4.469; Ribeiro KT, 1998, ECOL ENTOMOL, V23, P491, DOI 10.1046/j.1365-2311.1998.00162.x; Ribeiro Servio P., 2011, Memoirs of the Queensland Museum, V55, P481; Ribeiro SP, 2007, ECOGRAPHY, V30, P663, DOI 10.1111/j.2007.0906-7590.05083.x; Ribeiro SP, 2005, ECOGRAPHY, V28, P315, DOI 10.1111/j.0906-7590.2005.04104.x; Ribeiro SP, 2003, ARTHROPODS OF TROPICAL FORESTS, P348; Sanches MC, 2010, TREES-STRUCT FUNCT, V24, P79, DOI 10.1007/s00468-009-0380-6; Schongart J, 2005, OECOLOGIA, V145, P454, DOI 10.1007/s00442-005-0147-8; Sereneski-de Lima C, 2013, REV MEX BIODIVERS, V84, P1159, DOI 10.7550/rmb.32149; Sioli H., 1991, AMAZONIA FUNDAMENTOS; Sobrado MA, 2010, J TROP ECOL, V26, P215, DOI 10.1017/S0266467409990538; Southwood T. R. E., 1960, P HAWAII ENTOMOL SOC, V17, P229; Sullivan LL, 2011, ECOLOGY, V92, P1559, DOI 10.1890/10-1116.1; Tooker JF, 2008, NEW PHYTOL, V178, P657, DOI 10.1111/j.1469-8137.2008.02392.x; Tribuzy ES, 2003, 7 LBA ECO SCI TEAM B, P94; TRIBUZY ES, 2005, THESIS U SAO PAULO B; TURNER IM, 1994, FUNCT ECOL, V8, P669, DOI 10.2307/2390225; Veldtman R, 2003, AUSTRAL ECOL, V28, P1, DOI 10.1046/j.1442-9993.2003.01234.x; Victoria RL, 2000, AMAZONIA ECOSSISTEMA, P163; Waldhoff D., 2010, AMAZONIAN FLOODPLAIN, V210, DOI [10.1007/978-90-481-8725-6_9, DOI 10.1007/978-90-481-8725-6_9]; Fernandes GW, 2010, ENVIRON ENTOMOL, V39, P1134, DOI 10.1603/EN09199; Wittmann F, 2004, FOREST ECOL MANAG, V196, P199, DOI 10.1016/j.foreco.2004.02.060; Wittmann F, 2002, J TROP ECOL, V18, P805, DOI 10.1017/S0266467402002523; Worbes M., 1997, CENTRAL AMAZON FLOOD, VVol. 126, P223, DOI [DOI 10.1007/978-3-662-03416-3_11, 10.1007/978-3-662-03416-3_11]; Wright Mark G., 1996, Biodiversity Letters, V3, P151, DOI 10.2307/2999733; Wright MG, 1998, OECOLOGIA, V115, P427, DOI 10.1007/s004420050537; Yang MM, 1998, US FOR SERV T R NC, V199, P44; Yukawa Junichi, 2001, Esakia, V41, P11	75	26	29	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114986	10.1371/journal.pone.0114986	http://dx.doi.org/10.1371/journal.pone.0114986			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551769	gold, Green Published, Green Submitted			2022-12-26	WOS:000347119100021
J	Kao, LT; Liu, SP; Lin, HC; Lee, HC; Tsai, MC; Chung, SD				Kao, Li-Ting; Liu, Shih-Ping; Lin, Herng-Ching; Lee, Hsin-Chien; Tsai, Ming-Chieh; Chung, Shiu-Dong			Poor Clinical Outcomes among Pneumonia Patients with Depressive Disorder	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; COMMON COLD; PSYCHOLOGICAL STRESS; MORTALITY; MORBIDITY; PSYCHONEUROIMMUNOLOGY; HOSPITALIZATION; SUSCEPTIBILITY; EPIDEMIOLOGY; PERSPECTIVES	Background: Some studies suggested that psychological stress may be associated with the severity and duration of infectious diseases. In this population-based study, we investigated associations between depressive disorder (DD) and pneumonia outcomes in Taiwan with a large-scale database from the National Health Insurance. Methods: Our study defined 112,198 patients who were hospitalized with a principal diagnosis of pneumonia. We defined their admission date for treatment of pneumonia as the index date. Subsequently, we selected 2,394 patients with DD within 3 years prior to their index date and 11,970 matched patients without DD. We carried out separate conditional logistic regressions to explore the association of clinical pneumonia treatment outcome (ICU admission, use of mechanical ventilation, acute respiratory failure and in-hospital death) with previously diagnosed DD. Results: Patients with DD had a significantly higher probability of an intensive care unit admission (18.1% vs. 12.9%; p< 0.001), need for mechanical ventilation (21.9% vs. 18.1%; p< 0.001) and in-hospital death (10.4% vs. 9.0%; p=0.025) than patients without DD. The study showed that pneumonia patients with DD were respectively 1.41- (95% CI: 1.25 similar to 1.59, p< 0.001), 1.28- (95% CI: 1.14 similar to 1.43, p< 0.001), and 1.17- times (95% CI: 1.01 similar to 1.36, p=0.039) greater odds of being admitted to the ICU, need for mechanical ventilation, and in-hospital death than patients without DD after adjusting for monthly income, urbanization level, geographic region and Charlson Comorbidity Index score. Conclusions: In conclusion, we found that pneumonia patients with DD were associated with poor treatment outcomes compared to patients without DD.	[Kao, Li-Ting] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Kao, Li-Ting; Lin, Herng-Ching; Chung, Shiu-Dong] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Liu, Shih-Ping] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Liu, Shih-Ping] Coll Med, Taipei, Taiwan; [Lin, Herng-Ching; Tsai, Ming-Chieh] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Lee, Hsin-Chien] Taipei Med Univ, Sch Med, Dept Psychiat, Taipei, Taiwan; [Tsai, Ming-Chieh] Cathay Gen Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Div Urol, Taipei, Taiwan	National Defense Medical Center; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Medical University; Cathay General Hospital; Far Eastern Memorial Hospital	Chung, SD (corresponding author), Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan.	chungshiudong@gmail.com	Kao, Li-Ting/W-9287-2018	Kao, Li-Ting/0000-0003-0692-7408; lee, hsin-chien/0000-0002-7557-8259; LIU, SHIH-PING/0000-0002-8015-0695	Ministry of Science and Technology in Taiwan [102-2632-B-038-001-MY3]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported partially by a grant from the Ministry of Science and Technology in Taiwan (Project No. 102-2632-B-038-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow GD, 2003, LANCET INFECT DIS, V3, P476, DOI 10.1016/S1473-3099(03)00721-7; Chen YH, 2011, SCHIZOPHRENIA BULL, V37, P1088, DOI 10.1093/schbul/sbq019; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Cohen S, 1998, HEALTH PSYCHOL, V17, P214, DOI 10.1037/0278-6133.17.3.214; Davydow DS, 2013, AM J MED, V126, P615, DOI 10.1016/j.amjmed.2012.12.006; Davydow DS, 2014, J PSYCHOSOM RES; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Godbout JP, 2006, J NEUROIMMUNE PHARM, V1, P421, DOI 10.1007/s11481-006-9036-0; Gutierrez F, 2008, DRUG AGING, V25, P585, DOI 10.2165/00002512-200825070-00005; Hak E, 2005, FAM PRACT, V22, P375, DOI 10.1093/fampra/cmi020; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Insel TR, 2003, JAMA-J AM MED ASSOC, V289, P3167, DOI 10.1001/jama.289.23.3167; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kiecolt-Glaser JK, 1998, AM PSYCHOL, V53, P1209, DOI 10.1037/0003-066X.53.11.1209; Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4; Kiecolt-Glaser JK, 2002, ANNU REV PSYCHOL, V53, P83, DOI 10.1146/annurev.psych.53.100901.135217; KIECOLTGLASER JK, 1995, LANCET, V346, P1194, DOI 10.1016/S0140-6736(95)92899-5; Kornum JB, 2007, DIABETES CARE, V30, P2251, DOI 10.2337/dc06-2417; Lepine Jean-Pierre, 2011, Neuropsychiatr Dis Treat, V7, P3, DOI 10.2147/NDT.S19617; Leserman J, 1999, PSYCHOSOM MED, V61, P397, DOI 10.1097/00006842-199905000-00021; McAlister FA, 2005, DIABETES CARE, V28, P810, DOI 10.2337/diacare.28.4.810; Petretta M, 2000, Am Heart J, V140, pE28, DOI 10.1067/mhj.2000.110935; Polverino E, 2011, MINERVA ANESTESIOL, V77, P196; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Restrepo MI, 2006, EUR RESPIR J, V28, P346, DOI 10.1183/09031936.06.00131905; STONE AA, 1992, BEHAV MED, V18, P115, DOI 10.1080/08964289.1992.9936961; Yende S, 2005, AM J RESP CRIT CARE, V172, P1440, DOI 10.1164/rccm.200506-888OC	30	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116436	10.1371/journal.pone.0116436	http://dx.doi.org/10.1371/journal.pone.0116436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551389	Green Submitted, Green Published, gold			2022-12-26	WOS:000347119100141
J	Ohtani, T; Nestor, PG; Bouix, S; Saito, Y; Hosokawa, T; Kubicki, M				Ohtani, Toshiyuki; Nestor, Paul G.; Bouix, Sylvain; Saito, Yukiko; Hosokawa, Taiga; Kubicki, Marek			Medial Frontal White and Gray Matter Contributions to General Intelligence	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; VENTROMEDIAL PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; P-FIT; CONNECTIVITY; ARCHITECTURE; REWARD; INTEGRITY	The medial orbitofrontal cortex (mOFC) and rostral anterior cingulate cortex (rACC) are part of a wider neural network that plays an important role in general intelligence and executive function. We used structural brain imaging to quantify magnetic resonance gray matter volume and diffusion tensor white matter integrity of the mOFC-rACC network in 26 healthy participants who also completed neuropsychological tests of intellectual abilities and executive function. Stochastic tractography, the most effective Diffusion Tensor Imaging method for examining white matter connections between adjacent gray matter regions, was employed to assess the integrity of mOFC-rACC pathways. Fractional anisotropy (FA), which reflects the integrity of white matter connections, was calculated. Results indicated that higher intelligence correlated with greater gray matter volumes for both mOFC and rACC, as well as with increased FA for left posterior mOFC-rACC connectivity. Hierarchical regression analyses revealed that DTI-derived FA of left posterior mOFC-rACC uniquely accounted for 29%-34% of the variance in IQ, in comparison to 11%-16% uniquely explained by gray matter volume of the left rACC. Together, left rACC gray matter volume and white matter connectivity between left posterior mOFC and rACC accounted for up to 50% of the variance in general intelligence. This study is to our knowledge the first to examine white matter connectivity between OFC and ACC, two gray matter regions of interests that are very close in physical proximity, and underscores the important independent contributions of variations in rACC gray matter volume and mOFC-rACC white matter connectivity to individual differences in general intelligence.	[Ohtani, Toshiyuki; Bouix, Sylvain; Saito, Yukiko; Hosokawa, Taiga; Kubicki, Marek] Harvard Univ, Brigham & Womens Hosp, Sch Med, Psychiat Neuroimaging Lab,Dept Psychiat & Radiol, Boston, MA 02115 USA; [Ohtani, Toshiyuki; Nestor, Paul G.; Hosokawa, Taiga] Harvard Univ, Sch Med, Vet Affairs VA Boston Healthcare Syst, Clin Neurosci Div,Lab Neurosci,Dept Psychiat, Brockton, MA 02401 USA; [Nestor, Paul G.] Univ Massachusetts, Dept Psychol, Boston, MA 02125 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; University of Massachusetts System; University of Massachusetts Boston	Kubicki, M (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Psychiat Neuroimaging Lab,Dept Psychiat & Radiol, Boston, MA 02115 USA.	kubicki@bwh.harvard.edu	Ohtani, Toshiyuki/I-2042-2018	Bouix, Sylvain/0000-0003-1326-6054; Ohtani, Toshiyuki/0000-0002-8013-0424	National Institutes of Health [R01 AG042512, R01 MH102377, R01 MH 082918, R01MH 074794]; National Institutes of Health through the NIH Roadmap for Medical Research [U54 EB005149]; Center for Integration of Medicine and Innovative Technology Soldier in Medicine Award; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB005149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082918, R01MH102377, R01MH074794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG042512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through the NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Integration of Medicine and Innovative Technology Soldier in Medicine Award; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institutes of Health (R01 AG042512 and R01 MH102377 to MK, R01 MH 082918 to SB and R01MH 074794 to CFW). This work is also part of the National Alliance for Medical Image Computing (NAMIC), funded by the National Institutes of Health through the NIH Roadmap for Medical Research, Grant U54 EB005149 (MK, CFW). In addition, this work has been funded in part by the Center for Integration of Medicine and Innovative Technology Soldier in Medicine Award (to SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 1997, MAGN RESON MED, V38, P1016, DOI 10.1002/mrm.1910380623; Allman JM, 2001, ANN NY ACAD SCI, V935, P107, DOI 10.1111/j.1749-6632.2001.tb03476.x; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bjornemo M, 2002, LECT NOTES COMPUT SC, V2488, P435; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chiang MC, 2009, J NEUROSCI, V29, P2212, DOI 10.1523/JNEUROSCI.4184-08.2009; Choi JS, 2004, J PSYCHIATR RES, V38, P193, DOI 10.1016/j.jpsychires.2003.08.001; Colom R, 2009, INTELLIGENCE, V37, P124, DOI 10.1016/j.intell.2008.07.007; de Marco G, 2006, NEUROIMAGE, V30, P1030, DOI 10.1016/j.neuroimage.2005.10.001; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Deary IJ, 2006, NEUROLOGY, V66, P505, DOI 10.1212/01.wnl.0000199954.81900.e2; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; First MB, 2002, STRUCTURED CLIN INTE; Garlick D, 2002, PSYCHOL REV, V109, P116, DOI 10.1037//0033-295X.109.1.116; Glascher J, 2009, CEREB CORTEX, V19, P483, DOI 10.1093/cercor/bhn098; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Gray JR, 2004, NAT REV NEUROSCI, V5, P471, DOI 10.1038/nrn1405; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Heaton, 1981, WISCONSIN CARD SORTI; Heid O., 2000, P 8 ANN M ISMRM, V8, P799; Hollingshead AB, 1965, 2 FACTOR INDEX SOCIA; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Koski L, 2000, EXP BRAIN RES, V133, P55, DOI 10.1007/s002210000400; Kreher BW, 2008, NEUROIMAGE, V43, P81, DOI 10.1016/j.neuroimage.2008.06.023; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kubicki M, 2002, HARVARD REV PSYCHIAT, V10, P324, DOI 10.1093/hrp/10.6.324; Kubicki M, 2011, NEUROIMAGE, V55, P1657, DOI 10.1016/j.neuroimage.2011.01.047; Nestor PG, 2008, NEUROPSYCHOLOGY, V22, P246, DOI 10.1037/0894-4105.22.2.246; Neubauer AC, 2009, NEUROSCI BIOBEHAV R, V33, P1004, DOI 10.1016/j.neubiorev.2009.04.001; Oishi K, 2009, J NEUROIMAGING, V19, P127, DOI 10.1111/j.1552-6569.2008.00262.x; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Penke L, 2012, MOL PSYCHIATR, V17, P1026, DOI 10.1038/mp.2012.66; Pernice V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002059; Powell HWR, 2006, NEUROIMAGE, V32, P388, DOI 10.1016/j.neuroimage.2006.03.011; Reitan RM, 1992, TRAIL MAKING TEST MA; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Szatkowska I, 2011, NEUROBIOL LEARN MEM, V96, P385, DOI 10.1016/j.nlm.2011.06.014; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Wechsler D., 1997, WECHSLER ADULT INTEL; Zald DH, 1996, J NEUROPSYCH CLIN N, V8, P249	49	15	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e112691	10.1371/journal.pone.0112691	http://dx.doi.org/10.1371/journal.pone.0112691			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551572	gold, Green Published, Green Submitted			2022-12-26	WOS:000347119100004
J	Shoji, T; Kuroda, H; Suzuki, M; Baba, M; Hangai, M; Araie, M; Yoneya, S				Shoji, Takuhei; Kuroda, Hiroto; Suzuki, Masayuki; Baba, Motoyoshi; Hangai, Masanori; Araie, Makoto; Yoneya, Shin			Correlation between Lamina Cribrosa Tilt Angles, Myopia and Glaucoma Using OCT with a Wide Bandwidth Femtosecond Mode-Locked Laser	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NORMAL-TENSION GLAUCOMA; DISC MARGIN ANATOMY; NERVE HEAD; DISPLACEMENT; THICKNESS; DAMAGE; REVERSAL; EYES	Purpose: To measure horizontal and vertical lamina cribrosa (LC) tilt angles and investigate associated factors using prototype optical coherence tomography (OCT) with a broad wavelength laser light source. Design: Cross sectional study. Methods: Twenty-eight no glaucoma eyes (from 15 subjects) and 25 glaucoma eyes (from 14 patients) were enrolled. A total of 300 optic nerve head B-scans were obtained in 10 mm steps and the inner edge of Bruch's membrane opening (BMO) was identified as the reference plane. The vertical and horizontal angles between BMO line and approximate the best-fitting line for the surface of the LC were measured and potential associated factors were estimated with univariate and multivariate logistic regression analyses. Results: The median (interquartile range) horizontal and vertical tilt angles were 7.10 (2.43-11.45) degrees and 4.15 (2.60-6.85) degrees in eyes without glaucoma and 8.50 (4.40-14.10) degrees and 9.30 (6.90-14.15) degrees in glaucoma eyes, respectively. The refractive errors had a statistically significant association with horizontal LC tilt angles (coefficients, -1.53 per diopter) and glaucoma had a significant correlation with vertical tilt angles (coefficients, 6.56) using multiple logistic regression analysis (p<0.001). Conclusions: OCT allowed evaluation of the internal tilting of the LC compared with the BMO. The horizontal internal LC tilt angle was correlated with refractive errors, corresponding to myopic physiological changes, and vertical internal LC tilt was correlated with glaucoma, corresponding to glaucomatous pathological changes. These parameters have important implications for investigation of the correlation between myopia, glaucoma and LC morphological features.	[Shoji, Takuhei; Kuroda, Hiroto; Suzuki, Masayuki; Hangai, Masanori; Araie, Makoto; Yoneya, Shin] Saitama Med Univ, Dept Ophthalmol, Iruma, Saitama, Japan; [Shoji, Takuhei; Kuroda, Hiroto; Suzuki, Masayuki; Baba, Motoyoshi; Hangai, Masanori; Yoneya, Shin] Saitama Med Univ, Dept Ophthalmol, Adv Laser Med Ctr, Iruma, Saitama, Japan; [Araie, Makoto] Kanto Cent Hosp, Dept Ophthalmol, Tokyo, Japan	Saitama Medical University; Saitama Medical University	Shoji, T (corresponding author), Saitama Med Univ, Dept Ophthalmol, Iruma, Saitama, Japan.	shoojii@saitama-med.ac.jp	Shoji, Takuhei/W-1856-2017	Shoji, Takuhei/0000-0002-5464-2573	Suda Memorial Fund for Glaucoma Research, Chiyoda, Tokyo, Japan; Takeda Science Foundation, Tokyo, Japan; Japan Society for the Promotion of Science [25870678, 24760048]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [25870678] Funding Source: KAKEN	Suda Memorial Fund for Glaucoma Research, Chiyoda, Tokyo, Japan; Takeda Science Foundation, Tokyo, Japan(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Suda Memorial Fund for Glaucoma Research, Chiyoda, Tokyo, Japan; by the Takeda Science Foundation, Tokyo, Japan; and by a Grant-in-Aid for Young Scientists (B) (number 25870678 and 24760048) from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2000, AM J OPHTHALMOL, V130, P827, DOI 10.1016/S0002-9394(00)00665-6; Furlanetto RL, 2013, INVEST OPHTH VIS SCI, V54, P4836, DOI 10.1167/iovs.12-11530; Hosseini H, 2013, AM J OPHTHALMOL, V156, P737, DOI 10.1016/j.ajo.2013.05.036; Inoue R, 2009, OPHTHALMOLOGY, V116, P214, DOI 10.1016/j.ophtha.2008.09.008; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P401; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047237; Kim TW, 2012, OPHTHALMOLOGY, V119, P21, DOI 10.1016/j.ophtha.2011.07.051; Kuroda H, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824493; Kuroda H, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4812342; Lee EJ, 2013, OPHTHALMOLOGY, V120, P553, DOI 10.1016/j.ophtha.2012.08.047; Lee EJ, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.034; Mari JM, 2013, INVEST OPHTH VIS SCI, V54, P2238, DOI 10.1167/iovs.12-11327; Nakazawa M, 2008, ACTA OPHTHALMOL, V86, P626, DOI 10.1111/j.1600-0420.2007.01139.x; Park HYL, 2012, OPHTHALMOLOGY, V119, P1844, DOI 10.1016/j.ophtha.2012.03.006; Park HYL, 2013, OPHTHALMOLOGY, V120, P745, DOI 10.1016/j.ophtha.2012.09.051; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; Park SC, 2012, OPHTHALMOLOGY, V119, P3, DOI 10.1016/j.ophtha.2011.07.012; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; RADIUS RL, 1981, ARCH OPHTHALMOL-CHIC, V99, P2159; Reis ASC, 2012, OPHTHALMOLOGY, V119, P738, DOI 10.1016/j.ophtha.2011.09.054; Roberts MD, 2010, INVEST OPHTH VIS SCI, V51, P5675, DOI 10.1167/iovs.10-5411; Sigal IA, 2011, INVEST OPHTH VIS SCI, V52, P1896, DOI 10.1167/iovs.10-5500; Strouthidis NG, 2009, INVEST OPHTH VIS SCI, V50, P2165, DOI 10.1167/iovs.08-2786; Strouthidis NG, 2009, INVEST OPHTH VIS SCI, V50, P214, DOI 10.1167/iovs.08-2302; Tay E, 2005, AM J OPHTHALMOL, V139, P247, DOI 10.1016/j.ajo.2004.08.076; WILCZEK M, 1947, BRIT J OPHTHALMOL, V31, P551, DOI 10.1136/bjo.31.9.551; Yang HL, 2007, INVEST OPHTH VIS SCI, V48, P4597, DOI 10.1167/iovs.07-0349; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P7109, DOI 10.1167/iovs.11-7448; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P345, DOI 10.1167/iovs.09-5122	31	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116305	10.1371/journal.pone.0116305	http://dx.doi.org/10.1371/journal.pone.0116305			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551632	Green Submitted, Green Published, gold			2022-12-26	WOS:000347119100130
J	Tagliaferri, C; Davicco, MJ; Lebecque, P; George, S; Amiot, MJ; Mercier, S; Dhaussy, A; Huertas, A; Walrand, S; Wittrant, Y; Coxam, V				Tagliaferri, Camille; Davicco, Marie-Jeanne; Lebecque, Patrice; George, Stephane; Amiot, Marie-Jo; Mercier, Sylvie; Dhaussy, Amelie; Huertas, Alain; Walrand, Stephane; Wittrant, Yohann; Coxam, Veronique			Olive Oil and Vitamin D Synergistically Prevent Bone Loss in Mice	PLOS ONE			English	Article							OVARIECTOMY/INFLAMMATION EXPERIMENTAL-MODEL; INFLAMMATION-INDUCED OSTEOPOROSIS; OXIDATIVE STRESS; MEDITERRANEAN DIET; MINERAL DENSITY; OVARIECTOMIZED MICE; NITRIC-OXIDE; MACROPHAGE ACTIVATION; ANTIOXIDANT SYSTEM; PHENOLIC-COMPOUNDS	As the Mediterranean diet (and particularly olive oil) has been associated with bone health, we investigated the impact of extra virgin oil as a source of polyphenols on bone metabolism. In that purpose sham-operated (SH) or ovariectomized (OVX) mice were subjected to refined or virgin olive oil. Two supplementary OVX groups were given either refined or virgin olive oil fortified with vitamin D3, to assess the possible synergistic effects with another liposoluble nutrient. After 30 days of exposure, bone mineral density and gene expression were evaluated. Consistent with previous data, ovariectomy was associated with increased bone turnover and led to impaired bone mass and micro-architecture. The expression of oxidative stress markers were enhanced as well. Virgin olive oil fortified with vitamin D3 prevented such changes in terms of both bone remodeling and bone mineral density. The expression of inflammation and oxidative stress mRNA was also lower in this group. Overall, our data suggest a protective impact of virgin olive oil as a source of polyphenols in addition to vitamin D3 on bone metabolism through improvement of oxidative stress and inflammation.	[Tagliaferri, Camille; Davicco, Marie-Jeanne; Lebecque, Patrice; Mercier, Sylvie; Walrand, Stephane; Wittrant, Yohann; Coxam, Veronique] INRA, Unite Mixte Rech UMR 1019, Unite Nutr Humaine, Ctr Rech Nutr Humaine CRNH Auvergne, Clermont Ferrand, France; [Tagliaferri, Camille; Davicco, Marie-Jeanne; Lebecque, Patrice; Mercier, Sylvie; Walrand, Stephane; Wittrant, Yohann; Coxam, Veronique] Univ Auvergne, Clermont Univ, Clermont Ferrand, France; [Tagliaferri, Camille; Dhaussy, Amelie; Huertas, Alain] Lesieur, F-92665 Asnieres, France; [George, Stephane] CTCPA, Dept Biochem, F-84911 Avignon 9, France; [Amiot, Marie-Jo] INRA, UMR 1260, Marseille, France; [Amiot, Marie-Jo] INSERM, UMR 1260, F-13258 Marseille, France; [Amiot, Marie-Jo] Univ Aix Marseille, Fac Med, Marseille, France	INRAE; Universite Clermont Auvergne (UCA); INRAE; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Coxam, V (corresponding author), INRA, Unite Mixte Rech UMR 1019, Unite Nutr Humaine, Ctr Rech Nutr Humaine CRNH Auvergne, Clermont Ferrand, France.	veronique.coxam@clermont.inra.fr	Amiot, Marie Josephe/M-1203-2017; AMIOT, MARIE JOSEPHE/N-8894-2019; Amiot, Marie Josephe/C-4457-2015	Amiot, Marie Josephe/0000-0003-4563-4587; AMIOT, MARIE JOSEPHE/0000-0003-4563-4587; Walrand, Stephane/0000-0002-4349-3664	Conventions Industrielles de Formation par la REcherche grant (CIFRE) grant from the French National Association for Research and Technology [2011/99]; Lesieur; CIFRE; pOLIVd3 ANR (French National Research Agency) [ANR-10-ALIA-0008]	Conventions Industrielles de Formation par la REcherche grant (CIFRE) grant from the French National Association for Research and Technology; Lesieur; CIFRE; pOLIVd3 ANR (French National Research Agency)(French National Research Agency (ANR))	CT was funded by a Conventions Industrielles de Formation par la REcherche grant (CIFRE; no 2011/99) from the French National Association for Research and Technology (http://www.anrt.asso.fr/) in partnership with Lesieur. This work was supported by both the CIFRE grant and the pOLIVd3 ANR (French National Research Agency; http://www.agence-nationale-recherche.fr/) program ANR-10-ALIA-0008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami S, 2009, OSTEOPOROSIS INT, V20, P239, DOI 10.1007/s00198-008-0650-y; Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Arai M, 2007, IUBMB LIFE, V59, P27, DOI 10.1080/15216540601156188; Armour KE, 1999, J BONE MINER RES, V14, P2137, DOI 10.1359/jbmr.1999.14.12.2137; Armour KJ, 2001, ARTHRITIS RHEUM, V44, P2790, DOI 10.1002/1529-0131(200112)44:12<2790::AID-ART466>3.0.CO;2-X; Basu S, 2001, BIOCHEM BIOPH RES CO, V288, P275, DOI 10.1006/bbrc.2001.5747; Beauchamp GK, 2005, NATURE, V437, P45, DOI 10.1038/437045a; Benetou V, 2013, OSTEOPOROSIS INT, V24, P1587, DOI 10.1007/s00198-012-2187-3; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Boonen S, 2007, J CLIN ENDOCR METAB, V92, P1415, DOI 10.1210/jc.2006-1404; Boskou D., 2006, OLIVE OIL, V2nd, P41, DOI [DOI 10.1016/B978-1-893997-88-2.50008-0, 10.1016/B978-1-893997-88-2.50008-0]; Cano A, 2008, OSTEOPOROSIS INT, V19, P793, DOI 10.1007/s00198-007-0498-6; CANTATORE FP, 1995, CLIN RHEUMATOL, V14, P157, DOI 10.1007/BF02214935; Cicerale S, 2010, INT J MOL SCI, V11, P458, DOI 10.3390/ijms11020458; Cuzzocrea S, 2003, ENDOCRINOLOGY, V144, P1098, DOI 10.1210/en.2002-220597; Dai J, 2008, AM J CLIN NUTR, V88, P1364, DOI 10.3945/ajcn.2008.26528; de la Puerta R, 1999, BIOCHEM PHARMACOL, V57, P445, DOI 10.1016/S0006-2952(98)00320-7; De Stefano D, 2007, EUR J PHARMACOL, V566, P192, DOI 10.1016/j.ejphar.2007.03.051; Faine LA, 2006, CAN J PHYSIOL PHARM, V84, P239, DOI 10.1139/Y05-124; FINKELMAN RD, 1992, P NATL ACAD SCI USA, V89, P12190, DOI 10.1073/pnas.89.24.12190; Fito M, 2008, EUR J CLIN NUTR, V62, P570, DOI 10.1038/sj.ejcn.1602724; Galtier O, 2007, ANAL CHIM ACTA, V595, P136, DOI 10.1016/j.aca.2007.02.033; Gonzalez-Correa JA, 2007, LIPIDS, V42, P921, DOI 10.1007/s11745-007-3097-6; Gregory LS, 2006, BONE, V39, P134, DOI 10.1016/j.bone.2005.12.017; Hagiwara K, 2011, EUR J PHARMACOL, V662, P78, DOI 10.1016/j.ejphar.2011.04.023; Hilger J, 2014, BRIT J NUTR, V111, P23, DOI 10.1017/S0007114513001840; Iacono A, 2010, ARTHRITIS RHEUM-US, V62, P1675, DOI 10.1002/art.27437; IKEDA T, 1993, BIOCHEM BIOPH RES CO, V194, P1228, DOI 10.1006/bbrc.1993.1954; JOHNELL O, 1992, OSTEOPOROSIS INT, V2, P298, DOI 10.1007/BF01623186; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; KANIS JA, 1993, OSTEOPOROSIS INT, V3, pS10; Keiler AM, 2013, EUR J NUTR; Khanal P, 2011, CARCINOGENESIS, V32, P545, DOI 10.1093/carcin/bgr001; Kontogianni MD, 2009, NUTRITION, V25, P165, DOI 10.1016/j.nut.2008.07.019; Liang HD, 2013, MOL BIOL REP, V40, P757, DOI 10.1007/s11033-012-2065-2; Lips P, 2010, J STEROID BIOCHEM, V121, P297, DOI 10.1016/j.jsbmb.2010.02.021; Mailer A.R., 2006, PRIME FACTS, V227, P1; Maiuri MC, 2005, N-S ARCH PHARMACOL, V371, P457, DOI 10.1007/s00210-005-1078-y; Fernandez-Real JM, 2012, J CLIN ENDOCR METAB, V97, P3792, DOI 10.1210/jc.2012-2221; Martinez-Dominguez E, 2001, INFLAMM RES, V50, P102, DOI 10.1007/s000110050731; Moreno JJ, 2003, FREE RADICAL BIO MED, V35, P1073, DOI 10.1016/S0891-5849(03)00465-9; Musumeci G, 2013, ACTA HISTOCHEM; Muthusami S, 2005, CLIN CHIM ACTA, V360, P81, DOI 10.1016/j.cccn.2005.04.014; Ovesen L, 2003, P NUTR SOC, V62, P813, DOI 10.1079/PNS2003297; Park Y, 2013, FOOD CHEM, V140, P280, DOI 10.1016/j.foodchem.2012.12.067; PECK WA, 1993, AM J MED, V94, P646; Perez-Lopez FR, 2009, MATURITAS, V64, P67, DOI 10.1016/j.maturitas.2009.07.013; Puel C, 2004, BRIT J NUTR, V92, P119, DOI 10.1079/BJN20041181; Puel C, 2008, J AGR FOOD CHEM, V56, P9417, DOI 10.1021/jf801794q; Puel C, 2007, BRIT J NUTR, V97, P1012, DOI 10.1017/S0007114507659030; Puel C, 2006, CLIN NUTR, V25, P859, DOI 10.1016/j.clnu.2006.03.009; Ranalli A, 1999, J AGR FOOD CHEM, V47, P417, DOI 10.1021/jf9800256; Rivas A, 2013, INT J FOOD SCI NUTR, V64, P155, DOI 10.3109/09637486.2012.718743; Saleh NK, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-10; Santiago-Mora R, 2011, OSTEOPOROSIS INT, V22, P675, DOI 10.1007/s00198-010-1270-x; Servili M, 2004, J CHROMATOGR A, V1054, P113, DOI 10.1016/S0021-9673(04)01423-2; Spilmont M, 2013, EUR J NUTR; Stark AH, 2002, NUTR REV, V60, P170, DOI 10.1301/002966402320243250; Strom O, 2011, Arch Osteoporos, V6, P59, DOI 10.1007/s11657-011-0060-1; Trichopoulou A, 1997, PREV MED, V26, P395, DOI 10.1006/pmed.1997.0160; van Driel M, 2006, J CELL BIOCHEM, V99, P922, DOI 10.1002/jcb.20875; Virruso C, 2013, REJUVENATION RES; Visioli F, 1998, BIOCHEM BIOPH RES CO, V247, P60, DOI 10.1006/bbrc.1998.8735; Wauquier F, 2009, TRENDS MOL MED, V15, P468, DOI 10.1016/j.molmed.2009.08.004; WILLETT WC, 1995, AM J CLIN NUTR, V61, p1402S, DOI 10.1093/ajcn/61.6.1402S; WRONSKI TJ, 1988, CALCIFIED TISSUE INT, V43, P179, DOI 10.1007/BF02571317; Zhang XM, 2009, N-S ARCH PHARMACOL, V379, P581, DOI 10.1007/s00210-009-0399-7	67	20	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115817	10.1371/journal.pone.0115817	http://dx.doi.org/10.1371/journal.pone.0115817			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551374	Green Published, gold			2022-12-26	WOS:000347119100064
J	Trammell, SA; Zabetakis, D; Moore, M; Verbarg, J; Stenger, DA				Trammell, Scott A.; Zabetakis, Dan; Moore, Martin; Verbarg, Jasenka; Stenger, David A.			Square Wave Voltammetry of TNT at Gold Electrodes Modified with Self-Assembled Monolayers Containing Aromatic Structures	PLOS ONE			English	Article							BRIDGES; EXPLOSIVES; 2,4,6-TRINITROTOLUENE; REDUCTION; MOLECULES	Square wave voltammetry for the reduction of 2,4,6-trinitrotoluene (TNT) was measured in 100 mM potassium phosphate buffer (pH 8) at gold electrodes modified with self-assembled monolayers (SAMs) containing either an alkane thiol or aromatic ring thiol structures. At 15 Hz, the electrochemical sensitivity (mu A/ppm) was similar for all SAMs tested. However, at 60 Hz, the SAMs containing aromatic structures had a greater sensitivity than the alkane thiol SAM. In fact, the alkane thiol SAM had a decrease in sensitivity at the higher frequency. When comparing the electrochemical response between simulations and experimental data, a general trend was observed in which most of the SAMs had similar heterogeneous rate constants within experimental error for the reduction of TNT. This most likely describes a rate limiting step for the reduction of TNT. However, in the case of the alkane SAM at higher frequency, the decrease in sensitivity suggests that the rate limiting step in this case may be electron tunneling through the SAM. Our results show that SAMs containing aromatic rings increased the sensitivity for the reduction of TNT when higher frequencies were employed and at the same time suppressed the electrochemical reduction of dissolved oxygen.	[Trammell, Scott A.; Zabetakis, Dan; Moore, Martin; Verbarg, Jasenka; Stenger, David A.] Ctr Bio Mol Sci & Engn, Naval Res Lab, Washington, DC 20375 USA	United States Department of Defense; United States Navy; Naval Research Laboratory	Zabetakis, D (corresponding author), Ctr Bio Mol Sci & Engn, Naval Res Lab, Washington, DC 20375 USA.	daniel.zabetakis@nrl.navy.mil	Trammell, Scott A./ABB-7140-2020; moore, martin/K-4559-2017	Trammell, Scott A./0000-0002-7996-590X; moore, martin/0000-0002-4214-0920	Office of Naval Research	Office of Naval Research(Office of Naval Research)	This work was funded by the Office of Naval Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agui L, 2005, ANAL BIOANAL CHEM, V382, P381, DOI 10.1007/s00216-004-3017-z; Alkire R., 2009, CHEM MODIFIED ELECTR; Bard A. J., 2001, ELECTROCHEMICAL METH; Bozic RG, 2008, SENSOR ACTUAT B-CHEM, V133, P509, DOI 10.1016/j.snb.2008.03.017; Britz D., 2005, DIGITAL SIMULATIONS; Creager S, 1999, J AM CHEM SOC, V121, P1059, DOI 10.1021/ja983204c; de Boer B, 2003, LANGMUIR, V19, P4272, DOI 10.1021/la0341052; Dudek SP, 2001, J AM CHEM SOC, V123, P8033, DOI 10.1021/ja0043340; Finklea HO, 1996, ELECTROANAL CHEM, V19, P109; Galik M, 2011, ELECTROANAL, V23, P1193, DOI 10.1002/elan.201000754; Gryko DT, 2000, J ORG CHEM, V65, P7345, DOI 10.1021/jo000487u; Honeychurch KC, 2003, BIOSENS BIOELECTRON, V19, P305, DOI 10.1016/S0956-5663(03)00208-2; Kaifer A. E., 1999, SUPRAMOLECULAR ELECT; Mandler D, 2011, J SOLID STATE ELECTR, V15, P1535, DOI 10.1007/s10008-011-1493-6; PEARSON J, 1948, T FARADAY SOC, V44, P683, DOI 10.1039/tf9484400683; SABATANI E, 1993, LANGMUIR, V9, P2974, DOI 10.1021/la00035a040; Sachs SB, 1997, J AM CHEM SOC, V119, P10563, DOI 10.1021/ja972244y; Schmelling DC, 1996, ENVIRON SCI TECHNOL, V30, P2547, DOI 10.1021/es950896l; Sikes HD, 2001, SCIENCE, V291, P1519, DOI 10.1126/science.1055745; Stapleton JJ, 2003, LANGMUIR, V19, P8245, DOI 10.1021/la035172z; Tour JM, 2001, CHEM-EUR J, V7, P5118, DOI 10.1002/1521-3765(20011203)7:23<5118::AID-CHEM5118>3.0.CO;2-1; Trammell SA, 2008, ANAL CHEM, V80, P4627, DOI 10.1021/ac702263t; Trammell SA, 2007, LANGMUIR, V23, P942, DOI 10.1021/la061555w; Trammell SA, 2011, SENSOR ACTUAT B-CHEM, V155, P737, DOI 10.1016/j.snb.2011.01.039; Trammell SA, 2009, J ELECTROANAL CHEM, V632, P127, DOI 10.1016/j.jelechem.2009.04.007; Ulman A., 1991, INTRO ULTRATHIN ORGA; WALCZAK MM, 1991, LANGMUIR, V7, P2687, DOI 10.1021/la00059a048; Wang J, 1998, TALANTA, V46, P1405, DOI 10.1016/S0039-9140(98)00005-8; Wang J, 2003, ANAL CHIM ACTA, V485, P139, DOI 10.1016/S0003-2670(03)00419-7; Wang J, 2007, ELECTROANAL, V19, P415, DOI 10.1002/elan.200603748; ZUMAN P, 1990, J ELECTROANAL CHEM, V296, P589, DOI 10.1016/0022-0728(90)87275-O	31	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115966	10.1371/journal.pone.0115966	http://dx.doi.org/10.1371/journal.pone.0115966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549081	Green Submitted, Green Published, gold			2022-12-26	WOS:000347063500044
J	Chen, LL; Liu, T; Zhou, JH; Wang, YF; Wang, XR; Di, W; Zhang, S				Chen, Lilan; Liu, Ting; Zhou, Jinhua; Wang, Yunfei; Wang, Xinran; Di, Wen; Zhang, Shu			Citrate Synthase Expression Affects Tumor Phenotype and Drug Resistance in Human Ovarian Carcinoma	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; VIMENTIN EXPRESSION; CISPLATIN-RESISTANCE; ERCC1 EXPRESSION; CELL SURVIVAL; EP-CAM; CANCER; PROTEIN; GENE; REPAIR	Citrate synthase (CS), one of the key enzymes in the tricarboxylic acid (TCA) cycle, catalyzes the reaction between oxaloacetic acid and acetyl coenzyme A to generate citrate. Increased CS has been observed in pancreatic cancer. In this study, we found higher CS expression in malignant ovarian tumors and ovarian cancer cell lines compared to benign ovarian tumors and normal human ovarian surface epithelium, respectively. CS knockdown by RNAi could result in the reduction of cell proliferation, and inhibition of invasion and migration of ovarian cancer cells in vitro. The drug resistance was also inhibited possibly through an excision repair cross complementing 1 (ERCC1)-dependent mechanism. Finally, upon CS knockdown we observed significant increase expression of multiple genes, including ISG15, IRF7, CASP7, and DDX58 in SKOV3 and A2780 cells by microarray analysis and real-time PCR. Taken together, these results suggested that CS might represent a potential therapeutic target for ovarian carcinoma.	[Chen, Lilan; Liu, Ting; Zhou, Jinhua; Wang, Yunfei; Wang, Xinran; Di, Wen; Zhang, Shu] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Obstet & Gynecol, Shanghai 200127, Peoples R China; [Chen, Lilan; Liu, Ting; Zhou, Jinhua; Wang, Yunfei; Wang, Xinran; Di, Wen; Zhang, Shu] Shanghai Key Lab Gynecol Oncol, Shanghai 200127, Peoples R China	Shanghai Jiao Tong University	Di, W (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Obstet & Gynecol, Shanghai 200127, Peoples R China.	diwen163@163.com; drzhangshu@hotmail.com			Shanghai Committee of Science and Technology [10dz2212100, 12411950200]; National Natural Science Foundation [81072137, 81172479]; Shanghai Health Bureau Key Disciplines and Specialties Foundation; Shanghai Education Commission Key Disciplines Foundation; Key Discipline Project of Ren Ji Hospital; Shanghai Jiao Tong University School of Medicine	Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Health Bureau Key Disciplines and Specialties Foundation; Shanghai Education Commission Key Disciplines Foundation; Key Discipline Project of Ren Ji Hospital; Shanghai Jiao Tong University School of Medicine	This work was supported by Shanghai Committee of Science and Technology (Grant No. 10dz2212100 and Grant No. 12411950200 to Wen Di), National Natural Science Foundation (Grant No. 81072137 to Wen Di, Grant No. 81172479 to Shu Zhang), Shanghai Health Bureau Key Disciplines and Specialties Foundation, Shanghai Education Commission Key Disciplines Foundation, the Key Discipline Project of Ren Ji Hospital, and the Shanghai Jiao Tong University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AS, 2013, EXP CELL RES, V319, P1431, DOI 10.1016/j.yexcr.2013.02.017; Atsumi Y, 2013, J BIOL CHEM, V288, P13269, DOI 10.1074/jbc.M112.402560; AUERSPERG N, 1984, IN VITRO CELL DEV B, V20, P743; Berchuck A, 1997, BIOCHEM PHARMACOL, V54, P541, DOI 10.1016/S0006-2952(97)00061-0; Bidwell B. N., 2012, NAT MED; Cufi S, 2012, ONCOTARGET; De Dosso S., 2013, CANC CHEMOTHER PHARM; Desai SD, 2008, MOL CANCER THER, V7, P1430, DOI 10.1158/1535-7163.MCT-07-2345; Dunfield Lesley D., 2002, Biol Proced Online, V4, P55; Erener S, 2012, MOL CELL, V46, P200, DOI 10.1016/j.molcel.2012.02.016; FIDLER IJ, 1990, J NATL CANCER I, V82, P166, DOI 10.1093/jnci/82.3.166; FRANKE WW, 1982, DIFFERENTIATION, V23, P43, DOI 10.1111/j.1432-0436.1982.tb01266.x; Gaude E, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-10; Gilles C, 1996, J PATHOL, V180, P175, DOI 10.1002/(SICI)1096-9896(199610)180:2<175::AID-PATH630>3.0.CO;2-G; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Horimoto Y, 2012, CELL ADHES MIGR, V6, P193, DOI 10.4161/cam.20631; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Kawashima A, 2012, ADV UROL, V2012, DOI 10.1155/2012/812398; Ko JC, 2010, BIOCHEM PHARMACOL, V79, P655, DOI 10.1016/j.bcp.2009.09.024; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Kusao I, 2008, CANCER GROWTH METAST, V1, P3; Lee WK, 2009, LUNG CANCER, V65, P19, DOI 10.1016/j.lungcan.2008.10.022; Li W, 2012, ONCOGENE, V31, P2412, DOI 10.1038/onc.2011.426; Lin CC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00785; LITVINOV SV, 1994, CELL ADHES COMMUN, V2, P417, DOI 10.3109/15419069409004452; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Lord RVN, 2002, CLIN CANCER RES, V8, P2286; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; McInroy L, 2007, BIOCHEM BIOPH RES CO, V360, P109, DOI 10.1016/j.bbrc.2007.06.036; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Milovic-Kovacevic M, 2011, J BUON, V16, P708; MUKHERJEE A, 1976, J BIOL CHEM, V251, P2155; Poulikakos PI, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001948; Qvarnstrom OF, 2009, INT J ONCOL, V35, P41, DOI 10.3892/ijo_00000311; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schlichtholz B, 2005, PANCREAS, V30, P99, DOI 10.1097/01.mpa.0000153326.69816.7d; Shao W, 2007, AUTOPHAGY, V3, P10, DOI 10.4161/auto.3270; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; SOMMERS CL, 1992, CANCER RES, V52, P5190; Sun YH, 2009, CANCER INVEST, V27, P891, DOI 10.3109/07357900902744536; Tester AM, 2001, CLIN EXP METASTAS, V18, P553, DOI 10.1023/A:1011953118186; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wang J, 2007, CANCER RES, V67, P11933, DOI 10.1158/0008-5472.CAN-07-5185; Wang YF, 2013, BIOMATERIALS, V34, P4068, DOI 10.1016/j.biomaterials.2012.12.033; Wang ZU, 2013, ANTI-CANCER DRUG, V24, P355, DOI 10.1097/CAD.0b013e32835df8b5; Wood LM, 2012, CANCER IMMUNOL IMMUN, V61, P689, DOI 10.1007/s00262-011-1129-9; Zhang P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.526	50	46	48	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115708	10.1371/journal.pone.0115708	http://dx.doi.org/10.1371/journal.pone.0115708			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545012	Green Published, gold, Green Submitted			2022-12-26	WOS:000347120200058
J	Hargrave, B; Strange, R; Navare, S; Stratton, M; Burcus, N; Murray, L; Lundberg, C; Bulysheva, A; Li, FY; Heller, R				Hargrave, Barbara; Strange, Robert, Jr.; Navare, Sagar; Stratton, Michael; Burcus, Nina; Murray, Len; Lundberg, Cathryn; Bulysheva, Anna; Li, Fanying; Heller, Richard			Gene Electro Transfer of Plasmid Encoding Vascular Endothelial Growth Factor for Enhanced Expression and Perfusion in the Ischemic Swine Heart	PLOS ONE			English	Article							LEFT-VENTRICULAR VOLUMES; MYOCARDIAL-INFARCTION; EJECTION FRACTION; ELECTROPORATION; ECHOCARDIOGRAPHY; DELIVERY; THERAPY; DNA	Myocardial ischemia can damage heart muscle and reduce the heart's pumping efficiency. This study used an ischemic swine heart model to investigate the potential for gene electro transfer of a plasmid encoding vascular endothelial growth factor for improving perfusion and, thus, for reducing cardiomyopathy following acute coronary syndrome. Plasmid expression was significantly greater in gene electro transfer treated tissue compared to injection of plasmid encoding vascular endothelial growth factor alone. Higher gene expression was also seen in ischemic versus non-ischemic groups with parameters 20 Volts (p<0.03), 40 Volts (p<0.05), and 90 Volts (p<0.05), but not with 60 Volts (p<0.09) while maintaining a pulse width of 20 milliseconds. The group with gene electro transfer of plasmid encoding vascular endothelial growth factor had increased perfusion in the area at risk compared to control groups. Troponin and creatine kinase increased across all groups, suggesting equivalent ischemia in all groups prior to treatment. Echocardiography was used to assess ejection fraction, cardiac output, stroke volume, left ventricular end diastolic volume, and left ventricular end systolic volume. No statistically significant differences in these parameters were detected during a 2-week time period. However, directional trends of these variables were interesting and offer valuable information about the feasibility of gene electro transfer of vascular endothelial growth factor in the ischemic heart. The results demonstrate that gene electro transfer can be applied safely and can increase perfusion in an ischemic area. Additional study is needed to evaluate potential efficacy.	[Hargrave, Barbara; Burcus, Nina; Lundberg, Cathryn; Bulysheva, Anna; Li, Fanying; Heller, Richard] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23529 USA; [Hargrave, Barbara; Heller, Richard] Old Dominion Univ, Coll Hlth Sci, Sch Med Diagnost & Translat Sci, Norfolk, VA USA; [Strange, Robert, Jr.; Navare, Sagar; Stratton, Michael] Naval Med Ctr Portsmouth, Portsmouth, VA USA; [Murray, Len] Sobran Inc, Fairfax, VA USA	Old Dominion University; Old Dominion University; United States Department of Defense; United States Navy	Heller, R (corresponding author), Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23529 USA.	rheller@odu.edu	Heller, Richard/ABF-1445-2020; Navare, Sagar/AAZ-1097-2021	Heller, Richard/0000-0003-1899-3859; Bulysheva, Anna/0000-0002-7287-9371	National Institutes of Health [R33 HL005441]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL089017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this work came from the National Institutes of Health R33 HL005441. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blenkie I, 1973, AM J CARDIOL, V31, P755; DARBELA PG, 1986, BRIT HEART J, V56, P445; Detter C, 2007, CIRCULATION, V116, P1007, DOI 10.1161/CIRCULATIONAHA.106.655936; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2001, ACTA HAEMATOL-BASEL, V106, P148, DOI 10.1159/000046610; Fihn SD, 2012, J AM COLL CARDIOL, V60, P1; Fortuin FD, 2003, AM J CARDIOL, V92, P436, DOI 10.1016/S0002-9149(03)00661-1; Hargrave B, 2013, GENE THER, V20, P151, DOI 10.1038/gt.2012.15; Harrison RL, 1998, FEBS LETT, V435, P1, DOI 10.1016/S0014-5793(98)00987-9; Hartikka J, 2001, MOL THER, V4, P407, DOI 10.1006/mthe.2001.0483; Heller LC, 2006, HUM GENE THER, V17, P890, DOI 10.1089/hum.2006.17.890; HENNING H, 1975, CIRCULATION, V52, P1069, DOI 10.1161/01.CIR.52.6.1069; Institute for Laboratory Animal Research, 2011, GUIDE CARE USE LAB A; KOSTUK WJ, 1973, CIRCULATION, V47, P1174, DOI 10.1161/01.CIR.47.6.1174; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Marshall WG, 2010, GENE THER, V17, P419, DOI 10.1038/gt.2009.153; Mayo Clinic Staff, 2013, MYOC ISCH; Mcfee RM, 2012, CELL TISSUE RES, V349, P635, DOI 10.1007/s00441-012-1330-y; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; POMBO JF, 1971, CIRCULATION, V43, P480, DOI 10.1161/01.CIR.43.4.480; POPP RL, 1973, AM J CARDIOL, V31, P152, DOI 10.1016/0002-9149(73)90974-0; Toivonen R, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-296; Udelson JE, 2011, CIRCULATION, V124, pE540, DOI 10.1161/CIRCULATIONAHA.111.071696; Yla-Herttuala S, 2013, GENE, V525, P217, DOI 10.1016/j.gene.2013.03.051; Zhao TQ, 2010, MICROVASC RES, V80, P188, DOI 10.1016/j.mvr.2010.03.014	25	8	8	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115235	10.1371/journal.pone.0115235	http://dx.doi.org/10.1371/journal.pone.0115235			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545364	Green Published, gold, Green Submitted			2022-12-26	WOS:000347120200029
J	Sarkar, T; Thankappan, R; Kumar, A; Mishra, GP; Dobaria, JR				Sarkar, Tanmoy; Thankappan, Radhakrishnan; Kumar, Abhay; Mishra, Gyan P.; Dobaria, Jentilal Ramjibhai			Heterologous Expression of the AtDREB1A Gene in Transgenic Peanut-Conferred Tolerance to Drought and Salinity Stresses	PLOS ONE			English	Article							ABIOTIC STRESS; TRANSCRIPTION FACTOR; TRANSPIRATION EFFICIENCY; PROLINE ACCUMULATION; LOW-TEMPERATURE; OXIDATIVE STRESS; TOBACCO PLANTS; SALT TOLERANCE; ARABIDOPSIS; L.	Research on genetic transformation in various crop plants using the DREB1A transcription factor has shown better abiotic stress tolerance in transgenic crops. The AtDREB1A transgenic peanut (Arachis hypogaea L. cv. GG 20), which was previously developed, was characterized in terms of its physio-biochemical, molecular and growth parameters. The tolerance of this transgenic peanut to drought and salinity stresses was evaluated at the seedling (18 days old) and maturity stages. Transgenic peanut lines showed improved tolerance to both stresses over wild-type, as observed by delayed and less severe wilting of leaves and by improved growth parameters that were correlated with physio-biochemical parameters such as proline content, total chlorophyll content, osmotic potential, electrolytic leakage and relative water content. The expression pattern of the AtDREB1A gene evaluated using qPCR at different time points demonstrated that transgene expression was induced within two hours of stress imposition. The better performance of transgenic AtDREB1A peanut at the seedling stage and the improved growth parameters were due to the expression of the transgene, which is a transcription factor, and the possible up-regulation of various stress-inducible, downstream genes in the signal transduction pathway under abiotic stress.	[Sarkar, Tanmoy; Thankappan, Radhakrishnan; Kumar, Abhay; Mishra, Gyan P.; Dobaria, Jentilal Ramjibhai] Directorate Groundnut Res, Crop Improvement Div, Junagadh, Gujarat, India	Indian Council of Agricultural Research (ICAR); ICAR - Directorate of Groundnut Research	Thankappan, R (corresponding author), Directorate Groundnut Res, Crop Improvement Div, Junagadh, Gujarat, India.	radhakrishnan.nrcg@gmail.com	Mishra, Gyan P./E-5980-2010; SARKAR, TANMOY/I-5145-2019; KUMAR, ABHAY/H-3073-2019	Mishra, Gyan P./0000-0002-7023-2638; SARKAR, TANMOY/0000-0002-1885-2864; KUMAR, ABHAY/0000-0002-1104-6771	Indian Council of Agricultural Research, New Delhi, India	Indian Council of Agricultural Research, New Delhi, India(Indian Council of Agricultural Research (ICAR))	This work was funded by the Indian Council of Agricultural Research, New Delhi, India, under the project entitled "ICAR Network Project on Transgenic Crops.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2010, MOL BIOL REP, V37, P1125, DOI 10.1007/s11033-009-9885-8; Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Akcay UC, 2010, PLANT GROWTH REGUL, V61, P21, DOI 10.1007/s10725-010-9445-1; Ban QY, 2011, J PLANT PHYSIOL, V168, P449, DOI 10.1016/j.jplph.2010.08.013; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Bartels D, 2001, TRENDS PLANT SCI, V6, P284, DOI 10.1016/S1360-1385(01)01983-5; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Behnam B., 2006, PLANT BIOTECHNOL-NAR, V23, P169, DOI [10.5511/plantbiotechnology.23.169, DOI 10.5511/PLANTBIOTECHNOLOGY.23.169]; Benjamin JG, 2006, FIELD CROP RES, V97, P248, DOI 10.1016/j.fcr.2005.10.005; Bharati Pandey, 2014, Australian Journal of Crop Science, V8, P44; Bhat SR, 2002, PLANT SCI, V163, P673, DOI 10.1016/S0168-9452(02)00152-8; Bhatnagar-Mathur P, 2008, PLANT CELL REP, V27, P411, DOI 10.1007/s00299-007-0474-9; Bhatnagar-Mathur P, 2007, PLANT CELL REP, V26, P2071, DOI 10.1007/s00299-007-0406-8; Bhatnagar-Mathur P, 2014, MOL BREEDING, V33, P327, DOI 10.1007/s11032-013-9952-7; Bhatnagar-Mathur P, 2009, J PLANT PHYSIOL, V166, P1207, DOI 10.1016/j.jplph.2009.01.001; Bhauso T. D., 2014, Australian Journal of Crop Science, V8, P413; Bouaziz D, 2013, MOL BIOTECHNOL, V54, P803, DOI 10.1007/s12033-012-9628-2; Calcagno AM, 2011, AUST J CROP SCI, V5, P695; Chen JH, 2009, BIOCHEM BIOPH RES CO, V378, P483, DOI 10.1016/j.bbrc.2008.11.071; Chen M, 2007, PLANT SOIL ENVIRON, V53, P490, DOI 10.17221/2302-PSE; Datta K, 2012, PLANT BIOTECHNOL J, V10, P579, DOI 10.1111/j.1467-7652.2012.00688.x; Rolla AAD, 2014, TRANSGENIC RES, V23, P75, DOI 10.1007/s11248-013-9723-6; DIAZPEREZ JC, 1995, J AM SOC HORTIC SCI, V120, P435, DOI 10.21273/JASHS.120.3.435; Du NX, 2012, PLANT CELL TISS ORG, V108, P181, DOI 10.1007/s11240-011-0026-4; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; FOBERT PR, 1991, PLANT MOL BIOL, V17, P837, DOI 10.1007/BF00037065; GOLDSBROUGH A, 1991, PLANT MOL BIOL, V16, P263, DOI 10.1007/BF00020557; HANDA S, 1986, PLANT PHYSIOL, V80, P938, DOI 10.1104/pp.80.4.938; Hasthanasombut S, 2011, PLANT CELL TISS ORG, V104, P79, DOI 10.1007/s11240-010-9807-4; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Holbrook CC, 2011, AGRONOMY-BASEL, V1, P3, DOI 10.3390/agronomy1010003; Hou XN, 2013, PLANT MOL BIOL REP, V31, P791, DOI 10.1007/s11105-012-0549-9; Huynh LN, 2005, J EXP BOT, V56, P1397, DOI 10.1093/jxb/eri141; Jagana S. R., 2012, Journal of SAT Agricultural Research, V10, punpaginated; Jami SK, 2008, PLANT PHYSIOL BIOCH, V46, P1019, DOI 10.1016/j.plaphy.2008.07.006; Kasuga M, 2004, PLANT CELL PHYSIOL, V45, P346, DOI 10.1093/pcp/pch037; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Khare N, 2010, PLANT CELL TISS ORG, V103, P267, DOI 10.1007/s11240-010-9776-7; Krishnamurthy L, 2007, FIELD CROP RES, V103, P189, DOI 10.1016/j.fcr.2007.06.009; Li C, 2013, PLANT PHYSIOL BIOCH, V70, P164, DOI 10.1016/j.plaphy.2013.05.005; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Liu QL, 2013, PLANT PHYSIOL BIOCH, V69, P27, DOI 10.1016/j.plaphy.2013.04.016; Liu XL, 2008, BIOTECHNOL LETT, V30, P1275, DOI 10.1007/s10529-008-9672-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052126; Mackova H, 2013, J EXP BOT, V64, P2805, DOI 10.1093/jxb/ert131; Mao XG, 2012, J EXP BOT, V63, P2933, DOI 10.1093/jxb/err462; Martinez Beltran J., 2005, International salinity forum - managing saline soils and water: science, technology and social issues. Oral Presentation Abstracts, Riverside Convention Center, Riverside, California, USA, 25-28 April 2005, P311; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Morran S, 2011, PLANT BIOTECHNOL J, V9, P230, DOI 10.1111/j.1467-7652.2010.00547.x; Oh SJ, 2005, PLANT PHYSIOL, V138, P341, DOI 10.1104/pp.104.059147; Pardo JM, 2010, CURR OPIN BIOTECH, V21, P185, DOI 10.1016/j.copbio.2010.02.005; Prabhavathi V, 2007, PLANT SCI, V173, P50, DOI 10.1016/j.plantsci.2007.04.004; Prabhavathi V, 2002, MOL BREEDING, V9, P137, DOI 10.1023/A:1026765026493; Rai AC, 2012, PLANT PHYSIOL BIOCH, V61, P108, DOI 10.1016/j.plaphy.2012.09.010; Rai AC, 2013, PHYTOCHEMISTRY, V85, P44, DOI 10.1016/j.phytochem.2012.09.007; Rai GK, 2013, PLANT PHYSIOL BIOCH, V69, P90, DOI 10.1016/j.plaphy.2013.05.002; Ravikumar G, 2014, TRANSGENIC RES, V23, P421, DOI 10.1007/s11248-013-9776-6; Reguera M, 2012, BBA-GENE REGUL MECH, V1819, P186, DOI 10.1016/j.bbagrm.2011.08.005; Sarkar T, 2013, P NAT C PLANT PHYS 1, P383; Sharma KK, 2000, IN VITRO CELL DEV-PL, V36, P83, DOI 10.1007/s11627-000-0019-1; Shoba D, 2012, EUPHYTICA, V188, P265, DOI 10.1007/s10681-012-0718-9; Singh R, 2007, J SAT AGR RES, V5; Surekha C, 2014, PLANT CELL TISS ORG, V116, P27, DOI 10.1007/s11240-013-0378-z; TAHARA M, 1990, EUPHYTICA, V49, P255; Tang LL, 2013, PLANT PHYSIOL BIOCH, V71, P22, DOI 10.1016/j.plaphy.2013.06.024; Vadez V., 2007, Journal of SAT Agricultural Research, V5, P1; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Wang YC, 2010, J PLANT PHYSIOL, V167, P222, DOI 10.1016/j.jplph.2009.09.008; Wang Z, 2008, PLANT SOIL, V310, P137, DOI 10.1007/s11104-008-9641-1; Wilson RA, 2014, J ENVIRON BIOL, V35, P383; WRIGHT GC, 1994, CROP SCI, V34, P92, DOI 10.2135/cropsci1994.0011183X003400010016x; Xiao H, 2006, PLANT CELL ENVIRON, V29, P1410, DOI 10.1111/j.1365-3040.2006.01524.x; Yadav NS, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-188; Zhang HJ, 2009, MOL BREEDING, V23, P289, DOI 10.1007/s11032-008-9233-z; Zhao JS, 2007, PLANT CELL REP, V26, P1521, DOI 10.1007/s00299-007-0362-3	76	54	61	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e110507	10.1371/journal.pone.0110507	http://dx.doi.org/10.1371/journal.pone.0110507			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545786	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200001
J	Liu, J; Wang, XB; Ren, YW; Li, XL; Zhang, XC; Zhou, BS				Liu, Jing; Wang, Xiaobo; Ren, Yangwu; Li, Xuelian; Zhang, Xichen; Zhou, Baosen			Effect of Single Nucleotide Polymorphism Rs189037 in ATM Gene on Risk of Lung Cancer in Chinese: A Case-Control Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BREAST-CANCER; DNA; SUSCEPTIBILITY; SMOKING; PATHWAY; TRANSCRIPTION; POPULATION; ACTIVATION; VARIANTS	Background: Accumulated evidence has indicated that ataxia-telangiectasia mutated (ATM) gene polymorphisms are closely related to lung cancer. We aimed to explore the prognostic value of rs189037 (G>A), one of ATM single nucleotide polymorphisms (SNPs), and detect whether it involves in the risk of lung cancer in Chinese Han people. Methods: In this hospital-based matched case-control study, 852 lung cancer patients and 852 healthy controls have been put into comparison to analyze the association between rs189037 and lung cancer risk in Chinese. The single nucleotide polymorphisms were determined by TaqMan real-time PCR and we used SPSS software to perform the statistical analyses. Results: Individuals carrying variant AA genotype of rs189037 had higher lung cancer risk (adjusted OR: 1.56) than those carrying GG genotype. After analyzing data respectively from different groups divided by genders and smoking status, we observed that the risk effect of AA genotype on the lung cancer was significant in females, non-smokers and female non-smokers, as well as the risk effect of GA genotype in male smokers. Compared with non-smokers carrying GG genotype, smokers carrying at least one A allele had higher risk of developing lung cancer than those with GG genotype (adjusted OR: 3.52 vs. adjusted OR: 2.53). Conclusions: This study suggested that rs189037 (G>A) polymorphism is associated with lung cancer risk in Chinese Han population. AA genotype and A allele may be dangerous lung cancer signals in Chinese and make contribution to diagnostic and treatment value.	[Liu, Jing; Wang, Xiaobo; Ren, Yangwu; Li, Xuelian; Zhang, Xichen; Zhou, Baosen] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang 110001, Liaoning Provin, Peoples R China; [Liu, Jing; Wang, Xiaobo; Ren, Yangwu; Li, Xuelian; Zhang, Xichen; Zhou, Baosen] Univ Liaoning Prov, Key Lab Canc Etiol & Intervent, Shenyang, Peoples R China; [Liu, Jing; Wang, Xiaobo] China Med Univ, Clin Med Seven Syst, Shenyang, Peoples R China	China Medical University; China Medical University	Zhou, BS (corresponding author), China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang 110001, Liaoning Provin, Peoples R China.	bszhou@mail.cmu.edu.cn			National Natural Science Foundation of China [81272293]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grant no. 81272293 from National Natural Science Foundation of China; BZ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bau DT, 2010, LARYNGOSCOPE, V120, P2417, DOI 10.1002/lary.21009; Bridevaux Pierre-Olivier, 2006, Rev Med Suisse, V2, P2611; Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680; Chen T, 2010, MECH AGEING DEV, V131, P636, DOI 10.1016/j.mad.2010.08.009; Chen Wanqing, 2010, Zhongguo Fei Ai Za Zhi, V13, P488, DOI 10.3779/j.issn.1009-3419.2010.05.20; Dong J, 2012, MOL CARCINOGEN, V51, P546, DOI 10.1002/mc.20819; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hsia TC, 2013, ANTICANCER RES, V33, P4067; Ito H, 2012, J THORAC ONCOL, V7, P790, DOI 10.1097/JTO.0b013e3182475028; Khalil HS, 2012, EXP BIOL MED, V237, P622, DOI 10.1258/ebm.2012.011378; Khalil HS, 2011, CURR OPIN BIOTECH, V22, pS115, DOI 10.1016/j.copbio.2011.05.374; Kim JH, 2006, HUM MOL GENET, V15, P1181, DOI 10.1093/hmg/ddl033; Kwasniewska Magdalena, 2003, Pol Merkur Lekarski, V15, P559; LEASK A, 1991, P NATL ACAD SCI USA, V88, P7948, DOI 10.1073/pnas.88.18.7948; Li YF, 2010, LANCET ONCOL, V11, P321, DOI 10.1016/S1470-2045(10)70042-5; Li ZX, 2013, FERTIL STERIL, V100, P1536, DOI 10.1016/j.fertnstert.2013.07.1995; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Lo YL, 2010, LUNG CANCER, V69, P148, DOI 10.1016/j.lungcan.2009.11.007; Lou JL, 2006, TOXICOLOGY, V224, P138, DOI 10.1016/j.tox.2006.04.040; Mu LN, 2013, CANCER CAUSE CONTROL, V24, P439, DOI 10.1007/s10552-012-0130-8; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Prokopcova J, 2007, BREAST CANCER RES TR, V104, P121, DOI 10.1007/s10549-006-9406-6; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Schneider J, 2008, ARCH MED RES, V39, P226, DOI 10.1016/j.arcmed.2007.08.004; Shen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096911; Shen L, 2012, MOL BIOL REP, V39, P5719, DOI 10.1007/s11033-011-1381-2; Shields PG, 2002, ONCOGENE, V21, P6870, DOI 10.1038/sj.onc.1205832; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Talukder KA, 2012, MICROB PATHOGENESIS, V52, P311, DOI 10.1016/j.micpath.2012.02.007; Tang L, 2010, ENVIRON HEALTH PERSP, V118, P1257, DOI 10.1289/ehp.0901587; Van Dyck E, 1999, NATURE, V398, P728, DOI 10.1038/43942; Wang HC, 2010, ANTICANCER RES, V30, P5217; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Xiong HH, 2013, INT J RADIAT ONCOL, V85, P1066, DOI 10.1016/j.ijrobp.2012.09.024; Xu L, 2012, J CLIN ENDOCR METAB, V97, P1913, DOI 10.1210/jc.2011-3299; Yang DQ, 2011, DRUG DISCOV TODAY, V16, P332, DOI 10.1016/j.drudis.2011.02.001; Yang HS, 2007, INT J CANCER, V121, P2254, DOI 10.1002/ijc.22918	38	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115845	10.1371/journal.pone.0115845	http://dx.doi.org/10.1371/journal.pone.0115845			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541996	Green Submitted, Green Published, gold			2022-12-26	WOS:000347239900096
J	Xu, XF; Zhang, FX; Zamponi, GW; Horne, WA				Xu, Xingfu; Zhang, Fangxiong; Zamponi, Gerald W.; Horne, William A.			Solution NMR and calorimetric analysis of Rem2 binding to the Ca2+ channel beta 4 subunit: a low affinity interaction is required for inhibition of Cav2.1 Ca2+ currents	FASEB JOURNAL			English	Article						RGK proteins; brain; electrophysiology; ion channel; synaptic transmission	DEPENDENT CALCIUM-CHANNELS; MOLECULAR DETERMINANTS; RGK FAMILY; PROTEINS; EXPRESSION; COMPLEX; SURFACE; MEMBER; CORE; GEM	Rem, Rad, Kir/Gem (RGK) proteins, including Rem2, mediate profound inhibition of high-voltage activated Ca2+ channels containing intracellular regulatory beta subunits. All RGK proteins bind to voltage-gated Ca2+ channel beta subunit (Cav beta) subunits in vitro, but the necessity of the interaction for current inhibition remains controversial. This study applies NMR and calorimetric techniques to map the binding site for Rem2 on human Cav beta 4a and measure its binding affinity. Our experiments revealed 2 binding surfaces on the beta 4 guanylate kinase domain contributing to a 156 +/- 18 mu M K-d interaction: a hydrophobic pocket lined by 4 critical residues (L173, N261, H262, and V303), mutation of any of which completely disrupted binding, and a nearby surface containing 3 residues (D206, L209, and D258) that when individually mutated decreased affinity. Voltage-gated Ca2+ channel alpha 1A subunit (Cav2.1) Ca2+ currents were completely inhibited by Rem2 when co-expressed with wild-type Cav beta 4a, but were unaffected by Rem2 when coexpressed with a Cav beta 4a site 1 (L173A/V303A) or site 2 (D258A) mutant. These results provide direct evidence for a low-affinity Rem2/Cav beta 4 interaction and show definitively that the interaction is required for Cav2.1 inhibition.	[Xu, Xingfu; Horne, William A.] Michigan State Univ, Coll Vet Med, Dept Clin Sci, E Lansing, MI 48824 USA; [Zhang, Fangxiong; Zamponi, Gerald W.] Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB, Canada	Michigan State University; University of Calgary	Horne, WA (corresponding author), Dept Clin Sci, 736 Wilson Rd, E Lansing, MI 48824 USA.	hornewil@cvm.msu.edu		Zamponi, Gerald W./0000-0002-0644-9066	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke Grant [NS42600]; National Science Foundation Grant [IOS 0719242]; Alberta Innovates-Health Solutions; Canadian Institutes for Health Research; Natural Sciences and Engineering Research Council; Canada Research Chair; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042600] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke Grant; National Science Foundation Grant(National Science Foundation (NSF)); Alberta Innovates-Health Solutions; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. Li Li and Ms. Heather De Feijter-Rupp for excellent technical support in all aspects of the project. This work was supported in part by U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke Grant NS42600 (to W.A.H.), and National Science Foundation Grant IOS 0719242 (to W.A.H.). F.Z. is supported by a postdoctoral fellowship from Alberta Innovates-Health Solutions. G.W.Z. is supported by grants from the Canadian Institutes for Health Research and from the Natural Sciences and Engineering Research Council and holds a Canada Research Chair. The authors declare no conflicts of interest.	Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Beguin P, 2007, J BIOL CHEM, V282, P11509, DOI 10.1074/jbc.M606423200; Beqollari D, 2014, BIOPHYS J, V106, P1950, DOI 10.1016/j.bpj.2014.03.033; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Chen HM, 2005, J NEUROSCI, V25, P9762, DOI 10.1523/JNEUROSCI.3111-05.2005; Correll RN, 2008, CELL SIGNAL, V20, P292, DOI 10.1016/j.cellsig.2007.10.028; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ebert AM, 2008, PHYSIOL GENOMICS, V35, P133, DOI 10.1152/physiolgenomics.90264.2008; Fan MM, 2012, J BIOL CHEM, V287, P22749, DOI 10.1074/jbc.M111.291872; Fan MM, 2010, P NATL ACAD SCI USA, V107, P14887, DOI 10.1073/pnas.1007543107; Finlin BS, 2006, J BIOL CHEM, V281, P23557, DOI 10.1074/jbc.M604867200; Finlin BS, 2005, J BIOL CHEM, V280, P41864, DOI 10.1074/jbc.M414261200; Finlin BS, 2000, BIOCHEM J, V347, P223, DOI 10.1042/0264-6021:3470223; Flynn R, 2008, BIOCHEM BIOPH RES CO, V368, P827, DOI 10.1016/j.bbrc.2008.02.020; Flynn R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041185; Flynn R, 2010, CHANNELS, V4, P434, DOI 10.4161/chan.4.6.12865; Ghiretti AE, 2014, J NEUROSCI, V34, P392, DOI 10.1523/JNEUROSCI.1328-13.2014; Goddard T. D., SPARKY 3; Helton TD, 2002, J NEUROSCI, V22, P1573, DOI 10.1523/JNEUROSCI.22-05-01573.2002; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Puhl HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100694; Rajarathnam K, 2014, BBA-BIOMEMBRANES, V1838, P69, DOI 10.1016/j.bbamem.2013.05.023; Seu L, 2006, J GEN PHYSIOL, V128, P605, DOI 10.1085/jgp.200609631; Simms BA, 2014, NEURON, V82, P24, DOI 10.1016/j.neuron.2014.03.016; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Van Petegem F, 2008, STRUCTURE, V16, P280, DOI 10.1016/j.str.2007.11.010; Vaynberg J, 2006, TRENDS BIOTECHNOL, V24, P22, DOI 10.1016/j.tibtech.2005.09.006; Xu XF, 2014, BIOMOL NMR ASSIGN, V8, P217, DOI 10.1007/s12104-013-9486-2; Yang TT, 2013, BBA-BIOMEMBRANES, V1828, P1644, DOI 10.1016/j.bbamem.2012.10.005; Yang TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037079; Yang TT, 2010, J PHYSIOL-LONDON, V588, P1665, DOI 10.1113/jphysiol.2010.187203	33	4	4	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1794	1804		10.1096/fj.14-264499	http://dx.doi.org/10.1096/fj.14-264499			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25563298	Green Published			2022-12-26	WOS:000354114600016
J	Priestley, RS; Nickolls, SA; Alexander, SPH; Kendall, DA				Priestley, Richard S.; Nickolls, Sarah A.; Alexander, Stephen P. H.; Kendall, David A.			A potential role for cannabinoid receptors in the therapeutic action of fenofibrate	FASEB JOURNAL			English	Article						allosteric modulation; PPAR; pharmacology; drug discovery; G protein-coupled receptor	PROTEIN-COUPLED RECEPTORS; ALLOSTERIC MODULATION; PPAR-ALPHA; INTERNATIONAL-UNION; CB1 RECEPTORS; PHARMACOLOGY; LIGANDS; IDENTIFICATION; ACTIVATION; SYSTEM	Cannabinoids are reported to have actions through peroxisome proliferator-activated receptors (PPARs), which led us to investigate PPAR agonists for activity at the cannabinoid receptors. Radio-ligand binding and functional assays were conducted using human recombinant cannabinoid type 1 (CB1) or cannabinoid type 2 (CB2) receptors, as well as the guinea pig isolated ileum, using the full agonist CP55940 as a positive control. The PPAR-a agonist fenofibrate exhibited submicromolar affinity for both receptors (pK(i)CB(1), 6.3 +/- 0.1; CB2, 7.7 +/- 0.1). Functionally, fenofibrate acted as an agonist at the CB2 receptor (pEC(50), 7.7 +/- 0.1) and a partial agonist at the CB1 receptor, although with a decrease in functional response at higher concentrations, producing bell-shaped concentration-response curves. High concentrations of fenofibrate were able to increase the dissociation rate constant for [H-3]-CP55940 at the CB1 receptor, (k(fast) without: 1.2 +/- 0.2/min; with: 3.8 +/- 0.1 x 10(-2)/min) and decrease the maximal response to CP55940 (R-max, 86 +/- 2%), which is consistent with a negative allosteric modulator. Fenofibrate also reduced electrically induced contractions in isolated guinea pig ileum via CB1 receptors (pEC50, 6.0 +/- 0.4). Fenofibrate is thus identified as an example of a new class of cannabinoid receptor ligand and allosteric modulator, with the potential to interact therapeutically with cannabinoid receptors in addition to its primary PPAR target.	[Priestley, Richard S.; Alexander, Stephen P. H.; Kendall, David A.] Univ Nottingham, Sch Med, Sch Life Sci, Nottingham NG7 2UH, England; [Nickolls, Sarah A.] Neusentis Pfizer Ltd, Cambridge, England	University of Nottingham; Pfizer	Kendall, DA (corresponding author), Univ Nottingham, Sch Med, Sch Life Sci, Queens Med Ctr, E Floor, Nottingham NG7 2UH, England.	dave.kendall@nottingham.ac.uk	Alexander, Steve P/B-8105-2009	Alexander, Steve P/0000-0003-4417-497X; Priestley, Richard/0000-0002-5284-5326	Biotechnology and Biological Sciences Research Council/Neusentis-Pfizer Limited Collaborative Awards in Science and Engineering (CASE) studentship award	Biotechnology and Biological Sciences Research Council/Neusentis-Pfizer Limited Collaborative Awards in Science and Engineering (CASE) studentship award	This work was supported by a Biotechnology and Biological Sciences Research Council/Neusentis-Pfizer Limited Collaborative Awards in Science and Engineering (CASE) studentship award. The authors declare no conflicts of interest.	Baillie GL, 2013, MOL PHARMACOL, V83, P322, DOI 10.1124/mol.112.080879; Baker D, 2006, TRENDS PHARMACOL SCI, V27, P1, DOI 10.1016/j.tips.2005.11.003; Bauer M, 2012, J BIOL CHEM, V287, P36944, DOI 10.1074/jbc.M112.382481; Bosier B, 2010, BIOCHEM PHARMACOL, V80, P1, DOI 10.1016/j.bcp.2010.02.013; CALDWELL J, 1989, CARDIOLOGY, V76, P33, DOI 10.1159/000174545; Choi IY, 2013, AM J PATHOL, V182, P928, DOI 10.1016/j.ajpath.2012.11.024; Christopoulos A, 1997, EUR J PHARMACOL, V339, P153, DOI 10.1016/S0014-2999(97)01379-4; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Cluny NL, 2009, NEUROGASTROENT MOTIL, V21, P420, DOI 10.1111/j.1365-2982.2008.01248.x; Dagon Y, 2007, FASEB J, V21, P2431, DOI 10.1096/fj.06-7705com; Duncan M, 2005, ALIMENT PHARM THER, V22, P667, DOI 10.1111/j.1365-2036.2005.02648.x; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; GERARD C, 1990, NUCLEIC ACIDS RES, V18, P7142, DOI 10.1093/nar/18.23.7142; Horswill JG, 2007, BRIT J PHARMACOL, V152, P805, DOI 10.1038/sj.bjp.0707347; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Lan RX, 1999, J MED CHEM, V42, P769, DOI 10.1021/jm980363y; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Mcguinness D, 2009, J BIOMOL SCREEN, V14, P49, DOI 10.1177/1087057108327329; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Murakami R, 2010, LIFE SCI, V87, P495, DOI 10.1016/j.lfs.2010.09.005; Netherland CD, 2010, ATHEROSCLEROSIS, V213, P102, DOI 10.1016/j.atherosclerosis.2010.07.060; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Perez-Fernandez R, 2011, ACS MED CHEM LETT, V2, P793, DOI 10.1021/ml200091q; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2006, INT J OBESITY, V30, pS13, DOI 10.1038/sj.ijo.0803272; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Sharir H, 2010, PHARMACOL THERAPEUT, V126, P301, DOI 10.1016/j.pharmthera.2010.02.004; Shore DM, 2014, J BIOL CHEM, V289, P5828, DOI 10.1074/jbc.M113.478495; Staels B, 2008, NAT CLIN PRACT CARD, V5, P542, DOI 10.1038/ncpcardio1278; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Steffens S, 2005, NATURE, V434, P782, DOI 10.1038/nature03389; Sun Y, 2007, BRIT J PHARMACOL, V152, P734, DOI 10.1038/sj.bjp.0707478; Valant C, 2008, J BIOL CHEM, V283, P29312, DOI 10.1074/jbc.M803801200; Valant C, 2012, ANNU REV PHARMACOL, V52, P153, DOI 10.1146/annurev-pharmtox-010611-134514; WAELBROECK M, 1994, MOL PHARMACOL, V46, P685; Wang XW, 2011, MOL PHARMACOL, V79, P758, DOI 10.1124/mol.110.068197; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Wright KL, 2008, BRIT J PHARMACOL, V153, P263, DOI 10.1038/sj.bjp.0707486	41	29	29	2	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1446	1455		10.1096/fj.14-263053	http://dx.doi.org/10.1096/fj.14-263053			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25550466				2022-12-26	WOS:000354115000030
J	Yuan, C; Smith, WL				Yuan, Chong; Smith, William L.			A Cyclooxygenase-2-dependent Prostaglandin E-2 Biosynthetic System in the Golgi Apparatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ENDOPEROXIDE-H SYNTHASE-1; CYTOSOLIC PHOSPHOLIPASE A(2)ALPHA; ENDOPLASMIC-RETICULUM; SUBCELLULAR-LOCALIZATION; PROTEIN-DEGRADATION; SEQUENCE HOMODIMER; MESSENGER-RNA; CANCER-CELLS; BINDING	Cydooxygenases (COXs) catalyze the committed step in prostaglandin (PG) biosynthesis. COX-1 is constitutively expressed and stable, whereas COX-2 is inducible and short lived. COX-2 is degraded via endoplasmic reticulum (ER)-associated degradation (ERAD) following post-translational glycosylation of Asn-594, COX-1 and COX-2 are found in abundance on the luminal surfaces of the ER and inner membrane of the nuclear envelope. Using confocal immtinocytofluorescence, we detected both COX-2 and microsomal PGE synthase-1 (mPGES-1) but not COX-1 in the Golgi apparatus. Inhibition of trafficking between the ER and Golgi retarded COX-2 ERAD. COX-2 has a C-terminal STEL sequence, which is an inefficient ER retention signal. Substituting this sequence with KDEL, a robust ER retention signal, concentrated COX-2 in the ER where it was stable and slowly glycosylated on Asn-594. Native COX-2 and a recombinant COX-2 having a Golgi targeting signal but not native COX-1 exhibited efficient catalytic coupling to mPGES-1 We conclude that N-glycosylation of Asn-594 of COX-2 occurs in the ER, leading to anterograde movement of COX-2 to the Golgi where the Asn-594-linked glycan is trimmed prior to retrograde COX-2 transport to the ER for ERAD. Having an inefficient ER retention signal leads to sluggish Golgi to ER transit of COX-2. This permits significant Golgi residence time during which COX-2 can function catalytically. Cytosolic phospholipase Ca2+, which mobilizes arachidonic acid for PG synthesis, preferentially translocates to the Golgi in response to physiologic Ca2+ mobilization. We propose that cytosolic phospholipase COX-2, and mPGES-1 in the Golgi comprise a dedicated system for COX-2-dependent PGE(2) biosynthesis.	[Yuan, Chong; Smith, William L.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Smith, WL (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 5301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	smithww@med.umich.edu			National Institutes of Health [GM68848, CA130810, HL117798]; NATIONAL CANCER INSTITUTE [P50CA130810, P30CA046592] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL117798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM68848, CA130810, and HL117798. William L. Smith has served on the scientific advisory board of Cayman Chemical Company, products from which were used in this study.	Appenzeller-Herzog C, 2005, MOL BIOL CELL, V16, P1258, DOI 10.1091/mbc.E04-08-0708; BHATTACHARYYA DK, 1995, ARCH BIOCHEM BIOPHYS, V317, P19, DOI 10.1006/abbi.1995.1130; Blum R, 1999, J CELL SCI, V112, P537; Chen SF, 2013, J BIOL CHEM, V288, P33462, DOI 10.1074/jbc.M113.521799; Chen Y, 2013, GLYCOBIOLOGY, V23, P904, DOI 10.1093/glycob/cwt027; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Dong L, 2013, J BIOL CHEM, V288, P28641, DOI 10.1074/jbc.M113.505503; Dong L, 2011, J BIOL CHEM, V286, P19035, DOI 10.1074/jbc.M111.231969; DVORAK AM, 1992, J HISTOCHEM CYTOCHEM, V40, P759, DOI 10.1177/40.6.1316915; Elsabrouty R, 2013, MOL BIOL CELL, V24, P3300, DOI 10.1091/mbc.E13-03-0157; Evans JH, 2004, J BIOL CHEM, V279, P6005, DOI 10.1074/jbc.M311246200; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Haddad A, 2012, J BIOL CHEM, V287, P17214, DOI 10.1074/jbc.M111.304220; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P651, DOI 10.1093/glycob/cwq013; Hou Z, 2011, CARCINOGENESIS, V32, P695, DOI 10.1093/carcin/bgr027; Jarving R, 2004, J BIOL CHEM, V279, P13624, DOI 10.1074/jbc.M313258200; Kamiya Y, 2008, J BIOL CHEM, V283, P1857, DOI 10.1074/jbc.M709384200; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kawasaki N, 2008, BLOOD, V111, P1972, DOI 10.1182/blood-2007-06-097022; Kojima F, 2004, ARTHRITIS RES THER, V6, pR355, DOI 10.1186/ar1195; KULMACZ RJ, 1984, J BIOL CHEM, V259, P6358; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Leslie CC, 2010, BIOCHIMIE, V92, P620, DOI 10.1016/j.biochi.2010.03.001; Liao WL, 2011, J BIOL CHEM, V286, P35499, DOI 10.1074/jbc.M111.263582; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Liou JY, 2001, J BIOL CHEM, V276, P34975, DOI 10.1074/jbc.M105946200; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Majed BH, 2012, PHARMACOL REV, V64, P540, DOI 10.1124/pr.111.004770; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; MORITA I, 1995, J BIOL CHEM, V270, P10902, DOI 10.1074/jbc.270.18.10902; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Murakami M, 2011, J BIOCHEM, V150, P233, DOI 10.1093/jb/mvr088; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Narumiya S, 2011, FASEB J, V25, P813, DOI 10.1096/fj.11-0302ufm; OTTO JC, 1993, J BIOL CHEM, V268, P18234; OTTO JC, 1994, J BIOL CHEM, V269, P19868; Otto JC, 1996, J BIOL CHEM, V271, P9906, DOI 10.1074/jbc.271.17.9906; Pan SJ, 2011, MOL BIOL CELL, V22, P2810, DOI 10.1091/mbc.E11-02-0118; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; REDDY ST, 1994, J BIOL CHEM, V269, P15473; ROLLINS TE, 1980, J BIOL CHEM, V255, P4872; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Shitashige M, 1998, BBA-LIPID LIPID MET, V1389, P57, DOI 10.1016/S0005-2760(97)00129-X; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; SMITH WL, 1986, ANNU REV PHYSIOL, V48, P251; Spencer AG, 1999, J BIOL CHEM, V274, P32936, DOI 10.1074/jbc.274.46.32936; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; Theesfeld CL, 2013, J BIOL CHEM, V288, P8519, DOI 10.1074/jbc.M112.404517; Tsai AL, 2010, ARCH BIOCHEM BIOPHYS, V493, P103, DOI 10.1016/j.abb.2009.08.019; Uddin MJ, 2010, CANCER RES, V70, P3618, DOI 10.1158/0008-5472.CAN-09-2664; Ushioda R, 2013, MOL BIOL CELL, V24, P3155, DOI 10.1091/mbc.E13-03-0138; Varvas K, 2009, INSECT BIOCHEM MOLEC, V39, P851, DOI 10.1016/j.ibmb.2009.10.002; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Wada M, 2009, J BIOL CHEM, V284, P30742, DOI 10.1074/jbc.M109.052415; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Yu Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003787; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200; Zhang H, 2013, J AM CHEM SOC, V135, P11663, DOI 10.1021/ja4056905; Zou HC, 2012, J LIPID RES, V53, P1336, DOI 10.1194/jlr.M026856	70	32	33	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5606	5620		10.1074/jbc.M114.632463	http://dx.doi.org/10.1074/jbc.M114.632463			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25548276	Green Published, hybrid			2022-12-26	WOS:000350044200031
J	Wei, Z; Behrman, B; Wu, WH; Chen, BS				Wei, Zhe; Behrman, Blake; Wu, Wei-Hua; Chen, Bo-Shiun			Subunit-specific Regulation of N-Methyl-D-aspartate (NMDA) Receptor Trafficking by SAP102 Protein Splice Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGUK SCAFFOLDING PROTEINS; DENDRITIC SPINE MORPHOLOGY; GUANYLATE KINASE DOMAINS; INTRAMOLECULAR INTERACTION; SYNAPTIC PLASTICITY; HIPPOCAMPAL SYNAPSES; SURFACE EXPRESSION; IN-VIVO; PSD-95; NEURONS	Synapse-associated protein 102 (SAP102) is a scaffolding protein abundantly expressed early in development that mediates glutamate receptor trafficking during synaptogenesis. Mutations in human SAP102 have been reported to cause intellectual disability, which is consistent with its important role during early postnatal development. SAP102 contains PDZ, SH3, and guanylate kinase (GK)-like domains, which mediate specific protein-protein interactions. SAP102 binds directly to N-methyl-D-aspartate receptors (NMDARs), anchors receptors at synapses, and facilitates transduction of NMDAR signals. Proper localization of SAP102 at the postsynaptic density is essential to these functions. However, how SAP102 is targeted to synapses is unclear. In the current study we find that synaptic localization of SAP102 is regulated by alternative splicing. The SAP102 splice variant that possesses a C-terminal insert (I2) between the SH3 and GK domains is highly enriched at dendritic spines. We also show that there is an intramolecular interaction between the SH3 and GK domains in SAP102 but that the I2 splicing does not influence SH3-GK interaction. Previously, we have shown that SAP102 expression promotes spine lengthening. We now find that the spine lengthening effect is independent of the C-terminal alternative splicing of SAP102. In addition, expression of I2-containing SAP102 isoforms is regulated developmentally. Knockdown of endogenous I2-containing SAP102 isoforms differentially affect NMDAR surface expression in a subunit-specific manner. These data shed new light on the role of SAP102 in the regulation of NMDAR trafficking.	[Chen, Bo-Shiun] Georgia Regents Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA 30912 USA; [Chen, Bo-Shiun] Georgia Regents Univ, Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Chen, BS (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, CA3008,1120 15th St, Augusta, GA 30912 USA.	bochen@gru.edu		Behrman, David/0000-0003-1801-3662	National Institutes of Health (NINDS) [R00NS057266]; National Institutes of Health (NCI) [1K22CA122453]; NATIONAL CANCER INSTITUTE [K22CA122453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS057266] Funding Source: NIH RePORTER	National Institutes of Health (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Career Transition Awards R00NS057266 (NINDS; to B.-S. C.) and 1K22CA122453 (NCI; W.-H. W.).	Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Chen BS, 2006, J BIOL CHEM, V281, P16583, DOI 10.1074/jbc.M513029200; Chen BS, 2012, CELL REP, V2, P1120, DOI 10.1016/j.celrep.2012.09.024; Chen BS, 2011, J NEUROSCI, V31, P89, DOI 10.1523/JNEUROSCI.1034-10.2011; Chen BS, 2009, NEURON, V62, P471, DOI 10.1016/j.neuron.2009.04.015; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 2000, J BIOL CHEM, V275, P23904, DOI 10.1074/jbc.M909919199; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Elias GM, 2008, P NATL ACAD SCI USA, V105, P20953, DOI 10.1073/pnas.0811025106; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Goebel-Goody SM, 2009, NEUROSCIENCE, V158, P1446, DOI 10.1016/j.neuroscience.2008.11.006; Gray JA, 2011, NEURON, V71, P1085, DOI 10.1016/j.neuron.2011.08.007; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; Losi G, 2003, J PHYSIOL-LONDON, V548, P21, DOI 10.1113/jphysiol.2002.034918; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matta JA, 2011, NEURON, V70, P339, DOI 10.1016/j.neuron.2011.02.045; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Murata Y, 2013, J NEUROSCI, V33, P5040, DOI 10.1523/JNEUROSCI.2896-12.2013; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nikandrova YA, 2010, J BIOL CHEM, V285, P923, DOI 10.1074/jbc.M109.033985; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Philips AK, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-49; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; Tarpey P, 2004, AM J HUM GENET, V75, P318, DOI 10.1086/422703; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Van Campenhout CA, 2011, DEV CELL, V21, P479, DOI 10.1016/j.devcel.2011.08.003; van Zundert B, 2004, TRENDS NEUROSCI, V27, P428, DOI 10.1016/j.tins.2004.05.010; Washbourne P, 2004, J NEUROSCI, V24, P8253, DOI 10.1523/JNEUROSCI.2555-04.2004; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100; Zanni G, 2010, NEUROGENETICS, V11, P251, DOI 10.1007/s10048-009-0224-y; Zheng CY, 2010, J NEUROSCI, V30, P4757, DOI 10.1523/JNEUROSCI.6108-09.2010; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	57	11	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5105	5116		10.1074/jbc.M114.599969	http://dx.doi.org/10.1074/jbc.M114.599969			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25555912	Green Published, hybrid			2022-12-26	WOS:000350042000050
J	Lee, JY; Lee, J; Yue, H; Lee, TH				Lee, Ju Yeon; Lee, Jaehyoun; Yue, Hongjun; Lee, Tae-Hee			Dynamics of Nucleosome Assembly and Effects of DNA Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE CHAPERONE NAP1; CPG METHYLATION; IN-VITRO; CHROMATIN; PROTEIN-1; STABILITY; RECONSTITUTION; DEACETYLASE; COMPLEXES; PATTERNS	The nucleosome is the fundamental packing unit of the eukaryotic genome, and CpG methylation is an epigenetic modification associated with gene repression and silencing. We investigated nucleosome assembly mediated by histone chaperone Nap1 and the effects of CpG methylation based on three-color single molecule FRET measurements, which enabled direct monitoring of histone binding in the context of DNA wrapping. According to our observation, (H3-H4)(2) tetramer incorporation must precede H2A-H2B dimer binding, which is independent of DNA termini wrapping. Upon CpG methylation, (H3-H4) 2 tetramer incorporation and DNA termini wrapping are facilitated, whereas proper incorporation of H2A-H2B dimers is inhibited. We suggest that these changes are due to rigidified DNA and increased random binding of histones to DNA. According to the results, CpG methylation expedites nucleosome assembly in the presence of abundant DNA and histones, which may help facilitate gene packaging in chromatin. The results also indicate that the slowest steps in nucleosome assembly are DNA termini wrapping and tetramer positioning, both of which are affected heavily by changes in the physical properties of DNA.	[Lee, Tae-Hee] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lee, TH (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	txl18@psu.edu	Lee, Tae-Hee/A-1266-2010	Seiler, Jae Hyoun/0000-0002-6351-3546	National Institutes of Health [GM097286]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097286] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM097286 (to T. H. L.).	Akey CW, 2003, CURR OPIN STRUC BIOL, V13, P6, DOI 10.1016/S0959-440X(03)00002-2; Andrews AJ, 2008, J BIOL CHEM, V283, P32412, DOI 10.1074/jbc.M805918200; Andrews AJ, 2011, METHOD ENZYMOL, P265, DOI 10.1016/B978-0-12-381268-1.00011-2; Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; Anselmi C, 2000, BIOPHYS J, V79, P601, DOI 10.1016/S0006-3495(00)76319-3; Azegami N, 2013, BIOCHEMISTRY-US, V52, P5155, DOI 10.1021/bi4005655; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Bohm V, 2011, NUCLEIC ACIDS RES, V39, P3093, DOI 10.1093/nar/gkq1279; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Choy JS, 2010, J AM CHEM SOC, V132, P1782, DOI 10.1021/ja910264z; Collings CK, 2013, NUCLEIC ACIDS RES, V41, P2918, DOI 10.1093/nar/gks893; D'Arcy S, 2013, MOL CELL, V51, P662, DOI 10.1016/j.molcel.2013.07.015; Davey C, 1997, J MOL BIOL, V267, P276, DOI 10.1006/jmbi.1997.0899; Davey CS, 2004, NUCLEIC ACIDS RES, V32, P4322, DOI 10.1093/nar/gkh749; Derreumaux S, 2001, NUCLEIC ACIDS RES, V29, P2314, DOI 10.1093/nar/29.11.2314; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; FUJIINAKATA T, 1992, J BIOL CHEM, V267, P20980; Fyodorov DV, 2003, METHOD ENZYMOL, V371, P499; Geahigan KB, 2000, BIOCHEMISTRY-US, V39, P4939, DOI 10.1021/bi9917636; Godde JS, 1996, J BIOL CHEM, V271, P24325, DOI 10.1074/jbc.271.40.24325; HOGAN ME, 1987, NATURE, V328, P554, DOI 10.1038/328554a0; Horsey I, 2000, CHEM COMMUN, P1043, DOI 10.1039/b002540m; Ito T, 1996, MOL CELL BIOL, V16, P3112; Jeong S, 2009, MOL CELL BIOL, V29, P5366, DOI 10.1128/MCB.00484-09; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Klein CB, 1997, MUTAT RES-REV MUTAT, V386, P163, DOI 10.1016/S1383-5742(96)00052-X; KORNBERG RD, 1981, SCI AM, V244, P48, DOI 10.1038/scientificamerican0281-52; Kulaeva OI, 2010, P NATL ACAD SCI USA, V107, P11325, DOI 10.1073/pnas.1001148107; Lee JY, 2012, BBA-PROTEINS PROTEOM, V1824, P974, DOI 10.1016/j.bbapap.2012.05.006; Lee JY, 2012, J AM CHEM SOC, V134, P173, DOI 10.1021/ja210273w; Lee JY, 2011, J BIOL CHEM, V286, P11099, DOI 10.1074/jbc.M110.192047; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mazurkiewicz J, 2006, J BIOL CHEM, V281, P16462, DOI 10.1074/jbc.M511619200; McQuibban GA, 1998, J BIOL CHEM, V273, P6582, DOI 10.1074/jbc.273.11.6582; Mosammaparast N, 2002, EMBO J, V21, P6527, DOI 10.1093/emboj/cdf647; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; Nakagawa T, 2001, J BIOL CHEM, V276, P27384, DOI 10.1074/jbc.M101331200; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nathan D, 2002, J MOL BIOL, V316, P7, DOI 10.1006/jmbi.2001.5247; Pennings Sari, 2005, Briefings in Functional Genomics & Proteomics, V3, P351, DOI 10.1093/bfgp/3.4.351; RIGGS AD, 1992, TRENDS GENET, V8, P169, DOI 10.1016/0168-9525(92)90219-T; Robertson KD, 2002, ONCOGENE, V21, P5361, DOI 10.1038/sj.onc.1205609; Rocha W, 2008, FEBS LETT, V582, P1938, DOI 10.1016/j.febslet.2008.03.006; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sheinin MY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3579; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Toth KF, 2005, J BIOL CHEM, V280, P15690, DOI 10.1074/jbc.M413329200; Wang YH, 1996, J BIOL CHEM, V271, P22937, DOI 10.1074/jbc.271.38.22937; Watrob HM, 2003, J AM CHEM SOC, V125, P7336, DOI 10.1021/ja034564p; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; WILHELM FX, 1978, NUCLEIC ACIDS RES, V5, P505, DOI 10.1093/nar/5.2.505	55	31	32	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4291	4303		10.1074/jbc.M114.619213	http://dx.doi.org/10.1074/jbc.M114.619213			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25550164	Green Published, hybrid			2022-12-26	WOS:000349458400039
J	Lee, CH; Lee, WC; Chang, SH; Wen, MS; Hung, KC				Lee, Cheng-Hung; Lee, Wen-Chen; Chang, Shang-Hung; Wen, Ming-Shien; Hung, Kuo-Chun			The N-Terminal Propeptide of Type III Procollagen in Patients with Acute Coronary Syndrome: A Link between Left Ventricular End-Diastolic Pressure and Cardiovascular Events	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; LEFT ATRIAL SIZE; CONGESTIVE-HEART-FAILURE; EJECTION FRACTION; PROGNOSTIC IMPLICATIONS; METABOLIC SYNDROME; ARTERY-DISEASE; TISSUE; DYSFUNCTION; FIBROSIS	Background: Despite the usefulness of N-terminal propeptide of type III procollagen (PIIINP) in detecting enhanced collagen turnover in patients with congestive heart failure, the value added by PIIINP to the use of clinical variables and echocardiography in relation to directly measured left ventricular (LV) enddiastolic pressure (EDP) and the outcome of acute coronary syndrome (ACS) has not been clearly defined. Methods and Results: This study involved 168 adult patients with ACS, who underwent echocardiography, measurement of serum PIIINP levels, and cardiac catheterization. Pulsed wave tissue Doppler imaging (PWTDI), which revealed mean peak systolic (s'), early (e'), and late diastolic (a') velocities, was carried out and the eas index of LV function was evaluated: e'/(a'xs'). The patients were divided into three study groups based on the degree of LVEDP - normal (<16 mmHg), intermediate (16-30 mmHg), and high (. 30 mmHg) LVEDP. All patients were followed-up to determine cardiac-related death and revascularization. Patients with high LVEDP had significantly more PIIINP than those with intermediate or normal LVEDP (all post hoc p<0.05). The presence of coronary artery disease, the left atrial volume index (LAVI), the ratio of transmitral early and late diastolic flow velocities, a', and the eas index were significantly correlated with LVEDP. According to multiple stepwise analysis, PIIINP, LAVI and the eas index were the three independent predictors of the level of LVEDP (PIIINP, p<0.001; LAVI, p=0.007; eas index, p=0.021). During follow-up (median, 24 months), 32 participants suffered from cardiac events, PIIINP and LAVI were significant predictors of cardiac mortality and hospitalization (PIIINP, hazard ratio (HR) 2.589, p=0.002; LAVI, HR 1.040, p=0.027). Conclusions: PIIINP is a highly effective means to evaluate LVEDP in patients with ACS. The PIIINP is also correlated with cardiac mortality and revascularization, providing an additional means of evaluating and managing patients with ACS.	[Lee, Cheng-Hung; Lee, Wen-Chen; Chang, Shang-Hung; Wen, Ming-Shien; Hung, Kuo-Chun] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Internal Med,Div Cardiol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Hung, KC (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Internal Med,Div Cardiol, Taoyuan, Taiwan.	hkuo.chun@gmail.com	Lee, Cheng-Hung/ABA-8070-2021		National Science Council of Taiwan [NSC-102-2314-B-182A-109)]; Chang Gung Memorial Hospital [CMRPG390991]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The authors would like to thank the National Science Council of Taiwan (Contract No. NSC-102-2314-B-182A-109) and Chang Gung Memorial Hospital (Contract No. CMRPG390991) for financially supporting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 1999, JPN CIRC J, V63, P763, DOI 10.1253/jcj.63.763; Abhayaratna WP, 2006, J AM COLL CARDIOL, V47, P2357, DOI 10.1016/j.jacc.2006.02.048; APPLETON CP, 1993, J AM COLL CARDIOL, V22, P1972, DOI 10.1016/0735-1097(93)90787-2; Armstrong PW, 1998, CIRCULATION, V98, P1860, DOI 10.1161/01.CIR.98.18.1860; Bagai A, 2013, AM HEART J, V166, P913, DOI 10.1016/j.ahj.2013.08.006; Banerjee T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090527; Baranova A, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-91; Berger PB, 1997, CIRCULATION, V96, P122; Campbell DJ, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-80; CAPASSO JM, 1991, AM J PHYSIOL, V260, pH651, DOI 10.1152/ajpheart.1991.260.3.H651; CARROLL JD, 1985, CIRCULATION, V72, P119, DOI 10.1161/01.CIR.72.1.119; Cerisano G, 2001, J AM COLL CARDIOL, V37, P793, DOI 10.1016/S0735-1097(00)01203-1; Doi R, 2000, J HYPERTENS, V18, P111, DOI 10.1097/00004872-200018010-00016; Du X, 2012, INT J CARDIOL, V156, P24, DOI 10.1016/j.ijcard.2010.10.036; GOLDSTEIN JA, 1990, CIRCULATION, V82, P359, DOI 10.1161/01.CIR.82.2.359; GOULD KL, 1974, AM J CARDIOL, V34, P48, DOI 10.1016/0002-9149(74)90092-7; Gressner OA, 2007, CLIN CHIM ACTA, V381, P107, DOI 10.1016/j.cca.2007.02.038; Hayashi M, 2003, CIRCULATION, V107, P2559, DOI 10.1161/01.CIR.0000068340.96506.0F; Hayashi M, 2001, J AM COLL CARDIOL, V38, P1375, DOI 10.1016/S0735-1097(01)01539-X; Herlitz J, 2002, INT J CARDIOL, V82, P259, DOI 10.1016/S0167-5273(02)00006-2; HORSLEVPETERSEN K, 1988, APMIS, V96, P793, DOI 10.1111/j.1699-0463.1988.tb00946.x; HOST NB, 1995, AM J CARDIOL, V76, P869, DOI 10.1016/S0002-9149(99)80251-3; Jellis C, 2011, CIRC-CARDIOVASC IMAG, V4, P693, DOI 10.1161/CIRCIMAGING.111.963587; JOHNSON LW, 1989, CATHETER CARDIO DIAG, V17, P5, DOI 10.1002/ccd.1810170103; Kawamura M, 2012, EUROPACE, V14, P1719, DOI 10.1093/europace/eus162; Kern MJ, 1998, CATHETER CARDIO DIAG, V44, P70, DOI 10.1002/(SICI)1097-0304(199805)44:1<70::AID-CCD17>3.0.CO;2-T; Kosmala W, 2012, EUR HEART J-CARD IMG, V13, P459, DOI 10.1093/ejechocard/jer291; LASKEY W, 1993, CATHETER CARDIO DIAG, V30, P185, DOI 10.1002/ccd.1810300302; Leber AW, 2004, J AM COLL CARDIOL, V43, P1241, DOI 10.1016/j.jacc.2003.10.059; Lee CH, 2011, INT J CLIN PRACT, V65, P852, DOI 10.1111/j.1742-1241.2011.02699.x; Levine GN, 2005, CATHETER CARDIO INTE, V66, P149, DOI 10.1002/ccd.20469; Li BS, 1997, AM J PHYSIOL-HEART C, V273, pH2508, DOI 10.1152/ajpheart.1997.273.5.H2508; LITTLE WC, 1995, CIRCULATION, V92, P1933, DOI 10.1161/01.CIR.92.7.1933; Lopez B, 2010, CIRCULATION, V121, P1645, DOI 10.1161/CIRCULATIONAHA.109.912774; Martos R, 2007, CIRCULATION, V115, P888, DOI 10.1161/CIRCULATIONAHA.106.638569; Meyer O, 2006, JOINT BONE SPINE, V73, P490, DOI 10.1016/j.jbspin.2006.01.022; Mielniczuk Lisa M, 2007, Congest Heart Fail, V13, P209, DOI 10.1111/j.1527-5299.2007.06624.x; Mornos C, 2009, INT J CARDIOL, V136, P120, DOI 10.1016/j.ijcard.2008.04.029; Olariu A, 2003, Eur J Echocardiogr, V4, P162, DOI 10.1016/S1525-2167(02)00160-9; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Poulsen SH, 2000, CIRCULATION, V101, P1527, DOI 10.1161/01.CIR.101.13.1527; Rossi A, 2004, HEART, V90, P650, DOI 10.1136/hrt.2002.005371; Simpson IA, 1997, HEART, V78, P211, DOI 10.1136/hrt.78.3.211; Tsang TSM, 2006, J AM COLL CARDIOL, V47, P1018, DOI 10.1016/j.jacc.2005.08.077; Tsang TSM, 2003, J AM COLL CARDIOL, V42, P1199, DOI 10.1016/S0735-1097(03)00943-4; Van Herck PL, 2007, HEART, V93, P1231, DOI 10.1136/hrt.2006.100818; Vanderheyden Marc, 2005, Eur J Echocardiogr, V6, P47, DOI 10.1016/j.euje.2004.06.006; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Wang TJ, 2007, AM HEART J, V154, P291, DOI 10.1016/j.ahj.2007.04.006; Westermann D, 2008, CIRCULATION, V117, P2051, DOI 10.1161/CIRCULATIONAHA.107.716886; Zannad F, 2000, CIRCULATION, V102, P2700, DOI 10.1161/01.CIR.102.22.2700	51	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e114097	10.1371/journal.pone.0114097	http://dx.doi.org/10.1371/journal.pone.0114097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559610	Green Submitted, Green Published, gold			2022-12-26	WOS:000348102200007
J	Li, HE; Yao, WJ; Fu, YR; Li, SK; Guo, QQ				Li, Huie; Yao, Weijie; Fu, Yaru; Li, Shaoke; Guo, Qiqiang			De Novo Assembly and Discovery of Genes That Are Involved in Drought Tolerance in Tibetan Sophora moorcroftiana	PLOS ONE			English	Article							DEHYDRIN GENES; DIFFERENTIAL EXPRESSION; TRANSCRIPTOME PROFILES; RESPONSIVE GENES; ABIOTIC STRESSES; LOW-TEMPERATURE; IDENTIFICATION; COLD; ARABIDOPSIS; PLANT	Sophora moorcroftiana, a Leguminosae shrub species that is restricted to the arid and semi-arid regions of the Qinghai-Tibet Plateau, is an ecologically important foundation species and exhibits substantial drought tolerance in the Plateau. There are no functional genomics resources in public databases for understanding the molecular mechanism underlying the drought tolerance of S. moorcroftiana. Therefore, we performed a large-scale transcriptome sequencing of this species under drought stress using the Illumina sequencing technology. A total of 62,348,602 clean reads were obtained. The assembly of the clean reads resulted in 146,943 transcripts, including 66,026 unigenes. In the assembled sequences, 1534 transcription factors were identified and classified into 23 different common families, and 9040 SSR loci, from di-to hexa-nucleotides, whose repeat number is greater than five, were presented. In addition, we performed a gene expression profiling analysis upon dehydration treatment. The results indicated significant differences in the gene expression profiles among the control, mild stress and severe stress. In total, 4687, 5648 and 5735 genes were identified from the comparison of mild versus control, severe versus control and severe versus mild stress, respectively. Based on the differentially expressed genes, a Gene Ontology annotation analysis indicated many dehydration-relevant categories, including 'response to water 'stimulus' and 'response to water deprivation'. Meanwhile, the Kyoto Encyclopedia of Genes and Genomes pathway analysis uncovered some important pathways, such as 'metabolic pathways' and 'plant hormone signal transduction'. In addition, the expression patterns of 25 putative genes that are involved in drought tolerance resulting from quantitative real-time PCR were consistent with their transcript abundance changes as identified by RNA-seq. The globally sequenced genes covered a considerable proportion of the S. moorcroftiana transcriptome, and the expression results may be useful to further extend the knowledge on the drought tolerance of this plant species that survives under Plateau conditions.	[Li, Huie; Yao, Weijie; Fu, Yaru; Li, Shaoke; Guo, Qiqiang] Tibet Univ, Agr & Anim Husb Coll, Nyingchi, Tibet, Peoples R China; [Yao, Weijie; Fu, Yaru; Li, Shaoke; Guo, Qiqiang] Tibet Univ, Minist Educ, Key Lab Forest Ecol Tibet Plateau, Nyingchi, Tibet, Peoples R China; [Yao, Weijie; Fu, Yaru; Li, Shaoke; Guo, Qiqiang] Natl Key Stn Field Sci Observat & Expt, Nyingchi, Tibet, Peoples R China	Tibet University; Tibet University	Guo, QQ (corresponding author), Tibet Univ, Agr & Anim Husb Coll, Nyingchi, Tibet, Peoples R China.	hnguoqiqiang@126.com			National Natural Science Foundation of China [31260189]; Collaborative Innovation Center Construction of Research and development on Tibetan characteristic agricultural and animal husbandry resources----plateau ecology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Innovation Center Construction of Research and development on Tibetan characteristic agricultural and animal husbandry resources----plateau ecology	This research was supported by the National Natural Science Foundation of China (31260189) and Collaborative Innovation Center Construction of Research and development on Tibetan characteristic agricultural and animal husbandry resources----plateau ecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-64; Bak Soren, 2011, Arabidopsis Book, V9, pe0144, DOI 10.1199/tab.0144; Chen D, 2008, ACTA PHYSIOL PLANT, V30, P183, DOI 10.1007/s11738-007-0107-5; Cui XF, 2009, CLIMATIC CHANGE, V94, P47, DOI 10.1007/s10584-009-9556-8; da Silva MD, 2013, J NUCLEIC ACIDS, V2013, DOI 10.1155/2013/763945; Dang ZH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-29; Dobra J, 2011, J PLANT PHYSIOL, V168, P1588, DOI 10.1016/j.jplph.2011.02.009; Dugas DV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-514; Eriksson SK, 2011, ECOL STUD-ANAL SYNTH, V215, P289, DOI 10.1007/978-3-642-19106-0_14; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Gao CQ, 2012, INT J MOL SCI, V13, P3751, DOI 10.3390/ijms13033751; Gao CQ, 2010, PLANT MOL BIOL REP, V28, P77, DOI 10.1007/s11105-009-0129-9; Guimaraes PM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-387; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; Huang DQ, 2008, J EXP BOT, V59, P2991, DOI 10.1093/jxb/ern155; Kang Y, 2011, PLANT J, V68, P871, DOI 10.1111/j.1365-313X.2011.04738.x; Kantartzi Stella K., 2013, MICROSATELLITES METH; Liu CH, 2013, PLANT GROWTH REGUL, V70, P187, DOI 10.1007/s10725-013-9791-x; Liu MQ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-88; Liu TM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-130; Ma DY, 2014, PLANT PHYSIOL BIOCH, V80, P60, DOI 10.1016/j.plaphy.2014.03.024; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moumeni A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-174; Mowla SB, 2002, PLANTA, V215, P716, DOI 10.1007/s00425-002-0819-0; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Nam KH, 2013, FOOD SCI BIOTECHNOL, V22, P1351, DOI 10.1007/s10068-013-0222-6; Nishiyama R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032124; Qian G, 2008, CAN J PLANT SCI, V88, P899, DOI 10.4141/CJPS08015; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Shen WY, 2006, PLANT CELL, V18, P422, DOI 10.1105/tpc.105.039750; Silva PIT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-17; Suprunova T, 2004, PLANT CELL ENVIRON, V27, P1297, DOI 10.1111/j.1365-3040.2004.01237.x; Tang WJ, 2013, PLANT PHYSIOL, V163, P857, DOI 10.1104/pp.113.224386; Tian DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-827; Torales SL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-705; Wang XC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-415; Wisniewski ME, 2006, TREE PHYSIOL, V26, P575, DOI 10.1093/treephys/26.5.575; Xu YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-662; Xue X, 2009, GEOMORPHOLOGY, V108, P182, DOI 10.1016/j.geomorph.2009.01.004; Yang MX, 2004, COLD REG SCI TECHNOL, V39, P47, DOI 10.1016/j.coldregions.2004.01.002; Yang YZ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-140; Yoshimura K, 2008, PLANT CELL PHYSIOL, V49, P226, DOI 10.1093/pcp/pcm180; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yu SC, 2012, PLANT MOL BIOL REP, V30, P17, DOI 10.1007/s11105-011-0313-6; Zhao ZG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-222	49	169	183	11	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e111054	10.1371/journal.pone.0111054	http://dx.doi.org/10.1371/journal.pone.0111054			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559297	Green Published, Green Submitted, gold			2022-12-26	WOS:000348102200003
J	Yin, F; Zhang, JN; Wang, SW; Zhou, CH; Zhao, MM; Fan, WH; Fan, M; Liu, S				Yin, Feng; Zhang, Jian Ning; Wang, Shu Wei; Zhou, Chun Hui; Zhao, Ming Ming; Fan, Wen Hong; Fan, Ming; Liu, Shuang			MiR-125a-3p Regulates Glioma Apoptosis and Invasion by Regulating Nrg1	PLOS ONE			English	Article							MICRORNAS; PROLIFERATION; EXPRESSION; MIGRATION; GROWTH; CANCER; CELLS; DIFFERENTIATION; IDENTIFICATION; SUPPRESSES	The current study was designed to examine the functional role and mechanism of miR-125a-3p in glioma development. Quantitative RT-PCR was used to evaluate miR-125a-3p expression in 60 glioma cases of different malignant grades. Then, the clinic pathologic significance of miR-125a-3p expression was determined in combination with the prognosis of the patients. In addition, the effects and mechanisms of miR-125a-3p on the proliferation, apoptosis and invasion of glioma cells were further investigated. The results showed that the expression of miR-125a-3p was decreased significantly in most malignant glioma samples relative to normal brain tissues and glioma tissues of low-malignant degree. Further kaplan-meier survival analysis showed that the lower expression of miR-125a-3p was associated with a poor prognosis of GBM patients. Functional analysis showed that the reintroduction of miR-125a-3p into glioblastoma cell lines induces markedly the apoptosis and suppresses the proliferation and migration of glioblastoma cells in vitro and in vivo. Luciferase assay and Western blot analysis revealed that Nrg1 is a direct target of miR-125a-3p. Furthermore, an increased expression of Nrg1 could reverse the effects of overexpression of miR-125a-3p on the proliferation, apoptosis and migration of glioblastoma cells. These findings suggest that miR-125a-3p performed an important role in glioma development mediated by directly regulating the expression of Nrg1. This study also provides a potential target for diagnosis and treatment of malignant glioma.	[Yin, Feng; Zhang, Jian Ning; Wang, Shu Wei; Zhou, Chun Hui; Zhao, Ming Ming; Liu, Shuang] Chinese PLA Navy Gen Hosp, Dept Neurosurg, Beijing 100048, Peoples R China; [Fan, Wen Hong; Fan, Ming] Beijing Inst Basic Med Sci, Dept Brain Protect Plast Res, Beijing 100850, Peoples R China	Sixth Medical Center of Chinese PLA General Hospital; Academy of Military Medical Sciences - China	Fan, M (corresponding author), Beijing Inst Basic Med Sci, Dept Brain Protect Plast Res, Beijing 100850, Peoples R China.	fanmingchina@126.com; shuangff@sina.com			National Nature Science Foundation of China [81172384, 30873029]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Nature Science Foundation of China (grants no. 81172384, no. 30873029) (http://www.nsfc.gov.cn/) SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BEMSTEIN HG, 2006, BRAIN RES BULL, V69, P546, DOI DOI 10.1016/J.BRAINRESBULL.2006.02.017; CARRAWAY KL, 1995, CURR OPIN NEUROBIOL, V5, P606, DOI 10.1016/0959-4388(95)80065-4; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ferretti E, 2009, INT J CANCER, V124, P568, DOI 10.1002/ijc.23948; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Guo X, 2009, RNA BIOL, V6, P575, DOI 10.4161/rna.6.5.10079; He XY, 2010, J CANCER RES CLIN, V136, P1023, DOI 10.1007/s00432-009-0747-5; Hijazi MM, 2000, INT J ONCOL, V17, P629; Hisaoka M, 2011, GENE CHROMOSOME CANC, V50, P137, DOI 10.1002/gcc.20837; Jiang LL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-318; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Laneve P, 2007, P NATL ACAD SCI USA, V104, P7957, DOI 10.1073/pnas.0700071104; Li W, 2009, J MED GENET, V46, P358, DOI 10.1136/jmg.2008.063123; Liu S, 2014, J CELL BIOCHEM, V115, P1368, DOI 10.1002/jcb.24786; Miller MW, 2006, J NEUROCHEM, V97, P1182, DOI 10.1111/j.1471-4159.2006.03858.x; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Nilsson P, 2001, TUMOR BIOL, V22, P229, DOI 10.1159/000050621; Nishida N, 2011, CLIN CANCER RES, V17, P2725, DOI 10.1158/1078-0432.CCR-10-2132; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Prevot V, 2003, J NEUROSCI, V23, P230; Ritch PA, 2003, J BIOL CHEM, V278, P20971, DOI 10.1074/jbc.M213074200; Ritch PS, 2005, GLIA, V51, P217, DOI 10.1002/glia.20197; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Spizzo R, 2009, CELL, V137, P586, DOI 10.1016/j.cell.2009.04.040; Thuringer D, 2011, J BIOL CHEM, V286, P3418, DOI 10.1074/jbc.M110.154823; Wang GF, 2009, FEBS J, V276, P5571, DOI 10.1111/j.1742-4658.2009.07238.x; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wilson TR, 2011, CANCER CELL, V20, P158, DOI 10.1016/j.ccr.2011.07.011; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005; Xu XF, 2011, INT J ONCOL, V38, P1385, DOI 10.3892/ijo.2011.961; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Zhao WJ, 2013, J NEUROPATH EXP NEUR, V72, P244, DOI 10.1097/NEN.0b013e3182863dc5; Zhao WJ, 2011, CELL TISSUE RES, V344, P313, DOI 10.1007/s00441-011-1157-y; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126	43	44	48	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e0116759	10.1371/journal.pone.0116759	http://dx.doi.org/10.1371/journal.pone.0116759			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25560389	Green Published, Green Submitted, gold			2022-12-26	WOS:000348102200017
J	Barnes, S; Xu, YH; Zhang, WJ; Liou, B; Setchell, KDR; Bao, LM; Grabowski, GA; Sun, Y				Barnes, Sonya; Xu, You-Hai; Zhang, Wujuan; Liou, Benjamin; Setchell, Kenneth D. R.; Bao, Liming; Grabowski, Gregory A.; Sun, Ying			Ubiquitous Transgene Expression of the Glucosylceramide-Synthesizing Enzyme Accelerates Glucosylceramide Accumulation and Storage Cells in a Gaucher Disease Mouse Model	PLOS ONE			English	Article							ACID BETA-GLUCOSIDASE; HUMAN METACHROMATIC LEUKODYSTROPHY; SUBSTRATE REDUCTION THERAPY; GLYCOSPHINGOLIPID SYNTHESIS; GLUCOCEREBROSIDASE GENE; DEFICIENT MICE; CERAMIDE GLUCOSYLTRANSFERASE; GANGLIOSIDE METABOLISM; ELIGLUSTAT TARTRATE; SANDHOFF DISEASES	Gaucher disease is a lysosomal storage disease caused by defective activity of acid beta-glucosidase (GCase), which leads to the accumulation of its major substrates, glucosylceramide (GlcCer) and glucosylsphingosine (GlcSph) in many cells. To modulate cellular substrate concentration in viable mouse models of Gaucher disease (Gba1 mutants), a novel mouse model was created with enhanced glycosphingolipid biosynthesis. This was accomplished by crossbreeding Gba1 mutant mice with mice expressing a transgene (GCStg) containing the mouse glucosylceramide synthase (GCS, Ugcg) cDNA driven by the ROSA promoter, yielding GCStg/Gba1 mice. The GCStg rescued Ugcg null mice from embryonic lethality. GCStg/Gba1 mice showed 2-3 fold increases in tissue GCS activity as well as accelerated GlcCer accumulation and the appearance of lipid-laden CD68 positive macrophages in visceral organs. Although GlcCer/GlcSph concentrations were elevated in the brain, there was no neurodegenerative phenotype up to 1 yr of age conceivably due to the greater residual GCase hydrolytic activity in the brains than in the visceral tissues of 9V/null mice. These studies provide 'proof of principle' for threshold substrate flux that modifies phenotypic development in Gaucher disease and other lysosomal storage diseases.	[Barnes, Sonya; Xu, You-Hai; Liou, Benjamin; Grabowski, Gregory A.; Sun, Ying] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Zhang, Wujuan; Setchell, Kenneth D. R.] Cincinnati Childrens Hosp Med Ctr, Div Pathol & Lab Med, Cincinnati, OH 45229 USA; [Xu, You-Hai; Setchell, Kenneth D. R.; Sun, Ying] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Bao, Liming] Dartmouth Coll, Geisel Sch Med, Dartmouth Hitchcock Med Ctr, Lebanon, NH 03756 USA; [Grabowski, Gregory A.] Synageva BioPharma Corp, Lexington, MA USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Dartmouth College	Sun, Y (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA.	ying.sun@cchmc.org			National Institutes of Health (NIH) [DK 36729]; Synageva; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Synageva; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Institutes of Health (NIH) (DK 36729) to GAG. Synageva provided support in the form of a salary for author GAG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankleshwaria C, 2014, J HUM GENET, V59, P223, DOI 10.1038/jhg.2014.5; ARORA RC, 1972, J LIPID RES, V13, P86; Ashe KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021758; BASU S, 1968, J BIOL CHEM, V243, P5802; Belmatoug N, 2011, J INHERIT METAB DIS, V34, P991, DOI 10.1007/s10545-011-9368-7; Bennett LL, 2013, ANN PHARMACOTHER, V47, P1182, DOI 10.1177/1060028013500469; Choy FYM, 2007, BLOOD CELL MOL DIS, V38, P287, DOI 10.1016/j.bcmd.2006.11.003; CONRADI NG, 1984, ACTA NEUROPATHOL, V65, P99, DOI 10.1007/BF00690463; COSTE H, 1986, BIOCHIM BIOPHYS ACTA, V858, P6, DOI 10.1016/0005-2736(86)90285-3; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; Elliot-Smith E, 2008, MOL GENET METAB, V94, P204, DOI 10.1016/j.ymgme.2008.02.005; Enquist IB, 2007, P NATL ACAD SCI USA, V104, P17483, DOI 10.1073/pnas.0708086104; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Furukawa K, 2004, SEMIN CELL DEV BIOL, V15, P389, DOI 10.1016/j.semcdb.2004.03.006; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Gillard BK, 1998, GLYCOBIOLOGY, V8, P885, DOI 10.1093/glycob/8.9.885; Ginns EI, 2014, MOL GENET METAB, V111, P152, DOI 10.1016/j.ymgme.2013.12.003; Grabowski G. A., 2010, METABOLIC MOL BASES; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hess B, 1996, P NATL ACAD SCI USA, V93, P14821, DOI 10.1073/pnas.93.25.14821; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Ichikawa S, 1996, P NATL ACAD SCI USA, V93, P4638, DOI 10.1073/pnas.93.10.4638; Ichikawa S, 1998, BIOCHEM BIOPH RES CO, V253, P707, DOI 10.1006/bbrc.1998.9855; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; Jennemann R, 2005, P NATL ACAD SCI USA, V102, P12459, DOI 10.1073/pnas.0500893102; Jeong SY, 2011, BLOOD CELL MOL DIS, V46, P11, DOI 10.1016/j.bcmd.2010.07.010; Jeyakumar M, 1999, P NATL ACAD SCI USA, V96, P6388, DOI 10.1073/pnas.96.11.6388; Karaca E, 2012, J PEDIATR ENDOCR MET, V25, P957, DOI 10.1515/jpem-2012-0155; KATTLOVE HE, 1969, BLOOD-J HEMATOL, V33, P379, DOI 10.1182/blood.V33.2.379.379; KELSEY PR, 1988, J CLIN PATHOL, V41, P960, DOI 10.1136/jcp.41.9.960; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Koprivica V, 2000, AM J HUM GENET, V66, P1777, DOI 10.1086/302925; Kuter DJ, 2013, BLOOD CELL MOL DIS, V51, P116, DOI 10.1016/j.bcmd.2013.04.005; Le Stunff H, 2007, J BIOL CHEM, V282, P34372, DOI 10.1074/jbc.M703329200; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lukina E, 2014, BLOOD CELL MOL DIS, V53, P274, DOI 10.1016/j.bcmd.2014.04.002; Lukina E, 2010, BLOOD, V116, P893, DOI 10.1182/blood-2010-03-273151; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Marks DL, 1999, J BIOL CHEM, V274, P451, DOI 10.1074/jbc.274.1.451; Marshall J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015033; Marshall J, 2010, J INHERIT METAB DIS, V33, P281, DOI 10.1007/s10545-010-9072-z; Mizukami H, 2002, J CLIN INVEST, V109, P1215, DOI 10.1172/JCI200214530; Nordstrom V, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001506; Phaneuf D, 1996, HUM MOL GENET, V5, P1, DOI 10.1093/hmg/5.1.1; Platt FM, 2001, J INHERIT METAB DIS, V24, P275, DOI 10.1023/A:1010335505357; Poole RM, 2014, DRUGS, V74, P1829, DOI 10.1007/s40265-014-0296-3; QI XY, 1994, J BIOL CHEM, V269, P16746; Ramakrishnan H, 2007, J NEUROSCI, V27, P9482, DOI 10.1523/JNEUROSCI.2287-07.2007; Sabourdy F, 2008, BBA-MOL CELL BIOL L, V1781, P145, DOI 10.1016/j.bbalip.2008.01.004; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; Sardi SP, 2011, P NATL ACAD SCI USA, V108, P12101, DOI 10.1073/pnas.1108197108; Shayman JA, 2010, DRUG FUTURE, V35, P613, DOI 10.1358/dof.2010.035.08.1505566; Shayman JA, 2014, J LIPID RES, V55, P1215, DOI 10.1194/jlr.R047167; Shen W, 2014, J NEUROCHEM; Sidransky E, 2004, MOL GENET METAB, V83, P6, DOI 10.1016/j.ymgme.2004.08.015; SMITH WC, 1968, LANCET, V2, P780; Sun Y, 2005, J LIPID RES, V46, P2102, DOI 10.1194/jlr.M500202-JLR200; Sun Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057560; Sun Y, 2012, J BIOL CHEM, V287, P4275, DOI 10.1074/jbc.M111.280016; Tammachote R, 2013, J HUM GENET, V58, P594, DOI 10.1038/jhg.2013.60; Tepper AD, 2000, J BIOL CHEM, V275, P34810, DOI 10.1074/jbc.M005142200; TYBULEWICZ VLJ, 1992, NATURE, V357, P407, DOI 10.1038/357407a0; Veldman RJ, 2003, FASEB J, V17, P1144, DOI 10.1096/fj.02-1053fje; VUNNAM RR, 1980, CHEM PHYS LIPIDS, V26, P265; Xu YH, 2003, AM J PATHOL, V163, P2093, DOI 10.1016/S0002-9440(10)63566-3; Xu YH, 1998, MOL GENET METAB, V64, P87, DOI 10.1006/mgme.1998.2709; Xu YH, 2008, MOL GENET METAB, V94, P190, DOI 10.1016/j.ymgme.2008.01.013; Xu YH, 2010, J LIPID RES, V51, P1643, DOI 10.1194/jlr.R003996; Xu YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010750; YAMAGUCHI Y, 1994, J BIOCHEM-TOKYO, V116, P704, DOI 10.1093/oxfordjournals.jbchem.a124584; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142	72	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116023	10.1371/journal.pone.0116023	http://dx.doi.org/10.1371/journal.pone.0116023			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551612	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100088
J	Chen, Y; Lin, PX; Hsieh, CL; Peng, CC; Peng, RY				Chen, Yeh; Lin, Ping-Xiao; Hsieh, Chiu-Lan; Peng, Chiung-Chi; Peng, Robert Y.			The Proteomic and Genomic Teratogenicity Elicited by Valproic Acid Is Preventable with Resveratrol and alpha-Tocopherol	PLOS ONE			English	Article							HISTONE DEACETYLASE; SKELETAL-MUSCLE; INSULIN SENSITIVITY; N-ACETYLCYSTEINE; GENE-EXPRESSION; MECHANISM; PROTEIN; INHIBITORS; METABOLISM; DIFFERENTIATION	Background: Previously, we reported that valproic acid (VPA), a common antiepileptic drug and a potent teratogenic, dowregulates RBP4 in chicken embryo model (CEM) when induced by VPA. Whether such teratogenicity is associated with more advanced proteomic and genomic alterations, we further performed this present study. Methodology/Principal Findings: VPA (60 mu M) was applied to 36 chicken embryos at HH stage 10 (day-1.5). Resveratrol (RV) and vitamin E (vit E) (each at 0.2 and 2.0 mu M) were applied simultaneously to explore the alleviation effect. The proteins in the cervical muscles of the day-1 chicks were analyzed using 2D-electrophoresis and LC/MS/MS. While the genomics associated with each specific protein alteration was examined with RT-PCR and qPCR. At earlier embryonic stage, VPA downregulated PEBP1 and BHMT genes and at the same time upregulated MYL1, ALB and FLNC genes significantly (p<0.05) without affecting PKM2 gene. Alternatively, VPA directly inhibited the folate-independent (or the betaine-dependent) remethylation pathway. These features were effectively alleviated by RV and vit E. Conclusions: VPA alters the expression of PEBP1, BHMT, MYL1, ALB and FLNC that are closely related with metabolic myopathies, myogenesis, albumin gene expression, and haemolytic anemia. On the other hand, VPA directly inhibits the betaine-dependent remethylation pathway. Taken together, VPA elicits hemorrhagic myoliposis via these action mechanisms, and RV and vit E are effective for alleviation of such adverse effects.	[Chen, Yeh; Peng, Robert Y.] Hungkuang Univ, Biotechnol Res Inst, Taichung 43302, Shalu County, Taiwan; [Lin, Ping-Xiao; Hsieh, Chiu-Lan] Changhua Univ Educ, Grad Inst Biotechnol, Changhua 50007, Taiwan; [Peng, Chiung-Chi] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei 11031, Taiwan; [Peng, Robert Y.] Taipei Med Univ, Coll Med, Res Inst Med Sci, Taipei 11031, Taiwan	Hungkuang University; National Changhua University of Education; Taipei Medical University; Taipei Medical University	Hsieh, CL (corresponding author), Changhua Univ Educ, Grad Inst Biotechnol, 1 Jin De Rd, Changhua 50007, Taiwan.	clhsieh@cc.ncue.edu.tw; ypeng@seed.net.tw			National Science Council [NSC 102-2313-B-018 -001 -MY3, NSC 101-2320-B-039-040]; Taipei Medical University [TMU101-AE1-B11]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Medical University	This work was funded by the National Science Council NSC 102-2313-B-018 -001 -MY3 and NSC 101-2320-B-039-040 and the Taipei Medical University [TMU101-AE1-B11]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MR, 2007, AM J MED GENET A, V143A, P1726, DOI 10.1002/ajmg.a.31812; Bettaieb A, 2013, J BIOL CHEM, V288, P17360, DOI 10.1074/jbc.M112.441469; BOLLENGIER F, 1988, J NEUROCHEM, V50, P1210, DOI 10.1111/j.1471-4159.1988.tb10594.x; Canepari M, 2010, ACTA PHYSIOL, V199, P465, DOI 10.1111/j.1748-1716.2010.02118.x; Chango A, 2009, J NUTR BIOCHEM, V20, P312, DOI 10.1016/j.jnutbio.2008.04.004; Chuang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043692; Combs AP, 2010, J MED CHEM, V53, P2333, DOI 10.1021/jm901090b; D'Amico A, 2013, HAND CLINIC, V113, P1437, DOI 10.1016/B978-0-444-59565-2.00013-7; Dashwood RH, 2007, SEMIN CANCER BIOL, V17, P363, DOI 10.1016/j.semcancer.2007.04.001; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Frayne J, 1999, CELL TISSUE RES, V298, P415, DOI 10.1007/s004419900113; Gelfi C, 2011, J PROTEOMICS, V74, P774, DOI 10.1016/j.jprot.2011.02.028; GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gultekin GI, 2012, J VET INTERN MED, V26, P935, DOI 10.1111/j.1939-1676.2012.00958.x; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hrzenjak A, 2006, MOL CANCER THER, V5, P2203, DOI 10.1158/1535-7163.MCT-05-0480; Hsieh CL, 2014, CLIN EXP PHARMACOL P, V41, P210, DOI 10.1111/1440-1681.12205; Hsieh CL, 2013, ROM J MORPHOL EMBRYO, V54, P993; Hsieh CL, 2012, TOXICOLOGY, V291, P32, DOI 10.1016/j.tox.2011.10.015; Iezzi S, 2002, P NATL ACAD SCI USA, V99, P7757, DOI 10.1073/pnas.112218599; Johannessen CU, 2000, NEUROCHEM INT, V37, P103, DOI 10.1016/S0197-0186(00)00013-9; Karabiber H, 2003, BRAIN DEV-JPN, V25, P113, DOI 10.1016/S0387-7604(02)00163-8; Ker YB, 2013, CHEM RES TOXICOL, V26, P325, DOI 10.1021/tx300456t; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kolling J, 2013, CELL BIOCHEM FUNCT, V31, P575, DOI 10.1002/cbf.2938; Lee BR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-60; Lheureux PER, 2005, CRIT CARE, V9, P431, DOI 10.1186/cc3742; Lin CY, 2009, PROTEOMICS, V9, P696, DOI 10.1002/pmic.200700470; LUDER AS, 1990, J CLIN INVEST, V86, P1574, DOI 10.1172/JCI114877; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; MCNALLY EM, 1989, NUCLEIC ACIDS RES, V17, P2753, DOI 10.1093/nar/17.7.2753; Menegola Elena, 2006, Birth Defects Research, V78, P345, DOI 10.1002/bdrc.20082; Moresi V, 2012, P NATL ACAD SCI USA, V109, P1649, DOI 10.1073/pnas.1121159109; Neri P, 2008, BRIT J HAEMATOL, V143, P520, DOI 10.1111/j.1365-2141.2008.07387.x; Ohlendieck K, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00105; Ou XP, 2007, BIOCHEM J, V401, P87, DOI 10.1042/BJ20061119; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Rosenberg G, 2007, CELL MOL LIFE SCI, V64, P2090, DOI 10.1007/s00018-007-7079-x; Roy M, 2008, J CELL BIOCHEM, V105, P467, DOI 10.1002/jcb.21847; Rugino TA, 2003, PEDIATR NEUROL, V29, P440, DOI 10.1016/S0887-8994(03)00310-2; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; Schulpis KH, 2006, TOXICOLOGY, V217, P228, DOI 10.1016/j.tox.2005.10.004; Sun WJ, 2012, ACTA BIOCH BIOPH SIN, V44, P80, DOI 10.1093/abbs/gmr113; Tabatabaei AR, 1999, CHEM RES TOXICOL, V12, P323, DOI 10.1021/tx9801864; Ubeda N, 2002, J NUTR, V132, P2737, DOI 10.1093/jn/132.9.2737; van Gelder MMHJ, 2010, HUM REPROD UPDATE, V16, P378, DOI 10.1093/humupd/dmp052; van Woudenberg AB, 2014, REPROD TOXICOL, V49, P101, DOI 10.1016/j.reprotox.2014.07.082; Venturelli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073097; Vercellati C, 2013, CLIN LAB, V59, P421, DOI 10.7754/Clin.Lab.2012.120905; Warang P, 2013, BLOOD CELL MOL DIS, V51, P133, DOI 10.1016/j.bcmd.2013.05.006; Woods KM, 2008, INT J RADIAT ONCOL, V72, P153, DOI 10.1016/j.ijrobp.2008.04.072; Yeung K, 2000, MOL CELL BIOL, V20, P3079, DOI 10.1128/MCB.20.9.3079-3085.2000; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686	55	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116534	10.1371/journal.pone.0116534	http://dx.doi.org/10.1371/journal.pone.0116534			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551574	gold, Green Published, Green Submitted			2022-12-26	WOS:000347119100143
J	Franklin, AM; Squires, ZE; Stuart-Fox, D				Franklin, Amanda M.; Squires, Zoe E.; Stuart-Fox, Devi			Does Predation Risk Affect Mating Behavior? An Experimental Test in Dumpling Squid (Euprymna tasmanica)	PLOS ONE			English	Article							COPULATION DURATION; MULTIPLE PATERNITY; FEMALE CHOICE; MATE CHOICE; COURTSHIP; REPRODUCTION; CUTTLEFISH; DECISIONS; COMPETITION; SURVIVAL	Introduction: One of the most important trade-offs for many animals is that between survival and reproduction. This is particularly apparent when mating increases the risk of predation, either by increasing conspicuousness, reducing mobility or inhibiting an individual's ability to detect predators. Individuals may mitigate the risk of predation by altering their reproductive behavior (e.g. increasing anti-predator responses to reduce conspicuousness). The degree to which individuals modulate their reproductive behavior in relation to predation risk is difficult to predict because both the optimal investment in current and future reproduction (due to life-history strategies) and level of predation risk may differ between the sexes and among species. Here, we investigate the effect of increased predation risk on the reproductive behavior of dumpling squid (Euprymna tasmanica). Results: Females, but not males, showed a substantial increase in the number of inks (an anti-predator behavior) before mating commenced in the presence of a predator (sand flathead Platycephalus bassensis). However, predation risk did not affect copulation duration, the likelihood of mating, female anti-predator behavior during or after mating or male anti-predator behavior at any time. Conclusions: Inking is a common anti-predator defense in cephalopods, thought to act like a smokescreen, decoy or distraction. Female dumpling squid are probably using this form of defense in response to the increase in predation risk prior to mating. Conversely, males were undeterred by the increase in predation risk. A lack of change in these variables may occur if the benefit of completing mating outweighs the risk of predation. Prioritizing current reproduction, even under predation risk, can occur when the chance of future reproduction is low, there is substantial energetic investment into mating, or the potential fitness payoffs of mating are high.	[Franklin, Amanda M.; Squires, Zoe E.; Stuart-Fox, Devi] Univ Melbourne, Dept Zool, Melbourne, Vic 3010, Australia	University of Melbourne	Franklin, AM (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic 3010, Australia.	amanda.franklin@tufts.edu		Stuart-Fox, Devi/0000-0003-3362-1412; Squires, Zoe/0000-0002-3878-6753; Franklin, Amanda/0000-0002-8650-8344	Hermon Slade Foundation [HSF 08/2]	Hermon Slade Foundation	Hermon Slade Foundation, HSF 08/2, http://www.hermonslade.org.au/, DS-F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MCB, 2003, BEHAV ECOL, V14, P531, DOI 10.1093/beheco/arg015; Andres JA, 2000, ANIM BEHAV, V59, P695, DOI 10.1006/anbe.1999.1372; BLOODGOOD RA, 1977, TISSUE CELL, V9, P197, DOI 10.1016/0040-8166(77)90016-7; Boal JG, 1997, BEHAVIOUR, V134, P975, DOI 10.1163/156853997X00340; Bonachea LA, 2011, ETHOLOGY, V117, P400, DOI 10.1111/j.1439-0310.2011.01889.x; Candolin U, 1998, P ROY SOC B-BIOL SCI, V265, P1171, DOI 10.1098/rspb.1998.0415; Candolin U, 1997, BEHAV ECOL SOCIOBIOL, V41, P81, DOI 10.1007/s002650050367; Dunn AM, 2008, ANIM BEHAV, V76, P1289, DOI 10.1016/j.anbehav.2008.06.013; Emery AM, 2001, MOL ECOL, V10, P1265, DOI 10.1046/j.1365-294X.2001.01258.x; Fisher DO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015226; Franklin AM, 2012, BIOL LETTERS, V8, P754, DOI 10.1098/rsbl.2012.0556; Fuller R, 1996, BEHAV ECOL, V7, P69, DOI 10.1093/beheco/7.1.69; Godin JGJ, 1996, ANIM BEHAV, V51, P117, DOI 10.1006/anbe.1996.0010; Guerra C, 2012, AQUAC RES, V43, P756, DOI 10.1111/j.1365-2109.2011.02885.x; Guerrero-Ferreira RC, 2007, CLADISTICS, V23, P497, DOI 10.1111/j.1096-0031.2007.00155.x; GWYNNE DT, 1989, TRENDS ECOL EVOL, V4, P54, DOI 10.1016/0169-5347(89)90144-4; Hanlon R, 2007, CURR BIOL, V17, pR400, DOI 10.1016/j.cub.2007.03.034; Hanlon RT, 1999, MAR BIOL, V134, P719, DOI 10.1007/s002270050588; Hanlon RT, 1996, CEPHALOPOD BEHAV; Herberstein ME, 2011, J ETHOL, V29, P9, DOI 10.1007/s10164-010-0213-5; Kelly CD, 2001, BEHAV ECOL SOCIOBIOL, V51, P95, DOI 10.1007/s002650100410; Kemp DJ, 2012, BEHAV ECOL, V23, P191, DOI 10.1093/beheco/arr173; KLUMPP DW, 1983, AUST J MAR FRESH RES, V34, P745; Koga T, 1998, P ROY SOC B-BIOL SCI, V265, P1385, DOI 10.1098/rspb.1998.0446; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; MAGNHAGEN C, 1990, BEHAV ECOL SOCIOBIOL, V26, P331; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; MCCAULEY DE, 1986, AM NAT, V127, P112, DOI 10.1086/284472; McLean CA, 2010, BEHAVIOUR, V147, P1803, DOI 10.1163/000579510X537378; Moltschaniwskyj NA, 2007, REV FISH BIOL FISHER, V17, P455, DOI 10.1007/s11160-007-9056-8; Naud MJ, 2005, P ROY SOC B-BIOL SCI, V272, P1047, DOI 10.1098/rspb.2004.3031; Norman MD, 1997, J MAR BIOL ASSOC UK, V77, P1109, DOI 10.1017/S0025315400038662; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rodriguez-Munoz R, 2011, CURR BIOL, V21, P1716, DOI 10.1016/j.cub.2011.08.053; Roff Derek A., 1992; ROWE L, 1994, ANIM BEHAV, V48, P1049, DOI 10.1006/anbe.1994.1338; RYAN MJ, 1982, AM NAT, V119, P136, DOI 10.1086/283899; Shaw PW, 2004, MAR ECOL PROG SER, V270, P173, DOI 10.3354/meps270173; SIH A, 1990, AM NAT, V135, P284, DOI 10.1086/285044; SIH A, 1994, J FISH BIOL, V45, P111, DOI 10.1111/j.1095-8649.1994.tb01087.x; Squires ZE, 2014, MAR ECOL PROG SER, V511, P93, DOI 10.3354/meps10898; Squires ZE, 2013, J MOLLUS STUD, V79, P263, DOI 10.1093/mollus/eyt025; Staudinger MD, 2011, ANIM BEHAV, V81, P585, DOI 10.1016/j.anbehav.2010.12.002; Stearns S.C., 1992, pi; Taylor AR, 2005, J ARACHNOL, V33, P76, DOI 10.1636/S03-59; TRAVERS SE, 1991, ECOLOGY, V72, P2123, DOI 10.2307/1941564; Velde LV, 2012, BEHAV ECOL SOCIOBIOL, V66, P347, DOI 10.1007/s00265-011-1281-4; Wong BBM, 2009, BIOL LETTERS, V5, P600, DOI 10.1098/rsbl.2009.0350; Wood JB, 2010, J EXP MAR BIOL ECOL, V388, P20, DOI 10.1016/j.jembe.2010.03.010	49	12	12	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115027	10.1371/journal.pone.0115027	http://dx.doi.org/10.1371/journal.pone.0115027			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551378	gold, Green Published, Green Submitted			2022-12-26	WOS:000347119100023
J	Han, ST; Wong, RKW; Lee, TCM; Shen, LH; Li, SYR; Fan, XD				Han, Shengtong; Wong, Raymond K. W.; Lee, Thomas C. M.; Shen, Linghao; Li, Shuo-Yen R.; Fan, Xiaodan			A Full Bayesian Approach for Boolean Genetic Network Inference	PLOS ONE			English	Article							FLAT FOOT; FLEXIBLE FLATFOOT; OVERWEIGHT; CHILDREN; FEET; PREVALENCE; ARCH	Boolean networks are a simple but efficient model for describing gene regulatory systems. A number of algorithms have been proposed to infer Boolean networks. However, these methods do not take full consideration of the effects of noise and model uncertainty. In this paper, we propose a full Bayesian approach to infer Boolean genetic networks. Markov chain Monte Carlo algorithms are used to obtain the posterior samples of both the network structure and the related parameters. In addition to regular link addition and removal moves, which can guarantee the irreducibility of the Markov chain for traversing the whole network space, carefully constructed mixture proposals are used to improve the Markov chain Monte Carlo convergence. Both simulations and a real application on cell-cycle data show that our method is more powerful than existing methods for the inference of both the topology and logic relations of the Boolean network from observed data.	[Han, Shengtong; Fan, Xiaodan] Chinese Univ Hong Kong, Dept Stat, Shatin, Hong Kong, Peoples R China; [Wong, Raymond K. W.] Iowa State Univ, Dept Stat, Ames, IA USA; [Lee, Thomas C. M.] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA; [Shen, Linghao; Li, Shuo-Yen R.] Chinese Univ Hong Kong, Dept Informat Engn, Shatin, Hong Kong, Peoples R China; [Li, Shuo-Yen R.] Univ Elect Sci & Technol China, Chengdu 610054, Peoples R China	Chinese University of Hong Kong; Iowa State University; University of California System; University of California Davis; Chinese University of Hong Kong; University of Electronic Science & Technology of China	Fan, XD (corresponding author), Chinese Univ Hong Kong, Dept Stat, Shatin, Hong Kong, Peoples R China.	xfan@sta.cuhk.edu.hk	Han, Shengtong/T-1358-2019; Li, Shuo/GXV-6545-2022; Fan, Xiaodan/Q-2208-2018; Li, Shuo/N-5364-2019	Han, Shengtong/0000-0002-7203-1143; Fan, Xiaodan/0000-0002-2744-9030; Li, Shuo/0000-0002-5184-3230; Wong, Raymond K. W./0000-0001-9342-3755; Lee, Thomas/0000-0001-7067-405X	Research Grants Council of the Hong Kong SAR [CUHK 400913]; CUHK direct grant [CUHK 2060419]; University Grants Committee of the Hong Kong Special Administrative Region, China [AoE/E-02/08]; National Science Foundation of USA [1007520, 1209226, 1209232]; National Basic Research Program of China (973 Program) [2012CB315901, 2012CB315904]	Research Grants Council of the Hong Kong SAR(Hong Kong Research Grants Council); CUHK direct grant(Chinese University of Hong Kong); University Grants Committee of the Hong Kong Special Administrative Region, China; National Science Foundation of USA(National Science Foundation (NSF)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research is partially supported by a grant from the Research Grants Council of the Hong Kong SAR (Project no. CUHK 400913), a CUHK direct grant (Project no. CUHK 2060419), a grant from the University Grants Committee of the Hong Kong Special Administrative Region, China (Project No. AoE/E-02/08), three grants from the National Science Foundation of USA (Grant No. 1007520, 1209226, and 1209232), and a grant from the National Basic Research Program of China (973 Program, No. 2012CB315901, No. 2012CB315904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benaglia T, 2009, MIXTOOLS R PACKAGE A; Berger V.W, 2005, ENCY STAT BEHAV SCI; CAVANAGH PR, 1987, J BIOMECH, V20, P547, DOI 10.1016/0021-9290(87)90255-7; Chang JH, 2010, EUR J PEDIATR, V169, P447, DOI 10.1007/s00431-009-1050-9; Chen KC, 2011, EUR J PEDIATR, V170, P931, DOI 10.1007/s00431-010-1380-7; Dyal CM, 1997, FOOT ANKLE INT, V18, P85, DOI 10.1177/107110079701800208; El O, 2006, RHEUMATOL INT, V26, P1050, DOI 10.1007/s00296-006-0128-1; FORRIOL F, 1990, FOOT ANKLE, V11, P101, DOI 10.1177/107110079001100208; Harris Edwin J, 2004, J Foot Ankle Surg, V43, P341; Kaufman KR, 1999, AM J SPORT MED, V27, P585, DOI 10.1177/03635465990270050701; Kohls-Gatzoulis J, 2004, BMJ-BRIT MED J, V329, P1328, DOI 10.1136/bmj.329.7478.1328; Levinger P, 2010, GAIT POSTURE, V32, P519, DOI 10.1016/j.gaitpost.2010.07.013; Lin CH, 2006, PHYSIOL MEAS, V27, P119, DOI 10.1088/0967-3334/27/2/003; Lin CJ, 2001, J PEDIATR ORTHOPED, V21, P378, DOI 10.1097/00004694-200105000-00022; Mathieson I., 1999, FOOT, V9, P145, DOI [10.1054/foot.1999.0544, DOI 10.1054/FOOT.1999.0544]; Mauch M, 2008, INT J OBESITY, V32, P1068, DOI 10.1038/ijo.2008.52; Mickle KJ, 2006, OBESITY, V14, P1949, DOI 10.1038/oby.2006.227; Nikolaidou M., 2006, FOOT, V16, P82, DOI [DOI 10.1016/J.F00T.2006.02.001, 10.1016/j.foot.2006.02.001]; Onodera Andrea Naomi, 2008, Foot (Edinb), V18, P142, DOI 10.1016/j.foot.2008.03.003; Pfeiffer M, 2006, PEDIATRICS, V118, P634, DOI 10.1542/peds.2005-2126; RAO UB, 1992, J BONE JOINT SURG BR, V74, P525, DOI 10.1302/0301-620X.74B4.1624509; ROSE GK, 1985, J BONE JOINT SURG BR, V67, P71, DOI 10.1302/0301-620X.67B1.3968149; SILVINO N, 1980, CLIN ORTHOP RELAT R, P265; STAHELI LT, 1987, J BONE JOINT SURG AM, V69A, P426; Tudor A, 2009, PEDIATRICS, V123, pe386, DOI 10.1542/peds.2008-2262; Tweed JL, 2008, J AM PODIAT MED ASSN, V98, P436, DOI 10.7547/0980436; Villarroya MA, 2008, INT J PEDIATR OBES, V3, P39, DOI 10.1080/17477160701520298; Welton E A, 1992, Foot Ankle, V13, P462	28	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115806	10.1371/journal.pone.0115806	http://dx.doi.org/10.1371/journal.pone.0115806			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551820	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100063
J	Hayashi, M; Takeshita, K; Uchida, Y; Yamamoto, K; Kikuchi, R; Nakayama, T; Nomura, E; Cheng, XW; Matsushita, T; Nakamura, S; Murohara, T				Hayashi, Motoharu; Takeshita, Kyosuke; Uchida, Yasuhiro; Yamamoto, Koji; Kikuchi, Ryosuke; Nakayama, Takayuki; Nomura, Emiko; Cheng, Xian Wu; Matsushita, Tadashi; Nakamura, Shigeo; Murohara, Toyoaki			Angiotensin II Receptor Blocker Ameliorates Stress-Induced Adipose Tissue Inflammation and Insulin Resistance	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; SYSTEM; GENE; HYPERTENSION; TARGET; EXPRESSION; IRBESARTAN; OBESITY; MICE; LINK	A strong causal link exists between psychological stress and insulin resistance as well with hypertension. Meanwhile, stress-related responses play critical roles in glucose metabolism in hypertensive patients. As clinical trials suggest that angiotensin-receptor blocker delays the onset of diabetes in hypertensive patients, we investigated the effects of irbesartan on stress-induced adipose tissue inflammation and insulin resistance. C57BL/6J mice were subjected to 2-week intermittent restraint stress and orally treated with vehicle, 3 and 10 mg/kg/day irbesartan. The plasma concentrations of lipid and proinflammatory cytokines [Monocyte Chemoattractant Protein-1 (MCP-1), tumor necrosis factor-alpha, and interleukin-6] were assessed with enzyme-linked immunosorbent assay. Monocyte/macrophage accumulation in inguinal white adipose tissue (WAT) was observed with CD11b-positive cell counts and mRNA expressions of CD68 and F4/80 using immunohistochemistry and RT-PCR methods respectively. The mRNA levels of angiotensinogen, proinflammatory cytokines shown above, and adiponectin in WAT were also assessed with RT-PCR method. Glucose metabolism was assessed by glucose tolerance tests (GTTs) and insulin tolerance tests, and mRNA expression of insulin receptor substrate-1 (IRS-1) and glucose transporter 4 (GLUT4) in WAT. Restraint stress increased monocyte accumulation, plasma free fatty acids, expression of angiotensinogen and proinflammatory cytokines including MCP-1, and reduced adiponectin. Irbesartan reduced stress-induced monocyte accumulation in WAT in a dose dependent manner. Irbesartan treatment also suppressed induction of adipose angiotensinogen and proinflammatory cytokines in WAT and blood, and reversed changes in adiponectin expression. Notably, irbesartan suppressed stress-induced reduction in adipose tissue weight and free fatty acid release, and improved insulin tolerance with restoration of IRS-1 and GLUT4 mRNA expressions in WAT. The results indicate that irbesartan improves stress-induced adipose tissue inflammation and insulin resistance. Our results suggests that irbesartan treatment exerts additive benefits for glucose metabolism in hypertensive patients with mental stress.	[Hayashi, Motoharu; Takeshita, Kyosuke; Uchida, Yasuhiro; Cheng, Xian Wu; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Takeshita, Kyosuke; Kikuchi, Ryosuke] Nagoya Univ Hosp, Dept Clin Lab, Nagoya, Aichi, Japan; [Yamamoto, Koji; Nomura, Emiko; Matsushita, Tadashi] Nagoya Univ Hosp, Dept Blood Transfus, Nagoya, Aichi, Japan; [Nakamura, Shigeo] Nagoya Univ Hosp, Dept Pathol, Nagoya, Aichi, Japan; [Nakayama, Takayuki] Aichi Med Univ Hosp, Dept Blood Transfus, Nagakute, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University; Aichi Medical University	Takeshita, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan.	kyousuke@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014; Takeshita, Kyosuke/B-7008-2012; Kikuchi, Ryosuke/AAX-4971-2021; Takeshita, Kyosuke/AAD-9515-2020; Matsushita, Tadadshi/I-7349-2014	Takeshita, Kyosuke/0000-0002-8283-3799; Takeshita, Kyosuke/0000-0002-8283-3799; Nakayama, Takayuki/0000-0003-2389-2542	SENSHIN Medical Research Foundation; Suzuken Memorial Foundation;  [25461336]	SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Suzuken Memorial Foundation; 	This study was supported by research grants from SENSHIN Medical Research Foundation (to KT), Suzuken Memorial Foundation (to KT), and a Grant-in-Aid for Scientific Research (Kakenhi 25461336 to KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Aoyama T, 2009, BIOCHEM BIOPH RES CO, V383, P216, DOI 10.1016/j.bbrc.2009.03.154; Arnaldi G, 2010, NEUROENDOCRINOLOGY, V92, P86, DOI 10.1159/000314213; Benito Manuel, 2011, Archives of Physiology and Biochemistry, V117, P96, DOI 10.3109/13813455.2011.563748; Brasier AR, 1996, HYPERTENSION, V27, P465, DOI 10.1161/01.HYP.27.3.465; Cheung BMY, 2012, CURR ATHEROSCLER REP, V14, P160, DOI 10.1007/s11883-012-0227-2; Cox SS, 2014, BRAIN BEHAV IMMUN, V36, P183, DOI 10.1016/j.bbi.2013.11.018; Elliott WJ, 2007, LANCET, V369, P201, DOI 10.1016/S0140-6736(07)60108-1; Fliers E, 2003, J NEUROENDOCRINOL, V15, P1005, DOI 10.1046/j.1365-2826.2003.01096.x; Groeschel M, 2011, AM J PHYSIOL-RENAL, V300, pF1, DOI 10.1152/ajprenal.00208.2010; Hamer M, 2010, NEUROSCI BIOBEHAV R, V35, P76, DOI 10.1016/j.neubiorev.2009.11.004; Harte A, 2005, CIRCULATION, V111, P1954, DOI 10.1161/01.CIR.0000161954.17870.5D; Hussey SE, 2013, DIABETOLOGIA; Jain S, 2007, AM J PHYSIOL-CELL PH, V293, pC401, DOI 10.1152/ajpcell.00433.2006; Kalupahana NS, 2012, OBES REV, V13, P136, DOI 10.1111/j.1467-789X.2011.00942.x; Kintscher U, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-12; Nieto-Vazquez Iria, 2008, Archives of Physiology and Biochemistry, V114, P183, DOI [10.1080/13813450802181047, 10.1080/13813450802181047 ]; Prasad A, 2004, CIRCULATION, V110, P1507, DOI 10.1161/01.CIR.0000141736.76561.78; Putnam K, 2012, AM J PHYSIOL-HEART C, V302, pH1219, DOI 10.1152/ajpheart.00796.2011; Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176; Schupp M, 2005, DIABETES, V54, P3442, DOI 10.2337/diabetes.54.12.3442; Smith MM, 2012, J PHYSIOL-LONDON, V590, P1787, DOI 10.1113/jphysiol.2011.221036; Suganami T, 2010, J LEUKOCYTE BIOL, V88, P33, DOI 10.1189/jlb.0210072; Takeshita K, 2004, CIRCULATION, V109, P1776, DOI 10.1161/01.CIR.0000124224.48962.32; Takeshita K, 2002, SEMIN THROMB HEMOST, V28, P545, DOI 10.1055/s-2002-36699; Takeshita K, 2014, HYPERTENS RES; Tamura Y, 2008, ARTERIOSCL THROM VAS, V28, P2195, DOI 10.1161/ATVBAHA.108.168633; Tsukuda K, 2011, BIOCHEM BIOPH RES CO, V409, P275, DOI 10.1016/j.bbrc.2011.04.142; Uchida Y, 2012, DIABETES, V61, P1552, DOI 10.2337/db11-0828; Wang CH, 2007, J BIOL CHEM, V282, P7991, DOI 10.1074/jbc.M700098200; Yamamoto K, 2002, P NATL ACAD SCI USA, V99, P890, DOI 10.1073/pnas.022608799; Yang Y, 2013, METABOLISM, V62, P1858, DOI 10.1016/j.metabol.2013.08.008; Yasue S, 2010, AM J HYPERTENS, V23, P425, DOI 10.1038/ajh.2009.263; Yvan-Charvet L, 2011, KIDNEY INT, V79, P162, DOI 10.1038/ki.2010.391	34	21	23	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116163	10.1371/journal.pone.0116163	http://dx.doi.org/10.1371/journal.pone.0116163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551221	Green Submitted, Green Published, gold			2022-12-26	WOS:000347119100105
J	Prigozhin, DM; Krieger, IV; Huizar, JP; Mavrici, D; Waldo, GS; Hung, LW; Sacchettini, JC; Terwilliger, TC; Alber, T				Prigozhin, Daniil M.; Krieger, Inna V.; Huizar, John P.; Mavrici, Daniela; Waldo, Geoffrey S.; Hung, Li-Wei; Sacchettini, James C.; Terwilliger, Thomas C.; Alber, Tom			Subfamily-Specific Adaptations in the Structures of Two Penicillin-Binding Proteins from Mycobacterium tuberculosis	PLOS ONE			English	Article							PEPTIDOGLYCAN BIOSYNTHESIS; CELL-WALLS; IN-VITRO; MODEL; RESOLUTION; COMPLEX; SYSTEM; SUITE	Beta-lactam antibiotics target penicillin-binding proteins including several enzyme classes essential for bacterial cell-wall homeostasis. To better understand the functional and inhibitor-binding specificities of penicillin-binding proteins from the pathogen, Mycobacterium tuberculosis, we carried out structural and phylogenetic analysis of two predicted D,D-carboxypeptidases, Rv2911 and Rv3330. Optimization of Rv2911 for crystallization using directed evolution and the GFP folding reporter method yielded a soluble quadruple mutant. Structures of optimized Rv2911 bound to phenylmethylsulfonyl fluoride and Rv3330 bound to meropenem show that, in contrast to the nonspecific inhibitor, meropenem forms an extended interaction with the enzyme along a conserved surface. Phylogenetic analysis shows that Rv2911 and Rv3330 belong to different clades that emerged in Actinobacteria and are not represented in model organisms such as Escherichia coli and Bacillus subtilis. Clade-specific adaptations allow these enzymes to fulfill distinct physiological roles despite strict conservation of core catalytic residues. The characteristic differences include potential protein-protein interaction surfaces and specificity-determining residues surrounding the catalytic site. Overall, these structural insights lay the groundwork to develop improved beta-lactam therapeutics for tuberculosis.	[Prigozhin, Daniil M.; Huizar, John P.; Mavrici, Daniela; Alber, Tom] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Prigozhin, Daniil M.; Huizar, John P.; Mavrici, Daniela; Alber, Tom] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Krieger, Inna V.; Waldo, Geoffrey S.; Hung, Li-Wei; Terwilliger, Thomas C.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Krieger, Inna V.; Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Los Alamos National Laboratory; Texas A&M University System; Texas A&M University College Station	Prigozhin, DM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	daniil.prigozhin@gmail.com	Terwilliger, Thomas/AAM-4079-2020; Terwilliger, Thomas/AEF-4827-2022; Terwilliger, Thomas C/K-4109-2012	Terwilliger, Thomas/0000-0001-6384-0320; Terwilliger, Thomas C/0000-0001-6384-0320; Prigozhin, Daniil M/0000-0003-2075-0231; Hung, Li-Wei/0000-0001-6690-8458	National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH) [AI095208]; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NIH, National Institute of General Medical Sciences; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI095208] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NIH, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by the National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH) grant AI095208. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract No. DE-AC02-05CH11231. The BCSB is supported in part by the NIH, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bourai N, 2012, MICROB PATHOGENESIS, V52, P109, DOI 10.1016/j.micpath.2011.11.003; Chen Y, 2009, J AM CHEM SOC, V131, P14345, DOI 10.1021/ja903773f; Cordillot M, 2013, ANTIMICROB AGENTS CH, V57, P5940, DOI 10.1128/AAC.01663-13; Crick DC, 2001, GLYCOBIOLOGY, V11, p107R, DOI 10.1093/glycob/11.9.107R; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fedarovich A, 2012, J MOL BIOL, V418, P316, DOI 10.1016/j.jmb.2012.02.021; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498; Janin YL, 2007, BIOORGAN MED CHEM, V15, P2479, DOI 10.1016/j.bmc.2007.01.030; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar P, 2012, MOL MICROBIOL, V86, P367, DOI 10.1111/j.1365-2958.2012.08199.x; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; LEDERER E, 1975, MOL CELL BIOCHEM, V7, P87, DOI 10.1007/BF01792076; Lovering AL, 2012, ANNU REV BIOCHEM, V81, P451, DOI 10.1146/annurev-biochem-061809-112742; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; Mahapatra S, 2005, J BACTERIOL, V187, P2341, DOI 10.1128/JB.187.7.2341-2347.2005; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Sauvage E, 2007, J MOL BIOL, V371, P528, DOI 10.1016/j.jmb.2007.05.071; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Szwedziak P, 2013, CURR OPIN MICROBIOL, V16, P745, DOI 10.1016/j.mib.2013.09.003; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong S, 2004, P NATL ACAD SCI USA, V101, P17456, DOI 10.1073/pnas.0407061101	38	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116249	10.1371/journal.pone.0116249	http://dx.doi.org/10.1371/journal.pone.0116249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551456	Green Submitted, Green Published, gold			2022-12-26	WOS:000347119100114
J	Waschbisch, A; Sanderson, N; Krumbholz, M; Vlad, G; Theil, D; Schwab, S; Maurer, M; Derfuss, T				Waschbisch, Anne; Sanderson, Nicholas; Krumbholz, Markus; Vlad, George; Theil, Diethilde; Schwab, Stefan; Maeurer, Mathias; Derfuss, Tobias			Interferon Beta and Vitamin D Synergize to Induce Immunoregulatory Receptors on Peripheral Blood Monocytes of Multiple Sclerosis Patients	PLOS ONE			English	Article							T-CELL RESPONSES; DENDRITIC CELLS; SUPPRESSOR-CELLS; RELAPSE RISK; 25-HYDROXYVITAMIN D; SOLUBLE ILT3; TRANSCRIPT 3; EXPRESSION; ACTIVATION; B7-H1	Immunoglobulin-like transcript (ILT) 3 and 4 are inhibitory receptors that modulate immune responses. Their expression has been reported to be affected by interferon, offering a possible mechanism by which this cytokine exerts its therapeutic effect in multiple sclerosis, a condition thought to involve excessive immune activity. To investigate this possibility, we measured expression of ILT3 and ILT4 on immune cells from multiple sclerosis patients, and in post-mortem brain tissue. We also studied the ability of interferon beta, alone or in combination with vitamin D, to induce upregulation of these receptors in vitro, and compared expression levels between interferon-treated and untreated multiple sclerosis patients. In vitro interferon beta treatment led to a robust upregulation of ILT3 and ILT4 on monocytes, and dihydroxyvitamin D3 increased expression of ILT3 but not ILT4. ILT3 was abundant in demyelinating lesions in postmortem brain, and expression on monocytes in the cerebrospinal fluid was higher than in peripheral blood, suggesting that the central nervous system milieu induces ILT3, or that ILT3 positive monocytes preferentially enter the brain. Our data are consistent with involvement of ILT3 and ILT4 in the modulation of immune responsiveness in multiple sclerosis by both interferon and vitamin D.	[Waschbisch, Anne; Schwab, Stefan; Maeurer, Mathias] Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Germany; [Sanderson, Nicholas; Derfuss, Tobias] Univ Basel Hosp, Dept Neurol & Biomed, CH-4031 Basel, Switzerland; [Krumbholz, Markus] Univ Munich, Klinikum Grosshadern, Inst Clin Neuroimmunol, D-80539 Munich, Germany; [Vlad, George] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Theil, Diethilde] Univ Munich, Klinikum Grosshadern, Dept Neurol, Munich, Germany	University of Erlangen Nuremberg; University of Basel; University of Munich; Columbia University; University of Munich	Waschbisch, A (corresponding author), Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Germany.	Anne.Waschbisch@uk-erlangen.de	sanderson, nicholas/GQH-2848-2022	sanderson, nicholas/0000-0003-1711-7275; Derfuss, Tobias/0000-0001-8656-4250	Merck Serono GmbH, a division of Merck KGaA, Darmstadt, Germany; Else-Kroner Fresenius Stiftung [A_123]	Merck Serono GmbH, a division of Merck KGaA, Darmstadt, Germany; Else-Kroner Fresenius Stiftung	This study was in part funded by the Merck Serono GmbH, a division of Merck KGaA, Darmstadt, Germany, and the Else-Kroner Fresenius Stiftung (A_123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, JAMA NEUROL; Ascherio A, 2010, LANCET NEUROL, V9, P599, DOI 10.1016/S1474-4422(10)70086-7; Cella M, 1997, J EXP MED, V185, P1743, DOI 10.1084/jem.185.10.1743; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Chang CC, 2009, J IMMUNOL, V182, P5208, DOI 10.4049/jimmunol.0804048; Gleissner CA, 2007, EUR J IMMUNOL, V37, P177, DOI 10.1002/eji.200636498; James E, 2013, MULT SCLER J, V19, P1571, DOI 10.1177/1352458513489756; Jensen MA, 2010, MULT SCLER, V16, P30, DOI 10.1177/1352458509352794; Joller N, 2012, IMMUNOL REV, V248, P122, DOI 10.1111/j.1600-065X.2012.01136.x; Kim-Schulze S, 2006, J IMMUNOL, V176, P2790, DOI 10.4049/jimmunol.176.5.2790; Korn T, 2008, J NEUROL, V255, P2, DOI 10.1007/s00415-008-6001-2; Lassmann H, 1998, J NEUROIMMUNOL, V86, P213, DOI 10.1016/S0165-5728(98)00031-9; Lu HK, 2009, J BIOL CHEM, V284, P34839, DOI 10.1074/jbc.M109.035683; Manavalan JS, 2003, TRANSPL IMMUNOL, V11, P245, DOI 10.1016/S0966-3274(03)00058-3; Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817; Ortler S, 2008, EUR J IMMUNOL, V38, P1734, DOI 10.1002/eji.200738071; Penna G, 2005, BLOOD, V106, P3490, DOI 10.1182/blood-2005-05-2044; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rottman JB, 2001, NAT IMMUNOL, V2, P605, DOI 10.1038/89750; Runia TF, 2012, NEUROLOGY, V79, P261, DOI 10.1212/WNL.0b013e31825fdec7; Salama AD, 2003, J EXP MED, V198, P71, DOI 10.1084/jem.20022119; Schreiner B, 2004, J NEUROIMMUNOL, V155, P172, DOI 10.1016/j.jneuroim.2004.06.013; Simpson S, 2010, ANN NEUROL, V68, P193, DOI 10.1002/ana.22043; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stewart N, 2012, NEUROLOGY, V79, P254, DOI 10.1212/WNL.0b013e31825fded9; Suciu-Foca N, 2007, J IMMUNOL, V178, P7432, DOI 10.4049/jimmunol.178.11.7432; Vlad G, 2008, DIABETES, V57, P1878, DOI 10.2337/db08-0054; Vlad George, 2013, Methods Mol Biol, V1034, P359, DOI 10.1007/978-1-62703-493-7_23; Vlad G, 2012, EXP MOL PATHOL, V93, P294, DOI 10.1016/j.yexmp.2012.09.011; Vlad G, 2010, INT REV IMMUNOL, V29, P119, DOI 10.3109/08830180903281185; Wiendl H, 2003, FASEB J, V17, P1892, DOI 10.1096/fj.03-0039fje	31	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115488	10.1371/journal.pone.0115488	http://dx.doi.org/10.1371/journal.pone.0115488			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551576	Green Published, gold, Green Submitted			2022-12-26	WOS:000347119100039
J	Nizhnikov, AA; Alexandrov, AI; Ryzhova, TA; Mitkevich, OV; Dergalev, AA; Ter-Avanesyan, MD; Galkin, AP				Nizhnikov, Anton A.; Alexandrov, Alexander I.; Ryzhova, Tatyana A.; Mitkevich, Olga V.; Dergalev, Alexander A.; Ter-Avanesyan, Michael D.; Galkin, Alexey P.			Proteomic Screening for Amyloid Proteins	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; EXPANDED POLYGLUTAMINE; TRANSCRIPTION FACTOR; YEAST PRION; PSI+ PRION; HUNTINGTIN FRAGMENT; CELLULAR TOXICITY; Q/N-RICH; SUP35; PURIFICATION	Despite extensive study, progress in elucidation of biological functions of amyloids and their role in pathology is largely restrained due to the lack of universal and reliable biochemical methods for their discovery. All biochemical methods developed so far allowed only identification of glutamine/asparagine-rich amyloid-forming proteins or proteins comprising amyloids that form large deposits. In this article we present a proteomic approach which may enable identification of a broad range of amyloid-forming proteins independently of specific features of their sequences or levels of expression. This approach is based on the isolation of protein fractions enriched with amyloid aggregates via sedimentation by ultracentrifugation in the presence of strong ionic detergents, such as sarkosyl or SDS. Sedimented proteins are then separated either by 2D difference gel electrophoresis or by SDS-PAGE, if they are insoluble in the buffer used for 2D difference gel electrophoresis, after which they are identified by mass-spectrometry. We validated this approach by detection of known yeast prions and mammalian proteins with established capacity for amyloid formation and also revealed yeast proteins forming detergent-insoluble aggregates in the presence of human huntingtin with expanded polyglutamine domain. Notably, with one exception, all these proteins contained glutamine/asparagine-rich stretches suggesting that their aggregates arose due to polymerization cross-seeding by human huntingtin. Importantly, though the approach was developed in a yeast model, it can easily be applied to any organism thus representing an efficient and universal tool for screening for amyloid proteins.	[Nizhnikov, Anton A.; Ryzhova, Tatyana A.; Galkin, Alexey P.] St Petersburg State Univ, Dept Genet & Biotechnol, St Petersburg 199034, Russia; [Nizhnikov, Anton A.; Ryzhova, Tatyana A.; Galkin, Alexey P.] Russian Acad Sci, Vavilov Inst Gen Genet, St Petersburg Branch, St Petersburg, Russia; [Alexandrov, Alexander I.; Mitkevich, Olga V.; Dergalev, Alexander A.; Ter-Avanesyan, Michael D.] Russian Acad Sci, AN Bach Inst Biochem, Moscow, Russia	Saint Petersburg State University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Vavilov Institute of General Genetics; Research Center of Biotechnology RAS; Russian Academy of Sciences	Galkin, AP (corresponding author), St Petersburg State Univ, Dept Genet & Biotechnol, St Petersburg 199034, Russia.	apgalkin@mail.ru	Belashova, Tatyana A/G-2156-2015; Dergalev, Alexander/AAU-5972-2021; Nizhnikov, Anton A./H-9983-2013; Alexandrov, Alexander/C-9579-2019; Galkin, Alexey Petrovich/K-2968-2013	Belashova, Tatyana A/0000-0001-9433-6987; Nizhnikov, Anton A./0000-0002-8338-3494; Alexandrov, Alexander/0000-0001-7250-4740; Galkin, Alexey Petrovich/0000-0002-7362-8857	Russian Academy of Sciences; Russian Foundation for Basic Research [13-04-01247, 14-04-00073]; St. Petersburg Government for young PhDs; St. Petersburg State University [0.37.696.2013, 1.50.2543.2013]	Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); St. Petersburg Government for young PhDs; St. Petersburg State University	This work was supported by the Molecular and Cellular Biology Program from the Russian Academy of Sciences (MDT), by the grants of Russian Foundation for Basic Research (APG #13-04-01247 and AIA, AAD, MDT #14-04-00073) and the grant from St. Petersburg Government for young PhDs (AAN). The authors acknowledge St. Petersburg State University for research grants (0.37.696.2013 and 1.50.2543.2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Bhak G, 2009, BMB REP, V42, P541, DOI 10.5483/BMBRep.2009.42.9.541; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Coalier KA, 2013, BBA-PROTEINS PROTEOM, V1834, P65, DOI 10.1016/j.bbapap.2012.08.017; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Furukawa Y, 2009, J NEUROSCI, V29, P5153, DOI 10.1523/JNEUROSCI.0783-09.2009; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gong H, 2012, PLOS GENET, V8, P223, DOI 10.1371/journal.pgen.1002634; Halfmann R, 2012, PRION, V6, P391, DOI 10.4161/pri.20199; Harrison PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r40; Hazeki N, 2000, BIOCHEM BIOPH RES CO, V277, P386, DOI 10.1006/bbrc.2000.3682; INABA K, 1993, J CELL SCI, V104, P907; Iranzo M, 2002, MICROBIOL-SGM, V148, P1329, DOI 10.1099/00221287-148-5-1329; Iuchi S, 2003, P NATL ACAD SCI USA, V100, P2409, DOI 10.1073/pnas.0437660100; Kiktev DA, 2012, MOL CELL BIOL, V32, P4960, DOI 10.1128/MCB.00875-12; Kochneva-Pervukhova NV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029832; Kryndushkin D, 2013, J BIOL CHEM, V288, P27100, DOI 10.1074/jbc.M113.485359; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kushnirov VV, 2006, METHODS, V39, P50, DOI 10.1016/j.ymeth.2006.04.007; Mazan M, 2007, BIOLOGIA, V62, P128, DOI 10.2478/s11756-007-0038-z; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Meriin AB, 2003, MOL CELL BIOL, V23, P7554, DOI 10.1128/MCB.23.21.7554-7565.2003; Mitkevich OV, 2012, PRION, V6, P400, DOI 10.4161/pri.20678; Mitsui K, 2006, METHOD ENZYMOL, V412, P63, DOI 10.1016/S0076-6879(06)12005-4; Moreno-Gonzalez I, 2011, SEMIN CELL DEV BIOL, V22, P482, DOI 10.1016/j.semcdb.2011.04.002; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Peretz D, 2006, J VIROL, V80, P322, DOI 10.1128/JVI.80.1.322-331.2006; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Rogoza T, 2010, P NATL ACAD SCI USA, V107, P10573, DOI 10.1073/pnas.1005949107; Rose MD., 1990, METHODS YEAST GENETI; Rubel AA, 2008, MOL BIOL+, V42, P110, DOI 10.1134/S0026893308010160; Rubel AA, 2013, PRION, V7, P469, DOI 10.4161/pri.26867; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Suzuki G, 2012, SCIENCE, V336, P355, DOI 10.1126/science.1219491; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Urakov VN, 2010, PRION, V4, P45, DOI 10.4161/pri.4.1.11074; Vishveshwara N, 2009, MOL MICROBIOL, V73, P1101, DOI 10.1111/j.1365-2958.2009.06836.x; Wang Y, 2007, PRION, V1, P128, DOI 10.4161/pri.1.2.4440; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Yamanaka T, 2008, EMBO J, V27, P827, DOI 10.1038/emboj.2008.23; Yamanaka T, 2010, HUM MOL GENET, V19, P2099, DOI 10.1093/hmg/ddq087; Zhao XH, 2012, J BIOL CHEM, V287, P23346, DOI 10.1074/jbc.M111.287748	56	40	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116003	10.1371/journal.pone.0116003	http://dx.doi.org/10.1371/journal.pone.0116003			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549323	Green Published, gold, Green Submitted			2022-12-26	WOS:000347063500046
J	Dave, K; Averineni, R; Sahdev, P; Perumal, O				Dave, Kaushalkumar; Averineni, Ranjith; Sahdev, Preety; Perumal, Omathanu			Transpapillary Drug Delivery to the Breast	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; C-TYPE LECTIN; NEISSERIA-MENINGITIDIS LIPOPOLYSACCHARIDE; LINKED-IMMUNOSORBENT-ASSAY; HUMAN DENDRITIC CELLS; SEROGROUP-B DISEASE; CORE LIPOPOLYSACCHARIDE; ADJUVANT ACTIVITY; ESCHERICHIA-COLI; IMMUNE-RESPONSES	The study was aimed at investigating localized topical drug delivery to the breast via mammary papilla (nipple). 5-fluorouracil (5-FU) and estradiol (EST) were used as model hydrophilic and hydrophobic compounds respectively. Porcine and human nipple were used for in-vitro penetration studies. The removal of keratin plug enhanced the drug transport through the nipple. The drug penetration was significantly higher through the nipple compared to breast skin. The drug's lipophilicity had a significant influence on drug penetration through nipple. The ducts in the nipple served as a major transport pathway to the underlying breast tissue. Results showed that porcine nipple could be a potential model for human nipple. The topical application of 5-FU on the rat nipple resulted in high drug concentration in the breast and minimal drug levels in plasma and other organs. Overall, the findings from this study demonstrate the feasibility of localized drug delivery to the breast through nipple.	[Dave, Kaushalkumar; Averineni, Ranjith; Sahdev, Preety; Perumal, Omathanu] S Dakota State Univ, Dept Pharmaceut Sci, Brookings, SD 57007 USA	South Dakota State University	Perumal, O (corresponding author), S Dakota State Univ, Dept Pharmaceut Sci, Brookings, SD 57007 USA.	omathanu.perumal@sdstate.edu		Dave, Kaushalkumar/0000-0001-6179-9483	Governor's Translational Cancer Research Center, South Dakota State University (SDSU), Brookings, South Dakota; Functional Core Genomics Facility at South Dakota University	Governor's Translational Cancer Research Center, South Dakota State University (SDSU), Brookings, South Dakota; Functional Core Genomics Facility at South Dakota University	This work was funded by the Governor's 2010 Translational Cancer Research Center, South Dakota State University (SDSU), Brookings, South Dakota. Fluorescence microscopy studies were supported by funding from Functional Core Genomics Facility at South Dakota University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Al-Bader T, 2004, CELL MICROBIOL, V6, P651, DOI 10.1111/j.1462-5822.2004.00392.x; Al-Bader T, 2003, INFECT IMMUN, V71, P5590, DOI 10.1128/IAI.71.10.5590-5597.2003; ALAALDEEN DAA, 1994, INFECT IMMUN, V62, P2984, DOI 10.1128/IAI.62.7.2984-2990.1994; Andrews SM, 2014, LANCET INFECT DIS, V14, P426, DOI 10.1016/S1473-3099(13)70341-4; Arigita C, 2005, VACCINE, V23, P5091, DOI 10.1016/j.vaccine.2005.06.001; Arigita C, 2003, VACCINE, V21, P950, DOI 10.1016/S0264-410X(02)00546-7; Baldridge JR, 1999, METHODS, V19, P103, DOI 10.1006/meth.1999.0834; BARCLAY GR, 1987, INFECT IMMUN, V55, P2706, DOI 10.1128/IAI.55.11.2706-2714.1987; Bjerre A, 2002, J INFECT DIS, V185, P220, DOI 10.1086/338269; Borrow R, 2001, MENINGOCOCCAL VACCIN; Callaghan MJ, 2011, INFECT IMMUN, V79, P2810, DOI 10.1128/IAI.01338-10; Caminschi I, 2001, MOL IMMUNOL, V38, P365, DOI 10.1016/S0161-5890(01)00067-0; de Vries JJC, 2009, VACCINE, V27, P947, DOI 10.1016/j.vaccine.2008.11.046; Fisseha M, 2005, INFECT IMMUN, V73, P4070, DOI 10.1128/IAI.73.7.4070-4080.2005; Fransen F, 2007, INFECT IMMUN, V75, P5939, DOI 10.1128/IAI.00846-07; FREDRIKSEN J H, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P67; FREDRIKSEN JH, 1991, NIPH ANN, V14, P79; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Holst J, 2007, HUM VACCINES, V3, P290, DOI 10.4161/hv.4513; Holst J, 2013, HUM VACC IMMUNOTHER, V9, P1241, DOI 10.4161/hv.24129; IDANPAANHEIKKILA I, 1995, J MED MICROBIOL, V43, P335, DOI 10.1099/00222615-43-5-335; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jennings MP, 1995, MOL MICROBIOL, V18, P729, DOI 10.1111/j.1365-2958.1995.mmi_18040729.x; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Keiser PB, 2011, VACCINE, V29, P1413, DOI 10.1016/j.vaccine.2010.12.039; Klena J, 2005, J BACTERIOL, V187, P1710, DOI 10.1128/JB.187.5.1710-1715.2005; LESSE AJ, 1990, J IMMUNOL METHODS, V126, P109, DOI 10.1016/0022-1759(90)90018-Q; Lewis S, 2009, EXPERT REV VACCINES, V8, P729, DOI [10.1586/erv.09.30, 10.1586/ERV.09.30]; LINDBERG AA, 1980, J GEN MICROBIOL, V116, P25; MCGUINNESS B, 1990, J EXP MED, V171, P1871, DOI 10.1084/jem.171.6.1871; Nagaoka K, 2005, INT IMMUNOL, V17, P827, DOI 10.1093/intimm/dxh264; Nagaputra JC, 2014, CLIN VACCINE IMMUNOL, V21, P234, DOI 10.1128/CVI.00561-13; Park CG, 2001, INT IMMUNOL, V13, P1283, DOI 10.1093/intimm/13.10.1283; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PLIKAYTIS BD, 1991, J CLIN MICROBIOL, V29, P1439, DOI 10.1128/JCM.29.7.1439-1446.1991; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rosenqvist E, 2001, METH MOLEC MED, V66, P255, DOI 10.1385/1-59259-148-5:255; Saleem M, 2012, METHODS MOL BIOL, V799, P91, DOI 10.1007/978-1-61779-346-2_6; Steeghs L, 2006, CELL MICROBIOL, V8, P316, DOI 10.1111/j.1462-5822.2005.00623.x; Steeghs L, 2008, INFECT IMMUN, V76, P3801, DOI 10.1128/IAI.00005-08; Stoddard MB, 2010, CLIN VACCINE IMMUNOL, V17, P98, DOI 10.1128/CVI.00342-09; Svajger U, 2010, CELL SIGNAL; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tappero JW, 1999, JAMA-J AM MED ASSOC, V281, P1520, DOI 10.1001/jama.281.16.1520; van der Ley P, 2001, INFECT IMMUN, V69, P5981, DOI 10.1128/IAI.69.10.5981-5990.2001; vanderLey P, 1997, FEMS MICROBIOL LETT, V146, P247, DOI 10.1016/S0378-1097(96)00484-3; Wetzler LM, 2010, FUTURE MICROBIOL, V5, P749, DOI 10.2217/FMB.10.41; Weynants V, 2009, INFECT IMMUN, V77, P2084, DOI 10.1128/IAI.01108-08; Wright JC, 2004, J BACTERIOL, V186, P6970, DOI 10.1128/JB.186.20.6970-6982.2004; Wright JC, 2006, HDB MENINGOCOCCAL DI; Zimmer SM, 2007, GLYCOBIOLOGY, V17, P847, DOI 10.1093/glycob/cwm057	52	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115712	10.1371/journal.pone.0115712	http://dx.doi.org/10.1371/journal.pone.0115712			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545150	Green Submitted, Green Published, gold			2022-12-26	WOS:000347120200059
J	Hatamoto, M; Kimura, M; Sato, T; Koizumi, M; Takahashi, M; Kawakami, S; Araki, N; Yamaguchi, T				Hatamoto, Masashi; Kimura, Masafumi; Sato, Takafumi; Koizumi, Masato; Takahashi, Masanobu; Kawakami, Shuji; Araki, Nobuo; Yamaguchi, Takashi			Enrichment of Denitrifying Methane-Oxidizing Microorganisms Using Up-Flow Continuous Reactors and Batch Cultures	PLOS ONE			English	Article							DEPENDENT ANAEROBIC METHANE; METHANOTROPHIC BACTERIA; OXIDATION PROCESS; WASTE-WATER; NITRITE; AMMONIUM; DENITRIFICATION; MICROBES; NITROGEN; REMOVAL	Denitrifying anaerobic methane oxidizing (DAMO) microorganisms were enriched from paddy field soils using continuous-flow and batch cultures fed with nitrate or nitrite as a sole electron acceptor. After several months of cultivation, the continuous-flow cultures using nitrite showed remarkable simultaneous methane oxidation and nitrite reduction and DAMO bacteria belonging to phylum NC10 were enriched. A maximum volumetric nitrite consumption rate of 70.4 +/- 3.4 mg N.L-1.day(-1) was achieved with very short hydraulic retention time of 2.1 hour. In the culture, about 68% of total microbial cells were bacteria and no archaeal cells were detected by fluorescence in situ hybridization. In the nitrate-fed continuous-flow cultures, 58% of total microbial cells were bacteria while archaeal cells accounted for 7% of total cell numbers. Phylogenetic analysis of pmoA gene sequence showed that enriched DAMO bacteria in the continuous-flow cultivation had over 98% sequence similarity to DAMO bacteria in the inoculum. In contrast, for batch culture, the enriched pmoA gene sequences had 89-91% sequence similarity to DAMO bacteria in the inoculum. These results indicate that electron acceptor and cultivation method strongly affect the microbial community structures of DAMO consortia.	[Hatamoto, Masashi; Kimura, Masafumi; Sato, Takafumi; Koizumi, Masato; Takahashi, Masanobu; Yamaguchi, Takashi] Nagaoka Univ Technol, Dept Civil & Environm Engn, Nagaoka, Niigata 9402188, Japan; [Takahashi, Masanobu] Tohoku Univ, Dept Civil & Environm Engn, Sendai, Miyagi 9808579, Japan; [Kawakami, Shuji] Anan Natl Coll Technol, Dept Construct Syst Engn, Anan, Tokushima 7740017, Japan; [Araki, Nobuo] Nagaoka Natl Coll Technol, Dept Civil Engn, Nagaoka, Niigata 9408532, Japan	Nagaoka University of Technology; Tohoku University	Hatamoto, M (corresponding author), Nagaoka Univ Technol, Dept Civil & Environm Engn, Nagaoka, Niigata 9402188, Japan.	hatamoto@vos.nagaokaut.ac.jp	Hatamoto, Masashi/E-3111-2010		Exploratory Research of Adaptable and Seamless Technology Transfer Program through target-driven R&D program (A-STEP) from Japan Science and Technology Agency; JSPS KAKENHI [25701010]; Institute for Fermentation, Osaka; Grants-in-Aid for Scientific Research [25701010] Funding Source: KAKEN	Exploratory Research of Adaptable and Seamless Technology Transfer Program through target-driven R&D program (A-STEP) from Japan Science and Technology Agency; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Institute for Fermentation, Osaka(Institute for Fermentation (IFO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by Exploratory Research of Adaptable and Seamless Technology Transfer Program through target-driven R&D program (A-STEP) from Japan Science and Technology Agency, and JSPS KAKENHI Grant Number 25701010, and by a Grant-in-Aid from the Institute for Fermentation, Osaka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Ettwig KF, 2008, ENVIRON MICROBIOL, V10, P3164, DOI 10.1111/j.1462-2920.2008.01724.x; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; Ettwig KF, 2009, APPL ENVIRON MICROB, V75, P3656, DOI 10.1128/AEM.00067-09; Haroon MF, 2013, NATURE, V500, P567, DOI 10.1038/nature12375; Hatamoto M, 2007, APPL ENVIRON MICROB, V73, P1332, DOI 10.1128/AEM.02053-06; Hatamoto M, 2010, WATER RES, V44, P1409, DOI 10.1016/j.watres.2009.11.021; Hu SH, 2011, ENV MICROBIOL REP, V3, P315, DOI 10.1111/j.1758-2229.2010.00227.x; Hu SH, 2009, ENV MICROBIOL REP, V1, P377, DOI 10.1111/j.1758-2229.2009.00083.x; Imachi H, 2011, ISME J, V5, P1913, DOI 10.1038/ismej.2011.64; Kampman C, 2014, J HAZARD MATER, V274, P428, DOI 10.1016/j.jhazmat.2014.04.031; Kampman C, 2012, J HAZARD MATER, V227, P164, DOI 10.1016/j.jhazmat.2012.05.032; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luesken FA, 2011, APPL MICROBIOL BIOT, V92, P845, DOI 10.1007/s00253-011-3361-9; Luesken FA, 2011, APPL ENVIRON MICROB, V77, P6802, DOI 10.1128/AEM.05539-11; Meulepas RJW, 2009, BIOTECHNOL BIOENG, V104, P458, DOI 10.1002/bit.22412; Narihiro T, 2013, MICROBES ENVIRON, V28, P163, DOI 10.1264/jsme2.ME2802rh; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; Shen LD, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00269; Shi Y, 2013, ENVIRON SCI TECHNOL, V47, P11577, DOI 10.1021/es402775z; Stahl D. A., 1991, NUCL ACID TECHNIQUES; Wang Y, 2012, FEMS MICROBIOL LETT, V336, P79, DOI 10.1111/j.1574-6968.2012.02654.x; Zhu BL, 2012, APPL ENVIRON MICROB, V78, P8657, DOI 10.1128/AEM.02102-12; Zhu BL, 2011, BIOCHEM SOC T, V39, P1822, DOI 10.1042/BST20110704	25	26	28	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115823	10.1371/journal.pone.0115823	http://dx.doi.org/10.1371/journal.pone.0115823			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545013	Green Submitted, Green Published, gold			2022-12-26	WOS:000347120200073
J	Herrador, Z; Sordo, L; Gadisa, E; Buno, A; Gomez-Rioja, R; Iturzaeta, JM; de Armas, LF; Benito, A; Aseffa, A; Moreno, J; Canavate, C; Custodio, E				Herrador, Zaida; Sordo, Luis; Gadisa, Endalamaw; Buno, Antonio; Gomez-Rioja, Ruben; Manuel Iturzaeta, Jose; Fernandez de Armas, Lisset; Benito, Agustin; Aseffa, Abraham; Moreno, Javier; Canavate, Carmen; Custodio, Estefania			Micronutrient Deficiencies and Related Factors in School-Aged Children in Ethiopia: A Cross-Sectional Study in Libo Kemkem and Fogera Districts, Amhara Regional State	PLOS ONE			English	Article							VITAMIN-A-DEFICIENCY; DEVELOPING-COUNTRIES; SOUTHERN ETHIOPIA; RISK-FACTORS; NORTHWEST ETHIOPIA; NUTRITIONAL-STATUS; NORTHERN ETHIOPIA; PREVALENCE; HEALTH; ZINC	Introduction: The present study describes the distribution of selected micronutrients and anaemia among school-aged children living in Libo Kemkem and Fogera (Amhara State, Ethiopia), assessing differences by socio-demographic characteristics, health status and dietary habits. Methods: A cross-sectional survey was carried out during May-December 2009. Socio-demographic characteristics, health status and dietary habits were collected. Biomarkers were determined for 764 children. Bivariate and multivariable statistical methods were employed to assess micronutrient deficiencies (MD), anaemia, and their association with different factors. Results: More than two thirds of the school-aged children (79.5%) had at least one MD and 40.5% had two or more coexisting micronutrient deficiencies. The most prevalent deficiencies were of zinc (12.5%), folate (13.9%), vit A (29.3%) and vit D (49%). Anaemia occurred in 30.9% of the children. Children living in rural areas were more likely to have vit D insufficiency [OR: 5.9 (3.7-9.5)] but less likely to have folate deficiency [OR: 0.2 (0.1-0.4)] and anaemia [OR: 0.58 (0.35-0.97)]. Splenomegaly was positively associated with folate deficiency and anaemia [OR: 2.77 (1.19-6.48) and 4.91 (2.47-9.75)]. Meat and fish consumption were inversely correlated with zinc and ferritin deficiencies [OR: 0.2 (0.1-0.8) and 0.2 (0.1-0.9)], while oil consumption showed a negative association with anaemia and deficiencies of folate and vitamin A [0.58 (0.3-0.9), OR: 0.5 (0.3-0.9) and 0.6 (0.40.9)]. Serum ferritin levels were inversely correlated to the presence of anaemia (p<0.005). Conclusion: There is a high prevalence of vitamin A deficiency and vitamin D insufficiency and a moderate prevalence of zinc and folate deficiencies in schoolaged children in this area. The inverse association of anaemia and serum ferritin levels may be due to the presence of infectious diseases in the area. To effectively tackle malnutrition, strategies should target not only isolated micronutrient supplementation but also diet diversification.	[Herrador, Zaida; Benito, Agustin; Custodio, Estefania] Inst Salud Carlos III, Natl Ctr Trop Med, Madrid, Spain; [Herrador, Zaida; Benito, Agustin; Custodio, Estefania] Trop Dis Res Network RICET Spanish, Madrid, Spain; [Sordo, Luis] ISCIII, Natl Ctr Epidemiol, Madrid, Spain; [Sordo, Luis] Univ Complutense, Fac Med, Dept Prevent Med & Publ Hlth, E-28040 Madrid, Spain; [Sordo, Luis] Epidemiol & Publ Hlth CIBERESP Spanish, Network Biomed Res Ctr, Madrid, Spain; [Gadisa, Endalamaw; Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Buno, Antonio; Gomez-Rioja, Ruben; Manuel Iturzaeta, Jose] Univ Hosp La Paz, Madrid, Spain; [Fernandez de Armas, Lisset] Orense Univ Hosp, Orense, Spain; [Moreno, Javier; Canavate, Carmen] ISCIII, Natl Ctr Microbiol, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT); Instituto de Salud Carlos III; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario La Paz; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Custodio, E (corresponding author), Inst Salud Carlos III, Natl Ctr Trop Med, Madrid, Spain.	ecustodio2014@gmail.com	Aseffa, Abraham/J-3248-2016; Moreno, Javier/AAB-5386-2021; Soto, Antonio Buño/AAM-4851-2020	Aseffa, Abraham/0000-0002-8028-1150; Soto, Antonio Buño/0000-0002-8306-889X; Herrador, Zaida/0000-0002-6508-3818; sordo, Luis/0000-0003-1760-9472; Benito, Agustin/0000-0001-8229-5540; Moreno, Javier/0000-0003-0087-4659	UBS Optimus Foundation	UBS Optimus Foundation	Funding was provided by UBS Optimus Foundation. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Adebara OV, 2011, OPEN J PEDIAT, V1, P12; Adelekan DA, 2003, NUTRITION, V19, P473, DOI 10.1016/S0899-9007(03)00032-7; Allen L, 2008, Med Trop (Mars), V68, P182; Allen L, 2006, GUIDELINES FOOD FORT; Allen LH, 2003, J NUTR, V133, p3875S, DOI 10.1093/jn/133.11.3875S; Amare B, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-108; Amare B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-752; [Anonymous], 2009, WHO GLOBAL DATABASE; Arabi A, 2010, NAT REV ENDOCRINOL, V6, P550, DOI 10.1038/nrendo.2010.146; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Arimond M, 2002, PROGR DEV INFANT CHI; Arnaud J, 2001, BRIT J NUTR, V85, P741, DOI 10.1079/BJN2001362; Belachew T, 2005, E AFR MED J, V82; Belew TA, 2008, NUTR COUNTRY PROFILE; Bhaskaram P, 2002, NUTR REV, V60, pS40, DOI 10.1301/00296640260130722; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Prieto MB, 2011, INT J ENV RES PUB HE, V8, P4353, DOI 10.3390/ijerph8114353; Brown KH, 2004, 1 IZINCG; Centers for Disease Control and Prevention (CDC), 2012, 2 CDC; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Custodio E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001813; Das JK, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-67; de Benoist B, 2006, LANCET, V367, P816, DOI 10.1016/S0140-6736(06)68334-7; Degarege Abraham, 2010, BMC Res Notes, V3, P143, DOI 10.1186/1756-0500-3-143; Degye Goshu, 2013, Journal of Development and Agricultural Economics, V5, P174; Demissie T, 2010, FOOD NUTR BULL, V31, P234, DOI 10.1177/156482651003100206; Dong YB, 2010, PEDIATRICS, V125, P1104, DOI 10.1542/peds.2009-2055; *ETH FED MIN HLTH, 2004, NAT GUID CONTR PREV; Ethiopian Investment Agency, 2012, INV OPP PROF PALM OI; *FAO, 2001, TARG NUTR IMPR RES A; Ferro-Luzzi A, 2001, INT FOOD POLICY RES; Gebremedhin S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-898; Gibson RS, 2008, J NUTR, V138, P581, DOI 10.1093/jn/138.3.581; Gillespie S, 1998, P C HELD SEPT 16 17; Haidar J, 2010, J HEALTH POPUL NUTR, V28, P359; Hall A, 2008, TROP MED INT HEALTH, V13, P1518, DOI 10.1111/j.1365-3156.2008.02168.x; Headey D.D., 2012, IMPROVING MEASUREMEN; Hermiston ML, 2002, PEDIATR CLIN N AM, V49, P877, DOI 10.1016/S0031-3955(02)00029-9; Herrador Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105880; HOLICK MF, 1989, LANCET, V2, P1104; Household Economy Approach (HEA), TAN ZUR LIV ZON TZA; International Zinc Nutrition Consultative Group (IZiNCG), 2007, DET RISK ZINC DEF AS; IZiNCG, 2007, ASS POP ZINC STAT SE; Joint statement by the World Health Organization (WHO) the World Food Programme (WFP) and the United Nations Children's Fund (UNICEF), 2007, PREV CONTR MICR DEF; Kassaye T, 2001, B WORLD HEALTH ORGAN, V79, P415; Kassu A, 2008, BIOL TRACE ELEM RES, V122, P97, DOI 10.1007/s12011-007-8067-6; Kennedy G., 2011, GUID MEAS HOUS IND D; Kim SunHyo, 2006, Korean Journal of Nutrition, V39, P381; Lim HS, 2002, J NUTR SCI VITAMINOL, V48, P290, DOI 10.3177/jnsv.48.290; Lulseged S, 1999, E AFR MED J, V76, P457; Mahmud MA, 2013, PATHOG GLOB HEALTH, V107, P58, DOI 10.1179/2047773213Y.0000000074; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; Micronutrient Initiative FFI Global Alliance for Improved Nutrition (GAIN) United States Agency for International Development (USAID) The World Bank United Nations Children's Fund (UNICEF), 2009, INV FUT UN CALL ACTI; Organization WH, 2009, GLOB HLTH RISKS MORT; Pettifor JM, 2004, AM J CLIN NUTR, V80, p1725S, DOI 10.1093/ajcn/80.6.1725S; Prentice A, 2009, CLIN REV BONE MINER, V7, P94, DOI 10.1007/s12018-009-9038-6; Radhika M. S., 2003, Food and Nutrition Bulletin, V24, P208; Sauberlich HE., 1999, LAB TESTS ASSESSMENT; Schleicher RL, 2009, AM J CLIN NUTR, V90, P1252, DOI 10.3945/ajcn.2008.27016; Semba RD, 2012, WORLD REV NUTR DIET, V104, P1; Siekmann JH, 2003, J NUTR, V133, p3972S, DOI 10.1093/jn/133.11.3972S; Sordo L, 2012, AM J TROP MED HYG, V86, P955, DOI 10.4269/ajtmh.2012.11-0436; Stoecker BJ, 2009, EUR J CLIN NUTR, V63, P916, DOI 10.1038/ejcn.2008.77; UNICEF and MI, 2004, VIT MIN DEF GLOB DAM; United Nations Children's Fund (UNICEF), 2013, IMPR CHILD NUTR ACH; van den Broek N, 2003, BRIT MED BULL, V67, P149, DOI 10.1093/bmb/ldg004; WHO, 2007, ASS IR STAT POP INCL; *WHO, 1996, IND ASS VIT A DEF TH; WHO, 2001, IRON DEFICIENCY ANAE; World Health Organization, 2011, SER FERR CONC ASS IR; [World Health Organization (WHO) Regional Office for Africa], 2006, HLTH PEOPL AFR REG H; World Health Organization (WHO), 2014, 2012 2013 BIENN REP; World Health Organization (WHO), CHILD HLTH ETH	74	35	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e112858	10.1371/journal.pone.0112858	http://dx.doi.org/10.1371/journal.pone.0112858			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546056	gold, Green Published, Green Submitted			2022-12-26	WOS:000347120200003
J	Liu, M; Xu, RQ; Merrill, C; Hong, LW; Von Lanken, C; Hunt, AG; Li, QSQ				Liu, Man; Xu, Ruqiang; Merrill, Carrie; Hong, Liwei; Von Lanken, Carol; Hunt, Arthur G.; Li, Qingshun Q.			Integration of Developmental and Environmental Signals via a Polyadenylation Factor in Arabidopsis	PLOS ONE			English	Article							MESSENGER-RNA POLYADENYLATION; LATERAL ROOT-FORMATION; ZINC-FINGER PROTEINS; SPECIFICITY FACTOR; FACTOR SUBUNIT; PLANT DEVELOPMENT; SITE CHOICE; CLEAVAGE; INTERACTS; ORTHOLOG	The ability to integrate environmental and developmental signals with physiological responses is critical for plant survival. How this integration is done, particularly through posttranscriptional control of gene expression, is poorly understood. Previously, it was found that the 30 kD subunit of Arabidopsis cleavage and polyadenylation specificity factor (AtCPSF30) is a calmodulin-regulated RNA-binding protein. Here we demonstrated that mutant plants (oxt6) deficient in AtCPSF30 possess a novel range of phenotypes-reduced fertility, reduced lateral root formation, and altered sensitivities to oxidative stress and a number of plant hormones (auxin, cytokinin, gibberellic acid, and ACC). While the wild-type AtCPSF30 (C30G) was able to restore normal growth and responses, a mutant AtCPSF30 protein incapable of interacting with calmodulin (C30GM) could only restore wild-type fertility and responses to oxidative stress and ACC. Thus, the interaction with calmodulin is important for part of AtCPSF30 functions in the plant. Global poly(A) site analysis showed that the C30G and C30GM proteins can restore wild-type poly(A) site choice to the oxt6 mutant. Genes associated with hormone metabolism and auxin responses are also affected by the oxt6 mutation. Moreover, 19 genes that are linked with calmodulin-dependent CPSF30 functions, were identified through genome-wide expression analysis. These data, in conjunction with previous results from the analysis of the oxt6 mutant, indicate that the polyadenylation factor AtCPSF30 is a regulatory hub where different signaling cues are transduced, presumably via differential mRNA 39 end formation or alternative polyadenylation, into specified phenotypic outcomes. Our results suggest a novel function of a polyadenylation factor in environmental and developmental signal integration.	[Liu, Man; Xu, Ruqiang; Li, Qingshun Q.] Miami Univ, Dept Biol, Oxford, OH 45045 USA; [Merrill, Carrie; Von Lanken, Carol; Hunt, Arthur G.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA; [Hong, Liwei; Li, Qingshun Q.] Xiamen Univ, Key Lab, Minist Educ Costal Wetland Ecosyst, Coll Environm & Ecol, Xiamen 361102, Fujian, Peoples R China; [Li, Qingshun Q.] Fujian Acad Agr Sci, Rice Res Inst, Fuzhou 350003, Fujian, Peoples R China	University System of Ohio; Miami University; University of Kentucky; Xiamen University; Fujian Academy of Agricultural Sciences	Hunt, AG (corresponding author), Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA.	aghunt00@uky.edu; liq@miamioh.edu	Xu, Ruqiang/GWQ-6267-2022	Xu, Ruqiang/0000-0002-8966-2670; Hunt, Arthur/0000-0002-0008-4158; Li, Qingshun/0000-0003-4105-1480	US National Science Foundation [IOS0817818]; Ohio Plant Biotech Consortium; Fujian Hundred Talent Plan; Xiamen University	US National Science Foundation(National Science Foundation (NSF)); Ohio Plant Biotech Consortium; Fujian Hundred Talent Plan; Xiamen University(Xiamen University)	US National Science Foundation (IOS0817818) to QQL and AGH, and a grant from Ohio Plant Biotech Consortium to QQL. QQL also received funding support while working on this paper from the Fujian Hundred Talent Plan and from Xiamen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addepalli B, 2008, FEBS LETT, V582, P2577, DOI 10.1016/j.febslet.2008.06.029; Addepalli B, 2008, ARCH BIOCHEM BIOPHYS, V473, P88, DOI 10.1016/j.abb.2008.02.027; Addepalli B, 2008, PROTEIN PEPTIDE LETT, V15, P76; Addepalli B, 2007, NUCLEIC ACIDS RES, V35, P4453, DOI 10.1093/nar/gkm457; Addepalli B, 2010, FEBS LETT, V584, P4408, DOI 10.1016/j.febslet.2010.09.043; Barabino SML, 1997, GENE DEV, V11, P1703, DOI 10.1101/gad.11.13.1703; Bashandy T, 2011, PLANT SIGNAL BEHAV, V6, P117, DOI 10.4161/psb.6.1.14203; Bell SA, 2010, FEBS LETT, V584, P1449, DOI 10.1016/j.febslet.2010.03.007; Benjamins R, 2003, PLANT PHYSIOL, V132, P1623, DOI 10.1104/pp.103.019943; Brown VL, 2015, METHODS MOL BIOL, V1203, P175, DOI 10.1007/978-1-4939-1357-2_17; Bruggeman Q, 2014, PLANT PHYSIOL, V165, P732, DOI 10.1104/pp.114.236083; Cecchetti V, 2008, PLANT CELL, V20, P1760, DOI 10.1105/tpc.107.057570; Chan S, 2011, WIRES RNA, V2, P321, DOI 10.1002/wrna.54; Chan SL, 2014, GENE DEV, V28, P2370, DOI 10.1101/gad.250993.114; Chen CW, 2006, PLANT CELL PHYSIOL, V47, P1, DOI 10.1093/pcp/pci216; Chen YH, 2012, PROTOPLASMA, V249, P187, DOI 10.1007/s00709-011-0277-2; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; Cheng H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000440; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Collart C, 2005, GENES CELLS, V10, P897, DOI 10.1111/j.1365-2443.2005.00887.x; Collart C, 2009, DEVELOPMENT, V136, P3451, DOI 10.1242/dev.027714; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Delaney KJ, 2006, PLANT PHYSIOL, V140, P1507, DOI 10.1104/pp.105.070672; Doerner P, 2008, CSH PROTOC, V2008; Fukaki H, 2009, PLANT MOL BIOL, V69, P437, DOI 10.1007/s11103-008-9417-2; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; Hall AE, 2003, PLANT CELL, V15, P2032, DOI 10.1105/tpc.013060; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Hunt AG, 2008, CURR TOP MICROBIOL, V326, P151; Hunt AG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-220; Ito T, 2007, PLANT CELL, V19, P3516, DOI 10.1105/tpc.107.055467; Kauschmann A, 1996, PLANT J, V9, P701, DOI 10.1046/j.1365-313X.1996.9050701.x; Keller W, 1997, CURR OPIN CELL BIOL, V9, P329, DOI 10.1016/S0955-0674(97)80004-X; KELLER W, 1991, EMBO J, V10, P4241, DOI 10.1002/j.1460-2075.1991.tb05002.x; Lalanne E, 2002, PLANT PHYSIOL, V129, P865, DOI 10.1104/pp.003301; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Liu YF, 2008, PLANT J, V55, P844, DOI 10.1111/j.1365-313X.2008.03557.x; Ma LY, 2014, METHODS, V67, P74, DOI 10.1016/j.ymeth.2013.06.037; Ma LY, 2014, P NATL ACAD SCI USA, V111, P9, DOI 10.1073/pnas.1321025111; MACDONALD CC, 1994, MOL CELL BIOL, V14, P6647, DOI 10.1128/MCB.14.10.6647; Malamy JE, 1997, DEVELOPMENT, V124, P33; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Rao S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-51; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Snedden WA, 2001, NEW PHYTOL, V151, P35, DOI 10.1046/j.1469-8137.2001.00154.x; Sonmez C, 2011, P NATL ACAD SCI USA, V108, P8508, DOI 10.1073/pnas.1105334108; Tacahashi Y, 2003, NUCLEIC ACIDS RES, V31, P1744, DOI 10.1093/nar/gkg265; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thomas PE, 2012, PLANT CELL, V24, P4376, DOI 10.1105/tpc.112.096107; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Xing DH, 2008, PLANT J, V54, P899, DOI 10.1111/j.1365-313X.2008.03455.x; Xing DH, 2008, PLANT PHYSIOL, V148, P2059, DOI 10.1104/pp.108.129817; Xing SP, 2011, PLANT SIGNAL BEHAV, V6, P934, DOI 10.4161/psb.6.7.15668; Xu RQ, 2006, PLANT MOL BIOL, V61, P799, DOI 10.1007/s11103-006-0051-6; Yang Q, 2011, WIRES RNA, V2, P732, DOI 10.1002/wrna.88; Zhang JX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002410; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	62	17	17	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115779	10.1371/journal.pone.0115779	http://dx.doi.org/10.1371/journal.pone.0115779			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546057	Green Submitted, Green Published, gold			2022-12-26	WOS:000347120200067
J	Wang, X; Li, YL; Han, R; He, C; Wang, GL; Wang, JW; Zheng, JL; Pei, M; Wei, L				Wang, Xin; Li, Yanlin; Han, Rui; He, Chuan; Wang, Guoliang; Wang, Jianwei; Zheng, Jiali; Pei, Mei; Wei, Lei			Demineralized Bone Matrix Combined Bone Marrow Mesenchymal Stem Cells, Bone Morphogenetic Protein-2 and Transforming Growth Factor-beta 3 Gene Promoted Pig Cartilage Defect Repair	PLOS ONE			English	Article							CHONDROGENIC DIFFERENTIATION; COLLAGEN SCAFFOLDS; EXPRESSION; CONSTRUCTION; CHONDROCYTES; TGF-BETA-3; STRATEGIES; VECTOR; MSC	Objectives: To investigate whether a combination of demineralized bone matrix (DBM) and bone marrow mesenchymal stem cells (BMSCs) infected with adenovirus-mediated-bone morphogenetic protein (Ad-BMP-2) and transforming growth factor-beta 3 (Ad-TGF-beta 3) promotes the repair of the full-thickness cartilage lesions in pig model. Methods: BMSCs isolated from pig were cultured and infected with Ad-BMP-2(B group), Ad-TGF-beta 3 (T group), Ad-BMP-2 + Ad-TGF-beta 3(BT group), cells infected with empty Ad served as a negative group(N group), the expression of the BMP-2 and TGF-beta 3 were confirmed by immunofluorescence, PCR, and ELISA, the expression of SOX-9, type II collagen(COL-2A), aggrecan (ACAN) in each group were evaluated by real-time PCR at 1w, 2w, 3w, respectively. The chondrogenic differentiation of BMSCs was evaluated by type II collagen at 21d with immunohistochemical staining. The third-passage BMSCs infected with Ad-BMP-2 and Ad-TGF-beta 3 were suspended and cultured with DBM for 6 days to construct a new type of tissue engineering scaffold to repair full-thickness cartilage lesions in the femur condyles of pig knee, the regenerated tissue was evaluated at 1,2 and 3 months after surgery by gross appearance, H&E, safranin O staining and O'driscoll score. Results: Ad-BMP-2 and Ad-TGF-beta 3 (BT group) infected cells acquired strong type II collagen staining compared with Ad-BMP-2 (B group) and Ad-TGF-beta 3 (T group) along. The Ad-BMP-2 and Ad-TGF-beta 3 infected BMSCs adhered and propagated well in DBM and the new type of tissue engineering scaffold produced hyaline cartilage morphology containing a stronger type II collagen and safranin O staining, the O'driscoll score was higher than other groups. Conclusions: The DBM compound with Ad-BMP-2 and Ad-TGF-beta 3 infected BMSCs scaffold has a good biocompatibility and could well induce cartilage regeneration to repair the defects of joint cartilage. This technology may be efficiently employed for cartilage lesions repair in vivo.	[Wang, Xin; Li, Yanlin; He, Chuan; Wang, Guoliang; Wang, Jianwei; Zheng, Jiali] Kunming Med Univ, Affiliated Hosp 1, Dept Sports Med, Kunming, Peoples R China; [Han, Rui] Kunming Med Univ, Affiliated Hosp 1, Dept Diabetol, Kunming, Peoples R China; [Pei, Mei] W Virginia Univ, Dept Orthoped, Morgantown, WV 26506 USA; [Wei, Lei] Brown Univ, Warren Alpert Med Sch, Dept Orthoped, Providence, RI 02912 USA	Kunming Medical University; Kunming Medical University; West Virginia University; Brown University	Li, YL (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Dept Sports Med, Kunming, Peoples R China.	852387873@qq.com	Pei, Ming/N-8175-2017		Specialized Research Fund for the Doctoral Program of Higher Education [20115317110001]; Natural Science Foundation of Yunnan Province [2011FB169]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province)	(No. 20115317110001) Specialized Research Fund for the Doctoral Program of Higher Education www.cutech.edu.cn and (No. 2011FB169) Natural Science Foundation of Yunnan Province www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2008, GENE THER, V15, P109, DOI 10.1038/sj.gt.3303067; Aulin C, 2013, LAB ANIM-UK, V47, P58, DOI 10.1177/0023677212473716; Becher C, 2010, KNEE SURG SPORT TR A, V18, P656, DOI 10.1007/s00167-009-1036-1; Bhang SH, 2011, BIOTECHNOL APPL BIOC, V58, P271, DOI 10.1002/bab.39; Caron MMJ, 2013, OSTEOARTHR CARTILAGE, V21, P604, DOI 10.1016/j.joca.2013.01.009; Esquivies L, 2014, J BIOL CHEM, V289, P1788, DOI 10.1074/jbc.M113.529180; Fan HB, 2010, J BIOMED MATER RES A, V95A, P982, DOI 10.1002/jbm.a.32899; Feng JAQ, 2010, FASEB J, V24, P1879, DOI 10.1096/fj.09-144659; Froelich K, 2012, INT J ARTIF ORGANS, V35, P1047, DOI 10.5301/ijao.5000132; Gao C, 2013, EUR CELLS MATER, V26, P195, DOI 10.22203/eCM.v026a14; Grunder T, 2004, OSTEOARTHR CARTILAGE, V12, P559, DOI 10.1016/j.joca.2004.04.001; Hui JHP, 2013, ARTHROSCOPY, V29, P1992, DOI 10.1016/j.arthro.2013.06.009; Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024; Jeng L, 2013, TISSUE ENG PT A, V19, P2267, DOI [10.1089/ten.tea.2013.0013, 10.1089/ten.TEA.2013.0013]; Kurkalli BGS, 2010, CURR STEM CELL RES T, V5, P49, DOI 10.2174/157488810790442831; Lehmann M, 2013, EUR J HISTOCHEM, V57, P205, DOI 10.4081/ejh.2013.e31; Liao IC, 2013, ADV FUNCT MATER, V23, P5833, DOI 10.1002/adfm.201300483; Liu DP, 2013, MOL MED REP, V7, P659, DOI 10.3892/mmr.2012.1237; Mafi P, 2012, CURR STEM CELL RES T, V7, P302, DOI 10.2174/157488812800793045; Minehara H, 2011, CELL TISSUE BANK, V12, P199, DOI 10.1007/s10561-010-9185-5; Muller S, 2010, OPEN ORTHOP J, V4, P111; Neumann AJ, 2013, TISSUE ENG PT A, V19, P1285, DOI [10.1089/ten.tea.2012.0411, 10.1089/ten.TEA.2012.0411]; O'Driscoll SW, 2001, CLIN ORTHOP RELAT R, pS397; Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18; Pourmohammadali H, 2013, P I MECH ENG H, V227, P310, DOI 10.1177/0954411912468638; Redman S N, 2005, Eur Cell Mater, V9, P23; Reyes R, 2013, EUR CELLS MATER, V25, P351, DOI 10.22203/eCM.v025a25; Ronziere MC, 2010, BIO-MED MATER ENG, V20, P145, DOI 10.3233/BME-2010-0626; Rui YF, 2010, CHINESE MED J-PEKING, V123, P3040, DOI 10.3760/cma.j.issn.0366-6999.2010.21.017; Santhagunam A, 2012, BIOTECHNOL APPL BIOC, V59, P121, DOI 10.1002/bab.1016; Shintani N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053086; Stevens MM, 2004, J ORTHOP RES, V22, P1114, DOI 10.1016/j.orthres.2003.12.021; Tsuzuki N, 2013, CAN VET J, V54, P573; Wu W, 2013, J HUAZHONG U SCI TEC; Zhang F, 2010, J CONTROL RELEASE, V142, P70, DOI 10.1016/j.jconrel.2009.09.027; Zhang XJ, 2006, ADV DRUG DELIVER REV, V58, P515, DOI 10.1016/j.addr.2006.03.006; Zhu L, 2010, BRIT J ORAL MAX SURG, V48, P462, DOI 10.1016/j.bjoms.2009.08.012	37	33	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116061	10.1371/journal.pone.0116061	http://dx.doi.org/10.1371/journal.pone.0116061			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545777	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200096
J	Lin, J; Yang, J; Wen, XM; Yang, L; Deng, ZQ; Qian, Z; Ma, JC; Guo, H; Zhang, YY; Qian, W; Qian, J				Lin, Jiang; Yang, Jing; Wen, Xiang-mei; Yang, Lei; Deng, Zhao-qun; Qian, Zhen; Ma, Ji-chun; Guo, Hong; Zhang, Ying-ying; Qian, Wei; Qian, Jun			Detection of SRSF2-P95 Mutation by High-Resolution Melting Curve Analysis and Its Effect on Prognosis in Myelodysplastic Syndrome	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; SPLICEOSOMAL MACHINERY; SPLICING MACHINERY; PATHWAY; SF3B1; IMPACT; U2AF1	Hotspot mutations of serine/arginine-rich splicing factor 2 (SRSF2) gene have been identified in a proportion of hematologic malignancies including myelodysplastic syndrome (MDS). The aim of the present study was to develop a new approach to screen SRSF2 mutation and analyze the clinical relevance of SRSF2 mutations in Chinese MDS. A protocol based on high-resolution melting analysis (HRMA) was established to screen SRSF2-P95 mutation in 108 MDS patients and was compared with Sanger sequencing. The clinical relevance of SRSF2 mutations was further evaluated. HRMA identified five (4.6%) cases with SRSF2 mutation, completely validated by Sanger sequencing without false positive or negative results. The sensitivities of HRMA and Sanger sequencing were 10% and 25% for the detection of SRSF2-P95H mutation, respectively, against the background of wild-type DNA. Patients with SRSF2 mutation had shorter overall survival time than those with wild-type SRSF2 in both the whole cohort of cases and those with normal karyotype (P=0.069 and 0.023, respectively). Multivariate analysis confirmed SRSF2 mutation as an independent risk factor in both patient populations. We established a fast, high-throughput, and inexpensive HRMA-based method to screen SRSF2 mutation, which could be used in clinical diagnostic laboratories. SRSF2 mutations were significantly associated with mortality rate in the MDS affected Chinese.	[Lin, Jiang; Wen, Xiang-mei; Ma, Ji-chun; Guo, Hong; Qian, Wei] Jiangsu Univ, Affiliated Peoples Hosp, Lab Ctr, Zhenjiang, Jiangsu, Peoples R China; [Yang, Jing; Yang, Lei; Deng, Zhao-qun; Qian, Zhen; Zhang, Ying-ying; Qian, Jun] Jiangsu Univ, Affiliated Peoples Hosp, Dept Hematol, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	Qian, W (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Lab Ctr, Zhenjiang, Jiangsu, Peoples R China.	dwqian@yahoo.com; qianjun0007@hotmail.com			National Natural Science foundation of China [81270630, 81172592]; Science and Technology Special Project in Clinical Medicine of Jiangsu Province [BL2012056]; 333 Project of Jiangsu Province [BRA2011085, BRA2013136]; Science and Technology Infrastructure Program of Zhenjiang [SS2012003]; Social Development Foundation of Zhenjiang [SH2013042, SH2013082]; Research and Development Foundation of Clinical Medicine of Jiangsu University [JLY20120013]; Key Medical Talent Program of Zhenjiang City; Jiangsu Government Scholarship for Overseas Studies	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Special Project in Clinical Medicine of Jiangsu Province; 333 Project of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Science and Technology Infrastructure Program of Zhenjiang; Social Development Foundation of Zhenjiang; Research and Development Foundation of Clinical Medicine of Jiangsu University; Key Medical Talent Program of Zhenjiang City; Jiangsu Government Scholarship for Overseas Studies	This study was supported by National Natural Science foundation of China (81270630, 81172592), Science and Technology Special Project in Clinical Medicine of Jiangsu Province (BL2012056), 333 Project of Jiangsu Province (BRA2011085, BRA2013136), Science and Technology Infrastructure Program of Zhenjiang (SS2012003), Social Development Foundation of Zhenjiang (SH2013042, SH2013082), Research and Development Foundation of Clinical Medicine of Jiangsu University (JLY20120013), Key Medical Talent Program of Zhenjiang City, and Jiangsu Government Scholarship for Overseas Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamia S, 2014, CLIN CANCER RES, V20, P1135, DOI 10.1158/1078-0432.CCR-13-0956; Bejar R, 2012, J CLIN ONCOL, V30, P3376, DOI 10.1200/JCO.2011.40.7379; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Bourgeois CF, 2004, PROG NUCLEIC ACID RE, V78, P37, DOI 10.1016/S0079-6603(04)78002-2; Damm F, 2012, BLOOD, V119, P3211, DOI 10.1182/blood-2011-12-400994; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Hanssens K, 2014, HAEMATOLOGICA, V99, P830, DOI 10.3324/haematol.2013.095133; Je EM, 2013, INT J CANCER, V133, P260, DOI 10.1002/ijc.28011; Kelemen O, 2013, GENE, V514, P1, DOI 10.1016/j.gene.2012.07.083; Lasho TL, 2012, BLOOD, V120, P4168, DOI 10.1182/blood-2012-05-429696; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Maciejewski JP, 2012, BRIT J HAEMATOL, V158, P165, DOI 10.1111/j.1365-2141.2012.09158.x; Makishima H, 2012, BLOOD, V119, P3203, DOI 10.1182/blood-2011-12-399774; Meggendorfer M, 2012, BLOOD, V120, P3080, DOI 10.1182/blood-2012-01-404863; Mian SA, 2013, HAEMATOLOGICA, V98, P1058, DOI 10.3324/haematol.2012.075325; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; Patnaik MM, 2013, AM J HEMATOL, V88, P201, DOI 10.1002/ajh.23373; Qian J, 2010, CLIN CHIM ACTA, V411, P2097, DOI 10.1016/j.cca.2010.08.020; Swen JJ, 2012, CLIN CHEM LAB MED, V50, P279, DOI 10.1515/CCLM.2011.758; Swerdlow SH, 2008, WHO CLASSIFICATION T; Thol F, 2012, BLOOD, V119, P3578, DOI 10.1182/blood-2011-12-399337; Vannucchi AM, 2013, LEUKEMIA, V27, P1861, DOI 10.1038/leu.2013.119; Visconte V, 2012, LEUKEMIA, V26, P2447, DOI 10.1038/leu.2012.130; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; Wu SJ, 2012, BLOOD, V120, P3106, DOI 10.1182/blood-2012-02-412296; Yang J, 2013, GENET TEST MOL BIOMA, V17, P342, DOI 10.1089/gtmb.2012.0364; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zhou ZH, 2013, CHROMOSOMA, V122, P191, DOI 10.1007/s00412-013-0407-z	31	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115693	10.1371/journal.pone.0115693	http://dx.doi.org/10.1371/journal.pone.0115693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541999	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900072
J	Zhang, Y; Li, L; Dong, XC; Kong, M; Gao, L; Dong, XJ; Xu, WT				Zhang, Ying; Li, Lin; Dong, Xiaochun; Kong, Mei; Gao, Lu; Dong, Xiaojing; Xu, Wenti			Influenza Surveillance and Incidence in a Rural Area in China during the 2009/2010 Influenza Pandemic	PLOS ONE			English	Article							DISEASE; INFORMATION; SPACE; TIME	Background: Most influenza surveillance is based on data from urban sentinel hospitals; little is known about influenza activity in rural communities. We conducted influenza surveillance in a rural region of China with the aim of detecting influenza activity in the 2009/2010 influenza season. Methods: The study was conducted from October 2009 to March 2010. Real-time polymerase chain reaction was used to confirm influenza cases. Over-the-counter (OTC) drug sales were daily collected in drugstores and hospitals/clinics. Space-time scan statistics were used to identify clusters of ILI in community. The incidence rate of ILI/influenza was estimated on the basis of the number of ILI/influenza cases detected by the hospitals/clinics. Results: A total of 434 ILI cases (3.88% of all consultations) were reported; 64.71% of these cases were influenza A (H1N1) pdm09. The estimated incidence rate of ILI and influenza were 5.19/100 and 0.40/100, respectively. The numbers of ILI cases and OTC drug purchases in the previous 7 days were strongly correlated (Spearman rank correlation coefficient [r] = 0.620, P = 0.001). Four ILI outbreaks were detected by space-time permutation analysis. Conclusions: This rural community surveillance detected influenza A (H1N1) pdm09 activity and outbreaks in the 2009/2010 influenza season and enabled estimation of the incidence rate of influenza. It also provides a scientific data for public health measures.	[Zhang, Ying; Li, Lin; Dong, Xiaochun; Gao, Lu; Xu, Wenti] Tianjin Ctr Dis Control & Prevent, Dept Infect Dis, Tianjin, Peoples R China; [Kong, Mei] Tianjin Ctr Dis Control & Prevent, Inst Pathogen Microbiol, Tianjin, Peoples R China; [Dong, Xiaojing] Hangu Centers Dis Control & Prevent, Binhai New Area, Tianjin, Peoples R China	Tianjin Center for Disease Control & Prevention; Tianjin Center for Disease Control & Prevention	Xu, WT (corresponding author), Tianjin Ctr Dis Control & Prevent, Dept Infect Dis, Tianjin, Peoples R China.	wenti_xwt@163.com			Health Bureau of Tianjin [09KZ43]	Health Bureau of Tianjin	Funding: The project was funded by the Health Bureau of Tianjin (Grant: 09KZ43).	Adjemian JZ, 2009, AM J TROP MED HYG, V80, P72, DOI 10.4269/ajtmh.2009.80.72; Boyle JR, 2011, MED J AUSTRALIA, V194, pS28; Cooper DL, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-16; Das D, 2005, MMWR-MORBID MORTAL W, V54, pS41; Fleming DM, 2003, EUR J PUBLIC HEALTH, V13, P80, DOI 10.1093/eurpub/13.suppl_1.80; Ghosh TS, 2008, AM J PUBLIC HEALTH, V98, P213, DOI 10.2105/AJPH.2006.106138; Guo Jian-Hua, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P307; Horst MA, 2010, J AM BOARD FAM MED, V23, P32, DOI 10.3122/jabfm.2010.01.090137; Huang SS, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000238; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Lee JS, 2007, EPIDEMIOL INFECT, V135, P1117, DOI 10.1017/S0950268807007820; Mainassara HB, 2010, GEOSPATIAL HEALTH, V5, P93, DOI 10.4081/gh.2010.190; Metzger KB, 2004, MMWR-MORBID MORTAL W, V53, pS106; Pearl DL, 2006, EPIDEMIOL INFECT, V134, P699, DOI 10.1017/S0950268805005741; Socan M, 2012, CENT EUR J PUBL HEAL, V20, P156, DOI 10.21101/cejph.a3735; Uphoff H, 2004, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V47, P279, DOI 10.1007/s00103-003-0768-1; van den Wijngaard CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010406; Wang X, 2011, EPIDEMIOL INFECT, V139, P1551, DOI 10.1017/S0950268810002694; Yang P, 2011, INT J INFECT DIS, V15, pE151, DOI 10.1016/j.ijid.2010.11.001	19	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115347	10.1371/journal.pone.0115347	http://dx.doi.org/10.1371/journal.pone.0115347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542003	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900036
J	Reigstad, CS; Salmonson, CE; Rainey, JF; Szurszewski, JH; Linden, DR; Sonnenburg, JL; Farrugia, G; Kashyap, PC				Reigstad, Christopher S.; Salmonson, Charles E.; Rainey, John F., III; Szurszewski, Joseph H.; Linden, David R.; Sonnenburg, Justin L.; Farrugia, Gianrico; Kashyap, Purna C.			Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells	FASEB JOURNAL			English	Article						5-hydroxytryptamine; gnotobiotic; gut motility; host-microbe interaction; microbiome	IRRITABLE-BOWEL-SYNDROME; ENTEROENDOCRINE CELLS; IN-VITRO; MICE; EXPRESSION; MOTILITY; RECEPTORS; INTESTINE; DIET; TRANSPORTERS	Gut microbiota alterations have been described in several diseases with altered gastrointestinal (GI) motility, and awareness is increasing regarding the role of the gut microbiome in modulating GI function. Serotonin [5-hydroxytryptamine (5-HT)] is a key regulator of GI motility and secretion. To determine the relationship among gut microbes, colonic contractility, and host serotonergic gene expression, we evaluated mice that were germ-free (GF) or humanized (HM; ex-GF colonized with human gutmicrobiota). 5-HT reduced contractile duration in both GF and HM colons. Microbiota from HM and conventionally raised (CR) mice significantly increased colonic mRNAs Tph1 [(tryptophan hydroxylase) 1, rate limiting for mucosal 5-HT synthesis; P < 0.01] and chromogranin A (neuroendocrine secretion; P < 0.01), with no effect on monoamine oxidase A (serotonin catabolism), serotonin receptor 5-HT4, or mouse serotonin transporter. HM and CR mice also had increased colonic Tph1 protein (P < 0.05) and 5-HT concentrations (GF, 17 +/- 3 ng/mg; HM, 25 +/- 2 ng/mg; and CR, 35 +/- 3 ng/mg; P < 0.05). Enterochromaffin (EC) cell numbers (cells producing 5-HT) were unchanged. Short-chain fatty acids (SCFAs) promoted TPH1 transcription in BON cells (human EC cell model). Thus, gut microbiota acting through SCFAs are important determinants of enteric 5-HT production and homeostasis.	[Reigstad, Christopher S.; Salmonson, Charles E.; Rainey, John F., III; Szurszewski, Joseph H.; Linden, David R.; Farrugia, Gianrico; Kashyap, Purna C.] Mayo Clin, Enter NeuroSci Program, Rochester, MN 55905 USA; [Reigstad, Christopher S.; Salmonson, Charles E.; Rainey, John F., III; Szurszewski, Joseph H.; Farrugia, Gianrico; Kashyap, Purna C.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Szurszewski, Joseph H.; Linden, David R.; Farrugia, Gianrico] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Sonnenburg, Justin L.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Stanford University	Kashyap, PC (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.	kashyap.purna@mayo.edu			U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [K08 DK100638, P30DK84567, R01 DK085025]; Global Probiotic Council; Minnesota Partnership for Biotechnology and Genomics; Center for Individualized Medicine, Mayo Clinic; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK100638, P30DK084567, R01DK085025] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Global Probiotic Council; Minnesota Partnership for Biotechnology and Genomics; Center for Individualized Medicine, Mayo Clinic; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Courtney M. Townsend, Jr., for the generous gift of the BON cell line, Kristy Zodrow for administrative assistance, and Mr. Peter R. Strege for preparing the figures. This work was made possible by funding from U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases Grants K08 DK100638 and P30DK84567 (to P.C.K.), and R01 DK085025 (to J.L.S.), as well as funding from the Global Probiotic Council (to P.C.K.), Minnesota Partnership for Biotechnology and Genomics (to P.C.K.), and the Center for Individualized Medicine, Mayo Clinic (to P.C.K.). C.S.R. and P.C.K. designed the research study. C.S.R., J.F.R., and C.E.S. performed the research. C.S.R., D.R.L., J.H.S., J.L.S., G.F., and P.C.K. analyzed the data and contributed to interpretation of data. C.S.R. and P.C.K. wrote the manuscript. Each author has read the final manuscript and approved it. The authors declare no conflicts of interest.	Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Barrett E, 2012, J APPL MICROBIOL, V113, P411, DOI 10.1111/j.1365-2672.2012.05344.x; Bogunovic M, 2007, AM J PHYSIOL-GASTR L, V292, pG1770, DOI 10.1152/ajpgi.00249.2006; Chen JJ, 2001, J NEUROSCI, V21, P6348, DOI 10.1523/JNEUROSCI.21-16-06348.2001; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; Crowell MD, 2004, BRIT J PHARMACOL, V141, P1285, DOI 10.1038/sj.bjp.0705762; Ebert-Zavos E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058477; Esmaili A, 2009, GASTROENTEROLOGY, V137, P2074, DOI 10.1053/j.gastro.2009.09.002; Essien BE, 2013, GASTROENTEROLOGY, V144, P1466, DOI 10.1053/j.gastro.2013.01.057; EVERS BM, 1991, GASTROENTEROLOGY, V101, P303, DOI 10.1016/0016-5085(91)90004-5; Gahete MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023302; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Gershon MD, 2013, CURR OPIN ENDOCRINOL, V20, P14, DOI 10.1097/MED.0b013e32835bc703; Heredia DJ, 2013, J PHYSIOL-LONDON, V591, P5939, DOI 10.1113/jphysiol.2013.256230; Hoffman JM, 2012, GASTROENTEROLOGY, V142, P844, DOI 10.1053/j.gastro.2011.12.041; HOVERSTAD T, 1986, J NUTR, V116, P1772, DOI 10.1093/jn/116.9.1772; Hu Y, 2002, J BIOL CHEM, V277, P44462, DOI 10.1074/jbc.M205784200; Jeffery IB, 2012, GUT, V61, P997, DOI 10.1136/gutjnl-2011-301501; Karaki S, 2006, CELL TISSUE RES, V324, P353, DOI 10.1007/s00441-005-0140-x; Kashyap PC, 2013, GASTROENTEROLOGY, V144, P967, DOI 10.1053/j.gastro.2013.01.047; Lee AK, 2010, NUTRITION, V26, P411, DOI 10.1016/j.nut.2009.05.007; Ley RE, 2006, APPL ENVIRON MICROB, V72, P3685, DOI 10.1128/AEM.72.5.3685-3695.2006; Li ZS, 2011, J NEUROSCI, V31, P8998, DOI 10.1523/JNEUROSCI.6684-10.2011; Liu C, 2010, NAT NEUROSCI, V13, P1190, DOI 10.1038/nn.2623; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomasney KW, 2014, NEUROGASTROENT MOTIL, V26, P887, DOI 10.1111/nmo.12328; Mawe GM, 2013, NAT REV GASTRO HEPAT, V10, P473, DOI 10.1038/nrgastro.2013.105; McOrist AL, 2011, J NUTR, V141, P883, DOI 10.3945/jn.110.128504; Minderhoud IM, 2007, CLIN GASTROENTEROL H, V5, P714, DOI 10.1016/j.cgh.2007.02.013; Ohman Lena, 2013, Curr Gastroenterol Rep, V15, P323, DOI 10.1007/s11894-013-0323-7; PAREKH D, 1994, PANCREAS, V9, P83, DOI 10.1097/00006676-199401000-00013; Reichardt F, 2013, J PHYSIOL-LONDON, V591, P5125, DOI 10.1113/jphysiol.2013.262733; Siddique ZL, 2009, NEUROENDOCRINOLOGY, V89, P458, DOI 10.1159/000209330; Sjogren K, 2012, J BONE MINER RES, V27, P1357, DOI 10.1002/jbmr.1588; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stackebrandt E., 1991, NUCL ACID TECHNIQUES; Stappenbeck TS, 2002, METHOD ENZYMOL, V356, P167; Taylor NS, 2007, J CLIN MICROBIOL, V45, P2166, DOI 10.1128/JCM.00137-07; Tazoe H, 2008, J PHYSIOL PHARMACOL, V59, P251; Tazoe H, 2009, BIOMED RES-TOKYO, V30, P149, DOI 10.2220/biomedres.30.149; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Tran VS, 2004, ANN NY ACAD SCI, V1014, P179, DOI 10.1196/annals.1294.019; Tsukamoto K, 2007, AM J PHYSIOL-REG I, V293, pR64, DOI 10.1152/ajpregu.00856.2006; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Zhang ZF, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-23	47	549	588	30	244	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1395	1403		10.1096/fj.14-259598	http://dx.doi.org/10.1096/fj.14-259598			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25550456	Green Published			2022-12-26	WOS:000354115000025
J	Frederiksen, RF; Yoshimura, Y; Storgaard, BG; Paspaliari, DK; Petersen, BO; Chen, K; Larsen, T; Duus, JO; Ingmer, H; Bovin, NV; Westerlind, U; Blixt, O; Palcic, MM; Leisner, JJ				Frederiksen, Rikki F.; Yoshimura, Yayoi; Storgaard, Birgit G.; Paspaliari, Dafni K.; Petersen, Bent O.; Chen, Kowa; Larsen, Tanja; Duus, Jens O.; Ingmer, Hanne; Bovin, Nicolai V.; Westerlind, Ulrika; Blixt, Ola; Palcic, Monica M.; Leisner, Jorgen J.			A Diverse Range of Bacterial and Eukaryotic Chitinases Hydrolyzes the LacNAc (Gal beta 1-4GlcNAc) and LacdiNAc (GalNAc beta 1-4GlcNAc) Motifs Found on Vertebrate and Insect Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENTLY LABELED OLIGOSACCHARIDES; SALMONELLA-ENTERICA; PLANT CHITINASES; REPEATING UNIT; CHITOTRIOSIDASE; PROTEINS; TRANSMISSION; EXPRESSION; EVOLUTION; INFECTION	There is emerging evidence that chitinases have additional functions beyond degrading environmental chitin, such as involvement in innate and acquired immune responses, tissue remodeling, fibrosis, and serving as virulence factors of bacterial pathogens. We have recently shown that both the human chitotriosidase and a chitinase from Salmonella enterica serovar Typhimurium hydrolyze LacNAc from Gal beta 1-4GlcNAc beta-tetramethylrhodamine (LacNAc-TMR (Gal beta 1-4GlcNAc beta (CH2)(8)-CONH(CH2)(2)NHCO-TMR)), a fluorescently labeled model substrate for glycans found in mammals. In this study we have examined the binding affinities of the Salmonella chitinase by carbohydrate microarray screening and found that it binds to a range of compounds, including five that contain LacNAc structures. We have further examined the hydrolytic specificity of this enzyme and chitinases from Sodalis glossinidius and Polysphondylium pallidum, which are phylogenetically related to the Salmonella chitinase, as well as unrelated chitinases from Listeria monocytogenes using the fluorescently labeled substrate analogs LacdiNAc-TMR (GalNAc beta 1-4GlcNAc beta-TMR), LacNAc-TMR, and LacNAc beta 1-6LacNAc beta-TMR. We found that all chitinases examined hydrolyzed LacdiNAc from the TMR aglycone to various degrees, whereas they were less active toward LacNAc-TMR conjugates. LacdiNAc is found in the mammalian glycome and is a common motif in invertebrate glycans. This substrate specificity was evident for chitinases of different phylogenetic origins. Three of the chitinases also hydrolyzed the beta 1-6 bond in LacNAc beta 1-6LacNAc beta-TMR, an activity that is of potential importance in relation to mammalian glycans. The enzymatic affinities for these mammalian-like structures suggest additional functional roles of chitinases beyond chitin hydrolysis.	[Frederiksen, Rikki F.; Storgaard, Birgit G.; Paspaliari, Dafni K.; Larsen, Tanja; Ingmer, Hanne; Leisner, Jorgen J.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, DK-1870 Frederiksberg C, Denmark; [Yoshimura, Yayoi; Storgaard, Birgit G.; Petersen, Bent O.; Duus, Jens O.; Palcic, Monica M.] Carlsberg Lab, DK-1799 Copenhagen V, Denmark; [Chen, Kowa] Univ Copenhagen, Fac Hlth & Med Sci, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, DK-2200 Kbh N, Denmark; [Bovin, Nicolai V.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Westerlind, Ulrika] Gesell Forderung Analyt Wissensch eV, ISAS Leibnitz Inst Analyt Sci, D-44227 Dortmund, Germany; [Blixt, Ola] Univ Copenhagen, Dept Chem, DK-1871 Frederiksberg C, Denmark	University of Copenhagen; University of Copenhagen; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); University of Copenhagen	Leisner, JJ (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Gronnegaardsvej 10, DK-1870 Frederiksberg C, Denmark.	jjl@sund.ku.dk	Bovin, Nicolai/P-2948-2017; Duus, Jens Øllgaard/N-4279-2013; Leisner, Jørgen/L-7835-2018	Bovin, Nicolai/0000-0001-8669-4477; Duus, Jens Øllgaard/0000-0003-3625-1250; Blixt, Ola/0000-0003-4143-6276; Larsen, Tanja/0000-0002-1920-6274; Ingmer, Hanne/0000-0002-8350-5631; Frederiksen, Rikki Franklin/0000-0003-2835-1008	EU-FP7, EuroGlycoArrays [215536]; EU-FP7 Glyco-BioM [259869]; Russian Science Foundation [14-14-00579] Funding Source: Russian Science Foundation	EU-FP7, EuroGlycoArrays; EU-FP7 Glyco-BioM; Russian Science Foundation(Russian Science Foundation (RSF))	All NMR spectra were recorded on the Bruker Avance 800 spectrometer of the Danish Instrument Center for NMR Spectroscopy of Biological Macromolecules. Glycans for microarray were kindly provided by Dr. Carlo Unverzagt (Bayreuth) and supported by EU-FP7, EuroGlycoArrays (215536), and EU-FP7 Glyco-BioM (259869).	Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Boot RG, 1999, ARTERIOSCL THROM VAS, V19, P687, DOI 10.1161/01.ATV.19.3.687; Chaudhuri S, 2013, MBIO, V4, DOI 10.1128/mBio.00617-12; Cummings RD, 2009, MOL BIOSYST, V5, P1087, DOI 10.1039/b907931a; Dale C, 2001, P NATL ACAD SCI USA, V98, P1883, DOI 10.1073/pnas.021450998; Di Rosa M, 2006, EUR J NEUROSCI, V23, P2648, DOI 10.1111/j.1460-9568.2006.04780.x; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Frederiksen RF, 2013, MICROBIOL-SGM, V159, P833, DOI 10.1099/mic.0.051839-0; Goy R, 2013, EUR J INORG CHEM, V2013, P4466, DOI 10.1002/ejic.201300537; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Holt PS, 2007, APPL ENVIRON MICROB, V73, P6030, DOI 10.1128/AEM.00803-07; Horn SJ, 2006, FEBS J, V273, P491, DOI 10.1111/j.1742-4658.2005.05079.x; Karlsson M, 2009, J MOL MICROB BIOTECH, V16, P208, DOI 10.1159/000151220; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Keyhani NO, 1999, BBA-GEN SUBJECTS, V1473, P108, DOI 10.1016/S0304-4165(99)00172-5; KOPANIC RJ, 1994, J FOOD PROTECT, V57, P125, DOI 10.4315/0362-028X-57.2.125; KURANDA MJ, 1991, J BIOL CHEM, V266, P19758; Larsen T, 2014, FEBS LETT, V588, P746, DOI 10.1016/j.febslet.2013.12.035; Larsen T, 2011, GLYCOBIOLOGY, V21, P426, DOI 10.1093/glycob/cwq174; Le XC, 1997, J CHROMATOGR A, V781, P515, DOI 10.1016/S0021-9673(97)00607-9; Lee CG, 2012, J IMMUNOL, V189, P2635, DOI 10.4049/jimmunol.1201115; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Leisner JJ, 2008, APPL ENVIRON MICROB, V74, P3823, DOI 10.1128/AEM.02701-07; Leisner JJ, 2009, J APPL MICROBIOL, V107, P2080, DOI 10.1111/j.1365-2672.2009.04420.x; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Moore BC, 2003, APPL ENVIRON MICROB, V69, P4556, DOI 10.1128/AEM.69.8.4556-4560.2003; Murata T, 2005, BIOCHEM BIOPH RES CO, V336, P514, DOI 10.1016/j.bbrc.2005.08.123; North SJ, 2006, GLYCOCONJUGATE J, V23, P345, DOI 10.1007/s10719-006-6693-4; Olsen AR, 2000, J FOOD PROTECT, V63, P958, DOI 10.4315/0362-028X-63.7.958; Schaap P, 2006, SCIENCE, V314, P661, DOI 10.1126/science.1130670; SCHLUMBAUM A, 1986, NATURE, V324, P365, DOI 10.1038/324365a0; Severov VV, 2007, RUSS J BIOORG CHEM+, V33, P122, DOI 10.1134/S1068162007010141; Shih NR, 1997, PLANT SCI, V130, P145, DOI 10.1016/S0168-9452(97)00229-X; Shilova N, 2012, GLYCOCONJUGATE J, V29, P87, DOI 10.1007/s10719-011-9368-8; Shoda S, 2006, CELLULOSE, V13, P477, DOI 10.1007/s10570-006-9066-z; Taira T., 2010, Journal of Applied Glycoscience, V57, P167, DOI 10.5458/jag.57.167; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Yu TA, 2011, GLYCOBIOLOGY, V21, P206, DOI 10.1093/glycob/cwq151; ZHANG YN, 1995, ANAL BIOCHEM, V227, P368, DOI 10.1006/abio.1995.1293	42	18	18	2	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5354	5366		10.1074/jbc.M114.607291	http://dx.doi.org/10.1074/jbc.M114.607291			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25561735	Green Published, hybrid			2022-12-26	WOS:000350044200010
J	Chiba, T; Sakurada, T; Watanabe, R; Yamaguchi, K; Kimura, Y; Kioka, N; Kawagishi, H; Matsuo, M; Ueda, K				Chiba, Tomohiro; Sakurada, Tsuyoshi; Watanabe, Rie; Yamaguchi, Kohji; Kimura, Yasuhisa; Kioka, Noriyuki; Kawagishi, Hirokazu; Matsuo, Michinori; Ueda, Kazumitsu			Fomiroid A, a Novel Compound from the Mushroom Fomitopsis nigra, Inhibits NPC1L1-Mediated Cholesterol Uptake via a Mode of Action Distinct from That of Ezetimibe	PLOS ONE			English	Article							INTESTINAL NPC1L1 EXPRESSION; PICK C1-LIKE 1; ABSORPTION INHIBITOR; DIETARY; PROTEIN; ATHEROSCLEROSIS; MEMBRANE; BINDING; TARGET; CELLS	Hypercholesterolemia is one of the key risk factors for coronary heart disease, a major cause of death in developed countries. Suppression of NPC1L1-mediated dietary and biliary cholesterol absorption is predicted to be one of the most effective ways to reduce the risk of hypercholesterolemia. In a screen for natural products that inhibit ezetimibe glucuronide binding to NPC1L1, we found a novel compound, fomiroid A, in extracts of the mushroom Fomitopsis nigra. Fomiroid A is a Ianosterone derivative with molecular formula C30H48O3. Fomiroid A inhibited ezetimibe glucuronide binding to NPC1L1, and dose-dependently prevented NPC1L1-mediated cholesterol uptake and formation of esterified cholesterol in NPC1L1-expressing Caco2 cells. Fomiroid A exhibited a pharmacological chaperone activity that corrected trafficking defects of the L1072T/L1168I mutant of NPC1L1. Because ezetimibe does not have such an activity, the binding site and mode of action of fomiroid A are likely to be distinct from those of ezetimibe.	[Chiba, Tomohiro; Sakurada, Tsuyoshi; Watanabe, Rie; Yamaguchi, Kohji] FANCL Corp, FANCL Res Inst, Totsuka Ku, Yokohama, Kanagawa 2440806, Japan; [Chiba, Tomohiro; Kimura, Yasuhisa; Kioka, Noriyuki; Matsuo, Michinori; Ueda, Kazumitsu] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan; [Chiba, Tomohiro; Ueda, Kazumitsu] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Sakyo Ku, Kyoto 6068502, Japan; [Kawagishi, Hirokazu] Shizuoka Univ, Grad Sch Sci & Technol, Suruga Ku, Shizuoka 4228529, Japan; [Kawagishi, Hirokazu] Shizuoka Univ, Res Inst Green Sci & Technol, Suruga Ku, Shizuoka 4228529, Japan; [Kawagishi, Hirokazu] Shizuoka Univ, Grad Sch Agr, Suruga Ku, Shizuoka 4228529, Japan; [Matsuo, Michinori] Kyoto Womens Univ, Dept Food & Nutr, Higashiyama Ku, Kyoto 6058501, Japan	FANCL Corporation; Kyoto University; Kyoto University; Shizuoka University; Shizuoka University; Shizuoka University; Kyoto Womens University	Ueda, K (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	uedak@kais.kyoto-u.ac.jp		Kimura, Yasuhisa/0000-0001-6466-1324; Ueda, Kazumitsu/0000-0003-2980-6078; Kioka, Noriyuki/0000-0002-2708-537X	FANCL Corporation; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [25221203, 24580139]; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; World Premier International Research Center Initiative, MEXT	FANCL Corporation; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); World Premier International Research Center Initiative, MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Financial support for this study was partly provided by FANCL Corporation (http://www.fancl.co.jp/). This work was supported by Grants-in-aid for Scientific research (S) (25221203) for KU, Scientific Research (C) (24580139) for MM from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). Additional support came from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation for NK, MM, and KU. This work was also supported by the World Premier International Research Center Initiative, MEXT. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; BURNETT DA, 1994, J MED CHEM, V37, P1733, DOI 10.1021/jm00038a001; Clader JW, 2004, J MED CHEM, V47, P1, DOI 10.1021/jm030283g; Davies JP, 2000, GENOMICS, V65, P137, DOI 10.1006/geno.2000.6151; Davis HR, 2007, J ATHEROSCLER THROMB, V14, P99, DOI 10.5551/jat.14.99; Davis HR, 2001, ARTERIOSCL THROM VAS, V21, P2032, DOI 10.1161/hq1201.100260; During A, 2005, J NUTR, V135, P2305, DOI 10.1093/jn/135.10.2305; Field FJ, 2007, J LIPID RES, V48, P1735, DOI 10.1194/jlr.M700029-JLR200; Gadgil MD, 2014, J ACAD NUTR DIET, V114, P238, DOI 10.1016/j.jand.2013.09.021; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Garmy N, 2005, J LIPID RES, V46, P36, DOI 10.1194/jlr.M400199-JLR200; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hawes BE, 2007, MOL PHARMACOL, V71, P19, DOI 10.1124/mol.106.027896; Karaki F, 2014, BIOORGAN MED CHEM, V22, P3587, DOI 10.1016/j.bmc.2014.05.022; Karaki F, 2013, BIOORGAN MED CHEM, V21, P5297, DOI 10.1016/j.bmc.2013.06.022; Kumar P, 2011, AM J PHYSIOL-GASTR L, V301, pG148, DOI 10.1152/ajpgi.00119.2011; Kwon HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018722; Li PS, 2014, NAT MED, V20, P80, DOI 10.1038/nm.3417; Mathur SN, 2007, J LIPID RES, V48, P395, DOI 10.1194/jlr.M600325-JLR200; Matsumoto H, 2005, Japan Patent Tokkai, Patent No. [2005-213144, 2005213144]; Narushima K, 2008, MOL PHARMACOL, V74, P42, DOI 10.1124/mol.107.043034; Nekohashi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097901; Reboul E, 2012, BRIT J NUTR, V107, P1296, DOI 10.1017/S0007114511004405; Sane AT, 2006, J LIPID RES, V47, P2112, DOI 10.1194/jlr.M600174-JLR200; Tang WQ, 2011, BBA-MOL CELL BIOL L, V1811, P549, DOI 10.1016/j.bbalip.2011.05.013; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; van Heek M, 2000, BRIT J PHARMACOL, V129, P1748, DOI 10.1038/sj.bjp.0703235; van Heek M, 2003, BRIT J PHARMACOL, V138, P1459, DOI 10.1038/sj.bjp.0705187; Wang J, 2009, J LIPID RES, V50, P1653, DOI 10.1194/jlr.M800669-JLR200; Weinglass AB, 2008, P NATL ACAD SCI USA, V105, P11140, DOI 10.1073/pnas.0800936105; Weinglass AB, 2008, MOL PHARMACOL, V73, P1072, DOI 10.1124/mol.107.043844; WILSON MD, 1994, J LIPID RES, V35, P943; Yamanashi Y, 2007, J PHARMACOL EXP THER, V320, P559, DOI 10.1124/jpet.106.114181; Zhang JH, 2011, J BIOL CHEM, V286, P25088, DOI 10.1074/jbc.M111.244475	35	9	9	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116162	10.1371/journal.pone.0116162	http://dx.doi.org/10.1371/journal.pone.0116162			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551765	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100104
J	Dreischarf, M; Albiol, L; Rohlmann, A; Pries, E; Bashkuev, M; Zander, T; Duda, G; Druschel, C; Strube, P; Putzier, M; Schmidt, H				Dreischarf, Marcel; Albiol, Laia; Rohlmann, Antonius; Pries, Esther; Bashkuev, Maxim; Zander, Thomas; Duda, Georg; Druschel, Claudia; Strube, Patrick; Putzier, Michael; Schmidt, Hendrik			Age-Related Loss of Lumbar Spinal Lordosis and Mobility - A Study of 323 Asymptomatic Volunteers	PLOS ONE			English	Article							LOW-BACK-PAIN; SAGITTAL PLANE; RECIPROCAL ANGULATION; RADIOGRAPHIC ANALYSIS; NORMATIVE DATABASE; VERTEBRAL BODIES; ALIGNMENT; BALANCE; PELVIS; MOTION	Background: The understanding of the individual shape and mobility of the lumbar spine are key factors for the prevention and treatment of low back pain. The influence of age and sex on the total lumbar lordosis and the range of motion as well as on different lumbar sub-regions (lower, middle and upper lordosis) in asymptomatic subjects still merits discussion, since it is essential for patient-specific treatment and evidence-based distinction between painful degenerative pathologies and asymptomatic aging. Methods and Findings: A novel non-invasive measuring system was used to assess the total and local lumbar shape and its mobility of 323 asymptomatic volunteers (age: 20-75 yrs; BMI <26.0 kg/m(2); males/females: 139/184). The lumbar lordosis for standing and the range of motion for maximal upper body flexion (RoF) and extension (RoE) were determined. The total lordosis was significantly reduced by approximately 20%, the RoF by 12% and the RoE by 31% in the oldest (>50 yrs) compared to the youngest age cohort (20-29 yrs). Locally, these decreases mostly occurred in the middle part of the lordosis and less towards the lumbo-sacral and thoraco-lumbar transitions. The sex only affected the RoE. Conclusions: During aging, the lower lumbar spine retains its lordosis and mobility, whereas the middle part flattens and becomes less mobile. These findings lay the ground for a better understanding of the incidence of level-and age-dependent spinal disorders, and may have important implications for the clinical long-term success of different surgical interventions.	[Dreischarf, Marcel; Albiol, Laia; Rohlmann, Antonius; Pries, Esther; Bashkuev, Maxim; Zander, Thomas; Duda, Georg; Schmidt, Hendrik] Charite, Julius Wolff Inst, D-13353 Berlin, Germany; [Druschel, Claudia; Strube, Patrick; Putzier, Michael] Charite, Ctr Muskuloskeletale Chirurg, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Dreischarf, M (corresponding author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.	dreischarf@julius-wolff-institut.de	Duda, Georg N/H-2085-2016; Strube, Patrick/AAH-5408-2019; Rohlmann, Antonius/E-4778-2011	Duda, Georg N/0000-0001-7605-3908; Strube, Patrick/0000-0003-3210-5301; Bashkuev, Maxim/0000-0003-0339-6998; Schmidt, Hendrik/0000-0003-3300-8685; Rohlmann, Antonius/0000-0002-0083-2793	Deutsche Forschungsgemeinschaft (DFG), Bonn, Germany [PU 510/2-1]; Bundesinstitut fur Sportwissenschaft, Bonn, Germany (MiSpEx - Network)	Deutsche Forschungsgemeinschaft (DFG), Bonn, Germany(German Research Foundation (DFG)); Bundesinstitut fur Sportwissenschaft, Bonn, Germany (MiSpEx - Network)	This study was supported financially by the Deutsche Forschungsgemeinschaft (DFG PU 510/2-1), Bonn, Germany, and by the Bundesinstitut fur Sportwissenschaft, Bonn, Germany (MiSpEx - Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MA, 1986, CLIN BIOMECH, V1, P130, DOI 10.1016/0268-0033(86)90002-1; AMONOOKUOFI HS, 1992, ACTA ANAT, V145, P373; Barrey C, 2007, EUR SPINE J, V16, P1459, DOI 10.1007/s00586-006-0294-6; BATTIE MC, 1987, PHYS THER, V67, P653, DOI 10.1093/ptj/67.5.653; Berthonnaud E, 2005, J SPINAL DISORD TECH, V18, P40, DOI 10.1097/01.bsd.0000117542.88865.77; Bible JE, 2008, SPINE, V33, P1793, DOI 10.1097/BRS.0b013e31817b8f3a; Boden SD, 1996, J BONE JOINT SURG AM, V78A, P114, DOI 10.2106/00004623-199601000-00017; Boulay C, 2006, EUR SPINE J, V15, P415, DOI 10.1007/s00586-005-0984-5; Consmuller T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050135; Consmuller T, 2012, EUR SPINE J, V21, P2170, DOI 10.1007/s00586-012-2312-1; Dvorak J, 1995, Eur Spine J, V4, P18, DOI 10.1007/BF00298413; GELB DE, 1995, SPINE, V20, P1351, DOI 10.1097/00007632-199506000-00005; Guermazi M., 2006, Annales de Readaptation et de Medecine Physique, V49, P172, DOI 10.1016/j.annrmp.2006.03.001; Hammerberg EM, 2003, J SPINAL DISORD TECH, V16, P44, DOI 10.1097/00024720-200302000-00008; HANSSON T, 1985, SPINE, V10, P154, DOI 10.1097/00007632-198503000-00008; Intolo P, 2009, MANUAL THER, V14, P596, DOI 10.1016/j.math.2009.08.006; JACKSON RP, 1994, SPINE, V19, P1611, DOI 10.1097/00007632-199407001-00010; Janik TJ, 1998, J ORTHOPAED RES, V16, P766, DOI 10.1002/jor.1100160620; Janssen MMA, 2009, SPINE, V34, pE826, DOI 10.1097/BRS.0b013e3181a9fd85; Korovessis P, 1999, J SPINAL DISORD, V12, P131; Korovessis PG, 1998, SPINE, V23, P700, DOI 10.1097/00007632-199803150-00010; Labelle H, 2005, SPINE, V30, pS27, DOI 10.1097/01.brs.0000155560.92580.90; Lang-Tapia M, 2011, J APPL BIOMECH, V27, P143, DOI 10.1123/jab.27.2.143; Legaye J, 1998, Eur Spine J, V7, P99, DOI 10.1007/s005860050038; Lin R M, 1992, J Formos Med Assoc, V91, P329; Mac-Thiong JM, 2007, EUR SPINE J, V16, P227, DOI 10.1007/s00586-005-0013-8; Mac-Thiong JM, 2010, SPINE, V35, pE1193, DOI 10.1097/BRS.0b013e3181e50808; MCGREGOR AH, 1995, SPINE, V20, P2421, DOI 10.1097/00007632-199511001-00009; MILNE JS, 1974, ANN HUM BIOL, V1, P327, DOI 10.1080/03014467400000351; National Research Council, 1989, DIET HLTH IMPL RED C; Nourbakhsh MR, 2001, J SPINAL DISORD, V14, P283, DOI 10.1097/00002517-200108000-00002; Pellet N, 2011, Eur Spine J, V20 Suppl 5, P647, DOI 10.1007/s00586-011-1933-0; Rajnics P, 2002, INT ORTHOP, V26, P104, DOI 10.1007/s00264-001-0317-1; Roussouly P, 2005, SPINE, V30, P346, DOI 10.1097/01.brs.0000152379.54463.65; Roussouly P, 2011, EUR SPINE J S5, V20, P578, DOI [10.1007/s00586-011-1924-1, DOI 10.1007/S00586-011-1924-1]; Schroder J, 2014, ORTHOPADE, V43, P841, DOI 10.1007/s00132-014-2316-0; Schwab F, 2006, SPINE, V31, pE959, DOI 10.1097/01.brs.0000248126.96737.0f; Schwab F, 2009, SPINE, V34, P1828, DOI 10.1097/BRS.0b013e3181a13c08; STAGNARA P, 1982, SPINE, V7, P335, DOI 10.1097/00007632-198207000-00003; STOKES IAF, 1987, SPINE, V12, P355, DOI 10.1097/00007632-198705000-00009; Strube P, 2012, J SPINAL DISORD TECH, DOI [10.1097/BSD.0b013e31827f434e, DOI 10.1097/BSD.0B013E31827F434E]; SULLIVAN MS, 1994, SPINE, V19, P682, DOI 10.1097/00007632-199403001-00007; Takeda N, 2009, J ORTHOP SCI, V14, P748, DOI 10.1007/s00776-009-1394-z; Taylor WR, 2010, MED ENG PHYS, V32, P1080, DOI 10.1016/j.medengphy.2010.07.011; Troke M, 2005, MANUAL THER, V10, P198, DOI 10.1016/j.math.2004.10.004; Troke M, 2001, CLIN REHABIL, V15, P371, DOI 10.1191/026921501678310171; Trudelle-Jackson E, 2010, SPINE, V35, P1539, DOI 10.1097/BRS.0b013e3181b0c3d1; Tsuji T, 2001, J Orthop Sci, V6, P307, DOI 10.1007/s007760100023; Tuzun C, 1999, CLIN RHEUMATOL, V18, P308, DOI 10.1007/s100670050107; Van Herp G, 2000, RHEUMATOLOGY, V39, P1337, DOI 10.1093/rheumatology/39.12.1337; Vaz G, 2002, EUR SPINE J, V11, P80, DOI 10.1007/s005860000224; Vialle R, 2005, J BONE JOINT SURG AM, V87A, P260, DOI 10.2106/JBJS.D.02043	52	43	43	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116186	10.1371/journal.pone.0116186	http://dx.doi.org/10.1371/journal.pone.0116186			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549085	Green Submitted, gold, Green Published			2022-12-26	WOS:000347063500059
J	Jaudszus, A; Degen, C; Barth, SW; Klempt, M; Schlormann, W; Roth, A; Rohrer, C; Sauerwein, H; Sachse, K; Jahreis, G				Jaudszus, Anke; Degen, Christian; Barth, Stephan W.; Klempt, Martin; Schloermann, Wiebke; Roth, Alexander; Rohrer, Carsten; Sauerwein, Helga; Sachse, Konrad; Jahreis, Gerhard			Loss of FADS2 Function Severely Impairs the Use of HeLa Cells as an In Vitro Model for Host Response Studies Involving Fatty Acid Effects	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; NF-KAPPA-B; EPITHELIAL-CELLS; CHLAMYDIA-TRACHOMATIS; GENE-CLUSTER; EXPRESSION; ACTIVATION; COX-2; METABOLISM; INFECTION	Scope: Established epithelial cell lines equipped with pattern recognition receptors such as the Toll-like receptor (TLR)-2 are common tools for immune response studies on invading pathogens, e.g. the obligate intracellular species of Chlamydia. Moreover, such models are widely used to elucidate fatty acid-mediated immune effects. In several transformed cell lines, however, unusual loss of metabolic functions was described. The cell lines A549 and HeLa are poorly characterized in this respect. Therefore, we comparatively assessed the metabolic capacity of A549 and HeLa prior to proposed application as in vitro model for fatty acid effects on chlamydial infection. Methodology/Principal Findings: We incubated both cell lines either with substrates (C18:2n-6 or C18:3n-3) or products (C18:3n-6, C18:4n-3) of fatty acid desaturase-2 (FADS2), and analysed the fatty acid profiles after 24 h and 72 h by gas chromatography. Based on these data, we suspected that the complete discontinuation of normal biosynthesis of long-chain polyunsaturated fatty acids (LC-PUFA) in HeLa was due to loss of FADS2 function. Consequently, prostaglandin E2 (PGE2) formation was less inducible by TLR2 stimulation in HeLa, likely as a result of not only insufficient supply of precursors but also weak cyclooxygenase-2 (COX-2) response. In accordance, Chlamydia infection rates were consistently lower in HeLa than in A549. Sequence analysis revealed no alteration within the FADS2 gene in HeLa. The FADS2 expression level, however, was significantly lower and, in contrast to A549, not regulated by C18: 2n-6. A549 exhibited regular fatty acid metabolism and enzyme functionality. Conclusions/Significance: Our data show that HeLa cells considerably differ from A549 at several stages of fatty acid metabolism. The poor metabolic potential of HeLa, mainly concerning FADS2 upstream of COX-2 function, calls into question whether these cells represent a good model to unveil fatty acid or downstream eicosanoid effects in the course of intracellular bacterial infection.	[Jaudszus, Anke; Barth, Stephan W.; Roth, Alexander] Max Rubner Inst, Fed Res Inst Nutr & Food, Dept Physiol & Biochem Nutr, Karlsruhe, Germany; [Degen, Christian; Schloermann, Wiebke; Rohrer, Carsten; Jahreis, Gerhard] Univ Jena, Inst Nutr, Dept Nutr Physiol, Jena, Germany; [Klempt, Martin] Max Rubner Inst, Fed Res Inst Nutr & Food, Dept Safety & Qual Milk & Fish Prod, Kiel, Germany; [Sauerwein, Helga] Univ Bonn, Inst Anim Sci, Physiol & Hyg Unit, Bonn, Germany; [Sachse, Konrad] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, Jena, Germany	Friedrich Schiller University of Jena; University of Bonn; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute	Jaudszus, A (corresponding author), Max Rubner Inst, Fed Res Inst Nutr & Food, Dept Physiol & Biochem Nutr, Karlsruhe, Germany.	anke.jaudszus@mri.bund.de	Sauerwein, Helga/R-8242-2019; Sachse, Konrad/GWC-4999-2022	Sachse, Konrad/0000-0003-1230-1786; Roth, Alexander/0000-0002-5975-0573	German Research Council DFG [Ja 893/5]; North Rhine-Westphalian Ministry of Environment, Conservation, Agriculture and Consumers Protection (MUNLV) within the Inter-Departmental Center of Sustainable Agriculture (USL)	German Research Council DFG(German Research Foundation (DFG)); North Rhine-Westphalian Ministry of Environment, Conservation, Agriculture and Consumers Protection (MUNLV) within the Inter-Departmental Center of Sustainable Agriculture (USL)	This study was financially supported by a grant from the German Research Council DFG Ja 893/5) and a grant provided by the North Rhine-Westphalian Ministry of Environment, Conservation, Agriculture and Consumers Protection (MUNLV) within the Inter-Departmental Center of Sustainable Agriculture (USL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELETTI C, 1995, MOL CELL BIOCHEM, V143, P99, DOI 10.1007/BF01816942; Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; Beckett EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039460; Bernard JJ, 2010, J IMMUNOL, V185, P6535, DOI 10.4049/jimmunol.1002009; Birchler T, 2001, EUR J IMMUNOL, V31, P3131, DOI 10.1002/1521-4141(200111)31:11<3131::AID-IMMU3131>3.0.CO;2-G; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bokor S, 2010, J LIPID RES, V51, P2325, DOI 10.1194/jlr.M006205; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Chene G, 2007, BBA-MOL CELL BIOL L, V1771, P576, DOI 10.1016/j.bbalip.2007.02.014; Derecka K, 2008, MOL CELL ENDOCRINOL, V287, P65, DOI 10.1016/j.mce.2008.02.015; Deva R, 2003, J IMMUNOL, V171, P3047, DOI 10.4049/jimmunol.171.6.3047; Fukuda EY, 2005, INFECT IMMUN, V73, P4017, DOI 10.1128/IAI.73.7.4017-4024.2005; Goellner S, 2006, INFECT IMMUN, V74, P4801, DOI 10.1128/IAI.01487-05; GRAMMATIKOS SI, 1994, ANN NY ACAD SCI, V745, P92; Grun M, 2009, J MICROBIOL METH, V78, P360, DOI 10.1016/j.mimet.2009.06.016; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; HRELIA S, 1995, BIOCHEM BIOPH RES CO, V216, P11, DOI 10.1006/bbrc.1995.2585; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jaudszus A, 2013, J LIPID RES, V54, P923, DOI 10.1194/jlr.P031260; Jaudszus A, 2012, BBA-MOL CELL BIOL L, V1821, P1316, DOI 10.1016/j.bbalip.2012.06.010; Jaudszus A, 2010, ANN NUTR METAB, V57, P103, DOI 10.1159/000319877; Joyee AG, 2008, CURR PHARM DESIGN, V14, P593, DOI 10.2174/138161208783885344; Lattka E, 2010, J LIPID RES, V51, P182, DOI 10.1194/jlr.M900289-JLR200; Liu W, 2006, MICROBES INFECT, V8, P478, DOI 10.1016/j.micinf.2005.07.026; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Massari P, 2013, INFECT IMMUN, V81, P303, DOI 10.1128/IAI.01062-12; NAVAL J, 1993, BIOCHEM J, V291, P841, DOI 10.1042/bj2910841; Nwankwo JO, 2003, J LIPID RES, V44, P2311, DOI 10.1194/jlr.M300273-JLR200; Park WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028186; Park WJ, 2009, J LIPID RES, V50, P1195, DOI 10.1194/jlr.M800630-JLR200; Portolesi R, 2008, LIPIDS, V43, P91, DOI 10.1007/s11745-007-3122-9; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Serhan CN, 2005, CURR OPIN CLIN NUTR, V8, P115, DOI 10.1097/00075197-200503000-00003; Shimasaki S, 2010, BIOCHEM BIOPH RES CO, V402, P235, DOI 10.1016/j.bbrc.2010.09.132; Sprecher H, 1995, J LIPID RES, V36, P2471; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Xie P, 2012, POULTRY SCI, V91, P1670, DOI 10.3382/ps.2011-02097; Xu F, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-16	40	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115610	10.1371/journal.pone.0115610	http://dx.doi.org/10.1371/journal.pone.0115610			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549244	gold, Green Published, Green Submitted			2022-12-26	WOS:000347063500020
J	Jiang, Y; Chen, JH; Tong, J; Chen, T				Jiang, Yan; Chen, Jiahong; Tong, Jian; Chen, Tao			Trichloroethylene-Induced Gene Expression and DNA Methylation Changes in B6C3F1 Mouse Liver	PLOS ONE			English	Article							PPAR-ALPHA; HOMOLOGOUS RECOMBINATION; HUMAN CANCER; CELL-CYCLE; RAT-LIVER; C-JUN; MICE; METABOLITES; RAD51; PROTOONCOGENES	Trichloroethylene (TCE), widely used as an organic solvent in the industry, is a common contaminant in air, soil, and water. Chronic TCE exposure induced hepatocellular carcinoma in mice, and occupational exposure in humans was suggested to be associated with liver cancer. To understand the role of non-genotoxic mechanism(s) for TCE action, we examined the gene expression and DNA methylation changes in the liver of B6C3F1 mice orally administered with TCE (0, 100, 500 and 1000 mg/kg b.w. per day) for 5 days. After 5 days TCE treatment at a dose level of 1000 mg/kg b.w., a total of 431 differentially expressed genes were identified in mouse liver by microarray, of which 291 were up-regulated and 140 down-regulated. The expression changed genes were involved in key signal pathways including PPAR, proliferation, apoptosis and homologous recombination. Notably, the expression level of a number of vital genes involved in the regulation of DNA methylation, such as Utrf1, Tet2, DNMT1, DNMT3a and DNMT3b, were dysregulated. Although global DNA methylation change was not detected in the liver of mice exposed to TCE, the promoter regions of Cdkn1a and Ihh were found to be hypo- and hypermethylated respectively, which correlated negatively with their mRNA expression changes. Furthermore, the gene expression and DNA methylation changes induced by TCE were dose dependent. The overall data indicate that TCE exposure leads to aberrant DNA methylation changes, which might alter the expression of genes involved in the TCE-induced liver tumorgenesis.	[Jiang, Yan] Soochow Univ, Sch Biol & Basic Med Sci, Dept Physiol, Suzhou, Peoples R China; [Chen, Jiahong; Tong, Jian; Chen, Tao] Soochow Univ, Sch Publ Hlth, Dept Toxicol, Suzhou, Peoples R China; [Jiang, Yan; Chen, Jiahong; Tong, Jian; Chen, Tao] Soochow Univ, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Chen, T (corresponding author), Soochow Univ, Sch Publ Hlth, Dept Toxicol, Suzhou, Peoples R China.	tchen@suda.edu.cn	chen, jiahong/GYR-2917-2022	Chen, Tao/0000-0002-6552-3457	Soochow University; Priority Academic Program Development of Jiangsu Higher Education Institutions	Soochow University; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the start-up funding of Soochow University and The Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhosin M, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-41; Anwar SL, 2014, WORLD J GASTROENTERO, V20, P7894, DOI 10.3748/wjg.v20.i24.7894; Bachman AN, 2006, TOXICOL SCI, V91, P393, DOI 10.1093/toxsci/kfj155; Bradford BU, 2011, TOXICOL SCI, V120, P206, DOI 10.1093/toxsci/kfq362; Budke B, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt362; Buitrago-Molina LE, 2013, HEPATOLOGY, V58, P1143, DOI 10.1002/hep.26412; Chen T, 2012, TOXICOLOGY, V292, P63, DOI 10.1016/j.tox.2011.10.020; Chen T, 2010, ENVIRON HEALTH PERSP, V118, P1597, DOI 10.1289/ehp.1002153; Chiu WA, 2011, TOXICOL APPL PHARM, V253, P203, DOI 10.1016/j.taap.2011.03.020; Counts JL, 1996, CARCINOGENESIS, V17, P1251, DOI 10.1093/carcin/17.6.1251; Dunlop MH, 2012, J BIOL CHEM, V287, P12343, DOI 10.1074/jbc.C112.352161; Fu XS, 2010, MOL CELL BIOCHEM, V337, P185, DOI 10.1007/s11010-009-0298-8; Guha N, 2012, LANCET ONCOL, V13, P1192, DOI 10.1016/S1470-2045(12)70485-0; Hansen J, 2013, JNCI-J NATL CANCER I, V105, P869, DOI 10.1093/jnci/djt107; Kinney SRM, 2013, ADV EXP MED BIOL, V754, P57, DOI 10.1007/978-1-4419-9967-2_3; Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/713608372; Laughter AR, 2004, TOXICOLOGY, V203, P83, DOI 10.1016/j.tox.2004.06.014; National Toxicology Program, 1990, 243 TR NTP; Palbykin B, 2011, CARDIOVASC TOXICOL, V11, P204, DOI 10.1007/s12012-011-9113-3; Pan HM, 2011, ANTI-CANCER AGENT ME, V11, P493, DOI 10.2174/187152011796011073; Phillips JM, 2008, TOXICOL SCI, V104, P86, DOI 10.1093/toxsci/kfn063; Plo I, 2008, CANCER RES, V68, P9404, DOI 10.1158/0008-5472.CAN-08-0861; Pogribny IP, 2014, CANCER LETT, V342, P223, DOI 10.1016/j.canlet.2012.01.038; Ramdhan DH, 2010, ENVIRON HEALTH PERSP, V118, P1557, DOI 10.1289/ehp.1001928; Risinger JI, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00139; Rusyn I, 2014, PHARMACOL THERAPEUT, V141, P55, DOI 10.1016/j.pharmthera.2013.08.004; Sano Y, 2009, ARCH TOXICOL, V83, P835, DOI 10.1007/s00204-009-0431-1; Taira N, 2012, J CLIN INVEST, V122, P859, DOI 10.1172/JCI60818; Takata M, 2000, MOL CELL BIOL, V20, P6476, DOI 10.1128/MCB.20.17.6476-6482.2000; Tao LH, 1999, J BIOCHEM MOL TOXIC, V13, P231; Tao LH, 2000, TOXICOL SCI, V54, P399, DOI 10.1093/toxsci/54.2.399; Teramen H, 2011, ACTA MED OKAYAMA, V65, P179; Tommasi S, 2013, NUCLEIC ACIDS RES, V41, P182, DOI 10.1093/nar/gks1051; U. S. EPA (U. S. Environmental Protection Agency), 2011, TRICHL TOX REV APP; Wiese C, 2007, MOL CELL, V28, P482, DOI 10.1016/j.molcel.2007.08.027	35	23	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116179	10.1371/journal.pone.0116179	http://dx.doi.org/10.1371/journal.pone.0116179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549359	gold, Green Published, Green Submitted			2022-12-26	WOS:000347063500057
J	Cioli, C; Abdi, H; Beaton, D; Burnod, Y; Mesmoudi, S				Cioli, Claudia; Abdi, Herve; Beaton, Derek; Burnod, Yves; Mesmoudi, Salma			Differences in Human Cortical Gene Expression Match the Temporal Properties of Large-Scale Functional Networks	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; KISS-AND-RUN; CALCIUM-CHANNEL; NEUROTRANSMITTER RELEASE; SODIUM-CHANNELS; HUMAN BRAIN; PATTERNS; ORGANIZATION; CONNECTIVITY; MODULATION	We explore the relationships between the cortex functional organization and genetic expression (as provided by the Allen Human Brain Atlas). Previous work suggests that functional cortical networks (resting state and task based) are organized as two large networks (differentiated by their preferred information processing mode) shaped like two rings. The first ring-Visual-SensorimotorAuditory (VSA)-comprises visual, auditory, somatosensory, and motor cortices that process real time world interactions. The second ring-Parieto-Temporo-Frontal (PTF)-comprises parietal, temporal, and frontal regions with networks dedicated to cognitive functions, emotions, biological needs, and internally driven rhythms. We found-with correspondence analysis-that the patterns of expression of the 938 genes most differentially expressed across the cortex organized the cortex into two sets of regions that match the two rings. We confirmed this result using discriminant correspondence analysis by showing that the genetic profiles of cortical regions can reliably predict to what ring these regions belong. We found that several of the proteins-coded by genes that most differentiate the rings-were involved in neuronal information processing such as ionic channels and neurotransmitter release. The systematic study of families of genes revealed specific proteins within families preferentially expressed in each ring. The results showed strong congruence between the preferential expression of subsets of genes, temporal properties of the proteins they code, and the preferred processing modes of the rings. Ionic channels and release-related proteins more expressed in the VSA ring favor temporal precision of fast evoked neural transmission (Sodium channels SCNA1, SCNB1 potassium channel KCNA1, calcium channel CACNA2D2, Synaptotagmin SYT2, Complexin CPLX1, Synaptobrevin VAMP1). Conversely, genes expressed in the PTF ring favor slower, sustained, or rhythmic activation ( Sodium channels SCNA3, SCNB3, SCN9A potassium channels KCNF1, KCNG1) and facilitate spontaneous transmitter release (calcium channel CACNA1H, Synaptotagmins SYT5, Complexin CPLX3, and synaptobrevin VAMP2).	[Cioli, Claudia; Burnod, Yves] Univ Paris 06, Lab Imagerie Biomed, UMR UMR S 1146 7371, Sorbonne Univ, Paris, France; [Cioli, Claudia; Burnod, Yves; Mesmoudi, Salma] ISC PIF Inst Syst Complexes Paris Ile de France, Paris, France; [Abdi, Herve; Beaton, Derek] Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX 75230 USA; [Mesmoudi, Salma] Univ Paris 01, Sorbonne Univ, Equipement Excellence MATRICE, F-75231 Paris 05, France	UDICE-French Research Universities; Sorbonne Universite; University of Texas System; University of Texas Dallas; UDICE-French Research Universities; Sorbonne Universite	Cioli, C (corresponding author), Univ Paris 06, Lab Imagerie Biomed, UMR UMR S 1146 7371, Sorbonne Univ, Paris, France.	claudia.cioli.c@gmail.com		Abdi, Herve/0000-0002-9522-1978	French National Agency; region Paris-Ile de France; EURIAS fellowship at the "Institut d'Etudes Avancees de Paris'' (France); European Union's 7th Framework Program for Research; French State managed by the Agence Nationale de la Recherche, program "investissements d'avenir,'' [ANR-11-LABX-0027-01 Labex RFIEA+]; NIH Training Award from the National Institute on Drug Abuse NRSA [F31DA035039]; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA035039] Funding Source: NIH RePORTER	French National Agency(French National Research Agency (ANR)); region Paris-Ile de France; EURIAS fellowship at the "Institut d'Etudes Avancees de Paris'' (France); European Union's 7th Framework Program for Research; French State managed by the Agence Nationale de la Recherche, program "investissements d'avenir,''(French National Research Agency (ANR)); NIH Training Award from the National Institute on Drug Abuse NRSA; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work benefitted from a grant from the French National Agency for Research investment ANR "Investissement Avenir'' (MATRICE project). CC's work benefitted from a doctoral fellowship from the "region Paris-Ile de France.'' HA's work benefitted from an EURIAS fellowship at the "Institut d'Etudes Avancees de Paris'' (France) made possible with the support of the European Union's 7th Framework Program for Research, and from funding from the French State managed by the Agence Nationale de la Recherche, program "investissements d'avenir,'' (ANR-11-LABX-0027-01 Labex RFIEA+). DB's work benefitted from a NIH Training Award from the National Institute on Drug Abuse NRSA # F31DA035039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; Abdi H., 2007, ENCY MEASUREMENT STA, P270; Abdi H., 2014, ENCY SOCIAL NETWORK, P275, DOI DOI 10.1007/978-1-4614-6170-8_140; Abdi H, 2010, ENCY RES DESIGN, P267; Abdi H, 2009, NEUROIMAGE, V45, P89, DOI 10.1016/j.neuroimage.2008.11.008; Allen PD, 2012, J NEUROSCI, V32, P2538, DOI 10.1523/JNEUROSCI.1958-11.2012; Aman TK, 2009, J NEUROSCI, V29, P2027, DOI 10.1523/JNEUROSCI.4531-08.2009; Baccei ML, 2014, NEUROSCIENTIST, V20, P197, DOI 10.1177/1073858414521499; Beaton D, 2014, COMPUT STAT DATA AN, V72, P176, DOI 10.1016/j.csda.2013.11.006; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bocksteins E, 2012, PHYSIOLOGY, V27, P73, DOI 10.1152/physiol.00023.2011; Bohland JW, 2010, METHODS, V50, P105, DOI 10.1016/j.ymeth.2009.09.001; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cao P, 2013, J NEUROSCI, V33, P1714, DOI 10.1523/JNEUROSCI.4087-12.2013; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Catterall WA, 2014, EXP PHYSIOL, V99, P35, DOI 10.1113/expphysiol.2013.071969; Cauda F, 2014, NEUROIMAGE-CLIN, V4, P676, DOI 10.1016/j.nicl.2014.04.007; Cauda F, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00104; Cheong E, 2013, PHYSIOL REV, V93, P961, DOI 10.1152/physrev.00010.2012; Chung C, 2013, J NEUROCHEM, V126, P146, DOI 10.1111/jnc.12245; Cummins TR, 2001, J NEUROSCI, V21, P5952, DOI 10.1523/JNEUROSCI.21-16-05952.2001; Cusdin FS, 2010, J BIOL CHEM, V285, P33404, DOI 10.1074/jbc.M110.114058; Doucet G, 2011, J NEUROPHYSIOL, V105, P2753, DOI 10.1152/jn.00895.2010; Edvardson S, 2013, J MED GENET, V50, P118, DOI 10.1136/jmedgenet-2012-101223; Estacion M, 2010, EXP NEUROL, V224, P362, DOI 10.1016/j.expneurol.2010.04.012; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; French Leon, 2011, Front Neuroinform, V5, P12, DOI 10.3389/fninf.2011.00012; French L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001049; Friedland DR, 2008, HEARING RES, V243, P105, DOI 10.1016/j.heares.2008.06.009; Fuster J., 1989, DISSERT ABSTRACTS IN, V60, P255; Fuster JM, 2006, INT J PSYCHOPHYSIOL, V60, P125, DOI 10.1016/j.ijpsycho.2005.12.015; Fuster JM, 2012, TRENDS COGN SCI, V16, P207, DOI 10.1016/j.tics.2012.03.005; Gittelman JX, 2006, J NEUROPHYSIOL, V96, P1203, DOI 10.1152/jn.00092.2005; Goel P, 2014, HUM BRAIN MAPP, V35, P4204, DOI 10.1002/hbm.22471; Goyal MS, 2014, CELL METAB, V19, P49, DOI 10.1016/j.cmet.2013.11.020; Granados-Fuentes D, 2012, J NEUROSCI, V32, P10045, DOI 10.1523/JNEUROSCI.0174-12.2012; Grange P, 2011, STAT ANAL COEXPRESSI; Grange P, 2014, P NATL ACAD SCI USA, V111, P5397, DOI 10.1073/pnas.1312098111; Greenacre Michael, 1984, THEORY APPL CORRES A; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Harata NC, 2006, J NEUROCHEM, V97, P1546, DOI 10.1111/j.1471-4159.2006.03987.x; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Ison JR, 2012, JARO-J ASSOC RES OTO, V13, P351, DOI 10.1007/s10162-011-0312-1; Jones AR, 2009, NAT REV NEUROSCI, V10, P821, DOI 10.1038/nrn2722; Jorquera RA, 2012, J NEUROSCI, V32, P18234, DOI 10.1523/JNEUROSCI.3212-12.2012; Kaeser-Woo YJ, 2012, J NEUROSCI, V32, P2877, DOI 10.1523/JNEUROSCI.3360-11.2012; Karcz A, 2011, J PHYSIOL-LONDON, V589, P1143, DOI 10.1113/jphysiol.2010.203331; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Kochubey O, 2011, NEURON, V69, P736, DOI 10.1016/j.neuron.2011.01.013; Kramer JW, 1998, AM J PHYSIOL-CELL PH, V274, pC1501, DOI 10.1152/ajpcell.1998.274.6.C1501; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Lacinova L, 2004, ARCH BIOCHEM BIOPHYS, V425, P207, DOI 10.1016/j.abb.2004.03.010; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Lebart L., 1984, MULTIVARIATE DESCRIP; Luria A. R., 2012, HIGHER CORTICAL FUNC; Martin JA, 2011, CURR BIOL, V21, P97, DOI 10.1016/j.cub.2010.12.014; Mesmoudi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067444; MILNER B, 1985, HUM NEUROBIOL, V4, P137; Moghadam Paanteha K, 2013, Front Endocrinol (Lausanne), V4, P124, DOI 10.3389/fendo.2013.00124; Murray JD, 2014, NAT NEUROSCI, V17, P1661, DOI 10.1038/nn.3862; Premi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106500; Qu Y, 2001, MOL CELL NEUROSCI, V18, P570, DOI 10.1006/mcne.2001.1039; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Saegusa C, 2002, J BIOL CHEM, V277, P24499, DOI 10.1074/jbc.M202767200; Sansom SN, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002519; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schlaggar BL, 2011, NEURON, V72, P499, DOI 10.1016/j.neuron.2011.10.024; Sepulcre J, 2012, J NEUROSCI, V32, P10649, DOI 10.1523/JNEUROSCI.0759-12.2012; Sepulcre J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000808; Shankle WR, 1998, P NATL ACAD SCI USA, V95, P4023, DOI 10.1073/pnas.95.7.4023; Shelley C, 2012, J PHYSIOL-LONDON, V590, P5723, DOI 10.1113/jphysiol.2012.238006; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Soden ME, 2013, NEURON, V80, P997, DOI 10.1016/j.neuron.2013.07.044; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Thirion B, 2014, LECT NOTES COMPUT SC, V8674, P741, DOI 10.1007/978-3-319-10470-6_92; Vanoye CG, 2013, J GEN PHYSIOL, V141, P193, DOI 10.1085/jgp.201210919; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Weiss N, 2012, J BIOL CHEM, V287, P2810, DOI 10.1074/jbc.M111.290882; Weller S.C., 1990, METRIC SCALING CORRE; Wolf L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002040; Yan H, 2009, NEUROIMAGE, V47, P1579, DOI 10.1016/j.neuroimage.2009.05.080; Yang XF, 2013, P NATL ACAD SCI USA, V110, P20777, DOI 10.1073/pnas.1321367110; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373; Zimmermann J, 2014, J NEUROPHYSIOL, V112, P1559, DOI 10.1152/jn.00340.2014	89	36	36	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115913	10.1371/journal.pone.0115913	http://dx.doi.org/10.1371/journal.pone.0115913			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546015	Green Submitted, Green Published, gold			2022-12-26	WOS:000347120200082
J	Dai, WJ; Wang, X; Di, ZR; Wu, JS				Dai, Wenjie; Wang, Xin; Di, Zengru; Wu, Jinshan			Logical Gaps in the Approximate Solutions of the Social Learning Game and an Exact Solution	PLOS ONE			English	Article							INFORMATIONAL CASCADES; BEHAVIOR; MODEL; FADS	After the social learning models were proposed, finding solutions to the games becomes a well-defined mathematical question. However, almost all papers on the games and their applications are based on solutions built either upon an ad-hoc argument or a twisted Bayesian analysis of the games. Here, we present logical gaps in those solutions and offer an exact solution of our own. We also introduce a minor extension to the original game so that not only logical differences but also differences in action outcomes among those solutions become visible.	[Dai, Wenjie; Wang, Xin; Di, Zengru; Wu, Jinshan] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China	Beijing Normal University	Wu, JS (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China.	jinshanw@bnu.edu.cn	Wu, Jinshan/C-1203-2010	Wu, Jinshan/0000-0001-5014-385X	Fundamental Research Funds for the Central Universities of China	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acemoglu D, 2011, REV ECON STUD, V78, P1201, DOI 10.1093/restud/rdr004; BANERJEE AV, 1992, Q J ECON, V107, P797, DOI 10.2307/2118364; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Bikhchandani S, 1998, J ECON PERSPECT, V12, P151, DOI 10.1257/jep.12.3.151; Bikhchandani Sushil, 2008, NEW PALGRAVE DICT EC; Bose S, 2008, ECON THEOR, V37, P203, DOI 10.1007/s00199-007-0313-9; Bose S, 2006, RAND J ECON, V37, P910, DOI 10.1111/j.1756-2171.2006.tb00063.x; Callander S, 2009, J ECON THEORY, V144, P1421, DOI 10.1016/j.jet.2009.02.001; Easley D, 2010, NETWORKS CROWDS MARK; Gill D, 2008, GAME ECON BEHAV, V63, P663, DOI 10.1016/j.geb.2006.07.004; Guarino A, 2011, GAME ECON BEHAV, V73, P167, DOI 10.1016/j.geb.2011.01.003; Liu T, 2012, ECON THEOR, V51, P627, DOI 10.1007/s00199-011-0614-x; Moscarini G, 1998, ECON THEOR, V11, P657, DOI 10.1007/s001990050207; Neill DB, 2005, RATION SOC, V17, P191, DOI 10.1177/1043463105051633; Smith L, 2000, ECONOMETRICA, V68, P371, DOI 10.1111/1468-0262.00113; Szolnoki A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00576	16	0	0	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115706	10.1371/journal.pone.0115706	http://dx.doi.org/10.1371/journal.pone.0115706			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UN	25546736	Green Published, gold, Green Submitted			2022-12-26	WOS:000347120200057
J	Dunn, JM; Krause, PJ; Davis, S; Vannier, EG; Fitzpatrick, MC; Rollend, L; Belperron, AA; States, SL; Stacey, A; Bockenstedt, LK; Fish, D; Diuk-Wasser, MA				Dunn, Jessica M.; Krause, Peter J.; Davis, Stephen; Vannier, Edouard G.; Fitzpatrick, Meagan C.; Rollend, Lindsay; Belperron, Alexia A.; States, Sarah L.; Stacey, Andrew; Bockenstedt, Linda K.; Fish, Durland; Diuk-Wasser, Maria A.			Borrelia burgdorferi Promotes the Establishment of Babesia microti in the Northeastern United States	PLOS ONE			English	Article							WHITE-FOOTED MICE; TICK-BORNE PATHOGENS; IXODES-SCAPULARIS TICKS; HUMAN GRANULOCYTIC EHRLICHIOSIS; SENSU-STRICTO STRAINS; LYME-DISEASE PATIENTS; PEROMYSCUS-LEUCOPUS; HEMATOGENOUS DISSEMINATION; ANAPLASMA-PHAGOCYTOPHILUM; C3H/HEJ MICE	Babesia microti and Borrelia burgdorferi, the respective causative agents of human babesiosis and Lyme disease, are maintained in their enzootic cycles by the blacklegged tick (Ixodes scapularis) and use the white-footed mouse (Peromyscus leucopus) as primary reservoir host. The geographic range of both pathogens has expanded in the United States, but the spread of babesiosis has lagged behind that of Lyme disease. Several studies have estimated the basic reproduction number (R-0) for B. microti to be below the threshold for persistence (<1), a finding that is inconsistent with the persistence and geographic expansion of this pathogen. We tested the hypothesis that host coinfection with B. burgdorferi increases the likelihood of B. microti transmission and establishment in new areas. We fed I. scapularis larva on P. leucopus mice that had been infected in the laboratory with B. microti and/or B. burgdorferi. We observed that coinfection in mice increases the frequency of B. microti infected ticks. To identify the ecological variables that would increase the probability of B. microti establishment in the field, we integrated our laboratory data with field data on tick burden and feeding activity in an R0 model. Our model predicts that high prevalence of B. burgdorferi infected mice lowers the ecological threshold for B. microti establishment, especially at sites where larval burden on P. leucopus is lower and where larvae feed simultaneously or soon after nymphs infect mice, when most of the transmission enhancement due to coinfection occurs. Our studies suggest that B. burgdorferi contributes to the emergence and expansion of B. microti and provides a model to predict the ecological factors that are sufficient for emergence of B. microti in the wild.	[Dunn, Jessica M.; Davis, Stephen; Stacey, Andrew] RMIT Univ, Sch Math & Geospatial Sci, Melbourne, Vic, Australia; [Krause, Peter J.; Fitzpatrick, Meagan C.; Rollend, Lindsay; States, Sarah L.; Fish, Durland; Diuk-Wasser, Maria A.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA; [Krause, Peter J.; Belperron, Alexia A.; Bockenstedt, Linda K.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Vannier, Edouard G.] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA; [States, Sarah L.; Diuk-Wasser, Maria A.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA	Royal Melbourne Institute of Technology (RMIT); Yale University; Yale University; Tufts Medical Center; Columbia University	Diuk-Wasser, MA (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.	mad2256@columbia.edu	Fitzpatrick, Meagan C/K-5083-2012	Fitzpatrick, Meagan C/0000-0002-5248-2668; States, Sarah/0000-0002-4278-0901	Gordon and Llura Gund Foundation; NIAID Multidisciplinary Parasitology Training Program [2T32AI007404]; National Science Foundation/National Institute of Health Ecology and Evolution of Infectious Diseases Program [NIH R01 GM10524601]; Environmental Protection Agency [835120]; G. Harold and Leila Y. Mathers Charitable Foundation; US Department of Agriculture-Agricultural Research Service Cooperative Agreement [58-0790-5068]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105246] Funding Source: NIH RePORTER	Gordon and Llura Gund Foundation; NIAID Multidisciplinary Parasitology Training Program; National Science Foundation/National Institute of Health Ecology and Evolution of Infectious Diseases Program; Environmental Protection Agency(United States Environmental Protection Agency); G. Harold and Leila Y. Mathers Charitable Foundation; US Department of Agriculture-Agricultural Research Service Cooperative Agreement(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Gordon and Llura Gund Foundation (PJK, EV); the NIAID Multidisciplinary Parasitology Training Program 2T32AI007404 (MCF); the National Science Foundation/National Institute of Health Ecology and Evolution of Infectious Diseases Program award NIH R01 GM10524601 (MD); the Environmental Protection Agency 835120 (MD); The G. Harold and Leila Y. Mathers Charitable Foundation (DF); and the US Department of Agriculture-Agricultural Research Service Cooperative Agreement no. 58-0790-5068 (DF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JF, 1987, APPL ENVIRON MICROB, V53, P892, DOI 10.1128/AEM.53.4.892-894.1987; ANDERSON JF, 1991, J CLIN MICROBIOL, V29, P2779, DOI 10.1128/JCM.29.12.2779-2783.1991; Belongia EA, 2002, VECTOR-BORNE ZOONOT, V2, P265, DOI 10.1089/153036602321653851; Bockenstedt LK, 2006, INFECT IMMUN, V74, P2154, DOI 10.1128/IAI.74.4.2154-2160.2006; Borggraefe I, 2006, INFECT IMMUN, V74, P3204, DOI 10.1128/IAI.01560-05; Brunner JL, 2008, ECOLOGY, V89, P2259, DOI 10.1890/07-0665.1; Bunikis J, 2004, J INFECT DIS, V189, P1515, DOI 10.1086/382594; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; Casalegno JS, 2010, CLIN MICROBIOL INFEC, V16, P326, DOI 10.1111/j.1469-0691.2010.03167.x; Davis S, 2011, J THEOR BIOL, V269, P96, DOI 10.1016/j.jtbi.2010.10.011; Derdakova M, 2004, APPL ENVIRON MICROB, V70, P6783, DOI 10.1128/AEM.70.11.6783-6788.2004; Devevey G, 2012, PARASITOLOGY, V139, P915, DOI 10.1017/S003118201200008X; Diekmann O, 2000, MATH EPIDEMIOLOGY IN, Vxvi; Diterich I, 2003, INFECT IMMUN, V71, P3979, DOI 10.1128/IAI.71.7.3979-3987.2003; Diuk-Wasser MA, 2014, EMERG INFECT DIS, V20, P225, DOI 10.3201/eid2002.130644; Diuk-Wasser MA, 2012, AM J TROP MED HYG, V86, P320, DOI 10.4269/ajtmh.2012.11-0395; Diuk-Wasser MA, 2010, GLOBAL ECOL BIOGEOGR, V19, P504, DOI 10.1111/j.1466-8238.2010.00526.x; Druilhe P, 2005, TRENDS PARASITOL, V21, P359, DOI 10.1016/j.pt.2005.06.011; Dunn JM, 2013, J THEOR BIOL, V335, P213, DOI 10.1016/j.jtbi.2013.06.035; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Ezenwa VO, 2011, INTEGR COMP BIOL, V51, P540, DOI 10.1093/icb/icr058; FISH D, 1993, ECOLOGY ENV MANAGEME; Gatewood AG, 2009, APPL ENVIRON MICROB, V75, P2476, DOI 10.1128/AEM.02633-08; Giambartolomei GH, 1998, INFECT IMMUN, V66, P2691, DOI 10.1128/IAI.66.6.2691-2697.1998; Gibson LR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-248; Ginsberg HS, 2008, EXP APPL ACAROL, V46, P29, DOI 10.1007/s10493-008-9175-5; Hamer SA, 2012, TICKS TICK-BORNE DIS, V3, P65, DOI 10.1016/j.ttbdis.2011.11.004; Hamer SA, 2010, ECOHEALTH, V7, P47, DOI 10.1007/s10393-010-0287-0; Hanincova K, 2008, APPL ENVIRON MICROB, V74, P153, DOI 10.1128/AEM.01567-07; Hanincova K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073066; Hartemink NA, 2008, AM NAT, V171, P743, DOI 10.1086/587530; Hersh MH, 2012, EMERG INFECT DIS, V18, P1951, DOI 10.3201/eid1812.111392; Homer MJ, 2000, CLIN MICROBIOL REV, V13, P451, DOI 10.1128/CMR.13.3.451-469.2000; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Joseph JT, 2011, EMERG INFECT DIS, V17, P843, DOI 10.3201/eid1705.101334; Krause PJ, 2013, NEW ENGL J MED, V368, P291, DOI 10.1056/NEJMc1215469; Krause PJ, 2003, AM J TROP MED HYG, V68, P431, DOI 10.4269/ajtmh.2003.68.431; Krause PJ, 1996, JAMA-J AM MED ASSOC, V275, P1657, DOI 10.1001/jama.275.21.1657; KRAUSE PJ, 1991, J CLIN MICROBIOL, V29, P1; Lawn SD, 2006, CLIN INFECT DIS, V42, P1040, DOI 10.1086/501018; Lello J, 2008, AM NAT, V171, P176, DOI 10.1086/525257; Levin ML, 2001, VECTOR-BORNE ZOONOT, V1, P139, DOI 10.1089/153036601316977741; Levin ML, 2000, INFECT IMMUN, V68, P2183, DOI 10.1128/IAI.68.4.2183-2186.2000; Li S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039612; Liveris D, 1996, J CLIN MICROBIOL, V34, P1306, DOI 10.1128/JCM.34.5.1306-1309.1996; Liveris D, 1999, J CLIN MICROBIOL, V37, P565, DOI 10.1128/JCM.37.3.565-569.1999; Lopez-Villavicencio M, 2011, EVOLUTION, V65, P1357, DOI 10.1111/j.1558-5646.2010.01207.x; Magnarelli LA, 1997, J WILDLIFE DIS, V33, P466, DOI 10.7589/0090-3558-33.3.466; MAGNARELLI LA, 1995, J CLIN MICROBIOL, V33, P3054, DOI 10.1128/JCM.33.11.3054-3057.1995; Magnarelli LA, 2013, J WILDLIFE DIS, V49, P294, DOI 10.7589/2012-06-172; MATHER TN, 1990, EXP PARASITOL, V70, P55, DOI 10.1016/0014-4894(90)90085-Q; Menis M, 2012, EMERG INFECT DIS, V18, P128, DOI 10.3201/eid1801.110305; Nazario S, 1998, AM J TROP MED HYG, V58, P780, DOI 10.4269/ajtmh.1998.58.780; Nonaka E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011745; Ogden NH, 2013, J APPL ECOL, V50, P510, DOI [10.1111/1365-2664.12050, 10.1111/]; PIESMAN J, 1982, EXP PARASITOL, V53, P242, DOI 10.1016/0014-4894(82)90065-0; PIESMAN J, 1987, J CLIN MICROBIOL, V25, P557, DOI 10.1128/JCM.25.3.557-558.1987; PIESMAN J, 1986, ACTA TROP, V43, P263; PIESMAN J, 1986, J CLIN MICROBIOL, V24, P446, DOI 10.1128/JCM.24.3.446-447.1986; Randolph SE, 2000, PARASITOLOGY, V121, P15, DOI 10.1017/S0031182099006083; Richer LM, 2014, J INFECT DIS, V209, P1972, DOI 10.1093/infdis/jiu005; Rollend L, 2013, VECTOR-BORNE ZOONOT, V13, P784, DOI 10.1089/vbz.2011.0935; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; SCHUG MD, 1991, J MAMMAL, V72, P360, DOI 10.2307/1382107; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; Snyder DP, 1956, SURVIVAL RATES LONGE; Stafford KC, 1999, J CLIN MICROBIOL, V37, P2887, DOI 10.1128/JCM.37.9.2887-2892.1999; States SL, 2014, INFECT GENET EVOL; Steiner FE, 2008, J MED ENTOMOL, V45, P289, DOI 10.1603/0022-2585(2008)45[289:IACROA]2.0.CO;2; Swanson SJ, 2006, CLIN MICROBIOL REV, V19, P708, DOI 10.1128/CMR.00011-06; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Tokarz R, 2010, VECTOR-BORNE ZOONOT, V10, P217, DOI 10.1089/vbz.2009.0036; Tsao JI, 2004, P NATL ACAD SCI USA, V101, P18159, DOI 10.1073/pnas.0405763102; Vannier E, 2012, NEW ENGL J MED, V366, P2397, DOI 10.1056/NEJMra1202018; Varde S, 1998, EMERG INFECT DIS, V4, P97, DOI 10.3201/eid0401.980113; Voordouw MJ, 2013, VECTOR-BORNE ZOONOT, V13, P203, DOI 10.1089/vbz.2012.1003; Wang G, 2001, INFECT IMMUN, V69, P4303, DOI 10.1128/IAI.69.7.4303-4312.2001; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Wormser GP, 1999, J INFECT DIS, V180, P720, DOI 10.1086/314922; Zeidner NS, 2000, PARASITE IMMUNOL, V22, P581, DOI 10.1046/j.1365-3024.2000.00339.x	81	71	72	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115494	10.1371/journal.pone.0115494	http://dx.doi.org/10.1371/journal.pone.0115494			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545393	gold, Green Published, Green Submitted			2022-12-26	WOS:000347120200045
J	Fricke, S; Pfefferkorn, C; Wolf, D; Riemschneider, S; Kohlschmidt, J; Hilger, N; Fueldner, C; Knauer, J; Sack, U; Emmrich, F; Lehmann, J				Fricke, Stephan; Pfefferkorn, Cathleen; Wolf, Doris; Riemschneider, Sina; Kohlschmidt, Janine; Hilger, Nadja; Fueldner, Christiane; Knauer, Jens; Sack, Ulrich; Emmrich, Frank; Lehmann, Joerg			Characterization of the Murine Myeloid Precursor Cell Line MuMac-E8	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELL; BONE-MARROW-CELLS; SERUM DEPRIVATION; RHEUMATOID-ARTHRITIS; SYNOVIAL-MEMBRANE; SUPPRESSOR-CELLS; DENDRITIC CELLS; SCID MICE; IN-VITRO; NANOG	Starting point for the present work was the assumption that the cell line MuMac-E8 represents a murine cell population with stem cell properties. Preliminary studies already pointed to the expression of stem-cell associated markers and a self-regenerative potential of the cells. The cell line MuMac-E8 should be examined for their differential stage within stem cell hierarchy. MuMac-E8 cells were derived from a chimeric mouse model of arthritis. It could be shown that MuMac-E8 cells express mRNA of some genes associated with pluripotent stem cells (Nanog, Nucleostemin), of genes for hematopoietic markers (EPCR, Sca-1, CD11b, CD45), for the mesenchymal marker CD105 and of genes for the neural markers Pax-6 and Ezrin. In methylcellulose and May-Grunwald-Giemsa staining, hematopoietic colonies were obtained but the hematopoietic system of lethally irradiated mice could not be rescued. Osteogenic differentiation was not detectable. Thus, it became evident that MuMac-E8 represents not a stem cell line. However, MuMac-E8 cells expressed several myeloid surface markers (i.e. CD11b, F4/80, CD14, CD64), showed phagocytosis and is capable of producing nitric oxide. Thus, this cell line seems to be arrested an advanced stage of myeloid differentiation. Adherence data measured by impedance-based real-time cell analysis together with cell morphology data suggested that MuMac-E8 represents a new macrophage precursor cell line exhibiting weak adherence. This cell line is suitable as an in-vitro model for testing of macrophage functions. Moreover, it might be also useful for differentiation or reprogramming studies.	[Fricke, Stephan; Pfefferkorn, Cathleen; Wolf, Doris; Riemschneider, Sina; Kohlschmidt, Janine; Hilger, Nadja; Fueldner, Christiane; Knauer, Jens; Sack, Ulrich; Emmrich, Frank; Lehmann, Joerg] Fraunhofer Inst Cell Therapy & Immunol IZI, Leipzig, Germany; [Fricke, Stephan; Sack, Ulrich; Emmrich, Frank] Univ Leipzig, Inst Clin Immunol, Leipzig, Germany; [Fricke, Stephan; Sack, Ulrich; Emmrich, Frank] Univ Leipzig, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany; [Wolf, Doris] Univ Leipzig, Dept Surg, Res Labs, Leipzig, Germany	Fraunhofer Gesellschaft; Leipzig University; Leipzig University; Leipzig University	Lehmann, J (corresponding author), Fraunhofer Inst Cell Therapy & Immunol IZI, Leipzig, Germany.	joerg.lehmann@izi.fraunhofer.de	Lehmann, Joerg/AAV-3264-2020; Sack, Ulrich/J-6301-2015; Fricke, Stephan/AAF-1629-2021	Sack, Ulrich/0000-0002-7813-0492; Lehmann, Jorg/0000-0001-8560-648X	German Federal Ministry of Education and Research (BMBF) [1315883]; Fraunhofer-Gesellschaft zur Forderung der angewandten Forschung e.V.	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Fraunhofer-Gesellschaft zur Forderung der angewandten Forschung e.V.	The work presented in this paper was made possible by funding from the German Federal Ministry of Education and Research (BMBF 1315883) and the Fraunhofer-Gesellschaft zur Forderung der angewandten Forschung e.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry FP, 1999, BIOCHEM BIOPH RES CO, V265, P134, DOI 10.1006/bbrc.1999.1620; Bradfute SB, 2005, EXP HEMATOL, V33, P836, DOI 10.1016/j.exphem.2005.04.001; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cho SK, 2001, BLOOD, V98, P3635, DOI 10.1182/blood.V98.13.3635; Chou RC, 2003, BRAIN RES PROTOC, V11, P162, DOI 10.1016/S1385-299X(03)00043-6; Condamine T, 2014, J CLIN INVEST, V124, P2626, DOI 10.1172/JCI74056; Dolhain RJEM, 1996, ARTHRITIS RHEUM-US, V39, P1961, DOI 10.1002/art.1780391204; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Fricke S, 2014, CELL MOL LIFE SCI, V71, P2135, DOI 10.1007/s00018-013-1476-0; Fricke S, 2012, CYTOM PART A, V81A, P476, DOI 10.1002/cyto.a.22061; Fricke S, 2010, CELL MOL LIFE SCI, V67, P4095, DOI 10.1007/s00018-010-0427-2; Fricke S, 2011, METHODS MOL BIOL, V690, P315, DOI 10.1007/978-1-60761-962-8_21; Fricke S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006157; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Ghassabeh GH, 2006, BLOOD, V108, P575, DOI 10.1182/blood-2005-04-1485; Goissis MD, 2007, REPROD DOMEST ANIM, V42, P660, DOI 10.1111/j.1439-0531.2006.00839.x; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hart AH, 2005, CANCER, V104, P2092, DOI 10.1002/cncr.21435; HAYNESWORTH SE, 1992, BONE, V13, P69, DOI 10.1016/8756-3282(92)90363-2; Hoei-Hansen CE, 2005, HISTOPATHOLOGY, V47, P48, DOI 10.1111/j.1365-2559.2005.02182.x; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; INABA K, 1993, P NATL ACAD SCI USA, V90, P3038, DOI 10.1073/pnas.90.7.3038; Ito CY, 2003, BLOOD, V101, P517, DOI 10.1182/blood-2002-06-1918; KARASUYAMA H, 1988, J EXP MED, V167, P1377, DOI 10.1084/jem.167.4.1377; Kostlin N, 2014, EUR J IMMUNOL, V44, P2582, DOI 10.1002/eji.201344200; Laoui D, 2014, CANCER RES, V74, P24, DOI 10.1158/0008-5472.CAN-13-1196; Laoui D, 2011, IMMUNOBIOLOGY, V216, P1192, DOI 10.1016/j.imbio.2011.06.007; Lehmann J, 2000, J AUTOIMMUN, V15, P301, DOI 10.1006/jaut.2000.0435; Liechtenstein T, 2014, ONCOTARGET, V5, P7843, DOI 10.18632/oncotarget.2279; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; OCONNELL PJ, 1992, CLIN EXP IMMUNOL, V90, P154; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pfefferkorn P, 2008, BIOCHEMICA, V4, P14; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ploemacher RE, 1997, BAILLIERE CLIN HAEM, V10, P429, DOI 10.1016/S0950-3536(97)80019-4; Raes G, 2012, IMMUNOBIOLOGY, V217, P1223, DOI 10.1016/j.imbio.2012.10.001; Ramachandran M, 2014, J IMMUNOL, V193, P2287, DOI 10.4049/jimmunol.1400339; Sack U, 1999, J AUTOIMMUN, V13, P335, DOI 10.1006/jaut.1999.0328; SIMON AK, 1994, P NATL ACAD SCI USA, V91, P8562, DOI 10.1073/pnas.91.18.8562; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPANGRUDE GJ, 1993, BLOOD, V82, P3327; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Van der Jeught K, 2014, ONCOTARGET, V5, P10100; Van Ginderachter JA, 2010, EUR J IMMUNOL, V40, P2976, DOI 10.1002/eji.201040911; Vendramin A, 2014, BIOL BLOOD MARROW S, V1083-8791, P566; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Yaghoobi MM, 2005, NEUROSCI LETT, V390, P81, DOI 10.1016/j.neulet.2005.08.011; Zhang EM, 2005, BIOCHEM BIOPH RES CO, V333, P1171, DOI 10.1016/j.bbrc.2005.05.200; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004	54	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e113743	10.1371/journal.pone.0113743	http://dx.doi.org/10.1371/journal.pone.0113743			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546418	Green Published, gold, Green Submitted			2022-12-26	WOS:000347120200007
J	Namjou, B; Ni, YZ; Harley, ITW; Chepelev, I; Cobb, B; Kottyan, LC; Gaffney, PM; Guthridge, JM; Kaufman, K; Harley, JB				Namjou, Bahram; Ni, Yizhao; Harley, Isaac T. W.; Chepelev, Iouri; Cobb, Beth; Kottyan, Leah C.; Gaffney, Patrick M.; Guthridge, Joel M.; Kaufman, Kenneth; Harley, John B.			The Effect of Inversion at 8p23 on BLK Association with Lupus in Caucasian Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN-CHROMOSOME 8P23; CHINESE HAN; ERYTHEMATOSUS; POLYMORPHISM; HAPLOTYPE; VARIANTS; GENE; TRANSCRIPTION; IMPACT	To explore the potential influence of the polymorphic 8p23.1 inversion on known autoimmune susceptibility risk at or near BLK locus, we validated a new bioinformatics method that utilizes SNP data to enable accurate, high-throughput genotyping of the 8p23.1 inversion in a Caucasian population. Methods: Principal components analysis (PCA) was performed using markers inside the inversion territory followed by k-means cluster analyses on 7416 European derived and 267 HapMaP CEU and TSI samples. A logistic regression conditional analysis was performed. Results: Three subgroups have been identified; inversion homozygous, heterozygous and non-inversion homozygous. The status of inversion was further validated using HapMap samples that had previously undergone Fluorescence in situ hybridization (FISH) assays with a concordance rate of above 98%. Conditional analyses based on the status of inversion were performed. We found that overall association signals in the BLK region remain significant after controlling for inversion status. The proportion of lupus cases and controls (cases/controls) in each subgroup was determined to be 0.97 for the inverted homozygous group (1067 cases and 1095 controls), 1.12 for the inverted heterozygous group (1935 cases 1717 controls) and 1.36 for non-inverted subgroups (924 cases and 678 controls). After calculating the linkage disequilibrium between inversion status and lupus risk haplotype we found that the lupus risk haplotype tends to reside on non-inversion background. As a result, a new association effect between non-inversion status and lupus phenotype has been identified ((p=8.18 x 10(-7), OR=1.18, 95%CI=1.10-1.26). Conclusion: Our results demonstrate that both known lupus risk haplotype and inversion status act additively in the pathogenesis of lupus. Since inversion regulates expression of many genes in its territory, altered expression of other genes might also be involved in the development of lupus.	[Namjou, Bahram; Harley, Isaac T. W.; Chepelev, Iouri; Cobb, Beth; Kottyan, Leah C.; Kaufman, Kenneth; Harley, John B.] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Namjou, Bahram; Harley, Isaac T. W.; Chepelev, Iouri; Cobb, Beth; Kottyan, Leah C.; Kaufman, Kenneth; Harley, John B.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Ni, Yizhao] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Harley, Isaac T. W.] Univ Colorado Denver, Div Rheumatol, Aurora, CO 80045 USA; [Harley, Isaac T. W.] Univ Colorado Denver, Dept Internal Med, Aurora, CO 80045 USA; [Gaffney, Patrick M.; Guthridge, Joel M.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Harley, John B.] Dept Vet Affairs Med Ctr, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Oklahoma Medical Research Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center	Namjou, B (corresponding author), Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Bahram.namjou@cchmc.org	Kottyan, Leah C./H-3050-2019	Kottyan, Leah C./0000-0003-3979-2220; Harley, Isaac/0000-0003-1282-5395; Guthridge, Joel/0000-0002-9308-237X; Chepelev, Iouri/0000-0002-2121-8805; Gaffney, Patrick/0000-0002-1580-869X; Ni, Yizhao/0000-0001-8599-454X	National Human Genomic Research Institute: NIH [U01 HG006828, R37 AI024717, P01 AI083194]; US Department of Veterans Affairs (IMMA9) Department of Defense [PR094002]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083194, R37AI024717] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001834] Funding Source: NIH RePORTER	National Human Genomic Research Institute: NIH; US Department of Veterans Affairs (IMMA9) Department of Defense; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by the National Human Genomic Research Institute: NIH (U01 HG006828, R37 AI024717, P01 AI083194)-BN-JBH-KK-BC-LC-IC and the US Department of Veterans Affairs (IMMA9) Department of Defense (PR094002)-JBH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonacci F, 2009, HUM MOL GENET, V18, P2555, DOI 10.1093/hmg/ddp187; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Broman KW, 2003, INST MATH S, V40, P237; Delgado-Vega AM, 2012, ANN RHEUM DIS, V71, P1219, DOI 10.1136/annrheumdis-2011-200987; Deng LB, 2008, HUM MUTAT, V29, P1209, DOI 10.1002/humu.20775; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Gourh P, 2010, J AUTOIMMUN, V34, P155, DOI 10.1016/j.jaut.2009.08.014; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Guthridge JM, 2014, AM J HUM GENET, V94, P586, DOI 10.1016/j.ajhg.2014.03.008; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Jaarola M, 1998, AM J HUM GENET, V63, P218, DOI 10.1086/301900; Kirkpatrick M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000501; Lessard CJ, 2013, NAT GENET, V45, P1284, DOI 10.1038/ng.2792; Ma JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040224; Myers AJ, 2007, NEUROBIOL DIS, V25, P561, DOI 10.1016/j.nbd.2006.10.018; Namjou B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069404; Namjou B, 2012, ARTHRITIS RHEUM-US, V64, P1960, DOI 10.1002/art.34361; Navarro A, 2005, NAT GENET, V37, P115, DOI 10.1038/ng0205-115; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Salm MPA, 2012, GENOME RES, V22, P1144, DOI 10.1101/gr.126037.111; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Sugawara H, 2003, GENOMICS, V82, P238, DOI 10.1016/S0888-7543(03)00108-3; Tsuchiya Naoyuki, 2010, Nihon Rinsho Meneki Gakkai Kaishi, V33, P57; Yin H, 2009, ARTHRITIS RHEUM-US, V60, P2468, DOI 10.1002/art.24701; Zhang Z, 2010, ARCH DERMATOL RES, V302, P619, DOI 10.1007/s00403-010-1029-4	29	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115614	10.1371/journal.pone.0115614	http://dx.doi.org/10.1371/journal.pone.0115614			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545785	gold, Green Published, Green Submitted			2022-12-26	WOS:000347120200049
J	Okada, K; Fukai, A; Mori, D; Hosaka, Y; Yano, F; Chung, U; Kawaguchi, H; Tanaka, S; Ikeda, T; Saito, T				Okada, Keita; Fukai, Atsushi; Mori, Daisuke; Hosaka, Yoko; Yano, Fumiko; Chung, Ung-il; Kawaguchi, Hiroshi; Tanaka, Sakae; Ikeda, Toshiyuki; Saito, Taku			Identification of SCAN Domain Zinc-Finger Gene ZNF449 as a Novel Factor of Chondrogenesis	PLOS ONE			English	Article							CHONDROCYTE DIFFERENTIATION PATHWAY; OSTEOARTHRITIS DEVELOPMENT; ENDOCHONDRAL OSSIFICATION; COLLAGEN GENE; SOX9; L-SOX5; GROWTH; STEPS	Transcription factors SOX9, SOX5 and SOX6 are indispensable for generation and differentiation of chondrocytes. However, molecular mechanisms to induce the SOX genes are poorly understood. To address this issue, we previously determined the human embryonic enhancer of SOX6 by 5'RACE analysis, and identified the 46-bp core enhancer region (CES6). We initially performed yeast one-hybrid assay for screening other chondrogenic factors using CES6 as bait, and identified a zinc finger protein ZNF449. ZNF449 and Zfp449, a counterpart in mouse, transactivated enhancers or promoters of SOX6, SOX9 and COL2A1. Zfp449 was expressed in mesenchyme-derived tissues including cartilage, calvaria, muscle and tendon, as well as in other tissues including brain, lung and kidney. In limb cartilage of mouse embryo, Zfp449 protein was abundantly located in periarticular chondrocytes, and decreased in accordance with the differentiation. Zfp449 protein was also detected in articular cartilage of an adult mouse. During chondrogenic differentiation of human mesenchymal stem cells, ZNF449 was increased at an early stage, and its overexpression enhanced SOX9 and SOX6 only at the initial stage of the differentiation. We further generated Zfp449 knockout mice to examine the in vivo roles; however, no obvious abnormality was observed in skeletal development or articular cartilage homeostasis. ZNF449 may regulate chondrogenic differentiation from mesenchymal progenitor cells, although the underlying mechanisms are still unknown.	[Okada, Keita; Fukai, Atsushi; Mori, Daisuke; Hosaka, Yoko; Yano, Fumiko; Kawaguchi, Hiroshi; Tanaka, Sakae; Ikeda, Toshiyuki; Saito, Taku] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Yano, Fumiko; Chung, Ung-il] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Tokyo 113, Japan; [Ikeda, Toshiyuki] Univ Tokyo, Fac Med, Div Transfus Med, Tokyo 113, Japan; [Fukai, Atsushi] Japan Labour Hlth & Welf Org, Kanto Rosai Hosp, Kanagawa, Japan; [Hosaka, Yoko] Tokyo Metropolitan Bokutoh Hosp, Tokyo, Japan; [Kawaguchi, Hiroshi] Japan Community Hlth Care Org, Tokyo Shinjuku Med Ctr, Spine Ctr, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Saito, T (corresponding author), Univ Tokyo, Fac Med, Tokyo 113, Japan.	tasaitou-tky@umin.ac.jp	Ikeda, Toshiyuki/GVS-5588-2022; Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414	Japanese Ministry of Education, Culture, Sports, Science and Technology [19109007, 24659664]; Grants-in-Aid for Scientific Research [25293316] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (#19109007, #24659664).	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Hosaka Y, 2013, P NATL ACAD SCI USA, V110, P1875, DOI 10.1073/pnas.1207458110; Ikeda T, 2007, BIOCHEM BIOPH RES CO, V357, P383, DOI 10.1016/j.bbrc.2007.03.133; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Luo KT, 2006, MOL BIOL REP, V33, P51, DOI 10.1007/s11033-005-3966-0; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777	15	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115169	10.1371/journal.pone.0115169	http://dx.doi.org/10.1371/journal.pone.0115169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546433	Green Submitted, Green Published, gold			2022-12-26	WOS:000347120200024
J	Rath, T; Zwaschka, L; Hage, L; Kugler, M; Menendez, K; Naehrlich, L; Schulz, R; Roderfeld, M; Roeb, E				Rath, Timo; Zwaschka, Lisa; Hage, Lisa; Kuegler, Marion; Menendez, Katrin; Naehrlich, Lutz; Schulz, Richard; Roderfeld, Martin; Roeb, Elke			Identification of Neutrophil Activation Markers as Novel Surrogate Markers of CF Lung Disease	PLOS ONE			English	Article							CYSTIC-FIBROSIS; MATRIX METALLOPROTEINASES; PHENOTYPE CORRELATIONS; PULMONARY-FUNCTION; SPUTUM BIOMARKERS; FUNCTION DECLINE; YKL-40; AIRWAY; INFLAMMATION; MORTALITY	Background and aims: Cystic Fibrosis (CF) lung disease is characterized by progressively declining lung function and represents a major factor contributing to the high morbidity and mortality associated with CF. However, apart from spirometry, respiratory disease surrogate markers reliably indicating CF lung disease and the occurrence of pulmonary exacerbations (PEx) are still lacking. Within this study, we aimed to identify new experimental biomarkers for the detection of CF lung disease. Methods: 54 adult and 26 pediatric CF patients were included in the study and serum concentrations of MMP-1, -2, -8, -9, -13, TIMP-1, TIMP-2, YKL-40, hyaluronic acid, procollagen III peptide were quantified by ELISA. CF lung disease was diagnosed by lung function test, PEx was defined based on a clinical scoring established by Rosenfeld in 2001. Results: Adults and children with moderate to severe CF lung disease exhibited significantly increased serum expression of MMP-8, MMP-9, YKL-40 and TIMP-1. Further, MMP-8, MMP-9 and YKL-40 were significantly increased in adult CF patients suffering from PEx compared to those without clinical signs of respiratory exacerbation. MMP-8, MMP-9, YKL-40, and TIMP-1 serum levels were unaffected by the presence or absence of CF liver disease or pancreatic insufficiency. Conclusions: MMP-8, MMP-9, and YKL-40 might serve as novel non-invasive biomarkers of CF lung disease and PEx.	[Rath, Timo; Zwaschka, Lisa; Hage, Lisa; Kuegler, Marion; Menendez, Katrin; Roderfeld, Martin; Roeb, Elke] Univ Giessen, Dept Gastroenterol, D-35390 Giessen, Germany; [Rath, Timo] Univ Erlangen Nurnberg, Dept Med 1, D-91054 Erlangen, Germany; [Naehrlich, Lutz] Univ Giessen, Dept Pediat, Div Pulmonol, D-35390 Giessen, Germany; [Schulz, Richard] Univ Giessen, Dept Pulmonol, D-35390 Giessen, Germany	Justus Liebig University Giessen; University of Erlangen Nuremberg; Justus Liebig University Giessen; Justus Liebig University Giessen	Roeb, E (corresponding author), Univ Giessen, Dept Gastroenterol, D-35390 Giessen, Germany.	Elke.Roeb@innere.med.uni-giessen.de	, Martin/AHD-5202-2022; Naehrlich, Lutz/F-4574-2015	, Martin/0000-0002-3232-1277; Naehrlich, Lutz/0000-0002-7146-6997; Rath, Timo/0000-0002-7728-9338	Deutsche Forschungsgemeinschaft [RO 957/7-1, RO 957/8-1]; University Medical Center Giessen Marburg (UKGM) [10/2010 GI]; ZooMAP (Bundesministerium fur Bildung und Forschung, BMBF) [01KI1003E]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University Medical Center Giessen Marburg (UKGM); ZooMAP (Bundesministerium fur Bildung und Forschung, BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (RO 957/7-1 and RO 957/8-1), a research Grant of the University Medical Center Giessen & Marburg (UKGM 10/2010 GI), and from ZooMAP (01KI1003E, Bundesministerium fur Bildung und Forschung, BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle MP, 2007, JAMA-J AM MED ASSOC, V298, P1787, DOI 10.1001/jama.298.15.1787; CAMPOCCIA D, 1993, BIOMATERIALS, V14, P1135, DOI 10.1016/0142-9612(93)90156-V; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Corey M, 1997, J PEDIATR-US, V131, P809, DOI 10.1016/S0022-3476(97)70025-8; Corey M, 1996, AM J EPIDEMIOL, V143, P1007, DOI 10.1093/oxfordjournals.aje.a008664; Dakin C, 2001, PEDIATR PULM, V31, P436, DOI 10.1002/ppul.1072; Debray D, 2011, J CYST FIBROS, V10, pS29, DOI 10.1016/S1569-1993(11)60006-4; DORING G, 1994, AM J RESP CRIT CARE, V150, pS114; Dray X, 2003, GASTROENTEROLOGY, V125, P1286, DOI 10.1016/j.gastro.2003.08.016; Durno C, 2002, GASTROENTEROLOGY, V123, P1857, DOI 10.1053/gast.2002.37042; Elkington PTG, 2006, THORAX, V61, P259, DOI 10.1136/thx.2005.051979; Fantino E, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-28; Ferkol T, 2006, J PEDIATR-US, V148, P259, DOI 10.1016/j.jpeds.2005.10.019; Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; Gaggar A, 2007, AM J PHYSIOL-LUNG C, V293, pL96, DOI 10.1152/ajplung.00492.2006; Gault Rachel, 2002, Pediatr Phys Ther, V14, P157; Gressner OA, 2007, CLIN CHIM ACTA, V381, P107, DOI 10.1016/j.cca.2007.02.038; Gueders MM, 2006, EUR J PHARMACOL, V533, P133, DOI 10.1016/j.ejphar.2005.12.082; Hartl D, 2007, NAT MED, V13, P1423, DOI 10.1038/nm1690; Harutyunyan M, 2013, IMMUNOBIOLOGY, V218, P945, DOI 10.1016/j.imbio.2012.10.015; Hector A, 2011, PLOS ONE, V6; Hilliard TN, 2007, THORAX, V62, P1074, DOI 10.1136/thx.2006.074641; Jackson PL, 2010, MOL MED, V16, P159, DOI 10.2119/molmed.2009.00109; Kadoglou PE, 2014, EXP CLIN ENDOCR DIAB, V122, P44, DOI 10.1055/s-0033-1358762; KEREM E, 1992, NEW ENGL J MED, V326, P1187, DOI 10.1056/NEJM199204303261804; Kerem Eitan, 2005, J Cyst Fibros, V4, P7, DOI 10.1016/j.jcf.2004.12.002; Kraynack NC, 2011, PEDIATR PULM, V46, P870, DOI 10.1002/ppul.21442; Lee JH, 2012, J DIABETES COMPLICAT, V26, P308, DOI 10.1016/j.jdiacomp.2012.04.012; Letuve S, 2008, J IMMUNOL, V181, P5167, DOI 10.4049/jimmunol.181.7.5167; Lewandowski KC, 2011, ARCH MED SCI, V7, P294, DOI 10.5114/aoms.2011.22081; Ma YG, 2014, ATHEROSCLEROSIS, V232, P231, DOI 10.1016/j.atherosclerosis.2013.09.013; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mayer-Hamblett N, 2007, AM J RESP CRIT CARE, V175, P822, DOI 10.1164/rccm.200609-1354OC; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nordenbaek C, 1999, J INFECT DIS, V180, P1722, DOI 10.1086/315050; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Parks WC, 2001, RESP RES, V2, P10, DOI 10.1186/rr33; Perez A, 2008, AM J PHYSIOL-LUNG C, V295, pL303, DOI 10.1152/ajplung.90276.2008; RAMSEY BW, 1994, J PEDIATR-US, V124, P177, DOI 10.1016/S0022-3476(94)70301-9; Rath T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058955; Ratjen F, 2002, THORAX, V57, P930, DOI 10.1136/thorax.57.11.930; Rosenfeld M, 2001, J PEDIATR-US, V139, P359, DOI 10.1067/mpd.2001.117288; Sagel SD, 2012, AM J RESP CRIT CARE, V186, P857, DOI 10.1164/rccm.201203-0507OC; Sagel SD, 2005, PEDIATR PULM, V39, P224, DOI 10.1002/ppul.20165; Shoki AH, 2013, CHEST, V144, P1659, DOI 10.1378/chest.13-0693; Volck B, 1998, P ASSOC AM PHYSICIAN, V110, P351; Walsh DE, 2001, J BIOL CHEM, V276, P35494, DOI 10.1074/jbc.M103543200	48	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115847	10.1371/journal.pone.0115847	http://dx.doi.org/10.1371/journal.pone.0115847			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545245	Green Published, gold, Green Submitted			2022-12-26	WOS:000347120200075
J	Song, YF; Forsgren, S; Liu, JX; Yu, JG; Stal, P				Song, Yafeng; Forsgren, Sture; Liu, Jing-Xia; Yu, Ji-Guo; Stal, Per			Unilateral Muscle Overuse Causes Bilateral Changes in Muscle Fiber Composition and Vascular Supply	PLOS ONE			English	Article							THYROID-HORMONE REGULATION; MAMMALIAN SKELETAL-MUSCLE; CROSS-EDUCATION; VASTUS-LATERALIS; ELECTRICAL-STIMULATION; ISOFORM COMPOSITION; POSSIBLE MECHANISMS; GENE-EXPRESSION; SOLEUS MUSCLE; STRENGTH	Unilateral strength training can cause cross-transfer strength effects to the homologous contralateral muscles. However, the impact of the cross-over effects on the muscle tissue is unclear. To test the hypothesis that unilateral muscle overuse causes bilateral alterations in muscle fiber composition and vascular supply, we have used an experimental rabbit model with unilateral unloaded overstrain exercise via electrical muscle stimulation (E/EMS). The soleus (SOL) and gastrocnemius (GA) muscles of both exercised (E) and contralateral non-exercised (NE) legs (n=24) were morphologically analyzed after 1w, 3w and 6w of EMS. Non-exercised rabbits served as controls (n=6). After unilateral intervention the muscles of both E and NE legs showed myositis and structural and molecular tissue changes that to various degrees mirrored each other. The fiber area was bilaterally smaller than in controls after 3w of E/EMS in both SOL (E 4420 and NE 4333 mu m(2) vs. 5183 mu m(2), p<0.05) and GA (E 3572 and NE 2983 mu m(2) vs. 4697 mu m(2), p<0.02) muscles. After 6w of E/ EMS, the percentage of slow MyHCI fibers was lower than in controls in the NE legs of SOL (88.1% vs. 98.1%, p, 0.009), while the percentage of fast MyHCIIa fibers was higher in the NE legs of GA (25.7% vs. 15.8%, p=0.02). The number of capillaries around fibers in the E and NE legs was lower (SOL 13% and 15%, respectively, GA 25% and 23%, respectively, p<0.05) than in controls. The overall alterations were more marked in the fast GA muscle than in the slow SOL muscle, which on the other hand showed more histopathological muscle changes. We conclude that unilateral repetitive unloaded overuse exercise via EMS causes myositis and muscle changes in fiber type proportions, fiber area and fiber capillarization not only in the exercised leg, but also in the homologous muscles in the non-exercised leg.	[Song, Yafeng; Forsgren, Sture; Liu, Jing-Xia; Stal, Per] Umea Univ, Sect Anat, Dept Integrat Med Biol, Umea, Sweden; [Yu, Ji-Guo] Umea Univ, Sports Med Unit, Dept Surg & Perioperat Sci, Umea, Sweden	Umea University; Umea University	Stal, P (corresponding author), Umea Univ, Sect Anat, Dept Integrat Med Biol, Umea, Sweden.	per.stal@anatomy.umu.se		Stal, Per/0000-0002-9340-5298; Yu, Jiguo/0000-0001-7607-475X	Faculty of Medicine; Umea University; Swedish National Centre for Research in Sports (CIF); J. C. Kempe Memorial Foundation; Seth M. Kempe Memorial Foundation; China Scholarship Council	Faculty of Medicine; Umea University; Swedish National Centre for Research in Sports (CIF); J. C. Kempe Memorial Foundation; Seth M. Kempe Memorial Foundation; China Scholarship Council(China Scholarship Council)	Financial support was received from the Faculty of Medicine, Umea University, the Swedish National Centre for Research in Sports (CIF) and the J. C. Kempe and Seth M. Kempe Memorial Foundations. A stipendium was provided from China Scholarship Council. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN JL, 1994, ACTA PHYSIOL SCAND, V151, P135, DOI 10.1111/j.1748-1716.1994.tb09730.x; Andersson G, 2011, BRIT J SPORT MED, V45, P399, DOI 10.1136/bjsm.2009.068122; ARMSTRONG RB, 1982, AM J ANAT, V163, P87, DOI 10.1002/aja.1001630107; BACKMAN C, 1990, J ORTHOPAED RES, V8, P541, DOI 10.1002/jor.1100080410; Baldwin KM, 2002, AM J PHYS MED REHAB, V81, pS40, DOI 10.1097/00002060-200211001-00006; Bezerra P, 2009, MUSCLE NERVE, V40, P430, DOI 10.1002/mus.21329; Borisov AB, 2000, ANAT REC, V258, P292; Brey EM, 2002, MICROVASC RES, V63, P279, DOI 10.1006/mvre.2002.2395; BRZANK KD, 1986, ANAT ANZEIGER, V161, P243; CABRIC M, 1987, INT J SPORTS MED, V8, P256, DOI 10.1055/s-2008-1025665; CAIOZZO VJ, 1992, J APPL PHYSIOL, V73, P1432, DOI 10.1152/jappl.1992.73.4.1432; Canepari M, 1998, ARCH PHYSIOL BIOCHEM, V106, P308, DOI 10.1076/apab.106.4.308.4373; Carroll TJ, 2006, J APPL PHYSIOL, V101, P1514, DOI 10.1152/japplphysiol.00531.2006; Chang YW, 2010, J PAIN, V11, P119, DOI 10.1016/j.jpain.2009.06.009; Charifi N, 2004, J PHYSIOL-LONDON, V554, P559, DOI 10.1113/jphysiol.2003.046953; CHO M, 1994, J CELL SCI, V107, P2361; Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453; CORSI A, 1990, J EXP BIOL, V152, P265; Dalakas MC, 2012, AUTOIMMUN REV, V11, P203, DOI 10.1016/j.autrev.2011.05.013; Dedkov EI, 2002, MICROVASC RES, V63, P96, DOI 10.1006/mvre.2001.2372; DEVINE KL, 1981, PHYS THER, V61, P898, DOI 10.1093/ptj/61.6.898; Dubowitz V, 2007, MUSCLE BIOPSY, P37; ESBJORNSSON M, 1993, ACTA PHYSIOL SCAND, V149, P245, DOI 10.1111/j.1748-1716.1993.tb09618.x; Farthing JP, 2009, J APPL PHYSIOL, V106, P830, DOI 10.1152/japplphysiol.91331.2008; Fitts R H, 1996, Exerc Sport Sci Rev, V24, P427; GOLLNICK PD, 1974, PFLUG ARCH EUR J PHY, V348, P247, DOI 10.1007/BF00587415; GRIMBY G, 1976, SCAND J REHABIL MED, V8, P37; Hamalainen N, 1996, FEBS LETT, V399, P220, DOI 10.1016/S0014-5793(96)01325-7; Heil M, 2006, J CELL MOL MED, V10, P45, DOI 10.1111/j.1582-4934.2006.tb00290.x; Heil M, 2007, CURR PHARM BIOTECHNO, V8, P35, DOI 10.2174/138920107779941408; HOH JFY, 1975, BIOCHEMISTRY-US, V14, P742, DOI 10.1021/bi00675a015; Hortobagyi T, 1997, MED SCI SPORT EXER, V29, P107, DOI 10.1097/00005768-199701000-00015; Hortobagyi T, 1999, MOTOR CONTROL, V3, P205, DOI 10.1123/mcj.3.2.205; Hortobagyi T, 2000, J PHYSIOL-LONDON, V524, P293, DOI 10.1111/j.1469-7793.2000.00293.x; Howatson G, 2007, EUR J APPL PHYSIOL, V101, P207, DOI 10.1007/s00421-007-0489-5; Hudlicka O, 2003, J PHYSIOL-LONDON, V546, P813, DOI 10.1113/jphysiol.2002.030569; HUGHES SM, 1993, DEV BIOL, V158, P183, DOI 10.1006/dbio.1993.1178; JANSSON E, 1978, ACTA PHYSIOL SCAND, V104, P235, DOI 10.1111/j.1748-1716.1978.tb06272.x; Kelly S, 2007, EUR J NEUROSCI, V26, P935, DOI 10.1111/j.1460-9568.2007.05737.x; Koltzenburg M, 1999, TRENDS NEUROSCI, V22, P122, DOI 10.1016/S0166-2236(98)01302-2; LARSSON L, 1995, ACTA PHYSIOL SCAND, V153, P109, DOI 10.1111/j.1748-1716.1995.tb09841.x; Lee M, 2007, SPORTS MED, V37, P1, DOI 10.2165/00007256-200737010-00001; LEVINE JD, 1985, J RHEUMATOL, V12, P406; Liu JX, 2002, J HISTOCHEM CYTOCHEM, V50, P171, DOI 10.1177/002215540205000205; Liu Y, 2003, J APPL PHYSIOL, V94, P2282, DOI 10.1152/japplphysiol.00830.2002; Lu DX, 1997, ANAT REC, V248, P355; Lucas K, 2012, J IMMUNOL, V189, P1237, DOI 10.4049/jimmunol.1103264; McCall GE, 1998, CAN J APPL PHYSIOL, V23, P594, DOI 10.1139/h98-034; Munn J, 2005, J APPL PHYSIOL, V99, P1880, DOI 10.1152/japplphysiol.00559.2005; Munn J, 2004, J APPL PHYSIOL, V96, P1861, DOI 10.1152/japplphysiol.00541.2003; Osterlund C, 2013, HISTOCHEM CELL BIOL; Paddon-Jones D, 2001, EUR J APPL PHYSIOL, V85, P466, DOI 10.1007/s004210100467; PANIN N, 1961, Arch Phys Med Rehabil, V42, P47; Perez M, 2002, PFLUG ARCH EUR J PHY, V443, P866, DOI 10.1007/s00424-001-0769-6; PETTE D, 1985, MUSCLE NERVE, V8, P676, DOI 10.1002/mus.880080810; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pette D, 1997, Int Rev Cytol, V170, P143, DOI 10.1016/S0074-7696(08)61622-8; Pettersson J, 2010, J PLAST RECONSTR AES, V63, P1893, DOI 10.1016/j.bjps.2009.11.024; Schiaffino S., 2008, SKELETAL MUSCLE REPA; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; SEWRY CA, 1995, HISTOCHEM J, V27, P497; Shenker N, 2003, RHEUMATOLOGY, V42, P1279, DOI 10.1093/rheumatology/keg397; Shima N, 2002, EUR J APPL PHYSIOL, V86, P287, DOI 10.1007/s00421-001-0559-z; SILBERSTEIN L, 1986, CELL, V46, P1075, DOI 10.1016/0092-8674(86)90707-5; Sluka KA, 2001, MUSCLE NERVE, V24, P37, DOI 10.1002/1097-4598(200101)24:1<37::AID-MUS4>3.0.CO;2-8; Song Y, 2013, ISRN INFLAMMATION, V2013, P19; Song YF, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-134; Song YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052230; Spang C, 2012, INFLAMMATION, V35, P39, DOI 10.1007/s10753-010-9287-z; Stal PS, 2000, J ANAT, V197, P275, DOI 10.1017/S0021878299006627; Starbuck C, 2012, EUR J APPL PHYSIOL, V112, P1005, DOI 10.1007/s00421-011-2053-6; Staron RS, 1998, HISTOCHEM CELL BIOL, V110, P73, DOI 10.1007/s004180050267; STERNBERGER LA, 1979, J HISTOCHEM CYTOCHEM, V27, P1657, DOI 10.1177/27.12.392001; Tse KH, 2010, J BIOMED MATER RES A, V95A, P701, DOI 10.1002/jbm.a.32889; Twining CM, 2004, PAIN, V110, P299, DOI 10.1016/j.pain.2004.04.008; WARHOL MJ, 1985, AM J PATHOL, V118, P331; Weir JP, 1997, J ORTHOP SPORT PHYS, V25, P264, DOI 10.2519/jospt.1997.25.4.264; Wilson JM, 2012, J STRENGTH COND RES, V26, P1724, DOI 10.1519/JSC.0b013e318234eb6f; Zhou S, 2000, Exerc Sport Sci Rev, V28, P177	79	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116455	10.1371/journal.pone.0116455	http://dx.doi.org/10.1371/journal.pone.0116455			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545800	gold, Green Published, Green Submitted			2022-12-26	WOS:000347120200113
J	Todberg, T; Koch, A; Andersson, M; Olsen, SF; Lous, J; Homoe, P				Todberg, Tanja; Koch, Anders; Andersson, Mikael; Olsen, Sjurdur F.; Lous, Jorgen; Homoe, Preben			Incidence of Otitis Media in a Contemporary Danish National Birth Cohort	PLOS ONE			English	Article							UNITED-STATES; CHILDREN; EPIDEMIOLOGY; TYMPANOMETRY; POPULATION; VALIDITY; HEALTH; BIAS; CARE	Objectives: In recent years welfare in Denmark has increased which might be expected to reduce otitis media (OM) incidence. We examined the age-specific incidence of OM in a nation-wide cohort of children aged 0-7 years born in 19962003 (Danish National Birth Cohort, DNBC). Only selection was ability to understand and speak Danish. Methods: Information of OM and ventilation tubes (VT) was collected through three maternal interviews at 6-month, 18-month and 7-years of age and based on this age-specific and cumulative incidence of OM was calculated. As different numbers of the total population answered the different interviews, the calculations are done with different denominators. The information in DNBC was validated against two population based registries containing information of VT insertions. Results: Cumulative incidence of OM at 7 years was 60.6% (31,982/52,755). For children with OM, 16.2% (7143/44194) had their first OM episodes between 06 months of age, 44.3% (19579/44194) between 7-18 months, and 39.5% (17472/44194) between 19 months and 7 years. Four or more OM episodes before 7 years were reported by 39.5% (12620/31982) and by 64.0% (2482/3881) of those who had their OM debut between 0-6 months; by 48.2% (4998/10378) with debut between 7-18 months; and by 28.7% (4996/17344) with debut between 19 months and 7 years. These figures are essentially unchanged from earlier figures from Denmark. VT insertion at least once was reported by 26,1% in the 7-year interview. Assuming recordings in the Danish National Patient Registry to be gold standard, maternal self-reportings in DNBC of insertion of VTshowed high sensitivity (96.4%), specificity (98.2%), and positive (94.8%) and negative predictive values (98.8%). Conclusion: OM affects nearly 2/3 of preschool children in Denmark despite reduction in known OM risk factors.	[Todberg, Tanja; Homoe, Preben] Univ Copenhagen Hosp, Rigshosp, Dept Otolaryngol Head & Neck Surg & Audiol, DK-2100 Copenhagen, Denmark; [Todberg, Tanja; Koch, Anders; Andersson, Mikael; Olsen, Sjurdur F.] Statens Serum Inst, Ctr Fetal Programming, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Lous, Jorgen] Univ Southern Denmark, Inst Publ Hlth, Res Unit Gen Practice, Odense, Denmark; [Homoe, Preben] Koge Univ Hosp, Dept Otorhinolaryngol & Maxillofacial Surg, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Statens Serum Institut; University of Southern Denmark	Todberg, T (corresponding author), Univ Copenhagen Hosp, Rigshosp, Dept Otolaryngol Head & Neck Surg & Audiol, DK-2100 Copenhagen, Denmark.	gjb710@gmail.com		Koch, Anders/0000-0001-9205-1048; Homoe, Preben/0000-0003-2877-3518; Olsen, Sjurdur/0000-0003-3017-7096	Danish National Research Foundation; Danish Pharmaceutical Association; March of Dimes Birth Defects Foundation; Danish Council for Independent Research; Ministry of Science, Innovation and Higher Education	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Pharmaceutical Association; March of Dimes Birth Defects Foundation(March of Dimes); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Ministry of Science, Innovation and Higher Education	Main sponsors for The Danish National Birth Cohort were The Danish National Research Foundation, The Danish Pharmaceutical Association and The March of Dimes Birth Defects Foundation. This study was sponsored by The Danish Council for Independent Research, which is a part of The Ministry of Science, Innovation and Higher Education. The Danish Council for Independent Research funds specific research activities based on researchers' own initiatives. Amount: 110,000 DKR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams SW, 2011, CURR ALLERGY ASTHM R, V11, P508, DOI 10.1007/s11882-011-0218-3; Cars O, 2001, LANCET, V357, P1851, DOI 10.1016/S0140-6736(00)04972-2; FIELLAUNIKOLAJSEN M, 1979, ARCH OTOLARYNGOL, V105, P461; Froom J, 2001, J Am Board Fam Pract, V14, P406; Greene N, 2011, EPIDEMIOLOGY, V22, P815, DOI 10.1097/EDE.0b013e31822939fd; Hansen AE, 2003, BARSELSORLOV 100 ARS; Hellstrom S, 2011, OTOLARYNG HEAD NECK, V145, P383, DOI 10.1177/0194599811409862; Ingvarsson L, 1985, Auris Nasus Larynx, V12 Suppl 1, pS105; Jacobsen TN, 2010, EUR J EPIDEMIOL, V25, P349, DOI 10.1007/s10654-010-9448-2; Jansen AGSC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001480.pub3; Jensen RG, 2012, PEDIATR INFECT DIS J, V31, P139, DOI 10.1097/INF.0b013e318238c0a4; Johansen Eva Charlotte Jung, 2010, Ugeskr Laeger, V172, P2530; Karevold G, 2007, INT J PEDIATR OTORHI, V71, P1035, DOI 10.1016/j.ijporl.2007.03.010; Klemmensen AK, 2007, AM J EPIDEMIOL, V166, P117, DOI 10.1093/aje/kwm139; Kogan MD, 2000, AM J PUBLIC HEALTH, V90, P245, DOI 10.2105/AJPH.90.2.245; Labout JAM, 2011, EUR J EPIDEMIOL, V26, P61, DOI 10.1007/s10654-010-9500-2; Laine MK, 2010, PEDIATRICS, V125, pE1154, DOI 10.1542/peds.2009-2689; Liese JG, 2014, EPIDEMIOL INFECT, V142, P1778, DOI 10.1017/S0950268813002744; LOUS J, 1981, INT J PEDIATR OTORHI, V3, P303, DOI 10.1016/0165-5876(81)90055-0; Lous J, 2012, INT J PEDIATR OTORHI, V76, P370, DOI 10.1016/j.ijporl.2011.12.011; Marom T, 2014, JAMA PEDIATR, V168, P68, DOI 10.1001/jamapediatrics.2013.3924; Moller L F, 1994, Ugeskr Laeger, V156, P7197; Monasta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036226; Nohr EA, 2006, EPIDEMIOLOGY, V17, P413, DOI 10.1097/01.ede.0000220549.14177.60; Nystad W, 2008, ACTA PAEDIATR, V97, P657, DOI 10.1111/j.1651-2227.2008.00756.x; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Pichichero ME, 2008, PEDIATR INFECT DIS J, V27, P958, DOI 10.1097/INF.0b013e318179a2ac; PUKANDER J, 1982, ACTA OTO-LARYNGOL, V94, P479, DOI 10.3109/00016488209128938; Rosenfeld RM, 2013, OTOLARYNG HEAD NECK, V149, P8, DOI 10.1177/0194599813490141; Schappert S M, 1992, Adv Data, P1; Schilder AGM, 2004, INT J PEDIATR OTORHI, V68, P29, DOI 10.1016/j.ijporl.2003.09.002; Sigsgaard J., 1978, FOLKEBORNEHAVE SOCIA; Silva P A, 1990, Paediatr Perinat Epidemiol, V4, P76, DOI 10.1111/j.1365-3016.1990.tb00621.x; STANGERUP SE, 1986, AM J OTOLARYNG, V7, P47, DOI 10.1016/S0196-0709(86)80034-5; Vernacchio L, 2007, J AM BOARD FAM MED, V20, P160, DOI 10.3122/jabfm.2007.02.060125; VESTERMARK V, 1991, SCAND J SOC MED, V19, P105, DOI 10.1177/140349489101900205; VINTHER B, 1979, ACTA OTO-LARYNGOL, P135	37	48	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e111732	10.1371/journal.pone.0111732	http://dx.doi.org/10.1371/journal.pone.0111732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UN	25545891	Green Published, gold, Green Submitted			2022-12-26	WOS:000347120200002
J	Ohno, M; Kanayama, T; Moore, R; Ray, M; Negishi, M				Ohno, Marumi; Kanayama, Tomohiko; Moore, Rick; Ray, Manas; Negishi, Masahiko			The Roles of Co-Chaperone CCRP/DNAJC7 in Cyp2b10 Gene Activation and Steatosis Development in Mouse Livers	PLOS ONE			English	Article							NUCLEAR RECEPTOR CAR; ARYL-HYDROCARBON RECEPTOR; CONSTITUTIVE ACTIVE/ANDROSTANE RECEPTOR; X-ASSOCIATED PROTEIN-2; INTERACTING PROTEIN; J-DOMAIN; INDUCTION; COMPLEX; EXPRESSION; ELEMENTS	Cytoplasmic constitutive active/androstane receptor (CAR) retention protein (CCRP and also known as DNAJC7) is a co-chaperone previously characterized to retain nuclear receptor CAR in the cytoplasm of HepG2 cells. Here we have produced CCRP knockout (KO) mice and demonstrated that CCRP regulates CAR at multiple steps in activation of the cytochrome (Cyp) 2b10 gene in liver: nuclear accumulation, RNA polymerase II recruitment and epigenetic modifications. Phenobarbital treatment greatly increased nuclear CAR accumulation in the livers of KO males as compared to those of wild type (WT) males. Despite this accumulation, phenobarbital-induced activation of the Cyp2b10 gene was significantly attenuated. In ChIP assays, a CAR/retinoid X receptor-alpha (RXRa) heterodimer binding to the Cyp2b10 promoter was already increased before phenobarbital treatment and further pronounced after treatment. However, RNA polymerase II was barely recruited to the promoter even after phenobarbital treatment. Histone H3K27 on the Cyp2b10 promoter was de-methylated only after phenobarbital treatment in WT but was fully de-methylated before treatment in KO males. Thus, CCRP confers phenobarbital-induced de-methylation capability to the promoter as well as the phenobarbital responsiveness of recruiting RNA polymerase II, but is not responsible for the binding between CAR and its cognate sequence, phenobarbital responsive element module. In addition, KO males developed steatotic livers and increased serum levels of total cholesterol and high density lipoprotein in response to fasting. CCRP appears to be involved in various hepatic regulations far beyond CAR-mediated drug metabolism.	[Ohno, Marumi; Kanayama, Tomohiko; Moore, Rick; Negishi, Masahiko] NIEHS, Pharmacogenet Sect, Reprod & Dev Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Ray, Manas] NIEHS, Knockout Core, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Negishi, M (corresponding author), NIEHS, Pharmacogenet Sect, Reprod & Dev Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	negishi@niehs.nih.gov	Negishi, Masahiko/F-7805-2019	Negishi, Masahiko/0000-0002-2076-8928; Ohno, Marumi/0000-0003-1086-8244	National Institutes of Health [Z01ES1005-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102425, ZICES102445, ZIAES080040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Intramural Research program:: Z01ES1005-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell DR, 2000, J BIOL CHEM, V275, P36407, DOI 10.1074/jbc.M004236200; Brychzy A, 2003, EMBO J, V22, P3613, DOI 10.1093/emboj/cdg362; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Hedman E, 2006, PROTEOMICS, V6, P3114, DOI 10.1002/pmic.200500266; Hestermann EV, 2003, MOL CELL BIOL, V23, P7920, DOI 10.1128/MCB.23.21.7920-7925.2003; Honkakoski P, 1998, J BIOCHEM MOL TOXIC, V12, P3; Inagaki M, 2008, GENESIS, V46, P431, DOI 10.1002/dvg.20418; Kakizaki S, 2003, BBA-GEN SUBJECTS, V1619, P239, DOI 10.1016/S0304-4165(02)00482-8; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Kobayashi K, 2003, MOL PHARMACOL, V64, P1069, DOI 10.1124/mol.64.5.1069; Koike C, 2007, MOL PHARMACOL, V71, P1217, DOI 10.1124/mol.107.034538; Kubo N, 2013, BIOCHEM BIOPH RES CO, V430, P1034, DOI 10.1016/j.bbrc.2012.11.121; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Lempiainen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018216; Lin BC, 2007, J BIOL CHEM, V282, P35924, DOI 10.1074/jbc.M705471200; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; Meyer BK, 1999, BIOCHEMISTRY-US, V38, P8907, DOI 10.1021/bi982223w; Moffatt NSC, 2008, BIOCHEMISTRY-US, V47, P8203, DOI 10.1021/bi800770g; Mutoh S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003705; Nakamura K, 2007, J BIOL CHEM, V282, P9768, DOI 10.1074/jbc.M610072200; Nukaya M, 2010, J BIOL CHEM, V285, P35599, DOI 10.1074/jbc.M110.132043; Petrulis JR, 2000, J BIOL CHEM, V275, P37448, DOI 10.1074/jbc.M006873200; Phillips JM, 2007, TOXICOL SCI, V96, P72, DOI 10.1093/toxsci/kfl188; Riggs DL, 2003, EMBO J, V22, P1158, DOI 10.1093/emboj/cdg108; Saito K, 2013, BIOCHEM BIOPH RES CO, V436, P730, DOI 10.1016/j.bbrc.2013.06.025; Saito K, 2013, TOXICOL SCI, V132, P151, DOI 10.1093/toxsci/kfs338; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schulke JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011717; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Squires EJ, 2004, J BIOL CHEM, V279, P49307, DOI 10.1074/jbc.M407281200; Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; SUEYOSHI T, 1995, MOL CELL BIOL, V15, P4158; Sugatani J, 2002, BIOCHEM BIOPH RES CO, V292, P492, DOI 10.1006/bbrc.2002.6683; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; Warrier M, 2010, ENDOCRINOLOGY, V151, P3225, DOI 10.1210/en.2009-1158; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; Wiwi CA, 2004, MOL ENDOCRINOL, V18, P1975, DOI 10.1210/me.2004-0129; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Yamamoto Y, 2003, ARCH BIOCHEM BIOPHYS, V409, P207, DOI 10.1016/S0003-9861(02)00456-3; Yang H, 2014, MOL PHARMACOL, V85, P249, DOI 10.1124/mol.113.089763	43	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115663	10.1371/journal.pone.0115663	http://dx.doi.org/10.1371/journal.pone.0115663			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542016	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900066
J	Wex, E; Thaler, E; Blum, S; Lamb, D				Wex, Eva; Thaler, Eva; Blum, Sylvia; Lamb, David			A Novel Model of IgE-Mediated Passive Pulmonary Anaphylaxis in Rats	PLOS ONE			English	Article							HUMAN MAST-CELL; TYROSINE KINASE; AIRWAY HYPERRESPONSIVENESS; ALLERGIC-ASTHMA; SYK; INFLAMMATION; INHIBITION; ACTIVATION; RHINITIS; MOUSE	Mast cells are central effector cells in allergic asthma and are augmented in the airways of asthma patients. Attenuating mast cell degranulation and with it the early asthmatic response is an important intervention point to inhibit bronchoconstriction, plasma exudation and tissue oedema formation. To validate the efficacy of novel pharmacological interventions, appropriate and practicable in vivo models reflecting mast cell-dependent mechanisms in the lung, are missing. Thus, we developed a novel model of passive pulmonary anaphylaxis in rats. Rats were passively sensitized by concurrent intratracheal and intradermal (ear) application of an antiDNP IgE antibody. Intravenous application of the antigen, DNP-BSA in combination with Evans blue dye, led to mast cell degranulation in both tissues. Quantification of mast cell degranulation in the lung was determined by (1) mediator release into bronchoalveolar lavage, (2) extravasation of Evans blue dye into tracheal and bronchial lung tissue and (3) invasive measurement of antigen-induced bronchoconstriction. Quantification of mast cell degranulation in the ear was determined by extravasation of Evans blue dye into ear tissue. We pharmacologically validated our model using the SYK inhibitor Fostamatinib, the H1-receptor antagonist Desloratadine, the mast cell stabilizer disodium cromoglycate (DSCG) and the beta(2)-adrenergic receptor agonist Formoterol. Fostamatinib was equally efficacious in lung and ear. Desloratadine effectively inhibited bronchoconstriction and ear vascular leakage, but was less effective against pulmonary vascular leakage, perhaps reflecting the differing roles for histamine receptor sub-types. DSCG attenuated both vascular leakage in the lung and bronchoconstriction, but with a very short duration of action. As an inhaled approach, Formoterol was more effective in the lung than in the ear. This model of passive pulmonary anaphylaxis provides a tissue relevant readout of early mast cell activity and pharmacological benchmarking broadly reflects responses observed in patients with asthma.	[Wex, Eva; Thaler, Eva; Blum, Sylvia; Lamb, David] Boehringer Ingelheim Pharma GmbH & Co KG, Resp Dis Res, Biberach, Germany	Boehringer Ingelheim	Wex, E (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Resp Dis Res, Biberach, Germany.	eva.wex@boehringer-ingelheim.com		Wex, Eva/0000-0002-4643-1899	Boehringer Ingelheim Pharma GmbH Co. KG	Boehringer Ingelheim Pharma GmbH Co. KG(Boehringer Ingelheim)	The funder (Boehringer Ingelheim Pharma GmbH & Co. KG) provided support in the form of salaries for authors [EW, ET, SB, DL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions section.	Andersson CK, 2011, J ALLERGY CLIN IMMUN, V127, P905, DOI 10.1016/j.jaci.2011.01.022; Barnes PJ, 2011, J BIOL CHEM, V286, P32899, DOI 10.1074/jbc.R110.206466; BARNES PJ, 1991, AGENT ACTION SUPPL, V33, P103; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Castells MC, 2011, ANAPHYLAXIS AND HYPERSENSITIVITY REACTIONS, P1, DOI 10.1007/978-1-60327-951-2; Church Martin K, 2013, Indian J Dermatol, V58, P219, DOI 10.4103/0019-5154.110832; Genovese A, 1997, CLIN EXP ALLERGY, V27, P559, DOI 10.1046/j.1365-2222.1997.270860.x; Gonzalez-Nunez V, 2013, EXPERT OPIN DRUG SAF, V12, P445, DOI 10.1517/14740338.2013.788148; Hart PH, 2001, IMMUNOL CELL BIOL, V79, P149, DOI 10.1046/j.1440-1711.2001.00983.x; Lemanske Robert F. Jr., 2003, Journal of Allergy and Clinical Immunology, V111, pS502; MACONOCHIE JG, 1979, BRIT J CLIN PHARMACO, V7, P231, DOI 10.1111/j.1365-2125.1979.tb00927.x; Matsubara S, 2006, AM J RESP CELL MOL, V34, P426, DOI 10.1165/rcmb.2005-0298OC; Matsubara S, 2006, AM J RESP CRIT CARE, V173, P56, DOI 10.1164/rccm.200503-361OC; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; MURPHY S, 1987, DRUG INTEL CLIN PHAR, V21, P22, DOI 10.1177/10600280870211P102; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; O'Byrne PM, 2009, ALLERGY ASTHMA IMMUN, V1, P3, DOI 10.4168/aair.2009.1.1.3; OVARY Z, 1958, J IMMUNOL, V81, P355; Ruzza P, 2009, EXPERT OPIN THER PAT, V19, P1361, DOI 10.1517/13543770903207039; SCHWARTZ LB, 1989, J CLIN INVEST, V83, P1551, DOI 10.1172/JCI114051; THOMSON DS, 1973, CLIN EXP IMMUNOL, V13, P537; Ulanova M, 2005, EXPERT OPIN THER TAR, V9, P901, DOI 10.1517/14728222.9.5.901; Weston MC, 1998, GEN PHARMACOL-VASC S, V31, P715, DOI 10.1016/S0306-3623(98)00080-9; Wex E, 2011, EUR J IMMUNOL, V41, P3208, DOI 10.1002/eji.201141502; Xu YD, 2010, RESP RES, V11, DOI [10.1186/1465-9921-11-166, 10.1186/1465-9921-11-107]	25	10	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116166	10.1371/journal.pone.0116166	http://dx.doi.org/10.1371/journal.pone.0116166			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541997	Green Submitted, gold, Green Published			2022-12-26	WOS:000347239900153
J	Baranovskiy, AG; Zhang, YB; Suwa, Y; Babayeva, ND; Gu, JY; Pavlov, YI; Tahirov, TH				Baranovskiy, Andrey G.; Zhang, Yinbo; Suwa, Yoshiaki; Babayeva, Nigar D.; Gu, Jianyou; Pavlov, Youri I.; Tahirov, Tahir H.			Crystal Structure of the Human Primase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-ALPHA; C-TERMINAL DOMAIN; RNA PRIMER SYNTHESIS; P58 SUBUNIT; EUKARYOTIC REPLISOME; NMR SYSTEM; IN-VIVO; REPLICATION; MECHANISM; COMPLEX	DNA replication in bacteria and eukaryotes requires the activity of DNA primase, a DNA-dependent RNA polymerase that lays short RNA primers for DNA polymerases. Eukaryotic and archaeal primases are heterodimers consisting of small catalytic and large accessory subunits, both of which are necessary for RNA primer synthesis. Understanding of RNA synthesis priming in eukaryotes is currently limited due to the lack of crystal structures of the full-length primase and its complexes with substrates in initiation and elongation states. Here we report the crystal structure of the full-length human primase, revealing the precise overall organization of the enzyme, the relative positions of its functional domains, and the mode of its interaction with modeled DNA and RNA. The structure indicates that the dramatic conformational changes in primase are necessary to accomplish the initiation and then elongation of RNA synthesis. The presence of a long linker between the N- and C-terminal domains of p58 provides the structural basis for the bulk of enzyme's conformational flexibility. Deletion of most of this linker affected the initiation and elongation steps of the primer synthesis.	[Tahirov, Tahir H.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Zhang, Yinbo; Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Tahirov, TH (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	ttahirov@unmc.edu	Pavlov, Youri/T-7532-2017	Pavlov, Youri/0000-0003-1179-5796; Tahirov, Tahir/0000-0002-1238-0069; Gu, Jianyou/0000-0003-0285-8919	National Institutes of Health (NIH), NIGMS [GM101167, P41 GM103403]; NIH, NCI [CA129925]; NIH Cancer Center [P30CA036727]; United States DOE [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA129925, P30CA036727] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101167, P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States DOE(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NIGMS, Grant GM101167 (to T. H. T.) and NIH, NCI, Grant CA129925 (to Y. I. P.). The Eppley Institute X-ray Crystallography Core Facility is supported by NIH Cancer Center Support Grant P30CA036727. This work is also based upon research conducted at the Advanced Photon Source on the NECAT beamlines, which are supported by NIH, NIGMS, Grant P41 GM103403. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the United States DOE under Contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agarkar VB, 2011, CELL CYCLE, V10, P926, DOI 10.4161/cc.10.6.15010; Arezi B, 1999, BIOCHEMISTRY-US, V38, P12899, DOI 10.1021/bi9908991; Augustin MA, 2001, NAT STRUCT BIOL, V8, P57, DOI 10.1038/83060; Baranovskiy AG, 2014, ACTA CRYSTALLOGR F, V70, P206, DOI 10.1107/S2053230X13034432; Baranovskiy AG, 2012, J BIOL CHEM, V287, P17281, DOI 10.1074/jbc.M112.351122; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Copeland WC, 1997, PROTEIN EXPRES PURIF, V9, P1, DOI 10.1006/prep.1996.0665; COPELAND WC, 1995, J BIOL CHEM, V270, P3905, DOI 10.1074/jbc.270.8.3905; COPELAND WC, 1993, J BIOL CHEM, V268, P26179; Corn JE, 2005, MOL CELL, V20, P391, DOI 10.1016/j.molcel.2005.09.004; FOIANI M, 1989, J BIOL CHEM, V264, P2189; FRANCESCONI S, 1991, P NATL ACAD SCI USA, V88, P3877, DOI 10.1073/pnas.88.9.3877; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Geibel S, 2009, P NATL ACAD SCI USA, V106, P7810, DOI 10.1073/pnas.0902910106; Goldman SR, 2009, SCIENCE, V324, P927, DOI 10.1126/science.1169237; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ito N, 2003, GENES CELLS, V8, P913, DOI 10.1111/j.1365-2443.2003.00693.x; Kato M, 2004, J BIOL CHEM, V279, P30554, DOI 10.1074/jbc.M403485200; Kato M, 2003, MOL CELL, V11, P1349, DOI 10.1016/S1097-2765(03)00195-3; Kilkenny ML, 2012, J BIOL CHEM, V287, P23740, DOI 10.1074/jbc.M112.368951; Kilkenny ML, 2013, P NATL ACAD SCI USA, V110, P15961, DOI 10.1073/pnas.1311185110; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; KOO HS, 1986, NATURE, V320, P501, DOI 10.1038/320501a0; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Lao-Sirieix SH, 2005, NAT STRUCT MOL BIOL, V12, P1137, DOI 10.1038/nsmb1013; Leipe DD, 1999, NUCLEIC ACIDS RES, V27, P3389, DOI 10.1093/nar/27.17.3389; Lipps G, 2004, NAT STRUCT MOL BIOL, V11, P157, DOI 10.1038/nsmb723; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; MIRKIN SM, 1994, ANNU REV BIOPH BIOM, V23, P541, DOI 10.1146/annurev.bb.23.060194.002545; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; OGAWA T, 1980, ANNU REV BIOCHEM, V49, P421, DOI 10.1146/annurev.bi.49.070180.002225; Pan H, 2000, STRUCTURE, V8, P231, DOI 10.1016/S0969-2126(00)00101-5; Pellegrini Luca, 2012, Subcell Biochem, V62, P157, DOI 10.1007/978-94-007-4572-8_9; Perera RL, 2013, ELIFE, V2, DOI 10.7554/eLife.00482; PODUST VN, 1992, EUR J BIOCHEM, V206, P7, DOI 10.1111/j.1432-1033.1992.tb16895.x; Sauguet L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010083; SHEAFF RJ, 1994, BIOCHEMISTRY-US, V33, P2247, DOI 10.1021/bi00174a035; SHEAFF RJ, 1993, BIOCHEMISTRY-US, V32, P3027, DOI 10.1021/bi00063a014; Simon AC, 2014, NATURE, V510, P293, DOI 10.1038/nature13234; SINGH H, 1986, J BIOL CHEM, V261, P8564; THOMPSON HC, 1995, NUCLEIC ACIDS RES, V23, P4109, DOI 10.1093/nar/23.20.4109; Vaithiyalingam S, 2014, J MOL BIOL, V426, P558, DOI 10.1016/j.jmb.2013.11.007; Vaithiyalingam S, 2010, P NATL ACAD SCI USA, V107, P13684, DOI 10.1073/pnas.1002009107; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Zakharova OD, 1995, BIOCHIMIE, V77, P699, DOI 10.1016/0300-9084(96)88184-3; Zerbe LK, 2002, BIOCHEMISTRY-US, V41, P4891, DOI 10.1021/bi016030b; Zhang YB, 2014, J BIOL CHEM, V289, P22021, DOI 10.1074/jbc.M114.570333	51	39	39	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5635	5646		10.1074/jbc.M114.624742	http://dx.doi.org/10.1074/jbc.M114.624742			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25550159	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000350044200033
J	Jay, AG; Chen, AN; Paz, MA; Hung, JP; Hamilton, JA				Jay, Anthony G.; Chen, Alexander N.; Paz, Miguel A.; Hung, Justin P.; Hamilton, James A.			CD36 Binds Oxidized Low Density Lipoprotein (LDL) in a Mechanism Dependent upon Fatty Acid Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE-DERIVED MACROPHAGES; SCAVENGER RECEPTOR CD36; FOAM CELL-FORMATION; MEMBRANE-PROTEINS; SR-BI; LONG; EXPRESSION; DYNAMICS; ATHEROSCLEROSIS; TRAFFICKING	The association of unesterified fatty acid (FA) with the scavenger receptor CD36 has been actively researched, with focuses on FA and oxidized low density lipoprotein (oxLDL) uptake. CD36 has been shown to bind FA, but this interaction has been poorly characterized to date. To gain new insights into the physiological relevance of binding of FA to CD36, we characterized FA binding to the ectodomain of CD36 by the biophysical method surface plasmon resonance. Five structurally distinct FAs (saturated, monounsaturated (cis and trans), polyunsaturated, and oxidized) were pulsed across surface plasmon resonance channels, generating association and dissociation binding curves. Except for the oxidized FA HODE, all FAs bound to CD36, with rapid association and dissociation kinetics similar to HSA. Next, to elucidate the role that each FA might play in CD36-mediated oxLDL uptake, we used a fluorescent oxLDL (Dii-oxLDL) live cell assay with confocal microscopy imaging. CD36-mediated uptake in serum-free medium was very low but greatly increased when serum was present. The addition of exogenous FA in serum-free medium increased oxLDL binding and uptake to levels found with serum and affected CD36 plasma membrane distribution. Binding/uptake of oxLDL was dependent upon the FA dose, except for docosahexaenoic acid, which exhibited binding to CD36 but did not activate the uptake of oxLDL. HODEalso did not affect oxLDL uptake. High affinity FA binding to CD36 and the effects of each FA on oxLDL uptake have important implications for protein conformation, binding of other ligands, functional properties of CD36, and high plasma FA levels in obesity and type 2 diabetes.	[Jay, Anthony G.] Boston Univ, Dept Biochem, Boston, MA 02118 USA; [Jay, Anthony G.; Chen, Alexander N.; Paz, Miguel A.; Hung, Justin P.; Hamilton, James A.] Boston Univ, Dept Physiol & Biophys, Boston, MA 02118 USA	Boston University; Boston University	Hamilton, JA (corresponding author), Boston Univ, Dept Physiol & Biophys, 700 Albany St,W302, Boston, MA 02118 USA.	jhamilt@gmail.com		Jay, Anthony G./0000-0003-0346-9480; Hamilton, James/0000-0002-4747-7071	American Diabetes Association [1-11-BS-R62]	American Diabetes Association(American Diabetes Association)	This work was supported by the American Diabetes Association Grant 1-11-BS-R62 (to J. A. H.).	Abumrad N, 1999, BBA-MOL CELL BIOL L, V1441, P4, DOI 10.1016/S1388-1981(99)00137-7; Amezaga N, 2014, J LEUKOCYTE BIOL, V95, P509, DOI 10.1189/jlb.1212660; Avraham-Davidi I, 2013, EXP CELL RES, V319, P1298, DOI 10.1016/j.yexcr.2013.01.009; Baillie AGS, 1996, J MEMBRANE BIOL, V153, P75, DOI 10.1007/s002329900111; Baranova IN, 2012, J IMMUNOL, V188, P1371, DOI 10.4049/jimmunol.1100350; Bassett CMC, 2010, J NUTR, V140, P18, DOI 10.3945/jn.109.105163; Brunaldi K, 2010, J LIPID RES, V51, P120, DOI [10.1194/M900200-JLR200, 10.1194/jlr.M900200-JLR200]; Byun JY, 2006, MOL VIS, V12, P949; Cai J, 2012, BIOPHYS J, V102, P2585, DOI 10.1016/j.bpj.2012.04.039; CROUSE JR, 1985, J LIPID RES, V26, P566; de Villiers WJS, 2001, J LIPID RES, V42, P1231; Degrace-Passilly P, 2012, CURR OPIN CLIN NUTR, V15, P107, DOI 10.1097/MCO.0b013e32834ff19c; Dushkin MI, 2012, BIOCHEMISTRY-MOSCOW+, V77, P327, DOI 10.1134/S0006297912040025; Ebbert JO, 2013, NUTRIENTS, V5, P498, DOI 10.3390/nu5020498; FOLCIK VA, 1994, J LIPID RES, V35, P1570; Martinez VG, 2011, PHARMACOL REV, V63, P967, DOI 10.1124/pr.111.004523; Gaubatz JW, 2007, J LIPID RES, V48, P348, DOI 10.1194/jlr.M600249-JLR200; GERICH JE, 1974, J CLIN INVEST, V53, P1284, DOI 10.1172/JCI107675; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; Gruarin P, 2001, J IMMUNOL, V167, P6510, DOI 10.4049/jimmunol.167.11.6510; Hamilton JA, 2013, BBA-GEN SUBJECTS, V1830, P5418, DOI 10.1016/j.bbagen.2013.08.002; HARMON CM, 1991, J MEMBRANE BIOL, V121, P261, DOI 10.1007/BF01951559; HARMON CM, 1992, BIOCHEM SOC T, V20, P811, DOI 10.1042/bst0200811; HARMON CM, 1993, J MEMBRANE BIOL, V133, P43; Hebling CM, 2010, ANAL CHEM, V82, P5415, DOI 10.1021/ac100962c; Hofnagel O, 2007, BBA-MOL CELL BIOL L, V1771, P1117, DOI 10.1016/j.bbalip.2007.06.003; Hoosdally SJ, 2009, J BIOL CHEM, V284, P16277, DOI 10.1074/jbc.M109.007849; Kanicky JR, 2002, J COLLOID INTERF SCI, V256, P201, DOI 10.1006/jcis.2001.8009; Kar NS, 2008, J BIOL CHEM, V283, P8765, DOI 10.1074/jbc.M709195200; KASHIWAGI H, 1995, J CLIN INVEST, V95, P1040, DOI 10.1172/JCI117749; Kashyap SR, 2009, OBESITY, V17, P2142, DOI 10.1038/oby.2009.179; Khan-Merchant N, 2002, J NUTR, V132, P3256, DOI 10.1093/jn/132.11.3256; Kozai Y, 2014, BIOSCI BIOTECH BIOCH, V78, P839, DOI 10.1080/09168451.2014.891934; Krammer J, 2011, INT J MED SCI, V8, P599, DOI 10.7150/ijms.8.599; Krenzel ES, 2013, BIOCHEMISTRY-US, V52, P1559, DOI 10.1021/bi301458b; KU G, 1992, J BIOL CHEM, V267, P14183; Kuda O, 2013, J BIOL CHEM, V288, P15547, DOI 10.1074/jbc.M113.473298; Le Foll C, 2013, DIABETES, V62, P2709, DOI 10.2337/db12-1689; Madonna R, 2011, THROMB HAEMOSTASIS, V106, P500, DOI 10.1160/TH10-09-0574; Maiolino G, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/714653; Martin CA, 2007, PROTEIN SCI, V16, P2531, DOI 10.1110/ps.073007207; McDonnell JM, 2001, CURR OPIN CHEM BIOL, V5, P572, DOI 10.1016/S1367-5931(00)00251-9; Mittendorfer B, 2009, OBESITY, V17, P1872, DOI 10.1038/oby.2009.224; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Murphy JE, 2005, ATHEROSCLEROSIS, V182, P1, DOI 10.1016/j.atherosclerosis.2005.03.036; Navazo MDP, 1996, ARTERIOSCL THROM VAS, V16, P1033, DOI 10.1161/01.ATV.16.8.1033; Neculai D, 2013, NATURE, V504, P172, DOI 10.1038/nature12684; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; Pillai BK, 2009, J BIOL CHEM, V284, P33296, DOI 10.1074/jbc.M109.043737; Pluddemann A, 2007, METHODS, V43, P207, DOI 10.1016/j.ymeth.2007.06.004; Pownall H, 2014, ARTERIOSCL THROM VAS, V34, pE8, DOI 10.1161/ATVBAHA.114.303380; Ramos-Arellano LE, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-54; Rasmussen JT, 1998, EUR J BIOCHEM, V257, P488, DOI 10.1046/j.1432-1327.1998.2570488.x; Robbins AK, 1998, BIOTECHNIQUES, V25, P240, DOI 10.2144/98252st04; Saez-Cirion A, 2002, BBA-BIOMEMBRANES, V1564, P57, DOI 10.1016/S0005-2736(02)00400-5; Silverstein RL, 2009, CLEVE CLIN J MED S2, V76, pS27, DOI DOI 10.3949/CCJM.76.S2.06; Silverstein Roy L, 2010, Trans Am Clin Climatol Assoc, V121, P206; Simard JR, 2010, J LIPID RES, V51, P914, DOI 10.1194/jlr.M900251; SPECTOR AA, 1975, J LIPID RES, V16, P165; Stachowska E, 2004, EUR J NUTR, V43, P313, DOI 10.1007/s00394-004-0479-x; STOLL LL, 1984, IN VITRO CELL DEV B, V20, P732; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Sun B, 2007, J LIPID RES, V48, P2560, DOI 10.1194/jlr.M700163-JLR200; Sun B, 2006, J LIPID RES, V47, P1700, DOI 10.1194/jlr.M500450-JLR200; Takai M, 2014, BIOSCI BIOTECH BIOCH, V78, P238, DOI 10.1080/09168451.2014.882750; Tarhda Z, 2013, BIOINFORM BIOL INSIG, V7, P369, DOI 10.4137/BBI.S12276; Xu S, 2013, BIOCHEMISTRY-US, V52, P7254, DOI 10.1021/bi400914c; Yaney GC, 2001, DIABETES, V50, P56, DOI 10.2337/diabetes.50.1.56; Zhang FL, 1997, J BIOMOL NMR, V9, P213, DOI 10.1023/A:1018666522787; Zhang FL, 1996, BIOCHEMISTRY-US, V35, P16055, DOI 10.1021/bi961685b	70	49	52	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4590	4603		10.1074/jbc.M114.627026	http://dx.doi.org/10.1074/jbc.M114.627026			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25555908	hybrid, Green Published			2022-12-26	WOS:000350042000006
J	Jendresen, CB; Cui, H; Zhang, X; Vlodavsky, I; Nilsson, LNG; Li, JP				Jendresen, Charlotte B.; Cui, Hao; Zhang, Xiao; Vlodavsky, Israel; Nilsson, Lars N. G.; Li, Jin-Ping			Overexpression of Heparanase Lowers the Amyloid Burden in Amyloid-beta Precursor Protein Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; A-BETA; SULFATE PROTEOGLYCANS; GLYCOSAMINOGLYCANS; ACCUMULATION; AGGREGATION; INHIBITION; REGULATORS; PEPTIDES; DEPOSITS	Heparan sulfate (HS) and HS proteoglycans (HSPGs) colocalize with amyloid-beta (A beta) deposits in Alzheimer disease brain and in A beta precursor protein (A beta PP) transgenic mouse models. Heparanase is an endoglycosidase that specifically degrades the unbranched glycosaminoglycan side chains of HSPGs. The aim of this study was to test the hypothesis that HS and HSPGs are active participators of A beta pathogenesis in vivo. We therefore generated a double-transgenic mouse model overexpressing both human heparanase and human A beta PP harboring the Swedish mutation (tgHpa*Swe). Overexpression of heparanase did not affect A beta PP processing because the steady-state levels of A beta(1-40), A beta(1-42), and soluble A beta PP beta were the same in 2- to 3-month-old double-transgenic tgHpa*Swe and single-transgenic tgSwe mice. In contrast, the Congo red-positive amyloid burden was significantly lower in 15-month-old tgHpa*Swe brain than in tgSwe brain. Likewise, the A beta burden, measured by A beta(x-40) and A beta(x-42) immunohistochemistry, was reduced significantly in tgHpa*Swe brain. The intensity of HS-stained plaques correlated with the A beta(x-42) burden and was reduced in tgHpa*Swe mice. Moreover, the HS-like molecule heparin facilitated A beta(1-42)-aggregation in an in vitro Thioflavin T assay. The findings suggest that HSPGs contribute to amyloid deposition in tgSwe mice by increasing A beta fibril formation because heparanase-induced fragmentation of HS led to a reduced amyloid burden. Therefore, drugs interfering with A beta-HSPG interactions might be a potential strategy for Alzheimer disease treatment.	[Jendresen, Charlotte B.; Nilsson, Lars N. G.] Univ Oslo, Dept Pharmacol, N-0316 Oslo, Norway; [Jendresen, Charlotte B.; Nilsson, Lars N. G.] Oslo Univ Hosp, N-0316 Oslo, Norway; [Cui, Hao; Li, Jin-Ping] Uppsala Univ, Biomed Ctr, SciLifeLab Uppsala, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; [Zhang, Xiao] Uppsala Univ, Dept Neurosci & Pharmacol, S-75124 Uppsala, Sweden; [Vlodavsky, Israel] Technion Israel Inst Technol, Fac Med, Canc & Vasc Biol Res Ctr Rappaport, IL-31096 Haifa, Israel	University of Oslo; University of Oslo; SciLifeLab; Uppsala University; Uppsala University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Nilsson, LNG (corresponding author), Univ Oslo, Dept Pharmacol, Postboks 1057 Blindern, N-0316 Oslo, Norway.	lars.nilsson@medisin.uio.no; jin-ping.li@imbim.uu.se		nilsson, lars/0000-0002-8362-1042	University of Oslo; Anders Jahres Stiftelse; Helse Sor-Ost; Civitan Foundation; Joint Programme Neurodegenerative Disease Research grant; Swedish Heart and Lung Foundation [20110131]; Swedish Research Council [K2012-67X-21128-01-4]; Polysackaridforskning Foundation (Uppsala)	University of Oslo; Anders Jahres Stiftelse; Helse Sor-Ost; Civitan Foundation; Joint Programme Neurodegenerative Disease Research grant; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Polysackaridforskning Foundation (Uppsala)	This work was supported by funding from the University of Oslo, by Anders Jahres Stiftelse, by Helse Sor-Ost, by the Civitan Foundation, by a Joint Programme Neurodegenerative Disease Research grant (to L. N. G. N.), by Swedish Heart and Lung Foundation Grant 20110131, by Swedish Research Council Grant K2012-67X-21128-01-4, and by the Polysackaridforskning Foundation (Uppsala) (to J. P. L.).	Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Castillo GM, 1999, J NEUROCHEM, V72, P1681, DOI 10.1046/j.1471-4159.1999.721681.x; Cotman SL, 2000, MOL CELL NEUROSCI, V15, P183, DOI 10.1006/mcne.1999.0816; Cui P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023219; Englund H, 2007, J NEUROCHEM, V103, P334, DOI 10.1111/j.1471-4159.2007.04759.x; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; Galvis MLE, 2007, NAT CHEM BIOL, V3, P773, DOI 10.1038/nchembio.2007.41; KNOPS J, 1995, J BIOL CHEM, V270, P2419, DOI 10.1074/jbc.270.6.2419; Lander AD, 1998, MATRIX BIOL, V17, P465, DOI 10.1016/S0945-053X(98)90093-2; Leveugle B, 1997, NEUROCHEM INT, V30, P543, DOI 10.1016/S0197-0186(96)00103-9; Levy-Adam F, 2003, BIOCHEM BIOPH RES CO, V308, P885, DOI 10.1016/S0006-291X(03)01478-5; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Lord A, 2011, AM J PATHOL, V178, P2286, DOI 10.1016/j.ajpath.2011.01.052; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; O'Callaghan P, 2008, BRAIN PATHOL, V18, P548, DOI 10.1111/j.1750-3639.2008.00152.x; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Pepys MB, 2002, NATURE, V417, P254, DOI 10.1038/417254a; Philipson O, 2009, NEUROBIOL AGING, V30, P1393, DOI 10.1016/j.neurobiolaging.2007.11.022; Potter H, 2001, NEUROBIOL AGING, V22, P923, DOI 10.1016/S0197-4580(01)00308-6; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Scholefield Z, 2003, J CELL BIOL, V163, P97, DOI 10.1083/jcb.200303059; SNOW AD, 1987, LAB INVEST, V56, P120; SNOW AD, 1994, NEURON, V12, P219, DOI 10.1016/0896-6273(94)90165-1; SNOW AD, 1989, NEUROBIOL AGING, V10, P481, DOI 10.1016/0197-4580(89)90108-5; van Horssen J, 2002, NEUROBIOL AGING, V23, P537, DOI 10.1016/S0197-4580(02)00010-6; Vlodavsky I, 2002, SEMIN CANCER BIOL, V12, P121, DOI 10.1006/scbi.2001.0420; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Watson DJ, 1997, J BIOL CHEM, V272, P31617, DOI 10.1074/jbc.272.50.31617; Weller RO, 2008, BRAIN PATHOL, V18, P253, DOI 10.1111/j.1750-3639.2008.00133.x; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068; Zhang X, 2012, ACTA NEUROPATHOL, V124, P465, DOI 10.1007/s00401-012-0997-1	35	35	37	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5053	5064		10.1074/jbc.M114.600569	http://dx.doi.org/10.1074/jbc.M114.600569			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25548284	hybrid, Green Published			2022-12-26	WOS:000350042000046
J	Mizushina, Y; Shirasuna, K; Usui, F; Karasawa, T; Kawashima, A; Kimura, H; Kobayashi, M; Komada, T; Inoue, Y; Mato, N; Yamasawa, H; Latz, E; Iwakura, Y; Kasahara, T; Bando, M; Sugiyama, Y; Takahashi, M				Mizushina, Yoshiko; Shirasuna, Koumei; Usui, Fumitake; Karasawa, Tadayoshi; Kawashima, Akira; Kimura, Hiroaki; Kobayashi, Motoi; Komada, Takanori; Inoue, Yoshiyuki; Mato, Naoko; Yamasawa, Hideaki; Latz, Eicke; Iwakura, Yoichiro; Kasahara, Tadashi; Bando, Masashi; Sugiyama, Yukihiko; Takahashi, Masafumi			NLRP3 Protein Deficiency Exacerbates Hyperoxia-induced Lethality through Stat3 Protein Signaling Independent of Interleukin-1 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LUNG INJURY; ISCHEMIA-REPERFUSION INJURY; INFLAMMASOME; MICE; CANCER; TRANSCRIPTION-3; CONTRIBUTES; TRANSDUCER; ACTIVATION; MECHANISMS	Supplemental oxygen inhalation is frequently used to treat severe respiratory failure; however, prolonged exposure to hyperoxia causes hyperoxic acute lung injury (HALI), which induces acute respiratory distress syndrome and leads to high mortality rates. Recent investigations suggest the possible role of NLRP3 inflammasomes, which regulate IL-1 beta production and lead to inflammatory responses, in the pathophysiology of HALI; however, their role is not fully understood. In this study, we investigated the role of NLRP3 inflammasomes in mice with HALI. Under hyperoxic conditions, NLRP3(-/-) mice died at a higher rate compared with wild-type and IL-1 beta(-/-) mice, and there was no difference in IL-1 beta production in their lungs. Under hyperoxic conditions, the lungs of NLRP3(-/-) mice exhibited reduced inflammatory responses, such as inflammatory cell infiltration and cytokine expression, as well as increased and decreased expression of MMP-9 and Bcl-2, respectively. NLRP3(-/-) mice exhibited diminished expression and activation of Stat3, which regulatesMMP-9 and Bcl-2, in addition to increased numbers of apoptotic alveolar epithelial cells. In vitro experiments revealed that alveolar macrophages and neutrophils promoted Stat3 activation in alveolar epithelial cells. Furthermore, NLRP3 deficiency impaired the migration of neutrophils and chemokine expression by macrophages. These findings demonstrate that NLRP3 regulates Stat3 signaling in alveolar epithelial cells by affecting macrophage and neutrophil function independent of IL-1 beta production and contributes to the pathophysiology of HALI.	[Mizushina, Yoshiko; Shirasuna, Koumei; Usui, Fumitake; Karasawa, Tadayoshi; Kawashima, Akira; Kimura, Hiroaki; Kobayashi, Motoi; Komada, Takanori; Inoue, Yoshiyuki; Kasahara, Tadashi; Takahashi, Masafumi] Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, Shimotsuke, Tochigi 3290498, Japan; [Mizushina, Yoshiko; Mato, Naoko; Yamasawa, Hideaki; Bando, Masashi; Sugiyama, Yukihiko] Jichi Med Univ, Dept Med, Div Pulm Med, Shimotsuke, Tochigi 3290498, Japan; [Latz, Eicke] Univ Bonn, Univ Hosp, Inst Innate Immun, D-53113 Bonn, Germany; [Latz, Eicke] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01655 USA; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Chiba 2780022, Japan; [Iwakura, Yoichiro] Chiba Univ, Med Mycol Ctr, Chiba 2608673, Japan	Jichi Medical University; Jichi Medical University; University of Bonn; University of Massachusetts System; University of Massachusetts Worcester; Tokyo University of Science; Chiba University	Takahashi, M (corresponding author), Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	masafumi2@jichi.ac.jp	Kimura, Hiroaki/E-3224-2010; Iwakura, Yoichiro/E-5457-2011; Latz, Eicke/H-3951-2014	Kimura, Hiroaki/0000-0002-7441-0382; Iwakura, Yoichiro/0000-0002-9934-5775; Latz, Eicke/0000-0003-1488-5666; Karasawa, Tadayoshi/0000-0002-6738-2360	Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-Leading Researchers (NEXT Program); Council for Science and Technology Policy (CSTP); Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Jichi Medical University	Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Jichi Medical University	This work was supported by grants from the Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-Leading Researchers (NEXT Program), initiated by the Council for Science and Technology Policy (CSTP) (to M. T.); the Ministry of Education, Culture, Sports, Science, and Technology (MEXT)-supported program for the Strategic Foundation at Private Universities (to M. T.); and a grant-in-aid for research activity start-up from the Jichi Medical University (to Y. M.).	Alas S, 2001, CANCER RES, V61, P5137; Bhandari V, 2008, FRONT BIOSCI-LANDMRK, V13, P6653, DOI 10.2741/3179; Bhandari V, 2007, J IMMUNOL, V178, P4993, DOI 10.4049/jimmunol.178.8.4993; Bhandari V, 2006, FREE RADICAL BIO MED, V41, P4, DOI 10.1016/j.freeradbiomed.2006.01.027; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; DOBBS LG, 2002, CULTURE EPITHELIAL C, P277; Fukumoto J, 2013, AM J PHYSIOL-CELL PH, V305, pC182, DOI 10.1152/ajpcell.00086.2013; Gonzalez Robert F, 2013, Methods Mol Biol, V945, P145, DOI 10.1007/978-1-62703-125-7_10; Hokuto I, 2004, J CLIN INVEST, V113, P28, DOI 10.1172/JCI200419491; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Inghirami G, 2005, CELL CYCLE, V4, P1131, DOI 10.4161/cc.4.9.1985; Inoue Y, 2014, J IMMUNOL, V192, P4342, DOI 10.4049/jimmunol.1302039; Jain D, 2008, AM J RESP CRIT CARE, V178, P805, DOI 10.1164/rccm.200804-582OC; Kallet RH, 2013, RESP CARE, V58, P123, DOI 10.4187/respcare.01963; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Kolliputi N, 2012, J CELL PHYSIOL, V227, P3310, DOI 10.1002/jcp.24026; Kolliputi N, 2010, J IMMUNOL, V184, P5819, DOI 10.4049/jimmunol.0902766; Komada T, 2014, AM J PATHOL, V184, P1287, DOI 10.1016/j.ajpath.2014.01.014; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lian XM, 2005, J IMMUNOL, V174, P7250, DOI 10.4049/jimmunol.174.11.7250; Lingappan K, 2013, TOXICOL APPL PHARM, V272, P281, DOI 10.1016/j.taap.2013.06.007; Quinton LJ, 2008, AM J RESP CELL MOL, V38, P699, DOI 10.1165/rcmb.2007-0365OC; Quinton LJ, 2012, J IMMUNOL, V188, P6300, DOI 10.4049/jimmunol.1200256; Shigeoka AA, 2010, J IMMUNOL, V185, P6277, DOI 10.4049/jimmunol.1002330; Takahashi M, 2011, TRENDS CARDIOVAS MED, V21, P37, DOI 10.1016/j.tcm.2012.02.002; Usui F, 2012, BIOCHEM BIOPH RES CO, V425, P162, DOI 10.1016/j.bbrc.2012.07.058; Yajima N, 2008, CIRCULATION, V117, P3079, DOI 10.1161/CIRCULATIONAHA.107.746453; Yang L, 2004, MOL ENDOCRINOL, V18, P1520, DOI 10.1210/me.2003-0458; You S, 2014, MOL CANCER THER, V13, P606, DOI 10.1158/1535-7163.MCT-13-0608; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhang Y, 2014, J IMMUNOL, V192, P5296, DOI 10.4049/jimmunol.1400653; Zuurbier CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040643	35	44	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5065	5077		10.1074/jbc.M114.603217	http://dx.doi.org/10.1074/jbc.M114.603217			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25548278	Green Published, hybrid			2022-12-26	WOS:000350042000047
J	Noor, SI; Dietz, S; Heidtmann, H; Boone, CD; McKenna, R; Deitmer, JW; Becker, HM				Noor, Sina Ibne; Dietz, Steffen; Heidtmann, Hella; Boone, Christopher D.; McKenna, Robert; Deitmer, Joachim W.; Becker, Holger M.			Analysis of the Binding Moiety Mediating the Interaction between Monocarboxylate Transporters and Carbonic Anhydrase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS OOCYTES; SLC16 GENE FAMILY; LACTATE TRANSPORT; RETINAL-PIGMENT; MCT2; EXPRESSION; CELLS; SITE; COTRANSPORTER; MEMBRANE	Proton-coupled monocarboxylate transporters (MCTs) mediate the exchange of high energy metabolites like lactate between different cells and tissues. We have reported previously that carbonic anhydrase II augments transport activity of MCT1 and MCT4 by a noncatalytic mechanism, while leaving transport activity of MCT2 unaltered. In the present study, we combined electrophysiological measurements in Xenopus oocytes and pulldown experiments to analyze the direct interaction between carbonic anhydrase II (CAII) and MCT1, MCT2, and MCT4, respectively. Transport activity of MCT2-WT, which lacks a putative CAII-binding site, is not augmented by CAII. However, introduction of a CAII-binding site into the C terminus of MCT2 resulted in CAII-mediated facilitation of MCT2 transport activity. Interestingly, introduction of three glutamic acid residues alone was not sufficient to establish a direct interaction between MCT2 and CAII, but the cluster had to be arranged in a fashion that allowed access to the binding moiety in CAII. We further demonstrate that functional interaction between MCT4 and CAII requires direct binding of the enzyme to the acidic cluster (EEE)-E-431 in the C terminus of MCT4 in a similar fashion as previously shown for binding of CAII to the cluster (EEE)-E-489 in the C terminus of MCT1. In CAII, binding to MCT1 and MCT4 is mediated by a histidine residue at position 64. Taken together, our results suggest that facilitation of MCT transport activity by CAII requires direct binding between histidine 64 in CAII and a cluster of glutamic acid residues in the C terminus of the transporter that has to be positioned in surroundings that allow access to CAII.	[Noor, Sina Ibne; Dietz, Steffen; Heidtmann, Hella; Becker, Holger M.] Univ Kaiserslautern, Div Zool Membrane Transport, Dept Biol, D-67653 Kaiserslautern, Germany; [Heidtmann, Hella; Deitmer, Joachim W.] Univ Kaiserslautern, Dept Biol, Div Gen Zool, D-67653 Kaiserslautern, Germany; [Boone, Christopher D.; McKenna, Robert] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	University of Kaiserslautern; University of Kaiserslautern; State University System of Florida; University of Florida	Becker, HM (corresponding author), Univ Kaiserslautern, Div Zool Membrane Transport, Dept Biol, POB 3049, D-67653 Kaiserslautern, Germany.	h.becker@biologie.uni-kl.de	Becker, Holger/AAB-4322-2020	Dietz, Steffen/0000-0003-1478-3969	Stiftung Rheinland-Pfalz fur Innovation Grant [961-386261/957]; Landesschwerpunkt Membrantransport	Stiftung Rheinland-Pfalz fur Innovation Grant; Landesschwerpunkt Membrantransport	This work was supported by Stiftung Rheinland-Pfalz fur Innovation Grant 961-386261/957 (to H. M. B.) and by the Landesschwerpunkt Membrantransport (to H. M. B. and J. W. D.).	Almquist J, 2010, J COMPUT SCI SYST BI, V3, P107, DOI DOI 10.4172/JCSB.1000066; Becker HM, 2004, BIOPHYS J, V86, P235, DOI 10.1016/S0006-3495(04)74099-0; Becker HM, 2005, J BIOL CHEM, V280, P39882, DOI 10.1074/jbc.M503081200; Becker HM, 2008, J BIOL CHEM, V283, P21655, DOI 10.1074/jbc.M802134200; Becker HM, 2007, J BIOL CHEM, V282, P13508, DOI 10.1074/jbc.M700066200; Becker HM, 2014, NEUROMETHODS, V90, P25, DOI 10.1007/978-1-4939-1059-5_2; Becker HM, 2014, SUBCELL BIOCHEM, V75, P105, DOI 10.1007/978-94-007-7359-2_7; Becker HM, 2011, P NATL ACAD SCI USA, V108, P3071, DOI 10.1073/pnas.1014293108; Becker HM, 2010, J MEMBRANE BIOL, V234, P125, DOI 10.1007/s00232-010-9240-y; Bergersen L, 2001, EXP BRAIN RES, V136, P523, DOI 10.1007/s002210000600; Broer S, 1997, J BIOL CHEM, V272, P30096, DOI 10.1074/jbc.272.48.30096; Broer S, 1999, BIOCHEM J, V341, P529, DOI 10.1042/0264-6021:3410529; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURG M, 1977, AM J PHYSIOL, V233, pF307, DOI 10.1152/ajprenal.1977.233.4.F307; Deitmer JW, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00291; DEITMER JW, 1991, J GEN PHYSIOL, V98, P637, DOI 10.1085/jgp.98.3.637; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher SZ, 2007, BIOCHEMISTRY-US, V46, P2930, DOI 10.1021/bi062066y; Frost SC, 2014, SUBCELL BIOCHEM, V75, P9, DOI 10.1007/978-94-007-7359-2_2; GARCIA CK, 1995, J BIOL CHEM, V270, P1843, DOI 10.1074/jbc.270.4.1843; Grollman EF, 2000, BIOCHEMISTRY-US, V39, P9351, DOI 10.1021/bi000464+; Gross E, 2002, J PHYSIOL-LONDON, V544, P679, DOI 10.1113/jphysiol.2002.029777; Halestrap AP, 2013, MOL ASPECTS MED, V34, P337, DOI 10.1016/j.mam.2012.05.003; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Jackson VN, 1996, J BIOL CHEM, V271, P861, DOI 10.1074/jbc.271.2.861; Jackson VN, 1997, BIOCHEM J, V324, P447, DOI 10.1042/bj3240447; Johnson D. E., 2009, DRUG DESIGN ZINC ENZ; KIFOR G, 1993, J MEMBRANE BIOL, V134, P169; Klier M, 2014, J BIOL CHEM, V289, P2765, DOI 10.1074/jbc.M113.537043; Klier M, 2011, J BIOL CHEM, V286, P27781, DOI 10.1074/jbc.M111.255331; Li XJ, 2002, J BIOL CHEM, V277, P36085, DOI 10.1074/jbc.M111952200; Li XJ, 2006, BIOCHEMISTRY-US, V45, P2414, DOI 10.1021/bi051132d; Loiselle FB, 2004, AM J PHYSIOL-CELL PH, V286, pC1423, DOI 10.1152/ajpcell.00382.2003; MAREN TH, 1967, PHYSIOL REV, V47, P595, DOI 10.1152/physrev.1967.47.4.595; Martinez C, 2010, FRONT NEUROENERGETIC, V2, P27, DOI DOI 10.3389/FNENE.2010.00027; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; Pellerin L, 1998, P NATL ACAD SCI USA, V95, P3990, DOI 10.1073/pnas.95.7.3990; Philp NJ, 2001, AM J PHYSIOL-CELL PH, V280, pC1319, DOI 10.1152/ajpcell.2001.280.5.C1319; Philp NJ, 1998, AM J PHYSIOL-REG I, V274, pR1824, DOI 10.1152/ajpregu.1998.274.6.R1824; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Pinheiro C, 2012, J BIOENERG BIOMEMBR, V44, P127, DOI 10.1007/s10863-012-9428-1; Pinheiro C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/427694; Pushkin A, 2004, J PHYSIOL-LONDON, V559, P55, DOI 10.1113/jphysiol.2004.065110; SASAKI S, 1989, AM J PHYSIOL, V257, pF947, DOI 10.1152/ajprenal.1989.257.6.F947; SEKI G, 1992, PFLUG ARCH EUR J PHY, V422, P60, DOI 10.1007/BF00381514; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; Stridh MH, 2012, J PHYSIOL-LONDON, V590, P2333, DOI 10.1113/jphysiol.2011.220152; Vince JW, 2000, BIOCHEMISTRY-US, V39, P5527, DOI 10.1021/bi992564p; Vince JW, 2000, BIOCHEMISTRY-US, V39, P13344, DOI 10.1021/bi0015111; Vince JW, 1998, J BIOL CHEM, V273, P28430, DOI 10.1074/jbc.273.43.28430; Wilson MC, 2009, J BIOL CHEM, V284, P20011, DOI 10.1074/jbc.M109.014217; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; Yoon HY, 1997, BIOCHEM BIOPH RES CO, V234, P90, DOI 10.1006/bbrc.1997.6588	56	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4476	4486		10.1074/jbc.M114.624577	http://dx.doi.org/10.1074/jbc.M114.624577			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25561737	Green Published, hybrid			2022-12-26	WOS:000349458400053
J	Hofmann, S; Braun, A; Pozgaj, R; Morowski, M; Vogtle, T; Nieswandt, B				Hofmann, Sebastian; Braun, Attila; Pozgaj, Rastislav; Morowski, Martina; Voegtle, Timo; Nieswandt, Bernhard			Mice Lacking the SLAM Family Member CD84 Display Unaltered Platelet Function in Hemostasis and Thrombosis	PLOS ONE			English	Article							DOMAIN-CONTAINING PROTEINS; ARTERIAL THROMBOSIS; ADHESION MOLECULE; GLYCOPROTEIN VI; ACTIVATION; INTEGRIN; CELLS; STABILITY; ANTIGEN; GROWTH	Background: Platelets are anuclear cell fragments derived from bone marrow megakaryocytes that safeguard vascular integrity by forming thrombi at sites of vascular injury. Although the early events of thrombus formation-platelet adhesion and aggregation-have been intensively studied, less is known about the mechanisms and receptors that stabilize platelet-platelet interactions once a thrombus has formed. One receptor that has been implicated in this process is the signaling lymphocyte activation molecule (SLAM) family member CD84, which can undergo homophilic interactions and becomes phosphorylated upon platelet aggregation. Objective: The role of CD84 in platelet physiology and thrombus formation was investigated in CD84-deficient mice. Methods and Results: We generated CD84-deficient mice and analyzed their platelets in vitro and in vivo. Cd84(-/-) platelets exhibited normal activation and aggregation responses to classical platelet agonists. Furthermore, CD84 deficiency did not affect integrin-mediated clot retraction and spreading of activated platelets on fibrinogen. Notably, also the formation of stable three-dimensional thrombi on collagen-coated surfaces under flow ex vivo was unaltered in the blood of Cd84(-/-) mice. In vivo, Cd84(-/-) mice exhibited unaltered hemostatic function and arterial thrombus formation. Conclusion: These results show that CD84 is dispensable for thrombus formation and stabilization, indicating that its deficiency may be functionally compensated by other receptors or that it may be important for platelet functions different from platelet-platelet interactions.	[Voegtle, Timo] Univ Wurzburg, Univ Hosp, Dept Expt Biomed, D-97070 Wurzburg, Germany; Univ Wurzburg, Rudolf Virchow Ctr, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Vogtle, T (corresponding author), Univ Wurzburg, Univ Hosp, Dept Expt Biomed, D-97070 Wurzburg, Germany.	timo.voegtle@virchow.uni-wuerzburg.de; bernhard.nieswandt@virchow.uni-wuerzburg.de		Vogtle, Timo/0000-0002-9400-4701	German Research Foundation [SFB 688]; Rudolf Virchow Center; German Research Foundation (DFG); University of Wurzburg	German Research Foundation(German Research Foundation (DFG)); Rudolf Virchow Center; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wurzburg	This work was supported by the German Research Foundation (SFB 688 to BN) and the Rudolf Virchow Center. This publication was funded by the German Research Foundation (DFG) and the University of Wurzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Errico D, 2011, J IMMUNOL, V187, P5577, DOI 10.4049/jimmunol.1101626; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Brass LF, 2005, J CLIN INVEST, V115, P3385, DOI 10.1172/JCI26869; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; delaFuente MA, 1997, BLOOD, V90, P2398; Dutting S, 2012, TRENDS PHARMACOL SCI, V33, P583, DOI 10.1016/j.tips.2012.07.004; Elvers M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000551; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Gruner S, 2004, CIRCULATION, V110, P2946, DOI 10.1161/01.CIR.0000146341.63677.3C; Hofmann S, 2012, J THROMB HAEMOST, V10, P2581, DOI 10.1111/jth.12013; Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515; Knight CG, 1999, CARDIOVASC RES, V41, P450, DOI 10.1016/S0008-6363(98)00306-X; Krause SW, 2000, BIOCHEM J, V346, P729, DOI 10.1042/0264-6021:3460729; Martin M, 2001, J IMMUNOL, V167, P3668, DOI 10.4049/jimmunol.167.7.3668; May F, 2009, BLOOD, V114, P3464, DOI 10.1182/blood-2009-05-222273; Morgenstern E, 1990, Blood Coagul Fibrinolysis, V1, P543, DOI 10.1097/00001721-199010000-00035; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nanda N, 2006, BLOOD CELL MOL DIS, V36, P228, DOI 10.1016/j.bcmd.2005.12.026; Nanda N, 2005, BLOOD, V106, P3028, DOI 10.1182/blood-2005-01-0333; Nieswandt B, 2000, BLOOD, V96, P2520; Nieswandt B, 2005, J THROMB HAEMOST, V3, P1725, DOI 10.1111/j.1538-7836.2005.01488.x; Nieswandt B, 2011, J THROMB HAEMOST, V9, P92, DOI 10.1111/j.1538-7836.2011.04361.x; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; Oliver-Vila I, 2008, MOL IMMUNOL, V45, P2138, DOI 10.1016/j.molimm.2007.12.006; Ozaki H, 2000, BIOCHEM BIOPH RES CO, V276, P873, DOI 10.1006/bbrc.2000.3574; Prevost N, 2005, P NATL ACAD SCI USA, V102, P9820, DOI 10.1073/pnas.0404065102; Romero X, 2005, J IMMUNOL, V174, P7033, DOI 10.4049/jimmunol.174.11.7033; SAVAGE B, 1992, J BIOL CHEM, V267, P11300; Tangye SG, 2003, J IMMUNOL, V171, P2485, DOI 10.4049/jimmunol.171.5.2485; Tangye SG, 2002, EUR J IMMUNOL, V32, P1640, DOI 10.1002/1521-4141(200206)32:6<1640::AID-IMMU1640>3.0.CO;2-S; Tucker KL, 2012, METHODS MOL BIOL, V788, P101, DOI 10.1007/978-1-61779-307-3_8; Wannemacher KM, 2010, BLOOD, V116, P5707, DOI 10.1182/blood-2010-04-279943; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x	34	12	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115306	10.1371/journal.pone.0115306	http://dx.doi.org/10.1371/journal.pone.0115306			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551754	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100034
J	Roderer, K; Neuenschwander, M; Codoni, G; Sasso, S; Gamper, M; Kast, P				Roderer, Kathrin; Neuenschwander, Martin; Codoni, Giosiana; Sasso, Severin; Gamper, Marianne; Kast, Peter			Functional Mapping of Protein-Protein Interactions in an Enzyme Complex by Directed Evolution	PLOS ONE			English	Article							SECRETED CHORISMATE MUTASE; AMINO-ACID BIOSYNTHESIS; T7 RNA-POLYMERASE; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; DAHP SYNTHASE; COMBINATORIAL MUTAGENESIS; CLONING VEHICLES; ACTIVE-SITE; EXPRESSION	The shikimate pathway enzyme chorismate mutase converts chorismate into prephenate, a precursor of Tyr and Phe. The intracellular chorismate mutase (MtCM) of Mycobacterium tuberculosis is poorly active on its own, but becomes >100-fold more efficient upon formation of a complex with the first enzyme of the shikimate pathway, 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase (MtDS). The crystal structure of the enzyme complex revealed involvement of C-terminal MtCM residues with the MtDS interface. Here we employed evolutionary strategies to probe the tolerance to substitution of the C-terminal MtCM residues from positions 84-90. Variants with randomized positions were subjected to stringent selection in vivo requiring productive interactions with MtDS for survival. Sequence patterns identified in active library members coincide with residue conservation in natural chorismate mutases of the AroQ(delta) subclass to which MtCM belongs. An Arg-Gly dyad at positions 85 and 86, invariant in AroQ(delta) sequences, was intolerant to mutation, whereas Leu88 and Gly89 exhibited a preference for small and hydrophobic residues in functional MtCM-MtDS complexes. In the absence of MtDS, selection under relaxed conditions identifies positions 84-86 as MtCM integrity determinants, suggesting that the more C-terminal residues function in the activation by MtDS. Several MtCM variants, purified using a novel plasmid-based T7 RNA polymerase gene expression system, showed that a diminished ability to physically interact with MtDS correlates with reduced activatability and feedback regulatory control by Tyr and Phe. Mapping critical protein-protein interaction sites by evolutionary strategies may pinpoint promising targets for drugs that interfere with the activity of protein complexes.	[Roderer, Kathrin; Neuenschwander, Martin; Codoni, Giosiana; Sasso, Severin; Gamper, Marianne; Kast, Peter] ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Kast, P (corresponding author), ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland.	kast@org.chem.ethz.ch		Sasso, Severin/0000-0002-2226-845X; Wurth-Roderer, Kathrin/0000-0002-0233-9863	ETH Zurich; Swiss National Science Foundation [31003A-116475, 31003A-135651]	ETH Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by funds from the ETH Zurich and the Swiss National Science Foundation (grants no. 31003A-116475 and 31003A-135651 to PK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Arora PS, 2009, NATURE, V462, P171, DOI 10.1038/462171a; BARTLETT PA, 1985, J AM CHEM SOC, V107, P7792, DOI 10.1021/ja00311a111; BERTRAND KP, 1983, GENE, V23, P149, DOI 10.1016/0378-1119(83)90046-X; Blackmore NJ, 2013, J MOL BIOL, V425, P1582, DOI 10.1016/j.jmb.2012.12.019; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; BRAUS GH, 1991, MICROBIOL REV, V55, P349, DOI 10.1128/MMBR.55.3.349-370.1991; Butz M, 2011, BIOCHEMISTRY-US, V50, P8594, DOI 10.1021/bi2011338; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CHOTHIA C, 1984, ANNU REV BIOCHEM, V53, P537; DOPHEIDE TA, 1972, J BIOL CHEM, V247, P4447; EUVERINK GJW, 1995, APPL ENVIRON MICROB, V61, P3796, DOI 10.1128/AEM.61.11.3796-3803.1995; Fuller JC, 2009, DRUG DISCOV TODAY, V14, P155, DOI 10.1016/j.drudis.2008.10.009; Gamper M, 2000, BIOCHEMISTRY-US, V39, P14087, DOI 10.1021/bi0016570; Grisostomi C, 1997, BIOORG CHEM, V25, P297, DOI 10.1006/bioo.1997.1073; Haslam E., 1993, SHIKIMIC ACID METABO; HUDSON GS, 1983, J BIOL CHEM, V258, P3114; Imburgio D, 2000, BIOCHEMISTRY-US, V39, P10419, DOI 10.1021/bi000365w; Janssen BD, 2012, ADV PROTEIN CHEM STR, V86, P151, DOI 10.1016/B978-0-12-386497-0.00005-0; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Kast P, 1996, TETRAHEDRON LETT, V37, P2691, DOI 10.1016/0040-4039(96)00338-3; Kast P, 1996, P NATL ACAD SCI USA, V93, P5043, DOI 10.1073/pnas.93.10.5043; KAST P, 1994, GENE, V138, P109, DOI 10.1016/0378-1119(94)90790-0; Kast P, 1997, J PHYS CHEM B, V101, P10976, DOI 10.1021/jp972501l; Kim SK, 2008, FEBS J, V275, P4824, DOI 10.1111/j.1742-4658.2008.06621.x; Kunzler D, 2005, J BIOL CHEM, V280, P32827, DOI 10.1074/jbc.M506883200; LEE AY, 1995, J AM CHEM SOC, V117, P3627, DOI 10.1021/ja00117a038; Li PP, 2013, APPL MICROBIOL BIOT, V97, P10373, DOI 10.1007/s00253-013-4806-0; Liberles JS, 2005, AMINO ACIDS, V28, P1, DOI 10.1007/s00726-004-0152-y; Liu DR, 1996, J AM CHEM SOC, V118, P1789, DOI 10.1021/ja953151o; Lutke-Eversloh T, 2005, APPL ENVIRON MICROB, V71, P7224, DOI 10.1128/AEM.71.11.7224-7228.2005; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Neuenschwander M, 2009, PROTEIN ENG HDB, P537; Neuenschwander M, 2007, THESIS ETH ZURICH; Neuenschwander M, 2007, NAT BIOTECHNOL, V25, P1145, DOI [10.1038/nbt1341, 10.1038/nbtl341]; Okvist M, 2006, J MOL BIOL, V357, P1483, DOI 10.1016/j.jmb.2006.01.069; Okvist M, 2009, ACTA CRYSTALLOGR F, V65, P1048, DOI 10.1107/S1744309109035878; Pittard J., 1996, ESCHERICHIA COLI SAL, V1, P458; Roderer K, 2012, THESIS ETH ZURICH; Roderer K, 2009, CHIMIA, V63, P313, DOI 10.2533/chimia.2009.313; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; Sambrook J., 2001, MOL CLONING LAB MANU; Sasso S, 2005, FEBS J, V272, P375, DOI 10.1111/j.1742-4658.2004.04478.x; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; SCHELL MA, 1986, J BACTERIOL, V166, P9, DOI 10.1128/jb.166.1.9-14.1986; SOGO SG, 1984, J AM CHEM SOC, V106, P2701, DOI 10.1021/ja00321a039; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Valkov E, 2012, TOP CURR CHEM, V317, P145, DOI 10.1007/128_2011_265	51	7	7	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116234	10.1371/journal.pone.0116234	http://dx.doi.org/10.1371/journal.pone.0116234			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551646	Green Published, gold, Green Submitted			2022-12-26	WOS:000347119100110
J	Bokman, CL; Pasquale, LR; Parrish, RK; Lee, RK				L. Bokman, Christine; Pasquale, Louis R.; Parrish, Richard K., II; Lee, Richard K.			Glaucoma Screening in the Haitian Afro-Caribbean Population of South Florida	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; DIABETES-MELLITUS; BARBADOS EYE; RISK-FACTORS; INTRAOCULAR-PRESSURE; UNITED-STATES; PREVALENCE; HYPERTENSION; VARIANTS; DISEASE	Objective: To evaluate the presence of clinical signs consistent with suspected glaucoma in Haitian Afro-Caribbean individuals residing in South Florida who do not receive regular eye examinations. Design: Retrospective, cross-sectional study. Methods: SETTING: Community health center in the Little Haiti district of Miami, Florida. PATIENT POPULATION: We reviewed medical records and screening forms from five health screenings between October 2011 to October 2013 of 939 Afro-Caribbean individuals older than 18 years, who were never diagnosed with glaucoma or had an eye examination within the last ten years. PROCEDURES: Measurements of distance visual acuity (VA), intraocular eye pressure (IOP), central corneal thickness (CCT), cup-to-disc ratio (CDR), frequency doubling technology (FDT) perimeter visual field (VF). Main Outcome Measures: Proportion of glaucoma suspects, based on IOP greater than or equal to 24 mm Hg or CDR greater than or equal to 0.7 in either eye, and determinants of CDR and IOP. Results: One hundred ninety-one (25.5%) of 750 patients were identified as glaucoma suspects. Glaucoma suspects were common in both the youngest and oldest age groups (<40 years, 20.9%; 95% confidence interval [CI], 17.9-23.9; >70 years, 25.0%; 95% CI, 21.8-28.2) and higher in men than women less than 70 years; the reverse was true after 70 years. Among all patients, mean IOP was 19.2 +/- 4.5 mmHg, mean CDR was 0.37 +/- 0.17, and mean CCT was 532 +/- 37.1 mu m. In multiple linear stepwise regression analysis, determinates of increased CDR included increasing age (P = 0.004), lack of insurance (P = 0.019), and higher IOP (P<0.001), while increasing CDR (P<0.001) and thicker CCT (P<0.001) were associated with higher IOP. Conclusions: This first glaucoma survey in a U.S. Haitian Afro-Caribbean population indicates glaucoma suspect status is high across all age groups, and suggests glaucoma monitoring in people less than 40 years of age is indicated in this population.	[L. Bokman, Christine; Parrish, Richard K., II; Lee, Richard K.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Pasquale, Louis R.] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Boston, MA 02115 USA; [Pasquale, Louis R.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA	Bascom Palmer Eye Institute; University of Miami; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lee, RK (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	rlee@med.miami.edu			Friends of the Congressional Glaucoma Caucus	Friends of the Congressional Glaucoma Caucus	The authors received no specific funding for this work, although some of the vision screenings were funded by non-profit foundation the Friends of the Congressional Glaucoma Caucus (which is no longer active). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bcuhanan AB, 2009, POPULATION HAITIAN A; Camarota S. A., 2010, FACT SHEET HAITIAN I; Cao D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039278; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Dielemans I, 1996, OPHTHALMOLOGY, V103, P1271, DOI 10.1016/S0161-6420(96)30511-3; Ellis JD, 2000, BRIT J OPHTHALMOL, V84, P1218, DOI 10.1136/bjo.84.11.1218; ERVIN AM, 2012, COMP EFFECTIVENESS R, V59; Fan BJ, 2011, INVEST OPHTH VIS SCI, V52, P1788, DOI 10.1167/iovs.10-6339; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Hennis A, 2003, OPHTHALMOLOGY, V110, P908, DOI 10.1016/S0161-6420(03)00075-7; Jiao XD, 2009, P NATL ACAD SCI USA, V106, P17105, DOI 10.1073/pnas.0907564106; KLEIN BEK, 1994, OPHTHALMOLOGY, V101, P1173; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Ladapo JA, 2012, ARCH OPHTHALMOL-CHIC, V130, P365, DOI 10.1001/archopthalmol.2011.1224; Leske MC, 2008, OPHTHALMOLOGY, V115, P85, DOI 10.1016/j.ophtha.2007.03.017; Leske MC, 2007, OPHTHALMOLOGY, V114, P1058, DOI 10.1016/j.ophtha.2006.08.051; LESKE MC, 1983, AM J EPIDEMIOL, V118, P166, DOI 10.1093/oxfordjournals.aje.a113626; LESKE MC, 1994, ARCH OPHTHALMOL-CHIC, V112, P821, DOI 10.1001/archopht.1994.01090180121046; Leske MC, 2001, ARCH OPHTHALMOL-CHIC, V119, P89; MASON RP, 1989, OPHTHALMOLOGY, V96, P1363; Mitchell P, 1997, OPHTHALMOLOGY, V104, P712, DOI 10.1016/S0161-6420(97)30247-4; Moyer VA, 2013, ANN INTERN MED, V159, P484, DOI 10.7326/0003-4819-159-6-201309170-00686; NEWSOME DA, 1983, J TROP MED HYG, V86, P37; Pasquale LR, 2006, OPHTHALMOLOGY, V113, P1081, DOI 10.1016/j.ophtha.2006.01.066; Quigley HA, 1997, INVEST OPHTH VIS SCI, V38, P83; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2009, ARCH OPHTHALMOL-CHIC, V127, P227, DOI 10.1001/archophthalmol.2008.596; Stein JD, 2008, OPHTHALMOLOGY, V115, P1315, DOI 10.1016/j.ophtha.2007.12.017; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; VARMA R, 1994, ARCH OPHTHALMOL-CHIC, V112, P1068, DOI 10.1001/archopht.1994.01090200074026; Varma R, 2012, AM J OPHTHALMOL, V154, P315, DOI 10.1016/j.ajo.2012.02.014	32	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115942	10.1371/journal.pone.0115942	http://dx.doi.org/10.1371/journal.pone.0115942			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549331	Green Submitted, gold, Green Published			2022-12-26	WOS:000347063500041
J	Weobong, B; ten Asbroek, AHA; Soremekun, S; Manu, AA; Owusu-Agyei, S; Prince, M; Kirkwood, BR				Weobong, Benedict; ten Asbroek, Augustinus H. A.; Soremekun, Seyi; Manu, Alexander A.; Owusu-Agyei, Seth; Prince, Martin; Kirkwood, Betty R.			Association of Antenatal Depression with Adverse Consequences for the Mother and Newborn in Rural Ghana: Findings from the DON Population-Based Cohort Study	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; COMMON MENTAL-DISORDERS; LOW-INCOME COUNTRIES; MATERNAL DEPRESSION; INFANT GROWTH; RISK-FACTORS; HEALTH-CARE; PREGNANCY; WOMEN; OUTCOMES	Background: Whilst there is compelling evidence of an almost 2-fold increased risk of still births, and suggestive evidence of increased mortality among offspring of mothers with psychotic disorders, only three studies have addressed the role of antenatal depression (AND) on survival of the baby. We examined these associations in a large cohort of pregnant women in Ghana. Methods: A Cohort study nested within 4-weekly surveillance of all women of reproductive age to identify pregnancies and collect data on births and deaths in the Kintampo Health Research Centre study area of Ghana. Women were screened for AND using the Patient Health Questionnaire (PHQ-9) to ascertain DSM-IV major or minor depression. Outcomes were adverse birth outcomes, maternal/infant morbidity, and uptake of key newborn care practices, examined using logistic regression; effect sizes reported as relative risks with 95% confidence intervals. Results: 20679 (89.6%) pregnant women completed the PHQ-9. The prevalence of AND was 9.9% (n=2032) (95% confidence interval 9.4%-10.2%). AND was associated with: prolonged labour (RR 1.25, 95% CI 1.02-1.53); peripartum complications (RR 1.11, 95% CI 1.07-1.15); postpartum complications (RR 1.27, 96% CI 1.21-1.34); non-vaginal delivery (RR 1.19, 95% CI 1.02-1.40); newborn illness (RR 1.52, 95% CI 1.16-1.99); and bed net use during pregnancy (RR 0.93, 95% CI 0.89-0.98), but not neonatal deaths, still births, low birth weight, immediate breast feeding initiation, or exclusive breastfeeding. AND was marginally associated with preterm births (RR 1.32, 95% CI 0.98-1.76). Conclusion: This paper has contributed important evidence on the role of antenatal depression as a potential contributor to maternal and infant morbidity. Non-pharmacological treatments anchored on primary care delivery structures are recommended as an immediate step. We further recommend that trials are designed to assess if treating antenatal depression in conjunction with improving the quality of obstetric care results in improved maternal and newborn outcomes.	[Weobong, Benedict; Manu, Alexander A.; Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Ghana Hlth Serv, Kintampo, Ghana; [ten Asbroek, Augustinus H. A.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [Weobong, Benedict; Soremekun, Seyi; Manu, Alexander A.; Owusu-Agyei, Seth; Kirkwood, Betty R.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Prince, Martin] Kings Coll London, Inst Psychiat, Hlth Serv, London WC2R 2LS, England; [Prince, Martin] Kings Coll London, Inst Psychiat, Populat Res Dept, London WC2R 2LS, England	Ghana Health Service; Kintampo Health Research Centre; University of Amsterdam; Academic Medical Center Amsterdam; University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London; University of London; King's College London	Weobong, B (corresponding author), Kintampo Hlth Res Ctr, Ghana Hlth Serv, Kintampo, Ghana.	bkweobong@gmail.com	Soremekun, Seyi/AAH-4018-2021; Prince, Martin J/A-9170-2010	Prince, Martin J/0000-0003-1379-7146; Soremekun, Seyi/0000-0002-5531-0220; Kirkwood, Betty/0000-0001-5274-6072; Owusu-Agyei, Seth/0000-0002-0807-1781	UK Department for International Development [EPHIHD66]; Save the Children's Saving Newborn Lives programme from The Bill & Melinda Gates Foundation [EPIDVA37]; World Health Organisation [EPNPVE28]; Psychiatric Research Trust (PALTHPA); London School of Hygiene and Tropical Medicine; UK Department for International Development	UK Department for International Development; Save the Children's Saving Newborn Lives programme from The Bill & Melinda Gates Foundation; World Health Organisation(World Health Organization); Psychiatric Research Trust (PALTHPA); London School of Hygiene and Tropical Medicine; UK Department for International Development	Funding for this study was provided by the UK Department for International Development (EPHIHD66), Save the Children's Saving Newborn Lives programme from The Bill & Melinda Gates Foundation (EPIDVA37), and World Health Organisation (EPNPVE28). WB also received support for his fees, travel, and subsistence from the Psychiatric Research Trust (PALTHPA), London School of Hygiene and Tropical Medicine, and the UK Department for International Development. The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	ADERIBIGBE YA, 1993, BRIT J PSYCHIAT, V163, P645, DOI 10.1192/bjp.163.5.645; Ae-Ngibise K, 2010, INT REV PSYCHIATR, V22, P558, DOI 10.3109/09540261.2010.536149; Bodnar LM, 2009, J CLIN PSYCHIAT, V70, P1290, DOI 10.4088/JCP.08m04651; Bonari L, 2004, CAN J PSYCHIAT, V49, P726, DOI 10.1177/070674370404901103; Boy A, 2004, INT J FERTIL WOMEN M, V49, P159; Chung TKH, 2001, PSYCHOSOM MED, V63, P830, DOI 10.1097/00006842-200109000-00017; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; COX JL, 1983, J AFFECT DISORDERS, V5, P1, DOI 10.1016/0165-0327(83)90030-7; Davalos DB, 2012, ARCH WOMEN MENT HLTH, V15, P1, DOI 10.1007/s00737-011-0251-1; Ferri CP, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-209; Field T, 2006, INFANT BEHAV DEV, V29, P445, DOI 10.1016/j.infbeh.2006.03.003; [GHS Ghana Health Service], 2011, GHAN HLTH SERV BRONG; Goedhart G, 2010, PSYCHOSOM MED, V72, P769, DOI 10.1097/PSY.0b013e3181ee4a62; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Benute GRG, 2010, CLINICS, V65, P1127, DOI 10.1590/S1807-59322010001100013; Halbreich U, 2005, AM J OBSTET GYNECOL, V193, P1312, DOI 10.1016/j.ajog.2005.02.103; Hanlon C, 2009, TROP MED INT HEALTH, V14, P156, DOI 10.1111/j.1365-3156.2008.02198.x; Hartley M, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-9; Kammerer M, 2009, ARCH WOMEN MENT HLTH, V12, P135, DOI 10.1007/s00737-009-0062-9; Kirkwood BR, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-58; Kirkwood BR, 2010, LANCET, V375, P1640, DOI 10.1016/S0140-6736(10)60311-X; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lancaster CA, 2010, AM J OBSTET GYNECOL, V202, P5, DOI 10.1016/j.ajog.2009.09.007; Larsen DA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S34; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; Nasreen HE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-515; Nicholson WK, 2006, OBSTET GYNECOL, V107, P798, DOI 10.1097/01.AOG.0000204190.96352.05; Nylen KJ, 2006, INFANT MENT HEALTH J, V27, P327, DOI 10.1002/imhj.20095; PAARLBERG KM, 1995, J PSYCHOSOM RES, V39, P563, DOI 10.1016/0022-3999(95)00018-6; Patel V, 2004, BMJ-BRIT MED J, V328, P820, DOI 10.1136/bmj.328.7443.820; Patel V, 2003, ARCH DIS CHILD, V88, P34, DOI 10.1136/adc.88.1.34; Pollack H, 2000, AM J PUBLIC HEALTH, V90, P395, DOI 10.2105/AJPH.90.3.395; Rahman A, 2007, ARCH WOMEN MENT HLTH, V10, P211, DOI 10.1007/s00737-007-0193-9; Rahman A, 2007, ACTA PSYCHIAT SCAND, V115, P481, DOI 10.1111/j.1600-0447.2006.00950.x; Rahman A, 2004, ARCH GEN PSYCHIAT, V61, P946, DOI 10.1001/archpsyc.61.9.946; Rondo PHC, 2003, EUR J CLIN NUTR, V57, P266, DOI 10.1038/sj.ejcn.1601526; Ross LE, 2013, JAMA PSYCHIAT, V70, P436, DOI 10.1001/jamapsychiatry.2013.684; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; STATA, 2009, STAT DAT AN; Udechuku A, 2010, AUST NZ J PSYCHIAT, V44, P978, DOI 10.3109/00048674.2010.507543; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Webb R, 2005, AM J PSYCHIAT, V162, P1045, DOI 10.1176/appi.ajp.162.6.1045; WEISSMAN MM, 1995, SCIENCE, V269, P799, DOI 10.1126/science.7638596; Weobong B, 2013, DETERMINANTS POSTNAT; Weobong B, 2009, J AFFECT DISORDERS, V113, P109, DOI 10.1016/j.jad.2008.05.009; Weobong B, 2014, J AFFECT DISORDERS, V165, P1, DOI 10.1016/j.jad.2014.04.009; WHO, 2012, BOM TOO SOON GLOB AC; Wurst KE, 2010, BIRTH DEFECTS RES A, V88, P159, DOI 10.1002/bdra.20627; You D., 2011, LEVELS TRENDS CHILD; Zwane E, 2012, INTERNET J EPIDEMIOL, V10	53	31	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116333	10.1371/journal.pone.0116333	http://dx.doi.org/10.1371/journal.pone.0116333			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX6YH	25549334	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000347063500076
J	Bhullar, D; Jalodia, R; Kalia, M; Vrati, S				Bhullar, Deepika; Jalodia, Richa; Kalia, Manjula; Vrati, Sudhanshu			Cytoplasmic Translocation of Polypyrimidine Tract-Binding Protein and Its Binding to Viral RNA during Japanese Encephalitis Virus Infection Inhibits Virus Replication	PLOS ONE			English	Article							RIBOSOME ENTRY SITE; MOUSE HEPATITIS-VIRUS; NITRIC-OXIDE SYNTHASE; 3' NONCODING REGION; MESSENGER-RNA; 3'-UNTRANSLATED REGION; UNTRANSLATED REGION; INTERNAL INITIATION; NUCLEAR-LOCALIZATION; WEST-NILE	Japanese encephalitis virus (JEV) has a single-stranded, positive-sense RNA genome containing a single open reading frame flanked by the 59- and 39-non-coding regions (NCRs). The virus genome replicates via a negative-sense RNA intermediate. The NCRs and their complementary sequences in the negative-sense RNA are the sites for assembly of the RNA replicase complex thereby regulating the RNA synthesis and virus replication. In this study, we show that the 55-kDa polypyrimidine tract-binding protein (PTB) interacts in vitro with both the 59-NCR of the positive-sense genomic RNA - 5NCR(+), and its complementary sequence in the negative-sense replication intermediate RNA - 3NCR(-). The interaction of viral RNA with PTB was validated in infected cells by JEV RNA co-immunoprecipitation and JEV RNA-PTB co-localization experiments. Interestingly, we observed phosphorylation-coupled translocation of nuclear PTB to cytoplasmic foci that co-localized with JEV RNA early during JEV infection. Our studies employing the PTB silencing and over-expression in cultured cells established an inhibitory role of PTB in JEV replication. Using RNA-protein binding assay we show that PTB competitively inhibits association of JEV 3NCR(-) RNA with viral RNA-dependent RNA polymerase (NS5 protein), an event required for the synthesis of the plus-sense genomic RNA. cAMP is known to promote the Protein kinase A (PKA)mediated PTB phosphorylation. We show that cells treated with a cAMP analogue had an enhanced level of phosphorylated PTB in the cytoplasm and a significantly suppressed JEV replication. Data presented here show a novel, cAMP-induced,	[Bhullar, Deepika; Jalodia, Richa; Vrati, Sudhanshu] Natl Inst Immunol, New Delhi 110067, India; [Kalia, Manjula; Vrati, Sudhanshu] Translat Hlth Sci & Technol Inst, Vaccine & Infect Dis Res Ctr, Gurgaon, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Vrati, S (corresponding author), Natl Inst Immunol, New Delhi 110067, India.	vrati@thsti.res.in	Kalia, Manjula/AAM-2767-2021	Kalia, Manjula/0000-0002-3376-3659	National institute of Immunology; Translational Health Science and Technology Institute; Department of Biotechnology, Govt. of India [BT/MB/01/VIDRC/08]	National institute of Immunology; Translational Health Science and Technology Institute; Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	This work was supported by the core grants of the National institute of Immunology and the Translational Health Science and Technology Institute and grant no. BT/MB/01/VIDRC/08 from Department of Biotechnology, Govt. of India to SV.	Aizaki H, 2006, J BIOMED SCI, V13, P469, DOI 10.1007/s11373-006-9088-4; ALI N, 1995, J VIROL, V69, P6367, DOI 10.1128/JVI.69.10.6367-6375.1995; Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005; [Anonymous], 1998, Wkly Epidemiol Rec, V73, P337; Anwar A, 2009, J BIOL CHEM, V284, P17021, DOI 10.1074/jbc.M109.006239; Agis-Juarez RA, 2009, J GEN VIROL, V90, P2893, DOI 10.1099/vir.0.013433-0; BORMAN A, 1993, J GEN VIROL, V74, P1775, DOI 10.1099/0022-1317-74-9-1775; BRINTON MA, 1988, VIROLOGY, V162, P290, DOI 10.1016/0042-6822(88)90468-0; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Chang KS, 2006, VIRUS RES, V115, P1, DOI 10.1016/j.virusres.2005.06.012; Chen CJ, 1997, J VIROL, V71, P3466, DOI 10.1128/JVI.71.5.3466-3473.1997; Chien HL, 2011, J VIROL, V85, P4698, DOI 10.1128/JVI.01950-10; Chio CC, 2004, CELL SIGNAL, V16, P565, DOI 10.1016/j.cellsig.2003.10.003; Choi KS, 2002, VIROLOGY, V303, P58, DOI 10.1006/viro.2002.1675; Coles LS, 2004, EUR J BIOCHEM, V271, P648, DOI 10.1111/j.1432-1033.2003.03968.x; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407; Domitrovich AM, 2005, VIROLOGY, V335, P72, DOI 10.1016/j.virol.2005.02.009; Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104; Espada-Murao LA, 2011, J VIROL, V85, P6736, DOI 10.1128/JVI.00233-11; Florez PM, 2005, J VIROL, V79, P6172, DOI 10.1128/JVI.79.10.6172-6179.2005; Fred RG, 2006, CURR DIABETES REV, V2, P363, DOI 10.2174/157339906777950570; Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739; GHETTI A, 1992, NUCLEIC ACIDS RES, V20, P3671, DOI 10.1093/nar/20.14.3671; Gutierrez AL, 1997, J VIROL, V71, P3826; HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4; Hamilton BJ, 2003, MOL CELL BIOL, V23, P510, DOI 10.1128/MCB.23.2.510-525.2003; Huang JL, 2004, J MED VIROL, V74, P589, DOI 10.1002/jmv.20218; Isken O, 2003, EMBO J, V22, P5655, DOI 10.1093/emboj/cdg562; Ito T, 1999, VIROLOGY, V254, P288, DOI 10.1006/viro.1998.9541; Jang SK, 2006, VIRUS RES, V119, P2, DOI 10.1016/j.virusres.2005.11.003; Jiang LB, 2009, BIOCHEM BIOPH RES CO, V385, P187, DOI 10.1016/j.bbrc.2009.05.036; Kamath RV, 2001, MOL BIOL CELL, V12, P3808, DOI 10.1091/mbc.12.12.3808; Karakasiliotis I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009562; Kim SM, 2006, VIRUS RES, V115, P131, DOI 10.1016/j.virusres.2005.07.013; Li B, 2002, J BIOL CHEM, V277, P10306, DOI 10.1074/jbc.M109686200; Li HP, 1999, J VIROL, V73, P772, DOI 10.1128/JVI.73.1.772-777.1999; Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08; Luo GX, 1999, VIROLOGY, V256, P105, DOI 10.1006/viro.1999.9639; Mackenzie JM, 2007, J GEN VIROL, V88, P1163, DOI 10.1099/vir.0.82552-0; Martinez-Salas E, 2008, J GEN VIROL, V89, P611, DOI 10.1099/vir.0.83426-0; Matus-Nicodemos R, 2011, J IMMUNOL, V186, P2164, DOI 10.4049/jimmunol.1003236; Millevoi S, 2009, NUCLEIC ACIDS RES, V37, P4672, DOI 10.1093/nar/gkp470; Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008; Nazmi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021761; Niepmann M, 1997, J VIROL, V71, P8330, DOI 10.1128/JVI.71.11.8330-8339.1997; Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0; Paranjape SM, 2007, J BIOL CHEM, V282, P30497, DOI 10.1074/jbc.M705755200; Pautz A, 2006, J BIOL CHEM, V281, P32294, DOI 10.1074/jbc.M603915200; Perez I, 1997, RNA, V3, P764; Romanelli MG, 2002, EUR J BIOCHEM, V269, P2727, DOI 10.1046/j.1432-1033.2002.02942.x; Salonen A, 2005, CURR TOP MICROBIOL, V285, P139; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Sola I, 2011, J VIROL, V85, P5136, DOI 10.1128/JVI.00195-11; Song YT, 2005, RNA, V11, P1809, DOI 10.1261/rna.7430405; Sooryanarain H, 2012, ARCH VIROL, V157, P1905, DOI 10.1007/s00705-012-1386-8; Spellman R, 2006, TRENDS BIOCHEM SCI, V31, P73, DOI 10.1016/j.tibs.2005.12.003; Spellman R, 2005, BIOCHEM SOC T, V33, P457, DOI 10.1042/BST0330457; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; SUMIYOSHI H, 1987, VIROLOGY, V161, P497, DOI 10.1016/0042-6822(87)90144-9; Ta M, 2000, J VIROL, V74, P5108, DOI 10.1128/JVI.74.11.5108-5115.2000; Tillmar L, 2002, J BIOL CHEM, V277, P1099, DOI 10.1074/jbc.M108340200; Tischendorf JJW, 2004, ARCH VIROL, V149, P1955, DOI 10.1007/s00705-004-0341-8; Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200; Vashist S, 2011, DNA CELL BIOL, V30, P339, DOI 10.1089/dna.2010.1114; Vashist S, 2009, J GEN VIROL, V90, P1343, DOI 10.1099/vir.0.010850-0; Verma B, 2010, J GEN VIROL, V91, P1245, DOI 10.1099/vir.0.018507-0; Vrati S, 1999, J GEN VIROL, V80, P1665, DOI 10.1099/0022-1317-80-7-1665; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; Xu MG, 2007, BIOL REPROD, V76, P1025, DOI 10.1095/biolreprod.107.060079; Yadav M, 2004, J IMMUNOL, V172, P5588, DOI 10.4049/jimmunol.172.9.5588; Yi ZG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001255; Yu L, 2008, VIROLOGY, V374, P170, DOI 10.1016/j.virol.2007.12.035; Zhang Y, 2002, BIOCHEM PHARMACOL, V63, P273, DOI 10.1016/S0006-2952(01)00831-0	76	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e114931	10.1371/journal.pone.0114931	http://dx.doi.org/10.1371/journal.pone.0114931			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545659	gold, Green Published, Green Submitted			2022-12-26	WOS:000347120200015
J	Gonzalez-Perez, S; Garces-Claver, A; Mallor, C; de Miera, LES; Fayos, O; Pomar, F; Merino, F; Silvar, C				Gonzalez-Perez, Susana; Garces-Claver, Ana; Mallor, Cristina; Saenz de Miera, Luis E.; Fayos, Oreto; Pomar, Federico; Merino, Fuencisla; Silvar, Cristina			New Insights into Capsicum spp Relatedness and the Diversification Process of Capsicum annuum in Spain	PLOS ONE			English	Article							CHILI-PEPPERS CAPSICUM; LINKAGE MAP; GENETIC DIVERSITY; MICROSATELLITE MARKERS; PROVIDES INSIGHTS; HIGH-RESOLUTION; GENUS CAPSICUM; SSR MARKERS; L.; SEQUENCE	The successful exploitation of germplasm banks, harbouring plant genetic resources indispensable for plant breeding, will depend on our ability to characterize their genetic diversity. The Vegetable Germplasm Bank of Zaragoza (BGHZ) (Spain) holds an important Capsicum annuum collection, where most of the Spanish pepper variability is represented, as well as several accessions of other domesticated and non-domesticated Capsicum spp from all over the five continents. In the present work, a total of 51 C. annuum landraces (mainly from Spain) and 51 accessions from nine Capsicum species maintained at the BGHZ were evaluated using 39 microsatellite (SSR) markers spanning the whole genome. The 39 polymorphic markers allowed the detection of 381 alleles, with an average of 9.8 alleles per locus. A sizeable proportion of alleles (41.2%) were recorded as specific alleles and the majority of these were present at very low frequencies (rare alleles). Multivariate and model-based analyses partitioned the collection in seven clusters comprising the ten different Capsicum spp analysed: C. annuum, C. chinense, C. frutescens, C. pubescens, C. bacatum, C. chacoense and C. eximium. The data clearly showed the close relationships between C. chinense and C. frutescens. C. cardenasii and C. eximium were indistinguishable as a single, morphologically variable species. Moreover, C. chacoense was placed between C. baccatum and C. pubescens complexes. The C. annuum group was structured into three main clusters, mostly according to the pepper fruit shape, size and potential pungency. Results suggest that the diversification of C. annuum in Spain may occur from a rather limited gene pool, still represented by few landraces with ancestral traits. This ancient population would suffer from local selection at the distinct	[Gonzalez-Perez, Susana; Pomar, Federico; Merino, Fuencisla; Silvar, Cristina] Univ A Coruna, Dept Ecol Plant & Anim Biol, La Coruna, Spain; [Garces-Claver, Ana; Mallor, Cristina; Fayos, Oreto] Agrifood Res & Technol Ctr Aragon CITA, Zaragoza, Spain; [Saenz de Miera, Luis E.] Univ Leon, Dept Mol Biol, E-24071 Leon, Spain	Universidade da Coruna; Universidad de Leon	Silvar, C (corresponding author), Univ A Coruna, Dept Ecol Plant & Anim Biol, La Coruna, Spain.	c.silvar@udc.es	Sáenz de Miera, Luis/ABA-4573-2021; Avellan, Oreto Fayos/W-7716-2018; Mallor, Cristina/AAK-9043-2020; Silvar, Cristina/G-5141-2010; GARCES-CLAVER, ANA/J-8545-2017; de Miera, Luis E Sáenz/D-6864-2018; Pomar, Federico/F-2236-2010	Sáenz de Miera, Luis/0000-0003-1871-7379; Avellan, Oreto Fayos/0000-0001-9332-3199; Mallor, Cristina/0000-0002-3150-5496; Silvar, Cristina/0000-0002-1782-8045; GARCES-CLAVER, ANA/0000-0002-6727-5928; de Miera, Luis E Sáenz/0000-0003-1871-7379; Pomar, Federico/0000-0001-8035-7103	Spanish Institute for Agricultural and Food Research and Technology (INIA); European Regional Development Fund (FEDER) [RTA2011-00118]	Spanish Institute for Agricultural and Food Research and Technology (INIA)(Instituto de Investigacion Agropecuaria (INIA)); European Regional Development Fund (FEDER)(European Commission)	This work was supported by the Spanish Institute for Agricultural and Food Research and Technology (INIA) and co-financed by the European Regional Development Fund (FEDER) (Project RTA2011-00118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YK, 2014, SCI HORTIC-AMSTERDAM, V170, P123, DOI 10.1016/j.scienta.2014.03.007; Albrecht E, 2012, GENET RESOUR CROP EV, V59, P517, DOI 10.1007/s10722-011-9700-y; ANDREWS J, 1993, GEOGR REV, V83, P194, DOI 10.2307/215257; Andrews J., 1984, PEPPERS DOMESTICATED; Ashrafi Hamid, 2012, BMC Genomics, V13, P571, DOI 10.1186/1471-2164-13-571; Baral J. B., 2002, Capsicum & Eggplant Newsletter, P11; Barchi L, 2007, GENOME, V50, P51, DOI 10.1139/G06-140; Bosland P. W., 2012, Peppers: vegetable and spice capsicums, DOI 10.1079/9781845938253.0000; Bosland PW, 1988, 530 NEW MEX STAT U C, V530; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Breton C, 2008, PLANT SCI, V175, P524, DOI 10.1016/j.plantsci.2008.05.025; Carravedo M, 2005, CATALOGO GENETICO PI; DeWitt D., 1996, PEPPERS WORLD IDENTI; Djian-Caporalino C, 2007, GENETIC RESOURCES CH, V3, P185, DOI [10.1201/9781420009569.ch6, DOI 10.1201/9781420009569.CH6]; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eshbaugh W. H., 1993, New crops., P132; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAO, 2010, MEJ GEN REC FIT NUEV; dos Santos ARF, 2011, TREE GENET GENOMES, V7, P1041, DOI 10.1007/s11295-011-0393-3; Geleta LF, 2005, BIODIVERS CONSERV, V14, P2361, DOI 10.1007/s10531-004-1669-9; Greenleaf WH, 1986, BREEDING VEGETABLE C, P67; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; Hammer K, 2003, NATURWISSENSCHAFTEN, V90, P241, DOI 10.1007/s00114-003-0433-4; Hill TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056200; Huang SW, 2001, EUPHYTICA, V117, P163, DOI 10.1023/A:1004059722512; Ibiza VP, 2012, GENET RESOUR CROP EV, V59, P1077, DOI 10.1007/s10722-011-9744-z; Ince AG, 2010, PLANT MOL BIOL REP, V28, P285, DOI 10.1007/s11105-009-0151-y; Ince AG, 2010, BIOCHEM GENET, V48, P83, DOI 10.1007/s10528-009-9297-4; IPGRI AVRDC CATIE, 1995, DESCR CAPS; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jeong HJ, 2010, GENOME, V53, P1029, DOI 10.1139/G10-094; Kang BC, 2001, THEOR APPL GENET, V102, P531, DOI 10.1007/s001220051678; Kim Seungill, 2014, Nat Genet, V46, P270, DOI 10.1038/ng.2877; Kraft KH, 2014, P NATL ACAD SCI USA, V111, P6165, DOI 10.1073/pnas.1308933111; Kumar S, 2006, HANDBOOK OF HERBS AND SPICES, VOL 3, P299, DOI 10.1533/9781845691717.3.299; Lanteri S, 2003, GENET RESOUR CROP EV, V50, P723, DOI 10.1023/A:1025075118200; Lanteri S., 1993, Euphytica, V67, P155, DOI 10.1007/BF00022739; Lee JM, 2004, THEOR APPL GENET, V108, P619, DOI 10.1007/s00122-003-1467-x; LEFEBVRE V, 1993, EUPHYTICA, V71, P189, DOI 10.1007/BF00040408; McLeod M. J., 1979, The biology and taxonomy of the Solanaceae, P701; Mimura Y, 2012, BREEDING SCI, V62, P93, DOI 10.1270/jsbbs.62.93; Minamiyama Y, 2006, MOL BREEDING, V18, P157, DOI 10.1007/s11032-006-9024-3; Moscone EA, 2007, ACTA HORTIC, P137, DOI 10.17660/ActaHortic.2007.745.5; Moses M, 2014, GENET RESOUR CROP EV, V61, P741, DOI 10.1007/s10722-013-0069-y; Nagy I, 2007, GENOME, V50, P668, DOI 10.1139/G07-047; NEI M, 1974, GENETICS, V76, P379; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nicolai M, 2013, GENET RESOUR CROP EV, V60, P2375, DOI 10.1007/s10722-013-0006-0; Nimmakayala P, 2014, MOL GENET GENOMICS, V289, P513, DOI 10.1007/s00438-014-0827-3; Nuez F., 1996, CULTIVO PIMIENTOS CH; Ogundiwin EA, 2005, GENOME, V48, P698, DOI 10.1139/G05-028; Olmstead RG, 2008, TAXON, V57, P1159, DOI 10.1002/tax.574010; Onus AN, 2004, ANN BOT-LONDON, V94, P289, DOI 10.1093/aob/mch139; Ortiz R, 2010, SCI HORTIC-AMSTERDAM, V126, P186, DOI 10.1016/j.scienta.2010.07.007; Panda Ramesh C., 2004, Cytologia (Tokyo), V69, P203, DOI 10.1508/cytologia.69.203; Paran I, 1998, EUPHYTICA, V99, P167, DOI 10.1023/A:1018301215945; Paran I, 2007, J EXP BOT, V58, P3841, DOI 10.1093/jxb/erm257; Park S.D.E., 2001, TRYPANOTOLERANCE W A; Park SDE, 2001, EXC MICR TOOLK; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perry L, 2007, SCIENCE, V315, P986, DOI 10.1126/science.1136914; PICKERSGILL B, 1988, BIOL ZBL, V107, P381; Pickersgill B, 1997, EUPHYTICA, V96, P129, DOI 10.1023/A:1002913228101; Pickersgill B., 1991, Chromosome engineering in plants: genetics, breeding, evolution. Part B., P139; Pickersgill B, 2007, ANN BOT-LONDON, V100, P925, DOI 10.1093/aob/mcm193; Porras-Hurtado Liliana, 2013, Frontiers in Genetics, V4, P98, DOI 10.3389/fgene.2013.00098; Portis E, 2007, PLANT SCI, V172, P640, DOI 10.1016/j.plantsci.2006.11.016; Portis E, 2006, CROP SCI, V46, P2517, DOI 10.2135/cropsci2006.04.0216; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; R Core Team, 2021, R LANGUAGE ENV STAT; Rai VP, 2013, PHYSIOL MOL BIOL PLA, V19, P575, DOI 10.1007/s12298-013-0185-3; Rodriguez-Maza MJ, 2012, MOL BREEDING, V30, P889, DOI 10.1007/s11032-011-9672-9; Ryzhova NN, 2004, RUSS J GENET+, V40, P892, DOI 10.1023/B:RUGE.0000039723.90902.b0; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shirasawa K, 2013, MOL BREEDING, V31, P101, DOI 10.1007/s11032-012-9774-z; Sugita T, 2013, MOL BREEDING, V31, P909, DOI 10.1007/s11032-013-9844-x; Tam SM, 2009, THEOR APPL GENET, V119, P973, DOI 10.1007/s00122-009-1102-6; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tong N, 1999, EUPHYTICA, V109, P71, DOI 10.1023/A:1003421217077; van Dooijeweert W, 2010, MEJORA GENETICA RECU, P513; Varshney RK, 2005, TRENDS PLANT SCI, V10, P621, DOI 10.1016/j.tplants.2005.10.004; Votava EJ, 2005, ECON BOT, V59, P8, DOI 10.1663/0013-0001(2005)059[0008:GDOCCA]2.0.CO;2; Walsh BM, 2001, INT J PLANT SCI, V162, P1409, DOI 10.1086/323273; Wu FN, 2009, THEOR APPL GENET, V118, P1279, DOI 10.1007/s00122-009-0980-y; Yi GB, 2006, THEOR APPL GENET, V114, P113, DOI 10.1007/s00122-006-0415-y; Yoon JB, 2006, BREEDING SCI, V56, P31, DOI 10.1270/jsbbs.56.31; Yumnam JS, 2012, PLANT MOL BIOL REP, V30, P1470, DOI 10.1007/s11105-012-0466-y; ZIJLSTRA S, 1991, HORTSCIENCE, V26, P585, DOI 10.21273/HORTSCI.26.5.585	90	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e0116276	10.1371/journal.pone.0116276	http://dx.doi.org/10.1371/journal.pone.0116276			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545628	gold, Green Published, Green Submitted			2022-12-26	WOS:000347120200110
J	Hernandez, BY; Goodman, MT; Lynch, CF; Cozen, W; Unger, ER; Steinau, M; Thompson, T; Saber, MS; Altekruse, SF; Lyu, C; Saraiya, M				Hernandez, Brenda Y.; Goodman, Marc T.; Lynch, Charles F.; Cozen, Wendy; Unger, Elizabeth R.; Steinau, Martin; Thompson, Trevor; Saber, Maria Sibug; Altekruse, Sean F.; Lyu, Christopher; Saraiya, Mona		HPV Typing Canc Workgrp	Human Papillomavirus Prevalence in Invasive Laryngeal Cancer in the United States	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; GENDER-DIFFERENCES; ORAL-CAVITY; HPV-DNA; HEAD; RISK; INFECTION; P53; ASSOCIATION; SURVIVAL	Purpose: Human papillomavirus (HPV) is a major risk factor for specific cancers of the head and neck, particularly malignancies of the tonsil and base of the tongue. However, the role of HPV in the development of laryngeal cancer has not been definitively established. We conducted a population-based, cancer registry study to evaluate and characterize the genotype-specific prevalence of HPV in invasive laryngeal cancer cases diagnosed in the U.S. Methods: The presence of genotype-specific HPV DNA was evaluated using the Linear Array HPV Genotyping Test and the INNO-LiPA HPV Genotyping Assay in formalin-fixed paraffin embedded tissue from 148 invasive laryngeal cancer cases diagnosed in 1993-2004 within the catchment area of three U. S. SEER cancer registries. Results: HPV DNA was detected in 31 of 148 (21%) invasive laryngeal cancers. Thirteen different genotypes were detected. Overall, HPV 16 and HPV 33 were the most commonly detected types. HPV was detected in 33% (9/27) of women compared with 18% (22/121) of men (p=0.08). After adjustment for age and year of diagnosis, female patients were more likely to have HPV-positive laryngeal tumors compared to males (adjusted OR 2.84, 95% CI 1.07-7.51). Viral genotype differences were also observed between the sexes. While HPV 16 and 18 constituted half of HPV-positive cases occurring in men, among women, only 1 was HPV 16 positive and none were positive for HPV 18. Overall 5-year survival did not vary by HPV status. Conclusions: HPV may be involved in the development of a subset of laryngeal cancers and its role may be more predominant in women compared to men.	[Hernandez, Brenda Y.] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Goodman, Marc T.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Lynch, Charles F.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA; [Cozen, Wendy; Saber, Maria Sibug] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, USC Keck Sch Med, Los Angeles, CA 90033 USA; [Cozen, Wendy; Saber, Maria Sibug] Univ So Calif, Dept Prevent Med, USC Keck Sch Med, Los Angeles, CA 90089 USA; [Cozen, Wendy; Saber, Maria Sibug] Univ So Calif, Dept Pathol, USC Keck Sch Med, Los Angeles, CA 90089 USA; [Unger, Elizabeth R.; Steinau, Martin] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Thompson, Trevor; Saraiya, Mona] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Altekruse, Sean F.] NCI, Div Canc Control & Populat Sci, Rockville, MD USA; [Lyu, Christopher] Battelle Mem Inst, Durham, NC USA	Cancer Research Center of Hawaii; University of Hawaii System; Cedars Sinai Medical Center; University of Iowa; University of Southern California; University of Southern California; University of Southern California; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hernandez, BY (corresponding author), Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA.	brenda@cc.hawaii.edu		Goodman, Marc/0000-0002-4839-3021; Rhoda, Dale/0000-0003-0948-1368; Unger, Elizabeth/0000-0002-2925-5635	Centers for Disease Control and Prevention (CDC); SEER Program; National Institutes of Health, Department of Health and Human Services [N01-PC-35139, N01-PC-35143, N01-PC-35137]; CDC intramural funds; Vaccine for Children Funds; California Department of Health Services, California Health and Safety [103885]; NationalCancer Institute, National Institutes of Health, Department of Health and Human Services [N01-PC-2010-00035]; Centers for Disease Control and Prevention [1U58DP000807-3]; NATIONAL CANCER INSTITUTE [P30CA071789] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP000807] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); SEER Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CDC intramural funds; Vaccine for Children Funds; California Department of Health Services, California Health and Safety; NationalCancer Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This project was supported in part by the Centers for Disease Control and Prevention (CDC) and the SEER Program, National Institutes of Health, Department of Health and Human Services, under Contracts N01-PC-35139 (Los Angeles), N01-PC-35143 (Iowa) and N01-PC-35137 (Hawaii). The support for coordination of genotyping data and genotyping was largely supported by CDC intramural funds and Vaccine for Children Funds. The collection of data from California was largely supported by the California Department of Health Services as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; by the NationalCancer Institute, National Institutes of Health, Department of Health and Human Services under Contract N01-PC-2010-00035; and cooperative agreement number 1U58DP000807-3 from the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; ANSINK AC, 1994, GYNECOL ONCOL, V52, P180, DOI 10.1006/gyno.1994.1028; Applebaum KM, 2007, JNCI-J NATL CANCER I, V99, P1801, DOI 10.1093/jnci/djm233; Baumann JL, 2009, LARYNGOSCOPE, V119, P1531, DOI 10.1002/lary.20509; BLOT WJ, 1988, CANCER RES, V48, P3282; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chiba I, 1996, ONCOGENE, V12, P1663; DAY GL, 1993, JNCI-J NATL CANCER I, V85, P465, DOI 10.1093/jnci/85.6.465; DERIENZO DP, 1991, ARCH OTOLARYNGOL, V117, P681; Derkay CS, 2008, LARYNGOSCOPE, V118, P1236, DOI 10.1097/MLG.0b013e31816a7135; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Fakhry C, 2006, J CLIN ONCOL, V24, P2606, DOI 10.1200/JCO.2006.06.1291; FOURET P, 1995, DIAGN MOL PATHOL, V4, P122, DOI 10.1097/00019606-199506000-00008; Fritz A, 2000, INT CLASSIFICATION D; Gargano JW, 2012, J LOW GENIT TRACT DI, V16, P471, DOI 10.1097/LGT.0b013e3182472947; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison Maura L., 1999, Current Opinion in Oncology, V11, P191, DOI 10.1097/00001622-199905000-00010; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Goodman MT, 2005, HUM PATHOL, V36, P812, DOI 10.1016/j.humpath.2005.03.010; Haraf DJ, 1996, CLIN CANCER RES, V2, P755; Heck JE, 2010, INT J EPIDEMIOL, V39, P166, DOI 10.1093/ije/dyp350; Howlader N, 2014, SEER CANC STAT REV 1; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V90, P1; Igissinov N, 2013, ASIAN PAC J CANCER P, V14, P7033, DOI 10.7314/APJCP.2013.14.11.7033; International Agency for Researchon Cancer(IARC), 2005, WORK GROUP EV CARC R, V90; KOKOSKA MS, 1995, ANN OTO RHINOL LARYN, V104, P419, DOI 10.1177/000348949510400601; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; de Souza DLB, 2011, CANCER EPIDEMIOL, V35, P328, DOI 10.1016/j.canep.2011.02.003; Li W, 2003, INT J CANCER, V106, P553, DOI 10.1002/ijc.11261; Licitra L, 2006, J CLIN ONCOL, V24, P5630, DOI 10.1200/JCO.2005.04.6136; Lont AP, 2006, INT J CANCER, V119, P1078, DOI 10.1002/ijc.21961; Lortet-Tieulent J, 2013, EUR J CANC; Lubin JH, 2011, CANCER CAUSE CONTROL, V22, P1217, DOI 10.1007/s10552-011-9792-x; Ma XL, 1998, J MED VIROL, V54, P186, DOI 10.1002/(SICI)1096-9071(199803)54:3&lt;186::AID-JMV8&gt;3.0.CO;2-1; Mellin H, 2000, INT J CANCER, V89, P300, DOI 10.1002/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G; MONK BJ, 1995, OBSTET GYNECOL, V85, P709, DOI 10.1016/0029-7844(95)00045-S; Morshed K, 2010, J MED VIROL, V82, P1017, DOI 10.1002/jmv.21749; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Piccirillo J. F., 2007, SEER SURVIVAL MONOGR; Pintos J, 1999, CANCER-AM CANCER SOC, V85, P1903, DOI 10.1002/(SICI)1097-0142(19990501)85:9<1903::AID-CNCR4>3.0.CO;2-6; Reimers N, 2007, INT J CANCER, V120, P1731, DOI 10.1002/ijc.22355; Ritchie JM, 2003, INT J CANCER, V104, P336, DOI 10.1002/ijc.10960; Schwartz SR, 2001, OTOLARYNG HEAD NECK, V125, P1, DOI 10.1067/mhn.2001.116979; SHIDARA K, 1994, LARYNGOSCOPE, V104, P1008; Steinau M, 2011, J MOL DIAGN, V13, P377, DOI 10.1016/j.jmoldx.2011.03.007; Stephen JK, 2012, OTOLARYNG HEAD NECK, V146, P730, DOI 10.1177/0194599811434482; SUZUKI T, 1994, JPN J CANCER RES, V85, P1087, DOI 10.1111/j.1349-7006.1994.tb02911.x; Syrjanen S, 2005, J CLIN VIROL, V32, pS59, DOI 10.1016/j.jcv.2004.11.017; Vu HL, 2010, CANCER LETT, V288, P149, DOI 10.1016/j.canlet.2009.06.026; Young JL, 2001, NIH PUB	51	30	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115931	10.1371/journal.pone.0115931	http://dx.doi.org/10.1371/journal.pone.0115931			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546150	gold, Green Submitted, Green Published			2022-12-26	WOS:000347120200083
J	Zhao, BY; Xu, P; Jiang, LG; Paaske, B; Kromann-Hansen, T; Jensen, JK; Sorensen, HP; Liu, Z; Nielsen, JT; Christensen, A; Hosseini, M; Sorensen, KK; Nielsen, NC; Jensen, KJ; Huang, MD; Andreasen, PA				Zhao, Baoyu; Xu, Peng; Jiang, Longguang; Paaske, Berit; Kromann-Hansen, Tobias; Jensen, Jan K.; Sorensen, Hans Peter; Liu, Zhuo; Nielsen, Jakob T.; Christensen, Anni; Hosseini, Masood; Sorensen, Kasper K.; Nielsen, Niels Christian; Jensen, Knud J.; Huang, Mingdong; Andreasen, Peter A.			A Cyclic Peptidic Serine Protease Inhibitor: Increasing Affinity by Increasing Peptide Flexibility	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR; UROKINASE; SPECIFICITY; SYSTEM; METASTASIS; LIBRARIES; MECHANISM; CANCER	Peptides are attracting increasing interest as protease inhibitors. Here, we demonstrate a new inhibitory mechanism and a new type of exosite interactions for a phage-displayed peptide library-derived competitive inhibitor, mupain-1 (CPAYSRYLDC), of the serine protease murine urokinase-type plasminogen activator (uPA). We used X-ray crystal structure analysis, site-directed mutagenesis, liquid state NMR, surface plasmon resonance analysis, and isothermal titration calorimetry and wild type and engineered variants of murine and human uPA. We demonstrate that Arg(6) inserts into the S1 specificity pocket, its carbonyl group aligning improperly relative to Ser(195) and the oxyanion hole, explaining why the peptide is an inhibitor rather than a substrate. Substitution of the P1 Arg with novel unnatural Arg analogues with aliphatic or aromatic ring structures led to an increased affinity, depending on changes in both P1 - S1 and exosite interactions. Site-directed mutagenesis showed that exosite interactions, while still supporting high affinity binding, differed substantially between different uPA variants. Surprisingly, high affinity binding was facilitated by Ala-substitution of Asp(9) of the peptide, in spite of a less favorable binding entropy and loss of a polar interaction. We conclude that increased flexibility of the peptide allows more favorable exosite interactions, which, in combination with the use of novel Arg analogues as P1 residues, can be used to manipulate the affinity and specificity of this peptidic inhibitor, a concept different from conventional attempts at improving inhibitor affinity by reducing the entropic burden.	[Zhao, Baoyu; Jiang, Longguang; Huang, Mingdong; Andreasen, Peter A.] Chinese Acad Sci, Fujian Inst Res Struct Matter, Danish Chinese Ctr Proteases & Canc, Fuzhou 350002, Peoples R China; [Xu, Peng; Kromann-Hansen, Tobias; Jensen, Jan K.; Sorensen, Hans Peter; Liu, Zhuo; Christensen, Anni; Andreasen, Peter A.] Aarhus Univ, Danish Chinese Ctr Proteases & Canc, Dept Mol Biol & Genet, Aarhus, Denmark; [Paaske, Berit; Nielsen, Jakob T.; Nielsen, Niels Christian] Univ Aarhus, Nanosci Ctr, Aarhus, Denmark; [Paaske, Berit; Nielsen, Jakob T.; Nielsen, Niels Christian] Univ Aarhus, Dept Chem, Aarhus, Denmark; [Hosseini, Masood; Sorensen, Kasper K.; Jensen, Knud J.] Univ Copenhagen, Dept Chem, Fac Sci, DK-2100 Copenhagen, Denmark	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Aarhus University; Aarhus University; Aarhus University; University of Copenhagen	Andreasen, PA (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, Danish Chinese Ctr Proteases & Canc, Fuzhou 350002, Peoples R China.	pa@mbg.au.dk	Xu, Peng/GXF-8681-2022; Jensen, Knud J/D-1145-2016; Nielsen, Jakob/E-7993-2017; Huang, Mingdong/J-4278-2017	Xu, Peng/0000-0003-3968-7279; Jensen, Knud J/0000-0003-3525-5452; Nielsen, Jakob/0000-0002-9554-4662; Huang, Mingdong/0000-0003-0085-9141; Jiang, Longguang/0000-0002-4734-3778; Nielsen, Niels Chr./0000-0003-2978-4366	Danish National Research Foundation [26-331-6]; Natural Science Foundation of China [31161130356, 31170707, 31370737]; Natural Science Foundation of the Fujian Province [2012J05071]; Lundbeck Foundation [R83-A7826]; Carlsberg Foundation [2012_01_0642]; Cancer Research Foundation; Chinese Academy of Sciences [2012T1G0023]; Aarhus University Research Foundation [10]	Danish National Research Foundation(Danmarks Grundforskningsfond); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Fujian Province(Natural Science Foundation of Fujian Province); Lundbeck Foundation(Lundbeckfonden); Carlsberg Foundation(Carlsberg Foundation); Cancer Research Foundation; Chinese Academy of Sciences(Chinese Academy of Sciences); Aarhus University Research Foundation	This work was supported by the Danish National Research Foundation (http://dg.dk; grant number 26-331-6 to PAA), the Natural Science Foundation of China (http://en.ustc.edu.cn/dictionary/201105/t20110509_111378.html; grant numbers 31161130356, 31170707, 31370737 to M. Huang), the Natural Science Foundation of the Fujian Province (grant number 2012J05071 to M. Huang), the Lundbeck Foundation (http://www.lundbeckfoundation.com; grant number R83-A7826 to PAA), the Carlsberg Foundation (http://www.carlsbergfondet.dk; grant number 2012_01_0642 to PAA), and the Cancer Research Foundation of 1989 (to PAA). PAA was awarded a Chinese Academy of Sciences visiting professorship for senior international scientists (grant number 2012T1G0023). M. Huang was awarded an Aarhus University Research Foundation visiting professorship (reference number 10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LM, 2008, BIOCHEM J, V412, P447, DOI 10.1042/BJ20071646; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Angelini A, 2012, ACS CHEM BIOL, V7, P817, DOI 10.1021/cb200478t; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen SY, 2013, J AM CHEM SOC, V135, P6562, DOI 10.1021/ja400461h; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Demmer O, 2009, DESIGN PEPTIDES PROT, P133; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; ELLIS V, 1991, J BIOL CHEM, V266, P12752; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Hajdin K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010445; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Heinis C, 2009, NAT CHEM BIOL, V5, P502, DOI 10.1038/nchembio.184; Hosseini M, 2011, MOL PHARMACOL, V80, P585, DOI 10.1124/mol.111.072280; Jiang LG, 2011, J MOL BIOL, V412, P235, DOI 10.1016/j.jmb.2011.07.028; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; KOIVUNEN E, 1994, METHOD ENZYMOL, V245, P346; Lin ZH, 2011, J BIOL CHEM, V286, P7027, DOI 10.1074/jbc.M110.204537; Nielsen HM, 2009, CHALLENGES DELIVERY, P1; Otwinowski Z., 1997, PROCESSING XRAY DIFF, P307; Puente Xose S., 2008, P3, DOI 10.1007/978-0-387-69057-5_1; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Roodbeen R, 2013, CHEMBIOCHEM; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SPRAGGON G, 1995, STRUCTURE, V3, P681, DOI 10.1016/S0969-2126(01)00203-9; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhao GX, 2007, J STRUCT BIOL, V160, P1, DOI 10.1016/j.jsb.2007.06.003	32	35	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115872	10.1371/journal.pone.0115872	http://dx.doi.org/10.1371/journal.pone.0115872			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545505	Green Published, gold, Green Submitted			2022-12-26	WOS:000347120200077
J	Fagman, JB; Wilhelmson, AS; Motta, BM; Pirazzi, C; Alexanderson, C; De Gendt, K; Verhoeven, G; Holmang, A; Anesten, F; Jansson, JO; Levin, M; Boren, J; Ohlsson, C; Krettek, A; Romeo, S; Tivesten, A				Fagman, Johan B.; Wilhelmson, Anna S.; Motta, Benedetta M.; Pirazzi, Carlo; Alexanderson, Camilla; De Gendt, Karel; Verhoeven, Guido; Holmang, Agneta; Anesten, Fredrik; Jansson, John-Olov; Levin, Malin; Boren, Jan; Ohlsson, Claes; Krettek, Alexandra; Romeo, Stefano; Tivesten, Asa			The androgen receptor confers protection against diet-induced atherosclerosis, obesity, and dyslipidemia in female mice	FASEB JOURNAL			English	Article						genetically altered mice; metabolism; sex hormones	VERY-LOW-DENSITY; CAROTID ATHEROSCLEROSIS; CARDIOVASCULAR EVENTS; ENDOGENOUS ANDROGENS; POSITION STATEMENT; HEPATIC STEATOSIS; DEFICIENT MICE; BREAST-CANCER; TESTOSTERONE; WOMEN	Androgens have important cardiometabolic actions in males, but their metabolic role in females is unclear. To determine the physiologic androgen receptor (AR)-dependent actions of androgens on atherogenesis in female mice, we generated female AR-knockout (ARKO) mice on an atherosclerosis-prone apolipoprotein E (apoE)-deficient background. After 8 weeks on a high-fat diet, but not on a normal chow diet, atherosclerosis in aorta was increased in ARKO females (+59% vs. control apoE-deficient mice with intact AR gene). They also displayed increased body weight (+18%), body fat percentage (+62%), and hepatic triglyceride levels, reduced insulin sensitivity, and a marked atherogenic dyslipidemia (serum cholesterol, +52%). Differences in atherosclerosis, body weight, and lipid levels between ARKO and controlmice were abolished in mice that were ovariectomized before puberty, consistent with a protective action of ovarian androgens mediated via the AR. Furthermore, the AR agonist dihydrotestosterone reduced atherosclerosis (-41%; thoracic aorta), subcutaneous fat mass (-44%), and cholesterol levels (-35%) in ovariectomized mice, reduced hepatocyte lipid accumulation in hepatoma cells in vitro, and regulated mRNA expression of hepatic genes pivotal for lipid homeostasis. In conclusion, we demonstrate that the AR protects against diet-induced atherosclerosis in female mice and propose that this is mediated by modulation of body composition and lipid metabolism.	[Fagman, Johan B.; Wilhelmson, Anna S.; Motta, Benedetta M.; Pirazzi, Carlo; Alexanderson, Camilla; Levin, Malin; Boren, Jan; Romeo, Stefano; Tivesten, Asa] Sahlgrens Univ Hosp, Wallenberg Lab Cardiovasc & Metab Res, Inst Med, S-41345 Gothenburg, Sweden; [De Gendt, Karel; Verhoeven, Guido] Katholieke Univ Leuven, Dept Expt Med, Lab Expt Med & Endocrinol, Leuven, Belgium; [Holmang, Agneta; Anesten, Fredrik; Jansson, John-Olov] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden; [Ohlsson, Claes] Univ Gothenburg, Sahlgrenska Acad, Ctr Bone & Arthrit Res, Inst Med, Gothenburg, Sweden; [Krettek, Alexandra] Nord Sch Publ Hlth, Gothenburg, Sweden; [Krettek, Alexandra] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Gothenburg, Sweden	Sahlgrenska University Hospital; KU Leuven; University of Gothenburg; University of Gothenburg; University of Gothenburg	Tivesten, A (corresponding author), Sahlgrens Univ Hosp, Wallenberg Lab Cardiovasc & Metab Res, Bruna Straket 16, S-41345 Gothenburg, Sweden.	asa.tivesten@medic.gu.se	Romeo, Stefano/L-6861-2015; Wilhelmson, Anna S/HCI-9867-2022; Motta, Benedetta Maria/AAA-8559-2020; Ohlsson, Claes/AGP-3544-2022	Romeo, Stefano/0000-0001-9168-4898; Wilhelmson, Anna S/0000-0003-0640-0251; Motta, Benedetta Maria/0000-0002-6681-2170; Ohlsson, Claes/0000-0002-9633-2805; Levin, Malin/0000-0003-1069-5275; Bourghardt Fagman, Johan/0000-0002-1527-5280	Swedish Research Council; Avtal om Lakarutbildning och Forskning research grant in Gothenburg; Swedish Heart-Lung Foundation; Marianne and Marcus Wallenberg Foundation; Lundberg Foundation; AFA Insurance; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF13OC0005785, NNF14OC0009321, NNF14OC0010799, NNF14OC0010513] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Avtal om Lakarutbildning och Forskning research grant in Gothenburg; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Marianne and Marcus Wallenberg Foundation; Lundberg Foundation(European Commission); AFA Insurance; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors thank Annelie Carlsson, Inger Johansson, and Annika Lundqvist for excellent technical assistance. The authors also thank Martin Adiels for statistical advice, Rosie Perkins for editing the manuscript, the Centre for Physiology and Bio-Imaging (Sahlgrenska Academy, University of Gothenburg) for assistance with metabolic characterization and blood pressure measurements, and the late Sven-Olof Olofsson for valuable discussions. This study was supported by the Swedish Research Council, a Avtal om Lakarutbildning och Forskning research grant in Gothenburg, the Swedish Heart-Lung Foundation, the Marianne and Marcus Wallenberg Foundation, the Lundberg Foundation, AFA Insurance, and the Novo Nordisk Foundation. The authors declare no conflicts of interest.	ADAMS MR, 1995, ARTERIOSCL THROM VAS, V15, P562, DOI 10.1161/01.ATV.15.5.562; Bernini GP, 1999, J CLIN ENDOCR METAB, V84, P2008, DOI 10.1210/jc.84.6.2008; Bhasin S, 2005, J CLIN ENDOCR METAB, V90, P4970, DOI 10.1210/jc.2005-1328; Bourghardt J, 2010, ENDOCRINOLOGY, V151, P5428, DOI 10.1210/en.2010-0663; Braunstein GD, 2007, J CLIN ENDOCR METAB, V92, P4091, DOI 10.1210/jc.2007-1709; Bruck B, 1997, ARTERIOSCL THROM VAS, V17, P2192, DOI 10.1161/01.ATV.17.10.2192; Chiuve SE, 2004, J CLIN ENDOCR METAB, V89, P2207, DOI 10.1210/jc.2003-031564; Christakou CD, 2008, WOMENS HEALTH, V4, P583, DOI 10.2217/17455057.4.6.583; Corbould A, 2008, DIABETES-METAB RES, V24, P520, DOI 10.1002/dmrr.872; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; Elhage R, 1997, ARTERIOSCL THROM VAS, V17, P2679, DOI 10.1161/01.ATV.17.11.2679; Fan WQ, 2005, DIABETES, V54, P1000, DOI 10.2337/diabetes.54.4.1000; Golden SH, 2002, AM J EPIDEMIOL, V155, P437, DOI 10.1093/aje/155.5.437; Graham MJ, 2013, CIRC RES, V112, P1479, DOI 10.1161/CIRCRESAHA.111.300367; Hewing B, 2012, EXPERT OPIN DRUG DIS, V7, P207, DOI 10.1517/17460441.2012.660143; Huff MW, 2013, CIRC RES, V112, P1405, DOI 10.1161/CIRCRESAHA.113.301464; Jo H, 2013, HEPATOLOGY, V57, P1366, DOI 10.1002/hep.26126; Jones TH, 2009, ATHEROSCLEROSIS, V207, P318, DOI 10.1016/j.atherosclerosis.2009.04.016; Kaczmarek A, 2003, INT J CARDIOL, V87, P53, DOI 10.1016/S0167-5273(02)00203-6; Kawano H, 2003, P NATL ACAD SCI USA, V100, P9416, DOI 10.1073/pnas.1533500100; Labrie F, 2003, ENDOCR REV, V24, P152, DOI 10.1210/er.2001-0031; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Laughlin GA, 2010, J CLIN ENDOCR METAB, V95, P740, DOI 10.1210/jc.2009-1693; Lin HY, 2008, HEPATOLOGY, V47, P1924, DOI 10.1002/hep.22252; Lin HY, 2005, DIABETES, V54, P1717, DOI 10.2337/diabetes.54.6.1717; Liu PY, 2003, ENDOCR REV, V24, P313, DOI 10.1210/er.2003-0005; Manolakou P, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-44; Mauvais-Jarvis F, 2011, TRENDS ENDOCRIN MET, V22, P24, DOI 10.1016/j.tem.2010.10.002; McInnes KJ, 2012, DIABETES, V61, P1072, DOI 10.2337/db11-1136; McRobb L, 2009, ENDOCRINOLOGY, V150, P841, DOI 10.1210/en.2008-0760; Montalcini T, 2007, NUTR METAB CARDIOVAS, V17, P705, DOI 10.1016/j.numecd.2006.09.007; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nestler JE, 2008, NEW ENGL J MED, V358, P47, DOI 10.1056/NEJMct0707092; O'Reilly MW, 2014, J STEROID BIOCHEM, V143, P277, DOI 10.1016/j.jsbmb.2014.04.008; Obasanjo IO, 1996, METABOLISM, V45, P463, DOI 10.1016/S0026-0495(96)90220-6; Ohlsson C, 2011, J AM COLL CARDIOL, V58, P1674, DOI 10.1016/j.jacc.2011.07.019; Patel SM, 2009, J CLIN ENDOCR METAB, V94, P4776, DOI 10.1210/jc.2009-0740; Pirazzi C, 2012, J HEPATOL, V57, P1276, DOI 10.1016/j.jhep.2012.07.030; PURCELLHUYNH DA, 1995, J CLIN INVEST, V95, P2246, DOI 10.1172/JCI117915; Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864; Rulli SB, 2002, ENDOCRINOLOGY, V143, P4084, DOI 10.1210/en.2002-220490; Shiina H, 2006, P NATL ACAD SCI USA, V103, P224, DOI 10.1073/pnas.0506736102; Sievers C, 2010, EUR J ENDOCRINOL, V163, P699, DOI 10.1530/EJE-10-0307; Sjoberg A, 1996, J LIPID RES, V37, P275; Strong A, 2012, CURR ATHEROSCLER REP, V14, P211, DOI 10.1007/s11883-012-0248-x; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; vanVlijmen BJM, 1996, J CLIN INVEST, V97, P1184, DOI 10.1172/JCI118532; VELDHUIS JD, 1993, HUM REPROD, V8, P84, DOI 10.1093/humrep/8.suppl_2.84; von Dehn G, 2001, HORM METAB RES, V33, P110, DOI 10.1055/s-2001-12405; Walters KA, 2007, ENDOCRINOLOGY, V148, P3674, DOI 10.1210/en.2007-0248; Walters KA, 2010, HUM REPROD UPDATE, V16, P543, DOI 10.1093/humupd/dmq003; Wang XW, 2011, J CLIN ENDOCR METAB, V96, P885, DOI 10.1210/jc.2010-2061; Wierman ME, 2014, J CLIN ENDOCR METAB, V99, P3489, DOI 10.1210/jc.2014-2260; Wild RA, 2010, J CLIN ENDOCR METAB, V95, P2038, DOI 10.1210/jc.2009-2724; Yeh SY, 2003, J EXP MED, V198, P1899, DOI 10.1084/jem.20031233; Yu IC, 2008, ENDOCRINOLOGY, V149, P2361, DOI 10.1210/en.2007-0516; Zhang H, 2013, J LIPID RES, V54, P345, DOI 10.1194/jlr.M028969	57	30	33	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1540	1550		10.1096/fj.14-259234	http://dx.doi.org/10.1096/fj.14-259234			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25550469	Green Published, hybrid			2022-12-26	WOS:000354115000038
J	Kinross, KM; Montgomery, KG; Mangiafico, SP; Hare, LM; Kleinschmidt, M; Bywater, MJ; Poulton, IJ; Vrahnas, C; Henneicke, H; Malaterre, J; Waring, PM; Cullinane, C; Sims, NA; McArthur, GA; Andrikopoulos, S; Phillips, WA				Kinross, Kathryn M.; Montgomery, Karen G.; Mangiafico, Salvatore P.; Hare, Lauren M.; Kleinschmidt, Margarete; Bywater, Megan J.; Poulton, Ingrid J.; Vrahnas, Christina; Henneicke, Holger; Malaterre, Jordane; Waring, Paul M.; Cullinane, Carleen; Sims, Natalie A.; McArthur, Grant A.; Andrikopoulos, Sofianos; Phillips, Wayne A.			Ubiquitous expression of the Pik3ca(H1047R) mutation promotes hypoglycemia, hypoinsulinemia, and organomegaly	FASEB JOURNAL			English	Article						PI3K; p110 alpha; mouse model; overgrowth syndrome; glucose metabolism	IN-VIVO; INSULIN-SECRETION; ACTIVATING MUTATIONS; METABOLIC-REGULATION; ENERGY-METABOLISM; MICE LACKING; PIK3CA CAUSE; BETA-CELLS; CANCER; KINASE	Mutations in PIK3CA, the gene encoding the p110 alpha catalytic subunit of PI3K, are among the most common mutations found in human cancer and have also recently been implicated in a range of overgrowth syndromes in humans. We have used a novel inducible "exonswitch" approach to knock in the constitutively active Pik3ca(H1047R) mutation into the endogenous Pik3ca gene of the mouse. Ubiquitous expression of the Pik3caH1047R mutation throughout the body resulted in a dramatic increase in body weight within 3 weeks of induction (mutant 150 +/- 5%; wild-type 117 +/- 3%, mean +/- SEM), which was associated with increased organ size rather than adiposity. Severe metabolic effects, including a reduction in blood glucose levels to 59 +/- 4% of baseline (11 days postinduction) and undetectable insulin levels, were also observed. Pik3ca(H1047R) mutant mice died earlier (median survival 46.5 d post-mutation induction) than wild-type control mice (100% survival > 250 days). Although deletion of Akt2 increased median survivalby 44%, neither organ overgrowth, nor hypoglycemia were rescued, indicating that both the growth and metabolic functions of constitutive PI3K activity can be Akt2 independent. This mouse model demonstrates the critical role of PI3K in the regulation of both organ size and glucose metabolism at the whole animal level.	[Kinross, Kathryn M.; Montgomery, Karen G.; Hare, Lauren M.; Phillips, Wayne A.] Peter MacCallum Canc Ctr, Surg Oncol Res Lab, East Melbourne, Vic, Australia; [Kinross, Kathryn M.; Cullinane, Carleen; McArthur, Grant A.; Phillips, Wayne A.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Mangiafico, Salvatore P.; Andrikopoulos, Sofianos] Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic, Australia; [Kleinschmidt, Margarete; Bywater, Megan J.; Cullinane, Carleen] Peter MacCallum Canc Ctr, Translat Res Labs, East Melbourne, Vic, Australia; [Poulton, Ingrid J.; Vrahnas, Christina; Sims, Natalie A.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Poulton, Ingrid J.; Vrahnas, Christina; Sims, Natalie A.] Univ Melbourne, Dept Med, Fitzroy, Vic 3065, Australia; [Henneicke, Holger] Univ Sydney, ANZAC Res Inst, Bone Res Program, Sydney, NSW 2006, Australia; [Malaterre, Jordane] Peter MacCallum Canc Ctr, Differentiat & Transcript Lab, East Melbourne, Vic, Australia; [Waring, Paul M.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [McArthur, Grant A.] Peter MacCallum Canc Ctr, Mol Oncol Lab, East Melbourne, Vic 8006, Australia; [Phillips, Wayne A.] Univ Melbourne, Dept Surg, St Vincents Hosp, Fitzroy, Vic 3065, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Peter Maccallum Cancer Center; St. Vincent's Institute of Medical Research; University of Melbourne; University of Sydney; ANZAC Research Institute; Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; St Vincent's Hospital Melbourne; University of Melbourne	Phillips, WA (corresponding author), Peter MacCallum Canc Ctr, Surg Oncol Res Lab, Locked Bag 1,ABeckett St PO, Melbourne, Vic 8006, Australia.	wayne.phillips@petermac.org	Bywater, Megan/X-5606-2018; Sims, Natalie Ann/A-7192-2012; Phillips, Wayne A/H-8070-2013; Henneicke, Holger/H-3383-2016; Research Institute, ANZAC/CAE-9030-2022	Bywater, Megan/0000-0002-7466-6927; Sims, Natalie Ann/0000-0003-1421-8468; Phillips, Wayne A/0000-0002-7961-638X; Henneicke, Holger/0000-0003-1746-9369; McArthur, Grant/0000-0001-8908-6071; Cullinane, Carleen/0000-0001-5833-6605	National Health and Medical Research Council of Australia [628620, 628621]; Cancer Council of Victoria	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria)	The authors thank Ryan Galea, Kevin Mills, Kerry Ardley, the animal facility staff, the Peter MacCallum Cancer Centre Department of Pathology, and the Research Division Microscopy and Histology Core Facility for their valuable advice and/or technical assistance. This work was supported, in part, by the National Health and Medical Research Council of Australia (project Grants 628620 and 628621, to W.A.P.). K.K. was supported by a grant-in-aid from the Cancer Council of Victoria.	Arya VB, 2014, J CLIN ENDOCR METAB, V99, P391, DOI 10.1210/jc.2013-3228; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cullinane C, 2005, CANCER RES, V65, P9633, DOI 10.1158/0008-5472.CAN-05-2285; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Denoyer D, 2011, J NUCL MED, V52, P115, DOI 10.2967/jnumed.110.078154; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Durban VM, 2013, J CLIN INVEST, V123, P5104, DOI 10.1172/JCI69619; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Ford-Hutchinson AF, 2007, J BONE MINER RES, V22, P1245, DOI 10.1359/JBMR.070420; Foukas LC, 2013, EMBO MOL MED, V5, P563, DOI 10.1002/emmm.201201953; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Gundberg CM, 1998, J CLIN ENDOCR METAB, V83, P3258, DOI 10.1210/jc.83.9.3258; Hare LM, 2014, BIOCHEM J, V458, P251, DOI 10.1042/BJ20131412; Hussain K, 2011, SCIENCE, V334, P474, DOI 10.1126/science.1210878; Kaneko K, 2010, CELL METAB, V12, P619, DOI 10.1016/j.cmet.2010.11.005; Keppler-Noreuil KM, 2014, AM J MED GENET A, V164, P1713, DOI 10.1002/ajmg.a.36552; Kinross KM, 2012, J CLIN INVEST, V122, P553, DOI 10.1172/JCI59309; Kinross KM, 2011, MOL CANCER THER, V10, P1440, DOI 10.1158/1535-7163.MCT-11-0240; Kolic J, 2013, DIABETOLOGIA, V56, P1339, DOI 10.1007/s00125-013-2882-4; Kurek KC, 2012, AM J HUM GENET, V90, P1108, DOI 10.1016/j.ajhg.2012.05.006; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lindhurst MJ, 2012, NAT GENET, V44, P928, DOI 10.1038/ng.2332; Liu SJ, 2014, CANCER RES, V74, P641, DOI 10.1158/0008-5472.CAN-13-2319; Mangiafico SP, 2011, J ENDOCRINOL, V210, P335, DOI 10.1530/JOE-11-0126; Mirzaa G, 2013, GENEREVIEWS, P1993; Rios JJ, 2013, HUM MOL GENET, V22, P444, DOI 10.1093/hmg/dds440; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Smith GC, 2012, BIOCHEM J, V442, P161, DOI 10.1042/BJ20111913; Sopasakis VR, 2010, CELL METAB, V11, P220, DOI 10.1016/j.cmet.2010.02.002; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tikoo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036924; Trejo CL, 2013, CANCER RES, V73, P6448, DOI 10.1158/0008-5472.CAN-13-0681; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8	45	18	18	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1426	1434		10.1096/fj.14-262782	http://dx.doi.org/10.1096/fj.14-262782			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25550458				2022-12-26	WOS:000354115000028
J	Royall, E; Doyle, N; Abdul-Wahab, A; Emmott, E; Morley, SJ; Goodfellow, I; Roberts, LO; Locker, N				Royall, Elizabeth; Doyle, Nicole; Abdul-Wahab, Azimah; Emmott, Ed; Morley, Simon J.; Goodfellow, Ian; Roberts, Lisa O.; Locker, Nicolas			Murine Norovirus 1 (MNV1) Replication Induces Translational Control of the Host by Regulating eIF4E Activity during Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INITIATION-FACTOR 4E; MESSENGER-RNAS; PHOSPHORYLATED EIF4E; SECONDARY STRUCTURE; NORWALK VIRUS; FACTOR EIF-4E; COMPLEX; VPG; BINDING	Protein synthesis is a tightly controlled process responding to several stimuli, including viral infection. As obligate intracellular parasites, viruses depend on the translation machinery of the host and can manipulate it by affecting the availability and function of specific eukaryotic initiation factors (eIFs). Human norovirus is a member of the Caliciviridae family and is responsible for gastroenteritis outbreaks. Previous studies on feline calicivirus and murine norovirus 1 (MNV1) demonstrated that the viral protein, genome-linked (VPg), acts to direct translation by hijacking the host protein synthesis machinery. Here we report that MNV1 infection modulates the MAPK pathway to activate eIF4E phosphorylation. Our results show that the activation of p38 and Mnk during MNV1 infection is important for MNV1 replication. Furthermore, phosphorylated eIF4E relocates to the polysomes, and this contributes to changes in the translational state of specific host mRNAs. We propose that global translational control of the host by eIF4E phosphorylation is a key component of the host-pathogen interaction.	[Royall, Elizabeth; Doyle, Nicole; Abdul-Wahab, Azimah; Roberts, Lisa O.; Locker, Nicolas] Univ Surrey, Fac Hlth & Med Sci, Sch Biosci & Med, Guildford GU2 7HX, Surrey, England; [Emmott, Ed; Goodfellow, Ian] Univ Cambridge, Dept Pathol, Addenbrookes Hosp, Div Virol, Cambridge CB2 2QQ, England; [Morley, Simon J.] Univ Sussex, Dept Biochem & Mol Biol, Sch Life Sci, Brighton BN1 9RH, E Sussex, England	University of Surrey; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Sussex	Locker, N (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Sch Biosci & Med, Guildford GU2 7HX, Surrey, England.	n.locker@surrey.ac.uk		Doyle, Nicole/0000-0002-6016-5830; Emmott, Edward/0000-0002-3239-8178; Abdul Wahab, Azimah/0000-0002-7381-5978; Locker, Nicolas/0000-0002-0053-2897; Goodfellow, Ian/0000-0002-9483-510X	Biotechnology and Biological Sciences Research Council [BB/I01232X/1, BB/I012303/1, BB/H009728/1]; Wellcome Trust [WT097997MA]; Majlis Amanah Rakyat (MARA), Government of Malaysia; University of Kuala Lumpur; Biotechnology and Biological Sciences Research Council [BB/H018956/1, BB/L018209/1] Funding Source: researchfish; BBSRC [BB/L018209/1, BB/H018956/1, BB/I012303/1, BB/I01232X/1, BB/H009728/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Majlis Amanah Rakyat (MARA), Government of Malaysia; University of Kuala Lumpur; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Research Grants BB/I01232X/1 (to L. O. R. and N. L.), BB/I012303/1 (to I. G.), and BB/H009728/1 (to S. J. M.) as well as Wellcome Trust Senior Fellowship WT097997MA (to I. G.).; Supported by Majlis Amanah Rakyat (MARA), Government of Malaysia, and the University of Kuala Lumpur.	Arias A, 2012, J GEN VIROL, V93, P1432, DOI 10.1099/vir.0.042176-0; Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855; BURROUGHS JN, 1978, J GEN VIROL, V40, P161, DOI 10.1099/0022-1317-40-1-161; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Capizzi T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-131; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cencic R, 2007, METHOD ENZYMOL, V431, P269, DOI 10.1016/S0076-6879(07)31013-6; Cencic R, 2011, J VIROL, V85, P6381, DOI 10.1128/JVI.00078-11; Cencic R, 2011, P NATL ACAD SCI USA, V108, P1046, DOI 10.1073/pnas.1011477108; Chaudhry Y, 2007, J GEN VIROL, V88, P2091, DOI 10.1099/vir.0.82940-0; Chaudhry Y, 2006, J BIOL CHEM, V281, P25315, DOI 10.1074/jbc.M602230200; Chen YJ, 2010, NUCLEIC ACIDS RES, V38, P764, DOI 10.1093/nar/gkp1034; Chuluunbaatar U, 2012, J VIROL, V86, P7771, DOI 10.1128/JVI.00622-12; Chung L, 2014, J BIOL CHEM, V289, P21738, DOI 10.1074/jbc.M114.550657; Clemens MJ, 2005, SEMIN CELL DEV BIOL, V16, P13, DOI 10.1016/j.semcdb.2004.11.011; Clemens MJ, 2001, J CELL MOL MED, V5, P221, DOI 10.1111/j.1582-4934.2001.tb00157.x; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Connor JH, 2002, J VIROL, V76, P10177, DOI 10.1128/JVI.76.20.10177-10187.2002; Daughenbaugh KF, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-33; Daughenbaugh KF, 2003, EMBO J, V22, P2852, DOI 10.1093/emboj/cdg251; Duizer E, 2004, J GEN VIROL, V85, P79, DOI 10.1099/vir.0.19478-0; DUNCAN R, 1987, J BIOL CHEM, V262, P380; Feoktistova K, 2013, P NATL ACAD SCI USA, V110, P13339, DOI 10.1073/pnas.1303781110; FLYNN A, 1995, J BIOL CHEM, V270, P21684, DOI 10.1074/jbc.270.37.21684; Fuentes C, 2012, J VIROL, V86, P10070, DOI 10.1128/JVI.00797-12; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Gingras AC, 2001, GENE DEV, V15, P2852; Goodfellow I, 2005, EMBO REP, V6, P968, DOI 10.1038/sj.embor.7400510; Gretton S, 2010, J GEN VIROL, V91, P671, DOI 10.1099/vir.0.016899-0; Halbeisen RE, 2009, METHODS, V48, P306, DOI 10.1016/j.ymeth.2009.04.003; Health Protection Agency, 2013, HOSP OUTBR REP; Herbert TP, 1997, J GEN VIROL, V78, P1033, DOI 10.1099/0022-1317-78-5-1033; Herdy B, 2012, NAT IMMUNOL, V13, P543, DOI 10.1038/ni.2291; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Ji WT, 2009, J GEN VIROL, V90, P3002, DOI 10.1099/vir.0.013953-0; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; JOSHI B, 1995, J BIOL CHEM, V270, P14597, DOI 10.1074/jbc.270.24.14597; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; Karst SM, 2010, VIRUSES-BASEL, V2, P748, DOI 10.3390/v2030748; Kawai Taro, 2006, Nihon Rinsho, V64, P1231; Khan RR, 2009, J PEDIATR GASTR NUTR, V48, P328, DOI 10.1097/MPG.0b013e31818255cc; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Lopman BA, 2004, EMERG INFECT DIS, V10, P1827, DOI 10.3201/eid1010.030941; MADER S, 1995, MOL CELL BIOL, V15, P4990; McFadden N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002413; McMahon R, 2011, J VIROL, V85, P853, DOI 10.1128/JVI.01873-10; Mohr I, 2012, CELL HOST MICROBE, V12, P470, DOI 10.1016/j.chom.2012.09.006; Morley SJ, 1997, FEBS LETT, V418, P327, DOI 10.1016/S0014-5793(97)01405-1; Moser LA, 2008, J VIROL, V82, P7475, DOI 10.1128/JVI.02193-07; Muller D, 2013, TRANSLATION, V1, DOI 10.4161/trla.25819; Nice TJ, 2013, J VIROL, V87, P327, DOI 10.1128/JVI.01864-12; Papafragkou E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063485; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Proud CG, 2015, BBA-GENE REGUL MECH, V1849, P766, DOI 10.1016/j.bbagrm.2014.10.003; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Pyronnet S, 2000, BIOCHEM PHARMACOL, V60, P1237, DOI 10.1016/S0006-2952(00)00429-9; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schwartz S, 2011, BLOOD, V117, P5850, DOI 10.1182/blood-2010-12-325886; Shi YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094011; Shveygert M, 2010, MOL CELL BIOL, V30, P5160, DOI 10.1128/MCB.00448-10; Slepenkov SV, 2006, J BIOL CHEM, V281, P14927, DOI 10.1074/jbc.M601653200; Stuart RL, 2010, PEDIATR INFECT DIS J, V29, P644, DOI 10.1097/INF.0b013e3181d824e1; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Thorne LG, 2014, J GEN VIROL, V95, P278, DOI 10.1099/vir.0.059634-0; Tuxworth WJ, 2004, BIOCHEM J, V378, P73, DOI 10.1042/BJ20031027; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Vashist S, 2009, FUTURE VIROL, V4, P353, DOI 10.2217/FVL.09.18; Walsh D, 2004, GENE DEV, V18, P660, DOI 10.1101/gad.1185304; Walsh D, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012351; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Willett M, 2006, EXP CELL RES, V312, P2942, DOI 10.1016/j.yexcr.2006.05.020; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Zhu S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003592	76	29	31	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4748	4758		10.1074/jbc.M114.602649	http://dx.doi.org/10.1074/jbc.M114.602649			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25561727	Green Published, hybrid			2022-12-26	WOS:000350042000018
J	Guo, C; Li, L; Wang, XF; Liang, C				Guo, Cheng; Li, Li; Wang, Xifeng; Liang, Chun			Alterations in SiRNA and MiRNA Expression Profiles Detected by Deep Sequencing of Transgenic Rice with SiRNA-Mediated Viral Resistance	PLOS ONE			English	Article							SMALL RNAS; MICRORNA; VIRUS; ROLES; IDENTIFICATION; BIOGENESIS; EFFICIENT; STRESS	RNA-mediated gene silencing has been demonstrated to serve as a defensive mechanism against viral pathogens by plants. It is known that specifically expressed endogenous siRNAs and miRNAs are involved in the self-defense process during viral infection. However, research has been rarely devoted to the endogenous siRNA and miRNA expression changes under viral infection if the resistance has already been genetically engineered in plants. Aiming to gain a deeper understanding of the RNA-mediated gene silencing defense process in plants, the expression profiles of siRNAs and miRNAs before and after viral infection in both wild type and transgenic anti-Rice stripe virus (RSV) rice plants were examined by small RNA high-throughput sequencing. Our research confirms that the newly generated siRNAs, which are derived from the engineered inverted repeat construct, is the major contributor of the viral resistance in rice. Further analysis suggests the accuracy of siRNA biogenesis might be affected when siRNAs machinery is excessively used in the transgenic plants. In addition, the expression levels of many known miRNAs are dramatically changed due to RSV infection on both wild type and transgenic rice plants, indicating potential function of those miRNAs involved in plant-virus interacting process.	[Guo, Cheng; Liang, Chun] Miami Univ, Dept Biol, Oxford, OH 45056 USA; [Li, Li; Wang, Xifeng; Liang, Chun] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Liang, Chun] Miami Univ, Dept Comp Sci & Software Engn, Oxford, OH 45056 USA	University System of Ohio; Miami University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; University System of Ohio; Miami University	Wang, XF (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	xfwang@ippcaas.cn; liangc@miamioh.edu	Wang, Xifeng/A-6476-2016	Wang, Xifeng/0000-0002-4982-8947	Office for the Advancement of Research and Scholarship (OARS); Special Fund for Agro-scientific Research in the Public Interest in China [201303021]; National R&D Project of Transgenic Crops of China [2011ZX08002-001]; Botany Department, Miami University, Oxford, Ohio, USA	Office for the Advancement of Research and Scholarship (OARS); Special Fund for Agro-scientific Research in the Public Interest in China; National R&D Project of Transgenic Crops of China; Botany Department, Miami University, Oxford, Ohio, USA	This project is funded partially by Office for the Advancement of Research and Scholarship (OARS) and Botany Department, Miami University, Oxford, Ohio, USA; partially by The Special Fund for Agro-scientific Research in the Public Interest (201303021) in China; and National R&D Project of Transgenic Crops of China (2011ZX08002-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arikit S, 2013, CURR OPIN PLANT BIOL, V16, P170, DOI 10.1016/j.pbi.2013.01.006; Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Barrera-Figueroa BE, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-132; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Bottino MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059423; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Buck AH, 2010, RNA, V16, P307, DOI 10.1261/rna.1819210; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dai Yang, 2010, Open Access Bioinformatics, V2, P29; de Lima JC, 2012, GENET MOL BIOL, V35, P1069, DOI 10.1590/S1415-47572012000600023; Ding SW, 2004, VIRUS RES, V102, P109, DOI 10.1016/j.virusres.2004.01.021; Du P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002176; Frazier TP, 2011, MOL BIOTECHNOL, V49, P159, DOI 10.1007/s12033-011-9387-5; Guo WX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046443; Haasnoot J, 2011, METHODS MOL BIOL, V721, P23, DOI 10.1007/978-1-61779-037-9_2; Hily JM, 2007, J AM SOC HORTIC SCI, V132, P850, DOI 10.21273/JASHS.132.6.850; Jeang KT, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-58; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li Y, 2010, J VIROL, V84, P3023, DOI 10.1128/JVI.02203-09; Liang XH, 2013, BBA-GENE REGUL MECH, V1829, P455, DOI 10.1016/j.bbagrm.2013.01.011; Llave C, 2010, TRENDS PLANT SCI, V15, P701, DOI 10.1016/j.tplants.2010.09.001; Lund E, 2011, GENE DEV, V25, P1121, DOI 10.1101/gad.2038811; Matthew L, 2004, COMP FUNCT GENOM, V5, P240, DOI 10.1002/cfg.396; Metpally Raghu Prasad Rao, 2013, Frontiers in Genetics, V4, P20, DOI 10.3389/fgene.2013.00020; Okamura K, 2013, GENE DEV, V27, P778, DOI 10.1101/gad.211698.112; Parent JS, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00179; Schott G, 2012, EMBO J, V31, P2553, DOI 10.1038/emboj.2012.92; Shu LF, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-108; Szittya G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000838; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Vodovar N, 2011, J VIROL, V85, P11016, DOI 10.1128/JVI.05647-11; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yan F, 2010, ARCH VIROL, V155, P935, DOI 10.1007/s00705-010-0670-8; Yu X, 2012, J EXP BOT, V63, P1025, DOI 10.1093/jxb/err337; Zhang CQ, 2012, BIOINFORMATICS, V28, P2561, DOI 10.1093/bioinformatics/bts500	43	27	30	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e0116175	10.1371/journal.pone.0116175	http://dx.doi.org/10.1371/journal.pone.0116175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559820	gold, Green Published, Green Submitted			2022-12-26	WOS:000348102200012
J	He, CY; Sun, LP; Xu, Q; Liu, JW; Jiang, JY; Dong, NN; Yuan, Y				He, Cai-yun; Sun, Li-ping; Xu, Qian; Liu, Jing-wei; Jiang, Jing-yi; Dong, Nan-nan; Yuan, Yuan			PGC TagSNP and Its Interaction with H. pylori and Relation with Gene Expression in Susceptibility to Gastric Carcinogenesis	PLOS ONE			English	Article							PEPSINOGEN-C; HELICOBACTER-PYLORI; CLINICAL-SIGNIFICANCE; VIRULENCE FACTORS; CANCER; POLYMORPHISM; ASSOCIATION; INFECTION; CHINESE	Background: Pepsinogen C (PGC) plays an important role in sustaining the cellular differentiation during the process of gastric carcinogenesis. This study aimed to assess the role of PGC tagSNPs and their interactions with Helicobacter pylori (H. pylori) in the development of gastric cancer and its precursor, atrophic gastritis. Methods: Four PGC tagSNPs (rs6941539, rs6912200, rs3789210 and rs6939861) were genotyped by Sequenom MassARRAY platform in a total of 2311 subjects consisting of 642 gastric cancer, 774 atrophic gastritis, and 895 healthy control subjects. The mRNA and protein expression levels of PGC in gastric tissues and in serum were respectively measured by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR), immunohistochemistry, and Eenzyme-linked immunoabsorbent assay (ELISA). Results: We found associations between PGC rs3789210 CG/GG genotypes and reduced gastric cancer risk and between PGC rs6939861 A variant allele and increased risks of both gastric cancer and atrophic gastritis. As for the haplotypes of PGC rs6941539-rs6912200-rs3789210-rs6939861 loci, the TTCA and TTGG haplotypes were respectively associated with increased and reduced risks of both gastric cancer and atrophic gastritis; additionally, the CTCA haplotype was associated with increased atrophic gastritis risk. Very interestingly, rs6912200 CT/TT genotypes had a positive interaction with H. pylori, synergistically elevating the gastric cancer risk. Moreover, healthy subjects who carried rs6912200 CT, TT and CT/TT variant genotypes had lower histological and serum expression levels of PGC protein. Conclusions: Our findings highlight an important role of PGC rs3789210 and rs6939861 in altering susceptibility to atrophic gastritis and/or gastric cancer. Moreover, people who carry rs6912200 variant genotypes exhibit higher gastric cancer risk in case of getting H. pylori infection, which strongly suggest a necessity of preventing and/or eliminating H. pylori infection in those individuals.	[He, Cai-yun; Sun, Li-ping; Xu, Qian; Liu, Jing-wei; Jiang, Jing-yi; Dong, Nan-nan; Yuan, Yuan] China Med Univ, Affiliated Hosp 1, Tumor Etiol & Screening Dept, Inst Canc, Shenyang, Peoples R China; [He, Cai-yun; Sun, Li-ping; Xu, Qian; Liu, Jing-wei; Jiang, Jing-yi; Dong, Nan-nan; Yuan, Yuan] China Med Univ, Affiliated Hosp 1, Shenyang, Peoples R China; [He, Cai-yun; Sun, Li-ping; Xu, Qian; Liu, Jing-wei; Jiang, Jing-yi; Dong, Nan-nan; Yuan, Yuan] China Med Univ, Liaoning Prov Educ Dept, Key Lab Canc Etiol & Prevent, Shenyang, Peoples R China; [He, Cai-yun] Sun Yat Sen Univ, Ctr Canc, Dept Mol Diagnost, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China	China Medical University; China Medical University; China Medical University; State Key Lab Oncology South China; Sun Yat Sen University	Yuan, Y (corresponding author), China Med Univ, Affiliated Hosp 1, Tumor Etiol & Screening Dept, Inst Canc, Shenyang, Peoples R China.	yyuan@mail.cmu.edu.cn	Yuan, Yuan/GVS-5120-2022		National Basic Research Program of China (973 Program) [2010CB529304]; National Natural Science Foundation of China [31200968]; Science Technology Project in Liaoning Province [2011225002]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Project in Liaoning Province	This study is supported by grants from National Basic Research Program of China (973 Program Ref No. 2010CB529304), the National Natural Science Foundation of China (Ref No. 31200968), and the Science Technology Project in Liaoning Province (Ref No. 2011225002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZUMA T, 1993, GUT, V34, P450, DOI 10.1136/gut.34.4.450; Di Mario F, 2004, DIGESTION, V70, P167, DOI 10.1159/000081517; Di Mario F, 2006, DIGEST DIS SCI, V51, P1791, DOI 10.1007/s10620-006-9206-1; Diaz M, 2002, INT J BIOL MARKER, V17, P125, DOI 10.1177/172460080201700208; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Fock KM, 2009, J GASTROEN HEPATOL, V24, P1587, DOI 10.1111/j.1440-1746.2009.05982.x; Gritti I, 2000, PHARMACOL RES, V41, P265, DOI 10.1006/phrs.1999.0586; He CY, 2011, J GASTROEN HEPATOL, V26, P1039, DOI 10.1111/j.1440-1746.2011.06692.x; He CY, 2014, MUTAT RES-REV MUTAT, V759, P14, DOI 10.1016/j.mrrev.2013.09.002; He CY, 2013, CARCINOGENESIS, V34, P1450, DOI 10.1093/carcin/bgt079; KONISHI N, 1995, J CLIN PATHOL, V48, P364, DOI 10.1136/jcp.48.4.364; Li P, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-22; Liu HJ, 2003, WORLD J GASTROENTERO, V9, P50, DOI 10.3748/wjg.v9.i1.50; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Massarrat S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/481607; Ning PF, 2005, WORLD J GASTROENTERO, V11, P2545, DOI 10.3748/wjg.v11.i17.2545; Nugalieva ZZ, 2006, HELICOBACTER, V11, P69, DOI 10.1111/j.1523-5378.2006.00380.x; Rojo JV, 2002, EUR J OBSTET GYN R B, V104, P58, DOI 10.1016/S0301-2115(01)00610-8; Roukos DH, 2009, EXPERT REV MOL DIAGN, V9, P1, DOI 10.1586/14737159.9.1.1; Scorilas A, 1999, CLIN CANCER RES, V5, P1778; Sun Li-Ping, 2009, Ai Zheng, V28, P487; Sun LP, 2009, J CANCER RES CLIN, V135, P1033, DOI 10.1007/s00432-008-0539-3; Truan N, 2001, INT J BIOL MARKER, V16, P31, DOI 10.1177/172460080101600104; Wen SC, 2009, CANCER LETT, V282, P1, DOI 10.1016/j.canlet.2008.11.016; Yasugi S, 2000, Hum Cell, V13, P177	25	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115955	10.1371/journal.pone.0115955	http://dx.doi.org/10.1371/journal.pone.0115955			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551587	Green Published, gold, Green Submitted			2022-12-26	WOS:000347119100081
J	Hulme, RS; Higginbottom, A; Palmer, J; Partridge, LJ; Monk, PN				Hulme, Rachel S.; Higginbottom, Adrian; Palmer, John; Partridge, Lynda J.; Monk, Peter N.			Distinct Regions of the Large Extracellular Domain of Tetraspanin CD9 Are Involved in the Control of Human Multinucleated Giant Cell Formation	PLOS ONE			English	Article							SPERM-EGG FUSION; STRUCTURAL DOMAINS; CD81 FUNCTION; IDENTIFICATION; PROTEINS; ASSOCIATION; RESIDUES; ADHESION; REQUIRES; BINDING	Multinucleated giant cells, formed by the fusion of monocytes/macrophages, are features of chronic granulomatous inflammation associated with infections or the persistent presence of foreign material. The tetraspanins CD9 and CD81 regulate multinucleated giant cell formation: soluble recombinant proteins corresponding to the large extracellular domain (EC2) of human but not mouse CD9 can inhibit multinucleated giant cell formation, whereas human CD81 EC2 can antagonise this effect. Tetraspanin EC2 are all likely to have a conserved three helix sub-domain and a much less well-conserved or hypervariable sub-domain formed by short helices and interconnecting loops stabilised by two or more disulfide bridges. Using CD9/CD81 EC2 chimeras and point mutants we have mapped the specific regions of the CD9 EC2 involved in multinucleated giant cell formation. These were primarily located in two helices, one in each sub-domain. The cysteine residues involved in the formation of the disulfide bridges in CD9 EC2 were all essential for inhibitory activity but a conserved glycine residue in the tetraspanin-defining 'CCG' motif was not. A tyrosine residue in one of the active regions that is not conserved between human and mouse CD9 EC2, predicted to be solvent-exposed, was found to be only peripherally involved in this activity. We have defined two spatially-distinct sites on the CD9 EC2 that are required for inhibitory activity. Agents that target these sites could have therapeutic applications in diseases in which multinucleated giant cells play a pathogenic role.	[Hulme, Rachel S.; Palmer, John; Partridge, Lynda J.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Higginbottom, Adrian] Univ Sheffield, Sch Med, Dept Neurosci, Sheffield, S Yorkshire, England; [Monk, Peter N.] Univ Sheffield, Sch Med, Dept Infect & Immun, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Monk, PN (corresponding author), Univ Sheffield, Sch Med, Dept Infect & Immun, Sheffield, S Yorkshire, England.	p.monk@shef.ac.uk	Monk, Peter/C-6155-2008	Monk, Peter/0000-0003-4637-3059	Humane Research Trust; Biotechnology and Biological Sciences Research Council [BB/F016832/1]; British Heart Foundation [PG/98163]	Humane Research Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This study was supported by Humane Research Trust PM LJP (http://www.humaneresearch.org.uk), Biotechnology and Biological Sciences Research Council studentship BB/F016832/1 LJP (http://www.bbsrc.ac.uk/home/home.as), British Heart Foundation PG/98163 PM (http://www.bhf.org.uk/#&panel1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008; Arduise C, 2008, J IMMUNOL, V181, P7002, DOI 10.4049/jimmunol.181.10.7002; Barreiro O, 2008, J CELL BIOL, V183, P527, DOI 10.1083/jcb.200805076; Burke ML, 2009, PARASITE IMMUNOL, V31, P163, DOI 10.1111/j.1365-3024.2009.01098.x; Charrin S, 2001, J BIOL CHEM, V276, P14329, DOI 10.1074/jbc.M011297200; Charrin S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2675; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Cook GA, 2002, BLOOD, V100, P4502, DOI 10.1182/blood.V100.13.4502; Ellerman DA, 2003, MOL BIOL CELL, V14, P5098, DOI 10.1091/mbc.E03-04-0244; Espenel C, 2008, J CELL BIOL, V182, P765, DOI 10.1083/jcb.200803010; Fanaei M, 2011, BIOCHEM SOC T, V39, P524, DOI 10.1042/BST0390524; Gordon-Alonso M, 2006, J IMMUNOL, V177, P5129, DOI 10.4049/jimmunol.177.8.5129; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Hassuna N, 2009, BIODRUGS, V23, P341, DOI 10.2165/11315650-000000000-00000; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Higginbottom A, 2000, J VIROL, V74, P3642, DOI 10.1128/JVI.74.8.3642-3649.2000; Higginbottom A, 2003, BIOCHEM BIOPH RES CO, V311, P208, DOI 10.1016/j.bbrc.2003.09.196; Ho SH, 2006, J VIROL, V80, P6487, DOI 10.1128/JVI.02539-05; Kazarov AR, 2002, J CELL BIOL, V158, P1299, DOI 10.1083/jcb.200204056; Kitadokoro K, 2002, BIOL CHEM, V383, P1447, DOI 10.1515/BC.2002.164; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Kitadokoro K, 2001, ACTA CRYSTALLOGR D, V57, P156, DOI 10.1107/S0907444900015468; Klinovska K, 2014, INT J MOL SCI, V15, P10652, DOI 10.3390/ijms150610652; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lay G, 2007, J PATHOL, V211, P76, DOI 10.1002/path.2092; Le Naour F, 2006, PROTEOMICS, V6, P6447, DOI 10.1002/pmic.200600282; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; Monk Peter N., 2012, Infectious Disorders - Drug Targets, V12, P4; Nordborg C, 2000, CLIN EXP RHEUMATOL, V18, pS18; Okamoto Hiroyuki, 2002, Nihon Rinsho, V60, P1801; Parthasarathy V, 2009, IMMUNOLOGY, V127, P237, DOI 10.1111/j.1365-2567.2008.02945.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powner D, 2011, BIOCHEM SOC T, V39, P563, DOI 10.1042/BST0390563; Rana S, 2011, BIOCHEM SOC T, V39, P559, DOI 10.1042/BST0390559; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rubinstein E, 2006, SEMIN CELL DEV BIOL, V17, P254, DOI 10.1016/j.semcdb.2006.02.012; Rubinstein E, 2011, BIOCHEM SOC T, V39, P501, DOI 10.1042/BST0390501; Schafer T, 2010, ALLERGY, V65, P1242, DOI 10.1111/j.1398-9995.2010.02350.x; Seigneuret M, 2006, BIOPHYS J, V90, P212, DOI 10.1529/biophysj.105.069666; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Shoham T, 2006, MOL CELL BIOL, V26, P1373, DOI 10.1128/MCB.26.4.1373-1385.2006; Symeonides M, 2014, VIRUSES-BASEL, V6, P1078, DOI 10.3390/v6031078; Tachibana I, 1999, J CELL BIOL, V146, P893, DOI 10.1083/jcb.146.4.893; Takeda Y, 2003, J CELL BIOL, V161, P945, DOI 10.1083/jcb.200212031; VANVOORHIS WC, 1982, NEW ENGL J MED, V307, P1593, DOI 10.1056/NEJM198212233072601; Vignery Agnes, 2008, V475, P149, DOI 10.1007/978-1-59745-250-2_9; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019112; Yalaoui S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000010; Yang XWH, 2012, J CELL SCI, V125, P1478, DOI 10.1242/jcs.093963; Zevian S, 2011, J BIOL CHEM, V286, P7496, DOI 10.1074/jbc.M110.173583; Zhu GZ, 2002, DEVELOPMENT, V129, P1995	52	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116289	10.1371/journal.pone.0116289	http://dx.doi.org/10.1371/journal.pone.0116289			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551757	Green Accepted, gold, Green Published			2022-12-26	WOS:000347119100125
J	Buchwald, UK; Adetifa, IMO; Bottomley, C; Owiafe, PK; Donkor, S; Bojang, AL; Sutherland, JS				Buchwald, Ulrike K.; Adetifa, Ifedayo M. O.; Bottomley, Christian; Owiafe, Patrick K.; Donkor, Simon; Bojang, Adama L.; Sutherland, Jayne S.			Broad Adaptive Immune Responses to M. tuberculosis Antigens Precede TST Conversion in Tuberculosis Exposed Household Contacts in a TB-Endemic Setting	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; SKIN-TEST; GENE-EXPRESSION; HUMAN CD4; INFECTION; CELLS; ASSAY; MEMORY; CHILDREN	Background: The identification of Mycobacterium-tuberculosis (Mtb) infected individuals remains a challenge due to an insufficient understanding of immune responses detected with the current diagnostic tests for latent tuberculosis i.e. the tuberculin skin test (TST) or IFN-gamma release assays (IGRAs) and an inability to distinguish infection stages with current immunologic assays. Further classification based on markers other than IFN-gamma may help to define markers of early Mtb infection. Methods: We assessed the TST status of Mtb-exposed household contacts at baseline and at 6 months. Contacts were classified into those with initial positive TST (TST+); those with baseline negative TST but TST conversion at 6 months (TST converters, TSTC) and those with persistently negative TST (PTST-). We assessed their short-and long-term immune responses to PPD and ESAT-6/CFP-10 (EC) via IFN-gamma ELISPOT and a multiplex cytokine array in relation to TST status and compared them to those of TB cases to identify immune profiles associated with a spectrum of infection stages. Results: After 1 and 6 days stimulation with EC, 12 cytokines (IFN-gamma, IL-2, IP-10, TNF-alpha, IL-13, IL-17, IL-10, GMCSF, MIP-1 beta, MCP-3, IL-2RA and IL-1A) were not different in TSTC compared to TST+ suggesting that robust adaptive Mtb-specific immune responses precede TST conversion. Stratifying contacts by baseline IFN-gamma ELISPOT to EC in combination with TST results revealed that IP-10 and IL-17 were highest in the group of TST converters with positive baseline ELISPOT, suggesting they might be markers for recent infection. Conclusion: We describe a detailed analysis of Mtb-specific biomarker profiles in exposed household contacts in a TB endemic area that provides insights into the dynamic immune responses to Mtb infection and may help to identify biomarkers for 'at-risk' populations beyond TST and IGRA.	[Buchwald, Ulrike K.; Adetifa, Ifedayo M. O.; Owiafe, Patrick K.; Donkor, Simon; Bojang, Adama L.; Sutherland, Jayne S.] MRC Unit, Banjul, Gambia; [Bottomley, Christian] London Sch Hyg & Trop Med, Med Res Council Trop Epidemiol Grp, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Buchwald, UK (corresponding author), MRC Unit, Banjul, Gambia.	ubuchwald@som.umaryland.edu; jsutherland@mrc.gm	Buchwald, Ulrike Kirsten/ABE-9030-2020	Sutherland, Jayne/0000-0002-7083-4997; Bottomley, Christian/0000-0002-5241-8412; Kwasi Owiafe, Patrick/0000-0002-4287-3577	Infectious Diseases Society of America (IDSA) Education and Research Foundation (ERF); National Foundation for Infectious Diseases (NFID) Merle A. Sande/Pfizer Fellowship Award in International Infectious Diseases; Bill & Melinda Gates Foundation [6-74]; Medical Research Council Unit, The Gambia; MRC [MC_U190071468, MC_UP_A900_1122] Funding Source: UKRI; Medical Research Council [MC_U190071468, MC_UP_A900_1122, MR/K012126/1] Funding Source: researchfish	Infectious Diseases Society of America (IDSA) Education and Research Foundation (ERF); National Foundation for Infectious Diseases (NFID) Merle A. Sande/Pfizer Fellowship Award in International Infectious Diseases; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council Unit, The Gambia(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	UKB was supported by the 2008 Infectious Diseases Society of America (IDSA) Education and Research Foundation (ERF) and the National Foundation for Infectious Diseases (NFID) Merle A. Sande/Pfizer Fellowship Award in International Infectious Diseases while a fellow in Infectious Diseases at New York University. This project was funded by the Bill & Melinda Gates Foundation (Grand Challenges for Global Health 6-74) and the Medical Research Council Unit, The Gambia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altet-Gomez N, 2011, EUR RESPIR J, V37, P1166, DOI 10.1183/09031936.00022710; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Biselli R, 2009, CLIN MICROBIOL INFEC; Butera O, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-182; Cehovin A, 2007, CLIN VACCINE IMMUNOL, V14, P796, DOI 10.1128/CVI.00093-07; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Dheda K, 2008, THORAX, V63, P566, DOI 10.1136/thx.2007.092205; Felber A, 2013, TUBERCULOSIS, V93, P647, DOI 10.1016/j.tube.2013.07.006; Gallant CJ, 2010, CHEST, V137, P1071, DOI 10.1378/chest.09-1852; Goldsack L, 2007, TUBERCULOSIS, V87, P465, DOI 10.1016/j.tube.2007.07.001; Goletti D, 2006, J INFECT DIS, V194, P984, DOI 10.1086/507427; Goletti D, 2010, J INFECTION, V61, P133, DOI 10.1016/j.jinf.2010.05.002; Govender L, 2010, VACCINE, V29, P51, DOI 10.1016/j.vaccine.2010.10.022; Hill PC, 2005, CLIN INFECT DIS, V40, P273, DOI 10.1086/427030; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Hill PC, 2010, LANCET INFECT DIS, V10, P723, DOI 10.1016/S1473-3099(10)70164-X; Hirsch CS, 1999, J INFECT DIS, V179, P945, DOI 10.1086/314667; Hur YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079742; Hussain R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007444; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Jepson A, 2001, INFECT IMMUN, V69, P3989, DOI 10.1128/IAI.69.6.3989-3994.2001; Lalvani T, 1998, P NATL ACAD SCI USA, V95, P270, DOI 10.1073/pnas.95.1.270; Leyten EMS, 2007, CLIN VACCINE IMMUNOL, V14, P880, DOI 10.1128/CVI.00132-07; Mahan CS, 2012, AM J TROP MED HYG, V86, P690, DOI 10.4269/ajtmh.2012.11-0553; Mancuso JD, 2012, AM J RESP CRIT CARE, V185, P427, DOI 10.1164/rccm.201107-1244OC; Marin ND, 2013, TUBERCULOSIS, V93, P155, DOI 10.1016/j.tube.2012.12.002; Mihret A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-257; Nunes-Alves C, 2014, NAT REV MICROBIOL, V12, P289, DOI 10.1038/nrmicro3230; Perreau M, 2013, EUR J IMMUNOL, V43, P939, DOI 10.1002/eji.201243090; Petruccioli E, 2013, J INFECTION, V66, P475, DOI 10.1016/j.jinf.2013.02.004; Prezzemolo T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00180; Ruhwald Morten, 2009, BMC Res Notes, V2, P19, DOI 10.1186/1756-0500-2-19; Salaman MR, 2013, TUBERCULOSIS, V93, P688, DOI 10.1016/j.tube.2013.08.007; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Sutherland JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012365; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Tao L, 2013, AM J TROP MED HYG, V89, P169, DOI 10.4269/ajtmh.12-0670; van Brummelen SE, 2010, CLIN VACCINE IMMUNOL, V17, P937, DOI 10.1128/CVI.00005-10; Winstone N, 2009, EUR J IMMUNOL, V39, P975, DOI 10.1002/eji.200839167; Wong HL, 2008, CANCER EPIDEM BIOMAR, V17, P3450, DOI 10.1158/1055-9965.EPI-08-0311	41	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116268	10.1371/journal.pone.0116268	http://dx.doi.org/10.1371/journal.pone.0116268			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549338	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000347063500071
J	Kornthong, N; Cummins, SF; Chotwiwatthanakun, C; Khornchatri, K; Engsusophon, A; Hanna, PJ; Sobhon, P				Kornthong, Napamanee; Cummins, Scott F.; Chotwiwatthanakun, Charoonroj; Khornchatri, Kanjana; Engsusophon, Attakorn; Hanna, Peter J.; Sobhon, Prasert			Identification of Genes Associated with Reproduction in the Mud Crab (Scylla olivacea) and Their Differential Expression following Serotonin Stimulation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PIGMENT-CONCENTRATING HORMONE; CRAYFISH PROCAMBARUS-CLARKII; GIANT TIGER SHRIMP; METHYL FARNESOATE; OVARIAN MATURATION; WHITE SHRIMP; MANDIBULAR ORGAN; ESTROGEN SULFOTRANSFERASE; LITOPENAEUS-VANNAMEI	The central nervous system (CNS) is often intimately involved in reproduction control and is therefore a target organ for transcriptomic investigations to identify reproduction-associated genes. In this study, 454 transcriptome sequencing was performed on pooled brain and ventral nerve cord of the female mud crab (Scylla olivacea) following serotonin injection (5 mu g/g BW). A total of 197,468 sequence reads was obtained with an average length of 828 bp. Approximately 38.7% of 2,183 isotigs matched with significant similarity (E value < 1e(-4)) to sequences within the Genbank non-redundant (nr) database, with most significant matches being to crustacean and insect sequences. Approximately 32 putative neuropeptide genes were identified from nonmatching blast sequences. In addition, we identified full-length transcripts for crustacean reproductive-related genes, namely farnesoic acid o-methyltransferase (FAMeT), estrogen sulfotransferase (ESULT) and prostaglandin F synthase (PGFS). Following serotonin injection, which would normally initiate reproductive processes, we found up-regulation of FAMeT, ESULT and PGFS expression in the female CNS and ovary. Our data here provides an invaluable new resource for understanding the molecular role of the CNS on reproduction in S. olivacea.	[Kornthong, Napamanee] Thammasat Univ, Chulabhorn Int Coll Med, Pathum Thani 12121, Thailand; [Kornthong, Napamanee; Chotwiwatthanakun, Charoonroj; Khornchatri, Kanjana; Engsusophon, Attakorn; Hanna, Peter J.; Sobhon, Prasert] Mahidol Univ, Fac Sci, Dept Anat, Bangkok 10400, Thailand; [Cummins, Scott F.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Maroochydore, Qld 4558, Australia; [Chotwiwatthanakun, Charoonroj] Mahidol Univ, Nakhonsawan 60130, Thailand; [Hanna, Peter J.] Deakin Univ, Fac Sci Engn & Built Environm, Pro Vice Chancellors Off, Geelong, Vic 3220, Australia	Chulabhorn Research Institute; Thammasat University; Mahidol University; University of the Sunshine Coast; Mahidol University; Deakin University	Cummins, SF (corresponding author), Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Maroochydore, Qld 4558, Australia.	scummins@usc.edu.au; prasert.sob@mahidol.ac.th	Chotwiwatthanakun, Charoonroj/T-4838-2019; Kornthong, Napamanee/J-4827-2014; Cummins, Scott/I-6420-2016	Kornthong, Napamanee/0000-0002-0422-2546; Cummins, Scott/0000-0002-1454-2076; Chotwiwatthanakun, Charoonroj/0000-0001-9137-8444	Distinguished Research Professor Grant; Thailand Research Fund; Commission on Higher Education (CHE); Mahidol University; Australian Research Council; CHE-Ph.D. Scholarship	Distinguished Research Professor Grant; Thailand Research Fund(Thailand Research Fund (TRF)); Commission on Higher Education (CHE)(Office of Higher Education Commission (OHEC)); Mahidol University; Australian Research Council(Australian Research Council); CHE-Ph.D. Scholarship	The study was financially supported by grants of a Distinguished Research Professor Grant, co-funded by the Thailand Research Fund, the Commission on Higher Education (CHE), and Mahidol University (to P. Sobhon), the Australian Research Council (to S. F. Cummins), and a CHE-Ph.D. Scholarship (to N. Kornthong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Borst DW, 2001, AM ZOOL, V41, P430, DOI 10.1668/0003-1569(2001)041[0430:ROTCMO]2.0.CO;2; Claerhout T, 1996, BIOL BULL, V191, P304, DOI 10.1086/BBLv191n2p304; Cole GB, 2010, P NATL ACAD SCI USA, V107, P6222, DOI 10.1073/pnas.0914904107; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; David P, 2003, MOL ECOL, V12, P2473, DOI 10.1046/j.1365-294X.2003.01913.x; DIRCKSEN H, 1988, CELL TISSUE RES, V251, P3, DOI 10.1007/BF00215441; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gao J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-585; Goodsell DS, 2006, ONCOLOGIST, V11, P418, DOI 10.1634/theoncologist.11-4-418; Guan ZB, 2014, AQUACULTURE, V418, P67, DOI 10.1016/j.aquaculture.2013.10.010; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; Heckmann LH, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-11; Homola E, 1997, COMP BIOCHEM PHYS B, V117, P347, DOI 10.1016/S0305-0491(96)00337-9; Hui JHL, 2010, PEPTIDES, V31, P451, DOI 10.1016/j.peptides.2009.10.003; Hui JHL, 2008, PEPTIDES, V29, P252, DOI 10.1016/j.peptides.2007.08.033; Jiang HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105122; Jo QT, 1999, INVERTEBR REPROD DEV, V36, P79, DOI 10.1080/07924259.1999.9652681; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kornthong N, 2014, MICROSC RES TECHNIQ, V77, P189, DOI 10.1002/jemt.22327; Kornthong N, 2013, GEN COMP ENDOCR, V185, P28, DOI 10.1016/j.ygcen.2013.01.011; Kwok R, 2005, J INSECT PHYSIOL, V51, P367, DOI 10.1016/j.jinsphys.2004.12.010; LANDAU M, 1989, INVERTEBR REPROD DEV, V16, P165, DOI 10.1080/07924259.1989.9672073; Laufer H, 1998, GEN COMP ENDOCR, V111, P113, DOI 10.1006/gcen.1998.7109; Leekitcharoenphon Pimlapas, 2010, BMC Research Notes, V3, DOI 10.1186/1756-0500-3-295; Leelatanawit R, 2009, COMP BIOCHEM PHYS A, V152, P66, DOI 10.1016/j.cbpa.2008.09.004; Leopoldo J, 2010, AQUACULTURE, V310, P84, DOI 10.1016/j.aquaculture.2010.09.038; Leu JH, 2011, MAR BIOTECHNOL, V13, P608, DOI 10.1007/s10126-010-9286-y; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Makkapan W, 2011, AQUACULTURE, V321, P101, DOI 10.1016/j.aquaculture.2011.08.016; MANGERICH S, 1986, CELL TISSUE RES, V245, P377; Miki Y, 2002, J CLIN ENDOCR METAB, V87, P5760, DOI 10.1210/jc.2002-020670; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Nagaraju GPC, 2003, CRUSTACEANA, V76, P1171, DOI 10.1163/156854003773123401; Nagaraju GPC, 2004, AQUACULTURE, V232, P603, DOI [10.1016/S0044-8486(03)00519-2, 10.1016/s0044-8486(03)00519-2]; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; QUINITIO ET, 1994, COMP BIOCHEM PHYS C, V109, P21, DOI 10.1016/0742-8413(94)00044-B; Reddy PR, 2004, J CRUSTACEAN BIOL, V24, P511, DOI 10.1651/C-2478; Rowley AF, 2005, J EXP BIOL, V208, P3, DOI 10.1242/jeb.01275; Ruan YC, 2011, PHYSIOLOGY, V26, P156, DOI 10.1152/physiol.00036.2010; Song WC, 2001, ANN NY ACAD SCI, V948, P43; Sousa GL, 2008, GEN COMP ENDOCR, V156, P454, DOI 10.1016/j.ygcen.2008.03.008; Southey BR, 2006, NUCLEIC ACIDS RES, V34, pW267, DOI 10.1093/nar/gkl161; SPAZIANI EP, 1993, J COMP PHYSIOL B, V163, P541, DOI 10.1007/BF00302112; Stollewerk Angelika, 2010, J Biol, V9, P21, DOI 10.1186/jbiol212; Sullivan JM, 2005, J NEUROBIOL, V65, P157, DOI 10.1002/neu.20195; Tahara D, 2003, AQUACULTURE, V220, P791, DOI 10.1016/S0044-8486(02)00402-7; Tassanakajon A, 2006, GENE, V384, P104, DOI 10.1016/j.gene.2006.07.012; Tinikul Y, 2011, CELL TISSUE RES, V345, P103, DOI 10.1007/s00441-011-1176-8; Tinikul Y, 2009, CRUSTACEANA, V82, P1007, DOI 10.1163/156854009X448844; Vaca AA, 2000, AQUACULTURE, V182, P373, DOI 10.1016/S0044-8486(99)00267-7; Wainwright G, 1998, BIOCHEM J, V334, P651, DOI 10.1042/bj3340651; Wang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084921; Wanggren K, 2008, HUM REPROD, V23, P2359, DOI 10.1093/humrep/den260; Warrier SR, 2001, COMP BIOCHEM PHYS A, V130, P283, DOI 10.1016/S1095-6433(01)00385-3; Wimuttisuk W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076934	56	17	17	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115867	10.1371/journal.pone.0115867	http://dx.doi.org/10.1371/journal.pone.0115867			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542017	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900099
J	van Soldt, BJ; Metscher, BD; Poelmann, RE; Vervust, B; Vonk, FJ; Muller, GB; Richardson, MK				van Soldt, Benjamin J.; Metscher, Brian D.; Poelmann, Robert E.; Vervust, Bart; Vonk, Freek J.; Mueller, Gerd B.; Richardson, Michael K.			Heterochrony and Early Left-Right Asymmetry in the Development of the Cardiorespiratory System of Snakes	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; BULBUS CORDIS; PYTHON-SEBAE; LUNG; PULMONARY; MORPHOGENESIS; SERPENTES; TRACHEAL; CLASSIFICATION; MORPHOLOGY	Snake lungs show a remarkable diversity of organ asymmetries. The right lung is always fully developed, while the left lung is either absent, vestigial, or well-developed (but smaller than the right). A 'tracheal lung' is present in some taxa. These asymmetries are reflected in the pulmonary arteries. Lung asymmetry is known to appear at early stages of development in Thamnophis radix and Natrix natrix. Unfortunately, there is no developmental data on snakes with a well-developed or absent left lung. We examine the adult and developmental morphology of the lung and pulmonary arteries in the snakes Python curtus breitensteini, Pantherophis guttata guttata, Elaphe obsoleta spiloides, Calloselasma rhodostoma and Causus rhombeatus using gross dissection, MicroCT scanning and 3D reconstruction. We find that the right and tracheal lung develop similarly in these species. By contrast, the left lung either: (1) fails to develop; (2) elongates more slowly and aborts early without (2a) or with (2b) subsequent development of faveoli; (3) or develops normally. A right pulmonary artery always develops, but the left develops only if the left lung develops. No pulmonary artery develops in relation to the tracheal lung. We conclude that heterochrony in lung bud development contributes to lung asymmetry in several snake taxa. Secondly, the development of the pulmonary arteries is asymmetric at early stages, possibly because the splanchnic plexus fails to develop when the left lung is reduced. Finally, some changes in the topography of the pulmonary arteries are consequent on ontogenetic displacement of the heart down the body. Our findings show that the left-right asymmetry in the cardiorespiratory system of snakes is expressed early in development and may become phenotypically expressed through heterochronic shifts in growth, and changes in axial relations of organs and vessels. We propose a step-wise model for reduction of the left lung during snake evolution.	[van Soldt, Benjamin J.; Vonk, Freek J.; Richardson, Michael K.] Leiden Univ, Inst Biol, Leiden, Netherlands; [Metscher, Brian D.; Mueller, Gerd B.] Univ Vienna, Dept Theoret Biol, Vienna, Austria; [Poelmann, Robert E.] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Vervust, Bart] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; [Vonk, Freek J.] NCB Nat, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; University of Vienna; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Antwerp	Richardson, MK (corresponding author), Leiden Univ, Inst Biol, Leiden, Netherlands.	m.k.richardson@biology.leidenuniv.nl	Metscher, Brian/I-1238-2019	Metscher, Brian/0000-0002-6514-4406; van Soldt, Benjamin/0000-0002-1670-6193	Leiden University Fund; Royal Dutch Zoological Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007088] Funding Source: NIH RePORTER	Leiden University Fund; Royal Dutch Zoological Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors were supported by the Leiden University Fund (LUF: http://www.luf.nl) and the Royal Dutch Zoological Society (KNDV: http:// www.kndv.nl) in their trip to Vienna to acquire data by MicroCT scanning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-Berry A, 2005, DEV DYNAM, V233, P145, DOI 10.1002/dvdy.20296; Arora R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002866; Atwood W.H., 1918, T WISC ACAD SCI, V19, P531; Atwood WH, 1916, WASH U STUDIES, V4, P3; Bellusci S, 1997, DEVELOPMENT, V124, P53; Boback SM, 2012, ZOOLOGY, V115, P38, DOI 10.1016/j.zool.2011.09.001; Boughner JC, 2007, ZOOLOGY, V110, P212, DOI 10.1016/j.zool.2007.01.005; Brongersma L. D., 1949, Bijdragen tot de Dierkunde Leiden 1949, V28, P57; Brongersma L. D., 1957, Proceedings Nederlandse Akademie Amsterdam, V60C, P299; Brongersma L. D., 1951, Nederlands Tijdschrift voor Geneeskunde, V95, P2490; Brongersma L. D., 1960, Verslagen van de Gewone Vergadering Akademie Amsterdam, V69, P125; Brongersma L. D., 1952, Proceedings Akad Sci Amsterdam, V55C, P62; Brongersma L. D., 1952, Archives Neerlandaises de Zoologie, V9, P561; Brongersma L. D., 1957, Proceedings Nederlandse Akademie Amsterdam, V60C, P451; Brongersma L. D., 1951, Zoologische Mededeelingen Leiden, V31, P107; Brongersma LD, 1957, P K NED AKAD C BIOL, V60, P309; Brongersma LD, 1951, ZOOL VERH-LEIDEN, V14, P3; Brongersma LD, 1951, ARCH NEERLANDAISES Z, V10, P514; Buchtova M, 2007, ZOOLOGY, V110, P231, DOI 10.1016/j.zool.2007.01.006; Cardoso WV, 2001, ANNU REV PHYSIOL, V63, P471, DOI 10.1146/annurev.physiol.63.1.471; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; de Jong IML, 2009, EVOL DEV, V11, P625, DOI 10.1111/j.1525-142X.2009.00370.x; De Silva PHDH, 1953, SPOLIA ZEYLANICA, V27, P47; deMello DE, 1997, AM J RESP CELL MOL, V16, P568, DOI 10.1165/ajrcmb.16.5.9160839; DERUITER MC, 1993, CIRCULATION, V87, P1306, DOI 10.1161/01.CIR.87.4.1306; Fisher KA, 2006, CURR TOP DEV BIOL, V74, P117, DOI 10.1016/S0070-2153(06)74004-2; Goodrich E.S., 1958, STUDIES STRUCTURE DE; Gould S. J., 1977, ONTOGENY PHYLOGENY; Greil A., 1903, Morphologisches Jahrbuch, Vxxxi, P123; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hall SM, 2000, AM J RESP CELL MOL, V23, P194, DOI 10.1165/ajrcmb.23.2.3975; Harrison BM, 1929, ANAT REC, V44, P101, DOI 10.1002/ar.1090440204; HART NH, 1969, J MORPHOL, V129, P369, DOI 10.1002/jmor.1051290308; HART NH, 1968, J MORPHOL, V125, P1, DOI 10.1002/jmor.1051250102; Hislop A A, 2000, Paediatr Respir Rev, V1, P321, DOI 10.1053/prrv.2000.0071; Hislop AA, 2002, J ANAT, V201, P325, DOI 10.1046/j.1469-7580.2002.00097.x; Hislop Alison, 2005, Paediatr Respir Rev, V6, P35, DOI 10.1016/j.prrv.2004.11.009; Jackson K, 2002, ZOOLOGY, V105, P203, DOI 10.1078/0944-2006-00077; Jensen B, 2010, ANAT SCI INT, V85, P194, DOI 10.1007/s12565-010-0079-1; Kardong K.V., 1972, Gegenbaurs Morphologisches Jahrbuch, V117, P285; KASHYAP H V, 1973, Journal of the University of Bombay, V42, P34; Khannoon ER, 2014, ACTA ZOOL-STOCKHOLM, V95, P472, DOI 10.1111/azo.12043; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Klingenberg CP, 1998, BIOL REV, V73, P79, DOI 10.1017/S000632319800512X; LANGER A, 1894, MORPHOL JB, V21, P40; Lillywhite HB, 2012, COMP BIOCHEM PHYS A, V161, P230, DOI 10.1016/j.cbpa.2011.10.029; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Mabee PM, 2000, EVOLUTION, V54, P2091; Maina JN, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-16; McDonald H. S., 1959, Herpetologica, V15, P193; Metscher Brian D, 2011, Cold Spring Harb Protoc, V2011, P1462, DOI 10.1101/pdb.prot067033; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Molin DGM, 2002, CARDIOVASC RES, V56, P312, DOI 10.1016/S0008-6363(02)00542-4; O'Donoghue CH, 1912, P ZOOL SOC LOND, V1912, P612; Perry Steven F., 1998, V19, P1; Pyron RA, 2011, MOL PHYLOGENET EVOL, V58, P329, DOI 10.1016/j.ympev.2010.11.006; Rawlins EL, 2011, DEV DYNAM, V240, P463, DOI 10.1002/dvdy.22482; Ray HC, 1934, J MORPHOL, V56, P533, DOI 10.1002/jmor.1050560306; Richardson MK, 1995, DEV BIOL, V172, P412, DOI 10.1006/dbio.1995.8041; ROBB JOAN, 1960, AUSTRALIAN JOUR ZOOL, V8, P181, DOI 10.1071/ZO9600181; Sadler TW, 2012, RESP SYSTEM LANGMANS, P384; SALASSA JR, 1977, ANN THORAC SURG, V24, P100, DOI 10.1016/S0003-4975(10)63716-2; Schachtner SK, 2000, AM J RESP CELL MOL, V22, P157, DOI 10.1165/ajrcmb.22.2.3766; Schmalhausen J. J., 1905, Anatomischer Anzeiger, Vxxvii, P511; Schulz-Mirbach T, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-63; SHANER RF, 1962, ANAT RECORD, V142, P519, DOI 10.1002/ar.1091420409; Smith KK, 2003, INT J DEV BIOL, V47, P613; Starck JM, 2009, J MORPHOL, V270, P673, DOI 10.1002/jmor.10706; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; TENHAVEOPBROEK AAW, 1991, EXP LUNG RES, V17, P111, DOI 10.3109/01902149109064406; VANBOURGONDIEN TM, 1969, AM MIDL NAT, V81, P107; Vidal N, 2002, CR BIOL, V325, P977, DOI 10.1016/S1631-0691(02)01510-X; Vidal N, 2002, J TOXICOL-TOXIN REV, V21, P21, DOI 10.1081/TXR-120004740; Vidal N, 2007, CR BIOL, V330, P182, DOI 10.1016/j.crvi.2006.10.001; Wallach Van, 1998, V19, P93; Wang Tobias, 1998, V19, P297; Zaher Hussam, 2009, Pap. Avulsos Zool., V49, P115; Zehr D. R., 1962, Copeia, V1962, P322, DOI 10.2307/1440898	80	13	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2015	10	1							e116416	10.1371/journal.pone.0116416	http://dx.doi.org/10.1371/journal.pone.0116416			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3XP	25555231	Green Submitted, Green Published, gold			2022-12-26	WOS:000348157400003
J	Capel, E; Parera, M; Martinez, MA				Capel, Elena; Parera, Mariona; Angel Martinez, Miguel			Epistasis as a Determinant of the HIV-1 Protease's Robustness to Mutation	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DELETERIOUS MUTATIONS; REVERSE-TRANSCRIPTASE; REPLICATION CAPACITY; CATALYTIC EFFICIENCY; GENETIC ROBUSTNESS; FITNESS LANDSCAPE; IN-VITRO; EVOLUTION; PROTEIN	The robustness of phenotypes to mutation is critical to protein evolution; robustness may be an adaptive trait if it promotes evolution. We hypothesised that native proteins subjected to natural selection in vivo should be more robust than proteins generated in vitro in the absence of natural selection. We compared the mutational robustness of two human immunodeficiency virus type 1 (HIV-1) proteases with comparable catalytic efficiencies, one isolated from an infected individual and the second generated in vitro via random mutagenesis. Single mutations in the protease (82 and 60 in the wild-type and mutant backgrounds, respectively) were randomly generated in vitro and the catalytic efficiency of each mutant was determined. No differences were observed between these two protease variants when lethal, neutral, and deleterious mutations were compared (P=0.8025, chi-squared test). Similarly, average catalytic efficiency (-72.6% and -64.5%, respectively) did not significantly differ between protease mutant libraries (P=0.3414, Mann Whitney test). Overall, the two parental proteins displayed similar mutational robustness. Importantly, strong and widespread epistatic interactions were observed when the effect of the same mutation was compared in both proteases, suggesting that epistasis can be a key determinant of the robustness displayed by the in vitro generated protease.	[Angel Martinez, Miguel] Hosp Badalona Germans Trias & Pujol, Fundacio IrsiCaixa, Badalona, Spain; Univ Autonoma Barcelona, E-08193 Barcelona, Spain	Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Autonomous University of Barcelona	Martinez, MA (corresponding author), Hosp Badalona Germans Trias & Pujol, Fundacio IrsiCaixa, Badalona, Spain.	mmartinez@irsicaixa.es	Martinez, Miguel Angel/K-6435-2014	Martinez, Miguel Angel/0000-0002-6681-4950; Parera Sallent, Mariona/0000-0002-0756-8307; Capel Malo, Elena/0000-0002-6041-6724	Spanish Ministry of Economy and Competitiveness [SAF2013-41421-R]; Fundacion para la Investigacion y la prevencion del SIDA en Espana [FIPSE 360766/09]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fundacion para la Investigacion y la prevencion del SIDA en Espana	This study was supported by grants from the Spanish Ministry of Economy and Competitiveness (SAF2013-41421-R) and from Fundacion para la Investigacion y la prevencion del SIDA en Espana (FIPSE 360766/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Bloom JD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100119; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Cabana M, 2002, VIROLOGY, V300, P71, DOI 10.1006/viro.2002.1520; Capel E, 2013, VIROLOGY, V444, P274, DOI 10.1016/j.virol.2013.06.023; Capel E, 2012, J GEN VIROL, V93, P2625, DOI 10.1099/vir.0.045492-0; Ceccherini-Silberstein F, 2004, AIDS, V18, pF11, DOI 10.1097/01.aids.0000131394.76221.02; CHAO SF, 1995, NUCLEIC ACIDS RES, V23, P803, DOI 10.1093/nar/23.5.803; de Visser JAGM, 2011, P ROY SOC B-BIOL SCI, V278, P3617, DOI 10.1098/rspb.2011.1537; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; Draghi JA, 2010, NATURE, V463, P353, DOI 10.1038/nature08694; Elena SF, 2006, EMBO REP, V7, P168, DOI 10.1038/sj.embor.7400636; Fernandez G, 2007, J VIROL, V81, P2485, DOI 10.1128/JVI.01594-06; Gervaix A, 1997, P NATL ACAD SCI USA, V94, P4653, DOI 10.1073/pnas.94.9.4653; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; Hinkley T, 2011, NAT GENET, V43, P487, DOI 10.1038/ng.795; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; KAWASHIMA H, 1992, PROTEIN ENG, V5, P171, DOI 10.1093/protein/5.2.171; Kouyos RD, 2007, TRENDS ECOL EVOL, V22, P308, DOI 10.1016/j.tree.2007.02.014; Lauring AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/nrmicro3003; LOEB DD, 1989, NATURE, V340, P397, DOI 10.1038/340397a0; MARKIEWICZ P, 1994, J MOL BIOL, V240, P421, DOI 10.1006/jmbi.1994.1458; Martinez MA, 2000, ANTIMICROB AGENTS CH, V44, P1132, DOI 10.1128/AAC.44.5.1132-1139.2000; Martinez MA, 1996, EMBO J, V15, P1203, DOI 10.1002/j.1460-2075.1996.tb00461.x; Mas A, 2010, J MOL BIOL, V397, P865, DOI 10.1016/j.jmb.2010.02.005; MASCHERA B, 1995, J VIROL, V69, P5431, DOI 10.1128/JVI.69.9.5431-5436.1995; Pannecouque C, 2008, NAT PROTOC, V3, P427, DOI 10.1038/nprot.2007.517; Parera M, 2007, MOL BIOL EVOL, V24, P382, DOI 10.1093/molbev/msl168; Parera M, 2014, MOL BIOL EVOL, V31, P1546, DOI 10.1093/molbev/msu113; Parera M, 2009, J MOL BIOL, V392, P243, DOI 10.1016/j.jmb.2009.07.015; Payne JL, 2014, SCIENCE, V343, P875, DOI 10.1126/science.1249046; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; RATNER L, 1987, AIDS RES HUM RETROV, V3, P57, DOI 10.1089/aid.1987.3.57; RENNELL D, 1991, J MOL BIOL, V222, P67, DOI 10.1016/0022-2836(91)90738-R; Rihn SJ, 2014, J VIROL; Rihn SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003461; Shao W, 1997, P NATL ACAD SCI USA, V94, P2243, DOI 10.1073/pnas.94.6.2243; Sices HJ, 1998, P NATL ACAD SCI USA, V95, P2828, DOI 10.1073/pnas.95.6.2828; Szendro IG, 2013, J STAT MECH-THEORY E, VP01; Vartanian JP, 1996, NUCLEIC ACIDS RES, V24, P2627, DOI 10.1093/nar/24.14.2627; Wagner A, 2005, FEBS LETT, V579, P1772, DOI 10.1016/j.febslet.2005.01.063; Weinreich DM, 2005, EVOLUTION, V59, P1165; Yasugi T, 1997, J VIROL, V71, P5942, DOI 10.1128/JVI.71.8.5942-5951.1997	47	1	1	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116301	10.1371/journal.pone.0116301	http://dx.doi.org/10.1371/journal.pone.0116301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551558	Green Published, gold, Green Submitted			2022-12-26	WOS:000347119100129
J	Cheng, JS; Craft, R; Yu, GQ; Ho, K; Wang, X; Mohan, G; Mangnitsky, S; Ponnusamy, R; Mucke, L				Cheng, Jason S.; Craft, Ryan; Yu, Gui-Qiu; Ho, Kaitlyn; Wang, Xin; Mohan, Geetha; Mangnitsky, Sergey; Ponnusamy, Ravikumar; Mucke, Lennart			Tau Reduction Diminishes Spatial Learning and Memory Deficits after Mild Repetitive Traumatic Brain Injury in Mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; ALZHEIMERS-DISEASE; MOUSE MODELS; NETWORK	Objective: Because reduction of the microtubule-associated protein Tau has beneficial effects in mouse models of Alzheimer's disease and epilepsy, we wanted to determine whether this strategy can also improve the outcome of mild traumatic brain injury (TBI). Methods: We adapted a mild frontal impact model of TBI for wildtype C57Bl/6J mice and characterized the behavioral deficits it causes in these animals. The Barnes maze, Y maze, contextual and cued fear conditioning, elevated plus maze, open field, balance beam, and forced swim test were used to assess different behavioral functions. Magnetic resonance imaging (MRI, 7 Tesla) and histological analysis of brain sections were used to look for neuropathological alterations. We also compared the functional effects of this TBI model and of controlled cortical impact in mice with two, one or no Tau alleles. Results: Repeated (2-hit), but not single (1-hit), mild frontal impact impaired spatial learning and memory in wildtype mice as determined by testing of mice in the Barnes maze one month after the injury. Locomotor activity, anxiety, depression and fear related behaviors did not differ between injured and sham-injured mice. MRI imaging did not reveal focal injury or mass lesions shortly after the injury. Complete ablation or partial reduction of tau prevented deficits in spatial learning and memory after repeated mild frontal impact. Complete tau ablation also showed a trend towards protection after a single controlled cortical impact. Complete or partial reduction of tau also reduced the level of axonopathy in the corpus callosum after repeated mild frontal impact. Interpretation: Tau promotes or enables the development of learning and memory deficits and of axonopathy after mild TBI, and tau reduction counteracts these adverse effects.	[Cheng, Jason S.; Craft, Ryan; Yu, Gui-Qiu; Ho, Kaitlyn; Wang, Xin; Ponnusamy, Ravikumar; Mucke, Lennart] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Cheng, Jason S.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Mucke, Lennart] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Mohan, Geetha; Mangnitsky, Sergey] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Mucke, L (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	lmucke@gladstone.ucsf.edu		Mohan, Geetha/0000-0002-4192-5785	National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) [NS041787, NS065780]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS065780, R01NS041787] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	LM received grants NS041787 and NS065780 from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH). http://www.ninds.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Dawson HN, 2001, J CELL SCI, V114, P1179; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Devos SL, 2013, J NEUROSCI, V33, P12887, DOI 10.1523/JNEUROSCI.2107-13.2013; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Durazzo TC, 2013, J NEUROTRAUM, V30, P1013, DOI 10.1089/neu.2012.2676; Freire MAM, 2012, W INDIAN MED J, V61, P751; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Gheyara AL, 2014, ANN NEUROL, V76, P443, DOI 10.1002/ana.24230; Holth JK, 2013, J NEUROSCI, V33, P1651, DOI 10.1523/JNEUROSCI.3191-12.2013; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kiraly MA, 2007, THESCIENTIFICWORLDJO, V7, P1768, DOI 10.1100/tsw.2007.269; Krainin BM, 2011, J SPEC OPER MED, V11, P38; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Li Z, 2014, NEUROBIOL AGING; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mauri M, 2006, FUNCT NEUROL, V21, P223; Morris M, 2013, NEUROBIOL AGING, V34, P1523, DOI 10.1016/j.neurobiolaging.2012.12.003; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pape TLB, 2013, PM&R, V5, P856, DOI 10.1016/j.pmrj.2013.06.007; Petraglia AL, 2014, J NEUROTRAUMA; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; Sanders MJ, 2005, NEUROBIOL LEARN MEM, V84, P33, DOI 10.1016/j.nlm.2005.03.001; Turner RC, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00186; Ullmann J.F., 2013, BRAIN STRUCT FUNCT; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zempel H, 2013, EMBO J, V32, P2920, DOI 10.1038/emboj.2013.207	42	68	69	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115765	10.1371/journal.pone.0115765	http://dx.doi.org/10.1371/journal.pone.0115765			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551452	Green Published, gold, Green Submitted			2022-12-26	WOS:000347119100059
J	Martin, LJ; Xu, BY; Yasui, Y				Martin, Leah J.; Xu, Biying; Yasui, Yutaka			Improving Google Flu Trends Estimates for the United States through Transformation	PLOS ONE			English	Article								Google Flu Trends (GFT) uses Internet search queries in an effort to provide early warning of increases in influenza-like illness (ILI). In the United States, GFT estimates the percentage of physician visits related to ILI (%ILINet) reported by the Centers for Disease Control and Prevention (CDC). However, during the 2012-13 influenza season, GFT overestimated %ILINet by an appreciable amount and estimated the peak in incidence three weeks late. Using data from 2010-14, we investigated the relationship between GFT estimates (%GFT) and %ILINet. Based on the relationship between the relative change in %GFT and the relative change in %ILINet, we transformed %GFT estimates to better correspond with %ILINet values. In 2010-13, our transformed %GFT estimates were within +/- 10% of %ILINet values for 17 of the 29 weeks that %ILINet was above the seasonal baseline value determined by the CDC; in contrast, the original %GFT estimates were within +/- 10% of %ILINet values for only two of these 29 weeks. Relative to the %ILINet peak in 2012-13, the peak in our transformed %GFT estimates was 2% lower and one week later, whereas the peak in the original %GFT estimates was 74% higher and three weeks later. The same transformation improved %GFT estimates using the recalibrated 2013 GFT model in early 2013-14. Our transformed %GFT estimates can be calculated approximately one week before %ILINet values are reported by the CDC and the transformation equation was stable over the time period investigated (2010-13). We anticipate our results will facilitate future use of GFT.	[Martin, Leah J.; Xu, Biying; Yasui, Yutaka] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Xu, Biying] Zhejiang Univ, Hangzhou 310003, Zhejiang, Peoples R China	University of Alberta; Zhejiang University	Martin, LJ (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	leah.martin@ualberta.ca; yyasui@ualberta.ca	Yasui, Yutaka/E-2564-2015	Yasui, Yutaka/0000-0002-7717-8638	Alberta Innovates-Health Solutions Postdoctoral Fellowship; Canada Research Chair Program; Alberta Innovates-Technology Futures (AITF) Alberta Innovates Centre for Machine Learning (AICML); China Scholarship Council	Alberta Innovates-Health Solutions Postdoctoral Fellowship; Canada Research Chair Program(Canada Research Chairs); Alberta Innovates-Technology Futures (AITF) Alberta Innovates Centre for Machine Learning (AICML); China Scholarship Council(China Scholarship Council)	Dr. LJ Martin is supported by an Alberta Innovates-Health Solutions Postdoctoral Fellowship. Dr. Y Yasui is supported by the Canada Research Chair Program. Both Drs. Martin and Yasui are supported by the Alberta Innovates-Technology Futures (AITF) Alberta Innovates Centre for Machine Learning (AICML). B Xu was supported by the China Scholarship Council. The funders provided support in the form of salaries for the authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the author contributions section.	Brammer L, 2013, MMWR-MORBID MORTAL W, V62, P473; Butler D, 2013, NATURE, V494, P155, DOI 10.1038/494155a; Centers for Disease Control and Prevention, 2010, 2010 2011 INFL SEAS; Centers for Disease Control and Prevention, 2013, OV INFL SURV US; Centers for Disease Control and Prevention, 2012, 2012 2013 INFL SEAS; Centers for Disease Control and Prevention, 2013, 2013 2014 INFL SEAS; Centers for Disease Control and Prevention, 2013, FLUVIEW NAT REG LEV; Centers for Disease Control and Prevention, 2011, 2011 2012 INFL SEAS; Cook S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023610, 10.1371/journal.pone.0025407]; Dugas AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056176; Dugas AF, 2012, CLIN INFECT DIS, V54, P463, DOI 10.1093/cid/cir883; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Google, 2014, GOOGL TRENDS; Google Flu Trends, 2013, GOOGL FLU TRENDS US; Kang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055205; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Martin LJ, 2014, REPLICATION DATA IMP; Nsoesie Elaine, 2013, PLOS CURR, V5; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Pelat C, 2009, EMERG INFECT DIS, V15, P1327, DOI 10.3201/eid1508.090299; R Core Team, 2013, LANG ENV STAT COMP; Santillana M, 2014, AM J PREV MED, V47, P341, DOI 10.1016/j.amepre.2014.05.020; Shaman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3837; Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109; Stefansen C, 2013, FLU TRENDS UPDATES M	25	14	14	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e109209	10.1371/journal.pone.0109209	http://dx.doi.org/10.1371/journal.pone.0109209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551391	gold, Green Published, Green Submitted			2022-12-26	WOS:000347119100002
J	Shiraishi, R; Tamura, T; Sone, M; Okazawa, H				Shiraishi, Risa; Tamura, Takuya; Sone, Masaki; Okazawa, Hitoshi			Systematic Analysis of Fly Models with Multiple Drivers Reveals Different Effects of Ataxin-1 and Huntingtin in Neuron Subtype-Specific Expression	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; DEPENDENT NEURODEGENERATION; DOPAMINERGIC-NEURONS; NERVOUS-SYSTEM; GLIAL-CELLS; DISEASE; SEQUENCES; PROTEINS; MEMORY; IDENTIFICATION	The fruit fly, Drosophila melanogaster, is a commonly used model organism for neurodegenerative diseases. Its major advantages include a short lifespan and its susceptibility to manipulation using sophisticated genetic techniques. Here, we report the systematic comparison of fly models of two polyglutamine (polyQ) diseases. We induced expression of the normal and mutant forms of full-length Ataxin-1 and Huntingtin exon 1 in cholinergic, dopaminergic, and motor neurons, and glial cells using cell type-specific drivers. We systematically analyzed their effects based on multiple phenotypes: eclosion rate, lifespan, motor performance, and circadian rhythms of spontaneous activity. This systematic assay system enabled us to quantitatively evaluate and compare the functional disabilities of different genotypes. The results suggest different effects of Ataxin-1 and Huntingtin on specific types of neural cells during development and in adulthood. In addition, we confirmed the therapeutic effects of LiCl and butyrate using representative models. These results support the usefulness of this assay system for screening candidate chemical compounds that modify the pathologies of polyQ diseases.	[Shiraishi, Risa; Tamura, Takuya; Okazawa, Hitoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Neuropathol, Bunkyo Ku, Tokyo, Japan; [Shiraishi, Risa; Tamura, Takuya; Okazawa, Hitoshi] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Bunkyo Ku, Tokyo, Japan; [Sone, Masaki] Toho Univ, Fac Sci, Dept Biomol Sci, Funabashi, Chiba 274, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Toho University	Okazawa, H (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Neuropathol, Bunkyo Ku, Tokyo, Japan.	okazawa.npat@mri.tmd.ac.jp	Sone, Masaki/Q-9058-2019		Strategic Research Program for Brain Sciences (SRPBS); (Foundation of Synapse and Neurocircuit Pathology) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; CREST from Japan Science Technology Agency; Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University; JSPS [24700374]	Strategic Research Program for Brain Sciences (SRPBS); (Foundation of Synapse and Neurocircuit Pathology) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; CREST from Japan Science Technology Agency; Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Strategic Research Program for Brain Sciences (SRPBS) and by a grant-in-aid for Scientific Research on Innovative Areas (Foundation of Synapse and Neurocircuit Pathology) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, CREST from Japan Science Technology Agency, and the Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University to H. O. and by a JSPS Grant-in-Aid for Young Scientists (24700374) to T. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambegaokar SS, 2010, NEUROBIOL DIS, V40, P29, DOI 10.1016/j.nbd.2010.05.026; Berger C, 2007, DEV DYNAM, V236, P3562, DOI 10.1002/dvdy.21372; Berger Z, 2005, HUM MOL GENET, V14, P3003, DOI 10.1093/hmg/ddi331; Chen XP, 2007, CELL TISSUE RES, V329, P169, DOI 10.1007/s00441-007-0401-y; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; DURA JM, 1993, J NEUROGENET, V9, P1, DOI 10.3109/01677069309167272; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Friggi-Grelin F, 2003, GENESIS, V35, P260, DOI 10.1002/gene.1082; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Fujita K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2828; Garcia-Lopez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001595; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Green EW, 2012, BIOCHEM SOC T, V40, P739, DOI 10.1042/BST20120072; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; HALTER DA, 1995, DEVELOPMENT, V121, P317; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kadener S, 2006, P NATL ACAD SCI USA, V103, P13537, DOI 10.1073/pnas.0605962103; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Muqit MMK, 2002, NAT REV NEUROSCI, V3, P237, DOI 10.1038/nrn751; Murata T, 2008, BIOSCI BIOTECH BIOCH, V72, P2255, DOI 10.1271/bbb.70829; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Romero E, 2008, NEURON, V57, P27, DOI 10.1016/j.neuron.2007.11.025; Salvaterra P M, 2001, Brain Res Gene Expr Patterns, V1, P73; Sanyal S, 2009, GENE EXPR PATTERNS, V9, P371, DOI 10.1016/j.gep.2009.01.002; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; Sinadinos C, 2009, NEUROBIOL DIS, V34, P389, DOI 10.1016/j.nbd.2009.02.012; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Tamura T, 2003, NEURON, V40, P1003, DOI 10.1016/S0896-6273(03)00732-3; Tamura T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027408; Tamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004262; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Vomel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001848; Wang WY, 2004, NEUROSCI RES, V48, P195, DOI 10.1016/j.neures.2003.10.012; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Yeste-Velasco M, 2009, NEUROSCIENCE, V159, P1135, DOI 10.1016/j.neuroscience.2009.01.035; Yoshimura N, 2006, FEBS LETT, V580, P2335, DOI 10.1016/j.febslet.2006.03.056; Yu ZM, 2011, INT REV NEUROBIOL, V99, P191, DOI 10.1016/B978-0-12-387003-2.00008-2; Zhang S, 2009, DIS MODEL MECH, V2, P247, DOI 10.1242/dmm.000653	42	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116567	10.1371/journal.pone.0116567	http://dx.doi.org/10.1371/journal.pone.0116567			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551764	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100146
J	Coon, TA; McKelvey, AC; Weathington, NM; Birru, RL; Lear, T; Leikauf, GD; Chen, BB				Coon, Tiffany A.; McKelvey, Alison C.; Weathington, Nate M.; Birru, Rahel L.; Lear, Travis; Leikauf, George D.; Chen, Bill B.			Novel PDE4 Inhibitors Derived from Chinese Medicine Forsythia	PLOS ONE			English	Article							PHOSPHODIESTERASE-4 INHIBITOR; OXIDATIVE STRESS; CYCLIC-AMP; SUSPENSA; PROTEIN; RATS; HYPERTENSION; INFLAMMATION; MACROPHAGES; METABOLISM	Cyclic adenosine monophosphate (cAMP) is a crucial intracellular second messenger molecule that converts extracellular molecules to intracellular signal transduction pathways generating cell- and stimulus-specific effects. Importantly, specific phosphodiesterase (PDE) subtypes control the amplitude and duration of cAMP-induced physiological processes and are therefore a prominent pharmacological target currently used in a variety of fields. Here we tested the extracts from traditional Chinese medicine, Forsythia suspense seeds, which have been used for more than 2000 years to relieve respiratory symptoms. Using structural-functional analysis we found its major lignin, Forsynthin, acted as an immunosuppressant by inhibiting PDE4 in inflammatory and immune cell. Moreover, several novel, selective small molecule derivatives of Forsythin were tested in vitro and in murine models of viral and bacterial pneumonia, sepsis and cytokine-driven systemic inflammation. Thus, pharmacological targeting of PDE4 may be a promising strategy for immune-related disorders characterized by amplified host inflammatory response.	[Coon, Tiffany A.; McKelvey, Alison C.; Weathington, Nate M.; Lear, Travis; Chen, Bill B.] Univ Pittsburgh, Dept Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA; [Chen, Bill B.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15213 USA; [Birru, Rahel L.; Leikauf, George D.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chen, BB (corresponding author), Univ Pittsburgh, Dept Med, Acute Lung Injury Ctr Excellence, 930 Scaife Hall, Pittsburgh, PA 15213 USA.	chenb@upmc.edu		Leikauf, George/0000-0002-4514-7060; Lear, Travis/0000-0001-9156-0844	National Institutes of Health R01 [HL116472, ES015675, HL077763]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116472, R01HL077763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES015675] Funding Source: NIH RePORTER	National Institutes of Health R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This material is based upon work supported by the National Institutes of Health R01 grants HL116472 (to B. B. C.), ES015675 and HL077763 (to G. D. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeumer Wolfgang, 2007, Inflammation & Allergy Drug Targets, V6, P17, DOI 10.2174/187152807780077318; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; Beghe B, 2013, AM J RESP CRIT CARE, V188, P271, DOI 10.1164/rccm.201301-0021PP; Brown DM, 2007, TOXICOL LETT, V168, P1, DOI 10.1016/j.toxlet.2006.10.016; Chang MJ, 2008, BIOSCI BIOTECH BIOCH, V72, P2750, DOI 10.1271/bbb.80392; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; Christie P, 2005, DRUGS TODAY, V41, P667, DOI 10.1358/dot.2005.41.10.920428; Deree J, 2008, CLINICS, V63, P321, DOI 10.1590/S1807-59322008000300006; Dinarello CA, 2007, EUR J IMMUNOL, V37, pS34, DOI 10.1002/eji.200737772; Essayan DM, 2001, J ALLERGY CLIN IMMUN, V108, P671, DOI 10.1067/mai.2001.119555; Ghiadoni L, 2008, CURR HYPERTENS REP, V10, P52, DOI 10.1007/s11906-008-0011-4; Hassimotto NMA, 2008, NUTR RES, V28, P198, DOI 10.1016/j.nutres.2007.12.012; Hertz AL, 2009, P NATL ACAD SCI USA, V106, P21978, DOI 10.1073/pnas.0911684106; Iffland A, 2005, BIOCHEMISTRY-US, V44, P8312, DOI 10.1021/bi047313h; Ikeda Y, 1999, THROMB HAEMOSTASIS, V82, P435; Jacob C, 2004, BRIT J PHARMACOL, V143, P257, DOI 10.1038/sj.bjp.0705927; Jeon YH, 2005, CELL MOL LIFE SCI, V62, P1198, DOI 10.1007/s00018-005-4533-5; Ko WC, 2004, BIOCHEM PHARMACOL, V68, P2087, DOI 10.1016/j.bcp.2004.06.030; Koes DR, 2012, NUCLEIC ACIDS RES, V40, pW409, DOI 10.1093/nar/gks378; Lee J, 2012, J BIOL CHEM, V287, P22799, DOI 10.1074/jbc.M111.337378; Li HB, 2005, J CHROMATOGR A, V1083, P102, DOI 10.1016/j.chroma.2005.06.025; Li QY, 2013, ACTA PHARMACOL SIN, V34, P1116, DOI 10.1038/aps.2013.25; Mallampalli RK, 2013, J IMMUNOL, V191, P5247, DOI 10.4049/jimmunol.1300456; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Oger S, 2005, J IMMUNOL, V174, P8082, DOI 10.4049/jimmunol.174.12.8082; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; Palmer D, 2000, MOL PHARMACOL, V58, P247, DOI 10.1124/mol.58.2.247; Piao XL, 2008, BIOORG MED CHEM LETT, V18, P1980, DOI 10.1016/j.bmcl.2008.01.115; Qu HH, 2008, J PHARM PHARMACOL, V60, P261, DOI 10.1211/jpp.60.2.0016; Rath HC, 2001, INFECT IMMUN, V69, P2277, DOI 10.1128/IAI.69.4.2277-2285.2001; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Schroll S, 2013, RESP PHYSIOL NEUROBI, V186, P61, DOI 10.1016/j.resp.2012.11.003; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Sheu CC, 2010, INTENS CARE MED, V36, P963, DOI 10.1007/s00134-010-1851-3; Sung BJ, 2003, NATURE, V425, P98, DOI 10.1038/nature01914; Toque HA, 2009, UROLOGY, V74, P216, DOI 10.1016/j.urology.2008.12.056; Tsuda T, 1999, FEBS LETT, V449, P179, DOI 10.1016/S0014-5793(99)00407-X; Uckert S, 2007, EXPERT OPIN EMERG DR, V12, P219, DOI 10.1517/14728214.12.2.219; Wang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029879	40	11	13	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115937	10.1371/journal.pone.0115937	http://dx.doi.org/10.1371/journal.pone.0115937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549252	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000347063500040
J	Ichijo, S; Furuya, F; Shimura, H; Hayashi, Y; Takahashi, K; Ohta, K; Kobayashi, T; Kitamura, K				Ichijo, Sayaka; Furuya, Fumihiko; Shimura, Hiroki; Hayashi, Yoshitaka; Takahashi, Kazuya; Ohta, Kazuyasu; Kobayashi, Tetsuro; Kitamura, Kenichiro			Activation of the RhoB Signaling Pathway by Thyroid Hormone Receptor beta in Thyroid Cancer Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-I; HISTONE DEACETYLASE; ANAPLASTIC CARCINOMA; MOUSE MODEL; GENE; EXPRESSION; GROWTH; INHIBITORS; FARNESYLTRANSFERASE; CARCINOGENESIS	Thyroid hormone receptor (TR) mediates the crucial effects of the thyroid hormone (T3) on cellular growth, development, and differentiation. Decreased expression or inactivating somatic mutations of TRs have been found in human cancers of the liver, breast, lung, and thyroid. The mechanisms of TR-associated carcinogenesis are still not clear. To establish the function of TR beta in thyroid cancer cell proliferation, we constructed a recombinant adenovirus vector, AdTR beta, which expresses human TR beta 1 cDNA. Thyroid cancer cell lines in which TR beta protein levels were significantly decreased as compared to intact thyroid tissues were infected with AdTR beta and the function of TR beta on cell proliferation and migration was analyzed. Ligand-bound TR beta induced HDAC1 and HDAC3 dissociation from, and histone acetylation associated with the RhoB promoter and enhanced the expression of RhoB mRNA and protein. In AdTR beta-infected cells, T3 and farnesyl transferase inhibitor (FTI)-treatment induced the distribution of RhoB on the cell membrane and enhanced the abundance of active GTP-bound RhoB. This RhoB protein led to p21-associated cell-cycle arrest in the G0/G1 phase, following inhibition of cell proliferation and invasion. Conversely, lowering cellular RhoB by small interfering RNA knockdown in AdTR beta-infected cells led to downregulation of p21 and inhibited cell-cycle arrest. The growth of BHP18-21v tumor xenografts in vivo was significantly inhibited by AdTR beta injection with FTIs-treatment, as compared to control virus-injected tumors. This novel signaling pathway triggered by ligand-bound TR beta provides insight into possible mechanisms of proliferation and invasion of thyroid cancer and may provide new therapeutic targets for thyroid cancers.	[Ichijo, Sayaka; Furuya, Fumihiko; Takahashi, Kazuya; Ohta, Kazuyasu; Kobayashi, Tetsuro; Kitamura, Kenichiro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Internal Med 3, Yamanashi, Japan; [Shimura, Hiroki] Fukushima Med Univ, Dept Lab Med, Fukushima, Japan; [Hayashi, Yoshitaka] Nagoya Univ, Environm Med Res Inst, Div Mol & Cellular Adaptat, Dept Endocrinol & Metab, Nagoya, Aichi 464, Japan	University of Yamanashi; Fukushima Medical University; Nagoya University	Furuya, F (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Internal Med 3, Yamanashi, Japan.	ffuruya@yamanashi.ac.jp	Hayashi, Yoshitaka/I-6168-2014	Hayashi, Yoshitaka/0000-0002-7557-4303	JSPS KAKENHI [24591359]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (Grant Number 24591359). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Croft DR, 2011, TRANSCR-AUSTIN, V2, P211, DOI 10.4161/trns.2.5.16904; Delarue FL, 2007, ONCOGENE, V26, P633, DOI 10.1038/sj.onc.1209819; Du W, 1999, CANCER RES, V59, P5492; ESTOUR B, 1989, VIRCHOWS ARCH B, V57, P167, DOI 10.1007/BF02899078; FAGIN JA, 1993, J CLIN INVEST, V91, P179, DOI 10.1172/JCI116168; Furuya F, 2006, P NATL ACAD SCI USA, V103, P1780, DOI 10.1073/pnas.0510849103; Furuya F, 2004, ENDOCRINOLOGY, V145, P5397, DOI 10.1210/en.2004-0631; Furuya F, 2004, ENDOCRINOLOGY, V145, P2865, DOI 10.1210/en.2003-1258; Furuya F, 2010, J BIOL CHEM, V285, P24477, DOI 10.1074/jbc.M109.100222; Furuya F, 2009, STEROIDS, V74, P628, DOI 10.1016/j.steroids.2008.10.009; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Hashimoto K, 2001, P NATL ACAD SCI USA, V98, P3998, DOI 10.1073/pnas.051454698; Hayashi Y, 1996, MOL ENDOCRINOL, V10, P100, DOI 10.1210/me.10.1.100; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Kamasani U, 2004, CANCER RES, V64, P8389, DOI 10.1158/0008-5472.CAN-04-2437; Kaneshige M, 2000, P NATL ACAD SCI USA, V97, P13209, DOI 10.1073/pnas.230285997; Kato Y, 2006, ONCOGENE, V25, P2736, DOI 10.1038/sj.onc.1209299; Kim WG, 2013, BBA-GEN SUBJECTS, V1830, P3928, DOI 10.1016/j.bbagen.2012.04.002; Li JW, 2000, MOL CELL BIOL, V20, P2031, DOI 10.1128/MCB.20.6.2031-2042.2000; Lin KH, 1997, ENDOCRINOLOGY, V138, P5308, DOI 10.1210/en.138.12.5308; Marlow LA, 2009, CANCER RES, V69, P1536, DOI 10.1158/0008-5472.CAN-08-3718; Mazieres J, 2004, CLIN CANCER RES, V10, P2742, DOI 10.1158/1078-0432.CCR-03-0149; NEL CJC, 1985, MAYO CLIN PROC, V60, P51, DOI 10.1016/S0025-6196(12)65285-9; Ohta K, 1997, J CLIN ENDOCR METAB, V82, P2633, DOI 10.1210/jc.82.8.2633; ONATE SA, 1995, SCIENCE, V270, P1354; Prendergast GC, 2001, NAT REV CANCER, V1, P162, DOI 10.1038/35101096; Rondanino C, 2007, TRAFFIC, V8, P932, DOI 10.1111/j.1600-0854.2007.00575.x; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; Shi YB, 2013, CURR TOP DEV BIOL, V105, P275, DOI 10.1016/B978-0-12-396968-2.00010-5; Shimura H, 2001, CANCER RES, V61, P3640; Suzuki H, 2002, THYROID, V12, P963, DOI 10.1089/105072502320908295; Vardouli L, 2008, FEBS J, V275, P4074, DOI 10.1111/j.1742-4658.2008.06549.x; VENKATESH YSS, 1990, CANCER-AM CANCER SOC, V66, P321, DOI 10.1002/1097-0142(19900715)66:2<321::AID-CNCR2820660221>3.0.CO;2-A; Wang SW, 2003, ONCOGENE, V22, P6204, DOI 10.1038/sj.onc.1206653; Weinberg WC, 2002, CRIT REV ORAL BIOL M, V13, P453, DOI 10.1177/154411130201300603; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; Ying H, 2007, MOL CELL BIOL, V27, P2359, DOI 10.1128/MCB.02189-06; Zhou JT, 2011, INT J CANCER, V128, P1057, DOI 10.1002/ijc.25445	41	11	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116252	10.1371/journal.pone.0116252	http://dx.doi.org/10.1371/journal.pone.0116252			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548921	Green Published, Green Submitted, gold			2022-12-26	WOS:000347063500068
J	Jackson, SA; Kleitman, S; Aidman, E				Jackson, Simon A.; Kleitman, Sabina; Aidman, Eugene			Low Cognitive Load and Reduced Arousal Impede Practice Effects on Executive Functioning, Metacognitive Confidence and Decision Making	PLOS ONE			English	Article							TEST-RETEST INTERVALS; INDIVIDUAL-DIFFERENCES; BOREDOM; FATIGUE; UNDERCONFIDENCE; INTELLIGENCE; PERFORMANCE; JUDGMENTS; SETTINGS; WORKLOAD	The present study investigated the effects of low cognitive workload and the absence of arousal induced via external physical stimulation (motion) on practice-related improvements in executive (inhibitory) control, short-term memory, metacognitive monitoring and decision making. A total of 70 office workers performed low and moderately engaging passenger tasks in two successive 20-minute simulated drives and repeated a battery of decision making and inhibitory control tests three times before, between and after these drives. For half the participants, visual simulation was synchronised with (moderately arousing) motion generated through LAnd Motion Platform, with vibration levels corresponding to a well-maintained unsealed road. The other half performed the same simulated drive without motion. Participants' performance significantly improved over the three test blocks, which is indicative of typical practice effects. The magnitude of these improvements was the highest when both motion and moderate cognitive load were present. The same effects declined either in the absence of motion (low arousal) or following a low cognitive workload task, thus suggesting two distinct pathways through which practice-related improvements in cognitive performance may be hampered. Practice, however, degraded certain aspects of metacognitive performance, as participants became less likely to detect incorrect decisions in the decision-making test with each subsequent test block. Implications include consideration of low cognitive load and arousal as factors responsible for performance decline and targets for the development of interventions/strategies in low load/arousal conditions such as autonomous vehicle operations and highway driving.	[Jackson, Simon A.; Kleitman, Sabina] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Aidman, Eugene] Def Sci & Technol Org, Land Div, Adelaide, SA, Australia	University of Sydney; Defence Science & Technology	Jackson, SA (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	simon.jackson@sydney.edu.au		Kleitman, Sabina/0000-0001-5772-5019; AIDMAN, Eugene/0000-0002-7711-794X	Defence Capability Development Group Project Land 121 Phase 4 [558023]	Defence Capability Development Group Project Land 121 Phase 4	SAJ, SK and EA were funded by the Defence Capability Development Group Project Land 121 Phase 4 (http://www.army.gov.au/Ourfuture/Projects/Project-LAND-121) under the Research Agreement 558023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Bohemia Interactive, 2007, VIRT BATTLESPACE VER; Busch RM, 2005, USING NORMS NEUROPSY; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Desmond PA, 2001, HUM FAC TRANSP, P455; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dunlosky J., 2008, METACOGNITION; Efklides A, 2008, EUR PSYCHOL, V13, P277, DOI 10.1027/1016-9040.13.4.277; Evans JST, 2013, PERSPECT PSYCHOL SCI, V8, P223, DOI 10.1177/1745691612460685; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Finn B, 2007, J EXP PSYCHOL LEARN, V33, P238, DOI 10.1037/0278-7393.33.1.238; FISHER CD, 1993, HUM RELAT, V46, P395, DOI 10.1177/001872679304600305; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Golding JF, 1998, BRAIN RES BULL, V47, P507, DOI 10.1016/S0361-9230(98)00091-4; Guilford J.P., 1954, J EDUC PSYCHOL, V2nd ed.; Hart CS, 2010, THESIS MIT; HART S G, 1988, P139; Harvey N, 2001, THINK REASONING, V7, P103, DOI DOI 10.1080/13546780042000064; Jackson SA, 2014, METACOGN LEARN, V9, P25, DOI 10.1007/s11409-013-9110-y; Kahneman D, 2009, AM PSYCHOL, V64, P515, DOI 10.1037/a0016755; Koriat A, 1996, PSYCHOL REV, V103, P490, DOI 10.1037/0033-295X.103.3.490; Koriat A, 2002, J EXP PSYCHOL GEN, V131, P147, DOI 10.1037//0096-3445.131.2.147; Loukidou L, 2009, INT J MANAG REV, V11, P381, DOI 10.1111/j.1468-2370.2009.00267.x; Maassen GH, 2009, J CLIN EXP NEUROPSYC, V31, P339, DOI 10.1080/13803390802169059; Mann S, 2009, BRIT EDUC RES J, V35, P243, DOI 10.1080/01411920802042911; McGrew KS, 2009, INTELLIGENCE, V37, P1, DOI 10.1016/j.intell.2008.08.004; Neubauer C, 2012, HUM FACTORS, V54, P734, DOI 10.1177/0018720811423261; PAESE PW, 1991, ORGAN BEHAV HUM DEC, V48, P100, DOI 10.1016/0749-5978(91)90008-H; Parker AM, 2014, J BEHAV DECIS MAKING, V27, P134, DOI 10.1002/bdm.1787; Pattyn N, 2008, PHYSIOL BEHAV, V93, P369, DOI 10.1016/j.physbeh.2007.09.016; Pekrun R, 2010, J EDUC PSYCHOL, V102, P531, DOI 10.1037/a0019243; Phillips RO, 2013, ACCIDENT ANAL PREV, V50, P138, DOI 10.1016/j.aap.2012.04.003; Roelofs A, 2003, PSYCHOL REV, V110, P88, DOI 10.1037/0033-295X.110.1.88; Rubio S, 2004, APPL PSYCHOL-INT REV, V53, P61, DOI 10.1111/j.1464-0597.2004.00161.x; Sagberg F, 1999, ACCIDENT ANAL PREV, V31, P639, DOI 10.1016/S0001-4575(99)00023-8; Saxby DJ, 2013, J EXP PSYCHOL-APPL, V19, P287, DOI 10.1037/a0034386; Scerbo M. W., 1998, VIEWING PSYCHOL WHOL, P145, DOI [10.1037/10290-006, DOI 10.1037/10290-006]; Stankov L, 2000, INTELLIGENCE, V28, P121, DOI 10.1016/S0160-2896(99)00033-1; Stankov L, 2015, MEASURES OF PERSONALITY AND SOCIAL PSYCHOLOGICAL CONSTRUCTS, P158, DOI 10.1016/B978-0-12-386915-9.00007-3; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Suchy Y, 2011, J INT NEUROPSYCH SOC, V17, P101, DOI 10.1017/S135561771000130X; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Thiffault P, 2003, ACCIDENT ANAL PREV, V35, P381, DOI 10.1016/S0001-4575(02)00014-3; Vogel-Walcutt JJ, 2012, EDUC PSYCHOL REV, V24, P89, DOI 10.1007/s10648-011-9182-7; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	47	19	19	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115689	10.1371/journal.pone.0115689	http://dx.doi.org/10.1371/journal.pone.0115689			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX6YH	25549327	Green Published, gold, Green Submitted			2022-12-26	WOS:000347063500021
J	Sullivan, JH; Muhammad, D; Warpeha, KM				Sullivan, Joe H.; Muhammad, DurreShahwar; Warpeha, Katherine M.			Phenylalanine Is Required to Promote Specific Developmental Responses and Prevents Cellular Damage in Response to Ultraviolet Light in Soybean (Glycine max) during the Seed-to-Seedling Transition	PLOS ONE			English	Article							UV-B RADIATION; CHLOROPHYLL FLUORESCENCE; EPIDERMAL-TRANSMITTANCE; SCREENING EFFECTIVENESS; TERRESTRIAL ECOSYSTEMS; PLANT-SENSITIVITY; DROUGHT TOLERANCE; BALANCING DAMAGE; AMBIENT LEVELS; PINUS-TAEDA	UV-radiation elicits a suite of developmental (photomorphogenic) and protective responses in plants, but responses early post-germination have received little attention, particularly in intensively bred plants of economic importance. We examined germination, hypocotyl elongation, leaf pubescence and subcellular responses of germinating and/or etiolated soybean (Glycine max (L.) Merr.) seedlings in response to treatment with discrete wavelengths of UV-A or UV-B radiation. We demonstrate differential responses of germinating/young soybean seedlings to a range of UV wavelengths that indicate unique signal transduction mechanisms regulate UV-initiated responses. We have investigated how phenylalanine, a key substrate in the phenylpropanoid pathway, may be involved in these responses. Pubescence may be a key location for phenylalanine-derived protective compounds, as UV-B irradiation increased pubescence and accumulation of UV-absorbing compounds within primary leaf pubescence, visualized by microscopy and absorbance spectra. Mass spectrometry analysis of pubescence indicated that sinapic esters accumulate in the UV-irradiated hairs compared to unirradiated primary leaf tissue. Deleterious effects of some UV-B wavelengths on germination and seedling responses were reduced or entirely prevented by inclusion of phenylalanine in the growth media. Key effects of phenylalanine were not duplicated by tyrosine or tryptophan or sucrose, nor is the specificity of response due to the absorbance of phenylalanine itself. These results suggest that in the seed-to-seedling transition, phenylalanine may be a limiting factor in the development of initial mechanisms of UV protection in the developing leaf.	[Sullivan, Joe H.] Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA; [Muhammad, DurreShahwar; Warpeha, Katherine M.] Univ Illinois, Dept Biol Sci, Mol Cell & Dev Program, Chicago, IL 60680 USA	University System of Maryland; University of Maryland College Park; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Warpeha, KM (corresponding author), Univ Illinois, Dept Biol Sci, Mol Cell & Dev Program, Chicago, IL 60680 USA.	kwarpeha@uic.edu	Sullivan, Joe H./AAC-2195-2020	Sullivan, Joe H./0000-0002-2082-0343; Warpeha, Katherine/0000-0001-6866-3028	United States Department of Agriculture; Illinois Soybean Association	United States Department of Agriculture(United States Department of Agriculture (USDA)); Illinois Soybean Association	Support was provided by the United States Department of Agriculture UV-B Monitoring Project to KMW, and check-off funds from the Illinois Soybean Association to KMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati G, 2010, NEW PHYTOL, V186, P786, DOI 10.1111/j.1469-8137.2010.03269.x; Aharoni A, 2004, PLANT CELL, V16, P2463, DOI 10.1105/tpc.104.022897; Anderson MB, 1999, PLANT CELL, V11, P1579, DOI 10.1105/tpc.11.8.1579; Ayres PG, 1995, FUNGI ENV CHANGE, P32; Barnes J., 1994, AIR POLLUTANTS LEAF, P195; BIGGS RH, 1981, PHYSIOL PLANTARUM, V53, P19, DOI 10.1111/j.1399-3054.1981.tb05039.x; Bilger W, 2001, J EXP BOT, V52, P2007, DOI 10.1093/jexbot/52.363.2007; BUCHHOLZ G, 1995, PLANT PHYSIOL, V108, P227, DOI 10.1104/pp.108.1.227; Burchard P, 2000, PLANT CELL ENVIRON, V23, P1373, DOI 10.1046/j.1365-3040.2000.00633.x; Caldwell MM, 2007, PHOTOCH PHOTOBIO SCI, V6, P252, DOI 10.1039/b700019g; CALDWELL MM, 1983, PHYSIOL PLANTARUM, V58, P445, DOI 10.1111/j.1399-3054.1983.tb04206.x; Caldwell MM., 1971, PHOTOPHYSIOLOGY, V6, P131, DOI [10.1016/b978-0-12-282606-1.50010-6, DOI 10.1016/B978-0-12-282606-1.50010-6, 10.1016/B978-0-12-282606-1.50010-6]; CEN YP, 1990, J EXP BOT, V41, P1489, DOI 10.1093/jxb/41.11.1489; Christie JM, 2012, SCIENCE, V335, P1492, DOI 10.1126/science.1218091; DACUNHA A, 1987, PHYTOCHEMISTRY, V26, P2723, DOI 10.1016/S0031-9422(00)83579-7; Day TA, 1996, PLANT CELL ENVIRON, V19, P101, DOI 10.1111/j.1365-3040.1996.tb00231.x; DAY TA, 1994, PHYSIOL PLANTARUM, V92, P207, DOI 10.1111/j.1399-3054.1994.tb05328.x; DAY TA, 1993, OECOLOGIA, V95, P542, DOI 10.1007/BF00317439; Essen LO, 2006, CELL MOL LIFE SCI, V63, P1266, DOI 10.1007/s00018-005-5447-y; Flint SD, 2004, PHOTOCHEM PHOTOBIOL, V79, P399, DOI 10.1562/0031-8655(2004)79<399:SFTOBS>2.0.CO;2; Frohnmeyer H, 2003, PLANT PHYSIOL, V133, P1420, DOI 10.1104/pp.103.030049; Gardner G, 2009, PLANT CELL ENVIRON, V32, P1573, DOI 10.1111/j.1365-3040.2009.02021.x; Gitz DC, 2005, ENVIRON EXP BOT, V53, P343, DOI 10.1016/j.envexpbot.2004.04.005; Holmes MG, 2002, PLANT CELL ENVIRON, V25, P85, DOI 10.1046/j.1365-3040.2002.00779.x; Jansen MAK, 1998, TRENDS PLANT SCI, V3, P131, DOI 10.1016/S1360-1385(98)01215-1; Jenkins GI, 2009, ANNU REV PLANT BIOL, V60, P407, DOI 10.1146/annurev.arplant.59.032607.092953; KARABOURNIOTIS G, 1993, ENVIRON EXP BOT, V33, P341, DOI 10.1016/0098-8472(93)90035-E; KARABOURNIOTIS G, 1992, PHYSIOL PLANTARUM, V86, P414, DOI 10.1111/j.1399-3054.1992.tb01337.x; Krizek DT, 1998, PHYSIOL PLANTARUM, V103, P1, DOI 10.1034/j.1399-3054.1998.1030101.x; LANDRY LG, 1995, PLANT PHYSIOL, V109, P1159, DOI 10.1104/pp.109.4.1159; Lee JH, 2013, J SCI FOOD AGR, V93, P3081, DOI 10.1002/jsfa.6142; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Liakopoulos G, 2006, ANN BOT-LONDON, V98, P257, DOI 10.1093/aob/mcl097; LIU L, 1995, PHYSIOL PLANTARUM, V93, P725, DOI 10.1111/j.1399-3054.1995.tb05123.x; MANDOLI DF, 1981, PLANT PHYSIOL, V67, P733, DOI 10.1104/pp.67.4.733; MARGNA U, 1989, PHYTOCHEMISTRY, V28, P469, DOI 10.1016/0031-9422(89)80034-2; Mazza CA, 2000, PLANT PHYSIOL, V122, P117, DOI 10.1104/pp.122.1.117; Merzlyak MN, 2008, J EXP BOT, V59, P349, DOI 10.1093/jxb/erm316; MIRECKI RM, 1984, PLANT PHYSIOL, V74, P475, DOI 10.1104/pp.74.3.475; Morales LO, 2010, TREE PHYSIOL, V30, P923, DOI 10.1093/treephys/tpq051; MURALI NS, 1986, PHOTOCHEM PHOTOBIOL, V44, P215, DOI 10.1111/j.1751-1097.1986.tb03588.x; Murphy A, 2000, PLANTA, V211, P315, DOI 10.1007/s004250000300; Orozco-Nunnelly DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093371; Pasko P, 2009, FOOD CHEM, V115, P994, DOI 10.1016/j.foodchem.2009.01.037; Peer WA, 2001, PLANT PHYSIOL, V126, P536, DOI 10.1104/pp.126.2.536; Percy KE, 1994, NATO ASI SERIES, V36; REED HE, 1992, CROP SCI, V32, P1214, DOI 10.2135/cropsci1992.0011183X003200050031x; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; ROBBERECHT R, 1978, OECOLOGIA, V32, P277, DOI 10.1007/BF00345107; Rohde A, 2004, PLANT CELL, V16, P2749, DOI 10.1105/tpc.104.023705; Rozema J, 2002, J PHOTOCH PHOTOBIO B, V66, P2, DOI 10.1016/S1011-1344(01)00269-X; Searles PS, 2001, OECOLOGIA, V127, P1, DOI 10.1007/s004420000592; Sheahan JJ, 1996, AM J BOT, V83, P679, DOI 10.2307/2445845; Shinkle JR, 2010, PHYSIOL PLANTARUM, V138, P113, DOI 10.1111/j.1399-3054.2009.01298.x; SINCLAIR TR, 1990, J ENVIRON QUAL, V19, P478, DOI 10.2134/jeq1990.00472425001900030020x; Sullivan JH, 2005, ENVIRON POLLUT, V137, P380, DOI 10.1016/j.envpol.2005.01.029; Sullivan JH, 2003, P SOC PHOTO-OPT INS, V4896, P135, DOI 10.1117/12.466182; Sullivan JH, 1996, PHYSIOL PLANTARUM, V98, P349, DOI 10.1034/j.1399-3054.1996.980217.x; Sullivan JH, 2007, PHOTOCHEM PHOTOBIOL, V83, P863, DOI 10.1111/j.1751-1097.2007.00138.x; Sutherland BM, 1996, PHOTOCHEM PHOTOBIOL, V64, P464, DOI 10.1111/j.1751-1097.1996.tb03092.x; TAN EM, 1970, J INVEST DERMATOL, V55, P439, DOI 10.1111/1523-1747.ep12260585; Tattini M, 2000, NEW PHYTOL, V148, P69, DOI 10.1046/j.1469-8137.2000.00743.x; TERAMURA AH, 1987, AM J BOT, V74, P975, DOI 10.2307/2443936; vanHeerden PS, 1996, J BIOL CHEM, V271, P12350, DOI 10.1074/jbc.271.21.12350; Voll LM, 2004, PLANT PHYSIOL, V136, P3058, DOI 10.1104/pp.104.047506; Wargent JJ, 2011, PLANT CELL ENVIRON, V34, P1401, DOI 10.1111/j.1365-3040.2011.02342.x; Warpeha KM, 2008, PLANT CELL ENVIRON, V31, P1756, DOI 10.1111/j.1365-3040.2008.01878.x; Warpeha KM, 2006, PLANT PHYSIOL, V140, P844, DOI 10.1104/pp.105.071282; Wilson KE, 2001, PHOTOCHEM PHOTOBIOL, V73, P678, DOI 10.1562/0031-8655(2001)073&lt;0678:EOUAEO&gt;2.0.CO;2; WMO, 2010, WORLD METEOROLOGICAL, V52, P516; Xu CP, 2008, ENVIRON EXP BOT, V63, P39, DOI 10.1016/j.envexpbot.2007.10.029; Xu CP, 2008, PHYTOCHEMISTRY, V69, P38, DOI 10.1016/j.phytochem.2007.06.010; YANG XS, 1995, INT J BIOMETEOROL, V38, P60, DOI 10.1007/BF01270660; Zhang JY, 2005, PLANT J, V42, P689, DOI 10.1111/j.1365-313X.2005.02405.x; ZISKA LH, 1992, AM J BOT, V79, P863, DOI 10.2307/2444995; Zu YQ, 2003, ENVIRON EXP BOT, V50, P87, DOI 10.1016/S0098-8472(03)00004-2	76	11	11	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e112301	10.1371/journal.pone.0112301	http://dx.doi.org/10.1371/journal.pone.0112301			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549094	Green Published, Green Submitted, gold			2022-12-26	WOS:000347063500004
J	Suzuki, A; Kobayashi, R; Okayasu, S; Kuze, B; Aoki, M; Mizuta, K; Itoh, Y				Suzuki, Akio; Kobayashi, Ryo; Okayasu, Shinji; Kuze, Bunya; Aoki, Mitsuhiro; Mizuta, Keisuke; Itoh, Yoshinori			Pharmacotherapy for Adverse Events Reduces the Length of Hospital Stay in Patients Admitted to Otolaryngology Ward: A Single Arm Intervention Study	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINE; NECK-CANCER; AMERICAN SOCIETY; ORAL MUCOSITIS; DRUG EVENTS; COSTS; CARE; DYSPHAGIA; HEAD; MORTALITY	Background: To determine whether adverse events extend the duration of hospitalization, and to evaluate the effectiveness of medical intervention in ameliorating adverse events and reducing the prolonged hospital stay associated with adverse events. Methods: A single arm intervention study was conducted from October 2012 to March 2014 in the otolaryngology ward of a 614-bed, university-affiliated hospital. Adverse events were monitored daily by physicians, pharmacists and nurses, and recorded in the electronic medical chart for each patient. Appropriate drug management of adverse events was performed by physicians in liaison with pharmacists. The Kaplan-Meier method was used to assess the length of hospitalization of patients who underwent medical intervention for adverse events. Results: Of 571 patients admitted to the otolaryngology ward in a year, 219 patients (38.4%) experienced adverse events of grade >= 2. The duration of hospitalization was affected by the grade of adverse events, with a mean duration of hospital stay of 9.2, 17.2, 28.3 and 47.0 days for grades 0, 1, 2, and 3-4, respectively. Medical intervention lowered the incidence of grade >= 2 adverse events to 14.5%. The length of hospitalization was significantly shorter in patients who showed an improvement of adverse events after medical intervention than those who did not (26.4 days vs. 41.6 days, hazard ratio 1.687, 95% confidence interval: 1.260-2.259, P<0.001). A multivariate Cox proportional hazard analysis indicated that insomnia, constipation, nausea/vomiting, infection, non-cancer pain, oral mucositis, odynophagia and neutropenia were significant risk factors for prolongation of hospital stay. Conclusion: Patients who experienced adverse events are at high risk of prolonged hospitalization. Medical intervention for adverse events was found to be effective in reducing the length of hospital stay associated with adverse events.	[Suzuki, Akio; Kobayashi, Ryo; Okayasu, Shinji; Itoh, Yoshinori] Gifu Univ Hosp, Dept Pharm, Gifu, Japan; [Kuze, Bunya; Aoki, Mitsuhiro; Mizuta, Keisuke] Gifu Univ, Grad Sch Med, Dept Otolaryngol, Gifu, Japan; [Aoki, Mitsuhiro] Gifu Univ Hosp, Dept Med Informat Div, Gifu, Japan	Gifu University; Gifu University; Gifu University	Suzuki, A (corresponding author), Gifu Univ Hosp, Dept Pharm, Gifu, Japan.	akio@gifu-u.ac.jp						Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Basch E, 2011, J CLIN ONCOL, V29, P4189, DOI [10.1200/JCO.2010.34.4614, 10.1200/JOP.2011.000397]; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; Benson AB, 2004, J CLIN ONCOL, V22, P2918, DOI 10.1200/jco.2004.04.132; Bratzler DW, 2013, AM J HEALTH-SYST PH, V70, P540; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; Evans R S, 1992, Proc Annu Symp Comput Appl Med Care, P437; Feng FY, 2007, INT J RADIAT ONCOL, V68, P1289, DOI 10.1016/j.ijrobp.2007.02.049; Forster AJ, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-259; Howard HH, 1989, NEW ENGL J MED, V324, P370; Kaushal R, 2007, CRIT CARE MED, V35, P2479, DOI 10.1097/01.CCM.0000284510.04248.66; Keefe DM, 2007, CANCER-AM CANCER SOC, V109, P820, DOI 10.1002/cncr.22484; Kronenberger Michael B., 1994, Dysphagia, V9, P236, DOI 10.1007/BF00301917; Kulbersh BD, 2006, LARYNGOSCOPE, V116, P883, DOI 10.1097/01.mlg.0000217278.96901.fc; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pS67; Mercadante S, 2010, INTERN EMERG MED, V5, pS31, DOI 10.1007/s11739-010-0448-8; NCCN, 2022, CLIN PRACTICE GUIDEL; Parmentier-Decrucq E, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-10; Schilling MB, 2011, EXP THER MED, V2, P859, DOI 10.3892/etm.2011.312; Shune SE, 2012, HEAD NECK-J SCI SPEC, V34, P776, DOI 10.1002/hed.21819; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Sonis ST, 2001, J CLIN ONCOL, V19, P2201, DOI 10.1200/JCO.2001.19.8.2201; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517; Watanabe T, 2010, INT J CANCER, V127, P1984, DOI 10.1002/ijc.25200; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	27	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115879	10.1371/journal.pone.0115879	http://dx.doi.org/10.1371/journal.pone.0115879			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549093	Green Published, Green Submitted, gold			2022-12-26	WOS:000347063500034
J	Adnan, WAHWM; Zaharan, NL; Wong, MH; Lim, SK				Adnan, Wan Ahmad Hafiz Wan Md; Zaharan, Nur Lisa; Wong, Mun Hoe; Lim, Soo Kun			The Effects of Intermittent Fasting during the Month of Ramadan in Chronic Haemodialysis Patients in a Tropical Climate Country	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ELECTROLYTE BALANCE; LIPID-LEVELS; RECOMMENDATIONS; DIALYSIS; FLUID	Background: Chronic kidney disease is an emerging problem in the majority Muslim countries. Despite the uncertainties of the risks involved, some Muslim patients undergoing chronic haemodialysis choose to observe intermittent fasting during the month of Ramadan. This study aims to investigate the effect of Ramadan fasting in haemodialysis patients residing in a tropical climate country. Methods: This prospective cross sectional study recruited Muslim patients on regular haemodialysis from three haemodialysis centres in Kuala Lumpur from 15th July 2011 to 29th August 2011. Patients who fasted for any number of days were included (n=35, 54% female, age 54 +/- 11 years). 89% of patients fasted for more than 15 days and 49% were diabetics. Dialysis parameters and blood samples were obtained one week prior to Ramadan and during the last week of Ramadan. The differences in dialysis parameters and biochemical values pre- and end-Ramadan were examined using paired t-test. Results: Both pre- and post-dialysis weight were significantly decreased during Ramadan fasting compared to the month prior (p= <0.001). There was a significant decrease in the amount of ultrafiltration (p=0.002). There were no significant differences in dry weight, inter-dialytic weight gain, mean urea reduction ratio or blood pressure measurements comparing pre- and end of Ramadan fasting. There was a significant increase in serum albumin level (p=0.006) and decrease in serum phosphate level (p=0.02) at the end of Ramadan. Conclusion: Ramadan fasting is associated with reduced weight, improved serum albumin and phosphate level in our population of haemodialysis patients. A larger multi-centre study will allow us to understand more about the effects of fasting in this population.	[Adnan, Wan Ahmad Hafiz Wan Md; Wong, Mun Hoe; Lim, Soo Kun] Univ Malaya, Dept Med, Nephrol Unit, Fac Med, Kuala Lumpur 50603, Malaysia; [Zaharan, Nur Lisa] Univ Malaya, Dept Pharmacol, Fac Med, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Adnan, WAHWM (corresponding author), Univ Malaya, Dept Med, Nephrol Unit, Fac Med, Kuala Lumpur 50603, Malaysia.	wahafiz@um.edu.my	Lim, Soo Kun/Q-2012-2019; Zaharan, Nur Lisa/F-8835-2012; LIM, SOO KUN/B-8868-2010; Wan Md Adnan, Wan Ahmad Hafiz/D-9088-2016	Lim, Soo Kun/0000-0001-7589-5150; Zaharan, Nur Lisa/0000-0002-8150-0642; LIM, SOO KUN/0000-0001-7589-5150; Wan Md Adnan, Wan Ahmad Hafiz/0000-0003-0818-5831	Head, Division of Nephrology, Faculty of Medicine, University of Malaya, Kuala Lumpur	Head, Division of Nephrology, Faculty of Medicine, University of Malaya, Kuala Lumpur	We would like to acknowledge the managers and staffs of the participating haemodialysis centres for making it possible for us to conduct this research. Financial assistance was provided by Associate Professor Dr Lim Soo Kun, Head, Division of Nephrology, Faculty of Medicine, University of Malaya, Kuala Lumpur.	Abdalla AH, 1998, AM J NEPHROL, V18, P101, DOI 10.1159/000013316; Aksungar FB, 2005, ANN NUTR METAB, V49, P77, DOI 10.1159/000084739; Al Wakeel J, 2013, PERITON DIALYSIS INT, V33, P86, DOI 10.3747/pdi.2010.00095; Al-Arouj M, 2010, DIABETES CARE, V33, P1895, DOI 10.2337/dc10-0896; ALKHADER AA, 1991, SAUDI MED J, V12, P30; Bernieh B, 2010, SAUDI J KIDNEY DIS T, V21, P898; CHEAH SH, 1990, BRIT J NUTR, V63, P329, DOI 10.1079/BJN19900119; El-Wakil HS, 2007, SAUDI J KIDNEY DIS T, V18, P349; Farag YMK, 2012, NEPHRON CLIN PRACT, V121, pC120, DOI 10.1159/000345149; HALLAK MH, 1988, AM J CLIN NUTR, V48, P1197, DOI 10.1093/ajcn/48.5.1197; HUSAIN R, 1987, BRIT J NUTR, V58, P41, DOI 10.1079/BJN19870067; KENNEDY HJ, 1983, GUT, V24, P702, DOI 10.1136/gut.24.8.702; Khedmat H, 2010, SAUDI J KIDNEY DIS T, V21, P417; Leiper JB, 2003, EUR J CLIN NUTR, V57, pS30, DOI 10.1038/sj.ejcn.1601899; Lim Y N, 2008, Med J Malaysia, V63 Suppl C, P5; MUSTAFA KY, 1978, BRIT J NUTR, V40, P583, DOI 10.1079/BJN19780162; Perk G, 2001, J HUM HYPERTENS, V15, P723, DOI 10.1038/sj.jhh.1001262; Pew Research Center, 2009, MAPPING GLOBAL MUSLI; Prodjosudjadi W, 2009, NEPHROLOGY, V14, P669, DOI 10.1111/j.1440-1797.2009.01137.x; Qurashi S, 2012, EXP CLIN TRANSPLANT, V10, P551, DOI 10.6002/ect.2012.0139; RASHED AH, 1989, LANCET, V1, P1396; RASHED AH, 1992, BRIT MED J, V304, P521, DOI 10.1136/bmj.304.6826.521; Roky R, 2004, ANN NUTR METAB, V48, P296, DOI 10.1159/000081076; Sahin I, 2009, RENAL FAILURE, V31, P920, DOI 10.3109/08860220903219265; Salti I, 2004, DIABETES CARE, V27, P2306, DOI 10.2337/diacare.27.10.2306; Termorshuizen F, 2004, J AM SOC NEPHROL, V15, P1061, DOI 10.1097/01.ASN.0000117976.29592.93	26	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e114262	10.1371/journal.pone.0114262	http://dx.doi.org/10.1371/journal.pone.0114262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546434	Green Submitted, gold, Green Published			2022-12-26	WOS:000347120200008
J	Cui, D; Zhang, LL; Li, J; Zhao, YF; Hu, XX; Dai, YP; Zhang, R; Li, N				Cui, Dan; Zhang, Linlin; Li, Jia; Zhao, Yaofeng; Hu, Xiaoxiang; Dai, Yunping; Zhang, Ran; Li, Ning			Bovine FcRn-Mediated Human Immunoglobulin G Transfer across the Milk-Blood Barrier in Transgenic Mice	PLOS ONE			English	Article							I-RELATED RECEPTOR; PH-DEPENDENT BINDING; RAT SMALL-INTESTINE; MAMMARY-GLAND; IGG TRANSPORT; NEONATAL RAT; BIDIRECTIONAL TRANSCYTOSIS; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; HUMAN PLACENTA	Maternal-fetal IgGs transport occurs either prenatally or postnatally, which confers the newborns with passive immunity before their own immune system has matured. However, little is known about the mechanisms of postnatal IgGs passage in the mammary gland. To investigate how FcRn mediates the IgGs transport in the mammary gland, we first generated bFcRn and anti-HAV mAb transgenic mice, and then obtained HF transgenic mice expressing both transgenes by mating the above two strains. Transgene expression of bFcRn in the four lines was determined by qRT-PCR and western blot. We then localized the expression of bFcRn to the acinar epithelial cells in the mammary gland, and anti-HAV mAb was mainly detected in the acini with weak staining in the acinar epithelial cells. Human IgGs could be detected in both milk and serum of HF transgenic mice by western blot and ELISA. A significantly lower milk to serum ratio of human IgGs in HF mice compared with that of anti-HAV mAb mice, indicating that bFcRn could transport human IgGs across the milk-blood barrier from milk to serum during lactation in HF mice. While, there were no transport of murine IgGs, IgAs, or IgMs. These results provide understandings about the mechanisms of maternal-fetal immunity transfer in the mammary gland.	[Cui, Dan; Zhang, Linlin; Li, Jia; Zhao, Yaofeng; Hu, Xiaoxiang; Zhang, Ran; Li, Ning] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Dai, Yunping] GenProt Biotech Ltd, Beijing, Peoples R China	China Agricultural University	Zhang, R (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	zhangran0628@gmail.com; ninglcau@cau.edu.cn			"863'' High-Tech Research Development Project [2011AA100601]; National Natural Scientific Foundation [81370840]	"863'' High-Tech Research Development Project(National High Technology Research and Development Program of China); National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC))	This project was supported in part by the "863'' High-Tech Research Development Project (Project Grant No. 2011AA100601) to Professor Ning Li and the URL is http://www.most.gov.cn, and the National Natural Scientific Foundation (Project Grant No. 81370840) to Professor Ning Li and the URL is http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski FM, 2000, MOL IMMUNOL, V37, P435, DOI 10.1016/S0161-5890(00)00065-1; AHOUSE JJ, 1993, J IMMUNOL, V151, P6076; Akilesh S, 2008, P NATL ACAD SCI USA, V105, P967, DOI 10.1073/pnas.0711515105; Andersen JT, 2006, EUR J IMMUNOL, V36, P3044, DOI 10.1002/eji.200636556; Antohe F, 2001, HUM IMMUNOL, V62, P93, DOI 10.1016/S0198-8859(00)00244-5; Bai Y, 2011, P NATL ACAD SCI USA, V108, P18406, DOI 10.1073/pnas.1115348108; Ben Suleiman Y, 2012, MUCOSAL IMMUNOL, V5, P87, DOI 10.1038/mi.2011.53; BENLOUNES N, 1995, BIOL NEONATE, V67, P254, DOI 10.1159/000244173; BLUMBERG RS, 1995, J CLIN INVEST, V95, P2397, DOI 10.1172/JCI117934; Borvak J, 1998, INT IMMUNOL, V10, P1289, DOI 10.1093/intimm/10.9.1289; Brambell F W, 1970, Biogr Mem Fellows R Soc, V16, P343; BRAMBELL FW, 1966, LANCET, V2, P1087, DOI 10.1016/S0140-6736(66)92190-8; BRAMBELL FWR, 1958, PROC R SOC SER B-BIO, V149, P1, DOI 10.1098/rspb.1958.0046; BUTLER JE, 1971, J DAIRY SCI, V54, P1315, DOI 10.3168/jds.S0022-0302(71)86026-5; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Cianga P, 1999, EUR J IMMUNOL, V29, P2515, DOI 10.1002/(SICI)1521-4141(199908)29:08&lt;2515::AID-IMMU2515&gt;3.0.CO;2-D; Claypool SM, 2004, MOL BIOL CELL, V15, P1746, DOI 10.1091/mbc.E03-11-0832; Dickinson BL, 1999, J CLIN INVEST, V104, P903, DOI 10.1172/JCI6968; Ellinger I, 1999, EUR J IMMUNOL, V29, P733, DOI 10.1002/(SICI)1521-4141(199903)29:03<733::AID-IMMU733>3.0.CO;2-C; Ghetie V, 1997, IMMUNOL TODAY, V18, P592, DOI 10.1016/S0167-5699(97)01172-9; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Ghetie V, 1996, EUR J IMMUNOL, V26, P690, DOI 10.1002/eji.1830260327; HARADA E, 1994, COMP BIOCHEM PHYS A, V109, P667, DOI 10.1016/0300-9629(94)90208-9; Israel EJ, 1996, IMMUNOLOGY, V89, P573, DOI 10.1046/j.1365-2567.1996.d01-775.x; ISRAEL EJ, 1993, IMMUNOLOGY, V79, P77; Junghans RP, 1996, P NATL ACAD SCI USA, V93, P5512, DOI 10.1073/pnas.93.11.5512; Kacskovics I, 2000, J IMMUNOL, V164, P1889, DOI 10.4049/jimmunol.164.4.1889; Kacskovics I, 2006, DEV COMP IMMUNOL, V30, P1203, DOI 10.1016/j.dci.2006.02.006; KANDIL E, 1995, J IMMUNOL, V154, P5907; Kim JH, 2006, AM J PHYSIOL-GASTR L, V290, pG352, DOI 10.1152/ajpgi.00286.2005; Kuo TT, 2009, J BIOL CHEM, V284, P8292, DOI 10.1074/jbc.M805877200; LARSON BL, 1980, J DAIRY SCI, V63, P665, DOI 10.3168/jds.S0022-0302(80)82988-2; Leach JL, 1996, J IMMUNOL, V157, P3317; Li ZL, 2011, P NATL ACAD SCI USA, V108, P4388, DOI 10.1073/pnas.1012861108; Liu S, 2012, TRANSGENIC RES, V21, P407, DOI 10.1007/s11248-011-9536-4; Lu W, 2007, IMMUNOLOGY, V122, P401, DOI 10.1111/j.1365-2567.2007.02654.x; Mayer B, 2002, VET IMMUNOL IMMUNOP, V87, P327, DOI 10.1016/S0165-2427(02)00059-4; McCarthy KM, 2000, J CELL SCI, V113, P1277; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; MORRIS IG, 1980, IMMUNOLOGY, V40, P273; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Praetor A, 1999, J CELL SCI, V112, P2291; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; ROBERTS DM, 1990, J CELL BIOL, V111, P1867, DOI 10.1083/jcb.111.5.1867; RODEWALD R, 1984, J CELL BIOL, V99, pS159, DOI 10.1083/jcb.99.1.159s; RODEWALD R, 1980, J CELL BIOL, V85, P18, DOI 10.1083/jcb.85.1.18; RODEWALD R, 1976, J CELL BIOL, V71, P666, DOI 10.1083/jcb.71.2.666; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Schnulle PM, 2003, VET IMMUNOL IMMUNOP, V91, P227, DOI 10.1016/S0165-2427(02)00294-5; SIMISTER NE, 1985, EUR J IMMUNOL, V15, P733, DOI 10.1002/eji.1830150718; Simister NE, 1996, EUR J IMMUNOL, V26, P1527, DOI 10.1002/eji.1830260718; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Stefaner I, 1999, J BIOL CHEM, V274, P8998, DOI 10.1074/jbc.274.13.8998; Telleman P, 2000, IMMUNOLOGY, V100, P245, DOI 10.1046/j.1365-2567.2000.00034.x; Tesar DB, 2006, TRAFFIC, V7, P1127, DOI 10.1111/j.1600-0854.2006.00457.x; Van de Perre P, 2003, VACCINE, V21, P3374, DOI 10.1016/S0264-410X(03)00336-0; Vaughn DE, 1998, STRUCTURE, V6, P63, DOI 10.1016/S0969-2126(98)00008-2; Waldmann T A, 1972, Ciba Found Symp, V9, P5; WALLACE KH, 1980, BIOCHEM J, V188, P9, DOI 10.1042/bj1880009; WATSON DL, 1980, AUST J BIOL SCI, V33, P403, DOI 10.1071/BI9800403; WEINER ML, 1988, FOOD CHEM TOXICOL, V26, P867, DOI 10.1016/0278-6915(88)90028-2; Wu Z, 2001, J BIOL CHEM, V276, P5240, DOI 10.1074/jbc.M006684200; Yu ZQ, 2006, DEV BIOL, V299, P122, DOI 10.1016/j.ydbio.2006.07.015; Zhang R, 2009, TRANSGENIC RES, V18, P445, DOI 10.1007/s11248-008-9241-0	65	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115972	10.1371/journal.pone.0115972	http://dx.doi.org/10.1371/journal.pone.0115972			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546424	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200087
J	Hoffmeister, M; Prelle, C; Kuchler, P; Kovacevic, I; Moser, M; Muller-Esterl, W; Oess, S				Hoffmeister, Meike; Prelle, Carola; Kuechler, Philipp; Kovacevic, Igor; Moser, Markus; Mueller-Esterl, Werner; Oess, Stefanie			The Ubiquitin E3 Ligase NOSIP Modulates Protein Phosphatase 2A Activity in Craniofacial Development	PLOS ONE			English	Article							INTERACTING PROTEIN; ERYTHROPOIETIN RECEPTOR; VENTRAL FOREBRAIN; OPITZ-SYNDROME; UBIQUITYLATION; SYNTHASE; IDENTIFICATION; MUTATIONS; MID1; GENE	Holoprosencephaly is a common developmental disorder in humans characterised by incomplete brain hemisphere separation and midface anomalies. The etiology of holoprosencephaly is heterogeneous with environmental and genetic causes, but for a majority of holoprosencephaly cases the genes associated with the pathogenesis could not be identified so far. Here we report the generation of knockout mice for the ubiquitin E3 ligase NOSIP. The loss of NOSIP in mice causes holoprosencephaly and facial anomalies including cleft lip/palate, cyclopia and facial midline clefting. By a mass spectrometry based protein interaction screen we identified NOSIP as a novel interaction partner of protein phosphatase PP2A. NOSIP mediates the monoubiquitination of the PP2A catalytic subunit and the loss of NOSIP results in an increase in PP2A activity in craniofacial tissue in NOSIP knockout mice. We conclude, that NOSIP is a critical modulator of brain and craniofacial development in mice and a candidate gene for holoprosencephaly in humans.	[Hoffmeister, Meike; Prelle, Carola; Kuechler, Philipp; Kovacevic, Igor; Mueller-Esterl, Werner; Oess, Stefanie] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60054 Frankfurt, Germany; [Moser, Markus] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany	Goethe University Frankfurt; Max Planck Society	Oess, S (corresponding author), Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60054 Frankfurt, Germany.	oess@biochem2.de		Kovacevic, Igor/0000-0003-1834-2378	German research foundation (DFG) [SFB 834 A3]; Adolf Messer Foundation	German research foundation (DFG)(German Research Foundation (DFG)); Adolf Messer Foundation	This work was supported by the German research foundation (DFG http://www.dfg.de) grant number SFB 834 A3 and by the Adolf Messer Foundation (http://www.adolf-messer-stiftung.de) to SO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batut J, 2008, DEVELOPMENT, V135, P2927, DOI 10.1242/dev.020842; Bengtsson L, 2009, J CELL SCI, V122, P1248, DOI 10.1242/jcs.039552; Brautigan DL, 2012, FEBS J; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Chu JH, 2005, DEVELOPMENT, V132, P5539, DOI 10.1242/dev.02157; Collison A, 2013, NATURE MED; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; Dedio J, 2001, FASEB J, V15, P79, DOI 10.1096/fj.00-0078com; Dreyer J, 2004, J NEUROSCI, V24, P10454, DOI 10.1523/JNEUROSCI.2265-04.2004; Dreyer J, 2003, NEUROSCI LETT, V350, P13, DOI 10.1016/S0304-3940(03)00771-7; Du HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107428; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Fernandes M, 2007, DEVELOPMENT, V134, P3789, DOI 10.1242/dev.004325; Friedman AD, 2003, J BIOL CHEM, V278, P26851, DOI 10.1074/jbc.M210039200; Fulda S, 2012, EMBO MOL MED, V4, P545, DOI 10.1002/emmm.201100707; Geng X, 2008, DEV CELL, V15, P236, DOI 10.1016/j.devcel.2008.07.003; Geng X, 2009, J CLIN INVEST, V119, P1403, DOI 10.1172/JCI38937; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Huang PL, 2000, J AM SOC NEPHROL, V11, pS120; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Jia H, 2009, DEVELOPMENT, V136, P307, DOI 10.1242/dev.030015; Konig P, 2005, J HISTOCHEM CYTOCHEM, V53, P155, DOI 10.1369/jhc.4A6453.2005; Konig P, 2002, GASTROENTEROLOGY, V123, P314, DOI 10.1053/gast.2002.34212; Krauss S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007471; Lancioni A, 2010, J NEUROSCI, V30, P2880, DOI 10.1523/JNEUROSCI.4196-09.2010; Latta EJ, 2012, MECH DEVELOP, V128, P560, DOI 10.1016/j.mod.2012.01.002; McConnell JL, 2010, BIOCHEMISTRY-US, V49, P1713, DOI 10.1021/bi901837h; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Nagy V, 2010, BIOL CHEM, V391, P163, DOI 10.1515/bc.2010.021; Oess S, 2006, BIOCHEM J, V396, P401, DOI 10.1042/BJ20060321; Oshikawa K, 2012, J PROTEOME RES, V11, P796, DOI 10.1021/pr200668y; Pineda-Alvarez DE, 2012, HUM GENET, V131, P301, DOI 10.1007/s00439-011-1078-6; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Roessler E, 2010, AM J MED GENET C, V154C, P52, DOI 10.1002/ajmg.c.30236; Sadowski M, 2012, IUBMB LIFE, V64, P136, DOI 10.1002/iub.589; Schleicher M, 2005, MOL CELL BIOL, V25, P8251, DOI 10.1128/MCB.25.18.8251-8258.2005; Sents W, 2013, FEBS J, V280, P644, DOI 10.1111/j.1742-4658.2012.08579.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Slupe Andrew M, 2011, Enzyme Res, V2011, P398751, DOI 10.4061/2011/398751; Su Y, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001747; Taniguchi K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002524; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Udeshi ND, 2013, NAT PROTOC, V8, P1950, DOI 10.1038/nprot.2013.120; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Viallet J, 2003, BIOCHIMIE, V85, P753, DOI 10.1016/J.biochi.2003.09.009; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Volpe P, 2009, PRENATAL DIAG, V29, P340, DOI 10.1002/pd.2208; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; Watkins GR, 2012, J BIOL CHEM, V287, P24207, DOI 10.1074/jbc.M112.368613; Wiszniak S, 2013, DEV BIOL, V383, P186, DOI 10.1016/j.ydbio.2013.09.024; Yu XB, 2002, DEVELOPMENT, V129, P505; Yu XW, 2012, J MOL HISTOL, V43, P661, DOI 10.1007/s10735-012-9460-9; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005; Zhang W, 2011, DIS MODEL MECH, V4, P368, DOI 10.1242/dmm.005744; Zou WG, 2011, NAT CELL BIOL, V13, P59, DOI 10.1038/ncb2134	64	12	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e0116150	10.1371/journal.pone.0116150	http://dx.doi.org/10.1371/journal.pone.0116150			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546391	Green Published, gold, Green Submitted			2022-12-26	WOS:000347120200101
J	Lundbo, LF; Clausen, LN; Weis, N; Schonning, K; Rosenorn, L; Benfield, T; Christensen, PB				Lundbo, Lene Fogt; Clausen, Louise Nygaard; Weis, Nina; Schonning, Kristian; Rosenorn, Lene; Benfield, Thomas; Christensen, Peer Brehm			Influence of Hepatitis C Virus and IL28B Genotypes on Liver Stiffness	PLOS ONE			English	Article							GENETIC-VARIATION; VIRAL LOAD; TRANSIENT ELASTOGRAPHY; SPONTANEOUS CLEARANCE; FIBROSIS PROGRESSION; ANTIVIRAL TREATMENT; HEMOPHILIC PATIENTS; INFECTED PATIENTS; NATURAL-HISTORY; HCV	Objective: Liver fibrosis has been associated with hepatitis C virus (HCV) genotype and genetic variation near the interleukin 28B (IL28B) gene, but the relative contribution is unknown. We aimed to investigate the relation between HCV genotypes, IL28B and development of liver stiffness. Patients and Methods: This cross-sectional study consists of 369 patients with chronic hepatitis C (CHC). Liver stiffness was evaluated using transient elastograhy (TE). Factors associated with development of liver fibrosis were identified by logistic regression analysis. Results: We identified 369 patients with CHC. 235 were male, 297 Caucasians, and 223 had been exposed to HCV through intravenous drug use. The overall median TE value was 7.4 kPa (interquartile range (IQR) 5.7-12.1). HCV replication was enhanced in patients carrying the IL28B CC genotype compared to TT and TC (5.8 vs. 5.4 log(10) IU/mL, p=0.03). Patients infected with HCV genotype 3 had significantly higher TE values (8.2 kPa; IQR, 5.9-14.5) compared to genotype 1 (6.9 kPa; IQR, 5.4-10.9) and 2 (6.7 kPa; IQR, 4.9-8.8) (p=0.02). Within patients with genotype 3, IL28B CC genotype had the highest TE values (p=0.04). However, in multivariate logistic regression, using various cut-off values for fibrosis and cirrhosis, only increasing age (odds ratio (OR) 1.09 (95% confidence interval (CI), 1.05-1.14 per year increment)), ALT (OR 1.01 (95% CI, 1.002-1.011), per unit increment) and HCV genotype 3 compared to genotype 1 (OR 2.40 (95% CI, 1.19-.81), were consistently associated with cirrhosis (TE> 17.1 kPa). Conclusions: Age, ALT and infection with HCV genotype 3 were associated with cirrhosis assessed by TE. However, IL28B genotype was not an independent predictor of fibrosis in our study.	[Lundbo, Lene Fogt; Clausen, Louise Nygaard; Weis, Nina; Rosenorn, Lene; Benfield, Thomas] Univ Copenhagen, Hvidovre Hosp, Dept Infect Dis, Copenhagen, Denmark; [Lundbo, Lene Fogt; Clausen, Louise Nygaard; Benfield, Thomas] Univ Copenhagen, Hvidovre Hosp, Clin Res Ctr, Copenhagen, Denmark; [Lundbo, Lene Fogt; Clausen, Louise Nygaard; Weis, Nina; Schonning, Kristian; Benfield, Thomas] Univ Copenhagen, Dept Clin Med, Fac Hlth & Med Sci, Copenhagen, Denmark; [Schonning, Kristian] Univ Copenhagen, Hvidovre Hosp, Dept Clin Microbiol, Copenhagen, Denmark; [Christensen, Peer Brehm] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Lundbo, LF (corresponding author), Univ Copenhagen, Hvidovre Hosp, Dept Infect Dis, Copenhagen, Denmark.	lene.lundbo@gmail.com	Christensen, Peer B./B-8042-2015; Weis, Nina/GLT-4232-2022	Weis, Nina/0000-0002-3133-2724; Benfield, Thomas/0000-0003-0698-9385; Christensen, Peer Brehm/0000-0003-1394-058X; Fogt Lundbo, Lene/0000-0001-8595-859X	Preben and Anna Simonsen's Foundation; Danish Agency for Science, Technology and Innovation [12127717]	Preben and Anna Simonsen's Foundation; Danish Agency for Science, Technology and Innovation	The IL28B genotyping was supported by Preben and Anna Simonsen's Foundation. The Danish Agency for Science, Technology and Innovation supported 50% redeeming from clinical work to research for Nina Weis (grant no 12127717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Ahmed MM, 1999, HAEMOPHILIA, V5, P49; Asselah T, 2006, GUT, V55, P123, DOI 10.1136/gut.2005.069757; Barreiro P, 2006, CLIN INFECT DIS, V42, P1032, DOI 10.1086/501021; Barreiro P, 2011, J INFECT DIS, V203, P1629, DOI 10.1093/infdis/jir113; Bochud PY, 2009, J HEPATOL, V51, P655, DOI 10.1016/j.jhep.2009.05.016; Bruno S, 2007, HEPATOLOGY, V46, P1350, DOI 10.1002/hep.21826; Cai T, 2011, J HEPATOL, V55, P529, DOI 10.1016/j.jhep.2010.12.020; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Clausen LN, 2012, AIDS, V26, P1509, DOI 10.1097/QAD.0b013e3283553581; Clausen LN, 2011, SCAND J INFECT DIS, V43, P798, DOI 10.3109/00365548.2011.589077; Degos F, 2010, J HEPATOL, V53, P1013, DOI 10.1016/j.jhep.2010.05.035; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hansen N, 2009, J VIRAL HEPATITIS, V16, P659, DOI 10.1111/j.1365-2893.2009.01126.x; Krarup HB, 1998, SCAND J CLIN LAB INV, V58, P415, DOI 10.1080/00365519850186391; Krarup HB, 2000, J VIRAL HEPATITIS, V7, P435, DOI 10.1046/j.1365-2893.2000.00258.x; Labarga P, 2011, AIDS, V25, P761, DOI 10.1097/QAD.0b013e32834488e7; Marabita F, 2011, HEPATOLOGY, V54, P1127, DOI 10.1002/hep.24503; McCarthy JJ, 2010, GASTROENTEROLOGY, V138, P2307, DOI 10.1053/j.gastro.2010.02.009; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Nijman IJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-95; Noureddin M, 2013, HEPATOLOGY, V58, P1548, DOI 10.1002/hep.26506; Petit JM, 2001, J HEPATOL, V35, P279, DOI 10.1016/S0168-8278(01)00143-X; Pittaluga F, 2008, J MED VIROL, V80, P254, DOI 10.1002/jmv.21073; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Probst A, 2011, J VIRAL HEPATITIS, V18, P745, DOI 10.1111/j.1365-2893.2011.01481.x; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rembeck K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029370; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Sabin CA, 1997, J INFECT DIS, V175, P164, DOI 10.1093/infdis/175.1.164; Tapper EB, 2012, CLIN GASTROENTEROL H, V10, P932, DOI 10.1016/j.cgh.2012.01.015; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Tillmann HL, 2011, J HEPATOL, V55, P1195, DOI 10.1016/j.jhep.2011.03.015; Westin J, 2002, J HEPATOL, V37, P837, DOI 10.1016/S0168-8278(02)00299-4; Westin J, 2007, J VIRAL HEPATITIS, V14, P29, DOI 10.1111/j.1365-2893.2006.00777.x; World Health Organization (WHO), HEP C; Ydreborg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080172; Yee TT, 2000, GUT, V47, P845, DOI 10.1136/gut.47.6.845; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	40	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115882	10.1371/journal.pone.0115882	http://dx.doi.org/10.1371/journal.pone.0115882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545640	Green Submitted, gold, Green Published			2022-12-26	WOS:000347120200078
J	Xie, Y; Hu, LX; Du, ZM; Sun, XY; Amombo, E; Fan, JB; Fu, JM				Xie, Yan; Hu, Longxing; Du, Zhimin; Sun, Xiaoyan; Amombo, Erick; Fan, Jibiao; Fu, Jinmin			Effects of Cadmium Exposure on Growth and Metabolic Profile of Bermudagrass [Cynodon dactylon (L.) Pers.]	PLOS ONE			English	Article							GAS-CHROMATOGRAPHY; CHLOROPHYLL FLUORESCENCE; PHRAGMITES-AUSTRALIS; SOLANUM-NIGRUM; HEAVY-METALS; AMINO-ACIDS; RICE PLANTS; TOXICITY; STRESS; ZINC	Metabolic responses to cadmium (Cd) may be associated with variations in Cd tolerance in plants. The objectives of this study were to examine changes in metabolic profiles in bermudagrass in response to Cd stress and to identify predominant metabolites associated with differential Cd tolerance using gas chromatography-mass spectrometry. Two genotypes of bermudagrass with contrasting Cd tolerance were exposed to 0 and 1.5 mM CdSO4 for 14 days in hydroponics. Physiological responses to Cd were evaluated by determining turf quality, growth rate, chlorophyll content and normalized relative transpiration. All these parameters exhibited higher tolerance in WB242 than in WB144. Cd treated WB144 transported more Cd to the shoot than in WB242. The metabolite analysis of leaf polar extracts revealed 39 Cd responsive metabolites in both genotypes, mainly consisting of amino acids, organic acids, sugars, fatty acids and others. A difference in the metabolic profiles was observed between the two bermudagrass genotypes exposed to Cd stress. Seven amino acids (norvaline, glycine, proline, serine, threonine, glutamic acid and gulonic acid), four organic acids (glyceric acid, oxoglutaric acid, citric acid and malic acid,) and three sugars (xylulose, galactose and talose) accumulated more in WB242 than WB144. However, compared to the control, WB144 accumulated higher quantities of sugars than WB242 in the Cd regime. The differential accumulation of these metabolites could be associated with the differential Cd tolerance in bermudagrass.	[Xie, Yan; Hu, Longxing; Du, Zhimin; Sun, Xiaoyan; Amombo, Erick; Fan, Jibiao; Fu, Jinmin] Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan Bot Garden, Wuhan, Hubei, Peoples R China; [Xie, Yan; Du, Zhimin; Sun, Xiaoyan; Fan, Jibiao] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Fu, JM (corresponding author), Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan Bot Garden, Wuhan, Hubei, Peoples R China.	jfu@wbgcas.cn	Amombo, Erick/P-2440-2019; Hu, Longxing/AAS-8287-2020	Du, Zhimin/0000-0002-3287-738X	Young Scientists Fund of the National Natural Science Foundation of China [31101563]; National Natural Science Foundation of China [31272194]; China-Africa Center for Research and Education, CAS [SAJC201325]	Young Scientists Fund of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China-Africa Center for Research and Education, CAS	This work was financially supported by the Young Scientists Fund of the National Natural Science Foundation of China (Grant No. 31101563), National Natural Science Foundation of China (Grant No. 31272194) and the China-Africa Center for Research and Education, CAS (SAJC201325). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 1999, ANAL BIOCHEM, V266, P77, DOI 10.1006/abio.1998.2906; Ali NA, 2002, PLANT SOIL, V239, P103, DOI 10.1023/A:1014995321560; [Anonymous], 1991, TURFGRASS MANAGEMENT; Archer MJG, 2004, WATER AIR SOIL POLL, V157, P257, DOI 10.1023/B:WATE.0000038900.66771.bf; Arthur E, 2000, INT J PHYTOREMEDIAT, V2, P1, DOI 10.1080/15226510008500027; Bailey NJC, 2003, PHYTOCHEMISTRY, V62, P851, DOI 10.1016/S0031-9422(02)00719-7; Baryla A, 2001, PLANTA, V212, P696, DOI 10.1007/s004250000439; BASSI R, 1993, ANN BOT-LONDON, V72, P151, DOI 10.1006/anbo.1993.1093; Bi XL, 2013, ENVIRON SCI TECHNOL, V47, P7593, DOI 10.1021/es402545j; Boddi B, 1995, PHOTOSYNTHETICA CZEC; Chaffei C, 2004, PLANT CELL PHYSIOL, V45, P1681, DOI 10.1093/pcp/pch192; Chen YX, 2003, CHEMOSPHERE, V50, P789, DOI 10.1016/S0045-6535(02)00220-5; Ciscato M, 1999, Z NATURFORSCH C, V54, P735; Costa G, 1997, PLANT SCI, V128, P131, DOI 10.1016/S0168-9452(97)00148-9; Das P, 1997, ENVIRON POLLUT, V98, P29, DOI 10.1016/S0269-7491(97)00110-3; Davidson C.M., 2013, HEAVY METALS SOILS, P97, DOI [10.1007/978-94-007-4470-7_4, DOI 10.1007/978-94-007-4470-7_4]; DAVIES BE, 1980, APPL SOIL TRACE ELEM; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Du HM, 2012, J AM SOC HORTIC SCI, V137, P411, DOI 10.21273/JASHS.137.6.411; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fu JM, 2003, J PLANT NUTR, V26, P81, DOI 10.1081/PLN-120016498; Gao Y, 2010, J HAZARD MATER, V181, P771, DOI 10.1016/j.jhazmat.2010.05.080; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Guy C, 2008, PHYSIOL PLANTARUM, V132, P220, DOI 10.1111/j.1399-3054.2007.00999.x; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; Hediji H, 2010, ECOTOX ENVIRON SAFE, V73, P1965, DOI 10.1016/j.ecoenv.2010.08.014; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Jamers A, 2013, AQUAT TOXICOL, V126, P355, DOI 10.1016/j.aquatox.2012.09.007; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kieffer P, 2008, PROTEOMICS, V8, P2514, DOI 10.1002/pmic.200701110; Kishor PBK, 2005, CURR SCI INDIA, V88, P424; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Kramer U, 1996, FREE HISTIDINE METAL; KRUPA Z, 1995, ACTA PHYSIOL PLANT, V17, P177; Larbi A, 2002, FUNCT PLANT BIOL, V29, P1453, DOI 10.1071/FP02090; Larsson EH, 1998, J EXP BOT, V49, P1031, DOI 10.1093/jexbot/49.323.1031; Lea PJ, 2007, ANN APPL BIOL, V150, P1, DOI 10.1111/j.1744-7348.2006.00104.x; Leita L, 1996, J PLANT NUTR, V19, P527, DOI 10.1080/01904169609365140; Madejon P, 2006, ENVIRON MONIT ASSESS, V114, P169, DOI 10.1007/s10661-006-2523-1; MOYA JL, 1995, J PLANT GROWTH REGUL, V14, P61, DOI 10.1007/BF00203115; NARAYAN VS, 1990, PHYTOCHEMISTRY, V29, P367, DOI 10.1016/0031-9422(90)85081-P; NISHIZONO H, 1989, PLANT CELL PHYSIOL, V30, P595, DOI 10.1093/oxfordjournals.pcp.a077780; PADMAJA K, 1990, PHOTOSYNTHETICA, V24, P399; Pietrini F, 2003, PLANT PHYSIOL, V133, P829, DOI 10.1104/pp.103.026518; Qiu Y, 2007, ANAL CHIM ACTA, V583, P277, DOI 10.1016/j.aca.2006.10.025; Quartacci MF, 2005, CHEMOSPHERE, V59, P1249, DOI 10.1016/j.chemosphere.2004.11.053; Rai VK, 2002, BIOL PLANTARUM, V45, P481, DOI 10.1023/A:1022308229759; RASCIO N, 1993, ARCH ENVIRON CON TOX, V25, P244, DOI 10.1007/BF00212136; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Salt DE, 1999, ENVIRON SCI TECHNOL, V33, P713, DOI 10.1021/es980825x; Sanita di Toppi L, 1999, ENVIRON EXP BOT, V41, P105, DOI 10.1016/S0098-8472(98)00058-6; Sarret G, 2002, PLANT PHYSIOL, V130, P1815, DOI 10.1104/pp.007799; Shah K, 1998, BIOL PLANTARUM, V40, P121, DOI 10.1023/A:1000956803911; Sheen J, 1999, CURR OPIN PLANT BIOL, V2, P410, DOI 10.1016/S1369-5266(99)00014-X; Shulaev V, 2008, PHYSIOL PLANTARUM, V132, P199, DOI 10.1111/j.1399-3054.2007.01025.x; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; SMIRNOFF N, 1987, NEW PHYTOL, V107, P671, DOI 10.1111/j.1469-8137.1987.tb00905.x; SRINIVAS V, 1995, LANGMUIR, V11, P2830, DOI 10.1021/la00007a077; Vasquez-Robinet C, 2008, J EXP BOT, V59, P2109, DOI 10.1093/jxb/ern073; Vassilev A, 1997, PHOTOSYNTHETICA, V34, P293, DOI 10.1023/A:1006805010560; Verkleij J., 1990, MECH METAL TOLERANCE; Vetter J, 2000, TOXICON, V38, P11, DOI 10.1016/S0041-0101(99)00128-2; Wagner GJ, 1993, ADV AGRONOMY, V51; Wagner GJ, 1993, ADV AGRONOMY; Wu FB, 2005, CHEMOSPHERE, V60, P1437, DOI 10.1016/j.chemosphere.2005.01.071; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xie Y., 2014, EMERGING MEMORY TECH, P1; Xu J, 2012, NEW PHYTOL, V196, P110, DOI 10.1111/j.1469-8137.2012.04235.x; Xu J, 2009, PLANT CELL REP, V28, P325, DOI 10.1007/s00299-008-0643-5; Yu XZ, 2007, ARCH ENVIRON CON TOX, V52, P503, DOI 10.1007/s00244-006-0155-7; Zhou WB, 2005, PLANT SCI, V169, P737, DOI 10.1016/j.plantsci.2005.05.030	75	53	57	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115279	10.1371/journal.pone.0115279	http://dx.doi.org/10.1371/journal.pone.0115279			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545719	gold, Green Published, Green Submitted			2022-12-26	WOS:000347120200033
J	Ng, SK; Huang, YT; Lee, YC; Low, EL; Chiu, CH; Chen, SL; Mao, LC; Chang, MDT				Ng, Sim-Kun; Huang, Yu-Tsyr; Lee, Yuan-Chuan; Low, Ee-Ling; Chiu, Cheng-Hsun; Chen, Shiu-Ling; Mao, Liang-Chi; Chang, Margaret Dah-Tsyr			A Recombinant Horseshoe Crab Plasma Lectin Recognizes Specific Pathogen-Associated Molecular Patterns of Bacteria through Rhamnose	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; BINDING LECTINS; ANIMAL LECTINS; DEFICIENT MUTANT; DTDP-RHAMNOSE; LIPOPOLYSACCHARIDE; GENE; POLYSACCHARIDE; CORE; BIOSYNTHESIS	Horseshoe crab is an ancient marine arthropod that, in the absence of a vertebrate-like immune system, relies solely on innate immune responses by defense molecules found in hemolymph plasma and granular hemocytes for host defense. A plasma lectin isolated from the hemolymph of Taiwanese Tachypleus tridentatus recognizes bacteria and lipopolysaccharides (LPSs), yet its structure and mechanism of action remain unclear, largely because of limited availability of horseshoe crabs and the lack of a heterogeneous expression system. In this study, we have successfully expressed and purified a soluble and functional recombinant horseshoe crab plasma lectin (rHPL) in an Escherichia coli system. Interestingly, rHPL bound not only to bacteria and LPSs like the native HPL but also to selective medically important pathogens isolated from clinical specimens, such as Gram-negative Pseudomonas aeruginosa and Klebsiella pneumoniae and Gram-positive Streptococcus pneumoniae serotypes. The binding was demonstrated to occur through a specific molecular interaction with rhamnose in pathogen-associated molecular patterns (PAMPs) on the bacterial surface. Additionally, rHPL inhibited the growth of P. aeruginosa PAO1 in a concentration-dependent manner. The results suggest that a specific protein-glycan interaction between rHPL and rhamnosyl residue may further facilitate development of novel diagnostic and therapeutic strategies for microbial pathogens.	[Ng, Sim-Kun; Huang, Yu-Tsyr; Lee, Yuan-Chuan; Low, Ee-Ling; Chang, Margaret Dah-Tsyr] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Ng, Sim-Kun; Huang, Yu-Tsyr; Lee, Yuan-Chuan; Low, Ee-Ling; Chang, Margaret Dah-Tsyr] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Lee, Yuan-Chuan] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Chiu, Cheng-Hsun; Chen, Shiu-Ling] Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Hsien, Taiwan; [Mao, Liang-Chi] Simpson Biotech Co Ltd, Kuei Shan, Taoyuan County, Taiwan	National Tsing Hua University; National Tsing Hua University; Johns Hopkins University; Chang Gung Memorial Hospital	Chang, MDT (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan.	dtchang@life.nthu.edu.tw			National Science Council, Taiwan [NSC 100-2628-B-007-003-MY3]; Ministry of Science and Technology, Taiwan [MOST 103-2627-M-007-006]; Chang Gung Memorial Hospital-National Tsing Hua University Collaborative Project [101N2762E1]; Simpson Biotech Co.; Shen's Culture & Education Foundation (Apex Biotechnology Corporation, Taiwan)	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital-National Tsing Hua University Collaborative Project; Simpson Biotech Co.; Shen's Culture & Education Foundation (Apex Biotechnology Corporation, Taiwan)	Funding: This work was supported in part by grants from the National Science Council, Taiwan (NSC 100-2628-B-007-003-MY3), Ministry of Science and Technology, Taiwan (MOST 103-2627-M-007-006), Chang Gung Memorial Hospital-National Tsing Hua University Collaborative Project (101N2762E1), and Simpson Biotech Co. Sim-Kun Ng was supported by Shen's Culture & Education Foundation (Apex Biotechnology Corporation, Taiwan). The funding sources had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mawgoud AM, 2010, APPL MICROBIOL BIOT, V86, P1323, DOI 10.1007/s00253-010-2498-2; Bozue JA, 2005, MICROB PATHOGENESIS, V38, P1, DOI 10.1016/j.micpath.2004.10.001; Burrows LL, 1996, MOL MICROBIOL, V22, P481, DOI 10.1046/j.1365-2958.1996.1351503.x; Bystrova OV, 2006, FEMS IMMUNOL MED MIC, V46, P85, DOI 10.1111/j.1574-695X.2005.00004.x; Bystrova OV, 2002, EUR J BIOCHEM, V269, P2194, DOI 10.1046/j.1432-1033.2002.02875.x; Chen SC, 2001, J BIOL CHEM, V276, P9631, DOI 10.1074/jbc.M008414200; Chiang SL, 1999, INFECT IMMUN, V67, P976, DOI 10.1128/IAI.67.2.976-980.1999; Chiou ST, 2000, J BIOL CHEM, V275, P1630, DOI 10.1074/jbc.275.3.1630; Collins BE, 2004, CURR OPIN CHEM BIOL, V8, P617, DOI 10.1016/j.cbpa.2004.10.004; Eckstein TM, 1998, J BACTERIOL, V180, P5567, DOI 10.1128/JB.180.21.5567-5573.1998; FIEDLER F, 1984, ARCH MICROBIOL, V138, P321, DOI 10.1007/BF00410898; Fox JL, 2013, NAT BIOTECHNOL, V31, P379, DOI 10.1038/nbt.2572; Gasparini F, 2008, DEV COMP IMMUNOL, V32, P1177, DOI 10.1016/j.dci.2008.03.006; Gupta GS, 2012, ANIMAL LECTINS FORM; Heimburg-Molinaro Jamie, 2011, Curr Protoc Protein Sci, VChapter 12, DOI 10.1002/0471140864.ps1210s64; HOSONO M, 1993, BIOL PHARM BULL, V16, P239; Inamori K, 1999, J BIOL CHEM, V274, P3272, DOI 10.1074/jbc.274.6.3272; Iwanaga S., 1998, FRONT BIOSCI-LANDMRK, V3, P973; Jia WZ, 2010, FISH PHYSIOL BIOCHEM, V36, P451, DOI 10.1007/s10695-009-9315-9; Jiang WQ, 2004, J MAGN MAGN MATER, V283, P210, DOI 10.1016/j.jmmm.2004.05.022; JIANG XM, 1991, MOL MICROBIOL, V5, P695, DOI 10.1111/j.1365-2958.1991.tb00741.x; Kaltner H, 1998, ACTA ANAT, V161, P162; Kerr KG, 2009, J HOSP INFECT, V73, P338, DOI 10.1016/j.jhin.2009.04.020; Kilpatrick DC, 2002, BBA-GEN SUBJECTS, V1572, P187, DOI 10.1016/S0304-4165(02)00308-2; Kjaer TR, 2013, INFECT IMMUN, V81, P452, DOI 10.1128/IAI.01148-12; Kuo TH, 2006, BIOCHEM J, V393, P757, DOI 10.1042/BJ20051108; Li Q, 2000, MICROBIOL-UK, V146, P2291, DOI 10.1099/00221287-146-9-2291; Loris R, 2002, BBA-GEN SUBJECTS, V1572, P198, DOI 10.1016/S0304-4165(02)00309-4; Ma YF, 2001, ANTIMICROB AGENTS CH, V45, P1407, DOI 10.1128/AAC.45.5.1407-1416.2001; Matsuura M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00109; Muta T, 1996, CURR OPIN IMMUNOL, V8, P41, DOI 10.1016/S0952-7915(96)80103-8; Naganuma T, 2006, MOL DIVERS, V10, P607, DOI 10.1007/s11030-006-9051-3; Nitta K, 2007, YAKUGAKU ZASSHI, V127, P553, DOI 10.1248/yakushi.127.553; OZEKI Y, 1991, BIOCHEMISTRY-US, V30, P2391, DOI 10.1021/bi00223a014; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Raman R, 2005, NAT METHODS, V2, P817, DOI 10.1038/NMETH807; Rautemaa R, 1999, MICROBES INFECT, V1, P785, DOI 10.1016/S1286-4579(99)80081-1; Rocchetta HL, 1999, MICROBIOL MOL BIOL R, V63, P523, DOI 10.1128/MMBR.63.3.523-553.1999; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sadovskaya I, 1998, EUR J BIOCHEM, V255, P673, DOI 10.1046/j.1432-1327.1998.2550673.x; Shirai T, 2009, J MOL BIOL, V391, P390, DOI 10.1016/j.jmb.2009.06.027; Spectral Diagnostics, 2008, ANN REP LEAD BATTL S; Sugihara R, 2000, IMMUNOPHARMACOLOGY, V49, P325, DOI 10.1016/S0162-3109(00)00247-2; Tateno H, 2002, DEV COMP IMMUNOL, V26, P543, DOI 10.1016/S0145-305X(02)00007-1; Tateno H, 2001, BIOSCI BIOTECH BIOCH, V65, P1328, DOI 10.1271/bbb.65.1328; Tateno H, 1998, J BIOL CHEM, V273, P19190, DOI 10.1074/jbc.273.30.19190; Terada T, 2007, BBA-GEN SUBJECTS, V1770, P617, DOI 10.1016/j.bbagen.2006.11.003; Vasta G.R., 1996, Progress in Molecular and Subcellular Biology, V17, P158; VASTA GR, 1994, ANN NY ACAD SCI, V712, P55, DOI 10.1111/j.1749-6632.1994.tb33562.x; Watanabe Y, 2009, DEV COMP IMMUNOL, V33, P187, DOI 10.1016/j.dci.2008.08.008; Watanabe Y, 2008, DEV COMP IMMUNOL, V32, P487, DOI 10.1016/j.dci.2007.08.007; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Xia XH, 2000, SYST BIOL, V49, P87, DOI 10.1080/10635150050207401; YADOMAE T, 1979, CARBOHYD RES, V75, P191, DOI 10.1016/S0008-6215(00)84638-8; Yamashita Y, 1999, INFECT IMMUN, V67, P3693, DOI 10.1128/IAI.67.7.3693-3697.1999; Yang SY, 2008, J MAGN MAGN MATER, V320, P2688, DOI 10.1016/j.jmmm.2008.05.048	56	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115296	10.1371/journal.pone.0115296	http://dx.doi.org/10.1371/journal.pone.0115296			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541995	gold, Green Submitted, Green Published			2022-12-26	WOS:000347239900033
J	Ren, AX; Moon, C; Zhang, WQ; Sinha, C; Yarlagadda, S; Arora, K; Wang, XS; Yue, JM; Parthasarathi, K; Heil-Chapdelaine, R; Tigyi, G; Naren, AP				Ren, Aixia; Moon, Changsuk; Zhang, Weiqiang; Sinha, Chandrima; Yarlagadda, Sunitha; Arora, Kavisha; Wang, Xusheng; Yue, Junming; Parthasarathi, Kaushik; Heil-Chapdelaine, Rick; Tigyi, Gabor; Naren, Anjaparavanda P.			Asymmetrical Macromolecular Complex Formation of Lysophosphatidic Acid Receptor 2 (LPA(2)) Mediates Gradient Sensing in Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING EVENTS; LIVING CELLS; G-PROTEIN; PHOSPHOLIPASE-C; LEADING-EDGE; CHEMOTAXIS; DICTYOSTELIUM; MOBILITY; MIGRATION; POLARIZATION	Chemotactic migration of fibroblasts toward growth factors relies on their capacity to sense minute extracellular gradients and respond to spatially confined receptor-mediated signals. Currently, mechanisms underlying the gradient sensing of fibroblasts remain poorly understood. Using single-particle tracking methodology, we determined that a lysophosphatidic acid (LPA) gradient induces a spatiotemporally restricted decrease in the mobility of LPA receptor 2 (LPA(2)) on chemotactic fibroblasts. The onset of decreased LPA(2) mobility correlates to the spatial recruitment and coupling to LPA(2)-interacting proteins that anchor the complex to the cytoskeleton. These localized PDZ motif-mediated macromolecular complexes of LPA(2) trigger a Ca2+ puff gradient that governs gradient sensing and directional migration in response to LPA. Disruption of the PDZ motif-mediated assembly of the macromolecular complex of LPA(2) disorganizes the gradient of Ca2+ puffs, disrupts gradient sensing, and reduces the directional migration of fibroblasts toward LPA. Our findings illustrate that the asymmetric macromolecular complex formation of chemoattractant receptors mediates gradient sensing and provides a new mechanistic basis for models to describe gradient sensing of fibroblasts.	[Ren, Aixia; Moon, Changsuk; Zhang, Weiqiang; Sinha, Chandrima; Yarlagadda, Sunitha; Arora, Kavisha; Yue, Junming; Parthasarathi, Kaushik; Tigyi, Gabor; Naren, Anjaparavanda P.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Moon, Changsuk; Yarlagadda, Sunitha; Arora, Kavisha; Naren, Anjaparavanda P.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Dept Pediat, Cincinnati, OH 45229 USA; [Zhang, Weiqiang] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Memphis, TN 38103 USA; [Wang, Xusheng] St Jude Childrens Res Hosp, Dept Struct Biol & Dev Neurobiol, Memphis, TN 38105 USA; [Heil-Chapdelaine, Rick] Olympus Amer Inc, Center Valley, PA 18034 USA	University of Tennessee System; University of Tennessee Health Science Center; Cincinnati Children's Hospital Medical Center; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; Olympus Corporation	Naren, AP (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Dept Pediat, MLC2120 3333 Burnet Ave, Cincinnati, OH 45229 USA.	anaren@cchmc.org			National Institutes of Health [DK080834, DK093045, CA092160]; NATIONAL CANCER INSTITUTE [R01CA092160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080834, R01DK093045] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK080834 and DK093045 (to A. P. N.) and CA092160 (to G. T.).	Ali GS, 2007, PLANT CELL PHYSIOL, V48, P1601, DOI 10.1093/pcp/pcm132; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; BRUNDAGE RA, 1991, SCIENCE, V254, P703, DOI 10.1126/science.1948048; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cha I, 2010, MOL CELLS, V30, P563, DOI 10.1007/s10059-010-0153-5; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; de Keijzer S, 2008, J CELL SCI, V121, P1750, DOI 10.1242/jcs.030692; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; E SY, 2009, J BIOL CHEM, V284, P14558, DOI 10.1074/jbc.M900185200; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Hasegawa Y, 2008, MOL ONCOL, V2, P54, DOI 10.1016/j.molonc.2008.03.009; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Heringdorf DMZ, 2004, J CELL BIOCHEM, V92, P937, DOI 10.1002/jcb.20107; HILDEBRANDT JP, 1995, J MEMBRANE BIOL, V144, P49; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Janetopoulos C, 2004, P NATL ACAD SCI USA, V101, P8951, DOI 10.1073/pnas.0402152101; Jasuja R, 1999, P NATL ACAD SCI USA, V96, P11346, DOI 10.1073/pnas.96.20.11346; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Lee SJ, 2013, MOL CELL BIOL, V33, P2016, DOI 10.1128/MCB.00038-13; Lee SJ, 2011, GASTROENTEROLOGY, V140, P924, DOI 10.1053/j.gastro.2010.11.054; Lee-Kwon W, 2005, AM J PHYSIOL-CELL PH, V288, pC942, DOI 10.1152/ajpcell.00417.2004; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Lin FT, 2008, BBA-MOL CELL BIOL L, V1781, P558, DOI 10.1016/j.bbalip.2008.04.013; Loovers HM, 2006, MOL BIOL CELL, V17, P1503, DOI 10.1091/mbc.E05-09-0825; Marchant JS, 2001, EMBO J, V20, P65, DOI 10.1093/emboj/20.1.65; Mouneimne G, 2004, J CELL BIOL, V166, P697, DOI 10.1083/jcb.200405156; Oh YS, 2004, MOL CELL BIOL, V24, P5069, DOI 10.1128/MCB.24.11.5069-5079.2004; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Plested AJR, 2009, J NEUROSCI, V29, P11912, DOI 10.1523/JNEUROSCI.2971-09.2009; Postma M, 2004, EMBO REP, V5, P35, DOI 10.1038/sj.embor.7400051; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rubin H., 2002, J BIOL CHEM, V277; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schaaf MJM, 2003, MOL CELL BIOL, V23, P1922, DOI 10.1128/MCB.23.6.1922-1934.2003; Schwarz-Romond T, 2010, EMBO J, V29, P2675, DOI 10.1038/emboj.2010.185; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shenolikar S, 2001, AM J PHYSIOL-RENAL, V280, pF389, DOI 10.1152/ajprenal.2001.280.3.F389; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; Sinha C, 2013, J BIOL CHEM, V288, P3786, DOI 10.1074/jbc.M112.435925; Stossel TP, 2006, J CELL SCI, V119, P3261, DOI 10.1242/jcs.02994; SWANSON JA, 1982, CELL, V28, P225, DOI 10.1016/0092-8674(82)90340-3; Theisen CS, 2007, MOL BIOL CELL, V18, P1220, DOI 10.1091/mbc.E06-10-0960; Ueda M, 2001, SCIENCE, V294, P864, DOI 10.1126/science.1063951; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; von Philipsborn A, 2007, INT REV CYTOL, V263, P1, DOI 10.1016/S0074-7696(07)63001-0; Wang DA, 2001, J BIOL CHEM, V276, P49213, DOI 10.1074/jbc.M107301200; Wei CL, 2010, CAN J PHYSIOL PHARM, V88, P105, DOI 10.1139/Y09-118; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Wessels D, 2007, J CELL SCI, V120, P2517, DOI 10.1242/jcs.010876; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451; Xiao Z, 1997, J CELL BIOL, V139, P365, DOI 10.1083/jcb.139.2.365; Xu XH, 2005, MOL BIOL CELL, V16, P676, DOI 10.1091/mbc.E04-07-0544; Xu XH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000980; Xu XH, 2009, METHODS MOL BIOL, V571, P371, DOI 10.1007/978-1-60761-198-1_25	61	6	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35757	35769		10.1074/jbc.M114.595512	http://dx.doi.org/10.1074/jbc.M114.595512			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25542932	Green Published, hybrid			2022-12-26	WOS:000346897900008
J	Moreno, M; Ortega, F; Xifra, G; Ricart, W; Fernandez-Real, JM; Moreno-Navarrete, JM				Moreno, Maria; Ortega, Francisco; Xifra, Gemma; Ricart, Wifredo; Manuel Fernandez-Real, Jose; Maria Moreno-Navarrete, Jose			Cytosolic aconitase activity sustains adipogenic capacity of adipose tissue connecting iron metabolism and adipogenesis	FASEB JOURNAL			English	Article						adipocyte differentiation; knockdown; NADPH	MITOCHONDRIAL BIOGENESIS; INSULIN SENSITIVITY; REGULATORY PROTEIN-1; PPAR-GAMMA; OXIDATIVE STRESS; LIPID-METABOLISM; DIETARY IRON; RESISTANCE; MICE; ROSIGLITAZONE	To gain insight into the regulation of intracellular iron homeostasis in adipose tissue, we investigated the role of iron regulatory protein 1/cytosolic aconitase 1 (ACO1). ACO1 gene expression and activity increased in parallel to expression of adipogenic genes during differentiation of both murine 3T3-L1 cells and human preadipocytes. Lentiviral knockdown (KD) of Aco1 in 3T3-L1 preadipocytes led to diminished cytosolic aconitase activity and isocitrate dehydrogenase 1 (NADP(+)), soluble (Idh1) mRNA levels, decreased intracellular NADPH: NADP ratio, and impaired adipogenesis during adipocyte differentiation. In addition, Aco1 KD in fully differentiated 3T3-L1 adipocytes decreased lipogenic, Idh1, Adipoq, and Glut4 gene expression. A bidirectional cross-talk was found between intracellular iron levels and ACO1 gene expression and protein activity. Although iron in excess, known to increase reactive oxygen species production, and iron depletion both resulted in decreased ACO1 mRNA levels and activity, Aco1 KD led to reduced gene expression of transferrin receptor (Tfrc) and transferrin, disrupting intracellular iron uptake. In agreement with these findings, in 2 human independent cohorts (n = 85 and n = 38), ACO1 gene expression was positively associated with adipogenic markers in subcutaneous and visceral adipose tissue. ACO1 gene expression was also positively associated with the gene expression of TFRC while negatively linked to ferroportin (solute carrier family 40 (iron-regulated transporter), member 1) mRNA levels. Altogether, these results suggest that ACO1 activity is required for the normal adipogenic capacity of adipose tissue by connecting iron, energy metabolism, and adipogenesis.	[Maria Moreno-Navarrete, Jose] Inst Invest Biomed Girona, CIBEROBN CB06 03 010, Dept Endocrinol Diabetol & Nutr, Girona, Spain; Inst Salud Carlos III, Girona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Instituto de Salud Carlos III	Moreno-Navarrete, JM (corresponding author), Hosp Girona Dr Josep Trueta, Sect Diabet Endocrinol & Nutr, Carretera Franca S-N, Girona 17007, Spain.	jmoreno@idibgi.org	Ortega, Francisco José J/F-3883-2016; Fernández-Real, Jose Manuel/AGH-3599-2022; Moreno-Navarrete, José María/H-9772-2015; Moreno-Navarrete, José María/ABG-5548-2021	Ortega, Francisco José J/0000-0003-2111-769X; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Moreno-Navarrete, José María/0000-0002-2883-511X; Moreno-Navarrete, José María/0000-0002-2883-511X; Ricart, Wifredo/0000-0002-3452-9098	Instituto de Salud Carlos III (ISCIII; Girona, Spain) [FIS-PI11/00214, FIS-PI12/02631]	Instituto de Salud Carlos III (ISCIII; Girona, Spain)	The authors acknowledge the technical assistance of Isabel Alonso [Institut d'Investigacio Biomedica de Girona (IdIBGi)], Emili Loshuertos (IdIBGi), and Oscar Rovira (IdIBGi). This work was partially supported by Research Grants FIS-PI11/00214 and FIS-PI12/02631 from the Instituto de Salud Carlos III (ISCIII; Girona, Spain). CIBEROBN Fisiopatologia de la Obesidad y Nutricion is an initiative from the ISCIII.	Chen JQ, 2013, ANAL BIOCHEM, V442, P97, DOI 10.1016/j.ab.2013.07.022; Dongiovanni P, 2013, AM J PATHOL, V182, P2254, DOI 10.1016/j.ajpath.2013.02.019; Enguix N, 2013, MOL METAB, V2, P215, DOI 10.1016/j.molmet.2013.05.004; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Festa M, 2000, J BIOL CHEM, V275, P36708, DOI 10.1074/jbc.M004988200; Gabrielsen JS, 2012, J CLIN INVEST, V122, P3529, DOI 10.1172/JCI44421; Hsiao G, 2011, AM J PHYSIOL-ENDOC M, V300, pE164, DOI 10.1152/ajpendo.00219.2010; Juurinen L, 2008, J CLIN ENDOCR METAB, V93, P118, DOI 10.1210/jc.2007-1825; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Koh HJ, 2004, J BIOL CHEM, V279, P39968, DOI 10.1074/jbc.M402260200; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Liew YF, 2005, J NUTR, V135, P2151, DOI 10.1093/jn/135.9.2151; LUZZATTO L, 2001, METABOLIC MOL BASES, V3, P4517; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Moreno-Navarrete JM, 2014, DIABETOLOGIA, V57, P1957, DOI 10.1007/s00125-014-3298-5; Moreno-Navarrete JM, 2014, DIABETES CARE, V37, P1092, DOI 10.2337/dc13-1602; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Nam WS, 2012, BBA-MOL BASIS DIS, V1822, P1181, DOI 10.1016/j.bbadis.2012.04.003; Narahari J, 2000, J BIOL CHEM, V275, P16227, DOI 10.1074/jbc.M910450199; Nguyen U., 2011, NAT METHODS, V8, pv, DOI [10.1038/nmeth.f.353, DOI 10.1038/NMETH.F.353, 10.1038/NMETH.F.353]; Orr JS, 2014, DIABETES, V63, P421, DOI 10.2337/db13-0213; Ortega FJ, 2010, OBESITY, V18, P13, DOI 10.1038/oby.2009.202; PANTOPOULOS K, 1995, EMBO J, V14, P2917, DOI 10.1002/j.1460-2075.1995.tb07291.x; Popovic Z, 2007, FEBS J, V274, P3108, DOI 10.1111/j.1742-4658.2007.05843.x; Qatanani M, 2013, DIABETES, V62, P855, DOI 10.2337/db12-0399; Ranganathan G, 2006, J LIPID RES, V47, P2444, DOI 10.1194/jlr.M600248-JLR200; Rensvold JW, 2013, CELL REP, V3, P237, DOI 10.1016/j.celrep.2012.11.029; Rodriguez-Cuenca S, 2012, FASEB J, V26, P1835, DOI 10.1096/fj.11-193631; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Shechter I, 2003, J LIPID RES, V44, P2169, DOI 10.1194/jlr.M300285-JLR200; Tong WH, 2007, BIOMETALS, V20, P549, DOI 10.1007/s10534-006-9047-6; Volz K, 2008, CURR OPIN STRUC BIOL, V18, P106, DOI 10.1016/j.sbi.2007.12.010; Wang FF, 2013, P NATL ACAD SCI USA, V110, P18656, DOI 10.1073/pnas.1314863110; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Xu YZ, 2010, FASEB J, V24, P609, DOI 10.1096/fj.09-135731; ZHENG LM, 1992, ARCH BIOCHEM BIOPHYS, V299, P356, DOI 10.1016/0003-9861(92)90287-7	37	20	20	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1529	1539		10.1096/fj.14-258996	http://dx.doi.org/10.1096/fj.14-258996			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25550467	Bronze			2022-12-26	WOS:000354115000037
J	Chen, ZG; Kang, XJ; Wang, LP; Dong, HL; Wang, CX; Xiong, Z; Zhao, WL; Jia, CH; Lin, J; Zhang, W; Yuan, WP; Zhong, M; Du, HZ; Bai, XC				Chen, Zhenguo; Kang, Xiangjin; Wang, Liping; Dong, Heling; Wang, Caixia; Xiong, Zhi; Zhao, Wanlu; Jia, Chunhong; Lin, Jun; Zhang, Wen; Yuan, Weiping; Zhong, Mei; Du, Hongzi; Bai, Xiaochun			Rictor/mTORC2 Pathway in Oocytes Regulates Folliculogenesis, and Its Inactivation Causes Premature Ovarian Failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4-VINYLCYCLOHEXENE DIEPOXIDE; MICE REVEALS; ACTIVATION; RICTOR; MTOR; GROWTH; PHOSPHORYLATION; DISRUPTION; MECHANISMS; DELETION	Molecular basis of ovarian folliculogenesis and etiopathogenesis of premature ovarian failure (POF), a common cause of infertility in women, are not fully understood. Mechanistic target of rapamycin complex 2 (mTORC2) is emerging as a central regulator of cell metabolism, proliferation, and survival. However, its role in folliculogenesis and POF has not been reported. Here, we showed that the signaling activity of mTORC2 is inhibited in a 4-vinylcyclohexene diepoxide (VCD)-induced POE mouse model. Notably, mice with oocyte-specific ablation of Rector, a key component of mTORC2, demonstrated POF phenotypes, including massive follicular death, excessive loss of functional ovarian follicles, abnormal gonadal hormone secretion, and consequently, secondary subfertility in conditional knock-out (cKO) mice. Furthermore, reduced levels of Ser-473-phosphorylated Akt and Ser-253-phosphorylated Foxo3a and elevated pro-apoptotic proteins, Bad, Bax, and cleaved poly ADP-ribose polymerase (PARP), were observed in cKO mice, replicating the signaling alterations in 4-VCD-treated ovaries. These results indicate a critical role of the Rictor/mTORC2/Akt/Foxo3a pro-survival signaling axis in folliculogenesis. Interestingly, loss of maternal Rictor did not cause obvious developmental defects in embryos or placentas from cKO mice, suggesting that maternal Rictor is dispensable for preimplantation embryonic development. Our results collectively indicate key roles of Rictor/mTORC2 in folliculogenesis, follicle survival, and female fertility and support the utility of oocyte-specific Rictor knock-out mice as a novel model for POF.	[Chen, Zhenguo; Dong, Heling; Wang, Caixia; Xiong, Zhi; Zhao, Wanlu; Jia, Chunhong; Lin, Jun; Bai, Xiaochun] Southern Med Univ, Sch Basic Med Sci, Dept Cell Biol, State Key Lab Organ Failure Res, Guangzhou 510515, Guangdong, Peoples R China; [Kang, Xiangjin; Zhang, Wen; Du, Hongzi] Guangzhou Med Univ, Affiliated Hosp 3, Ctr Reprod Med, Key Lab Reprod Med Guangdong Prov,Key Lab Major O, Guangzhou 510150, Guangdong, Peoples R China; [Kang, Xiangjin; Zhang, Wen; Du, Hongzi] Guangdong Higher Educ Inst, Key Lab Reprod & Genet, Guangzhou 510150, Guangdong, Peoples R China; [Wang, Liping; Zhong, Mei] Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, Guangzhou 510515, Guangdong, Peoples R China; [Yuan, Weiping] Chinese Acad Med Sci, State Key Lab Expt Hematol, Inst Hematol, Blood Dis Hosp, Tianjin 300020, Peoples R China; [Yuan, Weiping] Peking Union Med Coll, Tianjin 300020, Peoples R China	Southern Medical University - China; Guangzhou Medical University; Southern Medical University - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Du, HZ (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Ctr Reprod Med, Key Lab Reprod Med Guangdong Prov,Key Lab Major O, Guangzhou 510150, Guangdong, Peoples R China.	dhz_gz@hotmail.com; baixc15@smu.edu.cn		Chen, Zhenguo/0000-0003-3280-5201; Bai, Xiaochun/0000-0001-9631-4781	State Key Development Program for Basic Research of China [2013CB945203]; National Natural Sciences Foundation of China [81270088, 81301848, U1301222, 31271271, 31401224]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1142]	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This study was supported by The State Key Development Program for Basic Research of China (Grant 2013CB945203), the National Natural Sciences Foundation of China (Grants 81270088, 81301848, U1301222, 31271271, and 31401224), and the Program for Changjiang Scholars and Innovative Research Team in University (Grant IRT1142).	Adhikari BN, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075072, 10.1371/journal.pone.0053810]; Adhikari D, 2010, HUM MOL GENET, V19, P397, DOI 10.1093/hmg/ddp483; Adhikari D, 2009, MOL HUM REPROD, V15, P765, DOI 10.1093/molehr/gap092; Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Bai XC, 2010, CELL MOL LIFE SCI, V67, P239, DOI 10.1007/s00018-009-0163-7; Chen ZG, 2010, BIOCHEM CELL BIOL, V88, P737, DOI 10.1139/O10-012; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; de Vries WN, 2004, DEVELOPMENT, V131, P4435, DOI 10.1242/dev.01316; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; Goswami D, 2005, HUM REPROD UPDATE, V11, P391, DOI 10.1093/humupd/dmi012; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hoyer PB, 2007, BIRTH DEFECTS RES B, V80, P113, DOI 10.1002/bdrb.20103; Hoyer PB, 2001, TOXICOL PATHOL, V29, P91, DOI 10.1080/019262301301418892; Hu XM, 2001, BIOL REPROD, V65, P87, DOI 10.1095/biolreprod65.1.87; Jagarlamudi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006186; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Keating AF, 2011, BIOL REPROD, V84, P743, DOI 10.1095/biolreprod.110.087650; Kim Jin Yeong, 2012, Clin Exp Reprod Med, V39, P10, DOI 10.5653/cerm.2012.39.1.10; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Latham KE, 1999, INT REV CYTOL, V193, P71; Latham KE, 2001, FRONT BIOSCI, V6, pD748, DOI 10.2741/Latham; Nelson LM, 2009, NEW ENGL J MED, V360, P606, DOI 10.1056/NEJMcp0808697; Rajareddy S, 2007, MOL ENDOCRINOL, V21, P2189, DOI 10.1210/me.2007-0172; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Reddy P, 2010, TRENDS ENDOCRIN MET, V21, P96, DOI 10.1016/j.tem.2009.10.001; Richards Joanne S, 2010, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-02062-9_1; Richards JS, 2010, J CLIN INVEST, V120, P963, DOI 10.1172/JCI41350; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shelling AN, 2010, REPRODUCTION, V140, P633, DOI 10.1530/REP-09-0567; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Sobinoff AP, 2012, TOXICOL SCI, V128, P258, DOI 10.1093/toxsci/kfs137; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Sun QY, 2008, BIOL REPROD, V79, P1014, DOI 10.1095/biolreprod.108.070409; Takai Y, 2003, ENDOCRINOLOGY, V144, P69, DOI 10.1210/en.2002-220814; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Tilly JL, 2001, NAT REV MOL CELL BIO, V2, P838, DOI 10.1038/35099086; Treins C, 2010, ONCOGENE, V29, P1003, DOI 10.1038/onc.2009.401; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zheng WJ, 2012, MOL CELL ENDOCRINOL, V356, P24, DOI 10.1016/j.mce.2011.05.027; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	44	47	53	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6387	6396		10.1074/jbc.M114.605261	http://dx.doi.org/10.1074/jbc.M114.605261			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25564616	hybrid, Green Published			2022-12-26	WOS:000350732500043
J	Zirpoli, H; Abdillahi, M; Quadri, N; Ananthakrishnan, R; Wang, LJ; Rosario, R; Zhu, ZB; Deckelbaum, RJ; Ramasamy, R				Zirpoli, Hylde; Abdillahi, Mariane; Quadri, Nosirudeen; Ananthakrishnan, Radha; Wang, Lingjie; Rosario, Rosa; Zhu, Zhengbin; Deckelbaum, Richard J.; Ramasamy, Ravichandran			Acute Administration of n-3 Rich Triglyceride Emulsions Provides Cardioprotection in Murine Models after Ischemia-Reperfusion	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; ACTIVATED RECEPTOR-GAMMA; FATTY-ACIDS; MYOCARDIAL-ISCHEMIA; FISH-OIL; INJURY; OMEGA-3-FATTY-ACIDS; EXPRESSION; AKT; MECHANISMS	Dietary n-3 fatty acids (FAs) may reduce cardiovascular disease risk. We questioned whether acute administration of n-3 rich triglyceride (TG) emulsions could preserve cardiac function and decrease injury after ischemia/reperfusion (I/R) insult. We used two different experimental models: in vivo, C57BL/6 mice were exposed to acute occlusion of the left anterior descending coronary artery (LAD), and ex-vivo, C57BL/6 murine hearts were perfused using Langendorff technique (LT). In the LAD model, mice treated with n-3 TG emulsion (1.5g/kg body weight), immediately after ischemia and 1h later during reperfusion, significantly reduced infarct size and maintained cardiac function (p<0.05). In the LT model, administration of n-3 TG emulsion (300mgTG/100ml) during reperfusion significantly improved functional recovery (p<0.05). In both models, lactate dehydrogenase (LDH) levels, as a marker of injury, were significantly reduced by n-3 TG emulsion. To investigate the mechanisms by which n-3 FAs protects hearts from I/R injury, we investigated changes in key pathways linked to cardioprotection. In the ex-vivo model, we showed that n-3 FAs increased phosphorylation of AKT and GSK3a proteins (p<0.05). Acute n-3 TG emulsion treatment also increased Bcl-2 protein level and reduced an autophagy marker, Beclin-1 (p<0.05). Additionally, cardioprotection by n-3 TG emulsion was linked to changes in PPAR. protein expression (p<0.05). Rosiglitazone and p-AKT inhibitor counteracted the positive effect of n-3 TG; GSK3 beta inhibitor plus n-3 TG significantly inhibited LDH release. We conclude that acute n-3 TG injection during reperfusion provides cardioprotection. This may prove to be a novel acute adjunctive reperfusion therapy after treating patients with myocardial infarction.	[Zirpoli, Hylde; Abdillahi, Mariane; Deckelbaum, Richard J.] Columbia Univ, Inst Human Nutr, Coll Phys & Surg, New York, NY 10032 USA; [Zirpoli, Hylde; Deckelbaum, Richard J.] Columbia Univ, Dept Pediat, Coll Phys & Surg, New York, NY 10027 USA; [Abdillahi, Mariane; Quadri, Nosirudeen; Ananthakrishnan, Radha; Wang, Lingjie; Rosario, Rosa; Zhu, Zhengbin; Ramasamy, Ravichandran] NYU, Sch Med, Dept Med, New York, NY USA	Columbia University; Columbia University; New York University	Deckelbaum, RJ (corresponding author), Columbia Univ, Inst Human Nutr, Coll Phys & Surg, New York, NY 10032 USA.	ramasr02@nyumc.org; rjd20@columbia.edu		Ramasamy, Ravichandran/0000-0002-3666-3346	NIH [AG026467, HL61783]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061783, P01HL060901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG026467] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding provided by NIH AG026467 and NIH HL61783. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahman M, 2005, CARDIOVASC RES, V65, P772, DOI 10.1016/j.cardiores.2004.12.008; Abdillahi M, 2012, AM J PHYSIOL-HEART C, V303, pH297, DOI 10.1152/ajpheart.00999.2011; Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; Aleshin A, 2008, AM J PHYSIOL-HEART C, V294, pH1823, DOI 10.1152/ajpheart.01210.2007; Barandon L, 2005, CIRC RES, V96, P1299, DOI 10.1161/01.RES.0000171895.06914.2c; Barros KV, 2013, CLIN NUTR, V32, P993, DOI 10.1016/j.clnu.2013.02.010; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Birnbaum Y, 2011, BASIC RES CARDIOL, V106, P431, DOI 10.1007/s00395-011-0162-3; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Buja LM, 2005, CARDIOVASC PATHOL, V14, P170, DOI 10.1016/j.carpath.2005.03.006; Caputo M, 2011, J CELL PHYSIOL, V226, P187, DOI 10.1002/jcp.22323; CASTILLO RL, 2013, CELL BIOCHEMISTRY AN, V32, P274, DOI DOI 10.1002/CBF.3012PMID:24166314; Chang CL, 2013, CURR OPIN LIPIDOL, V24, P345, DOI 10.1097/MOL.0b013e3283616364; Chanoit G, 2008, AM J PHYSIOL-HEART C, V295, pH1227, DOI 10.1152/ajpheart.00610.2008; Chen ZY, 2001, AM J PHYSIOL-HEART C, V280, pH2313, DOI 10.1152/ajpheart.2001.280.5.H2313; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Delgado-Lista J, 2012, BRIT J NUTR, V107, pS201, DOI 10.1017/S0007114512001596; Densupsoontorn N, 2007, LIPIDS, V42, P885, DOI 10.1007/s11745-007-3093-x; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; Filion KB, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-24; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; GAO JY, 2011, CIRC J, V75, P843; Griendling KK, 2003, CIRCULATION, V108, P1912, DOI 10.1161/01.CIR.0000093660.86242.BB; Hwang YYC, 2004, FASEB J, V18, P1192, DOI 10.1096/fj.03-1400com; Imahashi K, 2004, CIRC RES, V95, P734, DOI 10.1161/01.RES.0000143898.67182.4c; Juhaszova M, 2009, CIRC RES, V104, P1240, DOI 10.1161/CIRCRESAHA.109.197996; Jung UJ, 2008, AM J CLIN NUTR, V87, p2003S, DOI 10.1093/ajcn/87.6.2003S; Jung UJ, 2012, ARTERIOSCL THROM VAS, V32, P2929, DOI 10.1161/ATVBAHA.112.300188; Kilter H, 2009, DIABETES OBES METAB, V11, P1060, DOI 10.1111/j.1463-1326.2009.01097.x; Li JY, 2012, ANESTHESIOLOGY, V117, P836, DOI 10.1097/ALN.0b013e3182655e73; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Lou PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087205; Marczin N, 2003, ARCH BIOCHEM BIOPHYS, V420, P222, DOI 10.1016/j.abb.2003.08.037; McKenney JM, 2007, PHARMACOTHERAPY, V27, P715, DOI 10.1592/phco.27.5.715; Morrison A, 2011, AM J PHYSIOL-HEART C, V301, pH895, DOI 10.1152/ajpheart.00137.2011; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; Murphy E, 2005, EXPERT OPIN THER TAR, V9, P447, DOI 10.1517/14728222.9.3.447; Murphy E, 2004, J CLIN INVEST, V113, P1526, DOI 10.1172/JCI200421986; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Murphy E, 2007, ANNU REV PHYSIOL, V69, P51, DOI 10.1146/annurev.physiol.69.031905.163645; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qi KM, 2002, BIOCHEMISTRY-US, V41, P3119, DOI 10.1021/bi015770h; Rahman S, 2011, ANESTHESIOLOGY, V115, P242, DOI 10.1097/ALN.0b013e318223b8b9; Rauch B, 2010, CIRCULATION, V122, P2152, DOI 10.1161/CIRCULATIONAHA.110.948562; Rodrigo R, 2013, CLIN SCI, V124, P1, DOI 10.1042/CS20110663; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Simoens CM, 2008, AM J CLIN NUTR, V88, P282, DOI 10.1093/ajcn/88.2.282; Skulas-Ray AC, 2011, AM J CLIN NUTR, V93, P243, DOI 10.3945/ajcn.110.003871; Son NH, 2007, J CLIN INVEST, V117, P2791, DOI 10.1172/JCI30335; Son NHP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046549; Sugden M C, 2012, Curr Mol Pharmacol, V5, P224; Vacek TP, 2012, CELL BIOCHEM BIOPHYS, V62, P1, DOI 10.1007/s12013-011-9281-6; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Wang G, 2005, METABOLISM, V54, P590, DOI 10.1016/j.metabol.2004.11.017; Williams JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056233; Xu TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102292; Xu ZL, 2014, J MOL CELL CARDIOL, V66, P12, DOI 10.1016/j.yjmcc.2013.10.016; Xue BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045990; Zhu Y, 2013, CELL PHYSIOL BIOCHEM, V32, P663, DOI 10.1159/000354470	60	13	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e0116274	10.1371/journal.pone.0116274	http://dx.doi.org/10.1371/journal.pone.0116274			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559887	Green Published, Green Submitted, gold			2022-12-26	WOS:000348102200014
J	Hazewindus, M; Haenen, GRMM; Weseler, AR; Bast, A				Hazewindus, Merel; Haenen, Guido R. M. M.; Weseler, Antje R.; Bast, Aalt			Protection against Chemotaxis in the Anti-Inflammatory Effect of Bioactives from Tomato Ketchup	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; ALPHA-TOCOPHEROL; GENE-EXPRESSION; MEDITERRANEAN DIET; ENDOTHELIAL-CELLS; VITAMIN-C; LYCOPENE; PREVENTION; ATHEROSCLEROSIS	The consumption of tomato products has been associated with a decreased risk for chronic inflammatory diseases. In this study, the anti-inflammatory potential of tomato ketchup was evaluated by studying the effect of tomato ketchup extracts and bioactives from tomato ketchup on human monocytes and vascular endothelial cells (HUVEC). HUVEC were pre-treated for 1 h with either individual bioactives (7.5 mu M lycopene, 1.4 mu M alpha-tocopherol or 55 mu M ascorbic acid) or a combination of these three compounds, or with the hydrophilic or lipophilic tomato ketchup extracts or with the two extracts combined. After the pretreatment, the cells were washed and challenged with TNF-alpha (10 ng/ml) for 6 h. The medium was used for the determination of the release of cytokines and the chemotaxis of monocytes. Inflammatory protein expression and production were assayed with real-time RT-PCR and ELISA. It was found that tomato ketchup extracts significantly reduced gene expression and release of the pro-inflammatory cytokines TNF-alpha and IL-8 in HUVEC after the inflammatory challenge, whereas the release of the anti-inflammatory cytokine IL-10 was increased. Chemotaxis was effectively impeded as demonstrated by a reduced monocyte migration. This effect correlated with the reduction of IL-8 production in the presence of the test compounds and extracts. The results consistently emphasize the contribution of lycopene to the anti-inflammatory effect of tomato ketchup. Other compounds in tomato ketchup such as a-tocopherol and ascorbic acid appeared to strengthen the anti-inflammatory effect of lycopene. The tomato ketchup extracts subtly interfered with several inflammatory phases that inhibit chemotaxis. Such a pleotropic mode of action exemplifies its potential mitigation of diseases characterized by prolonged low grade inflammation.	[Hazewindus, Merel; Haenen, Guido R. M. M.; Weseler, Antje R.; Bast, Aalt] Maastricht Univ, Dept Toxicol, Fac Hlth Med & Life Sci, Maastricht, Netherlands	Maastricht University	Haenen, GRMM (corresponding author), Maastricht Univ, Dept Toxicol, Fac Hlth Med & Life Sci, Maastricht, Netherlands.	g.haenen@maastrichtuniversity.nl	Bast, Aalt/I-7809-2013	Haenen, Guido/0000-0001-6986-290X; Bast, Aalt/0000-0002-5383-2789	Maastricht University	Maastricht University	The funding of the study was primarily from Maastricht University. All people that contributed to the study were employed directly by Maastricht University. H.J. Heinz Company also had no role in the study design, the data collection and analysis, decision to publish, or preparation of the manuscript. The funding of H.J. Heinz Company was used to pay the salary of Merel Hazewindus and as bench fee for chemicals and equipment. In addition, H.J. Heinz Company provided the tomato ketchup.	Agarwal Anita, 2001, J Med Food, V4, P9, DOI 10.1089/10966200152053668; Bast A, 2013, TRENDS PHARMACOL SCI, V34, P430, DOI 10.1016/j.tips.2013.05.010; Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132; Blum A, 2007, CLIN INVEST MED, V30, pE70; Bose KSC, 2007, ANN NUTR METAB, V51, P477, DOI 10.1159/000111170; Canene-Adams K, 2005, J NUTR, V135, P1226, DOI 10.1093/jn/135.5.1226; Carcamo JM, 2002, BIOCHEMISTRY-US, V41, P12995, DOI 10.1021/bi0263210; Cascio G, 2012, CURR DIABETES REV, V8, P2, DOI 10.2174/157339912798829241; Christman JW, 2000, BRAIN PATHOL, V10, P153; Denton CP, 1998, CLIN EXP IMMUNOL, V114, P293; Di Tomo P, 2012, MOL NUTR FOOD RES, V56, P217, DOI 10.1002/mnfr.201100500; Djuric Z, 2001, INT J FOOD SCI NUTR, V52, P143, DOI 10.1080/713671775; Ellinger S, 2009, AKTUEL UROL, V40, P37, DOI 10.1055/s-2008-1077031; Engelmann NJ, 2011, ADV NUTR, V2, P51, DOI 10.3945/an.110.000075; Erl W, 1997, AM J PHYSIOL, P634; Esfahani A, 2011, J AM COLL NUTR, V30, P285, DOI 10.1080/07315724.2011.10719971; Feng D, 2010, INFLAMM RES, V59, P115, DOI 10.1007/s00011-009-0077-8; Frusciante L, 2007, MOL NUTR FOOD RES, V51, P609, DOI 10.1002/mnfr.200600158; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Geraets L, 2007, EUR J PHARMACOL, V573, P241, DOI 10.1016/j.ejphar.2007.07.013; Gil A, 2011, PUBLIC HEALTH NUTR, V14, P2316, DOI 10.1017/S1368980011002576; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hazewindus M, 2012, FOOD CHEM, V132, P954, DOI 10.1016/j.foodchem.2011.11.075; Hung CF, 2008, EUR J PHARMACOL, V586, P275, DOI 10.1016/j.ejphar.2008.03.001; Jacob K, 2008, BRIT J NUTR, V99, P137, DOI 10.1017/S0007114507791894; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucier G, 2000, FACTORS AFFECTING TO, P282; Mackinnon ES, 2009, J MED FOOD, V12, P829, DOI 10.1089/jmf.2008.0118; Markovits N, 2009, ISR MED ASSOC J, V11, P598; Martin J, 2007, CURR PHARM DESIGN, V13, P1751, DOI 10.2174/138161207780831248; Minorsky PV, 2002, PLANT PHYSIOL, V130, P1077, DOI 10.1104/pp.900054; NIKI E, 1987, ANN NY ACAD SCI, V498, P186, DOI 10.1111/j.1749-6632.1987.tb23761.x; Niki E, 1987, FREE RADIC BIOL MED; Palozza P, 2011, CURR MED CHEM, V18, P1846, DOI 10.2174/092986711795496845; Palozza P, 2010, CURR MED CHEM, V17, P2547, DOI 10.2174/092986710791556041; Palozza P, 2011, J NUTR BIOCHEM, V22, P259, DOI 10.1016/j.jnutbio.2010.02.003; Palozza P, 2010, ARCH BIOCHEM BIOPHYS, V504, P26, DOI 10.1016/j.abb.2010.06.031; PEREZ P, 1995, MOL CELL BIOL, V15, P3523; Rao AV, 2002, EXP BIOL MED, V227, P908, DOI 10.1177/153537020222701011; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Re R, 2003, EUR J CLIN NUTR, V57, P1545, DOI 10.1038/sj.ejcn.1601723; Riccardi G, 2004, CLIN NUTR, V23, P447, DOI 10.1016/j.clnu.2004.02.006; Riso P, 2006, J AGR FOOD CHEM, V54, P2563, DOI 10.1021/jf053033c; Roberts LJ, 2007, FREE RADICAL BIO MED, V43, P1388, DOI 10.1016/j.freeradbiomed.2007.06.019; Sanchez-Moreno C, 2006, J NUTR BIOCHEM, V17, P183, DOI 10.1016/j.jnutbio.2005.07.001; Simone RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019652; Singh U, 2004, ANN NY ACAD SCI, V1031, P195, DOI 10.1196/annals.1331.019; Soehnlein O, 2009, BLOOD, V114, P4613, DOI 10.1182/blood-2009-06-221630; van Haaften RIM, 2001, BIOCHEM BIOPH RES CO, V280, P631, DOI 10.1006/bbrc.2000.4174; Wang Y, 2011, DEV GROWTH DIFFER, V53, P495, DOI 10.1111/j.1440-169X.2011.01265.x; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Weisburger JH, 1999, FOOD CHEM TOXICOL, V37, P943, DOI 10.1016/S0278-6915(99)00086-1; Yang YY, 2004, ATHEROSCLEROSIS, V174, P207, DOI 10.1016/j.atherosclerosis.2004.01.024	54	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114387	10.1371/journal.pone.0114387	http://dx.doi.org/10.1371/journal.pone.0114387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551565	gold, Green Published, Green Submitted			2022-12-26	WOS:000347119100011
J	Martin, C; Poudel-Tandukar, K; Poudel, KC				Martin, Catherine; Poudel-Tandukar, Kalpana; Poudel, Krishna C.			HIV Symptom Burden and Anemia among HIV-Positive Individuals: Cross-Sectional Results of a Community-Based Positive Living with HIV (POLH) Study in Nepal	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; INJECTION-DRUG USERS; C-REACTIVE PROTEIN; INFECTED PATIENTS; TREATMENT OPTIONS; KATHMANDU VALLEY; PREGNANT-WOMEN; RISK-FACTORS; PREVALENCE	Background: Previous research has reported high rates of anemia in people living with HIV/AIDS (PLWHA) in hospital or tertiary care settings. The objective of this community-based study was to measure the prevalence of anemia and describe the risk factors, with a specific emphasis on HIV symptom burden, in PLWHA in the Kathmandu Valley, Nepal. Methods: We conducted a cross-sectional survey of 319 PLWHA residing in the Kathmandu Valley, Nepal. We recruited participants from five non-governmental organizations in the Kathmandu Valley. Descriptive statistics and multivariable logistic regression analyses were used. Results: Our study found a 55.8% prevalence of anemia in PLWHA in the Kathmandu Valley. The prevalence of anemia among the participants with first, second, third, and fourth quartiles of HIV symptom burden was 44.8%, 49.3%, 60.3%, and 69.6%, respectively. Compared to the participants with lowest level of HIV symptom burden, the participants with highest level of HIV symptom burden were more likely to have anemia (adjusted odds ratio=2.14; 95% confidence interval=1.07 to 4.30). Conclusion: Due to a high prevalence of anemia in a community-based sample of PLWHA, HIV patients should be counseled on their risk of developing anemia and encouraged to seek timely care for HIV symptoms.	[Martin, Catherine; Poudel-Tandukar, Kalpana; Poudel, Krishna C.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Publ Hlth, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Poudel, KC (corresponding author), Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Publ Hlth, Amherst, MA 01003 USA.	krishna@schoolph.umass.edu			Japan Society for the Promotion of Science, The Ministry of Education, Culture, Sports, Science and Technology, Japan [22790581]; Waseda University Grants for Special Research Projects, General Grant/Ippan Josei, Japan [2012A-101]; National Center for Global Health and Medicine, Japan [21A-2]	Japan Society for the Promotion of Science, The Ministry of Education, Culture, Sports, Science and Technology, Japan; Waseda University Grants for Special Research Projects, General Grant/Ippan Josei, Japan; National Center for Global Health and Medicine, Japan	This study was partially supported by the Grant-in-Aid for Young Scientists (B) (22790581), Japan Society for the Promotion of Science, The Ministry of Education, Culture, Sports, Science and Technology, Japan; Waseda University Grants for Special Research Projects, General Grant/Ippan Josei, Japan, (2012A-101); and by the Grant for Research on Global Health and Medicine (No. 21A-2) from the National Center for Global Health and Medicine, Japan. The funding agency had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Agrawal P K, 2012, Nepal Med Coll J, V14, P80; Amiya RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090959; Amiya RM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-677; Antelman G, 2000, J NUTR, V130, P1950, DOI 10.1093/jn/130.8.1950; Attili Suresh Venkata Satya, 2008, Turk J Haematol, V25, P13; Belperio PS, 2004, AM J MED, V116, P27, DOI 10.1016/j.amjmed.2003.12.010; Bhatta L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-604; Bucceri A, 1997, EUR J OBSTET GYN R B, V72, P169, DOI 10.1016/S0301-2115(97)02699-7; CDC, 2009, NHIS AD TOB US GLOSS; Claster S, 2002, J INFECT DIS, V185, pS105, DOI 10.1086/340202; Commision on AIDS in Asia, 2008, RED AIDS AS CRAFT EF; Curkendall SM, 2007, HIV MED, V8, P483, DOI 10.1111/j.1468-1293.2007.00500.x; Devleesschauwer B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002634; Dikshit Byomakesh, 2009, BMC Blood Disord, V9, P5, DOI 10.1186/1471-2326-9-5; Eluwa George I, 2012, BMC Clin Pharmacol, V12, P7, DOI 10.1186/1472-6904-12-7; GRAHAM NMH, 1993, J ACQ IMMUN DEF SYND, V6, P1258; HORSBURGH CR, 1991, NEW ENGL J MED, V324, P1332, DOI 10.1056/NEJM199105093241906; Huffam SE, 2007, HIV MED, V8, P465, DOI 10.1111/j.1468-1293.2007.00498.x; Justice AC, 2001, J CLIN EPIDEMIOL, V54, pS77, DOI 10.1016/S0895-4356(01)00449-8; Kasthuri A. S., 2006, Indian Journal of Sexually Transmitted Diseases, V27, P9; Khalili H, 2009, PHARMACOEPIDEM DR S, V18, P848, DOI 10.1002/pds.1793; Levine AM, 2001, J ACQ IMMUN DEF SYND, V26, P28, DOI 10.1097/00126334-200101010-00004; Lundgren JD, 2003, CLIN INFECT DIS, V37, pS297, DOI 10.1086/376909; Meda N, 1998, INT J GYNECOL OBSTET, V61, P65, DOI 10.1016/S0020-7292(98)00016-2; Meidani M, 2012, J RES MED SCI, V17, P138; Mildvan D, 2007, CURR MED RES OPIN, V23, P343, DOI 10.1185/030079906X162683; MIR N, 1989, EUR J HAEMATOL, V42, P339; MOHP, 2012, NEP COUNTR PROGR REP; MOHP, 1998, NEP MICR STAT SURV 1; MOHP New Era ICF International, 2012, 2011 NEP DEM HLTH SU; Moore RD, 1998, J ACQ IMMUN DEF SYND, V19, P29, DOI 10.1097/00042560-199809010-00004; MOORE RD, 1991, ARCH INTERN MED, V151, P981, DOI 10.1001/archinte.151.5.981; MORFELDTMANSON L, 1991, SCAND J INFECT DIS, V23, P443, DOI 10.3109/00365549109075092; Murdoch DR, 2004, AM J TROP MED HYG, V70, P670, DOI 10.4269/ajtmh.2004.70.670; NAIDES SJ, 1993, J INFECT DIS, V168, P101, DOI 10.1093/infdis/168.1.101; NCASC, 2009, NAT ANT THER GUID; Phe T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060206; Poudel KC, 2003, TROP MED INT HEALTH, V8, P933, DOI 10.1046/j.1365-3156.2003.01110.x; Poudel Krishna C, 2014, J Int Assoc Provid AIDS Care, V13, P277, DOI 10.1177/2325957413500989; Poudel KC, 2011, J HEALTH POPUL NUTR, V29, P191, DOI 10.3329/jhpn.v29i3.7866; Poudel KC, 2010, INT J DRUG POLICY, V21, P507, DOI 10.1016/j.drugpo.2010.03.006; Poudel KC, 2009, AIDS BEHAV, V13, P1143, DOI 10.1007/s10461-008-9454-5; Poudel-Tandukar K, 2014, BRAIN BEHAV IMMUN, V42, P89, DOI 10.1016/j.bbi.2014.06.004; Poudel-Tandukar K, 2013, AIDS RES HUM RETROV, V29, P528, DOI [10.1089/aid.2012.0120, 10.1089/AID.2012.0120]; Rajesh Radhakrishnan, 2011, Int J Risk Saf Med, V23, P171, DOI 10.3233/JRS-2011-0531; Ramezani A, 2008, IRANIAN J PATHOLOGY, V3, P125; Ramon R, 1999, T ROY SOC TROP MED H, V93, P419, DOI 10.1016/S0035-9203(99)90143-8; Semba RD, 2002, J ACQ IMMUN DEF SYND, V29, P142, DOI 10.1097/00042560-200202010-00005; Semba RD, 2001, J ACQ IMMUN DEF SYND, V26, P315, DOI 10.1097/00126334-200104010-00003; Semba RD, 2002, CLIN INFECT DIS, V34, P260, DOI 10.1086/338151; Shen YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073807; Srikanth BA, 2012, J ADV PHARM TECHNOL, V3, P62, DOI 10.4103/2231-4040.93557; Subbaraman R, 2009, INT J STD AIDS, V20, P489, DOI 10.1258/ijsa.2008.008370; Sullivan PS, 1998, BLOOD, V91, P301, DOI 10.1182/blood.V91.1.301.301_301_308; Thein Mya, 2011, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V10, P299; Van der Werf MJ, 2000, ADDICTION, V95, P383, DOI 10.1046/j.1360-0443.2000.9533839.x; Volberding P, 2000, CLIN THER, V22, P1004, DOI 10.1016/S0149-2918(00)80081-8; Volberding PA, 2004, CLIN INFECT DIS, V38, P1459, DOI 10.1086/383031; Wills Todd S, 2004, AIDS Read, V14, P305; Wills TS, 2004, AIDS READ, V14, P313; World Health Organization, 2011, SER FERR CONC ASS IR; ZON LI, 1987, BRIT J HAEMATOL, V66, P251, DOI 10.1111/j.1365-2141.1987.tb01307.x	62	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116263	10.1371/journal.pone.0116263	http://dx.doi.org/10.1371/journal.pone.0116263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551656	Green Published, gold			2022-12-26	WOS:000347119100117
J	Ratkiewicz, M; Matosiuk, M; Saveljev, AP; Sidorovich, V; Ozolins, J; Mannil, P; Balciauskas, L; Kojola, I; Okarma, H; Kowalczyk, R; Schmidt, K				Ratkiewicz, Miroslaw; Matosiuk, Maciej; Saveljev, Alexander P.; Sidorovich, Vadim; Ozolins, Janis; Maennil, Peep; Balciauskas, Linas; Kojola, Ilpo; Okarma, Henryk; Kowalczyk, Rafal; Schmidt, Krzysztof			Long-Range Gene Flow and the Effects of Climatic and Ecological Factors on Genetic Structuring in a Large, Solitary Carnivore: The Eurasian Lynx	PLOS ONE			English	Article							MITOCHONDRIAL-DNA PHYLOGEOGRAPHY; BIALOWIEZA PRIMEVAL FOREST; LIONS PUMA-CONCOLOR; POPULATION-STRUCTURE; BROWN BEARS; ROE DEER; COMPUTER-PROGRAM; GLACIAL REFUGIA; EUROPEAN LYNX; URSUS-ARCTOS	Due to their high mobility, large terrestrial predators are potentially capable of maintaining high connectivity, and therefore low genetic differentiation among populations. However, previous molecular studies have provided contradictory findings in relation to this. To elucidate patterns of genetic structure in large carnivores, we studied the genetic variability of the Eurasian lynx, Lynx lynx throughout north-eastern Europe using microsatellite, mitochondrial DNA control region and Y chromosome-linked markers. Using SAMOVA we found analogous patterns of genetic structure based on both mtDNA and microsatellites, which coincided with a relatively little evidence for male-biased dispersal. No polymorphism for the cytochrome b and ATP6 mtDNA genes and Y chromosomelinked markers were found. Lynx inhabiting a large area encompassing Finland, the Baltic countries and western Russia formed a single genetic unit, while some marginal populations were clearly divergent from others. The existence of a migration corridor was suggested to correspond with distribution of continuous forest cover. The lowest variability (in both markers) was found in lynx from Norway and Bialowieza Primeval Forest (BPF), which coincided with a recent demographic bottleneck (Norway) or high habitat fragmentation (BPF). The Carpathian population, being monomorphic for the control region, showed relatively high microsatellite diversity, suggesting the effect of a past bottleneck (e.g. during Last Glacial Maximum) on its present genetic composition. Genetic structuring for the mtDNA control region was best explained by latitude and snow cover depth. Microsatellite structuring correlated with the lynx's main prey, especially the proportion of red deer (Cervus elaphus) in its diet. Eurasian lynx are capable of maintaining panmictic populations across eastern Europe unless they are severely limited by habitat continuity or a reduction in numbers. Different correlations of mtDNA and microsatellite population divergence patterns with climatic and ecological factors may suggest separate selective pressures acting on males and females in this solitary carnivore.	[Ratkiewicz, Miroslaw; Matosiuk, Maciej] Univ Bialystok, Inst Biol, Bialystok, Poland; [Saveljev, Alexander P.] Russian Acad Sci, BM Zhitkov Russian Res Inst Game Management & Far, Kirov, Russia; [Sidorovich, Vadim] Natl Acad Sci, Ctr Biol Resources, Minsk, BELARUS; [Ozolins, Janis] Latvian State Forest Res Inst Silava, Salaspils, Latvia; [Maennil, Peep] Estonian Environm Agcy, Tartu, Estonia; [Balciauskas, Linas] Nat Res Ctr, Vilnius, Lithuania; [Kojola, Ilpo] Univ Oulu, Finnish Game & Fisheries Res Inst, Oulu Game & Fisheries Res, SF-90100 Oulu, Finland; [Okarma, Henryk] Polish Acad Sci, Inst Nat Conservat, Krakow, Poland; [Kowalczyk, Rafal; Schmidt, Krzysztof] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland	University of Bialystok; Russian Academy of Sciences; Russian Institute of Game Management & Fur Farming; National Academy of Sciences of Belarus (NASB); Scientific & Practical Center for Bioresources of the National Academy of Sciences of Belarus; Latvian State Forest Research Institute "Silava"; Nature Research Center - Lithuania; Natural Resources Institute Finland (Luke); University of Oulu; Polish Academy of Sciences; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences	Schmidt, K (corresponding author), Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland.	kschmidt@ibs.bialowieza.pl	Balciauskas, Linas/GRS-8910-2022; Okarma, Henryk/W-2050-2019; Saveljev, Alexander/AAF-1089-2019; Balčiauskas, Linas/ABE-2454-2021; Ratkiewicz, Mirosław/AAI-9035-2020; Schmidt, Krzysztof/L-6437-2013; Saveljev, Alexander P./A-4697-2014	Saveljev, Alexander/0000-0002-8103-5787; Balčiauskas, Linas/0000-0001-9672-5265; Ratkiewicz, Mirosław/0000-0003-2929-3612; Kowalczyk, Rafal/0000-0001-7264-2158; Schmidt, Krzysztof/0000-0002-9043-291X; Okarma, Henryk/0000-0002-8912-3546; Matosiuk, Maciej/0000-0001-9595-690X	Ministry of Science and Higher Education [NN304 142536]; European Commission [PIRSES-GA-2009-247652]; WWF Poland	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Commission(European CommissionEuropean Commission Joint Research Centre); WWF Poland	The study was financed by the Ministry of Science and Higher Education grant no: NN304 142536. Obtaining samples from Russia was possible with the European Commission's 7th Framework Programme, Marie Curie Actions project "Biodiversity of East-European and Siberian large mammals on the level of genetic variation of populations" (BIOGEAST), contract No. PIRSES-GA-2009-247652. Samples from Belarus were obtained with support of WWF Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CR, 2004, J MAMMAL, V85, P1207, DOI 10.1644/BEL-111.1; Anderson GS, 1997, LANDSCAPE ECOL, V12, P261, DOI 10.1023/A:1007933623979; Anderson M.J., 2003, DISTLM FORWARD FORTR; Anderson MJ, 2004, DISTLM V 5 FORTRAN C; [Anonymous], 2013, INS PESTS POT GLOB, DOI DOI 10.1016/B978-0-12-386895-4.00005-3; Barnett R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-70; Bednorz E, 2004, INT J CLIMATOL, V24, P591, DOI 10.1002/joc.1014; Biek R, 2006, BIOL LETT-UK, V2, P312, DOI 10.1098/rsbl.2005.0437; Castilho CS, 2011, MAMM BIOL, V76, P476, DOI 10.1016/j.mambio.2010.08.002; Cegelski CC, 2003, MOL ECOL, V12, P2907, DOI 10.1046/j.1365-294X.2003.01969.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Culver M, 2000, J HERED, V91, P186, DOI 10.1093/jhered/91.3.186; Czarnomska SD, 2013, CONSERV GENET, V14, P573, DOI 10.1007/s10592-013-0446-2; Davoli F, 2013, MAMM BIOL, V78, P118, DOI 10.1016/j.mambio.2012.06.003; Dojlida M, 2006, THESIS WARSZAWA U LI; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Fernandez N, 2012, BIOL CONSERV, V153, P134, DOI 10.1016/j.biocon.2012.04.013; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gugolz D, 2008, J ZOOL, V275, P201, DOI 10.1111/j.1469-7998.2008.00428.x; Hame T, 2001, REMOTE SENS ENVIRON, V77, P76, DOI 10.1016/S0034-4257(01)00195-X; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hell Pavel, 1996, Acta Scientiarum Naturalium Academiae Scientiarum Bohemicae Brno, V30, P64; Hellborg L, 2003, MOL ECOL, V12, P283, DOI 10.1046/j.1365-294X.2003.01702.x; Hellborg L, 2002, CONSERV GENET, V3, P97, DOI 10.1023/A:1015217723287; Henaux V, 2011, METHODS ECOL EVOL, V2, P489, DOI 10.1111/j.2041-210X.2011.00107.x; Holbrook JD, 2012, J MAMMAL, V93, P989, DOI 10.1644/11-MAMM-A-326.2; Huck M, 2011, ACTA THERIOL, V56, P91, DOI 10.1007/s13364-010-0006-9; Hundertmark KJ, 2002, MOL PHYLOGENET EVOL, V22, P375, DOI 10.1006/mpev.2001.1058; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Jedrzejewski W, 1996, ECOGRAPHY, V19, P122, DOI 10.1111/j.1600-0587.1996.tb00163.x; JEDRZEJEWSKI W, 1993, ACTA THERIOL, V38, P385; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Keis M, 2013, J BIOGEOGR, V40, P915, DOI 10.1111/jbi.12043; Kojola I, 2006, J MAMMAL, V87, P281, DOI 10.1644/05-MAMM-A-061R2.1; Kozlovskiy IS, 2003, LYNX REGIONAL FEATUR, P168; Kyle CJ, 2002, J MAMMAL, V83, P1141, DOI 10.1644/1545-1542(2002)083<1141:COPACP>2.0.CO;2; Linnell JDC, 2010, ENVIRON MANAGE, V45, P1142, DOI 10.1007/s00267-010-9455-9; Lorenc H, 2005, ATLAS CLIMTAE POLAND; Luo SJ, 2007, J HERED, V98, P400, DOI 10.1093/jhered/esm063; Mcrae BH, 2005, MOL ECOL, V14, P1965, DOI 10.1111/j.1365-294X.2005.02571.x; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Molinari-Jobin A, 2002, WILDLIFE BIOL, V8, P109, DOI 10.2981/wlb.2002.015; Musiani M, 2007, MOL ECOL, V16, P4149, DOI 10.1111/j.1365-294X.2007.03458.x; Niedzialkowska M, 2006, BIOL CONSERV, V133, P63, DOI 10.1016/j.biocon.2006.05.022; Nilsen EB, 2009, J ANIM ECOL, V78, P741, DOI 10.1111/j.1365-2656.2009.01547.x; Okarma H, 1997, ACTA THERIOL, V42, P203, DOI 10.4098/AT.arch.97-22; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Pilot M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-104; Podgorski T, 2008, ACTA THERIOL, V53, P97, DOI 10.1007/BF03194243; Pritchard JK, 2000, GENETICS, V155, P945; PULLIAINEN E, 1995, ACTA THERIOL, V40, P181, DOI 10.4098/AT.arch.95-19; Ratkiewicz M, 2012, ANIM CONSERV, V15, P603, DOI 10.1111/j.1469-1795.2012.00556.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Row JR, 2012, CONSERV GENET, V13, P1259, DOI 10.1007/s10592-012-0369-3; Rueness EK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093675; Saarma U, 2007, MOL ECOL, V16, P401, DOI 10.1111/j.1365-294X.2006.03130.x; Samelius G, 2012, J ZOOL, V286, P120, DOI 10.1111/j.1469-7998.2011.00857.x; Schmidt K, 2006, WILDLIFE SOC B, V34, P462, DOI 10.2193/0091-7648(2006)34[462:USSTCH]2.0.CO;2; Schmidt K, 1998, ACTA THERIOL, V43, P391, DOI 10.4098/AT.arch.98-50; Schmidt K, 2011, MAMMAL REV, V41, P112, DOI 10.1111/j.1365-2907.2010.00180.x; Schmidt K, 2009, CONSERV GENET, V10, P497, DOI 10.1007/s10592-008-9795-7; Schwartz MK, 2003, MOL ECOL, V12, P1807, DOI 10.1046/j.1365-294X.2003.01878.x; Schwartz MK, 2002, NATURE, V415, P520, DOI 10.1038/415520a; Sidorovich VE, 2006, ACTA THERIOL, V51, P265, DOI 10.1007/BF03192678; SMITH JLD, 1993, BEHAVIOUR, V124, P165, DOI 10.1163/156853993X00560; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Sommer RS, 2006, MAMMAL REV, V36, P251, DOI 10.1111/j.1365-2907.2006.00093.x; Stenseth NC, 2004, P NATL ACAD SCI USA, V101, P10632, DOI 10.1073/pnas.0308674101; Stronen AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076454; Sunde P, 1997, ACTA THERIOL, V42, P189, DOI 10.4098/AT.arch.97-21; Sunquist ME, 2002, WILD CATS WORLD; TABERLET P, 1995, CONSERV BIOL, V9, P1255, DOI 10.1046/j.1523-1739.1995.951255.x; Valdiosera CE, 2007, MOL ECOL, V16, P5140, DOI 10.1111/j.1365-294X.2007.03590.x; Valdmann H, 2005, ACTA THERIOL, V50, P521, DOI 10.1007/BF03192645; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; von Arx M., 2004, STATUS CONSERVATION; Waits L, 2000, MOL ECOL, V9, P421, DOI 10.1046/j.1365-294x.2000.00892.x; Wan QH, 2004, ELECTROPHORESIS, V25, P2165, DOI 10.1002/elps.200305922; WASER PM, 1983, Q REV BIOL, V58, P355, DOI 10.1086/413385; Wilson GA, 2003, GENETICS, V163, P1177; Yom-Tov Y, 2011, AMBIO, V40, P43, DOI 10.1007/s13280-010-0070-z	91	26	26	1	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115160	10.1371/journal.pone.0115160	http://dx.doi.org/10.1371/journal.pone.0115160			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551216	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100029
J	Yuan, C; Wu, VWC; Yip, SP; Kwong, DLW; Ying, M				Yuan, Chuang; Wu, Vincent W. C.; Yip, Shea Ping; Kwong, Dora L. W.; Ying, Michael			Predictors of the Extent of Carotid Atherosclerosis in Patients Treated with Radiotherapy for Nasopharyngeal Carcinoma	PLOS ONE			English	Article							STENOSIS; RISK; DEFINITION; STROKE	Objective: To determine the predictors of the extent of carotid atherosclerosis in patients treated with radiotherapy (RT) for nasopharyngeal carcinoma (NPC). Methods: The present study investigated 129 post-RT NPC patients. Carotid atherosclerotic parameters, such as carotid intima-media thickness, carotid arterial stiffness and carotid plaque burden (plaque score, the presence of plaque and >= 50% stenosis) were assessed using ultrasonography. The association between carotid atherosclerotic parameters and nine potential predictors, including age, gender, post-RT duration, radiation dose, chemotherapy, diabetes mellitus, hypertension, hypercholesterolemia, and smoking, were determined using multiple regression. The cutoff values of age, post-RT duration and number of cardiovascular risk factors for the presence of carotid plaque or >= 50% carotid stenosis were analyzed using receiver operating characteristic (ROC) curve analysis. Multiple testing was corrected using Benjamini-Hochberg false discovery rate. Results: Age, post-RT duration and number of cardiovascular risk factors were significantly associated with carotid plaque burden (corrected P value, P-cor<0.05). Age of 44.5 years (sensitivity=99.2% and specificity=50%, P-cor< 0.01) and post-RT duration of 8.5 years (sensitivity=75.7% and specificity=64.3%, P-cor < 0.001) were the cutoff values for detecting carotid plaque, while post-RT duration of 13.5 years (sensitivity=66.7% and specificity=71.6%, P-cor< 0.001) and 1.5 cardiovascular risk factors (sensitivity=40.7% and specificity=84.3%, P-cor< 0.05) were the cutoff values for screening >= 50% carotid stenosis. Conclusions: Age, post-RT duration and number of cardiovascular risk factors are significant predictors of carotid atherosclerosis in post-RT NPC patients. Post-RT NPC patients, who are at least 45 years old, with post-RT duration of 9 years or above, and/or have >= 2 cardiovascular risk factors, are more susceptible to carotid atherosclerosis.	[Yuan, Chuang; Wu, Vincent W. C.; Yip, Shea Ping; Ying, Michael] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China; [Kwong, Dora L. W.] Univ Hong Kong, Dept Clin Oncol, Pokfulam, Hong Kong, Peoples R China	Hong Kong Polytechnic University; University of Hong Kong	Ying, M (corresponding author), Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China.	htmying@polyu.edu.hk	; Yip, Shea Ping/A-1185-2016	Ying, Michael/0000-0001-5979-6072; Yip, Shea Ping/0000-0002-2170-8185; WU, Wing Cheung Vincent/0000-0002-1257-4154	Hong Kong Polytechnic University (RU2R)	Hong Kong Polytechnic University (RU2R)	This research was funded by a research studentship for CY from the Hong Kong Polytechnic University (RU2R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; AUTRET A, 1987, LANCET, V1, P888; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chang YJ, 2009, J VASC SURG, V50, P280, DOI 10.1016/j.jvs.2009.01.033; Ford ES, 2010, INT J CARDIOL, V140, P226, DOI 10.1016/j.ijcard.2008.11.033; Glastonbury Christine M, 2007, Top Magn Reson Imaging, V18, P225, DOI 10.1097/RMR.0b013e3181572b3a; Gujral DM, 2014, RADIOTHER ONCOL, V110, P31, DOI 10.1016/j.radonc.2013.08.009; Huang TL, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-261; Lam WMM, 2001, CANCER, V92, P2357, DOI 10.1002/1097-0142(20011101)92:9<2357::AID-CNCR1583>3.0.CO;2-K; Lam WWM, 2001, HEAD NECK-J SCI SPEC, V23, P780, DOI 10.1002/hed.1111.abs; Li CS, 2010, CLIN NEUROL NEUROSUR, V112, P682, DOI 10.1016/j.clineuro.2010.05.007; Matthews KA, 2001, STROKE, V32, P1104, DOI 10.1161/01.STR.32.5.1104; Muzaffar K, 2000, LARYNGOSCOPE, V110, P1811, DOI 10.1097/00005537-200011000-00007; Nadareishvili ZG, 2002, ARCH NEUROL-CHICAGO, V59, P1162, DOI 10.1001/archneur.59.7.1162; Yuan C, 2014, J DIABETES RES	17	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116284	10.1371/journal.pone.0116284	http://dx.doi.org/10.1371/journal.pone.0116284			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551559	Green Submitted, Green Published, gold			2022-12-26	WOS:000347119100122
J	Bacchetta, J; Chun, RF; Gales, B; Zaritsky, JJ; Leroy, S; Wesseling-Perry, K; Boregaard, N; Rastogi, A; Salusky, IB; Hewison, M				Bacchetta, Justine; Chun, Rene F.; Gales, Barbara; Zaritsky, Joshua J.; Leroy, Sandrine; Wesseling-Perry, Katherine; Boregaard, Niels; Rastogi, Anjay; Salusky, Isidro B.; Hewison, Martin			Antibacterial Responses by Peritoneal Macrophages Are Enhanced Following Vitamin D Supplementation	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SECONDARY HYPERPARATHYROIDISM; PARATHYROID-HORMONE; HYPOVITAMINOSIS-D; DIALYSIS PATIENTS; CAPD PATIENTS; D DEFICIENCY; CHILDREN; INFLAMMATION; METABOLISM	Patients with chronic kidney disease (CKD), who usually display low serum 25-hydroxyvitamin D (25D) and 1,25-dihydroxyvitamin D (1,25D), are at high risk of infection, notably those undergoing peritoneal dialysis (PD). We hypothesized that peritoneal macrophages from PD patients are an important target for vitamin D-induced antibacterial activity. Dialysate effluent fluid was obtained from 27 noninfected PD patients. Flow cytometry indicated that PD cells were mainly monocytic (37.9 +/- 17.7% cells CD14(+)/CD45(+)). Ex vivo analyses showed that PD cells treated with 25D (100 nM, 6 hrs) or 1,25D (5 nM, 6 hrs) induced mRNA for antibacterial cathelicidin (CAMP) but conversely suppressed mRNA for hepcidin (HAMP). PD cells from patients with peritonitis (n=3) showed higher baseline expression of CAMP (18-fold +/- 9, p<0.05) and HAMP (64-fold +/- 7) relative to cells from noninfected patients. In 12 non-infected PD patients, oral supplementation with a single dose of vitamin D-2 (100,000 IU) increased serum levels of 25D from 18 +/- 8 to 41 +/- 15 ng/ml (p=0.002). This had no significant effect on PD cell CD14/CD45 expression, but mRNA for HAMP was suppressed significantly (0.5-fold, p=0.04). Adjustment for PD cell CD14/CD45 expression using a mixed linear statistical model also revealed increased expression of CAMP (mRNA in PD cells and protein in effluent) in vitamin D-supplemented patients. These data show for the first time that vitamin D supplementation in vitro and in vivo promotes innate immune responses that may enhance macrophage antibacterial responses in patients undergoing PD. This highlights a potentially important function for vitamin D in preventing infection-related complications in CKD.	[Bacchetta, Justine; Chun, Rene F.; Hewison, Martin] Univ Calif Los Angeles, David Geffen Sch Med, Orthoped Hosp Res Ctr, Los Angeles, CA 90095 USA; [Bacchetta, Justine; Gales, Barbara; Zaritsky, Joshua J.; Wesseling-Perry, Katherine; Salusky, Isidro B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Bacchetta, Justine] Ecole Normale Super, Inst Genom Fonct, Ctr Reference Malad Renales Rares, Lyon, France; [Bacchetta, Justine] Univ Lyon, Lyon, France; [Leroy, Sandrine] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France; [Rastogi, Anjay] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Boregaard, Niels] Univ Copenhagen, Dept Hematol, Copenhagen, Denmark	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Copenhagen	Hewison, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Orthoped Hosp Res Ctr, Los Angeles, CA 90095 USA.	mhewison@mednet.ucla.edu	Chun, Rene/A-9415-2010; Leroy, Sandrine/I-9136-2014; Bacchetta, Justine/B-3842-2016	Chun, Rene/0000-0002-0190-0807; Leroy, Sandrine/0000-0002-2964-2002; Bacchetta, Justine/0000-0002-0578-2529	Academie Francaise/Jean Walter Zellidja; Reunion Pediatrique de la Region Rhone Alpes; Societe Francaise de Pediatrie/Evian; Fondation pour la Recherche Medicale; Philippe Foundation; National Institutes of Health [DK0911672]; USPHS [DK67563, DK35423, DK 80984]; CTSI [UL1TR000124]; Casey Lee Ball Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR063020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK080984, R01DK035423, R01DK067563] Funding Source: NIH RePORTER	Academie Francaise/Jean Walter Zellidja; Reunion Pediatrique de la Region Rhone Alpes; Societe Francaise de Pediatrie/Evian; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Philippe Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); CTSI; Casey Lee Ball Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by educational grants (Academie Francaise/Jean Walter Zellidja, Reunion Pediatrique de la Region Rhone Alpes, Societe Francaise de Pediatrie/Evian, Fondation pour la Recherche Medicale, Philippe Foundation, JB), by National Institutes of Health grants DK0911672 (MH), by USPHS grants DK67563 (IBS), DK35423 (IBS), DK 80984 (KWP), by CTSI grant UL1TR000124 (IBS) and funds from the Casey Lee Ball Foundation (IBS and KWP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736; Bacchetta J ZJ, 2013, J AM SOC NEPHROLOGY; Bacchetta J, 2013, J BONE MINER RES, V28, P46, DOI 10.1002/jbmr.1740; Bacchetta J, 2010, J CLIN ENDOCR METAB, V95, P1741, DOI 10.1210/jc.2009-1576; Belostotsky V, 2008, ARCH DIS CHILD, V93, P959, DOI 10.1136/adc.2007.134866; BETJES MGH, 1993, KIDNEY INT, V43, P641, DOI 10.1038/ki.1993.93; Bouts AHM, 2005, PEDIATR NEPHROL, V20, P1161, DOI 10.1007/s00467-005-1850-8; Brown AJ, 2007, NAT CLIN PRACT ENDOC, V3, P134, DOI 10.1038/ncpendmet0394; Chonchol M, 2011, ANN MED, V43, P273, DOI 10.3109/07853890.2010.543923; COWLAND JB, 1995, FEBS LETT, V368, P173, DOI 10.1016/0014-5793(95)00634-L; Dalrymple LS, 2008, CLIN J AM SOC NEPHRO, V3, P1487, DOI 10.2215/CJN.01290308; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Edfeldt K, 2010, P NATL ACAD SCI USA, V107, P22593, DOI 10.1073/pnas.1011624108; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Ganz T, 2009, CURR OPIN IMMUNOL, V21, P63, DOI 10.1016/j.coi.2009.01.011; GOLDSTEIN CS, 1986, J LEUKOCYTE BIOL, V39, P457, DOI 10.1002/jlb.39.4.457; GOLDSTEIN CS, 1984, KIDNEY INT, V26, P733, DOI 10.1038/ki.1984.209; Gombart AF, 2009, CLIN INFECT DIS; HAYES ME, 1987, FEBS LETT, V220, P307, DOI 10.1016/0014-5793(87)80836-0; Hewison M, 2011, NAT REV ENDOCRINOL, V7, P336, DOI 10.1038/nrendo.2010.226; Hewison M, 2010, MOL CELL ENDOCRINOL, V321, P103, DOI 10.1016/j.mce.2010.02.013; Holick MF, 2005, AM J KIDNEY DIS, V45, P1119, DOI 10.1053/j.ajkd.2005.04.015; KDOQI Work Group, 2009, Am J Kidney Dis, V53, pS11, DOI 10.1053/j.ajkd.2008.11.017; LEWIS S, 1991, PERITON DIALYSIS INT, V11, P14; Li M, 2009, KIDNEY INT, V76, P1219, DOI 10.1038/ki.2009.390; Li PKT, 2012, NAT REV NEPHROL, V8, P77, DOI 10.1038/nrneph.2011.194; Li YC, 2004, J STEROID BIOCHEM, V89-90, P387, DOI 10.1016/j.jsbmb.2004.03.004; Liberek T, 2002, PERITON DIALYSIS INT, V22, P663; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mehrotra R, 2008, CLIN J AM SOC NEPHRO, V3, P1144, DOI 10.2215/CJN.05781207; Mehrotra R, 2009, KIDNEY INT, V76, P977, DOI 10.1038/ki.2009.288; Menon S, 2008, PEDIATR NEPHROL, V23, P1831, DOI 10.1007/s00467-008-0842-x; Nessim SJ, 2011, SEMIN NEPHROL, V31, P199, DOI 10.1016/j.semnephrol.2011.01.008; Perez-Fontan M, 2006, PERITON DIALYSIS INT, V26, P174; PETERSON PK, 1985, INFECT IMMUN, V49, P212, DOI 10.1128/IAI.49.1.212-218.1985; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; SHANY S, 1991, KIDNEY INT, V39, P1005, DOI 10.1038/ki.1991.127; Shin DM, 2010, CELL MICROBIOL, V12, P1648, DOI 10.1111/j.1462-5822.2010.01497.x; Shroff R, 2012, CLIN J AM SOC NEPHRO, V7, P216, DOI 10.2215/CJN.04760511; Sorensen O, 1997, J IMMUNOL METHODS, V206, P53, DOI 10.1016/S0022-1759(97)00084-7; Stubbs JR, 2010, J AM SOC NEPHROL, V21, P353, DOI 10.1681/ASN.2009040451; Tjabringa GS, 2005, PULM PHARMACOL THER, V18, P321, DOI 10.1016/j.pupt.2005.01.001; VERBRUGH HA, 1983, J INFECT DIS, V147, P1018, DOI 10.1093/infdis/147.6.1018; Wesseling-Perry K, 2011, KIDNEY INT, V79, P112, DOI 10.1038/ki.2010.352; Wesseling-Perry K, 2009, CURR OPIN NEPHROL HY, V18, P308, DOI 10.1097/MNH.0b013e32832c7654; Zaritsky J, 2011, SEMIN NEPHROL, V31, P213, DOI 10.1016/j.semnephrol.2011.01.009; Zehnder D, 2008, KIDNEY INT, V74, P1343, DOI 10.1038/ki.2008.453; Zehnder D, 2007, NEPHRON CLIN PRACT, V107, pC109, DOI 10.1159/000108652	50	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116530	10.1371/journal.pone.0116530	http://dx.doi.org/10.1371/journal.pone.0116530			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549329	Green Submitted, Green Published, gold			2022-12-26	WOS:000347063500086
J	Oh, IH; Lee, JH; Park, DC; Kim, M; Chung, JH; Kim, SH; Yeo, SG				Oh, In-Hwan; Lee, Jong Hoon; Park, Dong Choon; Kim, MyungGu; Chung, Ji Hyun; Kim, Sang Hoon; Yeo, Seung Geun			Hearing Loss as a Function of Aging and Diabetes Mellitus: A Cross Sectional Study	PLOS ONE			English	Article							IMPAIRMENT; HYPERTENSION	Background: Although hearing loss may be caused by various factors, it is also a natural phenomenon associated with the aging process. This study was designed to assess the contributions of diabetes mellitus (DM) and hypertension, both chronic diseases associated with aging, as well as aging itself, to hearing loss in health screening examinees. Methods: This study included 37,773 individuals who underwent health screening examinations from 2009 to 2012. The relationships between hearing threshold and subject age, hearing threshold at each frequency based on age group, the degree of hearing loss and the presence or absence of hypertension and DM were evaluated. Results: The prevalence of hearing loss increased with age, being 1.6%, 1.8%, 4.6%, 14.0%, 30.8%, and 49.2% in subjects in their twenties, thirties, forties, fifties, sixties, and seventies, respectively (p<0.05). Hearing value per frequency showed aging-based changes, in the order of 6000, 4000, 2000, 1000 and 500 Hz, indicating greater hearing losses at high frequencies. The degree of hearing loss ranged from mild to severe. Aging and DM were correlated with the prevalence of hearing loss (p<0.05). There was no statistically significant association between hearing loss and hypertension after adjusting for age and DM. Conclusions: The prevalence of hearing loss increases with age and the presence of DM. Hearing loss was greatest at high frequencies. In all age groups, mild hearing loss was the most common form of hearing loss.	[Oh, In-Hwan] Kyung Hee Univ, Sch Med, Dept Prevent Med, Seoul, South Korea; [Lee, Jong Hoon] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Radiat Oncol, Suwon, South Korea; [Park, Dong Choon] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Obstet & Gynecol, Suwon, South Korea; [Kim, MyungGu] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Dept Otorhinolaryngol Head & Neck Surg, Chang Won, South Korea; [Chung, Ji Hyun; Kim, Sang Hoon; Yeo, Seung Geun] Kyung Hee Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Kyung Hee University; Catholic University of Korea; Catholic University of Korea; Sungkyunkwan University (SKKU); Samsung Medical Center; Kyung Hee University	Yeo, SG (corresponding author), Kyung Hee Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.	yeo2park@gmail.com	Oh, In Hwan/AAI-9070-2020	Oh, In Hwan/0000-0002-5450-9887	National Research Foundation of Korea (NRF) - Korea government(MSIP) [2011-0030072]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI 13C0729]	National Research Foundation of Korea (NRF) - Korea government(MSIP); Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government(MSIP) (No. 2011-0030072) and by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (Grant number HI 13C0729). URLs: http://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi-sso-return2=none and http://www.khidi.or.kr/www/run.do. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2013, INDIAN J OTOLARYNGOL, V65, pS614, DOI 10.1007/s12070-013-0630-1; [Anonymous], 2008, ASS HEAR ELD AG DEG; Bachor E, 2001, ACTA OTO-LARYNGOL, V121, P35; Bayazit Y, 2000, J NEUROL SCI, V181, P29, DOI 10.1016/S0022-510X(00)00400-7; Cohn ES, 1999, CLIN GERIATR MED, V15, P145; Dalton DS, 1998, DIABETES CARE, V21, P1540, DOI 10.2337/diacare.21.9.1540; Das T, 2001, J Indian Med Assoc, V99, P86; Das T, 2001, J INDIAN MED ASSOC, V84, P86; Davis A C, 1990, Acta Otolaryngol Suppl, V476, P23; de Leon-Morales LVD, 2005, ARCH MED RES, V36, P507, DOI 10.1016/j.arcmed.2005.02.002; de Moraes Marchiori Luciana Lozza, 2006, Braz J Otorhinolaryngol, V72, P533; deEspana R, 1995, ORL J OTO-RHINO-LARY, V57, P325, DOI 10.1159/000276774; Fransen E, 2003, EXP GERONTOL, V38, P353, DOI 10.1016/S0531-5565(03)00032-9; Frisina ST, 2006, HEARING RES, V211, P103, DOI 10.1016/j.heares.2005.09.002; GATES GA, 1993, ARCH OTOLARYNGOL, V119, P156; Huang Q, 2010, EUR ARCH OTO-RHINO-L, V267, P1179, DOI 10.1007/s00405-010-1270-7; Janssen GMC, 1999, J BIOL CHEM, V274, P29744, DOI 10.1074/jbc.274.42.29744; Kundu S, 2001, J INDIAN MED ASSOC, V99, P89; Kwon IS, 2007, J KOREAN MED ASSOC, V50, P208, DOI 10.5124/jkma.2007.50.3.208; Lim HW, 2011, J KOREAN MED ASSOC, V54, P910, DOI 10.5124/jkma.2011.54.9.910; Lisowska G, 2001, OTOL NEUROTOL, V22, P316, DOI 10.1097/00129492-200105000-00008; MOSCICKI EK, 1985, EAR HEARING, V6, P184, DOI 10.1097/00003446-198507000-00003; OHINATA Y, 1994, ACTA OTO-LARYNGOL, V114, P601, DOI 10.3109/00016489409126112; OSTERHAMMEL D, 1980, SCAND AUDIOL, V9, P13, DOI 10.3109/01050398009076329; Rarey KE, 1996, HEARING RES, V102, P63, DOI 10.1016/S0378-5955(96)00148-7; Rey JF, 2002, ACTA OTORRINOLAR ESP, V53, P572; ROSEN S, 1962, ANN OTO RHINOL LARYN, V71, P727, DOI 10.1177/000348946207100313; SIEGER A, 1983, ANN OTO RHINOL LARYN, V92, P237, DOI 10.1177/000348948309200305; Sugimoto S, 2013, ACTA OTO-LARYNGOL, V133, P1165, DOI 10.3109/00016489.2013.803599; Vaughan N, 2006, OTOL NEUROTOL, V27, P37, DOI 10.1097/01.mao.0000194812.69556.74; 김보형, 2006, [Korean Journal of Otorhinolaryngology Head and Neck Surgery, 대한이비인후과학회지 두경부외과학], V49, P962	31	28	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116161	10.1371/journal.pone.0116161	http://dx.doi.org/10.1371/journal.pone.0116161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549095	Green Published, gold, Green Submitted			2022-12-26	WOS:000347063500054
J	Guidolin, AS; Fresia, P; Consoli, FL				Guidolin, Aline S.; Fresia, Pablo; Consoli, Fernando L.			The Genetic Structure of an Invasive Pest, the Asian Citrus Psyllid Diaphorina citri (Hemiptera: Liviidae)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-GENETICS; CYTOCHROME-OXIDASE; BIOLOGY; CONSERVATION; PARASITOIDS; HYMENOPTERA; HOMOPTERA; SEQUENCES; HISTORY	The Asian citrus psyllid Diaphorina citri is currently the major threat to the citrus industry as it is the vector of Candidatus Liberibacter, the causal agent of huanglongbing disease (HLB). D. citri is native to Asia and now colonizes the Americas. Although it has been known in some countries for a long time, invasion routes remain undetermined. There are no efficient control methods for the HLB despite the intensive management tools currently in use. We investigated the genetic variability and structure of populations of D. citri to aid in the decision making processes toward sustainable management of this species/disease. We employed different methods to quantify and compare the genetic diversity and structure of D. citri populations among 36 localities in Brazil, using an almost complete sequence of the cytochrome oxidase I (COI) gene. Our analyses led to the identification of two geographically and genetically structured groups. The indices of molecular diversity pointed to a recent population expansion, and we discuss the role of multiple invasion events in this scenario. We also argue that such genetic diversity and population structure may have implications for the best management strategies to be adopted for controlling this psyllid and/or the disease it vectors in Brazil.	[Guidolin, Aline S.; Consoli, Fernando L.] Univ Sao Paulo, Lab Interacoes Insetos, Dept Entomol & Acarol, ESALQ, BR-13418900 Sao Paulo, Brazil; [Fresia, Pablo] Univ Sao Paulo, Lab Resistencia Artropodes Tat Controle, Dept Entomol & Acarol, ESALQ, BR-13418900 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Consoli, FL (corresponding author), Univ Sao Paulo, Lab Interacoes Insetos, Dept Entomol & Acarol, ESALQ, Av Padua Dias 11, BR-13418900 Sao Paulo, Brazil.	fconsoli@usp.br	Guidolin, Aline Sartori/K-6897-2019; FRESIA, pablo/AGF-5679-2022; Guidolin, Aline Sartori/A-1197-2013; Consoli, Fernando Luis/D-5706-2012	Guidolin, Aline Sartori/0000-0001-5521-9067; Guidolin, Aline Sartori/0000-0001-5521-9067; Consoli, Fernando Luis/0000-0002-2287-0782	CNPq; CAPES; Fundecitrus; MAPA/CNPq [2008-9/578797]; FAPESP [2010/50412-5]; Sao Paulo Research Foundation	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundecitrus; MAPA/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	ASG was a MSc fellow from CNPq. PFC was a post-doctoral fellow from CAPES. FLC received funding support from Fundecitrus, MAPA/CNPq (Grant # 2008-9/578797) and FAPESP (Grant # 2010/50412-5, Sao Paulo Research Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa Kenryo, 2007, Research Bulletin of the Plant Protection Service Japan, V43, P23; Ascunce MS, 2011, SCIENCE, V331, P1066, DOI 10.1126/science.1198734; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Ballard JWO, 2010, MOL ECOL, V19, P1523, DOI 10.1111/j.1365-294X.2010.04594.x; Ballard JWO, 2007, EVOLUTION, V61, P1735, DOI 10.1111/j.1558-5646.2007.00133.x; Barnabe C, 2000, PARASITOLOGY, V120, P513, DOI 10.1017/S0031182099005661; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Boina DR, 2009, ENVIRON ENTOMOL, V38, P1250, DOI 10.1603/022.038.0436; Bonani JP, 2010, ENTOMOL EXP APPL, V134, P35, DOI 10.1111/j.1570-7458.2009.00937.x; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Bove JM, 2006, J PLANT PATHOL, V88, P7; Boykin LM, 2012, B ENTOMOL RES, V17, P1; Carmichael LE, 2007, MOL ECOL, V16, P3466, DOI 10.1111/j.1365-294X.2007.03381.x; Chapman RE, 2001, ECOL LETT, V4, P650, DOI 10.1046/j.1461-0248.2001.00253.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CRANDALL KA, 1993, GENETICS, V134, P959; de Leon JH, 2011, ANN ENTOMOL SOC AM, V104, P1392, DOI 10.1603/AN11086; Donadio LC, 2005, CITROS, P3; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Fundecitrus, 2014, LEV; Guidolin AS, 2013, MICROB ECOL, V65, P475, DOI 10.1007/s00248-012-0150-7; Guillemaud T, 2011, CR BIOL, V334, P237, DOI 10.1016/j.crvi.2010.12.008; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; HARRISON RG, 1989, TRENDS ECOL EVOL, V4, P6, DOI 10.1016/0169-5347(89)90006-2; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jourdie V, 2010, MOL ECOL, V19, P2168, DOI 10.1111/j.1365-294X.2010.04625.x; Kobori Y, 2011, APPL ENTOMOL ZOOL, V46, P27, DOI 10.1007/s13355-010-0004-z; Lima A. M. da C, 1936, TERCEIRO CATALOGO IN; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lopes SA, 2007, EUR J PLANT PATHOL, V119, P463, DOI 10.1007/s10658-007-9173-1; Marsaro Jr AL, 2010, C BRAS ENT; McFarland CD, 2001, FLA ENTOMOL, V84, P227, DOI 10.2307/3496171; Meiklejohn CD, 2007, TRENDS GENET, V23, P259, DOI 10.1016/j.tig.2007.03.008; MORITZ C, 1994, MOL ECOL, V3, P401, DOI 10.1111/j.1365-294X.1994.tb00080.x; Nachman MW, 1998, GENETICA, V102-3, P61, DOI 10.1023/A:1017030708374; Nava DE, 2007, J APPL ENTOMOL, V131, P709, DOI 10.1111/j.1439-0418.2007.01230.x; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Pennings PS, 2011, J EVOLUTION BIOL, V24, P871, DOI 10.1111/j.1420-9101.2010.02223.x; Pichaud N, 2012, EVOLUTION, V66, P3189, DOI 10.1111/j.1558-5646.2012.01683.x; Pinho C, 2007, BIOL J LINN SOC, V91, P121, DOI 10.1111/j.1095-8312.2007.00774.x; Porretta D, 2007, J APPL ECOL, V44, P682, DOI 10.1111/j.1365-2664.2007.01301.x; Rand DM, 2004, TRENDS ECOL EVOL, V19, P645, DOI 10.1016/j.tree.2004.10.003; Remais JV, 2011, PLOS PATH, V7, P4; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Segelbacher G, 2010, CONSERV GENET, V11, P375, DOI 10.1007/s10592-009-0044-5; Shao R, 2007, PARASITOLOGY, V134, P153, DOI 10.1017/S0031182006001429; Silva A. G. A., 1968, QUARTO CATALOGO INSE, V1a; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Texeira DC, 2005, PLANT DIS, V89, P107, DOI 10.1094/PD-89-0107A; Tsai JH, 2000, J ECON ENTOMOL, V93, P1721, DOI 10.1603/0022-0493-93.6.1721; YAMAMOTO PT, 2009, BIOASSAY, V4, P9; Zayed A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000868; Zhang DX, 1997, INSECT MOL BIOL, V6, P143, DOI 10.1111/j.1365-2583.1997.tb00082.x	60	20	21	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115749	10.1371/journal.pone.0115749	http://dx.doi.org/10.1371/journal.pone.0115749			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545788	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200065
J	Nestola, P; Martins, DL; Peixoto, C; Roederstein, S; Schleuss, T; Alves, PM; Mota, JPB; Carrondo, MJT				Nestola, Piergiuseppe; Martins, Duarte L.; Peixoto, Cristina; Roederstein, Susanne; Schleuss, Tobias; Alves, Paula M.; Mota, Jose P. B.; Carrondo, Manuel J. T.			Evaluation of Novel Large Cut-Off Ultrafiltration Membranes for Adenovirus Serotype 5 (Ad5) Concentration	PLOS ONE			English	Article							TANGENTIAL FLOW FILTRATION; PURIFICATION PROCESS; RETROVIRAL VECTORS; ANION-EXCHANGE; VIRUS; CHROMATOGRAPHY; TECHNOLOGY; MICROFILTRATION; PARTICLES; RECOVERY	The purification of virus particles and viral vectors for vaccine and gene therapy applications is gaining increasing importance in order to deliver a fast, efficient, and reliable production process. Ultrafiltration (UF) is a widely employed unit operation in bioprocessing and its use is present in several steps of the downstream purification train of biopharmaceuticals. However, to date few studies have thoroughly investigated the performance of several membrane materials and cutoffs for virus concentration/diafiltration. The present study aimed at developing a novel class of UF cassettes for virus concentration/ diafiltration. A detailed study was conducted to evaluate the effects of (i) membrane materials, namely polyethersulfone (PES), regenerated cellulose (RC), and highly cross-linked RC (xRC), (ii) nominal cut-off, and (iii) UF device geometry at different production scales. The results indicate that the xRC cassettes with a cut-off of approximately 500 kDa are able to achieve a 10-fold concentration factor with 100% recovery of particles with a process time twice as fast as that of a commercially available hollow fiber. DNA and host cell protein clearances, as well as hydraulic permeability and fouling behavior, were also assessed.	[Nestola, Piergiuseppe; Martins, Duarte L.; Peixoto, Cristina; Alves, Paula M.; Mota, Jose P. B.; Carrondo, Manuel J. T.] Inst Biol Expt & Tecnol, P-2781901 Oeiras, Portugal; [Nestola, Piergiuseppe; Peixoto, Cristina; Alves, Paula M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal; [Mota, Jose P. B.] Univ Nova Lisboa, Requimte CQFB, Dept Quim, Fac Ciencias & Tecnol, P-2829516 Caparica, Portugal; [Carrondo, Manuel J. T.] Univ Nova Lisboa, Dept Quim, Fac Ciencias & Tecnol, P-2829516 Caparica, Portugal; [Roederstein, Susanne; Schleuss, Tobias] Sartorius Stedim Biotech, D-37079 Gottingen, Germany	Universidade Nova de Lisboa; Universidade Nova de Lisboa; Universidade Nova de Lisboa	Carrondo, MJT (corresponding author), Inst Biol Expt & Tecnol, Apartado 12, P-2781901 Oeiras, Portugal.	mjtc@itqb.unl.pt	Mota, José P B/D-5812-2013; Alves, Paula M/C-1070-2008; Peixoto, Cristina/K-8945-2014	Mota, José P B/0000-0001-6752-5766; Alves, Paula M/0000-0003-1445-3556; Peixoto, Cristina/0000-0002-0995-6637; Nestola, Piergiuseppe/0000-0003-3186-5149; Carrondo, Manuel/0000-0002-4550-4574	Sartorius Stedim Biotech; Portuguese Science Foundation (FCT-MCTES) [SFRH/BD/82032/2011 PTDC/EBB-BIO/101992/2008 PTDC/EBB457BIO/119501/2010]	Sartorius Stedim Biotech; Portuguese Science Foundation (FCT-MCTES)(Portuguese Foundation for Science and Technology)	Financial support from Sartorius Stedim Biotech and from the Portuguese Science Foundation (FCT-MCTES) (SFRH/BD/82032/2011 PTDC/EBB-BIO/101992/2008 and PTDC/EBB457BIO/119501/2010). Sartorius Stedim Biotech provided support in the form of salaries for authors SR and TS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Antony A, 2014, J MEMBRANE SCI, V454, P193, DOI 10.1016/j.memsci.2013.11.052; Bandeira V, 2012, HUM GENE THER METHOD, V23, P255, DOI 10.1089/hgtb.2012.059; BELFORT G, 1994, J MEMBRANE SCI, V96, P1, DOI 10.1016/0376-7388(94)00119-7; Burova E, 2005, GENE THER, V12, pS5, DOI 10.1038/sj.gt.3302611; Cheryan M., 1998, ULTRAFILTRATION MICR, DOI [10.1201/9781482278743, DOI 10.1201/9781482278743]; Cramer SM, 2011, CURR OPIN CHEM ENG, V1, P27, DOI 10.1016/j.coche.2011.08.008; Eglon MN, 2009, J GENE MED, V11, P978, DOI 10.1002/jgm.1383; Farid SS, 2007, J CHROMATOGR B, V848, P8, DOI 10.1016/j.jchromb.2006.07.037; Goerke AR, 2005, BIOTECHNOL BIOENG, V91, P12, DOI 10.1002/bit.20406; Grzenia DL, 2008, J MEMBRANE SCI, V321, P373, DOI 10.1016/j.memsci.2008.05.020; Peinador RI, 2011, J MEMBRANE SCI, V372, P366, DOI 10.1016/j.memsci.2011.02.022; Kalbfuss B, 2007, BIOTECHNOL BIOENG, V97, P73, DOI 10.1002/bit.21139; Kamen A, 2004, J GENE MED, V6, pS184, DOI 10.1002/jgm.503; KESTIN J, 1978, J PHYS CHEM REF DATA, V7, P941, DOI 10.1063/1.555581; Konz JO, 2005, HUM GENE THER, V16, P1346, DOI 10.1089/hum.2005.16.1346; Konz JO, 2005, BIOTECHNOL PROGR, V21, P466, DOI 10.1021/bp049644r; Konz JO, 2008, US Patent, Patent No. [0118970 A1, 0118970]; Liu HF, 2010, MABS-AUSTIN, V2, P480, DOI 10.4161/mabs.2.5.12645; Luitjens A, 2012, US Patent, Patent No. [0315696 A1, 0315696]; Mehta A, 2005, J MEMBRANE SCI, V249, P245, DOI 10.1016/j.memsci.2004.09.040; Segura MM, 2013, EXPERT OPIN BIOL TH, V13, P987, DOI 10.1517/14712598.2013.779249; Segura MM, 2012, HUM GENE THER METHOD, V23, P182, DOI 10.1089/hgtb.2012.058; Negrete A, 2014, J VIROL METHODS, V195, P240, DOI 10.1016/j.jviromet.2013.10.017; Nestola P, 2014, J BIOTECHNOL, V181, P1, DOI 10.1016/j.jbiotec.2014.04.003; Paulen R, 2012, J MEMBRANE SCI, V411, P160, DOI 10.1016/j.memsci.2012.04.028; Peixoto C, 2008, BIOTECHNOL PROGR, V24, P1290, DOI 10.1002/btpr.25; Rodrigues T, 2007, J GENE MED, V9, P233, DOI 10.1002/jgm.1021; Rodrigues T, 2007, J BIOTECHNOL, V127, P520, DOI 10.1016/j.jbiotec.2006.07.028; Silva AC, 2012, CLINIBOOK CLIN GENE, P245; Subramanian S, 2005, BIOTECHNOL PROGR, V21, P851, DOI 10.1021/bp049561a; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; van Reis R, 2007, J MEMBRANE SCI, V297, P16, DOI 10.1016/j.memsci.2007.02.045; Vellekamp G, 2001, HUM GENE THER, V12, P1923, DOI 10.1089/104303401753153974; Vicente T, 2009, GENE THER, V16, P766, DOI 10.1038/gt.2009.33; Weggeman M, 2005, European Patent, Patent No. [1780269 B1, 1780269]; Wickramasinghe SR, 2010, J MEMBRANE SCI, V365, P160, DOI 10.1016/j.memsci.2010.09.002; Wickramasinghe SR, 2005, BIOTECHNOL BIOENG, V92, P199, DOI 10.1002/bit.20599; Wolff MW, 2011, EXPERT REV VACCINES, V10, P1451, DOI [10.1586/erv.11.111, 10.1586/ERV.11.111]; Zydney AL, 2009, BIOTECHNOL BIOENG, V103, P227, DOI 10.1002/bit.22308	39	19	20	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115802	10.1371/journal.pone.0115802	http://dx.doi.org/10.1371/journal.pone.0115802			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546428	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200071
J	Nakao, LS; Everley, RA; Marino, SM; Lo, SM; de Souza, LE; Gygi, SP; Gladyshev, VN				Nakao, Lia S.; Everley, Robert A.; Marino, Stefano M.; Lo, Sze M.; de Souza, Luiz E.; Gygi, Steven P.; Gladyshev, Vadinn N.			Mechanism-based Proteomic Screening Identifies Targets of Thioredoxin-like Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; INTERMEMBRANE SPACE; SACCHAROMYCES-CEREVISIAE; MOLECULAR-MECHANISMS; CYSTEINE RESIDUES; REDOX SWITCHES; NUCLEOREDOXIN; MITOCHONDRIA; REDUCTASE; MOUSE	Thioredoxin (Trx)-fold protein. protagonists of numerous cellular pathways that are subject to thiol-based redox control, The best characterized regulator of thiols in proteins is Trx1 itself, which together with thioredoxin reductase 1 (TR1) and peroxiredoxins (Prxs) comprises a key redox regulatory system in mammalian cells. However, there are numerous other Trx-like proteins, whose functions and redox interactors are unknown. It is also unclear if the principles of Trx1-based redox control apply to these proteins. Here, we employed a proteomic strategy to four Trx-like proteins containing CXXC motifs, namely Trxl, Rdx12, Trx-like protein 1 (Txnl1) and nucleoredoxin 1 (Nrx1), whose cellular targets were trapped in vivo using mutant Trx-like proteins, under conditions of low endogenous expression of these proteins. Prxs were detected as key redox targets of Trxl, but this approach also supported the detection of TR1, which is the Trxl reductant, as well as rnitochondrial intermembrane proteins AIF and Mia40. In addition, glutathione peroxidase 4 was found to be a Rdx12 redox target. In contrast, no redox targets of Txnl1 and Nrx1 could be detected, suggesting that their CXXC motifs do not engage in mixed disulfides with cellular proteins. For some Trx-like proteins, the method allowed distinguishing redox and non-redox interactions. Parallel, comparative analyses of multiple thiol oxidoreductases revealed differences in the functions of their CXXC motifs, providing important insights into thiol-based redox control of cellular processes.	[Nakao, Lia S.; Marino, Stefano M.; Gladyshev, Vadinn N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Nakao, Lia S.; Marino, Stefano M.; Gladyshev, Vadinn N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Nakao, Lia S.; Lo, Sze M.; de Souza, Luiz E.] Univ Fed Parana, Dept Patol Basica, BR-81531980 Curitiba, Parana, Brazil; [Everley, Robert A.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Universidade Federal do Parana; Harvard University; Harvard Medical School	Gladyshev, VN (corresponding author), 77 Ave Louis Pasteur,Rm 435, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	Nakao, Lia S/M-1507-2018	Nakao, Lia S/0000-0001-9647-6350; Gladyshev, Vadim/0000-0002-0372-7016; de Souza, Luiz Eduardo Rizzo/0000-0001-8794-7720	National Institutes of Health [GM065204]; Brazil Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship [3737/10]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM065204, R01GM065204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brazil Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065204 (to V. N. G.).; Recipient of Brazil Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship 3737/10.	Andersen KM, 2011, ANTIOXID REDOX SIGN, V14, P1601, DOI 10.1089/ars.2010.3329; Andersen KM, 2009, J BIOL CHEM, V284, P15246, DOI 10.1074/jbc.M900016200; Apostolova N, 2006, CELL DEATH DIFFER, V13, P354, DOI 10.1038/sj.cdd.4401776; Balmer Y, 2004, P NATL ACAD SCI USA, V101, P2642, DOI 10.1073/pnas.0308583101; Banci L, 2013, CHEM BIOL, V20, P747, DOI 10.1016/j.chembiol.2013.05.007; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Dasgupta S, 2009, ONCOGENE, V28, P2860, DOI 10.1038/onc.2009.145; Dasgupta S, 2011, J BIOL CHEM, V286, P25935, DOI 10.1074/jbc.M111.254599; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Dikiy A, 2007, BIOCHEMISTRY-US, V46, P6871, DOI 10.1021/bi602462q; Engelhard J, 2011, FREE RADICAL BIO MED, V50, P1234, DOI 10.1016/j.freeradbiomed.2011.01.035; Felberbaum-Corti M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001144; Fomenko DE, 2012, ANTIOXID REDOX SIGN, V16, P193, DOI 10.1089/ars.2011.3980; Fu CX, 2009, MOL CELL PROTEOMICS, V8, P1674, DOI 10.1074/mcp.M800580-MCP200; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Funato Y, 2013, BIOCHEM BIOPH RES CO, V440, P737, DOI 10.1016/j.bbrc.2013.09.138; Hagglund P, 2008, J PROTEOME RES, V7, P5270, DOI 10.1021/pr800633y; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Hayashi T, 2010, J BIOL CHEM, V285, P18586, DOI 10.1074/jbc.M110.106468; Hirasaka K, 2011, ANTIOXID REDOX SIGN, V15, P2645, DOI 10.1089/ars.2011.3888; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Inarrea P, 2007, BIOCHEM J, V405, P173, DOI 10.1042/BJ20061809; Jimenez A, 2006, FEBS LETT, V580, P960, DOI 10.1016/j.febslet.2006.01.025; Joza N, 2008, CELL DEATH DIFFER, V15, P1009, DOI 10.1038/cdd.2008.24; Kim Y, 2009, ANTIOXID REDOX SIGN, V11, P907, DOI 10.1089/ars.2008.2316; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Klomsiri C, 2011, ANTIOXID REDOX SIGN, V14, P1065, DOI 10.1089/ars.2010.3376; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Lechward K, 2006, FEBS LETT, V580, P3631, DOI 10.1016/j.febslet.2006.04.101; Lee KK, 1998, J BIOL CHEM, V273, P19160, DOI 10.1074/jbc.273.30.19160; Liu J, 2013, EUKARYOT CELL, V12, P1588, DOI 10.1128/EC.00082-13; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Mack C, 2008, P NATL ACAD SCI USA, V105, P3094, DOI 10.1073/pnas.0800168105; Marino SM, 2010, BIOCHEMISTRY-US, V49, P7709, DOI 10.1021/bi100677a; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Muller L, 2011, FEBS LETT, V585, P596, DOI 10.1016/j.febslet.2011.01.024; Paes AMD, 2011, J LEUKOCYTE BIOL, V90, P799, DOI 10.1189/jlb.0610324; Pai HV, 2007, ANTIOXID REDOX SIGN, V9, P2027, DOI 10.1089/ars.2007.1642; Powis G, 2001, ANNU REV BIOPH BIOM, V30, P421, DOI 10.1146/annurev.biophys.30.1.421; Schwertassek U., 2007, SCI STKE, V2007, pl8; Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445; Shchedrina VA, 2011, J BIOL CHEM, V286, P42937, DOI 10.1074/jbc.M111.310920; Sturm N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000383; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Terziyska N, 2005, FEBS LETT, V579, P179, DOI 10.1016/j.febslet.2004.11.072; Turanov AA, 2010, BIOCHEM J, V430, P285, DOI 10.1042/BJ20091378; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wiseman RL, 2009, J BIOL CHEM, V284, P15233, DOI 10.1074/jbc.M109.002121; Wu CG, 2011, ANTIOXID REDOX SIGN, V15, P2565, DOI 10.1089/ars.2010.3831; Wu RH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009654; Xu W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.27; Yamazaki D, 2004, PLANT CELL PHYSIOL, V45, P18, DOI 10.1093/pcp/pch019; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	58	25	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5685	5695		10.1074/jbc.M114.597245	http://dx.doi.org/10.1074/jbc.M114.597245			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25561728	Green Published, hybrid			2022-12-26	WOS:000350044200037
J	Zhang, DY; Liang, YG; Xie, QP; Gao, GX; Wei, JL; Huang, HS; Li, JX; Gao, JM; Huang, CS				Zhang, Dongyun; Liang, Yuguang; Xie, Qipeng; Gao, Guangxun; Wei, Jinlong; Huang, Haishan; Li, Jingxia; Gao, Jimin; Huang, Chuanshu			A Novel Post-translational Modification of Nucleolin, SUMOylation at Lys-294, Mediates Arsenite-induced Cell Death by Regulating gadd45 alpha mRNA Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE MODIFIER; OXIDATIVE STRESS; PROTEIN SUMOYLATION; SUMO; APOPTOSIS; CANCER; PHOSPHORYLATION; EXPRESSION; IDENTIFICATION; INDUCTION	Nucleolin is a ubiquitously expressed protein and participates in many important biological processes, such as cell cycle regulation and ribosomal biogenesis. The activity of nucleolin is regulated by intracellular localization and post-translational modifications, including phosphorylation, methylation, and ADP-ribosylation. Small ubiquitin-like modifier (SUMO) is a category of recently verified forms of post-translational modifications and exerts various effects on the target proteins. In the studies reported here, we discovered SUMOylational modification of human nucleolin protein at Lys-294, which facilitated the mRNA binding property of nucleolin by maintaining its nuclear localization. In response to arsenic exposure, nucleolin-SUMO was induced and promoted its binding with gadd45 alpha mRNA, which increased gadd45 alpha mRNA stability and protein expression, subsequently causing GADD45 alpha-mediated cell death. On the other hand, ectopic expression of Mn-SOD attenuated the arsenite-generated superoxide radical level, abrogated nucleolin-SUMO, and in turn inhibited arsenite-induced apoptosis by reducing GADD45 alpha expression. Collectively, our results for the first time demonstrate that nucleolin-SUMO at K294R plays a critical role in its nucleus sequestration and gadd45 alpha mRNA binding activity. This novel biological function of nucleolin is distinct from its conventional role as a proto-oncogene. Therefore, our findings here not only reveal a new modification of nucleolin protein and its novel functional paradigm in mRNA metabolism but also expand our understanding of the dichotomous roles of nucleolin in terms of cancer development, which are dependent on multiple intracellular conditions and consequently the appropriate regulations of its modifications, including SUMOylation.	[Zhang, Dongyun; Liang, Yuguang; Gao, Guangxun; Li, Jingxia; Huang, Chuanshu] NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY 10987 USA; [Zhang, Dongyun; Xie, Qipeng; Wei, Jinlong; Huang, Haishan; Gao, Jimin] Wenzhou Med Univ, Zhejiang Prov Key Lab Technol & Applicat Model Or, Sch Life Sci, Wenzhou 325035, Zhejiang, Peoples R China	New York University; Wenzhou Medical University	Huang, CS (corresponding author), NYU, Sch Med, Nelson Inst Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	chuanshu.huang@nyumc.org		Huang, Chuanshu/0000-0003-4133-5096	National Institutes of Health (NIH), NCI [CA112557, CA177665, CA165980]; NIH, NIEHS [ES000260]; National Science Foundation of China [C81472945]; NATIONAL CANCER INSTITUTE [R01CA112557, R01CA177665, P01CA165980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NCI, Grants CA112557, CA177665, and CA165980 and by NIH, NIEHS, Grant ES000260. This work was also supported by National Science Foundation of China Grant C81472945.	Abdelmohsen K, 2012, RNA BIOL, V9, P799, DOI 10.4161/rna.19718; Abe JI, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/953463; Aguirre RS, 2013, MOL PHARMACOL, V84, P218, DOI 10.1124/mol.113.085555; Anderson DB, 2009, SUMO REGULATION OF CELLULAR PROCESSES, P233, DOI 10.1007/978-90-481-2649-1_14; Baczyk D, 2013, PLACENTA, V34, P606, DOI 10.1016/j.placenta.2013.03.012; Blomster HA, 2010, J BIOL CHEM, V285, P19324, DOI 10.1074/jbc.M110.106955; Blomster HA, 2009, MOL CELL PROTEOMICS, V8, P1382, DOI 10.1074/mcp.M800551-MCP200; Bolognani F, 2008, J NEUROSCI RES, V86, P481, DOI 10.1002/jnr.21473; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Bower JJ, 2006, FREE RADICAL BIO MED, V41, P285, DOI 10.1016/j.freeradbiomed.2006.04.007; Castillo-Lluva S, 2010, NAT CELL BIOL, V12, P1078, DOI 10.1038/ncb2112; Caudle WM, 2009, NEUROSCI LETT, V459, P11, DOI 10.1016/j.neulet.2009.04.060; Chang QS, 2007, CANCER RES, V67, P6146, DOI 10.1158/0008-5472.CAN-07-0867; Chen CY, 2000, GENE DEV, V14, P1236; Chen YC, 1998, J CELL PHYSIOL, V177, P324, DOI 10.1002/(SICI)1097-4652(199811)177:2<324::AID-JCP14>3.0.CO;2-9; Chiou HYC, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-53; Cong R, 2011, PROTEIN REV, V15, P185, DOI 10.1007/978-1-4614-0514-6_9; Connor KM, 2007, CANCER RES, V67, P10260, DOI 10.1158/0008-5472.CAN-07-1204; CREANCIER L, 1993, MOL BIOL CELL, V4, P1239, DOI 10.1091/mbc.4.12.1239; Da Silva-Ferrada E, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/875148; Daniely Y, 2000, J CELL BIOL, V149, P799, DOI 10.1083/jcb.149.4.799; Deyrieux AF, 2007, J CELL SCI, V120, P125, DOI 10.1242/jcs.03317; Ding M, 2002, MOL CELL BIOCHEM, V234, P81, DOI 10.1023/A:1015901232124; Dranovsky A, 2001, NEUROBIOL AGING, V22, P517, DOI 10.1016/S0197-4580(00)00248-7; Fang Y, 2012, J BIOL CHEM, V287, P35234, DOI 10.1074/jbc.M112.389494; Ghioni P, 2005, CELL CYCLE, V4, P183, DOI 10.4161/cc.4.1.1359; Ginisty H, 1999, J CELL SCI, V112, P761; Greco A, 2009, REV MED VIROL, V19, P201, DOI 10.1002/rmv.614; Grinstein E, 2007, J BIOL CHEM, V282, P12439, DOI 10.1074/jbc.M608068200; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Han YH, 2008, MOL CELLS, V26, P18; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hoshino D, 2009, J BIOL CHEM, V284, P27315, DOI 10.1074/jbc.M109.041400; Hovanessian AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015787; Jentsch S., 2009, UBIQUITIN SYSTEM HLT, P1; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kim SK, 2003, DNA CELL BIOL, V22, P171, DOI 10.1089/104454903321655792; LAPEYRE B, 1987, P NATL ACAD SCI USA, V84, P1472, DOI 10.1073/pnas.84.6.1472; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; Liu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035682; Liu JY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176982; Maiti S, 2000, ENVIRON TOXICOL PHAR, V8, P227, DOI 10.1016/S1382-6689(00)00046-6; Manza LL, 2004, CHEM RES TOXICOL, V17, P1706, DOI 10.1021/tx049767l; Mates JM, 2012, ARCH TOXICOL, V86, P1649, DOI 10.1007/s00204-012-0906-3; NORDENSON I, 1991, HUM HERED, V41, P71, DOI 10.1159/000153979; Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874; Pal S, 2010, J VIROL METHODS, V163, P498, DOI 10.1016/j.jviromet.2009.11.010; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Ruse CI, 2008, J PROTEOME RES, V7, P2140, DOI 10.1021/pr800147u; Sakurai T, 1998, CHEM RES TOXICOL, V11, P273, DOI 10.1021/tx9701384; SALNIKOW K, 1994, CANCER RES, V54, P6407; Schwab MS, 1997, EUR J CELL BIOL, V73, P287; Seko Y, 2006, AUTOIMMUN REV, V5, P299, DOI 10.1016/j.autrev.2005.10.013; Shibata Y, 2002, MOL CELL BIOL, V22, P6788, DOI 10.1128/MCB.22.19.6788-6796.2002; Shin I, 2005, J BIOL CHEM, V280, P6055, DOI 10.1074/jbc.M412367200; Sinha M, 2008, J BIOCHEM MOL TOXIC, V22, P15, DOI 10.1002/jbt.20209; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Song L, 2006, J CELL BIOL, V175, P607, DOI 10.1083/jcb.200602149; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Storck Sebastien, 2007, Subcell Biochem, V41, P125; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; Tuteja R, 1998, CRIT REV BIOCHEM MOL, V33, P407, DOI 10.1080/10409239891204260; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; WARRENER P, 1991, BIOCHEM BIOPH RES CO, V180, P716, DOI 10.1016/S0006-291X(05)81124-6; Xu Z, 2008, FASEB J, V22, P127, DOI 10.1096/fj.06-7871com; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251; Yang ML, 2006, J BIOL CHEM, V281, P8264, DOI 10.1074/jbc.M510364200; Yang P, 2007, J TOXICOL ENV HEAL A, V70, P976, DOI 10.1080/15287390701290832; Yang W, 2008, J NEUROCHEM, V106, P989, DOI 10.1111/j.1471-4159.2008.05404.x; Yasui K, 2006, INFLAMM RES, V55, P359, DOI 10.1007/s00011-006-5195-y; Yu JX, 2012, J BIOL CHEM, V287, P13752, DOI 10.1074/jbc.M111.337469; Zhang DY, 2006, J BIOL CHEM, V281, P34113, DOI 10.1074/jbc.M602821200; Zhang DY, 2012, J BIOL CHEM, V287, P34361, DOI 10.1074/jbc.M112.365882; Zhang J, 2008, CANCER RES, V68, P1046, DOI 10.1158/0008-5472.CAN-07-1927	80	25	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4784	4800		10.1074/jbc.M114.598219	http://dx.doi.org/10.1074/jbc.M114.598219			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25561743	Green Published, hybrid			2022-12-26	WOS:000350042000021
J	de Araujo, WS; Vieira, MC; Lewinsohn, TM; Almeida-Neto, M				de Araujo, Walter Santos; Vieira, Marcos Costa; Lewinsohn, Thomas M.; Almeida-Neto, Myrio			Contrasting Effects of Land Use Intensity and Exotic Host Plants on the Specialization of Interactions in Plant-Herbivore Networks	PLOS ONE			English	Article							INSECT HERBIVORES; HABITAT MODIFICATION; SPECIES RICHNESS; CONSEQUENCES; PREDATORS; DIVERSITY; COMMUNITY; TIME	Human land use tends to decrease the diversity of native plant species and facilitate the invasion and establishment of exotic ones. Such changes in land use and plant community composition usually have negative impacts on the assemblages of native herbivorous insects. Highly specialized herbivores are expected to be especially sensitive to land use intensification and the presence of exotic plant species because they are neither capable of consuming alternative plant species of the native flora nor exotic plant species. Therefore, higher levels of land use intensity might reduce the proportion of highly specialized herbivores, which ultimately would lead to changes in the specialization of interactions in plant-herbivore networks. This study investigates the community-wide effects of land use intensity on the degree of specialization of 72 plant-herbivore networks, including effects mediated by the increase in the proportion of exotic plant species. Contrary to our expectation, the net effect of land use intensity on network specialization was positive. However, this positive effect of land use intensity was partially canceled by an opposite effect of the proportion of exotic plant species on network specialization. When we analyzed networks composed exclusively of endophagous herbivores separately from those composed exclusively of exophagous herbivores, we found that only endophages showed a consistent change in network specialization at higher land use levels. Altogether, these results indicate that land use intensity is an important ecological driver of network specialization, by way of reducing the local host range of herbivore guilds with highly specialized feeding habits. However, because the effect of land use intensity is offset by an opposite effect owing to the proportion of exotic host species, the net effect of land use in a given herbivore assemblage will likely depend on the extent of the replacement of native host species with exotic ones.	[de Araujo, Walter Santos; Vieira, Marcos Costa] Univ Fed Goias, Programa Posgrad Ecol & Evolucao, Inst Ciencias Biol, Goiania, Go, Brazil; [de Araujo, Walter Santos; Vieira, Marcos Costa; Almeida-Neto, Myrio] Univ Fed Goias, Lab Interacoes Ecol & Biodiversidade, Inst Ciencias Biol, Dept Ecol, Goiania, Go, Brazil; [Lewinsohn, Thomas M.] Univ Estadual Campinas, Lab Interacoes Insetos Plantas, Inst Biol, Sao Paulo, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade de Sao Paulo; Universidade Estadual de Campinas	de Araujo, WS (corresponding author), Univ Fed Goias, Programa Posgrad Ecol & Evolucao, Inst Ciencias Biol, Goiania, Go, Brazil.	walterbioaraujo@yahoo.com.br	Lewinsohn, Thomas M/D-5880-2012; de Araújo, Walter S/C-8546-2013; Almeida-Neto, M./A-6389-2009; de Araújo, Walter Santos/AAA-4606-2020	Lewinsohn, Thomas M/0000-0001-5950-5343; Almeida-Neto, M./0000-0002-2161-2968; de Araújo, Walter Santos/0000-0003-0157-6151	Coordenacao deAperfeicoamento de Pessoal de Nivel Superior (CAPES); Brazilian Research Council (CNPq)	Coordenacao deAperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors are thankful to the Coordenacao deAperfeicoamento de Pessoal de Nivel Superior (CAPES) for the grant to WSdA and to the Brazilian Research Council (CNPq) for a graduate fellowship to MCV and for a productivity grant to TML and MAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo WS, 2014, BIODIVERS CONSERV; ARBUCKLE JL, 2003, AMOS USERS GUIDE 5 0; Brandle M, 2008, DIVERS DISTRIB, V14, P905, DOI 10.1111/j.1472-4642.2008.00511.x; Castagneyrol B, 2014, J APPL ECOL, V51, P134, DOI 10.1111/1365-2664.12175; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fonseca CR, 2009, CONSERV BIOL, V23, P1507, DOI 10.1111/j.1523-1739.2009.01327.x; Forister ML, 2012, ECOLOGY, V93, P981, DOI 10.1890/11-0650.1; FOX LR, 1981, SCIENCE, V211, P887, DOI 10.1126/science.211.4485.887; GASTON KJ, 1992, ECOL ENTOMOL, V17, P86, DOI 10.1111/j.1365-2311.1992.tb01044.x; Gorley C.K., 2006, GETTING STARTED PRIM; Grace JB., 2015, STRUCTURAL EQUATION; Gravel D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019374; Harvey JA, 2010, BIOL CONSERV, V143, P2251, DOI 10.1016/j.biocon.2010.03.004; Henneman ML, 2001, SCIENCE, V293, P1314, DOI 10.1126/science.1060788; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Kaartinen R, 2011, J ANIM ECOL, V80, P622, DOI 10.1111/j.1365-2656.2011.01811.x; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Laliberte E, 2010, ECOLOGY, V91, P1740, DOI 10.1890/09-1328.1; Lewinsohn T.M., 1991, P525; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Masetti A, 2004, ANN ENTOMOL SOC AM, V97, P1252, DOI 10.1603/0013-8746(2004)097[1252:FSOTAD]2.0.CO;2; Memmott J, 2000, J ANIM ECOL, V69, P1, DOI 10.1046/j.1365-2656.2000.00367.x; Morais HC, 2011, BIOTROPICA, V43, P467, DOI 10.1111/j.1744-7429.2010.00736.x; Nakagawa M, 2003, B ENTOMOL RES, V93, P455, DOI 10.1079/BER2003257; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Nyman T, 2010, BIOL REV, V85, P393, DOI 10.1111/j.1469-185X.2009.00109.x; Odegaard F, 2005, ECOL LETT, V8, P612, DOI 10.1111/j.1461-0248.2005.00758.x; Perre P, 2011, URBAN ECOSYST, V14, P711, DOI 10.1007/s11252-011-0179-2; Petermann JS, 2010, J ANIM ECOL, V79, P709, DOI 10.1111/j.1365-2656.2010.01674.x; Piazzon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019637; Prado PI, 2004, J ANIM ECOL, V73, P1168, DOI 10.1111/j.0021-8790.2004.00891.x; Preacher KJ, 2006, COMPUTING POWER MINI; Price PW, 2002, ECOL RES, V17, P241, DOI 10.1046/j.1440-1703.2002.00483.x; Santos J.P. dos, 2006, Arq. Inst. Biol., V73, P235, DOI 10.1590/1808-1657v73p2352006; Schweiger O, 2008, OECOLOGIA, V157, P485, DOI 10.1007/s00442-008-1082-2; Strauss SY, 2004, ANNU REV ECOL EVOL S, V35, P435, DOI 10.1146/annurev.ecolsys.35.112202.130215; Thebault E, 2008, OIKOS, V117, P555, DOI 10.1111/j.0030-1299.2008.16485.x; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Tscharntke T, 2004, ANNU REV ENTOMOL, V49, P405, DOI 10.1146/annurev.ento.49.061802.123339; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Vila M, 2004, OIKOS, V105, P229, DOI 10.1111/j.0030-1299.2004.12682.x; Villa-Galaviz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053009; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; With KA, 2011, LANDSCAPE ECOL, V26, P1035, DOI 10.1007/s10980-011-9627-x	49	47	49	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2015	10	1							e0115606	10.1371/journal.pone.0115606	http://dx.doi.org/10.1371/journal.pone.0115606			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4BS	25565141	gold, Green Published, Green Submitted			2022-12-26	WOS:000348167900001
J	Barasona, JA; Mulero-Pazmany, M; Acevedo, P; Negro, JJ; Torres, MJ; Gortazar, C; Vicente, J				Barasona, Jose A.; Mulero-Pazmany, Margarita; Acevedo, Pelayo; Negro, Juan J.; Torres, Maria J.; Gortazar, Christian; Vicente, Joaquin			Unmanned Aircraft Systems for Studying Spatial Abundance of Ungulates: Relevance to Spatial Epidemiology	PLOS ONE			English	Article							TUBERCULOSIS-LIKE LESIONS; WILD BOAR; BOVINE TUBERCULOSIS; RED DEER; MYCOBACTERIUM-BOVIS; AERIAL VEHICLES; CATTLE; LIVESTOCK; TERRITORIALITY; TRANSMISSION	Complex ecological and epidemiological systems require multidisciplinary and innovative research. Low cost unmanned aircraft systems (UAS) can provide information on the spatial pattern of hosts' distribution and abundance, which is crucial as regards modelling the determinants of disease transmission and persistence on a fine spatial scale. In this context we have studied the spatial epidemiology of tuberculosis (TB) in the ungulate community of Donana National Park (South-western Spain) by modelling species host (red deer, fallow deer and cattle) abundance at fine spatial scale. The use of UAS high-resolution images has allowed us to collect data to model the environmental determinants of host abundance, and in a further step to evaluate their relationships with the spatial risk of TB throughout the ungulate community. We discuss the ecological, epidemiological and logistic conditions under which UAS may contribute to study the wildlife/livestock sanitary interface, where the spatial aggregation of hosts becomes crucial. These findings are relevant for planning and implementing research, fundamentally when managing disease in multi-host systems, and focusing on risky areas. Therefore, managers should prioritize the implementation of control strategies to reduce disease of conservation, economic and social relevance.	[Barasona, Jose A.; Acevedo, Pelayo; Gortazar, Christian; Vicente, Joaquin] Natl Wildlife Res Inst CSIC UCLM JCCM, SaBio IREC, Ciudad Real, Spain; [Mulero-Pazmany, Margarita; Negro, Juan J.] CSIC, Dept Evolutionary Ecol, Donana Biol Stn, E-41080 Seville, Spain; [Torres, Maria J.] Univ Seville, Dept Microbiol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Sevilla	Barasona, JA (corresponding author), Natl Wildlife Res Inst CSIC UCLM JCCM, SaBio IREC, Ciudad Real, Spain.	joseangel.barasona@uclm.es	Mulero-Pazmany, Margarita/M-5596-2013; Barasona, Jose/ABH-7368-2020; Torres, Maria/GVU-3391-2022; Gortazar, Christian/E-7918-2012; Negro, Juan Jose/I-2653-2015; Acevedo, Pelayo/L-6737-2013; IBIS, TUBERCULOSIS/O-9334-2015	Mulero-Pazmany, Margarita/0000-0002-0303-9360; Barasona, Jose/0000-0003-4066-8454; Gortazar, Christian/0000-0003-0012-4006; Negro, Juan Jose/0000-0002-8697-5647; Acevedo, Pelayo/0000-0002-3509-7696; 	Junta de Comunidades Castilla-La Mancha (JCCM) [PEII10-0262-7673]; Ministerio de Economia y Competitividad (MINECO) [AGL2013-48523-C3-1-R]; EU (FP7 grant) [613779 WildTBVac]; Aeromab Project [P07-RNM-03246]; PLANET Project (EU, Cooperation, 7th FP); FPU; MINECO-UCLM through 'Ramon y Cajal' contract [RYC-2012-11970]; European Research on Emerging and Major Infectious Diseases of Livestock [EMIDA-467 ERA-NET]; grant APHAEA [219235-FP7-ERA-NET-EMIDA]	Junta de Comunidades Castilla-La Mancha (JCCM); Ministerio de Economia y Competitividad (MINECO)(Spanish Government); EU (FP7 grant); Aeromab Project; PLANET Project (EU, Cooperation, 7th FP); FPU(Spanish Government); MINECO-UCLM through 'Ramon y Cajal' contract; European Research on Emerging and Major Infectious Diseases of Livestock; grant APHAEA	We would like to thank E. Guerrero and M.A. Aguilar, the pilots and technicians who controlled the UAS and prepared the image mosaic. The present work has benefited from the financial aid of research grants Junta de Comunidades Castilla-La Mancha (JCCM; PEII10-0262-7673), Ministerio de Economia y Competitividad (MINECO; AGL2013-48523-C3-1-R), EU (FP7 grant 613779 WildTBVac), Aeromab Project (P07-RNM-03246), and the PLANET Project (EU, Cooperation, 7th FP, 2010). J.A.B. holds an FPU pre-doctoral scholarship. P.A. is supported by MINECO-UCLM through 'Ramon y Cajal' contract (RYC-2012-11970) and partly by European Research on Emerging and Major Infectious Diseases of Livestock (EMIDA-467 ERA-NET) grant APHAEA (219235-FP7-ERA-NET-EMIDA; www.aphaea.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2010, ECOL INDIC, V10, P1226, DOI 10.1016/j.ecolind.2010.04.006; Acevedo P, 2014, ECOL INDIC, V36, P594, DOI 10.1016/j.ecolind.2013.09.019; Acevedo P, 2011, LANDSCAPE ECOL, V26, P19, DOI 10.1007/s10980-010-9538-2; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150; Apollonio M., 2010, EUROPEAN UNGULATES T; Barasona JA, 2013, PREV VET MED, V111, P42, DOI 10.1016/j.prevetmed.2013.03.009; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Bisanzio D, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-230; Blanchong J. A., 2007, Biology Letters, V3, P104; Boadella M, 2012, PREV VET MED, V107, P214, DOI 10.1016/j.prevetmed.2012.06.001; BRAZA F, 1987, Miscellania Zoologica (Barcelona), V11, P363; Brezger A, 2006, COMPUT STAT DATA AN, V50, P967, DOI 10.1016/j.csda.2004.10.011; Bugalho MN, 2003, FOREST ECOL MANAG, V181, P23, DOI 10.1016/S0378-1127(03)00125-7; Cameron A.C., 2013, REGRESSION ANAL COUN, V53; CARRANZA J, 1990, ANIM BEHAV, V40, P79, DOI 10.1016/S0003-3472(05)80667-0; CARRANZA J, 1991, APPL ANIM BEHAV SCI, V30, P363, DOI 10.1016/0168-1591(91)90141-J; Cooper SM, 2010, J WILDLIFE DIS, V46, P152, DOI 10.7589/0090-3558-46.1.152; de Garine-Wichatitsky M, 2013, COMP IMMUNOL MICROB, V36, P321, DOI 10.1016/j.cimid.2012.10.007; Etherington TR, 2009, J BIOGEOGR, V36, P845, DOI 10.1111/j.1365-2699.2008.02041.x; Focardi S, 2001, WILDLIFE SOC B, V29, P133; Frolich K, 2002, ANN NY ACAD SCI, V969, P4, DOI 10.1111/j.1749-6632.2002.tb04343.x; Getzin S, 2012, METHODS ECOL EVOL, V3, P397, DOI 10.1111/j.2041-210X.2011.00158.x; Gortazar C, 2007, EUR J WILDLIFE RES, V53, P241, DOI 10.1007/s10344-007-0098-y; Gortazar C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-27; Gortazar C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002776; Grenfell B. T., 1995, ECOLOGY INFECT DIS N; Held L, 2010, STATISTICAL MODELLING AND REGRESSION STRUCTURES, P91, DOI 10.1007/978-3-7908-2413-1_6; Jones GP, 2006, WILDLIFE SOC B, V34, P750, DOI 10.2193/0091-7648(2006)34[750:AAOSUA]2.0.CO;2; Kukielka E, 2013, PREV VET MED, V112, P213, DOI 10.1016/j.prevetmed.2013.08.008; Martinez-Lopez B, 2013, PREV VET ME IN PRESS; Meliker JR, 2011, SPAT SPATIO-TEMPORAL, V2, P1, DOI 10.1016/j.sste.2010.10.001; Morellet N, 2007, J APPL ECOL, V44, P634, DOI 10.1111/j.1365-2664.2007.01307.x; Mulero-Pazmany M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083873; Munyeme M, 2008, PREV VET MED, V85, P317, DOI 10.1016/j.prevetmed.2008.03.006; Osnas EE, 2009, ECOL APPL, V19, P1311, DOI 10.1890/08-0578.1; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Phillips CJC, 2003, RES VET SCI, V74, P1, DOI 10.1016/S0034-5288(02)00145-5; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Renwick AR, 2007, EPIDEMIOL INFECT, V135, P529, DOI 10.1017/S0950268806007205; Rodriguez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050336; Rodriguez-Prieto V, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-148; Russo L, 1997, ETHOL ECOL EVOL, V9, P287, DOI 10.1080/08927014.1997.9522888; Schrodle B, 2011, ENVIRONMETRICS, V22, P725, DOI 10.1002/env.1065; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Tuyttens FAM, 2000, J ANIM ECOL, V69, P815, DOI 10.1046/j.1365-2656.2000.00437.x; Vermeulen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054700; Vicente J, 2006, VET RES, V37, P107, DOI 10.1051/vetres:2005044; Vicente J, 2013, TRANSBOUND EMERG DIS, V60, P92, DOI 10.1111/tbed.12167; Vicente J, 2007, VET RES, V38, P451, DOI 10.1051/vetres:2007002; Watts A. C., 2008, Ecological Restoration, V26, P13, DOI 10.3368/er.26.1.13; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; [No title captured]; [No title captured]	54	56	60	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115608	10.1371/journal.pone.0115608	http://dx.doi.org/10.1371/journal.pone.0115608			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551673	Green Published, gold			2022-12-26	WOS:000347119100048
J	Blanchet, CL; Frank, M; Schouten, S				Blanchet, Cecile L.; Frank, Martin; Schouten, Stefan			Asynchronous Changes in Vegetation, Runoff and Erosion in the Nile River Watershed during the Holocene	PLOS ONE			English	Article							LONG-CHAIN ALKENONES; SIMULATED CLIMATE; LATE PLEISTOCENE; LAKE TANA; AFRICA; SEDIMENTS; FORAMINIFERA; EXTRACTION; QUATERNARY; INDICATORS	The termination of the African Humid Period in northeastern Africa during the early Holocene was marked by the southward migration of the rain belt and the disappearance of the Green Sahara. This interval of drastic environmental changes was also marked by the initiation of food production by North African hunter-gatherer populations and thus provides critical information on human-environment relationships. However, existing records of regional climatic and environmental changes exhibit large differences in timing and modes of the wet/dry transition at the end of the African Humid Period. Here we present independent records of changes in river runoff, vegetation and erosion in the Nile River watershed during the Holocene obtained from a unique sedimentary sequence on the Nile River fan using organic and inorganic proxy data. This high-resolution reconstruction allows to examine the phase relationship between the changes of these three parameters and provides a detailed picture of the environmental conditions during the Paleolithic/Neolithic transition. The data show that river runoff decreased gradually during the wet/arid transition at the end of the AHP whereas rapid shifts of vegetation and erosion occurred earlier between 8.7 and similar to 6 ka BP. These asynchronous changes are compared to other regional records and provide new insights into the threshold responses of the environment to climatic changes. Our record demonstrates that the degradation of the environment in northeastern Africa was more abrupt and occurred earlier than previously thought and may have accelerated the process of domestication in order to secure sustainable food resources for the Neolithic African populations.	[Blanchet, Cecile L.; Frank, Martin] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Blanchet, Cecile L.; Schouten, Stefan] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Organ Biogeochem, T Horntje, Texel, Netherlands	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Blanchet, CL (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany.	cblanchet@geomar.de	Blanchet, Cecile/C-6370-2013; Blanchet, Cecile/AAK-2270-2021	Blanchet, Cecile/0000-0002-7146-705X; Blanchet, Cecile/0000-0002-7146-705X; Frank, Martin/0000-0002-8606-4421	German Science Foundation (DFG) [BL1112-1/1]	German Science Foundation (DFG)(German Research Foundation (DFG))	CLB - Personal Grant by the German Science Foundation (DFG, http://www.dfg.de) BL1112-1/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bemis BE, 1998, PALEOCEANOGRAPHY, V13, P150, DOI 10.1029/98PA00070; Blanchet CL, 2013, EARTH PLANET SC LETT, V364, P98, DOI 10.1016/j.epsl.2013.01.009; BRAY EE, 1961, GEOCHIM COSMOCHIM AC, V22, P2, DOI 10.1016/0016-7037(61)90069-2; Brooks N, 2006, QUATERN INT, V151, P29, DOI 10.1016/j.quaint.2006.01.013; Butzer K.W., 1976, EARLY HYDRAULIC CIVI; BUTZER KW, 1980, SAHARA NILE, P253, DOI DOI 10.1126/SCIENCE.208.4445.736-A; Castaneda IS, 2011, QUATERNARY SCI REV, V30, P2851, DOI 10.1016/j.quascirev.2011.07.009; Castaneda IS, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001740; Castaneda IS, 2009, P NATL ACAD SCI USA, V106, P20159, DOI 10.1073/pnas.0905771106; Claussen M, 2013, NAT GEOSCI, V6, P954, DOI [10.1038/ngeo1962, 10.1038/NGEO1962]; Claussen M, 1999, GEOPHYS RES LETT, V26, P2037, DOI 10.1029/1999GL900494; Cockerton HE, 2013, QUATERNARY SCI REV, V66, P4, DOI 10.1016/j.quascirev.2012.12.005; COHEN RW, 1988, ENTOMOL EXP APPL, V48, P303; Collins JA, 2011, NAT GEOSCI, V4, P42, DOI [10.1038/ngeo1039, 10.1038/NGEO1039]; Conte MH, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001054; Costa K, 2014, QUATERNARY SCI REV, V83, P58, DOI 10.1016/j.quascirev.2013.10.031; di Lernia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056879; Diefendorf AF, 2011, GEOCHIM COSMOCHIM AC, V75, P7472, DOI 10.1016/j.gca.2011.09.028; Drake NA, 2011, P NATL ACAD SCI USA, V108, P458, DOI 10.1073/pnas.1012231108; Ducassou E, 2008, QUATERNARY RES, V70, P382, DOI 10.1016/j.yqres.2008.02.011; Dunne J, 2012, NATURE, V486, P390, DOI 10.1038/nature11186; EGLINTON G, 1967, SCIENCE, V156, P1322, DOI 10.1126/science.156.3780.1322; Emeis KC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2000PA000617; Feseker T, 2010, GEO-MAR LETT, V30, P169, DOI 10.1007/s00367-010-0192-0; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; Garcea EAA, 2004, J WORLD PREHIST, V18, P107, DOI 10.1007/s10963-004-2878-6; Garcin Y, 2012, EARTH PLANET SC LETT, V331, P322, DOI 10.1016/j.epsl.2012.03.016; Gat JR, 1996, J GEOPHYS RES-OCEANS, V101, P6441, DOI 10.1029/95JC02829; Gifford-Gonzalez D, 2011, J WORLD PREHIST, V24, P1, DOI DOI 10.1007/s10963-010-9042-2; Gutjahr M, 2007, CHEM GEOL, V242, P351, DOI 10.1016/j.chemgeo.2007.03.021; Hassan FA., 2002, DROUGHTS FOOD CULTUR, P11, DOI DOI 10.1007/0-306-47547-2_2; Hoefs MJL, 2002, GEOCHIM COSMOCHIM AC, V66, P2719, DOI 10.1016/S0016-7037(02)00864-5; Hopmans EC, 2004, EARTH PLANET SC LETT, V224, P107, DOI 10.1016/j.epsl.2004.05.012; Hopmans EC, 2000, RAPID COMMUN MASS SP, V14, P585, DOI 10.1002/(SICI)1097-0231(20000415)14:7<585::AID-RCM913>3.3.CO;2-E; HORWITZ EP, 1992, SOLVENT EXTR ION EXC, V10, P313, DOI 10.1080/07366299208918107; JACOBSEN SB, 1980, EARTH PLANET SC LETT, V50, P139, DOI 10.1016/0012-821X(80)90125-9; Jolly D, 1998, QUATERNARY SCI REV, V17, P629, DOI 10.1016/S0277-3791(98)00015-8; Jung SJA, 2004, EARTH PLANET SC LETT, V221, P27, DOI 10.1016/S0012-821X(04)00095-0; Kim JH, 2007, GEOLOGY, V35, P387, DOI 10.1130/G23251A.1; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Leduc G, 2013, EARTH PLANET SC LETT, V362, P151, DOI 10.1016/j.epsl.2012.12.003; Linseele V, 2013, STUDIES EARLY NEAR E, P97; Liu ZY, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028062; Marshall MH, 2011, GLOBAL PLANET CHANGE, V78, P147, DOI 10.1016/j.gloplacha.2011.06.004; Mayaux P, 2003, 20665 EUR EN; PACHUR HJ, 1987, SCIENCE, V237, P298, DOI 10.1126/science.237.4812.298; Padoan M, 2011, GEOCHIM COSMOCHIM AC, V75, P3627, DOI 10.1016/j.gca.2011.03.042; PRAHL FG, 1988, GEOCHIM COSMOCHIM AC, V52, P2303, DOI 10.1016/0016-7037(88)90132-9; Rohling EJ, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2007PA001437; Rohling EJ, 2002, DROUGHTS FOOD CULTUR, P35; Schouten S, 2007, ANAL CHEM, V79, P2940, DOI 10.1021/ac062339v; Shanahan TM, 2006, PALAEOGEOGR PALAEOCL, V242, P287, DOI 10.1016/j.palaeo.2006.06.007; Stock F, 2013, AFR ARCHAEOL REV, V30, P51, DOI 10.1007/s10437-013-9131-6; Ternois Y, 1997, DEEP-SEA RES PT I, V44, P271, DOI 10.1016/S0967-0637(97)89915-3; Tierney JE, 2013, SCIENCE, V342, P843, DOI 10.1126/science.1240411; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Williams M, 2006, QUATERNARY SCI REV, V25, P2651, DOI 10.1016/j.quascirev.2005.07.019	59	25	26	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115958	10.1371/journal.pone.0115958	http://dx.doi.org/10.1371/journal.pone.0115958			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551633	Green Published, gold, Green Accepted			2022-12-26	WOS:000347119100082
J	Ronn, PF; Smith, LS; Andersen, GS; Carstensen, B; Bjerregaard, P; Jorgensen, ME				Ronn, Pernille Falberg; Smith, Laerke Steenberg; Andersen, Gregers Stig; Carstensen, Bendix; Bjerregaard, Peter; Jorgensen, Marit Eika			Birth Weight and Risk of Adiposity among Adult Inuit in Greenland	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; BODY-COMPOSITION; SUBCUTANEOUS FAT; VISCERAL FAT; OBESITY; ASSOCIATION; SIZE; ENVIRONMENT; POPULATION; DISEASE	Objective: The Inuit population in Greenland has undergone rapid socioeconomic and nutritional changes simultaneously with an increasing prevalence of obesity. Therefore, the objective was to examine fetal programming as part of the aetiology of obesity among Inuit in Greenland by investigating the association between birth weight and measures of body composition and fat distribution in adulthood. Methods: The study was based on cross-sectional data from a total of 1,473 adults aged 18-61 years in two population-based surveys conducted in Greenland between 1999-2001 and 2005-2010. Information on birth weight was collected from birth records. Adiposity was assessed by anthropometry, fat mass index (FMI), fat-free mass index (FFMI), and visceral (VAT) and subcutaneous adipose tissue (SAT) estimated by ultrasound. The associations to birth weight were analyzed using linear regression models and quadratic splines. Analyses were stratified by sex, and adjusted for age, birthplace, ancestry and family history of obesity. Results: Spline analyses showed linear relations between birth weight and adult adiposity. In multiple regression analyses, birth weight was positively associated with BMI, waist circumference, FMI, FFMI and SAT with generally weaker associations among women compared to men. Birth weight was only associated with VAT after additional adjustment for waist circumference and appeared to be specific and inverse for men only. Conclusions: Higher birth weight among Inuit was associated with adiposity in adulthood. More studies are needed to explore a potential inverse association between birth size and VAT.	[Ronn, Pernille Falberg; Smith, Laerke Steenberg; Andersen, Gregers Stig; Carstensen, Bendix; Jorgensen, Marit Eika] Steno Diabet Ctr AS, Clin Epidemiol, Gentofte, Denmark; [Bjerregaard, Peter] Univ Southern Denmark, Natl Inst Publ Hlth, Ctr Hlth Res Greenland, Copenhagen, Denmark	Steno Diabetes Center; University of Southern Denmark	Ronn, PF (corresponding author), Steno Diabet Ctr AS, Clin Epidemiol, Gentofte, Denmark.	prfr@steno.dk	Bjerregaard, Peter/ABD-8894-2020; andersen, gregers/AAG-3685-2021; Rønn, Pernille Falberg/AAT-3523-2021	Bjerregaard, Peter/0000-0001-7153-8447; andersen, gregers/0000-0001-6125-300X; Rønn, Pernille Falberg/0000-0001-6338-6615; Jorgensen, Marit Eika/0000-0001-8356-5565	Karen Elise Jensen's Foundation; NunaFonden; Medical Research Council of Denmark; Medical Research Council of Greenland; Commission for Scientific Research in Greenland	Karen Elise Jensen's Foundation; NunaFonden; Medical Research Council of Denmark; Medical Research Council of Greenland; Commission for Scientific Research in Greenland	The work was supported by Karen Elise Jensen's Foundation, NunaFonden, Medical Research Council of Denmark, Medical Research Council of Greenland, and the Commission for Scientific Research in Greenland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Bjerregaard P, 1996, Arctic Med Res, V55, P156; Bjerregaard P, 2011, INUIT HLTH TRANSITIO; BJERREGAARD P, 2007, BEFOLKNINGSUNDERSOGE; Bjerregaard P., 2003, INT J CIRCUMPOL HEAL, V62, P3, DOI [10.3402/ijch.v62i0.18212, DOI 10.3402/IJCH.V62I0.18212]; CARSTENSEN B, PACKAGE STAT ANAL EP; Choi CS, 2000, DIABETES RES CLIN PR, V49, P53, DOI 10.1016/S0168-8227(00)00131-5; Chomtho S, 2008, AM J CLIN NUTR, V88, P1040, DOI 10.1093/ajcn/88.4.1040; Cottrell EC, 2008, PHYSIOL BEHAV, V94, P17, DOI 10.1016/j.physbeh.2007.11.017; Demerath EW, 2009, OBESITY, V17, P2060, DOI 10.1038/oby.2009.105; GLUCKMAN PD, 2009, EARLY LIFE ORIGINS O; Golan R, 2012, DIABETES CARE, V35, P640, DOI 10.2337/dc11-1583; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Harding J., 2004, Fetal nutrition and adult disease: programming of chronic disease through fetal exposure to undernutrition, P21, DOI 10.1079/9780851998213.0021; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Jorgensen ME, 2012, DIABETIC MED, V29, P755, DOI 10.1111/j.1464-5491.2011.03527.x; Jorgensen ME, 2008, ATHEROSCLEROSIS, V196, P772, DOI 10.1016/j.atherosclerosis.2007.01.008; Jorgensen ME, 2013, DIABETES CARE, V36, P2988, DOI 10.2337/dc12-2703; Jorgensen ME, 2003, INT J OBESITY, V27, P1507, DOI 10.1038/sj.ijo.0802434; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; McNeely MJ, 2007, OBESITY, V15, P816, DOI 10.1038/oby.2007.596; Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883; Niclasen B, 2007, INT J CIRCUMPOL HEAL, V66, P215, DOI 10.3402/ijch.v66i3.18257; Philipsen A, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.23; Pilgaard K, 2010, J DEV ORIG HLTH DIS, V1, P319, DOI 10.1017/S2040174410000413; Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280; Power C, 2010, ATHEROSCLEROSIS, V211, P643, DOI 10.1016/j.atherosclerosis.2010.03.015; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Rogers I, 2003, INT J OBESITY, V27, P755, DOI 10.1038/sj.ijo.0802316; Rolfe ED, 2010, AM J CLIN NUTR, V92, P347, DOI 10.3945/ajcn.2010.29247; Sachdev HS, 2005, AM J CLIN NUTR, V82, P456, DOI 10.1093/ajcn/82.2.456; Schellong K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047776; Singhal A, 2003, AM J CLIN NUTR, V77, P726, DOI 10.1093/ajcn/77.3.726; Stolk RP, 2001, INT J OBESITY, V25, P1346, DOI 10.1038/sj.ijo.0801734; te Velde SJ, 2003, OBES RES, V11, P202, DOI 10.1038/oby.2003.32; Tu YK, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-2; Wells JCK, 2001, ARCH DIS CHILD, V85, P67, DOI 10.1136/adc.85.1.67; Wells JCK, 2002, AM J PHYS ANTHROPOL, V119, P276, DOI 10.1002/ajpa.10137; Wells JCK, 2002, J THEOR BIOL, V214, P413, DOI 10.1006/jtbi.2001.2465; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Yliharsila H, 2007, INT J OBESITY, V31, P1392, DOI 10.1038/sj.ijo.0803612	41	7	9	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115976	10.1371/journal.pone.0115976	http://dx.doi.org/10.1371/journal.pone.0115976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551382	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100085
J	Wall, CC; Lembke, C; Hu, CM; Mann, DA				Wall, Carrie C.; Lembke, Chad; Hu, Chuanmin; Mann, David A.			Fish Sound Production in the Presence of Harmful Algal Blooms in the Eastern Gulf of Mexico	PLOS ONE			English	Article							OPHIDION-MARGINATUM OPHIDIIDAE; ATLANTIC CROAKER; DIEL PERIODICITY; GLIDERS; HYPOXIA; SLOCUM	This paper presents the first known research to examine sound production by fishes during harmful algal blooms (HABs). Most fish sound production is species-specific and repetitive, enabling passive acoustic monitoring to identify the distribution and behavior of soniferous species. Autonomous gliders that collect passive acoustic data and environmental data concurrently can be used to establish the oceanographic conditions surrounding sound-producing organisms. Three passive acoustic glider missions were conducted off west-central Florida in October 2011, and September and October 2012. The deployment period for two missions was dictated by the presence of red tide events with the glider path specifically set to encounter toxic Karenia brevis blooms (a.k.a red tides). Oceanographic conditions measured by the glider were significantly correlated to the variation in sounds from six known or suspected species of fish across the three missions with depth consistently being the most significant factor. At the time and space scales of this study, there was no detectable effect of red tide on sound production. Sounds were still recorded within red tide-affected waters from species with overlapping depth ranges. These results suggest that the fishes studied here did not alter their sound production nor migrate out of red tide-affected areas. Although these results are preliminary because of the limited measurements, the data and methods presented here provide a proof of principle and could serve as protocol for future studies on the effects of algal blooms on the behavior of soniferous fishes. To fully capture the effects of episodic events, we suggest that stationary or vertically profiling acoustic recorders and environmental sampling be used as a complement to glider measurements.	[Wall, Carrie C.; Hu, Chuanmin] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Lembke, Chad] Univ S Florida, Ctr Ocean Technol, St Petersburg, FL 33701 USA; [Mann, David A.] Loggerhead Instruments Inc, Sarasota, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Wall, CC (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA.	carrie.bell@colorado.edu	Hu, Chuanmin/AAB-9604-2021	Hu, Chuanmin/0000-0003-3949-6560; Higgs, Dennis/0000-0002-0771-4642	State of Florida via the College of Marine Science Interdisciplinary Research Grant Program [NFI2010]; BP/Gulf of Mexico Research Initiative; Center for Integrated Modeling and Analysis of Gulf Ecosystems (C-IMAGE) [SA 12-10/GoMRI-007]; U.S. NASA Ocean Biology and Biogeochemistry (OBB) program [NNX13AD08G]	State of Florida via the College of Marine Science Interdisciplinary Research Grant Program; BP/Gulf of Mexico Research Initiative; Center for Integrated Modeling and Analysis of Gulf Ecosystems (C-IMAGE); U.S. NASA Ocean Biology and Biogeochemistry (OBB) program	The authors received no specific funding for this work. This manuscript is a result of an unfunded analysis from an opportunistic dataset. The funding sources for the glider operations that allowed for this opportunistic dataset were provided by the State of Florida via the College of Marine Science Interdisciplinary Research Grant Program, NFI2010, and the Gulf of Mexico Ocean Observing System (GCOOS), NA08NOS4730411 99-S120305. Funding for the satellite imagery was provided by the BP/Gulf of Mexico Research Initiative with the Center for Integrated Modeling and Analysis of Gulf Ecosystems (C-IMAGE) Contract, # SA 12-10/GoMRI-007, and the U.S. NASA Ocean Biology and Biogeochemistry (OBB) program, NNX13AD08G.	Amorim Maria Clara P., 2006, P71; Anderson D.M., 1989, P11; Baumgartner MF, 2008, LIMNOL OCEANOGR, V53, P2197, DOI 10.4319/lo.2008.53.5_part_2.2197; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brand LE, 2007, HARMFUL ALGAE, V6, P232, DOI 10.1016/j.hal.2006.08.005; BRANTLEY RK, 1994, ETHOLOGY, V96, P213, DOI 10.1111/j.1439-0310.1994.tb01011.x; Connaughton MA, 2002, LISTENING FISH PASSI, P15; COUTANT CC, 1985, T AM FISH SOC, V114, P31, DOI 10.1577/1548-8659(1985)114<31:SBTADO>2.0.CO;2; Craig JK, 2005, MAR ECOL PROG SER, V294, P79, DOI 10.3354/meps294079; Davis RE, 2008, LIMNOL OCEANOGR, V53, P2151, DOI 10.4319/lo.2008.53.5_part_2.2151; Fine ML, 2004, J ACOUST SOC AM, V116, P1271, DOI 10.1121/1.1736271; Fish M. P., 1970, SOUNDS W N ATLANTIC; Hawkins A.D., 1986, P114; Hollings B., 2010, OCEANS 2010 IEEE SYD, P1, DOI [DOI 10.1109/OCEANSSYD.2010.5603630, 10.1109/OCEANSSYD.2010.5603630]; Johnson KS, 2009, PROSPECTS GLOBAL ARR, V22, P217; Jones D. L., 2012, FATHOM TOOLBOX MATLA; Kasumyan A.O., 2008, J ICHTHYOL, V48, P981, DOI [10.1134/S0032945208110039, DOI 10.1134/S0032945208110039]; Kirkpatrick B, 2004, HARMFUL ALGAE, V3, P99, DOI 10.1016/j.hal.2003.08.005; Kuznetsov MY, 2009, ACOUST PHYS+, V55, P866, DOI 10.1134/S1063771009060219; Ladich F, 2004, SENSES OF FISH: ADAPTATIONS FOR THE RECEPTION OF NATURAL STIMULI, P210; Lammers MO, 2008, J ACOUST SOC AM, V123, P1720, DOI 10.1121/1.2836780; Landsberg JH, 2009, HARMFUL ALGAE, V8, P598, DOI 10.1016/j.hal.2008.11.010; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lobel Phillip S., 2002, Bioacoustics, V12, P286; Lobel PS, 2010, REPRODUCTION AND SEXUALITY IN MARINE FISHES: PATTERNS AND PROCESSES, P307; Locascio JV, 2008, T AM FISH SOC, V137, P606, DOI 10.1577/T06-069.1; Locascio JV, 2005, BIOL LETTERS, V1, P362, DOI 10.1098/rsbl.2005.0309; Luczkovich JJ, 2008, T AM FISH SOC, V137, P533, DOI 10.1577/T06-258.1; Mann DA, 2009, MAR ECOL PROG SER, V375, P65, DOI 10.3354/meps07720; Mann DA, 1997, COPEIA, P610, DOI 10.2307/1447568; Mann David A., 1995, Bioacoustics, V6, P199; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Moline MA, 2005, J ATMOS OCEAN TECH, V22, P1797, DOI 10.1175/JTECH1809.1; Nelson MD, 2011, AQUAT BIOL, V12, P97, DOI 10.3354/ab00325; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rao R, 1995, QUESTIIO, V17, P23; RETZER ME, 1991, COPEIA, P703; Ripley JL, 2007, MAR ENVIRON RES, V63, P350, DOI 10.1016/j.marenvres.2006.10.003; Robbins IC, 2006, HARMFUL ALGAE, V5, P749, DOI 10.1016/j.hal.2006.03.005; Rountree Rodney A., 2002, Bioacoustics, V12, P240; Rudnick DL, 2004, MAR TECHNOL SOC J, V38, P73, DOI 10.4031/002533204787522703; Schofield O, 2005, HARMFUL ALGAL BLOOMS; Schofield O, 2007, J FIELD ROBOT, V24, P473, DOI 10.1002/rob.20200; Sellner KG, 2003, J IND MICROBIOL BIOT, V30, P383, DOI 10.1007/s10295-003-0074-9; Sprague MW, 2001, COPEIA, P854, DOI 10.1643/0045-8511(2001)001[0854:DSCEOM]2.0.CO;2; Steidinger KA, 2009, HARMFUL ALGAE, V8, P549, DOI 10.1016/j.hal.2008.11.009; Van Parijs SM, 2009, MAR ECOL PROG SER, V395, P21, DOI 10.3354/meps08123; VANDENWOLLENBERG AL, 1977, PSYCHOMETRIKA, V42, P207, DOI 10.1007/BF02294050; Vargo GA, 2009, HARMFUL ALGAE, V8, P573, DOI 10.1016/j.hal.2008.11.002; Wall CC, 2014, J FISH BIOL, V85, P1470, DOI 10.1111/jfb.12500; Wall CC, 2013, MAR ECOL PROG SER, V484, P173, DOI 10.3354/meps10268; Wall CC, 2012, MAR ECOL PROG SER, V449, P55, DOI 10.3354/meps09549; Webb DC, 2001, IEEE J OCEANIC ENG, V26, P447, DOI 10.1109/48.972077; Zhao J, 2013, HARMFUL ALGAE, V29, P22, DOI 10.1016/j.hal.2013.07.004	55	2	2	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114893	10.1371/journal.pone.0114893	http://dx.doi.org/10.1371/journal.pone.0114893			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551564	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100018
J	Fossepre, M; Leherte, L; Laaksonen, A; Vercauteren, DP				Fossepre, Mathieu; Leherte, Laurence; Laaksonen, Aatto; Vercauteren, Daniel P.			On the Modularity of the Intrinsic Flexibility of the mu Opioid Receptor: A Computational Study	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; MOLECULAR-DYNAMICS SIMULATIONS; CRYSTAL-STRUCTURE; BINDING-SITE; TRANSFER-RNA; SODIUM-IONS; ACTIVATION; RHODOPSIN; INSIGHTS; GPCRS	The mu opioid receptor (mu OR), the principal target to control pain, belongs to the G protein-coupled receptors (GPCRs) family, one of the most highlighted protein families due to their importance as therapeutic targets. The conformational flexibility of GPCRs is one of their essential characteristics as they take part in ligand recognition and subsequent activation or inactivation mechanisms. It is assessed that the intrinsic mechanical properties of the mu OR, more specifically its particular flexibility behavior, would facilitate the accomplishment of specific biological functions, at least in their first steps, even in the absence of a ligand or any chemical species usually present in its biological environment. The study of the mechanical properties of the mu OR would thus bring some indications regarding the highly efficient ability of the mu OR to transduce cellular message. We therefore investigate the intrinsic flexibility of the mu OR in its apo-form using all-atom Molecular Dynamics simulations at the sub-microsecond time scale. We particularly consider the mu OR embedded in a simplified membrane model without specific ions, particular lipids, such as cholesterol moieties, or any other chemical species that could affect the flexibility of the mu OR. Our analyses highlighted an important local effect due to the various bendability of the helices resulting in a diversity of shape and volume sizes adopted by the mu OR binding site. Such property explains why the mu OR can interact with ligands presenting highly diverse structural geometry. By investigating the topology of the mu OR binding site, a conformational global effect is depicted: the correlation between the motional modes of the extra-and intracellular parts of mu OR on one hand, along with a clear rigidity of the central mu OR domain on the other hand. Our results show how the modularity of the mu OR flexibility is related to its preability to activate and to present a basal activity.	[Fossepre, Mathieu; Leherte, Laurence; Vercauteren, Daniel P.] Univ Namur UNamur, Lab Physicochim Informat, Unite Chim Phys Theor & Struct, Namur, Belgium; [Fossepre, Mathieu; Laaksonen, Aatto] Stockholm Univ, Arrhenius Lab, Div Phys Chem, S-10691 Stockholm, Sweden; [Fossepre, Mathieu; Leherte, Laurence; Vercauteren, Daniel P.] Univ Namur UNamur, Namur Med & Drug Innovat Ctr NAMEDIC, Namur, Belgium; [Laaksonen, Aatto] Univ Stellenbosch, Stellenbosch Inst Adv Study STIAS, Wallenberg Res Ctr, ZA-7600 Stellenbosch, South Africa	Stockholm University; Stellenbosch University	Fossepre, M (corresponding author), Univ Namur UNamur, Lab Physicochim Informat, Unite Chim Phys Theor & Struct, Namur, Belgium.	Mathieu.fossepre@unamur.be	Laaksonen, Aatto/G-7904-2012	Laaksonen, Aatto/0000-0001-9783-4535; Fossepre, Mathieu/0000-0003-1506-3146; Leherte, Laurence/0000-0001-8468-5462	Belgian National Fund for Research; Belgian Science Policy Office [7/05]; Swedish Science Council (VR)	Belgian National Fund for Research(Fonds de la Recherche Scientifique - FNRS); Belgian Science Policy Office(Belgian Federal Science Policy Office); Swedish Science Council (VR)(Swedish Research Council)	MF thanks the Belgian National Fund for Research (F.R.S.-FNRS) for his F.R.I.A. doctoral scholarship. MF, LL, and DPV thank the Interuniversity Attraction Poles Programmes no 7/05: "Functional supramolecular systems'' initiated by the Belgian Science Policy Office for partial financial support. AL wishes to thank the Swedish Science Council (VR) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MP, 1989, MOL SIMULAT, V4, P1, DOI 10.1080/08927028908021960; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Benyamin R, 2008, PAIN PHYSICIAN, V11, pS105; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Chandrasekhar S, 1943, REV MOD PHYS, V15, P0001, DOI 10.1103/RevModPhys.15.1; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Costanzi S, 2014, ADV EXP MED BIOL, V796, P3, DOI 10.1007/978-94-007-7423-0_1; Cui X, 2013, EUR J PHARMACOL, V702, P309, DOI 10.1016/j.ejphar.2013.01.060; Dahl ACE, 2012, BIOINFORMATICS, V28, P2193, DOI 10.1093/bioinformatics/bts357; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Bakker P, 2002, RAMPAGE WEBSERVER; Fanelli F, 2011, CHEM REV, V111, pPR438, DOI 10.1021/cr100437t; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Georgoussi Z, 2012, CURR DRUG TARGETS, V13, P80, DOI 10.2174/138945012798868470; Ghanouni P, 2000, J BIOL CHEM, V275, P3121, DOI 10.1074/jbc.275.5.3121; Ghosh A, 2014, COMPUT BIOL CHEM, V48, P29, DOI 10.1016/j.compbiolchem.2013.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; GOLDSTEIN A, 1989, MOL PHARMACOL, V36, P265; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Grossfield A, 2011, BBA-BIOMEMBRANES, V1808, P1868, DOI 10.1016/j.bbamem.2011.03.010; Gutierrez-de-Teran H, 2013, BIOCHEM SOC T, V41, P205, DOI 10.1042/BST20120287; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jafurulla M, 2013, CURR MED CHEM, V20, P47; Johnston JM, 2011, CURR OPIN STRUC BIOL, V21, P552, DOI 10.1016/j.sbi.2011.06.008; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kelley C., 2011, GNUPLOT 4 5 INTERACT; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Ko J, 2011, NUCLEIC ACIDS RES, V39, pW210, DOI 10.1093/nar/gkr352; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kooistra AJ, 2014, ADV EXP MED BIOL, V796, P129, DOI 10.1007/978-94-007-7423-0_7; Lee YS, 2010, BIOORG MED CHEM LETT, V20, P4080, DOI 10.1016/j.bmcl.2010.05.078; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; Mahmood MI, 2013, CHEM PHARM BULL, V61, P426; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Meye FJ, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.130; Mondal M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01357; Ng HW, 2013, J CHEM INF MODEL, V53, P1168, DOI 10.1021/ci300610w; Oates J., 2011, CURR OPIN CHEM BIOL, V21, P1; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park PSH, 2012, CURR MED CHEM, V19, P1146; Parrill AL, 2011, PHARMACEUTICALS, V4, P7, DOI 10.3390/ph4010007; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pyrkosz AB, 2010, J MOL BIOL, V397, P1350, DOI 10.1016/j.jmb.2010.02.003; Rodriguez D, 2011, BIOCHEMISTRY-US, V50, P4194, DOI 10.1021/bi200100t; Romanowska J, 2012, J CHEM THEORY COMPUT, V8, P2588, DOI 10.1021/ct300206j; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sadee W, 2005, LIFE SCI, V76, P1427, DOI 10.1016/j.lfs.2004.10.024; Schiller PW, 2010, LIFE SCI, V86, P598, DOI 10.1016/j.lfs.2009.02.025; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Shang Y, 2014, BIOCHEMISTRY-US, V53, P5140, DOI 10.1021/bi5006915; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Shim J, 2013, J PHYS CHEM B, V117, P7907, DOI 10.1021/jp404238n; STEINBACH PJ, 1994, J COMPUT CHEM, V15, P667, DOI 10.1002/jcc.540150702; Stevens RC, 2013, NAT REV DRUG DISCOV, V12, P25, DOI 10.1038/nrd3859; Tsoulos IG, 2011, COMPUT PHYS COMMUN, V182, P834, DOI 10.1016/j.cpc.2010.11.032; Unal H, 2012, TRENDS PHARMACOL SCI, V33, P79, DOI 10.1016/j.tips.2011.09.007; Vaidehi N, 2010, DRUG DISCOV TODAY, V15, P951, DOI 10.1016/j.drudis.2010.08.018; Velazquez-Muriel JA, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-6; Vuckovic S, 2009, CURR MED CHEM, V16, P2468, DOI 10.2174/092986709788682074; Wang DX, 2004, J PHARMACOL EXP THER, V308, P512, DOI 10.1124/jpet.103.054049; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yu J, 2010, BIOINFORMATICS, V26, P46, DOI 10.1093/bioinformatics/btp599; Yuan SG, 2013, ANGEW CHEM INT EDIT, V52, P10112, DOI 10.1002/anie.201302244; Zohar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008752; Zou YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046039	72	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115856	10.1371/journal.pone.0115856	http://dx.doi.org/10.1371/journal.pone.0115856			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549261	Green Published, gold			2022-12-26	WOS:000347063500030
J	Li, HL; Zhang, ZF; Bi, Y; Yang, DD; Zhang, LT; Liu, JG				Li, Hailong; Zhang, Zhifeng; Bi, Ying; Yang, Dandan; Zhang, Litao; Liu, Jianguo			Expression Characteristics of beta-Catenin in Scallop Chlamys farreri Gonads and Its Role as a Potential Upstream Gene of Dax1 through Canonical Wnt Signalling Pathway Regulating the Spermatogenesis	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; STEM-CELLS; MECHANISMS; INHIBITOR; CLONING; APC; DICKKOPF-1; QUERCETIN; RECEPTOR; POLARITY	beta-catenin is a key signaling molecule in the canonical Wnt pathway, which is involved in animal development. However, little information has been reported for beta-catenin in bivalves. In the present study, we cloned a homolog of beta-catenin from the scallop Chlamys farreri and determined its expression characteristics. The full-length cDNA of beta-catenin was 3,353 bp, including a 2,511 bp open reading frame that encoded a predicted 836 amino acid protein. Level of the beta-catenin mRNA increased significantly (P<0.05) with C. farreri gonadal development and presented a sexually dimorphic expression pattern in the gonads, which was significantly high in ovaries detected by quantitative real-time polymerase chain reaction (qRT-PCR). Immunohistochemical analysis revealed that the beta-catenin was mainly located in germ cells of the gonads, with obvious positive immune signals in the oogonia and oocytes of ovaries as well as in the spermatogonia and spermatocytes of testes, implying beta-catenin might be involved in the gametogenesis of C. farreri. Furthermore, when 0.1 mu g/mL and 0.2 mu g/mL DKK-1 (an inhibitor of the canonical Wnt pathway) were added in vitro to culture medium containing testis cells of C. farreri, the expression of beta-catenin decreased significantly detected by qRT-PCR (P<0.05), suggesting the canonical Wnt signal pathway exists in the scallop testis. Similarly, when 50 mu M and 100 mu M quercetin (an inhibitor of beta-catenin) were added in vitro to the culture system, Dax1 expression was significantly down-regulated compared with controls (P<0.05), implying the beta-catenin is an upstream gene of Dax1 and is involved in the regulation of C. farreri spermatogenesis.	[Li, Hailong; Zhang, Zhifeng; Bi, Ying; Yang, Dandan; Zhang, Litao; Liu, Jianguo] Ocean Univ China, Minist Educ, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China; [Li, Hailong] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China	Ocean University of China; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS	Zhang, ZF (corresponding author), Ocean Univ China, Minist Educ, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China.	zzfp107@ouc.edu.cn	YANG, Dan/HHD-2733-2022		National High Technology Research and Development Program of China [2012AA10A402]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program of China (2012AA10A402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2000, CYTOKINE GROWTH F R, V11, P273, DOI 10.1016/S1359-6101(00)00011-3; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Byrum CA, 2009, DEV DYNAM, V238, P1649, DOI 10.1002/dvdy.21978; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; El Wakil A, 2011, MOL CELL ENDOCRINOL, V332, P32, DOI 10.1016/j.mce.2010.11.014; Freese JL, 2010, NEUROBIOL DIS, V38, P148, DOI 10.1016/j.nbd.2009.09.003; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200; Guo HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051005; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Hobmayer E, 1996, GENE, V172, P155, DOI 10.1016/0378-1119(96)00162-X; Hu XL, 2006, AQUAC RES, V37, P1187, DOI 10.1111/j.1365-2109.2006.01546.x; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Kawakami Y, 2006, GENE DEV, V20, P3232, DOI 10.1101/gad.1475106; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Li HL, 2014, J OCEAN U CHINA, V13, P696, DOI 10.1007/s11802-014-2299-9; Liao C. Y., 1983, J FISH CHINA, V1, P1; Lin G, 2008, DEV BIOL, V316, P323, DOI 10.1016/j.ydbio.2008.01.032; Liu CF, 2009, HUM MOL GENET, V18, P405, DOI 10.1093/hmg/ddn362; Liu JG, 2014, J STEROID BIOCHEM, V141, P77, DOI 10.1016/j.jsbmb.2014.01.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu JF, 1997, GENE, V196, P201, DOI 10.1016/S0378-1119(97)00228-X; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mani P, 2010, DEV DYNAM, V239, P354, DOI 10.1002/dvdy.22072; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; McFarland KA, 2008, DEV BIOL, V318, P162, DOI 10.1016/j.ydbio.2008.03.016; Mizusaki H, 2003, MOL ENDOCRINOL, V17, P507, DOI 10.1210/me.2002-0362; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Rubinfeld B, 1997, CANCER RES, V57, P4624; Schneider SQ, 2003, J EXP ZOOL PART B, V295B, P25, DOI 10.1002/jez.b.00006; Shan BE, 2009, CANCER INVEST, V27, P604, DOI 10.1080/07357900802337191; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; Strutt D, 2012, GENETICS, V192, P1295, DOI 10.1534/genetics.112.144592; Sugimura R, 2010, BIRTH DEFECTS RES C, V90, P243, DOI 10.1002/bdrc.20195; von Kries JP, 2000, NAT STRUCT BIOL, V7, P800; Wang HY, 2003, SCIENCE, V300, P1529, DOI 10.1126/science.1085259; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Woll PS, 2008, BLOOD, V111, P122, DOI 10.1182/blood-2007-04-084186; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021; Yang F. Y., 2009, J ANHUI AGR SCI, V37, P4073; Yang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017089; Zhang H, 2012, COMP BIOCHEM PHYS C, V156, P51, DOI 10.1016/j.cbpc.2012.03.007; Zhou QR, 2010, CHIN J OCEANOL LIMN, V28, P37, DOI 10.1007/s00343-010-9231-y; Zinovyeva AY, 2008, GENETICS, V179, P1357, DOI 10.1534/genetics.108.090290	53	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115917	10.1371/journal.pone.0115917	http://dx.doi.org/10.1371/journal.pone.0115917			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549092	gold, Green Published, Green Submitted			2022-12-26	WOS:000347063500039
J	Nissan, N; Golan, T; Furman-Haran, E; Apter, S; Inbar, Y; Ariche, A; Bar-Zakay, B; Goldes, Y; Schvimer, M; Grobgeld, D; Degani, H				Nissan, Noam; Golan, Talia; Furman-Haran, Edna; Apter, Sara; Inbar, Yael; Ariche, Arie; Bar-Zakay, Barak; Goldes, Yuri; Schvimer, Michael; Grobgeld, Dov; Degani, Hadassa			Diffusion Tensor Magnetic Resonance Imaging of the Pancreas	PLOS ONE			English	Article							INTRAVOXEL-INCOHERENT-MOTION; WEIGHTED MRI; B-VALUES; KIDNEY; BODY; DIFFERENTIATION; ARCHITECTURE; CARCINOMA; DIAGNOSIS; REDUCTION	Purpose: To develop a diffusion-tensor-imaging (DTI) protocol that is sensitive to the complex diffusion and perfusion properties of the healthy and malignant pancreas tissues. Materials and Methods: Twenty-eight healthy volunteers and nine patients with pancreatic-ductal-adenocacinoma (PDAC), were scanned at 3T with T2-weighted and DTI sequences. Healthy volunteers were also scanned with multi-b diffusion-weighted-imaging (DWI), whereas a standard clinical protocol complemented the PDAC patients' scans. Image processing at pixel resolution yielded parametric maps of three directional diffusion coefficients lambda 1, lambda 2, lambda 3, apparent diffusion coefficient (ADC), and fractional anisotropy (FA), as well as a lambda 1-vector map, and a main diffusion-direction map. Results: DTI measurements of healthy pancreatic tissue at b-values 0,500 s/mm(2) yielded: lambda 1=(2.65 +/- 0.35) x 10(-3), lambda 2 = (1.87 +/- 0.22) x 10(-3), lambda 3=(1.20 +/- 0.18) x 10(-3), ADC=(1.91 +/- 0.22) x10(-3) (all in mm(2)/s units) and FA=0.38 +/- 0.06. Using b-values of 100,500 s/mm(2) led to a significant reduction in lambda 1, lambda 2, lambda 3 and ADC (p<.0001) and a significant increase (p<0.0001) in FA. The reduction in the diffusion coefficients suggested a contribution of a fast intra-voxel-incoherent-motion (IVIM) component at b <= 100 s/mm(2), which was confirmed by the multi-b DWI results. In PDACs, lambda 1, lambda 2, lambda 3 and ADC in both 0,500 s/mm(2) and 100,500 s/mm(2) b-values sets, as well as the reduction in these diffusion coefficients between the two sets, were significantly lower in comparison to the distal normal pancreatic tissue, suggesting higher cellularity and diminution of the fast-IVIM component in the cancer tissue. Conclusion: DTI using two reference b-values 0 and 100 s/mm(2) enabled characterization of the water diffusion and anisotropy of the healthy pancreas, taking into account a contribution of IVIM. The reduction in the diffusion coefficients of PDAC, as compared to normal pancreatic tissue, and the smaller change in these coefficients in PDAC when the reference b-value was modified from 0 to 100 s/mm(2), helped identifying the presence of malignancy.	[Nissan, Noam; Grobgeld, Dov; Degani, Hadassa] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Golan, Talia; Apter, Sara; Inbar, Yael; Ariche, Arie; Bar-Zakay, Barak; Goldes, Yuri; Schvimer, Michael] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Golan, Talia] Sheba Med Ctr, Inst Oncol, Tel Hashomer, Israel; [Furman-Haran, Edna] Weizmann Inst Sci, Unit Biol Serv, IL-76100 Rehovot, Israel; [Apter, Sara; Inbar, Yael] Sheba Med Ctr, Div Diagnost Imaging, Tel Hashomer, Israel; [Ariche, Arie; Bar-Zakay, Barak; Goldes, Yuri] Sheba Med Ctr, Dept Hepatopancreatobiliary Surg, Tel Hashomer, Israel; [Schvimer, Michael] Sheba Med Ctr, Dept Pathol, Tel Hashomer, Israel	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Weizmann Institute of Science; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Nissan, N (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	Noamniss@gmail.com			Weizmann Institute of Science - Chaim Sheba Medical Center Collaborative Grant in Biomedical Research [2012-4]; Lustgarten Foundation for Pancreatic Cancer Research [2012-4]	Weizmann Institute of Science - Chaim Sheba Medical Center Collaborative Grant in Biomedical Research; Lustgarten Foundation for Pancreatic Cancer Research	This study was supported by Weizmann Institute of Science - Chaim Sheba Medical Center Collaborative Grant in Biomedical Research (2012-4) and by the Lustgarten Foundation (http://www.lustgarten.org/) for Pancreatic Cancer Research (2012-4). H.D. is the incumbent of the Fred and Andrea Fallek Professorial Chair for Breast Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bakir B, 2010, EUR J RADIOL, V74, P214, DOI 10.1016/j.ejrad.2009.02.003; Bali MA, 2011, RADIOLOGY, V261, P456, DOI 10.1148/radiol.11103515; Concia M, 2014, INVEST RADIOL, V49, P93, DOI 10.1097/RLI.0b013e3182a71cc3; Cutajar M, 2011, EUR J RADIOL, V80, pE263, DOI 10.1016/j.ejrad.2010.12.018; de Heer P, 2012, MAGN RESON MED, V68, P1317, DOI 10.1002/mrm.24438; Dietrich O, 2008, EUR J RADIOL, V65, P29, DOI 10.1016/j.ejrad.2007.11.005; Dietrich O, 2010, EUR J RADIOL, V76, P314, DOI 10.1016/j.ejrad.2010.02.018; Eyal E, 2012, INVEST RADIOL, V47, P284, DOI 10.1097/RLI.0b013e3182438e5d; Fattahi R, 2009, J MAGN RESON IMAGING, V29, P350, DOI 10.1002/jmri.21651; Fukukura Y, 2012, RADIOLOGY, V263, P732, DOI 10.1148/radiol.12111222; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510; Herrmann J, 2013, J MAGN RESON IMAGING, V37, P886, DOI 10.1002/jmri.23871; Heusch P, 2013, J MAGN RESON IMAGING, V37, P233, DOI 10.1002/jmri.23751; Heyn C, 2012, J MAGN RESON IMAGING, V36, P1037, DOI 10.1002/jmri.23708; Hueper K, 2012, INVEST RADIOL, V47, P430, DOI 10.1097/RLI.0b013e31824f272d; In't Veld P, 2010, ADV EXP MED BIOL, V654, P1, DOI 10.1007/978-90-481-3271-3_1; Jambawalikar S, 2010, SKELETAL RADIOL, V39, P1073, DOI 10.1007/s00256-010-0974-5; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Kang KM, 2014, RADIOLOGY, V270, P444, DOI 10.1148/radiol.13122712; Kido A, 2010, ACTA RADIOL, V51, P1059, DOI 10.3109/02841851.2010.504741; Klauss M, 2013, INVEST RADIOL, V48, P129, DOI 10.1097/RLI.0b013e31827ac0f1; Klauss M, 2011, INVEST RADIOL, V46, P57, DOI 10.1097/RLI.0b013e3181fb3bf2; Koh DM, 2011, AM J ROENTGENOL, V196, P1351, DOI 10.2214/AJR.10.5515; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Lee JW, 2006, INVEST RADIOL, V41, P553, DOI 10.1097/01.rli.0000221325.03899.48; Lee SS, 2008, J MAGN RESON IMAGING, V28, P928, DOI 10.1002/jmri.21508; Legrand L, 2014, ABDOM IMAGING; Lemke A, 2011, MAGN RESON IMAGING, V29, P766, DOI 10.1016/j.mri.2011.03.004; Lemke A, 2010, MAGN RESON MED, V64, P1580, DOI 10.1002/mrm.22565; Lemke A, 2009, INVEST RADIOL, V44, P769, DOI 10.1097/RLI.0b013e3181b62271; Low G, 2011, RADIOGRAPHICS, V31, P993, DOI 10.1148/rg.314105731; Machann J, 2008, PHYS MEDICA, V24, P63, DOI 10.1016/j.ejmp.2008.01.011; Manenti G, 2007, INVEST RADIOL, V42, P412, DOI 10.1097/01.rli.0000264059.46444.bf; Matsuki M, 2007, ABDOM IMAGING, V32, P481, DOI 10.1007/s00261-007-9192-6; Merkle EM, 2006, AM J ROENTGENOL, V186, P1524, DOI 10.2214/AJR.05.0932; Muhi A, 2012, J MAGN RESON IMAGING, V35, P827, DOI 10.1002/jmri.22881; Nissan N, 2014, RADIOLOGY, V271, P672, DOI 10.1148/radiol.14132084; Notohamiprodjo M, 2008, INVEST RADIOL, V43, P677, DOI 10.1097/RLI.0b013e31817d14e6; Notohamiprodjo M, 2010, INVEST RADIOL, V45, P245, DOI 10.1097/RLI.0b013e3181d83abc; Paran Y, 2004, NMR BIOMED, V17, P170, DOI 10.1002/nbm.882; Partensky C, 2013, PANCREAS, V42, P729, DOI 10.1097/MPA.0b013e318288107a; Price WS, 1998, BIOPHYS J, V74, P2259, DOI 10.1016/S0006-3495(98)77935-4; Re TJ, 2011, MAGN RESON MED, V66, P1327, DOI 10.1002/mrm.22931; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Reisert M, 2011, P 19 ANN M ISMRM MON; Ries M, 2001, J MAGN RESON IMAGING, V14, P42, DOI 10.1002/jmri.1149; Sandrasegaran K, 2010, AM J ROENTGENOL, V195, P42, DOI 10.2214/AJR.10.4421; Schoennagel BP, 2011, J MAGN RESON IMAGING, V34, P861, DOI 10.1002/jmri.22743; Sigmund EE, 2012, RADIOLOGY, V263, P758, DOI 10.1148/radiol.12111327; Sinha S, 2004, MAGN RESON MED, V52, P530, DOI 10.1002/mrm.20190; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Sunamura M, 1998, J Hepatobiliary Pancreat Surg, V5, P62, DOI 10.1007/PL00009952; Szafer A, 1995, NMR BIOMED, V8, P289, DOI 10.1002/nbm.1940080704; Taouli B, 2004, AM J ROENTGENOL, V183, P677, DOI 10.2214/ajr.183.3.1830677; Taouli B, 2008, J MAGN RESON IMAGING, V28, P89, DOI 10.1002/jmri.21227; Tirkes T, 2012, RADIOL CLIN N AM, V50, P379, DOI 10.1016/j.rcl.2012.03.003; Wang Y, 2011, J MAGN RESON IMAGING, V33, P136, DOI 10.1002/jmri.22414; Watanabe T, 1997, PANCREAS, V15, P48, DOI 10.1097/00006676-199707000-00007; Watanabe T, 1999, PANCREAS, V18, P349, DOI 10.1097/00006676-199905000-00004; Wu MT, 2006, CIRCULATION, V114, P1036, DOI 10.1161/CIRCULATIONAHA.105.545863; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	64	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115783	10.1371/journal.pone.0115783	http://dx.doi.org/10.1371/journal.pone.0115783			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549366	Green Published, gold, Green Submitted			2022-12-26	WOS:000347063500027
J	Danielsson, A; Ponten, F; Fagerberg, L; Hallstrom, BM; Schwenk, JM; Uhlen, M; Korsgren, O; Lindskog, C				Danielsson, Angelika; Ponten, Fredrik; Fagerberg, Linn; Hallstrom, Bjorn M.; Schwenk, Jochen M.; Uhlen, Mathias; Korsgren, Olle; Lindskog, Cecilia			The Human Pancreas Proteome Defined by Transcriptomics and Antibody-Based Profiling	PLOS ONE			English	Article							TISSUE DISTRIBUTION; RNA-SEQ; EXPRESSION; TYPE-1; TOOL; IDENTIFICATION; ASSOCIATION	The pancreas is composed of both exocrine glands and intermingled endocrine cells to execute its diverse functions, including enzyme production for digestion of nutrients and hormone secretion for regulation of blood glucose levels. To define the molecular constituents with elevated expression in the human pancreas, we employed a genome-wide RNA sequencing analysis of the human transcriptome to identify genes with elevated expression in the human pancreas. This quantitative transcriptomics data was combined with immunohistochemistry-based protein profiling to allow mapping of the corresponding proteins to different compartments and specific cell types within the pancreas down to the single cell level. Analysis of whole pancreas identified 146 genes with elevated expression levels, of which 47 revealed a particular higher expression as compared to the other analyzed tissue types, thus termed pancreas enriched. Extended analysis of in vitro isolated endocrine islets identified an additional set of 42 genes with elevated expression in these specialized cells. Although only 0.7% of all genes showed an elevated expression level in the pancreas, this fraction of transcripts, in most cases encoding secreted proteins, constituted 68% of the total mRNA in pancreas. This demonstrates the extreme specialization of the pancreas for production of secreted proteins. Among the elevated expression profiles, several previously not described proteins were identified, both in endocrine cells (CFC1, FAM159B, RBPJL and RGS9) and exocrine glandular cells (AQP12A, DPEP1, GATM and ERP27). In summary, we provide a global analysis of the pancreas transcriptome and proteome with a comprehensive list of genes and proteins with elevated expression in pancreas. This list represents an important starting point for further studies of the molecular repertoire of pancreatic cells and their relation to disease states or treatment effects.	[Danielsson, Angelika; Ponten, Fredrik; Korsgren, Olle; Lindskog, Cecilia] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Fagerberg, Linn; Hallstrom, Bjorn M.; Schwenk, Jochen M.; Uhlen, Mathias] KTH Royal Inst Technol, Sci Life Lab, Stockholm, Sweden	Uppsala University; Royal Institute of Technology	Ponten, F (corresponding author), Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.	Fredrik.Ponten@igp.uu.se	Lindskog, Cecilia/AAO-2441-2021; Schwenk, Jochen M/F-1730-2010; Uhlen, Mathias/AAV-8746-2021; Lindskog, Cecilia/AAE-5462-2019; Schwenk, Jochen/AAS-4164-2021; Uhlen, Mathias/B-3262-2016	Schwenk, Jochen M/0000-0001-8141-8449; Schwenk, Jochen/0000-0001-8141-8449; Uhlen, Mathias/0000-0002-4858-8056; Fagerberg, Linn/0000-0003-0198-7137; Lindskog, Cecilia/0000-0001-5611-1015; Korsgren, Olle/0000-0002-8524-9547	Knut and Alice Wallenberg Foundation; Swedish Medical Research Council (VR) [K2011-65X-12219-15-6]; Nordic Insulin Fund; Ernfors Family Fund; Swedish Diabetes Association; Diabetes Wellness Foundation; Juvenile Diabetes Foundation International; National Institutes of Health [2U01AI065192-06]; Swedish national strategic research initiative EXODIAB (Excellence Of Diabetes Research in Sweden); Juvenile Diabetes Research Foundation; Novo Nordisk Fonden [NNF14OC0010935] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI065192] Funding Source: NIH RePORTER	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Medical Research Council (VR)(Swedish Medical Research Council (SMRC)Swedish Research Council); Nordic Insulin Fund; Ernfors Family Fund; Swedish Diabetes Association; Diabetes Wellness Foundation; Juvenile Diabetes Foundation International; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish national strategic research initiative EXODIAB (Excellence Of Diabetes Research in Sweden); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the Knut and Alice Wallenberg Foundation, the Swedish Medical Research Council (VR K2011-65X-12219-15-6), the Nordic Insulin Fund, the Ernfors Family Fund, the Swedish Diabetes Association, the Diabetes Wellness Foundation and the Juvenile Diabetes Foundation International. OK's position is in part supported by National Institutes of Health 2U01AI065192-06. Human pancreatic islets were obtained from The Nordic network for Clinical islet Transplantation, supported by the Swedish national strategic research initiative EXODIAB (Excellence Of Diabetes Research in Sweden) and the Juvenile Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, WIND AD TRIMM TOOL F; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asplund A, 2012, PROTEOMICS, V12, P2067, DOI 10.1002/pmic.201100504; Bao LM, 1998, ARCH BIOCHEM BIOPHYS, V350, P95, DOI 10.1006/abbi.1997.0486; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Chen XQ, 2010, J PROTEOME RES, V9, P885, DOI 10.1021/pr900784c; Choi JH, 2011, MOL BIOSYST, V7, P3104, DOI 10.1039/c1mb05326d; Dorrell C, 2011, DIABETOLOGIA, V54, P2832, DOI 10.1007/s00125-011-2283-5; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Friberg AS, 2008, CELL TRANSPLANT, V17, P1305, DOI 10.3727/096368908787648100; Goto M, 2004, TRANSPLANTATION, V78, P1367, DOI 10.1097/01.TP.0000140882.53773.DC; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Lee JH, 2011, ONCOL REP, V25, P971, DOI 10.3892/or.2011.1132; Lindskog C, 2012, J PROTEOMICS, V75, P2611, DOI 10.1016/j.jprot.2012.03.008; Lindskog C, 2010, DISCOV MED, V9, P565; Martemyanov KA, 2009, PROG MOL BIOL TRANSL, V86, P205, DOI 10.1016/S1877-1173(09)86007-9; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nica AC, 2013, GENOME RES; O'Hurley G, 2014, MOL ONCOL, V8, P783, DOI 10.1016/j.molonc.2014.03.008; O'Reilly Derek A, 2014, World J Gastrointest Pathophysiol, V5, P71, DOI 10.4291/wjgp.v5.i2.71; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Schneider S, 2008, DIABETES OBES METAB, V10, P109, DOI 10.1111/j.1463-1326.2008.00944.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; YEO EJ, 1994, P NATL ACAD SCI USA, V91, P210, DOI 10.1073/pnas.91.1.210	34	26	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115421	10.1371/journal.pone.0115421	http://dx.doi.org/10.1371/journal.pone.0115421			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546435	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200041
J	Ning, XJ; Zhan, CQ; Yang, YH; Yang, L; Tu, J; Gu, HF; Su, TC; Wang, JH				Ning, Xianjia; Zhan, Changqing; Yang, Yihe; Yang, Li; Tu, Jun; Gu, Hongfei; Su, Ta-Chen; Wang, Jinghua			Secular Trends in Prevalence of Overweight and Obesity among Adults in Rural Tianjin, China from 1991 to 2011: A Population-Based Study	PLOS ONE			English	Article							BODY-MASS INDEX; ALL-CAUSE MORTALITY; AGED FINNISH MEN; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; RISK-FACTORS; US ADULTS; HYPERTENSION; PREVENTION	Objectives: Obesity is associated with cardiovascular diseases and has become the main public health issue in western countries and urban China. However, the prevalence and secular trends of obesity in rural China are currently unknown. The aim of this study was to investigate secular trends in the prevalence of overweight and obesity among rural adults in northern China between 1991 and 2011. Method: The prevalence of overweight and obesity was assessed in adults aged 35-74 years living in a rural area in northern China by comparing two surveys that were conducted in 1991 and 2011, respectively. Result: The age-adjusted prevalence of overweight increased from 24.5% in 1991 to 42.0% in 2011, and the prevalence of obesity increased from 5.7% in 1991 to 19.6% in 2011. Over the 21-year period, there were significant increases in the prevalence of overweight and obesity for both men and women in all age groups; however, the greatest increase was observed in men aged 35-44 years, with an 10.3-fold increase in obesity prevalence. The prevalence of obesity increased significantly in all risk factors categories, including education levels, blood pressure categories, diabetes previous history, current smoking situation and alcohol drinking situation over the past 21 years overall (p<0.05). The greatest increase in obesity prevalence appeared among those who consumed alcohol (increased by 8.0-fold). Next, there was a 5.3-fold increase in the prevalence of obesity in illiterate residents. Conclusion: The prevalence of overweight and obesity has increased rapidly among rural adults in Tianjin over the past 21 years, with the most dramatic increase observed in young men. Therefore, the burden of obesity should serve as a call for action.	[Ning, Xianjia; Zhan, Changqing; Tu, Jun; Wang, Jinghua] Tianjin Neurol Inst, Dept Epidemiol, Tianjin, Peoples R China; [Ning, Xianjia; Zhan, Changqing; Yang, Li; Tu, Jun; Wang, Jinghua] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin, Peoples R China; [Yang, Yihe] Northwestern Univ, Feinberg Sch Med, Dept Publ Hlth, Chicago, IL 60611 USA; [Gu, Hongfei] Tianjin Dagang Oilfield Gen Hosp, Dept Neurol, Tianjin, Peoples R China; [Su, Ta-Chen] Natl Taiwan Univ Hosp, Ctr Cardiovasc, Taipei, Taiwan; [Su, Ta-Chen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	Tianjin Medical University; Chicago Department of Public Health; Northwestern University; Feinberg School of Medicine; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Ning, XJ (corresponding author), Tianjin Neurol Inst, Dept Epidemiol, Tianjin, Peoples R China.	xjn0906@gmail.com; jhw8799@yahoo.com		SU, TA-CHEN/0000-0001-7523-7166	Tianjin Medical University General Hospital; People's Republic of China Ministry of Science and Technology; Ministry of Health through the 7th, 8th, and 10th National Five-Year Key Research Plan [85-915-01-01, 85-91501-02, 2001BA703B01]	Tianjin Medical University General Hospital; People's Republic of China Ministry of Science and Technology; Ministry of Health through the 7th, 8th, and 10th National Five-Year Key Research Plan	This study was supported in part by Tianjin Medical University General Hospital, and the People's Republic of China Ministry of Science and Technology and the Ministry of Health through the 7th, 8th, and 10th National Five-Year Key Research Plan (contracts 85-915-01-01, 85-91501-02, and 2001BA703B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad OB, 2001, GPE DISCUSSION PAPER, V31, P1; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Arnett DK, 2002, AM J EPIDEMIOL, V156, P929, DOI 10.1093/aje/kwf133; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Gu Dongfeng, 2002, Zhonghua Yi Xue Za Zhi, V82, P1018; Hu G, 2004, ARCH INTERN MED, V164, P892, DOI 10.1001/archinte.164.8.892; Hu G, 2004, EUR HEART J, V25, P2212, DOI 10.1016/j.ehj.2004.10.020; Hu G, 2004, HYPERTENSION, V43, P25, DOI 10.1161/01.HYP.0000107400.72456.19; Hu G, 2005, INT J OBESITY, V29, P894, DOI 10.1038/sj.ijo.0802870; James PT, 2004, CLIN DERMATOL, V22, P276, DOI 10.1016/j.clindermatol.2004.01.010; James PT, 2004, EUR J CARDIOV PREV R, V11, P3, DOI 10.1097/01.hjr.0000114707.27531.48; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Malta Deborah Carvalho, 2014, Rev. bras. epidemiol., V17, P267, DOI 10.1590/1809-4503201400050021; Ministries of Health and Science and Technology and the National Bureau of Statistics of the Peoples Republic of China, 2004, NUTR HLTH STAT CHIN; Ng M, 2014, LANCET, V6736, P604; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Panagiotakos DB, 2004, OBES RES, V12, P1914, DOI 10.1038/oby.2004.239; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; Singh GP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064893, 10.1371/journal.pone.0065174]; Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053069; Sun XR, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096503, 10.1371/journal.pone.0105469, 10.1371/journal.pone.0091068]; von Ruesten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027455; Wang J, 2014, J HUM HYPERTENS, V28, P25, DOI 10.1038/jhh.2013.44; Wang JH, 2014, STROKE, V45, P1626, DOI 10.1161/STROKEAHA.113.003899; Wang Jinghua, 2014, NEUROLOGY IN PRESS; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; Wang YC, 2007, OBESITY, V15, P2855, DOI 10.1038/oby.2007.339; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Yang X.G., 2005, P INT S NEW ADV NUTR, V8, P9; Zaninotto P, 2009, J EPIDEMIOL COMMUN H, V63, P140, DOI 10.1136/jech.2008.077305; Zhang XG, 2008, OBESITY, V16, P168, DOI 10.1038/oby.2007.43; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245	40	23	23	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116019	10.1371/journal.pone.0116019	http://dx.doi.org/10.1371/journal.pone.0116019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25544990	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200089
J	Unno, K; Ono, M; Winder, AD; Maniar, KP; Paintal, AS; Yu, Y; Wei, JJ; Lurain, JR; Kim, JJ				Unno, Kenji; Ono, Masanori; Winder, Abigail D.; Maniar, Kruti P.; Paintal, Ajit S.; Yu, Yanni; Wei, Jian-Jun; Lurain, John R.; Kim, J. Julie			Establishment of Human Patient-Derived Endometrial Cancer Xenografts in NOD scid Gamma Mice for the Study of Invasion and Metastasis	PLOS ONE			English	Article							PAPILLARY SEROUS CARCINOMA; E-CADHERIN; MOUSE; ACCUMULATION; RECEPTOR; PATHWAY; CAPSULE; MODELS; TUMORS; CELLS	Objective: Most endometrial cancers are detected early and have a good prognosis, while some endometrial cancers are highly invasive, metastasize early, and respond suboptimally to therapy. Currently, appropriate model systems to study the aggressive nature of these tumors are lacking. The objective of this study was to establish a mouse xenograft model of endometrial tumors derived from patients in order to study the biological aggressive characteristics that underlie invasion and metastasis. Methods: Endometrial tumor tissue fragments (1.5 mm x 1.5 mm) from patients undergoing surgery, were transplanted under the renal capsule of NOD scid gamma mice. After 6-8 weeks, tumors were excised and serially transplanted into additional mice for propagation. Immunohistochemical analysis of the tumors was done for various tumor markers. Results: Four cases of different subtypes of endometrial cancer were grown and propagated in mice. Three of the four tumor cases invaded into the kidneys and to adjacent organs. While all tumors exhibited minimal to no staining for estrogen receptor a, progesterone receptor staining was observed for tumor grafts. In addition, levels and localization of E-cadherin, cytokeratin and vimentin varied depending on subtype. Finally, all tumor xenografts stained positively for urokinase plasminogen activator while 3 tumor xenografts, which showed invasive characteristics, stained positively for urokinase plasminogen activator receptor. Conclusion: Endometrial tumors transplanted under the renal capsule exhibit growth, invasion and local spread. These tumors can be propagated and used to study aggressive endometrial cancer.	[Unno, Kenji; Ono, Masanori; Yu, Yanni; Kim, J. Julie] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Div Reprod Sci Med, Chicago, IL 60611 USA; [Winder, Abigail D.; Lurain, John R.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Chicago, IL 60611 USA; [Maniar, Kruti P.; Paintal, Ajit S.; Wei, Jian-Jun] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Kim, JJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Div Reprod Sci Med, Chicago, IL 60611 USA.	j-kim4@northwestern.edu	WEI, JJ/AAN-2638-2020	Kim, J Julie/0000-0001-9834-8213	National Cancer Institute [RO1CA155513]; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA155513] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute RO1CA155513. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Colas E, 2012, CLIN TRANSL ONCOL, V14, P715, DOI 10.1007/s12094-012-0866-3; Dowdy SC, 2006, MOL CANCER THER, V5, P2767, DOI 10.1158/1535-7163.MCT-06-0209; Elston MS, 2009, J CLIN ENDOCR METAB, V94, P1436, DOI 10.1210/jc.2008-2075; Ferber EC, 2008, J BIOL CHEM, V283, P12691, DOI 10.1074/jbc.M708887200; Ge X, 2013, INT J GYNECOL CANCER, V23, P52, DOI 10.1097/IGC.0b013e31827912b8; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; GOFF BA, 1994, GYNECOL ONCOL, V54, P264, DOI 10.1006/gyno.1994.1208; HENDRICKSON M, 1982, AM J SURG PATHOL, V6, P93, DOI 10.1097/00000478-198203000-00002; Ishii K, 2005, LAB INVEST, V85, P1086, DOI 10.1038/labinvest.3700310; Ishikawa H, 2010, ENDOCRINOLOGY, V151, P2433, DOI 10.1210/en.2009-1225; Kamat AA, 2007, CLIN CANCER RES, V13, P7487, DOI 10.1158/1078-0432.CCR-07-1017; Kim JJ, 2013, ENDOCR REV, V34, P130, DOI 10.1210/er.2012-1043; Kwaan HC, 2013, SEMIN THROMB HEMOST, V39, P382, DOI 10.1055/s-0033-1338127; Lee CH, 2005, GYNECOL ONCOL, V96, P48, DOI 10.1016/j.ygyno.2004.09.025; Lee JW, 2010, CLIN CANCER RES, V16, P2562, DOI 10.1158/1078-0432.CCR-10-0017; Memarzedeh S, 2002, P NATL ACAD SCI USA, V99, P10647, DOI 10.1073/pnas.152127499; Moore KN, 2011, CLIN OBSTET GYNECOL, V54, P278, DOI 10.1097/GRF.0b013e318218c755; Morgan J, 2009, GYNECOL ONCOL, V114, P293, DOI 10.1016/j.ygyno.2009.04.036; Ono M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036935; OTT CE, 1976, FED PROC, V35, P1872; Pant A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041593; Parmar H, 2002, ENDOCRINOLOGY, V143, P4886, DOI 10.1210/en.2002-220570; Press JZ, 2008, GYNECOL ONCOL, V110, P256, DOI 10.1016/j.ygyno.2008.03.011; Salahshor S, 2008, MODERN PATHOL, V21, P271, DOI 10.1038/modpathol.3800990; Setiawan VW, 2013, J CLIN ONCOL, V31, P2607, DOI 10.1200/JCO.2012.48.2596; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Silverberg SG, 2000, MODERN PATHOL, V13, P309, DOI 10.1038/modpathol.3880053; Smith HO, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.01.004; Spoelstra NS, 2006, CANCER RES, V66, P3893, DOI 10.1158/0008-5472.CAN-05-2881; Takahashi K, 2011, CANCER SCI, V102, P2272, DOI 10.1111/j.1349-7006.2011.02099.x; Tashiro H, 1997, AM J PATHOL, V150, P177; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	34	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116064	10.1371/journal.pone.0116064	http://dx.doi.org/10.1371/journal.pone.0116064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542024	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900138
J	Bartoszewska, S; Kochan, K; Piotrowski, A; Kamysz, W; Ochocka, RJ; Collawn, JF; Bartoszewski, R				Bartoszewska, Sylwia; Kochan, Kinga; Piotrowski, Arkadiusz; Kamysz, Wojciech; Ochocka, Renata J.; Collawn, James F.; Bartoszewski, Rafal			The hypoxia-inducible miR-429 regulates hypoxia-inducible factor-1 alpha expression in human endothelial cells through a negative feedback loop	FASEB JOURNAL			English	Article						hypoxamiR; angiogenesis; VEGF A; HIF-2; miRNA	FACTOR-I; MESSENGER-RNA; GENE-TRANSCRIPTION; TUMOR-SUPPRESSOR; FACTOR 1-ALPHA; PROTEIN; TARGET; RESPONSES; HIF-1; DEGRADATION	Hypoxia-inducible factors (HIFs) 1 and 2 are dimeric alpha/beta transcription factors that regulate cellular responses to low oxygen. HIF-1 is induced first, whereas HIF-2 is associated with chronic hypoxia. To determine how HIF1AmRNA, the inducible subunit of HIF-1, is regulated during hypoxia, we followed HIF1A mRNA levels in primary HUVECs over 24 hours using quantitative PCR. HIF1A and VEGF A (VEGFA) mRNA, a transcriptional target of HIF-1, increased similar to 2.5- and 8-fold at 2-4 hours, respectively. To determine how the mRNAs were regulated, we identified a microRNA (miRNA), miR-429, that destabilized HIF1A message and decreased VEGFA mRNA by inhibiting HIF1A. Target protector analysis, which interferes with miRNA-mRNA complex formation, confirmed that miR-429 targeted HIF1A message. Desferoxamine treatment, which inhibits the hydroxylases that promote HIF-1 alpha protein degradation, stabilized HIF-1 activity during normoxic conditions and elevated miR-429 levels, demonstrating that HIF-1 promotes miR-429 expression. RNA-sequencing-based transcriptome analysis indicated that inhibition of miRNA-429 in HUVECs up-regulated 209 mRNAs, a number of which regulate angiogenesis. The results demonstrate that HIF-1 is in a negative regulatory loop with miR-429, that miR-429 attenuates HIF-1 activity by decreasing HIF1A message during the early stages of hypoxia before HIF-2 is activated, and this regulatory network helps explain the HIF-1 transition to HIF-2 during chronic hypoxia in endothelial cells.	[Bartoszewska, Sylwia; Kamysz, Wojciech] Med Univ Gdansk, Dept Inorgan Chem, Gdansk, Poland; [Kochan, Kinga; Piotrowski, Arkadiusz; Ochocka, Renata J.; Bartoszewski, Rafal] Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Gdansk, Poland; [Collawn, James F.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; University of Alabama System; University of Alabama Birmingham	Collawn, JF (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 1918 Univ Ave,MCLM 395, Birmingham, AL 35294 USA.	jcollawn@uab.edu; rafalbar@gumed.edu.pl	Bartoszewski, Rafal A/D-6311-2011; Bartoszewska, Sylwia/L-3922-2019; Piotrowski, Arkadiusz/A-5484-2010	Bartoszewski, Rafal A/0000-0002-2864-6757; Bartoszewska, Sylwia/0000-0001-8063-1272; Collawn, James/0000-0002-2528-2759; Kamysz, Wojciech/0000-0001-5335-3043; Piotrowski, Arkadiusz/0000-0002-0823-0607	National Science Center Opportunities for Promoting Understanding through Synthesis Program [DEC-2011/03/B/NZ3/04387]; U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [5R01DK060065]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060065] Funding Source: NIH RePORTER	National Science Center Opportunities for Promoting Understanding through Synthesis Program; U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Zsuzsa Bebok for helpful discussions and initial support and the Heflin Center for Genomics Sciences Core Facility for performing the RNA-sequencing analysis. All of the experiments described here besides the RNA-sequencing analysis were performed in the Department of Pharmaceutical Botany at the Medical University of Gdansk. This work has been supported by the National Science Center Opportunities for Promoting Understanding through Synthesis Program under contract DEC-2011/03/B/NZ3/04387 to R.B. and a U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases Grant 5R01DK060065 to J.F.C.	Alexiou P, 2010, NUCLEIC ACIDS RES, V38, pD137, DOI 10.1093/nar/gkp888; Bartoszewski R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092128; Bartoszewski R, 2011, J BIOL CHEM, V286, P41862, DOI 10.1074/jbc.M111.304956; Bartoszewski R, 2011, METHOD ENZYMOL, V491, P3, DOI 10.1016/B978-0-12-385928-0.00001-8; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bosch-Marce M, 2007, CIRC RES, V101, P1310, DOI 10.1161/CIRCRESAHA.107.153346; Bruning U, 2011, MOL CELL BIOL, V31, P4087, DOI 10.1128/MCB.01276-10; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Chan SY, 2010, CELL CYCLE, V9, P1072, DOI 10.4161/cc.9.6.11006; Chan YC, 2011, J BIOL CHEM, V286, P2047, DOI 10.1074/jbc.M110.158790; Chen J, 2011, GYNECOL ONCOL, V121, P200, DOI 10.1016/j.ygyno.2010.12.339; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; DERRICK TR, 1994, MED SCI SPORT EXER, V26, P919; Du R, 2014, MOL BIOL CELL, V25, P2650, DOI 10.1091/mbc.E14-01-0044; Fandrey J, 2006, CARDIOVASC RES, V71, P642, DOI 10.1016/j.cardiores.2006.05.005; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Gehrke SG, 2003, BLOOD, V101, P3288, DOI 10.1182/blood-2002-07-2192; Goodsell DS, 2002, ONCOLOGIST, V7, P569, DOI 10.1634/theoncologist.7-6-569; Greco S, 2014, ANTIOXID REDOX SIGN, V21, P1202, DOI 10.1089/ars.2013.5403; Greco S, 2014, ANTIOXID REDOX SIGN, V21, P1164, DOI 10.1089/ars.2014.6083; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Hatipoglu OF, 2009, J BIOL CHEM, V284, P16325, DOI 10.1074/jbc.M109.001313; Hebert C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-5; Hicks K., 2014, FASEB J, V28; Ho JJD, 2012, J BIOL CHEM, V287, P29003, DOI 10.1074/jbc.M112.373365; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kim JH, 2012, ONCOL REP, V28, P1701, DOI 10.3892/or.2012.2012; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Lee ST, 2010, STROKE, V41, P1646, DOI 10.1161/STROKEAHA.110.579649; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JP, 2007, MOL CELL BIOL, V27, P7345, DOI 10.1128/MCB.02201-06; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Madanecki P, 2013, CELL MOL BIOL LETT, V18, P47, DOI 10.2478/s11658-012-0037-0; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Manisterski M, 2010, CELL CYCLE, V9, P3723, DOI 10.4161/cc.9.18.12931; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; Michiels C, 2004, AM J PATHOL, V164, P1875, DOI 10.1016/S0002-9440(10)63747-9; Mole DR, 2001, IUBMB LIFE, V52, P43; Persano L, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.153; Piret JP, 2002, ANN NY ACAD SCI, V973, P443, DOI 10.1111/j.1749-6632.2002.tb04680.x; Prabhakar NR, 2012, PHYSIOL REV, V92, P967, DOI 10.1152/physrev.00030.2011; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Schmid T, 2004, BIOCHEM J, V380, P289, DOI 10.1042/BJ20031299; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2000, CRIT REV BIOCHEM MOL, V35, P71, DOI 10.1080/10409230091169186; Staton AA, 2011, NAT PROTOC, V6, P2035, DOI 10.1038/nprot.2011.423; Storz G, 2004, CURR OPIN MICROBIOL, V7, P140, DOI 10.1016/j.mib.2004.02.015; Takata K, 2008, MOL CANCER THER, V7, P1551, DOI 10.1158/1535-7163.MCT-07-0428; Thomas JD, 2007, RNA, V13, P1116, DOI 10.1261/rna.534807; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Thornton RD, 2000, BIOCHEM J, V350, P307, DOI 10.1042/0264-6021:3500307; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vaupel P, 2004, ONCOLOGIST, V9, P10, DOI 10.1634/theoncologist.9-90005-10; Veschini L, 2007, BLOOD, V109, P2565, DOI 10.1182/blood-2006-06-032664; Ziello Jennifer E, 2007, Yale J Biol Med, V80, P51	69	90	92	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1467	1479		10.1096/fj.14-267054	http://dx.doi.org/10.1096/fj.14-267054			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25550463	Green Published			2022-12-26	WOS:000354115000032
J	Yang, SR; Shang, XY; Tao, J; Liu, JY; Hua, P				Yang, Song-ran; Shang, Xin-yuan; Tao, Jun; Liu, Jian-yang; Hua, Ping			Voxel-Based Analysis of Fractional Anisotropy in Post-Stroke Apathy	PLOS ONE			English	Article							ISCHEMIC-STROKE; BASAL GANGLIA; ALZHEIMERS-DISEASE; DEPRESSION; CIRCUITS; VALIDITY	Objective: To explore the structural basis of post-stroke apathy by using voxel-based analysis (VBA) of fractional anisotropy (FA) maps. Methods: We enrolled 54 consecutive patients with ischemic stroke during convalescence, and divided them into apathy (n=31) and non-apathy (n=23) groups. We obtained magnetic resonance images of their brains, including T1, T2 and DTI sequences. Age, sex, education level, Hamilton Depression Scale (HAMD) scores, Mini-Mental State Examination (MMSE) scores, National Institutes of Health Stroke Scale (NIHSS) scores, and infarct locations for the two groups were compared. Finally, to investigate the structural basis of post-stroke apathy, VBA of FA maps was performed in which we included the variables that a univariate analysis determined had P-values less than 0.20 as covariates. Results: HAMD (P=0.01) and MMSE (P<0.01) scores differed significantly between the apathy and non-apathy groups. After controlling for age, education level, HAMD scores, and MMSE scores, significant FA reduction was detected in four clusters with peak voxels at the genu of the corpus callosum (X=-16, Y=30, Z=8), left anterior corona radiata (222, 30, 10), splenium of the corpus callosum (-24, -56, 18), and right inferior frontal gyrus white matter (52, 24, 18), after familywise error correction for multiple comparisons. Conclusions: Post-stroke apathy is related to depression and cognitive decline. Damage to the genu of the corpus callosum, left anterior corona radiata, splenium of the corpus callosum, and white matter in the right inferior frontal gyrus may lead to apathy after ischemic stroke.	[Yang, Song-ran] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Shang, Xin-yuan] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Tao, Jun; Liu, Jian-yang; Hua, Ping] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Cardiovasc Surg, Guangzhou 510275, Guangdong, Peoples R China	University of Oxford; Guangzhou Medical University; Sun Yat Sen University	Hua, P (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Cardiovasc Surg, Guangzhou 510275, Guangdong, Peoples R China.	huaping88@sina.com			National Natural Science Foundation of China [81000508]; Fundamental Research Funds for the Central Universities [11ykpy30]; Social Development Science and Technology Program of Guangdong Province [2012B03180025]; Pearl River Science and Technology Star Fund [2012J2200090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Social Development Science and Technology Program of Guangdong Province; Pearl River Science and Technology Star Fund	This work was supported by the National Natural Science Foundation of China (No. 81000508), the Fundamental Research Funds for the Central Universities (11ykpy30), the Social Development Science and Technology Program of Guangdong Province (2012B03180025), and the Pearl River Science and Technology Star Fund (2012J2200090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brodaty H, 2013, J NEUROPSYCH CLIN N, V25, P283, DOI 10.1176/appi.neuropsych.12040080; Caeiro L, 2013, CEREBROVASC DIS, V35, P23, DOI 10.1159/000346076; Cui ZX, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00042; Cummings JL, 1995, ANN NY ACAD SCI, V769, P1, DOI 10.1111/j.1749-6632.1995.tb38127.x; Hahn C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053493; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Jorge RE, 2010, CAN J PSYCHIAT, V55, P350, DOI 10.1177/070674371005500603; Kang SY, 2008, NEUROLOGY, V70, P2386, DOI 10.1212/01.wnl.0000314686.94007.d0; Kim J, 2005, AM J NEURORADIOL, V26, P2224; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Levy R, 2006, J NEUROL, V253, P54, DOI 10.1007/s00415-006-7012-5; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Mendez M.F., 2010, BRAIN BEHAV INTRO BE; Mezzich JE, 2002, PSYCHOPATHOLOGY, V35, P72, DOI 10.1159/000065122; Okada K, 1997, STROKE, V28, P2437, DOI 10.1161/01.STR.28.12.2437; Onoda K, 2011, CEREBROVASC DIS, V31, P6, DOI 10.1159/000319771; Robert PH, 2006, CLIN NEUROL NEUROSUR, V108, P733, DOI 10.1016/j.clineuro.2006.02.003; Rugg-Gunn FJ, 2001, BRAIN, V124, P627, DOI 10.1093/brain/124.3.627; Starkstein SE, 2001, AM J PSYCHIAT, V158, P872, DOI 10.1176/appi.ajp.158.987.872; Stuss DT, 2000, NEUROPSYCHOLOGY EMOT, P340; Tang WK, 2013, CEREBROVASC DIS, V35, P566, DOI 10.1159/000351152; Thomalla G, 2004, NEUROIMAGE, V22, P1767, DOI 10.1016/j.neuroimage.2004.03.041; van Dalen JW, 2013, STROKE, V44, P851, DOI 10.1161/STROKEAHA.112.674614; van Reekum R, 2005, J NEUROPSYCH CLIN N, V17, P7, DOI 10.1176/appi.neuropsych.17.1.7; Withall A, 2011, INT PSYCHOGERIATR, V23, P264, DOI 10.1017/S1041610209991116; Yang S, 2015, EUR J NEUROL, V22, P341, DOI 10.1111/ene.12575; Yang SR, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-164; Yao H, 2009, HYPERTENS RES, V32, P586, DOI 10.1038/hr.2009.65	29	71	75	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2015	10	1							e116168	10.1371/journal.pone.0116168	http://dx.doi.org/10.1371/journal.pone.0116168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3XP	25555189	gold, Green Published, Green Submitted			2022-12-26	WOS:000348157400002
J	Kanno, H; Kawakami, Z; Mizoguchi, K; Ikarashi, Y; Kase, Y				Kanno, Hitomi; Kawakami, Zenji; Mizoguchi, Kazushige; Ikarashi, Yasushi; Kase, Yoshio			Yokukansan, a Kampo Medicine, Protects PC12 Cells from Glutamate-Induced Death by Augmenting Gene Expression of Cystine/Glutamate Antiporter System Xc(-)	PLOS ONE			English	Article							TRADITIONAL JAPANESE MEDICINE; THIAMINE-DEFICIENT RATS; PSYCHOLOGICAL SYMPTOMS; CORTICAL-NEURONS; OXIDATIVE STRESS; NERVOUS-SYSTEM; CYSTINE UPTAKE; DEMENTIA; NEUROTOXICITY; X(C)(-)	Effects of the kampo medicine yokukansan on gene expression of the cystine/glutamate antiporter system Xc(-), which protects against glutamate-induced cytotoxicity, were examined in Pheochromocytoma cells (PC12 cells). Yokukansan inhibited glutamate-induced PC12 cell death. Similar cytoprotective effects were found in Uncaria hook. Experiments to clarify the active compounds revealed that geissoschizine methyl ether, hirsuteine, hirsutine, and procyanidin B1 in Uncaria hook, had cytoprotective effects. These components enhanced gene expressions of system Xc(-) subunits xCT and 4F2hc, and also ameliorated the glutamate-induced decrease in glutathione levels. These results suggest that the cytoprotective effect of yokukansan may be attributed to geissoschizine methyl ether, hirsuteine, hirsutine, and procyanidin B1 in Uncaria hook.	[Kanno, Hitomi; Kawakami, Zenji; Mizoguchi, Kazushige; Ikarashi, Yasushi; Kase, Yoshio] Tsumura & Co, Kampo Sci Strategies Div, Tsumura Res Labs, Inashiki, Ibaraki, Japan	Tsumura & Company	Kanno, H (corresponding author), Tsumura & Co, Kampo Sci Strategies Div, Tsumura Res Labs, Inashiki, Ibaraki, Japan.	kanno_hitomi@mail.tsumura.co.jp			Tsumura Co.	Tsumura Co.(Tsumura & Company)	This study was funded by Tsumura & Co. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Behrens PF, 2002, BRAIN, V125, P1908, DOI 10.1093/brain/awf180; Bridges RJ, 2012, BRIT J PHARMACOL, V165, P20, DOI 10.1111/j.1476-5381.2011.01480.x; Chen JY, 2012, MOL CELL, V45, P196, DOI 10.1016/j.molcel.2011.11.023; Cheung NS, 1998, NEUROPHARMACOLOGY, V37, P1419, DOI 10.1016/S0028-3908(98)00123-3; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; Conrad M, 2012, AMINO ACIDS, V42, P231, DOI 10.1007/s00726-011-0867-5; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Edwards MA, 2007, NEUROTOXICOLOGY, V28, P876, DOI 10.1016/j.neuro.2007.04.006; EYER P, 1986, ANAL BIOCHEM, V153, P57, DOI 10.1016/0003-2697(86)90061-8; FROISSARD P, 1994, NEUROCHEM INT, V24, P485, DOI 10.1016/0197-0186(94)90096-5; Han F, 2008, NEUROSCI LETT, V430, P275, DOI 10.1016/j.neulet.2007.11.021; Harkany T, 2000, EUR J NEUROSCI, V12, P2735, DOI 10.1046/j.1460-9568.2000.00164.x; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Iizuka S, 2010, NEUROPATHOLOGY, V30, P524, DOI 10.1111/j.1440-1789.2010.01101.x; Ikarashi Y, 2009, BIOL PHARM BULL, V32, P1701, DOI 10.1248/bpb.32.1701; Imamura S, 2011, CELL MOL NEUROBIOL, V31, P787, DOI 10.1007/s10571-011-9676-3; Iwasaki K, 2005, J CLIN PSYCHIAT, V66, P248, DOI 10.4088/JCP.v66n0214; Iwasaki K, 2012, PSYCHOGERIATRICS, V12, P235, DOI 10.1111/j.1479-8301.2012.00413.x; Kanno H, 2013, J ETHNOPHARMACOL, V149, P360, DOI 10.1016/j.jep.2013.06.052; Kawakami Z, 2009, NEUROSCIENCE, V159, P1397, DOI 10.1016/j.neuroscience.2009.02.004; Kawakami Z, 2011, CELL MOL NEUROBIOL, V31, P1203, DOI 10.1007/s10571-011-9722-1; Kawakami Z, 2011, J ETHNOPHARMACOL, V134, P74, DOI 10.1016/j.jep.2010.11.063; Kawakami Z, 2010, EUR J PHARMACOL, V626, P154, DOI 10.1016/j.ejphar.2009.09.046; Kubota K., 2013, Journal of Traditional Medicines, V30, P102; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Lewerenz J, 2012, AMINO ACIDS, V42, P171, DOI 10.1007/s00726-011-0862-x; Lo M, 2008, J CELL PHYSIOL, V215, P593, DOI 10.1002/jcp.21366; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsuda Y, 2013, HUM PSYCHOPHARM CLIN, V28, P80, DOI 10.1002/hup.2286; MICHAELS RL, 1990, J NEUROSCI, V10, P283; Mizukami K, 2009, INT J NEUROPSYCHOPH, V12, P191, DOI 10.1017/S146114570800970X; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; MURPHY TH, 1990, FASEB J, V4, P1624, DOI 10.1096/fasebj.4.6.2180770; Nagata K, 2012, PHYTOMEDICINE, V19, P524, DOI 10.1016/j.phymed.2012.02.008; Penugonda S, 2005, BRAIN RES, V1056, P132, DOI 10.1016/j.brainres.2005.07.032; Pereira CF, 2000, NEUROSCI RES, V37, P227, DOI 10.1016/S0168-0102(00)00124-3; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; SAKAI M, 1994, J BIOL CHEM, V269, P31430; Todd KG, 2001, METHODS, V23, P55, DOI 10.1006/meth.2000.1105; Tsuji M, 2001, J BIOL CHEM, V276, P32779, DOI 10.1074/jbc.M101403200; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Vazhappilly R, 2010, NEUROCHEM INT, V56, P569, DOI 10.1016/j.neuint.2009.12.020	45	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116275	10.1371/journal.pone.0116275	http://dx.doi.org/10.1371/journal.pone.0116275			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551766	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100118
J	Li, IH; Ma, KH; Weng, SJ; Huang, SS; Liang, CM; Huang, YS				Li, I-Hsun; Ma, Kuo-Hsing; Weng, Shao-Ju; Huang, Shiang-Suo; Liang, Chang-Min; Huang, Yuahn-Sieh			Autophagy Activation Is Involved in 3,4-Methylenedioxymethamphetamine ('Ecstasy')-Induced Neurotoxicity in Cultured Cortical Neurons	PLOS ONE			English	Article							CELL-DEATH; SIGNALING PATHWAYS; RAT; 3-METHYLADENINE; PHOSPHORYLATION; MECHANISMS; TOXICITY; ECSTASY; CONTRIBUTES; MODULATION	Autophagic (type II) cell death, characterized by the massive accumulation of autophagic vacuoles in the cytoplasm of cells, has been suggested to play pathogenetic roles in cerebral ischemia, brain trauma, and neurodegenerative disorders. 3,4-Methylenedioxymethamphetamine (MDMA or ecstasy) is an illicit drug causing long-term neurotoxicity in the brain. Apoptotic (type I) and necrotic (type III) cell death have been implicated in MDMA-induced neurotoxicity, while the role of autophagy in MDMA-elicited neurotoxicity has not been investigated. The present study aimed to evaluate the occurrence and contribution of autophagy to neurotoxicity in cultured rat cortical neurons challenged with MDMA. Autophagy activation was monitored by expression of microtubule-associated protein 1 light chain 3 (LC3; an autophagic marker) using immunofluorescence and western blot analysis. Here, we demonstrate that MDMA exposure induced monodansylcadaverine (MDC)- and LC3B-densely stained autophagosome formation and increased conversion of LC3B-I to LC3B-II, coinciding with the neurodegenerative phase of MDMA challenge. Autophagy inhibitor 3-methyladenine (3-MA) pretreatment significantly attenuated MDMA-induced autophagosome accumulation, LC3B-II expression, and ameliorated MDMA-triggered neurite damage and neuronal death. In contrast, enhanced autophagy flux by rapamycin or impaired autophagosome clearance by bafilomycin A1 led to more autophagosome accumulation in neurons and aggravated neurite degeneration, indicating that excessive autophagosome accumulation contributes to MDMA-induced neurotoxicity. Furthermore, MDMA induced phosphorylation of AMP-activated protein kinase (AMPK) and its downstream unc-51-like kinase 1 (ULK1), suggesting the AMPK/ULK1 signaling pathway might be involved in MDMA-induced autophagy activation.	[Li, I-Hsun] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Pharm Practice, Taipei, Taiwan; [Ma, Kuo-Hsing; Weng, Shao-Ju; Huang, Yuahn-Sieh] Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan; [Huang, Shiang-Suo] Chung Shan Med Univ, Coll Med, Dept Pharmacol, Taichung, Taiwan; [Huang, Shiang-Suo] Chung Shan Med Univ, Coll Med, Inst Med, Taichung, Taiwan; [Liang, Chang-Min] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Liang, Chang-Min] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Chung Shan Medical University; Chung Shan Medical University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Huang, YS (corresponding author), Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan.	anatoman2001@yahoo.com.tw			National Science Council Taiwan [NSC 102-2320-B-016-002]	National Science Council Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council Taiwan (Grant No. NSC 102-2320-B-016-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abounit Kadija, 2012, World J Biol Chem, V3, P1, DOI 10.4331/wjbc.v3.i1.1; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Bach M, 2011, BIOCHEM J, V440, P283, DOI 10.1042/BJ20101894; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Capela JP, 2009, MOL NEUROBIOL, V39, P210, DOI 10.1007/s12035-009-8064-1; Chae M, 2009, MOL CELLS, V27, P571, DOI 10.1007/s10059-009-0075-2; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; El-Mallakh Rif S, 2007, Ann Clin Psychiatry, V19, P45, DOI 10.1080/10401230601163592; Halpin LE, 2014, LIFE SCI, V97, P37, DOI 10.1016/j.lfs.2013.07.014; Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lee Jin-A, 2012, Exp Neurobiol, V21, P1, DOI 10.5607/en.2012.21.1.1; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Munafo DB, 2001, J CELL SCI, V114, P3619; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nixon RA, 2012, COLD SPRING HARB PER, V4; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Parrott AC, 2002, PHARMACOL BIOCHEM BE, V71, P837, DOI 10.1016/S0091-3057(01)00711-0; Perez-Carrion MD, 2012, J NEUROCHEM, V120, P259, DOI 10.1111/j.1471-4159.2011.07556.x; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Popko J, 2009, CYTOM PART A, V75A, P371, DOI 10.1002/cyto.a.20660; Ramamurthy Santosh, 2012, Exp Neurobiol, V21, P52, DOI 10.5607/en.2012.21.2.52; Ricaurte GA, 2000, NEUROPSYCHOBIOLOGY, V42, P5, DOI 10.1159/000026664; Sadasivan S, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-21; Sarkar S, 2010, CURR PHARM BIOTECHNO, V11, P460, DOI 10.2174/138920110791591490; Scarlatti F, 2009, CELL DEATH DIFFER, V16, P12, DOI 10.1038/cdd.2008.101; Schmued LC, 2003, BRAIN RES, V974, P127, DOI 10.1016/S0006-8993(03)02563-0; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408; Shen HM, 2011, AUTOPHAGY, V7, P457, DOI 10.4161/auto.7.5.14226; Shi RY, 2012, CNS NEUROSCI THER, V18, P250, DOI 10.1111/j.1755-5949.2012.00295.x; SMITS A, 1991, P NATL ACAD SCI USA, V88, P8159, DOI 10.1073/pnas.88.18.8159; Soleimani S, 2012, CELL J, V13, P275; Son JH, 2012, EXP MOL MED, V44, P89, DOI 10.3858/emm.2012.44.2.031; Takatsuka C, 2004, PLANT CELL PHYSIOL, V45, P265, DOI 10.1093/pcp/pch031; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tsvetkov AS, 2010, P NATL ACAD SCI USA, V107, P16982, DOI 10.1073/pnas.1004498107; Wang JY, 2011, J NEUROPATH EXP NEUR, V70, P314, DOI 10.1097/NEN.0b013e31821352bd; Wang Y, 2008, AUTOPHAGY, V4, P214, DOI 10.4161/auto.5369; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014	56	28	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116565	10.1371/journal.pone.0116565	http://dx.doi.org/10.1371/journal.pone.0116565			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551657	Green Submitted, Green Published, gold			2022-12-26	WOS:000347119100145
J	Yang, M; Zhang, Y; Qi, L; Mei, XY; Liao, JJ; Ding, XP; Deng, WP; Fan, LM; He, XH; Vivanco, JM; Li, CY; Zhu, YY; Zhu, SS				Yang, Min; Zhang, Yu; Qi, Lei; Mei, Xinyue; Liao, Jingjing; Ding, Xupo; Deng, Weiping; Fan, Limin; He, Xiahong; Vivanco, Jorge M.; Li, Chengyun; Zhu, Youyong; Zhu, Shusheng			Plant-Plant-Microbe Mechanisms Involved in Soil-Borne Disease Suppression on a Maize and Pepper Intercropping System	PLOS ONE			English	Article							SUSTAINABLE AGRICULTURE; SPECIES DIVERSITY; HDMBOA-GLC; MIXTURES; BIODIVERSITY; CHEMOTAXIS; ZOOSPORES; DEFENSE; YIELD; WHEAT	Background: Intercropping systems could increase crop diversity and avoid vulnerability to biotic stresses. Most studies have shown that intercropping can provide relief to crops against wind-dispersed pathogens. However, there was limited data on how the practice of intercropping help crops against soil-borne Phytophthora disease. Principal Findings: Compared to pepper monoculture, a large scale intercropping study of maize grown between pepper rows reduced disease levels of the soil-borne pepper Phytophthora blight. These reduced disease levels of Phytophthora in the intercropping system were correlated with the ability of maize plants to form a "root wall" that restricted the movement of Phytophthora capsici across rows. Experimentally, it was found that maize roots attracted the zoospores of P. capsici and then inhibited their growth. When maize plants were grown in close proximity to each other, the roots produced and secreted larger quantities of 2,4-dihydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one (DIMBOA) and 6-methoxy-2-benzoxazolinone (MBOA). Furthermore, MBOA, benzothiazole (BZO), and 2-(methylthio)-benzothiazole (MBZO) were identified in root exudates of maize and showed antimicrobial activity against P. capsici. Conclusions: Maize could form a "root wall" to restrict the spread of P. capsici across rows in maize and pepper intercropping systems. Antimicrobe compounds secreted by maize root were one of the factors that resulted in the inhibition of P. capsici. These results provide new insights into plant-plant-microbe mechanisms involved in intercropping systems.	[Yang, Min; Zhang, Yu; Qi, Lei; Mei, Xinyue; Liao, Jingjing; Ding, Xupo; Deng, Weiping; Fan, Limin; He, Xiahong; Li, Chengyun; Zhu, Youyong; Zhu, Shusheng] Yunnan Agr Univ, Educ Minist China, Key Lab Agrobiodivers & Pest Management, Kunming, Yunnan, Peoples R China; [Vivanco, Jorge M.] Colorado State Univ, Dept Hort & Landscape Architecture, Ft Collins, CO 80523 USA; [Vivanco, Jorge M.] Colorado State Univ, Ctr Rhizosphere Biol, Ft Collins, CO 80523 USA	Yunnan Agricultural University; Colorado State University; Colorado State University	Zhu, SS (corresponding author), Yunnan Agr Univ, Educ Minist China, Key Lab Agrobiodivers & Pest Management, Kunming, Yunnan, Peoples R China.	shushengzhu79@126.com			"973'' program from the Ministry of Science and Technology of China [2011CB100400]; Natural Science Foundation of China [30800731, 31260447]; Special Fund for Agro-scientific Research in the Public Interest of the People's Republic of China [201003004]	"973'' program from the Ministry of Science and Technology of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of the People's Republic of China	This study was partially supported by the "973'' program (2011CB100400) from the Ministry of Science and Technology of China, the Natural Science Foundation of China (30800731 and 31260447), and the Special Fund for Agro-scientific Research in the Public Interest of the People's Republic of China (201003004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Monaim MF, 2012, CROP PROT, V32, P41, DOI 10.1016/j.cropro.2011.10.011; Ahmad S, 2011, PLANT PHYSIOL, V157, P317, DOI 10.1104/pp.111.180224; Badri DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046640; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; BJOSTAD LB, 1992, J CHEM ECOL, V18, P931, DOI 10.1007/BF00980054; Boudreau MA, 2013, ANNU REV PHYTOPATHOL, V51, P499, DOI 10.1146/annurev-phyto-082712-102246; Bouws H, 2008, PLANT PATHOL, V57, P916, DOI 10.1111/j.1365-3059.2008.01860.x; Broz AK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-115; Calonnec A, 1996, EUR J PLANT PATHOL, V102, P733, DOI 10.1007/BF01877147; CAMERON JN, 1978, NATURE, V271, P448, DOI 10.1038/271448a0; Carlile M.J., 1983, PHYTOPHTHORA ITS BIO, P95, DOI 10.3/JQUERY-UI.JS; CHIN KM, 1984, PLANT PATHOL, V33, P89, DOI 10.1111/j.1365-3059.1984.tb00592.x; Cohen Y, 1995, PHYTOPATHOLOGY, V85, P1500, DOI 10.1094/Phyto-85-1500; DEACON JW, 1988, MICROBIOL SCI, V5, P249; Dong LL, 2014, J EXP BOT, V65, P131, DOI 10.1093/jxb/ert356; Dybzinski R, 2008, OECOLOGIA, V158, P85, DOI 10.1007/s00442-008-1123-x; Erwin DC, 1996, PHYTOPHTHORA DIS WOR, P262; Fan KW, 2002, MYCOLOGIA, V94, P569, DOI 10.2307/3761708; Flombaum P, 2008, P NATL ACAD SCI USA, V105, P6087, DOI 10.1073/pnas.0704801105; Gao X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095031; Gaquerel E, 2009, PLANT PHYSIOL, V149, P1408, DOI 10.1104/pp.108.130799; Gianoli E, 1997, OIKOS, V80, P269, DOI 10.2307/3546595; He Haibin, 2005, Ying Yong Sheng Tai Xue Bao, V16, P2383; He X., 2010, J RESOUR ECOL, V1, P45, DOI [10.3969/j.issn.1674-764x.2010.01.006, DOI 10.3969/J.ISSN.1674-764X.2010.01.006]; HOAGLAND DR, 1950, 347 CAL AGR EXPT STA; Hu ZH, 2009, TREES-STRUCT FUNCT, V23, P1003, DOI 10.1007/s00468-009-0342-z; Krogh SS, 2006, J AGR FOOD CHEM, V54, P1064, DOI 10.1021/jf051147i; KUMAR P, 1993, J CHEM ECOL, V19, P2453, DOI 10.1007/BF00980682; Lane N, 2004, J CHEM ECOL, V30, P425, DOI 10.1023/B:JOEC.0000017986.49513.f7; Li CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008049; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; Lithourgidis AS, 2011, AUST J CROP SCI, V5, P396; Machado S, 2009, J SOIL WATER CONSERV, V64, p55A, DOI 10.2489/jswc.64.2.55A; Mahall BE, 1996, AM J BOT, V83, P93, DOI 10.2307/2445959; MEAD R, 1980, EXP AGR, V16, P217, DOI 10.1017/S0014479700010978; Michel VV, 1997, PLANT PATHOL, V46, P600, DOI 10.1046/j.1365-3059.1997.d01-45.x; MORRIS PF, 1992, PHYSIOL MOL PLANT P, V40, P17, DOI 10.1016/0885-5765(92)90067-6; MUEHLSTEIN LK, 1988, APPL ENVIRON MICROB, V54, P1668, DOI 10.1128/AEM.54.7.1668-1672.1988; Newton AC, 2009, ANN APPL BIOL, V154, P309, DOI 10.1111/j.1744-7348.2008.00303.x; Newton AC, 2009, FIELD CROP RES, V110, P225, DOI 10.1016/j.fcr.2008.09.002; NEWTON AC, 1991, EUPHYTICA, V59, P73; Newton AC, 2008, J SCI FOOD AGR, V88, P2142, DOI 10.1002/jsfa.3326; Niemeyer HM, 2009, J AGR FOOD CHEM, V57, P1677, DOI 10.1021/jf8034034; Oikawa A, 2004, PHYTOCHEMISTRY, V65, P2995, DOI 10.1016/j.phytochem.2004.09.006; Oikawa A, 2001, PHYTOCHEMISTRY, V56, P669, DOI 10.1016/S0031-9422(00)00494-5; Park WJ, 2004, J PLANT PHYSIOL, V161, P981, DOI 10.1016/j.jplph.2004.01.005; Ren LX, 2008, SOIL BIOL BIOCHEM, V40, P834, DOI 10.1016/j.soilbio.2007.11.003; Sun Hao-yuan, 2003, Journal of Forestry Research (Harbin), V14, P127, DOI 10.1007/BF02856778; Sun Yan, 2006, Acta Horticulturae Sinica, V33, P995; TANG CS, 1982, PLANT PHYSIOL, V69, P155, DOI 10.1104/pp.69.1.155; Thrupp LA, 2000, INT AFF, V76, P265, DOI 10.1111/1468-2346.00133; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; van West P, 2002, MOL PLANT MICROBE IN, V15, P790, DOI 10.1094/MPMI.2002.15.8.790; Wentzell AM, 2008, PLANT PHYSIOL, V147, P415, DOI 10.1104/pp.107.115279; WOLFE MS, 1985, ANNU REV PHYTOPATHOL, V23, P251, DOI 10.1146/annurev.py.23.090185.001343; WOODWARD MD, 1978, PLANT PHYSIOL, V61, P796, DOI 10.1104/pp.61.5.796; Xu CK, 2004, SOIL BIOL BIOCHEM, V36, P1997, DOI 10.1016/j.soilbio.2004.07.020; Xu Ning, 2012, Acta Horticulturae Sinica, V39, P1511; Yadav P. S., 2011, International Journal of Pharmaceutical Sciences and Drug Research, V3, P1; Zhang J, 2000, CHEM BIOL, V7, P611, DOI 10.1016/S1074-5521(00)00007-7; Zhang SH, 2011, POL J ENVIRON STUD, V20, P1359; Zhu SS, 2007, PHYTOPATHOLOGY, V97, P643, DOI 10.1094/PHYTO-97-5-0643; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046; Zhu YY, 2005, PHYTOPATHOLOGY, V95, P433, DOI 10.1094/PHYTO-95-0433; Zou CS, 2007, SOIL BIOL BIOCHEM, V39, P2371, DOI 10.1016/j.soilbio.2007.04.009	65	47	58	8	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115052	10.1371/journal.pone.0115052	http://dx.doi.org/10.1371/journal.pone.0115052			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551554	Green Submitted, gold, Green Published			2022-12-26	WOS:000347119100025
J	Yu, KQ; Zhao, YR; Li, XL; Shao, YN; Liu, F; He, Y				Yu, Ke-Qiang; Zhao, Yan-Ru; Li, Xiao-Li; Shao, Yong-Ni; Liu, Fei; He, Yong			Hyperspectral Imaging for Mapping of Total Nitrogen Spatial Distribution in Pepper Plant	PLOS ONE			English	Article							INFRARED-SPECTROSCOPY; VARIABLE SELECTION; QUALITY EVALUATION; SPECTRAL INDEXES; MATTER CONTENT; RANDOM FROG; REFLECTANCE; DEFICIENCY; PREDICTION; CALIBRATION	Visible/near-infrared (Vis/NIR) hyperspectral imaging was employed to determine the spatial distribution of total nitrogen in pepper plant. Hyperspectral images of samples (leaves, stems, and roots of pepper plants) were acquired and their total nitrogen contents (TNCs) were measured using Dumas combustion method. Mean spectra of all samples were extracted from regions of interest (ROIs) in hyperspectral images. Random frog (RF) algorithm was implemented to select important wavelengths which carried effective information for predicting the TNCs in leaf, stem, root, and whole-plant (leaf-stem-root), respectively. Based on full spectra and the selected important wavelengths, the quantitative relationships between spectral data and the corresponding TNCs in organs (leaf, stem, and root) and whole-plant (leaf-stem-root) were separately developed using partial least-squares regression (PLSR). As a result, the PLSR model built by the important wavelengths for predicting TNCs in whole-plant (leaf-stem-root) offered a promising result of correlation coefficient (R) for prediction (R-P=0.876) and root mean square error (RMSE) for prediction (RMSEP=0.426%). Finally, the TNC of each pixel within ROI of the sample was estimated to generate the spatial distribution map of TNC in pepper plant. The achievements of the research indicated that hyperspectral imaging is promising and presents a powerful potential to determine nitrogen contents spatial distribution in pepper plant.	[Yu, Ke-Qiang; Zhao, Yan-Ru; Li, Xiao-Li; Shao, Yong-Ni; Liu, Fei; He, Yong] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Xiao-Li; Shao, Yong-Ni; Liu, Fei; He, Yong] Minist Agr, Key Lab Equipment & Informatizat Environm Control, Beijing, Peoples R China	Zhejiang University; Ministry of Agriculture & Rural Affairs	He, Y (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China.	yhe@zju.edu.cn	He, Yong/E-3218-2010; LIU, Fei/A-9493-2009; Li, Xiaoli/GYQ-7384-2022	He, Yong/0000-0001-6752-1757; LIU, Fei/0000-0003-0266-6896; Li, Xiaoli/0000-0001-9689-9054	863 National High-Tech Research and Development Plan [2013AA102301]	863 National High-Tech Research and Development Plan(National High Technology Research and Development Program of China)	This study was supported by 863 National High-Tech Research and Development Plan (Project No. 2013AA102301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1983, BIOPHYSICAL PLANT PH; Anten NPR, 1998, OECOLOGIA, V113, P314, DOI 10.1007/s004420050382; Barbarino E, 2009, LIMNOL OCEANOGR-METH, V7, P751, DOI 10.4319/lom.2009.7.751; Barbin DF, 2013, INNOV FOOD SCI EMERG, V18, P226, DOI 10.1016/j.ifset.2012.12.011; Blackmer TM, 1996, AGRON J, V88, P1, DOI 10.2134/agronj1996.00021962008800010001x; Bondada BR, 2001, J PLANT NUTR, V24, P469, DOI 10.1081/PLN-100104973; Bosland P. W., 1992, HortTechnology, V2, P6; Boussadia O, 2010, SCI HORTIC-AMSTERDAM, V123, P336, DOI 10.1016/j.scienta.2009.09.023; Bronson KF, 2006, AGRON J, V98, P212, DOI 10.2134/agronj2005.0149; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Cheng JH, 2014, FOOD RES INT, V56, P190, DOI 10.1016/j.foodres.2013.12.009; Cho MA, 2006, REMOTE SENS ENVIRON, V101, P181, DOI 10.1016/j.rse.2005.12.011; Cruz-Durán Jairo Aarón de la, 2011, Terra Latinoam, V29, P259; Demirel K, 2014, FRESEN ENVIRON BULL, V23, P1232; Diacono M, 2013, AGRON SUSTAIN DEV, V33, P219, DOI 10.1007/s13593-012-0111-z; DURAN C, 2013, REFLECTANCIA HOJAS P; Elmasry G, 2012, CRIT REV FOOD SCI, V52, P999, DOI 10.1080/10408398.2010.543495; Evans RD, 2001, TRENDS PLANT SCI, V6, P121, DOI 10.1016/S1360-1385(01)01889-1; *FAOST, 2001, FAO WAT DEV MAN UN; Fauzi A, 2013, MAR POLLUT BULL, V76, P42, DOI 10.1016/j.marpolbul.2013.09.033; Feng L, 2006, SPECTROSC SPECT ANAL, V26, P1749; Galvao RKH, 2005, TALANTA, V67, P736, DOI 10.1016/j.talanta.2005.03.025; Geladi P, 2004, CHEMOMETR INTELL LAB, V72, P209, DOI 10.1016/j.chemolab.2004.01.023; He HJ, 2014, J FOOD ENG, V126, P156, DOI 10.1016/j.jfoodeng.2013.11.015; He HJ, 2013, INNOV FOOD SCI EMERG, V18, P237, DOI 10.1016/j.ifset.2013.02.009; HOPKINS W. G., 2008, INTRO PLANT PHYSL, VFourth; Hortensteiner S, 2002, J EXP BOT, V53, P927, DOI 10.1093/jexbot/53.370.927; Inoue Y, 2012, REMOTE SENS ENVIRON, V126, P210, DOI 10.1016/j.rse.2012.08.026; Jackman P, 2008, MEAT SCI, V80, P1273, DOI 10.1016/j.meatsci.2008.06.001; Jackman P, 2009, PATTERN RECOGN, V42, P751, DOI 10.1016/j.patcog.2008.09.009; Johnson CD, 1996, HORTSCIENCE, V31, P1119, DOI 10.21273/HORTSCI.31.7.1119; Kamnev AA, 2008, MICROBIOLOGY+, V77, P240, DOI 10.1134/S0026261708020197; Kokaly RF, 2001, REMOTE SENS ENVIRON, V75, P153, DOI 10.1016/S0034-4257(00)00163-2; Kumagai E, 2009, PHOTOSYNTHETICA, V47, P241, DOI 10.1007/s11099-009-0038-z; Lee YJ, 2008, AGRON J, V100, P205, DOI 10.2134/agrojnl2007.0018; Li D, 2012, SOIL TILL RES, V123, P78, DOI 10.1016/j.still.2012.03.013; Li F, 2014, EUR J AGRON, V52, P198, DOI 10.1016/j.eja.2013.09.006; Li HD, 2012, ANAL CHIM ACTA, V740, P20, DOI 10.1016/j.aca.2012.06.031; Li JW, 2009, FIELD CROP RES, V114, P426, DOI 10.1016/j.fcr.2009.09.009; Li XL, 2013, COMPUT ELECTRON AGR, V98, P46, DOI 10.1016/j.compag.2013.07.014; Liu D, 2014, FOOD BIOPROCESS TECH, V7, P307, DOI 10.1007/s11947-013-1193-6; Martin ME, 1997, ECOL APPL, V7, P431, DOI 10.1890/1051-0761(1997)007[0431:HSRRSO]2.0.CO;2; MARTINEZ ESJ, 2014, DIAGNOSIS NITROGENO; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Moscetti R, 2014, POSTHARVEST BIOL TEC, V87, P88, DOI 10.1016/j.postharvbio.2013.08.010; *NAT FARM INF SERV, 2014, CROP MAN GREENH NURS; NELSON DW, 1973, AGRON J, V65, P109, DOI 10.2134/agronj1973.00021962006500010033x; PATE J S, 1973, Soil Biology and Biochemistry, V5, P109, DOI 10.1016/0038-0717(73)90097-7; PATE JS, 1980, ANNU REV PLANT PHYS, V31, P313, DOI 10.1146/annurev.pp.31.060180.001525; PENA RG, 2011, REFLECTANCIA HOJAS C; PENUELAS J, 1993, INT J REMOTE SENS, V14, P1887, DOI 10.1080/01431169308954010; Rossel RAV, 2010, GEODERMA, V158, P46, DOI 10.1016/j.geoderma.2009.12.025; Shaahan MM, 1999, SCI HORTIC-AMSTERDAM, V82, P339, DOI 10.1016/S0304-4238(99)00060-6; Shi JY, 2012, SCI HORTIC-AMSTERDAM, V138, P190, DOI 10.1016/j.scienta.2012.02.024; SKJODT P, 2003, SENSOR BASED NITROGE; Smith ML, 2003, IEEE T GEOSCI REMOTE, V41, P1332, DOI 10.1109/TGRS.2003.813128; STEVENSON FJ, 1982, CROP NITROGEN REQUIR, P567; Tylova-Munzarova E, 2005, AQUAT BOT, V81, P326, DOI 10.1016/j.aquabot.2005.01.006; Valous NA, 2009, MEAT SCI, V81, P132, DOI 10.1016/j.meatsci.2008.07.009; Van Hezewijk BH, 2008, BIOL CONTROL, V46, P332, DOI 10.1016/j.biocontrol.2008.04.003; Vigneau N, 2011, FIELD CROP RES, V122, P25, DOI 10.1016/j.fcr.2011.02.003; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wu D, 2008, J FOOD ENG, V84, P124, DOI 10.1016/j.jfoodeng.2007.04.031; Wu D, 2011, J FOOD ENG, V102, P278, DOI 10.1016/j.jfoodeng.2010.09.002; Wu D, 2010, ANAL CHIM ACTA, V659, P229, DOI 10.1016/j.aca.2009.11.045; Yan J, 2014, MOL INFORM, V33, P503, DOI 10.1002/minf.201300161; Yao X, 2010, INT J APPL EARTH OBS, V12, P89, DOI 10.1016/j.jag.2009.11.008; Yu KQ, 2014, FOOD BIOPROCESS TECH, V7, P3077, DOI 10.1007/s11947-014-1357-z; Yu KQ, 2014, COMPUT ELECTRON AGR, V103, P1, DOI 10.1016/j.compag.2014.01.016; Yun YH, 2013, SPECTROCHIM ACTA A, V111, P31, DOI 10.1016/j.saa.2013.03.083; Zhang XL, 2013, BIOSYST ENG, V115, P56, DOI 10.1016/j.biosystemseng.2013.02.007; Zhao CJ, 2010, PRECIS AGRIC, V11, P557, DOI 10.1007/s11119-009-9148-7; Zhu FL, 2014, FOOD BIOPROCESS TECH, V7, P1208, DOI 10.1007/s11947-013-1228-z; Zou XB, 2010, CHEMOMETR INTELL LAB, V104, P265, DOI 10.1016/j.chemolab.2010.08.019	74	59	62	6	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116205	10.1371/journal.pone.0116205	http://dx.doi.org/10.1371/journal.pone.0116205			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549353	Green Submitted, gold, Green Published			2022-12-26	WOS:000347063500062
J	Pasetto, S; Pardi, V; Murata, RM				Pasetto, Silvana; Pardi, Vanessa; Murata, Ramiro Mendonca			Anti-HIV-1 Activity of Flavonoid Myricetin on HIV-1 Infection in a Dual-Chamber In Vitro Model	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIOXIDANT ACTIVITY; NATURAL-PRODUCTS; HEART-DISEASE; CELL LINE; INHIBITION; QUERCETIN; MICROBICIDES; INFLAMMATION; TRANSMISSION	HIV infection by sexual transmission remains an enormous global health concern. More than 1 million new infections among women occur annually. Microbicides represent a promising prevention strategy that women can easily control. Among emerging therapies, natural small molecules such as flavonoids are an important source of new active substances. In this study we report the in vitro cytotoxicity and anti-HIV-1 and microbicide activity of the following flavonoids: Myricetin, Quercetin and Pinocembrin. Cytotoxicity tests were conducted on TZM-bl, HeLa, PBMC, and H9 cell cultures using 0.01-100 mu M concentrations. Myricetin presented the lowest toxic effect, with Quercetin and Pinocembrin relatively more toxic. The anti-HIV-1 activity was tested with TZM-bl cell plus HIV-1 BaL (R5 tropic), H9 and PBMC cells plus HIV-1 MN (X4 tropic), and the dual tropic (X4R5) HIV-1 89.6. All flavonoids showed anti-HIV activity, although Myricetin was more effective than Quercetin or Pinocembrin. In TZM-bl cells, Myricetin inhibited >= 90% of HIV-1 BaL infection. The results were confirmed by quantification of HIV-1 p24 antigen in supernatant from H9 and PBMC cells following flavonoid treatment. In H9 and PBMC cells infected by HIV-1 MN and HIV-1 89.6, Myricetin showed more than 80% anti-HIV activity. Quercetin and Pinocembrin presented modest anti-HIV activity in all experiments. Myricetin activity was tested against HIV-RT and inhibited the enzyme by 49%. Microbicide activities were evaluated using a dual-chamber female genital tract model. In the in vitro microbicide activity model, Myricetin showed promising results against different strains of HIV-1 while also showing insignificant cytotoxic effects. Further studies of Myricetin should be performed to identify its molecular targets in order to provide a solid biological foundation for translational research.	[Pasetto, Silvana; Pardi, Vanessa; Murata, Ramiro Mendonca] Univ So Calif, Ostrow Sch Dent, Div Periodontol Diagnost Sci Dent Hyg & Biomed Sc, Los Angeles, CA 90045 USA	University of Southern California	Murata, RM (corresponding author), Univ So Calif, Ostrow Sch Dent, Div Periodontol Diagnost Sci Dent Hyg & Biomed Sc, Los Angeles, CA 90045 USA.	ramiro.murata@usc.edu	Murata, Ramiro M/P-9052-2014; PASETTO, SILVANA/O-5586-2015; Pardi, Vanessa/AAV-3252-2021	Murata, Ramiro M/0000-0002-8478-6981; Pardi, Vanessa/0000-0001-7120-4332	National Center for Complementary and Alternative Medicine of the National Institutes of Health [R00AT006507]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R00AT006507] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	Research reported in this publication was supported by the National Center for Complementary and Alternative Medicine of the National Institutes of Health under award number R00AT006507. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arien KK, 2011, REV MED VIROL; Arien KK, 2011, CURR PROTOC CELL BIO; Ataher Q, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-2; Basso LA, 2005, MEM I OSWALDO CRUZ, V100, P575, DOI 10.1590/S0074-02762005000600001; Bomsel M, 1997, NAT MED, V3, P42, DOI 10.1038/nm0197-42; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; Comalada M, 2005, EUR J IMMUNOL, V35, P584, DOI 10.1002/eji.200425778; Coombs RW, 2003, AIDS, V17, P455, DOI 10.1097/00002030-200303070-00001; Critchfield JW, 1996, AIDS RES HUM RETROV, V12, P39, DOI 10.1089/aid.1996.12.39; Cutler B, 2008, LANCET INFECT DIS, V8, P685, DOI 10.1016/S1473-3099(08)70254-8; D'Cruz OJ, 2004, CURR PHARM DESIGN, V10, P315, DOI 10.2174/1381612043386374; De Clercq E, 2010, CURR OPIN PHARMACOL, V10, P507, DOI 10.1016/j.coph.2010.04.011; Di Stasi LC, 2002, FITOTERAPIA, V73, P69, DOI 10.1016/S0367-326X(01)00362-8; FESEN MR, 1994, BIOCHEM PHARMACOL, V48, P595, DOI 10.1016/0006-2952(94)90291-7; Gali Y, 2010, J VIROL METHODS, V165, P186, DOI 10.1016/j.jviromet.2010.01.018; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Goncalves MAFV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010954; Gordon MH, 1998, CHEM PHYS LIPIDS, V97, P79, DOI 10.1016/S0009-3084(98)00098-X; GURGO C, 1988, VIROLOGY, V164, P531, DOI 10.1016/0042-6822(88)90568-5; HAVSTEEN B, 1983, BIOCHEM PHARMACOL, V32, P1141, DOI 10.1016/0006-2952(83)90262-9; HERTOG MGL, 1995, ARCH INTERN MED, V155, P381, DOI 10.1001/archinte.155.4.381; KANDASWAMI C, 1994, ADV EXP MED BIOL, V366, P351; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim QA, 2010, CLIN INFECT DIS, V50, pS122, DOI 10.1086/651483; Kim HJ, 1998, J NAT PROD, V61, P145, DOI 10.1021/np970171q; Kim ME, 2014, ANTICANCER RES, V34, P701; Lee KW, 2007, CARCINOGENESIS, V28, P1918, DOI 10.1093/carcin/bgm110; Lee-Huang S, 2003, BIOCHEM BIOPH RES CO, V307, P1029, DOI 10.1016/S0006-291X(03)01292-0; Li BQ, 2000, BIOCHEM BIOPH RES CO, V276, P534, DOI 10.1006/bbrc.2000.3485; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Lyu SY, 2005, ARCH PHARM RES, V28, P1293, DOI 10.1007/BF02978215; Marquez N, 2005, ANTIVIR RES, V66, P137, DOI 10.1016/j.antiviral.2005.02.006; Mehla R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027915; Middleton E, 2000, PHARMACOL REV, V52, P673; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; NIH, 2012, AR EMPH MICR, P77; Nijhuis M., 2009, V189, P299, DOI 10.1007/978-3-540-79086-0_11; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Ochsenbauer-Jambor C, 2006, BIOTECHNIQUES, V40, P91, DOI 10.2144/000112072; ONO K, 1990, J BIOCHEM-TOKYO, V108, P609, DOI 10.1093/oxfordjournals.jbchem.a123251; Popovic M, 1989, RETROVIRUSES HUMAN A, P21; Rajotte D, 2013, ANTIMICROB AGENTS CH, V57, P2712, DOI 10.1128/AAC.00113-13; REITZ MS, 1992, AIDS RES HUM RETROV, V8, P1950; Richman DD, 2001, CURR PROTOC IMMUNOL; Richman DD, 2006, ANTIVIR RES, V71, P117, DOI 10.1016/j.antiviral.2006.03.004; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Sala A, 2003, EUR J PHARMACOL, V461, P53, DOI 10.1016/S0014-2999(02)02953-9; Santos AC, 1998, FREE RADICAL BIO MED, V24, P1455, DOI 10.1016/S0891-5849(98)00003-3; Schnitzler P, 2010, PHYTOTHER RES, V24, pS20, DOI 10.1002/ptr.2868; Sharma R, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-292; Stone A, 2010, REGULATORY ISSUES MI; TAN GT, 1991, J NAT PROD, V54, P143, DOI 10.1021/np50073a012; UNAIDS, 2013, UNAIDS GLOB AIDS EP, p1 ; UNAIDS, 2012, TOG WE WILL END AIDS, P1; Uzel A, 2005, MICROBIOL RES, V160, P189, DOI 10.1016/j.micres.2005.01.002; Van Herrewege Y, 2007, ANTIVIR RES, V74, P111, DOI 10.1016/j.antiviral.2006.10.010; WOOD KV, 1990, J BIOLUM CHEMILUM, V5, P107, DOI 10.1002/bio.1170050206; Young JF, 1999, AM J CLIN NUTR, V69, P87; Yu YB, 2007, ARCH PHARM RES, V30, P820, DOI 10.1007/BF02978831	60	80	87	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115323	10.1371/journal.pone.0115323	http://dx.doi.org/10.1371/journal.pone.0115323			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546350	gold, Green Published, Green Submitted			2022-12-26	WOS:000347120200038
J	Sakaguchi, Y; Fujii, N; Shoji, T; Hayashi, T; Rakugi, H; Iseki, K; Tsubakihara, Y; Isaka, Y				Sakaguchi, Yusuke; Fujii, Naohiko; Shoji, Tatsuya; Hayashi, Terumasa; Rakugi, Hiromi; Iseki, Kunitoshi; Tsubakihara, Yoshiharu; Isaka, Yoshitaka		Japanese Soc Dialysis Therapy	Magnesium Modifies the Cardiovascular Mortality Risk Associated with Hyperphosphatemia in Patients Undergoing Hemodialysis: A Cohort Study	PLOS ONE			English	Article							REGULAR DIALYSIS TREATMENT; KIDNEY-DISEASE; MINERAL METABOLISM; DIETARY MAGNESIUM; SERUM MAGNESIUM; CALCIUM; CALCIFICATION; PHOSPHORUS; HYPOMAGNESEMIA; METAANALYSIS	Background: In vitro studies have shown inhibitory effects of magnesium (Mg) on phosphate-induced calcification of vascular smooth muscle cells, raising the possibility that maintaining a high Mg level may be useful for reducing cardiovascular risks of patients with hyperphosphatemia. We examined how serum Mg levels affect the association between serum phosphate levels and the risk of cardiovascular mortality in patients undergoing hemodialysis. Methods: A nationwide register-based cohort study was conducted using database of the Renal Data Registry of the Japanese Society for Dialysis Therapy in 2009. We identified 142,069 patients receiving in-center hemodialysis whose baseline serum Mg and phosphate levels were available. Study outcomes were one-year cardiovascular and all-cause mortality. Serum Mg levels were categorized into three groups (lower, <2.7 mg/dL; intermediate, >= 2.7, <3.1 mg/dL; and higher, >= 3.1 mg/dL). Results: During follow-up, 11,401 deaths occurred, out of which 4,751 (41.7%) were ascribed to cardiovascular disease. In multivariable analyses, an increase in serum phosphate levels elevated the risk of cardiovascular mortality in the lowerand intermediate-Mg groups, whereas no significant risk increment was observed in the higher-Mg group. Moreover, among patients with serum phosphate levels of >= 6.0 mg/dL, the cardiovascular mortality risk significantly decreased with increasing serum Mg levels (adjusted odds ratios [95% confidence intervals] of the lower-, intermediate-, and higher-Mg groups were 1.00 (reference), 0.81 [0.66- 0.99], and 0.74 [0.56-0.97], respectively.). An interaction between Mg and phosphate on the risk of cardiovascular mortality was statistically significant (P=0.03). Conclusion: Serum Mg levels significantly modified the mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis.	[Sakaguchi, Yusuke; Rakugi, Hiromi; Isaka, Yoshitaka] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; [Fujii, Naohiko; Iseki, Kunitoshi; Tsubakihara, Yoshiharu] Japanese Soc Dialysis Therapy, Comm Renal Data Registry, Tokyo, Japan; [Shoji, Tatsuya; Hayashi, Terumasa] Osaka Gen Med Ctr, Dept Kidney Dis & Hypertens, Osaka 5588558, Japan	Osaka University	Isaka, Y (corresponding author), Osaka Univ, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	isaka@kid.med.osaka-u.ac.jp	Fujii, Naohiko/ABG-8766-2021	Fujii, Naohiko/0000-0002-6411-8599; Rakugi, Hiromi/0000-0001-6508-4338				[Anonymous], 2009, ANN DAT REP ATL CHRO; Ayus JC, 2007, KIDNEY INT, V71, P336, DOI 10.1038/sj.ki.5002044; Ayus JC, 2005, J AM SOC NEPHROL, V16, P2778, DOI 10.1681/ASN.2005040392; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Bowler M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093625; Covic A, 2013, NEPHROL DIAL TRANSPL, V28, P2383, DOI 10.1093/ndt/gft203; D'Haese PC, 1999, CLIN CHEM, V45, P1548; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; Del Gobbo LC, 2013, AM J CLIN NUTR, V98, P160, DOI 10.3945/ajcn.112.053132; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Hruby A, 2014, JACC-CARDIOVASC IMAG, V7, P59, DOI 10.1016/j.jcmg.2013.10.006; Ishimura E, 2007, CLIN NEPHROL, V68, P222; Kanbay M, 2012, AM J NEPHROL, V36, P228, DOI 10.1159/000341868; Kircelli F, 2012, NEPHROL DIAL TRANSPL, V27, P514, DOI 10.1093/ndt/gfr321; KROLL MH, 1985, CLIN CHEM, V31, P244; Larsson SC, 2012, AM J CLIN NUTR, V95, P362, DOI 10.3945/ajcn.111.022376; Louvet L, 2013, NEPHROL DIAL TRANSPL, V28, P869, DOI 10.1093/ndt/gfs520; Maier JAM, 2012, CLIN SCI, V122, P397, DOI 10.1042/CS20110506; Massy ZA, 2012, CLIN KIDNEY J, V5, P52, DOI 10.1093/ndtplus/sfr167; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Montezano AC, 2010, HYPERTENSION, V56, P453, DOI 10.1161/HYPERTENSIONAHA.110.152058; Nakai S, 2012, THER APHER DIAL, V16, P483, DOI 10.1111/j.1744-9987.2012.01143.x; Nakai S, 2012, THER APHER DIAL, V16, P11, DOI 10.1111/j.1744-9987.2011.01050.x; Naves-Diaz M, 2011, NEPHROL DIAL TRANSPL, V26, P1938, DOI 10.1093/ndt/gfq304; Qu XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057720; Sakaguchi Y, 2014, KIDNEY INT, V85, P174, DOI 10.1038/ki.2013.327; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Tzanakis I, 1997, NEPHROL DIAL TRANSPL, V12, P2036, DOI 10.1093/ndt/12.9.2036; Van Laecke S, 2012, NEPHROL DIAL TRANSPL, V27, P4003, DOI 10.1093/ndt/gfs126; Wyskida K, 2012, J RENAL NUTR, V22, P19, DOI 10.1053/j.jrn.2011.03.001	31	46	47	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e0116273	10.1371/journal.pone.0116273	http://dx.doi.org/10.1371/journal.pone.0116273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545498	Green Published, gold, Green Submitted			2022-12-26	WOS:000347120200109
J	Zhu, WL; Tong, HL; Teh, JT; Wang, M				Zhu, Wan Long; Tong, Honglian; Teh, Jing Tsong; Wang, Mei			Forkhead Box Protein O3 Transcription Factor Negatively Regulates Autophagy in Human Cancer Cells by Inhibiting Forkhead Box Protein O1 Expression and Cytosolic Accumulation	PLOS ONE			English	Article							FACTOR FOXO1; PHOSPHORYLATION; ACETYLATION; TARGET; AKT; SENSITIVITY; MECHANISMS; APOPTOSIS; PATHWAYS; DEATH	FoxO proteins are important regulators in cellular metabolism and are recognized to be nodes in multiple signaling pathways, most notably those involving PI3K/AKT and mTOR. FoxO proteins primarily function as transcription factors, but recent study suggests that cytosolic FoxO1 participates in the regulation of autophagy. In the current study, we find that cytosolic FoxO1 indeed stimulates cellular autophagy in multiple cancer cell lines, and that it regulates not only basal autophagy but also that induced by rapamycin and that in response to nutrient deprivation. These findings illustrate the importance of FoxO1 in cell metabolism regulation independent of its transcription factor function. In contrast to FoxO1, we find the closely related FoxO3a is a negative regulator of autophagy in multiple cancer cell lines, a previously unrecognized function for this protein, different from its function in benign fibroblast and muscle cells. The induction of autophagy by the knockdown of FoxO3a was found not to be mediated through the suppression of mTORC1 signaling; rather, the regulatory role of FoxO3a on autophagy was determined to be through its ability to transcriptionally suppress FoxO1. This complicated interplay of FoxO1 and FoxO3a suggests a complex checks- and balances-relationship between FoxO3a and FoxO1 in regulating autophagy and cell metabolism.	[Zhu, Wan Long; Tong, Honglian; Teh, Jing Tsong; Wang, Mei] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore; [Zhu, Wan Long; Wang, Mei] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Wang, M (corresponding author), Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore.	mei.wang@duke-nus.edu.sg	Zhu, Wan Long/GYA-3382-2022	Wang, Mei/0000-0001-6887-6840; zhu, Wanlong/0000-0003-0025-6674	Agency for Science, Technology and Research (A*STAR); National Medical Research Council of Singapore	Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This work was supported by Agency for Science, Technology and Research (A*STAR) and National Medical Research Council of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Boccitto M, 2011, CURR DRUG TARGETS, V12, P1303, DOI 10.2174/138945011796150316; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Cao Y, 2006, J BIOL CHEM, V281, P40242, DOI 10.1074/jbc.M608116200; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Chiacchiera F, 2009, CELL DEATH DIFFER, V16, P1203, DOI 10.1038/cdd.2009.36; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Qiang L, 2010, J BIOL CHEM, V285, P27396, DOI 10.1074/jbc.M110.140228; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Sawyers CL, 2003, CANCER CELL, V4, P343, DOI 10.1016/S1535-6108(03)00275-7; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Singh A, 2011, CURR DRUG TARGETS, V12, P1311, DOI 10.2174/138945011796150271; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Wang M, 2010, ONCOGENE, V29, P4959, DOI 10.1038/onc.2010.247; Wang M, 2008, J BIOL CHEM, V283, P18678, DOI 10.1074/jbc.M801855200; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zhou JY, 2012, AUTOPHAGY, V8, P1712, DOI 10.4161/auto.21830; Zhu WL, 2011, J BIOL CHEM, V286, P35291, DOI 10.1074/jbc.M111.280990	44	15	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115087	10.1371/journal.pone.0115087	http://dx.doi.org/10.1371/journal.pone.0115087			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546383	Green Submitted, Green Published, gold			2022-12-26	WOS:000347120200022
J	Lewis, DY; Champion, S; Wyper, D; Dewar, D; Pimlott, S				Lewis, David Y.; Champion, Sue; Wyper, David; Dewar, Deborah; Pimlott, Sally			Assessment of [I-125]WYE-230949 as a Novel Histamine H-3 Receptor Radiopharmaceutical	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; RAT-BRAIN; ISOFLURANE ANESTHESIA; RADIOLIGAND BINDING; GLUCOSE-UTILIZATION; DRUG-METABOLISM; H3 RECEPTOR; IN-VIVO; PET; RELEASE	Histamine H-3 receptor therapeutics have been proposed for several diseases such as schizophrenia, attention deficit hyperactivity disorder, Alzheimer's disease and obesity. We set out to evaluate the novel compound, [I-125] WYE-230949, as a potential radionuclide imaging agent for the histamine H-3 receptor in brain. [I-125] WYE-230949 had a high in vitro affinity for the rat histamine H-3 receptor (K-d of 6.9 nM). The regional distribution of [I-125] WYE-230949 binding sites in rat brain, demonstrated by in vitro autoradiography, was consistent with the known distribution of the histamine H-3 receptor. Rat brain uptake of intravenously injected [I-125] WYE-230949 was low (0.11 % ID/g) and the ratio of specific: non-specific binding was less than 1.4, as determined by ex vivo autoradiography. In plasma, metabolism of [I-125] WYE-230949 into a less lipophilic species occurred, such that less than 38% of the parent compound remained 30 minutes after injection. Brain uptake and metabolism of [I-125] WYE-230949 were increased and specific binding was reduced in anaesthetised compared to conscious rats. [I-125]WYE230949 is not a potential radiotracer for imaging rat histamine H-3 receptors in vivo due to low brain uptake, in vivo metabolism of the parent compound and low specific binding.	[Lewis, David Y.; Champion, Sue; Wyper, David; Dewar, Deborah] Univ Glasgow, Coll Med Vet & Life Sci, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Pimlott, Sally] Greater Glasgow NHS Trust, Dept Clin Phys, Glasgow, Lanark, Scotland; [Pimlott, Sally] Univ Glasgow, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	Lewis, DY (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England.	david.lewis@cruk.cam.ac.uk	Pimlott, Sally Louise/F-8098-2010; Lewis, David/AAN-9235-2021	Pimlott, Sally Louise/0000-0002-8396-3392; Lewis, David/0000-0001-9329-1326	Translational Medicine Research Collaboration [NS_AU_084]; HNS Health Board (Grampian); HNS Health Board (Tayside); HNS Health Board (Lothian); HNS Health Board (Greater Glasgow Clyde); Scottish Enterprise; Wyeth Pharmaceutical; Scottish Imaging Network: A Platform for Scientific Excellence (SINAPSE)	Translational Medicine Research Collaboration; HNS Health Board (Grampian); HNS Health Board (Tayside); HNS Health Board (Lothian); HNS Health Board (Greater Glasgow Clyde); Scottish Enterprise; Wyeth Pharmaceutical(Wyeth); Scottish Imaging Network: A Platform for Scientific Excellence (SINAPSE)	This work was supported by an award (Ref: NS_AU_084) from the Translational Medicine Research Collaboration a consortium made up of the Universities of Aberdeen, Dundee, Edinburgh and Glasgow, the four associated HNS Health Boards (Grampian, Tayside, Lothian and Greater Glasgow & Clyde), Scottish Enterprise and Wyeth Pharmaceutical. Dr. S. Champion is funded by the Scottish Imaging Network: A Platform for Scientific Excellence (SINAPSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen AJ, 2006, NUCL MED BIOL, V33, P801, DOI 10.1016/j.nucmedbio.2006.05.008; Anichtchik OV, 2001, NEUROBIOL DIS, V8, P707, DOI 10.1006/nbdi.2001.0413; ARRANG JM, 1983, NATURE, V302, P832, DOI 10.1038/302832a0; ARRANG JM, 1995, BRIT J PHARMACOL, V114, P1518, DOI 10.1111/j.1476-5381.1995.tb13379.x; Ashworth S, 2014, BRIT J PHARMACOL, V171, P1241, DOI 10.1111/bph.12505; Ashworth S, 2010, J NUCL MED, V51, P1021, DOI 10.2967/jnumed.109.071753; Bao XF, 2012, J MED CHEM, V55, P2406, DOI 10.1021/jm201690h; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cain SM, 2009, EPILEPSIA, V50, P1962, DOI 10.1111/j.1528-1167.2009.02095.x; Champion S, 2011, J LABELLED COMPD RAD, V54, P674, DOI 10.1002/jlcr.1899; CLAPHAM J, 1992, BRIT J PHARMACOL, V107, P919, DOI 10.1111/j.1476-5381.1992.tb13386.x; Cole DC, 2010, US Pat Appl Publ US, Patent No. 7820825; Cole DC, 2010, BIOORG MED CHEM LETT, V20, P1237, DOI 10.1016/j.bmcl.2009.11.122; DISCHINO DD, 1983, J NUCL MED, V24, P1030; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Elfving B, 2003, EUR J NUCL MED MOL I, V30, P912, DOI 10.1007/s00259-003-1171-8; Funaki Y, 2007, NUCL MED BIOL, V34, P981, DOI 10.1016/j.nucmedbio.2007.07.012; Funke U, 2013, J LABELLED COMPD RAD, V56, P120, DOI 10.1002/jlcr.3038; Hamill TG, 2009, SYNAPSE, V63, P1122, DOI 10.1002/syn.20689; JANSEN FP, 1994, BRIT J PHARMACOL, V113, P355, DOI 10.1111/j.1476-5381.1994.tb16995.x; Jansen FP, 1997, THESIS LEIDEN AMSTER; Jin CY, 2009, BRIT J PHARMACOL, V157, P118, DOI 10.1111/j.1476-5381.2009.00149.x; Jucaite A, 2013, INT J NEUROPSYCHOPH, V16, P1231, DOI 10.1017/S1461145712001411; Lenz C, 1998, ANESTHESIOLOGY, V89, P1480, DOI 10.1097/00000542-199812000-00026; LIGNEAU X, 1994, J PHARMACOL EXP THER, V271, P452; Logan J, 2012, PSYCHOPHARMACOLOGY, V223, P447, DOI 10.1007/s00213-012-2733-x; MAEKAWA T, 1986, ANESTHESIOLOGY, V65, P144, DOI 10.1097/00000542-198608000-00003; Medhurst AD, 2009, BRIT J PHARMACOL, V157, P130, DOI 10.1111/j.1476-5381.2008.00075.x; Panula P, 2013, NAT REV NEUROSCI, V14, P472, DOI 10.1038/nrn3526; Passani MB, 2011, TRENDS PHARMACOL SCI, V32, P242, DOI 10.1016/j.tips.2011.01.003; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pike VW, 2009, TRENDS PHARMACOL SCI, V30, P431, DOI 10.1016/j.tips.2009.05.005; Pillot C, 2002, NEUROSCIENCE, V114, P173, DOI 10.1016/S0306-4522(02)00135-5; Plisson C, 2009, J NUCL MED, V50, P2064, DOI 10.2967/jnumed.109.062919; POLLARD H, 1993, NEUROSCIENCE, V52, P169, DOI 10.1016/0306-4522(93)90191-H; Rahman M, 1996, J APPL TOXICOL, V16, P331; Sasse A, 2001, ARCH PHARM, V334, P45, DOI 10.1002/1521-4184(200102)334:2<45::AID-ARDP45>3.0.CO;2-2; SCHLICKER E, 1989, N-S ARCH PHARMACOL, V340, P633, DOI 10.1007/BF00717738; SCHLICKER E, 1993, J NEURAL TRANSM-GEN, V93, P1, DOI 10.1007/BF01244933; SCHLICKER E, 1988, N-S ARCH PHARMACOL, V337, P588; Schwartz JC, 2011, BRIT J PHARMACOL, V163, P713, DOI 10.1111/j.1476-5381.2011.01286.x; Sheng Y, 2012, J NEUROL SCI, V315, P110, DOI 10.1016/j.jns.2011.11.013; Tavares AAS, 2012, NUCL MED BIOL, V39, P127, DOI 10.1016/j.nucmedbio.2011.06.011; Teuscher C, 2007, P NATL ACAD SCI USA, V104, P10146, DOI 10.1073/pnas.0702291104; Van Laere KJ, 2014, J NUCL MED, V55, P65, DOI 10.2967/jnumed.113.122515; Waterhouse Rikki N, 2003, Mol Imaging Biol, V5, P376, DOI 10.1016/j.mibio.2003.09.014; Wilson AA, 2001, APPL RADIAT ISOTOPES, V54, P203, DOI 10.1016/S0969-8043(00)00269-4; Windhorst AD, 1999, BIOORGAN MED CHEM, V7, P1761, DOI 10.1016/S0968-0896(99)00108-X; Windhorst AD, 1999, NUCL MED BIOL, V26, P651, DOI 10.1016/S0969-8051(99)00014-1; WOOD M, 1984, ANESTH ANALG, V63, P709	50	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115876	10.1371/journal.pone.0115876	http://dx.doi.org/10.1371/journal.pone.0115876			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542008	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000347239900102
J	Simon, G; Larsen, LE; Durrwald, R; Foni, E; Harder, T; Van Reeth, K; Markowska-Daniel, I; Reid, SM; Dan, A; Maldonado, J; Huovilainen, A; Billinis, C; Davidson, I; Aguero, M; Vila, T; Herve, S; Breum, SO; Chiapponi, C; Urbaniak, K; Kyriakis, CS; Brown, IH; Loeffen, W				Simon, Gaelle; Larsen, Lars E.; Duerrwald, Ralf; Foni, Emanuela; Harder, Timm; Van Reeth, Kristien; Markowska-Daniel, Iwona; Reid, Scott M.; Dan, Adam; Maldonado, Jaime; Huovilainen, Anita; Billinis, Charalambos; Davidson, Irit; Agueero, Montserrat; Vila, Thais; Herve, Severine; Breum, Solvej Ostergaard; Chiapponi, Chiara; Urbaniak, Kinga; Kyriakis, Constantinos S.; Brown, Ian H.; Loeffen, Willie		ESNIP3 Consortium	European Surveillance Network for Influenza in Pigs: Surveillance Programs, Diagnostic Tools and Swine Influenza Virus Subtypes Identified in 14 European Countries from 2010 to 2013	PLOS ONE			English	Article							PANDEMIC H1N1 2009; UNIVERSAL PRIMER SET; A VIRUS; GENETIC REASSORTMENT; PCR ASSAY; RT-PCR; TRANSMISSION; H3N2; EVOLUTION; PORCINE	Swine influenza causes concern for global veterinary and public health officials. In continuing two previous networks that initiated the surveillance of swine influenza viruses (SIVs) circulating in European pigs between 2001 and 2008, a third European Surveillance Network for Influenza in Pigs (ESNIP3, 2010-2013) aimed to expand widely the knowledge of the epidemiology of European SIVs. ESNIP3 stimulated programs of harmonized SIV surveillance in European countries and supported the coordination of appropriate diagnostic tools and subtyping methods. Thus, an extensive virological monitoring, mainly conducted through passive surveillance programs, resulted in the examination of more than 9 000 herds in 17 countries. Influenza A viruses were detected in 31% of herds examined from which 1887 viruses were preliminary characterized. The dominating subtypes were the three European enzootic SIVs: avian-like swine H1N1 (53.6%), human-like reassortant swine H1N2 (13%) and human-like reassortant swine H3N2 (9.1%), as well as pandemic A/H1N1 2009 (H1N1pdm) virus (10.3%). Viruses from these four lineages co-circulated in several countries but with very different relative levels of incidence. For instance, the H3N2 subtype was not detected at all in some geographic areas whereas it was still prevalent in other parts of Europe. Interestingly, H3N2-free areas were those that exhibited highest frequencies of circulating H1N2 viruses. H1N1pdm viruses were isolated at an increasing incidence in some countries from 2010 to 2013, indicating that this subtype has become established in the European pig population. Finally, 13.9% of the viruses represented reassortants between these four lineages, especially between previous enzootic SIVs and H1N1pdm. These novel viruses were detected at the same time in several countries, with increasing prevalence. Some of them might become established in pig herds, causing implications for zoonotic infections.	[Simon, Gaelle; Herve, Severine] Anses, Swine Virol Immunol Unit, Ploufragan Plouzane Lab, Ploufragan, France; [Larsen, Lars E.; Breum, Solvej Ostergaard] Tech Univ Denmark, Natl Vet Inst, Copenhagen, Denmark; [Duerrwald, Ralf] IDT Biol GmbH, Dessau Rosslau, Germany; [Foni, Emanuela; Chiapponi, Chiara] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Parma, Italy; [Harder, Timm] Friedrich Loeffler Inst, Greifswald, Germany; [Van Reeth, Kristien] Univ Ghent, Fac Vet Med, Virol Lab, Merelbeke, Belgium; [Markowska-Daniel, Iwona; Urbaniak, Kinga] Natl Inst Vet Res, Pulawy, Poland; [Reid, Scott M.; Brown, Ian H.] Anim Hlth & Vet Labs Agcy, Weybridge, Surrey, England; [Dan, Adam] Mol Biol Lab, Vet Diagnost Directorate, Natl Food Chain Safety Off, Budapest, Hungary; [Maldonado, Jaime] Hipra, Girona, Spain; [Huovilainen, Anita] Finnish Food Safety Author, Helsinki, Finland; [Billinis, Charalambos; Kyriakis, Constantinos S.] Univ Thessaly, Fac Vet Med, Lab Microbiol & Parasitol, Kardhitsa, Greece; [Davidson, Irit] Kimron Vet Inst, Rishon Ltzion, Israel; [Agueero, Montserrat] Lab Cent Vet Sanidad Anim, Algete, Spain; [Vila, Thais] Merial, Lyon, France; [Loeffen, Willie] Wageningen UR, Cent Vet Inst, Lelystad, Netherlands	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Technical University of Denmark; IDT Biologika; IZS Lombardia e Emilia; Friedrich Loeffler Institute; Ghent University; National Veterinary Institute - National Research Institute; Veterinary Laboratories Agency; HIPRA; Finnish Food Authority; University of Thessaly; Kimron Veterinary Institute; Merial SASU; Wageningen University & Research	Simon, G (corresponding author), Anses, Swine Virol Immunol Unit, Ploufragan Plouzane Lab, Ploufragan, France.	gaelle.simon@anses.fr	Loeffen, Willie/M-5344-2015; Dán, Ádám/G-6018-2012; Brown, Ian H/E-1119-2011; Davidson, Irit/Q-4452-2019; Harder, Timm/AAE-2932-2019; Pybus, Oliver G/B-2640-2012; Maldonado, Jaime/ABG-3226-2020; Simon, Gaelle/ABI-1479-2020; Larsen, Lars E/G-3827-2015	Loeffen, Willie/0000-0003-4732-4590; Dán, Ádám/0000-0001-7849-7721; Harder, Timm/0000-0003-2387-378X; Pybus, Oliver G/0000-0002-8797-2667; Simon, Gaelle/0000-0003-1099-5075; Larsen, Lars E/0000-0003-0730-5555; Kyriakis, Constantinos/0000-0001-7171-923X; Markowska-Daniel, Iwona/0000-0003-2889-6745; Chiapponi, Chiara/0000-0001-8808-4680; Urbaniak, Kinga/0000-0002-7965-9216	European Union FP7-INFLUENZA program [259949]	European Union FP7-INFLUENZA program	Financial support to ESNIP3 was provided by European Union FP7-INFLUENZA-2010 program, grant #259949. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balint A, 2012, ACTA VET HUNG, V61, P125; Banyai K, 2012, J VIROL, V86, P13133, DOI 10.1128/JVI.02503-12; Breum SO, 2013, GENOME ANNOUNC, V1; Brookes SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009068; Brown I. H., 2013, Pig Journal, V68, P8; Brown IH, 1998, J GEN VIROL, V79, P2947, DOI 10.1099/0022-1317-79-12-2947; Cardinale E, 2012, EMERG INFECT DIS, V18, P1665, DOI 10.3201/eid1810.120398; CASTRUCCI MR, 1993, VIROLOGY, V193, P503, DOI 10.1006/viro.1993.1155; Cheung TKW, 2007, ANN NY ACAD SCI, V1102, P1, DOI 10.1196/annals.1408.001; Chiapponi C, 2013, GENOME ANNOUNC, V1; Chiapponi C, 2003, SUBTYPING H1N1 H1N2, P257; Chiapponi C, 2012, J VIROL METHODS, V184, P117, DOI 10.1016/j.jviromet.2012.05.020; Chiapponi C, 2010, J VIROL METHODS, V163, P162, DOI 10.1016/j.jviromet.2009.09.017; de Jong JC, 1999, VACCINE, V17, P1321, DOI 10.1016/S0264-410X(98)00392-2; De Vleeschauwer A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006662; Ducatez MF, 2011, EMERG INFECT DIS, V17, P1624, DOI 10.3201/eid1709.110338; Durrwald R, 2010, EMERG INFECT DIS, V16, P1029, DOI 10.3201/eid1606.100138; Epperson S, 2013, CLIN INFECT DIS, V57, pS4, DOI 10.1093/cid/cit272; Fereidouni SR, 2012, J VIROL METHODS, V186, P119, DOI 10.1016/j.jviromet.2012.08.002; Fereidouni SR, 2008, J VIROL METHODS, V154, P14, DOI 10.1016/j.jviromet.2008.09.011; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Gall A, 2008, J CLIN MICROBIOL, V46, P2561, DOI 10.1128/JCM.00466-08; Gall A, 2009, J CLIN MICROBIOL, V47, P327, DOI 10.1128/JCM.01330-08; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Grontvedt C.A, 2011, INFLUENZA RES TREAT; HAESEBROUCK F, 1985, AM J VET RES, V46, P1926; Harder TC, 2013, J VIROL, V87, P10460, DOI 10.1128/JVI.00381-13; Herve S, 2012, B EPIDEMIOLOGIQUE SA, V51, P22; Hoffmann B, 2010, BERL MUNCH TIERARZTL, V123, P286, DOI 10.2376/0005-9366-123-286; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hofshagen M, 2009, EUROSURVEILLANCE, V14, P15; Howard WA, 2011, EMERG INFECT DIS, V17, P1049, DOI [10.3201/eid1706.101886, 10.3201/eid/1706.101886]; Howden KJ, 2009, CAN VET J, V50, P1153; Kitikoon P, 2013, J GEN VIROL, V94, P1236, DOI [10.1099/vir.0.51839-0, 10.1099/vir.0.051839-0]; Kowalczyk A, 2013, J VIROL METHODS, V187, P228, DOI 10.1016/j.jviromet.2012.08.011; Kuntz-Simon G, 2009, ZOONOSES PUBLIC HLTH, V56, P310, DOI 10.1111/j.1863-2378.2009.01236.x; Kyriakis CS, 2013, VET MICROBIOL, V162, P543, DOI 10.1016/j.vetmic.2012.11.014; Kyriakis CS, 2011, ZOONOSES PUBLIC HLTH, V58, P93, DOI 10.1111/j.1863-2378.2009.01301.x; Kyriakis CS, 2010, EMERG INFECT DIS, V16, P96, DOI 10.3201/eid1601.091190; Lange E, 2009, J GEN VIROL, V90, P2119, DOI 10.1099/vir.0.014480-0; Lange J, 2013, VET MICROBIOL, V167, P345, DOI 10.1016/j.vetmic.2013.09.024; Liang HY, 2014, J VIROL, V88, P10864, DOI 10.1128/JVI.01327-14; Liu QF, 2012, ARCH VIROL, V157, P555, DOI 10.1007/s00705-011-1203-9; Loeffen WLA, 2011, VET MICROBIOL, V152, P304, DOI 10.1016/j.vetmic.2011.05.027; Markowska-Daniel I, 2013, B VET I PULAWY, V57, P293, DOI 10.2478/bvip-2013-0051; Marozin S, 2002, J GEN VIROL, V83, P735, DOI 10.1099/0022-1317-83-4-735; Moreno Ana, 2010, Open Virol J, V4, P52, DOI 10.2174/1874357901004010052; Munch M, 2001, ARCH VIROL, V146, P87, DOI 10.1007/s007050170193; Nelson MI, 2012, J GEN VIROL, V93, P2584, DOI 10.1099/vir.0.045930-0; Nelson MI, 2012, J GEN VIROL, V93, P2195, DOI 10.1099/vir.0.044974-0; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nokireki T, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-69; OIE, 2012, MANUAL DIAGNOSTIC TE; PENSAERT M, 1981, B WORLD HEALTH ORGAN, V59, P75; Pol F, 2011, J VIROL METHODS, V171, P241, DOI 10.1016/j.jviromet.2010.11.007; Poon LLM, 2010, CLIN CHEM, V56, P1340, DOI 10.1373/clinchem.2010.149179; Reeth VK, 2012, DIS SWINE, V10th, P557; Simon G, 2013, ISIRV 7 8 MARCH DUBL, P43; Simon G, 2013, B EPIDEMIOLOGIQUE SA, V56, P17; Slomka MJ, 2010, INFLUENZA OTHER RESP, V4, P277, DOI 10.1111/j.1750-2659.2010.00149.x; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Starick E, 2012, J GEN VIROL, V93, P1658, DOI 10.1099/vir.0.042648-0; Starick E, 2011, J GEN VIROL, V92, P1184, DOI 10.1099/vir.0.028662-0; Trebbien R, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-290; Van Reeth K, 2008, INFLUENZA OTHER RESP, V2, P99, DOI 10.1111/j.1750-2659.2008.00043.x; Vijaykrishna D, 2011, NATURE, V473, P519, DOI 10.1038/nature10004; Vincent A, 2014, ZOONOSES PUBLIC HLTH, V61, P4, DOI 10.1111/zph.12049; Welsh MD, 2010, VET REC, V166, P642, DOI 10.1136/vr.4851; Zell R, 2008, ARCH VIROL, V153, P2085, DOI 10.1007/s00705-008-0244-1; Zell R, 2008, J GEN VIROL, V89, P271, DOI 10.1099/vir.0.83338-0; Zell R, 2013, CURR TOP MICROBIOL, V370, P29, DOI 10.1007/82_2012_267	73	78	81	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115815	10.1371/journal.pone.0115815	http://dx.doi.org/10.1371/journal.pone.0115815			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542013	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900093
J	Jacobo, SMP; Kazlauskas, A				Jacobo, Sarah Melissa P.; Kazlauskas, Andrius			Insulin-like Growth Factor 1 (IGF-1) Stabilizes Nascent Blood Vessels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I RECEPTOR; LYSOPHOSPHATIDIC ACID; ENDOTHELIAL-CELLS; RETINAL NEOVASCULARIZATION; VASCULAR MORPHOGENESIS; DIABETIC-RETINOPATHY; ANGIOGENESIS; ACTIVATION; REGRESSION; MIGRATION	Here we report that VEGF-A and IGF-1 differ in their ability to stabilize newly formed blood vessels and endothelial cell tubes. Although VEGF-A failed to support an enduring vascular response, IGF-1 stabilized neovessels generated from primary endothelial cells derived from various vascular beds and mouse retinal explants. In these experimental systems, destabilization/regression was driven by lysophosphatidic acid (LPA). Because previous studies have established that Erk antagonizes LPA-mediated regression, we considered whether Erk was an essential component of IGF-dependent stabilization. Indeed, IGF-1 lost its ability to stabilize neovessels when the Erk pathway was inhibited pharmacologically. Furthermore, stabilization was associated with prolonged Erk activity. In the presence of IGF-1, Erk activity persisted longer than in the presence of VEGF or LPA alone. These studies reveal that VEGF and IGF-1 can have distinct inputs in the angiogenic process. In contrast to VEGF, IGF-1 stabilizes neovessels, which is dependent on Erk activity and associated with prolonged activation.	[Kazlauskas, Andrius] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02115 USA; Massachusetts Eye & Ear Infirm, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Massachusetts Eye & Ear Infirmary	Kazlauskas, A (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02115 USA.	andrius_kazlauskas@meei.harvard.edu		Jacobo, Sarah Melissa/0000-0002-1341-7222	Knights Templar Eye Foundation Early Career Award	Knights Templar Eye Foundation Early Career Award	This work was supported by a Knights Templar Eye Foundation Early Career Award (to S. M. P. J.).	Albers HMHG, 2010, P NATL ACAD SCI USA, V107, P7257, DOI 10.1073/pnas.1001529107; Anand-Apte B, 1997, J BIOL CHEM, V272, P30688, DOI 10.1074/jbc.272.49.30688; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Aranda J, 2013, DIABETOLOGIA, V56, P1444, DOI 10.1007/s00125-013-2884-2; Aranda J, 2012, DIABETES, V61, P1225, DOI 10.2337/db11-1189; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Cheng HY, 2012, ARTERIOSCL THROM VAS, V32, P24, DOI 10.1161/ATVBAHA.111.234708; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; Darland DC, 1999, J CLIN INVEST, V103, P157, DOI 10.1172/JCI6127; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Goede V, 1998, LAB INVEST, V78, P1385; Graf K, 1997, HYPERTENSION, V29, P334, DOI 10.1161/01.HYP.29.1.334; Grammer TC, 1997, ONCOGENE, V14, P1635, DOI 10.1038/sj.onc.1201000; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; Hellstrom A, 2002, J CLIN ENDOCR METAB, V87, P3413, DOI 10.1210/jc.87.7.3413; Hellstrom A, 2003, PEDIATRICS, V112, P1016, DOI 10.1542/peds.112.5.1016; Hoang MV, 2011, BLOOD, V117, P1751, DOI 10.1182/blood-2010-05-286831; Hoang MV, 2004, P NATL ACAD SCI USA, V101, P1874, DOI 10.1073/pnas.0308525100; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Im E, 2005, MOL BIOL CELL, V16, P3488, DOI 10.1091/mbc.E04-11-1029; Im E, 2007, J BIOL CHEM, V282, P29122, DOI 10.1074/jbc.M702637200; Im E, 2006, EMBO J, V25, P2075, DOI 10.1038/sj.emboj.7601100; Im E, 2006, CELL CYCLE, V5, P2057, DOI 10.4161/cc.5.18.3210; Im E, 2010, MOL CELL BIOL, V30, P2401, DOI 10.1128/MCB.01275-09; Jacobo SMP, 2013, MOL CELL BIOL, V33, P1976, DOI 10.1128/MCB.01283-12; Kayali AG, 1998, J BIOL CHEM, V273, P13808, DOI 10.1074/jbc.273.22.13808; Kondo T, 2003, J CLIN INVEST, V111, P1835, DOI 10.1172/JCI200317455; Kwon H, 2011, J CELL MOL MED, V15, P888, DOI 10.1111/j.1582-4934.2010.01079.x; Lin SC, 2011, J CLIN INVEST, V121, P1905, DOI 10.1172/JCI44362; Lofqvist C, 2006, PEDIATRICS, V117, P1930, DOI 10.1542/peds.2005-1926; Lofqvist C, 2006, ARCH OPHTHALMOL-CHIC, V124, P1711, DOI 10.1001/archopht.124.12.1711; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Meadows KN, 2001, J BIOL CHEM, V276, P49289, DOI 10.1074/jbc.M108069200; Motiejunaite R, 2014, MICROVASC RES, V93, P62, DOI 10.1016/j.mvr.2014.03.003; Panetti TS, 2000, ARTERIOSCL THROM VAS, V20, P1013, DOI 10.1161/01.ATV.20.4.1013; Park EY, 2012, BIOSCIENCE REP, V32, P393, DOI 10.1042/BSR20120033; Ptaszynska MM, 2010, MOL CANCER RES, V8, P309, DOI 10.1158/1541-7786.MCR-09-0288; Pukac L, 1998, EXP CELL RES, V242, P548, DOI 10.1006/excr.1998.4138; Rao S, 2007, DEVELOPMENT, V134, P4449, DOI 10.1242/dev.012187; Roberts DD, 2011, BLOOD, V117, P1444, DOI 10.1182/blood-2010-11-317198; Ruan GX, 2012, EMBO J, V31, P1692, DOI 10.1038/emboj.2012.21; SEELY BL, 1995, J BIOL CHEM, V270, P19151, DOI 10.1074/jbc.270.32.19151; Smith LEH, 1999, NAT MED, V5, P1390, DOI 10.1038/70963; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Stortelers C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-387; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Teo ST, 2009, IUBMB LIFE, V61, P791, DOI 10.1002/iub.220; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458	53	40	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6349	6360		10.1074/jbc.M114.634154	http://dx.doi.org/10.1074/jbc.M114.634154			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25564613	Green Published, hybrid			2022-12-26	WOS:000350732500040
J	Moayeri, M; Leysath, CE; Tremblay, JM; Vrentas, C; Crown, D; Leppla, SH; Shoemaker, CB				Moayeri, Mahtab; Leysath, Clinton E.; Tremblay, Jacqueline M.; Vrentas, Catherine; Crown, Devorah; Leppla, Stephen H.; Shoemaker, Charles B.			A Heterodimer of a VHH (Variable Domains of Camelid Heavy Chain-only) Antibody That Inhibits Anthrax Toxin Cell Binding Linked to a VHH Antibody That Blocks Oligomer Formation Is Highly Protective in an Anthrax Spore Challenge Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LETHAL FACTOR; MONOCLONAL-ANTIBODIES; ANTIGEN; MICE; NANOBODIES; CLEARANCE; LIBRARIES; AFFINITY; RECEPTOR; AGENTS	Anthrax disease is caused by a toxin consisting of protective antigen (PA), lethal factor, and edema factor. Antibodies against PA have been shown to be protective against the disease. Variable domains of camelid heavy chain-only antibodies (VHHs) with affinity for PA were obtained from immunized alpacas and screened for anthrax neutralizing activity in macrophage toxicity assays. Two classes of neutralizing VHHs were identified recognizing distinct, non-overlapping epitopes. One class recognizes domain 4 of PA at a well characterized neutralizing site through which PA binds to its cellular receptor. A second neutralizing VHH (JKH-C7) recognizes a novel epitope. This antibody inhibits conversion of the PA oligomer from "pre-pore" to its SDS and heat-resistant "pore" conformation while not preventing cleavage of full-length 83-kDa PA (PA83) by cell surface proteases to its oligomer-competent 63-kDa form (PA63). The antibody prevents endocytosis of the cell surface-generated PA63 subunit but not preformed PA63 oligomers formed in solution. JKH-C7 and the receptor-blocking VHH class (JIK-B8) were expressed as a heterodimeric VHH-based neutralizing agent (VNA2-PA). This VNA displayed improved neutralizing potency in cell assays and protected mice from anthrax toxin challenge with much better efficacy than the separate component VHHs. The VNA protected virtually all mice when separately administered at a 1:1 ratio to toxin and protected mice against Bacillus anthracis spore infection. Thus, our studies show the potential of VNAs as anthrax therapeutics. Due to their simple and stable nature, VNAs should be amenable to genetic delivery or administration via respiratory routes.	[Moayeri, Mahtab; Leysath, Clinton E.; Vrentas, Catherine; Crown, Devorah; Leppla, Stephen H.] Tufts Univ, Dept Infect Dis & Global Hlth, Cummings Sch Vet Med, North Grafton, MA 01536 USA; [Tremblay, Jacqueline M.; Shoemaker, Charles B.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	Tufts University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shoemaker, CB (corresponding author), Tufts Univ, Dept Infect Dis & Global Hlth, Cummings Sch Vet Med, 200 Westboro Rd, North Grafton, MA 01536 USA.	charles.shoemaker@tufts.edu		Moayeri, Mahtab/0000-0002-4448-8883	National Institutes of Health [U54 AI057159]; Intramural Research Program of the National Institutes of Health (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, ZIAAI001032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institutes of Health (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant U54 AI057159 (NIAID) and by the Intramural Research Program of the National Institutes of Health (NIAID).	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Alberti MO, 2013, GENE THER, V20, P733, DOI 10.1038/gt.2012.91; Bakherad H, 2013, MOL BIOTECHNOL, V55, P159, DOI 10.1007/s12033-013-9669-1; Ben Abderrazek R, 2009, BIOCHEM J, V424, P263, DOI 10.1042/BJ20090697; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Chen ZC, 2011, TOXINS, V3, P1004, DOI 10.3390/toxins3081004; Chen ZC, 2009, INFECT IMMUN, V77, P3902, DOI 10.1128/IAI.00200-09; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Hassanzadeh-Ghassabeh G, 2013, NANOMEDICINE-UK, V8, P1013, DOI [10.2217/nnm.13.86, 10.2217/NNM.13.86]; Hmila I, 2008, MOL IMMUNOL, V45, P3847, DOI 10.1016/j.molimm.2008.04.011; Kaur M, 2013, EXPERT REV VACCINES, V12, P955, DOI 10.1586/14760584.2013.814860; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; LITTLE SF, 1988, INFECT IMMUN, V56, P1807, DOI 10.1128/IAI.56.7.1807-1813.1988; Liu SH, 2014, TRENDS MICROBIOL, V22, P317, DOI 10.1016/j.tim.2014.02.012; Lui SH, 2010, CELL HOST MICROBE, V8, P455, DOI 10.1016/j.chom.2010.10.004; Maass DR, 2007, J IMMUNOL METHODS, V324, P13, DOI 10.1016/j.jim.2007.04.008; Maass DR, 2007, INT J PARASITOL, V37, P953, DOI 10.1016/j.ijpara.2007.02.005; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; Moayeri M, 2007, INFECT IMMUN, V75, P5175, DOI 10.1128/IAI.00719-07; Moayeri M, 2006, INFECT IMMUN, V74, P3707, DOI 10.1128/IAI.00051-06; Moayeri M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001222; Mukherjee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106422; Mukherjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029941; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nguyen A, 2006, PROTEIN ENG DES SEL, V19, P291, DOI 10.1093/protein/gzl011; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Pomerantsev AP, 2006, INFECT IMMUN, V74, P682, DOI 10.1128/IAI.74.1.682-693.2006; Razai A, 2005, J MOL BIOL, V351, P158, DOI 10.1016/j.jmb.2005.06.003; Richard G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069495; Rosovitz MJ, 2003, J BIOL CHEM, V278, P30936, DOI 10.1074/jbc.M301154200; Sepulveda J, 2010, INFECT IMMUN, V78, P756, DOI 10.1128/IAI.01084-09; Sheoran AS, 2015, INFECT IMMUN, V83, P286, DOI 10.1128/IAI.02360-14; SINGH Y, 1994, J BIOL CHEM, V269, P29039; Tremblay JM, 2013, INFECT IMMUN, V81, P4592, DOI 10.1128/IAI.01033-13; Tremblay JM, 2010, TOXICON, V56, P990, DOI 10.1016/j.toxicon.2010.07.003; van der Goot G, 2009, MOL ASPECTS MED, V30, P406, DOI 10.1016/j.mam.2009.08.007; Vance DJ, 2013, J BIOL CHEM, V288, P36538, DOI 10.1074/jbc.M113.519207; Verheesen P, 2006, BBA-PROTEINS PROTEOM, V1764, P1307, DOI 10.1016/j.bbapap.2006.05.011; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Wang Fei, 2004, Human Antibodies, V13, P105; Yang ZY, 2014, J INFECT DIS, V210, P964, DOI 10.1093/infdis/jiu196	42	24	26	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6584	6595		10.1074/jbc.M114.627943	http://dx.doi.org/10.1074/jbc.M114.627943			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25564615	hybrid, Green Published			2022-12-26	WOS:000350732500060
J	Bae, C; Sachs, F; Gottlieb, PA				Bae, Chilman; Sachs, Frederick; Gottlieb, Philip A.			Protonation of the Human PIEZO1 Ion Channel Stabilizes Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANOSENSITIVE CHANNELS; MUTATIONS; PATCH; CELL	PIEZO1 is a recently cloned eukaryotic cation-selective channel that opens with mechanical force. We found that extracellular protonation inhibits channel activation by approximate to 90% by increased occupancy in the closed or the inactivated state. Titration between pH 6.3 and 8.3 exhibited a pK of approximate to 6.9. The steepness of the titration data suggests positive cooperativity, implying the involvement of at least two protonation sites. Whole-cell recordings yielded results similar to patches, and pH 6.5 reduced whole-cell currents by >80%. The effects were reversible. To assess whether pH acts on the open or the inactivated state, we tested a double-mutant PIEZO1 that does not inactivate. Cell-attached patches and whole-cell currents from this mutant channel were pH-insensitive. Thus, protonation appears to be associated with domain(s) of the channel involved with inactivation. pH also did not affect mutant channels with point mutations at position 2456 that are known to exhibit slow inactivation. To determine whether the physical properties of the membrane are altered by pH and thereby affect channel gating, we measured patch capacitance during mechanical stimuli at pH 6.5 and 7.3. The rate constants for changes in patch capacitance were independent of pH, suggesting that bilayer mechanics are not involved. In summary, low pH stabilizes the inactivated state. This effect may be important when channels are activated under pathological conditions in which the pH is reduced, such as during ischemia.	[Bae, Chilman; Sachs, Frederick; Gottlieb, Philip A.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Gottlieb, PA (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, 302 Cary Hall, Buffalo, NY 14214 USA.	philgott@buffalo.edu	Gottlieb, Philip/C-3113-2019	Gottlieb, Philip/0000-0003-3764-9885	National Institutes of Health through the NHLBI [5R01HL054887-19]; United States Army Research Office; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054887] Funding Source: NIH RePORTER	National Institutes of Health through the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); United States Army Research Office; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01HL054887-19 (to F. S.) through the NHLBI. This work was also supported by the United States Army Research Office (to F. S.).	Albuisson J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2899; Andolfo I, 2013, BLOOD, V121, P3925, DOI 10.1182/blood-2013-02-482489; Bae C, 2013, BIOPHYS J, V105, P880, DOI 10.1016/j.bpj.2013.07.019; Bae C, 2013, P NATL ACAD SCI USA, V110, pE1162, DOI 10.1073/pnas.1219777110; CHAZAN JA, 1968, NEW ENGL J MED, V278, P360, DOI 10.1056/NEJM196802152780703; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Ducret T, 2006, J PHYSIOL-LONDON, V575, P913, DOI 10.1113/jphysiol.2006.115154; Faucherre A, 2014, HAEMATOLOGICA, V99, P70, DOI 10.3324/haematol.2013.086090; Faucherre A, 2013, J NEUROSCI, V 33, P17089, DOI 10.1523/JNEUROSCI.0522-13.2013; Gailly P, 2007, J PHYSIOL-LONDON, V582, P1261, DOI 10.1113/jphysiol.2007.132191; Gottlieb PA, 2012, CHANNELS, V6, P214, DOI 10.4161/chan.21050; Gottlieb PA, 2012, CHANNELS, V6, P282, DOI 10.4161/chan.21064; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Li J., 2014, ELECTRON J DIFFER EQ, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0089893; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; Sachs F, 2010, PHYSIOLOGY, V25, P50, DOI 10.1152/physiol.00042.2009; Suchyna TM, 2007, J PHYSIOL-LONDON, V581, P369, DOI 10.1113/jphysiol.2006.125021; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Suchyna TM, 2004, PHYS BIOL, V1, P1, DOI 10.1088/1478-3967/1/1/001; Sukharev S, 2012, J CELL SCI, V125, P3075, DOI 10.1242/jcs.092353; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251; Yeung EW, 2005, J PHYSIOL-LONDON, V562, P367, DOI 10.1113/jphysiol.2004.075275; Zarychanski R, 2012, BLOOD, V120, P1908, DOI 10.1182/blood-2012-04-422253	26	32	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5167	5173		10.1074/jbc.M114.604033	http://dx.doi.org/10.1074/jbc.M114.604033			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25561736	hybrid, Green Published			2022-12-26	WOS:000350042000055
J	La Montanara, P; Rusconi, L; Locarno, A; Forti, L; Barbiero, I; Tramarin, M; Chandola, C; Kilstrup-Nielsen, C; Landsberger, N				La Montanara, Paolo; Rusconi, Laura; Locarno, Albina; Forti, Lia; Barbiero, Isabella; Tramarin, Marco; Chandola, Chetan; Kilstrup-Nielsen, Charlotte; Landsberger, Nicoletta			Synaptic Synthesis, Dephosphorylation, and Degradation A NOVEL PARADIGM FOR AN ACTIVITY-DEPENDENT NEURONAL CONTROL OF CDKL5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BDNF TRANSCRIPTION; PROTEIN-SYNTHESIS; RETT-SYNDROME; CDKL5; KINASE; MECHANISMS; PHOSPHORYLATION; EXPRESSION; PLASTICITY; RECEPTORS	Mutations in the X-linked CDKL5 (cyclin-dependent kinase-like 5) gene have been associated with several forms of neurodevelopmental disorders, including atypical Rett syndrome, autism spectrum disorders, and early infantile epileptic encephalopathy. Accordingly, loss of CDKL5 in mice results in autistic-like features and impaired neuronal communication. Although the biological functions of CDKL5 remain largely unknown, recent pieces of evidence suggest that CDKL5 is involved in neuronal plasticity. Herein, we show that, at all stages of development, neuronal depolarization induces a rapid increase in CDKL5 levels, mostly mediated by extrasomatic synthesis. In young neurons, this induction is prolonged, whereas in more mature neurons, NMDA receptor stimulation induces a protein phosphatase 1-dependent dephosphorylation of CDKL5 that is mandatory for its proteasome-dependent degradation. As a corollary, neuronal activity leads to a prolonged induction of CDKL5 levels in immature neurons but to a short lasting increase of the kinase in mature neurons. Recent results demonstrate that many genes associated with autism spectrum disorders are crucial components of the activity-dependent signaling networks regulating the composition, shape, and strength of the synapse. Thus, we speculate that CDKL5 deficiency disrupts activity-dependent signaling and the consequent synapse development, maturation, and refinement.	[La Montanara, Paolo; Rusconi, Laura; Locarno, Albina; Forti, Lia; Barbiero, Isabella; Tramarin, Marco; Chandola, Chetan; Kilstrup-Nielsen, Charlotte; Landsberger, Nicoletta] Univ Insubria, Sect Biomed Res, Dept Theoret & Appl Sci, I-21052 Busto Arsizio, Italy; [Landsberger, Nicoletta] Ist Sci San Raffaele, Div Neurosci, San Raffaele Rett Res Unit, I-20132 Milan, Italy	University of Insubria; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Landsberger, N (corresponding author), Univ Insubria, Sect Biomed Res, Dept Theoret & Appl Sci, Via Manara 7, I-21052 Busto Arsizio, Italy.	landsben@uninsubria.it	Forti, Lia/AAU-8156-2020; Forti, Lia/E-9957-2018	Forti, Lia/0000-0003-3979-0284; Forti, Lia/0000-0003-3979-0284; Kilstrup-Nielsen, Charlotte/0000-0003-4977-4077; La Montanara, Paolo/0000-0002-5146-9269; Landsberger, Nicoletta/0000-0003-0820-3155	Italian parents' association L'Albero di Greta; Italian parents' association ProRett Ricerca	Italian parents' association L'Albero di Greta; Italian parents' association ProRett Ricerca	We are indebted to Dr. R. Fesce for valuable suggestions and thank Desiree Zambroni from the ALEMBIC facility for expertise in the microscopy analysis. We thank the Italian parents' associations L'Albero di Greta and ProRett Ricerca for supporting our research.	Amendola E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091613; Bertani I, 2006, J BIOL CHEM, V281, P32048, DOI 10.1074/jbc.M606325200; Carouge D, 2010, NEUROBIOL DIS, V38, P414, DOI 10.1016/j.nbd.2010.02.014; Chen QA, 2010, J NEUROSCI, V30, P12777, DOI 10.1523/JNEUROSCI.1102-10.2010; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; De Rubeis S, 2013, NEURON, V79, P1169, DOI 10.1016/j.neuron.2013.06.039; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Gkogkas C, 2010, J BIOL CHEM, V285, P31913, DOI 10.1074/jbc.R110.154476; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Kameshita I, 2008, BIOCHEM BIOPH RES CO, V377, P1162, DOI 10.1016/j.bbrc.2008.10.113; Kilstrup-Nielsen C, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/728267; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lombardi G, 1996, BRIT J PHARMACOL, V117, P189, DOI 10.1111/j.1476-5381.1996.tb15173.x; Mari F, 2005, HUM MOL GENET, V14, P1935, DOI 10.1093/hmg/ddi198; Nalavadi VC, 2012, J NEUROSCI, V32, P2582, DOI 10.1523/JNEUROSCI.5057-11.2012; Okuno H, 2011, NEUROSCI RES, V69, P175, DOI 10.1016/j.neures.2010.12.007; Ricciardi S, 2012, NAT CELL BIOL, V14, P911, DOI 10.1038/ncb2566; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Ricciardi S, 2009, HUM MOL GENET, V18, P4590, DOI 10.1093/hmg/ddp426; Rusconi L, 2008, J BIOL CHEM, V283, P30101, DOI 10.1074/jbc.M804613200; Rusconi L, 2011, J BIOL CHEM, V286, P36550, DOI 10.1074/jbc.M111.235630; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Sekiguchi M, 2013, ARCH BIOCHEM BIOPHYS, V535, P257, DOI 10.1016/j.abb.2013.04.012; Szafranski P, 2015, EUR J HUM GENET, V23, P915, DOI 10.1038/ejhg.2014.217; Verpelli C, 2010, J NEUROSCI, V30, P5830, DOI 10.1523/JNEUROSCI.0119-10.2010; Wang ITJ, 2012, P NATL ACAD SCI USA, V109, P21516, DOI 10.1073/pnas.1216988110; Williamson SL, 2012, HUM GENET, V131, P187, DOI 10.1007/s00439-011-1058-x; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; Zhu YC, 2013, P NATL ACAD SCI USA, V110, P9118, DOI 10.1073/pnas.1300003110	31	20	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4512	4527		10.1074/jbc.M114.589762	http://dx.doi.org/10.1074/jbc.M114.589762			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25555910	Green Published, hybrid			2022-12-26	WOS:000349458400056
J	Quan, XL; Nguyen, TT; Choi, SK; Xu, SH; Das, R; Cha, SK; Kim, N; Han, J; Wiederkehr, A; Wollheim, CB; Park, KS				Quan, Xianglan; Tuyet Thi Nguyen; Choi, Seong-Kyung; Xu, Shanhua; Das, Ranjan; Cha, Seung-Kuy; Kim, Nari; Han, Jin; Wiederkehr, Andreas; Wollheim, Claes B.; Park, Kyu-Sang			Essential Role of Mitochondrial Ca2+ Uniporter in the Generation of Mitochondrial pH Gradient and Metabolism-Secretion Coupling in Insulin-releasing Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESSENTIAL COMPONENT; BETA-CELL; OXIDATIVE-PHOSPHORYLATION; CALCIUM UNIPORTER; MCU; MICU1; ACTIVATION; EXCHANGER; MEMBRANE; DEFECTS	In pancreatic beta-cells, ATP acts as a signaling molecule initiating plasma membrane electrical activity linked to Ca2+ influx, which triggers insulin exocytosis. The mitochondrial Ca2+ uniporter (MCU) mediates Ca2+ uptake into the organelle, where energy metabolism is further stimulated for sustained second phase insulin secretion. Here, we have studied the contribution of the MCUto the regulation of oxidative phosphorylation and metabolism-secretion coupling in intact and permeabilized clonal beta-cells as well as rat pancreatic islets. Knockdown of MCU with siRNA transfection blunted matrix Ca2+ rises, decreased nutrient-stimulated ATP production as well as insulin secretion. Furthermore, MCUknockdown lowered the expression of respiratory chain complexes, mitochondrial metabolic activity, and oxygen consumption. The pH gradient formed across the inner mitochondrial membrane following nutrient stimulation was markedly lowered in MCU-silenced cells. In contrast, nutrient- induced hyperpolarization of the electrical gradient was not altered. In permeabilized cells, knockdown of MCU ablated matrix acidification in response to extramitochondrial Ca2+. Suppression of the putative Ca2+/H+ antiporter leucine zipper-EF hand-containing transmembrane protein 1 (LETM1) also abolished Ca2+-induced matrix acidification. These results demonstrate that MCU-mediated Ca2+ uptake is essential to establish a nutrient-induced mitochondrial pH gradient which is critical for sustained ATP synthesis and metabolism-secretion coupling in insulin-releasing cells.	[Quan, Xianglan; Tuyet Thi Nguyen; Choi, Seong-Kyung; Xu, Shanhua; Das, Ranjan; Cha, Seung-Kuy; Park, Kyu-Sang] Yonsei Univ, Wonju Coll Med, Dept Physiol, Wonju 220701, Gangwon Do, South Korea; [Kim, Nari; Han, Jin] Inje Univ, Coll Med, Dept Physiol, Pusan 614735, South Korea; [Wiederkehr, Andreas] Nestle Inst Hlth Sci, CH-1015 Lausanne, Switzerland; [Wollheim, Claes B.] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland	Yonsei University; Inje University; Nestle SA; University of Geneva	Park, KS (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Physiol, Inst Lifestyle Med, Wonju 220701, Gangwon Do, South Korea.	qsang@yonsei.ac.kr	DAS, RANJAN/ABE-4002-2021; Das, Ranjan/AFQ-6329-2022	Das, Ranjan/0000-0002-7951-4121; Park, Kyu-Sang/0000-0003-0322-9807; T. Nguyen, Tuyet/0000-0002-2686-6895	Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2010-0020224]; Swiss National Foundation [310000-116750/1]; EuroDia a European-Community project [LSHM-CT-2006-518153]	Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Swiss National Foundation(Swiss National Science Foundation (SNSF)); EuroDia a European-Community project	This work was supported by Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0020224) (to J. H.) and grants from the Swiss National Foundation (310000-116750/1) and EuroDia (LSHM-CT-2006-518153) a European-Community funded project under framework program 6 (to C. B. W.).	Akhmedov D, 2010, FASEB J, V24, P4613, DOI 10.1096/fj.10-162222; Alam MR, 2012, J BIOL CHEM, V287, P34445, DOI 10.1074/jbc.M112.392084; Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; de la Fuente S, 2014, BIOCHEM J, V458, P33, DOI 10.1042/BJ20131025; De Marchi U, 2014, J BIOL CHEM, V289, P9182, DOI 10.1074/jbc.M113.513184; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Drago I, 2012, P NATL ACAD SCI USA, V109, P12986, DOI 10.1073/pnas.1210718109; Froschauer E, 2005, BBA-BIOMEMBRANES, V1711, P41, DOI 10.1016/j.bbamem.2005.02.018; Gauthier BR, 2009, CELL METAB, V10, P110, DOI 10.1016/j.cmet.2009.07.002; Griffiths EJ, 2009, BBA-BIOENERGETICS, V1787, P1324, DOI 10.1016/j.bbabio.2009.01.019; Hart L, 2014, DIS MODEL MECH, V7, P535, DOI 10.1242/dmm.014464; JANJIC D, 1992, DIABETOLOGIA, V35, P482, DOI 10.1007/BF02342448; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kuum M, 2012, J CELL SCI, V125, P625, DOI 10.1242/jcs.090126; Lee B, 2003, DIABETES, V52, P965, DOI 10.2337/diabetes.52.4.965; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; NICHOLLS DG, 1980, FEBS LETT, V111, P261, DOI 10.1016/0014-5793(80)80806-4; Nita II, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046649; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Park KS, 2008, J BIOL CHEM, V283, P33347, DOI 10.1074/jbc.M806251200; Patron M, 2014, MOL CELL, V53, P726, DOI 10.1016/j.molcel.2014.01.013; Pendin D, 2014, CELL CALCIUM, V55, P139, DOI 10.1016/j.ceca.2014.02.008; Pitter JG, 2002, CELL CALCIUM, V31, P97, DOI 10.1054/ceca.2001.0264; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Qiu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3034; Quan X, 2013, MOL CELL ENDOCRINOL, V381, P198, DOI 10.1016/j.mce.2013.08.003; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; Tsai MF, 2014, J GEN PHYSIOL, V143, P67, DOI 10.1085/jgp.201311096; Waldeck-Weiermair M, 2013, J BIOL CHEM, V288, P15367, DOI 10.1074/jbc.M113.462259; Wiederkehr A, 2012, MOL CELL ENDOCRINOL, V353, P128, DOI 10.1016/j.mce.2011.07.016; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302; Wollheim CB, 2000, DIABETOLOGIA, V43, P265, DOI 10.1007/s001250050044	46	48	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4086	4096		10.1074/jbc.M114.632547	http://dx.doi.org/10.1074/jbc.M114.632547			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25548283	Green Published, hybrid			2022-12-26	WOS:000349458400020
J	Vettermann, C; Timblin, GA; Lim, V; Lai, EC; Schlissel, MS				Vettermann, Christian; Timblin, Greg A.; Lim, Vivian; Lai, Ernest C.; Schlissel, Mark S.			The Proximal J Kappa Germline-Transcript Promoter Facilitates Receptor Editing through Control of Ordered Recombination	PLOS ONE			English	Article							V(D)J RECOMBINATION; KII SITES; GENE; CHAIN; REARRANGEMENT; ACTIVATION; INITIATION; SEQUENCE; SIGNAL; LOCUS	V(D) J recombination creates antibody light chain diversity by joining a Vk gene segment with one of four J. segments. Two J. germline-transcript (GT) promoters control Vk-Jk joining, but the mechanisms that govern Jk choice are unclear. Here, we show in genetargeted mice that the proximal GT promoter helps targeting rearrangements to Jk1 by preventing premature DNA breaks at Jk2. Consequently, cells lacking the proximal GT promoter show a biased utilization of downstream Jk segments, resulting in a diminished potential for receptor editing. Surprisingly, the proximal-in contrast to the distal-GT promoter is transcriptionally inactive prior to Igk recombination, indicating that its role in Jk choice is independent of classical promoter function. Removal of the proximal GT promoter increases H3K4me3 levels at Jk segments, suggesting that this promoter could act as a suppressor of recombination by limiting chromatin accessibility to RAG. Our findings identify the first cis-element critical for Jk choice and demonstrate that ordered Igk recombination facilitates receptor editing.	[Vettermann, Christian; Timblin, Greg A.; Lim, Vivian; Lai, Ernest C.; Schlissel, Mark S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [Vettermann, Christian] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Div Mol Immunol, D-91054 Erlangen, Germany	University of California System; University of California Berkeley; University of Erlangen Nuremberg	Vettermann, C (corresponding author), Amgen Inc, PKDM, Dept Bioanalyt Sci, Thousand Oaks, CA 91320 USA.	cvetterm@amgen.com		Vettermann, Christian/0000-0003-3794-6441; Lim, Vivian/0000-0002-2851-4391; Timblin, Greg/0000-0001-9351-3646	Marie Curie International Outgoing Fellowship within the 7th Framework Program of the European Commission [PIOF-GA-2009-235297]; California Institute of Regenerative Medicine Predoctoral Fellowship (CIRM Training Program) - University of California Berkeley Stem Cell Center [TG2-01164]; NIH [HL48702, AI40227]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040227, R01AI040227] Funding Source: NIH RePORTER	Marie Curie International Outgoing Fellowship within the 7th Framework Program of the European Commission; California Institute of Regenerative Medicine Predoctoral Fellowship (CIRM Training Program) - University of California Berkeley Stem Cell Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	C.V. was supported by a Marie Curie International Outgoing Fellowship (PIOF-GA-2009-235297) within the 7th Framework Program of the European Commission (http://ec.europa.eu/research/mariecurieactions/).G.A.T. was supported by a California Institute of Regenerative Medicine Predoctoral Fellowship (CIRM Training Program TG2-01164) awarded by the University of California Berkeley Stem Cell Center (http://www.cirm.ca.gov/). This work was funded by NIH grants HL48702 and AI40227 to M.S.S. (www.nih.gov). The funding agencies had no	Abarrategui I, 2007, EMBO J, V26, P4380, DOI 10.1038/sj.emboj.7601866; Abarrategui I, 2006, NAT IMMUNOL, V7, P1109, DOI 10.1038/ni1379; Amin RH, 2009, P NATL ACAD SCI USA, V106, P522, DOI 10.1073/pnas.0808895106; Arakawa H, 1996, INT IMMUNOL, V8, P91, DOI 10.1093/intimm/8.1.91; Bossen C, 2012, ANNU REV IMMUNOL, V30, P337, DOI 10.1146/annurev-immunol-020711-075003; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; Chopra VS, 2012, P NATL ACAD SCI USA, V109, P9460, DOI 10.1073/pnas.1102625108; Cocea L, 1999, J EXP MED, V189, P1443, DOI 10.1084/jem.189.9.1443; Cowell LG, 2004, IMMUNOL REV, V200, P57, DOI 10.1111/j.0105-2896.2004.00171.x; Cowell LG, 2002, GENOME BIOL, V3; FEDDERSEN RM, 1990, MOL CELL BIOL, V10, P569, DOI 10.1128/MCB.10.2.569; FEDDERSEN RM, 1985, P NATL ACAD SCI USA, V82, P4793, DOI 10.1073/pnas.82.14.4793; Feeney AJ, 2009, ADV EXP MED BIOL, V650, P73; FRANCES V, 1994, EMBO J, V13, P5937, DOI 10.1002/j.1460-2075.1994.tb06939.x; Grundy GJ, 2010, P NATL ACAD SCI USA, V107, P22487, DOI 10.1073/pnas.1014958107; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Inlay M, 2002, NAT IMMUNOL, V3, P463, DOI 10.1038/ni790; Kondilis-Mangum HD, 2010, J IMMUNOL, V184, P6970, DOI 10.4049/jimmunol.0903923; Krangel MS, 2003, NAT IMMUNOL, V4, P624, DOI 10.1038/ni0703-624; Lee AI, 2003, PLOS BIOL, V1, P56, DOI 10.1371/journal.pbio.0000001; Liang HE, 2004, CELL, V118, P19, DOI 10.1016/j.cell.2004.06.019; MARTIN DJ, 1989, MOL CELL BIOL, V9, P4560, DOI 10.1128/MCB.9.10.4560; MARTIN DJ, 1990, MOL CELL BIOL, V10, P1950, DOI 10.1128/MCB.10.5.1950; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Merelli I, 2010, NUCLEIC ACIDS RES, V38, pW262, DOI 10.1093/nar/gkq391; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Montalbano A, 2003, J IMMUNOL, V171, P5296, DOI 10.4049/jimmunol.171.10.5296; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; Nadel B, 1998, J EXP MED, V187, P1495, DOI 10.1084/jem.187.9.1495; Okitsu CY, 2010, MOL CELL BIOL, V30, P2933, DOI 10.1128/MCB.01478-09; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; PRAK EL, 1995, J EXP MED, V182, P541, DOI 10.1084/jem.182.2.541; Raschke EE, 1999, J IMMUNOL, V163, P4375; Sato H, 2001, J IMMUNOL, V166, P6704, DOI 10.4049/jimmunol.166.11.6704; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Schlissel MS, 2004, IMMUNOL REV, V200, P215, DOI 10.1111/j.0105-2896.2004.00157.x; Schlissel MS, 2003, NAT REV IMMUNOL, V3, P890, DOI 10.1038/nri1225; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; Shimazaki N, 2009, MOL CELL, V34, P535, DOI 10.1016/j.molcel.2009.05.011; Singh N, 2003, J EXP MED, V197, P743, DOI 10.1084/jem.20021392; Taylor B, 2009, P NATL ACAD SCI USA, V106, P516, DOI 10.1073/pnas.0808764105; Tian JY, 1997, EUR J IMMUNOL, V27, P750, DOI 10.1002/eji.1830270325; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; VANNESS BG, 1981, CELL, V27, P593, DOI 10.1016/0092-8674(81)90401-3; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Yamagami T, 1999, IMMUNITY, V11, P317, DOI 10.1016/S1074-7613(00)80107-7; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; Zhou XR, 2010, J IMMUNOL, V185, P7544, DOI 10.4049/jimmunol.1002665	48	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e0113824	10.1371/journal.pone.0113824	http://dx.doi.org/10.1371/journal.pone.0113824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559567	Green Published, gold, Green Submitted			2022-12-26	WOS:000348102200006
J	Cone, J; Rand, DG				Cone, Jeremy; Rand, David G.			Time Pressure Increases Cooperation in Competitively Framed Social Dilemmas	PLOS ONE			English	Article							INDIRECT RECIPROCITY; DECISION-MAKING; EGO DEPLETION; EVOLUTION; SELF; PERSPECTIVE; REFLECTION; PUNISHMENT; NETWORKS; GAMES	What makes people willing to pay costs to benefit others? Does such cooperation require effortful self-control, or do automatic, intuitive processes favor cooperation? Time pressure has been shown to increase cooperative behavior in Public Goods Games, implying a predisposition towards cooperation. Consistent with the hypothesis that this predisposition results from the fact that cooperation is typically advantageous outside the lab, it has further been shown that the time pressure effect is undermined by prior experience playing lab games (where selfishness is the more advantageous strategy). Furthermore, a recent study found that time pressure increases cooperation even in a game framed as a competition, suggesting that the time pressure effect is not the result of social norm compliance. Here, we successfully replicate these findings, again observing a positive effect of time pressure on cooperation in a competitively framed game, but not when using the standard cooperative framing. These results suggest that participants' intuitions favor cooperation rather than norm compliance, and also that simply changing the framing of the Public Goods Game is enough to make it appear novel to participants and thus to restore the time pressure effect.	[Cone, Jeremy; Rand, David G.] Yale Univ, New Haven, CT 06520 USA	Yale University	Cone, J (corresponding author), Yale Univ, New Haven, CT 06520 USA.	jeremy.cone@yale.edu		Rand, David/0000-0001-8975-2783	John Templeton Foundation	John Templeton Foundation	Funding was graciously provided by the John Templeton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031461; Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Balliet D, 2010, GROUP PROCESS INTERG, V13, P227, DOI 10.1177/1368430209353634; Bartlett MY, 2006, PSYCHOL SCI, V17, P319, DOI 10.1111/j.1467-9280.2006.01705.x; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Bowles S, 2003, DAHL WS ENV, P429; Bowles S, 2002, EC EVOLVING COMPLEX, V3, P339; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cappelen A. W., 2014, FAIRNESS IS INTUITIV; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; Chudek M, 2011, TRENDS COGN SCI, V15, P218, DOI 10.1016/j.tics.2011.03.003; Cornelissen G, 2011, PERS SOC PSYCHOL B, V37, P1080, DOI 10.1177/0146167211405996; Crockett MJ, 2013, TRENDS COGN SCI, V17, P363, DOI 10.1016/j.tics.2013.06.005; CUSHMAN F, 2009, COEVOLUTION PUNISHME; Delton AW, 2011, P NATL ACAD SCI USA, V108, P13335, DOI 10.1073/pnas.1102131108; DeWall CN, 2008, PERS SOC PSYCHOL B, V34, P1653, DOI 10.1177/0146167208323981; Dreber A., 2014, ALTRUISM SELF CONTRO; Engel C, 2014, ECON LETT, V122, P386, DOI 10.1016/j.econlet.2013.12.020; Evans AM, 2014, REACTION TIMES REFLE; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fiedler S, 2013, ORGAN BEHAV HUM DEC, V120, P272, DOI 10.1016/j.obhdp.2012.07.002; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Fu F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00460; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; FUDENBERG D, 1990, AM ECON REV, V80, P274; Halali E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00240; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HAUGE KE, 2014, U GOTHENBURG WORKING; Hauser OP, 2014, NATURE, V511, P220, DOI 10.1038/nature13530; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; Jin Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep04095; Jordan JJ, MORAL BRAIN MULTIDIS; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kahneman D., 2011, THINKING FAST SLOW; Kieslich PJ, 2014, JUDGM DECIS MAK, V9, P510; Kinnunen SP, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00193; Kiyonari T, 2000, EVOL HUM BEHAV, V21, P411, DOI 10.1016/S1090-5138(00)00055-6; Kovarik J, 2009, ECON LETT, V102, P152, DOI 10.1016/j.econlet.2008.12.005; Liberman V, 2004, PERS SOC PSYCHOL B, V30, P1175, DOI 10.1177/0146167204264004; Manapat ML, 2012, J EC BEHAV ORG; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Peysakhovich A., 2013, HABITS VIRTUE CREATI; Piff PK, 2012, P NATL ACAD SCI USA, V109, P4086, DOI 10.1073/pnas.1118373109; Piovesan M, 2009, ECON LETT, V105, P193, DOI 10.1016/j.econlet.2009.07.017; Rand D., 2014, POSITIVE EMOTION DIS; Rand D. G., 2014, P NATL ACAD SCI; Rand DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109687; Rand DG, 2015, J BEHAV DECIS MAKING, V28, P159, DOI 10.1002/bdm.1837; Rand DG, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00300; Rand DG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4677; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Rand DG, 2013, NATURE, V498, pE2, DOI 10.1038/nature12195; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Rand DG, 2012, J THEOR BIOL, V299, P172, DOI 10.1016/j.jtbi.2011.03.004; RIGHETTI F, 2013, PSYCHOL SCI; Roch SG, 2000, ORGAN BEHAV HUM DEC, V83, P185, DOI 10.1006/obhd.2000.2915; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Rubinstein A, 2007, ECON J, V117, P1243, DOI 10.1111/j.1468-0297.2007.02081.x; Rubinstein A, 2013, JUDGM DECIS MAK, V8, P540; Ruff CC, 2013, SCIENCE, V342, P482, DOI 10.1126/science.1241399; Schulz JF, 2014, J ECON PSYCHOL, V41, P77, DOI 10.1016/j.joep.2012.08.007; Sigmund K, 2010, PRINC SER THEOR COMP, P1; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Stanovich KE, 1998, J EXP PSYCHOL GEN, V127, P161, DOI 10.1037/0096-3445.127.2.161; Tinghog G, 2013, NATURE, V498, pE1, DOI 10.1038/nature12194; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P733, DOI 10.1037/0022-3514.73.4.733; Verkoeijen PPJL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096654; Xu HY, 2012, J EXP SOC PSYCHOL, V48, P1183, DOI 10.1016/j.jesp.2012.03.007; Yamagishi T., 2007, CULTURAL ECOLOGICAL, P11; Yoeli E, 2013, P NATL ACAD SCI USA, V110, P10424, DOI 10.1073/pnas.1301210110	83	46	47	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115756	10.1371/journal.pone.0115756	http://dx.doi.org/10.1371/journal.pone.0115756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UC	25551386	Green Published, gold			2022-12-26	WOS:000347119100058
J	de Ruyter, JC; Katan, MB; Kas, R; Olthof, MR				de Ruyter, Janne C.; Katan, Martijn B.; Kas, Rosa; Olthof, Margreet R.			Can Children Discriminate Sugar-Sweetened from Non-Nutritively Sweetened Beverages and How Do They Like Them?	PLOS ONE			English	Article							HIGH-INTENSITY SWEETENERS; BODY-WEIGHT; SOFT DRINKS; FOOD-INTAKE; SUCROSE; CONSUMPTION; LIKING; TRIAL	Background: Replacement of sugar-sweetened by non-nutritively sweetened beverages or water may reduce excess weight gain in children. However, it is unclear whether children like non-nutritively sweetened beverages as much as sugar-sweetened beverages. We examined whether children could taste a difference between non-nutritively sweetened beverages and matching sugar-sweetened beverages, and which of the two types of beverage they liked best. Methods: 89 children aged 5 to 12 tasted seven non-nutritively sweetened beverages and matching sugar-sweetened beverages, for a total of 14 beverages. We used Triangle tests to check their ability to discriminate between the matched versions, and a 5-point scale to measure how much the children liked each individual beverage. Results: Overall, 24% of children appeared to be genuinely capable of distinguishing between non-nutritively sweetened and sugar-sweetened beverages. The mean +/- SD score for how much the children liked the non-nutritively sweetened beverages was 3.39 +/- 0.7 and that for the sugar-sweetened beverages 3.39 +/- 0.6 (P=0.9) on a scale running from 1 (disgusting) to 5 (delicious). The children preferred some beverages to others irrespective of whether they were sugar-sweetened or non-nutritively sweetened (P=0.000). Children who correctly identified which of three drinks contained the same sweetener and which one was different also showed no preference for either type. Conclusion: We found that about one in four children were able to discriminate between non-nutritively sweetened and sugar-sweetened beverages but children liked both varieties equally. Non-nutritively sweetened beverages may therefore be an acceptable alternative to sugar-sweetened beverages although water remains the healthiest beverage for children.	[de Ruyter, Janne C.; Katan, Martijn B.; Kas, Rosa; Olthof, Margreet R.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Hlth Sci, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	de Ruyter, JC (corresponding author), Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Hlth Sci, Amsterdam, Netherlands.	J.C.de.ruyter@vu.nl	Katan, Martijn/ABB-6613-2021	, Margreet/0000-0002-1982-9244	VU University Amsterdam; Royal Netherlands Academy of Arts and Sciences [ISK/741/PAH]	VU University Amsterdam; Royal Netherlands Academy of Arts and Sciences	The study was funded by VU University Amsterdam and by an Academy Professorship awarded by the Royal Netherlands Academy of Arts and Sciences to prof. dr. M. B. Katan (https://www.knaw.nl/en?set_language=en. Grant number: ISK/741/PAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SJ, 1998, ACAD RADIOL, V5, pS259, DOI 10.1016/S1076-6332(98)80326-7; AMERINE AM, 1965, PRINCIPLES SENSORY E; Anton SD, 2010, APPETITE, V55, P37, DOI 10.1016/j.appet.2010.03.009; AYYA N, 1992, CHEM SENSES, V17, P245, DOI 10.1093/chemse/17.3.245; Beridot-Therond ME, 1998, APPETITE, V31, P67, DOI 10.1006/appe.1997.0153; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; de Ruyter JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078039; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; Gambon DL, 2012, BRIT DENT J, V213, P55, DOI 10.1038/sj.bdj.2012.613; Hanger LY, 1996, J FOOD SCI, V61, P456, DOI 10.1111/j.1365-2621.1996.tb14216.x; Kamerud JK, 2007, CHEM SENSES, V32, P803, DOI 10.1093/chemse/bjm050; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; LARSONPOWERS N, 1978, J FOOD SCI, V43, P41, DOI 10.1111/j.1365-2621.1978.tb09732.x; Lawless H. T., 2010, SENSORY EVALUATION F; Leon F, 1999, FOOD QUAL PREFER, V10, P93, DOI 10.1016/S0950-3293(98)00046-9; O'Mahony M., 1986, SENSORY EVALUATION F; Ocke MC, 2009, 350030002 RIVM; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; ROLLS BJ, 1989, APPETITE, V13, P115, DOI 10.1016/0195-6663(89)90109-8; SCHIFFMAN SS, 1985, PHYSIOL BEHAV, V34, P369, DOI 10.1016/0031-9384(85)90198-2; Van Wymelbeke V, 2004, EUR J CLIN NUTR, V58, P154, DOI 10.1038/sj.ejcn.1601762; Vlieg-Boerstra BJ, 2004, J ALLERGY CLIN IMMUN, V113, P341, DOI 10.1016/j.jaci.2003.10.039	23	2	3	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115113	10.1371/journal.pone.0115113	http://dx.doi.org/10.1371/journal.pone.0115113			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551758	Green Submitted, Green Published, gold			2022-12-26	WOS:000347119100028
J	Fu, CL; Donovan, WP; Shikapwashya-Hasser, O; Ye, XD; Cole, RH				Fu, Changlin; Donovan, William P.; Shikapwashya-Hasser, Olga; Ye, Xudong; Cole, Robert H.			Hot Fusion: An Efficient Method to Clone Multiple DNA Fragments as Well as Inverted Repeats without Ligase	PLOS ONE			English	Article							LIGATION-INDEPENDENT CLONING; MUTAGENESIS	Molecular cloning is utilized in nearly every facet of biological and medical research. We have developed a method, termed Hot Fusion, to efficiently clone one or multiple DNA fragments into plasmid vectors without the use of ligase. The method is directional, produces seamless junctions and is not dependent on the availability of restriction sites for inserts. Fragments are assembled based on shared homology regions of 17-30 bp at the junctions, which greatly simplifies the construct design. Hot Fusion is carried out in a one-step, single tube reaction at 50 degrees C for one hour followed by cooling to room temperature. In addition to its utility for multi-fragment assembly Hot Fusion provides a highly efficient method for cloning DNA fragments containing inverted repeats for applications such as RNAi. The overall cloning efficiency is in the order of 90-95%.	[Fu, Changlin; Donovan, William P.; Shikapwashya-Hasser, Olga; Ye, Xudong; Cole, Robert H.] Monsanto Co, Biotechnol, St Louis, MO 63167 USA	Monsanto	Fu, CL (corresponding author), Monsanto Co, Biotechnol, St Louis, MO 63167 USA.	changlin.fu@monsanto.com			Monsanto Company	Monsanto Company	This work has been sponsored by Monsanto Company. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Benoit RM, 2006, PROTEIN EXPRES PURIF, V45, P66, DOI 10.1016/j.pep.2005.09.022; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Fernandes S, 2009, ANAL BIOCHEM, V385, P171, DOI 10.1016/j.ab.2008.10.008; Fu CL, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn167; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Invitrogen CA, 2003, INSTR MAN GAT CLON T; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Jiang XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030267; JONES DH, 1991, BIOTECHNIQUES, V10, P62; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Petersen LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024531; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Sleight SC, 2010, NUCLEIC ACIDS RES, V38, P2624, DOI 10.1093/nar/gkq179; System Biosciences, 2014, INSTR MAN COLD FUS C; Thieme F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020556; Tsuge K, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng133; Urban A, 1997, NUCLEIC ACIDS RES, V25, P2227, DOI 10.1093/nar/25.11.2227; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Yan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038186; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536	26	86	92	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115318	10.1371/journal.pone.0115318	http://dx.doi.org/10.1371/journal.pone.0115318			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551825	Green Submitted, Green Published, gold			2022-12-26	WOS:000347119100035
J	Iversen, M; Gronsberg, IM; van den Berg, J; Fischer, K; Aheto, DW; Bohn, T				Iversen, Marianne; Gronsberg, Idun M.; van den Berg, Johnnie; Fischer, Klara; Aheto, Denis Worlanyo; Bohn, Thomas			Detection of Transgenes in Local Maize Varieties of Small-Scale Farmers in Eastern Cape, South Africa	PLOS ONE			English	Article							BT-COTTON; GM CROPS; INSECT RESISTANCE; RECOMBINANT DNAS; FIELD-RESISTANCE; PEST RESISTANCE; GENE FLOW; BIOTECHNOLOGY; INFORMATION; GLYPHOSATE	Small-scale subsistence farmers in South Africa have been introduced to genetically modified (GM) crops for more than a decade. Little is known about i) the extent of transgene introgression into locally recycled seed, ii) what short and long-term ecological and socioeconomic impacts such mixing of seeds might have, iii) how the farmers perceive GM crops, and iv) to what degree approval conditions are followed and controlled. This study conducted in the Eastern Cape, South Africa, aims primarily at addressing the first of these issues. We analysed for transgenes in 796 individual maize plants (leaves) and 20 seed batches collected in a village where GM insect resistant maize was previously promoted and grown as part of an governmental agricultural development program over a seven year period (2001-2008). Additionally, we surveyed the varieties of maize grown and the farmers' practices of recycling and sharing of seed in the same community (26 farmers were interviewed). Recycling and sharing of seeds were common in the community and may contribute to spread and persistence of transgenes in maize on a local or regional level. By analysing DNA we found that the commonly used transgene promoter p35s occurred in one of the 796 leaf samples (0.0013%) and in five of the 20 seed samples (25%). Three of the 20 seed samples (15%) included herbicide tolerant maize (NK603) intentionally grown by the farmers from seed bought from local seed retailers or acquired through a currently running agricultural development program. The two remaining positive seed samples (10%) included genes for insect resistance (from MON810). In both cases the farmers were unaware of the transgenes present. In conclusion, we demonstrate that transgenes are mixed into seed storages of small-scale farming communities where recycling and sharing of seeds are common, i.e. spread beyond the control of the formal seed system.	[Iversen, Marianne; Gronsberg, Idun M.; Bohn, Thomas] GenOk Ctr Biosafety, Tromso, Norway; [van den Berg, Johnnie] North West Univ, Unit Environm Sci & Dev, Potchefstroom, South Africa; [Fischer, Klara] Swedish Univ Agr Sci, Dept Urban & Rural Dev, Uppsala, Sweden; [Aheto, Denis Worlanyo] Univ Cape Coast, Sch Biol Sci, Coll Agr & Nat Sci, Cape Coast, Ghana; [Bohn, Thomas] UIT Arctic Univ Norway, Fac Hlth Sci, Tromso, Norway	North West University - South Africa; Swedish University of Agricultural Sciences; University of Cape Coast; UiT The Arctic University of Tromso	Iversen, M (corresponding author), GenOk Ctr Biosafety, Tromso, Norway.	marianne.iversen@genok.org	Van den Berg, Johnnie/M-7256-2013; Fischer, Klara/I-2962-2019	Van den Berg, Johnnie/0000-0002-6831-3180; Fischer, Klara/0000-0001-6590-4025	Norwegian Agency for Development Cooperation (Norad)	Norwegian Agency for Development Cooperation (Norad)	Funding for this work was received from The Norwegian Agency for Development Cooperation (Norad) to GenOk - Centre for Biosafety. URL: http://www.norad.no/en/front-page. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aheto D. W., 2013, GM CROP CULTIVATION, V17, P93; Aheto Denis Worlanyo, 2011, Environmental Sciences Europe, V23, P9, DOI 10.1186/2190-4715-23-9; [Anonymous], ASPECTS APPL BIOL; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; Beckie HJ, 2008, PLANT SCI, V175, P615, DOI 10.1016/j.plantsci.2008.05.021; Bennett R, 2004, J AGR SCI-CAMBRIDGE, V142, P665, DOI 10.1017/S0021859605004892; BiosafetySouthAfrica, 2013, GEN MOD GM CROPS GRA; Bohn T, 2014, AGR SYSTEMS IN PRESS; Bohn Thomas, 2013, GM CROP CULTIVATION, P104; [曹际娟 Cao Jijuan], 2003, [玉米科学, Maize Science], V11, P19; Caprio MA, 2001, J ECON ENTOMOL, V94, P698, DOI 10.1603/0022-0493-94.3.698; Devos Y, 2009, AGRON SUSTAIN DEV, V29, P11, DOI 10.1051/agro:2008051; Ellis JM, 2003, WEED TECHNOL, V17, P452, DOI 10.1614/WT01-110; Gepts Paul, 2003, Environmental Biosafety Research, V2, P89, DOI 10.1051/ebr:2003009; Gouse M., 2012, AgBioForum, V15, P163; Heuberger S, 2011, ENVIRON ENTOMOL, V40, P484, DOI 10.1603/EN10247; ISO, 2005, 215692005 ISO; Jacobson K, 2013, THESIS SWEDISH U AGR; Jacobson K, 2013, J ENVIRON DEV, V22, P104, DOI 10.1177/1070496512466856; James C., 2013, GLOBAL STATUS COMMER; Kruger M, 2012, J APPL ENTOMOL, V136, P38, DOI 10.1111/j.1439-0418.2011.01616.x; Kruger M, 2009, CROP PROT, V28, P684, DOI 10.1016/j.cropro.2009.04.001; Lalitha N, 2009, ROUTL EXPLOR ENVIRON, V19, P135; Li JS, 2013, EXP AGR, V49, P114, DOI 10.1017/S001447971200097X; MARRS RH, 1993, AGR ECOSYST ENVIRON, V45, P283, DOI 10.1016/0167-8809(93)90077-3; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; Marvier M, 2011, J VERBRAUCH LEBENSM, V6, P113, DOI 10.1007/s00003-011-0675-6; Matsuoka T, 2000, J FOOD HYG SOC JPN, V41, P137, DOI 10.3358/shokueishi.41.137; Matsuoka T, 2002, J AGR FOOD CHEM, V50, P2100, DOI 10.1021/jf011157t; Matsuoka T, 2001, J FOOD HYG SOC JPN, V42, P24, DOI 10.3358/shokueishi.42.24; Mercer K, 2008, EVOL APPL, V1, P489, DOI 10.1111/j.1752-4571.2008.00038.x; Messeguer J, 2006, PLANT BIOTECHNOL J, V4, P633, DOI 10.1111/j.1467-7652.2006.00207.x; Onishi M, 2005, J AGR FOOD CHEM, V53, P9713, DOI 10.1021/jf0515476; Pemsl D, 2004, CROP PROT, V23, P1249, DOI 10.1016/j.cropro.2004.05.011; Perales H, 2003, ECON BOT, V57, P21, DOI 10.1663/0013-0001(2003)057[0007:LOMICM]2.0.CO;2; Pineyro-Nelson A, 2009, MOL ECOL, V18, P750, DOI 10.1111/j.1365-294X.2008.03993.x; SANBI, 2011, MON ENV IMP GM MAIZ; Shi GM, 2013, NAT BIOTECHNOL, V31, P111, DOI 10.1038/nbt.2496; Soleri D, 2006, BIOSCIENCE, V56, P503, DOI 10.1641/0006-3568(2006)56[503:TCACVD]2.0.CO;2; Stone GD, 2004, HUM ORGAN, V63, P127, DOI 10.17730/humo.63.2.jgvu7rlfafk9jwf9; Stone GD, 2007, CURR ANTHROPOL, V48, P67, DOI 10.1086/508689; Stone GD, 2011, WORLD DEV, V39, P387, DOI 10.1016/j.worlddev.2010.09.008; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tripp R, 2001, FOOD POLICY, V26, P249, DOI 10.1016/S0306-9192(01)00002-1; Van den Berg J, 2013, CROP PROT, V54, P154, DOI 10.1016/j.cropro.2013.08.010; van Heerwaarden J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046123; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Vencill WK, 2012, WEED SCI, V60, P2, DOI 10.1614/WS-D-11-00206.1	48	10	12	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116147	10.1371/journal.pone.0116147	http://dx.doi.org/10.1371/journal.pone.0116147			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551616	Green Submitted, Green Published, gold			2022-12-26	WOS:000347119100102
J	Schollaert, KL; Stephens, MR; Gray, JK; Fulkerson, PC				Schollaert, Kaila L.; Stephens, Michael R.; Gray, Jerilyn K.; Fulkerson, Patricia C.			Generation of Eosinophils from Cryopreserved Murine Bone Marrow Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; EX-VIVO EXPANSION; IN-VIVO; HEMATOPOIESIS; IL-5; MEPOLIZUMAB; PROGENITORS; EXPRESSION; INCREASES; MOUSE	Eosinophils are produced in the bone marrow from CD34(+) eosinophil lineage-committed progenitors, whose levels in the bone marrow are elevated in a variety of human diseases. These findings suggest that increased eosinophil lineage-committed progenitor production is an important process in disease-associated eosinophilia. The pathways central to the biology of the eosinophil lineage-committed progenitor remain largely unknown. Thus, developing new methods to investigate the regulators of eosinophil lineage-committed progenitor differentiation is needed to identify potential therapeutic targets to specifically inhibit eosinophil production. We tested cytokine regimens to optimize liquid cultures for the study of eosinophil lineage-committed progenitor and eosinophil precursor differentiation into mature eosinophils. Stem cell factor (but not fms-related tyrosine kinase 3 ligand) was required for optimal yield of eosinophils. Furthermore, we evaluated the effects of cell preservation and scale on the culture, successfully culturing functional eosinophils from fresh and frozen murine bone marrow cells and in a standard-sized and 96-well culture format. In summary, we have developed an adaptable culture system that yields functionally competent eosinophils from murine low-density bone marrow cells and whose cytokine regime includes expansion of progenitors with stem cell factor alone with subsequent differentiation with interleukin 5.	[Schollaert, Kaila L.; Stephens, Michael R.; Gray, Jerilyn K.; Fulkerson, Patricia C.] Univ Cincinnati, Coll Med, Dept Pediat, Div Allergy & Immunol,Cincinnati Childrens Hosp M, Cincinnati, OH 45220 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Fulkerson, PC (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Div Allergy & Immunol,Cincinnati Childrens Hosp M, Cincinnati, OH 45220 USA.	Patricia.Fulkerson@cchmc.org		Schollaert-Fitch, Kaila/0000-0001-9062-1772	NIH [K08AI093673]; Allergy, Asthma, Immunology Education and Research Organization (ARTrust) Faculty Development Award of the American Academy of Allergy, Asthma and Immunology; PHS [P30 DK078392]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077, UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI093673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allergy, Asthma, Immunology Education and Research Organization (ARTrust) Faculty Development Award of the American Academy of Allergy, Asthma and Immunology; PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NIH grant K08AI093673 (P.C.F.) and the Allergy, Asthma, Immunology Education and Research Organization (ARTrust) Faculty Development Award of the American Academy of Allergy, Asthma and Immunology (P.C.F.). This project was also supported in part by the PHS Grant P30 DK078392 (Research Flow Cytometry Core of the Digestive Disease Research Core Center in Cincinnati). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2005, CELL, V121, P160, DOI 10.1016/j.cell.2005.04.005; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Ben Baruch-Morgenstern N, 2014, NAT IMMUNOL, V15, P36, DOI 10.1038/ni.2757; Boiko JR, 2012, CYTOKINE, V57, P1, DOI 10.1016/j.cyto.2011.10.005; Bouffi C, 2013, J IMMUNOL, V191, P4317, DOI 10.4049/jimmunol.1301465; de Bruin AM, 2012, BLOOD, V119, P1543, DOI 10.1182/blood-2011-07-367706; Diehl A, 2007, CYTOTHERAPY, V9, P532, DOI 10.1080/14653240701452073; Dyer KD, 2008, J IMMUNOL, V181, P4004, DOI 10.4049/jimmunol.181.6.4004; Dyer KD, 2013, IMMUNOL LETT, V150, P41, DOI 10.1016/j.imlet.2012.12.002; Dyer Kimberly D, 2009, Open Immunol J, V2, P163; Dyer KD, 2011, J LEUKOCYTE BIOL, V90, P1101, DOI 10.1189/jlb.0211059; Dyer KD, 2010, J IMMUNOL, V184, P6327, DOI 10.4049/jimmunol.0904043; Dyer KD, 2009, BLOOD, V114, P2649, DOI 10.1182/blood-2009-01-199497; Flood-Page P, 2007, AM J RESP CRIT CARE, V176, P1062, DOI 10.1164/rccm.200701-085OC; Fulkerson PC, 2014, J IMMUNOL, V193, P4043, DOI 10.4049/jimmunol.1400732; Garcia NV, 2011, J IMMUNOL, V187, P2268, DOI 10.4049/jimmunol.1101008; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hu HY, 2012, EXP HEMATOL, V40, P675, DOI 10.1016/j.exphem.2012.03.003; Humbles AA, 2002, P NATL ACAD SCI USA, V99, P1479, DOI 10.1073/pnas.261462598; Iwasaki H, 2005, J EXP MED, V201, P1891, DOI 10.1084/jem.20050548; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; Lacy P, 2000, CHEM IMMUNOL, V76, P134; Lu TX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059397; Lu TX, 2013, J IMMUNOL, V190, P1576, DOI 10.4049/jimmunol.1202897; MCKENNA HJ, 1995, BLOOD, V86, P3413, DOI 10.1182/blood.V86.9.3413.bloodjournal8693413; Menzies-Gow A, 2003, J ALLERGY CLIN IMMUN, V111, P714, DOI 10.1067/mai.2003.1382; Milanovic M, 2008, J IMMUNOL, V181, P5045, DOI 10.4049/jimmunol.181.7.5045; Mori Y, 2009, J EXP MED, V206, P183, DOI 10.1084/jem.20081756; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Saito H, 2002, J IMMUNOL, V168, P3017, DOI 10.4049/jimmunol.168.6.3017; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; Sehmi R, 1997, J CLIN INVEST, V100, P2466, DOI 10.1172/JCI119789; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; Tomaki M, 2000, J IMMUNOL, V165, P4040, DOI 10.4049/jimmunol.165.7.4040; Wu L, 2007, IMMUNITY, V26, P741, DOI 10.1016/j.immuni.2007.06.006	35	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116141	10.1371/journal.pone.0116141	http://dx.doi.org/10.1371/journal.pone.0116141			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551463	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100100
J	Wei, J; Gao, DF; Wang, H; Yan, R; Liu, ZQ; Yuan, ZY; Liu, J; Chen, MX				Wei, Jin; Gao, Deng-Feng; Wang, Hao; Yan, Rui; Liu, Zhi-Quan; Yuan, Zu-Yi; Liu, Jian; Chen, Ming-Xia			Impairment of Myocardial Mitochondria in Viral Myocardial Disease and Its Reflective Window in Peripheral Cells	PLOS ONE			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; HEART-FAILURE; DNA MUTATIONS; DELETION; METABOLISM; CLASSIFICATION; EPIDEMIOLOGY; ASSOCIATION; CARDIOLOGY; DIAGNOSIS	Background: Viral myocardial disease (VMD) is a common disease inducing heart failure. It has not been clear the roles of mitochondrial damage in the pathological changes of cardiomyocytes in VMD. Methods: Myocardial tissues and lymphocytes were collected from 83 VMD patients. Control groups included 12 cases of healthy accidental death with myocardial autopsy and 23 healthy blood donors. The mouse model of viral myocarditis (VMC) was established by Coxsackie virus B-3 infection and myocardial tissues and skeletal muscle were collected. Mitochondrial DNA (mtDNA) deletion rate was quantitatively determined using polymerase chain reaction. Results: There was significantly difference of myocardial mitochondrial DNA deletion rate between VMD or VMC group and control group (P<0.05). Moreover, the loss of mitochondrial membrane phospholipids was significantly different between VMD or VMC group and control group. In VMC mice, there were negative correlations between myocardial mtDNA(3867) deletion rate and left ventricular peak systolic pressure (LVPSP) (r=-0.66, P<0.05), and between myocardial mtDNA(3867) deletion rate and +dp/dt(max) (r=-0.79, P<0.05), while there was positive correlation between myocardial mtDNA3867 deletion rate and -dp/dt(max) (r=0.80, P<0.05). Conclusion: Mitochondrial damage is an important pathophysiological mechanism leading to myocardial injury and cardiac dysfunction. The mitochondrial damage in the skeletal muscle and lymphocytes reflect a "window" of myocardial mitochondrial damage.	[Wei, Jin; Gao, Deng-Feng; Yan, Rui] Xi An Jiao Tong Univ, Dept Cardiol, Affiliated Hosp 2, Xian 710049, Shaanxi, Peoples R China; [Wang, Hao] Wake Forest Univ, Bowman Gray Sch Med, Dept Anesthesiol, Winston Salem, NC 27157 USA; [Liu, Zhi-Quan; Yuan, Zu-Yi] Xi An Jiao Tong Univ, Dept Cardiol, Affiliated Hosp 1, Xian 710049, Shaanxi, Peoples R China; [Liu, Jian; Chen, Ming-Xia] Xi An Jiao Tong Univ, Coll Med, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Wake Forest University; Wake Forest Baptist Medical Center; Xi'an Jiaotong University; Xi'an Jiaotong University	Wei, J (corresponding author), Xi An Jiao Tong Univ, Dept Cardiol, Affiliated Hosp 2, Xian 710049, Shaanxi, Peoples R China.	weijin@mail.xjtu.edu.cn		Yuan, Zuyi/0000-0002-4141-0298; Wang, Hao/0000-0003-1537-661X	Science and Technology Projects of Shaanxi Province [2007K13-03]; National Natural Science Foundation of China [81170209]	Science and Technology Projects of Shaanxi Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Science and Technology Projects of Shaanxi Province (No. 2007K13-03 to J.W.), and grants from National Natural Science Foundation of China (No. 81170209 to J.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI K, 1993, BIOCHEM BIOPH RES CO, V195, P945, DOI 10.1006/bbrc.1993.2135; Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0; Blauwet LA, 2010, PROG CARDIOVASC DIS, V52, P274, DOI 10.1016/j.pcad.2009.11.006; Caforio ALP, 1997, EUR HEART J, V18, P1051; Carvajal K, 2003, ARCH MED RES, V34, P89, DOI 10.1016/S0188-4409(03)00004-3; Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309; Chinese Heart Association, 2000, CHINESE J PRACTICAL, V15, P75; CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G; Craigen WJ, 2012, METHODS MOL BIOL, V837, P3, DOI 10.1007/978-1-61779-504-6_1; Eynon N, 2011, PHYSIOL GENOMICS, V43, P789, DOI 10.1152/physiolgenomics.00029.2011; Fan Zh, 2010, J LIAONING MED U, V31, P370; GRIFFITHS GM, 1992, P NATL ACAD SCI USA, V89, P549, DOI 10.1073/pnas.89.2.549; Haiyan D, 2006, J CHINESE MODERN PED, V3, P407; Hanaki Y, 1989, J MOL CELL CARDIOL, V21, P175; Hill MF, 1997, CIRCULATION, V96, P2414; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; INGWALL JS, 1993, CIRCULATION, V87, P58; Jing Y, 2012, J CLIN CARDIOLOGY CH, V28, P81; Kao SH, 1997, BIOCHEM MOL BIOL INT, V42, P285; Katz Arnold M., 1998, Cardiology Clinics, V16, P633, DOI 10.1016/S0733-8651(05)70040-0; Kim HE, 2000, J CLIN INVEST, V106, P857, DOI 10.1172/JCI8040; Lan Y, 1998, J SHANXI MED, V27, P598; Lezza AMS, 1999, FASEB J, V13, P1083, DOI 10.1096/fasebj.13.9.1083; Lv SC, 2013, HELL J CARDIOL, V54, P382; Mallat Z, 1998, CIRCULATION, V97, P1536, DOI 10.1161/01.CIR.97.16.1536; Marin-Garcia J, 2002, J CARD FAIL, V8, P347, DOI 10.1054/jcaf.2002.127774; Marin-Garcia J, 1999, CARDIOVASC PATHOL, V8, P217, DOI 10.1016/S1054-8807(99)00010-1; MarinGarcia J, 1996, CARDIOVASC RES, V31, P306; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Molina H, 1997, MECH AGEING DEV, V97, P1, DOI 10.1016/S0047-6374(97)01876-9; Panfoli I, 2011, EXPERT REV PROTEOMIC, V8, P231, DOI [10.1586/EPR.11.1, 10.1586/epr.11.1]; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; ROBINSON NC, 1982, BIOCHEMISTRY-US, V21, P184, DOI 10.1021/bi00530a031; Rose NR, 2008, CURR TOP MICROBIOL, V323, P293; Sen Z, 1964, PROGR PHYSL SCI, V6, P122; Shenkar R, 1996, AM J HUM GENET, V59, P772; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Wu F, 2009, P NATL ACAD SCI USA, V106, P7143, DOI 10.1073/pnas.0812768106; Yajima T, 2009, CIRCULATION, V119, P2615, DOI 10.1161/CIRCULATIONAHA.108.766022; Yanagawa B, 2003, LAB INVEST, V83, P75, DOI 10.1097/01.LAB.0000049349.56211.09; Zhang XX, 2002, CHINESE MED J-PEKING, V115, P1390; Zhiquan L, 1992, J MOL CELL CARDIOL, V24, P239; Zhiquan L, 1993, CHINESE J CARDIOLOGY, V21, P209	43	7	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116239	10.1371/journal.pone.0116239	http://dx.doi.org/10.1371/journal.pone.0116239			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551390	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100113
J	Zeng, FS; Sun, FK; Li, LL; Liu, K; Zhan, YG				Zeng, Fansuo; Sun, Fengkun; Li, Leilei; Liu, Kun; Zhan, Yaguang			Genome-Scale Transcriptome Analysis in Response to Nitric Oxide in Birch Cells: Implications of the Triterpene Biosynthetic Pathway	PLOS ONE			English	Article							ISOPRENOID BIOSYNTHESIS; DEFENSE RESPONSES; SALICYLIC-ACID; EXPRESSION; TOLERANCE; INHIBITION; SYNTHASE; STRESS; TOOL	Evidence supporting nitric oxide (NO) as a mediator of plant biochemistry continues to grow, but its functions at the molecular level remains poorly understood and, in some cases, controversial. To study the role of NO at the transcriptional level in Betula platyphylla cells, we conducted a genome-scale transcriptome analysis of these cells. The transcriptome of untreated birch cells and those treated by sodium nitroprusside (SNP) were analyzed using the Solexa sequencing. Data were collected by sequencing cDNA libraries of birch cells, which had a long period to adapt to the suspension culture conditions before SNP-treated cells and untreated cells were sampled. Among the 34,100 UniGenes detected, BLASTX search revealed that 20,631 genes showed significant (E-values <= 10(-5)) sequence similarity with proteins from the NR-database. Numerous expressed sequence tags (i.e., 1374) were identified as differentially expressed between the 12 h SNP-treated cells and control cells samples: 403 up-regulated and 971 down-regulated. From this, we specifically examined a core set of NO-related transcripts. The altered expression levels of several transcripts, as determined by transcriptome analysis, was confirmed by qRT-PCR. The results of transcriptome analysis, gene expression quantification, the content of triterpenoid and activities of defensive enzymes elucidated NO has a significant effect on many processes including triterpenoid production, carbohydrate metabolism and cell wall biosynthesis.	[Zeng, Fansuo; Zhan, Yaguang] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin 150040, Peoples R China; [Zeng, Fansuo; Sun, Fengkun; Li, Leilei; Liu, Kun; Zhan, Yaguang] Northeast Forestry Univ, Coll Life Sci, Harbin 150040, Peoples R China	Northeast Forestry University - China; Northeast Forestry University - China	Zhan, YG (corresponding author), Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin 150040, Peoples R China.	youpractise@126.com	ZENG, FANSUO/N-3105-2019	Fansuo, Zeng/0000-0002-3237-4651	Fundamental Research Funds for the Central Universities [2572014DA04]; National Natural Science Foundation of China [31070531, J1210053, 31200463]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by The Fundamental Research Funds for the Central Universities (NO: 2572014DA04) and the National Natural Science Foundation of China (NO: 31070531, J1210053 and 31200463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astier J, 2011, ANNU PLANT REV, V42, P147, DOI 10.1002/9781444328608.ch7; Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159; Besson-Bard A, 2008, ANNU REV PLANT BIOL, V59, P21, DOI 10.1146/annurev.arplant.59.032607.092830; Chen DQ, 2013, PLANT CELL, V25, P1657, DOI 10.1105/tpc.112.104869; Chintharlapalli S, 2007, CANCER RES, V67, P2816, DOI 10.1158/0008-5472.CAN-06-3735; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Csuk R, 2010, BIOORGAN MED CHEM, V18, P1344, DOI 10.1016/j.bmc.2009.12.024; Delledonne M, 2005, CURR OPIN PLANT BIOL, V8, P390, DOI 10.1016/j.pbi.2005.05.002; Fan GZ, 2013, PLANT MOL BIOL REP, V31, P296, DOI 10.1007/s11105-012-0501-z; Fan JP, 2006, J PHARMACEUT BIOMED, V41, P950, DOI 10.1016/j.jpba.2006.01.044; FORSTERMANN U, 1995, N-S ARCH PHARMACOL, V352, P351; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; Fukushima EO, 2011, PLANT CELL PHYSIOL, V52, P2050, DOI 10.1093/pcp/pcr146; FURCHGOTT RF, 1995, ANNU REV PHYSIOL, V57, P659; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Han RB, 2004, BIOTECHNOL PROGR, V20, P507, DOI 10.1021/bp034242p; Jagadeeswaran G, 2007, PLANT J, V51, P234, DOI 10.1111/j.1365-313X.2007.03130.x; Joseph Chappell FW, 1995, PLANT PHYSIOL, P1337; Karsi A, 2002, GENE, V285, P157, DOI 10.1016/S0378-1119(02)00414-6; Lamattina L, 2003, ANNU REV PLANT BIOL, V54, P109, DOI 10.1146/annurev.arplant.54.031902.134752; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Lu D, 2011, APPL MICROBIOL BIOT, V90, P1073, DOI 10.1007/s00253-011-3146-1; Moniz S, 2008, ONCOGENE, V27, P155, DOI 10.1038/sj.onc.1210931; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Newman JD, 1999, CRIT REV BIOCHEM MOL, V34, P95, DOI 10.1080/10409239991209228; Nobuta K, 2007, PLANT PHYSIOL, V144, P1144, DOI [10.1104/pp.107.097691, 10.1104/PP.107.097691]; Parani M, 2004, PLANT BIOTECHNOL J, V2, P359, DOI 10.1111/j.1467-7652.2004.00085.x; Penfield S, 2006, PLANT CELL, V18, P1887, DOI 10.1105/tpc.106.041277; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Rockel Peter, 2002, Journal of Experimental Botany, V53, P103, DOI 10.1093/jexbot/53.366.103; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Sapir-Mir M, 2008, PLANT PHYSIOL, V148, P1219, DOI 10.1104/pp.108.127951; Shen Q, 2011, PLANT CELL ENVIRON, V34, P752, DOI 10.1111/j.1365-3040.2011.02279.x; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Wang S, 2011, PLANT MOL BIOL REP, V29, P794, DOI 10.1007/s11105-010-0281-2; Wang YC, 2012, TREE GENET GENOMES, V8, P1031, DOI 10.1007/s11295-012-0483-x; Wentzinger LF, 2002, PLANT PHYSIOL, V130, P334, DOI 10.1104/pp.004655; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Wilson ID, 2008, PLANT CELL ENVIRON, V31, P622, DOI 10.1111/j.1365-3040.2007.01761.x; Xu MJ, 2005, PLANT PHYSIOL, V139, P991, DOI 10.1104/pp.105.066407; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin J, 2012, MOL BIOL REP, V39, P2321, DOI 10.1007/s11033-011-0982-0; Zhang B, 2012, APPL MICROBIOL BIOT, V93, P455, DOI 10.1007/s00253-011-3658-8; Zhang RS, 2011, PLANT MOL BIOL REP, V29, P898, DOI 10.1007/s11105-011-0306-5; Zhao MG, 2009, PLANT PHYSIOL, V151, P755, DOI 10.1104/pp.109.140996	46	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116157	10.1371/journal.pone.0116157	http://dx.doi.org/10.1371/journal.pone.0116157			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551661	gold, Green Published, Green Submitted			2022-12-26	WOS:000347119100103
J	Rydenfelt, M; Garcia, HG; Cox, RS; Phillips, R				Rydenfelt, Mattias; Garcia, Hernan G.; Cox, Robert Sidney, III; Phillips, Rob			The Influence of Promoter Architectures and Regulatory Motifs on Gene Expression in Escherichia coli	PLOS ONE			English	Article							INTEGRATION HOST FACTOR; TRANSCRIPTIONAL REGULATION; BINDING-SITE; RNA-POLYMERASE; DNA; PROTEIN; ACTIVATION; REPRESSION; REGULON; FNR	The ability to regulate gene expression is of central importance for the adaptability of living organisms to changes in their external and internal environment. At the transcriptional level, binding of transcription factors (TFs) in the promoter region can modulate the transcription rate, hence making TFs central players in gene regulation. For some model organisms, information about the locations and identities of discovered TF binding sites have been collected in continually updated databases, such as RegulonDB for the well-studied case of E. coli. In order to reveal the general principles behind the binding-site arrangement and function of these regulatory architectures we propose a random promoter architecture model that preserves the overall abundance of binding sites to identify overrepresented binding site configurations. This model is analogous to the random network model used in the study of genetic network motifs, where regulatory motifs are identified through their overrepresentation with respect to a "randomly connected" genetic network. Using our model we identify TF pairs which coregulate operons in an overrepresented fashion, or individual TFs which act at multiple binding sites per promoter by, for example, cooperative binding, DNA looping, or through multiple binding domains. We furthermore explore the relationship between promoter architecture and gene expression, using three different genome-wide protein copy number censuses. Perhaps surprisingly, we find no systematic correlation between the number of activator and repressor binding sites regulating a gene and the level of gene expression. A position-weight-matrix model used to estimate the binding affinity of RNA polymerase (RNAP) to the promoters of activated and repressed genes suggests that this lack of correlation might in part be due to differences in basal transcription levels, with repressed genes having a higher basal activity level. This quantitative catalogue relating promoter architecture and function provides a first step towards genome-wide predictive models of regulatory function.	[Rydenfelt, Mattias] CALTECH, Dept Phys, Pasadena, CA 91125 USA; [Rydenfelt, Mattias] Humboldt Univ, Integrat Res Inst Life Sci, D-10099 Berlin, Germany; [Rydenfelt, Mattias] Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany; [Garcia, Hernan G.] Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; [Cox, Robert Sidney, III] Kobe Univ, Dept Chem Sci & Engn, Kobe, Hyogo 657, Japan; [Phillips, Rob] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Phillips, Rob] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Humboldt University of Berlin; Humboldt University of Berlin; Princeton University; Kobe University; California Institute of Technology; California Institute of Technology	Phillips, R (corresponding author), CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA.	phillips@pboc.caltech.edu		Garcia, Hernan G./0000-0002-5212-3649	National Institute Of General Medical Sciences of the National Institutes of Health [R01 GM085286, R01 GM085286-01S]; National Institutes of Health [DP1 OD000217]; Burroughs Wellcome Fund; Princeton Dicke Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085286] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000217] Funding Source: NIH RePORTER	National Institute Of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Princeton Dicke Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by the National Institute Of General Medical Sciences of the National Institutes of Health under Award Number R01 GM085286 and R01 GM085286-01S (M.R., H.G.G., R.P), as well as National Institutes of Health Pioneer award DP1 OD000217 (R.P.). The content is solely the responsibility of the authors and does notnecessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. H.G.G. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund and a Princeton Dicke Fellowship.	Abramowitz M., 1964, HDB MATH FUNCTIONS F; ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Alon U, 2007, INTRO SYSTEMS BIOL D; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Babu MM, 2003, NUCLEIC ACIDS RES, V31, P1234, DOI 10.1093/nar/gkg210; Bai Q, 1998, J BACTERIOL, V180, P6173; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Brewster RC, 2014, CELL, V156, P1312, DOI 10.1016/j.cell.2014.02.022; Brewster RC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002811; BRUNNER M, 1987, EMBO J, V6, P3139, DOI 10.1002/j.1460-2075.1987.tb02624.x; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Chen Z, 2007, NUCLEIC ACIDS RES, V35, P6762, DOI 10.1093/nar/gkm631; COHEN SP, 1993, J BACTERIOL, V175, P1484, DOI 10.1128/JB.175.5.1484-1492.1993; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Darwin AJ, 1998, J BACTERIOL, V180, P4192, DOI 10.1128/JB.180.16.4192-4198.1998; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Djordjevic M, 2013, INTEGR BIOL-UK, V5, P796, DOI [10.1039/c3ib20221f, 10.1039/c3b20221f]; Dove SL, 1997, NATURE, V386, P627, DOI 10.1038/386627a0; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Garcia HG, 2007, BIOPOLYMERS, V85, P115, DOI 10.1002/bip.20627; Garcia HG, 2012, CELL REP, V2, P150, DOI 10.1016/j.celrep.2012.06.004; Garcia HG, 2011, P NATL ACAD SCI USA, V108, P12173, DOI 10.1073/pnas.1015616108; Geanacopoulos M, 1997, J BACTERIOL, V179, P228, DOI 10.1128/jb.179.1.228-234.1997; Gershenzon NI, 2005, NUCLEIC ACIDS RES, V33, P2290, DOI 10.1093/nar/gki519; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; HIRASHIMA A, 1974, P NATL ACAD SCI USA, V71, P4149, DOI 10.1073/pnas.71.10.4149; Hochschild A, 1998, CELL, V92, P597, DOI 10.1016/S0092-8674(00)81126-5; Huerta AM, 2003, J MOL BIOL, V333, P261, DOI 10.1016/j.jmb.2003.07.017; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; KIM J, 1989, GENE, V85, P15, DOI 10.1016/0378-1119(89)90459-9; Kim S, 2013, SCIENCE, V339, P816, DOI 10.1126/science.1229223; Kinney JB, 2010, P NATL ACAD SCI USA, V107, P9158, DOI 10.1073/pnas.1004290107; Klumpp S, 2009, CELL; LAIMINS LA, 1981, P NATL ACAD SCI-BIOL, V78, P464, DOI 10.1073/pnas.78.1.464; Levanon SS, 2005, BIOTECHNOL BIOENG, V89, P556; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; MACNAB RM, 1992, ANNU REV GENET, V26, P131, DOI 10.1146/annurev.ge.26.120192.001023; Martin RG, 1999, MOL MICROBIOL, V34, P431, DOI 10.1046/j.1365-2958.1999.01599.x; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; MCCLURE WR, 1980, P NATL ACAD SCI-BIOL, V77, P5634, DOI 10.1073/pnas.77.10.5634; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; Mermod M, 2012, BIOMETALS, V25, P33, DOI 10.1007/s10534-011-9510-x; Mettert EL, 2007, J BACTERIOL, V189, P3036, DOI 10.1128/JB.00052-07; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; MULLIGAN ME, 1984, NUCLEIC ACIDS RES, V12, P789, DOI 10.1093/nar/12.1Part2.789; Myers KS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003565; NISHIMURA K, 1988, ANN I STAT MATH, V40, P77, DOI 10.1007/BF00053956; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; Overton TW, 2006, BIOCHEM SOC T, V34, P104, DOI 10.1042/BST0340104; PAVCO PA, 1991, NUCLEIC ACIDS RES, V19, P4639, DOI 10.1093/nar/19.17.4639; PAVCO PA, 1990, J BIOL CHEM, V265, P9960; PEREZMARTIN J, 1994, MICROBIOL REV, V58, P268; PLUMBRIDGE J, 1993, MOL MICROBIOL, V10, P973, DOI 10.1111/j.1365-2958.1993.tb00969.x; PTASHNE M, 2002, GENES SIGNALS; RABIN RS, 1993, J BACTERIOL, V175, P3259, DOI 10.1128/jb.175.11.3259-3268.1993; RAO NN, 1993, J BACTERIOL, V175, P74, DOI 10.1128/JB.175.1.74-79.1993; Reif F., 1965, FUNDAMENTALS STAT TH; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rojo F, 1999, J BACTERIOL, V181, P2987, DOI 10.1128/JB.181.10.2987-2991.1999; Ruths T, 2013, P NATL ACAD SCI USA, V110, P7754, DOI 10.1073/pnas.1217630110; Rydenfelt M, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012702; Ryu S, 1998, GENE, V223, P235, DOI 10.1016/S0378-1119(98)00237-6; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Schneider R, 2001, NUCLEIC ACIDS RES, V29, P5107, DOI 10.1093/nar/29.24.5107; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; Seshasayee ASN, 2009, GENOME RES, V19, P79, DOI 10.1101/gr.079715.108; Sherman MS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002407; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Sui SJH, 2007, NUCLEIC ACIDS RES, V35, pW245, DOI 10.1093/nar/gkm427; TAKAHASHI S, 1979, CAN J BIOCHEM CELL B, V57, P855, DOI 10.1139/o79-105; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; THELEN P, 1991, J BACTERIOL, V173, P6553, DOI 10.1128/jb.173.20.6553-6557.1991; TIAN GL, 1992, J MOL BIOL, V226, P387, DOI 10.1016/0022-2836(92)90954-I; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; Tramonti A, 2008, MOL MICROBIOL, V70, P965, DOI 10.1111/j.1365-2958.2008.06458.x; Troxell B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-236; Vershinina OA, 2002, MICROBIOLOGY+, V71, P497, DOI 10.1023/A:1020547616096; WANNER BL, 1990, BIOL CHEM H-S, V371, P180; WEICKERT MJ, 1992, J MOL BIOL, V226, P69, DOI 10.1016/0022-2836(92)90125-4; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470	91	22	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e114347	10.1371/journal.pone.0114347	http://dx.doi.org/10.1371/journal.pone.0114347			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549361	Green Accepted, Green Published, gold			2022-12-26	WOS:000347063500007
J	Consiglio, M; Destefanis, M; Morena, D; Foglizzo, V; Forneris, M; Pescarmona, G; Silvagno, F				Consiglio, Marco; Destefanis, Michele; Morena, Deborah; Foglizzo, Valentina; Forneris, Mattia; Pescarmona, Gianpiero; Silvagno, Francesca			The Vitamin D Receptor Inhibits the Respiratory Chain, Contributing to the Metabolic Switch that Is Essential for Cancer Cell Proliferation	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; NUCLEAR RECEPTORS; MITOCHONDRIA; EXPRESSION; GLUCOCORTICOIDS; CHOLESTEROL; GROWTH; GENES; NCOR1; ASSAY	We recently described the mitochondrial localization and import of the vitamin D receptor (VDR) in actively proliferating HaCaT cells for the first time, but its role in the organelle remains unknown. Many metabolic intermediates that support cell growth are provided by the mitochondria; consequently, the identification of proteins that regulate mitochondrial metabolic pathways is of great interest, and we sought to understand whether VDR may modulate these pathways. We genetically silenced VDR in HaCaT cells and studied the effects on cell growth, mitochondrial metabolism and biosynthetic pathways. VDR knockdown resulted in robust growth inhibition, with accumulation in the G0G1 phase of the cell cycle and decreased accumulation in the M phase. The effects of VDR silencing on proliferation were confirmed in several human cancer cell lines. Decreased VDR expression was consistently observed in two different models of cell differentiation. The impairment of silenced HaCaT cell growth was accompanied by sharp increases in the mitochondrial membrane potential, which sensitized the cells to oxidative stress. We found that transcription of the subunits II and IV of cytochrome c oxidase was significantly increased upon VDR silencing. Accordingly, treatment of HaCaT cells with vitamin D downregulated both subunits, suggesting that VDR may inhibit the respiratory chain and redirect TCA intermediates toward biosynthesis, thus contributing to the metabolic switch that is typical of cancer cells. In order to explore this hypothesis, we examined various acetyl-CoA-dependent biosynthetic pathways, such as the mevalonate pathway (measured as cholesterol biosynthesis and prenylation of small GTPases), and histone acetylation levels; all of these pathways were inhibited by VDR silencing. These data provide evidence of the role of VDR as a gatekeeper of mitochondrial respiratory chain activity and a facilitator of the diversion of acetyl-CoA from the energy-producing TCA cycle toward biosynthetic pathways that are essential for cellular proliferation.	[Consiglio, Marco; Destefanis, Michele; Morena, Deborah; Foglizzo, Valentina; Pescarmona, Gianpiero; Silvagno, Francesca] Univ Turin, Dept Oncol, Turin, Italy; [Morena, Deborah; Foglizzo, Valentina] S Giovanni Battista Hosp, Ctr Expt Res & Med Studies, Turin, Italy; [Forneris, Mattia] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Ctr Mol Biotechnol, Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin	Silvagno, F (corresponding author), Univ Turin, Dept Oncol, Turin, Italy.	francesca.silvagno@unito.it		Foglizzo, Valentina/0000-0001-5059-3279; Forneris, Mattia/0000-0002-2126-9207	Ministero dell'Istruzione Universita e Ricerca	Ministero dell'Istruzione Universita e Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by Ministero dell'Istruzione Universita e Ricerca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin SA, 2006, ANTICANCER RES, V26, P2557; Abedin SA, 2009, CARCINOGENESIS, V30, P449, DOI 10.1093/carcin/bgp005; Banwell CM, 2006, CLIN CANCER RES, V12, P2004, DOI 10.1158/1078-0432.CCR-05-1218; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Bikle DD, 2005, J STEROID BIOCHEM, V97, P83, DOI 10.1016/j.jsbmb.2005.06.001; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Campbell AM, 2008, J BIOENERG BIOMEMBR, V40, P193, DOI 10.1007/s10863-008-9138-x; Campia I, 2009, CELL MOL LIFE SCI, V66, P1580, DOI 10.1007/s00018-009-9018-5; Carlberg C, 2007, DERMATOL CLIN, V25, P515, DOI 10.1016/j.det.2007.06.004; Castagnoli C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840363; Chen JQ, 2009, BBA-MOL CELL RES, V1793, P1540, DOI 10.1016/j.bbamcr.2009.06.001; Chen JQ, 2004, AM J PHYSIOL-ENDOC M, V286, pE1011, DOI 10.1152/ajpendo.00508.2003; Cioffi F, 2013, MOL CELL ENDOCRINOL, V379, P51, DOI 10.1016/j.mce.2013.06.006; Di Cerbo V, 2013, BRIEF FUNCT GENOMICS, V12, P231, DOI 10.1093/bfgp/els065; Doig CL, 2013, CARCINOGENESIS, V34, P248, DOI 10.1093/carcin/bgs331; Galluzzi L, 2010, MOL ASPECTS MED, V31, P1, DOI 10.1016/j.mam.2009.08.002; Gavrilova-Jordan LP, 2007, SEMIN REPROD MED, V25, P154, DOI 10.1055/s-2007-973428; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu YM, 2012, CELL RES, V22, P399, DOI 10.1038/cr.2011.145; Huhtakangas JA, 2004, MOL ENDOCRINOL, V18, P2660, DOI 10.1210/me.2004-0116; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Khanim FL, 2004, ONCOGENE, V23, P6712, DOI 10.1038/sj.onc.1207772; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Lee J, 2008, J NEUROSCI RES, V86, P961, DOI 10.1002/jnr.21564; Lee SR, 2013, PROG BIOPHYS MOL BIO, V112, P44, DOI 10.1016/j.pbiomolbio.2013.04.001; MARESPERLMAN JA, 1988, CANCER RES, V48, P602; Morrish F, 2006, MITOCHONDRION, V6, P143, DOI 10.1016/j.mito.2006.04.002; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murtola TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039445; Ordonez-Moran P, 2008, J CELL BIOL, V183, P697, DOI 10.1083/jcb.200803020; Ozdag H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-90; Park J, 2010, AM J PATHOL, V177, P3133, DOI 10.2353/ajpath.2010.100595; Psarra AMG, 2011, BBA-MOL CELL RES, V1813, P1814, DOI 10.1016/j.bbamcr.2011.05.014; Psarra AMG, 2009, BBA-BIOENERGETICS, V1787, P431, DOI 10.1016/j.bbabio.2008.11.011; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Sequeira VB, 2012, MOL ENDOCRINOL, V26, P574, DOI 10.1210/me.2011-1161; Silvagno F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054716; Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Vasconsuelo A, 2013, AGEING RES REV, V12, P907, DOI 10.1016/j.arr.2013.09.001; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Zaidi N, 2012, CANCER RES, V72, P3709, DOI 10.1158/0008-5472.CAN-11-4112	47	45	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115816	10.1371/journal.pone.0115816	http://dx.doi.org/10.1371/journal.pone.0115816			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546457	Green Published, gold			2022-12-26	WOS:000347120200072
J	Furtado, J; Bento, M; Correia, E; Inacio, JM; Belo, JA				Furtado, Joao; Bento, Margaret; Correia, Elizabeth; Inacio, Jose Manuel; Belo, Jose Antonio			Expression and Function of Ccbe1 in the Chick Early Cardiogenic Regions Are Required for Correct Heart Development	PLOS ONE			English	Article							CARDIAC PROGENITOR CELLS; AVIAN PRECARDIAC CELLS; NEURAL CREST; EXTRACELLULAR-MATRIX; TRANSCRIPTION FACTOR; VENTRAL MORPHOGENESIS; MOVEMENT PATTERNS; CONDUCTION SYSTEM; TUBE FORMATION; MIGRATION	During the course of a differential screen to identify transcripts specific for chick heart/hemangioblast precursor cells, we have identified Ccbe1 (Collagen and calcium-binding EGF-like domain 1). While the importance of Ccbe1 for the development of the lymphatic system is now well demonstrated, its role in cardiac formation remained unknown. Here we show by whole-mount in situ hybridization analysis that cCcbe1 mRNA is initially detected in early cardiac progenitors of the two bilateral cardiogenic fields (HH4), and at later stages on the second heart field (HH9-18). Furthermore, cCcbe1 is expressed in multipotent and highly proliferative cardiac progenitors. We characterized the role of cCcbe1 during early cardiogenesis by performing functional studies. Upon morpholino-induced cCcbe1 knockdown, the chick embryos displayed heart malformations, which include aberrant fusion of the heart fields, leading to incomplete terminal differentiation of the cardiomyocytes. cCcbe1 overexpression also resulted in severe heart defects, including cardia bifida. Altogether, our data demonstrate that although cardiac progenitors cells are specified in cCcbe1 morphants, the migration and proliferation of cardiac precursors cells are impaired, suggesting that cCcbe1 is a key gene during early heart development.	[Furtado, Joao; Bento, Margaret; Correia, Elizabeth; Inacio, Jose Manuel; Belo, Jose Antonio] Univ Algarve, Regenerat Med Program, Dept Ciencias Biomed & Med, Faro, Portugal; [Furtado, Joao; Bento, Margaret; Correia, Elizabeth; Inacio, Jose Manuel; Belo, Jose Antonio] Univ Algarve, IBB Inst Biotechnol & Bioengn, Ctr Biomed Mol & Estrutural, P-8005135 Faro, Portugal; [Inacio, Jose Manuel; Belo, Jose Antonio] Univ Nova Lisboa, Fac Ciencias Med, CEDOC, NOVA Med Sch, P-1169056 Lisbon, Portugal	Universidade do Algarve; Universidade do Algarve; Universidade Nova de Lisboa	Belo, JA (corresponding author), Univ Algarve, Regenerat Med Program, Dept Ciencias Biomed & Med, Faro, Portugal.	jose.belo@fcm.unl.pt	Belo, José A. A/F-4444-2012; Inacio, Jose M/O-1455-2018	Belo, José A. A/0000-0001-7384-0949; Inacio, Jose M/0000-0002-9790-8335; Furtado, Joao/0000-0003-0689-1978	FCT [SFRH/BD/65628/2009, SFRH/BPD/86497/2012, SFRH/BPD/41081/2007]; F.C.T.B.I. fellowship [PTDC/SAU-BID/114902/ 2009]; FCT; Institute for Biotechnology Bioengineering (Centro Biomedicina Molecular e Celular (IBB/CBME), Laboratorio Associado (LA) in the frame of Project [PestOE/EQB/LA0023/2013]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); F.C.T.B.I. fellowship; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Institute for Biotechnology Bioengineering (Centro Biomedicina Molecular e Celular (IBB/CBME), Laboratorio Associado (LA) in the frame of Project	J. Furtado is a PhD student funded by FCT (SFRH/BD/65628/2009). M. Bento (SFRH/BPD/86497/2012) and J. M. Inacio (SFRH/BPD/41081/2007) are Fundacao Ciencia e Tecnologia (FCT) pos-doctoral fellows. E. Correia is a recipient of a F.C.T.B.I. fellowship (PTDC/SAU-BID/114902/ 2009). This work was supported by research grants from FCT to J. A. Belo and from Institute for Biotechnology Bioengineering (Centro Biomedicina Molecular e Celular (IBB/CBME), Laboratorio Associado (LA) in the frame of Project Ref o PestOE/EQB/LA0023/2013.	Abu-Issa R, 2007, ANNU REV CELL DEV BI, V23, P45, DOI 10.1146/annurev.cellbio.23.090506.123331; Alders M, 2009, NAT GENET, V41, P1272, DOI 10.1038/ng.484; AOYAMA N, 1995, LAB INVEST, V72, P355; Barton CA, 2010, BRIT J CANCER, V102, P87, DOI 10.1038/sj.bjc.6605429; Bento M, 2011, GENE EXPR PATTERNS, V11, P437, DOI 10.1016/j.gep.2011.07.002; Blom NA, 1999, CIRCULATION, V99, P800, DOI 10.1161/01.CIR.99.6.800; Bos FL, 2011, CIRC RES, V109, P486, DOI 10.1161/CIRCRESAHA.111.250738; BRONNERFRASER M, 1987, DEV BIOL, V123, P321, DOI 10.1016/0012-1606(87)90390-3; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Camp E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051948; Chuck ET, 1997, DEV DYNAM, V209, P182, DOI 10.1002/(SICI)1097-0177(199706)209:2<182::AID-AJA4>3.3.CO;2-T; Connell F, 2010, HUM GENET, V127, P231, DOI 10.1007/s00439-009-0766-y; ENGEL J, 1989, FEBS LETT, V251, P1, DOI 10.1016/0014-5793(89)81417-6; Facucho-Oliveira J, 2011, INT J DEV BIOL, V55, P1007, DOI 10.1387/ijdb.113394jf; Glickman NS, 2002, SEMIN CELL DEV BIOL, V13, P507, DOI 10.1016/S1084952102001040; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Hutson Mary Redmond, 2003, Birth Defects Research, V69, P2, DOI 10.1002/bdrc.10002; Jeltsch M, 2014, CIRCULATION, V129, P1962, DOI 10.1161/CIRCULATIONAHA.113.002779; Keyte A, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.04.005; Kirby ML, 2002, PEDIATR DEVEL PATHOL, V5, P516, DOI 10.1007/s10024-002-0004-2; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; LINASK KK, 1988, DEV BIOL, V129, P324, DOI 10.1016/0012-1606(88)90379-X; LINASK KK, 1988, DEV BIOL, V129, P315, DOI 10.1016/0012-1606(88)90378-8; LITTLE CD, 1995, EXPERIENTIA, V51, P873, DOI 10.1007/BF01921738; Mjaatvedt CH, 2001, DEV BIOL, V238, P97, DOI 10.1006/dbio.2001.0409; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Momose T, 1999, DEV GROWTH DIFFER, V41, P335; Munsterberg A, 2008, CELL ADHES MIGR, V2, P74, DOI 10.4161/cam.2.2.6295; Nakajima Y, 2001, ANAT RECORD, V263, P326, DOI 10.1002/ar.1099; Nakamura T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2319; New DAT, 1955, EMBRYOL EXP MORPHOL, V3, P326; Noseda M, 2011, CIRC RES, V108, P129, DOI 10.1161/CIRCRESAHA.110.223792; Rawles Mary E., 1943, PHYSIOL ZOOL, V16, P22; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; SISSMAN J, 1966, NATURE, V210, P504; Song JF, 2014, P NATL ACAD SCI USA, V111, P7337, DOI 10.1073/pnas.1321764111; STALSBERG H, 1969, DEV BIOL, V19, P128, DOI 10.1016/0012-1606(69)90052-9; Tavares AT, 2007, DEVELOPMENT, V134, P2051, DOI 10.1242/dev.000901; van den Berg G, 2009, PEDIATR CARDIOL, V30, P580, DOI 10.1007/s00246-008-9369-y; van den Berg G, 2009, CIRC RES, V104, P179, DOI 10.1161/CIRCRESAHA.108.185843; VINCENT M, 1984, DEV BIOL, V103, P468, DOI 10.1016/0012-1606(84)90334-8; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Waldo KL, 2005, DEV BIOL, V281, P66, DOI 10.1016/j.ydbio.2005.02.011; Wilkinson DG., 1992, SITU HYBRIDIZATION P, P75; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3; Yue Q, 2008, DEVELOPMENT, V135, P1029, DOI 10.1242/dev.015321	51	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115481	10.1371/journal.pone.0115481	http://dx.doi.org/10.1371/journal.pone.0115481			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545279	Green Submitted, gold, Green Published			2022-12-26	WOS:000347120200044
J	Lewis, JD; Wilton, M; Mott, GA; Lu, WW; Hassan, JA; Guttman, DS; Desveaux, D				Lewis, Jennifer D.; Wilton, Mike; Mott, G. Adam; Lu, Wenwan; Hassan, Jana A.; Guttman, David S.; Desveaux, Darrell			Immunomodulation by the Pseudomonas syringae HopZ Type III Effector Family in Arabidopsis	PLOS ONE			English	Article							DISEASE RESISTANCE GENE; YOPJ SUPERFAMILY; ACETYLATION; PATTERN; PROTEIN; SPECIFICITY; PERCEPTION; ACTIVATION; SECRETION; FLAGELLIN	Pseudomonas syringae employs a type III secretion system to inject 20-30 different type III effector (T3SE) proteins into plant host cells. A major role of T3SEs is to suppress plant immune responses and promote bacterial infection. The YopJ/HopZ acetyltransferases are a superfamily of T3SEs found in both plant and animal pathogenic bacteria. In P. syringae, this superfamily includes the evolutionarily diverse HopZ1, HopZ2 and HopZ3 alleles. To investigate the roles of the HopZ family in immunomodulation, we generated dexamethasone-inducible T3SE transgenic lines of Arabidopsis for HopZ family members and characterized them for immune suppression phenotypes. We show that all of the HopZ family members can actively suppress various facets of Arabidopsis immunity in a catalytic residuedependent manner. HopZ family members can differentially suppress the activation of mitogen-activated protein (MAP) kinase cascades or the production of reactive oxygen species, whereas all members can promote the growth of non-virulent P. syringae. Localization studies show that four of the HopZ family members containing predicted myristoylation sites are localized to the vicinity of the plasma membrane while HopZ3 which lacks the myristoylation site is at least partially nuclear localized, suggesting diversification of immunosuppressive mechanisms. Overall, we demonstrate that despite significant evolutionary diversification, all HopZ family members can suppress immunity in Arabidopsis.	[Lewis, Jennifer D.; Wilton, Mike; Mott, G. Adam; Lu, Wenwan; Guttman, David S.; Desveaux, Darrell] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Lewis, Jennifer D.] USDA, Ctr Plant Gene Express, Albany, CA USA; [Lewis, Jennifer D.; Hassan, Jana A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Guttman, David S.; Desveaux, Darrell] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada	University of Toronto; United States Department of Agriculture (USDA); University of California System; University of California Berkeley; University of Toronto	Lewis, JD (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	jdlewis@berkeley.edu	Guttman, David S/A-7839-2011	Guttman, David S/0000-0001-8479-3869; Mott, Adam/0000-0001-9803-103X	Natural Sciences and Engineering Research Council of Canada; Canada Research Chair in Plant-Microbe Systems Biology or Comparative Genomics; Centre for the Analysis of Genome Evolution and Function; United States Department of Agriculture Agricultural Research Service [5335-21000- 040-00D]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair in Plant-Microbe Systems Biology or Comparative Genomics; Centre for the Analysis of Genome Evolution and Function; United States Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by Natural Sciences and Engineering Research Council of Canada awards to DSG and DD; a Canada Research Chair in Plant-Microbe Systems Biology (DD) or Comparative Genomics (DSG); the Centre for the Analysis of Genome Evolution and Function (DD and DSG); United States Department of Agriculture Agricultural Research Service 5335-21000- 040-00D (JDL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Deslandes L, 2012, TRENDS PLANT SCI, V17, P644, DOI 10.1016/j.tplants.2012.06.011; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Feng F, 2012, CURR OPIN PLANT BIOL, V15, P469, DOI 10.1016/j.pbi.2012.03.004; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Guo M, 2009, MOL PLANT MICROBE IN, V22, P1069, DOI 10.1094/MPMI-22-9-1069; INNES RW, 1993, PLANT J, V4, P813, DOI 10.1046/j.1365-313X.1993.04050813.x; Jiang SS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003715; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Lee AHY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002523; Lee J, 2012, PLANT PHYSIOL, V158, P1803, DOI 10.1104/pp.111.190686; Lewis JD, 2008, J BACTERIOL, V190, P2880, DOI 10.1128/JB.01702-07; Lewis JD, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27563; Lewis JD, 2013, P NATL ACAD SCI USA, V110, P18722, DOI 10.1073/pnas.1315520110; Lewis JD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-8; Lewis JD, 2011, MOL PLANT PATHOL, V12, P928, DOI [10.1111/J.1364-3703.2011.00719.X, 10.1111/j.1364-3703.2011.00719.x]; Lewis JD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000894; Lewis JD, 2009, SEMIN CELL DEV BIOL, V20, P1055, DOI 10.1016/j.semcdb.2009.06.003; Lindeberg M, 2012, TRENDS MICROBIOL, V20, P199, DOI 10.1016/j.tim.2012.01.003; Ma WB, 2006, PLOS GENET, V2, P2131, DOI 10.1371/journal.pgen.0020209; Macho AP, 2014, SCIENCE, V343, P1509, DOI 10.1126/science.1248849; Macho AP, 2010, NEW PHYTOL, V187, P1018, DOI 10.1111/j.1469-8137.2010.03381.x; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Mudgett MB, 1999, MOL MICROBIOL, V32, P927, DOI 10.1046/j.1365-2958.1999.01403.x; Mukherjee S, 2007, TRENDS BIOCHEM SCI, V32, P210, DOI 10.1016/j.tibs.2007.03.007; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Paquette N, 2012, P NATL ACAD SCI USA, V109, P12710, DOI 10.1073/pnas.1008203109; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Roine E, 1997, P NATL ACAD SCI USA, V94, P3459, DOI 10.1073/pnas.94.7.3459; SIMONICH MT, 1995, MOL PLANT MICROBE IN, V8, P637, DOI 10.1094/MPMI-8-0637; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Ustun S, 2014, MOL PLANT MICROBE IN, V27, P611, DOI 10.1094/MPMI-12-13-0363-R; Vinatzer BA, 2006, MOL MICROBIOL, V62, P26, DOI 10.1111/j.1365-2958.2006.05350.x; Wilton M, 2010, PLANT SIGNAL BEHAV, V5, P746, DOI [10.4161/psb.5.6.11703, 10.1073/pnas.0904739107]; Wilton M, 2010, P NATL ACAD SCI USA, V107, P2349, DOI 10.1073/pnas.0904739107; Zhou HB, 2011, CELL HOST MICROBE, V9, P177, DOI 10.1016/j.chom.2011.02.007; Zhou HB, 2009, MOL PLANT MICROBE IN, V22, P176, DOI 10.1094/MPMI-22-2-0176; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	42	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e0116152	10.1371/journal.pone.0116152	http://dx.doi.org/10.1371/journal.pone.0116152			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546415	gold, Green Published			2022-12-26	WOS:000347120200102
J	Reuter, S; Soonpaa, MH; Firulli, AB; Chang, AN; Field, LJ				Reuter, Sean; Soonpaa, Mark H.; Firulli, Anthony B.; Chang, Audrey N.; Field, Loren J.			Recombinant Neuregulin 1 Does Not Activate Cardiomyocyte DNA Synthesis in Normal or Infarcted Adult Mice	PLOS ONE			English	Article							CARDIAC MYOCYTES; TRANSGENIC MICE; DILATED CARDIOMYOPATHY; VENTRICULAR MYOCYTES; STEM-CELLS; HEART; EXPRESSION; ERBB2; RECEPTOR; PROLIFERATION	Objectives: Neuregulin 1 signaling plays an important role in cardiac trabecular development, and in sustaining functional integrity in adult hearts. Treatment with neuregulin 1 enhances adult cardiomyocyte differentiation, survival and/or function in vitro and in vivo. It has also been suggested that recombinant neuregulin 1 beta 1 (NRG1 beta 1) induces cardiomyocyte proliferation in normal and injured adult hearts. Here we further explore the impact of neuregulin 1 signaling on adult cardiomyocyte cell cycle activity. Methods and Results: Adult mice were subjected to 9 consecutive daily injections of recombinant NRG1 beta 1 or vehicle, and cardiomyocyte DNA synthesis was quantitated via bromodeoxyuridine (BrdU) incorporation, which was delivered using mini-osmotic pumps over the entire duration of NRG1 beta 1 treatment. NRG1 beta 1 treatment inhibited baseline rates of cardiomyocyte DNA synthesis in normal mice (cardiomyocyte labelling index: 0.019 +/- 0.005% vs. 0.003 +/- 0.001%, saline vs. NRG1 beta 1, P<0.05). Acute NRG1 beta 1 treatment did result in activation of Erk1/2 and cardiac myosin regulatory light chain (down-stream mediators of neuregulin signalling), as well as activation of DNA synthesis in non-cardiomyocytes, validating the biological activity of the recombinant protein. In other studies, mice were subjected to permanent coronary artery occlusion, and cardiomyocyte DNA synthesis was monitored via tritiated thymidine incorporation which was delivered as a single injection 7 days post-infarction. Daily NRG1 beta 1 treatment had no impact on cardiomyocyte DNA synthesis in the infarcted myocardium (cardiomyocyte labelling index: 0.039 +/- 0.011% vs. 0.027 +/- 0.021%, saline vs. NRG1 beta 1, P>0.05). Summary: These data indicate that NRG1 beta 1 treatment does not increase cardiomyocyte DNA synthesis (and consequently does not increase the rate of cardiomyocyte renewal) in normal or infarcted adult mouse hearts. Thus, any improvement in cardiac structure and function observed following neuregulin treatment of injured hearts likely occurs independently of overt myocardial regeneration.	[Reuter, Sean; Soonpaa, Mark H.; Firulli, Anthony B.; Field, Loren J.] Indiana Univ, Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; [Reuter, Sean; Soonpaa, Mark H.; Firulli, Anthony B.; Field, Loren J.] Wells Ctr Pediat Res, Riley Heart Res Ctr, Indianapolis, IN USA; [Reuter, Sean; Soonpaa, Mark H.; Firulli, Anthony B.; Field, Loren J.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Chang, Audrey N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; University of Texas System; University of Texas Southwestern Medical Center Dallas	Field, LJ (corresponding author), Indiana Univ, Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA.	ljfield@iu.edu		/0000-0001-6687-8949	National Institutes of Health Heart, Lung and Blood Instititue [HL109205, 083126]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122123, R01HL083126, R01HL109205, R01HL120920] Funding Source: NIH RePORTER	National Institutes of Health Heart, Lung and Blood Instititue; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant # HL109205 & 083126 from the National Institutes of Health Heart, Lung and Blood Instititue, http://www.nhlbi.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang KL, 2010, AM J PHYSIOL-CELL PH, V298, pC1603, DOI 10.1152/ajpcell.00435.2009; Angert D, 2011, CIRC RES, V108, P1226, DOI 10.1161/CIRCRESAHA.110.239046; Baliga RR, 1999, AM J PHYSL, V277; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bian Y, 2009, AM J PHYSIOL-HEART C, V297, pH1974, DOI 10.1152/ajpheart.01010.2008; Braun T, 2009, DEV CELL, V17, P151, DOI 10.1016/j.devcel.2009.07.022; Chang AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066720; CREAMER B, 1961, GUT, V2, P110, DOI 10.1136/gut.2.2.110; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Esper RM, 2006, BRAIN RES REV, V51, P161, DOI 10.1016/j.brainresrev.2005.11.006; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Formiga FR, 2013, J CONTROL RELEASE; Fukazawa R, 2003, J MOL CELL CARDIOL, V35, P1473, DOI 10.1016/j.yjmcc.2003.09.012; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; Gao R, 1907, J AM COLL CARDIOL, V55, P1907; Garcia-Rivello H, 2005, AM J PHYSIOL-HEART C, V289, pH1153, DOI 10.1152/ajpheart.00048.2005; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Geiger S, ANTICANCER DRUGS, V21, P578; Giraud MN, 2005, J APPL PHYSIOL, V99, P313, DOI 10.1152/japplphysiol.00609.2004; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Gu X, CARDIOVASC RES, V88, P334; Jabbour A, EUR J HEART FAIL, V13, P83; Junqueira LCU, 1992, BASIC HISTOLOGY; Keulenaer GW De, CIRC RES, V106, P35; KOH GY, 1995, J CLIN INVEST, V96, P2034, DOI 10.1172/JCI118251; Kuramochi Y, 2004, J BIOL CHEM, V279, P51141, DOI 10.1074/jbc.M408662200; Kuramochi Y, 2006, J MOL CELL CARDIOL, V41, P228, DOI 10.1016/j.yjmcc.2006.04.007; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lemmens K, 2007, CIRCULATION, V116, P954, DOI 10.1161/CIRCULATIONAHA.107.690487; Liu XF, 2006, J AM COLL CARDIOL, V48, P1438, DOI 10.1016/j.jacc.2006.05.057; Marguerie A, 2006, CARDIOVASC RES, V71, P50, DOI 10.1016/j.cardiores.2006.03.021; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nakajima H, 2006, CIRC RES, V98, P141, DOI 10.1161/01.RES.0000197783.70106.4a; Nakajima H, 2004, CIRC RES, V94, P1606, DOI 10.1161/01.RES.0000132279.99249.f4; Nakajima H, 2000, CIRC RES, V86, P571, DOI 10.1161/01.RES.86.5.571; Odiete O, 2012, CIRC RES, V111, P1376, DOI 10.1161/CIRCRESAHA.112.267286; Ozcelik C, 2002, P NATL ACAD SCI USA, V99, P8880, DOI 10.1073/pnas.122249299; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Pasumarthi KBS, 2000, CIRC RES, V86, P1069, DOI 10.1161/01.RES.86.10.1069; Rohrbach S, 1999, CIRCULATION, V100, P407, DOI 10.1161/01.CIR.100.4.407; Rohrbach S, 2005, BASIC RES CARDIOL, V100, P240, DOI 10.1007/s00395-005-0514-4; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Soonpaa MH, 2013, BBA-MOL CELL RES, V1833, P799, DOI 10.1016/j.bbamcr.2012.10.029; SOONPAA MH, 1994, SCIENCE, V264, P98, DOI 10.1126/science.8140423; Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, pH220, DOI 10.1152/ajpheart.1997.272.1.H220; Soonpaa MH, 1997, J CLIN INVEST, V99, P2644, DOI 10.1172/JCI119453; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; SOONPAA MH, 1994, AM J PHYSIOL, V266, pH1439, DOI 10.1152/ajpheart.1994.266.4.H1439; Timolati F, 2006, J MOL CELL CARDIOL, V41, P845, DOI 10.1016/j.yjmcc.2006.08.002; Uray IP, 2002, J HEART LUNG TRANSPL, V21, P771, DOI 10.1016/S1053-2498(02)00390-X; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261	52	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115871	10.1371/journal.pone.0115871	http://dx.doi.org/10.1371/journal.pone.0115871			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545368	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200076
J	Nolan, K; Kattamuri, C; Luedeke, DM; Angerman, EB; Rankin, SA; Stevens, ML; Zorn, AM; Thompson, TB				Nolan, Kristof; Kattamuri, Chandramohan; Luedeke, David M.; Angerman, Elizabeth B.; Rankin, Scott A.; Stevens, Mariana L.; Zorn, Aaron M.; Thompson, Thomas B.			Structure of Neuroblastoma Suppressor of Tumorigenicity 1 (NBL1) INSIGHTS FOR THE FUNCTIONAL VARIABILITY ACROSS BONE MORPHOGENETIC PROTEIN (BMP) ANTAGONISTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAN GENE-PRODUCT; RECEPTOR-BINDING; GENOMIC ANALYSIS; FAMILY; WNT; GREMLIN; MEMBER; DIFFERENTIATION; FIBROBLASTS; FOLLISTATIN	Bone morphogenetic proteins (BMPs) are antagonized through the action of numerous extracellular protein antagonists, including members from the differential screening-selected gene aberrative in neuroblastoma (DAN) family. In vivo, misregulation of the balance between BMP signaling and DAN inhibition can lead to numerous disease states, including cancer, kidney nephropathy, and pulmonary arterial hypertension. Despite this importance, very little information is available describing how DAN family proteins effectively inhibit BMP ligands. Furthermore, our understanding for how differences in individual DAN family members arise, including affinity and specificity, remains underdeveloped. Here, we present the structure of the founding member of the DAN family, neuroblastoma suppressor of tumorigenicity 1 (NBL1). Comparing NBL1 to the structure of protein related to Dan and Cerberus (PRDC), a more potent BMP antagonist within the DAN family, a number of differences were identified. Through a mutagenesis-based approach, we were able to correlate the BMP binding epitope in NBL1 with that in PRDC, where introduction of specific PRDC amino acids in NBL1 (A58F and S67Y) correlated with a gain-of-function inhibition toward BMP2 and BMP7, but not GDF5. Although NBL1(S67Y) was able to antagonize BMP7 as effectively as PRDC, NBL1(S67Y) was still 32-fold weaker than PRDC against BMP2. Taken together, this data suggests that alterations in the BMP binding epitope can partially account for differences in the potency of BMP inhibition within the DAN family.	[Nolan, Kristof; Kattamuri, Chandramohan; Luedeke, David M.; Angerman, Elizabeth B.; Thompson, Thomas B.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Rankin, Scott A.; Stevens, Mariana L.; Zorn, Aaron M.] Univ Cincinnati, Perinatal Inst, Cincinnati Childrens Res Fdn, Cincinnati, OH 45229 USA; [Rankin, Scott A.; Stevens, Mariana L.; Zorn, Aaron M.] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Thompson, TB (corresponding author), 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	tom.thompson@uc.edu		Thompson, Thomas/0000-0002-7041-5047	National Institutes of Health from the NIGMS [R01 GM084186]; National Institutes of Health from the NIDDK [R01 DK070858]; American Heart Association [14PRE20480142]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084186, R01GM114640] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health from the NIDDK; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM084186 from the NIGMS (to T. B. T.) and Grant R01 DK070858 from the NIDDK, and American Heart Association Grant 14PRE20480142 (to K. N.).	Ahn Y, 2010, DEVELOPMENT, V137, P3221, DOI 10.1242/dev.054668; Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; Bezooijen RL, 2005, CYTOKINE GROWTH F R, V16, P319, DOI 10.1016/j.cytogfr.2005.02.005; Bourhis E, 2011, STRUCTURE, V19, P1433, DOI 10.1016/j.str.2011.07.005; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Cahill E, 2012, CIRCULATION, V125, P920, DOI 10.1161/CIRCULATIONAHA.111.038125; Cai J, 2012, FEBS LETT, V586, P1993, DOI 10.1016/j.febslet.2012.04.030; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dionne MS, 2001, MOL CELL BIOL, V21, P636, DOI 10.1128/MCB.21.2.636-643.2001; Eimon PM, 2001, MECH DEVELOP, V107, P187, DOI 10.1016/S0925-4773(01)00462-2; Gao H, 2012, CELL, V150, P764, DOI 10.1016/j.cell.2012.06.035; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Hung WT, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096172; Kattamuri C, 2012, J MOL BIOL, V424, P313, DOI 10.1016/j.jmb.2012.10.003; Kattamuri C, 2012, PROTEIN EXPRES PURIF, V82, P389, DOI 10.1016/j.pep.2012.02.010; Kim AS, 2003, DEV BRAIN RES, V145, P159, DOI 10.1016/S0165-3806(03)00213-X; KONDO K, 1995, BIOCHEM BIOPH RES CO, V216, P209, DOI 10.1006/bbrc.1995.2612; Lintern KB, 2009, J BIOL CHEM, V284, P23159, DOI 10.1074/jbc.M109.025478; Nolan K, 2014, PROTEIN SCI, V23, P999, DOI 10.1002/pro.2485; Nolan K, 2013, STRUCTURE, V21, P1417, DOI 10.1016/j.str.2013.06.005; Ohtori S, 2002, NEUROSCIENCE, V110, P579, DOI 10.1016/S0306-4522(01)00590-5; OZAKI T, 1995, CANCER RES, V55, P895; Ozaki T, 1997, DNA CELL BIOL, V16, P1031, DOI 10.1089/dna.1997.16.1031; OZAKI T, 1994, CANCER RES, V54, P646; Pearce JJH, 1999, DEV BIOL, V209, P98, DOI 10.1006/dbio.1999.9240; Rider CC, 2010, BIOCHEM J, V429, P1, DOI 10.1042/BJ20100305; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Sidis Y, 2005, ENDOCRINOLOGY, V146, P130, DOI 10.1210/en.2004-1041; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Tamminen JA, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.29; Tanwar V, 2014, STEM CELLS, V32, P1774, DOI 10.1002/stem.1703; Tardif G, 2009, OSTEOARTHR CARTILAGE, V17, P263, DOI 10.1016/j.joca.2008.06.022; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Weidauer SE, 2009, BIOCHEM BIOPH RES CO, V380, P160, DOI 10.1016/j.bbrc.2009.01.062; Yanagita M, 2012, NEPHROL DIAL TRANSPL, V27, P3686, DOI 10.1093/ndt/gfs381; Zhang JL, 2008, DEV CELL, V14, P739, DOI 10.1016/j.devcel.2008.02.017; Zhang YL, 2009, BIOCHEM BIOPH RES CO, V383, P1, DOI 10.1016/j.bbrc.2009.03.086	41	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4759	4771		10.1074/jbc.M114.628412	http://dx.doi.org/10.1074/jbc.M114.628412			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25561725	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000350042000019
J	Bhat, KP; Betous, R; Cortez, D				Bhat, Kamakoti P.; Betous, Remy; Cortez, David			High-affinity DNA-binding Domains of Replication Protein A (RPA) Direct SMARCAL1-dependent Replication Fork Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNO-OSSEOUS DYSPLASIA; SINGLE-STRANDED-DNA; HELICASE ACTIVITY; GENOME STABILITY; REPAIR; SMARCAL1; MECHANISM; SUBSTRATE; RECG; STIMULATION	SMARCAL1 catalyzes replication fork remodeling to maintain genome stability. It is recruited to replication forks via an interaction with replication protein A (RPA), the major ssDNA-binding protein in eukaryotic cells. In addition to directing its localization, RPA also activates SMARCAL1 on some fork substrates but inhibits it on others, thereby conferring substrate specificity to SMARCAL1 fork-remodeling reactions. We investigated the mechanism by which RPA regulates SMARCAL1. Our results indicate that although an interaction between SMARCAL1 and RPA is essential for SMARCAL1 activation, the location of the interacting surface on RPA is not. Counter-intuitively, high-affinity DNA binding of RPA DNA-binding domain (DBD) A and DBD-B near the fork junction makes it easier for SMARCAL1 to remodel the fork, which requires removing RPA. We also found that RPA DBD-C and DBD-D are not required for SMARCAL1 regulation. Thus, the orientation of the high-affinity RPA DBDs at forks dictates SMARCAL1 substrate specificity.	[Bhat, Kamakoti P.; Betous, Remy; Cortez, David] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University	Cortez, D (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA.	david.cortez@vanderbilt.edu	Bétous, Rémy/P-2355-2014; Bétous, Rémy/ABF-4789-2020; Classen, Scott/AAY-8176-2020; Bhat, Kamakoti/L-3613-2019	Bétous, Rémy/0000-0003-0518-1763; Bhat, Kamakoti/0000-0001-7425-8336	Structural Biology of DNA Repair Machines Grant from the National Institutes of Health [P01CA092584]; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA136933] Funding Source: NIH RePORTER	Structural Biology of DNA Repair Machines Grant from the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Miaw-Sheue Tsai for the production of baculovirus to purify SMARCAL1 proteins (supported by Structural Biology of DNA Repair Machines Grant P01CA092584 from the National Institutes of Health). We also thank Dr. Marc S. Wold (University of Iowa) for all of the purified RPA proteins used in this study.	Abd Wahab S, 2013, J BIOL CHEM, V288, P26397, DOI 10.1074/jbc.M113.500223; Arunkumar AI, 2003, J BIOL CHEM, V278, P41077, DOI 10.1074/jbc.M305871200; Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Betous R, 2013, CELL REP, V3, P1958, DOI 10.1016/j.celrep.2013.05.002; Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Bochkareva E, 2000, J BIOL CHEM, V275, P27332; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Borgstahl GEO, 2014, DNA REPAIR, V21, P12, DOI 10.1016/j.dnarep.2014.05.005; Brosey CA, 2013, NUCLEIC ACIDS RES, V41, P2313, DOI 10.1093/nar/gks1332; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Buss JA, 2008, NUCLEIC ACIDS RES, V36, P7029, DOI 10.1093/nar/gkn795; Carroll C, 2013, PEDIATR BLOOD CANCER, V60, pE88, DOI 10.1002/pbc.24542; Chen R, 2014, BIOESSAYS, V36, P1156, DOI 10.1002/bies.201400107; Ciccia A, 2009, GENE DEV, V23, P2415, DOI 10.1101/gad.1832309; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Couch FB, 2013, GENE DEV, V27, P1610, DOI 10.1101/gad.214080.113; Delagoutte E, 2011, BIOCHEMISTRY-US, V50, P932, DOI 10.1021/bi101583e; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; Elizondo LI, 2009, J MED GENET, V46, P49, DOI 10.1136/jmg.2008.060095; Fan J, 2012, GENE DEV, V26, P2337, DOI 10.1101/gad.194787.112; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Gibb B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087922; Haring SJ, 2008, J BIOL CHEM, V283, P19095, DOI 10.1074/jbc.M800881200; Hass CS, 2012, J BIOL CHEM, V287, P3908, DOI 10.1074/jbc.M111.287441; Jiang XH, 2006, EMBO J, V25, P5516, DOI 10.1038/sj.emboj.7601432; Kolpashchikov DM, 2001, NUCLEIC ACIDS RES, V29, P373, DOI 10.1093/nar/29.2.373; Lavrik OI, 1999, NUCLEIC ACIDS RES, V27, P4235, DOI 10.1093/nar/27.21.4235; Machwe A, 2011, J BIOL CHEM, V286, P3497, DOI 10.1074/jbc.M110.105411; Manosas M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3368; Nguyen B, 2014, J MOL BIOL, V426, P3246, DOI 10.1016/j.jmb.2014.07.014; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; Postow L, 2009, J BIOL CHEM, V284, P35951, DOI 10.1074/jbc.M109.048330; Ranalli TA, 2002, J BIOL CHEM, V277, P1719, DOI 10.1074/jbc.M109053200; Shen JC, 1998, NUCLEIC ACIDS RES, V26, P2879, DOI 10.1093/nar/26.12.2879; Shereda RD, 2007, J BIOL CHEM, V282, P19247, DOI 10.1074/jbc.M608011200; Sommers JA, 2014, J BIOL CHEM, V289, P19928, DOI 10.1074/jbc.M113.542456; Suhasini AN, 2009, J BIOL CHEM, V284, P18458, DOI 10.1074/jbc.M109.012229; Walther AP, 1999, BIOCHEMISTRY-US, V38, P3963, DOI 10.1021/bi982370u; Wyka IM, 2003, BIOCHEMISTRY-US, V42, P12909, DOI 10.1021/bi034930h; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409; Yusufzai T, 2008, SCIENCE, V322, P748, DOI 10.1126/science.1161233; Yusufzai T, 2009, GENE DEV, V23, P2400, DOI 10.1101/gad.1831509; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897	45	39	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4110	4117		10.1074/jbc.M114.627083	http://dx.doi.org/10.1074/jbc.M114.627083			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25552480	hybrid, Green Published			2022-12-26	WOS:000349458400022
J	Toupet, K; Maumus, M; Luz-Crawford, P; Lombardo, E; Lopez-Belmonte, J; van Lent, P; Garin, MI; van den Berg, W; Dalemans, W; Jorgensen, C; Noel, D				Toupet, Karine; Maumus, Marie; Luz-Crawford, Patricia; Lombardo, Eleuterio; Lopez-Belmonte, Juan; van Lent, Peter; Garin, Marina I.; van den Berg, Wim; Dalemans, Wilfried; Jorgensen, Christian; Noel, Daniele			Survival and Biodistribution of Xenogenic Adipose Mesenchymal Stem Cells Is Not Affected by the Degree of Inflammation in Arthritis	PLOS ONE			English	Article							INTRAARTICULAR INJECTION; OSTEOARTHRITIS; CHONDROCYTES	Background Application of mesenchymal stem/stromal cells (MSCs) in treating different disorders, in particular osteo-articular diseases, is currently under investigation. We have already documented the safety of administrating human adipose tissue-derived stromal MSCs (hASCs) in immunodeficient mice. In the present study, we investigated whether the persistence of MSC is affected by the degree of inflammation and related to the therapeutic effect in two inflammatory models of arthritis. Methodology/Principal Findings We used C57BL/6 or DBA/1 mice to develop collagenase-induced osteoarthritis (CIOA) or collagen-induced arthritis (CIA), respectively. Normal and diseased mice were administered 2.5x10(5) hASCs in the knee joints (IA) or 10(6) in the tail vein (IV). For CIA, clinical scores were monitored during the time course of the disease while for CIOA, OA scores were assessed by histology at euthanasia. Thirteen tissues were recovered at different time points and processed for real-time PCR and Alu sequence detection. Immunological analyses were performed at euthanasia. After IV infusion, no significant difference in the percentage of hASCs was quantified in the lungs of normal and CIA mice at day 1 while no cell was detected at day 10 taking into account the sensitivity of the assay, indicating that a high level of inflammation did not affect the persistence of cells. In CIOA mice, we reported the therapeutic efficacy of hASCs at reducing OA clinical scores at day 42 when hASCs were not detected in the joints. However, the percentage and distribution of hASCs were similar in osteoarthritic and normal mice at day 1 and 10 after implantation indicating that moderate inflammation does not alter hASC persistence in vivo. Conclusions/Significance While inflammatory signals are required for the immunosuppressive function of MSCs, they do not enhance their capacity to survive in vivo, as evaluated in two xenogeneic inflammatory pre-clinical models of arthritis.	[Toupet, Karine; Maumus, Marie; Luz-Crawford, Patricia; Jorgensen, Christian; Noel, Daniele] Hop St Eloi, INSERM, U 844, Montpellier, France; [Toupet, Karine; Maumus, Marie; Luz-Crawford, Patricia; Jorgensen, Christian; Noel, Daniele] Univ Montpellier I, UFR Med, Montpellier, France; [Lombardo, Eleuterio] TiGenix, Madrid, Spain; [Lopez-Belmonte, Juan] Farma Cros Iber, Albacete, Spain; [van Lent, Peter; van den Berg, Wim] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Garin, Marina I.] CIEMAT CIBERER, Madrid, Spain; [Dalemans, Wilfried] TiGenix, Leuven, Belgium; [Jorgensen, Christian] Hop Lapeyronie, Serv Immunorhumatol, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Radboud University Nijmegen; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universite de Montpellier; CHU de Montpellier	Noel, D (corresponding author), Hop St Eloi, INSERM, U 844, Montpellier, France.	daniele.noel@inserm.fr	van Lent, Peter/A-4047-2014; Noel, Daniele/E-5719-2016; Garin, Marina I/C-5094-2014; Maumus, Marie/AAD-1725-2019	Garin, Marina I/0000-0001-7956-6792; jorgensen, christian/0000-0001-6947-8094; Luz Crawford, Patricia/0000-0003-0067-7743; Noel, Daniele/0000-0002-3498-3776	Inserm Institute; University of Montpellier I; ReumaFonds [12-2-405] Funding Source: researchfish	Inserm Institute(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Montpellier I; ReumaFonds	Work in the laboratory Inserm U844 was supported by the Inserm Institute, the University of Montpellier I and funding from the European Community for the collaborative projects: "ADIPOA: Adipose-derived stromal cells for osteoarthritis treatment" (contract no. Health-2009-1.4-3-241719) and "REGENERAR: Bringing Regenerative Medicine into the market: Allogeneic eASCs Phase IB/IIA clinical trial for treating Rheumatoid Arthritis" (contract no. 279174 EC). The authors also thank the Agence Nationale pour la Recherche for support of the national infrastructure: "ECELLFRANCE: Development of a national adult mesenchymal stem cell based therapy platform" (ANR-11-INSB-005). Tigenix and Farmacros got funding from the European Union's Seventh Programme for research, technological development and demonstration under grant agreement No 279174 to perform these studies. The funders had no role in study design, decision to publish, or preparation of the manuscript. EL and WD are employees of TiGenix; JLB is employee of FarmaCross-Iberica. TiGenix and FarmaCrossIberica provided support in the form of salaries for authors EL, WD and JLB, but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816; Bouffi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014247; Chen FH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2514; Desando G, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4156; Djouad F, 2005, ARTHRITIS RHEUM-US, V52, P1595, DOI 10.1002/art.21012; Djouad F, 2009, NAT REV RHEUMATOL, V5, P392, DOI 10.1038/nrrheum.2009.104; Eggenhofer E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00148; Gonzalez MA, 2009, ARTHRITIS RHEUM-US, V60, P1006, DOI 10.1002/art.24405; Jorgensen C, 2013, JOINT BONE SPINE, V80, P565, DOI 10.1016/j.jbspin.2013.08.004; Kang SK, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/342968; Kavanagh DPJ, 2014, STEM CELL REV REP, V10, P587, DOI 10.1007/s12015-014-9510-7; Krampera M, 2013, CYTOTHERAPY, V15, P1054, DOI 10.1016/j.jcyt.2013.02.010; Kurth TB, 2011, ARTHRITIS RHEUM-US, V63, P1289, DOI 10.1002/art.30234; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Liu YY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3187; Mancheno-Corvo P, 2013, BIORESEARCH OPEN ACC, V2, P431, DOI 10.1089/biores.2013.0040; Manferdini C, 2013, ARTHRITIS RHEUM-US, V65, P1271, DOI 10.1002/art.37908; Markides H, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt337; Maumus M, 2013, STEM CELL RES, V11, P834, DOI 10.1016/j.scr.2013.05.008; Menard C, 2013, STEM CELLS DEV, V22, P1789, DOI 10.1089/scd.2012.0594; Murphy MB, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.94; Parolini O, 2014, ARTHRITIS RHEUMATOL, V66, P327, DOI 10.1002/art.38206; Popp FC, 2008, TRANSPL IMMUNOL, V20, P55, DOI 10.1016/j.trim.2008.08.004; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Schelbergen RF, 2014, OSTEOARTHR CARTILAGE, V22, P1158, DOI 10.1016/j.joca.2014.05.022; ter Huurne M, 2012, ARTHRITIS RHEUM-US, V64, P3604, DOI 10.1002/art.34626; Toupet K, 2013, ARTHRITIS RHEUM-US, V65, P1786, DOI 10.1002/art.37960; VANBUUL GM, 2014, J ORTHOP RES; Vincent TL, 2012, RHEUMATOLOGY, V51, P1931, DOI 10.1093/rheumatology/kes035; von Bahr L, 2012, STEM CELLS, V30, P1575, DOI 10.1002/stem.1118; Zangi L, 2009, STEM CELLS, V27, P2865, DOI 10.1002/stem.217	31	57	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e0114962	10.1371/journal.pone.0114962	http://dx.doi.org/10.1371/journal.pone.0114962			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559623	Green Published, gold, Green Submitted			2022-12-26	WOS:000348102200008
J	Zhang, MJ; Feng, MC; Xiao, LJ; Song, XY; Yang, WD; Ding, GW				Zhang, Mei-jun; Feng, Mei-chen; Xiao, Lu-jie; Song, Xiao-yan; Yang, Wu-de; Ding, Guang-wei			Impact of Water Content and Temperature on the Degradation of Cry1Ac Protein in Leaves and Buds of Bt Cotton in the Soil	PLOS ONE			English	Article							THURINGIENSIS SUBSP KURSTAKI; BACILLUS-THURINGIENSIS; INSECTICIDAL PROTEINS; DELTA-ENDOTOXIN; RAPID DEGRADATION; TRANSGENIC CORN; HUMIC ACIDS; TOXIN; PERSISTENCE; PLANTS	Determining the influence of soil environmental factors on degradation of Cry1Ac protein from Bt cotton residues is vital for assessing the ecological risks of this commercialized transgenic crop. In this study, the degradation of Cry1Ac protein in leaves and in buds of Bt cotton in soil was evaluated under different soil water content and temperature settings in the laboratory. An exponential model and a shift-log model were used to fit the degradation dynamics of Cry1Ac protein and estimate the DT50 and DT90 values. The results showed that Cry1Ac protein in the leaves and buds underwent rapid degradation in the early stage (before day 48), followed by a slow decline in the later stage under different soil water content and temperature. Cry1Ac protein degraded the most rapidly in the early stage at 35 degrees C with 70% soil water holding capacity. The DT50 values were 12.29 d and 10.17 d and the DT90 values were 41.06 d and 33.96 d in the leaves and buds, respectively. Our findings indicated that the soil temperature was a major factor influencing the degradation of Cry1Ac protein from Bt cotton residues. Additionally, the relative higher temperature (25 degrees C and 35 degrees C) was found to be more conducive to degradation of Cry1Ac protein in the soil and the greater water content (100% WHC) retarded the process. These findings suggested that under appropriate soil temperature and water content, Cry1Ac protein from Bt cotton residues will not persist and accumulate in soil.	[Zhang, Mei-jun; Feng, Mei-chen; Xiao, Lu-jie; Song, Xiao-yan; Yang, Wu-de] Shanxi Agr Univ, Coll Agr, Taigu, Peoples R China; [Ding, Guang-wei] Northern State Univ, Dept Chem, Aberdeen, SD USA	Shanxi Agricultural University; Northern State University	Yang, WD (corresponding author), Shanxi Agr Univ, Coll Agr, Taigu, Peoples R China.	sxauywd@126.com; guangwei.ding@northern.edu		Meichen, Feng/0000-0002-0338-7963	Programs for Science and Technology Development of Shanxi Province, China [2012011030-2]	Programs for Science and Technology Development of Shanxi Province, China	This work was supported by grants from the Programs for Science and Technology Development of Shanxi Province, China (2012011030-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accinelli C, 2008, J AGR FOOD CHEM, V56, P1025, DOI 10.1021/jf073172p; Bai YaoYu, 2006, Scientia Agricultura Sinica, V39, P721; [白耀宇 Bai Yaoyu], 2005, [生态学报, Acta Ecologica Sinica], V25, P1583; Clive J, 2012, CHINESE J BIOTECHNOL, V31, P1; Crecchio C, 1998, SOIL BIOL BIOCHEM, V30, P463, DOI 10.1016/S0038-0717(97)00147-8; Crecchio C, 2001, SOIL BIOL BIOCHEM, V33, P573, DOI 10.1016/S0038-0717(00)00199-1; Daudu CK, 2009, AGR ECOSYST ENVIRON, V134, P153, DOI 10.1016/j.agee.2009.06.012; Donegan KK, 1996, TRANSGENIC RES, V5, P25, DOI 10.1007/BF01979919; Feng YJ, 2011, SOIL BIOL BIOCHEM, V43, P1600, DOI 10.1016/j.soilbio.2011.04.011; Flores S, 2005, SOIL BIOL BIOCHEM, V37, P1073, DOI 10.1016/j.soilbio.2004.11.006; Head G, 2002, ENVIRON ENTOMOL, V31, P30, DOI 10.1603/0046-225X-31.1.30; Helassa N, 2011, SOIL BIOL BIOCHEM, V43, P1089, DOI 10.1016/j.soilbio.2011.01.030; Herman RA, 2002, J AGR FOOD CHEM, V50, P7076, DOI 10.1021/jf025630u; Herman RA, 2002, ENVIRON ENTOMOL, V31, P208, DOI 10.1603/0046-225X-31.2.208; Hopkins DW, 2005, CAN J SOIL SCI, V85, P19, DOI 10.4141/S03-073; Icoz I, 2008, TRANSGENIC RES, V17, P609, DOI 10.1007/s11248-007-9133-8; Icoz I, 2008, SOIL BIOL BIOCHEM, V40, P559, DOI 10.1016/j.soilbio.2007.11.002; Koskella J, 1997, APPL ENVIRON MICROB, V63, P3561, DOI 10.1128/AEM.63.9.3561-3568.1997; Koskella J, 2002, CAN J MICROBIOL, V48, P262, DOI [10.1139/w02-005, 10.1139/W02-005]; Lee L, 2003, APPL ENVIRON MICROB, V69, P4111, DOI 10.1128/AEM.69.7.4111-4115.2003; Li Fan, 2013, Yingyong Shengtai Xuebao, V24, P1907; Lin DY, 2002, SCI SOIL; Liu Jie, 2010, Acta Pedologica Sinica, V47, P786; Losey JE, 1999, NATURE, V399, P214, DOI 10.1038/20338; Marchetti E, 2007, AGRON SUSTAIN DEV, V27, P231, DOI 10.1051/agro:2007010; Miethling-Graff R, 2010, EUR J SOIL BIOL, V46, P41, DOI 10.1016/j.ejsobi.2009.10.003; Palm CJ, 1996, CAN J MICROBIOL, V42, P1258, DOI 10.1139/m96-163; PALM CJ, 1994, MOL ECOL, V3, P145, DOI 10.1111/j.1365-294X.1994.tb00115.x; Point B, 2005, BIOCONTROL SCI TECHN, V15, P341, DOI 10.1080/09583150400016969; Sander M, 2010, ENVIRON SCI TECHNOL, V44, P8870, DOI 10.1021/es103008s; SANVIDO O, 2006, ART SCHRIFTENREIHE, V1, P1; Saxena D, 2000, FEMS MICROBIOL ECOL, V33, P35, DOI 10.1111/j.1574-6941.2000.tb00724.x; Saxena D, 2004, PLANT PHYSIOL BIOCH, V42, P383, DOI 10.1016/j.plaphy.2004.03.004; Saxena D, 2002, SOIL BIOL BIOCHEM, V34, P111, DOI 10.1016/S0038-0717(01)00193-6; Saxena D, 2002, SOIL BIOL BIOCHEM, V34, P133, DOI 10.1016/S0038-0717(01)00161-4; Saxena D, 1999, NATURE, V402, P480, DOI 10.1038/44997; Saxena D., 2003, COLLECTION BIOSAFETY, P7; Sims SR, 1996, ENVIRON ENTOMOL, V25, P659, DOI 10.1093/ee/25.3.659; Sims SR, 1997, J AGR FOOD CHEM, V45, P1502, DOI 10.1021/jf960647w; Stotzky G, 2004, PLANT SOIL, V266, P77; TAPP H, 1994, SOIL BIOL BIOCHEM, V26, P663, DOI 10.1016/0038-0717(94)90258-5; Wang BaoMin, 2002, Journal of Agricultural Biotechnology, V10, P215; Wang Jian-wu, 2009, Shengtaixue Zazhi, V28, P1324; [王建武 Wang Jianwu], 2005, [生态学杂志, Chinese Journal of Ecology], V24, P1063; Wang JianWu, 2003, Scientia Agricultura Sinica, V36, P1279; Wang SA, 1994, INTRO CROP CULTIVATI; Wang YM, 2013, SOIL BIOL BIOCHEM, V58, P107, DOI 10.1016/j.soilbio.2012.11.007; [张运红 ZHANG Yunhong], 2007, [华中农业大学学报, Journal of Huazhong Agricultural University], V26, P486; Zurbrugg C, 2010, TRANSGENIC RES, V19, P257, DOI 10.1007/s11248-009-9304-x; Zwahlen C, 2003, MOL ECOL, V12, P765, DOI 10.1046/j.1365-294X.2003.01767.x	50	8	9	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e1152400	10.1371/journal.pone.0115240	http://dx.doi.org/10.1371/journal.pone.0115240			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559638	Green Published, Green Submitted, gold			2022-12-26	WOS:000348102200009
J	Kusrini, MD; Rowley, JJL; Khairunnisa, LR; Shea, GM; Altig, R				Kusrini, Mirza D.; Rowley, Jodi J. L.; Khairunnisa, Luna R.; Shea, Glenn M.; Altig, Ronald			The Reproductive Biology and Larvae of the First Tadpole-Bearing Frog, Limnonectes larvaepartus	PLOS ONE			English	Article							DICROGLOSSIDAE; ANURA	Most of the reproductive modes of frogs include an exotrophic tadpole, but a number of taxa have some form of endotrophic development that lacks a feeding tadpole stage. The dicroglossid frog genus Limnonectes ranges from China south into Indonesia. The breeding biologies of the approximately 60 described species display an unusual diversity that range from exotrophic tadpoles to endotrophic development in terrestrial nests. There have been mentions of oviductal production of typical, exotrophic tadpoles in an undescribed species of Limnonectes from Sulawesi, Indonesia. Here we examine newly collected specimens of this species, now described as L. larvaepartus and present the first substantial report on this unique breeding mode. Typical exotrophic tadpoles that are retained to an advanced developmental stage in the oviducts of a female frog are birthed into slow-flowing streams or small, non-flowing pools adjacent to the streams.	[Kusrini, Mirza D.; Khairunnisa, Luna R.] Bogor Agr Univ, Dept Forest Resources Conservat & Ecotourism, Bogor, Indonesia; [Rowley, Jodi J. L.; Shea, Glenn M.] Australian Museum, Res Inst, Sydney, NSW 2000, Australia; [Shea, Glenn M.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Altig, Ronald] Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA	Bogor Agricultural University; Australian Museum; University of Sydney; Mississippi State University	Kusrini, MD (corresponding author), Bogor Agr Univ, Dept Forest Resources Conservat & Ecotourism, Bogor, Indonesia.	mirza_kusrini@yahoo.com	Kusrini, Mirza Dikari/GQB-2150-2022; Rowley, Jodi J. L./F-2466-2012	Rowley, Jodi/0000-0002-2011-9143	The Ministry of Education, Republic of Indonesia through BOPTN DIKTI-IPB [2013.089.521219]; ADM Capital Foundation	The Ministry of Education, Republic of Indonesia through BOPTN DIKTI-IPB; ADM Capital Foundation	The Ministry of Education, Republic of Indonesia provided funding to MDK and LRK through BOPTN DIKTI-IPB Number 2013.089.521219, and ADM Capital Foundation provided funding for JJLR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altig R, 1999, TADPOLES, P24; Brown R. M., 2009, ENCY ISLANDS, P347; Evans BJ, 2003, SYST BIOL, V52, P794, DOI 10.1080/10635150390251063; Frost D.R., 2021, AMPHIBIAN SPECIES WO; GOICOECHEA O, 1986, J HERPETOL, V20, P168, DOI 10.2307/1563941; Gosner K. L., 1960, Herpetologica, V16, P183; Haddad CFB, 2005, BIOSCIENCE, V55, P207, DOI 10.1641/0006-3568(2005)055[0207:RMIFAT]2.0.CO;2; INGER RF, 1988, COPEIA, P1060, DOI 10.2307/1445733; INGER RF, 1986, COPEIA, P523, DOI 10.2307/1445012; Iskandar D.T., 1985, P 1 INT C E IND AUST, P39; Iskandar Djoko T., 2006, Amphibian & Reptile Conservation, V4, P60, DOI 10.1514/journal.arc.0040016; Iskandar DT, 2014, PLOSONE; McLeod DS, 2010, MOL PHYLOGENET EVOL, V56, P991, DOI 10.1016/j.ympev.2010.04.004; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Rowley JJL, 2012, AMPHIBIA-REPTILIA, V33, P145, DOI 10.1163/156853812X626179; Setiadi MI, 2011, AM NAT, V178, P221, DOI 10.1086/660830; TOWNSEND DS, 1981, SCIENCE, V212, P469, DOI 10.1126/science.6894203	17	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2015	10	1							e116154	10.1371/journal.pone.0116154	http://dx.doi.org/10.1371/journal.pone.0116154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3XP	25555000	Green Published, Green Submitted, gold			2022-12-26	WOS:000348157400001
J	Herzberger, AJ; Duncan, DS; Jackson, RD				Herzberger, Anna J.; Duncan, David S.; Jackson, Randall D.			Bouncing Back: Plant-Associated Soil Microbes Respond Rapidly to Prairie Establishment	PLOS ONE			English	Article							FATTY-ACID ANALYSIS; COMMUNITY COMPOSITION; BACTERIAL COMMUNITY; MANAGEMENT; GRASSLAND; DIVERSITY; STORAGE	It is well established that soil microbial communities change in response to altered land use and land cover, but less is known about the timing of these changes. Understanding temporal patterns in recovering microbial communities is an important part of improving how we assess and manage reconstructed ecosystems. We assessed patterns of community-level microbial diversity and abundance in corn and prairie plots 2 to 4 years after establishment in agricultural fields, using phospholipid fatty acid biomarkers. Principal components analysis of the lipid biomarkers revealed differing composition between corn and prairie soil microbial communities. Despite no changes to the biomass of Gram-positive bacteria and actinomycetes, total biomass, arbuscular mycorrhizal fungi biomass, and Gramnegative bacteria biomass were significantly higher in restored prairie plots, approaching levels found in long-established prairies. These results indicate that plant-associated soil microbes in agricultural soils can shift in less than 2 years after establishment of perennial grasslands.	[Herzberger, Anna J.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Duncan, David S.; Jackson, Randall D.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Duncan, David S.; Jackson, Randall D.] Univ Wisconsin, DOE Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA	Michigan State University; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Jackson, RD (corresponding author), Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA.	rdjackson@wisc.edu	Jackson, Randall/AAE-5573-2022	Duncan, David/0000-0002-2867-0378	US Department of Energy's Great Lakes Bioenergy Research Center (DOE Biological and Environmental Research Office of Science) [DE-FC02-07ER64494]; National Science Foundation [DBI-1063085]	US Department of Energy's Great Lakes Bioenergy Research Center (DOE Biological and Environmental Research Office of Science)(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	DSD and RDJ received funding from the US Department of Energy's Great Lakes Bioenergy Research Center (DOE Biological and Environmental Research Office of Science DE-FC02-07ER64494; https://www.glbrc.org/). AJH received funding from the National Science Foundation (DBI-1063085; www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Suleiman AKA, 2013, SYST APPL MICROBIOL, V36, P137, DOI 10.1016/j.syapm.2012.10.007; Allison VJ, 2005, SOIL SCI SOC AM J, V69, P1412, DOI 10.2136/sssaj2004.0252; Balser TC, 2005, BIOGEOCHEMISTRY, V73, P395, DOI 10.1007/s10533-004-0372-y; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; Buyer JS, 2012, APPL SOIL ECOL, V61, P127, DOI 10.1016/j.apsoil.2012.06.005; Carrasco L, 2010, MICROB ECOL, V60, P265, DOI 10.1007/s00248-009-9619-4; Cui H, 2014, EUR J SOIL BIOL, V63, P55, DOI 10.1016/j.ejsobi.2014.05.006; Fernandes MF, 2013, MICROB ECOL, V66, P145, DOI 10.1007/s00248-013-0195-2; Fichtner A, 2014, SOIL BIOL BIOCHEM, V70, P79, DOI 10.1016/j.soilbio.2013.12.015; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Gliessman S. R., 2007, AGROECOLOGY ECOLOGY, P23; Harris J, 2009, SCIENCE, V325, P573, DOI 10.1126/science.1172975; Hedlund K, 2002, SOIL BIOL BIOCHEM, V34, P1299, DOI 10.1016/S0038-0717(02)00073-1; Huang YM, 2011, J PLANT NUTR SOIL SC, V174, P765, DOI 10.1002/jpln.201000397; Jonsson LM, 2001, OIKOS, V93, P353, DOI 10.1034/j.1600-0706.2001.930301.x; Kowalchuk GA, 2002, ANTON LEEUW INT J G, V81, P509, DOI 10.1023/A:1020565523615; Kulmatiski A, 2008, SOIL BIOL BIOCHEM, V40, P1059, DOI 10.1016/j.soilbio.2007.11.020; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lenth R. V., 2013, ISMEANS LEAST SQUARE; Liang C., 2011, Agricultural Sciences, V2, P131, DOI 10.4236/as.2011.22019; Liang C, 2012, APPL SOIL ECOL, V54, P24, DOI 10.1016/j.apsoil.2011.11.015; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Millard P, 2010, NUTR CYCL AGROECOSYS, V88, P147, DOI 10.1007/s10705-009-9314-3; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pinheiro J, 2020, R PACKAGE VERSION 31; R Core Team, 2021, R LANGUAGE ENV STAT; Sayer EJ, 2013, SOIL BIOL BIOCHEM, V61, P61, DOI 10.1016/j.soilbio.2013.02.012; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 2013, PLANT SOIL, V363, P1, DOI 10.1007/s11104-012-1545-4; Wallenius K, 2010, J MICROBIOL METH, V81, P48, DOI 10.1016/j.mimet.2010.01.021; Wu YP, 2009, GEODERMA, V150, P171, DOI 10.1016/j.geoderma.2009.02.003	34	24	25	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115775	10.1371/journal.pone.0115775	http://dx.doi.org/10.1371/journal.pone.0115775			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551613	Green Submitted, Green Published, gold			2022-12-26	WOS:000347119100061
J	Lutz, A; Sanwald, J; Thomas, M; Feuer, R; Sawodny, O; Ederer, M; Borner, C; Humar, M; Merfort, I				Lutz, Anna; Sanwald, Julia; Thomas, Maria; Feuer, Ronny; Sawodny, Oliver; Ederer, Michael; Borner, Christoph; Humar, Matjaz; Merfort, Irmgard			Interleukin-1 beta Enhances FasL-Induced Caspase-3/-7 Activity without Increasing Apoptosis in Primary Mouse Hepatocytes	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; LIVER; PHOSPHORYLATION; BIM; MEMBRANE; PROTEIN; BAX; ACTIVATION; DEATH; CELLS	Sustained inflammation may increase the susceptibility of hepatocytes to apoptotic cell death and therefore exacerbate liver damage. Here we report that the proinflammatory cytokine IL-1 beta sensitizes primary murine hepatocytes to Fas ligand (FasL)-induced caspase-3/-7 activity. This process was dependent on JNK1/2 and the BH3-only proteins Bim and Bid. Mathematical modeling revealed that incubation of hepatocytes with IL-1 beta depleted the anti-apoptotic Bcl-2 protein pool and thus shifted hepatocytes to mitochondrial type II apoptosis following Fas activation. As a consequence, IL-1 beta and FasL treatment enhanced cytochrome c release. Surprisingly, despite increased caspase-3/-7 activation, FasL-induced cell death was reduced by IL-1 beta pre-treatment. This protective effect was independent of JNK1/2, Bim or Bid. Furthermore, elevated caspase-3/-7 activity upon IL-1 beta and FasL treatment did not result in enhanced PARP cleavage. The protective effect of IL-1 beta was seen after 3 h of pre-incubation, indicating an anti-apoptotic transcriptional response. Indeed, NF-kappa B DNA binding was increased in response to IL-1 beta plus FasL and gene-expression profiling of NF-kappa B regulated genes revealed a transcriptional and translational upregulation of the caspase-8 inhibitor A20. A mathematical model was developed to explain the contradictious occurrence of both increased caspase-3/-7 activity and elevated cell viability by including a heterogeneous distribution of Bcl-2 proteins and variations in Fas signaling resulting in different subpopulations of hepatocytes.	[Lutz, Anna; Humar, Matjaz; Merfort, Irmgard] Univ Freiburg, Dept Pharmaceut Biol & Biotechnol, D-79106 Freiburg, Germany; [Sanwald, Julia; Feuer, Ronny; Sawodny, Oliver; Ederer, Michael] Univ Stuttgart, Inst Syst Dynam, D-70174 Stuttgart, Germany; [Thomas, Maria] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Borner, Christoph] Univ Freiburg, Inst Mol Med & Cell Res, D-79106 Freiburg, Germany; [Borner, Christoph; Merfort, Irmgard] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79106 Freiburg, Germany; [Borner, Christoph] Univ Freiburg, Bioss Ctr Biol Signaling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Stuttgart; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Freiburg; University of Freiburg; University of Freiburg	Merfort, I (corresponding author), Univ Freiburg, Dept Pharmaceut Biol & Biotechnol, Hugstetter Str 55, D-79106 Freiburg, Germany.	irmgard.merfort@pharmazie.uni-freiburg.de	Thomas, Maria/F-3315-2011	Thomas, Maria/0000-0001-6394-8710; Feuer, Ronny/0000-0002-5653-7670; Rex, Julia/0000-0002-8189-9243	BMBF research grant Virtual Liver [FKZ 0315766, FKZ 0315751, FKZ 0315755]; Albert Ludwigs University Freiburg	BMBF research grant Virtual Liver; Albert Ludwigs University Freiburg	This work was supported by the BMBF (http://www.bmbf.de/) research grant Virtual Liver (FKZ 0315766, FKZ 0315751, FKZ 0315755). The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulton R, 1997, HEPATOLOGY, V26, P49; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Daniel S, 2004, BLOOD, V104, P2376, DOI 10.1182/blood-2003-02-0635; Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319; Finch A, 1997, FEBS LETT, V418, P144, DOI 10.1016/S0014-5793(97)01364-1; Geissler A, 2013, CELL DEATH DIFFER, V20, P1317, DOI 10.1038/cdd.2013.78; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kallenberger SM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004738; KARIN M, 2002, TRENDS CELL BIOL, V18, P528, DOI DOI 10.1016/J.TCB.2008.08.003; Klingmuller U, 2006, IEE P SYST BIOL, V153, P433, DOI 10.1049/ip-syb:20050067; Kramer F, 2008, MOL IMMUNOL, V45, P2678, DOI 10.1016/j.molimm.2007.12.017; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Ma JH, 2014, HEPATOLOGY, V59, P2010, DOI 10.1002/hep.26769; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Rehm M, 2009, CELL DEATH DIFFER, V16, P613, DOI 10.1038/cdd.2008.187; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schlatter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018646; Schmich K, 2011, HEPATOLOGY, V53, P282, DOI 10.1002/hep.23987; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Spencer SL, 2011, CELL, V144, P926, DOI 10.1016/j.cell.2011.03.002; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Szabo G, 2012, J HEPATOL, V57, P642, DOI 10.1016/j.jhep.2012.03.035; Tacke F, 2009, CLIN REV ALLERG IMMU, V36, P4, DOI 10.1007/s12016-008-8091-0; Takehara T, 1999, GASTROENTEROLOGY, V117, P661, DOI 10.1016/S0016-5085(99)70460-9; Tamm I, 1998, CANCER RES, V58, P5315; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Verma G, 2010, APOPTOSIS, V15, P864, DOI 10.1007/s10495-010-0498-4; Walter D, 2008, HEPATOLOGY, V48, P1942, DOI 10.1002/hep.22541; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Yang JY, 2004, MOL CELL BIOL, V24, P10425, DOI 10.1128/MCB.24.23.10425-10436.2004	40	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115603	10.1371/journal.pone.0115603	http://dx.doi.org/10.1371/journal.pone.0115603			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551609	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100047
J	Lv, SD; Wu, YS; Zhou, JS; Lian, M; Li, CW; Xu, YQ; Liu, SH; Wang, C; Meng, QX				Lv, Shidong; Wu, Yuanshuang; Zhou, Jiangsheng; Lian, Ming; Li, Changwen; Xu, Yongquan; Liu, Shunhang; Wang, Chao; Meng, Qingxiong			The Study of Fingerprint Characteristics of Dayi Pu-Erh Tea Using a Fully Automatic HS-SPME/GC-MS and Combined Chemometrics Method	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS-SPECTROMETRY; SOLID-PHASE MICROEXTRACTION; PERFORMANCE LIQUID-CHROMATOGRAPHY; BLACK TEA; VOLATILE COMPOUNDS; QUALITY ASSESSMENT; CAMELLIA-SINENSIS; ELECTRONIC NOSE; AROMA COMPOUNDS; GREEN TEAS	The quality of tea is presently evaluated by the sensory assessment of professional tea tasters, however, this approach is both inconsistent and inaccurate. A more standardized and efficient method is urgently needed to objectively evaluate tea quality. In this study, the chemical fingerprint of 7 different Dayi Pu-erh tea brands and 3 different Ya'an tea brands on the market were analyzed using fully automatic headspace solid-phase microextraction (HS-SPME) combined with gas chromatography-mass spectrometry (GC-MS). A total of 78 volatiles were separated, among 75 volatiles were identified by GC-MS in seven Dayi Pu-erh teas, and the major chemical components included methoxyphenolic compounds, hydrocarbons, and alcohol compounds, such as 1,2,3-trimethoxybenzene, 1,2,4-trimethoxybenzene, 2,6,10,14-tetramethyl-pentadecane, linalool and its oxides, a-terpineol, and phytol. The overlapping ratio of peaks (ORP) of the chromatogram in the seven Dayi Pu-erh tea samples was greater than 89.55%, whereas the ORP of Ya'an tea samples was less than 79.10%. The similarity and differences of the Dayi Pu-erh tea samples were also characterized using correlation coefficient similarity and principal component analysis (PCA). The results showed that the correlation coefficient of similarity of the seven Dayi Pu-erh tea samples was greater than 0.820 and was gathered in a specific area, which showed that samples from different brands were basically the same, despite have some slightly differences of chemical indexes was found. These results showed that the GC-MS fingerprint combined with the PCA approach can be used as an effective tool for the quality assessment and control of Pu-erh tea.	[Lv, Shidong; Wu, Yuanshuang; Zhou, Jiangsheng; Lian, Ming; Meng, Qingxiong] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China; [Lv, Shidong] Kunming Grain & Oil & Feed Prod Qual Inspect Ctr, Kunming, Yunnan, Peoples R China; [Li, Changwen; Xu, Yongquan; Liu, Shunhang; Wang, Chao] Yunnan Tasly Deepure Biol Tea Technol Ltd Inc, Puer, Yunnan, Peoples R China	Kunming University of Science & Technology	Meng, QX (corresponding author), Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China.	qxmeng@scbg.ac.cn			National Natural Science Foundation of China [31460228]; scientific research funds in Yunnan province department of education [2014Y089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); scientific research funds in Yunnan province department of education	This work was supported by the National Natural Science Foundation of China (No. 31460228) and scientific research funds in Yunnan province department of education (No. 2014Y089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2008, INT J FOOD MICROBIOL, V124, P199, DOI 10.1016/j.ijfoodmicro.2008.03.008; Altaki MS, 2009, TALANTA, V78, P1315, DOI 10.1016/j.talanta.2009.02.003; Anselmi C, 2000, J AGR FOOD CHEM, V48, P1285, DOI 10.1021/jf991156p; Banerjee R, 2012, J FOOD ENG, V110, P356, DOI 10.1016/j.jfoodeng.2011.12.037; Bhattacharyya R, 2012, J FOOD ENG, V109, P120, DOI 10.1016/j.jfoodeng.2011.09.026; Bylund D, 2002, J CHROMATOGR A, V961, P237, DOI 10.1016/S0021-9673(02)00588-5; Cao YH, 2006, J PHARMACEUT BIOMED, V41, P845, DOI 10.1016/j.jpba.2006.01.060; [陈常颂 Chen Changsong], 2011, [食品与发酵工业, Food and Fermentation Industries], V37, P165; Chen QS, 2008, J PHARMACEUT BIOMED, V48, P1321, DOI 10.1016/j.jpba.2008.09.016; Deng JW, 2013, ANAL CHIM ACTA, V785, P82, DOI 10.1016/j.aca.2013.04.056; Du LP, 2013, J AGR FOOD CHEM, V61, P561, DOI 10.1021/jf304470k; Gan F, 2006, J CHROMATOGR A, V1104, P100, DOI 10.1016/j.chroma.2005.11.099; Ghasemi-Varnamkhasti M, 2010, J FOOD ENG, V100, P377, DOI 10.1016/j.jfoodeng.2010.04.032; Gong JS, 2012, J ANAL APPL PYROL, V95, P189, DOI 10.1016/j.jaap.2012.02.006; Ikeda T, 2007, J AGR FOOD CHEM, V55, P9908, DOI 10.1021/jf0717642; Jeng KC, 2007, J AGR FOOD CHEM, V55, P8787, DOI 10.1021/jf071629p; Jin Y, 2009, J CHROMATOGR A, V1216, P2136, DOI 10.1016/j.chroma.2008.04.010; Jumtee K, 2011, J BIOSCI BIOENG, V112, P252, DOI 10.1016/j.jbiosc.2011.05.008; Kanani DM, 2003, IND ENG CHEM RES, V42, P6924, DOI 10.1021/ie0340185; Kato M, 2001, J AGR FOOD CHEM, V49, P1394, DOI 10.1021/jf001321x; KAWAKAMI M, 1995, J AGR FOOD CHEM, V43, P200, DOI 10.1021/jf00049a037; Li YP, 2007, J PHARMACEUT BIOMED, V43, P1667, DOI 10.1016/j.jpba.2006.12.028; Lian M., 2014, J CHEM PHARM RES, V6, P2025; Lin J, 2012, J ZHEJIANG UNIV-SC B, V13, P972, DOI 10.1631/jzus.B1200086; Lu GH, 2005, J CHROMATOGR A, V1073, P383, DOI 10.1016/j.chroma.2004.11.080; Lv HP, 2013, FOOD RES INT, V53, P608, DOI 10.1016/j.foodres.2013.02.043; Lv HP, 2012, FOOD CHEM, V130, P1074, DOI 10.1016/j.foodchem.2011.07.135; Lv SD, 2014, FOOD ANAL METHOD, DOI [10.1007/s12161-014-9900-0, DOI 10.1007/S12161-014-9900-0.]; Lv ShiDong, 2014, Journal of Chemical and Pharmaceutical Research, V6, P246; Lv SD, 2014, J AGR FOOD CHEM, V62, P1810, DOI 10.1021/jf405237u; Ma LJ, 2007, J CHROMATOGR B, V846, P139, DOI 10.1016/j.jchromb.2006.08.048; Maggi F, 2010, FOOD CHEM, V123, P983, DOI 10.1016/j.foodchem.2010.05.049; Meng J, 2005, CHEM PHARM BULL, V53, P1484, DOI 10.1248/cpb.53.1484; Pongsuwan W, 2007, J AGR FOOD CHEM, V55, P231, DOI 10.1021/jf062330u; Qin PY, 2011, J FOOD SCI, V76, pS401, DOI 10.1111/j.1750-3841.2011.02223.x; Qin ZH, 2013, FOOD RES INT, V53, P864, DOI 10.1016/j.foodres.2013.02.005; Rottava I, 2010, LWT-FOOD SCI TECHNOL, V43, P1128, DOI 10.1016/j.lwt.2010.03.001; Schuh C, 2006, J AGR FOOD CHEM, V54, P916, DOI 10.1021/jf052495n; Sun JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049534; Wang KB, 2011, INT J FOOD SCI TECH, V46, P1406, DOI 10.1111/j.1365-2621.2011.02629.x; [王力 Wang Li], 2010, [食品科学, Food Science], V31, P293; Wang LF, 2008, FOOD CHEM, V109, P196, DOI 10.1016/j.foodchem.2007.12.054; Wang LY, 2014, FOOD CHEM, V146, P98, DOI 10.1016/j.foodchem.2013.09.043; Wu SB, 2013, J CHROMATOGR A, V1314, P154, DOI 10.1016/j.chroma.2013.09.017; Xie PS, 2006, J CHROMATOGR A, V1112, P171, DOI 10.1016/j.chroma.2005.12.091; Xu X, 2005, ENG LIFE SCI, V5, P382, DOI 10.1002/elsc.200520083; Yang LW, 2005, J CHROMATOGR A, V1070, P35, DOI 10.1016/j.chroma.2005.02.081; Yao SS, 2005, J AGR FOOD CHEM, V53, P8688, DOI 10.1021/jf058059i; Zhang L, 2011, J CHINESE PHARM SCI, V20, P352; Zhang L, 2013, FOOD RES INT, V53, P600, DOI 10.1016/j.foodres.2013.01.016	50	20	25	2	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116428	10.1371/journal.pone.0116428	http://dx.doi.org/10.1371/journal.pone.0116428			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551231	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100140
J	Meachen, JA; Janowicz, AC; Avery, JE; Sadleir, RW				Meachen, Julie A.; Janowicz, Adrianna C.; Avery, Jori E.; Sadleir, Rudyard W.			Ecological Changes in Coyotes (Canis latrans) in Response to the Ice Age Megafaunal Extinctions	PLOS ONE			English	Article							RANCHO LA BREA; INTERFERENCE COMPETITION; MANDIBULAR CORPUS; WOLVES; PLEISTOCENE; WOLF; CARNIVORANS; YELLOWSTONE; CALIFORNIA; EVOLUTION	Coyotes (Canis latrans) are an important species in human-inhabited areas. They control pests and are the apex predators in many ecosystems. Because of their importance it is imperative to understand how environmental change will affect this species. The end of the Pleistocene Ice Age brought with it many ecological changes for coyotes and here we statistically determine the changes that occurred in coyotes, when these changes occurred, and what the ecological consequences were of these changes. We examined the mandibles of three coyote populations: Pleistocene Rancho La Brean (13-29 Ka), earliest Holocene Rancho La Brean (8-10 Ka), and Recent from North America, using 2D geometric morphometrics to determine the morphological differences among them. Our results show that these three populations were morphologically distinct. The Pleistocene coyotes had an overall robust mandible with an increased shearing arcade and a decreased grinding arcade, adapted for carnivory and killing larger prey; whereas the modern populations show a gracile morphology with a tendency toward omnivory or grinding. The earliest Holocene populations are intermediate in morphology and smallest in size. These findings indicate that a niche shift occurred in coyotes at the Pleistocene/Holocene boundary - from a hunter of large prey to a small prey/more omnivorous animal. Species interactions between Canis were the most likely cause of this transition. This study shows that the Pleistocene extinction event affected species that did not go extinct as well as those that did.	[Meachen, Julie A.; Janowicz, Adrianna C.; Avery, Jori E.] Des Moines Univ, Dept Anat, Des Moines, IA 50312 USA; [Sadleir, Rudyard W.] St Xavier Univ, Dept Biol Sci, Chicago, IL USA		Meachen, JA (corresponding author), Des Moines Univ, Dept Anat, Des Moines, IA 50312 USA.	julie.meachen@dmu.edu			Des Moines University	Des Moines University	JAM and ACJ were supported by start-up funds (JAM) and student mentored research funds (ACJ) from Des Moines University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjo WM, 1999, CAN J ZOOL, V77, P1919, DOI 10.1139/z99-177; Atwood TC, 2008, ANIM BEHAV, V75, P753, DOI 10.1016/j.anbehav.2007.08.024; Atwood TC, 2010, J MAMMAL, V91, P490, DOI 10.1644/09-MAMM-A-078.1; Berger KM, 2008, ECOLOGY, V89, P818, DOI 10.1890/07-0193.1; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; Biknevicius AR, 1997, ZOOL J LINN SOC-LOND, V120, P139; BIKNEVICIUS AR, 1992, J ZOOL, V228, P479, DOI 10.1111/j.1469-7998.1992.tb04450.x; Biknevicius AR, 1996, CARNIVORE BEHAV ECOL, VII, P393; Bookstein FL, 1991, MORPHOMETRIC TOOLS L; Carbone C, 2009, BIOL LETTERS, V5, P81, DOI 10.1098/rsbl.2008.0526; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Dodge WB, 2013, J FISH WILDL MANAG, V4, P377, DOI 10.3996/062013-JFWM-040; Dundas RG, 1999, BOREAS, V28, P375, DOI 10.1080/030094899422109; Ewer, 1998, CARNIVORES; Figueirido B, 2011, ACTA PALAEONTOL POL, V56, P225, DOI 10.4202/app.2010.0005; Friscia AR, 2007, J ZOOL, V272, P82, DOI 10.1111/j.1469-7998.2006.00246.x; Fuller BT, 2014, QUAT GEOCHRONOL, V22, P85, DOI 10.1016/j.quageo.2014.03.002; Gehrt SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075718; GESE EM, 1988, J WILDLIFE MANAGE, V52, P647, DOI 10.2307/3800924; Gese EM, 2012, J ETHOL, V30, P413, DOI 10.1007/s10164-012-0339-8; GILES EUGENE, 1960, UNIV CALIFORNIA PUBL GEOL PUBL GEOL SCI, V36, P369; IBM, 2013, IBM SPSS STAT WIND; Koblmuller S, 2012, BIOL LETTERS, V8, P644, DOI 10.1098/rsbl.2012.0162; Krefting L.W., 1969, NATURALIST, V20, P24; Leonard JA, 2007, CURR BIOL, V17, P1146, DOI 10.1016/j.cub.2007.05.072; LYDEARD C, 1988, J MAMMAL, V69, P773, DOI 10.2307/1381632; Meachen JA, 2014, J EVOLUTION BIOL, V27, P714, DOI 10.1111/jeb.12340; Meachen JA, 2012, P NATL ACAD SCI USA, V109, P4191, DOI 10.1073/pnas.1113788109; Merkle JA, 2009, CAN J ZOOL, V87, P56, DOI 10.1139/Z08-136; Nowak R.M., 1979, University of Kansas Museum of Natural History Monograph, P1; O'Keefe F. Robin, 2009, Contributions in Science (Los Angeles), P1; OGLE T F, 1971, Northwest Science, V45, P213; OZOGA JJ, 1966, J WILDLIFE MANAGE, V30, P809, DOI 10.2307/3798288; Ripple WJ, 2013, BIOL CONSERV, V160, P70, DOI 10.1016/j.biocon.2012.12.033; Rohlf F, 2013, TPSDIG2 2; Sheets HD, 2005, PCAGEN7 IMP 7; Smith DW, 2003, BIOSCIENCE, V53, P330, DOI 10.1641/0006-3568(2003)053[0330:YAW]2.0.CO;2; THURBER JM, 1991, J MAMMAL, V72, P750, DOI 10.2307/1381838; van Valkenburgh B., 1990, P181; VANVALKENBURGH B, 1993, SYM ZOOL S, P15; VANVALKENBURGH B, 1993, SCIENCE, V261, P456, DOI 10.1126/science.261.5120.456; Waser NM, 2014, NATURWISSENSCHAFTEN, V101, P427, DOI 10.1007/s00114-014-1172-4; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	43	23	22	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116041	10.1371/journal.pone.0116041	http://dx.doi.org/10.1371/journal.pone.0116041			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551387	Green Published, gold, Green Submitted			2022-12-26	WOS:000347119100092
J	Stevens, M; Lown, AE; Wood, LE				Stevens, Martin; Lown, Alice E.; Wood, Louisa E.			Camouflage and Individual Variation in Shore Crabs (Carcinus maenas) from Different Habitats	PLOS ONE			English	Article							COLOR POLYMORPHISM; DISRUPTIVE COLORATION; ANIMAL CAMOUFLAGE; GREEN CRAB; JUVENILE; EVOLUTION; PREDATION; POPULATION; SELECTION; PATTERNS	Camouflage is widespread throughout the natural world and conceals animals from predators in a vast range of habitats. Because successful camouflage usually involves matching aspects of the background environment, species and populations should evolve appearances tuned to their local habitat, termed phenotype-environment associations. However, although this has been studied in various species, little work has objectively quantified the appearances of camouflaged animals from different habitats, or related this to factors such as ontogeny and individual variation. Here, we tested for phenotype-environment associations in the common shore crab (Carcinus maenas), a species highly variable in appearance and found in a wide range of habitats. We used field surveys and digital image analysis of the colors and patterns of crabs found in four locations around Cornwall in the UK to quantify how individuals vary with habitat (predominantly rockpool, mussel bed, and mudflat). We find that individuals from sites comprising different backgrounds show substantial differences in several aspects of color and pattern, and that this is also dependent on life stage (adult or juvenile). Furthermore, the level of individual variation is dependent on site and life stage, with juvenile crabs often more variable than adults, and individuals from more homogenous habitats less diverse. Ours is the most comprehensive study to date exploring phenotype-environment associations for camouflage and individual variation in a species, and we discuss the implications of our results in terms of the mechanisms and selection pressures that may drive this.	[Stevens, Martin; Lown, Alice E.; Wood, Louisa E.] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn, Cornwall, England	University of Exeter	Stevens, M (corresponding author), Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn Campus, Penryn, Cornwall, England.	martin.stevens@exeter.ac.uk		Wood, Louisa/0000-0002-8649-5010; Wood, Louisa/0000-0002-8053-2474; Stevens, Martin/0000-0001-7768-3426	Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Research Fellowship [BB/G022887/1]; BBSRC [BB/G022887/1, BB/G022887/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G022887/1, BB/G022887/2] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Research Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MS and AEL were supported by a Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Research Fellowship (BB/G022887/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEYAWAKUMFI C, 1987, MAR ECOL PROG SER, V37, P153, DOI 10.3354/meps037153; Audet D, 2008, J SHELLFISH RES, V27, P427, DOI 10.2983/0730-8000(2008)27[427:BCOANE]2.0.CO;2; Barbosa A, 2008, VISION RES, V48, P1242, DOI 10.1016/j.visres.2008.02.011; Bedini R, 2002, CRUSTACEANA, V75, P703, DOI 10.1163/156854002760202688; BENNETT ATD, 1994, AM NAT, V144, P848, DOI 10.1086/285711; Bond AB, 2006, P NATL ACAD SCI USA, V103, P3214, DOI 10.1073/pnas.0509963103; Bond AB, 2002, NATURE, V415, P609, DOI 10.1038/415609a; Boratynski Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094342; Brian JV, 2006, J EXP MAR BIOL ECOL, V329, P47, DOI 10.1016/j.jembe.2005.08.002; BYERS BA, 1989, VELIGER, V32, P394; CAIN AJ, 1950, HEREDITY, V4, P275, DOI 10.1038/hdy.1950.22; Chiao CC, 2009, VISION RES, V49, P1647, DOI 10.1016/j.visres.2009.04.002; CLARKE B, 1969, HEREDITY, V24, P347, DOI 10.1038/hdy.1969.52; Cook LM, 2012, BIOL LETTERS, V8, P609, DOI 10.1098/rsbl.2011.1136; Cott H.B., 1940, ADAPTIVE COLORATION; Crothers J. H., 1967, Field Studies, V2, P407; Crothers J. H., 1968, Field Studies, V2, P579; Cuthill IC, 2005, NATURE, V434, P72, DOI 10.1038/nature03312; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; Domingues CP, 2010, MAR ECOL PROG SER, V410, P111, DOI 10.3354/meps08610; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Gacic Z, 2007, FISH PHYSIOL BIOCHEM, V33, P21, DOI 10.1007/s10695-006-9113-6; Hanlon RT, 2009, PHILOS T R SOC B, V364, P429, DOI 10.1098/rstb.2008.0270; Hemmi JM, 2006, J EXP BIOL, V209, P4140, DOI 10.1242/jeb.02483; HOGARTH PJ, 1978, MAR BIOL, V44, P337, DOI 10.1007/BF00390898; Houston AI, 2007, BEHAV ECOL, V18, P769, DOI 10.1093/beheco/arm039; Hultgren K, 2011, ANIMAL CAMOUFLAGE ME; Hultgren KM, 2008, OECOLOGIA, V155, P519, DOI 10.1007/s00442-007-0926-5; Hultgren KM, 2010, BEHAV ECOL, V21, P329, DOI 10.1093/beheco/arp192; Kang CK, 2012, J EVOLUTION BIOL, V25, P1695, DOI 10.1111/j.1420-9101.2012.02557.x; Kang CK, 2014, BEHAV ECOL, DOI [10.1093/beheco/aru1150, DOI 10.1093/BEHECO/ARU1150]; KETTLEWELL H. B. D., 1955, HEREDITY, V9, P323, DOI 10.1038/hdy.1955.36; Komdeur J, 2005, BEHAV ECOL, V16, P805, DOI 10.1093/beheco/ari059; Lovell PG, 2013, CURR BIOL, V23, P260, DOI 10.1016/j.cub.2012.12.031; Lovell PG, 2005, J OPT SOC AM A, V22, P2060, DOI 10.1364/JOSAA.22.002060; Maan ME, 2008, EVOLUTION, V62, P2334, DOI 10.1111/j.1558-5646.2008.00454.x; Marshall KLA, 2014, BEHAV ECOL, V25, P1325, DOI 10.1093/beheco/aru126; McLean CA, 2014, BIOL REV, V89, P860, DOI 10.1111/brv.12083; Merilaita S, 2005, P ROY SOC B-BIOL SCI, V272, P665, DOI 10.1098/rspb.2004.3000; Merilaita S, 2003, EVOLUTION, V57, P1248; Merilaita S, 2001, EVOL ECOL, V15, P103, DOI 10.1023/A:1013814623311; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Nosil P, 2006, P NATL ACAD SCI USA, V103, P9090, DOI 10.1073/pnas.0601575103; Odeen A, 2010, BIOL LETTERS, V6, P370, DOI 10.1098/rsbl.2009.0877; Palma AT, 2001, ECOLOGY, V82, P2961, DOI 10.2307/2679974; POWELL B. L., 1962, CRUSTACEANA, V4, P93, DOI 10.1163/156854062X00120; POWELL BL, 1962, J ANIM ECOL, V31, P251, DOI 10.2307/2139; R Core Team, 2021, R LANGUAGE ENV STAT; Roman J, 2004, MOL ECOL, V13, P2891, DOI 10.1111/j.1365-294X.2004.02255.x; Rosenblum EB, 2006, AM NAT, V167, P1, DOI 10.1086/498397; Rowland HM, 2007, ANIM BEHAV, V74, P1249, DOI 10.1016/j.anbehav.2007.01.030; SHAND J, 1988, J COMP PHYSIOL A, V163, P699, DOI 10.1007/BF00603854; Silva IC, 2010, SCI MAR, V74, P435, DOI 10.3989/scimar.2010.74n3435; Skelhorn J, 2010, SCIENCE, V327, P51, DOI 10.1126/science.1181931; Spottiswoode CN, 2011, P ROY SOC B-BIOL SCI, V278, P3566, DOI 10.1098/rspb.2011.0401; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Stevens M, 2013, SENSORY ECOLOGY, BEHAVIOUR, AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199601776.001.0001; Stevens M., 2011, ANIMAL CAMOUFLAGE ME; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stevens M, 2006, P R SOC B, V273, P2433, DOI 10.1098/rspb.2006.3614; Stevens M, 2006, P R SOC B, V273, P2141, DOI 10.1098/rspb.2006.3556; Stevens M, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00014; Stevens M, 2013, BIOL J LINN SOC, V109, P257, DOI 10.1111/bij.12039; Stevens M, 2009, INT J PRIMATOL, V30, P893, DOI 10.1007/s10764-009-9356-z; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Stoddard MC, 2008, AM NAT, V171, P755, DOI 10.1086/587526; Stoddard MC, 2010, P ROY SOC B-BIOL SCI, V277, P1387, DOI 10.1098/rspb.2009.2018; Stuart-Fox D, 2009, PHILOS T R SOC B, V364, P463, DOI 10.1098/rstb.2008.0254; Surmacki A, 2013, NATURWISSENSCHAFTEN, V100, P533, DOI 10.1007/s00114-013-1049-y; Tankus A, 2009, PHILOS T R SOC B, V364, P529, DOI 10.1098/rstb.2008.0211; Todd PA, 2006, MAR BIOL, V148, P1357, DOI 10.1007/s00227-005-0159-2; Todd PA, 2012, ECOL COMPLEX, V12, P58, DOI 10.1016/j.ecocom.2012.09.005; Trivedi J.N., 2012, Arthropods, V1, P129; Umbers KDL, 2014, BIOL REV, V89, P820, DOI 10.1111/brv.12079; Wallace AR, 1889, DARWINISM; Webster RJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0501; Westland S, 2004, COMPUTATIONAL COLOUR; Yamada SB, 2005, BIOL INVASIONS, V7, P309, DOI 10.1007/s10530-004-0877-2	79	35	35	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115586	10.1371/journal.pone.0115586	http://dx.doi.org/10.1371/journal.pone.0115586			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551233	Green Published, gold, Green Submitted			2022-12-26	WOS:000347119100043
J	Denis, M; Enquobahrie, DA; Tadesse, MG; Gelaye, B; Sanchez, SE; Salazar, M; Ananth, CV; Williams, MA				Denis, Marie; Enquobahrie, Daniel A.; Tadesse, Mahlet G.; Gelaye, Bizu; Sanchez, Sixto E.; Salazar, Manuel; Ananth, Cande V.; Williams, Michelle A.			Placental Genome and Maternal-Placental Genetic Interactions: A Genome-Wide and Candidate Gene Association Study of Placental Abruption	PLOS ONE			English	Article							PENALIZED LOGISTIC-REGRESSION; C-OXIDASE DEFICIENCY; STUDY 100K PROJECT; FACTOR-V-LEIDEN; RISK-FACTORS; CIGARETTE-SMOKING; PERINATAL-MORTALITY; PREGNANCY OUTCOMES; PRETERM BIRTH; SELECTION	While available evidence supports the role of genetics in the pathogenesis of placental abruption (PA), PA-related placental genome variations and maternal-placental genetic interactions have not been investigated. Maternal blood and placental samples collected from participants in the Peruvian Abruptio Placentae Epidemiology study were genotyped using Illumina's Cardio-Metabochip platform. We examined 118,782 genome-wide SNPs and 333 SNPs in 32 candidate genes from mitochondrial biogenesis and oxidative phosphorylation pathways in placental DNA from 280 PA cases and 244 controls. We assessed maternal-placental interactions in the candidate gene SNPS and two imprinted regions (IGF2/H19 and C19MC). Univariate and penalized logistic regression models were fit to estimate odds ratios. We examined the combined effect of multiple SNPs on PA risk using weighted genetic risk scores (WGRS) with repeated ten-fold cross-validations. A multinomial model was used to investigate maternal-placental genetic interactions. In placental genome-wide and candidate gene analyses, no SNP was significant after false discovery rate correction. The top genome-wide association study (GWAS) hits were rs544201, rs1484464 (CTNNA2), rs4149570 (TNFRSF1A) and rs13055470 (ZNRF3) (p-values: 1.11e-05 to 3.54e-05). The top 200 SNPs of the GWAS overrepresented genes involved in cell cycle, growth and proliferation. The top candidate gene hits were rs16949118 (COX10) and rs7609948 (THRB) (pvalues: 6.00e-03 and 8.19e-03). Participants in the highest quartile of WGRS based on cross-validations using SNPs selected from the GWAS and candidate gene analyses had a 8.40-fold (95% CI: 5.8-12.56) and a 4.46-fold (95% CI: 2.94-6.72) higher odds of PA compared to participants in the lowest quartile. We found maternal-placental genetic interactions on PA risk for two SNPs in PPARG (chr3: 12313450 and chr3: 12412978) and maternal imprinting effects for multiple SNPs in the C19MC and IGF2/H19 regions. Variations in the placental genome and interactions between maternal-placental genetic variations may contribute to PA risk. Larger studies may help advance our understanding of PA pathogenesis.	[Denis, Marie; Gelaye, Bizu; Williams, Michelle A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Denis, Marie] CIRAD, UMR AGAP Ameliorat Genet & Adaptat Plantes Medite, Montpellier, France; [Enquobahrie, Daniel A.] Swedish Med Ctr, Ctr Perinatal Studies, Seattle, WA USA; [Enquobahrie, Daniel A.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Tadesse, Mahlet G.] Georgetown Univ, Dept Math & Stat, Washington, DC USA; [Sanchez, Sixto E.] Univ San Martin Porres, Fac Med Humana, Secc Post Grado, Lima, Peru; [Sanchez, Sixto E.] AC PROESA, Lima, Peru; [Salazar, Manuel] San Marcos Univ, Dept Obstet & Gynecol, Lima, Peru; [Ananth, Cande V.] Columbia Univ, Med Ctr, Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY USA; [Ananth, Cande V.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Harvard University; Harvard T.H. Chan School of Public Health; CIRAD; Universite de Montpellier; Swedish Medical Center; University of Washington; University of Washington Seattle; Georgetown University; Universidad de San Martin de Porres; Universidad Nacional Mayor de San Marcos; Columbia University; Columbia University	Denis, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	marie.denis@cirad.fr		Sanchez, Sixto/0000-0003-0354-0523; Gelaye, Bizu/0000-0001-7934-548X	National Institutes of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD059827]; National Heart Lung and Blood Institute [K01HL10374]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059827] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL010374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the National Institutes of Health, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD059827) and the National Heart Lung and Blood Institute (K01HL10374). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth HE, 2011, GENET EPIDEMIOL, V35, P19, DOI 10.1002/gepi.20547; Ananth CV, 2008, HUM GENET, V124, P137, DOI 10.1007/s00439-008-0531-7; Ananth CV, 2007, OBSTET GYNECOL, V110, P128, DOI 10.1097/01.AOG.0000266983.77458.71; Ananth CV, 2006, EUR J OBSTET GYN R B, V128, P15, DOI 10.1016/j.ejogrb.2006.01.016; Ananth CV, 2004, OBSTET GYNECOL, V104, P71, DOI 10.1097/01.AOG.0000128172.71408.a0; Ananth CV, 1996, AM J EPIDEMIOL, V144, P881, DOI 10.1093/oxfordjournals.aje.a009022; Ananth CV, 2001, AM J EPIDEMIOL, V153, P332, DOI 10.1093/aje/153.4.332; Ananth CV, 2007, AM J OBSTET GYNECOL, V197, p273e1; Arnold DL, 2009, J OBSTET GYNAECOL RE, V35, P446, DOI 10.1111/j.1447-0756.2008.00980.x; Ayers KL, 2010, GENET EPIDEMIOL, V34, P879, DOI 10.1002/gepi.20543; Bailey SD, 2010, DIABETES CARE, V33, P2250, DOI 10.2337/dc10-0452; Bank S, 2014, PHARMACOGENOMICS J, V14, P526, DOI 10.1038/tpj.2014.19; Bank S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098815; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Benjamin EJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S11; Benjamini Y, 2001, ANN STAT, V29, P1165; Borel V, 2008, PPAR RES, V2008, DOI 10.1155/2008/758562; Breathnach FM, 2013, AUST NZ J OBSTET GYN, V53, P553, DOI 10.1111/ajo.12131; Breheny P, 2011, ANN APPL STAT, V5, P232, DOI 10.1214/10-AOAS388; Breheny P, 2009, STAT INTERFACE, V2, P369; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Burgess S, 2013, INT J EPIDEMIOL, V42, P1134, DOI 10.1093/ije/dyt093; Crawford Dana C, 2013, Pac Symp Biocomput, P188; Darin N, 2003, NEUROPEDIATRICS, V34, P311; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; de Paz NC, 2011, J AFFECT DISORDERS, V130, P280, DOI 10.1016/j.jad.2010.07.024; Di Simone N, 2003, BIOL REPROD, V69, P1129, DOI 10.1095/biolreprod.103.015800; Dizon-Townson D, 2005, OBSTET GYNECOL, V106, P517, DOI 10.1097/01.AOG.0000173986.32528.ca; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; DUTHIE SJ, 1991, AUST NZ J OBSTET GYN, V31, P125, DOI 10.1111/j.1479-828X.1991.tb01799.x; Fox CS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S18; Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104; Gargano JW, 2010, BJOG-INT J OBSTET GY, V117, P445, DOI 10.1111/j.1471-0528.2009.02472.x; Gargano JW, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.060; Haddow JE, 2011, OBSTET GYNECOL, V117, P287, DOI 10.1097/AOG.0b013e31820513d9; Hocher B, 2010, PHARMACOGENET GENOM, V20, P139, DOI 10.1097/FPC.0b013e3283357337; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Howey R, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-149; Huang J, 2012, STAT SCI, V27, P481, DOI 10.1214/12-STS392; Iams J, 1998, NEW ENGL J MED, V338, P54, DOI 10.1056/NEJM199801013380110; Ishida M, 2013, MOL ASPECTS MED, V34, P826, DOI 10.1016/j.mam.2012.06.009; Jaaskelainen E, 2004, PLACENTA, V25, P730, DOI 10.1016/j.placenta.2004.02.006; Jarvenpaa J, 2006, GYNECOL OBSTET INVES, V62, P28, DOI 10.1159/000091814; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Kundu S, 2011, EUR J EPIDEMIOL, V26, P261, DOI 10.1007/s10654-011-9567-4; Leunen K, 2003, J TROP PEDIATRICS, V49, P231, DOI 10.1093/tropej/49.4.231; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Li M, 2014, GENET EPIDEMIOL, V38, P198, DOI 10.1002/gepi.21793; Liang MB, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/396184; Lupo PJ, 2014, MOL GENET METAB, V111, P46, DOI 10.1016/j.ymgme.2013.11.004; Lyssenko V, 2013, DIABETES CARE, V36, pS120, DOI 10.2337/dcS13-2009; Mannisto T, 2013, J CLIN ENDOCR METAB, V98, P2725, DOI 10.1210/jc.2012-4233; Meigs JB, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S16; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Moore A, 2012, INT J MOL EPIDEMIOL, V3, P305; NAEYE RL, 1977, AM J OBSTET GYNECOL, V128, P740, DOI 10.1016/0002-9378(77)90714-1; NAEYE RL, 1980, OBSTET GYNECOL, V55, P701; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; Odendaal H J, 2000, J Obstet Gynaecol, V20, P358; Oyelese Y, 2006, OBSTET GYNECOL, V108, P1005, DOI 10.1097/01.AOG.0000239439.04364.9a; Phillips CM, 2010, J LIPID RES, V51, P1793, DOI 10.1194/jlr.M003046; Pitceathly RDS, 2013, JAMA NEUROL, V70, P1556, DOI 10.1001/jamaneurol.2013.3242; Ray JG, 1999, PLACENTA, V20, P519, DOI 10.1053/plac.1999.0417; SALAFIA CM, 1995, AM J OBSTET GYNECOL, V173, P1049, DOI 10.1016/0002-9378(95)91325-4; Sanchez SE, 2006, AM J OBSTET GYNECOL, V194, P225, DOI 10.1016/j.ajog.2005.05.013; Sanchez SE, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-30; Sennikov SV, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/745909; Signore C, 2006, OBSTET GYNECOL, V108, P338, DOI 10.1097/01.AOG.0000216014.72503.09; Sinsheimer JS, 2003, GENET EPIDEMIOL, V24, P1, DOI 10.1002/gepi.10211; Sinsheimer JS, 2010, J BIOMED BIOTECHNOL, V2010, P4597; SPINILLO A, 1993, EARLY HUM DEV, V35, P45, DOI 10.1016/0378-3782(93)90138-K; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Toivonen S, 2004, CLIN GENET, V66, P244, DOI 10.1111/j.1399-0004.2004.00294.x; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; Uhl GR, 2010, PHARMACOGENOMICS, V11, P357, DOI [10.2217/pgs.09.156, 10.2217/PGS.09.156]; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Wieser F, 2008, PPAR RES, V2008, DOI 10.1155/2008/527048; Wilk JB, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S8; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; WILLIAMS MA, 1991, AM J EPIDEMIOL, V134, P965, DOI 10.1093/oxfordjournals.aje.a116181; Williams MA, 2013, INT J MOL EPIDEMIOL, V4, P120; Workalemahu T, 2013, INT J MOL EPIDEMIOL, V4, P128; Yilmaz Y, 2012, DNA CELL BIOL, V31, P92, DOI 10.1089/dna.2010.1169; Younis JS, 2003, BEST PRACT RES CL HA, V16, P135, DOI 10.1016/S1521-6926(02)00099-3; Zdoukopoulos N, 2008, EPIDEMIOLOGY, V19, P309, DOI 10.1097/EDE.0b013e3181635694; Zhou H, 2010, BIOINFORMATICS, V26, P2375, DOI 10.1093/bioinformatics/btq448	89	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116346	10.1371/journal.pone.0116346	http://dx.doi.org/10.1371/journal.pone.0116346			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549360	Green Published, gold, Green Submitted			2022-12-26	WOS:000347063500077
J	Gurarie, D; King, CH				Gurarie, David; King, Charles H.			Population Biology of Schistosoma Mating, Aggregation, and Transmission Breakpoints: More Reliable Model Analysis for the End-Game in Communities at Risk	PLOS ONE			English	Article							AGE-STRUCTURED MODEL; DYNAMICS; INFECTION; MANSONI; DISEASE; CHEMOTHERAPY; MOLLUSCICIDE; STRATEGIES; VALIDATION; ESTATE	Mathematical modeling is widely used for predictive analysis of control options for infectious agents. Challenging problems arise for modeling host-parasite systems having complex life-cycles and transmission environments. Macroparasites, like Schistosoma, inhabit highly fragmented habitats that shape their reproductive success and distribution. Overdispersion and mating success are important factors to consider in modeling control options for such systems. Simpler models based on mean worm burden (MWB) formulations do not take these into account and overestimate transmission. Proposed MWB revisions have employed prescribed distributions and mating factor corrections to derive modified MWB models that have qualitatively different equilibria, including 'breakpoints' below which the parasite goes to extinction, suggesting the possibility of elimination via long-term mass-treatment control. Despite common use, no one has attempted to validate the scope and hypotheses underlying such MWB approaches. We conducted a systematic analysis of both the classical MWB and more recent "stratified worm burden'' (SWB) modeling that accounts for mating and reproductive hurdles (Allee effect). Our analysis reveals some similarities, including breakpoints, between MWB and SWB, but also significant differences between the two types of model. We show the classic MWB has inherent inconsistencies, and propose SWB as a reliable alternative for projection of long-term control outcomes.	[Gurarie, David] Case Western Reserve Univ, Dept Math, Cleveland, OH 44106 USA; [Gurarie, David; King, Charles H.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	King, CH (corresponding author), Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA.	chk@cwru.edu	Gurarie, David/AAA-2096-2021	King, Charles/0000-0001-8349-9270; Gurarie, David/0000-0002-5314-7888	sabbatical fellowship at NIMBioS (University of Tennessee); Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) - University of Georgia Research Foundation from the Bill and Melinda Gates Foundation; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation	sabbatical fellowship at NIMBioS (University of Tennessee); Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) - University of Georgia Research Foundation from the Bill and Melinda Gates Foundation; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	D. Gurarie was supported by the sabbatical fellowship at NIMBioS (University of Tennessee) during Academic Year 2012-13. This work is also supported by the Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) funded by the University of Georgia Research Foundation through a grant from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Barbour AD, 1996, AM J TROP MED HYG, V55, P135, DOI 10.4269/ajtmh.1996.55.135; BARNISH G, 1982, T ROY SOC TROP MED H, V76, P602, DOI 10.1016/0035-9203(82)90220-6; BRADLEY DJ, 1978, T ROY SOC TROP MED H, V72, P262, DOI 10.1016/0035-9203(78)90205-5; Bustinduy AL, 2009, SEQUELAE AND LONG-TERM CONSEQUENCES OF INFECTIOUS DISEASES, P291; CHAN MS, 1994, PARASITOLOGY, V109, P389, DOI 10.1017/S0031182000078422; CHAN MS, 1995, EPIDEMIOL INFECT, V115, P325, DOI 10.1017/S0950268800058453; Churcher TS, 2005, PARASITOLOGY, V131, P121, DOI 10.1017/S0031182005007341; Clarke V de V, 1973, Cent Afr J Med, P14; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Cornell SJ, 2010, ADV EXP MED BIOL, V673, P66; COURAFILHO P, 1992, REV INST MED TROP SP, V34, P427, DOI 10.1590/S0036-46651992000500009; DOBSON A, 1994, PARASITOLOGY, V109, pS97, DOI 10.1017/S0031182000085115; DUKE BOL, 1976, TROPENMED PARASITOL, V27, P297; FENWICK A, 1972, B WORLD HEALTH ORGAN, V47, P579; FENWICK A, 1970, B WORLD HEALTH ORGAN, V42, P589; FILHO PC, 1992, REV I MED TROP, V34, P543, DOI 10.1590/S0036-46651992000600008; Gurarie D, 2005, PARASITOLOGY, V130, P49, DOI 10.1017/S0031182004006341; Gurarie D, 2010, PARASITOLOGY, V137, P1951, DOI 10.1017/S0031182010000867; JORDAN P, 1980, ACTA TROP, V37, P95; King CH, 2006, TRENDS PARASITOL, V22, P575, DOI 10.1016/j.pt.2006.09.006; MACDONAL.G, 1965, T ROY SOC TROP MED H, V59, P489, DOI 10.1016/0035-9203(65)90152-5; MAY RM, 1977, MATH BIOSCI, V35, P301, DOI 10.1016/0025-5564(77)90030-X; MAY RM, 1978, J ANIM ECOL, V47, P249, DOI 10.2307/3934; MAY RM, 1993, PARASITOLOGY, V107, P287, DOI 10.1017/S0031182000079269; MORAND S, 1993, ECOLOGY, V74, P2444, DOI 10.2307/1939595; NASELL I, 1978, J MATH BIOL, V6, P21, DOI 10.1007/BF02478514; NASELL I, 1973, COMMUN PUR APPL MATH, V26, P395, DOI 10.1002/cpa.3160260402; Prichard RK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001549; Pugliese A, 2000, THEOR POPUL BIOL, V57, P145, DOI 10.1006/tpbi.1999.1443; Ribeiro-Paes J. T., 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P337, DOI 10.1590/S0036-46651997000600006; Savioli L., 2012, ACCELERATING WORK OV; Shaw DJ, 1998, PARASITOLOGY, V117, P597, DOI 10.1017/S0031182098003448; STURROCK R F, 1973, International Journal for Parasitology, V3, P175, DOI 10.1016/0020-7519(73)90023-4; Thomas J.D., 1973, Advances Parasit, V11, P307, DOI 10.1016/S0065-308X(08)60189-X; Wang XX, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001903; WARREN KS, 1974, AM J TROP MED HYG, V23, P902, DOI 10.4269/ajtmh.1974.23.902; WARREN KS, 1982, REV INFECT DIS, V4, P715; WOOLHOUSE MEJ, 1989, PARASITOLOGY, V98, P21, DOI 10.1017/S0031182000059655; Woolhouse MEJ, 1998, PARASITOLOGY, V117, P475, DOI 10.1017/S003118209800331X	41	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115875	10.1371/journal.pone.0115875	http://dx.doi.org/10.1371/journal.pone.0115875			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549362	gold, Green Submitted, Green Published			2022-12-26	WOS:000347063500032
J	Li, Z; Hao, YJ; Wang, LL; Xiang, H; Zhou, ZY				Li, Zhi; Hao, Youjin; Wang, Linling; Xiang, Heng; Zhou, Zeyang			Genome-Wide Identification and Comprehensive Analyses of the Kinomes in Four Pathogenic Microsporidia Species	PLOS ONE			English	Article							SPORE WALL PROTEIN; GLYCOGEN-SYNTHASE KINASE-3; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; CK2 PHOSPHORYLATION; CATALYTIC DOMAIN; DNA-REPLICATION; NOSEMA-CERANAE; POLAR TUBE; YEAST	Microsporidia have attracted considerable attention because they infect a wide range of hosts, from invertebrates to vertebrates, and cause serious human diseases and major economic losses in the livestock industry. There are no prospective drugs to counteract this pathogen. Eukaryotic protein kinases (ePKs) play a central role in regulating many essential cellular processes and are therefore potential drug targets. In this study, a comprehensive summary and comparative analysis of the protein kinases in four microsporidia-Enterocytozoon bieneusi, Encephalitozoon cuniculi, Nosema bombycis and Nosema ceranae-was performed. The results show that there are 34 ePKs and 4 atypical protein kinases (aPKs) in E. bieneusi, 29 ePKs and 6 aPKs in E. cuniculi, 41 ePKs and 5 aPKs in N. bombycis, and 27 ePKs and 4 aPKs in N. ceranae. These data support the previous conclusion that the microsporidian kinome is the smallest eukaryotic kinome. Microsporidian kinomes contain only serine-threonine kinases and do not contain receptor-like and tyrosine kinases. Many of the kinases related to nutrient and energy signaling and the stress response have been lost in microsporidian kinomes. However, cell cycle-, development-and growth-related kinases, which are important to parasites, are well conserved. This reduction of the microsporidian kinome is in good agreement with genome compaction, but kinome density is negatively correlated with proteome size. Furthermore, the protein kinases in each microsporidian genome are under strong purifying selection pressure. No remarkable differences in kinase family classification, domain features, gain and/or loss, and selective pressure were observed in these four species. Although microsporidia adapt to different host types, the coevolution of microsporidia and their hosts was not clearly reflected in the protein kinases. Overall, this study enriches and updates the microsporidian protein kinase database and may provide valuable information and candidate targets for the design of treatments for pathogenic diseases.	[Li, Zhi; Hao, Youjin; Wang, Linling; Zhou, Zeyang] Chongqing Normal Univ, Coll Life Sci, Chongqing, Peoples R China; [Zhou, Zeyang] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Xiang, Heng] Southwest Univ, Coll Anim Sci & Technol, Chongqing, Peoples R China	Chongqing Normal University; Southwest University - China; Southwest University - China	Zhou, ZY (corresponding author), Chongqing Normal Univ, Coll Life Sci, Chongqing, Peoples R China.	zyzhou@swu.edu.cn			National Science and Technology Plan Subject of China (863 Program) [2012AA101301]; National Basic Research Program of China (973 Program) [2012CB114604]; Natural Science Foundation of China [31101770]; Par-Eu Scholars Program of Chongqing; Natural Science Foundation Project of Chongqing CSTC [cstc2011jjA80019]; Science and Technology Project of the Chongqing Municipal Education Commission of China [KJ100616]	National Science and Technology Plan Subject of China (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Par-Eu Scholars Program of Chongqing; Natural Science Foundation Project of Chongqing CSTC(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Science and Technology Project of the Chongqing Municipal Education Commission of China	This work was supported by the National Science and Technology Plan Subject of China (863 Program, No.2012AA101301, http://www. most.gov.cn/eng/), the National Basic Research Program of China (973 Program, No. 2012CB114604, http://www.most.gov.cn/eng/), the Natural Science Foundation of China (No. 31101770, http://www.nsfc.gov.cn/Portal0/), the Par-Eu Scholars Program of Chongqing (by Bin Chen, http://www.cqjw.gov.cn/site/html/cqjwportal/ portal/index/), the Natural Science Foundation Project of Chongqing CSTC (No.cstc2011jjA80019, http://www.ctin.ac.cn/Index.aspx), and the Science and Technology Project of the Chongqing Municipal Education Commission of China (No. KJ100616, http://www.cqjw.gov.cn/site/html/ cqjwportal/portal/index/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade LF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-215; Angermayr M, 2002, MOL MICROBIOL, V44, P309, DOI 10.1046/j.1365-2958.2002.02881.x; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Bhat SA, 2009, AFR J AGR RES, V4, P1519; BIDWAI AP, 1995, J BIOL CHEM, V270, P10395, DOI 10.1074/jbc.270.18.10395; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Bush EW, 2000, BIOCHEMISTRY-US, V39, P8480, DOI 10.1021/bi992142f; Capella-Gutierrez S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-47; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Carroll AS, 2002, TRENDS BIOCHEM SCI, V27, P87, DOI 10.1016/S0968-0004(01)02040-0; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Coccetti P, 2004, MOL MICROBIOL, V51, P447, DOI 10.1046/j.1365-2958.2003.03836.x; Coccetti P, 2008, CELL CYCLE, V7, P1391, DOI 10.4161/cc.7.10.5825; Coccetti P, 2006, BIOCHEM BIOPH RES CO, V346, P786, DOI 10.1016/j.bbrc.2006.05.171; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dohrmann PR, 2006, GENETICS, V174, P87, DOI 10.1534/genetics.106.060236; Drewes G, 2003, FEBS LETT, V554, P45, DOI 10.1016/S0014-5793(03)01080-9; Du KY, 2005, ONCOGENE, V24, P7401, DOI 10.1038/sj.onc.1209099; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feng Y, 2000, MOL CELL BIOL, V20, P5350, DOI 10.1128/MCB.20.14.5350-5359.2000; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fisher RP, 2005, J CELL SCI, V118, P5171, DOI 10.1242/jcs.02718; Goldberg AV, 2008, NATURE, V452, P624, DOI 10.1038/nature06606; Hanks SK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-111; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; Harper JW, 1998, GENE DEV, V12, P285, DOI 10.1101/gad.12.3.285; HARWOOD AJ, 1995, CELL, V80, P139, DOI 10.1016/0092-8674(95)90458-1; Hatanaka M, 2001, YEAST, V18, P207, DOI 10.1002/1097-0061(200102)18:3<207::AID-YEA661>3.0.CO;2-I; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Hon WC, 1997, CELL, V89, P887, DOI 10.1016/S0092-8674(00)80274-3; Idanheimo N, 2014, BIOCHEM BIOPH RES CO, V445, P457, DOI 10.1016/j.bbrc.2014.02.013; IINO Y, 1995, GENETICS, V140, P1235; INSELBURG J, 1983, J PARASITOL, V69, P592, DOI 10.2307/3281375; Jung JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-215; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keeling PJ, 2000, MOL BIOL EVOL, V17, P23, DOI 10.1093/oxfordjournals.molbev.a026235; Ko TK, 2001, J CELL SCI, V114, P2591; Kosti I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-133; Krylov DM, 2003, CURR BIOL, V13, P173, DOI 10.1016/S0960-9822(03)00008-3; Larochelle S, 1998, GENE DEV, V12, P370, DOI 10.1101/gad.12.3.370; Lee H, 2009, P NATL ACAD SCI USA, V106, P21359, DOI 10.1073/pnas.0906651106; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; Lehmler C, 1997, EMBO J, V16, P3464, DOI 10.1093/emboj/16.12.3464; Lev S, 1999, P NATL ACAD SCI USA, V96, P13542, DOI 10.1073/pnas.96.23.13542; LEVIN DE, 1990, P NATL ACAD SCI USA, V87, P8272, DOI 10.1073/pnas.87.21.8272; Li YH, 2009, INT J PARASITOL, V39, P391, DOI 10.1016/j.ijpara.2008.08.011; Li Z, 2012, EUKARYOT CELL, V11, P229, DOI 10.1128/EC.05127-11; Liao H, 1999, J MOL BIOL, V294, P1041, DOI 10.1006/jmbi.1999.3313; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lower BH, 2003, J BACTERIOL, V185, P3436, DOI 10.1128/JB.185.11.3436-3445.2003; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Manning Gerard, 2005, WormBook, P1; Manning G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r66; Marchal C, 2000, J BIOL CHEM, V275, P23608, DOI 10.1074/jbc.M001735200; Marchal C, 2002, J CELL SCI, V115, P217; Masek KS, 2006, J CELL SCI, V119, P4565, DOI 10.1242/jcs.03206; Mielnichuk N, 2009, J CELL SCI, V122, P4130, DOI 10.1242/jcs.052233; Miranda-Saavedra D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-309; Miranda-Saavedra D, 2007, PROTEINS, V68, P893, DOI 10.1002/prot.21444; Morrison DK, 2000, J CELL BIOL, V150, pF57, DOI 10.1083/jcb.150.2.F57; Mylonakis E, 2004, MOL MICROBIOL, V54, P407, DOI 10.1111/j.1365-2958.2004.04310.x; Noselli S, 1998, TRENDS GENET, V14, P33, DOI 10.1016/S0168-9525(97)01320-6; Ohtoshi A, 1997, MOL GEN GENET, V254, P562, DOI 10.1007/s004380050452; Pan GQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-186; Panigada D, 2013, DEV CELL, V26, P483, DOI 10.1016/j.devcel.2013.07.013; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; PERRIMON N, 1989, DEV BIOL, V135, P287, DOI 10.1016/0012-1606(89)90180-2; Pike BL, 2003, J BIOL CHEM, V278, P30421, DOI 10.1074/jbc.C300227200; PINES J, 1995, BIOCHEM J, V308, P697, DOI 10.1042/bj3080697; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Rangarajan R, 2005, EMBO REP, V6, P464, DOI 10.1038/sj.embor.7400404; RIEDEL H, 1993, J BIOL CHEM, V268, P3456; Robert-Gangneux F., 2001, Annales Pharmaceutiques Francaises, V59, P297; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Scheeff ED, 2010, PROTEINS, V78, P1470, DOI 10.1002/prot.22663; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Schwartz MF, 2003, CELL CYCLE, V2, P384, DOI 10.4161/cc.2.4.457; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; SIMPSON P, 1988, DEVELOPMENT, V103, P391; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Southern TR, 2007, EUKARYOT CELL, V6, P1354, DOI 10.1128/EC.00113-07; St-Denis A, 1999, J IMMUNOL, V163, P5505; Steinberg G, 1998, J CELL SCI, V111, P2235; Stronach B, 2002, GENE DEV, V16, P377, DOI 10.1101/gad.953002; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Takada R, 2005, GENES CELLS, V10, P919, DOI 10.1111/j.1365-2443.2005.00889.x; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Vanrobays E, 2001, EMBO J, V20, P4204, DOI 10.1093/emboj/20.15.4204; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vinals F, 1999, J BIOL CHEM, V274, P26776, DOI 10.1074/jbc.274.38.26776; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949; WILLIAMS JG, 1993, PHILOS T ROY SOC B, V340, P305, DOI 10.1098/rstb.1993.0072; Wittner M., 1999, MICROSPORIDIA MICROS; Xu YJ, 2005, INT J PARASITOL, V35, P941, DOI 10.1016/j.ijpara.2005.04.003; Xu YJ, 2006, INFECT IMMUN, V74, P239, DOI 10.1128/IAI.74.1.239-247.2006; Yang DL, 2014, J INVERTEBR PATHOL, V115, P1, DOI 10.1016/j.jip.2013.10.004; YOON HJ, 1993, MOL BIOL CELL, V4, P195, DOI 10.1091/mbc.4.2.195; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	108	4	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115890	10.1371/journal.pone.0115890	http://dx.doi.org/10.1371/journal.pone.0115890			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549259	Green Published, Green Submitted, gold			2022-12-26	WOS:000347063500035
J	Batool, T; Rasool, N; Gull, Y; Noreen, M; Nasim, FU; Yaqoob, A; Zubair, M; Rana, UA; Khan, SUD; Zia-Ul-Haq, M; Jaafar, HZE				Batool, Tannaza; Rasool, Nasir; Gull, Yasmeen; Noreen, Mnaza; Nasim, Faiz-ul-Hassan; Yaqoob, Asma; Zubair, Muhammad; Rana, Usman Ali; Khan, Salah Ud-Din; Zia-Ul-Haq, M.; Jaafar, Hawa Z. E.			A Convenient Method for the Synthesis of (Prop-2-Ynyloxy)Benzene Derivatives via Reaction with Propargyl Bromide, Their Optimization, Scope and Biological Evaluation	PLOS ONE			English	Article							4-COMPONENT REACTION; CLICK SYNTHESIS; EFFICIENT; 1,2,3-TRIAZOLES; ALKYNES; UREASE; PEPTIDOTRIAZOLES; NANOPARTICLES; INHIBITION; DENDRIMERS	A highly convenient method has been developed for the synthesis of (prop-2-ynyloxy) benzene and its derivatives. Differently substituted phenol and aniline derivatives were allowed to react with propargyl bromide in the presence of K2CO3 base and acetone as solvent. The compounds were synthesized in good yields (53-85%). Low cost, high yields and easy availability of compounds helped in the synthesis. Electron withdrawing groups favor the formation of stable phenoxide ion thus in turn favors the formation of product while electron donating groups do not favor the reaction. Phenol derivatives gave good yields as compared to that of aniline. As aprotic polar solvents favor S(N)2 type reactions so acetone provided best solvation for the reactions. K2CO3 was proved to be good for the synthesis. Antibacterial, Antiurease and NO scavenging activity of synthesized compounds were also examined. 4-bromo-2-chloro-1-(prop-2-ynyloxy) benzene 2a was found most active compound against urease enzyme with a percentage inhibition of 82.00 +/- 0.09 at 100 mu g/mL with IC50 value of 60.2. 2-bromo-4-methyl-1-(prop-2-ynyloxy)benzene 2d was found potent antibacterial against Bacillus subtillus showing excellent inhibitory action with percentage inhibition of 55.67 +/- 0.26 at 100 mu g/ml wih IC50 value of 79.9. Based on results, it can be concluded that some of the synthesized compounds may have potential antiurease and antibacterial effects against several harmful substances.	[Batool, Tannaza; Rasool, Nasir; Gull, Yasmeen; Noreen, Mnaza; Zubair, Muhammad] Govt Coll Univ Faisalabad, Dept Chem, Faisalabad, Pakistan; [Nasim, Faiz-ul-Hassan; Yaqoob, Asma] Islamia Univ Bahawalpur, Dept Chem, Bahawalpur, Pakistan; [Rana, Usman Ali; Khan, Salah Ud-Din] King Saud Univ, Coll Engn, Deanship Sci Res, Riyadh, Saudi Arabia; [Zia-Ul-Haq, M.] Patent Off, Karachi, Pakistan; [Jaafar, Hawa Z. E.] Fac Agr, Dept Crop Sci, Upm Serdang 43400, Selangor, Malaysia	Government College University Faisalabad; Islamia University of Bahawalpur; King Saud University; Universiti Putra Malaysia	Rasool, N (corresponding author), Govt Coll Univ Faisalabad, Dept Chem, Faisalabad, Pakistan.	nasirrasool@gcuf.edu.pk; hawazej@gmail.com	Khan, Shahab/GSO-1694-2022; Rasool, Nasir/ABC-6212-2021; Zia-Ul-Haq, Muhammad/J-1798-2015; Nasim, Faiz/F-6397-2015; Nasim, Faiz-ul Hassan/G-5799-2010; rasool, nasir/I-6871-2015; Khan, Salah Ud-Din/ABC-5995-2020	Nasim, Faiz-ul Hassan/0000-0001-9107-7449; 	HEC (HEC Project) [20-1465/R D/09/5458]; Deanship of Scientific Research at King Saud University [RGP-VPP-255]	HEC (HEC Project); Deanship of Scientific Research at King Saud University(King Saud University)	The present data is the part of M. Phil thesis research work of Tannaza Batool. The authors gratefully acknowledge the financial support by HEC (HEC Project No. 20-1465/R& D/09/5458). S. U. Khan would like to extend his sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding through the Research Group Project no RGP-VPP-255. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agag T, 2001, MACROMOLECULES, V34, P7257, DOI 10.1021/ma0107915; Agalave SG, 2011, CHEM-ASIAN J, V6, P2696, DOI 10.1002/asia.201100432; Alonso F, 2012, HETEROCYCLES, V84, P1033, DOI 10.3987/COM-11-S(P)81; Antoni P, 2007, CHEM COMMUN, P2249, DOI 10.1039/b703547k; Bahulayan D, 2012, TETRAHEDRON LETT, V53, P2850, DOI 10.1016/j.tetlet.2012.03.116; Basak A, 2009, INT J CHEM, V1, P63; Binder WH, 2006, CURR ORG CHEM, V10, P1791, DOI 10.2174/138527206778249838; Booth SE, 1994, J CHEM SOC P1, V1, P99; Chippada S.C., 2011, J CHEM BIO PHY SCI, V1, P260; Dabiri M, 2010, J COMB CHEM, V12, P638, DOI 10.1021/cc100043z; Garrat D.C, 1964, QUANTITATIVE ANAL DR, V3rd; Gull Y, 2013, MOLECULES, V18, P8845, DOI 10.3390/molecules18088845; He JB, 2012, BIOORGAN MED CHEM, V20, P1665, DOI 10.1016/j.bmc.2012.01.019; Huang YJ, 2011, INT J HYDROGEN ENERG, V36, P15333, DOI 10.1016/j.ijhydene.2011.08.093; Joshi MC, 2007, BIOORG MED CHEM LETT, V17, P3226, DOI 10.1016/j.bmcl.2007.03.007; Krim J, 2009, ARKIVOC, P142, DOI 10.3998/ark.5550190.0010.d12; Kundu NG, 2001, J ORG CHEM, V66, P20, DOI 10.1021/jo000826j; Lee JW, 2006, B KOR CHEM SOC, V27, P1795; Lee LV, 2003, J AM CHEM SOC, V125, P9588, DOI 10.1021/ja0302836; Martin-Matute B, 2003, J AM CHEM SOC, V125, P5757, DOI 10.1021/ja029125p; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Mendoza-Espinosa D, 2014, MOLECULES, V19, P55, DOI 10.3390/molecules19010055; Pal M, 2003, ORG LETT, V5, P349, DOI 10.1021/ol027382t; Quan ZJ, 2013, TETRAHEDRON, V69, P881, DOI 10.1016/j.tet.2012.10.097; Rahman A, 2005, BIOASSAY TECHNIQUES, P8; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Samai S, 2010, TETRAHEDRON LETT, V51, P5555, DOI 10.1016/j.tetlet.2010.08.043; Serwar M, 2009, ARKIVOC, P210, DOI 10.3998/ark.5550190.0010.720; Sharghi H, 2009, ADV SYNTH CATAL, V351, P2391, DOI 10.1002/adsc.200900353; Singh Dharmendra, 2012, INT J PHARM PHARM SC, V2, P42; Sokmen BB, 2012, J SERB CHEM SOC, V77, P1353, DOI 10.2298/JSC120105042S; Speers AE, 2003, J AM CHEM SOC, V125, P4686, DOI 10.1021/ja034490h; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Wei LL, 2001, TETRAHEDRON, V57, P459, DOI 10.1016/S0040-4020(00)01014-0; Wu P, 2004, ANGEW CHEM INT EDIT, V43, P3928, DOI 10.1002/anie.200454078; Yadav JS, 2009, TETRAHEDRON LETT, V50, P6029, DOI 10.1016/j.tetlet.2009.08.027; Zhang YN, 2011, J POLYM SCI POL CHEM, V49, P4766, DOI 10.1002/pola.24923	38	15	16	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115457	10.1371/journal.pone.0115457	http://dx.doi.org/10.1371/journal.pone.0115457			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545159	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000347120200043
J	Nino, G; Huseni, S; Perez, GF; Pancham, K; Mubeen, H; Abbasi, A; Wang, J; Eng, S; Colberg-Poley, AM; Pillai, DK; Rose, MC				Nino, Gustavo; Huseni, Shehlanoor; Perez, Geovanny F.; Pancham, Krishna; Mubeen, Humaira; Abbasi, Aleeza; Wang, Justin; Eng, Stephen; Colberg-Poley, Anamaris M.; Pillai, Dinesh K.; Rose, Mary C.			Directional Secretory Response of Double Stranded RNA-Induced Thymic Stromal Lymphopoetin (TSLP) and CCL11/Eotaxin-1 in Human Asthmatic Airways	PLOS ONE			English	Article							HUMAN EPITHELIAL-CELLS; LYMPHOPOIETIN EXPRESSION; ALLERGIC INFLAMMATION; TNF-ALPHA; MODEL; HYPERRESPONSIVENESS; MICROBES; CHILDREN; CCR3	Background: Thymic stromal lymphoproetin (TSLP) is a cytokine secreted by the airway epithelium in response to respiratory viruses and it is known to promote allergic Th2 responses in asthma. This study investigated whether virally-induced secretion of TSLP is directional in nature (apical vs. basolateral) and/or if there are TSLP-mediated effects occurring at both sides of the bronchial epithelial barrier in the asthmatic state. Methods: Primary human bronchial epithelial cells (HBEC) from control (n=3) and asthmatic (n=3) donors were differentiated into polarized respiratory tract epithelium under air-liquid interface (ALI) conditions and treated apically with dsRNA (viral surrogate) or TSLP. Sub-epithelial effects of TSLP were examined in human airway smooth muscle cells (HASMC) from normal (n=3) and asthmatic (n=3) donors. Clinical experiments examined nasal airway secretions obtained from asthmatic children during naturally occurring rhinovirus-induced exacerbations (n=20) vs. non-asthmatic uninfected controls (n=20). Protein levels of TSLP, CCL11/eotaxin-1, CCL17/TARC, CCL22/MDC, TNF-alpha and CXCL8 were determined with a multiplex magnetic bead assay. Results: Our data demonstrate that: 1) Asthmatic HBEC exhibit an exaggerated apical, but not basal, secretion of TSLP after dsRNA exposure; 2) TSLP exposure induces unidirectional (apical) secretion of CCL11/eotaxin-1 in asthmatic HBEC and enhanced CCL11/eotaxin-1 secretion in asthmatic HASMC; 3) Rhinovirus-induced asthma exacerbations in children are associated with in vivo airway secretion of TSLP and CCL11/eotaxin-1. Conclusions: There are virally-induced TSLP-driven secretory immune responses at both sides of the bronchial epithelial barrier characterized by enhanced CCL11/eotaxin-1 secretion in asthmatic airways. These results suggest a new model of TSLP-mediated eosinophilic responses in the asthmatic airway during viral-induced exacerbations.	[Nino, Gustavo; Huseni, Shehlanoor; Perez, Geovanny F.; Pancham, Krishna; Wang, Justin; Eng, Stephen; Rose, Mary C.] Childrens Natl Med Ctr, Div Pulm & Sleep Med, Washington, DC 20010 USA; [Nino, Gustavo; Abbasi, Aleeza; Colberg-Poley, Anamaris M.; Pillai, Dinesh K.; Rose, Mary C.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA; [Nino, Gustavo; Colberg-Poley, Anamaris M.; Pillai, Dinesh K.; Rose, Mary C.] George Washington Univ, Dept Integrat Syst Biol, Washington, DC USA; [Nino, Gustavo; Mubeen, Humaira; Colberg-Poley, Anamaris M.; Pillai, Dinesh K.; Rose, Mary C.] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Colberg-Poley, Anamaris M.; Rose, Mary C.] George Washington Univ, Dept Biochem & Mol Med, Washington, DC USA	Children's National Health System; George Washington University; George Washington University; Children's National Health System; George Washington University	Nino, G (corresponding author), Childrens Natl Med Ctr, Div Pulm & Sleep Med, Washington, DC 20010 USA.	gnino@childrensnational.org		Perez, Geovanny/0000-0003-2843-6837	NIH National Center for Advancing Translational Sciences [NHLBI/HL090020, NICHC/HD001399, UL1TR000075 KL2TR000076]; Board of Visitors (BOV) Grant of Children's National Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001399] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000076, UL1TR000075] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL090020] Funding Source: NIH RePORTER	NIH National Center for Advancing Translational Sciences; Board of Visitors (BOV) Grant of Children's National Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grants NHLBI/HL090020 (K12 Genomics of Lung), NICHC/HD001399 (K12 Child Health Research Career Development Award), UL1TR000075 KL2TR000076 Awards from the NIH National Center for Advancing Translational Sciences and a Board of Visitors (BOV) Grant of Children's National Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Bogiatzi SI, 2007, J IMMUNOL, V178, P3373, DOI 10.4049/jimmunol.178.6.3373; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Cheng DT, 2013, J ALLERGY CLIN IMMUN, V132, P455, DOI 10.1016/j.jaci.2013.05.011; Choi JP, 2012, ALLERGY, V67, P1138, DOI 10.1111/j.1398-9995.2012.02871.x; Dvorak A, 2011, AM J RESP CELL MOL, V44, P465, DOI 10.1165/rcmb.2009-0453OC; Freishtat RJ, 2011, AM J RESP CELL MOL, V44, P863, DOI 10.1165/rcmb.2010-0029OC; Gauvreau GM, 2014, NEW ENGL J MED, V370, P2102, DOI 10.1056/NEJMoa1402895; Hackett NR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018378; Hansel TT, 2013, LANCET, V381, P861, DOI 10.1016/S0140-6736(12)62202-8; Hardyman MA, 2013, J ALLERGY CLIN IMMUN, V132, P665, DOI 10.1016/j.jaci.2013.03.005; Hershenson MB, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/405876; Hirota JA, 2012, CURR OPIN IMMUNOL, V24, P740, DOI 10.1016/j.coi.2012.08.012; Hui CCK, 2014, CLIN EXP ALLERGY, V44, P953, DOI 10.1111/cea.12330; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Kaur D, 2012, CHEST, V142, P76, DOI 10.1378/chest.11-1782; Khetsuriani N, 2007, J ALLERGY CLIN IMMUN, V119, P314, DOI 10.1016/j.jaci.2006.08.041; Lee HC, 2012, J ALLERGY CLIN IMMUN, V130, P1187, DOI 10.1016/j.jaci.2012.07.031; Ma W, 2002, J CLIN INVEST, V109, P621, DOI 10.1172/JCI200214097; Mahmutovic-Persson I, 2014, ALLERGY, V69, P348, DOI 10.1111/all.12329; Malavia NK, 2009, AM J RESP CELL MOL, V41, P297, DOI 10.1165/rcmb.2008-0358OC; Nagarkar DR, 2013, J ALLERGY CLIN IMMUN, V132, P593, DOI 10.1016/j.jaci.2013.04.005; Nagarkar DR, 2012, J ALLERGY CLIN IMMUN, V130, P225, DOI 10.1016/j.jaci.2012.04.019; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; Nino G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032078; Nino G, 2010, J ALLERGY CLIN IMMUN, V125, P1020, DOI 10.1016/j.jaci.2010.02.007; Panina-Bordignon P, 2001, J CLIN INVEST, V107, P1357, DOI 10.1172/JCI12655; Perez GF, 2014, EUR RESPIR J, V44, P1075, DOI 10.1183/09031936.00049214; Pillai DK, 2014, AM J RESP CELL MOL, V50, P292, DOI 10.1165/rcmb.2013-0188OC; Redhu NS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02301; Saetta M, 2001, EUR RESPIR J, V18, p18S, DOI 10.1183/09031936.01.00229501; Saglani S, 2014, CURR OPIN ALLERGY CL, V14, P143, DOI 10.1097/ACI.0000000000000045; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Torres D, 2010, J IMMUNOL, V185, P451, DOI 10.4049/jimmunol.0902833; Uller L, 2010, THORAX, V65, P626, DOI 10.1136/thx.2009.125930; Wang Q, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002070; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wu D, 2014, J ASTHMA, V13, P1; Xu G, 2010, ALLERGY, V65, P581, DOI 10.1111/j.1398-9995.2009.02252.x; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Ying S, 1997, EUR J IMMUNOL, V27, P3507, DOI 10.1002/eji.1830271252; Zhang KQ, 2007, AM J PHYSIOL-LUNG C, V293, pL375, DOI 10.1152/ajplung.00045.2007; Ziegler SF, 2012, J ALLERGY CLIN IMMUN, V130, P845, DOI 10.1016/j.jaci.2012.07.010; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	45	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115398	10.1371/journal.pone.0115398	http://dx.doi.org/10.1371/journal.pone.0115398			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546419	Green Submitted, Green Published, gold			2022-12-26	WOS:000347120200040
J	Sueta, A; Yamamoto, Y; Yamamoto-Ibusuki, M; Hayashi, M; Takeshita, T; Yamamoto, S; Iwase, H				Sueta, Aiko; Yamamoto, Yutaka; Yamamoto-Ibusuki, Mutsuko; Hayashi, Mitsuhiro; Takeshita, Takashi; Yamamoto, Satoko; Iwase, Hirotaka			An Integrative Analysis of PIK3CA Mutation, PTEN, and INPP4B Expression in Terms of Trastuzumab Efficacy in HER2-Positive Breast Cancer	PLOS ONE			English	Article							PLUS ADJUVANT CHEMOTHERAPY; TUMOR-SUPPRESSOR; SOMATIC MUTATION; PI3K PATHWAY; COPY NUMBER; DIGITAL PCR; FOLLOW-UP; ACTIVATION; RESISTANCE; IMMUNOHISTOCHEMISTRY	The phosphoinositide-3-kinase (PI3K) pathway is commonly deregulated in breast cancer through several mechanisms, including PIK3CA mutation and loss of phosphatase and tensin homolog (PTEN) and inositol polyphosphate 4phosphatase- II (INPP4B). We aimed to evaluate the predictive relevance of these biomarkers to trastuzumab efficacy in HER2-positive disease. We evaluated the effect of trastuzumab in 43 breast cancer patients with HER2-overexpression who received neoadjuvant treatment. PIK3CA mutation was examined by direct sequencing and digital PCR assay, and PIK3CA copy number was assessed by digital PCR assay of pretreatment tissues. PTEN, pAkt, and INPP4B were assessed by immunohistochemistry. Direct sequencing detected mutant DNA in 21% of all patients, but the incidence increased to 49% using digital PCR. The pathological complete response (pCR) rate in patients with PIK3CA mutations was 29% compared with 67% for those without PIK3CA mutations (P=0.093), when the mutation was defined as positive if the mutant proportion was more than 10% of total genetic content by digital PCR. Low PTEN expression was associated with less pCR compared to high expression (33% versus 72%, P=0.034). There were no significant associations of PIK3CA copy number, pAKt, or INPP4B with trastuzumab efficacy. In multivariate analysis, activation of the PI3K pathway due to either PIK3CA mutation or low PTEN were related to poorer response to trastuzumab (OR of predictive pCR was 0.11, 95% CI; 0.03-0.48). In conclusion, activating the PI3K pathway is associated with low pCR to trastuzumab-based treatment in HER2-positive breast cancer. Combined analysis of PIK3CA mutation and PTEN expression may serve as critical indicators to identify patients unlikely to respond to trastuzumab.	[Sueta, Aiko; Yamamoto, Yutaka; Yamamoto-Ibusuki, Mutsuko; Hayashi, Mitsuhiro; Takeshita, Takashi; Yamamoto, Satoko; Iwase, Hirotaka] Kumamoto Univ, Grad Sch Med Sci, Dept Breast & Endocrine Surg, Chuo Ku, Kumamoto 8608556, Japan; [Sueta, Aiko; Yamamoto, Yutaka] Kumamoto Univ Hosp, Dept Mol Targeting Therapy Breast Canc, Chuo Ku, Kumamoto 8608556, Japan	Kumamoto University; Kumamoto University	Yamamoto, Y (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Breast & Endocrine Surg, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	ys-yama@triton.ocn.ne.jp	Takeshita, Takashi/J-1423-2019	Takeshita, Takashi/0000-0002-8559-8181; Hayashi, Mitsuhiro/0000-0001-6656-8502				Agoulnik IU, 2011, ONCOTARGET, V2, P321; Beaver JA, 2014, CLIN CANCER RES, V20, P2643, DOI 10.1158/1078-0432.CCR-13-2933; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chandarlapaty S, 2012, CLIN CANCER RES, V18, P6784, DOI 10.1158/1078-0432.CCR-12-1785; Cizkova M, 2013, BRIT J CANCER, V108, P1807, DOI 10.1038/bjc.2013.164; Dave B, 2011, J CLIN ONCOL, V29, P166, DOI 10.1200/JCO.2009.27.7814; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Esteva FJ, 2010, AM J PATHOL, V177, P1647, DOI 10.2353/ajpath.2010.090885; Fedele CG, 2010, P NATL ACAD SCI USA, V107, P22231, DOI 10.1073/pnas.1015245107; Fujita T, 2006, BRIT J CANCER, V94, P247, DOI 10.1038/sj.bjc.6602926; Gabriel N., 2013, J CLIN ONCOL, V31; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Gonzalez-Angulo AM, 2012, CANCER, V119, P7; Gori S, 2009, ANN ONCOL, V20, P648, DOI 10.1093/annonc/mdn681; Hanker AB, 2013, P NATL ACAD SCI USA, V110, P14372, DOI 10.1073/pnas.1303204110; Hodgson MC, 2011, CANCER RES, V71, P572, DOI 10.1158/0008-5472.CAN-10-2314; Isler JA, 2007, PHARMACOGENOMICS, V8, P353, DOI 10.2217/14622416.8.4.353; Jensen JD, 2012, ANN ONCOL, V23, P2034, DOI 10.1093/annonc/mdr546; Jones N, 2013, INT J CANCER, V133, P323, DOI 10.1002/ijc.28021; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Loi S, 2013, JNCI-J NATL CANCER I, V105, P960, DOI 10.1093/jnci/djt121; Loibl S, 2013, 36 SANANTONIO BREAST; Loibl S, 2014, J CLIN ONCOL, V32, P3212, DOI 10.1200/JCO.2014.55.7876; Lopez-Knowles E, 2010, INT J CANCER, V126, P1121, DOI 10.1002/ijc.24831; Montemurro F, 2006, ONCOLOGIST, V11, P318, DOI 10.1634/theoncologist.11-4-318; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Perez EA, 2011, J CLIN ONCOL, V29, P3366, DOI 10.1200/JCO.2011.35.0868; Perez-Lorenzo R, 2014, J INVEST DERMATOL, V134, P1359, DOI 10.1038/jid.2013.511; Pohlmann PR, 2009, CLIN CANCER RES, V15, P7479, DOI 10.1158/1078-0432.CCR-09-0636; Razis E, 2011, BREAST CANCER RES TR, V128, P447, DOI 10.1007/s10549-011-1572-5; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Sakr RA, 2010, APPL IMMUNOHISTO M M, V18, P371, DOI 10.1097/PAI.0b013e3181d50bd5; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Treilleux I, 2013, J CLIN ONCOL, V31; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Vora SR, 2014, CANCER CELL, V26, P136, DOI 10.1016/j.ccr.2014.05.020; Wang HL, 2010, ADV ANAT PATHOL, V17, P23, DOI 10.1097/PAP.0b013e3181c6962f; Whale AS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks203; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wu GJ, 2005, BREAST CANCER RES, V7, pR609, DOI 10.1186/bcr1262; Yamamoto S, 2013, BREAST CANCER-TOKYO, V20, P262, DOI 10.1007/s12282-012-0332-7; Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622	47	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116054	10.1371/journal.pone.0116054	http://dx.doi.org/10.1371/journal.pone.0116054			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542038	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900135
J	Arik, AJ; Hun, LV; Quicke, K; Piatt, M; Ziegler, R; Scaraffia, PY; Badgandi, H; Riehle, MA				Arik, Anam J.; Hun, Lewis V.; Quicke, Kendra; Piatt, Michael; Ziegler, Rolf; Scaraffia, Patricia Y.; Badgandi, Hemant; Riehle, Michael A.			Increased Akt signaling in the mosquito fat body increases adult survivorship	FASEB JOURNAL			English	Article						Aedes aegypti; aging; Anopheles stephensi; insulin signaling; vitellogenin	YELLOW-FEVER MOSQUITO; LIFE-SPAN; STRESS RESISTANCE; OXIDATIVE STRESS; INSULIN-RECEPTOR; DROSOPHILA; LONGEVITY; FITNESS; LONG; REPRODUCTION	Akt signaling regulates diverse physiologies in a wide range of organisms. We examine the impact of increased Akt signaling in the fat body of 2 mosquito species, the Asian malaria mosquito Anopheles stephensi and the yellow fever mosquito Aedes aegypti. Overexpression of a myristoylated and active form of A. stephensi and Ae. aegypti Akt in the fat body of transgenic mosquitoes led to activation of the downstream signaling molecules forkhead box O (FOXO) and p70 S6 kinase in a tissue and blood meal-specific manner. In both species, increased Akt signaling in the fat body after blood feeding significantly increased adult survivorship relative to nontransgenic sibling controls. In A. stephensi, survivorship was increased by 15% to 45%, while in Ae. aegypti, it increased 14% to 47%. Transgenic mosquitoes fed only sugar, and thus not expressing active Akt, had no significant difference in survivorship relative to nontransgenic siblings. Expression of active Akt also increased expression of fat body vitellogenin, but the number of viable eggs did not differ significantly between transgenic and nontransgenic controls. This work demonstrates a novel mechanism of enhanced survivorship through increased Akt signaling in the fat bodies of multiple mosquito genera and provides new tools to unlock the molecular underpinnings of aging in eukaryotic organisms.	[Arik, Anam J.; Hun, Lewis V.; Piatt, Michael; Ziegler, Rolf; Riehle, Michael A.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Quicke, Kendra] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Scaraffia, Patricia Y.] Tulane Univ, Sch Publ Hlth & Trop Med, Vector Borne Infect Dis Res Ctr, Dept Trop Med, New Orleans, LA USA; [Badgandi, Hemant] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Arizona; Emory University; Tulane University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Riehle, MA (corresponding author), Univ Arizona, Dept Entomol, 1140 E South Campus Dr,Forbes 410, Tucson, AZ 85721 USA.	mriehle@ag.arizona.edu	Riehle, Michael A/O-2852-2017	Badgandi, Hemant/0000-0001-6181-4241; Scaraffia, Patricia/0000-0003-2985-933X; Riehle, Michael/0000-0001-9747-3872	U.S. National Institutes of Health National Institute of Allergies and Infectious Diseases [AI073745, AI088092]; Grand Challenges Exploration grant from the Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088092, R01AI073745] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Institute of Allergies and Infectious Diseases; Grand Challenges Exploration grant from the Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the U.S. National Institutes of Health National Institute of Allergies and Infectious Diseases Grants AI073745 to M.A.R. and AI088092 to P.Y.S.; and a Grand Challenges Exploration grant from the Bill and Melinda Gates Foundation. The authors thank Dr. Frank Ramberg for his assistance in maintaining the TG mosquito colonies and Dr. Jenya Antonova for her advice and guidance.	Amenya DA, 2010, INSECT MOL BIOL, V19, P263, DOI 10.1111/j.1365-2583.2009.00986.x; Antonova Y., 2012, INSECT ENDOCRINOL, P63, DOI DOI 10.1016/B978-0-12-384749-2.10002-0; Arik Anam J., 2009, BMC Physiology, V9, P15, DOI 10.1186/1472-6793-9-15; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Bai H, 2012, AGING CELL, V11, P978, DOI 10.1111/acel.12000; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Catteruccia F, 2003, SCIENCE, V299, P1225, DOI 10.1126/science.1081453; Clements AN., 1992, BIOL MOSQUITOES DEV; Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; Flatt T, 2011, EXP GERONTOL, V46, P369, DOI 10.1016/j.exger.2010.10.008; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Hauck ES, 2013, MICROBES INFECT, V15, P775, DOI 10.1016/j.micinf.2013.05.006; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Hyun J, 2011, FLY, V5, P53, DOI 10.4161/fly.5.1.14080; Irvin N, 2004, P NATL ACAD SCI USA, V101, P891, DOI 10.1073/pnas.0305511101; Isaacs AT, 2012, P NATL ACAD SCI USA, V109, pE1922, DOI 10.1073/pnas.1207738109; Jenkins NL, 2004, P ROY SOC B-BIOL SCI, V271, P2523, DOI 10.1098/rspb.2004.2897; Kang MA, 2008, J EXP BIOL, V211, P741, DOI 10.1242/jeb.012955; Keaney M, 2004, FREE RADICAL BIO MED, V37, P239, DOI 10.1016/j.freeradbiomed.2004.04.005; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kokoza V, 2001, INSECT BIOCHEM MOLEC, V31, P1137, DOI 10.1016/S0965-1748(01)00120-5; Li CY, 2008, J HERED, V99, P275, DOI 10.1093/jhered/esn004; Magwere T, 2006, MECH AGEING DEV, V127, P356, DOI 10.1016/j.mad.2005.12.009; Moreira LA, 2004, GENETICS, V166, P1337, DOI 10.1534/genetics.166.3.1337; Mukhopadhyay A, 2007, TRENDS CELL BIOL, V17, P65, DOI 10.1016/j.tcb.2006.12.004; Nirmala X, 2006, INSECT BIOCHEM MOLEC, V36, P694, DOI 10.1016/j.ibmb.2006.05.011; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Paaby AB, 2009, FLY, V3, P29, DOI 10.4161/fly.3.1.7771; Petrovski G, 2010, J CELL MOL MED, V14, P2543, DOI 10.1111/j.1582-4934.2010.01196.x; Piper MDW, 2008, J INTERN MED, V263, P179, DOI 10.1111/j.1365-2796.2007.01906.x; Piper MDW, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030057; Promislow DEL, 1996, GENETICS, V143, P839; Raikhel AS, 2002, INSECT BIOCHEM MOLEC, V32, P1275, DOI 10.1016/S0965-1748(02)00090-5; Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013; Riehle MA, 1999, INSECT BIOCHEM MOLEC, V29, P855, DOI 10.1016/S0965-1748(99)00084-3; Roy SG, 2007, INSECT BIOCHEM MOLEC, V37, P1317, DOI 10.1016/j.ibmb.2007.08.004; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Selman C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016144; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; Toivonen JM, 2009, MOL CELL ENDOCRINOL, V299, P39, DOI 10.1016/j.mce.2008.07.005; Wessells RJ, 2004, NAT GENET, V36, P1275, DOI 10.1038/ng1476	48	21	22	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1404	1413		10.1096/fj.14-261479	http://dx.doi.org/10.1096/fj.14-261479			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25550465	Green Published			2022-12-26	WOS:000354115000026
J	Rodriguez-Carballo, E; Gamez, B; Mendez-Lucas, A; Sanchez-Freutrie, M; Zorzano, A; Bartrons, R; Alcantara, S; Perales, JC; Ventura, F				Rodriguez-Carballo, Edgardo; Gamez, Beatriz; Mendez-Lucas, Andres; Sanchez-Freutrie, Manuela; Zorzano, Antonio; Bartrons, Ramon; Alcantara, Soledad; Carlos Perales, Jose; Ventura, Francesc			p38 alpha function in osteoblasts influences adipose tissue homeostasis	FASEB JOURNAL			English	Article						bone; NPY; metabolism; adipocyte; energy expenditure; osteocalcin	ACID-CONTAINING PROTEIN; NEUROPEPTIDE-Y; IN-VIVO; PERIPHERAL MECHANISMS; ENERGY-METABOLISM; KINASE PATHWAYS; INDUCED OBESITY; KNOCKOUT MICE; BODY-WEIGHT; BONE MASS	The skeleton acts as an endocrine organ that regulates energy metabolism and calcium and phosphorous homeostasis through the secretion of osteocalcin (Oc) and fibroblast growth factor 23 (FGF23). However, evidence suggests that osteoblasts secrete additional unknown factors that contribute to the endocrine function of bone. To search for these additional factors, we generated mice with a conditional osteoblast-specific deletion of p38 alpha MAPK known to display profound defects in bone homeostasis. Herein, we show that impaired osteoblast function is associated with a strong decrease in body weight and adiposity (P < 0.01). The differences in adiposity were not associated with diminished caloric intake, but rather reflected 20% increased energy expenditure and the up-regulation of uncoupling protein-1 (Ucp1) in white adipose tissue (WAT) and brown adipose tissue (BAT) (P < 0.05). These alterations in lipid metabolism and energy expenditure were correlated with a decrease in the bloodlevels of neuropeptide Y (NPY) (40% lower) rather than changes in the serum levels of insulin, Oc, or FGF23. Among all Npy-expressing tissues, only bone and primary osteoblasts showed a decline in Npy expression (P < 0.01). Moreover, the intraperitoneal administration of recombinant NPY partially restored the WAT weight and adipocyte size of p38 alpha-deficient mice (P < 0.05). Altogether, these results further suggest that, in addition to Oc, other bone-derived signals affect WAT and energy expenditure contributing to the regulation of energy metabolism.	[Rodriguez-Carballo, Edgardo; Gamez, Beatriz; Mendez-Lucas, Andres; Bartrons, Ramon; Carlos Perales, Jose; Ventura, Francesc] Univ Barcelona, Dept Ciencies Fisiol 2, Inst Invest Biomed Bellvitge, E-08907 Lhospitalet De Llobregat, Spain; [Alcantara, Soledad] Univ Barcelona, Dept Patol & Terapeut, Inst Invest Biomed Bellvitge, E-08907 Lhospitalet De Llobregat, Spain; [Sanchez-Freutrie, Manuela; Zorzano, Antonio] Univ Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain; [Sanchez-Freutrie, Manuela; Zorzano, Antonio] Inst Biomed Res, Barcelona, Spain; [Sanchez-Freutrie, Manuela; Zorzano, Antonio] Inst Salud Carlos III, Ctr Invest Biomed Red CIBER Diabet & Enfermedades, Madrid, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III	Ventura, F (corresponding author), Univ Barcelona, IDIBELL, Dept Ciencies Fisiol 2, C Feixa Llarga S-N, E-08907 Lhospitalet De Llobregat, Spain.	fventura@ub.edu	PERALES, JOSE C./AAC-3156-2019; Zorzano, Antonio/R-5479-2018; Ventura, Francesc/K-9700-2014; Alcantara, Soledad/K-3648-2014; PERALES, JOSE C. C/D-5586-2012; Lucas, Andres Mendez/AAG-7488-2020; Ventura, Francesc/ABG-2285-2020; PERALES, JOSE C/J-7457-2017	PERALES, JOSE C./0000-0001-7363-2226; Ventura, Francesc/0000-0001-9673-9405; Alcantara, Soledad/0000-0003-3313-2715; PERALES, JOSE C. C/0000-0001-7363-2226; Lucas, Andres Mendez/0000-0002-0725-4375; Ventura, Francesc/0000-0001-9673-9405; PERALES, JOSE C/0000-0001-7363-2226; Rodriguez-Carballo, Eddie/0000-0003-4321-508X	Ministry of Education and Science of Spain [BFU2011-24254]; Fundacio La Marato de TV3; Instituto de Salud Carlos III [RETIC RD06/0020]; Institut d'Investigacio Biomedica de Bellvitge (Barcelona, Spain)	Ministry of Education and Science of Spain(Spanish Government); Fundacio La Marato de TV3; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Institut d'Investigacio Biomedica de Bellvitge (Barcelona, Spain)	The authors thank Dr. K. Zhang and Dr. L. Bonewald for the IDG-SW3 and the MLO-Y4 cell lines. The authors also thank A. Angelo, E. Sanchez-Garcia, E. Adanero, Dr. E. Castano, and Dr. B. Torrejon for technical assistance, and C. Saldarriaga for assistance in graphic design. The authors also acknowledge B. Gamarra, A. Gimeno, and A. Altafaj for assistance in animal handling, and Drs. M. J. Ortuno and A. Ulsamer for critical discussions on the topics associated with this work. Dr. E. Rodriguez-Carballo received a fellowship from the Institut d'Investigacio Biomedica de Bellvitge (Barcelona, Spain). This work was supported through the Ministry of Education and Science of Spain (Grant BFU2011-24254), Fundacio La Marato de TV3, and Instituto de Salud Carlos III (Grant RETIC RD06/0020).	Asada N, 2013, CELL STEM CELL, V12, P737, DOI 10.1016/j.stem.2013.05.001; Baldock PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008415; Bulloch JM, 2014, PHARMACOL THERAPEUT, V143, P61, DOI 10.1016/j.pharmthera.2014.02.005; Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009; Davey RA, 2012, TRANSGENIC RES, V21, P885, DOI 10.1007/s11248-011-9581-z; de Ferranti S, 2008, CLIN CHEM, V54, P945, DOI 10.1373/clinchem.2007.100156; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Foresta C, 2010, J CLIN ENDOCR METAB, V95, P3502, DOI 10.1210/jc.2009-2557; GARRARD G, 1974, J ANAT, V117, P531; Ge CX, 2012, J BONE MINER RES, V27, P538, DOI 10.1002/jbmr.561; Gelfo F, 2011, PEPTIDES, V32, P1320, DOI 10.1016/j.peptides.2011.03.023; Greenblatt MB, 2013, ANNU REV CELL DEV BI, V29, P63, DOI 10.1146/annurev-cellbio-101512-122347; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Han SP, 2005, PEPTIDES, V26, P2603, DOI 10.1016/j.peptides.2005.05.024; Hirsch D, 2012, CELL MOL NEUROBIOL, V32, P645, DOI 10.1007/s10571-011-9793-z; HOOPER ACB, 1978, J ANAT, V127, P117; Hu MC, 2013, ANNU REV PHYSIOL, V75, P503, DOI 10.1146/annurev-physiol-030212-183727; Igwe JC, 2009, J CELL BIOCHEM, V108, P621, DOI 10.1002/jcb.22294; Ortuno MJ, 2010, J BIOL CHEM, V285, P31985, DOI 10.1074/jbc.M110.123612; Kageyama H, 2012, NEUROPEPTIDES, V46, P285, DOI 10.1016/j.npep.2012.09.007; Kajimura D, 2013, CELL METAB, V17, P901, DOI 10.1016/j.cmet.2013.04.009; KALRA SP, 1991, P NATL ACAD SCI USA, V88, P10931, DOI 10.1073/pnas.88.23.10931; Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763; Kos K, 2007, AM J PHYSIOL-ENDOC M, V293, pE1335, DOI 10.1152/ajpendo.00333.2007; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Ma YY, 2012, MOL CELLS, V33, P611, DOI 10.1007/s10059-012-0053-y; Matic I, 2012, J MUSCULOSKEL NEURON, V12, P209; Nunes AF, 2010, FEBS J, V277, P263, DOI 10.1111/j.1742-4658.2009.07482.x; Oury F, 2013, J CLIN INVEST, V123, P2421, DOI 10.1172/JCI65952; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Pi M, 2011, J BONE MINER RES, V26, P1680, DOI 10.1002/jbmr.390; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P3374, DOI 10.1073/pnas.73.10.3374; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P1447, DOI 10.1073/pnas.73.5.1447; Reid IR, 2008, OSTEOPOROSIS INT, V19, P595, DOI 10.1007/s00198-007-0492-z; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rodriguez-Carballo E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102032; Rosser J, 2012, METHODS MOL BIOL, V816, P67, DOI 10.1007/978-1-61779-415-5_6; Sato M, 2013, CELL METAB, V18, P749, DOI 10.1016/j.cmet.2013.09.014; Shi YC, 2013, CELL METAB, V17, P236, DOI 10.1016/j.cmet.2013.01.006; Shi YC, 2012, BONE, V50, P430, DOI 10.1016/j.bone.2011.10.001; Shi YC, 2011, OBESITY, V19, P2137, DOI 10.1038/oby.2011.99; Sindelar DK, 2004, ENDOCRINOLOGY, V145, P3363, DOI 10.1210/en.2003-1727; Sindelar DK, 2002, DIABETES, V51, P778, DOI 10.2337/diabetes.51.3.778; Singer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057929; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Swart I, 2002, AM J PHYSIOL-REG I, V283, pR1020, DOI 10.1152/ajpregu.00501.2001; TATEMOTO K, 1982, NATURE, V296, P659, DOI 10.1038/296659a0; Thouverey C, 2012, CELL MOL LIFE SCI, V69, P3115, DOI 10.1007/s00018-012-0983-8; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Wang FQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062988, 10.1371/journal.pone.0061792, 10.1371/journal.pone.0069284, 10.1371/journal.pone.0064373, 10.1371/journal.pone.0080480, 10.1371/journal.pone.0078025]; Wang LY, 2004, BONE, V34, P499, DOI 10.1016/j.bone.2003.11.022; Wei JW, 2014, J CLIN INVEST, V124, P1781, DOI 10.1172/JCI72323; Wei JW, 2014, DIABETES, V63, P1021, DOI 10.2337/db13-0887; Woo SM, 2011, J BONE MINER RES, V26, P2634, DOI 10.1002/jbmr.465; Yoshikawa Y, 2011, J BONE MINER RES, V26, P2012, DOI 10.1002/jbmr.417; Zhang L, 2010, INT J OBESITY, V34, P357, DOI 10.1038/ijo.2009.232	58	12	13	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1414	1425		10.1096/fj.14-261891	http://dx.doi.org/10.1096/fj.14-261891			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25550462				2022-12-26	WOS:000354115000027
J	Scazzari, M; Amm, I; Wolf, DH				Scazzari, Mario; Amm, Ingo; Wolf, Dieter H.			Quality Control of a Cytoplasmic Protein Complex CHAPERONE MOTORS AND THE UBIQUITIN-PROTEASOME SYSTEM GOVERN THE FATE OF ORPHAN FATTY ACID SYNTHASE SUBUNIT Fas2 OF YEAST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END RULE PATHWAY; ER-ASSOCIATED DEGRADATION; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; CYTOSOLIC PROTEINS; LUMINAL PROTEIN; ACID SYNTHASE; BUDDING YEAST; LIGASE UBR1; METHIONINE	For the assembly of protein complexes in the cell, the presence of stoichiometric amounts of the respective protein subunits is of utmost importance. A surplus of any of the subunits may trigger unspecific and harmful protein interactions and has to be avoided. A stoichiometric amount of subunits must finally be reached via transcriptional, translational, and/or post-translational regulation. Synthesis of saturated 16 and 18 carbon fatty acids is carried out by fatty acid synthase: in yeast Saccharomyces cerevisiae, a 2.6-MDa molecular mass assembly containing six protomers each of two different subunits, Fas1 (beta) and Fas2 (alpha). The (alpha)(6)(beta)(6) complex carries six copies of all eight enzymatic activities required for fatty acid synthesis. The FAS1 and FAS2 genes in yeast are unlinked and map on two different chromosomes. Here we study the fate of the alpha-subunit of the complex, Fas2, when its partner, the beta-subunit Fas1, is absent. Individual subunits of fatty acid synthase are proteolytically degraded when the respective partner is missing. Elimination of Fas2 is achieved by the proteasome. Here we show that a ubiquitin transfer machinery is required for Fas2 elimination. The major ubiquitin ligase targeting the superfluous Fas2 subunit to the proteasome is Ubr1. The ubiquitin-conjugating enzymes Ubc2 and Ubc4 assist the degradation process. The AAA-ATPase Cdc48 and the Hsp70 chaperone Ssa1 are crucially involved in the elimination of Fas2.	[Scazzari, Mario; Amm, Ingo; Wolf, Dieter H.] Univ Stuttgart, Inst Biochem, D-70569 Stuttgart, Germany	University of Stuttgart	Wolf, DH (corresponding author), Univ Stuttgart, Inst Biochem, Pfaffenwaldring 55, D-70569 Stuttgart, Germany.	dieter.wolf@ibc.uni-stuttgart.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft.	Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; ARFIN SM, 1988, BIOCHEMISTRY-US, V27, P7979, DOI 10.1021/bi00421a001; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Ausubel FM, 1992, CURRENT PROTOCOLS MO; Barbin L, 2010, BIOCHEM BIOPH RES CO, V394, P335, DOI 10.1016/j.bbrc.2010.03.005; Becker J, 1996, MOL CELL BIOL, V16, P4378; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; BURKL G, 1972, MOL GEN GENET, V119, P315, DOI 10.1007/BF00272089; CHIANG HL, 1991, NATURE, V350, P313, DOI 10.1038/350313a0; Ciechanover A, 2014, BBA-MOL CELL RES, V1843, P86, DOI 10.1016/j.bbamcr.2013.07.007; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; EGNER R, 1993, J BIOL CHEM, V268, P27269; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Franke J, 2013, NAT PROD REP, V30, P1299, DOI 10.1039/c3np70012g; Gauss R, 2005, YEAST, V22, P1, DOI 10.1002/yea.1187; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Goetze S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000236; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guthrie C, 1991, METHOD ENZYMOL, V194, P3; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Li X, 1995, P NATL ACAD SCI USA, V92, P12357, DOI 10.1073/pnas.92.26.12357; Lomakin IB, 2007, CELL, V129, P319, DOI 10.1016/j.cell.2007.03.013; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Nillegoda NB, 2010, MOL BIOL CELL, V21, P2102, DOI 10.1091/mbc.E10-02-0098; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHULLER HJ, 1992, EUR J BIOCHEM, V203, P607, DOI 10.1111/j.1432-1033.1992.tb16590.x; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; SHERMAN F, 1985, BIOESSAYS, V3, P27, DOI 10.1002/bies.950030108; SIEBENLIST U, 1990, YEAST, V6, P411, DOI 10.1002/yea.320060506; Stolz A, 2013, P NATL ACAD SCI USA, V110, P15271, DOI 10.1073/pnas.1304928110; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Wolf DH, 2011, FEBS LETT, V585, P2769, DOI 10.1016/j.febslet.2011.08.020; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832	55	19	19	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4677	4687		10.1074/jbc.M114.596064	http://dx.doi.org/10.1074/jbc.M114.596064			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25564609	Green Published, hybrid			2022-12-26	WOS:000350042000012
J	Vazquez-Victorio, G; Caligaris, C; Del Valle-Espinosa, E; Sosa-Garrocho, M; Gonzalez-Arenas, NR; Reyes-Cruz, G; Briones-Orta, MA; Macias-Silva, M				Vazquez-Victorio, Genaro; Caligaris, Cassandre; Del Valle-Espinosa, Eugenio; Sosa-Garrocho, Marcela; Gonzalez-Arenas, Nelly R.; Reyes-Cruz, Guadalupe; Briones-Orta, Marco A.; Macias-Silva, Marina			Novel Regulation of Ski Protein Stability and Endosomal Sorting by Actin Cytoskeleton Dynamics in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORMING-GROWTH-FACTOR; TGF-BETA RECEPTOR; LIVER-REGENERATION; SMAD PROTEINS; C-SKI; CELL-PROLIFERATION; ONCOPROTEIN; PATHWAY; SNON; GENE	TGF-beta-induced antimitotic signals are highly regulated during cell proliferation under normal and pathological conditions, such as liver regeneration and cancer. Up-regulation of the transcriptional cofactors Ski and SnoN during liver regeneration may favor hepatocyte proliferation by inhibiting TGF-beta signals. In this study, we found a novel mechanism that regulates Ski protein stability through TGF-beta and G protein-coupled receptor (GPCR) signaling. Ski protein is distributed between the nucleus and cytoplasm of normal hepatocytes, and the molecular mechanisms controlling Ski protein stability involve the participation of actin cytoskeleton dynamics. Cytoplasmic Ski is partially associated with actin and localized in cholesterol-rich vesicles. Ski protein stability is decreased by TGF-beta/Smads, GPCR/Rho signals, and actin polymerization, whereas GPCR/cAMP signals and actin depolymerization promote Ski protein stability. In conclusion, TGF-beta and GPCR signals differentially regulate Ski protein stability and sorting in hepatocytes, and this cross-talk may occur during liver regeneration.	[Vazquez-Victorio, Genaro; Caligaris, Cassandre; Del Valle-Espinosa, Eugenio; Sosa-Garrocho, Marcela; Gonzalez-Arenas, Nelly R.; Briones-Orta, Marco A.; Macias-Silva, Marina] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City 04510, DF, Mexico; [Reyes-Cruz, Guadalupe] CINVESTAV IPN, Dept Biol Celular, Mexico City 07000, DF, Mexico	Universidad Nacional Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Macias-Silva, M (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City 04510, DF, Mexico.	mmacias@ifc.unam.mx	Briones-Orta, Marco A/ABE-4747-2021	Briones-Orta, Marco A/0000-0001-6627-1901; Briones-Orta, Marco Antonio/0000-0003-0808-0570; Vazquez-Victorio, Genaro/0000-0002-2319-8772; Macias-Silva, Marina/0000-0002-3972-0983	PAPIIT/DGAPA/UNAM [IN222909, IN206012]; CONACyT [101826]; CONACyT	PAPIIT/DGAPA/UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by PAPIIT/DGAPA/UNAM Grants IN222909 and IN206012) and CONACyT Grant 101826 (to M. M. S.).; Student of the Ph.D. Program in Ciencias Biomedicas, UNAM and recipient of a fellowship from CONACyT.	Atanasoski S, 2004, NEURON, V43, P499, DOI 10.1016/j.neuron.2004.08.001; Awasthi-Kalia M, 2001, BIOCHEM BIOPH RES CO, V287, P77, DOI 10.1006/bbrc.2001.5536; Berk M, 1997, GENE DEV, V11, P2029, DOI 10.1101/gad.11.16.2029; Bonnon C, 2012, CELL TISSUE RES, V347, P51, DOI 10.1007/s00441-011-1180-z; Briones-Orta MA, 2013, CANCER RES, V73, P1800, DOI 10.1158/0008-5472.CAN-12-1916; Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283; Delgado-Coello B, 2011, LIVER INT, V31, P1271, DOI 10.1111/j.1478-3231.2011.02542.x; Delgado-Coello B, 2010, MOL CELL BIOCHEM, V344, P117, DOI 10.1007/s11010-010-0535-1; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Doyle AJ, 2012, NAT GENET, V44, P1249, DOI 10.1038/ng.2421; Ferrand N, 2010, CANCER RES, V70, P8457, DOI 10.1158/0008-5472.CAN-09-4088; Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5; Grewal T, 2000, J BIOL CHEM, V275, P33806, DOI 10.1074/jbc.M002662200; Herrera B, 2004, J CELL PHYSIOL, V201, P385, DOI 10.1002/jcp.20078; Imamura T, 2013, J BIOCHEM, V154, P481, DOI 10.1093/jb/mvt097; Jacob C, 2008, J CELL BIOL, V182, P519, DOI 10.1083/jcb.200710161; Kokura K, 2003, J BIOL CHEM, V278, P20133, DOI 10.1074/jbc.M210855200; Krakowski AR, 2005, P NATL ACAD SCI USA, V102, P12437, DOI 10.1073/pnas.0504107102; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Liu X, 2008, BIOCHEM J, V409, P289, DOI 10.1042/BJ20070545; Luo KX, 2004, CURR OPIN GENET DEV, V14, P65, DOI 10.1016/j.gde.2003.11.003; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Macias-Silva M, 2002, J BIOL CHEM, V277, P28483, DOI 10.1074/jbc.M202403200; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Marcelain K, 2005, ONCOGENE, V24, P4321, DOI 10.1038/sj.onc.1208631; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Mu XX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063436; Nagata M, 2006, GENES CELLS, V11, P1267, DOI 10.1111/j.1365-2443.2006.01018.x; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Prunier C, 2003, J BIOL CHEM, V278, P26249, DOI 10.1074/jbc.M304459200; Reed JA, 2005, CANCER METAST REV, V24, P265, DOI 10.1007/s10555-005-1576-x; Romero-Gallo J, 2005, ONCOGENE, V24, P3028, DOI 10.1038/sj.onc.1208475; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Shinagawa T, 2001, ONCOGENE, V20, P8100, DOI 10.1038/sj.onc.1204987; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Slimane TA, 2003, MOL BIOL CELL, V14, P611, DOI 10.1091/mbc.E02-08-0528; Soeta C, 2001, DEV GROWTH DIFFER, V43, P155; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Tecalco-Cruz AC, 2012, J BIOL CHEM, V287, P26764, DOI 10.1074/jbc.M112.386599; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Wang L, 2004, HEPATOLOGY, V39, P892, DOI 10.1002/hep.20039; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Xu WD, 2000, P NATL ACAD SCI USA, V97, P5924, DOI 10.1073/pnas.090097797; Ye F, 2011, J BIOL CHEM, V286, P40013, DOI 10.1074/jbc.M111.292029; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037	48	10	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4487	4499		10.1074/jbc.M114.579532	http://dx.doi.org/10.1074/jbc.M114.579532			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25561741	Green Published, hybrid			2022-12-26	WOS:000349458400054
J	Spencer, NC; Gilchrist, HG; Mallory, ML				Spencer, Nora C.; Gilchrist, H. Grant; Mallory, Mark L.			Annual Movement Patterns of Endangered Ivory Gulls: The Importance of Sea Ice	PLOS ONE			English	Article							EASTERN LANCASTER SOUND; NEST-SITE FIDELITY; LONG-LIVED SEABIRD; PAGOPHILA-EBURNEA; CLIMATE-CHANGE; POLAR BEARS; POPULATIONS; MIGRATION; SURVIVAL; TRANSMITTERS	The ivory gull (Pagophila eburnea) is an endangered seabird that spends its entire year in the Arctic environment. In the past three decades, threats from various sources have contributed to a >70% decline in Canada. To assess the annual habitat needs of this species, we attached satellite transmitters to 12 ivory gulls on Seymour Island, Nunavut in 2010, which provided up to four breeding seasons of tracking data. Analysis of migratory behaviour revealed considerable individual variation of post-breeding migratory route selection. Ivory gulls traveled a median of 74 days during post-breeding migration, but only 18 days during pre-breeding migration. In contrast to predictions, ivory gulls did not use the Greenland coast during migratory periods. Ivory gulls overwintered near the ice edge in Davis Strait, but also used the Labrador Sea in late February and March. We suggest that the timing of formation and recession and extent of sea ice plays a large role in ivory gull distribution and migratory timing.	[Spencer, Nora C.; Mallory, Mark L.] Acadia Univ, Dept Biol, Wolfville, NS B0P 1X0, Canada; [Gilchrist, H. Grant] Carleton Univ, Environm Canada, Natl Wildlife Res Ctr, Ottawa, ON K1S 5B6, Canada	Acadia University; Carleton University; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada	Mallory, ML (corresponding author), Acadia Univ, Dept Biol, Wolfville, NS B0P 1X0, Canada.	mark.mallory@acadiau.ca	Mallory, Mark L/A-1952-2017	Mallory, Mark L/0000-0003-2744-3437	Kenneth Molson Foundation [58-0-205568]; Environment Canada [K4E21-12-0850]; Natural Sciences and Engineering Research Council of Canada [41-0-205561]	Kenneth Molson Foundation; Environment Canada(CGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was supported by the Kenneth Molson Foundation, cheque number: 58-0-205568 (http://www.kennethmolsonfoundation.ca/); Environment Canada, agreement number: K4E21-12-0850, (http://www.ec.gc.ca/default.asp?lang=En &); Natural Sciences and Engineering Research Council of Canada, agreement 41-0-205561, (http://www.nserc-crsng.gc.ca/index_eng.asp). Dr. Karel Allard and Dr. Birgit Braune of Environment Canada were involved in the data collection of this project. Environment Canada was involved in the study design and the preparation of the manuscript. No other funders had a role in study design, data analysis, decision to publish or preparation of the manuscript.	AINLEY DG, 1984, ORNITHOLOGICAL MONOG, V32; Akesson S, 2007, BIOSCIENCE, V57, P123, DOI 10.1641/B570207; BATESON P. P. G., 1959, BRIT BIRDS, V52, P105; *BIRDLIFE INT, 2014, SPEC FACTSH PAG EB; Blackmer AL, 2004, BIOL CONSERV, V116, P141, DOI 10.1016/S0006-3207(03)00185-X; Boyd IL, 2006, CONSERV BIOL SER, P1, DOI 10.1017/CBO9780511541964.002; BRADSTREET MSW, 1982, ARCTIC, V35, P1; Burger AE, 2008, AUK, V125, P253, DOI 10.1525/auk.2008.1408; *CLS, 2014, ARG US MAN, P68; Conover M.R., 1979, P COLONIAL WATERBIRD, V2, P41, DOI 10.2307/1520932; *COSEWIC, 2006, ASS UPD STAT REP IV; Day R.H., 2001, BIRDS N AM ONLINE; Environment Canada, 2014, SPEC RISK ACT REC ST; FALK K, 1995, POLAR BIOL, V15, P495; Fiedler W, 2003, AVIAN MIGRATION, P21; Fort J, 2009, J EXP BIOL, V212, P2483, DOI 10.1242/jeb.032300; Furness RW, 2006, ARDEA, V94, P631; Gaston A.J., 2004, SEABIRDS NATURAL HIS; Gaston AJ, 2005, ECOGRAPHY, V28, P331, DOI 10.1111/j.0906-7590.2005.04179.x; Gaston AJ, 2012, POLAR BIOL, V35, P1221, DOI 10.1007/s00300-012-1168-5; Gaston AJ, 2009, ENVIRON REV, V17, P267, DOI 10.1139/A09-013; Gaston AJ, 2009, J FIELD ORNITHOL, V80, P135, DOI 10.1111/j.1557-9263.2009.00215.x; Gehrold A, 2014, J AVIAN BIOL, V45, P131, DOI 10.1111/j.1600-048X.2013.00248.x; Gilchrist HG, 2005, BIOL CONSERV, V121, P303, DOI 10.1016/j.biocon.2004.04.021; Gilg O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064614; Gilg O, 2012, ANN NY ACAD SCI, V1249, P166, DOI 10.1111/j.1749-6632.2011.06412.x; Gilg O, 2010, J AVIAN BIOL, V41, P532, DOI 10.1111/j.1600-048X.2010.05125.x; Gilg O, 2009, POLAR BIOL, V32, P1275, DOI 10.1007/s00300-009-0623-4; Gonzalez-Solis J, 2011, MAR ECOL PROG SER, V435, P251, DOI 10.3354/meps09233; Hatch S. A., 2009, BIRDS N AM ONLINE; Hatch SA, 2010, CAN J FISH AQUAT SCI, V67, P386, DOI 10.1139/F09-184; HOLM S, 1979, SCAND J STAT, V6, P65; Howell SNG, 2001, WATERBIRDS, V24, P438, DOI 10.2307/1522078; Hunter CM, 2010, ECOLOGY, V91, P2883, DOI 10.1890/09-1641.1; Irons DB, 2008, GLOBAL CHANGE BIOL, V14, P1455, DOI 10.1111/j.1365-2486.2008.01581.x; Johnston DW, 2005, CLIM RES, V29, P209, DOI 10.3354/cr029209; Karnovsky NJ, 2009, ARCTIC, V62, P65; Klaassen RHG, 2012, BEHAV ECOL, V23, P58, DOI 10.1093/beheco/arr150; Lindsay RW, 2005, J CLIMATE, V18, P4879, DOI 10.1175/JCLI3587.1; Mallory ML, 2010, LITTLE LESS ARCTIC: TOP PREDATORS IN THE WORLDS LARGEST NORTHERN INLAND SEA, HUDSON BAY, P179, DOI 10.1007/978-90-481-9121-5_9; Mallory Mark L., 2008, Marine Ornithology, V36, P183; Mallory ML, 2003, ARCTIC, V56, P293; Mallory ML, 2008, BIRDS N AM ONLINE; Maslanik J., 1999, NEAR REAL TIME DMSP; Maslanik JA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL032043; MCLAREN PL, 1982, ARCTIC, V35, P88; Molnar PK, 2010, BIOL CONSERV, V143, P1612, DOI 10.1016/j.biocon.2010.04.004; Mundy CJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038837; Naves LC, 2006, OIKOS, V115, P263; Nuijten RJM, 2014, J AVIAN BIOL, V45, P113, DOI 10.1111/j.1600-048X.2013.00287.x; OLDEN B, 1985, J FIELD ORNITHOL, V56, P17; ORR CD, 1982, CAN FIELD NAT, V96, P323; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; RENAUD WE, 1982, ARCTIC, V35, P141; Roberts JJ, 2010, ENVIRON MODELL SOFTW, V25, P1197, DOI 10.1016/j.envsoft.2010.03.029; Robertson GJ, 2007, AVIAN CONSERV ECOL, V2; SALYER JAMES W., 1962, JOUR WILDLIFE MANAGEMENT, V26, P219, DOI 10.2307/3798610; Senechal E, 2011, OECOLOGIA, V165, P593, DOI 10.1007/s00442-010-1853-4; Stenhouse IJ, 2012, IBIS, V154, P42, DOI 10.1111/j.1474-919X.2011.01180.x; Stenhouse IJ, 2004, WATERBIRDS, V27, P486, DOI 10.1675/1524-4695(2004)027[0486:RASROI]2.0.CO;2; Stirling I, 1997, J MARINE SYST, V10, P9, DOI 10.1016/S0924-7963(96)00054-1; Stirling I, 2006, ARCTIC, V59, P261; SWITZER PV, 1993, EVOL ECOL, V7, P533, DOI 10.1007/BF01237820; THOMAS VG, 1987, ARCTIC, V40, P211	64	27	29	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115231	10.1371/journal.pone.0115231	http://dx.doi.org/10.1371/journal.pone.0115231			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551556	Green Submitted, Green Published, gold			2022-12-26	WOS:000347119100032
J	Storms, ZJ; Sauvageau, D				Storms, Zachary J.; Sauvageau, Dominic			Evidence That the Heterogeneity of a T4 Population Is the Result of Heritable Traits	PLOS ONE			English	Article							LONG TAIL-FIBER; HOST-RANGE; BACTERIOPHAGE; ADSORPTION; PHAGE; RECEPTOR; ATTACHMENT; ORGANIZATION; KINETICS; PROTEIN	Many bacteriophage populations display heterogeneity in their adsorption characteristics; a portion of the phage population remains free in solution throughout adsorption experiments (residual fraction). This residual fraction generally constitutes a minority of phages that exhibit significantly slower adsorption kinetics than the main phage stock (main fraction). While this phenomenon is likely the result of evolutionary driving forces, the present study demonstrates that the residual fraction is not always the result of phenotypic variations within a single genotype, as is generally thought. Experiments with phage T4 showed that two subgroups with distinct adsorption traits that were passed on to their progeny could be isolated from the original phage stock. Sequencing of genes involved in adsorption revealed two point mutations in gene 37 of residual fraction isolates, which resulted in modifications to the long tail-fiber, the organelle of attachment and host cell recognition. Adsorption studies consistently showed that T4 phage stocks amplified from residual fraction isolates had significantly lower adsorption efficiencies than those amplified from main fractions. The conducted experiments provide convincing evidence that the observed heterogeneity in T4 adsorption behavior is the result of conserved mutations to the phage genome and is not exclusively the result of phenotypic variations within the population. While it is believed high mutation rates exist to hasten phage adaptation, this study shows that this bet hedging strategy can also, in the short term, inadvertently handicap the phage's adsorption capabilities to a given host under normal infection conditions, resulting in the residual fraction observed in adsorption experiments.	[Storms, Zachary J.; Sauvageau, Dominic] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB, Canada	University of Alberta	Sauvageau, D (corresponding author), Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB, Canada.	dominic.sauvageau@ualberta.ca			Natural Sciences and Engineering Research Council of Canada; Alberta Innovates - Technology Futures Postdoctoral Fellowship; University of Alberta	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates - Technology Futures Postdoctoral Fellowship; University of Alberta(University of Alberta)	ZS holds a Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship as well as an Alberta Innovates - Technology Futures Postdoctoral Fellowship. DS received funding from the University of Alberta start-up funds for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MH, 1959, BACTERIOPHAGES; ANDERSON TF, 1949, BOT REV, V15, P464, DOI 10.1007/BF02861677; Bartual SG, 2010, P NATL ACAD SCI USA, V107, P20287, DOI 10.1073/pnas.1011218107; BENDER RA, 1989, J BACTERIOL, V171, P1035, DOI 10.1128/jb.171.2.1035-1040.1989; BRAUN G, 1984, MOL GEN GENET, V195, P321, DOI 10.1007/BF00332766; Cerritelli ME, 1996, J MOL BIOL, V260, P767, DOI 10.1006/jmbi.1996.0436; CHRISTENSEN JR, 1965, VIROLOGY, V26, P727, DOI 10.1016/0042-6822(65)90336-3; Delbruck M, 1940, J GEN PHYSIOL, V23, P631, DOI 10.1085/jgp.23.5.631; DREXLER K, 1991, J MOL BIOL, V219, P655, DOI 10.1016/0022-2836(91)90662-P; DREXLER K, 1989, J MOL BIOL, V207, P797, DOI 10.1016/0022-2836(89)90245-3; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Gallet R, 2012, EVOLUTION, V66, P3485, DOI 10.1111/j.1558-5646.2012.01690.x; GAREN A, 1954, BIOCHIM BIOPHYS ACTA, V14, P163, DOI 10.1016/0006-3002(54)90155-9; GAREN A, 1951, J EXP MED, V94, P177, DOI 10.1084/jem.94.3.177; Goldberg Edward, 1994, P347; HABERER K, 1982, J VIROL, V41, P501, DOI 10.1128/JVI.41.2.501-507.1982; Hyman P, 2010, ADV APPL MICROBIOL, V70, P217, DOI 10.1016/S0065-2164(10)70007-1; KING J, 1971, J MOL BIOL, V62, P465, DOI 10.1016/0022-2836(71)90148-3; Moldovan R, 2007, BIOPHYS J, V93, P303, DOI 10.1529/biophysj.106.102962; PHILIPPI T, 1989, TRENDS ECOL EVOL, V4, P41, DOI 10.1016/0169-5347(89)90138-9; PUCK TT, 1953, COLD SPRING HARB SYM, V18, P149, DOI 10.1101/SQB.1953.018.01.024; PUCK TT, 1951, J EXP MED, V93, P65, DOI 10.1084/jem.93.1.65; Rakhuba DV, 2010, POL J MICROBIOL, V59, P145, DOI 10.33073/pjm-2010-023; Ripp S, 1997, MICROBIOL-UK, V143, P2065, DOI 10.1099/00221287-143-6-2065; Schlesinger M., 1932, Z HYG INFEKTIONSKR, V114, P136, DOI 10.1007/BF02176514; SCHWARTZ M, 1976, J MOL BIOL, V103, P521, DOI 10.1016/0022-2836(76)90215-1; STEENSMA HY, 1982, A VAN LEEUW J MICROB, V48, P183, DOI 10.1007/BF00405202; STENT GS, 1952, BIOCHIM BIOPHYS ACTA, V8, P260, DOI 10.1016/0006-3002(52)90041-3; Stockdale SR, 2013, J BIOL CHEM, V288, P5581, DOI 10.1074/jbc.M112.444901; Storms ZJ, 2012, BIOCHEM ENG J, V64, P22, DOI 10.1016/j.bej.2012.02.007; Storms ZJ, 2010, BIOPROC BIOSYST ENG, V33, P823, DOI 10.1007/s00449-009-0405-y; Tetart F, 1996, J MOL BIOL, V258, P726, DOI 10.1006/jmbi.1996.0281; Uchiyama J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026648; WATANABE K, 1982, AGR BIOL CHEM TOKYO, V46, P697, DOI 10.1080/00021369.1982.10865142; Whitehead DJ, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-18; Williamson SJ, 2001, APPL ENVIRON MICROB, V67, P1682, DOI 10.1128/AEM.67.4.1682-1688.2001; Wilson WH, 1997, AQUAT MICROB ECOL, V13, P95, DOI 10.3354/ame013095; Zonenstein Y, 2010, BIOCHEM ENG J, V48, P225, DOI 10.1016/j.bej.2009.10.016	38	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116235	10.1371/journal.pone.0116235	http://dx.doi.org/10.1371/journal.pone.0116235			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551763	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100111
J	Ventura, GT; da Costa, ECB; Capaccia, AM; Mohana-Borges, R				Ventura, Gustavo Tavares; Brasil da Costa, Emmerson Correa; Capaccia, Anne Miranda; Mohana-Borges, Ronaldo			pH-Dependent Conformational Changes in the HCV NS3 Protein Modulate Its ATPase and Helicase Activities	PLOS ONE			English	Article							HEPATITIS-C VIRUS; RNA HELICASE; CRYSTAL-STRUCTURE; ENZYMATIC-ACTIVITIES; PRIMASE INHIBITORS; SERINE-PROTEASE; DUPLEX RNA; DOMAIN; REPLICATION; BINDING	The hepatitis C virus (HCV) infects 170 to 200 million people worldwide and is, therefore, a major health problem. The lack of efficient treatments that specifically target the viral proteins or RNA and its high chronicity rate make hepatitis C the cause of many deaths and hepatic transplants annually. The NS3 protein is considered an important target for the development of anti-HCV drugs because it is composed of two domains (a serine protease in the N-terminal portion and an RNA helicase/NTPase in the C-terminal portion), which are essential for viral replication and proliferation. We expressed and purified both the NS3 helicase domain (NS3hel) and the full-length NS3 protein (NS3FL) and characterized pH-dependent structural changes associated with the increase in their ATPase and helicase activities at acidic pH. Using intrinsic fluorescence experiments, we have observed that NS3hel was less stable at pH 6.4 than at pH 7.2. Moreover, binding curves using an extrinsic fluorescent probe (bis-ANS) and ATPase assays performed under different pH conditions demonstrated that the hydrophobic clefts of NS3 are significantly more exposed to the aqueous medium at acidic pH. Using fluorescence spectroscopy and anisotropy assays, we have also observed more protein interaction with DNA upon pH acidification, which suggests that the hydrophobic clefts exposure on NS3 might be related to a loss of stability that could lead it to adopt a more open conformation. This conformational change at acidic pH would stimulate both its ATPase and helicase activities, as well as its ability to bind DNA. Taken together, our results indicate that the NS3 protein adopts a more open conformation due to acidification from pH 7.2 to 6.4, resulting in a more active form at a pH that is found near Golgi-derived membranes. This increased activity could better allow NS3 to carry out its functions during HCV replication.	[Ventura, Gustavo Tavares; Brasil da Costa, Emmerson Correa; Capaccia, Anne Miranda; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, Brazil.	mohana@biof.ufrj.br	Borges, Ronaldo S Mohana/C-5575-2013		Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCTINBEB); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCTINBEB); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by the following Brazilian funding agencies: Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCTINBEB), Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abian O, 2010, BIOPHYS J, V99, P3811, DOI 10.1016/j.bpj.2010.10.037; Alvisi G, 2011, RNA BIOL, V8, P258, DOI 10.4161/rna.8.2.15011; Asselah T, 2011, LIVER INT, V31, P68, DOI 10.1111/j.1478-3231.2010.02411.x; Aydin C, 2013, PROTEIN SCI, V22, P1786, DOI 10.1002/pro.2378; Belon CA, 2009, FUTURE VIROL, V4, P277, DOI 10.2217/FVL.09.7; Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; Cho HS, 1998, J BIOL CHEM, V273, P15045, DOI 10.1074/jbc.273.24.15045; Crute JJ, 2002, NAT MED, V8, P386, DOI 10.1038/nm0402-386; Dubuisson J, 2007, WORLD J GASTROENTERO, V13, P2406, DOI 10.3748/wjg.v13.i17.2406; Fiske CH, 1927, SCIENCE, V65, P401, DOI 10.1126/science.65.1686.401; Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1; Frick DN, 2004, NUCLEIC ACIDS RES, V32, P5519, DOI 10.1093/nar/gkh891; Frick DN, 2004, J BIOL CHEM, V279, P1269, DOI 10.1074/jbc.M310630200; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gallinari P, 1998, J VIROL, V72, P6758, DOI 10.1128/JVI.72.8.6758-6769.1998; Gwack Y, 1996, BIOCHEM BIOPH RES CO, V225, P654, DOI 10.1006/bbrc.1996.1225; Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Kleymann G, 2002, NAT MED, V8, P392, DOI 10.1038/nm0402-392; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Kwong AD, 2011, NAT BIOTECHNOL, V29, P993, DOI 10.1038/nbt.2020; Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006; Lam AMI, 2004, NUCLEIC ACIDS RES, V32, P4060, DOI 10.1093/nar/gkh743; Lam AMI, 2003, J BIOL CHEM, V278, P44514, DOI 10.1074/jbc.M306444200; Lam AMI, 2003, J VIROL, V77, P3950, DOI 10.1128/JVI.77.7.3950-3961.2003; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lim SR, 2012, ANTIMICROB AGENTS CH, V56, P271, DOI 10.1128/AAC.05636-11; Liu WJ, 2002, J VIROL, V76, P10766, DOI 10.1128/JVI.76.21.10766-10775.2002; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Mackintosh SG, 2006, J BIOL CHEM, V281, P3528, DOI 10.1074/jbc.M512100200; Matlock DL, 2010, BIOCHEMISTRY-US, V49, P2097, DOI 10.1021/bi901977k; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Pace CN, 2000, PROTEINS, P1; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Pawlotsky JM, 2014, SEMIN LIVER DIS, V34, P22, DOI 10.1055/s-0034-1371007; Piccininni S, 2002, J BIOL CHEM, V277, P45670, DOI 10.1074/jbc.M204124200; Sali DL, 1998, BIOCHEMISTRY-US, V37, P3392, DOI 10.1021/bi972010r; Serafino A, 2003, J MED VIROL, V70, P31, DOI 10.1002/jmv.10367; Serebrov V, 2009, J BIOL CHEM, V284, P2512, DOI 10.1074/jbc.M805460200; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Taremi SS, 1998, PROTEIN SCI, V7, P2143, DOI 10.1002/pro.5560071011; Tsai WL, 2010, ONCOGENE, V29, P2309, DOI 10.1038/onc.2010.36; Uhl P, 2014, INT J MOL SCI, V15, P7500, DOI 10.3390/ijms15057500; Vaughan R, 2012, VIRUS RES, V169, P80, DOI 10.1016/j.virusres.2012.07.007; Vega S, 2013, INT J MOL SCI, V14, P13282, DOI 10.3390/ijms140713282; Venkatraman S, 2012, TRENDS PHARMACOL SCI, V33, P289, DOI 10.1016/j.tips.2012.03.012; Wardell AD, 1999, J GEN VIROL, V80, P701, DOI 10.1099/0022-1317-80-3-701; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463; Yau AHL, 2014, CAN J GASTROENTEROL, V28, P445, DOI 10.1155/2014/549624	52	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115941	10.1371/journal.pone.0115941	http://dx.doi.org/10.1371/journal.pone.0115941			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551442	gold, Green Published, Green Submitted			2022-12-26	WOS:000347119100079
J	Balasubramanian, R; Robaye, B; Boeynaems, JM; Jacobson, KA				Balasubramanian, Ramachandran; Robaye, Bernard; Boeynaems, Jean-Marie; Jacobson, Kenneth A.			Enhancement of Glucose Uptake in Mouse Skeletal Muscle Cells and Adipocytes by P2Y(6) Receptor Agonists	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; G(Q)-COUPLED RECEPTOR; DEPENDENT MECHANISM; INSULIN-SECRETION; GLUT4 PROMOTER; IN-VIVO; TRANSCRIPTION; TRANSPORT; MICE; UDP	Glucose uptake by peripheral tissues such as skeletal muscles and adipocytes is important in the maintenance of glucose homeostasis. We previously demonstrated that P2Y(6) receptor (P2Y(6)R) agonists protect pancreatic islet cells from apoptosis and stimulate glucose-dependent insulin release. Here, we investigated the effects of P2Y(6)R activation on glucose uptake in insulin target tissues. An agonist of the P2Y(6)R, P-1-(5'-uridine)-P-3-(5'-N-4-methoxycytidine)-triphosphate (MRS2957), significantly increased the uptake of [H-3]2-deoxyglucose in mouse C2C12 myotubes and 3T3-L1 adipocytes, and this stimulation was significantly decreased by a selective P2Y6R antagonist N,N'-1,4-butanediyl-bis[N'-(3-isothiocyanatophenyl)thiourea] (MRS2578). Pre-incubation with Compound C (an inhibitor of 5'-AMP-activated protein kinase, AMPK), or AMPK siRNA abolished the stimulatory effect of MRS2957 on glucose uptake. Also, MRS2957 (60 min incubation) increased recruitment of the facilitated glucose transporter-4 (GLUT4) to the cell membrane, which was blocked by MRS2578. Treatment of C2C12 myotubes with MRS2957 induced significant phosphorylation of AMPK, which increase GLUT4 expression through histone deacetylase (HDAC) 5 signaling. Glucose uptake in primary mouse adipocytes from wild-type mice was stimulated upon P2Y6R activation by either MRS2957 or native agonist UDP, and the P2Y(6)R effect was antagonized by MRS2578. However, in adipocytes from P2Y(6)R-knockout mice P2Y(6)R agonists had no effect on glucose uptake, and there was no change in the glucose uptake by insulin. Our results indicate that the P2Y(6)R promotes glucose metabolism in peripheral tissues, which may be mediated through AMPK signaling.	[Balasubramanian, Ramachandran; Jacobson, Kenneth A.] NIDDK, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Robaye, Bernard] Univ Libre Bruxelles, IRIBHM, Inst Interdisciplinary Res, Gosselies, Belgium; [Boeynaems, Jean-Marie] Univ Libre Bruxelles, Brussels, Belgium	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Universite Libre de Bruxelles; Universite Libre de Bruxelles	Jacobson, KA (corresponding author), NIDDK, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA.	kajacobs@helix.nih.gov	Jacobson, Kenneth Alan/A-1530-2009	Jacobson, Kenneth Alan/0000-0001-8104-1493	Intramural Research Program of NIDDK, National Institutes of Health, Bethesda, MD, USA [Z01 DK031116-27]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031116, Z01DK031116] Funding Source: NIH RePORTER	Intramural Research Program of NIDDK, National Institutes of Health, Bethesda, MD, USA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Intramural Research Program of NIDDK, National Institutes of Health, Bethesda, MD, USA; Grant: Z01 DK031116-27. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amisten S, 2010, DIABETOLOGIA, V53, P1927, DOI 10.1007/s00125-010-1807-8; Aune UL, 2013, JOVE-J VIS EXP, DOI 10.3791/50191; Balasubramanian R, 2013, BIOCHEM PHARMACOL, V85, P991, DOI 10.1016/j.bcp.2012.11.029; Bar I, 2008, MOL PHARMACOL, V74, P777, DOI 10.1124/mol.108.046904; Burnstock G, 2012, WIRES COMPUT STAT, V1, P116, DOI [10.1002/wmts.14., DOI 10.1002/WMTS.14]; Christensen DP, 2011, MOL MED, V17, P378, DOI 10.2119/molmed.2011.00021; Communi D, 1996, BIOCHEM BIOPH RES CO, V222, P303, DOI 10.1006/bbrc.1996.0739; El-Tayeb A, 2011, J MED CHEM, V54, P2878, DOI 10.1021/jm1016297; Ginsburg-Shmuel T, 2010, J MED CHEM, V53, P1673, DOI 10.1021/jm901450d; Gong HJ, 2011, MED SCI SPORT EXER, V43, P1441, DOI 10.1249/MSS.0b013e31820f6093; Guns PJDF, 2010, BRIT J PHARMACOL, V159, P326, DOI 10.1111/j.1476-5381.2009.00497.x; Inazuka F, 2006, PCT Int Appl, Patent No. [WO 2006052007 A1 20060518, 2006052007]; Jain S, 2013, J CLIN INVEST, V123, P1750, DOI 10.1172/JCI66432; Karczewska J, 2011, BIOCHEM BIOPH RES CO, V404, P723, DOI 10.1016/j.bbrc.2010.12.051; Kim SG, 2003, CELL MOL NEUROBIOL, V23, P401, DOI 10.1023/A:1023696806609; Koistinen HA, 2003, DIABETES, V52, P1066, DOI 10.2337/diabetes.52.5.1066; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee YJ, 2005, AM J PHYSIOL-CELL PH, V289, pC1268, DOI 10.1152/ajpcell.00002.2005; Li JH, 2013, ENDOCRINOLOGY, V154, P3539, DOI 10.1210/en.2012-2127; Mamedova LK, 2008, PHARMACOL RES, V58, P232, DOI 10.1016/j.phrs.2008.08.004; Mamedova LK, 2004, BIOCHEM PHARMACOL, V67, P1763, DOI 10.1016/j.bcp.2004.01.011; Maruoka H, 2010, J MED CHEM, V53, P4488, DOI 10.1021/jm100287t; Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843; Merlin J, 2010, CELL SIGNAL, V22, P1104, DOI 10.1016/j.cellsig.2010.03.004; Moore DJ, 2001, BBA-GENE STRUCT EXPR, V1521, P107, DOI 10.1016/S0167-4781(01)00291-3; Mukwevho E, 2008, AM J PHYSIOL-ENDOC M, V294, pE582, DOI 10.1152/ajpendo.00312.2007; Murgia M, 2009, J PHYSIOL-LONDON, V587, P4319, DOI 10.1113/jphysiol.2009.174888; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; Parandeh F, 2008, BIOCHEM BIOPH RES CO, V370, P499, DOI 10.1016/j.bbrc.2008.03.119; Rachdaoui N, 2003, AM J PHYSIOL-ENDOC M, V285, pE545, DOI 10.1152/ajpendo.00160.2003; Ruan H, 2003, J BIOL CHEM, V278, P47585, DOI 10.1074/jbc.M305257200; Sassmann A, 2010, J CLIN INVEST, V120, P2184, DOI 10.1172/JCI41541; Schwartz MW, 2013, NATURE, V503, P59, DOI 10.1038/nature12709; Shibata H, 1996, J BIOL CHEM, V271, P9704, DOI 10.1074/jbc.271.16.9704; Solini A, 2003, J CELL PHYSIOL, V197, P435, DOI 10.1002/jcp.10379; Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8; Sparling DP, 2008, J BIOL CHEM, V283, P7429, DOI 10.1074/jbc.M800481200; Thaning P, 2010, DIABETES, V59, P182, DOI 10.2337/db09-1068; Vieira RP, 2011, AM J RESP CRIT CARE, V184, P215, DOI 10.1164/rccm.201011-1762OC; Warny M, 2001, J BIOL CHEM, V276, P26051, DOI 10.1074/jbc.M102568200; Weems JC, 2012, DIABETES, V61, P1404, DOI 10.2337/db11-0737	42	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116203	10.1371/journal.pone.0116203	http://dx.doi.org/10.1371/journal.pone.0116203			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549240	Green Published, Green Submitted, gold			2022-12-26	WOS:000347063500060
J	Couto, A; Monceau, K; Bonnard, O; Thiery, D; Sandoz, JC				Couto, Antoine; Monceau, Karine; Bonnard, Olivier; Thiery, Denis; Sandoz, Jean-Christophe			Olfactory Attraction of the Hornet Vespa velutina to Honeybee Colony Odors and Pheromones	PLOS ONE			English	Article							MISCHOCYTTARUS-FLAVITARSIS HYMENOPTERA; APIS-MELLIFERA; VOLATILE COMPOUNDS; WASPS HYMENOPTERA; FORAGING BEHAVIOR; CRASSOSTREA-GIGAS; ACTIVE COMPONENT; BROOD PHEROMONE; AROMA COMPOUNDS; PREY QUANTITY	Since the beginning of the last century, the number of biological invasions has continuously increased worldwide. Due to their environmental and economical consequences, invasive species are now a major concern. Social wasps are particularly efficient invaders because of their distinctive biology and behavior. Among them, the yellow-legged hornet, Vespa velutina, is a keen hunter of domestic honeybees. Its recent introduction to Europe may induce important beekeeping, pollination, and biodiversity problems. Hornets use olfactory cues for the long-range detection of food sources, in this case the location of honeybee colonies, but the exact nature of these cues remains unknown. Here, we studied the orientation behavior of V. velutina workers towards a range of hive products and protein sources, as well as towards prominent chemical substances emitted by these food sources. In a multiple choice test performed under controlled laboratory conditions, we found that hornets are strongly attracted to the odor of some hive products, especially pollen and honey. When testing specific compounds, the honeybee aggregation pheromone, geraniol, proved highly attractive. Pheromones produced by honeybee larvae or by the queen were also of interest to hornet workers, albeit to a lesser extent. Our results indicate that V. velutina workers are selectively attracted towards olfactory cues from hives (stored food, brood, and queen), which may signal a high prey density. This study opens new perspectives for understanding hornets' hunting behavior and paves the way for developing efficient trapping strategies against this invasive species.	[Couto, Antoine; Sandoz, Jean-Christophe] CNRS, UPR 9034, Evolut Genomes & Speciat Lab LEGS, Gif Sur Yvette, France; [Monceau, Karine] Univ Bourgogne, Equipe Ecol Evolut, UMR CNRS Biogeosci 6282, Dijon, France; [Bonnard, Olivier; Thiery, Denis] INRA, UMR St & Agroecol Vignoble 1065, Villenave Dornon, France; [Bonnard, Olivier; Thiery, Denis] Univ Bordeaux, ISVV, UMR St & Agroecol Vignoble 1065, Villenave Dornon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Universite de Bourgogne; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Sandoz, JC (corresponding author), CNRS, UPR 9034, Evolut Genomes & Speciat Lab LEGS, Gif Sur Yvette, France.	sandoz@legs.cnrs-gif.fr	SANDOZ, Jean-Christophe/A-6085-2012	SANDOZ, Jean-Christophe/0000-0002-5423-9645; Monceau, Karine/0000-0003-3786-1835; Couto, Antoine/0000-0002-5528-7331	Region Ile-de-France (DIM R2DS); French Academy of Agriculture (Bourse Dufrenoy)	Region Ile-de-France (DIM R2DS)(Region Ile-de-France); French Academy of Agriculture (Bourse Dufrenoy)	This work was supported by a grant from Region Ile-de-France to JCS (DIM R2DS, http://www.r2ds-ile-de-france.com/, project 2011-05) and by a travel grant from the French Academy of Agriculture (Bourse Dufrenoy, http://www.academie-agriculture.fr/) to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo CA, 2011, PROC FOOD SCI, V1, P549, DOI 10.1016/j.profoo.2011.09.083; Agila A, 2013, J FOOD SCI, V78, pC184, DOI 10.1111/1750-3841.12033; Akre RD, 1980, US DEP AGR HDB, V552; Arca M, 2014, BEHAV PROCESS, V106, P122, DOI 10.1016/j.beproc.2014.05.002; Armstrong TR, 2003, BEHAV ECOL SOCIOBIOL, V54, P310, DOI 10.1007/s00265-003-0624-1; Baraldi R, 1999, PHYS CHEM EARTH PT B, V24, P729, DOI 10.1016/S1464-1909(99)00073-8; BOCH R, 1962, NATURE, V195, P1018, DOI 10.1038/1951018b0; BOCH R, 1962, NATURE, V194, P704, DOI 10.1038/194704b0; BORGKARLSON AK, 1985, CHEM SCRIPTA, V25, P283; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Brockmann A, 2006, J CHEM ECOL, V32, P657, DOI 10.1007/s10886-005-9027-2; Brodmann J, 2009, CURR BIOL, V19, P1368, DOI 10.1016/j.cub.2009.06.067; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Choi M.B., 2011, ENTOMOL RES, V41, P276, DOI [10.1111/j.1748-5967.2011.00370.x, DOI 10.1111/J.1748-5967.2011.00370.X]; Christlbauer M, 2011, J AGR FOOD CHEM, V59, P13122, DOI 10.1021/jf203340a; COLLINS AM, 1982, J CHEM ECOL, V8, P463, DOI 10.1007/BF00987794; CORNELIUS ML, 1993, J INSECT BEHAV, V6, P771, DOI 10.1007/BF01201676; D'Adamo P, 2004, J INSECT BEHAV, V17, P809, DOI 10.1023/B:JOIR.0000048990.22170.96; D'Adamo P, 2003, NEW ZEAL J ZOOL, V30, P171, DOI 10.1080/03014223.2003.9518336; D'Adamo P, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.10301; d'Ippolito G, 2003, ORG LETT, V5, P885, DOI 10.1021/ol034057c; Day SE, 2001, ENVIRON ENTOMOL, V30, P157, DOI 10.1603/0046-225X-30.2.157; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; Edwards R, 1980, THEIR BEHAV CONTROL; Elton C. S., 1958, ECOLOGY INVASIONS AN; Faraji H, 2004, J AGR FOOD CHEM, V52, P7164, DOI 10.1021/jf035291k; Formisano C, 2009, MOLECULES, V14, P4597, DOI 10.3390/molecules14114597; Free J. B., 1987, PHEROMONES SOCIAL BE; Grigorakis K, 2003, AQUACULTURE, V225, P109, DOI 10.1016/S0044-8486(03)00283-7; Haxaire Jean, 2006, Bulletin de la Societe Entomologique de France, V111, P194; HENDRICHS J, 1994, OECOLOGIA, V99, P88, DOI 10.1007/BF00317087; Hilker M, 2002, J EXP BIOL, V205, P455; Hochberg ME, 2005, TRENDS ECOL EVOL, V20, P211, DOI 10.1016/j.tree.2005.03.005; Janes D, 2009, FOOD CHEM, V112, P120, DOI 10.1016/j.foodchem.2008.05.048; Jung C, 2008, KOREAN J APIC, V24, P61; Keeling CI, 2003, P NATL ACAD SCI USA, V100, P4486, DOI 10.1073/pnas.0836984100; Ken T, 2005, NATURWISSENSCHAFTEN, V92, P492, DOI 10.1007/s00114-005-0026-5; KENNEDY JS, 1978, PHYSIOL ENTOMOL, V3, P91, DOI 10.1111/j.1365-3032.1978.tb00138.x; LE CONTE Y, 1990, NATURWISSENSCHAFTEN, V77, P334, DOI 10.1007/BF01138390; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; Li JJ, 2008, J APICULT RES, V47, P174, DOI 10.1080/00218839.2008.11101449; Lozada M, 2009, ENVIRON ENTOMOL, V38, P803, DOI 10.1603/022.038.0333; Lozada M, 2006, J INSECT BEHAV, V19, P591, DOI 10.1007/s10905-006-9045-0; Lozada M, 2011, J INSECT BEHAV, V24, P159, DOI 10.1007/s10905-010-9244-6; Maisonnasse A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013531; Matsuura M., 1990, BIOL VESPINE WASPS; MATTIACCI L, 1995, P NATL ACAD SCI USA, V92, P2036, DOI 10.1073/pnas.92.6.2036; McPheron LJ, 2007, ENTOMOL GEN, V30, P105; McPheron LJ, 2007, ENTOMOL GEN, V29, P125; Mohammedi A, 1996, CR ACAD SCI III-VIE, V319, P769; Moller H, 1996, BIOL CONSERV, V78, P125, DOI 10.1016/0006-3207(96)00022-5; Monceau K, 2013, INSECT SOC, V60, P437, DOI 10.1007/s00040-013-0308-4; Monceau K, 2014, INSECT SCI; Monceau K, 2014, J PEST SCI, V87, P1, DOI 10.1007/s10340-013-0537-3; Monceau K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066492; Moreyra S, 2012, ANN ENTOMOL SOC AM, V105, P128, DOI 10.1603/AN11097; Morgan ED, 2009, PHYSIOL ENTOMOL, V34, P1, DOI 10.1111/j.1365-3032.2008.00658.x; ONO M, 1995, NATURE, V377, P334, DOI 10.1038/377334a0; Pankiw T, 2000, NATURWISSENSCHAFTEN, V87, P487, DOI 10.1007/s001140050764; Papachristoforou A, 2007, CURR BIOL, V17, pR795, DOI 10.1016/j.cub.2007.07.033; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Park K, 2004, ECOL SOC, V9; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Perrard A, 2009, ANN SOC ENTOMOL FR, V45, P119, DOI 10.1080/00379271.2009.10697595; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Piveteau F, 2000, J AGR FOOD CHEM, V48, P4851, DOI 10.1021/jf991394k; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Refsgaard HHF, 1999, J AGR FOOD CHEM, V47, P1114, DOI 10.1021/jf9807770; Richter MR, 2000, ANNU REV ENTOMOL, V45, P121, DOI 10.1146/annurev.ento.45.1.121; Rome Quentin, 2011, Aliens (Auckland), V31, P7; Rota V, 2006, ACS SYM SER, V920, P73; Santos JR, 2003, J CHROMATOGR A, V985, P395, DOI 10.1016/S0021-9673(02)01396-1; SCHMIDT JO, 1994, J CHEM ECOL, V20, P1053, DOI 10.1007/BF02059741; Selli S, 2006, J AGR FOOD CHEM, V54, P9496, DOI 10.1021/jf0619582; Shafir S, 1996, BIOTROPICA, V28, P243, DOI 10.2307/2389078; SHEARER DA, 1965, NATURE, V206, P530, DOI 10.1038/206530a0; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; SLESSOR KN, 1988, NATURE, V332, P354, DOI 10.1038/332354a0; Snyder WE, 2006, ANNU REV ECOL EVOL S, V37, P95, DOI 10.1146/annurev.ecolsys.37.091305.110107; Spradbery JP, 1973, WASPS ACCOUNT BIOL N; Stamp NE, 2001, ECOL ENTOMOL, V26, P292, DOI 10.1046/j.1365-2311.2001.00325.x; Tan K, 2007, NATURWISSENSCHAFTEN, V94, P469, DOI 10.1007/s00114-006-0210-2; Tan K, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14102; Tan K, 2013, NATURWISSENSCHAFTEN, V100, P245, DOI 10.1007/s00114-013-1019-4; Tan K, 2012, ANIM BEHAV, V83, P879, DOI 10.1016/j.anbehav.2011.12.031; Toh Y, 2003, ZOOL SCI, V20, P311, DOI 10.2108/zsj.20.311; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Varlet V, 2006, J AGR FOOD CHEM, V54, P3391, DOI 10.1021/jf053001p; Vasta V, 2007, J AGR FOOD CHEM, V55, P4630, DOI 10.1021/jf063432n; Vasta V, 2012, MEAT SCI, V90, P451, DOI 10.1016/j.meatsci.2011.09.006; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Vitousek PM, 1996, AM SCI, V84, P468; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Wang ZW, 2014, INSECT SOC, V61, P67, DOI 10.1007/s00040-013-0326-2; Weiss MR, 2004, ANIM BEHAV, V68, P45, DOI 10.1016/j.anbehav.2003.07.010; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Winston M.L., 1991, BIOL HONEY BEE; Zhang ZM, 2009, FOOD CHEM, V115, P1150, DOI 10.1016/j.foodchem.2008.12.099	99	34	34	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115943	10.1371/journal.pone.0115943	http://dx.doi.org/10.1371/journal.pone.0115943			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549358	gold, Green Submitted, Green Published			2022-12-26	WOS:000347063500042
J	Grill, E; Schaffler, F; Huppert, D; Muller, M; Kapfhammer, HP; Brandt, T				Grill, Eva; Schaeffler, Florian; Huppert, Doreen; Mueller, Martin; Kapfhammer, Hans-Peter; Brandt, Thomas			Self-Efficacy Beliefs Are Associated with Visual Height Intolerance: A Cross-Sectional Survey	PLOS ONE			English	Article							HEALTH SURVEY; PHOBIA; FEAR; ACROPHOBIA; DETERMINANTS; DISORDERS; VERTIGO; DANGER; MOTION; SPACE	Background: Responses to height may range from indifference to minor distress to severe symptoms of fear of heights (acrophobia); visual height intolerance (vHI) denotes the whole spectrum of symptoms. Although there are options to manage vHI, only a small part of persons affected by vHI are willing to seek professional help or confront their problem. Purpose of this study was to determine if persons with vHI, specifically those who show avoidant behavior towards heights (avoiders), score lower in their general self-efficacy (GSE) than those who confront vHI (confronters). Method: Cross-sectional survey in 607 individuals living in the urban region of Munich, Germany, using a mailed questionnaire on presence or absence of vHI, confronting or avoiding behaviour, and GSE. Results: Of all participants (mean age 53.9, 50.3% female), 407 reported life-time presence of vHI. Participants with vHI had a mean GSE score of 31.8 (SD 4.3) points (participants without vHI: 32.5, SD 4.3, p = 0.008 for difference). Among individuals with vHI, 23% reported confronting behavior. Confronters were significantly younger (p<.0001, 50.2 vs. 55.7 years), more likely to be female (p=0.0039, 64.3% female), and had a higher GSE score (p=0.0049, 32.5 vs. 31.1). Associations remained significant after multiple adjustment. Conclusions: Our study provides evidence for the association of GSE and vHI. These findings may have consequences for strategies of alleviation and therapy of vHI.	[Grill, Eva; Schaeffler, Florian; Mueller, Martin] Univ Munich, Inst Med Informat Proc Biometr & Epidemiol IBE, D-81377 Munich, Germany; [Grill, Eva; Huppert, Doreen; Mueller, Martin; Brandt, Thomas] Univ Munich, German Ctr Vertigo & Balance Disorders, D-81377 Munich, Germany; [Schaeffler, Florian] Hsch Munchen Univ Appl Sci, Dept Appl Social Sci, D-81243 Munich, Germany; [Huppert, Doreen; Brandt, Thomas] Univ Munich, Inst Clin Neurosci, D-81377 Munich, Germany; [Kapfhammer, Hans-Peter] Med Univ Graz, Dept Psychiat, A-8036 Graz, Austria	University of Munich; University of Munich; University of Munich; Medical University of Graz	Grill, E (corresponding author), Univ Munich, Inst Med Informat Proc Biometr & Epidemiol IBE, Marchioninistr 17, D-81377 Munich, Germany.	eva.grill@med.uni-muenchen.de	Grill, Eva/AAF-8104-2020; Grill, Eva/D-1875-2010; Mueller, Martin/AAH-1527-2019	Grill, Eva/0000-0002-0273-7984; Grill, Eva/0000-0002-0273-7984; Mueller, Martin/0000-0002-5575-442X	German Federal Ministry of Education and Research [01 EO 0901]; Hertie Foundation	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Hertie Foundation	This project was supported by funds from the German Federal Ministry of Education and Research under the Grant code 01 EO 0901 and the Hertie Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Asghari A, 2001, PAIN, V94, P85, DOI 10.1016/S0304-3959(01)00344-X; Baker A, 2010, BEHAV RES THER, V48, P1139, DOI 10.1016/j.brat.2010.07.009; BAKER BL, 1973, BEHAV RES THER, V11, P79, DOI 10.1016/0005-7967(73)90071-5; BANDURA A, 1983, J PERS SOC PSYCHOL, V45, P464, DOI 10.1037/0022-3514.45.2.464; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 1988, ANXIETY RES, V1, P77, DOI DOI 10.1080/10615808808248222; BRANDT T, 1980, ACTA OTO-LARYNGOL, V89, P513, DOI 10.3109/00016488009127169; Brandt T, 2012, J NEUROL, V259, P759, DOI 10.1007/s00415-011-6238-z; Clerkin EM, 2009, J ANXIETY DISORD, V23, P381, DOI 10.1016/j.janxdis.2008.12.002; Coelho CM, 2010, DEPRESS ANXIETY, V27, P864, DOI 10.1002/da.20698; Coelho CM, 2009, J ANXIETY DISORD, V23, P563, DOI 10.1016/j.janxdis.2009.01.014; Cole SR, 2010, INT J EPIDEMIOL, V39, P417, DOI 10.1093/ije/dyp334; Davey GCL, 1997, BEHAV RES THER, V35, P997, DOI 10.1016/S0005-7967(97)10004-3; Depla MFIA, 2008, SOC PSYCH PSYCH EPID, V43, P200, DOI 10.1007/s00127-007-0291-z; Gallagher MW, 2013, BEHAV RES THER, V51, P767, DOI 10.1016/j.brat.2013.09.001; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Hinz A, 2006, DIAGNOSTICA, V52, P26, DOI 10.1026/0012-1924.52.1.26; Huppert D, 2013, J NEUROL, V260, P597, DOI 10.1007/s00415-012-6685-1; Jacob RG, 2009, J NEUROL NEUROSUR PS, V80, P74, DOI 10.1136/jnnp.2007.136432; JACOB RG, 1995, J ANXIETY DISORD, V9, P411, DOI 10.1016/0887-6185(95)00021-F; JACOB RG, 1993, J PSYCHOPATHOL BEHAV, V15, P299, DOI 10.1007/BF00965035; Jagella C, 2000, SCHWEIZ MED WSCHR, V130, P209; Jerusalem M., 1981, SKALEN BEFINDLICHKEI, P15; Jerusalem M., 1999, SKALEN ERFASSUNG LEH; Kapfhammer HP, 2014, EUR ARCH PSYCHIAT CL; KIRSCH I, 1983, BEHAV THER, V14, P520, DOI 10.1016/S0005-7894(83)80075-6; Knueppel S, 2010, EPIDEMIOLOGY, V21, P159, DOI 10.1097/EDE.0b013e3181c307ce; LeBeau RT, 2010, DEPRESS ANXIETY, V27, P148, DOI 10.1002/da.20655; Luszczynska A, 2005, J PSYCHOL, V139, P439, DOI 10.3200/JRLP.139.5.439-457; Magee WJ, 1996, ARCH GEN PSYCHIAT, V53, P159; Marks JM, 1967, ROLE LEARNING PSYCHO; Menzies R, 1997, PHOBIAS HDB THEORY R, P139; MENZIES RG, 1995, BEHAV RES THER, V33, P215, DOI 10.1016/0005-7967(94)P4443-X; Moritz SE, 2000, RES Q EXERCISE SPORT, V71, P280, DOI 10.1080/02701367.2000.10608908; Oosterink FMD, 2009, EUR J ORAL SCI, V117, P135, DOI 10.1111/j.1600-0722.2008.00602.x; Pearl J.., 2009, CAUSALITY; Redfern MS, 2001, J ANXIETY DISORD, V15, P81, DOI 10.1016/S0887-6185(00)00043-8; REDFERN MS, 1994, J VESTIBUL RES-EQUIL, V4, P221; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; RITTER B, 1969, BEHAV RES THER, V7, P41, DOI 10.1016/0005-7967(69)90047-3; Rohrig N, 2014, J CLIN EPIDEMIOL, V67, P199, DOI 10.1016/j.jclinepi.2013.08.012; Schaeffler F, 2013, QUAL LIFE RES; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; VanderWeele TJ, 2012, AM J EPIDEMIOL, V176, P608, DOI 10.1093/aje/kws213; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WILLIAMS SL, 1985, BEHAV THER, V16, P136, DOI 10.1016/S0005-7894(85)80041-1; World Health Organization, 1993, ICD 10 CLASS MENT BE, V10th ed.	50	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116220	10.1371/journal.pone.0116220	http://dx.doi.org/10.1371/journal.pone.0116220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX6YH	25548910	Green Published, gold, Green Submitted			2022-12-26	WOS:000347063500063
J	Le Parc, A; Houeto, EH; Pigat, N; Chat, S; Leonil, J; Chanat, E				Le Parc, Annabelle; Houeto, Edith Honvo; Pigat, Natascha; Chat, Sophie; Leonil, Joelle; Chanat, Eric			The Membrane-Associated Form of alpha(s1)-Casein Interacts with Cholesterol-Rich Detergent-Resistant Microdomains	PLOS ONE			English	Article							MILK PROTEIN SECRETION; MAMMARY-GLAND; CASEIN SECRETION; GOLGI-APPARATUS; BREFELDIN-A; TRANSPORT; GLYCOSYLATION; TRAFFICKING; INVOLVEMENT; MICELLE	Caseins, the main milk proteins, interact with colloidal calcium phosphate to form the casein micelle. The mesostructure of this supramolecular assembly markedly influences its nutritional and technological functionalities. However, its detailed molecular organization and the cellular mechanisms involved in its biogenesis have been only partially established. There is a growing body of evidence to support the concept that alpha(s1)-casein takes center stage in casein micelle building and transport in the secretory pathway of mammary epithelial cells. Here we have investigated the membrane-associated form of alpha(s1)-casein in rat mammary epithelial cells. Using metabolic labelling we show that alpha(s1)-casein becomes associated with membranes at the level of the endoplasmic reticulum, with no subsequent increase at the level of the Golgi apparatus. From morphological and biochemical data, it appears that caseins are in a tight relationship with membranes throughout the secretory pathway. On the other hand, we have observed that the membrane-associated form of alpha(s1)-casein co-purified with detergent-resistant membranes. It was poorly solubilised by Tween 20, partially insoluble in Lubrol WX, and substantially insoluble in Triton X-100. Finally, we found that cholesterol depletion results in the release of the membrane-associated form of alpha(s1)-casein. These experiments reveal that the insolubility of alpha(s1)-casein reflects its partial association with a cholesterol-rich detergent-resistant microdomain. We propose that the membrane-associated form of alpha(s1)-casein interacts with the lipid microdomain, or lipid raft, that forms within the membranes of the endoplasmic reticulum, for efficient forward transport and sorting in the secretory pathway of mammary epithelial cells.	[Le Parc, Annabelle; Houeto, Edith Honvo; Pigat, Natascha; Chat, Sophie; Chanat, Eric] INRA, Genom & Physiol Lactat UR1196, Jouy En Josas, France; [Leonil, Joelle] Inst Natl Rech Agronom, Sci & Technol Lait & CEuf UMR1253, Rennes, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE	Chanat, E (corresponding author), Inst Natl Rech Agronom, UMR Phys Environm & Genet Anim & Syst Elevage, St Gilles, France.	eric.chanat@rennes.inra.fr	barile, daniela/AAA-3892-2020	barile, daniela/0000-0002-3889-1596; Chat, Sophie/0000-0003-0671-5229	Institut National de la Recherche Agronomique	Institut National de la Recherche Agronomique	ALP was an "Agent Scientifique Contractuel'' funded by the Institut National de la Recherche Agronomique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfalah M, 2005, J BIOL CHEM, V280, P42636, DOI 10.1074/jbc.M505924200; Boisgard R, 2000, BBA-MOL CELL RES, V1495, P281, DOI 10.1016/S0167-4889(99)00167-6; Bouguyon E, 2006, BIOCHEM BIOPH RES CO, V343, P450, DOI 10.1016/j.bbrc.2006.03.005; Boumahrou N, 2009, J PHYSIOL PHARMACOL, V60, P113; Boumahrou N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-80; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown Deborah A., 1992, Trends in Cell Biology, V2, P338; BUCHHEIM W, 1989, KIELER MILCHW FORSCH, V41, P253; Burgoyne RD, 1998, J MAMMARY GLAND BIOL, V3, P275, DOI 10.1023/A:1018763427108; Chanat E, 1999, J CELL SCI, V112, P3399; Chat S, 2011, EUR J CELL BIOL, V90, P401, DOI 10.1016/j.ejcb.2011.01.002; Christa L, 2000, EUR J BIOCHEM, V267, P1665, DOI 10.1046/j.1432-1327.2000.01159.x; Clegg RA, 1998, MOL CELL ENDOCRINOL, V141, P163, DOI 10.1016/S0303-7207(98)00080-X; CLERMONT Y, 1993, ANAT REC, V235, P363, DOI 10.1002/ar.1092350305; David D, 1998, J CELL BIOL, V143, P1167, DOI 10.1083/jcb.143.5.1167; Didier A, 2006, J HISTOCHEM CYTOCHEM, V54, P1255, DOI 10.1369/jhc.5A6880.2006; Falguieres T, 2001, MOL BIOL CELL, V12, P2453, DOI 10.1091/mbc.12.8.2453; FARRELL HM, 1973, J DAIRY SCI, V56, P1195, DOI 10.3168/jds.S0022-0302(73)85335-4; FRANKE WW, 1976, J CELL BIOL, V69, P173, DOI 10.1083/jcb.69.1.173; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Hein Z, 2009, EXP CELL RES, V315, P348, DOI 10.1016/j.yexcr.2008.10.038; HOLT C, 1992, ADV PROTEIN CHEM, V43, P63, DOI 10.1016/S0065-3233(08)60554-9; Horne DS, 1998, INT DAIRY J, V8, P171, DOI 10.1016/S0958-6946(98)00040-5; Huppertz T., 2013, ADV DAIRY CHEM A, V4th, P135, DOI [10.1007/978-1-4614-4714-6_4, DOI 10.1007/978-1-4614-4714-6_4]; Kolb AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021775; KUMAR S, 1994, P NATL ACAD SCI USA, V91, P6138, DOI 10.1073/pnas.91.13.6138; Lavialle F, 2008, ANIMAL, V2, P491, DOI 10.1017/S1751731107001309; Le Parc A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-65; LEE RWH, 1983, J BIOL CHEM, V258, P1326; Malin EL, 2005, J DAIRY SCI, V88, P2318, DOI 10.3168/jds.S0022-0302(05)72910-6; Mather I. H., 1983, Biochemistry of lactation, P231; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X; Paiement J, 2004, CELL BIOL, P41; Patrick F., 2013, ADV DAIRY CHEM A, V1A, P185, DOI [DOI 10.1007/978-1-4614-4714-6_6, 10.1007/978-1-4614-4714-6_6]; Pauloin A, 1997, EUR J CELL BIOL, V72, P324; Pechoux C, 2005, BBA-MOL CELL RES, V1743, P317, DOI 10.1016/j.bbamcr.2005.01.006; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Sarnataro D, 2004, MOL BIOL CELL, V15, P4031, DOI 10.1091/mbc.E03-05-0271; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Surma MA, 2012, BBA-MOL CELL BIOL L, V1821, P1059, DOI 10.1016/j.bbalip.2011.12.008; TURNER MD, 1992, J CELL BIOL, V117, P269, DOI 10.1083/jcb.117.2.269; TURNER MD, 1993, J CELL SCI, V106, P1221; Walmsley AR, 2001, EMBO J, V20, P703, DOI 10.1093/emboj/20.4.703	48	4	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115903	10.1371/journal.pone.0115903	http://dx.doi.org/10.1371/journal.pone.0115903			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549363	gold, Green Published			2022-12-26	WOS:000347063500037
J	Mabrouk, R; Rusjan, PM; Mizrahi, R; Jacobs, MF; Koshimori, Y; Houle, S; Ko, JH; Strafella, AP				Mabrouk, Rostom; Rusjan, Pablo M.; Mizrahi, Romina; Jacobs, Mark F.; Koshimori, Yuko; Houle, Sylvain; Ko, Ji Hyun; Strafella, Antonio P.			Image Derived Input Function for [F-18]-FEPPA: Application to Quantify Translocator Protein (18 kDa) in the Human Brain	PLOS ONE			English	Article							PERIPHERAL BENZODIAZEPINE-RECEPTORS; MICROGLIAL ACTIVATION; RADIOLIGAND BINDING; PET LIGAND; EXTRACTION; AFFINITY; RADIOSYNTHESIS; PLASMA; MONKEY; BLOOD	In [F-18]-FEPPA positron emission topography (PET) imaging, automatic blood sampling system (ABSS) is currently the gold standard to obtain the blood time activity curve (TAC) required to extract the input function (IF). Here, we compare the performance of two image-based methods of IF extraction to the ABSS gold standard method for the quantification of translocator protein (TSPO) in the human brain. The IFs were obtained from a direct delineation of the internal carotid signal (CS) and a new concept of independent component analysis (ICA). PET scans were obtained from 18 healthy volunteers. The estimated total distribution volume (V-T) by CS-IF and ICA-IF were compared to the reference V-T obtained by ABSS-IF in the frontal and temporal cortex, cerebellum, striatum and thalamus regions. The V-T values estimated using ICA-IF were more reliable than CS-IF for all brain regions. Specifically, the slope regression in the frontal cortex with ICA-IF was r(2) = 0.91 (p<0.05), and r(2) = 0.71 (p<0.05) using CS-IF.	[Mabrouk, Rostom; Rusjan, Pablo M.; Mizrahi, Romina; Koshimori, Yuko; Houle, Sylvain; Strafella, Antonio P.] Ctr Addict & Mental Hlth, Res Imaging Ctr, Toronto, ON, Canada; [Strafella, Antonio P.] Univ Toronto, Toronto Western Hosp, UHN, EJ Safra Parkinson Dis Program,Morton & Gloria Sh, Toronto, ON, Canada; [Jacobs, Mark F.; Koshimori, Yuko; Strafella, Antonio P.] Univ Toronto, UHN, TorontoWestern Res Inst, Div Brain Imaging & Behav Syst Neurosci, Toronto, ON, Canada; [Ko, Ji Hyun] Univ Manitoba, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Mizrahi, Romina] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Manitoba; University of Toronto	Mabrouk, R (corresponding author), Ctr Addict & Mental Hlth, Res Imaging Ctr, Toronto, ON, Canada.	rostom.mabrouk@camh.ca	Mabrouk, Rostom/M-1674-2019; Ko, Ji Hyun/E-5150-2011	Ko, Ji Hyun/0000-0002-9700-7692; Rusjan, Pablo/0000-0003-0075-2918; Mizrahi, Romina/0000-0001-6667-7928; Houle, Sylvain/0000-0002-4231-6316	Canadian Institutes of Health Research [INE 117891]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100043] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Canadian Institutes of Health Research (INE 117891) to AS; Canadian Institutes of Health Research to YK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amari S, 1998, NEURAL COMPUT, V10, P251, DOI 10.1162/089976698300017746; Backes H, 2009, EUR J NUCL MED MOL I, V36, P1960, DOI 10.1007/s00259-009-1244-4; Boutin H, 2007, J NUCL MED, V48, P573, DOI 10.2967/jnumed.106.036764; Briard E, 2008, J MED CHEM, V51, P17, DOI 10.1021/jm0707370; Comtat C, 2004, NUCL SCI S IEEE; Croteau E, 2010, EUR J NUCL MED MOL I, V37, P1539, DOI 10.1007/s00259-010-1443-z; Dolle F, 2008, J LABELLED COMPD RAD, V51, P435, DOI 10.1002/jlcr.1559; Fujimura Y, 2009, J NUCL MED, V50, P1047, DOI 10.2967/jnumed.108.060186; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Hahn A, 2012, NEUROIMAGE, V62, P199, DOI 10.1016/j.neuroimage.2012.04.047; Hilton J, 2000, NUCL MED BIOL, V27, P627, DOI 10.1016/S0969-8051(00)00125-6; Hirvonen J, 2012, J NUCL MED, V53, P234, DOI 10.2967/jnumed.111.091694; Hong IK, 2007, IEEE T MED IMAGING, V26, P789, DOI 10.1109/TMI.2007.892644; Hsu PH, 2012, ANN NUCL MED MOL IMA, V25, P126; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Jons PH, 1997, HUM BRAIN MAPP, V5, P119, DOI 10.1002/(SICI)1097-0193(1997)5:2<119::AID-HBM5>3.3.CO;2-E; Kreisl WC, 2013, BRAIN, V136, P2228, DOI 10.1093/brain/awt145; Kreisl WC, 2010, NEUROIMAGE, V49, P2924, DOI 10.1016/j.neuroimage.2009.11.056; Kreisl WC, 2009, ARCH NEUROL-CHICAGO, V66, P1288, DOI 10.1001/archneurol.2009.208; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Mabrouk R, 2012, COMPUT MED IMAG GRAP, V36, P484, DOI 10.1016/j.compmedimag.2012.05.002; Mabrouk R, 2013, IEEE T BIO-MED ENG, V60, P63, DOI 10.1109/TBME.2012.2221463; Maeda J, 2004, SYNAPSE, V52, P283, DOI 10.1002/syn.20027; MEYER E, 1989, J NUCL MED, V30, P1069; Mizrahi R, 2012, J CEREBR BLOOD F MET, V32, P968, DOI 10.1038/jcbfm.2012.46; Mourik JEM, 2008, NEUROIMAGE, V39, P1041, DOI 10.1016/j.neuroimage.2007.10.022; Naganawa M, 2005, IEEE T BIO-MED ENG, V52, P201, DOI 10.1109/TBME.2004.840193; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Owen DR, 2012, J CEREBR BLOOD F MET, V32, P1, DOI 10.1038/jcbfm.2011.147; Owen DRJ, 2011, J NUCL MED, V52, P24, DOI 10.2967/jnumed.110.079459; PHELPS ME, 1979, J NUCL MED, V20, P328; Rusjan P, 2006, PSYCHIAT RES-NEUROIM, V147, P79, DOI 10.1016/j.pscychresns.2006.01.011; Rusjan PM, 2011, J CEREBR BLOOD F MET, V31, P1807, DOI 10.1038/jcbfm.2011.55; Sossi V, 2005, IEEE NUCL SCI CONF R, P2195; Tomasi G, 2008, J NUCL MED, V49, P1249, DOI 10.2967/jnumed.108.050583; Turkheimer FE, 2007, J NUCL MED, V48, P158; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; van der Weerdt AP, 2001, J NUCL MED, V42, P1622; Wilson AA, 2008, NUCL MED BIOL, V35, P305, DOI 10.1016/j.nucmedbio.2007.12.009; Yu KM, 2005, COMMUN STAT-THEOR M, V34, P1867, DOI 10.1080/03610920500199018; Zanotti-Fregonara P, 2011, J CEREBR BLOOD F MET, V31, P1986, DOI 10.1038/jcbfm.2011.107; Zhang MR, 2007, J NUCL MED, V48, P1853, DOI 10.2967/jnumed.107.043505	45	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115768	10.1371/journal.pone.0115768	http://dx.doi.org/10.1371/journal.pone.0115768			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549260	Green Published, Green Submitted, gold			2022-12-26	WOS:000347063500025
J	Belon, C; Gannoun-Zaki, L; Lutfalla, G; Kremer, L; Blanc-Potard, AB				Belon, Claudine; Gannoun-Zaki, Laila; Lutfalla, Georges; Kremer, Laurent; Blanc-Potard, Anne-Beatrice			Mycobacterium marinum MgtC Plays a Role in Phagocytosis but is Dispensable for Intracellular Multiplication	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA-ENTERICA; VIRULENCE FACTOR; INTRAMACROPHAGE SURVIVAL; TUBERCULOUS GRANULOMA; EPITHELIAL-CELLS; YERSINIA-PESTIS; ZEBRAFISH; MACROPHAGES; HOST	MgtC is a virulence factor involved in intramacrophage growth that has been reported in several intracellular pathogens, including Mycobacterium tuberculosis and Salmonella enterica serovar Typhimurium. MgtC participates also in adaptation to Mg2+ deprivation. Herein, we have constructed a mgtC mutant in Mycobacterium marinum to further investigate the role of MgtC in mycobacteria. We show that the M. marinum mgtC gene (Mma mgtC) is strongly induced upon Mg2+ deprivation and is required for optimal growth in Mg2+-deprived medium. The behaviour of the Mma mgtC mutant has been investigated in the Danio rerio infection model using a transgenic reporter zebrafish line that specifically labels neutrophils. Although the mgtC mutant is not attenuated in the zebrafish embryo model based on survival curves, our results indicate that phagocytosis by neutrophils is enhanced with the mgtC mutant compared to the wild-type strain following subcutaneous injection. Increased phagocytosis of the mutant strain is also observed ex vivo with the murine J774 macrophage cell line. On the other hand, no difference was found between the mgtC mutant and the wild-type strain in bacterial adhesion to macrophages and in the internalization into epithelial cells. Unlike the role reported for MgtC in other intracellular pathogens, Mma MgtC does not contribute significantly to intramacrophage replication. Taken together, these results indicate an unanticipated function of Mma MgtC at early step of infection within phagocytic cells. Hence, our results indicate that although the MgtC function is conserved among pathogens regarding adaptation to Mg2+ deprivation, its role towards phagocytic cells can differ, possibly in relation with the specific pathogen's lifestyles.	[Belon, Claudine; Gannoun-Zaki, Laila; Lutfalla, Georges; Kremer, Laurent; Blanc-Potard, Anne-Beatrice] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, F-34095 Montpellier 05, France; [Belon, Claudine; Gannoun-Zaki, Laila; Lutfalla, Georges; Kremer, Laurent; Blanc-Potard, Anne-Beatrice] Univ Montpellier I, Lab Dynam Interact Membranaires Normales & Pathol, F-34095 Montpellier 05, France; [Belon, Claudine; Gannoun-Zaki, Laila; Lutfalla, Georges; Kremer, Laurent; Blanc-Potard, Anne-Beatrice] CNRS, UMR5235, Montpellier, France; [Kremer, Laurent] INSERM, Montpellier, France	Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Blanc-Potard, AB (corresponding author), Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, Pl Eugene Bataillon, F-34095 Montpellier 05, France.	anne.blanc-potard@univ-montp1.fr	Lutfalla, Georges/AAW-9386-2021; Kremer, Laurent/M-4935-2017; Blanc-Potard, Anne/AAI-9542-2021	Kremer, Laurent/0000-0002-6604-4458; Blanc-Potard, Anne/0000-0001-9963-6786; LUTFALLA, Georges/0000-0002-6591-7894; Gannoun, Laila/0000-0002-9644-1083	French National Agency (ANR ZebraFlam); European Community's Seventh Framework Programme (FP7-PEOPLE-ITN) for the Marie-Curie Initial Training Network FishForPharma [PITN-GA-2011-289209]; French Ministry of Research; Fondation for Medical Research [FRM FDT20140930905]	French National Agency (ANR ZebraFlam)(French National Research Agency (ANR)); European Community's Seventh Framework Programme (FP7-PEOPLE-ITN) for the Marie-Curie Initial Training Network FishForPharma; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Fondation for Medical Research	French National Agency (ANR ZebraFlam) and European Community's Seventh Framework Programme (FP7-PEOPLE-2011-ITN) under Grant Agreement PITN-GA-2011-289209 for the Marie-Curie Initial Training Network FishForPharma. CB is supported by a MRT fellowship from the French Ministry of Research and the Fondation for Medical Research (FRM FDT20140930905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibaud L, 2014, J BIOL CHEM, V289, P215, DOI 10.1074/jbc.M113.525550; Alibaud L, 2011, MOL MICROBIOL, V80, P919, DOI 10.1111/j.1365-2958.2011.07618.x; Alix E, 2007, TRENDS MICROBIOL, V15, P252, DOI 10.1016/j.tim.2007.03.007; Alix E, 2008, MICROB PATHOGENESIS, V45, P236, DOI 10.1016/j.micpath.2008.06.001; Astarie-Dequeker C, 2010, DRUG DISCOV TODAY DI, V7, pe33, DOI DOI 10.1016/j.ddmec.2010.09.003; Astarie-Dequeker C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000289; BERMUDEZ LE, 1995, TUBERCLE LUNG DIS, V76, P240, DOI 10.1016/S0962-8479(05)80012-7; Blanc-Potard AB, 2003, J MOL EVOL, V57, P479, DOI 10.1007/s00239-003-2496-4; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; Buchmeier N, 2000, MOL MICROBIOL, V35, P1375, DOI 10.1046/j.1365-2958.2000.01797.x; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Collins CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000430; Colucci-Guyon E, 2011, J CELL SCI, V124, P3053, DOI 10.1242/jcs.082792; Dobson G., 1995, CHEM METHODS BACTERI, P237; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; Flesselles B, 1999, FEMS MICROBIOL LETT, V177, P237, DOI 10.1111/j.1574-6968.1999.tb13738.x; Grabenstein JP, 2006, INFECT IMMUN, V74, P3727, DOI 10.1128/IAI.00255-06; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Larsen M.H., 2007, CURRENT PROTOCOLS MI; Lavigne JP, 2005, INFECT IMMUN, V73, P3160, DOI 10.1128/IAI.73.5.3160-3163.2005; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Lee EJ, 2013, CELL, V154, P146, DOI 10.1016/j.cell.2013.06.004; Maloney KE, 2006, INFECT IMMUN, V74, P5477, DOI 10.1128/IAI.00798-06; Meijer AH, 2014, CELL MICROBIOL, V16, P39, DOI 10.1111/cmi.12236; Mostowy S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003588; Prajsnar TK, 2008, CELL MICROBIOL, V10, P2312, DOI 10.1111/j.1462-5822.2008.01213.x; Ramakrishnan L, 2013, ADV EXP MED BIOL, V783, P251, DOI 10.1007/978-1-4614-6111-1_13; Rang C, 2007, MOL MICROBIOL, V63, P605, DOI 10.1111/j.1365-2958.2006.05542.x; Ren HP, 2007, MOL MICROBIOL, V63, P1345, DOI 10.1111/j.1365-2958.2007.05603.x; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Retamal P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005551; Rousseau C, 2003, CELL MICROBIOL, V5, P405, DOI 10.1046/j.1462-5822.2003.00289.x; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; SCHLESINGER LS, 1991, J EXP MED, V174, P1031, DOI 10.1084/jem.174.5.1031; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Stokes RW, 2004, INFECT IMMUN, V72, P5676, DOI 10.1128/IAI.72.10.5676-5686.2004; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Tabouret G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001159; Thompson JA, 2011, MICROBIOL-SGM, V157, P2084, DOI 10.1099/mic.0.048926-0; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Torraca V, 2014, DIS MODEL MECH, V7, P785, DOI 10.1242/dmm.015594; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Vilcheze C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004115; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Yang CT, 2012, CELL HOST MICROBE, V12, P301, DOI 10.1016/j.chom.2012.07.009; Yang YS, 2012, J BACTERIOL, V194, P6255, DOI 10.1128/JB.01424-12; Zhou DS, 2005, FEMS MICROBIOL LETT, V250, P85, DOI 10.1016/j.femsle.2005.06.053	51	19	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116052	10.1371/journal.pone.0116052	http://dx.doi.org/10.1371/journal.pone.0116052			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545682	Green Published, gold			2022-12-26	WOS:000347120200095
J	Castley, A; Berry, C; French, M; Fernandez, S; Krueger, R; Nolan, D				Castley, Alison; Berry, Cassandra; French, Martyn; Fernandez, Sonia; Krueger, Romano; Nolan, David			Elevated Plasma Soluble CD14 and Skewed CD16+Monocyte Distribution Persist despite Normalisation of Soluble CD163 and CXCL10 by Effective HIV Therapy: A Changing Paradigm for Routine HIV Laboratory Monitoring?	PLOS ONE			English	Article							MONOCYTE SUBSET; ANTIRETROVIRAL THERAPY; PREDICT MORTALITY; IMMUNE ACTIVATION; INFECTION; INFLAMMATION; TRANSMIGRATION; PROGRESSION; EXPRESSION; BIOMARKERS	Objective: We investigated plasma and flow cytometric biomarkers of monocyte status that have been associated with prognostic utility in HIV infection and other chronic inflammatory diseases, comparing 81 HIV+ individuals with a range of treatment outcomes to a group of 21 healthy control blood donors. Our aim is to develop and optimise monocyte assays that combine biological relevance, clinical utility, and ease of adoption into routine HIV laboratory practice. Design: Cross-sectional evaluation of concurrent plasma and whole blood samples. Methods: A flow cytometry protocol was developed comprising single-tube CD45, CD14, CD16, CD64, CD163, CD143 analysis with appropriately matched isotype controls. Plasma levels of soluble CD14 (sCD14), soluble CD163 (sCD163) and CXCL10 were measured by ELISA. Results: HIV status was associated with significantly increased expression of CD64, CD143 and CD163 on CD16(+) monocytes, irrespective of the virological response to HIV therapy. Plasma levels of sCD14, sCD163 and CXCL10 were also significantly elevated in association with viremic HIV infection. Plasma sCD163 and CXCL10 levels were restored to healthy control levels by effective antiretroviral therapy while sCD14 levels remained elevated despite virological suppression (p<0.001). Conclusions: Flow cytometric and plasma biomarkers of monocyte activation indicate an ongoing systemic inflammatory response to HIV infection, characterised by persistent alterations of CD16(+) monocyte expression profiles and elevated sCD14 levels, that are not corrected by antiretroviral therapy and likely to be prognostically significant. In contrast, sCD163 and CXCL10 levels declined on antiretroviral therapy, suggesting multiple activation pathways revealed by these biomarkers. Incorporation of these assays into routine clinical care is feasible and warrants further consideration, particularly in light of emerging therapeutic strategies that specifically target innate immune activation in HIV infection.	[Castley, Alison; Berry, Cassandra] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Nolan, David] Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia; [Castley, Alison; French, Martyn; Krueger, Romano; Nolan, David] Royal Perth Hosp, Dept Clin Immunol, Perth, WA 6001, Australia; [French, Martyn; Fernandez, Sonia] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia	Murdoch University; Murdoch University; Royal Perth Hospital; University of Western Australia; University of Western Australia	Nolan, D (corresponding author), Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia.	d.nolan@murdoch.edu.au	Fernandez, Sonia/H-9176-2014; Berry, Cassandra/AAX-7145-2020	Fernandez, Sonia/0000-0001-8753-466X; French, Martyn/0000-0002-4644-1982; Berry, Cassandra/0000-0003-0768-0857	Practitioner Research Fellowship; department of Clinical Immunology, Royal Perth Hospital	Practitioner Research Fellowship; department of Clinical Immunology, Royal Perth Hospital	This investigation was funded with support from a Practitioner Research Fellowship awarded to Dr. David Nolan provided by the Royal Perth Hospital Medical Research Foundation. The flow cytometry component was also funded by the department of Clinical Immunology, Royal Perth Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Ancuta P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-403; Burdo TH, 2011, J INFECT DIS, V204, P154, DOI 10.1093/infdis/jir214; Chevalier MF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003453; Romero-Sanchez MC, 2012, ANTIMICROB AGENTS CH, V56, P5858, DOI 10.1128/AAC.01406-12; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Fischer-Smith T, 2008, AIDS RES HUM RETROV, V24, P417, DOI 10.1089/aid.2007.0193; Funderburg NT, 2014, CLIN INFECT DIS, V58, P588, DOI 10.1093/cid/cit748; Funderburg NT, 2012, BLOOD, V120, P4599, DOI 10.1182/blood-2012-05-433946; Gale HB, 2013, CLIN INFECT DIS, V56, P1340, DOI 10.1093/cid/cit004; Hattab S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-122; Holl V, 2004, J IMMUNOL, V173, P6274, DOI 10.4049/jimmunol.173.10.6274; Jude C, 2013, SOLUBLE CD163 SERUM; Justice AC, 2012, CLIN INFECT DIS, V54, P984, DOI 10.1093/cid/cir989; Kamat A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030881; Kasang C, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-14; Lake J, 2014, HIV MED IN PRESS FEB; Lawrence P, 2012, AIDS, V26, P785, DOI 10.1097/QAD.0b013e328351426e; Li Y, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3017; Liovat AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046143; Mendez-Lagares G, 2013, J INFECT DIS, V207, P1221, DOI 10.1093/infdis/jit025; Merlini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046073; Parihar A, 2010, J INNATE IMMUN, V2, P204, DOI 10.1159/000296507; Reiner AP, 2013, ARTERIOSCL THROM VAS, V33, P158, DOI 10.1161/ATVBAHA.112.300421; Rogacev KS, 2012, J AM COLL CARDIOL, V60, P1512, DOI 10.1016/j.jacc.2012.07.019; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Sax PE, 2013, CLIN INFECT DIS, V56, P1344, DOI 10.1093/cid/cit008; Sereti I, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003890; Simmons RP, 2013, AIDS, V27, P2505, DOI 10.1097/01.aids.0000432455.06476.bc; Subramanian S, 2012, JAMA-J AM MED ASSOC, V308, P379, DOI 10.1001/jama.2012.6698; Tippett E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019968; Ulrich C, 2010, NEPHROL DIAL TRANSPL, V25, P2265, DOI 10.1093/ndt/gfq012; Williams DW, 2012, J LEUKOCYTE BIOL, V91, P401, DOI 10.1189/jlb.0811394; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827	34	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115226	10.1371/journal.pone.0115226	http://dx.doi.org/10.1371/journal.pone.0115226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25544986	Green Submitted, Green Published, gold			2022-12-26	WOS:000347120200026
J	Conroy, S; Kruyt, FAE; Joseph, JV; Balasubramaniyan, V; Bhat, KP; Wagemakers, M; Enting, RH; Walenkamp, AME; den Dunnen, WFA				Conroy, Siobhan; Kruyt, Frank A. E.; Joseph, Justin V.; Balasubramaniyan, Veerakumar; Bhat, Krishna P.; Wagemakers, Michiel; Enting, Roelien H.; Walenkamp, Annemiek M. E.; den Dunnen, Wilfred F. A.			Subclassification of Newly Diagnosed Glioblastomas through an Immunohistochemical Approach	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; STEM-CELL SUBTYPE; GENE-EXPRESSION; IDH1 MUTATIONS; BRAIN-TUMORS; SECONDARY GLIOBLASTOMA; ADJUVANT TEMOZOLOMIDE; MOLECULAR PATHOLOGY; GLIOMAS; MULTIFORME	Molecular signatures in Glioblastoma (GBM) have been described that correlate with clinical outcome and response to therapy. The Proneural (PN) and Mesenchymal (MES) signatures have been identified most consistently, but others including Classical (CLAS) have also been reported. The molecular signatures have been detected by array techniques at RNA and DNA level, but these methods are costly and cannot take into account individual contributions of different cells within a tumor. Therefore, the aim of this study was to investigate whether subclasses of newly diagnosed GBMs could be assessed and assigned by application of standard pathology laboratory procedures. 123 newly diagnosed GBMs were analyzed for the tumor cell expression of 23 pre-identified proteins and EGFR amplification, together allowing for the subclassification of 65% of the tumors. Immunohistochemistry (IHC)-based profiling was found to be analogous to transcription-based profiling using a 9-gene transcriptional signature for PN and MES subclasses. Based on these data a novel, minimal IHC-based scheme for subclass assignment for GBMs is proposed. Positive staining for IDH1(R132H) can be used for PN subclass assignment, high EGFR expression for the CLAS subtype and a combined high expression of PTEN, VIM and/or YKL40 for the MES subclass. The application of the proposed scheme was evaluated in an independent tumor set, which resulted in similar subclass assignment rates as those observed in the training set. The IHC-based subclassification scheme proposed in this study therefore could provide very useful in future studies for stratification of individual patient samples.	[Conroy, Siobhan; den Dunnen, Wilfred F. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Pathol, Groningen, Netherlands; [Kruyt, Frank A. E.; Joseph, Justin V.; Walenkamp, Annemiek M. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands; [Balasubramaniyan, Veerakumar] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Bhat, Krishna P.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Wagemakers, Michiel] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosurg, Groningen, Netherlands; [Enting, Roelien H.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Texas System; UTMD Anderson Cancer Center; University of Groningen; University of Groningen	Conroy, S (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Pathol, Groningen, Netherlands.	s.conroy@umcg.nl		Kruyt, Frank/0000-0002-2445-9380; den Dunnen, Wilfred/0000-0002-4168-1207	Graduate School of Medical Sciences, BCN-BRAIN, UMCG; Jan Kornelis de Cock Foundation	Graduate School of Medical Sciences, BCN-BRAIN, UMCG; Jan Kornelis de Cock Foundation	The work in this article was funded by (1) the Graduate School of Medical Sciences, BCN-BRAIN, UMCG and (2) Jan Kornelis de Cock Foundation to ms S. Conroy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, NATURE, V455, P1061; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Beier CP, 2012, STEM CELLS DEV, V21, P2753, DOI 10.1089/scd.2011.0660; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Capper D, 2010, BRAIN PATHOL, V20, P245, DOI 10.1111/j.1750-3639.2009.00352.x; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; De Bacco F, 2012, CANCER RES, V72, P4537, DOI 10.1158/0008-5472.CAN-11-3490; Donev K, 2010, NEUROPATH APPL NEURO, V36, P411, DOI 10.1111/j.1365-2990.2010.01078.x; Federatie van Medisch Wetenschappelijke Verenigingen, 2011, VER OMG LICH TEN BEH; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Horbinski C, 2011, BRAIN PATHOL, V21, P57, DOI 10.1111/j.1750-3639.2010.00453.x; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Joseph JV, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.395; Le Mercier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045475; Lee CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030098; Lee KH, 2012, CHILD NERV SYST, V28, P1879, DOI 10.1007/s00381-012-1883-9; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ma XL, 2012, NEURO-ONCOLOGY, V14, P1153, DOI 10.1093/neuonc/nos145; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Misra A, 2005, CLIN CANCER RES, V11, P2907, DOI 10.1158/1078-0432.CCR-04-0708; Motomura K, 2012, CANCER SCI, V103, P1871, DOI 10.1111/j.1349-7006.2012.02377.x; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Pallud J, 2012, J NEUROSURG, V117, P476, DOI 10.3171/2012.5.JNS111670; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Popova SN, 2014, HISTOPATHOLOGY, V64, P365, DOI 10.1111/his.12252; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; Rahaman SO, 2002, ONCOGENE, V21, P8404, DOI 10.1038/sj.onc.1206047; Specht K, 2001, AM J PATHOL, V158, P419, DOI 10.1016/S0002-9440(10)63985-5; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sulman EP, 2009, SEMIN RADIAT ONCOL, V19, P142, DOI 10.1016/j.semradonc.2009.02.001; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Tso CL, 2006, CANCER RES, V66, P159, DOI 10.1158/0008-5472.CAN-05-0077; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; van den Bent MJ, 2010, CLIN CANCER RES, V16, P1597, DOI 10.1158/1078-0432.CCR-09-2902; Varlet P, 2004, NEUROSURGERY, V55, P1377, DOI 10.1227/01.NEU.0000143033.36582.40; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; von Deimling A, 2011, BRAIN PATHOL, V21, P74, DOI 10.1111/j.1750-3639.2010.00454.x; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Wiltshire RN, 2000, NEURO-ONCOLOGY, V2, P164, DOI 10.1093/neuonc/2.3.164; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	50	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115687	10.1371/journal.pone.0115687	http://dx.doi.org/10.1371/journal.pone.0115687			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546404	Green Published, gold			2022-12-26	WOS:000347120200054
J	Gonzalez-del Pozo, M; Mendez-Vidal, C; Bravo-Gil, N; Vela-Boza, A; Dopazo, J; Borrego, S; Antinolo, G				Gonzalez-del Pozo, Maria; Mendez-Vidal, Cristina; Bravo-Gil, Nereida; Vela-Boza, Alicia; Dopazo, Joaquin; Borrego, Salud; Antinolo, Guillermo			Exome Sequencing Reveals Novel and Recurrent Mutations with Clinical Significance in Inherited Retinal Dystrophies	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; CASSETTE TRANSPORTER GENE; SPLICE-SITE; SPANISH PATIENTS; RHODOPSIN GENE; ABCR; POPULATION; DISEASE; SERVER	This study aimed to identify the underlying molecular genetic cause in four Spanish families clinically diagnosed of Retinitis Pigmentosa (RP), comprising one autosomal dominant RP (adRP), two autosomal recessive RP (arRP) and one with two possible modes of inheritance: arRP or X-Linked RP (XLRP). We performed whole exome sequencing (WES) using NimbleGen SeqCap EZ Exome V3 sample preparation kit and SOLID 5500xl platform. All variants passing filter criteria were validated by Sanger sequencing to confirm familial segregation and the absence in local control population. This strategy allowed the detection of: (i) one novel heterozygous splice-site deletion in RHO, c. 937-2_ 944del, (ii) one rare homozygous mutation in C2orf71, c. 1795T>C; p. Cys599Arg, not previously associated with the disease, (iii) two heterozygous null mutations in ABCA4, c. 2041C>T; p. R681* and c. 6088C>T; p. R2030*, and (iv) one mutation, c. 2405-2406delAG; p. Glu802Glyfs* 31 in the ORF15 of RPGR. The molecular findings for RHO and C2orf71 confirmed the initial diagnosis of adRP and arRP, respectively, while patients with the two ABCA4 mutations, both previously associated with Stargardt disease, presented symptoms of RP with early macular involvement. Finally, the X-Linked inheritance was confirmed for the family with the RPGR mutation. This latter finding allowed the inclusion of carrier sisters in our preimplantational genetic diagnosis program.	[Gonzalez-del Pozo, Maria; Mendez-Vidal, Cristina; Bravo-Gil, Nereida; Borrego, Salud; Antinolo, Guillermo] Univ Seville, CSIC, Univ Hosp Virgen del Rocio, Inst Biomed Seville,Dept Genet Reprod & Fetal Med, Seville, Spain; [Gonzalez-del Pozo, Maria; Mendez-Vidal, Cristina; Bravo-Gil, Nereida; Borrego, Salud; Antinolo, Guillermo] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Seville, Spain; [Vela-Boza, Alicia; Dopazo, Joaquin; Antinolo, Guillermo] Genom & Bioinformat Platform Andalusia, Seville, Spain; [Dopazo, Joaquin] Prince Felipe Res Ctr CIPF, Dept Bioinformat, Valencia, Spain; [Dopazo, Joaquin] Prince Felipe Res Ctr CIPF, Funct Genom Node INB, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Prince Felipe Research Center; Prince Felipe Research Center	Antinolo, G (corresponding author), Univ Seville, CSIC, Univ Hosp Virgen del Rocio, Inst Biomed Seville,Dept Genet Reprod & Fetal Med, Seville, Spain.	guillermo.antinolo.sspa@juntadeandalucia.es	IBIS, REPRODUCCION/P-3399-2015; Borrego, Salud/M-6314-2015; Méndez-Vidal, Cristina/F-1366-2015; Gil, Nereida Bravo/C-3954-2015; Dopazo, Joaquin/A-9270-2014; González-del Pozo, María/N-1742-2015; IBIS, GENETICA/P-3384-2015	Méndez-Vidal, Cristina/0000-0002-1282-1688; Gil, Nereida Bravo/0000-0002-2086-0468; Dopazo, Joaquin/0000-0003-3318-120X; González-del Pozo, María/0000-0003-4858-938X; Antinolo Gil, Guillermo/0000-0002-2113-074X	Instituto de Salud Carlos III (ISCIII); Spanish Ministry of Economy and Competitiveness, Spain [PI1102923, CDTIFEDER-Innterconecta EXP00052887/ITC-20111037, BIO2011-27069]; Regional Ministry of Economy, Innovation, Science and Employment of the Autonomous Government of Andalusia [CTS-03687]; Foundation Ramon Areces [CIVP16A1856]; CIBERER is an initiative of the ISCIII, Spanish Ministry of Economy and Competitiveness; ISCIII [FI12/00545]	Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Economy and Competitiveness, Spain; Regional Ministry of Economy, Innovation, Science and Employment of the Autonomous Government of Andalusia; Foundation Ramon Areces; CIBERER is an initiative of the ISCIII, Spanish Ministry of Economy and Competitiveness; ISCIII(Instituto de Salud Carlos III)	This work was supported by the Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness, Spain (PI1102923, CIBERER ACCI, CDTIFEDER-Innterconecta EXP00052887/ITC-20111037, and BIO2011-27069), Regional Ministry of Economy, Innovation, Science and Employment of the Autonomous Government of Andalusia (CTS-03687), and the Foundation Ramon Areces (CIVP16A1856). The CIBERER is an initiative of the ISCIII, Spanish Ministry of Economy and Competitiveness. NBG is supported by fellowship FI12/00545 from ISCIII. The funders had no role in study design, data	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ALMAGHTHEH M, 1994, HUM MOL GENET, V3, P205, DOI 10.1093/hmg/3.1.205; Avila-Fernandez A, 2010, MOL VIS, V16, P2550; AYUSO C, 1995, CLIN GENET, V48, P120; Barragan I, 2010, HUM MUTAT, V31, pE1772, DOI 10.1002/humu.21334; BELL C, 1994, BRIT J OPHTHALMOL, V78, P933, DOI 10.1136/bjo.78.12.933; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; den Hollander AI, 2010, J CLIN INVEST, V120, P3042, DOI 10.1172/JCI42258; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; Pozo MGD, 2014, MOL GENET GENOM MED, V2, P124, DOI 10.1002/mgg3.50; Gonzalez-del Pozo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027894; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HUMPHRIES P, 1990, CLIN GENET, V38, P1; Jinda W, 2014, INVEST OPHTH VIS SCI, V55, P2259, DOI 10.1167/iovs.13-13567; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; Maugeri A, 1999, AM J HUM GENET, V64, P1024, DOI 10.1086/302323; Mendez-Vidal C, 2013, MOL VIS, V19, P2187; Neveling Kornelia, 2013, Methods Mol Biol, V935, P3, DOI 10.1007/978-1-62703-080-9_1; Nishiguchi KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041902; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Reese MG, 1997, SPLICE SITE PREDICTI; Reig C, 1996, HUM MUTAT, V8, P93, DOI 10.1002/(SICI)1098-1004(1996)8:1<93::AID-HUMU17>3.0.CO;2-M; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shroyer NF, 1999, VISION RES, V39, P2537, DOI 10.1016/S0042-6989(99)00037-1; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182; WEISS ER, 1994, BIOCHEMISTRY-US, V33, P7587, DOI 10.1021/bi00190a011; Whitehead JL, 1998, HUM MUTAT, pS295; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654; Xu Y, 2014, HUM GENET, V133, P1255, DOI 10.1007/s00439-014-1460-2	32	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e0116176	10.1371/journal.pone.0116176	http://dx.doi.org/10.1371/journal.pone.0116176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25544989	Green Submitted, Green Published, gold			2022-12-26	WOS:000347120200105
J	Tam, J; Cordier, GA; Balint, S; Alvarez, AS; Borbely, JS; Lakadamyali, M				Tam, Johnny; Alan Cordier, Guillaume; Balint, Stefan; Sandoval Alvarez, Angel; Steven Borbely, Joseph; Lakadamyali, Melike			A Microfluidic Platform for Correlative Live-Cell and Super-Resolution Microscopy	PLOS ONE			English	Article							MITOCHONDRIAL DYNAMICS; LOCALIZATION MICROSCOPY; REVEALS; SYSTEMS; STORM; ORGANELLES; RESOLUTION; MOVEMENT; GRADIENT; DISEASE	Recently, super-resolution microscopy methods such as stochastic optical reconstruction microscopy (STORM) have enabled visualization of subcellular structures below the optical resolution limit. Due to the poor temporal resolution, however, these methods have mostly been used to image fixed cells or dynamic processes that evolve on slow time-scales. In particular, fast dynamic processes and their relationship to the underlying ultrastructure or nanoscale protein organization cannot be discerned. To overcome this limitation, we have recently developed a correlative and sequential imaging method that combines live-cell and super-resolution microscopy. This approach adds dynamic background to ultrastructural images providing a new dimension to the interpretation of super-resolution data. However, currently, it suffers from the need to carry out tedious steps of sample preparation manually. To alleviate this problem, we implemented a simple and versatile microfluidic platform that streamlines the sample preparation steps in between live-cell and super-resolution imaging. The platform is based on a microfluidic chip with parallel, miniaturized imaging chambers and an automated fluid-injection device, which delivers a precise amount of a specified reagent to the selected imaging chamber at a specific time within the experiment. We demonstrate that this system can be used for live-cell imaging, automated fixation, and immunostaining of adherent mammalian cells in situ followed by STORM imaging. We further demonstrate an application by correlating mitochondrial dynamics, morphology, and nanoscale mitochondrial protein distribution in live and super-resolution images.	[Tam, Johnny; Alan Cordier, Guillaume; Balint, Stefan; Sandoval Alvarez, Angel; Steven Borbely, Joseph; Lakadamyali, Melike] ICFO Inst Ciencies Foton ICFO, Castelledefels 08860, Barcelona, Spain	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO)	Lakadamyali, M (corresponding author), ICFO Inst Ciencies Foton ICFO, Castelledefels 08860, Barcelona, Spain.	melike.lakadamyali@icfo.es	Tam, Johnny/AHD-6065-2022	Tam, Johnny/0000-0003-2300-0567; Borbely, Joseph/0000-0001-8618-1145	Fundacio CELLEX Barcelona; Systems Microscopy Network of Excellence consortium [FP-7-HEALTH.2010.2.1.2.2]; ERC-Starting grant [337191-MOTORS]; Plan Nacional Grant from the Spanish Ministry (Ministerio de Economia y Competitividad) [FIS2012-37753]; Whitaker International Fellows and Scholars Program	Fundacio CELLEX Barcelona(Foundation CELLEXEuropean Commission); Systems Microscopy Network of Excellence consortium; ERC-Starting grant(European Research Council (ERC)); Plan Nacional Grant from the Spanish Ministry (Ministerio de Economia y Competitividad); Whitaker International Fellows and Scholars Program	This project was financially supported by Fundacio CELLEX Barcelona, by the Systems Microscopy Network of Excellence consortium (call identifier number FP-7-HEALTH.2010.2.1.2.2) and by ERC-Starting grant (grant agreement number 337191-MOTORS) and the Plan Nacional Grant from the Spanish Ministry (Ministerio de Economia y Competitividad FIS2012-37753) to M.L. J.T was supported by the Whitaker International Fellows and Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balint S, 2013, P NATL ACAD SCI USA, V110, P3375, DOI 10.1073/pnas.1219206110; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Berthier E, 2012, LAB CHIP, V12, P1224, DOI 10.1039/c2lc20982a; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Cattoni DI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076268; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Cheong R, 2009, MOL CELL PROTEOMICS, V8, P433, DOI 10.1074/mcp.M800291-MCP200; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; Conrad C, 2011, NAT METHODS, V8, P246, DOI [10.1038/nmeth.1558, 10.1038/NMETH.1558]; Conrad C, 2010, J CELL BIOL, V188, P453, DOI 10.1083/jcb.200910105; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Fahraeus R, 1931, AM J PHYSIOL, V96, P562, DOI 10.1152/ajplegacy.1931.96.3.562; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Jans DC, 2013, P NATL ACAD SCI USA, V110, P8936, DOI 10.1073/pnas.1301820110; Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Lakadamyali M., 2013, CHEMPHYSCHEM; Lakadamyali M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030826; Lock JG, 2010, EXP CELL RES, V316, P1438, DOI 10.1016/j.yexcr.2010.04.001; Lovas JR, 2013, BBA-MOL CELL RES, V1833, P184, DOI 10.1016/j.bbamcr.2012.04.007; Mao HB, 2002, J AM CHEM SOC, V124, P4432, DOI 10.1021/ja017625x; Mitra Kasturi, 2010, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0425s46; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Plucinska G, 2012, J NEUROSCI, V32, P16203, DOI 10.1523/JNEUROSCI.1327-12.2012; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shim SH, 2012, P NATL ACAD SCI USA, V109, P13978, DOI 10.1073/pnas.1201882109; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Tam J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101772; Toepke MW, 2006, LAB CHIP, V6, P1484, DOI 10.1039/b612140c; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Weibel DB, 2006, CURR OPIN CHEM BIOL, V10, P584, DOI 10.1016/j.cbpa.2006.10.016; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wurm CA, 2011, P NATL ACAD SCI USA, V108, P13546, DOI 10.1073/pnas.1107553108; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Young EWK, 2010, CHEM SOC REV, V39, P1036, DOI 10.1039/b909900j; Zhu L, 2012, NAT METHODS, V9, P721, DOI [10.1038/NMETH.1978, 10.1038/nmeth.1978]	41	27	27	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115512	10.1371/journal.pone.0115512	http://dx.doi.org/10.1371/journal.pone.0115512			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545548	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200046
J	Gregory, JC; Buffa, JA; Org, E; Wang, ZN; Levison, BS; Zhu, WF; Wagner, MA; Bennett, BJ; Li, L; DiDonato, JA; Lusis, AJ; Hazen, SL				Gregory, Jill C.; Buffa, Jennifer A.; Org, Elin; Wang, Zeneng; Levison, Bruce S.; Zhu, Weifei; Wagner, Matthew A.; Bennett, Brian J.; Li, Lin; DiDonato, Joseph A.; Lusis, Aldons J.; Hazen, Stanley L.			Transmission of Atherosclerosis Susceptibility with Gut Microbial Transplantation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIMETHYLAMINE-N-OXIDE; INTESTINAL MICROBIOTA; PROGNOSTIC VALUE; METABOLISM; PHOSPHATIDYLCHOLINE; NUTRIENT; DEPENDS; MICE	Recent studies indicate both clinical and mechanistic links between atherosclerotic heart disease and intestinal microbial metabolism of certain dietary nutrients producing trimethylamine N-oxide (TMAO). Here we test the hypothesis that gut microbial transplantation can transmit choline diet-induced TMAO production and atherosclerosis susceptibility. First, a strong association was noted between atherosclerotic plaque and plasma TMAO levels in a mouse diversity panel (n = 22 strains, r = 0.38;p = 0.0001). An atherosclerosis-prone and high TMAO-producing strain, C57BL/6J, and an atherosclerosis-resistant and low TMAO-producing strain, NZW/LacJ, were selected as donors for cecal microbial transplantation into apolipoprotein e null mice in which resident intestinal microbes were first suppressed with antibiotics. Trimethylamine (TMA) and TmAo levels were initially higher in recipients on choline diet that received cecal microbes from C57B1/6J inbred mice; however, durability of choline diet-dependent differences in TMA/TMAO levels was not maintained to the end of the study. Mice receiving C57BL/6J cecal microbes demonstrated choline diet-dependent enhancement in atherosclerotic plaque burden as compared with recipients of NZW/LacJ microbes. Microbial DNA analyses in feces and cecum revealed transplantation of donor microbial community features into recipients with differences in taxa proportions between donor strains that were transmissible to recipients and that tended to show coincident proportions with TMA() levels. Proportions of specific taxa were also identified that correlated with plasma TmAo levels in donors and recipients and with atherosclerotic lesion area in recipients. Atherosclerosis susceptibility may be transmitted via transplantation of gut microbiota. Gut microbes may thus represent a novel therapeutic target for modulating atherosclerosis susceptibility.	[Gregory, Jill C.; Buffa, Jennifer A.; Wang, Zeneng; Levison, Bruce S.; Zhu, Weifei; Wagner, Matthew A.; Li, Lin; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Gregory, Jill C.; Buffa, Jennifer A.; Wang, Zeneng; Levison, Bruce S.; Zhu, Weifei; Wagner, Matthew A.; Li, Lin; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Org, Elin; Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Org, Elin; Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Bennett, Brian J.] Univ N Carolina, Inst Nutr Res, Dept Genet, Chapel Hill, NC 28081 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of North Carolina; University of North Carolina Chapel Hill	Hazen, SL (corresponding author), Cleveland Clin, Dept Cellular & Mol Med, 9500 Euclid Ave,NC 10, Cleveland, OH 44195 USA.	hazens@ccf.org	Wang, Zeneng/AAK-6119-2021; Org, Elin/AAJ-9631-2021; Hazen, Stanley L/ABD-5845-2021	Levison, Bruce/0000-0002-1816-368X; Org, Elin/0000-0003-1451-9375; Org, Elin/0000-0001-8688-9717; bennett, brian/0000-0002-0766-3195	National Institutes of Health from the Office of Dietary Supplements [R01 HL103866, P20 HL113452, HL28481, HL30568]; Cleveland Heart Lab, Inc.; Esperion; Liposciences Inc.; Merck Co., Inc.; Pfizer Inc.; Proctor Gamble; Abbott; Cleveland HeartLab; Liposciences, Inc.; Takeda; National Institutes of Health [T32 GM088088]; MOBILITAS [MJD252]; FP7-People-IOF from the European Union [330381]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103866, P01HL030568, P20HL113452, P01HL028481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088088] Funding Source: NIH RePORTER	National Institutes of Health from the Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cleveland Heart Lab, Inc.; Esperion; Liposciences Inc.; Merck Co., Inc.(Merck & Company); Pfizer Inc.(Pfizer); Proctor Gamble(Procter & Gamble); Abbott(Abbott Laboratories); Cleveland HeartLab; Liposciences, Inc.; Takeda(Takeda Pharmaceutical Company Ltd); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MOBILITAS; FP7-People-IOF from the European Union; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL103866 (to S. L. H.), P20 HL113452 to S. L. H.), and HL28481 and HL30568 (to A. J. L.) from the Office of Dietary Supplements. Drs. Hazen, Wang, and Levison are named as co-inventors on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics. Dr. Hazen reports he has been paid as a consultant or speaker by the following companies: Cleveland Heart Lab, Inc., Esperion, Liposciences Inc., Merck & Co., Inc., Pfizer Inc., and Proctor & Gamble. Dr. Hazen reports he has received research funds from Abbott, Cleveland HeartLab, Liposciences, Inc., Proctor & Gamble, and Takeda. Drs. Hazen, Wang, and Levison have the right to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics or therapeutics from Cleveland HeartLab, Inc., Esperion, and/or Frantz Biomarkers.; Supported in part by National Institutes of Health Training Grant T32 GM088088.; Supported in part by Postdoctoral Grants MJD252 (from MOBILITAS) and FP7-People-IOF (330381) (from the European Union).	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bennett BJ, 2013, CELL METAB, V17, P49, DOI 10.1016/j.cmet.2012.12.011; Bennett BJ, 2012, ARTERIOSCL THROM VAS, V32, P1790, DOI 10.1161/ATVBAHA.112.253864; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Brown JM, 2014, CURR OPIN LIPIDOL, V25, P48, DOI 10.1097/MOL.0000000000000036; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Dolman C. E., 1973, DICT SCI BIOGRAPHY, P420; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EISEMAN B, 1958, SURGERY, V44, P854; Ellekilde M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05922; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Koch R., 1880, INVESTIGATIONS ETIOL; Koch R, 1882, BERLINER KLIN WOCHEN, V19, P221, DOI DOI 10.25646/5088; Kohler C, 2007, CELL TISSUE RES, V330, P291, DOI 10.1007/s00441-007-0474-7; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Pirrung M, 2011, BIOINFORMATICS, V27, P3067, DOI 10.1093/bioinformatics/btr517; Rehg JE, 2012, TOXICOL PATHOL, V40, P345, DOI 10.1177/0192623311430695; Rooks MG, 2014, ISME J, V8, P1403, DOI 10.1038/ismej.2014.3; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Tang WHW, 2014, J AM COLL CARDIOL, V64, P1908, DOI 10.1016/j.jacc.2014.02.617; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang ZN, 2014, ANAL BIOCHEM, V455, P35, DOI 10.1016/j.ab.2014.03.016; Wang ZN, 2014, EUR HEART J, V35, P904, DOI 10.1093/eurheartj/ehu002; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922	37	307	329	4	83	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5647	5660		10.1074/jbc.M114.618249	http://dx.doi.org/10.1074/jbc.M114.618249			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25550161	Green Published, hybrid			2022-12-26	WOS:000350044200034
J	Katoch, P; Mitra, S; Ray, A; Kelsey, L; Roberts, BJ; Wahl, JK; Johnson, KR; Mehta, PP				Katoch, Parul; Mitra, Shalini; Ray, Anuttoma; Kelsey, Linda; Roberts, Brett J.; Wahl, James K., III; Johnson, Keith R.; Mehta, Parmender P.			The Carboxyl Tail of Connexin32 Regulates Gap Junction Assembly in Human Prostate and Pancreatic Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; LIVING CELLS; CYCLIC-AMP; ZONULA OCCLUDENS-1; EPITHELIAL-CELLS; RAT HEPATOCYTES; TIGHT JUNCTIONS; RAFT DOMAINS; E-CADHERIN; CHANNELS	Connexins, the constituent proteins of gap junctions, are transmembrane proteins. A connexin (Cx) traverses the membrane four times and has one intracellular and two extracellular loops with the amino and carboxyl termini facing the cytoplasm. The transmembrane and the extracellular loop domains are highly conserved among different Cxs, whereas the carboxyl termini, often called the cytoplasmic tails, are highly divergent. We have explored the role of the cytoplasmic tail of Cx32, a Cx expressed in polarized and differentiated cells, in regulating gap junction assembly. Our results demonstrate that compared with the full-length Cx32, the cytoplasmic tail-deleted Cx32 is assembled into small gap junctions in human pancreatic and prostatic cancer cells. Our results further document that the expression of the full-length Cx32 in cells, which express the tail-deleted Cx32, increases the size of gap junctions, whereas the expression of the tail-deleted Cx32 in cells, which express the full-length Cx32, has the opposite effect. Moreover, we show that the tail is required for the clustering of cell-cell channels and that in cells expressing the tail-deleted Cx32, the expression of cell surface-targeted cytoplasmic tail alone is sufficient to enhance the size of gap junctions. Our live-cell imaging data further demonstrate that gap junctions formed of the tail-deleted Cx32 are highly mobile compared with those formed of full-length Cx32. Our results suggest that the cytoplasmic tail of Cx32 is not required to initiate the assembly of gap junctions but for their subsequent growth and stability. Our findings suggest that the cytoplasmic tail of Cx32 may be involved in regulating the permeability of gap junctions by regulating their size.	[Katoch, Parul; Mitra, Shalini; Ray, Anuttoma; Kelsey, Linda; Roberts, Brett J.; Wahl, James K., III; Johnson, Keith R.; Mehta, Parmender P.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Dept Oral Biol, Eppley Inst Res Canc & Allied Dis,Fred & Pamela B, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Mehta, PP (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA.	pmehta@unmc.edu			National Institutes of Health Phase III CoBRE [5P30GM106397]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397] Funding Source: NIH RePORTER	National Institutes of Health Phase III CoBRE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Souvik Chakraborty for helpful discussion and suggestions. We thank Tom Dao for help with the live-cell imaging and Robert Svoboda for constructed membrane-targeted form of the cytoplasmic tail of connexin32. We also thank Drs. Steve Caplan and Naava Naslavsky for helpful suggestions regarding endocytosis throughout the course of this study. The live cell imaging studies were supported by the National Institutes of Health Phase III CoBRE Grant 5P30GM106397 (to K. R. J.).	ATKINSON MM, 1995, J CELL SCI, V108, P3079; Beyer Eric C., 2009, P3, DOI 10.1007/978-1-59745-489-6_1; Bosco D, 2011, PHYSIOL REV, V91, P1393, DOI 10.1152/physrev.00027.2010; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Bukauskas FF, 2000, P NATL ACAD SCI USA, V97, P2556, DOI 10.1073/pnas.050588497; Chai ZF, 2011, MOL BIOL CELL, V22, P4503, DOI 10.1091/mbc.E11-05-0438; Chakraborty S, 2010, J BIOL CHEM, V285, P10761, DOI 10.1074/jbc.M109.053348; Dobrowolski R, 2009, ANTIOXID REDOX SIGN, V11, P283, DOI 10.1089/ars.2008.2128; Duffy HS, 2007, J BIOL CHEM, V282, P9789, DOI 10.1074/jbc.M605261200; Foote CI, 1998, J CELL BIOL, V140, P1187, DOI 10.1083/jcb.140.5.1187; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Gemel J, 2004, J CELL SCI, V117, P2469, DOI 10.1242/jcs.01084; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; GOURDIE RG, 1991, J CELL SCI, V99, P41; Govindarajan R, 2002, J BIOL CHEM, V277, P50087, DOI 10.1074/jbc.M202652200; Govindarajan R, 2010, MOL BIOL CELL, V21, P4089, DOI 10.1091/mbc.E10-05-0403; GUERRIER A, 1995, J CELL SCI, V108, P2609; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Herve JC, 2012, BBA-BIOMEMBRANES, V1818, P1844, DOI 10.1016/j.bbamem.2011.12.009; Holm I, 1999, EUR J CELL BIOL, V78, P856, DOI 10.1016/S0171-9335(99)80087-9; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Johnson KE, 2013, MOL BIOL CELL, V24, P715, DOI 10.1091/mbc.E12-07-0537; Kelsey L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032846; Kojima T, 1999, BIOCHEM BIOPH RES CO, V266, P222, DOI 10.1006/bbrc.1999.1778; Kojima T, 2001, EXP CELL RES, V263, P193, DOI 10.1006/excr.2000.5103; Kusumi A, 2012, SEMIN CELL DEV BIOL, V23, P126, DOI 10.1016/j.semcdb.2012.01.018; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; Maass K, 2004, MOL BIOL CELL, V15, P4597, DOI 10.1091/mbc.E04-04-0324; Martin PEM, 2000, BIOCHEM J, V349, P281, DOI 10.1042/0264-6021:3490281; Mehta P, 1999, DEV GENET, V24, P91, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<91::AID-DVG10>3.0.CO;2-#; MEHTA PP, 1986, CELL, V44, P187, DOI 10.1016/0092-8674(86)90497-6; MEHTA PP, 1992, MOL BIOL CELL, V3, P839, DOI 10.1091/mbc.3.8.839; MEHTA PP, 1991, J MEMBRANE BIOL, V124, P207, DOI 10.1007/BF01994355; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Mitra S, 2006, MOL BIOL CELL, V17, P5400, DOI 10.1091/mbc.E06-04-0280; Nielsen PA, 2003, MOL BIOL CELL, V14, P2470, DOI 10.1091/mbc.E02-10-0637; Paulson AF, 2000, J CELL SCI, V113, P3037; Peracchia C, 2000, J BIOL CHEM, V275, P26220, DOI 10.1074/jbc.M004007200; Rhett JM, 2011, MOL BIOL CELL, V22, P1516, DOI 10.1091/mbc.E10-06-0548; Roberts BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077012; SAEZ JC, 1990, EUR J BIOCHEM, V192, P263, DOI 10.1111/j.1432-1033.1990.tb19223.x; SAEZ JC, 1989, AM J PHYSIOL, V257, pC1, DOI 10.1152/ajpcell.1989.257.1.C1; Schubert AL, 2002, BIOCHEMISTRY-US, V41, P5754, DOI 10.1021/bi0121656; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; SHEETZ MP, 1980, NATURE, V285, P510, DOI 10.1038/285510a0; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Simek J, 2009, J CELL SCI, V122, P554, DOI 10.1242/jcs.036970; Solan Joell L., 2009, P263, DOI 10.1007/978-1-59745-489-6_11; Sosinsky GE, 2005, BBA-BIOMEMBRANES, V1711, P99, DOI 10.1016/j.bbamem.2005.04.001; Sosinsky Gina E., 2009, P241, DOI 10.1007/978-1-59745-489-6_10; STAGG RB, 1990, ENDOCR REV, V11, P302, DOI 10.1210/edrv-11-2-302; Stauch K, 2012, J BIOL CHEM, V287, P27771, DOI 10.1074/jbc.M112.382572; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Tomishige M, 1998, J CELL BIOL, V142, P989, DOI 10.1083/jcb.142.4.989; Torok K, 1997, BIOCHEM J, V326, P479; VanSlyke JK, 2000, METHODS, V20, P156, DOI 10.1006/meth.1999.0933; WANG YJ, 1995, EUR J CELL BIOL, V67, P285; WANG YJ, 1995, J BIOL CHEM, V270, P26581, DOI 10.1074/jbc.270.44.26581; WANG YJ, 1995, J CELL SCI, V108, P3501; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Zhou L, 1999, J CELL BIOL, V144, P1033, DOI 10.1083/jcb.144.5.1033	65	12	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4647	4662		10.1074/jbc.M114.586057	http://dx.doi.org/10.1074/jbc.M114.586057			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25548281	hybrid, Green Published			2022-12-26	WOS:000350042000010
J	Wei, YC; Yang, CR; Wei, YP; Ge, ZJ; Zhao, ZA; Zhang, B; Hou, Y; Schatten, H; Sun, QY				Wei, Yanchang; Yang, Cai-Rong; Wei, Yan-Ping; Ge, Zhao-Jia; Zhao, Zhen-Ao; Zhang, Bing; Hou, Yi; Schatten, Heide; Sun, Qing-Yuan			Enriched Environment-induced Maternal Weight Loss Reprograms Metabolic Gene Expression in Mouse Offspring	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTER DNA METHYLATION; BODY-MASS INDEX; INSULIN-RESISTANCE; DIABETES-MELLITUS; OBESITY; CHILDHOOD; MICE; INHERITANCE; OOCYTES; OVERNUTRITION	The global prevalence of weight loss is increasing, especially in young women. However, the extent and mechanisms by which maternal weight loss affects the offspring is still poorly understood. Here, using an enriched environment (EE)-induced weight loss model, we show that maternal weight loss improves general health and reprograms metabolic gene expression in mouse offspring, and the epigenetic alterations can be inherited for at least two generations. EE in mothers induced weight loss and its associated physiological and metabolic changes such as decreased adiposity and improved glucose tolerance and insulin sensitivity. Relative to controls, their offspring exhibited improved general health such as reduced fat accumulation, decreased plasma and hepatic lipid levels, and improved glucose tolerance and insulin sensitivity. Maternal weight loss altered gene expression patterns in the liver of offspring with coherent down-regulation of genes involved in lipid and cholesterol biosynthesis. Epigenomic profiling of offspring livers revealed numerous changes in cytosine methylation depending on maternal weight loss, including reproducible changes in promoter methylation over several key lipid biosynthesis genes, correlated with their expression patterns. Embryo transfer studies indicated that oocyte alteration in response to maternal metabolic conditions is a strong factor in determining metabolic and epigenetic changes in offspring. Several important lipid metabolism-related genes have been identified to partially inherit methylated alleles from oocytes. Our study reveals a molecular and mechanistic basis of how maternal lifestyle modification affects metabolic changes in the offspring.	[Wei, Yanchang; Yang, Cai-Rong; Ge, Zhao-Jia; Zhao, Zhen-Ao; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Wei, Yan-Ping] Changyi Peoples Hosp, Dept Obstet & Gynecol, Weifang 261300, Peoples R China; [Zhang, Bing] Chinese Acad Sci, Chinese Acad Sci Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing 100029, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Missouri System; University of Missouri Columbia	Sun, QY (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, 1 Beichen West Rd, Beijing 100101, Peoples R China.	sunqy@ioz.ac.cn		Wei, Yanchang/0000-0003-4810-9761; Sun, Qing-Yuan/0000-0002-0148-2414; Yang, Cairong/0000-0001-9594-0529	National Natural Science Foundation of China [3147055]; National Basic Research Program of China [2012CB944404, 2011CB944501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grant 3147055 and National Basic Research Program of China Grants 2012CB944404 and 2011CB944501.	Acevedo N, 2007, BIOL REPROD, V77, P872, DOI 10.1095/biolreprod.107.060152; Aitken RJ, 2004, NATURE, V432, P48, DOI 10.1038/432048a; Anckaert E, 2010, BIOL REPROD, V83, P377, DOI 10.1095/biolreprod.109.082164; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Batsis JA, 2007, CLIN PHARMACOL THER, V82, P509, DOI 10.1038/sj.clpt.6100355; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Bouchard C, 2009, AM J CLIN NUTR, V89, pS1494, DOI 10.3945/ajcn.2009.27113C; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Cao L, 2011, CELL METAB, V14, P324, DOI 10.1016/j.cmet.2011.06.020; Cao L, 2010, CELL, V142, P52, DOI 10.1016/j.cell.2010.05.029; Champagne FA, 2008, FRONT NEUROENDOCRIN, V29, P386, DOI 10.1016/j.yfrne.2008.03.003; Chen H, 2008, ENDOCRINOLOGY, V149, P5348, DOI 10.1210/en.2008-0582; Chen ZJ, 2008, ARTERIOSCL THROM VAS, V28, P1738, DOI 10.1161/ATVBAHA.108.171538; Cioffi JA, 1997, MOL HUM REPROD, V3, P467, DOI 10.1093/molehr/3.6.467; Cropley JE, 2006, P NATL ACAD SCI USA, V103, P17308, DOI 10.1073/pnas.0607090103; Du Plessis SS, 2010, NAT REV UROL, V7, P153, DOI 10.1038/nrurol.2010.6; Dunn GA, 2009, ENDOCRINOLOGY, V150, P4999, DOI 10.1210/en.2009-0500; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fricke C, 2008, EVOLUTION, V62, P3170, DOI 10.1111/j.1558-5646.2008.00515.x; Gluckman PD, 2009, LANCET, V373, P1654, DOI 10.1016/S0140-6736(09)60234-8; Griffioen KJ, 2011, CELL METAB, V14, P287, DOI 10.1016/j.cmet.2011.08.002; Guo YF, 2006, J CLIN ENDOCR METAB, V91, P4001, DOI 10.1210/jc.2006-0549; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hypponen E, 2003, DIABETES CARE, V26, P2512, DOI 10.2337/diacare.26.9.2512; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Kiani J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003498; Lago R, 2008, CELL IMMUNOL, V252, P139, DOI 10.1016/j.cellimm.2007.09.004; Lane M, 2014, SCIENCE, V345, P756, DOI 10.1126/science.1254400; Li L, 2009, AM J CLIN NUTR, V89, P551, DOI 10.3945/ajcn.2008.26759; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muhlhausler BS, 2007, J NEUROENDOCRINOL, V19, P67, DOI 10.1111/j.1365-2826.2006.01505.x; Ooi EMM, 2013, CURR OPIN LIPIDOL, V24, P192, DOI 10.1097/MOL.0b013e3283613ba2; Ost A, 2014, CELL, V159, P1352, DOI 10.1016/j.cell.2014.11.005; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Pinhas-Hamiel O, 2005, J PEDIATR-US, V146, P693, DOI 10.1016/j.jpeds.2004.12.042; Pryke SR, 2009, SCIENCE, V323, P1605, DOI 10.1126/science.1168928; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Rakhshandehroo M, 2007, PPAR RES, V2007, DOI 10.1155/2007/26839; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Ratchford AM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1198, DOI 10.1152/ajpendo.00097.2007; Ratchford AM, 2008, MOL ENDOCRINOL, V22, P2643, DOI 10.1210/me.2007-0495; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Robker RL, 2009, J CLIN ENDOCR METAB, V94, P1533, DOI 10.1210/jc.2008-2648; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Sutton-McDowall ML, 2010, REPRODUCTION, V139, P685, DOI 10.1530/REP-09-0345; Tennant PWG, 2011, HUM REPROD, V26, P1501, DOI 10.1093/humrep/der052; Tomizawa SI, 2012, INT J DEV BIOL, V56, P867, DOI 10.1387/ijdb.120152gk; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wei YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020154; Wei YC, 2010, CELL REPROGRAM, V12, P213, DOI 10.1089/cell.2009.0090; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Xu J, 2006, DIABETES, V55, P3429, DOI 10.2337/db06-0260; Yates T, 2012, AM J PREV MED, V42, P1, DOI 10.1016/j.amepre.2011.09.022	64	18	19	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4604	4619		10.1074/jbc.M114.605642	http://dx.doi.org/10.1074/jbc.M114.605642			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25555918	Green Published, hybrid			2022-12-26	WOS:000350042000007
J	Laursen, KB; Kashyap, V; Scandura, J; Gudas, LJ				Laursen, Kristian B.; Kashyap, Vasundhra; Scandura, Joseph; Gudas, Lorraine J.			An Alternative Retinoic Acid-responsive Stra6 Promoter Regulated in Response to Retinol Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN RECEPTOR; VITAMIN-A HOMEOSTASIS; MATTHEW-WOOD-SYNDROME; EMBRYONIC STEM-CELLS; MEMBRANE-RECEPTOR; F9 CELLS; DOWN-REGULATION; CELLULAR UPTAKE; MICE LACKING; RAR-ALPHA	Cellular uptake of vitamin A (retinol) is essential for many biological functions. The Stra6 protein binds the serum retinolbinding protein, RBP4, and acts in conjunction with the enzyme lecithin: retinol acyltransferase to facilitate retinol uptake in some cell types. We show that in embryonic stem (ES) cells and in some tissues, the Stra6 gene encodes two distinct mRNAs transcribed from two different promoters. Whereas both are all-trans-retinoic acid (RA)-responsive in ES cells, the downstream promoter contains a half-site RA response element (RARE) and drives an similar to 13-fold, RA-associated increase in luciferase reporter activity. We employed CRISPR-Cas9 genome editing to show that the endogenous RARE is required for RA-induced transcription of both Stra6 isoforms. We further demonstrate that in ES cells, 1) both RAR gamma and RXR alpha are present at the Stra6 RARE; 2) RA increases co-activator p300 (KAT3B) binding and histone H3 Lys-27 acetylation at both promoters; 3) RA decreases Suz12 levels and histone H3 Lys-27 trimethylation epigenetic marks at both promoters; and 4) these epigenetic changes are diminished in the absence of RAR gamma. In the brains of WT mice, both the longer and the shorter Stra6 transcript (Stra6(L) and Stra6(S), respectively) are highly expressed, whereas these transcripts are found only at low levels in RAR gamma(-/-) mice. In the brains of vitamin A-deficient mice, both Stra6(L) and Stra6(S) levels are decreased. In contrast, in the vitamin A-deficient kidneys, the Stra6(L) levels are greatly increased, whereas Stra6(S) levels are decreased. Our data show that kidneys respond to retinol deficiency by differential Stra6 promoter usage, which may play a role in the retention of retinol when vitamin A is low.	[Laursen, Kristian B.; Kashyap, Vasundhra; Gudas, Lorraine J.] Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Scandura, Joseph; Gudas, Lorraine J.] Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA	Cornell University; Cornell University	Gudas, LJ (corresponding author), Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA.	ljgudas@med.cornell.edu	Kashyap, Vasundhra/H-8970-2019	Scandura, Joseph/0000-0002-9525-143X	National Institutes of Health, NCI [R01 CA043796]; Weill Cornell funds; NATIONAL CANCER INSTITUTE [R01CA043796] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Weill Cornell funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant R01 CA043796 (to L.J.G.). This work was also supported by Weill Cornell funds.	Alapatt P, 2013, J BIOL CHEM, V288, P1250, DOI 10.1074/jbc.M112.369132; Amengual J, 2014, HUM MOL GENET, V23, P5402, DOI 10.1093/hmg/ddu258; Amengual J, 2012, J BIOL CHEM, V287, P24216, DOI 10.1074/jbc.M112.353979; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berry DC, 2013, J BIOL CHEM, V288, P24528, DOI 10.1074/jbc.M113.484014; Berry DC, 2012, MOL CELL BIOL, V32, P3164, DOI 10.1128/MCB.00505-12; Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; BOYLAN JF, 1993, P NATL ACAD SCI USA, V90, P9601, DOI 10.1073/pnas.90.20.9601; Carrera S, 2013, CELL DEATH DIFFER, V20, P910, DOI 10.1038/cdd.2013.14; Chassaing N, 2013, CLIN GENET, V83, P244, DOI 10.1111/j.1399-0004.2012.01904.x; Chassaing N, 2009, HUM MUTAT, V30, pE673, DOI 10.1002/humu.21023; Chen CH, 2012, J BIOL CHEM, V287, P9694, DOI 10.1074/jbc.M111.301721; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Denissov S, 2014, DEVELOPMENT, V141, P526, DOI 10.1242/dev.102681; Faria TN, 1999, J BIOL CHEM, V274, P26783, DOI 10.1074/jbc.274.38.26783; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Golzio C, 2007, AM J HUM GENET, V80, P1179, DOI 10.1086/518177; Gudas LJ, 2012, BBA-MOL CELL BIOL L, V1821, P213, DOI 10.1016/j.bbalip.2011.08.002; Guillemette B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001354; Holmqvist PH, 2013, TRANSCR-AUSTIN, V4, P18, DOI 10.4161/trns.22601; Kashyap V, 2013, J CELL SCI, V126, P999, DOI 10.1242/jcs.119701; Kashyap V, 2011, J BIOL CHEM, V286, P3250, DOI 10.1074/jbc.M110.157545; Kashyap V, 2010, J BIOL CHEM, V285, P14534, DOI 10.1074/jbc.M110.115345; Kawaguchi R, 2008, J BIOL CHEM, V283, P15160, DOI 10.1074/jbc.M801060200; Kawaguchi R, 2008, BIOCHEMISTRY-US, V47, P5387, DOI 10.1021/bi8002082; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kawaguchi R, 2013, J MEMBRANE BIOL, V246, P647, DOI 10.1007/s00232-013-9578-z; Kim YK, 2008, J BIOL CHEM, V283, P5611, DOI 10.1074/jbc.M708885200; Laursen KB, 2013, NUCLEIC ACIDS RES, V41, P6430, DOI 10.1093/nar/gkt367; Laursen KB, 2012, NUCLEIC ACIDS RES, V40, P102, DOI 10.1093/nar/gkr637; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; Mendoza-Parra MA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.73; Mongan NP, 2007, DIFFERENTIATION, V75, P853, DOI 10.1111/j.1432-0436.2007.00206.x; Muenzner M, 2013, MOL CELL BIOL, V33, P4068, DOI 10.1128/MCB.00221-13; NAPOLI JL, 1995, J STEROID BIOCHEM, V53, P497, DOI 10.1016/0960-0760(95)00096-I; Norseen J, 2012, MOL CELL BIOL, V32, P2010, DOI 10.1128/MCB.06193-11; O'Byrne SM, 2013, J LIPID RES, V54, P1731, DOI 10.1194/jlr.R037648; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Ruiz A, 2012, INVEST OPHTH VIS SCI, V53, P3027, DOI 10.1167/iovs.11-8476; Skazik C, 2014, J INVEST DERMATOL, V134, P1579, DOI 10.1038/jid.2013.507; TANEJA R, 1995, P NATL ACAD SCI USA, V92, P7854, DOI 10.1073/pnas.92.17.7854; Urvalek A, 2014, SUBCELL BIOCHEM, V70, P129, DOI 10.1007/978-94-017-9050-5_7; Verdone Loredana, 2006, Briefings in Functional Genomics & Proteomics, V5, P209, DOI 10.1093/bfgp/ell028; Wu LL, 2010, J LIPID RES, V51, P378, DOI 10.1194/jlr.M001222; Zemany L, 2014, MOL CELL BIOL, V34, P1170, DOI 10.1128/MCB.01106-13; Zhong M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073838	50	22	23	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4356	4366		10.1074/jbc.M114.613968	http://dx.doi.org/10.1074/jbc.M114.613968			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25544292	Green Published, hybrid			2022-12-26	WOS:000349458400044
J	Yu, HY; Ahn, JH; Park, SW; Jung, YS				Yu, Hye Yon; Ahn, Ji Hun; Park, Se Won; Jung, Yi-Sook			Preventive Effect of Yuzu and Hesperidin on Left Ventricular Remodeling and Dysfunction in Rat Permanent Left Anterior Descending Coronary Artery Occlusion Model	PLOS ONE			English	Article							HEART-FAILURE; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; ACTIVATION; INJURY; MOUSE; DEATH; (-)-EPICATECHIN; INHIBITION; DISEASE	Left ventricular (LV) remodeling, which includes ventricular dilatation and increased interstitial fibrosis after myocardial infarction (MI), is the critical process underlying the progression to heart failure. Therefore, a novel approach for preventing LV remodeling after MI is highly desirable. Yuzu is a citrus plant originating in East Asia, and has a number of cardioprotective properties such as hesperidin. However, no study has proved whether yuzu can prevent LV remodeling. The aim of this study was to determine the effects of yuzu on heart failure (HF) and its potential impact on the LV remodeling process after MI. Our in vivo study using the permanent left anterior descending coronary artery (LAD) occlusion model demonstrate that one week pre-treatment with yuzu or its major metabolite hesperidin before LAD occlusion significantly attenuated cardiac dysfunction, myocyte apoptosis and inflammation. Not only yuzu but also hesperidin inhibited caspase-3 activity, myeloperoxidase expression, a-smooth muscle actin expression, and matrix metalloproteinase2 activity in a permanent LAD occlusion rat model. To our knowledge, our findings provide the first evidence that yuzu and hesperidin prevent MI-induced ventricular dysfunction and structural remodeling of myocardium.	[Yu, Hye Yon] Ajou Univ, Sch Med, Dept Physiol, Suwon 441749, South Korea; [Yu, Hye Yon; Jung, Yi-Sook] Ajou Univ, Coll Pharm, Suwon 441749, South Korea; [Ahn, Ji Hun] Soon Chun Hyang Univ, Gumi Hosp, Dept Cardiol, Gumi, South Korea; [Park, Se Won] Konkuk Univ, Coll Life & Environm Sci, Seoul, South Korea; [Jung, Yi-Sook] Ajou Univ, Res Inst Pharmaceut Sci & Technol, Suwon 441749, South Korea	Ajou University; Ajou University; Soonchunhyang University; Konkuk University; Ajou University	Jung, YS (corresponding author), Ajou Univ, Coll Pharm, Suwon 441749, South Korea.	yisjung@ajou.ac.kr			Bio-industry Technology Development Program [111093-3]; Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; Next-Generation BioGreen 21 Program [PJ009074]; Rural Development Administration, Republic of Korea	Bio-industry Technology Development Program; Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This research was supported by Bio-industry Technology Development Program (111093-3), Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea. This research was also supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ009074), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhlaghi M, 2010, PLANT FOOD HUM NUTR, V65, P193, DOI 10.1007/s11130-010-0182-4; Anatoliotakis N, 2013, CURR TOP MED CHEM, V13, P115, DOI 10.2174/1568026611313020004; Campian ME, 2010, EUR J HEART FAIL, V12, P653, DOI 10.1093/eurjhf/hfq066; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Diwan A, 2003, CURR MOL MED, V3, P161, DOI 10.2174/1566524033361537; Dorn GW, 2009, CARDIOVASC RES, V81, P465, DOI 10.1093/cvr/cvn243; Eapen Z, 2009, CURR OPIN CARDIOL, V24, P223, DOI 10.1097/HCO.0b013e32832a11ff; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Gonzalez A, 2011, J AM COLL CARDIOL, V58, P1833, DOI 10.1016/j.jacc.2011.06.058; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Jitkova Y, 2012, CIRCULATION, V125, P3159; Kandasamy AD, 2010, CARDIOVASC RES, V85, P413, DOI 10.1093/cvr/cvp268; Kido M, 2005, J AM COLL CARDIOL, V46, P2116, DOI 10.1016/j.jacc.2005.08.045; Kim MY, 2010, CARDIOVASC RES, V87, P119, DOI 10.1093/cvr/cvq048; Kim SJ, 2014, ARCH PHARM RES, V37, P1079, DOI 10.1007/s12272-013-0309-x; Konstam MA, 2011, JACC-CARDIOVASC IMAG, V4, P98, DOI 10.1016/j.jcmg.2010.10.008; Konstantinidis K, 2012, ARTERIOSCL THROM VAS, V32, P1552, DOI 10.1161/ATVBAHA.111.224915; Lal H, 2012, CIRCULATION, V125, P65, DOI 10.1161/CIRCULATIONAHA.111.050666; Paulus W J, 2000, Heart Fail Monit, V1, P50; Pchejetski D, 2012, EUR HEART J, V33, P2360, DOI 10.1093/eurheartj/ehr389; Samsamshariat SA, 2005, CARDIOVASC REVASCULA, V6, P70, DOI 10.1016/j.carrev.2005.07.002; Shin JW, 2014, BIOMOL THER, V22, P17, DOI 10.4062/biomolther.2013.102; Strauer BE, 2010, EUR J HEART FAIL, V12, P721, DOI 10.1093/eurjhf/hfq095; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Tang W H Wilson, 2011, Congest Heart Fail, V17, P105, DOI 10.1111/j.1751-7133.2011.00221.x; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; van Wijk B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044692; Yamazaki KG, 2008, AM J PHYSIOL-HEART C, V295, pH761, DOI 10.1152/ajpheart.00413.2008; Yamazaki KG, 2010, J AM COLL CARDIOL, V55, P2869, DOI 10.1016/j.jacc.2010.01.055; Yang B, 2013, EXPERT OPIN THER TAR, V17, P255, DOI 10.1517/14728222.2013.745513; Yang HI, 2013, BIOMOL THER, V21, P84, DOI 10.4062/biomolther.2012.101; Yi W, 2012, CIRCULATION, V125, P3159, DOI 10.1161/CIRCULATIONAHA.112.099937; Yu HY, 2011, FOOD CHEM TOXICOL, V49, P3018, DOI 10.1016/j.fct.2011.09.038	33	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e110596	10.1371/journal.pone.0110596	http://dx.doi.org/10.1371/journal.pone.0110596			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559243	Green Submitted, Green Published, gold			2022-12-26	WOS:000348102200002
J	Cheung, MC; Law, D; Yip, J				Cheung, Mei-chun; Law, Derry; Yip, Joanne			Evaluating Aesthetic Experience through Personal-Appearance Styles: A Behavioral and Electrophysiological Study	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CENTRAL EXECUTIVE FUNCTIONS; EEG COHERENCE; EMOTIONAL EXPRESSION; BRAIN ACTIVITY; THETA; ASYMMETRY; SYNCHRONIZATION; APPRECIATION; ACTIVATION	Consumers' aesthetic experience has often been linked with the concept of beauty, which is regarded as subjective and may vary between individuals, cultures and places, and across time. With the advent of brain-imaging techniques, there is more and more evidence to suggest that aesthetic experience lies not only in the eye of the beholder, but also in the brain of the beholder. However, there are gaps in the previous research in this area, as several significant issues have not yet been addressed. Specifically, it is unclear whether the human brain really pays more attention and generates more positive emotional responses to beautiful things. To explore the brain activity relating to consumers' aesthetic experiences, 15 participants were recruited voluntarily to view a series of personal-appearance styles. They were invited to make aesthetic judgments while their brain activity was recorded by electroencephalography. Two electroencephalographic (EEG) indicators, theta coherence and frontal alpha symmetry, were utilized. Theta coherence is a measure of linear synchronization between signals at two electrode sites. It reflects the degree of functional cooperation between the underlying neuronal substrates and was used to explore the attentional processing involved in aesthetic judgments. Frontal alpha asymmetry is derived by subtracting the log-transformed absolute alpha power of the left hemisphere from the analogous log-transformed alpha power of the right hemisphere. It was used as an indicator of emotional response. During aesthetic judgments, long-range theta coherence increased in both hemispheres and more positive frontal alpha asymmetry was found when the styles were judged to be beautiful. Therefore, participants demonstrated brain activity suggestive of central executive processing and more positive emotional responses when they considered styles to be beautiful. The study provides some insight into the brain activity associated with consumers' aesthetic experiences, and suggests new directions for exploring consumer behavior from the perspective of neuroscience.	[Cheung, Mei-chun] Chinese Univ Hong Kong, Dept Social Work, Shatin, Hong Kong, Peoples R China; [Law, Derry; Yip, Joanne] Hong Kong Polytech Univ, Inst Text & Clothing, Kowloon, Hong Kong, Peoples R China	Chinese University of Hong Kong; Hong Kong Polytechnic University	Cheung, MC (corresponding author), Chinese Univ Hong Kong, Dept Social Work, Shatin, Hong Kong, Peoples R China.	meichun@swk.cuhk.edu.hk	Cheung, Mei-chun/A-1261-2014; Yip, Joanne/P-6942-2014	Cheung, Mei-chun/0000-0002-0210-0772; Yip, Joanne/0000-0002-3270-4702; Law, Derry/0000-0002-8646-0512	Hong Kong Polytechnic University [4-ZZD1, G-UC37]	Hong Kong Polytechnic University(Hong Kong Polytechnic University)	This study was supported by the internal grants from The Hong Kong Polytechnic University (MC, DL, JY, 4-ZZD1) and (JY, G-UC37). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; [Anonymous], 1994, J Clin Neurophysiol, V11, P111; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Baltissen R., 1998, EMPIR STUD ARTS, V16, P97, DOI [10.2190/KK5M-GAM9-FFFG-0BCC, DOI 10.2190/KK5M-GAM9-FFFG-0BCC]; Barry RJ, 2009, INT J PSYCHOPHYSIOL, V71, P205, DOI 10.1016/j.ijpsycho.2008.09.003; Bartels A, 1998, P ROY SOC B-BIOL SCI, V265, P2327, DOI 10.1098/rspb.1998.0579; Bloch PH, 2003, J CONSUM RES, V29, P551, DOI 10.1086/346250; Boccia M, 2014, ATTEN PERCEPT PSYCHO, V76, P1516, DOI 10.3758/s13414-014-0739-7; Brattico E, 2003, ANN NY ACAD SCI, V999, P155, DOI 10.1196/annals.1284.018; Cazzato V, 2014, BEHAV BRAIN RES, V264, P188, DOI 10.1016/j.bbr.2014.02.001; Cela-Conde CJ, 2013, P NATL ACAD SCI USA, V110, P10454, DOI 10.1073/pnas.1302855110; Cela-Conde CJ, 2011, PROG NEUROBIOL, V94, P39, DOI 10.1016/j.pneurobio.2011.03.003; Cela-Conde CJ, 2009, P NATL ACAD SCI USA, V106, P3847, DOI 10.1073/pnas.0900304106; Cela-Conde CJ, 2004, P NATL ACAD SCI USA, V101, P6321, DOI 10.1073/pnas.0401427101; Chan AS, 2008, APPL PSYCHOPHYS BIOF, V33, P39, DOI 10.1007/s10484-008-9050-5; Chan Agnes S, 2011, Evid Based Complement Alternat Med, V2011, P543648, DOI 10.1093/ecam/nep198; Chan AS, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/180704; Chan AS, 2011, RES AUTISM SPECT DIS, V5, P237, DOI 10.1016/j.rasd.2010.04.005; Chan AS, 2011, RES AUTISM SPECT DIS, V5, P254, DOI 10.1016/j.rasd.2010.04.007; CHAN AS, 2011, EVID-BASED COMPL ALT, P1, DOI DOI 10.1093/ECAM/NEP043; Chatrian G. E., 1985, American Journal of EEG Technology, V25, P83; Chatterjee A., 2004, B PSYCHOL ARTS, V4, P56, DOI DOI 10.1037/E514602010-003; Chatterjee A, 2009, NEUROPSYCHOLOGY, V23, P135, DOI 10.1037/a0014430; Cheung MC, 2010, NEUROSCI LETT, V485, P178, DOI 10.1016/j.neulet.2010.09.006; Cheung MC, 2009, INT J PSYCHOPHYSIOL, V74, P132, DOI 10.1016/j.ijpsycho.2009.08.007; Clarke AR, 2008, INT J PSYCHOPHYSIOL, V67, P35, DOI 10.1016/j.ijpsycho.2007.10.001; Coan JA, 2003, ANN NY ACAD SCI, V1000, P375, DOI 10.1196/annals.1280.034; Coan JA, 2001, PSYCHOPHYSIOLOGY, V38, P912, DOI 10.1111/1469-8986.3860912; CUPCHIK GC, 1992, EMERGING VISIONS OF; Cupchik GC, 2009, BRAIN COGNITION, V70, P84, DOI 10.1016/j.bandc.2009.01.003; Davidson R. J., 2000, HDB PSYCHOPHYSIOLOGY, V2nd, P27; Davidson RJ, 2000, PSYCHOL BULL, V126, P890, DOI 10.1037/0033-2909.126.6.890; DAVIDSON RJ, 1982, SCIENCE, V218, P1235, DOI 10.1126/science.7146906; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; Davidson RJ, 1998, COGNITION EMOTION, V12, P307, DOI 10.1080/026999398379628; Davidson RJ, 2000, AM PSYCHOL, V55, P1196, DOI 10.1037/0003-066X.55.11.1196; Davidson RJ, 2003, PSYCHOSOM MED, V65, P564, DOI 10.1097/01.PSY.0000077505.67574.E3; Di Dio C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001201; Dupuy FE, 2008, INT J PSYCHOPHYSIOL, V70, P151, DOI 10.1016/j.ijpsycho.2008.07.012; EKMAN P, 1990, J PERS SOC PSYCHOL, V58, P342, DOI 10.1037/0022-3514.58.2.342; Fernandez M, 2003, J DEV BEHAV PEDIATR, V24, P261, DOI 10.1097/00004703-200308000-00007; FOX NA, 1991, AM PSYCHOL, V46, P863, DOI 10.1037/0003-066X.46.8.863; FOX NA, 1986, NEUROPSYCHOLOGIA, V24, P417, DOI 10.1016/0028-3932(86)90028-X; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Harmon-Jones E, 2003, COGNITION EMOTION, V17, P1, DOI 10.1080/02699930302278; Harmon-Jones E, 2001, J PERS SOC PSYCHOL, V80, P797, DOI 10.1037/0022-3514.80.5.797; Harmon-Jones E, 2010, BIOL PSYCHOL, V84, P451, DOI 10.1016/j.biopsycho.2009.08.010; Herz R.S, 1998, EMPIR STUD ARTS, V16, P137, DOI [10.2190/c43t-cjr2-9lpd-r0pb, DOI 10.2190/C43T-CJR2-9LPD-R0PB]; Hofel L, 2007, INT J PSYCHOPHYSIOL, V65, P20, DOI 10.1016/j.ijpsycho.2007.02.007; Humphreys GW, 1997, PHILOS T R SOC B, V352, P1275, DOI 10.1098/rstb.1997.0110; Ishizu T, 2013, EUR J NEUROSCI, V37, P1413, DOI 10.1111/ejn.12135; Ishizu T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021852; Jacobs RHAH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031248; Jacobsen T, 2006, NEUROIMAGE, V29, P276, DOI 10.1016/j.neuroimage.2005.07.010; Jacobsen T, 2001, EMPIR STUD ARTS, V19, P177, DOI DOI 10.2190/P7W1-5F1F-NJK9-X05B; Jacobsen T, 2003, COGN AFFECT BEHAV NE, V3, P289, DOI 10.3758/CABN.3.4.289; Jones S.J., 2005, FASHION DESIGN; Kaiser Susan B., 1995, CLOTH TEXT RES J, V13, P172, DOI DOI 10.1177/0887302X9501300304); Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Kirk U, 2009, BRAIN COGNITION, V69, P306, DOI 10.1016/j.bandc.2008.08.004; Kline JP, 2000, BIOL PSYCHOL, V52, P241, DOI 10.1016/S0301-0511(99)00046-0; Lane RD, 1999, NEUROPSYCHOLOGIA, V37, P989, DOI 10.1016/S0028-3932(99)00017-2; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; LAW DKM, 2009, ASIA DESIGN J, V4, P222; Leder H, 2004, BRIT J PSYCHOL, V95, P489, DOI 10.1348/0007126042369811; Leder H, 2014, BRIT J PSYCHOL, V105, P443, DOI 10.1111/bjop.12084; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; Mizuhara H, 2004, NEUROREPORT, V15, P1233, DOI 10.1097/01.wnr.0000126755.09715.b3; Mizuhara H, 2007, NEUROIMAGE, V36, P232, DOI 10.1016/j.neuroimage.2007.02.026; Norman D. A., 2004, EMOTIONAL DESIGN WHY; Nuwer MR, 1998, ELECTROEN CLIN NEURO, V106, P259, DOI 10.1016/S0013-4694(97)00106-5; Pessoa L, 2003, J NEUROSCI, V23, P3990; Reimann M, 2011, UNDERST INNOV, P45, DOI 10.1007/978-3-642-13757-0_3; Roye A, 2008, J PSYCHOPHYSIOL, V22, P41, DOI 10.1027/0269-8803.22.1.41; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Sauseng P, 2007, EUR J NEUROSCI, V25, P587, DOI 10.1111/j.1460-9568.2006.05286.x; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Srinivasan R, 2007, J NEUROSCI METH, V166, P41, DOI 10.1016/j.jneumeth.2007.06.026; Thatcher RW, 2008, HUM BRAIN MAPP, V29, P1400, DOI 10.1002/hbm.20474; Thatcher RW, 2005, CLIN NEUROPHYSIOL, V116, P2129, DOI 10.1016/j.clinph.2005.04.026; THATCHER RW, 1986, ELECTROEN CLIN NEURO, V64, P123, DOI 10.1016/0013-4694(86)90107-0; Tsukiura T, 2011, SOC COGN AFFECT NEUR, V6, P138, DOI 10.1093/scan/nsq025; Vartanian O, 2004, NEUROREPORT, V15, P893, DOI 10.1097/00001756-200404090-00032; VERYZER RW, 1993, ADV CONSUM RES, V20, P224; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Waldstein SR, 2000, BIOL PSYCHOL, V55, P3, DOI 10.1016/S0301-0511(00)00065-X; Weiss S, 2000, NEUROREPORT, V11, P2357, DOI 10.1097/00001756-200008030-00005; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Womelsdorf T, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00210; Zeki S, 1998, BRAIN, V121, P1669, DOI 10.1093/brain/121.9.1669; Zeki S, 1999, PHILOS T R SOC B, V354, P1371, DOI 10.1098/rstb.1999.0485; Zeki S, 1998, NEUROSCIENTIST, V4, P365, DOI 10.1177/107385849800400518; Zeki S., 1999, INNER VISION EXPLORA; Zeki S, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00068; Zhang ZM, 2012, J INTEGR NEUROSCI, V11, P477, DOI 10.1142/S0219635212500306	96	15	16	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115112	10.1371/journal.pone.0115112	http://dx.doi.org/10.1371/journal.pone.0115112			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7UC	25551635	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100027
J	Eriksen, RL; Hierro, JL; Eren, O; Andonian, K; Torok, K; Becerra, PI; Montesinos, D; Khetsuriani, L; Diaconu, A; Kesseli, R				Eriksen, Renee L.; Hierro, Jose L.; Eren, Ozkan; Andonian, Krikor; Toeroek, Katalin; Becerra, Pablo I.; Montesinos, Daniel; Khetsuriani, Liana; Diaconu, Alecu; Kesseli, Rick			Dispersal Pathways and Genetic Differentiation among Worldwide Populations of the Invasive Weed Centaurea solstitialis L. (Asteraceae)	PLOS ONE			English	Article							SEED SIZE; EVOLUTION; ADMIXTURE; SOFTWARE; HYBRIDIZATION; SUCCESS; GROWTH; COMMON	The natural history of introduced species is often unclear due to a lack of historical records. Even when historical information is readily available, important factors of the invasions such as genetic bottlenecks, hybridization, historical relationships among populations and adaptive changes are left unknown. In this study, we developed a set of nuclear, simple sequence repeat markers and used these to characterize the genetic diversity and population structure among native (Eurasian) and non-native (North and South American) populations of Centaurea solstitialis L., (yellow starthistle). We used these data to test hypotheses about the invasion pathways of the species that were based on historical and geographical records, and we make inferences about historical relationships among populations and demographic processes following invasion. We confirm that the center of diversity and the native range of the species is likely the eastern Mediterranean region in the vicinity of Turkey. From this region, the species likely proceeded to colonize other parts of Europe and Asia via a slow, stepwise range expansion. Spanish populations were the primary source of seed to invade South America via human-mediated events, as was evident from historical records, but populations from the eastern Mediterranean region were also important. North American populations were largely derived from South America, but had secondary contributors. We suggest that the introduction history of non-native populations from disparate parts of the native range have allowed not just one, but multiple opportunities first in South America then again in North America for the creation of novel genotypes via intraspecific hybridization. We propose that multiple intraspecific hybridization events may have created especially potent conditions for the selection of a noxious invader, and may explain differences in genetic patterns among North and South America populations, inferred differences in demographic processes, as well as morphological differences previously reported from common garden experiments.	[Eriksen, Renee L.; Kesseli, Rick] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA; [Hierro, Jose L.] Univ Nacl La Pampa, Consejo Nacl Invest Cient & Tecn, Inst Ciencias Tierra & Ambientales La Pampa, Santa Rosa, La Pampa, Argentina; [Eren, Ozkan] Adnan Menderes Univ, Fen Edebiyat Fak, Biyol Bolumu, Aydin, Turkey; [Andonian, Krikor] De Anza Coll, Dept Environm Studies, Cupertino, CA USA; [Toeroek, Katalin] Ctr Ecol Res MTA OK, Vacratot, Hungary; [Becerra, Pablo I.] Pontificia Univ Catolica Chile, Dept Ecosistemas & Medio Ambiente, Fac Agron & Ingn Forestal, Santiago, Chile; [Montesinos, Daniel] Univ Coimbra, Ctr Funct Ecol, Dept Ciencias Vida, Fac Ciencia & Tecnol, Coimbra, Portugal; [Khetsuriani, Liana] Ilia State Univ, Inst Bot, Tbilisi, Georgia; [Diaconu, Alecu] Inst Biol Res, Biol Control Lab, Iasi, Romania	University of Massachusetts System; University of Massachusetts Boston; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Adnan Menderes University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Pontificia Universidad Catolica de Chile; Universidade de Coimbra; Ilia State University; National Research Institute for Biological Sciences	Eriksen, RL (corresponding author), Univ Massachusetts, Dept Biol, Boston, MA 02125 USA.	renee.eriksen@gmail.com	Török, Katalin/AAP-3392-2021; DIACONU, Alecu/A-9299-2011; Montesinos, Daniel/A-9070-2012	Montesinos, Daniel/0000-0003-2893-0878	National Science Foundation [NSF 0820451]; Direct For Biological Sciences [0820451] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by National Science Foundation (NSF 0820451) (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard W, 1960, PRINCIPLES PF PLANT; ANDERSON E, 1954, EVOLUTION, V8, P378, DOI 10.2307/2405784; Anderson E., 1949, INTROGRESSIVE HYBRID; Andonian K, 2011, BIOL INVASIONS, V13, P2957, DOI 10.1007/s10530-011-9978-x; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Buswell JM, 2011, J ECOL, V99, P214, DOI 10.1111/j.1365-2745.2010.01759.x; DiTomaso J.M., 2007, WEEDS CALIFORNIA OTH, V3488; Dlugosch KM, 2013, G3-GENES GENOM GENET, V3, P359, DOI 10.1534/g3.112.003871; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Eriksen RL, 2012, BIOL INVASIONS, V14, P1459, DOI 10.1007/s10530-012-0172-6; Eriksen RL, 2009, MORPHOLOGICAL GENETI; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Garcia-Jacas N, 2006, ANN BOT-LONDON, V98, P741, DOI 10.1093/aob/mcl157; Gerlach JD, 1997, P CALIF WEED SCI SOC, V49, P136; Graebner RC, 2012, PLANT ECOL, V213, P545, DOI 10.1007/s11258-012-0020-x; Gross BL, 2007, MOL ECOL, V16, P5246, DOI 10.1111/j.1365-294X.2007.03574.x; Hierro JL, 2006, AM NAT, V168, P144, DOI 10.1086/505767; Hierro JL, 2013, OIKOS, V122, P583, DOI 10.1111/j.1600-0706.2012.00022.x; Hierro JL, 2011, BIOL INVASIONS, V13, P2249, DOI 10.1007/s10530-011-0037-4; Hierro JL, 2009, OIKOS, V118, P529, DOI [10.1111/j.1600-0706.2009.17283.x, 10.1111/j.1600-0706.2008.17283.x]; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Keller SR, 2014, J EVOLUTION BIOL, V27, P616, DOI 10.1111/jeb.12330; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Maddox D, 1981, INTRO PHENOLOGY DENS; Mayr E., 1964, SYSTEMATICS ORIGIN S; Molofsky J, 2014, ECOL EVOL, V4, P899, DOI 10.1002/ece3.966; Montesinos D, 2012, AM NAT, V180, P529, DOI 10.1086/667585; Murray J., 1910, REPORTS SCI EXPEDITI, P17; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Novak S, 2005, GENETIC BOTTLENECKS, P201; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pinke G, 2002, KITAIBELIA, V7, P249; Pitcairn M. J., 2006, California Agriculture, V60, P83, DOI 10.3733/ca.v060n02p83; Pritchard JK, 2000, GENETICS, V155, P945; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rieseberg LH, 2007, GENETICA, V129, P149, DOI 10.1007/s10709-006-9011-y; Rieseberg LH, 2009, CURR BIOL, V19, pR119, DOI 10.1016/j.cub.2008.12.016; Rius M, 2014, TRENDS ECOL EVOL, V29, P233, DOI 10.1016/j.tree.2014.02.003; Rozen S, 2000, Methods Mol Biol, V132, P365; STEBBINS GL, 1945, BOT REV, V11, P463, DOI 10.1007/BF02861140; Sun M, 1998, HEREDITY, V80, P225, DOI 10.1046/j.1365-2540.1998.00290.x; Sun M, 1997, CAN J BOT, V75, P1470, DOI 10.1139/b97-861; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Uygur S, 2004, WEED SCI, V52, P746, DOI 10.1614/WS-03-150R1; Widmer TL, 2007, WEED SCI, V55, P465, DOI 10.1614/WS-06-211R.1; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872	52	33	33	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e114786	10.1371/journal.pone.0114786	http://dx.doi.org/10.1371/journal.pone.0114786			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551223	gold, Green Published, Green Submitted			2022-12-26	WOS:000347119100015
J	Liang, LN; Zhang, W; Ma, G; Hoffmann, AA; Ma, CS				Liang, Li-Na; Zhang, Wei; Ma, Gang; Hoffmann, Ary A.; Ma, Chun-Sen			A Single Hot Event Stimulates Adult Performance but Reduces Egg Survival in the Oriental Fruit Moth, Grapholitha molesta	PLOS ONE			English	Article							THERMAL TOLERANCE; DROSOPHILA-MELANOGASTER; REPRODUCTIVE SUCCESS; INDUCED HORMESIS; HEAT-STRESS; TEMPERATURE; LEPIDOPTERA; LONGEVITY; FECUNDITY; EXPOSURE	Climate warming is expected to increase the exposure of insects to hot events (involving a few hours at extreme high temperatures). These events are unlikely to cause widespread mortality but may modify population dynamics via impacting life history traits such as adult fecundity and egg hatching. These effects and their potential impact on population predictions are still largely unknown. In this study, we simulated a single hot event (maximum of 38 degrees C lasting for 4 h) of a magnitude increasingly found under field conditions and examined its effect in the oriental fruit moth, Grapholitha molesta. This hot event had no impact on the survival of G. molesta adults, copulation periods or male longevity. However, the event increased female lifespan and the length of the oviposition period, leading to a potential increase in lifetime fecundity and suggesting hormesis. In contrast, exposure of males to this event markedly reduced the net reproductive value. Male heat treatment delayed the onset of oviposition in the females they mated with, as well as causing a decrease in the duration of oviposition period and lifetime fecundity. Both male and female stress also reduced egg hatch. Our findings of hormetic effects on female performance but concurrent detrimental effects on egg hatch suggest that hot events have unpredictable consequences on the population dynamics of this pest species with implications for likely effects associated with climate warming.	[Liang, Li-Na; Zhang, Wei; Ma, Gang; Ma, Chun-Sen] Chinese Acad Agr Sci, Inst Plant Protect, Climate Change Biol Res Grp, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Hoffmann, Ary A.] Univ Melbourne, Pest & Environm Adaptat Res Grp, Dept Zool, Inst Bio21, Melbourne, Vic 3010, Australia; [Hoffmann, Ary A.] Univ Melbourne, Pest & Environm Adaptat Res Grp, Dept Genet, Inst Bio21, Melbourne, Vic 3010, Australia	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; University of Melbourne; University of Melbourne	Ma, CS (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Climate Change Biol Res Grp, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	machunsen@caas.cn	Hoffmann, Ary/R-2972-2019; Hoffmann, Ary/C-2961-2011; Ma, Chun-Sen/K-5414-2019; Ma, Gang/ABY-9316-2022	Hoffmann, Ary/0000-0001-9497-7645; Ma, Chun-Sen/0000-0002-3253-6921; Ma, Gang/0000-0002-3378-9488; Zhang, Wei/0000-0002-9262-0631	National Special Fund for Agro-scientific Research in the Public Interest [201103024]; Scientific and Technology Program of Shanxi Province [20130311021-5]; Beijing Natural Science Foundation [5144032]; National Natural Science Foundation of China [31400323]	National Special Fund for Agro-scientific Research in the Public Interest; Scientific and Technology Program of Shanxi Province; Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors will make a change to their research grants. This research was supported by the National Special Fund for Agro-scientific Research in the Public Interest (No. 201103024), Scientific and Technology Program of Shanxi Province (No. 20130311021-5), Beijing Natural Science Foundation (No. 5144032) and National Natural Science Foundation of China (No. 31400323). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2001, J EVOLUTION BIOL, V14, P199, DOI 10.1046/j.1420-9101.2001.00281.x; Ayyanath MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074532; Battisti A, 2006, GLOBAL CHANGE BIOL, V12, P662, DOI 10.1111/j.1365-2486.2006.01124.x; Burgess SC, 2011, J EXP BIOL, V214, P2329, DOI 10.1242/jeb.054718; Calabrese EJ, 2005, TOXICOL APPL PHARM, V202, P289, DOI 10.1016/j.taap.2004.06.023; Calosi P, 2008, BIOL LETTERS, V4, P99, DOI 10.1098/rsbl.2007.0408; Cannon RJC, 1998, GLOBAL CHANGE BIOL, V4, P785, DOI 10.1046/j.1365-2486.1998.00190.x; Chang Xiang-qian, 2012, Yingyong Shengtai Xuebao, V23, P772; Nguyen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087535; Chidawanyika F, 2011, J INSECT PHYSIOL, V57, P108, DOI 10.1016/j.jinsphys.2010.09.013; de Morais RM, 2012, REV BRAS ENTOMOL, V56, P319, DOI 10.1590/S0085-56262012000300009; DEBARRO PJ, 1993, AUST J ZOOL, V41, P123, DOI 10.1071/ZO9930123; Denlinger DL, 1998, TEMPERATURES SENSITIVITY IN INSECTS AND APPLICATION IN INTEGRATED PEST MANAGEMENT, P7; Du J, 2009, THESIS NW A F U; Ducatez S, 2012, EVOLUTION, V66, P3558, DOI 10.1111/j.1558-5646.2012.01704.x; Einum S, 2000, NATURE, V405, P565, DOI 10.1038/35014600; Fasolo AG, 2004, BIOL J LINN SOC, V83, P197, DOI 10.1111/j.1095-8312.2004.00380.x; Fischer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015284; Forbes VE, 2000, FUNCT ECOL, V14, P12, DOI 10.1046/j.1365-2435.2000.00392.x; Fraser HW, 2001, CAN ENTOMOL, V133, P219, DOI 10.4039/Ent133219-2; Friedenberg NA, 2008, ENVIRON ENTOMOL, V37, P650, DOI 10.1603/0046-225X(2008)37[650:TEDDAS]2.0.CO;2; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Guedes RNC, 2009, J ECON ENTOMOL, V102, P170, DOI 10.1603/029.102.0124; Guo JY, 2012, ENVIRON ENTOMOL, V41, P1672, DOI 10.1603/EN12108; Harrington R, 2001, AGR FOREST ENTOMOL, V3, P233, DOI 10.1046/j.1461-9555.2001.00120.x; Hazell SP, 2010, J INSECT PHYSIOL, V56, P123, DOI 10.1016/j.jinsphys.2009.08.022; Hercus MJ, 2003, BIOGERONTOLOGY, V4, P149, DOI 10.1023/A:1024197806855; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; James DG, 2002, J ECON ENTOMOL, V95, P729, DOI 10.1603/0022-0493-95.4.729; Janowitz SA, 2011, J THERM BIOL, V36, P283, DOI 10.1016/j.jtherbio.2011.04.001; Javois J, 2004, ANIM BEHAV, V68, P249, DOI 10.1016/j.anbehav.2003.10.022; Jorgensen KT, 2006, J THERM BIOL, V31, P280, DOI 10.1016/j.jtherbio.2005.11.026; KREBS RA, 1994, FUNCT ECOL, V8, P730, DOI 10.2307/2390232; Le Bourg E, 2001, BIOGERONTOLOGY, V2, P155, DOI 10.1023/A:1011561107055; Le Bourg E, 2011, EXP GERONTOL, V46, P345, DOI 10.1016/j.exger.2010.08.003; Liu SS, 2002, ENVIRON ENTOMOL, V31, P221, DOI 10.1603/0046-225X-31.2.221; Ma CS, 2004, ENTOMOL EXP APPL, V110, P65, DOI 10.1111/j.0013-8703.2004.00123.x; Minois N, 2000, BIOGERONTOLOGY, V1, P15, DOI 10.1023/A:1010085823990; Mironidis GK, 2010, J THERM BIOL, V35, P59, DOI 10.1016/j.jtherbio.2009.11.001; Mitchell KA, 2010, FUNCT ECOL, V24, P694, DOI 10.1111/j.1365-2435.2009.01666.x; Muller HG, 2001, P ROY SOC B-BIOL SCI, V268, P445, DOI 10.1098/rspb.2000.1370; Nisbet RM, 2000, J ANIM ECOL, V69, P913, DOI 10.1046/j.1365-2656.2000.00448.x; Novoseltsev VN, 2003, MECH AGEING DEV, V124, P605, DOI 10.1016/S0047-6374(03)00061-7; Patton ZJ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P783, DOI 10.1086/323327; Petavy G, 2004, EVOL ECOL RES, V6, P873; Pincebourde S, 2007, J ANIM ECOL, V76, P424, DOI 10.1111/j.1365-2656.2007.01231.x; Rinehart JP, 2000, PHYSIOL ENTOMOL, V25, P330, DOI 10.1046/j.1365-3032.2000.00201.x; SaLM Kooijman, 2000, DYNAMIC ENERGY MASS, DOI 10.1017/CBO9780511565403; Scannapieco AC, 2007, BIOGERONTOLOGY, V8, P315, DOI 10.1007/s10522-006-9075-1; Silbermann R, 2000, EVOLUTION, V54, P2038; South A, 2011, BIOL REV, V86, P299, DOI 10.1111/j.1469-185X.2010.00145.x; Terblanche JS, 2010, ENTOMOL EXP APPL, V137, P304, DOI 10.1111/j.1570-7458.2010.01067.x; Wan FH, 2008, J INSECT SCI, V8, P49; Yu YS, 2010, PESTIC BIOCHEM PHYS, V98, P238, DOI 10.1016/j.pestbp.2010.06.013; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075923; Zhao F, 2014, J ANIM ECOL, V83, P769, DOI 10.1111/1365-2656.12196; Zizzari ZV, 2011, J INSECT PHYSIOL, V57, P421, DOI 10.1016/j.jinsphys.2011.01.002	58	24	29	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116339	10.1371/journal.pone.0116339	http://dx.doi.org/10.1371/journal.pone.0116339			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551751	Green Published, gold			2022-12-26	WOS:000347119100131
J	Anderson, JC; Minnich, DJ; Dobelbower, MC; Denton, AJ; Dussaq, AM; Gilbert, AN; Rohrbach, TD; Arafat, W; Welaya, K; Bonner, JA; Willey, CD				Anderson, Joshua C.; Minnich, Douglas J.; Dobelbower, M. Christian; Denton, Alexander J.; Dussaq, Alex M.; Gilbert, Ashley N.; Rohrbach, Timothy D.; Arafat, Waleed; Welaya, Karim; Bonner, James A.; Willey, Christopher D.			Kinomic Profiling of Electromagnetic Navigational Bronchoscopy Specimens: A New Approach for Personalized Medicine	PLOS ONE			English	Article							CELL LUNG-CANCER; TRANSBRONCHIAL NEEDLE ASPIRATION; KINASE-ACTIVITY; THERAPY; TARGETS; RESISTANCE; EFFICACY; TISSUE; TRIAL	Purpose: Researchers are currently seeking relevant lung cancer biomarkers in order to make informed decisions regarding therapeutic selection for patients in so-called "precision medicine.'' However, there are challenges to obtaining adequate lung cancer tissue for molecular analyses. Furthermore, current molecular testing of tumors at the genomic or transcriptomic level are very indirect measures of biological response to a drug, particularly for small molecule inhibitors that target kinases. Kinase activity profiling is therefore theorized to be more reflective of in vivo biology than many current molecular analysis techniques. As a result, this study seeks to prove the feasibility of combining a novel minimally invasive biopsy technique that expands the number of lesions amenable for biopsy with subsequent ex vivo kinase activity analysis. Methods: Eight patients with lung lesions of varying location and size were biopsied using the novel electromagnetic navigational bronchoscopy (ENB) technique. Basal kinase activity (kinomic) profiles and ex vivo interrogation of samples in combination with tyrosine kinase inhibitors erlotinib, crizotinib, and lapatinib were performed by PamStation 12 microarray analysis. Results: Kinomic profiling qualitatively identified patient specific kinase activity profiles as well as patient and drug specific changes in kinase activity profiles following exposure to inhibitor. Thus, the study has verified the feasibility of ENB as a method for obtaining tissue in adequate quantities for kinomic analysis and has demonstrated the possible use of this tissue acquisition and analysis technique as a method for future study of lung cancer biomarkers. Conclusions: We demonstrate the feasibility of using ENB-derived biopsies to perform kinase activity assessment in lung cancer patients.	[Anderson, Joshua C.; Dobelbower, M. Christian; Denton, Alexander J.; Gilbert, Ashley N.; Rohrbach, Timothy D.; Bonner, James A.; Willey, Christopher D.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35233 USA; [Minnich, Douglas J.] Univ Alabama Birmingham, Dept Surg, Div Cardiothorac Surg, Birmingham, AL 35294 USA; [Dussaq, Alex M.; Arafat, Waleed] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Welaya, Karim] Univ Alexandria, Alexandria, Egypt	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Egyptian Knowledge Bank (EKB); Alexandria University	Willey, CD (corresponding author), Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35233 USA.	cwilley@uab.edu		Anderson, Joshua/0000-0002-6977-9054; arafat, waleed/0000-0002-6617-5992	Department of Radiation Oncology Intramural Pilot Research Program, The University of Alabama at Birmingham; Egyptian Partnership and Ownership initiative (PAR-OWN) international research fellowship	Department of Radiation Oncology Intramural Pilot Research Program, The University of Alabama at Birmingham; Egyptian Partnership and Ownership initiative (PAR-OWN) international research fellowship	This work was supported by The Department of Radiation Oncology Intramural Pilot Research Program, The University of Alabama at Birmingham (to MCD), and also by the Egyptian Partnership and Ownership initiative (PAR-OWN) international research fellowship (to KW), http://www.estp.sci.eg/english/national_initiatives/mobility_grants/parown. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2014, RADIOTHER ONCOL; Anderson JC, 2014, RADIOTHER ONCOL, V111, P468, DOI 10.1016/j.radonc.2014.04.010; Cappuzzo F, 2007, J THORAC ONCOL, V2, pS12, DOI 10.1097/01.JTO.0000268634.17956.5e; Carbone DP, 2012, J THORAC ONCOL, V7, P1653, DOI 10.1097/JTO.0b013e31826c1155; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Cooke DT, 2014, J THORAC CARDIOV SUR, V148, P36, DOI 10.1016/j.jtcvs.2014.03.014; Duverger A, 2014, J VIROL, V88, P364, DOI 10.1128/JVI.02682-13; Eberhardt R, 2010, RESPIRATION, V79, P54, DOI 10.1159/000232394; Folkvord S, 2010, INT J RADIAT ONCOL, V78, P555, DOI 10.1016/j.ijrobp.2010.04.036; Fuchs FS, 2013, EUR RESPIR J, V41, P1401, DOI 10.1183/09031936.00062512; Garber K, 2006, NAT BIOTECHNOL, V24, P127, DOI 10.1038/nbt0206-127; Hirsch FR, 2010, CLIN CANCER RES, V16, P4909, DOI 10.1158/1078-0432.CCR-10-2005; Jarboe JS, 2012, RADIOTHER ONCOL, V103, P380, DOI 10.1016/j.radonc.2012.03.014; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Jurado J, 2013, ANN THORAC SURG, V96, P1196, DOI 10.1016/j.athoracsur.2013.05.066; Kikuchi T, 2012, MOL CELL PROTEOMICS, V11, P916, DOI 10.1074/mcp.M111.015370; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; McGuire JL, 2014, BRAIN RES, V1568, P42, DOI 10.1016/j.brainres.2014.04.029; Moreira AL, 2012, CLIN LUNG CANCER, V13, P334, DOI 10.1016/j.cllc.2012.01.004; Rafael OC, 2014, CANCER CYTOPATHOL, V122, P454, DOI 10.1002/cncy.21426; Sakairi Y, 2010, CLIN CANCER RES, V16, P4938, DOI 10.1158/1078-0432.CCR-10-0099; Sikkema AH, 2009, CANCER RES, V69, P5987, DOI 10.1158/0008-5472.CAN-08-3660; Suwinski R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041379; Thomas A, 2013, ANN ONCOL, V24, P577, DOI 10.1093/annonc/mds478; Wulfkuhle JD, 2008, J PROTEOME RES, V7, P1508, DOI 10.1021/pr7008127; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	28	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116388	10.1371/journal.pone.0116388	http://dx.doi.org/10.1371/journal.pone.0116388			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549342	Green Published, gold, Green Submitted			2022-12-26	WOS:000347063500081
J	Christensen, JC; Shiyanov, PA; Estepp, JR; Schlager, JJ				Christensen, James C.; Shiyanov, Pavel A.; Estepp, Justin R.; Schlager, John J.			Lack of Association between Human Plasma Oxytocin and Interpersonal Trust in a Prisoner's Dilemma Paradigm	PLOS ONE			English	Article							PERIPHERAL OXYTOCIN; SOCIAL-BEHAVIOR; VASOPRESSIN; BLOOD; RADIOIMMUNOASSAY; ALTRUISM; CORTISOL	Expanding interest in oxytocin, particularly the role of endogenous oxytocin in human social behavior, has created a pressing need for replication of results and verification of assay methods. In this study, we sought to replicate and extend previous results correlating plasma oxytocin with trust and trustworthy behavior. As a necessary first step, the two most commonly used commercial assays were compared in human plasma via the addition of a known quantity of exogenous oxytocin, with and without sample extraction. Plasma sample extraction was found to be critical in obtaining repeatable concentrations of oxytocin. In the subsequent trust experiment, twelve samples in duplicate, from each of 82 participants, were collected over approximately six hours during the performance of a Prisoner's Dilemma task paradigm that stressed human interpersonal trust. We found no significant relationship between plasma oxytocin concentrations and trusting or trustworthy behavior. In light of these findings, previous published work that used oxytocin immunoassays without sample extraction should be reexamined and future research exploring links between endogenous human oxytocin and trust or social behavior should proceed with careful consideration of methods and appropriate biofluids for analysis.	[Christensen, James C.; Estepp, Justin R.; Schlager, John J.] Air Force Res Lab, Wright Patterson AFB, OH 45433 USA; [Shiyanov, Pavel A.] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA	United States Department of Defense; United States Air Force; US Air Force Research Laboratory; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Christensen, JC (corresponding author), Air Force Res Lab, Wright Patterson AFB, OH 45433 USA.	james.christensen.7@us.af.mil			Office of the Director of National Intelligence (ODNI); Intelligence Advanced Research Projects Activity (IARPA)	Office of the Director of National Intelligence (ODNI); Intelligence Advanced Research Projects Activity (IARPA)	This research is based upon work supported by the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), via the Air Force Research Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMICO JA, 1983, J CLIN ENDOCR METAB, V57, P947, DOI 10.1210/jcem-57-5-947; AMICO JA, 1981, J CLIN ENDOCR METAB, V52, P988, DOI 10.1210/jcem-52-5-988; Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; Armstrong WE, 2006, AM J PHYSIOL-REG I, V291, pR26, DOI 10.1152/ajpregu.00879.2005; Benjamini Y, 2001, ANN STAT, V29, P1165; BERSCHEID E, 1989, J PERS SOC PSYCHOL, V57, P792, DOI 10.1037/0022-3514.57.5.792; Cantor N, 1986, HDB MOTIVATION COGNI, P96; Carson DS, 2013, J PSYCHOPHARMACOL, V27, P231, DOI 10.1177/0269881112473788; Carter CS, 2007, ANN NY ACAD SCI, V1098, P312, DOI 10.1196/annals.1384.006; Churchland PS, 2012, HORM BEHAV, V61, P392, DOI 10.1016/j.yhbeh.2011.12.003; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; ERMISCH A, 1985, J CEREBR BLOOD F MET, V5, P350, DOI 10.1038/jcbfm.1985.49; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feldman R, 2007, PSYCHOL SCI, V18, P965, DOI 10.1111/j.1467-9280.2007.02010.x; Gordon I, 2008, PSYCHOPHYSIOLOGY, V45, P349, DOI 10.1111/j.1469-8986.2008.00649.x; Gouin JP, 2010, PSYCHONEUROENDOCRINO, V35, P1082, DOI 10.1016/j.psyneuen.2010.01.009; Green LA, 2001, BIOL PSYCHIAT, V50, P609, DOI 10.1016/S0006-3223(01)01139-8; Ho JM, 2013, ENDOCRINOLOGY, V154, P589, DOI 10.1210/en.2012-1751; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; Keri S, 2009, SOC NEUROSCI-UK, V4, P287, DOI 10.1080/17470910802319710; Kiss Alexander, 2005, Endocr Regul, V39, P97; LEAKE RD, 1980, OBSTET GYNECOL, V56, P701; MAYER RC, 1995, ACAD MANAGE REV, V20, P709, DOI 10.2307/258792; Mayer RC, 1999, J APPL PSYCHOL, V84, P123, DOI 10.1037/0021-9010.84.1.123; McCullough ME, 2013, NEUROSCI BIOBEHAV R, V37, P1485, DOI 10.1016/j.neubiorev.2013.04.018; McEwen Barbara B, 2004, Adv Pharmacol, V50, P531; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Neumann ID, 2008, J NEUROENDOCRINOL, V20, P858, DOI 10.1111/j.1365-2826.2008.01726.x; Rahm VA, 2002, ACTA OBSTET GYN SCAN, V81, P1033, DOI 10.1034/j.1600-0412.2002.811107.x; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2004, NEUROREPORT, V15, P2539, DOI 10.1097/00001756-200411150-00022; RYDEN G, 1969, ACTA ENDOCRINOL-COP, V61, P425, DOI 10.1530/acta.0.0610425; SCHAMS D, 1983, ACTA ENDOCRINOL-COP, V103, P180, DOI 10.1530/acta.0.1030180; Spielberger CD, 1983, MANUAL FOR THE STATE; Szeto A, 2011, PSYCHOSOM MED, V73, P393, DOI 10.1097/PSY.0b013e31821df0c2; Taylor SE, 2010, PSYCHOL SCI, V21, P3, DOI 10.1177/0956797609356507; THOMSON JJ, 1986, RIGHTS RESTITUTION A; Tops M, 2007, PSYCHOPHYSIOLOGY, V44, P444, DOI 10.1111/j.1469-8986.2007.00510.x; Wedekind C, 1996, P NATL ACAD SCI USA, V93, P2686, DOI 10.1073/pnas.93.7.2686; Zak PJ, 2005, HORM BEHAV, V48, P522, DOI 10.1016/j.yhbeh.2005.07.009; Zhang GD, 2011, ANAL BIOCHEM, V416, P45, DOI 10.1016/j.ab.2011.04.041	43	42	42	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116172	10.1371/journal.pone.0116172	http://dx.doi.org/10.1371/journal.pone.0116172			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549255	Green Published, gold			2022-12-26	WOS:000347063500055
J	Guo, XJ; Liu, SF; Wu, LF; Tang, LL				Guo, Xiaojun; Liu, Sifeng; Wu, Lifeng; Tang, Lingling			Application of a Novel Grey Self-Memory Coupling Model to Forecast the Incidence Rates of Two Notifiable Diseases in China: Dysentery and Gonorrhea	PLOS ONE			English	Article							INFECTIOUS-DISEASES; PREDICTION MODEL; DEVELOPING-COUNTRIES; PANDEMIC INFLUENZA; NEURAL-NETWORKS; TIME; SURVEILLANCE; DYNAMICS; SYSTEM	Objective: In this study, a novel grey self-memory coupling model was developed to forecast the incidence rates of two notifiable infectious diseases (dysentery and gonorrhea); the effectiveness and applicability of this model was assessed based on its ability to predict the epidemiological trend of infectious diseases in China. Methods: The linear model, the conventional GM(1,1) model and the GM(1,1) model with self-memory principle (SMGM(1,1) model) were used to predict the incidence rates of the two notifiable infectious diseases based on statistical incidence data. Both simulation accuracy and prediction accuracy were assessed to compare the predictive performances of the three models. The best-fit model was applied to predict future incidence rates. Results: Simulation results show that the SMGM(1,1) model can take full advantage of the systematic multi-time historical data and possesses superior predictive performance compared with the linear model and the conventional GM(1,1) model. By applying the novel SMGM(1,1) model, we obtained the possible incidence rates of the two representative notifiable infectious diseases in China. Conclusion: The disadvantages of the conventional grey prediction model, such as sensitivity to initial value, can be overcome by the self-memory principle. The novel grey self-memory coupling model can predict the incidence rates of infectious diseases more accurately than the conventional model, and may provide useful references for making decisions involving infectious disease prevention and control.	[Guo, Xiaojun] Nantong Univ, Sch Sci, Nantong, Jiangsu, Peoples R China; [Guo, Xiaojun; Liu, Sifeng; Wu, Lifeng] Nanjing Univ Aeronaut & Astronaut, Coll Econ & Management, Nanjing, Jiangsu, Peoples R China; [Tang, Lingling] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY USA	Nantong University; Nanjing University of Aeronautics & Astronautics; Cornell University	Guo, XJ (corresponding author), Nantong Univ, Sch Sci, Nantong, Jiangsu, Peoples R China.	guoxj159@163.com		Liu, Sifeng/0000-0002-5872-9457; Wu, Lifeng/0000-0002-9548-9747	National Natural Science Foundation of China [71401051]; Nantong Science and Technology Program [HS2013026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nantong Science and Technology Program	This work was partially supported by the National Natural Science Foundation of China (No. 71401051) and the Funding of Nantong Science and Technology Program (No. HS2013026). But the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrus JK, 2011, VACCINE, V29, pD126, DOI 10.1016/j.vaccine.2011.06.023; Apisarnthanarak A, 2006, INFECT CONT HOSP EP, V27, P885, DOI 10.1086/505924; Brouqui P, 2009, CLIN MICROBIOL INFEC, V15, P700, DOI 10.1111/j.1469-0691.2009.02873.x; CAO HX, 1993, SCI CHINA SER B, V36, P845; Cao HX, 2002, SELF MEMORY PRINCIPL; Cui J, 2013, APPL MATH MODEL, V37, P4399, DOI 10.1016/j.apm.2012.09.052; Ding F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027295; Ding F, 2011, INFECT GENET EVOL, V11, P222, DOI 10.1016/j.meegid.2010.09.015; Dopson SA, 2009, BIOSECUR BIOTERROR, V7, P55, DOI 10.1089/bsp.2008.0021; [范习辉 Fan Xihui], 2003, [系统工程理论与实践, Systems Engineering-Theory & Practice], V23, P114; Gao L, 2014, AM J TROP MED HYG, V90, P697, DOI 10.4269/ajtmh.13-0198; Getachew Y, 2013, STAT MED, V32, P3224, DOI 10.1002/sim.5752; Gonzalez-Castillo J, 2013, ENFERM INFEC MICR CL, V31, P173, DOI 10.1016/j.eimc.2012.01.025; Guo H, 2013, APPL MATH COMPUT, V225, P216, DOI 10.1016/j.amc.2013.08.094; Guo Xiao-jun, 2014, Systems Engineering and Electronics, V36, P1124, DOI 10.3969/j.issn.1001-506X.2014.06.17; Hall IM, 2007, EPIDEMIOL INFECT, V135, P372, DOI 10.1017/S0950268806007084; Hsu LC, 2003, TECHNOL FORECAST SOC, V70, P563, DOI 10.1016/S0040-1625(02)00195-6; Hu MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038978; Jakopanec I, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-33; Li DC, 2012, OMEGA-INT J MANAGE S, V40, P767, DOI 10.1016/j.omega.2011.07.007; Li GD, 2011, INT J ELEC POWER, V33, P809, DOI 10.1016/j.ijepes.2010.11.005; Li J, 2006, PETROL SCI, V3, P89; Lin WZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049040; LIU SF, 2013, J GREY SYST UK, V0025, P00001; [刘湘平 Liu Xiangping], 2010, [岩土工程学报, Chinese Journal of Geotechnical Engineering], V32, P1535; Liu ZJ, 2013, NONLINEAR ANAL-REAL, V14, P1286, DOI 10.1016/j.nonrwa.2012.09.016; Lu HM, 2010, IEEE T KNOWL DATA EN, V22, P565, DOI 10.1109/TKDE.2009.115; Ma JQ, 2007, BIOMED ENVIRON SCI, V20, P208; Nishiura H, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-5; Nishiura H, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-15; Nunes B, 2011, STAT METHODS MED RES, V20, P331, DOI 10.1177/0962280209340201; Osei FB, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-118; Padhi R, 2009, COMPUT METH PROG BIO, V94, P207, DOI 10.1016/j.cmpb.2008.12.010; Rao VSH, 2010, NONLINEAR ANAL-REAL, V11, P1810, DOI 10.1016/j.nonrwa.2009.04.006; Ren YD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042055; Shen XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060601; Song B, 2010, SCI CHINA TECHNOL SC, V53, P2049, DOI 10.1007/s11431-010-3173-7; Sunil Bhatnagar, 2012, INDIAN J PUBLIC HLTH, V56, P281; The Ministry of Health of the People's Republic of China, 2013, CHIN HLTH STAT YB 20; Thomas S, 2013, EXPERT REV VACCINES, V12, P1301, DOI 10.1586/14760584.2013.840092; Wang W, 2012, CHINESE SCI BULL, V57, P3430, DOI 10.1007/s11434-012-5386-6; Watkins RE, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-263; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wu LF, 2013, APPL MATH MODEL, V37, P6577, DOI 10.1016/j.apm.2013.01.018; Xie NM, 2013, APPL MATH MODEL, V37, P5059, DOI 10.1016/j.apm.2012.10.037; Xu R, 2012, APPL MATH COMPUT, V218, P7927, DOI 10.1016/j.amc.2012.01.076; Yaesoubi R, 2011, EUR J OPER RES, V215, P679, DOI 10.1016/j.ejor.2011.07.016; Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031076; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063116; 陈向东, 2009, [中国科学. E辑, 技术科学, Science in China. Series E, Engineering and Materials Science], V39, P341	50	5	5	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115664	10.1371/journal.pone.0115664	http://dx.doi.org/10.1371/journal.pone.0115664			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546054	Green Submitted, Green Published, gold			2022-12-26	WOS:000347120200051
J	Somagoni, J; Boakye, CHA; Godugu, C; Patel, AR; Faria, HAM; Zucolotto, V; Singh, M				Somagoni, Jaganmohan; Boakye, Cedar H. A.; Godugu, Chandraiah; Patel, Apurva R.; Mendonca Faria, Henrique Antonio; Zucolotto, Valtencir; Singh, Mandip			Nanomiemgel - A Novel Drug Delivery System for Topical Application - In Vitro and In Vivo Evaluation	PLOS ONE			English	Article							LIPID NANOPARTICLES; SKIN INFLAMMATION; MODEL; COMBINATION; FORMULATION; INHIBITION; CAPSAICIN; RELEASE; PATHWAY; NSAIDS	Aim: The objective of this study was to formulate and evaluate a unique matrix mixture (nanomiemgel) of nanomicelle and nanoemulsion containing aceclofenac and capsaicin using in vitro and in vivo analyses and to compare it to a marketed formulation (Aceproxyvon). Methods: Nanomicelles were prepared using Vitamin E TPGS by solvent evaporation method and nanoemulsion was prepared by high-pressure homogenization method. In vitro drug release and human skin permeation studies were performed and analyzed using HPLC. The efficiency of nanomiemgel as a delivery system was investigated using an imiquimod-induced psoriatic like plaque model developed in C57BL/6 mice. Results: Atomic Force Microscopy images of the samples exhibited a globular morphology with an average diameter of 200, 250 and 220 nm for NMI, NEM and NMG, respectively. Nanomiemgel demonstrated a controlled release drug pattern and induced 2.02 and 1.97-fold more permeation of aceclofenac and capsaicin, respectively than Aceproxyvon through dermatomed human skin. Nanomiemgel also showed 2.94 and 2.09-fold greater Cmax of aceclofenac and capsaicin, respectively than Aceproxyvon in skin microdialysis study in rats. The PASI score, ear thickness and spleen weight of the imiquimod-induced psoriatic-like plaque model were significantly (p<0.05) reduced in NMG treated mice compared to free drug, NEM, NMI & Aceproxyvon. Conclusion: Using a new combination of two different drug delivery systems (NEM+ NMI), the absorption of the combined system (NMG) was found to be better than either of the individual drug delivery systems due to the utilization of the maximum possible paths of absorption available for that particular drug. of of	[Somagoni, Jaganmohan; Boakye, Cedar H. A.; Godugu, Chandraiah; Patel, Apurva R.; Singh, Mandip] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA; [Mendonca Faria, Henrique Antonio; Zucolotto, Valtencir] Univ Sao Paulo, Nanomed & Nanotoxicol Grp, Phys Inst Sao Carlos, BR-13566590 Sao Carlos, SP, Brazil	State University System of Florida; Florida A&M University; Universidade de Sao Paulo	Singh, M (corresponding author), Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA.	mandip.sachdeva@famu.edu	Faria, Henrique Antonio Mendonça/M-5774-2013; Zucolotto, Valtencir/B-9103-2012; Faria, Henrique A. M./K-2782-2019; Godugu, Chandraiah/F-4741-2018	Faria, Henrique Antonio Mendonça/0000-0001-6976-6897; Faria, Henrique A. M./0000-0001-6976-6897; Godugu, Chandraiah/0000-0001-5904-3134; HYDERABAD, NIPER/0000-0001-7521-1150; Zucolotto, Valtencir/0000-0003-4307-3077; Sachdeva, Mandip/0000-0001-9192-8143	NCRR NIH HHS [G12RR 03020] Funding Source: Medline; NIMHD NIH HHS [P20 MD006738, G12 MD007582] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003020] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007582] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Alvarez-Soria MA, 2006, ANN RHEUM DIS, V65, P998, DOI 10.1136/ard.2005.046920; Bhattacharyya S, 2014, BIOMATERIALS, V35, P509, DOI 10.1016/j.biomaterials.2013.09.073; Byamba D, 2014, EXP DERMATOL, V13, P12448; Chooluck K, 2013, PHARMAZIE, V68, P135, DOI 10.1691/ph.2013.2116; Chougule M, 2011, LUNG CANCER, V71, P271, DOI 10.1016/j.lungcan.2010.06.002; Chougule MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017733; Dasgupta S, 2013, CURR DRUG DELIV, V10, P656, DOI 10.2174/156720181006131125150023; Desai PR, 2013, J CONTROL RELEASE, V170, P51, DOI 10.1016/j.jconrel.2013.04.021; Desai PR, 2012, PHARM RES-DORDR, V29, P2587, DOI 10.1007/s11095-012-0789-2; Ercan N, 2013, INFLAMMOPHARMACOLOGY, V21, P413, DOI 10.1007/s10787-013-0175-7; Flutter B, 2013, EUR J IMMUNOL, V43, P3138, DOI 10.1002/eji.201343801; Gomes MJ, 2014, INT J NANOMED, V9, P1231, DOI 10.2147/IJN.S45561; Kakumanu S, 2011, NANOMED-NANOTECHNOL, V7, P277, DOI 10.1016/j.nano.2010.12.002; Lapeyre-Mestre M, 2013, FUND CLIN PHARMACOL, V27, P223, DOI 10.1111/j.1472-8206.2011.00991.x; Laporte JR, 2004, DRUG SAFETY, V27, P411, DOI 10.2165/00002018-200427060-00005; Lau WM, 2008, CURR PHARM DESIGN, V14, P794, DOI 10.2174/138161208784007653; Lee SE, 2013, EXP DERMATOL, V22, P59, DOI 10.1111/exd.12055; Manjanna KM, 2010, CRIT REV THER DRUG, V27, P509, DOI 10.1615/CritRevTherDrugCarrierSyst.v27.i6.20; Martin-Martinez J, 2014, 2014 POW SYST COMP C, P1, DOI 10.1109/VARI.2014. 6957088; Mizoguchi H, 2014, PEPTIDES, V51, P15, DOI 10.1016/j.peptides.2013.10.012; Mozsik G, 2014, PROG DRUG RES, V68, P209, DOI 10.1007/978-3-0348-0828-6_9; Nasr M, 2008, J MICROENCAPSUL, V25, P499, DOI [10.1080/02652040802055411, 10.1080/02652040802055411 ]; Oshima S, 2012, BIOL PHARM BULL, V35, P203, DOI 10.1248/bpb.35.203; Pande V, 2014, ADV PHARM BULL, V4, P121, DOI 10.5681/apb.2014.019; Puglia C, 2013, CURR MED CHEM, V20, P1847; Raza K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/406731; Sahoo S, 2014, DRUG DELIV, V20, P1; Shah PP, 2012, J CONTROL RELEASE, V161, P735, DOI 10.1016/j.jconrel.2012.05.011; Shah PP, 2012, BIOMATERIALS, V33, P1607, DOI 10.1016/j.biomaterials.2011.11.011; Singh TP, 2011, AM J PATHOL, V178, P699, DOI 10.1016/j.ajpath.2010.10.008; Tausend W, 2014, J CUTAN MED SURG, V18, P156, DOI 10.2310/7750.2013.13125; Tavano L, 2011, COLLOID SURFACE B, V87, P333, DOI 10.1016/j.colsurfb.2011.05.041; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wavikar P, 2013, AAPS PHARMSCITECH, V14, P222, DOI 10.1208/s12249-012-9908-y; Yu M, 2014, EUR J PHARM BIOPHARM, V2	35	43	45	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115952	10.1371/journal.pone.0115952	http://dx.doi.org/10.1371/journal.pone.0115952			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546392	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200085
J	Yang, LL; Liu, B; Li, Y; Wang, SX; Xu, Y; Wang, DP; Ye, HH; Shang, SC; Zhang, GZ; Peng, RY; Zeng, L; Li, WL				Yang Leilei; Liu Bing; Li Yang; Wang Shaoxia; Xu Yuan; Wang Dongping; Ye Huahu; Shang Shichen; Zhang Guangzhou; Peng Ruiyun; Zeng Lin; Li Wenlong			iRhom2 Mutation Leads to Aberrant Hair Follicle Differentiation in Mice	PLOS ONE			English	Article							PROTEOLYTIC CLEAVAGE; STEM-CELLS; NOTCH; SKIN; TACE; MORPHOGENESIS; ACTIVATION; BARRIER; CANCER; UNCV	iRhom1 and iRhom2 are inactive homologues of rhomboid intramembrane serine proteases lacking essential catalytic residues, which are necessary for the maturation of TNF alpha-converting enzyme (TACE). In addition, iRhoms regulate epidermal growth factor family secretion. The functional significance of iRhom2 during mammalian development is largely unclear. We have identified a spontaneous single gene deletion mutation of iRhom2 in Uncv mice. The iRhom2(Uncv/Uncv) mice exhibit hairless phenotype in a BALB/c genetic background. In this study, we observed dysplasia hair follicles in iRhom2(Uncv/Uncv) mice from postnatal day 3. Further examination found decreased hair matrix proliferation and aberrant hair shaft and inner root sheath differentiation in iRhom2(Uncv/Uncv) mutant hair follicles. iRhom2 is required for the maturation of TACE. Our data demonstrate that iRhom2(Uncv) cannot induce the maturation of TACE in vitro and the level of mature TACE is also significantly reduced in the skin of iRhom2(Uncv/Uncv) mice. The activation of Notch1, a substrate of TACE, is disturbed, associated with dramatically down-regulation of Lef1 in iRhom2(Uncv/Uncv) hair follicle matrix. This study identifies iRhom2 as a novel regulator of hair shaft and inner root sheath differentiation.	[Yang Leilei; Li Yang; Wang Shaoxia; Peng Ruiyun] Beijing Inst Radiat Med, Beijing 100850, Peoples R China; [Liu Bing; Wang Shaoxia; Xu Yuan; Wang Dongping; Ye Huahu; Shang Shichen; Zhang Guangzhou; Zeng Lin; Li Wenlong] Inst JingFeng Med Lab Anim, Beijing 100071, Peoples R China	Academy of Military Medical Sciences - China	Yang, LL (corresponding author), Beijing Inst Radiat Med, Beijing 100850, Peoples R China.	leileiyang@126.com; liwl@bmi.ac.cn			National Natural Science Foundation of China [31030058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31030058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Blaydon DC, 2012, AM J HUM GENET, V90, P340, DOI 10.1016/j.ajhg.2011.12.008; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Brooke MA, 2014, HUM MOL GENET; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Christova Y, 2013, EMBO REP; Dai X, 2004, CURR OPIN GENET DEV, V14, P485, DOI 10.1016/j.gde.2004.07.002; Ellis T, 2001, GENE DEV, V15, P2307, DOI 10.1101/gad.200101; Franzke CW, 2012, J EXP MED, V209, P1105, DOI 10.1084/jem.20112258; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Issuree PDA, 2013, J CLIN INVEST, V123, P928, DOI 10.1172/JCI66168; Johnson KR, 2003, GENOMICS, V81, P6, DOI 10.1016/S0888-7543(02)00013-7; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Li SR, 1999, GENET RES, V73, P233, DOI 10.1017/S0016672399003808; Lin MH, 2003, DEV BIOL, V263, P343, DOI 10.1016/j.ydbio.2003.07.007; Liu B., 2014, BMB REP; LYNCH MH, 1986, J CELL BIOL, V103, P2593, DOI 10.1083/jcb.103.6.2593; Maretzky T, 2013, P NATL ACAD SCI USA, V110, P11433, DOI 10.1073/pnas.1302553110; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Murthy A, 2012, IMMUNITY, V36, P105, DOI 10.1016/j.immuni.2012.01.005; OGUIN WM, 1992, J INVEST DERMATOL, V98, P24, DOI 10.1111/1523-1747.ep12494172; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Ramirez A, 1998, DNA CELL BIOL, V17, P177, DOI 10.1089/dna.1998.17.177; Ross DA, 2001, MOL CELL BIOL, V21, P7537, DOI 10.1128/MCB.21.22.7537-7544.2001; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Shi YZ, 2003, ACTA BIOCH BIOPH SIN, V35, P397; Siggs OM, 2012, BLOOD, V119, P5769, DOI 10.1182/blood-2012-03-417949; Spaulding C, 2007, BLOOD, V110, P2650, DOI 10.1182/blood-2007-04-084202; Stephenson NL, 2012, P NATL ACAD SCI USA, V109, pE2757, DOI 10.1073/pnas.1205788109; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Weinmaster G, 2000, CURR OPIN GENET DEV, V10, P363, DOI 10.1016/S0959-437X(00)00097-6; Yang LL, 2009, MOL BIOL CELL, V20, P882, DOI 10.1091/mbc.E08-07-0731; Yang LL, 2005, CANCER RES, V65, P8671, DOI 10.1158/0008-5472.CAN-05-0800; Yuhki M, 2004, DEVELOPMENT, V131, P1825, DOI 10.1242/dev.01079; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047	44	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115114	10.1371/journal.pone.0115114	http://dx.doi.org/10.1371/journal.pone.0115114			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546423	Green Published, Green Submitted, gold			2022-12-26	WOS:000347120200023
J	Zeng, H; Chen, JX				Zeng, Heng; Chen, Jian-Xiong			Conditional Knockout of Prolyl Hydroxylase Domain Protein 2 Attenuates High Fat-Diet-Induced Cardiac Dysfunction in Mice	PLOS ONE			English	Article							FACTOR-KAPPA-B; VENTRICULAR-FUNCTION; INSULIN-RESISTANCE; INDUCED OBESITY; HEART-FAILURE; HYPOXIA; HYPERTROPHY; INFLAMMATION; ACTIVATION; EXPRESSION	Oxygen sensor prolyl hydroxylases (PHDs) play important roles in the regulation of HIF-alpha and cell metabolisms. This study was designed to investigate the direct role of PHD2 in high fat-diet (HFD)-induced cardiac dysfunction. In HFD fed mice, PHD2 expression was increased without significant changes in PHD1 and PHD3 levels in the heart. This was accompanied by a significant upregulation of myeloid differentiation factor 88 (MYD88) and NF-kappa B. To explore the role of PHD2 in HFD-induced cardiac dysfunction, PHD2 conditional knockout mice were fed a HFD for 16 weeks. Intriguingly, knockout of PHD2 significantly reduced MYD88 and NF-kappa kb expression in HFD mouse hearts. Moreover, knockout of PHD2 inhibited TNFa and ICAM-1 expression, and reduced cell apoptosis and macrophage infiltration in HFD mice. This was accompanied by a significant improvement of cardiac function. Most importantly, conditional knockout of PHD2 at late stage in HFD mice significantly improved glucose tolerance and reversed cardiac dysfunction. Our studies demonstrate that PHD2 activity is a critical contributor to the HFD-induced cardiac dysfunction. Inhibition of PHD2 attenuates HFD-induced cardiac dysfunction by a mechanism involving suppression of MYD88/NF-kappa b pathway and inflammation.	[Zeng, Heng; Chen, Jian-Xiong] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center	Chen, JX (corresponding author), Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA.	JChen3@umc.edu			National Institutes of Health grant [HL102042]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102042] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from National Institutes of Health grant HL102042 to J. X. Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080; Andreakos E, 2005, FRONT BIOSCI-LANDMRK, V10, P2478, DOI 10.2741/1712; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Birks EJ, 2004, J HEART LUNG TRANSPL, V23, P228, DOI 10.1016/S1053-2498(03)00106-2; Brown MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1201, DOI 10.2741/1304; Chen JX, 2008, DIABETES, V57, P3335, DOI 10.2337/db08-0503; Chen JX, 2008, LAB INVEST, V88, P1316, DOI 10.1038/labinvest.2008.92; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Elmarakby AA, 2010, CLIN SCI, V118, P291, DOI 10.1042/CS20090395; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Frantz S, 2008, FRONT BIOSCI, V13, P5772; Frantz S, 2006, FASEB J, V20, P1918, DOI 10.1096/fj.05-5133fje; Fujita N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375964; Ha TZ, 2006, AM J PHYSIOL-HEART C, V290, pH985, DOI 10.1152/ajpheart.00720.2005; Ha TZ, 2005, CARDIOVASC RES, V68, P224, DOI 10.1016/j.cardiores.2005.05.025; Hamid T, 2011, CARDIOVASC RES, V89, P129, DOI 10.1093/cvr/cvq274; Kawamura N, 2005, CARDIOVASC RES, V66, P520, DOI 10.1016/j.cardiores.2005.02.007; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kim SJ, 2012, J NUTR BIOCHEM, V23, P113, DOI 10.1016/j.jnutbio.2010.10.012; Kiss J, 2012, J IMMUNOL, V189, P1955, DOI 10.4049/jimmunol.1103471; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Li T, 2009, J HYPERTENS, V27, P1084, DOI 10.1097/HJH.0b013e3283293c93; Lin Q, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000548; Lorenzo O, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/652097; Maier HJ, 2012, P NATL ACAD SCI USA, V109, P11794, DOI 10.1073/pnas.1116584109; Matsuura H, 2013, CIRCULATION, V127, P2078, DOI 10.1161/CIRCULATIONAHA.113.001742; Miyata T, 2010, NAT REV NEPHROL, V6, P83, DOI 10.1038/nrneph.2009.211; Mou SS, 2002, CRIT CARE MED, V30, P827, DOI 10.1097/00003246-200204000-00018; Nwogu JI, 2001, CIRCULATION, V104, P2216, DOI 10.1161/hc4301.097193; Rajesh M, 2010, J AM COLL CARDIOL, V56, P2115, DOI 10.1016/j.jacc.2010.07.033; Ritchie NE, 1998, CIRCULATION, V98, P1707, DOI 10.1161/01.CIR.98.17.1707; Rottman JN, 2007, ECHOCARDIOGR-J CARD, V24, P83, DOI 10.1111/j.1540-8175.2006.00356.x; Satoh M, 2006, INT J CARDIOL, V109, P226, DOI 10.1016/j.ijcard.2005.06.023; Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Singh MV, 2012, J MOL CELL CARDIOL, V52, P1135, DOI 10.1016/j.yjmcc.2012.01.021; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Takeda K, 2007, CIRCULATION, V116, P774, DOI 10.1161/CIRCULATIONAHA.107.701516; Takeda K, 2009, ARTERIOSCL THROM VAS, V29, P2132, DOI 10.1161/ATVBAHA.109.196071; Taniguchi CM, 2013, NAT MED, V19, P1325, DOI 10.1038/nm.3294; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Valen G, 2004, BASIC RES CARDIOL, V99, P1, DOI 10.1007/s00395-003-0442-7; Valen G, 2001, J AM COLL CARDIOL, V38, P307, DOI 10.1016/S0735-1097(01)01377-8; Van der Heiden K, 2010, CLIN SCI, V118, P593, DOI 10.1042/CS20090557; Van Tassell BW, 2010, J CARDIOVASC PHARM, V55, P385, DOI 10.1097/FJC.0b013e3181d3da24; Willam C, 2006, J MOL CELL CARDIOL, V41, P68, DOI 10.1016/j.yjmcc.2006.04.009; Yokoyama S, 2012, GENE, V497, P340, DOI 10.1016/j.gene.2012.01.024; Zeng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035905; Zhang H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001112	50	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115974	10.1371/journal.pone.0115974	http://dx.doi.org/10.1371/journal.pone.0115974			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546437	gold, Green Published, Green Submitted			2022-12-26	WOS:000347120200088
J	De Schacht, C; Hoffman, HJ; Mabunda, N; Lucas, C; Alons, CL; Madonela, A; Vubil, A; Ferreira, OC; Calu, N; Santos, IS; Jani, IV; Guay, L				De Schacht, Caroline; Hoffman, Heather J.; Mabunda, Nedio; Lucas, Carlota; Alons, Catharina L.; Madonela, Ana; Vubil, Adolfo; Ferreira, Orlando C., Jr.; Calu, Nurbai; Santos, Iolanda S.; Jani, Ilesh V.; Guay, Laura			High Rates of HIV Seroconversion in Pregnant Women and Low Reported Levels of HIV Testing among Male Partners in Southern Mozambique: Results from a Mixed Methods Study	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; MALE INVOLVEMENT; EASTERN UGANDA; INCIDENT HIV; PREVENTION; INFECTION; DETERMINANTS; ATTENDANCE; DELIVERY; SERVICES	Introduction: Prevention of acute HIV infections in pregnancy is required to achieve elimination of pediatric HIV. Identification and support for HIV negative pregnant women and their partners, particularly serodiscordant couples, are critical. A mixed method study done in Southern Mozambique estimated HIV incidence during pregnancy, associated risk factors and factors influencing partner's HIV testing. Methods: Between April 2008 and November 2011, a prospective cohort of 1230 HIV negative pregnant women was followed during pregnancy. A structured questionnaire, HIV testing, and collection of dried blood spots were done at 2-3 scheduled visits. HIV incidence rates were calculated by repeat HIV testing and risk factors assessed by Poisson regression. A qualitative study including 37 individual interviews with men, women, and nurses and 11 focus group discussions (n=94) with men, women and grandmothers explored motivators and barriers to uptake of male HIV testing. Results: HIV incidence rate was estimated at 4.28/100 women-years (95% CI: 2.33-7.16). Significant risk factors for HIV acquisition were early sexual debut (RR 3.79, 95% CI: 1.04-13.78, p=0.04) and living in Maputo Province (RR 4.35, 95% CI: 0.97-19.45, p=0.05). Nineteen percent of women reported that their partner had tested for HIV (93% knew the result with 8/213 indicating an HIV positive partner), 56% said their partner had not tested and 19% did not know their partner test status. Of the 14 seroconversions, only one reported being in a serodiscordant relationship. Fear of discrimination or stigma was reported as a key barrier to male HIV testing, while knowing the importance of getting tested and receiving care was the main motivator. Conclusions: HIV incidence during pregnancy is high in Southern Mozambique, but knowledge of partners' HIV status remains low. Knowledge of both partners' HIV status is critical for maximal effectiveness of prevention and treatment services to reach elimination of pediatric HIV/AIDS.	[De Schacht, Caroline; Lucas, Carlota; Alons, Catharina L.; Madonela, Ana] Elizabeth Glaser Pediat AIDS Fdn, Res Dept, Maputo, Mozambique; [Hoffman, Heather J.; Guay, Laura] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Epidemiol & Biostat, Washington, DC USA; [Mabunda, Nedio; Vubil, Adolfo; Jani, Ilesh V.] Inst Nacl Saude, Maputo, Mozambique; [Ferreira, Orlando C., Jr.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Calu, Nurbai] Minist Hlth, Xai Xai, Mozambique; [Santos, Iolanda S.] Minist Hlth, Matola, Mozambique; [Alons, Catharina L.; Guay, Laura] Elizabeth Glaser Pediat AIDS Fdn, Res Dept, Washington, DC USA	George Washington University; Universidade Federal do Rio de Janeiro	De Schacht, C (corresponding author), Elizabeth Glaser Pediat AIDS Fdn, Res Dept, Maputo, Mozambique.	carolineds11@gmail.com	Hoffman, Heather/AAF-6429-2020	Jani, Ilesh/0000-0002-6880-6655	Elizabeth Glaser Pediatric AIDS Foundation; Bill and Melinda Gates Foundation	Elizabeth Glaser Pediatric AIDS Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was supported by the Elizabeth Glaser Pediatric AIDS Foundation and the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker S, 2010, AIDS BEHAV, V14, P558, DOI 10.1007/s10461-009-9607-1; Byamugisha R, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-43; Byamugisha R, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-12; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; De Schacht C, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18808; Ditekemena J, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-32; Drake AL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001608; Dube K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084979; Ediau M, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-189; Feldblum PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097547; Fishel JD, 2011, HIV COUPLES MOZAMBIQ; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; INS INE GTM, 2013, ROND VIG EP HIV SIF; Katz DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007602; Kieffer MP, 2011, JAIDS-J ACQ IMM DEF, V57, pE85, DOI 10.1097/QAI.0b013e31821acc6e; Kinuthia J, 2014, C RETR OPP INF BOST; LEROY V, 1994, AIDS, V8, P983, DOI 10.1097/00002030-199407000-00017; Mbizvo M T, 2001, Cent Afr J Med, V47, P115; Mburu G, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17386; Moodley D, 2009, AIDS, V23, P1255, DOI 10.1097/QAD.0b013e32832a5934; Msuya SE, 2008, AIDS CARE, V20, P700, DOI 10.1080/09540120701687059; Njau B, 2012, AIDS CARE, V24, P413, DOI 10.1080/09540121.2011.608796; Nuwaha F, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17423; Orne-Gliemann J, 2013, AIDS, V27, P1167, DOI 10.1097/QAD.0b013e32835f1d8c; Peltzer K, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-57; Peltzer K, 2013, AIDS BEHAV, V17, P508, DOI 10.1007/s10461-012-0185-2; Sherr L, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17378; Ulin PR, 2005, QUALITATIVE METHODS; World Health Organization, 2010, PMTCT STRAT VIS 2010	29	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115014	10.1371/journal.pone.0115014	http://dx.doi.org/10.1371/journal.pone.0115014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542035	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900018
J	Klein, JD; Sherrill, JB; Morello, GM; Miguel, PJS; Ding, ZM; Liangpunsakul, S; Liang, TB; Muir, WM; Lumeng, L; Lossie, AC				Klein, Jonathon D.; Sherrill, Jeremy B.; Morello, Gabriella M.; Miguel, Phillip J. San; Ding, Zhenming; Liangpunsakul, Suthat; Liang, Tiebing; Muir, William M.; Lumeng, Lawrence; Lossie, Amy C.			A Snapshot of the Hepatic Transcriptome: Ad Libitum Alcohol Intake Suppresses Expression of Cholesterol Synthesis Genes in Alcohol-Preferring (P) Rats	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LIVER-DISEASE; MULTIPLE CONCENTRATIONS; CARDIOVASCULAR-DISEASE; SINGLE CONCENTRATION; CONCURRENT ACCESS; MESSENGER-RNA; ETHANOL; METABOLISM; PROTEIN	Research is uncovering the genetic and biochemical effects of consuming large quantities of alcohol. One prime example is the J- or U-shaped relationship between the levels of alcohol consumption and the risk of atherosclerotic cardiovascular disease. Moderate alcohol consumption in humans (about 30 g ethanol/d) is associated with reduced risk of coronary heart disease, while abstinence and heavier alcohol intake is linked to increased risk. However, the hepatic consequences of moderate alcohol drinking are largely unknown. Previous data from alcohol-preferring (P) rats showed that chronic consumption does not produce significant hepatic steatosis in this well-established model. Therefore, free-choice alcohol drinking in P rats may mimic low risk or nonhazardous drinking in humans, and chronic exposure in P animals can illuminate the molecular underpinnings of free-choice drinking in the liver. To address this gap, we captured the global, steady-state liver transcriptome following a 23 week free-choice, moderate alcohol consumption regimen (similar to 7.43 g ethanol/kg/day) in inbred alcoholpreferring (iP10a) rats. Chronic consumption led to down-regulation of nine genes in the cholesterol biosynthesis pathway, including HMG-CoA reductase, the rate-limiting step for cholesterol synthesis. These findings corroborate our phenotypic analyses, which indicate that this paradigm produced animals whose hepatic triglyceride levels, cholesterol levels and liver histology were indistinguishable from controls. These findings explain, at least in part, the J- or U-shaped relationship between cardiovascular risk and alcohol intake, and provide outstanding candidates for future studies aimed at understanding the mechanisms that underlie the salutary cardiovascular benefits of chronic low risk and nonhazardous alcohol intake.	[Klein, Jonathon D.; Muir, William M.; Lossie, Amy C.] Purdue Univ, Interdisciplinary Life Sci Grad Program, W Lafayette, IN 47907 USA; [Klein, Jonathon D.; Sherrill, Jeremy B.; Morello, Gabriella M.; Muir, William M.; Lossie, Amy C.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; Purdue Univ, Core Facil, W Lafayette, IN 47907 USA; [Miguel, Phillip J. San] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Ding, Zhenming] Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Liangpunsakul, Suthat; Liang, Tiebing; Muir, William M.; Lumeng, Lawrence; Lossie, Amy C.] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Lossie, AC (corresponding author), NIH, Off Behav & Social Sci Res, Off Director, Bldg 10, Bethesda, MD 20892 USA.	amy.lossie@nih.gov	Morello, Gabriela/P-1005-2017; SanMiguel, Phillip J/I-2196-2015	Morello, Gabriela/0000-0002-5439-969X; SanMiguel, Phillip J/0000-0002-3742-9527; Liang, Tiebing/0000-0002-8445-3765; Ding, Zheng-Ming/0000-0001-9202-4007	National Center for Advancing Translational Science [UL1TR00110801]; National Institute on Alcohol Abuse and Alcoholism [R24 AA015512 06, R24 AA015512 06S1, P60 AA007611 24]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA015512, U24AA015512, P60AA007611] Funding Source: NIH RePORTER	National Center for Advancing Translational Science; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was funded by grant numbers: UL1TR00110801 (National Center for Advancing Translational Science; http://www.ncats.nih.gov) to ACL and LL; R24 AA015512 06, R24 AA015512 06S1 and P60 AA007611 24 (National Institute on Alcohol Abuse and Alcoholism; http://www.niaaa.nih.gov) to LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmegeed MA, 2005, J PHARMACOL EXP THER, V315, P203, DOI 10.1124/jpet.105.084608; Bardag-Gorce F, 2002, GASTROENTEROLOGY, V123, P325, DOI 10.1053/gast.2002.34177; Bardag-Gorce F, 2006, EXP MOL PATHOL, V81, P191, DOI 10.1016/j.yexmp.2006.07.007; Bell RL, 2006, ADDICT BIOL, V11, P270, DOI 10.1111/j.1369-1600.2005.00029.x; Bell RL, 2004, ALCOHOL, V33, P107, DOI [10.1016/S0741-8329(04)00096-5, 10.1016/j.alcohol.2004.06.001]; Bell RL, 2003, ALCOHOL, V29, P137, DOI 10.1016/S0741-8329(03)00022-3; Bhave SV, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-59; Boujedidi H, 2012, ALCOHOL CLIN EXP RES, V36, P258, DOI 10.1111/j.1530-0277.2011.01627.x; Bradford BU, 2005, HEPATOLOGY, V41, P336, DOI 10.1002/hep.20532; Brandon-Warner E, 2012, ALCOHOL; Carnevale R, 2012, VASC PHARMACOL, V57, P69, DOI 10.1016/j.vph.2012.06.005; Carr LG, 2006, BEHAV GENET, V36, P285, DOI 10.1007/s10519-005-9021-z; CEDERBAUM AI, 1987, ANN NY ACAD SCI, V492, P35, DOI 10.1111/j.1749-6632.1987.tb48651.x; Cederbaum AI, 2012, CLIN LIVER DIS, V16, P667, DOI 10.1016/j.cld.2012.08.002; Crabb DW, 2004, P NUTR SOC, V63, P49, DOI 10.1079/PNS2003327; Deaciuc IV, 2004, ALCOHOL, V33, P17, DOI 10.1016/j.alcohol.2004.04.001; Deaciuc IV, 2004, ALCOHOL, V32, P113, DOI 10.1016/j.alcohol.2003.12.001; Esfandiari F, 2005, AM J PHYSIOL-GASTR L, V289, pG54, DOI 10.1152/ajpgi.00542.2004; Gunzerath L, 2004, ALCOHOL CLIN EXP RES, V28, P829, DOI 10.1097/01.ALC.0000128382.79375.B6; Hall PDM, 2001, ALCOHOL CLIN EXP RES, V25, p254S, DOI 10.1111/j.1530-0277.2001.tb02405.x; Hannuksela ML, 2002, CRIT REV CL LAB SCI, V39, P225, DOI 10.1080/10408360290795529; Jeong KS, 2000, ARCH BIOCHEM BIOPHYS, V384, P81, DOI 10.1006/abbi.2000.2119; Joenje H, 2011, NATURE, V475, P45, DOI 10.1038/475045a; Kannel WB, 1996, CLIN CHIM ACTA, V246, P59; KELLER H, 1993, ANN NY ACAD SCI, V684, P157, DOI 10.1111/j.1749-6632.1993.tb32279.x; Lakshman R, 2010, GENES NUTR, V5, P111, DOI 10.1007/s12263-009-0161-2; LAKSHMANAN MR, 1977, J LIPID RES, V18, P325; Leppala JM, 1999, CIRCULATION, V100, P1209, DOI 10.1161/01.CIR.100.11.1209; LESTER D, 1973, Pharmacology Biochemistry and Behavior, V1, P103, DOI 10.1016/0091-3057(73)90062-2; LIEBER CS, 1989, ALCOHOL ALCOHOLISM, V24, P197; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Majchrowicz E, 1979, BIOCH PHARM ETHANOL; MARMOT M, 1991, BMJ-BRIT MED J, V303, P565, DOI 10.1136/bmj.303.6802.565; Mason JB, 2005, ALCOHOL, V35, P235, DOI 10.1016/j.alcohol.2005.03.012; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mureddu GF, 2012, J CARDIOVASC MED, V13, P575, DOI 10.2459/JCM.0b013e32834bb3c8; Murphy JM, 2002, BEHAV GENET, V32, P363, DOI 10.1023/A:1020266306135; Muzio G, 2012, FREE RADICAL BIO MED, V52, P735, DOI 10.1016/j.freeradbiomed.2011.11.033; O'Keefe JH, 2007, J AM COLL CARDIOL, V50, P1009, DOI 10.1016/j.jacc.2007.04.089; Park SH, 2008, FOOD CHEM TOXICOL, V46, P1378, DOI 10.1016/j.fct.2007.08.029; Ramos EM, 2014, EUR J HUM GENET, V22, P144, DOI 10.1038/ejhg.2013.96; Rao MN, 2003, METABOLISM, V52, P1287, DOI 10.1016/S0026-0495(03)00191-4; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Sakakura Y, 2001, BIOCHEM BIOPH RES CO, V286, P176, DOI 10.1006/bbrc.2001.5375; Seth D, 2011, J GASTROEN HEPATOL, V26, P1089, DOI 10.1111/j.1440-1746.2011.06756.x; SONG BJ, 1986, J BIOL CHEM, V261, P6689; TSUKAMOTO H, 1984, AM J PHYSIOL, V247, pR595, DOI 10.1152/ajpregu.1984.247.3.R595; TSUTSUMI M, 1993, ARCH BIOCHEM BIOPHYS, V304, P209, DOI 10.1006/abbi.1993.1341; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yin HQ, 2007, TOXICOL APPL PHARM, V223, P225, DOI 10.1016/j.taap.2007.06.018; Yin HQ, 2009, TOXICOL APPL PHARM, V235, P312, DOI 10.1016/j.taap.2008.12.018; Yip-Schneider MT, 2011, ALCOHOL CLIN EXP RES, V35, P2216, DOI 10.1111/j.1530-0277.2011.01568.x; Yoon Y, 1998, AM J PHYSIOL-GASTR L, V274, pG757, DOI 10.1152/ajpgi.1998.274.4.G757; Zakhari S, 2006, ALCOHOL RES HEALTH, V29, P245	54	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e110501	10.1371/journal.pone.0110501	http://dx.doi.org/10.1371/journal.pone.0110501			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542004	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900003
J	Song, L; Zhang, JR; Li, C; Yao, J; Jiang, C; Li, Y; Liu, SK; Liu, ZJ				Song, Lin; Zhang, Jiaren; Li, Chao; Yao, Jun; Jiang, Chen; Li, Yun; Liu, Shikai; Liu, Zhanjiang			Genome-Wide Identification of Hsp40 Genes in Channel Catfish and Their Regulated Expression after Bacterial Infection	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MULTIPLE SEQUENCE ALIGNMENT; RNA-SEQ ANALYSIS; DIFFERENTIAL EXPRESSION; PLASMODIUM-FALCIPARUM; J-DOMAIN; RECEPTOR; HSP70; INNATE; RESPONSES	Heat shock proteins (HSPs) consist of a large group of chaperones whose expression is induced by high temperature, hypoxia, infection and a number of other stresses. Among all the HSPs, Hsp40 is the largest HSP family, which bind to Hsp70 ATPase domain in assisting protein folding. In this study, we identified 57 hsp40s in channel catfish (Ictalurus punctatus) through in silico analysis using RNA-Seq and genome databases. These genes can be classified into three different types, Type I, II and III, based on their structural similarities. Phylogenetic and syntenic analyses provided strong evidence in supporting the orthologies of these HSPs. Meta-analyses of RNA-Seq datasets were conducted to analyze expression profile of Hsp40s following bacterial infection. Twenty seven hsp40s were found to be significantly up-or down-regulated in the liver after infection with E. ictaluri; 19 hsp40s were found to be significantly regulated in the intestine after infection with E. ictaluri; and 19 hsp40s were found to be significantly regulated in the gill following infection with F. columnare. Altogether, a total of 42 Hsp40 genes were regulated under disease situations involving three tissues and two bacterial infections. The significant regulated expression of Hsp40 genes after bacterial infection suggested their involvement in disease defenses in catfish.	[Song, Lin; Zhang, Jiaren; Li, Chao; Yao, Jun; Jiang, Chen; Li, Yun; Liu, Shikai; Liu, Zhanjiang] Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Aquat Genom Unit, Fish Mol Genet & Biotechnol Lab, Auburn, AL 36849 USA	Auburn University System; Auburn University	Liu, ZJ (corresponding author), Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Aquat Genom Unit, Fish Mol Genet & Biotechnol Lab, 203 Swingle Hall, Auburn, AL 36849 USA.	liuzhan@auburn.edu	song, ling/GQZ-5934-2022; Liu, Zhanjiang/R-9633-2019; Song, Lin/GMW-6891-2022; Li, Chao/GSM-8117-2022; Liu, Shikai/D-4664-2013	Song, Lin/0000-0002-1245-681X; Li, Chao/0000-0001-6110-6210; Liu, Shikai/0000-0001-5777-489X; Li, Chao/0000-0002-1950-0190	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture (NIFA) [2009-35205-05101, 2010-65205-20356]	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture (NIFA)	This project was supported by Agriculture and Food Research Initiative Competitive Grants 2009-35205-05101 and 2010-65205-20356 from the USDA National Institute of Food and Agriculture (NIFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PA, 2001, J AQUAT ANIM HEALTH, V13, P173, DOI 10.1577/1548-8667(2001)013&lt;0173:PACSRO&gt;2.0.CO;2; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Botha M, 2007, INT J BIOCHEM CELL B, V39, P1781, DOI 10.1016/j.biocel.2007.02.011; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Cha IS, 2013, FISH SHELLFISH IMMUN, V34, P1455, DOI 10.1016/j.fsi.2013.03.355; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Chen F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011546; Chen W, 1999, J IMMUNOL, V162, P3212; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dong CW, 2006, FISH SHELLFISH IMMUN, V21, P146, DOI 10.1016/j.fsi.2005.11.002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Forsyth RB, 1997, J AQUAT ANIM HEALTH, V9, P18, DOI 10.1577/1548-8667(1997)009&lt;0018:SPEICS&gt;2.3.CO;2; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; Habich C, 2002, J IMMUNOL, V168, P569, DOI 10.4049/jimmunol.168.2.569; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Hennessy F, 2000, CELL STRESS CHAPERON, V5, P347, DOI 10.1379/1466-1268(2000)005<0347:AOTLOC>2.0.CO;2; Houry WA, 2001, CURR PROTEIN PEPT SC, V2, P227, DOI 10.2174/1389203013381134; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lassmann T, 2006, NUCLEIC ACIDS RES, V34, pW596, DOI 10.1093/nar/gkl191; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li C, 2012, FISH SHELLFISH IMMUN, V32, P816, DOI 10.1016/j.fsi.2012.02.004; Liu FH, 1999, J BIOL CHEM, V274, P34425, DOI 10.1074/jbc.274.48.34425; Liu SK, 2013, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-595; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844; Morahan BJ, 2011, EUKARYOT CELL, V10, P1492, DOI 10.1128/EC.05155-11; Nair S, 2013, J CANCER RES THER, V9, P624, DOI 10.4103/0973-1482.126460; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Peatman E, 2013, MOL IMMUNOL, V56, P317, DOI 10.1016/j.molimm.2013.04.014; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; Pridgeon JW, 2010, J FISH DIS, V33, P497, DOI 10.1111/j.1365-2761.2010.01159.x; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Roberts RJ, 2010, J FISH DIS, V33, P789, DOI 10.1111/j.1365-2761.2010.01183.x; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Singh-Jasuja H, 2000, EUR J IMMUNOL, V30, P2211, DOI 10.1002/1521-4141(2000)30:8<2211::AID-IMMU2211>3.0.CO;2-0; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Sun FY, 2012, DEV COMP IMMUNOL, V38, P169, DOI 10.1016/j.dci.2012.05.006; Sung YY., 2011, J AQUACUL RES DEV, V2, P006, DOI [10.4172/2155-9546, DOI 10.4172/2155-9546.S2-006, DOI 10.4172/2155-9546]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Walsh P, 2004, EUROPEAN MOL BIOL OR, V5, P5, DOI DOI 10.1038/SJ.EMB0R.7400172; Wang RJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-929; Wang S, 2011, SNP DISCOVERY EST DA; WELCH WJ, 1993, SCI AM, V268, P56, DOI 10.1038/scientificamerican0593-56	55	25	26	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115752	10.1371/journal.pone.0115752	http://dx.doi.org/10.1371/journal.pone.0115752			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542027	gold, Green Submitted, Green Published			2022-12-26	WOS:000347239900078
J	Zhou, Y; Li, NN; Grace, J; Yang, M; Lu, C; Geng, XM; Lei, GC; Zhu, W; Deng, YF				Zhou, Yan; Li, Nana; Grace, John; Yang, Meng; Lu, Cai; Geng, Xuemeng; Lei, Guangchun; Zhu, Wei; Deng, Yongfeng			Impact of Groundwater Table and Plateau Zokors (Myospalax baileyi) on Ecosystem Respiration in the Zoige Peatlands of China	PLOS ONE			English	Article							CARBON-DIOXIDE FLUX; NITROUS-OXIDE; ORGANIC-CARBON; SOIL; METHANE; EMISSIONS; SLURRY; FONTANIERII; TEMPERATURE; VEGETATION	Peatlands contain large amount of carbon stock that is vulnerable to release into the atmosphere. Mostly because of human impact, the peatlands at Zoige Wetlands face severe degradation, and the groundwater table is now lower than before, which has increased the population of the plateau zokor, a burrowing rodent. However, the impact of these changes on ecosystem carbon flows has not been studied. To investigate how the plateau zokor and the groundwater level alter the ecosystem respiration of the Zoige peatlands, we sampled the CO2 flux of hummocks shaped by the zokors and compared it with the CO2 flux of undisturbed sites with different groundwater table levels. The soil organic carbon (SOC), soil water content (SWC) and soil temperature at 5 cm (T-5) were measured. SOC showed no significant difference among the four sampling sites and did not correlate with the CO2 flux, while SWC was found to partly determine the CO2 flux. A linear equation could adequately describe the relationship between the natural logarithm of the ecosystem respiration and the soil temperature. It is demonstrated that descending groundwater table might accelerate ecosystem respiration and the CO2 flux from hummocks was higher than the CO2 flux from the control site in the non-growing season. With rising temperature, the CO2 flux from the control site accelerated faster than that from the hummocks. Our results show that ecosystem respiration was significantly lower from hummocks than at the control site in the growing season. The results on the impact of zokors on greenhouse gas emissions presented in this paper provide a useful reference to help properly manage not only this, but other litter-burrowing mammals at peatland sites.	[Zhou, Yan; Li, Nana; Yang, Meng; Lu, Cai; Geng, Xuemeng; Lei, Guangchun] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China; [Grace, John] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Zhu, Wei; Deng, Yongfeng] Management Bur Zoige Natl Nat Reserve, Qingchuan, Sichuan, Peoples R China	Beijing Forestry University; University of Edinburgh	Lei, GC (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China.	leiguangchunbjfu@gmail.com	Guangchun, Lei/ABC-8081-2021; Grace, John/N-9280-2013	Zhou, Yan/0000-0003-1774-7402	Special Research Program for Public-welfare Forestry [200804005]	Special Research Program for Public-welfare Forestry	Funding: This work was financially supported by the Special Research Program for Public-welfare Forestry (200804005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beetz S, 2013, BIOGEOSCIENCES, V10, P1067, DOI 10.5194/bg-10-1067-2013; Chadwick DR, 1997, AGR ECOSYST ENVIRON, V63, P51, DOI 10.1016/S0167-8809(96)01119-X; Chen H, 2009, ATMOS ENVIRON, V43, P4995, DOI 10.1016/j.atmosenv.2009.07.001; Chen L, 2010, J CHINA W NORMAL U N, V31, P122; Chen WW, 2011, PLANT SOIL, V340, P291, DOI 10.1007/s11104-010-0367-5; Couwenberg J, 2010, GLOBAL CHANGE BIOL, V16, P1715, DOI 10.1111/j.1365-2486.2009.02016.x; Davidson AD, 2012, FRONT ECOL ENVIRON, V10, P477, DOI 10.1890/110054; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Delibes-Mateos M, 2011, BIOL CONSERV, V144, P1335, DOI 10.1016/j.biocon.2011.02.012; Fan NaiChang, 1999, Ecologically-based management of rodent pests., P285; Fan ZS, 2013, GLOBAL CHANGE BIOL, V19, P604, DOI 10.1111/gcb.12041; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Grace J, 2000, NATURE, V404, P819, DOI 10.1038/35009170; Hogan BW, 2010, PLATEAU PIKA KEYSTON; Inc S, 2009, PASW STAT 17 0; Ives SL, 2013, ECOHYDROLOGY, V6, P38, DOI 10.1002/eco.274; Jagermeyr J, 2014, GLOBAL CHANGE BIOL, V20, P1191, DOI 10.1111/gcb.12443; Juszczak R, 2013, PLANT SOIL, V366, P505, DOI 10.1007/s11104-012-1441-y; Leifeld J, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051856; Limbach WE, 2000, FORMATION EVOLUTION, P509; Liu YS, 2013, PLANT SOIL, V366, P491, DOI 10.1007/s11104-012-1442-x; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luo Q, 2008, PLATEAU MOUNTAIN MET, P44; Makiranta P, 2012, SOIL BIOL BIOCHEM, V48, P1, DOI 10.1016/j.soilbio.2012.01.005; Maljanen M, 2001, PLANT SOIL, V231, P113, DOI 10.1023/A:1010372914805; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rochette P, 2004, SOIL SCI SOC AM J, V68, P1410, DOI 10.2136/sssaj2004.1410; Rochette P, 2008, CAN J SOIL SCI, V88, P175, DOI 10.4141/CJSS06016; Rodhe L, 2006, SOIL USE MANAGE, V22, P229, DOI 10.1111/j.1475-2743.2006.00043.x; Schmidt-Nielsen K., 1997, Animal physiology: adaptation and environment.; Semenov MV, 2010, EURASIAN SOIL SCI+, V43, P541, DOI 10.1134/S1064229310050078; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Turunen J, 2002, HOLOCENE, V12, P69, DOI 10.1191/0959683602hl522rp; Urbanova Z, 2012, PLANT ECOL DIVERS, V5, P89, DOI 10.1080/17550874.2012.688069; Yu Z., 2011, EOS T AM GEOPHYS UN, V92, P97, DOI DOI 10.1029/2011EO120001; Yu Zicheng, 2010, GEOPHYS RES LETT, V37; Zhang LH, 2012, EUR J SOIL BIOL, V48, P24, DOI 10.1016/j.ejsobi.2011.10.001; Zhang YM, 2003, MAMMAL REV, V33, P284, DOI 10.1046/j.1365-2907.2003.00020.x; Zhang YM, 2003, J MAMMAL, V84, P644, DOI 10.1644/1545-1542(2003)084&lt;0644:EOPZMF&gt;2.0.CO;2	40	8	10	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115542	10.1371/journal.pone.0115542	http://dx.doi.org/10.1371/journal.pone.0115542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542023	Green Submitted, gold, Green Published			2022-12-26	WOS:000347239900051
J	Guo, MH; Hundseth, K; Ding, H; Vidhyasagar, V; Inoue, A; Nguyen, CH; Zain, R; Lee, JS; Wu, YL				Guo, Manhong; Hundseth, Kristian; Ding, Hao; Vidhyasagar, Venkatasubramanian; Inoue, Akira; Chi-Hung Nguyen; Zain, Rula; Lee, Jeremy S.; Wu, Yuliang			A Distinct Triplex DNA Unwinding Activity of ChlR1 Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; REPLICATION PROTEIN-A; ATAXIA (GAA)(N) REPEATS; G-QUADRUPLEX DNA; MONOCLONAL-ANTIBODY; STRANDED DNA; BIOCHEMICAL-CHARACTERIZATION; H-DNA; FANCJ; HELIX	Mutations in the human ChlR1 (DDX11) gene are associated with a unique genetic disorder known as Warsaw breakage syndrome characterized by cellular defects in genome maintenance. The DNA triplex helix structures that form by Hoogsteen or reverse Hoogsteen hydrogen bonding are examples of alternate DNA structures that can be a source of genomic instability. In this study, we have examined the ability of human ChlR1 helicase to destabilize DNA triplexes. Biochemical studies demonstrated that ChlR1 efficiently melted both intermolecular and intramolecular DNA triplex substrates in an ATP-dependent manner. Compared with other substrates such as replication fork and G-quadruplex DNA, triplex DNA was a preferred substrate for ChlR1. Also, compared with FANCJ, a helicase of the same family, the triplex resolving activity of ChlR1 is unique. On the other hand, the mutant protein from a Warsaw breakage syndrome patient failed to unwind these triplexes. A previously characterized triplex DNA-specific antibody (Jel 466) bound triplex DNA structures and inhibited ChlR1 unwinding activity. Moreover, cellular assays demonstrated that there were increased triplex DNA content and double-stranded breaks in ChlR1-depleted cells, but not in FANCJ(-/-) cells, when cells were treated with a triplex stabilizing compound benzoquinoquinoxaline, suggesting that ChlR1 melting of triple-helix structures is distinctive and physiologically important to defend genome integrity. On the basis of our results, we conclude that the abundance of ChlR1 known to exist in vivo is likely to be a strong deterrent to the stability of triplexes that can potentially form in the human genome.	[Lee, Jeremy S.; Wu, Yuliang] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Inoue, Akira] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Chi-Hung Nguyen] CNRS, Inst Curie, Lab Pharmacochim, Ctr Univ,UMR176, F-91405 Orsay, France; [Zain, Rula] Karolinska Inst, Clin Res Ctr, Dept Lab Med, S-14186 Stockholm, Sweden	University of Saskatchewan; St Jude Children's Research Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Karolinska Institutet	Wu, YL (corresponding author), Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada.	yuliang.wu@usask.ca	Nguyen, Chi/GWR-1592-2022; Nguyen, Chi/GZG-5146-2022; Vidhyasagar, Venkatasubramanian/M-9442-2013	Vidhyasagar, Venkatasubramanian/0000-0001-8679-4021; Zain, Rula/0000-0001-8327-846X	Natural Sciences and Engineering Research Council of Canada; Canadian Breast Cancer Foundation; Leukemia & Lymphoma Society of Canada; American Cancer Society Research Scholar Grant [RSG CDD-120969]; Knut och Alice Wallenbergs Stiftelse; Magnus Bergvalls Stiftelse; Carl Tryggers Stiftelse for Vetenskaplig Forskning; Swedish Research Council	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Leukemia & Lymphoma Society of Canada; American Cancer Society Research Scholar Grant(American Cancer Society); Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Magnus Bergvalls Stiftelse; Carl Tryggers Stiftelse for Vetenskaplig Forskning; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported in part by the Natural Sciences and Engineering Research Council of Canada, the Canadian Breast Cancer Foundation, and the Leukemia & Lymphoma Society of Canada (to Y. W.); the American Cancer Society Research Scholar Grant RSG CDD-120969 (to A. I.); and the Knut och Alice Wallenbergs Stiftelse, Magnus Bergvalls Stiftelse, Carl Tryggers Stiftelse for Vetenskaplig Forskning, and the Swedish Research Council (to R. Z.).	AGAZIE YM, 1994, J BIOL CHEM, V269, P7019; Amiri H, 2005, J MOL BIOL, V351, P776, DOI 10.1016/j.jmb.2005.03.044; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Benet A, 1999, J MOL BIOL, V294, P851, DOI 10.1006/jmbi.1999.3295; Bergquist H, 2009, CHEMBIOCHEM, V10, P2629, DOI 10.1002/cbic.200900263; Bharti SK, 2014, CELL MOL LIFE SCI, V71, P2625, DOI 10.1007/s00018-014-1569-4; Bharti SK, 2013, J BIOL CHEM, V288, P28217, DOI 10.1074/jbc.M113.496463; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Boyer AS, 2013, J MOL BIOL, V425, P4767, DOI 10.1016/j.jmb.2013.09.022; Brosh RM, 2001, J BIOL CHEM, V276, P3024, DOI 10.1074/jbc.M006784200; BURKHOLDER GD, 1988, CHROMOSOMA, V97, P185, DOI 10.1007/BF00292959; BURKHOLDER GD, 1991, CHROMOSOMA, V101, P11, DOI 10.1007/BF00360681; Capo-Chichi JM, 2013, HUM MUTAT, V34, P103, DOI 10.1002/humu.22226; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; Duca M, 2008, NUCLEIC ACIDS RES, V36, P5123, DOI 10.1093/nar/gkn493; Farina A, 2008, J BIOL CHEM, V283, P20925, DOI 10.1074/jbc.M802696200; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; Goni JR, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-63; Guo MH, 2014, J BIOL CHEM, V289, P10551, DOI 10.1074/jbc.M113.538892; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Gupta R, 2007, BLOOD, V110, P2390, DOI 10.1182/blood-2006-11-057273; Hirota Y, 2000, NUCLEIC ACIDS RES, V28, P917, DOI 10.1093/nar/28.4.917; Inoue A, 2007, CELL CYCLE, V6, P1646, DOI 10.4161/cc.6.13.4411; Jain A, 2013, NUCLEIC ACIDS RES, V41, P10345, DOI 10.1093/nar/gkt804; Khan I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113293; Kitao H, 2011, GENES CELLS, V16, P714, DOI 10.1111/j.1365-2443.2011.01523.x; Krasilnikova MM, 2004, MOL CELL BIOL, V24, P2286, DOI 10.1128/MCB.24.6.2286-2295.2004; Kruisselbrink E, 2008, CURR BIOL, V18, P900, DOI 10.1016/j.cub.2008.05.013; Kumaraswamy E, 2007, MOL CELL BIOL, V27, P6733, DOI 10.1128/MCB.00961-07; LEE JS, 1987, NUCLEIC ACIDS RES, V15, P1047, DOI 10.1093/nar/15.3.1047; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Lin FLM, 2000, J BIOL CHEM, V275, P39117, DOI 10.1074/jbc.M005404200; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Parish JL, 2006, J CELL SCI, V119, P4857, DOI 10.1242/jcs.03262; Peng M, 2006, ONCOGENE, V25, P2245, DOI 10.1038/sj.onc.1209257; Peng M, 2007, EMBO J, V26, P3238, DOI 10.1038/sj.emboj.7601754; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Piergentili R, 2008, J CELL SCI, V121, P1605, DOI 10.1242/jcs.025320; Raghavan SC, 2005, J BIOL CHEM, V280, P22749, DOI 10.1074/jbc.M502952200; Rajeswari MR, 2012, J BIOSCIENCES, V37, P519, DOI 10.1007/s12038-012-9219-1; Rogers Faye A., 2013, Yale Journal of Biology and Medicine, V86, P471; Rudra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075435; Rudra S, 2012, CELL CYCLE, V11, P2114, DOI 10.4161/cc.20547; SAGLIO G, 1993, GENE CHROMOSOME CANC, V8, P1, DOI 10.1002/gcc.2870080102; Sakasai R, 2012, GENES CELLS, V17, P962, DOI 10.1111/gtc.12011; Salas TR, 2006, NUCLEIC ACIDS RES, V34, P4857, DOI 10.1093/nar/gkl564; Sarkies P, 2012, NUCLEIC ACIDS RES, V40, P1485, DOI 10.1093/nar/gkr868; SCHROTH GP, 1995, NUCLEIC ACIDS RES, V23, P1977, DOI 10.1093/nar/23.11.1977; Schwab RA, 2013, J CELL BIOL, V201, P33, DOI 10.1083/jcb.201208009; Shah N, 2013, EXP CELL RES, V319, P2244, DOI 10.1016/j.yexcr.2013.06.005; Skibbens RV, 2004, GENETICS, V166, P33, DOI 10.1534/genetics.166.1.33; Sommers JA, 2009, J BIOL CHEM, V284, P7505, DOI 10.1074/jbc.M809019200; Tiwari MK, 2013, NUCLEIC ACIDS RES, V41, P8979, DOI 10.1093/nar/gkt670; van der Lelij P, 2010, AM J HUM GENET, V86, P262, DOI 10.1016/j.ajhg.2010.01.008; Vannier JB, 2014, TRENDS CELL BIOL, V24, P416, DOI 10.1016/j.tcb.2014.01.004; Vannier JB, 2012, CELL, V149, P795, DOI 10.1016/j.cell.2012.03.030; Vasquez KM, 2002, Q REV BIOPHYS, V35, P89, DOI 10.1017/S0033583502003773; Wang GL, 2008, JNCI-J NATL CANCER I, V100, P1815, DOI 10.1093/jnci/djn385; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu Y, 2008, BIOCHEMISTRY-US, V47, P5068, DOI 10.1021/bi702102d; Wu YL, 2012, J BIOL CHEM, V287, P1007, DOI 10.1074/jbc.M111.276022; Xie J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002786; Zaid A, 2004, CHEMBIOCHEM, V5, P1550, DOI 10.1002/cbic.200400074; Zain R, 2003, CHEMBIOCHEM, V4, P856, DOI 10.1002/cbic.200300621; Zain R, 2003, CELL MOL LIFE SCI, V60, P862, DOI 10.1007/s00018-003-3046-3	70	35	35	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5174	5189		10.1074/jbc.M114.634923	http://dx.doi.org/10.1074/jbc.M114.634923			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25561740	hybrid, Green Published			2022-12-26	WOS:000350042000056
J	Kumar, D; Singla, SK; Puri, V; Puri, S				Kumar, Dev; Singla, Surinder K.; Puri, Veena; Puri, Sanjeev			The Restrained Expression of NF-kappa B in Renal Tissue Ameliorates Folic Acid Induced Acute Kidney Injury in Mice	PLOS ONE			English	Article							ACUTE TUBULAR-NECROSIS; INDUCED APOPTOSIS; GENE-EXPRESSION; CISPLATIN NEPHROTOXICITY; P53; CELL; ACTIVATION; FAILURE; INHIBITION; PROLIFERATION	The Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) represent family of structurally-related eukaryotic transcription factors which regulate diverse array of cellular processes including immunological responses, inflammation, apoptosis, growth & development. Increased expression of NF-kB has often been seen in many diverse diseases, suggesting the importance of genomic deregulation to disease pathophysiology. In the present study we focused on acute kidney injury (AKI), which remains one of the major risk factor showing a high rate of mortality and morbidity. The pathology associated with it, however, remains incompletely known though inflammation has been reported to be one of the major risk factor in the disease pathophysiology. The role of NF-kB thus seemed pertinent. In the present study we show that high dose of folic acid (FA) induced acute kidney injury (AKI) characterized by elevation in levels of blood urea nitrogen & serum creatinine together with extensive tubular necrosis, loss of brush border and marked reduction in mitochondria. One of the salient observations of this study was a coupled increase in the expression of renal, relA, NF-kB2, and p53 genes and proteins during folic acid induced AKI (FA AKI). Treatment of mice with NF-kB inhibitor, pyrrolidine dithio-carbamate ammonium (PDTC) lowered the expression of these transcription factors and ameliorated the aberrant renal function by decreasing serum creatinine levels. In conclusion, our results suggested that NF-kB plays a pivotal role in maintaining renal function that also involved regulating p53 levels during FA AKI.	[Kumar, Dev; Singla, Surinder K.] Panjab Univ, Dept Biochem, Chandigarh 160014, India; [Puri, Veena] Panjab Univ, Ctr Syst Biol & Bioinformat, Chandigarh 160014, India; [Puri, Sanjeev] Panjab Univ, Univ Inst Engn & Technol, Biotechnol Branch, Chandigarh 160014, India; [Puri, Sanjeev] Panjab Univ, Ctr Stem Cell & Tissue Engn, Chandigarh 160014, India	Panjab University; Panjab University; Panjab University; Panjab University	Puri, S (corresponding author), Panjab Univ, Univ Inst Engn & Technol, Biotechnol Branch, Chandigarh 160014, India.	spuri_1111@yahoo.com	puri, veena/AAH-7207-2021	Puri, Sanjeev/0000-0002-4314-9871; puri, veena/0000-0002-0639-5897; Puri, Sanjeev/0000-0002-3967-987X	Council of Scientific and Industrial Research (Human Resource Development Group), New Delhi, India; Department of Science and Technology (Purse Grant), New Delhi; Department of Biotechnology, New Delhi, India; Center for Stem cell and Tissue Engineering, Panjab University Chandigarh, India; Department of Biochemistry, Panjab University, Chandigarh, India; Centre with Potential for Excellence in Bio-medical Sciences, Panjab University, Chandigarh, India	Council of Scientific and Industrial Research (Human Resource Development Group), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (Purse Grant), New Delhi(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines); Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); Center for Stem cell and Tissue Engineering, Panjab University Chandigarh, India; Department of Biochemistry, Panjab University, Chandigarh, India; Centre with Potential for Excellence in Bio-medical Sciences, Panjab University, Chandigarh, India	This work is supported by Council of Scientific and Industrial Research (Human Resource Development Group), New Delhi, India, Department of Science and Technology (Purse Grant), New Delhi, Department of Biotechnology, New Delhi, India, Center for Stem cell and Tissue Engineering, Panjab University Chandigarh, India, Department of Biochemistry, Panjab University, Chandigarh, India, Centre with Potential for Excellence in Bio-medical Sciences, Panjab University, Chandigarh, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Akcay A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/137072; Baliga R, 1999, DRUG METAB REV, V31, P971, DOI 10.1081/DMR-100101947; Basile DP, 2007, KIDNEY INT, V72, P151, DOI 10.1038/sj.ki.5002312; Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; Bengatta S, 2009, J AM SOC NEPHROL, V20, P787, DOI 10.1681/ASN.2008050515; Blagosklonny MV, 2002, INT J CANCER, V98, P161, DOI 10.1002/ijc.10158; Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Cao CC, 2004, KIDNEY INT, V65, P834, DOI 10.1111/j.1523-1755.2004.00463.x; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chow BM, 2000, CELL DEATH DIFFER, V7, P712, DOI 10.1038/sj.cdd.4400704; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Collett GP, 2006, CARCINOGENESIS, V27, P1285, DOI 10.1093/carcin/bgi368; Edelstein CL, 2008, ADV CHRONIC KIDNEY D, V15, P222, DOI 10.1053/j.ackd.2008.04.003; Edelstein CL, 2007, DIS KIDNEY URINARY T, V2, P930; Edelstein CL, 2003, RENAL ELECT DISORDER, P401; Endre ZH, 2008, CLIN NEPHROTOXINS RE, P173; Esposti MD, 2002, METHODS, V26, P335, DOI 10.1016/S1046-2023(02)00039-7; Esson ML, 2002, ANN INTERN MED, V137, P744, DOI 10.7326/0003-4819-137-9-200211050-00010; Esteban V, 2004, J AM SOC NEPHROL, V15, P1514, DOI 10.1097/01.ASN.0000130564.75008.F5; Francescato HDC, 2007, TOXICOLOGY, V230, P64, DOI 10.1016/j.tox.2006.10.025; Friedewald JJ, 2004, KIDNEY INT, V66, P486, DOI 10.1111/j.1523-1755.2004.761_3.x; GOES N, 1995, TRANSPLANTATION, V59, P565; Gudkov Andrei V, 2011, Genes Cancer, V2, P503, DOI 10.1177/1947601911409747; Gudkov AV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001180; Guijarro C, 2001, KIDNEY INT, V59, P415, DOI 10.1046/j.1523-1755.2001.059002415.x; Gupta A, 2012, EXP TOXICOL PATHOL, V64, P225, DOI 10.1016/j.etp.2010.08.010; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hur E, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/313528; Jennewein C, 2012, ONCOGENE, V31, P1468, DOI 10.1038/onc.2011.333; Jeong KH, 2009, AM J NEPHROL, V29, P274, DOI 10.1159/000158635; Jeong SJ, 2004, BLOOD, V104, P1490, DOI 10.1182/blood-2003-12-4174; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Kielar ML, 2005, J AM SOC NEPHROL, V16, P3315, DOI 10.1681/asn.2003090757; Kim G, 2015, ONCOGENE, V34, P671, DOI 10.1038/onc.2014.4; Kim HJ, 2011, J PHARMACOL EXP THER, V337, P583, DOI 10.1124/jpet.110.175828; KONO Y, 1978, ARCH BIOCHEM BIOPHYS, V186, P189, DOI 10.1016/0003-9861(78)90479-4; Lemay S, 2000, TRANSPLANTATION, V69, P959; Liang CY, 2006, CELL SIGNAL, V18, P1309, DOI 10.1016/j.cellsig.2005.10.011; Liano F, 1996, KIDNEY INT, V50, P811, DOI 10.1038/ki.1996.380; Liano F, 1998, Kidney Int Suppl, V66, pS16; Lin BH, 1999, CELL DEATH DIFFER, V6, P570, DOI 10.1038/sj.cdd.4400528; Linkermann A, 2012, NEPHROL DIAL TRANSPL, V27, P3412, DOI 10.1093/ndt/gfs373; Lopez-Franco O, 2002, AM J PATHOL, V161, P1497, DOI 10.1016/S0002-9440(10)64425-2; Massy ZA, 1997, KIDNEY INT, V71, pS76; Matsushima H, 1998, J LAB CLIN MED, V131, P518, DOI 10.1016/S0022-2143(98)90060-9; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Murugan R, 2011, NAT REV NEPHROL, V7, P209, DOI 10.1038/nrneph.2011.13; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; OLSEN TS, 1990, APMIS, V98, P1139, DOI 10.1111/j.1699-0463.1990.tb05046.x; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; PEASE DC, 1955, J HISTOCHEM CYTOCHEM, V3, P295, DOI 10.1177/3.4.295; Plumpe J, 2000, AM J PHYSIOL-GASTR L, V278, pG173, DOI 10.1152/ajpgi.2000.278.1.G173; Powell DJ, 2008, CELL CYCLE, V7, P950, DOI 10.4161/cc.7.7.5626; Ramesh G, 2005, AM J PHYSIOL-RENAL, V289, pF166, DOI 10.1152/ajprenal.00401.2004; Rice JC, 2002, RENAL FAILURE, V24, P703, DOI 10.1081/JDI-120015673; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Safirstein R, 1901, AM J PHYSIOL 2, V261, pF1095; Sahu BD, 2013, PHYTOMEDICINE, V20, P453, DOI 10.1016/j.phymed.2012.12.001; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shimizu H, 2013, AM J NEPHROL, V37, P97, DOI 10.1159/000346420; Shimizu H, 2013, LIFE SCI, V92, P143, DOI 10.1016/j.lfs.2012.11.012; Shimizu H, 2011, AM J PHYSIOL-CELL PH, V301, pC1201, DOI 10.1152/ajpcell.00471.2010; Shimizu H, 2010, AM J PHYSIOL-CELL PH, V299, pC1110, DOI 10.1152/ajpcell.00217.2010; Simmons EM, 2004, KIDNEY INT, V65, P1357, DOI 10.1111/j.1523-1755.2004.00512.x; Sutton TA, 2013, J AM SOC NEPHROL, V24, P113, DOI 10.1681/ASN.2012050469; Tadagavadi RK, 2010, J AM SOC NEPHROL, V21, P53, DOI 10.1681/ASN.2009040407; Takase O, 2008, CLIN EXP NEPHROL, V12, P181, DOI 10.1007/s10157-008-0038-5; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Thurman JM, 2007, J IMMUNOL, V178, P1819, DOI 10.4049/jimmunol.178.3.1819; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Wang SW, 2002, BIOCHEM J, V367, P729, DOI 10.1042/BJ20020752; Wei QQ, 2007, AM J PHYSIOL-RENAL, V293, pF1282, DOI 10.1152/ajprenal.00230.2007; WU HY, 1994, J BIOL CHEM, V269, P20067; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Zhou L, 2010, J AM SOC NEPHROL, V21, P31, DOI 10.1681/ASN.2008111133; Ziyadeh FN, 2008, CURR DIABETES REV, V4, P39, DOI 10.2174/157339908783502370	82	64	68	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e115947	10.1371/journal.pone.0115947	http://dx.doi.org/10.1371/journal.pone.0115947			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559736	gold, Green Published, Green Submitted			2022-12-26	WOS:000348102200011
J	Brand, S; Amann, K; Mandel, P; Zimnol, A; Schupp, N				Brand, Susanne; Amann, Kerstin; Mandel, Philipp; Zimnol, Anna; Schupp, Nicole			Oxidative DNA Damage in Kidneys and Heart of Hypertensive Mice Is Prevented by Blocking Angiotensin II and Aldosterone Receptors	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; KAPPA-B PATHWAY; BLOOD-PRESSURE; RENAL INJURY; ENDOTHELIAL DYSFUNCTION; XANTHINE OXIDOREDUCTASE; ENHANCED EXPRESSION; METABOLIC SYNDROME; HEME OXYGENASE-1; ORGAN DAMAGE	Introduction: Recently, we could show that angiotensin II, the reactive peptide of the blood pressure-regulating renin-angiotensin-aldosterone-system, causes the formation of reactive oxygen species and DNA damage in kidneys and hearts of hypertensive mice. To further investigate on the one hand the mechanism of DNA damage caused by angiotensin II, and on the other hand possible intervention strategies against end-organ damage, the effects of substances interfering with the renin-angiotensin-aldosterone-system on angiotensin II-induced genomic damage were studied. Methods: In C57BL/6-mice, hypertension was induced by infusion of 600 ng/kg . min angiotensin II. The animals were additionally treated with the angiotensin II type 1 receptor blocker candesartan, the mineralocorticoid receptor blocker eplerenone and the antioxidant tempol. DNA damage and the activation of transcription factors were studied by immunohistochemistry and protein expression analysis. Results: Administration of angiotensin II led to a significant increase of blood pressure, decreased only by candesartan. In kidneys and hearts of angiotensin II-treated animals, significant oxidative stress could be detected (1.5-fold over control). The redox-sensitive transcription factors Nrf2 and NF-kappa B were activated in the kidney by angiotensin II-treatment (4- nd 3-fold over control, respectively) and reduced by all interventions. In kidneys and hearts an increase of DNA damage (3-and 2-fold over control, respectively) and of DNA repair (3-fold over control) was found. These effects were ameliorated by all interventions in both organs. Consistently, candesartan and tempol were more effective than eplerenone. Conclusion: Angiotensin II-induced DNA damage is caused by angiotensin II type 1 receptor-mediated formation of oxidative stress in vivo. The angiotensin II-mediated physiological increase of aldosterone adds to the DNA-damaging effects. Blocking angiotensin II and mineralocorticoid receptors therefore has beneficial effects on end-organ damage independent of blood pressure normalization.	[Brand, Susanne; Mandel, Philipp; Schupp, Nicole] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany; [Zimnol, Anna; Schupp, Nicole] Univ Dusseldorf, Inst Toxicol, Dusseldorf, Germany; [Amann, Kerstin] Univ Erlangen Nurnberg, Dept Pathol, D-91054 Erlangen, Germany	University of Wurzburg; Heinrich Heine University Dusseldorf; University of Erlangen Nuremberg	Schupp, N (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany.	nicole.schupp@toxi.uni-wuerzburg.de			German Cancer Aid [Deutsche Krebshilfe grant] [109328]; German Research Foundation [DFG] [SFB 423, Z2]	German Cancer Aid [Deutsche Krebshilfe grant]; German Research Foundation [DFG](German Research Foundation (DFG))	This work is supported by German Cancer Aid [Deutsche Krebshilfe grant #109328 to NS], http://www.krebshilfe.de, and German Research Foundation [DFG, SFB 423, Z2 to KA], http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa T, 2000, HYPERTENSION, V35, P800, DOI 10.1161/01.HYP.35.3.800; Aminzadeh MA, 2013, NEPHROL DIAL TRANSPL, V28, P2038, DOI 10.1093/ndt/gft022; Andreotti G, 2010, CARCINOGENESIS, V31, P614, DOI 10.1093/carcin/bgp321; Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027; Bianchi S, 2006, KIDNEY INT, V70, P2116, DOI 10.1038/sj.ki.5001854; Bogdanov MB, 1999, FREE RADICAL BIO MED, V27, P647, DOI 10.1016/S0891-5849(99)00113-6; Brand S, 2013, J HYPERTENS, V31, P333, DOI 10.1097/HJH.0b013e32835ba77e; Briones AM, 2011, J AM SOC HYPERTENS, V5, P137, DOI 10.1016/j.jash.2011.02.001; Brown NJ, 2000, KIDNEY INT, V58, P1219, DOI 10.1046/j.1523-1755.2000.00277.x; Chen H, 2013, KIDNEY BLOOD PRESS R, V37, P557, DOI 10.1159/000355736; Chen Y, 2004, AM J PHYSIOL-HEART C, V287, pH1104, DOI 10.1152/ajpheart.00102.2004; de Jong JW, 2000, J MOL CELL CARDIOL, V32, P2083, DOI 10.1006/jmcc.2000.1240; Dikalova A, 2005, CIRCULATION, V112, P2668, DOI 10.1161/CIRCULATIONAHA.105.538934; Durvasula RV, 2004, KIDNEY INT, V65, P30, DOI 10.1111/j.1523-1755.2004.00362.x; Esteban V, 2003, KIDNEY INT, V64, pS33, DOI 10.1046/j.1523-1755.64.s86.7.x; Fazeli G, 2012, MUTAGENESIS, V27, P673, DOI 10.1093/mutage/ges033; Fukuda S, 2011, CLIN EXP NEPHROL, V15, P41, DOI 10.1007/s10157-010-0373-1; Gomez-Guzman M, 2012, FREE RADICAL BIO MED, V52, P70, DOI 10.1016/j.freeradbiomed.2011.09.015; Grew IS, 2014, SCAND J CLIN LAB INV, V74, P336, DOI 10.3109/00365513.2014.891258; Grossman E, 2002, AM J MED, V112, P479, DOI 10.1016/S0002-9343(02)01049-5; Haggstrom C, 2011, INT J CANCER, V128, P1890, DOI 10.1002/ijc.25521; Hayden MR, 2007, AM J PHYSIOL-RENAL, V292, pF861, DOI 10.1152/ajprenal.00252.2006; Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288; Ikeda H, 2009, KIDNEY INT, V75, P147, DOI 10.1038/ki.2008.507; Ishizaka N, 2000, AM J PHYSIOL-HEART C, V279, pH672, DOI 10.1152/ajpheart.2000.279.2.H672; Jin HM, 2013, ENDOCRINOLOGY, V154, P4068, DOI 10.1210/en.2013-1115; Kabat GC, 2009, CANCER EPIDEM BIOMAR, V18, P2046, DOI 10.1158/1055-9965.EPI-09-0235; Kang SJ, 2011, ARCH PHARM RES, V34, P829, DOI 10.1007/s12272-011-0517-1; Kawano S, 2005, CARDIOVASC RES, V67, P689, DOI 10.1016/j.cardiores.2005.04.030; Kawarazaki H, 2010, NEPHROL DIAL TRANSPL, V25, P2879, DOI 10.1093/ndt/gfq197; Kim DK, 2001, FREE RADICAL BIO MED, V30, P563, DOI 10.1016/S0891-5849(00)00504-9; Kim HJ, 2011, J PHARMACOL EXP THER, V337, P583, DOI 10.1124/jpet.110.175828; Kim HJ, 2010, AM J PHYSIOL-RENAL, V298, pF662, DOI 10.1152/ajprenal.00421.2009; Klanke B, 2008, NEPHROL DIAL TRANSPL, V23, P3456, DOI 10.1093/ndt/gfn301; Knight SF, 2010, AM J PHYSIOL-RENAL, V298, pF86, DOI 10.1152/ajprenal.00351.2009; Kowala MC, 2004, J PHARMACOL EXP THER, V309, P275, DOI 10.1124/jpet.103.055855; Krug AW, 2010, HYPERTENSION, V55, P1476, DOI 10.1161/HYPERTENSIONAHA.109.148783; Kushiro T, 2005, CLIN EXP HYPERTENS, V27, P9, DOI 10.1081/CEH-200044244; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Lea WB, 2009, KIDNEY INT, V75, P936, DOI 10.1038/ki.2009.9; Li HG, 2013, TRENDS PHARMACOL SCI, V34, P313, DOI 10.1016/j.tips.2013.03.007; Liao TD, 2008, HYPERTENSION, V52, P256, DOI 10.1161/HYPERTENSIONAHA.108.112706; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Martin RM, 2010, CANCER CAUSE CONTROL, V21, P463, DOI 10.1007/s10552-009-9477-x; McCurley A, 2013, PFLUG ARCH EUR J PHY, V465, P1661, DOI 10.1007/s00424-013-1282-4; Mels CMC, 2014, FREE RADICAL RES, V48, P1291, DOI 10.3109/10715762.2014.951840; Mendes B, 2013, TALANTA, V116, P164, DOI 10.1016/j.talanta.2013.04.064; Negishi H, 2001, J HYPERTENS, V19, P529, DOI 10.1097/00004872-200103001-00002; Nishioka T, 2007, J CARDIOVASC PHARM, V49, P261, DOI 10.1097/FJC.0b013e318033dfd4; Ohashi N, 2009, CLIN EXP PHARMACOL P, V36, P750, DOI 10.1111/j.1440-1681.2009.05172.x; Panchal SK, 2013, EUR J NUTR, V52, P559, DOI 10.1007/s00394-012-0358-9; Peixoto EBMI, 2009, AM J NEPHROL, V29, P309, DOI 10.1159/000163767; Poulsen HE, 2014, BBA-GEN SUBJECTS, V1840, P801, DOI 10.1016/j.bbagen.2013.06.009; Queisser N, 2014, ANTIOXID REDOX SIGN, V21, P2126, DOI 10.1089/ars.2013.5565; Queisser N, 2013, FREE RADICAL BIO MED, V54, P17, DOI 10.1016/j.freeradbiomed.2012.10.549; Queisser N, 2011, MOL CARCINOGEN, V50, P123, DOI 10.1002/mc.20710; Redon J, 2003, HYPERTENSION, V41, P1096, DOI 10.1161/01.HYP.0000068370.21009.38; Rocha R, 1998, HYPERTENSION, V31, P451, DOI 10.1161/01.HYP.31.1.451; Rocha R, 2002, ENDOCRINOLOGY, V143, P4828, DOI 10.1210/en.2002-220120; Rugale C, 2007, J CARDIOVASC PHARM, V50, P293, DOI 10.1097/FJC.0b013e3180a72606; Sanz-Rosa D, 2005, AM J PHYSIOL-HEART C, V288, pH111, DOI 10.1152/ajpheart.01061.2003; Schmid U, 2008, CANCER RES, V68, P9239, DOI 10.1158/0008-5472.CAN-08-1310; Schupp N, 2010, HORM METAB RES, V42, P458, DOI 10.1055/s-0029-1243253; Schupp N, 2007, AM J PHYSIOL-RENAL, V292, pF1427, DOI 10.1152/ajprenal.00458.2006; Shibata S, 2007, HYPERTENSION, V49, P355, DOI 10.1161/01.HYP.0000255636.11931.a2; Simao S, 2011, EXP GERONTOL, V46, P468, DOI 10.1016/j.exger.2011.02.003; Sirker A, 2011, BASIC RES CARDIOL, V106, P735, DOI 10.1007/s00395-011-0190-z; Subash P, 2010, INDIAN J CLIN BIOCHE, V25, P127, DOI 10.1007/s12291-010-0024-z; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Taira M, 2008, EUR J PHARMACOL, V589, P264, DOI 10.1016/j.ejphar.2008.06.019; VANBELLE E, 1995, CARDIOVASC RES, V29, P27, DOI 10.1016/S0008-6363(96)88542-7; Weikert S, 2008, AM J EPIDEMIOL, V167, P438, DOI 10.1093/aje/kwm321; Westhoff JH, 2008, HYPERTENSION, V52, P123, DOI 10.1161/HYPERTENSIONAHA.107.099432; Wilcox CS, 2008, PHARMACOL REV, V60, P418, DOI 10.1124/pr.108.000240; Wu LY, 2004, P NATL ACAD SCI USA, V101, P7094, DOI 10.1073/pnas.0402004101; Xu SQ, 2011, HYPERTENSION, V58, P310, DOI 10.1161/HYPERTENSIONAHA.111.172031; Yagi S, 2010, HYPERTENSION, V55, P918, DOI 10.1161/HYPERTENSIONAHA.109.146076; Yamamoto E, 2007, HYPERTENSION, V50, P657, DOI 10.1161/HYPERTENSIONAHA.107.095315; Yamamoto M, 2008, NUTRITION, V24, P470, DOI 10.1016/j.nut.2008.01.010; Zhang J, 2014, AM J PHYSIOL-RENAL, V306, pF344, DOI 10.1152/ajprenal.00515.2013	81	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115715	10.1371/journal.pone.0115715	http://dx.doi.org/10.1371/journal.pone.0115715			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551569	gold, Green Published			2022-12-26	WOS:000347119100053
J	Foditsch, C; Santos, TMA; Teixeira, AGV; Pereira, RVV; Dias, JM; Gaeta, N; Bicalho, RC				Foditsch, Carla; Santos, Thiago M. A.; Teixeira, Andre G. V.; Pereira, Richard V. V.; Dias, Juliana M.; Gaeta, Natalia; Bicalho, Rodrigo C.			Isolation and Characterization of Faecalibacterium prausnitzii from Calves and Piglets	PLOS ONE			English	Article							TETRACYCLINE RESISTANCE GENE; BUTYRATE-PRODUCING BACTERIA; FUSOBACTERIUM-PRAUSNITZII; SUSCEPTIBILITY; BACTEROIDES; TET(W); CELLS; PCR	The goal of our study was to isolate and characterize Faecalibacterium prausnitzii from fecal samples of healthy calves and piglets, in order to develop a novel probiotic for livestock animals. We identified 203 isolates of Faecalibacterium sp., which were clustered in 40 genetically distinct groups. One representative isolate from each cluster was selected for further characterization. The concentrations of the short chain fatty acids (SCFA) acetate, butyrate, propionate and isobutyrate in the culture media were measured by gas chromatography. We observed reduction in the concentration of acetate followed by concomitant increase in the concentration of butyrate, suggesting that the isolates were consuming acetate present in the media and producing butyrate. Butyrate production correlated positively with bacterial growth. Since butyrate has many benefits to the colonic epithelial cells, the selection of strains that produce higher amounts of butyrate is extremely important for the development of this potential probiotic. The effect of pH and concentration of bile salts on bacterial growth was also evaluated in order to mimic the conditions encountered by F. prausnitzii in vivo. The optimal pH for growth ranged between 5.5 and 6.7, while most isolates were inhibited by of the lowest concentration of bile salts tested (0.1%). Antimicrobial resistance profile showed that most isolates of Faecalibacterium sp. were resistant against ciprofloxacin and sulfamethoxazole-trimethoprim. More than 50% of the isolates were resistant to tetracycline, amikacin, cefepime and cefoxitin. A total of 19 different combinations of multidrug resistance were observed among the isolates. Our results provide new insights into the cultural and physiological characteristics of Faecalibacterium prausnitzii illustrating large variability in short chain fatty acid production, in vitro growth, sensitivity to bile salts, and antibiotic resistance and suggesting that future probiotic candidates should be carefully studied before elected for in vivo studies.	[Foditsch, Carla; Teixeira, Andre G. V.; Pereira, Richard V. V.; Dias, Juliana M.; Gaeta, Natalia; Bicalho, Rodrigo C.] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Santos, Thiago M. A.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	Cornell University; University of Wisconsin System; University of Wisconsin Madison	Bicalho, RC (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	rcb28@cornell.edu	Pereira, Richard/L-2684-2019; Gaeta, Natália Carrillo/AAT-1550-2020; Carrillo Gaeta, Natália/Q-5791-2016; Teixeira, Andre Gustavo/B-2177-2017	Pereira, Richard/0000-0003-2028-8761; Gaeta, Natália Carrillo/0000-0001-6397-605X; Carrillo Gaeta, Natália/0000-0001-6397-605X; Teixeira, Andre Gustavo/0000-0002-8620-1422; Monteiro Araujo dos Santos, Thiago/0000-0002-0648-6078	Merck Animal Health	Merck Animal Health(Merck & Company)	This study was funded by a grant from Merck Animal Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamurugan R, 2010, BRIT J NUTR, V103, P335, DOI 10.1017/S0007114509992182; Barbosa TM, 1999, ENVIRON MICROBIOL, V1, P53, DOI 10.1046/j.1462-2920.1999.00004.x; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; BRYAN L E, 1979, Antimicrobial Agents and Chemotherapy, V15, P7; Chee-Sanford JC, 2001, APPL ENVIRON MICROB, V67, P1494, DOI 10.1128/AEM.67.4.1494-1502.2001; CHIN NX, 1984, ANTIMICROB AGENTS CH, V25, P319, DOI 10.1128/AAC.25.3.319; DRESSMAN JB, 1990, PHARMACEUT RES, V7, P756, DOI 10.1023/A:1015827908309; Duboc H, 2013, GUT, V62, P531, DOI 10.1136/gutjnl-2012-302578; Duncan SH, 2004, BRIT J NUTR, V91, P915, DOI 10.1079/BJN20041150; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Gorka P, 2011, J DAIRY SCI, V94, P5578, DOI 10.3168/jds.2011-4166; Guan LL, 2008, FEMS MICROBIOL LETT, V288, P85, DOI 10.1111/j.1574-6968.2008.01343.x; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Hold GL, 2003, APPL ENVIRON MICROB, V69, P4320, DOI 10.1128/AEM.69.7.4320-4324.2003; Kazimierczak KA, 2009, APPL ENVIRON MICROB, V75, P1717, DOI 10.1128/AEM.02206-08; Khan MT, 2012, ISME J, V6, P1578, DOI 10.1038/ismej.2012.5; Lopez-Siles M, 2012, APPL ENVIRON MICROB, V78, P420, DOI 10.1128/AEM.06858-11; Lund M, 2010, POULTRY SCI, V89, P1217, DOI 10.3382/ps.2010-00653; Machiels K., 2013, GUT; Magnet S, 2005, CHEM REV, V105, P477, DOI 10.1021/cr0301088; Maynard L.A., 1979, ANIM NUTR; Nava GM, 2011, GUT MICROBES, V2, P99, DOI 10.4161/gmic.2.2.15416; Oikonomou G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063157; Peterson DA, 2010, ADV IMMUNOL, V107, P71, DOI [10.1016/B978-0-12-381300-8.00003-4, 10.1016/S0065-2776(10)07005-7]; Ploger S, 2012, ANN NY ACAD SCI, V1258, P52, DOI 10.1111/j.1749-6632.2012.06553.x; Qiu XY, 2013, J CROHNS COLITIS, V7, pE558, DOI 10.1016/j.crohns.2013.04.002; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; ROSENBLATT JE, 1995, DIAGN MICR INFEC DIS, V22, P279, DOI 10.1016/0732-8893(95)00049-G; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Scott KP, 2000, ANTIMICROB AGENTS CH, V44, P775, DOI 10.1128/AAC.44.3.775-777.2000; Seville LA, 2009, MICROB DRUG RESIST, V15, P159, DOI 10.1089/mdr.2009.0916; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Suau A, 2001, SYST APPL MICROBIOL, V24, P139, DOI 10.1078/0723-2020-00015; Supelco I, 1998, B B, V856B; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van den Bogaard AE, 2002, J ANTIMICROB CHEMOTH, V49, P497, DOI 10.1093/jac/49.3.497; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; WANG G, 1993, NUCLEIC ACIDS RES, V21, P5930, DOI 10.1093/nar/21.25.5930; Wang W, 2013, J CLIN MICROBIOL; Wood J, 1998, APPL ENVIRON MICROB, V64, P3683; Wrzosek L, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-61; WUST J, 1978, ANTIMICROB AGENTS CH, V14, P384, DOI 10.1128/AAC.14.3.384	42	48	58	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116465	10.1371/journal.pone.0116465	http://dx.doi.org/10.1371/journal.pone.0116465			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551453	gold, Green Published, Green Submitted			2022-12-26	WOS:000347119100142
J	Lin, WR; Yen, TH; Lim, SN; Perng, MD; Lin, CY; Su, MY; Yeh, CT; Chiu, CT				Lin, Wey-Ran; Yen, Tzung-Hai; Lim, Siew-Na; Perng, Ming-Der; Lin, Chun-Yen; Su, Ming-Yo; Yeh, Chau-Ting; Chiu, Cheng-Tang			Granulocyte Colony-Stimulating Factor Reduces Fibrosis in a Mouse Model of Chronic Pancreatitis	PLOS ONE			English	Article							MARROW-DERIVED CELLS; STEM-CELLS; LIVER FIBROSIS; PROLIFERATION; CONTRIBUTES; REGRESSION; INJURY; REPAIR; MICE	Background: Chronic pancreatitis (CP) is a necroinflammatory process resulting in extensive pancreatic fibrosis. Granulocyte colony-stimulating factor (G-CSF), a hematopoietic stem cell mobilizer, has been shown to exert an anti-fibrotic effect partly through the enrichment of bone marrow (BM) cells in fibrotic organ. We aimed to test the effect of G-CSF on fibrosis in a mouse model of CP. Methods: CP was induced in C57Bl/6J mice by consecutive cerulein injection (50 mu g/kg/day, 2 days a week) for 6 weeks. Mice were then treated with G-CSF (200 mu g/kg/day, 5 day a week) or normal saline for 1 week, and sacrificed at week 7 or week 9 after first cerulein injection. Pancreatic histology, pancreatic matrix metallopeptidase 9 (MMP-9), MMP-13 and collagen expression were examined. Pancreatic myofibroblasts were isolated and cultured with G-CSF. Collagen, MMP-9 and MMP-13 expression by myofibroblasts was examined. The BM-mismatched mice model was used to examine the change of BM-derived myofibroblasts and non-myofibroblastic BM cells by G-CSF in the pancreas. Results: The pancreatic collagen expression were significantly decreased in the G-CSF-treated group sacrificed at week 9. While collagen produced from myofibroblasts was not affected by G-CSF, the increase of MMP13 expression was observed in vitro. There were no effect of G-CSF in the number of myofibroblasts and BM-derived myofibroblasts. However, the number of non-myofibroblastic BM cells and macrophages were significantly increased in the pancreata of cerulein- and G-CSF-treated mice, suggesting a potential anti-fibrotic role of non-myofibroblastic BM cells and macrophages stimulated by G-CSF. Conclusions: Our data indicated that G-CSF contributed to the regression of pancreatic fibrosis. The anti-fibrotic effects were possibly through the stimulation of MMP-13 from myofibroblasts, and the enhanced accumulation of non-myofibroblastic BM cells and macrophages in the pancreas.	[Lin, Wey-Ran; Lin, Chun-Yen; Su, Ming-Yo; Chiu, Cheng-Tang] Linkou Chang Gung Mem Hosp, Dept Gastroenterol, Taoyuan, Taiwan; [Lin, Wey-Ran; Yeh, Chau-Ting] Linkou Chang Gung Mem Hosp, Liver Res Unit, Taoyuan, Taiwan; [Lin, Wey-Ran; Yen, Tzung-Hai; Lin, Chun-Yen; Su, Ming-Yo; Yeh, Chau-Ting; Chiu, Cheng-Tang] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Yen, Tzung-Hai] Linkou Chang Gung Mem Hosp, Dept Nephrol, Taoyuan, Taiwan; [Lim, Siew-Na] Linkou Chang Gung Mem Hosp, Dept Neurol, Taoyuan, Taiwan; [Perng, Ming-Der] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Tsing Hua University	Yeh, CT (corresponding author), Linkou Chang Gung Mem Hosp, Liver Res Unit, Taoyuan, Taiwan.	chautingy@gmail.com; ctchiu@adm.cgmh.org.tw	Yen, Tzung-Hai/AAQ-4525-2020	Yen, Tzung-Hai/0000-0002-0907-1505; Lin, Chun-Yen/0000-0003-3007-3190	Chang Gung Memorial Hospital, Taiwan [CMRPG3B047, CMRPG3A092]; Ministry of Science and Technology [100-2314-B-182A-056, 101-2314-B-182-096]; New Century Health Care Promotion Foundation, Taiwan (IACUC) [2012081402]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); New Century Health Care Promotion Foundation, Taiwan (IACUC)	This study was funded by grants from Chang Gung Memorial Hospital, Taiwan (CMRPG3B047, CMRPG3A092), Ministry of Science and Technology (100-2314-B-182A-056, 101-2314-B-182-096) and The New Century Health Care Promotion Foundation, Taiwan (IACUC NO: 2012081402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avalos BR, 1996, BLOOD, V88, P761, DOI 10.1182/blood.V88.3.761.bloodjournal883761; Behrman SW, 2007, SURG CLIN N AM, V87, P1309, DOI 10.1016/j.suc.2007.09.001; Cui HF, 2003, WORLD J GASTROENTERO, V9, P2274; Dale DC, 2003, AM J HEMATOL, V72, P82, DOI 10.1002/ajh.10255; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Forechi L, 2012, PHARMACOL REP, V64, P643, DOI 10.1016/S1734-1140(12)70860-5; Forsmark CE, 2013, GASTROENTEROLOGY, V144, P1282, DOI 10.1053/j.gastro.2013.02.008; Higashiyama R, 2007, HEPATOLOGY, V45, P213, DOI 10.1002/hep.21477; Kisseleva T, 2012, J HEPATOL, V56, P965, DOI 10.1016/j.jhep.2011.09.021; LAYER P, 1994, GASTROENTEROLOGY, V107, P1481, DOI 10.1016/0016-5085(94)90553-3; Li N, 2010, TRANSPL P, V42, P3833, DOI 10.1016/j.transproceed.2010.09.010; Lin WR, 2008, CELLS TISSUES ORGANS, V188, P178, DOI 10.1159/000113530; Lin WR, 2012, INT J EXP PATHOL, V93, P130, DOI 10.1111/j.1365-2613.2011.00804.x; Marrache F, 2008, GUT, V57, P1113, DOI 10.1136/gut.2007.143271; Piscaglia AC, 2007, GASTROENTEROLOGY, V133, P619, DOI 10.1053/j.gastro.2007.05.018; Rangan GK, 2007, NEPHROLOGY, V12, P553, DOI 10.1111/j.1440-1797.2007.00855.x; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Russo FP, 2006, GASTROENTEROLOGY, V130, P1807, DOI 10.1053/j.gastro.2006.01.036; Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452; Saotome T, 1997, PANCREAS, V14, P373, DOI 10.1097/00006676-199705000-00008; Sato T, 2008, INT J CARDIOL, V127, P166, DOI 10.1016/j.ijcard.2007.05.007; Scarlett CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026088; Spahr L, 2008, HEPATOLOGY, V48, P221, DOI 10.1002/hep.22317; Szardien S, 2012, EUR HEART J, V33, P595, DOI 10.1093/eurheartj/ehr434; Terai S, 2006, STEM CELLS, V24, P2292, DOI 10.1634/stemcells.2005-0542; Tuo HF, 2005, J GASTROENTEROL, V40, P186, DOI 10.1007/s00535-004-1515-6; Tuo HF, 2005, PANCREAS, V30, pE16; Watanabe T, 2009, AM J PHYSIOL-GASTR L, V297, pG1138, DOI 10.1152/ajpgi.00123.2009; Zhang F, 2011, RESPIRATION, V82, P358, DOI 10.1159/000328762	30	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116229	10.1371/journal.pone.0116229	http://dx.doi.org/10.1371/journal.pone.0116229			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551560	Green Published, gold, Green Submitted			2022-12-26	WOS:000347119100108
J	Rodriguez-Bonilla, L; Cuevas, HE; Montero-Rojas, M; Bird-Pico, F; Luciano-Rosario, D; Siritunga, D				Rodriguez-Bonilla, Lorraine; Cuevas, Hugo E.; Montero-Rojas, Milly; Bird-Pico, Fernando; Luciano-Rosario, Dianiris; Siritunga, Dimuth			Assessment of Genetic Diversity of Sweet Potato in Puerto Rico	PLOS ONE			English	Article							BATATAS L. LAM.; DISPERSAL; MICROSATELLITES; SOFTWARE; GENOTYPE; ORIGIN	Sweet potato (Ipomoea batatas L.) is the seventh most important food crop due to its distinct advantages, such as adaptability to different environmental conditions and high nutritional value. Assessing the genetic diversity of this important crop is necessary due to the constant increase of demand for food and the need for conservation of agricultural and genetic resources. In Puerto Rico (PR), the genetic diversity of sweet potato has been poorly understood, although it has been part of the diet since Pre-Columbus time. Thus, 137 landraces from different localities around PR were collected and subjected to a genetic diversity analysis using 23 SSR-markers. In addition, 8 accessions from a collection grown in Gurabo, PR at the Agricultural Experimental Station (GAES), 10 US commercial cultivars and 12 Puerto Rican accessions from the USDA repository collection were included in this assessment. The results of the analysis of the 23 loci showed 255 alleles in the 167 samples. Observed heterozygosity was high across populations (0.71) while measurements of total heterozygosity revealed a large genetic diversity throughout the population and within populations. UPGMA clustering method revealed two main clusters. Cluster 1 contained 12 PR accessions from the USDA repository collection, while cluster 2 consisted of PR landraces, US commercial cultivars and the PR accessions from GAES. Population structure analysis grouped PR landraces in five groups including four US commercial cultivars. Our study shows the presence of a high level of genetic diversity of sweet potato across PR which can be related to the genetic makeup of sweet potato, human intervention and out-crossing nature of the plant. The history of domestication and dispersal of sweet potato in the Caribbean and the high levels of genetic diversity found through this study makes sweet potato an invaluable resource that needs to be protected and further studied.	[Rodriguez-Bonilla, Lorraine; Montero-Rojas, Milly; Bird-Pico, Fernando; Luciano-Rosario, Dianiris; Siritunga, Dimuth] Univ Puerto Rico, Dept Biol, Mayaguez, PR 00680 USA; [Cuevas, Hugo E.] ARS, Trop Agr Res Stn, USDA, Mayaguez, PR USA	University of Puerto Rico; University of Puerto Rico Mayaguez; United States Department of Agriculture (USDA)	Siritunga, D (corresponding author), Univ Puerto Rico, Dept Biol, Mayaguez, PR 00680 USA.	Dimuth.siritunga@upr.edu		Siritunga, Dimuth/0000-0002-4654-1369				Austin DF, 1996, TAXON, V45, P3, DOI 10.2307/1222581; Bruckner AW, 2004, THESIS N CAROLINA ST; Burri BJ, 2011, COMPR REV FOOD SCI F, V10, P118, DOI 10.1111/j.1541-4337.2010.00146.x; Buteler MI, 1999, THEOR APPL GENET, V99, P123, DOI 10.1007/s001220051216; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elameen A, 2008, GENET RESOUR CROP EV, V55, P397, DOI 10.1007/s10722-007-9247-0; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Food and Agriculture Organization, 2010, STAT WORLDS PLANT GE; Gichuki ST, 2003, GENET RESOUR CROP EV, V50, P429, DOI 10.1023/A:1023998522845; Gwandu C., 2012, African Journal of Biotechnology, V11, P9582; Hu JJ, 2004, SCI HORTIC-AMSTERDAM, V102, P375, DOI 10.1016/j.scienta.2004.04.014; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Karuri H. W., 2009, Journal of Applied Biosciences, V15, P820; KEEGAN WF, 1995, WORLD ARCHAEOL, V26, P400, DOI 10.1080/00438243.1995.9980284; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; OBRIEN PJ, 1972, AM ANTHROPOL, V74, P342, DOI 10.1525/aa.1972.74.3.02a00070; Oetting WS, 1995, GENOMICS, V30, P450, DOI 10.1006/geno.1995.1264; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Roullier C, 2013, HEREDITY, V110, P594, DOI 10.1038/hdy.2013.14; Roullier C, 2011, MOL ECOL, V20, P3963, DOI 10.1111/j.1365-294X.2011.05229.x; Sanjur OI, 2002, P NATL ACAD SCI USA, V99, P535, DOI 10.1073/pnas.012577299; Tseng YT, 2002, BOT BULL ACAD SINICA, V43, P99; Tumwegamire S, 2011, CROP SCI, V51, P1132, DOI 10.2135/cropsci2010.07.0407; Yada B, 2010, HORTSCIENCE, V45, P225, DOI 10.21273/HORTSCI.45.2.225; YANEZ AVO, 2002, AISLAMIENTO CARACTER; Zhang D, 2000, CIP PROGRAMME REPORT, P295; Zhang DP, 2004, GENET RESOUR CROP EV, V51, P115, DOI 10.1023/B:GRES.0000020853.04508.a0	32	26	27	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116184	10.1371/journal.pone.0116184	http://dx.doi.org/10.1371/journal.pone.0116184			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551388	Green Submitted, Green Published, gold			2022-12-26	WOS:000347119100106
J	Ali, K; Abo-Ali, EM; Kabir, MD; Riggins, B; Nguy, S; Li, L; Srivastava, U; Thinn, SMM				Ali, Kamilah; Abo-Ali, Ehab M.; Kabir, M. D.; Riggins, Bethany; Nguy, Susanna; Li, Lisa; Srivastava, Ujala; Thinn, Su Mya Mya			A Western-Fed Diet Increases Plasma HDL and LDL-Cholesterol Levels in ApoD-/- Mice	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; RECEPTOR CLASS-B; APOLIPOPROTEIN-D; SCAVENGER RECEPTOR; TARGETED MUTATION; SELECTIVE UPTAKE; SR-BI; REVEALS; PROTEIN; GENE	Objective: Plasma apolipoprotein (apo) D, a ubiquitously expressed protein that binds small hydrophobic ligands, is found mainly on HDL particles. According to studies of human genetics and lipid disorders, plasma apoD levels positively correlate with HDL-cholesterol and apoAI levels. Thus, we tested the hypothesis that apoD was a regulator of HDL metabolism. Methods & Results: We compared the plasma lipid and lipoprotein profiles of wild-type (WT) C57BL/6 mice with apoD-/- mice on a C57BL/6 background after receiving a high fat-high cholesterol diet for 12 weeks. ApoD-/- mice had higher HDL-cholesterol levels (61 +/- 13-apoD-/- vs. 52 +/- 10-WT-males; 37 +/- 11-apoD-/- vs. 22 +/- 2 WT-female) than WT mice with sex-specific changes in total plasma levels of cholesterol and other lipids. Compared to WT, the HDL of apoD-/- mice showed an increase in large, lipid-rich HDL particles and according to size various quantities and sizes of LDL particles. Plasma levels of lecithin: cholesterol acyltransferase in the control and apoD-/- mice were not different, however, plasma phospholipid transfer protein activity was modestly elevated (+10%) only in male apoD-/- mice. An in vivo HDL metabolism experiment with isolated Western-fed apoD-/- HDL particles showed that female apoD-/- mice had a 36% decrease in the fractional catabolic rate of HDL cholesteryl ester. Hepatic SR-BI and LDLR protein levels were significantly decreased; accordingly, LDL-cholesterol and apoB levels were increased in female mice. Conclusion: In the context of a high fat-high cholesterol diet, apoD deficiency in female mice is associated with increases in both plasma HDL and LDL-cholesterol levels, reflecting changes in expression of SR-BI and LDL receptors, which may impact diet-induced atherosclerosis.	[Ali, Kamilah; Abo-Ali, Ehab M.; Kabir, M. D.; Riggins, Bethany; Nguy, Susanna; Li, Lisa; Srivastava, Ujala; Thinn, Su Mya Mya] CUNY City Coll, Dept Biol, New York, NY 10031 USA; [Ali, Kamilah; Abo-Ali, Ehab M.] CUNY, Grad Ctr, New York, NY 10021 USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System	Ali, K (corresponding author), CUNY City Coll, Dept Biol, 138Th St & Convent Ave, New York, NY 10031 USA.	kali@ccny.cuny.edu		Kabir, Md/0000-0003-1792-2549	National Center for Research Resources [2G12RR03060-26A1]; National Institute on Minority Health and Health Disparities from National Institutes of Health [8G12MD007603-27]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1156512] Funding Source: National Science Foundation	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities from National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for Ujala Srivastava postdoctoral fellowship was provided by grants from the National Center for Research Resources (2G12RR03060-26A1) and the National Institute on Minority Health and Health Disparities (8G12MD007603-27) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ALAUPOVIC P, 1981, METABOLISM, V30, P805, DOI 10.1016/0026-0495(81)90027-5; ALBERS JJ, 1981, ATHEROSCLEROSIS, V39, P395, DOI 10.1016/0021-9150(81)90025-3; Albers JJ, 2012, BBA-MOL CELL BIOL L, V1821, P345, DOI 10.1016/j.bbalip.2011.06.013; Brundert M, 2005, ARTERIOSCL THROM VAS, V25, P143, DOI 10.1161/01.ATV.0000149381.16166.c6; CAMATO R, 1989, J LIPID RES, V30, P865; Camont L, 2011, TRENDS MOL MED, V17, P594, DOI 10.1016/j.molmed.2011.05.013; Caulfield MP, 2008, CLIN CHEM, V54, P1307, DOI 10.1373/clinchem.2007.100586; Dassati S, 2014, NEUROBIOL AGING, V35, P1632, DOI 10.1016/j.neurobiolaging.2014.01.148; Davidson WS, 2009, ARTERIOSCL THROM VAS, V29, P870, DOI 10.1161/ATVBAHA.109.186031; Desai PP, 2002, ATHEROSCLEROSIS, V163, P329, DOI 10.1016/S0021-9150(02)00012-6; Duivenvoorden R, 2012, CURR OPIN LIPIDOL, V23, P518, DOI 10.1097/MOL.0b013e32835916b3; Ganfornina MD, 2008, AGING CELL, V7, P506, DOI 10.1111/j.1474-9726.2008.00395.x; Havel R. J., 1980, METABOLIC CONTROL DI, P398; JAMES RW, 1986, ATHEROSCLEROSIS, V60, P49, DOI 10.1016/0021-9150(86)90086-9; Jimenez-Palomares M, 2011, METABOLISM, V60, P1767, DOI 10.1016/j.metabol.2011.04.013; KANNEL WB, 1979, ANN INTERN MED, V90, P85, DOI 10.7326/0003-4819-90-1-85; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; MCCONATHY WJ, 1976, BIOCHEMISTRY-US, V15, P515, DOI 10.1021/bi00648a010; Perdomo G, 2010, J LIPID RES, V51, P1298, DOI 10.1194/jlr.M001206; Rader DJ, 2012, NAT MED, V18, P1344, DOI 10.1038/nm.2937; Rainwater DL, 1999, ARTERIOSCL THROM VAS, V19, P777, DOI 10.1161/01.ATV.19.3.777; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; STEYRER E, 1988, BIOCHIM BIOPHYS ACTA, V958, P484, DOI 10.1016/0005-2760(88)90235-4; Tietge UJF, 2000, J BIOL CHEM, V275, P10077, DOI 10.1074/jbc.275.14.10077; Tsukamoto K, 2013, P NATL ACAD SCI USA, V110, P17023, DOI 10.1073/pnas.1315986110; Ueda Y, 2000, J BIOL CHEM, V275, P20368, DOI 10.1074/jbc.M000730200; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; Wang N, 1998, J BIOL CHEM, V273, P32920, DOI 10.1074/jbc.273.49.32920; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhang L, 2012, ARTERIOSCL THROM VAS, V32, P2541, DOI 10.1161/ATVBAHA.112.250571	33	13	14	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115744	10.1371/journal.pone.0115744	http://dx.doi.org/10.1371/journal.pone.0115744			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548917	gold, Green Published			2022-12-26	WOS:000347063500023
J	Hortensius, R; van Honk, J; de Gelder, B; Terburg, D				Hortensius, Ruud; van Honk, Jack; de Gelder, Beatrice; Terburg, David			Trait Dominance Promotes Reflexive Staring at Masked Angry Body Postures	PLOS ONE			English	Article							NON-CONSCIOUS RECOGNITION; BODILY EXPRESSIONS; VISUAL AWARENESS; EMOTIONAL FACES; FEAR; TESTOSTERONE; PERCEPTION; RESPONSES; AMYGDALA; INTEGRATION	It has been shown that dominant individuals sustain eye-contact when non-consciously confronted with angry faces, suggesting reflexive mechanisms underlying dominance behaviors. However, dominance and submission can be conveyed and provoked by means of not only facial but also bodily features. So far few studies have investigated the interplay of body postures with personality traits and behavior, despite the biological relevance and ecological validity of these postures. Here we investigate whether non-conscious exposure to bodily expressions of anger evokes reflex-like dominance behavior. In an interactive eye-tracking experiment thirty-two participants completed three social dominance tasks with angry, happy and neutral facial, bodily and face and body compound expressions that were masked from consciousness. We confirmed our predictions of slower gaze-aversion from both non-conscious bodily and compound expressions of anger compared to happiness in high dominant individuals. Results from a follow-up experiment suggest that the dominance behavior triggered by exposure to bodily anger occurs with basic detection of the category, but not recognition of the emotional content. Together these results suggest that dominant staring behavior is reflexively driven by non-conscious perception of the emotional content and triggered by not only facial but also bodily expression of anger.	[Hortensius, Ruud; de Gelder, Beatrice] Tilburg Univ, Cognit & Affect Neurosci Lab, NL-5000 LE Tilburg, Netherlands; [van Honk, Jack; Terburg, David] Univ Utrecht, Dept Expt Psychol, Utrecht, Netherlands; [van Honk, Jack; Terburg, David] Univ Cape Town, Dept Psychiat & Mental Hlth, ZA-7925 Cape Town, South Africa; [van Honk, Jack] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [de Gelder, Beatrice] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Brain & Emot Lab, Maastricht, Netherlands; [de Gelder, Beatrice] Katholieke Univ Leuven, Dept Neurosci, Div Psychiat, Brain & Emot Lab Leuven, Leuven, Belgium	Tilburg University; Utrecht University; University of Cape Town; University of Cape Town; Maastricht University; KU Leuven	Terburg, D (corresponding author), Univ Utrecht, Dept Expt Psychol, Utrecht, Netherlands.	d.terburg@uu.nl		Terburg, David/0000-0003-2356-8734; Hortensius, Ruud/0000-0002-5279-6202	Netherlands Organization for Scientific Research (NWO) [Brain & Cognition 056-24-010, VENI 451-13-004]; project TANGO; Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission under FET-Open grant [249858]; European Research Council under the European Union/ERC [295673]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); project TANGO; Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission under FET-Open grant; European Research Council under the European Union/ERC(European Research Council (ERC))	This study was supported by grants from the Netherlands Organization for Scientific Research (NWO; http://www.nwo.nl/): Brain & Cognition 056-24-010 (JvH); VENI 451-13-004 (D.T.). The work of BdG and RH was partly funded by the project TANGO. The project TANGO acknowledges the financial support of the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission (http://ec.europa.eu/research/fp7/index_en.cfm), under FET-Open grant number: 249858. BdG has also received funding from the European Research Council under the European Union's Seventh Frame-Work Programme (FP7/2007-2013)/ERC grant agreement number 295673. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2004, NAT NEUROSCI, V7, P339, DOI 10.1038/nn1213; [Anonymous], 2009, EXPRESS EMOT MAN; Carney DR, 2010, PSYCHOL SCI, V21, P1363, DOI 10.1177/0956797610383437; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; de Gelder B, 2001, ACTA PSYCHOL, V107, P183, DOI 10.1016/S0001-6918(01)00024-5; de Gelder B, 2006, NEUROREPORT, V17, P583, DOI 10.1097/00001756-200604240-00006; de Gelder B, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00054; de Gelder B, 2009, PHILOS T R SOC B, V364, P3475, DOI 10.1098/rstb.2009.0190; Ekman P., 1976, PICTURES FACIAL AFFE; Green DM, 1966, SIGNAL DETECTION THE; Hofman D, 2013, NEUROIMAGE, V79, P138, DOI 10.1016/j.neuroimage.2013.04.088; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; Pegna AJ, 2005, NAT NEUROSCI, V8, P24, DOI 10.1038/nn1364; Pessoa L, 2005, EMOTION, V5, P243, DOI 10.1037/1528-3542.5.2.243; Pichon S, 2012, CEREB CORTEX, V22, P274, DOI 10.1093/cercor/bhr060; Seirafi M, 2013, J VISION, V13, DOI 10.1167/13.2.12; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Stienen BMC, 2011, EMOTION, V11, P1182, DOI 10.1037/a0024032; Tamietto M, 2012, CURR BIOL, V22, P1449, DOI 10.1016/j.cub.2012.06.006; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Tamietto M, 2009, P NATL ACAD SCI USA, V106, P17661, DOI 10.1073/pnas.0908994106; Terburg D, 2013, EMOT REV, V5, P296, DOI 10.1177/1754073913477510; Terburg D, 2012, PSYCHOL SCI, V23, P459, DOI 10.1177/0956797611433336; Terburg D, 2011, PSYCHOL SCI, V22, P314, DOI 10.1177/0956797611398492; van de Riet WAC, 2009, SOC NEUROSCI-UK, V4, P101, DOI 10.1080/17470910701865367; Van den Stock J, 2015, BIOL PSYCHIAT, V77, pE31, DOI 10.1016/j.biopsych.2013.06.023; van Honk J, 2005, BIOL PSYCHIAT, V58, P218, DOI 10.1016/j.biopsych.2005.04.003; van Honk J., 2007, SOCIAL NEUROSCIENCE, P197; VANSELST M, 1993, CONSCIOUS COGN, V2, P194, DOI 10.1006/ccog.1993.1018; Williams LM, 2004, HUM BRAIN MAPP, V21, P64, DOI 10.1002/hbm.10154	35	16	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116232	10.1371/journal.pone.0116232	http://dx.doi.org/10.1371/journal.pone.0116232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549321	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000347063500066
J	Liu, JX; Wang, YZ; Wu, YZ; Ni, B; Liang, ZQ				Liu, Jingxia; Wang, Yanzhou; Wu, Yuzhang; Ni, Bing; Liang, Zhiqing			Sodium Butyrate Promotes the Differentiation of Rat Bone Marrow Mesenchymal Stem Cells to Smooth Muscle Cells through Histone Acetylation	PLOS ONE			English	Article							GENE-EXPRESSION; DEACETYLASE INHIBITOR; CLINICAL-APPLICATIONS; ACTIVATION; RECRUITMENT; DERIVATION; APOPTOSIS; BINDING; CYCLE	Establishing an effective method to improve stem cell differentiation is crucial in stem cell transplantation. Here we aimed to explore whether and how sodium butyrate (NaB) induces rat bone marrow mesenchymal stem cells (MSCs) to differentiate into bladder smooth muscle cells (SMCs). We found that NaB significantly suppressed MSC proliferation and promoted MSCs differentiation into SMCs, as evidenced by the enhanced expression of SMC specific genes in the MSCs. Co-culturing the MSCs with SMCs in a transwell system promoted the differentiation of MSCs into SMCs. NaB again promoted MSC differentiation in this system. Furthermore, NaB enhanced the acetylation of SMC gene-associated H3K9 and H4, and decreased the expression of HDAC2 and down-regulated the recruitment of HDAC2 to the promoter regions of SMC specific genes. Finally, we found that NaB significantly promoted MSC depolarization and increased the intracellular calcium level of MSCs upon carbachol stimulation. These results demonstrated that NaB effectively promotes MSC differentiation into SMCs, possibly by the marked inhibition of HDAC2 expression and disassociation of HDAC2 recruitment to SMC specific genes in MSCs, which further induces high levels of H3K9(ace) and H4(ace) and the enhanced expression of target genes, and this strategy could potentially be applied in clinical tissue engineering and cell transplantation.	[Liu, Jingxia; Wang, Yanzhou; Liang, Zhiqing] Third Mil Med Univ, Southwest Hosp, Dept Gynecol & Obstet, Chongqing 400038, Peoples R China; [Wu, Yuzhang; Ni, Bing] Third Mil Med Univ, PLA, Inst Immunol, Chongqing 400038, Peoples R China	Army Medical University; Army Medical University	Ni, B (corresponding author), Third Mil Med Univ, PLA, Inst Immunol, Chongqing 400038, Peoples R China.	nibingxi@yahoo.com; zhi.lzliang@gmail.com		Ni, Bing/0000-0002-4297-5346; wang, yanzhou/0000-0002-5985-5244; Wu, Yuzhang/0000-0002-4049-0214	General Program of National Natural Science Foundation of China [1170552, 30801234, 31200668]	General Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the General Program of National Natural Science Foundation of China (No. 1170552, 30801234 and 31200668), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Chen TH, 2007, BIOCHEM BIOPH RES CO, V355, P913, DOI 10.1016/j.bbrc.2007.02.057; Das ZC, 2010, CELL REPROGRAM, V12, P95, DOI 10.1089/cell.2009.0068; Findeisen HM, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0319-7; Findeisen HM, 2011, ARTERIOSCL THROM VAS, V31, P851, DOI 10.1161/ATVBAHA.110.221952; Forostyak S, 2013, BIOCHIMIE, V95, P2257, DOI 10.1016/j.biochi.2013.08.004; Hauser C, 2002, MOL CELL BIOL, V22, P7820, DOI 10.1128/MCB.22.22.7820-7830.2002; Ho CP, 2012, CURR OPIN OBSTET GYN, V24, P311, DOI 10.1097/GCO.0b013e328357ae03; Kavurma MM, 2007, BIOCHEM J, V407, P79, DOI 10.1042/BJ20070380; Kim N, 2013, KOREAN J INTERN MED, V28, P387, DOI 10.3904/kjim.2013.28.4.387; Knaan-Shanzer S, 2014, STEM CELLS, V32, P603, DOI 10.1002/stem.1568; Koprinarova M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-49; Kumar BM, 2007, J REPROD DEVELOP, V53, P903, DOI 10.1262/jrd.18180; Liao W, 2013, TRANSPL P, V45, P730, DOI 10.1016/j.transproceed.2012.08.023; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Manabe I, 2001, CIRC RES, V88, P1127, DOI 10.1161/hh1101.091339; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; McDonald OG, 2007, CIRC RES, V100, P1428, DOI 10.1161/01.RES.0000266448.30370.a0; Nor C, 2013, MOL NEUROBIOL, V48, P533, DOI 10.1007/s12035-013-8441-7; Paduraru O M, 2011, Fiziol Zh, V57, P15; Rahman MM, 2003, BLOOD, V101, P3451, DOI 10.1182/blood-2002-08-2622; Romagnoli Cecilia, 2014, World J Stem Cells, V6, P144, DOI 10.4252/wjsc.v6.i2.144; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Shah RD, 2013, J CELL BIOCHEM, V114, P854, DOI 10.1002/jcb.24422; Sinha S, 2006, STEM CELLS, V24, P1678, DOI 10.1634/stemcells.2006-0002; Surcel C, 2012, ROM J MORPHOL EMBRYO, V53, P151; Vrba J, 2011, BIOMED PAP, V155, P259, DOI 10.5507/bp.2011.033; Wang TZ, 2006, INT J CARDIOL, V109, P74, DOI 10.1016/j.ijcard.2005.05.072; Yin L, 2001, J BIOL CHEM, V276, P44641, DOI 10.1074/jbc.M105170200; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Zhang Q, 2011, CHINESE MED J-PEKING, V124, P3786, DOI 10.3760/cma.j.issn.0366-6999.2011.22.033; Zhou BD, 2011, CARDIOVASC RES, V90, P413, DOI 10.1093/cvr/cvr003; Zhou QJ, 2007, J CELL BIOCHEM, V100, P29, DOI 10.1002/jcb.20970	35	23	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116183	10.1371/journal.pone.0116183	http://dx.doi.org/10.1371/journal.pone.0116183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548915	gold, Green Published, Green Submitted			2022-12-26	WOS:000347063500058
J	Scheu, PD; Steinmetz, PA; Dempwolff, F; Graumann, PL; Unden, G				Scheu, Patrick D.; Steinmetz, Philipp A.; Dempwolff, Felix; Graumann, Peter L.; Unden, Gottfried			Polar Localization of a Tripartite Complex of the Two-Component System DcuS/DcuR and the Transporter DctA in Escherichia coli Depends on the Sensor Kinase DcuS	PLOS ONE			English	Article							ANAEROBIC CITRATE METABOLISM; ACID CYCLE ENZYMES; ACTIN-LIKE PROTEIN; SIGNAL-TRANSDUCTION; RESPONSE REGULATOR; BACILLUS-SUBTILIS; DCTA/DCUS SENSOR; HISTIDINE KINASE; CHEMORECEPTOR CLUSTERS; DYNAMIC LOCALIZATION	The C-4-dicarboxylate responsive sensor kinase DcuS of the DcuS/DcuR twocomponent system of E. coli is membrane-bound and reveals a polar localization. DcuS uses the C-4-dicarboxylate transporter DctA as a co-regulator forming DctA/DcuS sensor units. Here it is shown by fluorescence microscopy with fusion proteins that DcuS has a dynamic and preferential polar localization, even at very low expression levels. Single assemblies of DcuS had high mobility in fast time lapse acquisitions, and fast recovery in FRAP experiments, excluding polar accumulation due to aggregation. DctA and DcuR fused to derivatives of the YFP protein are dispersed in the membrane or in the cytosol, respectively, when expressed without DcuS, but co-localize with DcuS when co-expressed at appropriate levels. Thus, DcuS is required for location of DctA and DcuR at the poles and formation of tripartite DctA/DcuS/DcuR sensor/regulator complexes. Vice versa, DctA, DcuR and the alternative succinate transporter DauA were not essential for polar localization of DcuS, suggesting that the polar trapping occurs by DcuS. Cardiolipin, the high curvature at the cell poles, and the cytoskeletal protein MreB were not required for polar localization. In contrast, polar localization of DcuS required the presence of the cytoplasmic PAS(C) and the kinase domains of DcuS.	[Scheu, Patrick D.; Steinmetz, Philipp A.; Unden, Gottfried] Johannes Gutenberg Univ Mainz, Inst Microbiol & Wine Res, D-55122 Mainz, Germany; [Dempwolff, Felix; Graumann, Peter L.] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany	Johannes Gutenberg University of Mainz; University of Freiburg	Unden, G (corresponding author), Johannes Gutenberg Univ Mainz, Inst Microbiol & Wine Res, D-55122 Mainz, Germany.	unden@uni-mainz.de		Dempwolff, Felix/0000-0002-7788-8445; Graumann, Peter/0000-0002-8033-5171	Deutsche Forschungsgemeinschaft [UN49/12-2, FOR 929]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding provided by Deutsche Forschungsgemeinschaft UN49/12-2 (GU) and FOR 929 (PLG).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BARNES SJ, 1986, FEBS LETT, V201, P267, DOI 10.1016/0014-5793(86)80621-4; Bott M, 1997, ARCH MICROBIOL, V167, P78, DOI 10.1007/s002030050419; BOTT M, 1995, MOL MICROBIOL, V18, P533, DOI 10.1111/j.1365-2958.1995.mmi_18030533.x; Davies SJ, 1999, J BACTERIOL, V181, P5624, DOI 10.1128/JB.181.18.5624-5635.1999; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; Etzkorn M, 2008, NAT STRUCT MOL BIOL, V15, P1031, DOI 10.1038/nsmb.1493; Fukushima T, 2008, MOL MICROBIOL, V69, P621, DOI 10.1111/j.1365-2958.2008.06308.x; Fukushima T, 2011, MOL MICROBIOL, V79, P503, DOI 10.1111/j.1365-2958.2010.07464.x; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Graumann PL, 2007, ANNU REV MICROBIOL, V61, P589, DOI 10.1146/annurev.micro.61.080706.093236; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Iwai N, 2002, BIOSCI BIOTECH BIOCH, V66, P2658, DOI 10.1271/bbb.66.2658; Jacobs C, 2001, P NATL ACAD SCI USA, V98, P4095, DOI 10.1073/pnas.051609998; Janausch IG, 2002, J BIOL CHEM, V277, P39809, DOI 10.1074/jbc.M204482200; Janausch IG, 2002, BBA-BIOENERGETICS, V1553, P39, DOI 10.1016/S0005-2728(01)00233-X; Karinou E, 2013, MOL MICROBIOL, V87, P623, DOI 10.1111/mmi.12120; Kaufenstein M, 2011, J BACTERIOL, V193, P1633, DOI 10.1128/JB.01128-10; Kay WW, 1971, UPTAKE C4 DICARBOXYL; Kentner D, 2006, CURR OPIN MICROBIOL, V9, P619, DOI 10.1016/j.mib.2006.10.012; Kentner D, 2006, MOL MICROBIOL, V61, P407, DOI 10.1111/j.1365-2958.2006.05250.x; Kneuper H, 2005, J BIOL CHEM, V280, P20596, DOI 10.1074/jbc.M502015200; Kramer J, 2007, J BACTERIOL, V189, P4290, DOI 10.1128/JB.00168-07; Laloux G, 2014, J CELL SCI, V127, P11, DOI 10.1242/jcs.138628; Lam H, 2003, DEV CELL, V5, P149, DOI 10.1016/S1534-5807(03)00191-6; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; Lenn T, 2008, BIOCHEM SOC T, V36, P1032, DOI 10.1042/BST0361032; MADDOCK JR, 1993, SCIENCE, V259, P1717; Maier KS, 2008, MOL MICROBIOL, V68, P1471, DOI 10.1111/j.1365-2958.2008.06246.x; Matsumoto K, 2001, MOL MICROBIOL, V39, P1427, DOI 10.1046/j.1365-2958.2001.02320.x; Matsumoto K, 2006, MOL MICROBIOL, V61, P1110, DOI 10.1111/j.1365-2958.2006.05317.x; Mauriello EMF, 2010, EMBO J, V29, P315, DOI 10.1038/emboj.2009.356; Meile JC, 2006, PROTEOMICS, V6, P2135, DOI 10.1002/pmic.200500512; Meyer FM, 2011, METAB ENG, V13, P18, DOI 10.1016/j.ymben.2010.10.001; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Moraes TF, 2012, BBA-BIOMEMBRANES, V1818, P2687, DOI 10.1016/j.bbamem.2012.06.007; MOWBRAY J, 1976, EUR J BIOCHEM, V66, P25, DOI 10.1111/j.1432-1033.1976.tb10421.x; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Nilsen T, 2005, J BACTERIOL, V187, P6187, DOI 10.1128/JB.187.17.6187-6196.2005; Paul R, 2008, CELL, V133, P452, DOI 10.1016/j.cell.2008.02.045; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Ramamurthi KS, 2009, P NATL ACAD SCI USA, V106, P13541, DOI 10.1073/pnas.0906851106; Romantsov T, 2008, J BIOL CHEM, V283, P12314, DOI 10.1074/jbc.M709871200; Romantsov T, 2007, MOL MICROBIOL, V64, P1455, DOI 10.1111/j.1365-2958.2007.05727.x; Romantsov T, 2010, J BACTERIOL, V192, P912, DOI 10.1128/JB.00967-09; Rudner DZ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000307; Sambrook J., 2001, MOL CLONING LAB MANU, V3; Scheu PD, 2012, J BACTERIOL, V194, P636, DOI 10.1128/JB.06345-11; Scheu P, 2008, MICROBIOL-SGM, V154, P2463, DOI 10.1099/mic.0.2008/018614-0; Scheu PD, 2010, FUTURE MICROBIOL, V5, P1383, DOI 10.2217/FMB.10.103; Scheu PD, 2010, J BACTERIOL, V192, P3474, DOI 10.1128/JB.00082-10; Schulmeister S, 2008, P NATL ACAD SCI USA, V105, P6403, DOI 10.1073/pnas.0710611105; Sciara MI, 2008, MOL MICROBIOL, V70, P479, DOI 10.1111/j.1365-2958.2008.06427.x; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Shapiro L, 2009, SCIENCE, V326, P1225, DOI 10.1126/science.1175685; Shiomi D, 2006, MOL MICROBIOL, V60, P894, DOI 10.1111/j.1365-2958.2006.05145.x; Silhavy T.J., 1984, EXPT GENE FUSIONS; Sommer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077708; Soufo HJD, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-10; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Sousa PMF, 2011, BIOCHIMIE, V93, P418, DOI 10.1016/j.biochi.2010.10.014; Steinmetz PA, 2014, MOL MICROBIOL, V94, P218, DOI 10.1111/mmi.12759; Tadesse S, 2006, J BACTERIOL, V188, P3002, DOI 10.1128/JB.188.8.3002-3011.2006; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; Tetsch L, 2008, MOL MICROBIOL, V67, P570, DOI 10.1111/j.1365-2958.2007.06070.x; Thiem S, 2008, MOL MICROBIOL, V68, P1228, DOI 10.1111/j.1365-2958.2008.06227.x; WEISS RL, 1976, J BACTERIOL, V128, P668, DOI 10.1128/JB.128.2.668-670.1976; Witan J, 2012, BIOL CHEM, V393, P1291, DOI 10.1515/hsz-2012-0229; Witan J, 2012, MOL MICROBIOL, V85, P846, DOI 10.1111/j.1365-2958.2012.08143.x; Wittig I, 2009, BBA-BIOENERGETICS, V1787, P672, DOI 10.1016/j.bbabio.2008.12.016; Zientz E, 1998, J BACTERIOL, V180, P5421, DOI 10.1128/JB.180.20.5421-5425.1998	72	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115534	10.1371/journal.pone.0115534	http://dx.doi.org/10.1371/journal.pone.0115534			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549248	Green Published, Green Submitted, gold			2022-12-26	WOS:000347063500015
J	Blighe, K; Kenny, L; Patel, N; Guttery, DS; Page, K; Gronau, JH; Golshani, C; Stebbing, J; Coombes, RC; Shaw, JA				Blighe, Kevin; Kenny, Laura; Patel, Naina; Guttery, David S.; Page, Karen; Gronau, Julian H.; Golshani, Cyrus; Stebbing, Justin; Coombes, R. Charles; Shaw, Jacqueline A.			Whole Genome Sequence Analysis Suggests Intratumoral Heterogeneity in Dissemination of Breast Cancer to Lymph Nodes	PLOS ONE			English	Article							CHROMOSOMAL INSTABILITY; GENE-EXPRESSION; CLINICAL-IMPLICATIONS; CLONAL EVOLUTION; TP53 MUTATIONS; OVEREXPRESSION; METASTASIS; CARCINOMAS; REVEALS; DISEASE	Background: Intratumoral heterogeneity may help drive resistance to targeted therapies in cancer. In breast cancer, the presence of nodal metastases is a key indicator of poorer overall survival. The aim of this study was to identify somatic genetic alterations in early dissemination of breast cancer by whole genome next generation sequencing (NGS) of a primary breast tumor, a matched locally-involved axillary lymph node and healthy normal DNA from blood. Methods: Whole genome NGS was performed on 12 mg (range 11.1-13.3 mg) of DNA isolated from fresh-frozen primary breast tumor, axillary lymph node and peripheral blood following the DNA nanoball sequencing protocol. Single nucleotide variants, insertions, deletions, and substitutions were identified through a bioinformatic pipeline and compared to CIN25, a key set of genes associated with tumor metastasis. Results: Whole genome sequencing revealed overlapping variants between the tumor and node, but also variants that were unique to each. Novel mutations unique to the node included those found in two CIN25 targets, TGIF2 and CCNB2, which are related to transcription cyclin activity and chromosomal stability, respectively, and a unique frameshift in PDS5B, which is required for accurate sister chromatid segregation during cell division. We also identified dominant clonal variants that progressed from tumor to node, including SNVs in TP53 and ARAP3, which mediates rearrangements to the cytoskeleton and cell shape, and an insertion in TOP2A, the expression of which is significantly associated with tumor proliferation and can segregate breast cancers by outcome. Conclusion: This case study provides preliminary evidence that primary tumor and early nodal metastasis have largely overlapping somatic genetic alterations. There were very few mutations unique to the involved node. However, significant conclusions regarding early dissemination needs analysis of a larger number of patient samples.	[Blighe, Kevin; Guttery, David S.; Page, Karen; Shaw, Jacqueline A.] Leicester Royal Infirm, Dept Canc Studies & Mol Med, Leicester LE2 7LX, Leics, England; [Kenny, Laura; Patel, Naina; Gronau, Julian H.; Golshani, Cyrus; Stebbing, Justin; Coombes, R. Charles] Univ London Imperial Coll Sci Technol & Med, Div Canc, London W12 0NN, England	University of Leicester; Imperial College London	Shaw, JA (corresponding author), Leicester Royal Infirm, Dept Canc Studies & Mol Med, Robert Kilpatrick Clin Sci Bldg, Leicester LE2 7LX, Leics, England.	js39@leicester.ac.uk		Coombes, Raoul Charles/0000-0002-4811-1100; Blighe, Kevin/0000-0002-6322-6571; Page, Karen/0000-0003-0440-9244; Stebbing, Justin/0000-0002-1117-6947; Guttery, David/0000-0003-0418-580X; Shaw, Jacqui/0000-0003-4227-503X	Complete Genomics, Incorporated; Imperial EXperimental Cancer Medicine Centre (ECMC); Imperial Cancer Research UK (CRUK) Centre; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London; CRUK; NIHR [09/009]; Cancer Research UK [14549, 13462] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-053] Funding Source: researchfish	Complete Genomics, Incorporated; Imperial EXperimental Cancer Medicine Centre (ECMC); Imperial Cancer Research UK (CRUK) Centre; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London; CRUK(Cancer Research UK); NIHR(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by a grant from Complete Genomics, Incorporated. The research undertaken was additionally supported by the Imperial EXperimental Cancer Medicine Centre (ECMC), Imperial Cancer Research UK (CRUK) Centre, and the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. KP and DSG are funded by a programme grant award from CRUK to JS and RCC. KB was funded by CRUK while in Leicester. LK is funded by an NIHR Clinician Scientist grant (09/009). Tissue samples were provided by the Imperial College Healthcare NHS Trust Tissue Bank. Other investigators may have received samples from these same tissues. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baird RD, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-151; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Brown T.A., 2002, GENOMES, V2nd; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Campbell N, 2004, NAT REV GENET, V5, P87, DOI [10.1038/NRG1288, DOI 10.1038/NRG1288]; Carnevali P, 2012, J COMPUT BIOL, V19, P279, DOI 10.1089/cmb.2011.0201; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Denes V, 2010, ONCOGENE, V29, P3446, DOI 10.1038/onc.2010.100; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Forbes S. A., 2001, CURRENT PROTOCOLS HU; Gardberg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074923; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Geyer FC, 2010, J PATHOL, V220, P562, DOI 10.1002/path.2675; Gilbert S.F., 2000, DEV BIOL; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Heng HH, 2013, CANCER METAST REV, V32, P325, DOI 10.1007/s10555-013-9427-7; Imoto I, 2000, BIOCHEM BIOPH RES CO, V276, P264, DOI 10.1006/bbrc.2000.3449; Jatoi I, 1999, J CLIN ONCOL, V17, P2334, DOI 10.1200/JCO.1999.17.8.2334; Jechlinger W, 2005, J BIOTECHNOL, V116, P11, DOI 10.1016/j.jbiotec.2004.10.002; Kamihara J, 2014, HUM MUTAT, V35, P654, DOI 10.1002/humu.22559; Kim MS, 2013, HUM PATHOL, V44, P2234, DOI 10.1016/j.humpath.2013.04.017; KIRICUTA IC, 1994, INT J RADIAT ONCOL, V28, P387, DOI 10.1016/0360-3016(94)90062-0; Kwei KA, 2010, MOL ONCOL, V4, P255, DOI 10.1016/j.molonc.2010.04.001; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Martinez-Ramos D, 2009, WORLD J SURG, V33, P1659, DOI 10.1007/s00268-009-0078-3; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; Melhuish TA, 2001, J BIOL CHEM, V276, P32109, DOI 10.1074/jbc.M103377200; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Querzoli P, 2006, CLIN CANCER RES, V12, P6696, DOI 10.1158/1078-0432.CCR-06-0569; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Sarafan-Vasseur N, 2002, ONCOGENE, V21, P2051, DOI 10.1038/sj.onc.1205257; Shaw J, 2011, GENOME RES; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Suzuki M, 2008, FUTURE ONCOL, V4, P775, DOI 10.2217/14796694.4.6.775; Szasz AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056707; Theuns J, 2006, AM J HUM GENET, V78, P936, DOI 10.1086/504044; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Yagi R, 2011, ONCOGENE, V30, P1413, DOI 10.1038/onc.2010.522	43	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115346	10.1371/journal.pone.0115346	http://dx.doi.org/10.1371/journal.pone.0115346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546409	Green Published, gold, Green Submitted			2022-12-26	WOS:000347120200039
J	Fernandes, BJT; Cavalcanti, GDC; Ren, TI				Fernandes, Bruno J. T.; Cavalcanti, George D. C.; Ren, Tsang I.			Constructive Autoassociative Neural Network for Facial Recognition	PLOS ONE			English	Article							EXPRESSION RECOGNITION; RECEPTIVE-FIELD; LATERAL INHIBITION; ALGORITHMS; UNITS	Autoassociative artificial neural networks have been used in many different computer vision applications. However, it is difficult to define the most suitable neural network architecture because this definition is based on previous knowledge and depends on the problem domain. To address this problem, we propose a constructive autoassociative neural network called CANet (Constructive Autoassociative Neural Network). CANet integrates the concepts of receptive fields and autoassociative memory in a dynamic architecture that changes the configuration of the receptive fields by adding new neurons in the hidden layer, while a pruning algorithm removes neurons from the output layer. Neurons in the CANet output layer present lateral inhibitory connections that improve the recognition rate. Experiments in face recognition and facial expression recognition show that the CANet outperforms other methods presented in the literature.	[Fernandes, Bruno J. T.] Univ Pernambuco, Escola Politecn, Recife, PE, Brazil; [Cavalcanti, George D. C.; Ren, Tsang I.] Univ Fed Pernambuco, Ctr Informat, Recife, PE, Brazil	Universidade de Pernambuco (UPE); Universidade Federal de Pernambuco	Fernandes, BJT (corresponding author), Univ Pernambuco, Escola Politecn, Recife, PE, Brazil.	bjtf@ecomp.poli.br	Cavalcanti, George DC/C-2364-2017; Fernandes, Bruno J T/R-1237-2016; Ren, Tsang Ing/AAD-3221-2022	Cavalcanti, George DC/0000-0001-7714-2283; Fernandes, Bruno J T/0000-0002-6001-3925; 	CNPq; CAPES; Facepe	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Facepe(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	This work was partially supported by Brazilian agencies: CNPq, CAPES and Facepe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, NEURAL NETWORKS BRAI; Arkachar P, 2007, NEUROCOMPUTING, V70, P991, DOI 10.1016/j.neucom.2006.03.017; Ash T., 1989, Connection Science, V1, P365, DOI 10.1080/09540098908915647; Bashyal S, 2008, ENG APPL ARTIF INTEL, V21, P1056, DOI 10.1016/j.engappai.2007.11.010; Bishop C.M., 2007, NEURAL NETWORKS PATT, V1st; Cavalcanti GDC, 2004, P BRAZ S ART NEUR NE, V3656, P1; Cheng F, 2010, IEEE T NEURAL NETWOR, V21, P1685, DOI 10.1109/TNN.2010.2064176; Fahlman S.E., 1990, CARNEGIE MELLON U PI; Farabet C, 2013, IEEE T PATTERN ANAL, V35, P1915, DOI 10.1109/TPAMI.2012.231; Fernandes BJT, 2013, EXPERT SYST APPL, V40, P7258, DOI 10.1016/j.eswa.2013.06.080; Fernandes BJT, 2009, NEURAL NETW WORLD, V19, P21; Fernandes BJT, 2013, IEEE T CYBERNETICS, V43, P2082, DOI 10.1109/TCYB.2013.2240295; Ghosh K, 2010, IEEE T SYST MAN CY A, V40, P758, DOI 10.1109/TSMCA.2010.2044503; Grigorescu C, 2003, IEEE T IMAGE PROCESS, V12, P729, DOI 10.1109/TIP.2003.814250; Haykin S. O., 2008, NEURAL NETWORKS LEAR; HONAVAR V, 1993, INFORM SCIENCES, V70, P75, DOI 10.1016/0020-0255(93)90049-R; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; HUBEL DAVID H., 1963, SCI AMER, V209, P54; Igel C, 2003, NEUROCOMPUTING, V50, P105, DOI 10.1016/S0925-2312(01)00700-7; Islam MM, 2009, IEEE T SYST MAN CY B, V39, P705, DOI 10.1109/TSMCB.2008.2008724; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Kameyama K, 1997, 1997 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-4, P1523, DOI 10.1109/ICNN.1997.614119; Kwok TY, 1997, IEEE T NEURAL NETWOR, V8, P1131, DOI 10.1109/72.623214; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lei H., 2005, THESIS STATE U NEW Y; Lyons M. J., 1997, JAPANESE FEMALE FACI; Ma L, 2004, IEEE T SYST MAN CY B, V34, P1588, DOI 10.1109/TSMCB.2004.825930; Ma L, 2003, NEUROCOMPUTING, V51, P361, DOI 10.1016/S0925-2312(02)00597-0; Mao ZH, 2007, IEEE T NEURAL NETWOR, V18, P55, DOI 10.1109/TNN.2006.883724; Maronidis A, 2011, NEURAL NETWORKS, V24, P814, DOI 10.1016/j.neunet.2011.05.015; Martinez A. M., 1998, TECHNICAL REPORT; Martinez AM, 2001, IEEE T PATTERN ANAL, V23, P228, DOI 10.1109/34.908974; Mi JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059430; Mi JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042461; Nabet B, 1991, SENSORY NEURAL NETWO; Parekh R, 2000, IEEE T NEURAL NETWOR, V11, P436, DOI 10.1109/72.839013; Perez CA, 2003, IEEE T SYST MAN CY B, V33, P258, DOI 10.1109/TSMCB.2003.810441; Phung SL, 2007, IEEE T NEURAL NETWOR, V18, P329, DOI 10.1109/TNN.2006.884677; Rao KS, 2011, EXPERT SYST APPL, V38, P13181, DOI 10.1016/j.eswa.2011.04.129; REED R, 1993, IEEE T NEURAL NETWOR, V4, P740, DOI 10.1109/72.248452; RIEDMILLER M, 1993, 1993 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-3, P586, DOI 10.1109/ICNN.1993.298623; RIZZOLATTI G, 1975, BRAIN RES, V88, P357, DOI 10.1016/0006-8993(75)90399-6; Samaria F. S., 1994, Proceedings of the Second IEEE Workshop on Applications of Computer Vision (Cat. No.94TH06742), P138, DOI 10.1109/ACV.1994.341300; Sharma S. K., 2010, Proceedings of the 2010 International Conference on Computational Intelligence and Communication Networks (CICN 2010), P139, DOI 10.1109/CICN.2010.38; Sharma SK, 2010, INT J ENG SCI TECHNO, V2, P7847; Sun C, 2004, NEUROSCIENCE, V125, P495, DOI 10.1016/j.neuroscience.2004.01.036; Thompson BB, 2002, IEEE IJCNN, P2878, DOI 10.1109/IJCNN.2002.1007605; Wang M, 2005, IEEE T NEURAL NETWOR, V16, P557, DOI 10.1109/TNN.2005.847839; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Zavaschi THH, 2013, EXPERT SYST APPL, V40, P646, DOI 10.1016/j.eswa.2012.07.074; Zhi RC, 2011, IEEE T SYST MAN CY B, V41, P38, DOI 10.1109/TSMCB.2010.2044788; Zhu QH, 2013, PLOS ONE, P8	53	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115967	10.1371/journal.pone.0115967	http://dx.doi.org/10.1371/journal.pone.0115967			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542018	Green Published, gold			2022-12-26	WOS:000347239900120
J	Piazzi, M; Blalock, WL; Bavelloni, A; Faenza, I; Raffini, M; Tagliavini, F; Manzoli, L; Cocco, L				Piazzi, Manuela; Blalock, William L.; Bavelloni, Alberto; Faenza, Irene; Raffini, Mirco; Tagliavini, Francesca; Manzoli, Lucia; Cocco, Lucio			PI-PLC beta 1b affects Akt activation, cyclin E expression, and caspase cleavage, promoting cell survival in pro-B-lymphoblastic cells exposed to oxidative stress	FASEB JOURNAL			English	Article						ROS; MAPK; PKR; leukemia; effector caspases	PHOSPHOLIPASE C-BETA-1; HYDROGEN-PEROXIDE; INDUCED APOPTOSIS; MYELOID-LEUKEMIA; UP-REGULATION; MDS PATIENTS; NUCLEAR; PROTEIN; DEATH; DIFFERENTIATION	The phosphoinositide-dependent signal transduction pathway has been implicated in the control of a variety of biologic processes, such as the regulation of cellular metabolism and homeostasis, cell proliferation and differentiation, and apoptosis. One of the key players in the regulation of inositol lipid signaling is the phospholipase C beta 1 (PI-PLC beta 1), that hydrolyzes phosphatidylinositol 4,5-bisphosphate [PtIns(4,5)P2], giving rise to the second messengers inositol triphosphate and diacylglicerol. PI-PLC beta 1 has been associated with the regulation of several cellular functions, some of which have not yet been fully understood. In particular, it has been reported that PI-PLC beta 1 protects murine fibroblasts from oxidative stress-induced cell death. The mediators of oxidative stress, reactive oxygen species (ROS), have been shown to regulate major epigenetic processes, causing the silencing of tumor suppressors and enhancing the proliferation of leukemic cells under oxidative stress. Investigation of the interplay between ROS, PI-PLC beta 1, and their signaling mediators in leukemia might therefore reveal innovative targets of pharmacological therapy in the treatment for leukemia. In this work, we demonstrate that in pro-B-lymphoblastic cells (Ba/F3), treated with H2O2, PI-PLC beta 1b conferred resistance to cell death, promoting cell cycle progression and cell proliferation and influencing the expression of cyclin A and E. Interestingly, we found that, expression of PI-PLC beta 1b affects the activity of caspase-3, caspase-7, and of several protein kinases induced by oxidative stress. In particular, PI-PLC beta 1b expression completely abolished the phosphorylation of Erk1/2 MAP kinases, down-regulated phosphatase and tensin homolog (PTEN), and up-regulated the phosphorylation of Akt, thereby sustaining cellular proliferation.	[Piazzi, Manuela; Faenza, Irene; Manzoli, Lucia; Cocco, Lucio] Univ Bologna, Dept Biomed Sci, Cell Signaling Lab, I-40126 Bologna, Italy; [Blalock, William L.; Bavelloni, Alberto; Raffini, Mirco] Ist Ortoped Rizzoli, Struttura Complessa Lab Musculoskeletal Cell Biol, Bologna, Italy; [Blalock, William L.; Tagliavini, Francesca] Natl Res Council Italy, Inst Mol Genet, Bologna, Italy; [Bavelloni, Alberto; Raffini, Mirco] Ist Ortoped Rizzoli, RAMSES Lab, Bologna, Italy	University of Bologna; IRCCS Istituto Ortopedico Rizzoli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Istituto Ortopedico Rizzoli	Piazzi, M (corresponding author), Univ Bologna, Dept Biomed Sci, Cell Signaling Lab, Via Irnerio 48, I-40126 Bologna, Italy.	manuela.piazzi3@unibo.it	Piazzi, Manuela/AAD-5016-2020; Piazzi, Manuela/K-2147-2016; Bavelloni, Alberto/E-5726-2019; Cocco, Lucio/AAI-2206-2020; Blalock, William L/C-6959-2019; Faenza, Irene/AAC-4606-2022; Tagliavini, Francesca/N-5154-2015	Piazzi, Manuela/0000-0002-9072-2757; Piazzi, Manuela/0000-0002-9072-2757; Bavelloni, Alberto/0000-0002-6467-1431; Cocco, Lucio/0000-0002-9206-8277; Blalock, William L/0000-0002-8045-4840; Faenza, Irene/0000-0002-5227-3567; Tagliavini, Francesca/0000-0001-5679-2156	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca-Fondo per gli Investimenti della Ricerca di Base (MIUR-FIRB) Human ProteomeNet; Italian MIUR-FIRB [RBAP10447J]; "5 x 1000" fund	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca-Fondo per gli Investimenti della Ricerca di Base (MIUR-FIRB) Human ProteomeNet; Italian MIUR-FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); "5 x 1000" fund	The authors thank Dr. Aurelio Valmori, Dr. Elisabetta Longo, and Dr. Luca Cattini for technical assistance. This work was supported by the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca-Fondo per gli Investimenti della Ricerca di Base (MIUR-FIRB) 2010 Human ProteomeNet; Italian MIUR-FIRB 2010 (RBAP10447J); and the "5 x 1000" fund to the SC Laboratory of Musculoskeletal Cell Biology, Rizzoli Orthopedic Institute. The authors declare no conflicts of interest.	Bahk YY, 1998, BBA-LIPID LIPID MET, V1389, P76, DOI 10.1016/S0005-2760(97)00128-8; Bai XC, 2002, BIOCHEM J, V363, P395, DOI 10.1042/0264-6021:3630395; Bertagnolo V, 2007, CARCINOGENESIS, V28, P1638, DOI 10.1093/carcin/bgm078; Blalock WL, 2011, LEUKEMIA, V25, P236, DOI 10.1038/leu.2010.264; Blalock WL, 2009, J CELL PHYSIOL, V221, P232, DOI 10.1002/jcp.21848; Chetram MA, 2013, MOL CELL BIOCHEM, V376, P63, DOI 10.1007/s11010-012-1549-7; Faenza I, 2003, J CELL PHYSIOL, V195, P446, DOI 10.1002/jcp.10264; Faenza I, 2000, J BIOL CHEM, V275, P30520, DOI 10.1074/jbc.M004630200; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Fiume R, 2009, FASEB J, V23, P957, DOI 10.1096/fj.08-121244; Follo MY, 2012, LEUKEMIA, V26, P2474, DOI 10.1038/leu.2012.133; Follo MY, 2008, LEUKEMIA, V22, P2267, DOI 10.1038/leu.2008.122; Follo Matilde Y., 2013, Advances in Biological Regulation, V53, P2, DOI 10.1016/j.jbior.2012.09.009; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Jones DR, 2013, FASEB J, V27, P1644, DOI 10.1096/fj.12-218842; Keune WJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003223; Kim CG, 1996, J BIOL CHEM, V271, P21187, DOI 10.1074/jbc.271.35.21187; Lee YH, 2000, LIFE SCI, V67, P827, DOI 10.1016/S0024-3205(00)00677-9; Li L, 2011, CANCER CELL, V20, P591, DOI 10.1016/j.ccr.2011.09.011; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Matteucci A, 1998, CANCER RES, V58, P5057; Monturiol-Gross L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086475; O'Carroll SJ, 2009, CELL SIGNAL, V21, P926, DOI 10.1016/j.cellsig.2009.02.002; Piazzi M, 2013, MOL CELL PROTEOMICS, V12, P2220, DOI 10.1074/mcp.M113.029686; Poli A, 2013, CELL CYCLE, V12, P1713, DOI 10.4161/cc.24806; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Rello S, 2005, APOPTOSIS, V10, P201, DOI 10.1007/s10495-005-6075-6; Shiizaki Shigeru, 2013, Advances in Biological Regulation, V53, P135, DOI 10.1016/j.jbior.2012.09.006; Sinha D, 2004, J BIOL CHEM, V279, P10962, DOI 10.1074/jbc.M312048200; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Toyokuni S, 2006, ANTIOXID REDOX SIGN, V8, P1373, DOI 10.1089/ars.2006.8.1373; van Boxtel R, 2013, CELL DEATH DIFFER, V20, P1219, DOI 10.1038/cdd.2013.81; van Gorp AGM, 2006, CANCER RES, V66, P10760, DOI 10.1158/0008-5472.CAN-06-1111; Wang XT, 2001, J BIOL CHEM, V276, P28364, DOI 10.1074/jbc.M102693200; Waris G, 2006, J CARCINOG, V5, P14, DOI [10.1186/1477-3163-5-14, DOI 10.1186/1477-3163-5-14]; Yang JY, 2004, BIOCHEM PHARMACOL, V68, P1027, DOI 10.1016/j.bcp.2004.03.043; Yasuda E, 2008, BIOL PHARM BULL, V31, P719, DOI 10.1248/bpb.31.719; Zhou FL, 2013, J LEUKOCYTE BIOL, V94, P423, DOI 10.1189/jlb.0113006; Zhuang SG, 2007, AM J PHYSIOL-RENAL, V292, pF440, DOI 10.1152/ajprenal.00170.2006	40	7	9	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1383	1394		10.1096/fj.14-259051	http://dx.doi.org/10.1096/fj.14-259051			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25550457				2022-12-26	WOS:000354115000024
J	Ji, HL; Zhao, RZ; Komissarov, AA; Chang, YC; Liu, YF; Matthay, MA				Ji, Hong-Long; Zhao, Runzhen; Komissarov, Andrey A.; Chang, Yongchang; Liu, Yongfeng; Matthay, Michael A.			Proteolytic Regulation of Epithelial Sodium Channels by Urokinase Plasminogen Activator CUTTING EDGE AND CLEAVAGE SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALVEOLAR FLUID CLEARANCE; SINGLE-CHAIN UROKINASE; INDUCED PLEURAL INJURY; FIBRIN TURNOVER; NA+ CHANNELS; LUNG INJURY; ALPHA-MACROGLOBULIN; GAMMA-SUBUNIT; ENAC; EXPRESSION	Plasminogen activator inhibitor 1 (PAI-1) level is extremely elevated in the edematous fluid of acutely injured lungs and pleurae. Elevated PAI-1 specifically inactivates pulmonary urokinase-type (uPA) and tissue-type plasminogen activators (tPA). We hypothesized that plasminogen activation and fibrinolysis may alter epithelial sodium channel (ENaC) activity, a key player in clearing edematous fluid. Two-chain urokinase (tcuPA) has been found to strongly stimulate heterologous human alpha beta gamma ENaC activity in a dose-and time-dependent manner. This activity of tcuPA was completely ablated by PAI-1. Furthermore, a mutation (S195A) of the active site of the enzyme also prevented ENaC activation. By comparison, three truncation mutants of the amino-terminal fragment of tcuPA still activated ENaC. uPA enzymatic activity was positively correlated with ENaC current amplitude prior to reaching the maximal level. In sharp contrast to uPA, neither single-chain tPA nor derivatives, including two-chain tPA and tenecteplase, affected ENaC activity. Furthermore, gamma but not alpha subunit of ENaC was proteolytically cleaved at ((177)GR down arrow KR180) by tcuPA. In summary, the underlying mechanisms of urokinase-mediated activation of ENaC include release of self-inhibition, proteolysis of gamma ENaC, incremental increase in opening rate, and activation of closed (electrically "silent") channels. This study for the first time demonstrates multifaceted mechanisms for uPA-mediated up-regulation of ENaC, which form the cellular and molecular rationale for the beneficial effects of urokinase in mitigating mortal pulmonary edema and pleural effusions.	[Ji, Hong-Long; Zhao, Runzhen; Komissarov, Andrey A.] Univ Texas Hlth Sci Ctr, Dept Cellular & Mol Biol, Tyler, TX 75708 USA; [Ji, Hong-Long] Univ Texas Hlth Sci Ctr, Texas Lung Injury Inst, Tyler, TX 75708 USA; [Chang, Yongchang] St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Liu, Yongfeng] Xinxiang Med Univ, Coll Publ Hlth, Xinxiang 453100, Henan, Peoples R China; [Matthay, Michael A.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA; [Matthay, Michael A.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Anesthesia, San Francisco, CA 94143 USA	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Xinxiang Medical University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ji, HL (corresponding author), 11937 US Hwy 271,604 BMR, Tyler, TX 75708 USA.	james.ji@uthct.edu		Komissarov, Andrey/0000-0003-4346-8888	National Institutes of Health [HL87017, HL095435]; American Heart Association [14GRNT20130034]; University of Texas Health Science Center at Tyler Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL095435, R37HL051856, R01HL087017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Texas Health Science Center at Tyler Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL87017 and HL095435. This work was also supported by American Heart Association Grant 14GRNT20130034 and an institutional fund from the University of Texas Health Science Center at Tyler Research Council.	BERTOZZI P, 1990, NEW ENGL J MED, V322, P890, DOI 10.1056/NEJM199003293221304; Bhattacharya J, 2013, ANNU REV PHYSIOL, V75, P593, DOI 10.1146/annurev-physiol-030212-183756; Bouros D, 1996, EUR RESPIR J, V9, P1656, DOI 10.1183/09031936.96.09081656; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; CHAPMAN HA, 1986, AM REV RESPIR DIS, V133, P437; Chen XJ, 2004, AM J PHYSIOL-LUNG C, V287, pL366, DOI 10.1152/ajplung.00011.2004; Chen ZX, 2014, AM J PHYSIOL-LUNG C, V307, pL609, DOI 10.1152/ajplung.00126.2014; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Coombs GS, 1998, J BIOL CHEM, V273, P4323, DOI 10.1074/jbc.273.8.4323; Crippa MP, 2007, INT J BIOCHEM CELL B, V39, P690, DOI 10.1016/j.biocel.2006.10.008; Dagenais A, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-2; Davis IC, 2007, ADV EXP MED BIOL, V618, P127; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; DING L, 1995, P NATL ACAD SCI USA, V92, P7627, DOI 10.1073/pnas.92.17.7627; Eaton DC, 2009, ANNU REV PHYSIOL, V71, P403, DOI 10.1146/annurev.physiol.010908.163250; Fuller CM, 1996, J BIOL CHEM, V271, P26602, DOI 10.1074/jbc.271.43.26602; Garcia-Caballero A, 2008, J GEN PHYSIOL, V132, P521, DOI 10.1085/jgp.200810030; Glas GJ, 2013, J THROMB HAEMOST, V11, P17, DOI 10.1111/jth.12047; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; GROSS TJ, 1990, AM J RESP CELL MOL, V3, P449, DOI 10.1165/ajrcmb/3.5.449; Gunther A, 2003, AM J RESP CRIT CARE, V168, P1358, DOI 10.1164/rccm.2201082; Haerteis S, 2009, J BIOL CHEM, V284, P29024, DOI 10.1074/jbc.M109.018945; Haerteis S, 2012, J GEN PHYSIOL, V140, P375, DOI 10.1085/jgp.201110763; Hochberg I, 2008, INT J CARDIOL, V130, P125, DOI 10.1016/j.ijcard.2008.03.015; Huang LT, 2012, ACTA PHARMACOL SIN, V33, P991, DOI 10.1038/aps.2012.66; Hummler E, 2010, CELL PHYSIOL BIOCHEM, V25, P63, DOI 10.1159/000272051; IDELL S, 1992, AM J RESP CELL MOL, V7, P414, DOI 10.1165/ajrcmb/7.4.414; IDELL S, 1991, AM J PHYSIOL, V261, pL240, DOI 10.1152/ajplung.1991.261.4.L240; IDELL S, 1989, J CLIN INVEST, V84, P695, DOI 10.1172/JCI114217; IDELL S, 1992, CRIT CARE MED, V20, P1431, DOI 10.1097/00003246-199210000-00012; IDELL S, 1991, AM REV RESPIR DIS, V144, P187, DOI 10.1164/ajrccm/144.1.187; Idell S, 2008, CURR OPIN PULM MED, V14, P310, DOI 10.1097/MCP.0b013e3282fd0d9b; Idell S, 2007, EXP LUNG RES, V33, P419, DOI 10.1080/01902140701703333; Idell S, 2007, AM J PHYSIOL-LUNG C, V292, pL25, DOI 10.1152/ajplung.00118.2006; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Ji HL, 2006, J BIOL CHEM, V281, P8233, DOI 10.1074/jbc.M512293200; Ji HL, 2004, J BIOL CHEM, V279, P26939, DOI 10.1074/jbc.M401143200; Ji HL, 2001, AM J PHYSIOL-CELL PH, V281, pC64, DOI 10.1152/ajpcell.2001.281.1.C64; Ji HL, 1999, J BIOL CHEM, V274, P37693, DOI 10.1074/jbc.274.53.37693; Ji HL, 2012, AM J PHYSIOL-LUNG C, V303, pL1013, DOI 10.1152/ajplung.00206.2012; Ke SH, 1997, J BIOL CHEM, V272, P16603, DOI 10.1074/jbc.272.26.16603; Ke SH, 1997, J BIOL CHEM, V272, P20456, DOI 10.1074/jbc.272.33.20456; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Knight KK, 2008, J BIOL CHEM, V283, P27477, DOI 10.1074/jbc.M804176200; Komissarov AA, 2013, AM J PHYSIOL-LUNG C, V305, pL682, DOI 10.1152/ajplung.00102.2013; Komissarov AA, 2009, AM J PHYSIOL-LUNG C, V297, pL568, DOI 10.1152/ajplung.00066.2009; KOTANI I, 1995, THROMB RES, V77, P493, DOI 10.1016/0049-3848(95)00025-9; Kunzelmann K, 2000, P NATL ACAD SCI USA, V97, P10282, DOI 10.1073/pnas.160041997; Kuramoto E, 2009, AM J PHYSIOL-LUNG C, V296, pL337, DOI 10.1152/ajplung.90434.2008; KVASSMAN JO, 1995, J BIOL CHEM, V270, P27942, DOI 10.1074/jbc.270.46.27942; LEE KS, 1991, RADIOLOGY, V179, P771, DOI 10.1148/radiology.179.3.2027990; MacLaren R, 2002, PHARMACOTHERAPY, V22, P1140, DOI 10.1592/phco.22.13.1140.33519; MADISON EL, 1995, J BIOL CHEM, V270, P7558, DOI 10.1074/jbc.270.13.7558; Maron MB, 2009, AM J PHYSIOL-LUNG C, V297, pL487, DOI 10.1152/ajplung.90629.2008; MARSHALL BC, 1990, J BIOL CHEM, V265, P8198; Matthay MA, 2002, PHYSIOL REV, V82, P569, DOI 10.1152/physrev.00003.2002; Matthay MA, 2014, AM J RESP CRIT CARE, V189, P1301, DOI 10.1164/rccm.201403-0535OE; Miyake H, 1999, PROSTATE, V39, P123, DOI 10.1002/(SICI)1097-0045(19990501)39:2<123::AID-PROS7>3.0.CO;2-2; Molina R, 2011, BBA-BIOMEMBRANES, V1808, P1818, DOI 10.1016/j.bbamem.2011.03.004; Munster AMB, 2000, J AEROSOL MED, V13, P325; Neitzel J.J., 2010, NAT ED, V3, P21; Nishiuma T, 2004, AM J RESP CELL MOL, V31, P552, DOI 10.1165/rcmb.2004-0162OC; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Pechlaner C, 2002, ACTA MED AUST, V29, P80, DOI 10.1046/j.1563-2571.2002.02011.x; Planes C, 2007, CURR TOP DEV BIOL, V78, P23, DOI 10.1016/S0070-2153(06)78002-4; Prabhakaran P, 2003, AM J PHYSIOL-LUNG C, V285, pL20, DOI 10.1152/ajplung.00312.2002; Renckens R, 2008, J THROMB HAEMOST, V6, P660, DOI 10.1111/j.1538-7836.2008.02892.x; Rossier Bernard C, 2004, Proc Am Thorac Soc, V1, P4, DOI 10.1513/pats.2306007; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Sapru A, 2010, INTENS CARE MED, V36, P157, DOI 10.1007/s00134-009-1690-2; Schermuly RT, 2001, AM J PHYSIOL-LUNG C, V280, pL792, DOI 10.1152/ajplung.2001.280.4.L792; Schuliga M, 2013, CURR OPIN PHARMACOL, V13, P386, DOI 10.1016/j.coph.2013.05.014; Sedy J, 2008, PHYSIOL RES, V57, P499, DOI 10.33549/physiolres.931432; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Sherwood TW, 2012, AM J PHYSIOL-CELL PH, V303, pC699, DOI 10.1152/ajpcell.00188.2012; Shetty S, 2008, AM J PHYSIOL-LUNG C, V295, pL967, DOI 10.1152/ajplung.90349.2008; Sisson TH, 2007, CURR DRUG TARGETS, V8, P1016, DOI 10.2174/138945007781662319; Sisson TH, 2002, AM J PHYSIOL-LUNG C, V283, pL1023, DOI 10.1152/ajplung.00049.2002; Stewart RJ, 2000, J BIOL CHEM, V275, P10112, DOI 10.1074/jbc.275.14.10112; STRANGE C, 1995, AM J RESP CRIT CARE, V151, P508, DOI 10.1164/ajrccm.151.2.7842213; Stringer KA, 2004, CLIN EXP PHARMACOL P, V31, P327, DOI 10.1111/j.1440-1681.2004.03999.x; Stringer KA, 1998, FREE RADICAL BIO MED, V25, P184, DOI 10.1016/S0891-5849(98)00047-1; TAKAHASHI K, 1992, AM J RESP CELL MOL, V7, P90, DOI 10.1165/ajrcmb/7.1.90; Verspurten J, 2009, TRENDS BIOCHEM SCI, V34, P319, DOI 10.1016/j.tibs.2009.04.001; VISCARDI RM, 1992, AM REV RESPIR DIS, V146, P492, DOI 10.1164/ajrccm/146.2.492; Ware LB, 2005, NEW ENGL J MED, V353, P2788, DOI 10.1056/NEJMcp052699; Ware LB, 2006, AM J PHYSIOL-LUNG C, V291, pL307, DOI 10.1152/ajplung.00157.2006; Zeslawska E, 2003, J MOL BIOL, V328, P109, DOI 10.1016/S0022-2836(03)00267-5	91	27	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5241	5255		10.1074/jbc.M114.623496	http://dx.doi.org/10.1074/jbc.M114.623496			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25555911	Green Published, hybrid			2022-12-26	WOS:000350044200002
J	Li, L; He, MA; Zhou, L; Miao, XP; Wu, FQ; Huang, SL; Dai, XY; Wang, T; Wu, TC				Li, Lu; He, Meian; Zhou, Li; Miao, Xiaoping; Wu, Fangqing; Huang, Suli; Dai, Xiayun; Wang, Tian; Wu, Tangchun			Solute Carrier Family 22 Member 3 Variant rs3088442 G -> A Associated with Coronary Heart Disease Inhibits Lipopolysaccharide-induced Inflammatory Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; ARTERY-DISEASE; ATHEROSCLEROSIS; RISK; POLYMORPHISM; EXPRESSION; MIGRATION; MICRORNA; ADHESION; SLC22A3	Recent genome-wide association studies have identified single-nucleotide polymorphism (SNPs) within the SLC22A3 (solute carrier family 22 member 3) gene associated with coronary heart disease (CHD) in the Caucasian population. We performed molecular analysis to investigate the potential role of SLC22A3 variants in CHD. Our study showed that the common polymorphism rs3088442 G -> A, which is localized in the 3' UTR of the SLC22A3 gene, was associated with a decreased risk of CHD in the Chinese population by a case control study. In silico analysis indicated that G -> A substitution of SNP rs3088442 created a putative binding site for miR-147 in the SLC22A3 mRNA. By overexpressing miR-147 or inhibiting endogenous miR-147, we demonstrated that SNP rs3088442 G -> A recruited miR-147 to inhibit SLC22A3 expression. Moreover, SLC22A3 deficiency significantly decreased LPS-induced monocytic inflammatory response by interrupting NF-kappa B and MAPK signaling cascades in a histamine-dependent manner. Notably, the expression of SLC22A3(A) was also suppressed by LPS stimulus. Our findings might indicate a negative feedback mechanism against inflammatory response by which SLC22A3 polymorphisms decreased the risk of CHD.	[Li, Lu; He, Meian; Zhou, Li; Miao, Xiaoping; Huang, Suli; Dai, Xiayun; Wang, Tian; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Key Lab Environm & Hlth,Minist Educ, Wuhan 430030, Hubei, Peoples R China; [Li, Lu; He, Meian; Zhou, Li; Miao, Xiaoping; Huang, Suli; Dai, Xiayun; Wang, Tian; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, State Key Lab Environm Hlth Incubating, Minist Environm Protect,Sch Publ Hlth, Wuhan 430030, Hubei, Peoples R China; [Wu, Fangqing] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiol,Inst Cardiovasc Dis, Wuhan 430022, Hubei, Peoples R China; [Huang, Suli] Shenzhen Ctr Dis Control & Prevent, Key Lab Mol Biol Shenzhen, Shenzhen 518055, Guangdong, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Shenzhen Center for Disease Control & Prevention (SZCDC)	Wu, TC (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Key Lab Environm & Hlth,Minist Educ, Wuhan 430030, Hubei, Peoples R China.	wut@mails.tjmu.edu.cn	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722	National Basic Research Program Grant [2011CB503806]; Natural National Scientific Foundation of China [81230069]	National Basic Research Program Grant(National Basic Research Program of China); Natural National Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Basic Research Program Grant 2011CB503806 and Natural National Scientific Foundation of China Grant 81230069.	Brown TP, 2013, THROMB RES, V131, P150, DOI 10.1016/j.thromres.2012.11.034; Chen LG, 2010, PHARMACOGENET GENOM, V20, P687, DOI 10.1097/FPC.0b013e32833fe789; DELNESTE Y, 1994, CLIN EXP IMMUNOL, V98, P344; den Dekker WK, 2010, ATHEROSCLEROSIS, V209, P314, DOI 10.1016/j.atherosclerosis.2009.09.075; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Guo H, 2010, J CLIN ONCOL, V28, P1928, DOI 10.1200/JCO.2009.24.4954; Hoekstra M, 2010, BIOCHEM BIOPH RES CO, V394, P792, DOI 10.1016/j.bbrc.2010.03.075; Ishibashi M, 2004, ARTERIOSCL THROM VAS, V24, pE174, DOI 10.1161/01.ATV.0000143384.69170.2d; Kondo T, 2003, HEART, V89, P931, DOI 10.1136/heart.89.8.931; Lavergne E, 2005, ARTERIOSCL THROM VAS, V25, P847, DOI 10.1161/01.ATV.0000157150.23641.36; Li P, 2013, CARDIOVASC RES, V99, P185, DOI 10.1093/cvr/cvt082; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Martin MM, 2007, J BIOL CHEM, V282, P24262, DOI 10.1074/jbc.M701050200; Nies AT, 2009, HEPATOLOGY, V50, P1227, DOI 10.1002/hep.23103; Qi QB, 2012, EUR HEART J, V33, P325, DOI 10.1093/eurheartj/ehr350; Ramirez CM, 2013, CIRC RES, V112, P1592, DOI 10.1161/CIRCRESAHA.112.300626; Schneider E, 2005, J EXP MED, V202, P387, DOI 10.1084/jem.20050195; Schneider E, 2011, J ALLERGY CLIN IMMUN, V128, P864, DOI 10.1016/j.jaci.2011.04.043; Shaw SY, 2011, CIRC-CARDIOVASC GENE, V4, P296, DOI 10.1161/CIRCGENETICS.110.958470; Su EN, 2005, CURR EYE RES, V30, P205, DOI 10.1080/02713680590927524; Tan X, 2007, J IMMUNOL, V179, P7899, DOI 10.4049/jimmunol.179.11.7899; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Voura EB, 2001, MOL BIOL CELL, V12, P2699, DOI 10.1091/mbc.12.9.2699; Wang J, 2003, J BIOL CHEM, V278, P21751, DOI 10.1074/jbc.M212662200; Wang KY, 2011, ARTERIOSCL THROM VAS, V31, P800, DOI 10.1161/ATVBAHA.110.215228; Wang L, 2013, MOL CELL BIOL, V33, P1956, DOI 10.1128/MCB.01580-12; Wei YY, 2013, ARTERIOSCL THROM VAS, V33, P449, DOI 10.1161/ATVBAHA.112.300279; Wu C, 2013, NUTR METAB CARDIOVAS, V23, P693, DOI 10.1016/j.numecd.2012.02.009; Yan TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030110; Yu L, 2013, ONCOL LETT, V6, P1338, DOI 10.3892/ol.2013.1572	30	28	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5328	5340		10.1074/jbc.M114.584953	http://dx.doi.org/10.1074/jbc.M114.584953			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25561729	Green Published, hybrid			2022-12-26	WOS:000350044200008
J	Song, KK; Awata, J; Tritschler, D; Bower, R; Witmann, GB; Porter, ME; Nicastro, D				Song, Kangkang; Awata, Junya; Tritschler, Douglas; Bower, Raqual; Witmann, George B.; Porter, Mary E.; Nicastro, Daniela			In Situ Localization of N and C Termini of Subunits of the Flagellar Nexin-Dynein Regulatory Complex (N-DRC) Using SNAP Tag and Cryo-electron Tomography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROSCOPE TOMOGRAPHY; RADIAL SPOKES; CHLAMYDOMONAS; PROTEINS; CILIARY; VISUALIZATION; RESISTANCE; LABEL; CELLS	Cryo-electron tomography (cryo-ET) has reached nanoscale resolution for in situ three-dimensional imaging of macromolecular complexes and organelles. Yet its current resolution is not sufficient to precisely localize or identify most proteins in situ; for example, the location and arrangement of components of the nexin-dynein regulatory complex (N-DRC), a key regulator of ciliary/flagellar motility that is conserved from algae to humans, have remained elusive despite many cryo-ET studies of cilia and flagella. Here, we developed an in situ localization method that combines cryo-ET/subtomogram averaging with the clonable SNAP tag, a widely used cell biological probe to visualize fusion proteins by fluorescence microscopy. Using this hybrid approach, we precisely determined the locations of the N and C termini of DRC3 and the C terminus of DRC4 within the three-dimensional structure of the N-DRC in Chlamydomonas flagella. Our data demonstrate that fusion of SNAP with target proteins allowed for protein localization with high efficiency and fidelity using SNAP-linked gold nanoparticles, without disrupting the native assembly, structure, or function of the flagella. After cryo-ET and subtomogram averaging, we localized DRC3 to the L1 projection of the nexin linker, which interacts directly with a dynein motor, whereas DRC4 was observed to stretch along the N-DRC base plate to the nexin linker. Application of the technique developed here to the N-DRC revealed new insights into the organization and regulatory mechanism of this complex, and provides a valuable tool for the structural dissection of macromolecular complexes in situ.	[Song, Kangkang; Nicastro, Daniela] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Awata, Junya; Witmann, George B.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01655 USA; [Tritschler, Douglas; Bower, Raqual; Porter, Mary E.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	Brandeis University; University of Massachusetts System; University of Massachusetts Worcester; University of Minnesota System; University of Minnesota Twin Cities	Nicastro, D (corresponding author), Brandeis Univ, Dept Biol, Rosenstiel Ctr, MS029,415 South St, Waltham, MA 02454 USA.	nicastro@brandeis.edu		Nicastro, Daniela/0000-0002-0122-7173; Witman, George/0000-0002-9497-9218	National Institutes of Health [R01 GM083122, R01 GM055667, R37 GM030626]; Robert W. Booth Endowment at University of Massachusetts Medical School; March of Dimes Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030626, R01GM055667, R01GM083122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert W. Booth Endowment at University of Massachusetts Medical School; March of Dimes Foundation(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM083122 (to D. N.), R01 GM055667 (to M. E. P.), and R37 GM030626 (to G. B. W.). This work was also supported by Robert W. Booth Endowment at University of Massachusetts Medical School (to G. B. W.) and by the March of Dimes Foundation (to D. N.).	Austin-Tse C, 2013, AM J HUM GENET, V93, P672, DOI 10.1016/j.ajhg.2013.08.015; Awata J, 2014, J CELL SCI, V127, P4714, DOI 10.1242/jcs.155275; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Bosch PJ, 2014, BIOPHYS J, V107, P803, DOI 10.1016/j.bpj.2014.06.040; Bower R, 2013, MOL BIOL CELL, V24, P1134, DOI 10.1091/mbc.E12-11-0801; Bui KH, 2012, J CELL BIOL, V198, P913, DOI 10.1083/jcb.201201120; Correa IR, 2014, CURR OPIN CHEM BIOL, V20, P36, DOI 10.1016/j.cbpa.2014.04.007; Diestra E, 2009, J STRUCT BIOL, V165, P157, DOI 10.1016/j.jsb.2008.11.009; Gan L, 2012, Q REV BIOPHYS, V45, P27, DOI 10.1017/S0033583511000102; GARDNER LC, 1994, J CELL BIOL, V127, P1311, DOI 10.1083/jcb.127.5.1311; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Gregori L, 1997, J BIOL CHEM, V272, P58; HARAUZ G, 1986, OPTIK, V73, P146; Heumann JM, 2011, J STRUCT BIOL, V175, P288, DOI 10.1016/j.jsb.2011.05.011; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; Hoenger A, 2007, METHOD CELL BIOL, V79, P437, DOI 10.1016/S0091-679X(06)79017-3; Horani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072299; HUANG B, 1982, CELL, V28, P115, DOI 10.1016/0092-8674(82)90381-6; Iancu CV, 2006, NAT PROTOC, V1, P2813, DOI 10.1038/nprot.2006.432; Iomini C, 2009, METHOD CELL BIOL, V93, P121, DOI 10.1016/S0091-679X(08)93007-7; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lin JF, 2011, J BIOL CHEM, V286, P29175, DOI 10.1074/jbc.M111.241760; Linck R, 2014, J BIOL CHEM, V289, P17427, DOI 10.1074/jbc.M114.568949; Liu TK, 2014, ACS CHEM BIOL, V9, P2359, DOI 10.1021/cb500502n; Ludwig A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001640; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Mercogliano CP, 2007, J STRUCT BIOL, V160, P70, DOI 10.1016/j.jsb.2007.06.010; Mizuno N, 2012, J MOL BIOL, V422, P163, DOI 10.1016/j.jmb.2012.05.040; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Nicastro D, 2009, METHOD CELL BIOL, V91, P1, DOI 10.1016/S0091-679X(08)91001-3; Oda T., 2014, MOL BIOL CELL; Oda T, 2014, SCIENCE, V346, P857, DOI 10.1126/science.1260214; Oda T, 2014, J CELL BIOL, V204, P807, DOI 10.1083/jcb.201312014; Oda T, 2013, J STRUCT BIOL, V183, P305, DOI 10.1016/j.jsb.2013.07.003; Onelli E, 2008, J EXP BOT, V59, P3051, DOI 10.1093/jxb/ern154; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rupp G, 2003, J CELL BIOL, V162, P47, DOI 10.1083/jcb.200303019; SHAH N, 1995, ENDOCRINOLOGY, V136, P2825, DOI 10.1210/en.136.7.2825; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3; Wirschell M, 2013, NAT GENET, V45, P262, DOI 10.1038/ng.2533; WITMAN GB, 1986, METHOD ENZYMOL, V134, P280; Yang C, 2005, MOL BIOL CELL, V16, P637, DOI 10.1091/mbc.E04-09-0787	45	27	28	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5341	5353		10.1074/jbc.M114.626556	http://dx.doi.org/10.1074/jbc.M114.626556			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25564608	hybrid, Green Published			2022-12-26	WOS:000350044200009
J	Turco, E; Gallego, LD; Schneider, M; Kohler, A				Turco, Eleonora; Gallego, Laura D.; Schneider, Maren; Koehler, Alwin			Monoubiquitination of Histone H2B Is Intrinsic to the Bre1 RING Domain-Rad6 Interaction and Augmented by a Second Rad6-binding Site on Bre1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; CRYSTAL-STRUCTURE; H3K4 METHYLATION; LIGASE COMPLEX; DNA-BINDING; E3 LIGASE; NUCLEOSOME; UBIQUITYLATION; FINGER; RAD6	Ubiquitin signaling on chromatin is linked to diverse aspects of genome regulation, including gene expression and DNA repair. The yeast RING E3 ligase Bre1 combines with the E2 Rad6 to monoubiquitinate histone H2B during transcription. Little is known about how Bre1 directs Rad6 toward transferring only a single ubiquitin to a specific lysine residue. Using a defined in vitro system, we show that the Bre1 RING domain interaction with Rad6 is minimally sufficient to monoubiquitinate nucleosomes at histoneH2BLys-123. In addition, we reveal a cluster of charged residues on the Bre1 RING domain that is critical for recognizing the nucleosome surface. Notably, a second Rad6 binding domain of Bre1 interacts with the E2 backside and potentiates ubiquitin transfer to the substrate. Taken together, our study establishes a molecular framework for how distinct RING and non-RING E3 elements cooperate to regulate E2 reactivity and substrate selection during gene expression.	[Turco, Eleonora; Gallego, Laura D.; Schneider, Maren; Koehler, Alwin] Med Univ Vienna, Max F Perutz Labs, Vienna Bioctr VBC, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Kohler, A (corresponding author), Med Univ Vienna, Max F Perutz Labs, Vienna Bioctr VBC, Dr Bohr Gasse 9-3, A-1030 Vienna, Austria.	alwin.koehler@mfpl.ac.at		Gallego, Laura D./0000-0001-8481-8747; Turco, Eleonora/0000-0002-5266-4592	ERC [281354]; NPC GENEXPRESS; START Grant from the Austrian Science Fund [Y557-B11]; Austrian Science Fund (FWF) [Y 557] Funding Source: researchfish	ERC(European Research Council (ERC)European Commission); NPC GENEXPRESS; START Grant from the Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by ERC Grant 281354, NPC GENEXPRESS (to the Kohler laboratory), and START Grant Y557-B11 from the Austrian Science Fund.	Bailly V, 1997, MOL CELL BIOL, V17, P4536, DOI 10.1128/MCB.17.8.4536; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Braun S, 2012, EMBO REP, V13, P619, DOI 10.1038/embor.2012.78; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dou H, 2013, NAT STRUCT MOL BIOL, V20, P982, DOI 10.1038/nsmb.2621; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Hibbert RG, 2011, P NATL ACAD SCI USA, V108, P5590, DOI 10.1073/pnas.1017516108; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Kim J, 2009, J BIOL CHEM, V284, P20582, DOI 10.1074/jbc.M109.017442; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kohler A, 2010, CELL, V141, P606, DOI 10.1016/j.cell.2010.04.026; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mattiroli F, 2014, NAT STRUCT MOL BIOL, V21, P308, DOI 10.1038/nsmb.2792; Mattiroli F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4291; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Notenboom V, 2007, NUCLEIC ACIDS RES, V35, P5819, DOI 10.1093/nar/gkm615; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Pruneda JN, 2011, BIOCHEMISTRY-US, V50, P1624, DOI 10.1021/bi101913m; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Tomson BN, 2013, BBA-GENE REGUL MECH, V1829, P116, DOI 10.1016/j.bbagrm.2012.08.011; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	39	30	32	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5298	5310		10.1074/jbc.M114.626788	http://dx.doi.org/10.1074/jbc.M114.626788			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25548288	hybrid, Green Published			2022-12-26	WOS:000350044200006
J	Lecerf, M; Scheel, T; Pashov, AD; Jarossay, A; Ohayon, D; Planchais, C; Mesnage, S; Berek, C; Kaveri, SV; Lacroix-Desmazes, S; Dimitrov, JD				Lecerf, Maxime; Scheel, Tobias; Pashov, Anastas D.; Jarossay, Annaelle; Ohayon, Delphine; Planchais, Cyril; Mesnage, Stephane; Berek, Claudia; Kaveri, Srinivas V.; Lacroix-Desmazes, Sebastien; Dimitrov, Jordan D.			Prevalence and Gene Characteristics of Antibodies with Cofactor-induced HIV-1 Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMODYNAMIC STABILITY; ENVELOPE GLYCOPROTEIN; BINDING-SITE; V3 LOOP; HEME; AUTOANTIBODIES; AFFINITY; IMMUNOGLOBULINS; ACTIVATION; INHIBITION	The healthy immune repertoire contains a fraction of antibodies that bind to various biologically relevant cofactors, including heme. Interaction of heme with some antibodies results in induction of new antigen binding specificities and acquisition of binding polyreactivity. In vivo, extracellular heme is released as a result of hemolysis or tissue damage; hence the post-translational acquisition of novel antigen specificities might play an important role in the diversification of the immunoglobulin repertoire and host defense. Here, we demonstrate that seronegative immune repertoires contain antibodies that gain reactivity to HIV-1 gp120 upon exposure to heme. Furthermore, a panel of human recombinant antibodies was cloned from different B cell subpopulations, and the prevalence of antibodies with cofactor-induced specificity for gp120 was determined. Our data reveal that upon exposure to heme, similar to 24% of antibodies acquired binding specificity for divergent strains of HIV-1 gp120. Sequence analyses reveal that heme-sensitive antibodies do not differ in their repertoire of variable region genes and in most of the molecular features of their antigen-binding sites from antibodies that do not change their antigen binding specificity. However, antibodies with cofactor-induced gp120 specificity possess significantly lower numbers of somatic mutations in their variable region genes. This study contributes to the understanding of the significance of cofactor-binding antibodies in immunoglobulin repertoires and of the influence that the tissue microenvironment might have in shaping adaptive immune responses.	[Lecerf, Maxime; Jarossay, Annaelle; Ohayon, Delphine; Planchais, Cyril; Kaveri, Srinivas V.; Lacroix-Desmazes, Sebastien; Dimitrov, Jordan D.] Univ Paris 06, Ctr Rech Cordeliers, UMR S 1138, F-75006 Paris, France; [Lecerf, Maxime; Jarossay, Annaelle; Ohayon, Delphine; Planchais, Cyril; Kaveri, Srinivas V.; Lacroix-Desmazes, Sebastien; Dimitrov, Jordan D.] Univ Paris 05, UMR S 1138, F-75006 Paris, France; [Lecerf, Maxime; Jarossay, Annaelle; Ohayon, Delphine; Planchais, Cyril; Kaveri, Srinivas V.; Lacroix-Desmazes, Sebastien; Dimitrov, Jordan D.] INSERM, U1138, F-75006 Paris, France; [Scheel, Tobias; Berek, Claudia] Deutsch Rheuma Forschungszentrum, Inst Leibniz Gemeinschaft, D-10117 Berlin, Germany; [Pashov, Anastas D.] Bulgarian Acad Sci, Inst Microbiol, BU-1113 Sofia, Bulgaria; [Mesnage, Stephane] Univ Sheffield, Krebs Inst, Sheffield S10 2TN, S Yorkshire, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Deutsches Rheuma-Forschungszentrum (DRFZ); Bulgarian Academy of Sciences; Medical University Sofia; University of Sheffield	Dimitrov, JD (corresponding author), Ctr Rech Cordeliers, INSERM, UMR 1138, Equipe 16, F-75006 Paris, France.	jordan.dimitrov@crc.jussieu.fr	Pashov, Anastas/AAE-7997-2019; MESNAGE, Stephane/H-7156-2019; Dimitrov, Jordan/N-2141-2014	Lecerf, Maxime/0000-0002-1477-2162; MESNAGE, Stephane/0000-0003-1648-4890; Lacroix-Desmazes, Sebastien/0000-0001-5625-8447; Pashov, Anastas/0000-0002-6033-3566; Kaveri, Srini/0000-0002-0837-4053; Dimitrov, Jordan/0000-0001-8536-8995	INSERM; CNRS; UPMC-Paris 6; Centre de Recherche des Cordeliers (Prix Jeunes Chercheurs); Agence Nationale de la Recherche [ANR-13-JCV1-006-01]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); UPMC-Paris 6; Centre de Recherche des Cordeliers (Prix Jeunes Chercheurs); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants from INSERM, CNRS, and UPMC-Paris 6 and by grants from the Centre de Recherche des Cordeliers (Prix Jeunes Chercheurs 2008) and Agence Nationale de la Recherche (Grant ANR-13-JCV1-006-01).	Argyris EG, 1999, J BIOL CHEM, V274, P1549, DOI 10.1074/jbc.274.3.1549; BAKER H, 1967, NATURE, V215, P84, DOI 10.1038/215084a0; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; Brancaleon L, 2002, BIOPHYS CHEM, V96, P77, DOI 10.1016/S0301-4622(02)00035-2; Dairou J, 2004, ANTIVIR RES, V61, P37, DOI 10.1016/S0166-3542(03)00176-1; DEBNATH AK, 1994, J MED CHEM, V37, P1099, DOI 10.1021/jm00034a007; Devadas K, 2006, J IMMUNOL, V176, P4252, DOI 10.4049/jimmunol.176.7.4252; Dimitrov JD, 2006, J BIOL CHEM, V281, P439, DOI 10.1074/jbc.M509190200; Dimitrov JD, 2007, J BIOL CHEM, V282, P26696, DOI 10.1074/jbc.M702751200; Dimitrov JD, 2014, J BIOL CHEM, V289, P17767, DOI 10.1074/jbc.M114.556266; Dimitrov JD, 2014, TRENDS BIOCHEM SCI, V39, P221, DOI 10.1016/j.tibs.2014.02.010; Dimitrov JD, 2009, NAT BIOTECHNOL, V27, P892, DOI 10.1038/nbt1009-892a; Ditzel HJ, 1996, J IMMUNOL, V157, P739; FARAH FS, 1973, IMMUNOLOGY, V25, P217; Frimat M, 2013, BLOOD, V122, P282, DOI 10.1182/blood-2013-03-489245; Gladwin MT, 2012, J CLIN INVEST, V122, P1205, DOI 10.1172/JCI62972; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; James LC, 2005, P NATL ACAD SCI USA, V102, P12730, DOI 10.1073/pnas.0500909102; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Jimenez R, 2004, P NATL ACAD SCI USA, V101, P3803, DOI 10.1073/pnas.0305745101; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; KARJALAINEN K, 1976, EUR J IMMUNOL, V6, P88, DOI 10.1002/eji.1830060204; Krol M, 2006, J BIOMOL STRUCT DYN, V23, P407, DOI 10.1080/07391102.2006.10531235; Kuhl T, 2014, CHEMBIOCHEM, V15, P2024, DOI 10.1002/cbic.201402218; Kuhl T, 2011, CHEMBIOCHEM, V12, P2846, DOI 10.1002/cbic.201100556; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; LEVERE RD, 1991, P NATL ACAD SCI USA, V88, P1756, DOI 10.1073/pnas.88.5.1756; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Manivel V, 2000, IMMUNITY, V13, P611, DOI 10.1016/S1074-7613(00)00061-3; McEnaney PJ, 2012, ACS CHEM BIOL, V7, P1139, DOI 10.1021/cb300119g; McIntyre JA, 2004, THROMB RES, V114, P579, DOI 10.1016/j.thromres.2004.08.008; McIntyre JA, 2005, J AUTOIMMUN, V24, P311, DOI 10.1016/j.jaut.2005.03.005; McIntyre JA, 2010, INT J CANCER, V127, P491, DOI 10.1002/ijc.25038; McIntyre JA, 2009, CLIN REV ALLERG IMMU, V37, P49, DOI 10.1007/s12016-008-8093-y; Mouquet H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024078; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Munro Andrew W., 2009, P160, DOI 10.1007/978-0-387-78518-9_10; Murelli RP, 2009, J AM CHEM SOC, V131, P17090, DOI 10.1021/ja906844e; Neurath AR, 1995, J MOL RECOGNIT, V8, P345, DOI 10.1002/jmr.300080604; Nguyen HP, 2003, NAT STRUCT BIOL, V10, P1019, DOI 10.1038/nsb1014; Nouraie M, 2012, SEX TRANSM INFECT, V88, P528, DOI 10.1136/sextrans-2011-050459; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Parker CG, 2009, J AM CHEM SOC, V131, P16392, DOI 10.1021/ja9057647; Pavlovic S, 2011, CLIN IMMUNOL, V138, P162, DOI 10.1016/j.clim.2010.10.010; Planchais C, 2013, M S-MED SCI, V29, P937, DOI 10.1051/medsci/20132911002; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Rajagopalan K, 1996, P NATL ACAD SCI USA, V93, P6019, DOI 10.1073/pnas.93.12.6019; Roumenina LT, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206136; Sahoo N, 2013, P NATL ACAD SCI USA, V110, pE4036, DOI 10.1073/pnas.1313247110; Scheel T., 2009, THESIS HUMBOLDT U BE; Scheel T, 2011, ARTHRITIS RHEUM-US, V63, P63, DOI 10.1002/art.27767; Smith Ann, 2009, P184, DOI 10.1007/978-0-387-78518-9_11; Smith LJ, 2010, PROTEINS, V78, P2349, DOI 10.1002/prot.22747; Staudinger R, 1996, P ASSOC AM PHYSICIAN, V108, P47; Stopa B, 1997, BIOCHIMIE, V79, P23, DOI 10.1016/S0300-9084(97)87621-3; Sun SB, 2013, J AM CHEM SOC, V135, P9980, DOI 10.1021/ja402927u; Tang XD, 2003, NATURE, V425, P531, DOI 10.1038/nature02003; TERNYNCK T, 1986, IMMUNOL REV, V94, P99; Vzorov AN, 2002, ANTIMICROB AGENTS CH, V46, P3917, DOI 10.1128/AAC.46.12.3917-3925.2002; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Wang F, 2013, P NATL ACAD SCI USA, V110, P4261, DOI 10.1073/pnas.1301810110; WATSON CD, 1988, BIOCHEM INT, V16, P1067; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Xu Y, 2007, P NATL ACAD SCI USA, V104, P3681, DOI 10.1073/pnas.0611094104; Yin J, 2003, J MOL BIOL, V330, P651, DOI 10.1016/S0022-2836(03)00631-4; Zhang AX, 2010, J AM CHEM SOC, V132, P12711, DOI 10.1021/ja104591m; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x; Zhou TQ, 2005, P NATL ACAD SCI USA, V102, P14575, DOI 10.1073/pnas.0507267102; Zhu XY, 2006, P NATL ACAD SCI USA, V103, P3581, DOI 10.1073/pnas.0600251103; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11	72	21	22	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5203	5213		10.1074/jbc.M114.618124	http://dx.doi.org/10.1074/jbc.M114.618124			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25564611	Green Published, hybrid			2022-12-26	WOS:000350042000058
J	Nakayama, M; Inoue, T; Naito, M; Nakayama, K; Ohara, N				Nakayama, Masaaki; Inoue, Tetsuyoshi; Naito, Mariko; Nakayama, Koji; Ohara, Naoya			Attenuation of the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway by Porphyromonas gingivalis Gingipains RgpA, RgpB, and Kgp	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE B/AKT; EPITHELIAL-CELLS; PERIODONTAL PATHOGEN; MEDIATED INTERNALIZATION; MEMBRANE VESICLES; MAMMALIAN TARGET; IMMUNE-RESPONSES; PLASMA-MEMBRANE; POTENTIAL ROLE; LIPID RAFTS	Porphyromonas gingivalis is a major pathogen of periodontal diseases, including periodontitis. We have investigated the effect of P. gingivalis infection on the PI3K/Akt (protein kinase B) signaling pathway in gingival epithelial cells. Here, we found that live P. gingivalis, but not heat-killed P. gingivalis, reduced Akt phosphorylation at both Thr-308 and Ser-473, which implies a decrease in Akt activity. Actually, PI3K, which is upstream of Akt, was also inactivated by P. gingivalis. Furthermore, glycogen synthase kinase 3 alpha/beta, mammalian target of rapamycin, and Bad, which are downstream proteins in the PI3K/Akt cascade, were also dephosphorylated, a phenomenon consistent with Akt inactivation by P. gingivalis. However, these events did not require direct interaction between bacteria and host cells and were independent of P. gingivalis invasion into the cells. The use of gingipain-specific inhibitors and a gingipain-deficient P. gingivalis mutant KDP136 revealed that the gingipains and their protease activities were essential for the inactivation of PI3K and Akt. The associations between the PI3K regulatory subunit p85 alpha and membrane proteins were disrupted by wild-type P. gingivalis. Moreover, PDK1 translocation to the plasma membrane was reduced by wild-type P. gingivalis, but not KDP136, indicating little production of phosphatidylinositol 3,4,5-triphosphate by PI3K. Therefore, it is likely that PI3K failed to transmit homeostatic extracellular stimuli to intracellular signaling pathways by gingipains. Taken together, our findings indicate that P. gingivalis attenuates the PI3K/Akt signaling pathway via the proteolytic effects of gingipains, resulting in the dysregulation of PI3K/Akt-dependent cellular functions and the destruction of epithelial barriers.	[Nakayama, Masaaki; Inoue, Tetsuyoshi; Ohara, Naoya] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Microbiol, Okayama 7008558, Japan; [Nakayama, Masaaki; Inoue, Tetsuyoshi; Ohara, Naoya] Okayama Univ, Sch Dent, Adv Res Ctr Oral & Craniofacial Sci, Okayama 7008558, Japan; [Naito, Mariko; Nakayama, Koji] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Div Microbiol & Oral Infect, Nagasaki 8528588, Japan	Okayama University; Okayama University; Nagasaki University	Ohara, N (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Microbiol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	oharan@md.okayama-u.ac.jp	OHARA, Naoya/B-2481-2011	NAITO, Mariko/0000-0003-0769-7747	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ryobi Teien Memory Foundation; Takeda Science Foundation; Institute for Fermentation, Osaka	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ryobi Teien Memory Foundation(Ryobi Teien Memory Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Institute for Fermentation, Osaka(Institute for Fermentation (IFO))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by the Ryobi Teien Memory Foundation, by the Takeda Science Foundation, and by the Institute for Fermentation, Osaka.	Agarwal V, 2009, J BIOL CHEM, V284, P19427, DOI 10.1074/jbc.M109.003442; Allen LAH, 2005, J LEUKOCYTE BIOL, V78, P220, DOI 10.1189/jlb.0205091; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Bainbridge B, 2010, INFECT IMMUN, V78, P4560, DOI 10.1128/IAI.00703-10; Bansal M, 2013, J Med Life, V6, P244; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; Blair P, 2009, CIRC RES, V104, P346, DOI 10.1161/CIRCRESAHA.108.185785; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Chang LC, 2013, CELL MICROBIOL, V15, P1722, DOI 10.1111/cmi.12146; Cho TJ, 2014, ARCH ORAL BIOL, V59, P370, DOI 10.1016/j.archoralbio.2014.01.001; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Forsberg M, 2003, J LEUKOCYTE BIOL, V74, P620, DOI 10.1189/jlb.1202586; Frazer LT, 2006, VACCINE, V24, P6542, DOI 10.1016/j.vaccine.2006.06.013; Fujita Y, 2014, INFECT IMMUN, V82, P202, DOI 10.1128/IAI.01140-12; Furuta N, 2009, INFECT IMMUN, V77, P4761, DOI 10.1128/IAI.00841-09; Furuta N, 2009, INFECT IMMUN, V77, P4187, DOI 10.1128/IAI.00009-09; Gutierrez-Venegas G, 2013, MOL BIOL REP, V40, P477, DOI 10.1007/s11033-012-2083-0; Hajishengallis G, 2009, J IMMUNOL, V182, P6690, DOI 10.4049/jimmunol.0900524; Iacopino AM, 2000, J PERIODONTOL, V71, P1375, DOI 10.1902/jop.2000.71.8.1375; Inaba H, 2012, INFECT IMMUN, V80, P2847, DOI 10.1128/IAI.00258-12; Ishikawa M, 2013, BBA-MOL BASIS DIS, V1832, P2035, DOI 10.1016/j.bbadis.2013.07.012; Kadowaki T, 2007, FRONT BIOSCI-LANDMRK, V12, P4800, DOI 10.2741/2428; Kinane JA, 2012, CELL MICROBIOL, V14, P1085, DOI 10.1111/j.1462-5822.2012.01780.x; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee CH, 2014, GENE THER, V21, P309, DOI 10.1038/gt.2013.86; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Maira SM, 2001, SCIENCE, V294, P374, DOI 10.1126/science.1062030; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; McManus EJ, 2004, EMBO J, V23, P2071, DOI 10.1038/sj.emboj.7600218; Moffatt CE, 2012, CELL MICROBIOL, V14, P577, DOI 10.1111/j.1462-5822.2011.01743.x; Naito M, 2006, MOL MICROBIOL, V59, P152, DOI 10.1111/j.1365-2958.2005.04942.x; Nakao R, 2014, MICROBES INFECT, V16, P6, DOI 10.1016/j.micinf.2013.10.005; NAKAYAMA K, 1995, J BIOL CHEM, V270, P23619, DOI 10.1074/jbc.270.40.23619; Nakayama M, 2009, J BIOL CHEM, V284, P1612, DOI 10.1074/jbc.M806981200; Park CH, 2008, BRAIN RES, V1234, P148, DOI 10.1016/j.brainres.2008.07.082; Park SY, 2011, INT IMMUNOPHARMACOL, V11, P1907, DOI 10.1016/j.intimp.2011.07.023; Park YD, 2012, CYTOKINE, V60, P284, DOI 10.1016/j.cyto.2012.05.021; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Pendaries C, 2006, EMBO J, V25, P1024, DOI 10.1038/sj.emboj.7601001; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Quy PN, 2013, J BIOL CHEM, V288, P1125, DOI 10.1074/jbc.M112.399949; Saito A, 2012, MICROB PATHOGENESIS, V53, P234, DOI 10.1016/j.micpath.2012.08.005; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sauvonnet N, 2002, MOL MICROBIOL, V45, P805, DOI 10.1046/j.1365-2958.2002.03053.x; Shi Y, 1999, J BIOL CHEM, V274, P17955, DOI 10.1074/jbc.274.25.17955; Slomiany BL, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/807279; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Stafford P, 2013, MOL ORAL MICROBIOL, V28, P366, DOI 10.1111/omi.12030; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Takii R, 2005, INFECT IMMUN, V73, P883, DOI 10.1128/IAI.73.2.883-893.2005; Tsuda K, 2008, CELL STRUCT FUNCT, V33, P123, DOI 10.1247/csf.08012; Urnowey S, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-26; Wang JH, 2013, J MICROBIOL, V51, P644, DOI 10.1007/s12275-013-3040-x; Wiles TJ, 2008, MOL BIOL CELL, V19, P1427, DOI 10.1091/mbc.E07-07-0638; Yang WL, 2010, CELL CYCLE, V9, P486, DOI 10.4161/cc.9.3.10508; Yao L, 2010, MOL ORAL MICROBIOL, V25, P89, DOI 10.1111/j.2041-1014.2010.00569.x; Yilmaz O, 2004, INFECT IMMUN, V72, P3743, DOI 10.1128/IAI.72.7.3743-3751.2004; Zhou QD, 2009, P NATL ACAD SCI USA, V106, P10740, DOI 10.1073/pnas.0904412106	62	41	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5190	5202		10.1074/jbc.M114.591610	http://dx.doi.org/10.1074/jbc.M114.591610			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25564612	hybrid, Green Published			2022-12-26	WOS:000350042000057
J	Dennis, MD; Kimball, SR; Fort, PE; Jefferson, LS				Dennis, Michael D.; Kimball, Scot R.; Fort, Patrice E.; Jefferson, Leonard S.			Regulated in Development and DNA Damage 1 Is Necessary for Hyperglycemia-induced Vascular Endothelial Growth Factor Expression in the Retina of Diabetic Rodents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAP-INDEPENDENT TRANSLATION; PROTEIN-SYNTHESIS; MULLER CELLS; HIGH GLUCOSE; VEGF EXPRESSION; SKELETAL-MUSCLE; GENE-EXPRESSION; RETINOPATHY; INITIATION; HYPOXIA	Vascular endothelial growth factor (VEGF) is considered a major role player in the pathogenesis of diabetic retinopathy, yet the mechanisms regulating its expression are not fully understood. Our laboratory previously demonstrated that diabetes-induced VEGF expression in the retina was dependent on the repressor of mRNA translation 4E-BP1. Interaction of 4E-BP1 with the cap-binding protein eIF4E regulates protein expression by controlling the selection of mRNAs for translation. The process is regulated by the master kinase mTOR in complex 1 (mTORC1), which phosphorylates 4E-BP1, thus promoting its disassociation from eIF4E. In the present study, we investigated the role of the Akt/mTORC1 repressor REDD1 (regulated in development and DNA damage) in diabetes-induced VEGF expression. REDD1 expression was induced by hyperglycemia in the retina of diabetic rodents and by hyperglycemic conditions in Muller cells concomitant with increased VEGF expression. In Muller cells, hyperglycemic conditions attenuated global rates of protein synthesis and cap-dependent mRNA translation concomitant with up-regulated cap-independent VEGF mRNA translation, as assessed by a bicistronic luciferase reporter assay. Hyperglycemic conditions also attenuated mTORC1 signaling and enhanced 4E-BP1 binding to eIF4E. Furthermore, ectopic expression of REDD1 in Muller cells was sufficient to promote both increased 4E-BP1 binding to eIF4E and VEGF expression. Whereas the retina of wild-type mice exhibited increased expression of VEGF and tumor necrosis factor alpha (TNF-alpha) 4 weeks after streptozotocin administration, the retina of REDD1 knock-out mice failed to do so. Overall, the results demonstrate that REDD1 contributes to the pathogenesis of diabetes in the retina by mediating the pathogenic effects of hyperglycemia.	[Dennis, Michael D.; Kimball, Scot R.; Jefferson, Leonard S.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Fort, Patrice E.] Univ Michigan, Dept Ophthalmol & Visual Sci, Kellogg Eye Ctr, Ann Arbor, MI 48105 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Michigan System; University of Michigan	Dennis, MD (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, H166,500 Univ Dr, Hershey, PA 17033 USA.	mdennis@psu.edu		Fort, Patrice/0000-0003-3956-1908; Dennis, Michael/0000-0002-0645-6864	American Diabetes Association Pathway to Stop Diabetes Grant [1-14-INI-04]; National Institutes of Health [EY023612, DK15658, DK13499, EY020895]; NATIONAL EYE INSTITUTE [R01EY020895, R00EY023612, K99EY023612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013499, R01DK015658, P30DK020572, R37DK013499] Funding Source: NIH RePORTER	American Diabetes Association Pathway to Stop Diabetes Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the American Diabetes Association Pathway to Stop Diabetes Grant 1-14-INI-04 (to M. D. D.), and National Institutes of Health Grants EY023612 (to M. D. D.), DK15658 and DK13499 (to L. S. J.), and EY020895 (to P. E. F.).	Aas V, 2011, BBA-MOL BASIS DIS, V1812, P94, DOI 10.1016/j.bbadis.2010.09.014; Aghdam SY, 2013, BIOCHEM BIOPH RES CO, V432, P339, DOI 10.1016/j.bbrc.2013.01.101; Amin RH, 1997, INVEST OPHTH VIS SCI, V38, P36; Bastide A, 2008, NUCLEIC ACIDS RES, V36, P2434, DOI 10.1093/nar/gkn093; Bornes S, 2007, CIRC RES, V100, P305, DOI 10.1161/01.RES.0000258873.08041.c9; Brafman A, 2004, INVEST OPHTH VIS SCI, V45, P3796, DOI 10.1167/iovs.04-0052; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; D'Amore PA, 2007, AM J PATHOL, V171, P14, DOI 10.2353/ajpath.2007.070385; Dennis MD, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005103; Dennis MD, 2013, DIABETES, V62, P2204, DOI 10.2337/db12-1453; Dennis MD, 2012, J BIOL CHEM, V287, P42890, DOI 10.1074/jbc.M112.404822; Dennis MD, 2011, J BIOL CHEM, V286, P34286, DOI 10.1074/jbc.M111.259457; Donovan K, 2014, INVEST OPHTH VIS SCI, V55, P7862, DOI 10.1167/iovs.14-14048; Fort PE, 2014, DIABETES, V63, P3077, DOI 10.2337/db14-0235; Fort PE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026498; Gologorsky D, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/629452; Gordon BS, 2014, AM J PHYSIOL-ENDOC M, V307, pE703, DOI 10.1152/ajpendo.00250.2014; Hu JY, 2013, EXP EYE RES, V109, P31, DOI 10.1016/j.exer.2013.01.011; Huez I, 1998, MOL CELL BIOL, V18, P6178, DOI 10.1128/MCB.18.11.6178; Kim MY, 2012, EXP DIABETES RES, DOI 10.1155/2012/716425; Kimball SR, 1997, AM J PHYSIOL-CELL PH, V272, pC754, DOI 10.1152/ajpcell.1997.272.2.C754; Kimball SR, 1998, J BIOL CHEM, V273, P30945, DOI 10.1074/jbc.273.47.30945; Koritzinsky M, 2005, RADIOTHER ONCOL, V76, P177, DOI 10.1016/j.radonc.2005.06.036; LEVY AP, 1995, J BIOL CHEM, V270, P13333, DOI 10.1074/jbc.270.22.13333; Li J, 2012, ACTA PHARMACOL SIN, V33, P1030, DOI 10.1038/aps.2012.61; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; McGhee NK, 2009, J NUTR, V139, P828, DOI 10.3945/jn.108.099846; MILLER JW, 1994, AM J PATHOL, V145, P574; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Morris MJ, 2010, J AM CHEM SOC, V132, P17831, DOI 10.1021/ja106287x; Okamoto N, 1997, AM J PATHOL, V151, P281; Reiter CEN, 2006, DIABETES, V55, P1148, DOI 10.2337/diabetes.55.04.06.db05-0744; Rittenhouse KD, 2014, INVEST OPHTH VIS SCI, V55, P1232, DOI 10.1167/iovs.13-13449; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Salam A, 2011, ACTA OPHTHALMOL, V89, P405, DOI 10.1111/j.1755-3768.2010.02079.x; Schoenberger SD, 2012, INVEST OPHTH VIS SCI, V53, P5906, DOI 10.1167/iovs.12-10410; Schrufer TL, 2010, DIABETES, V59, P2107, DOI 10.2337/db10-0148; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Shelton MD, 2009, J BIOL CHEM, V284, P4759, DOI 10.1074/jbc.M805464200; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Svitkin YV, 2005, MOL CELL BIOL, V25, P10556, DOI 10.1128/MCB.25.23.10556-10565.2005; Thoreen CC, 2013, BIOCHEM SOC T, V41, P913, DOI 10.1042/BST20130082; Tolentino MJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P964, DOI 10.1001/archopht.1996.01100140172010; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Zhong YM, 2012, DIABETES, V61, P492, DOI 10.2337/db11-0315; Zhou JZ, 2012, CURR EYE RES, V37, P416, DOI 10.3109/02713683.2012.661114	51	32	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3865	3874		10.1074/jbc.M114.623058	http://dx.doi.org/10.1074/jbc.M114.623058			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25548280	Green Published, hybrid			2022-12-26	WOS:000349456000056
J	Peng, SW; Wang, JW; Karanam, B; Wang, CG; Huh, WK; Alvarez, RD; Pai, SI; Hung, CF; Wu, TC; Roden, RBS				Peng, Shiwen; Wang, Joshua W.; Karanam, Balasubramanyam; Wang, Chenguang; Huh, Warner K.; Alvarez, Ronald D.; Pai, Sara I.; Hung, Chien-fu; Wu, T. -C.; Roden, Richard B. S.			Sequential Cisplatin Therapy and Vaccination with HPV16 E6E7L2 Fusion Protein in Saponin Adjuvant GPI-0100 for the Treatment of a Model HPV16+Cancer	PLOS ONE			English	Article							VULVAL INTRAEPITHELIAL NEOPLASIA; PHASE-II TRIAL; HUMAN-PAPILLOMAVIRUS VACCINES; VIRUS-LIKE PARTICLE; DNA VACCINATION; CERVICAL-CANCER; TA-CIN; MUCOSAL VACCINATION; ANTITUMOR IMMUNITY; HEALTHY-VOLUNTEERS	Clinical studies suggest that responses to HPV16 E6E7L2 fusion protein (TA-CIN) vaccination alone are modest, and GPI-0100 is a well-tolerated, potent adjuvant. Here we sought to optimize both the immunogenicity of TA-CIN via formulation with GPI-0100 and treatment of HPV16+ cancer by vaccination after cisplatin chemotherapy. HPV16 neutralizing serum antibody titers, CD4+ T cell proliferative and E6/E7-specific CD8+ T cell responses were significantly enhanced when mice were vaccinated subcutaneously (s.c.) or intramuscularly (i.m.) with TA-CIN formulated with GPI-0100. Vaccination was tested for therapy of mice bearing syngeneic HPV16 E6/E7+ tumors (TC-1) either in the lung or subcutaneously. Mice treated with TA-CIN/GPI-0100 vaccination exhibited robust E7-specific CD8+ T cell responses, which were associated with reduced tumor burden in the lung, whereas mice receiving either component alone were similar to controls. Since vaccination alone was not sufficient for cure, mice bearing s.c. TC-1 tumor were first treated with two doses of cisplatin and then vaccinated. Vaccination with TA-CIN/GPI-0100 i.m. substantially retarded tumor growth and extended survival after cisplatin therapy. Injection of TA-CIN alone, but not GPI-0100, into the tumor (i.t.) was similarly efficacious after cisplatin therapy, but the mice eventually succumbed. However, tumor regression and extended remission was observed in 80% of the mice treated with cisplatin and then intra-tumoral TA-CIN/GPI-0100 vaccination. These mice also exhibited robust E7-specific CD8+ T cell and HPV16 neutralizing antibody responses. Thus formulation of TA-CIN with GPI-0100 and intra-tumoral delivery after cisplatin treatment elicits potent therapeutic responses in a murine model of HPV16+ cancer.	[Peng, Shiwen; Wang, Joshua W.; Karanam, Balasubramanyam; Hung, Chien-fu; Wu, T. -C.; Roden, Richard B. S.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21205 USA; [Wang, Chenguang] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Hung, Chien-fu; Wu, T. -C.; Roden, Richard B. S.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21205 USA; [Wu, T. -C.; Roden, Richard B. S.] Johns Hopkins Univ, Dept Gynecol & Obstet, Baltimore, MD 21205 USA; [Huh, Warner K.; Alvarez, Ronald D.] Univ Alabama Birmingham, Div Gynecol Oncol, Birmingham, AL USA; [Karanam, Balasubramanyam] Tuskegee Univ, Carver Res Fdn, Dept Biol, Tuskegee, AL 36088 USA; [Karanam, Balasubramanyam] Tuskegee Univ, Carver Res Fdn, Ctr Canc Res, Tuskegee, AL 36088 USA; [Pai, Sara I.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Alabama System; University of Alabama Birmingham; Tuskegee University; Tuskegee University; Harvard University; Massachusetts General Hospital	Roden, RBS (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21205 USA.	roden@jhmi.edu		Pai, Sara/0000-0002-6341-9971	V foundation; Public Health Service [P50 CA098252, RO1 CA133749, CA118790]; NATIONAL CANCER INSTITUTE [P50CA098252, R01CA133749, R01CA118790] Funding Source: NIH RePORTER	V foundation; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded by grants from the V foundation (www.jimmyv.org) to SP and RBSR, and Public Health Service (grants.nih.gov) grants P50 CA098252 to TCW, RO1 CA133749 to WKH, and CA118790 to RBSR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato RJ, 2013, J IMMUNOTHER, V36, P268, DOI 10.1097/CJI.0b013e3182917f59; Armarnik S, 2011, ARCH GYNECOL OBSTET, V283, P765, DOI 10.1007/s00404-011-1848-3; Bae SH, 2007, CLIN CANCER RES, V13, P341, DOI 10.1158/1078-0432.CCR-06-1838; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Cha HR, 2011, J IMMUNOL, V187, P3044, DOI 10.4049/jimmunol.1100402; Cuburu N, 2012, J CLIN INVEST, V122, P4606, DOI 10.1172/JCI63287; Cuburu N, 2011, EXPERT REV VACCINES, V10, P1245, DOI [10.1586/ERV.11.104, 10.1586/erv.11.104]; Daayana S, 2010, BRIT J CANCER, V102, P1129, DOI 10.1038/sj.bjc.6605611; Daling JR, 2004, CANCER-AM CANCER SOC, V101, P270, DOI 10.1002/cncr.20365; Davidson EJ, 2004, VACCINE, V22, P2722, DOI 10.1016/j.vaccine.2004.01.049; de Jong A, 2002, VACCINE, V20, P3456, DOI 10.1016/S0264-410X(02)00350-X; Domingos-Pereira S, 2013, J UROLOGY; Fiander AN, 2006, INT J GYNECOL CANCER, V16, P1075, DOI 10.1111/j.1525-1438.2006.00598.x; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Gambhira R, 2006, CANCER RES, V66, P11120, DOI 10.1158/0008-5472.CAN-06-2560; Gordon SN, 2012, J IMMUNOL, V188, P714, DOI 10.4049/jimmunol.1101404; Han RC, 1999, J VIROL, V73, P7039, DOI 10.1128/JVI.73.8.7039-7043.1999; Hildesheim A, 2007, JAMA-J AM MED ASSOC, V298, P743, DOI 10.1001/jama.298.7.743; Hitzeroth II, 2009, VACCINE, V27, P6432, DOI 10.1016/j.vaccine.2009.06.015; Jagu S, 2013, J VIROL, V87, P6127, DOI 10.1128/JVI.03218-12; JARRETT WFH, 1991, VIROLOGY, V184, P33, DOI 10.1016/0042-6822(91)90819-W; Ji HX, 1998, INT J CANCER, V78, P41, DOI 10.1002/(SICI)1097-0215(19980925)78:1<41::AID-IJC8>3.0.CO;2-X; Kang TH, 2013, CANCER RES, V73, P2493, DOI 10.1158/0008-5472.CAN-12-4241; Karanam B, 2009, VACCINE, V27, P1040, DOI 10.1016/j.vaccine.2008.11.099; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kwak K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097232; Leder C, 2001, J VIROL, V75, P9201, DOI 10.1128/JVI.75.19.9201-9209.2001; Lee SY, 2013, CANCER IMMUNOL IMMUN, V62, P1175, DOI 10.1007/s00262-013-1421-y; Lin KY, 1996, CANCER RES, V56, P21; Lin Z, 2009, AM J PATHOL, V174, P136, DOI 10.2353/ajpath.2009.080588; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Marciani DJ, 2000, VACCINE, V18, P3141, DOI 10.1016/S0264-410X(00)00118-3; Marciani DJ, 2003, VACCINE, V21, P3961, DOI 10.1016/S0264-410X(03)00298-6; Markman M, 2013, ONCOLOGY-BASEL, V84, P246, DOI 10.1159/000346804; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; Quenelle DC, 2006, VACCINE, V24, P1515, DOI 10.1016/j.vaccine.2005.10.017; Roden R, 2006, NAT REV CANCER, V6, P753, DOI 10.1038/nrc1973; Schiller JT, 2012, NAT REV MICROBIOL, V10, P681, DOI 10.1038/nrmicro2872; Slovin SF, 2005, VACCINE, V23, P3114, DOI 10.1016/j.vaccine.2005.01.072; Smith JS, 2009, OBSTET GYNECOL, V113, P917, DOI 10.1097/AOG.0b013e31819bd6e0; Smyth LJC, 2004, CLIN CANCER RES, V10, P2954, DOI 10.1158/1078-0432.CCR-03-0703; Stevceva L, 2004, CURR HIV RES, V2, P1, DOI 10.2174/1570162043485004; TINDLE RW, 1991, P NATL ACAD SCI USA, V88, P5887, DOI 10.1073/pnas.88.13.5887; Tseng CW, 2008, CLIN CANCER RES, V14, P3185, DOI 10.1158/1078-0432.CCR-08-0037; Tseng CW, 2009, CANCER IMMUNOL IMMUN, V58, P737, DOI 10.1007/s00262-008-0596-0; Vambutas A, 2005, VACCINE, V23, P5271, DOI 10.1016/j.vaccine.2005.04.049; van der Burg SH, 2001, VACCINE, V19, P3652, DOI 10.1016/S0264-410X(01)00086-X; van Esch EMG, 2012, EXPERT REV VACCINES, V11, P821, DOI [10.1586/ERV.12.56, 10.1586/erv.12.56]; van Meir H, 2014, ANTI-CANCER AGENT ME, V14, P190; van Poelgeest MIE, 2005, CLIN CANCER RES, V11, P5273, DOI 10.1158/1078-0432.CCR-05-0616; Vinzon SE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003924; Wallbillich JJ, 2012, GYNECOL ONCOL, V127, P312, DOI 10.1016/j.ygyno.2012.07.118; Winters U, 2008, CLIN CANCER RES, V14, P5292, DOI 10.1158/1078-0432.CCR-07-4760; Wu CY, 2014, CLIN CANCER RES, V20, P644, DOI 10.1158/1078-0432.CCR-13-1334; Ye LL, 2011, NAT BIOTECHNOL, V29, P158, DOI 10.1038/nbt.1742	56	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e116389	10.1371/journal.pone.0116389	http://dx.doi.org/10.1371/journal.pone.0116389			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25560237	Green Published, gold, Green Submitted			2022-12-26	WOS:000348102200016
J	Valen, R; Edvardsen, RB; Soviknes, AM; Drivenes, O; Helvik, JV				Valen, Ragnhild; Edvardsen, Rolf Brudvik; Soviknes, Anne Mette; Drivenes, Oyvind; Helvik, Jon Vidar			Molecular Evidence that Only Two Opsin Subfamilies, the Blue Light- (SWS2) and Green Light-Sensitive (RH2), Drive Color Vision in Atlantic Cod (Gadus morhua)	PLOS ONE			English	Article							CONE VISUAL PIGMENTS; GENE DUPLICATION; ULTRAVIOLET RECEPTORS; EVOLUTION; EXPRESSION; SEQUENCE; RETINA; FISH; WAVE; DIVERSIFICATION	Teleosts show a great variety in visual opsin complement, due to both gene duplication and gene loss. The repertoire ranges from one subfamily of visual opsins (scotopic vision) including rod opsin only retinas seen in many deep-sea species to multiple subfamilies of visual opsins in some pelagic species. We have investigated the opsin repertoire of Atlantic cod (Gadus morhua) using information in the recently sequenced cod genome and found that despite cod not being a deep sea species it lacks visual subfamilies sensitive towards the most extreme parts of the light spectra representing UV and red light. Furthermore, we find that Atlantic cod has duplicated paralogs of both blue-sensitive SWS2 and green-sensitive RH2 subfamilies, with members belonging to each subfamily linked in tandem within the genome (two SWS2-, and three RH2A genes, respectively). The presence of multiple cone opsin genes indicates that there have been duplication events in the cod ancestor SWS2 and RH2 opsins producing paralogs that have been retained in Atlantic. Our results are supported by expressional analysis of cone opsins, which further revealed an ontogenetic change in the array of cone opsins expressed. These findings suggest life stage specific programs for opsin regulation which could be linked to habitat changes and available light as the larvae is transformed into an early juvenile. Altogether we provide the first molecular evidence for color vision driven by only two families of cone opsins due to gene loss in a teleost.	[Valen, Ragnhild; Soviknes, Anne Mette; Drivenes, Oyvind; Helvik, Jon Vidar] Univ Bergen, Ctr High Technol, Dept Biol, N-5020 Bergen, Norway; [Edvardsen, Rolf Brudvik; Drivenes, Oyvind] Inst Marine Res, N-5817 Bergen, Norway	University of Bergen; Institute of Marine Research - Norway	Edvardsen, RB (corresponding author), Inst Marine Res, POB 1870, N-5817 Bergen, Norway.	rolfbe@imr.no; jon.helvik@bio.uib.no	Drivenes, Øyvind/ABE-3432-2021	Edvardsen, Rolf/0000-0001-8430-8042	Norwegian Research Council [199482]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	The current study was part of a project on cod development (CODE) funded by the Norwegian Research Council (www.forskningsradet.no/en/) with project number: 199482. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLBERT I-B, 1973, Acta Zoologica (Stockholm), V54, P241; BLAXTER JHS, 1967, J MAR BIOL ASSOC UK, V47, P677, DOI 10.1017/S002531540003527X; Bowmaker J.K., 1990, P81; Bowmaker JK, 2008, VISION RES, V48, P2022, DOI 10.1016/j.visres.2008.03.025; Bowmaker JK, 2008, VISUAL NEUROSCI, V25, P249, DOI 10.1017/S0952523808080152; Bowmaker JK, 2006, CURR BIOL, V16, pR484, DOI 10.1016/j.cub.2006.06.016; BOWMAKER JK, 1987, VISION RES, V27, P2101, DOI 10.1016/0042-6989(87)90124-6; Britt LL, 2001, J EXP BIOL, V204, P2581; Cannon J, 1997, REV STATE WORLD FISH, P15; Carleton KL, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-22; Carleton KL, 2005, MOL ECOL, V14, P4341, DOI 10.1111/j.1365-294X.2005.02735.x; Carleton KL, 2001, MOL BIOL EVOL, V18, P1540, DOI 10.1093/oxfordjournals.molbev.a003940; Chinen A, 2003, GENETICS, V163, P663; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Collin SP, 2003, CURR BIOL, V13, pR864, DOI 10.1016/j.cub.2003.10.044; Davies WL, 2009, MOL BIOL EVOL, V26, P1803, DOI 10.1093/molbev/msp089; Douglas R., 1990, VISUAL SYSTEM FISH, DOI [10.1007/978-94-009-0411-8, DOI 10.1007/978-94-009-0411-8]; EVANS BI, 1990, J NEUROBIOL, V21, P1037, DOI 10.1002/neu.480210709; Evans BI, 2004, AM FISH S S, V40, P145; EVANS BI, 1993, VISUAL NEUROSCI, V10, P1065, DOI 10.1017/S0952523800010178; Flamarique IN, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2490; HAWRYSHYN CW, 1989, VISUAL NEUROSCI, V2, P247, DOI 10.1017/S0952523800001164; Helvik JV, 2001, VISUAL NEUROSCI, V18, P767, DOI 10.1017/S095252380118510X; Helvik JV, 2001, J EXP BIOL, V204, P2553; Hofmann CM, 2010, MOL ECOL, V19, P2064, DOI 10.1111/j.1365-294X.2010.04621.x; Hofmann CM, 2009, INTEGR COMP BIOL, V49, P630, DOI 10.1093/icb/icp079; Hunt DM, 2009, PHILOS T R SOC B, V364, P2941, DOI 10.1098/rstb.2009.0044; IBBOTSON RE, 1992, P ROY SOC B-BIOL SCI, V247, P145, DOI 10.1098/rspb.1992.0021; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kawamura G, 1984, B JAPANESE SOC SCI F, V50; KJESBU OS, 1989, J FISH BIOL, V34, P195, DOI 10.1111/j.1095-8649.1989.tb03302.x; KUNZ YW, 1994, VISION RES, V34, P1375, DOI 10.1016/0042-6989(94)90136-8; Lagman D, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-238; Lythgoe J.N., 1979, ECOLOGY VISION; Matsumoto Y, 2006, GENE, V371, P268, DOI 10.1016/j.gene.2005.12.005; Maximov VV, 2000, PHILOS T ROY SOC B, V355, P1239, DOI 10.1098/rstb.2000.0675; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Olsvik Pal A, 2008, BMC Res Notes, V1, P47, DOI 10.1186/1756-0500-1-47; Ottersen G, 2005, ICES COOP RES REP, V274, P11; Pankhurst PM, 1996, MAR FRESHW BEHAV PHY, V28, P55, DOI 10.1080/10236249609378979; Pankhurst PM, 1996, NZ J MAR FRESH RES, V30, P70; PEDERSEN T, 1992, J FISH BIOL, V41, P449, DOI 10.1111/j.1095-8649.1992.tb02673.x; RAYMOND PA, 1995, J COMP NEUROL, V359, P537, DOI 10.1002/cne.903590403; Rennison DJ, 2012, MOL PHYLOGENET EVOL, V62, P986, DOI 10.1016/j.ympev.2011.11.030; Shand J, 1999, J COMP NEUROL, V412, P203, DOI 10.1002/(SICI)1096-9861(19990920)412:2<203::AID-CNE2>3.0.CO;2-3; Spady TC, 2006, MOL BIOL EVOL, V23, P1538, DOI 10.1093/molbev/msl014; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Stenevik EK, 2008, ICES J MAR SCI, V65, P1198, DOI 10.1093/icesjms/fsn101; Stenkamp DL, 1997, J COMP NEUROL, V382, P272, DOI 10.1002/(SICI)1096-9861(19970602)382:2<272::AID-CNE10>3.0.CO;2-U; Takechi M, 2005, J EXP BIOL, V208, P1337, DOI 10.1242/jeb.01532; Tam KJ, 2011, VISION RES, V51, P2295, DOI 10.1016/j.visres.2011.09.010; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor SM, 2011, VISUAL NEUROSCI, V28, P309, DOI 10.1017/S0952523810000362; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TUPPER M, 1995, CAN J FISH AQUAT SCI, V52, P1834, DOI 10.1139/f95-176; Wakefield MJ, 2008, VISUAL NEUROSCI, V25, P257, DOI 10.1017/S0952523808080255; Watson CT, 2011, J MOL EVOL, V72, P240, DOI 10.1007/s00239-010-9426-z; Watson CT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-87; WINDERICKX J, 1992, P NATL ACAD SCI USA, V89, P9710, DOI 10.1073/pnas.89.20.9710; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1	64	14	14	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115436	10.1371/journal.pone.0115436	http://dx.doi.org/10.1371/journal.pone.0115436			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551396	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100037
J	Abushufa, AM; Eldehni, MT; Odudu, A; Evans, PD; O'Sullivan, SE; McIntyre, CW				Abushufa, Adil M.; Eldehni, Mohamed T.; Odudu, Aghogho; Evans, Philip D.; O'Sullivan, Saoirse E.; McIntyre, Chris W.			Defining Uremic Arterial Functional Abnormalities in Patients Recently Started on Haemodialysis: Combined In Vivo and Ex Vivo Assessment	PLOS ONE			English	Article							ENDOTHELIUM-DEPENDENT VASODILATATION; STAGE RENAL-DISEASE; VASCULAR CALCIFICATION; RESISTANCE ARTERIES; FAILURE; DYSFUNCTION; STIFFNESS; OUTCOMES; VESSELS; RATS	Endothelial dysfunction is a key initiating event in vascular disease in chronic kidney disease (CKD) patients and haemodialysis (HD) patients exhibit significant vascular abnormalities. To understand this further, we examined how ex vivo intrinsic function in isolated arteries correlates with in vivo assessments of cardiovascular status in HD patients. Abdominal fat biopsies were obtained from 11 HD patients and 26 non-uremic controls. Subcutaneous arteries were dissected and mounted on a wire myograph, and cumulative concentration-response curves to noradrenalin, endothelin-1, a thromboxane A(2) agonist (U46619), angiotensin II, vasopressin, bradykinin (BK), acetylcholine (ACh) and sodium nitroprusside (SNP) were constructed. Pulse wave velocity and blood pressure were measured in HD patients. Enhanced (P<0.05-0.0001) maximal contractile responses (R-max) to all spasmogens (particularly vasopressin) were observed in arteries from HD patients compared to controls, and this effect was more pronounced in arteries with an internal diameter. 600 mm. The potency (pEC(50)) of U46619 (P<0.01) and vasopressin (P<0.001) was also increased in arteries >600 mu m of HD patients. The maximal relaxant response to the endothelium-dependent dilators ACh and BK were lower in HD patients (P<0.01-P<0.0001) (worse for ACh than BK); however the endothelium-independent dilator SNP was similar in both groups. PWV was significantly correlated with the vasoconstrictor response to vasopressin (P=0.042) in HD patients. HD patients are primed for hypertension and end organ demand ischaemia by a highly sensitised pressor response. The failure of arterial relaxation is mediated by endothelial dysfunction. Intrinsic vascular abnormalities may be important in sensitising HD patients to recurrent cumulative ischaemic end organ injury.	[Abushufa, Adil M.; Eldehni, Mohamed T.; Odudu, Aghogho; Evans, Philip D.; O'Sullivan, Saoirse E.; McIntyre, Chris W.] Univ Nottingham, Sch Med, Div Med Sci & Grad Entry Med, Nottingham, England; [Eldehni, Mohamed T.; Odudu, Aghogho; Evans, Philip D.; McIntyre, Chris W.] Royal Derby Hosp, Dept Renal Med, Derby, England	University of Nottingham; University of Nottingham	O'Sullivan, SE (corresponding author), Univ Nottingham, Sch Med, Div Med Sci & Grad Entry Med, Nottingham, England.	Saoirse.osullivan@nottingham.ac.uk	McIntyre, Christopher W/O-8927-2014; Odudu, Aghogho/K-9048-2014	Odudu, Aghogho/0000-0002-4863-1560; Eldehni, Mohamed/0000-0003-1681-9048; O'Sullivan, Saoirse Elizabeth/0000-0002-1672-6610				AALKJAER C, 1986, CLIN SCI, V71, P657, DOI 10.1042/cs0710657; Annuk M, 2001, NEPHROL DIAL TRANSPL, V16, P302, DOI 10.1093/ndt/16.2.302; Baylis C, 2008, AM J PHYSIOL-RENAL, V294, pF1, DOI 10.1152/ajprenal.00424.2007; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Bostom AG, 1999, J AM SOC NEPHROL; Burton JO, 2009, CLIN J AM SOC NEPHRO, V4, P914, DOI 10.2215/CJN.03900808; Eldehni MT, 2012, SEMIN DIALYSIS, V25, P253, DOI 10.1111/j.1525-139X.2012.01057.x; Ferraro B, 2003, KIDNEY INT, V63, P2207, DOI 10.1046/j.1523-1755.2003.00008.x; Hand MF, 1998, KIDNEY INT, V53, P1068, DOI 10.1046/j.1523-1755.1998.00851.x; Hasdan G, 2002, KIDNEY INT, V61, P586, DOI 10.1046/j.1523-1755.2002.00166.x; Kielstein JT, 2002, J AM SOC NEPHROL, V13, P170, DOI 10.1681/ASN.V131170; Luksha L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036056; Luksha R, 2011, CLIN SCI, V120, P525, DOI 10.1042/CS20100277; Mallamaci F, 2002, KIDNEY INT, V61, P609, DOI 10.1046/j.1523-1755.2002.00144.x; McIntyre CA, 1998, BRIT J PHARMACOL, V123, P1555, DOI 10.1038/sj.bjp.0701768; McIntyre CW, 2010, SEMIN DIALYSIS, V23, P449, DOI 10.1111/j.1525-139X.2010.00782.x; Morris STW, 2001, KIDNEY INT, V60, P1077, DOI 10.1046/j.1523-1755.2001.0600031077.x; Morris STW, 2000, NEPHROL DIAL TRANSPL, V15, P1194, DOI 10.1093/ndt/15.8.1194; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Oflaz H, 2003, CLIN TRANSPLANT, V17, P528, DOI 10.1046/j.1399-0012.2003.00100.x; Pucci G, 2012, J HYPERTENS; Raggi P, 2007, ADV CHRONIC KIDNEY D, V14, P37, DOI 10.1053/j.ackd.2006.10.006; Shinohara K, 2004, KIDNEY INT, V65, P936, DOI 10.1111/j.1523-1755.2004.00468.x; Sigrist MK, 2008, NEPHRON CLIN PRACT, V108, pC121, DOI 10.1159/000114202; VALLANCE P, 1992, LANCET, V339, P572; Van Biesen W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017148; Wabel P, 2008, NEPHROL DIAL TRANSPL, V23, P2965, DOI 10.1093/ndt/gfn228	27	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e113462	10.1371/journal.pone.0113462	http://dx.doi.org/10.1371/journal.pone.0113462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546407	Green Published, gold, Green Submitted			2022-12-26	WOS:000347120200006
J	Li, TX; Liu, JN; Smith, WW				Li, Tianxia; Liu, Jingnan; Smith, Wanli W.			Synphilin-1 Binds ATP and Regulates Intracellular Energy Status	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; INTERACTING PROTEIN; INCLUSION FORMATION; PHOSPHORYLATION	Recent studies have suggested that synphilin-1, a cytoplasmic protein, is involved in energy homeostasis. Overexpression of synphilin-1 in neurons results in hyperphagia and obesity in animal models. However, the mechanism by which synphilin-1 alters energy homeostasis is unknown. Here, we used cell models and biochemical approaches to investigate the cellular functions of synphilin-1 that may affect energy balance. Synphilin-1 was pulled down by ATP-agarose beads, and the addition of ATP and ADP reduced this binding, indicating that synphilin-1 bound ADP and ATP. Synphilin-1 also bound GMP, GDP, and GTP but with a lower affinity than it bound ATP. In contrast, synphilin-1 did not bind with CTP. Overexpression of synphilin-1 in HEK293T cells significantly increased cellular ATP levels. Genetic alteration to abolish predicted ATP binding motifs of synphilin-1 or knockdown of synphilin-1 by siRNA reduced cellular ATP levels. Together, these data demonstrate that synphilin-1 binds and regulates the cellular energy molecule, ATP. These findings provide a molecular basis for understanding the actions of synphilin-1 in energy homeostasis.	[Li, Tianxia; Liu, Jingnan; Smith, Wanli W.] Univ Maryland, Dept Pharmaceut Sci, Sch Pharm, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Smith, WW (corresponding author), Univ Maryland, Dept Pharmaceut Sci, Sch Pharm, Baltimore, MD 21201 USA.	wsmith@rx.umaryland.edu			National Institutes of Health [DK083410]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083410] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health, Grants: DK083410 to WWS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Castelao B, 2011, CELL MOL LIFE SCI, V68, P2643, DOI 10.1007/s00018-010-0592-3; Avraham E, 2005, J BIOL CHEM, V280, P42877, DOI 10.1074/jbc.M505608200; Bergman J., 1999, CREATION RES SOC Q, V36; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Giaime E, 2006, J BIOL CHEM, V281, P11515, DOI 10.1074/jbc.M508619200; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hernandez-Vargas R, 2011, GENESIS, V49, P392, DOI 10.1002/dvg.20740; Lee G, 2004, J BIOL CHEM, V279, P6834, DOI 10.1074/jbc.M312760200; Li X, 2012, INT J OBESITY, V36, P1215, DOI 10.1038/ijo.2011.235; Li X, 2010, NEUROSCIENCE, V165, P455, DOI 10.1016/j.neuroscience.2009.10.042; Liu J, 2012, INT J OBESITY, V36, P1529, DOI 10.1038/ijo.2012.111; Marx FP, 2007, FASEB J, V21, P1759, DOI 10.1096/fj.06-6734com; Nagano Y, 2003, J BIOL CHEM, V278, P51504, DOI 10.1074/jbc.M306347200; O'Farrell C, 2001, MOL BRAIN RES, V97, P94, DOI 10.1016/S0169-328X(01)00292-3; Ribeiro CS, 2002, J BIOL CHEM, V277, P23927, DOI 10.1074/jbc.M201115200; Smith WW, 2010, HUM MOL GENET, V19, P2087, DOI 10.1093/hmg/ddq086; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Szargel R, 2008, CELL MOL LIFE SCI, V65, P80, DOI 10.1007/s00018-007-7343-0; Wakabayashi K, 2000, ANN NEUROL, V47, P521, DOI 10.1002/1531-8249(200004)47:4<521::AID-ANA18>3.3.CO;2-2	20	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e115233	10.1371/journal.pone.0115233	http://dx.doi.org/10.1371/journal.pone.0115233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25545246	Green Submitted, Green Published, gold			2022-12-26	WOS:000347120200028
J	Hobbs, CV; Dixit, S; Penzak, SR; Sahu, T; Orr-Gonzalez, S; Lambert, L; Zeleski, K; Chen, JY; Neal, J; Borkowsky, W; Wu, YM; Duffy, PE				Hobbs, Charlotte V.; Dixit, Saurabh; Penzak, Scott R.; Sahu, Tejram; Orr-Gonzalez, Sachy; Lambert, Lynn; Zeleski, Katie; Chen, Jingyang; Neal, Jillian; Borkowsky, William; Wu, Yimin; Duffy, Patrick E.			Neither the HIV Protease Inhibitor Lopinavir-Ritonavir nor the Antimicrobial Trimethoprim-Sulfamethoxazole Prevent Malaria Relapse in Plasmodium cynomolgi-Infected Non-Human Primates	PLOS ONE			English	Article							ANTIMALARIAL-DRUGS; RHESUS-MONKEYS; MACACA-MULATTA; LIVER STAGES; IN-VITRO; PHARMACOKINETICS; HYPNOZOITE; FALCIPARUM; QUININE; VIVAX	Plasmodium vivax malaria causes significant morbidity and mortality worldwide, and only one drug is in clinical use that can kill the hypnozoites that cause P. vivax relapses. HIV and P. vivax malaria geographically overlap in many areas of the world, including South America and Asia. Despite the increasing body of knowledge regarding HIV protease inhibitors (HIV PIs) on P. falciparum malaria, there are no data regarding the effects of these treatments on P. vivax's hypnozoite form and clinical relapses of malaria. We have previously shown that the HIV protease inhibitor lopinavir-ritonavir (LPV-RTV) and the antibiotic trimethoprim sulfamethoxazole (TMP-SMX) inhibit Plasmodium actively dividing liver stages in rodent malarias and in vitro in P. falciparum, but effect against Plasmodium dormant hypnozoite forms remains untested. Separately, although other antifolates have been tested against hypnozoites, the antibiotic trimethoprim sulfamethoxazole, commonly used in HIV infection and exposure management, has not been evaluated for hypnozoite-killing activity. Since Plasmodium cynomolgi is an established animal model for the study of liver stages of malaria as a surrogate for P. vivax infection, we investigated the antimalarial activity of these drugs on Plasmodium cynomolgi relapsing malaria in rhesus macaques. Herein, we demonstrate that neither TMP-SMX nor LPV-RTV kills hypnozoite parasite liver stage forms at the doses tested. Because HIV and malaria geographically overlap, and more patients are being managed for HIV infection and exposure, understanding HIV drug impact on malaria infection is important.	[Hobbs, Charlotte V.; Dixit, Saurabh; Sahu, Tejram; Orr-Gonzalez, Sachy; Lambert, Lynn; Zeleski, Katie; Chen, Jingyang; Neal, Jillian; Wu, Yimin; Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD 20852 USA; [Penzak, Scott R.] Univ North Texas Syst Coll Pharm, Dept Pharmacotherapy, Ft Worth, TX 76107 USA; [Borkowsky, William] NYU, Dept Pediat, Sch Med, Div Infect Dis & Immunol, New York, NY 10016 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); New York University	Hobbs, CV (corresponding author), NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD 20852 USA.	charlotte.hobbs@nih.gov	Smolovich, Anatoly/R-8144-2017; dixit, saurabh/E-3296-2013	Smolovich, Anatoly/0000-0002-7557-272X; Hobbs, Charlotte/0000-0003-4829-0791; dixit, saurabh/0000-0002-9140-9543; Sahu, Tejram/0000-0002-0912-7660	National Institutes of Health Division of Intramural Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIGAI001047, ZIAAI001135] Funding Source: NIH RePORTER	National Institutes of Health Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by the National Institutes of Health Division of Intramural Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achan J, 2012, NEW ENGL J MED, V367, P2110, DOI 10.1056/NEJMoa1200501; Akabane T, 2010, DRUG METAB DISPOS, V38, P308, DOI 10.1124/dmd.109.028829; Andrews KT, 2006, ANTIMICROB AGENTS CH, V50, P639, DOI 10.1128/AAC.50.2.639-648.2006; [Anonymous], 2013, TREATM MAL GUID CLIN; Baird JK, 2013, CLIN MICROBIOL REV, V26, P36, DOI 10.1128/CMR.00074-12; Baird JK, 2005, NEW ENGL J MED, V352, P1565, DOI 10.1056/NEJMra043207; Birkett DJ., 2010, PHARMACOKINETICS MAD; Carpenter J.W., 2005, EXOTIC ANIMAL FORMUL, V3; COGSWELL FB, 1992, CLIN MICROBIOL REV, V5, P26, DOI 10.1128/CMR.5.1.26-35.1992; Collins WE, 2009, J PARASITOL, V95, P349, DOI 10.1645/GE-1797.1; Craig WA, 1973, J INFECT DIS S, V128; Dangerous Drugs England Dangerous Drugs Scotland., 2013, CONTROLLED DRUGS SUP; DAVIDSON DE, 1976, AM J TROP MED HYG, V25, P26, DOI 10.4269/ajtmh.1976.25.26; Dembele L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018162; Deye GA, 2012, AM J TROP MED HYG, V86, P931, DOI 10.4269/ajtmh.2012.11-0552; Dow GS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-212; Eastman RT, 2013, ANTIMICROB AGENTS CH, V57, P425, DOI 10.1128/AAC.00920-12; Ersmark K, 2006, MED RES REV, V26, P626, DOI 10.1002/med.20082; EYLES DE, 1962, AM J TROP MED HYG, V11, P175, DOI 10.4269/ajtmh.1962.11.175; FISK TL, 1989, AM J TROP MED HYG, V40, P235, DOI 10.4269/ajtmh.1989.40.235; Flateau C, 2011, LANCET INFECT DIS, V11, P541, DOI 10.1016/S1473-3099(11)70031-7; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; Hobbs CV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100138; Hobbs CV, 2013, AIDS, V27, P1674, DOI 10.1097/QAD.0b013e3283621dd4; Hobbs CV, 2012, J INFECT DIS, V206, P1706, DOI 10.1093/infdis/jis602; Hobbs CV, 2009, J INFECT DIS, V199, P134, DOI 10.1086/594369; Hobbs CV, 2013, J INFECT DIS; Ikilezi G, 2013, AM J TROP MED HYG; Ishimatsu M, 2007, MICROBES INFECT, V9, P475, DOI 10.1016/j.micinf.2007.01.005; JIANG JB, 1988, T ROY SOC TROP MED H, V82, P56, DOI 10.1016/0035-9203(88)90262-3; Krishna S, 1996, CLIN PHARMACOKINET, V30, P263, DOI 10.2165/00003088-199630040-00002; Laboratories A KALETRA, LOP TABL LOP RIT OR; Lek-Uthai U, 2008, ANTIMICROB AGENTS CH, V52, P2435, DOI 10.1128/AAC.00169-08; Li YJ, 2011, ANTIMICROB AGENTS CH, V55, P3039, DOI 10.1128/AAC.00085-11; Martins TM, 2006, ACTA TROP, V97, P212, DOI 10.1016/j.actatropica.2005.11.001; Moon SU, 2011, EXP PARASITOL, V128, P127, DOI 10.1016/j.exppara.2011.02.015; Nsanzabana C, 2011, ANTIMICROB AGENTS CH; Nyunt MM, 2012, CLIN PHARMACOL THER, V91, P889, DOI 10.1038/clpt.2011.326; Parikh S, 2005, ANTIMICROB AGENTS CH, V49, P2983, DOI 10.1128/AAC.49.7.2983-2985.2005; Peatey CL, 2010, ANTIMICROB AGENTS CH, V54, P1334, DOI 10.1128/AAC.01512-09; PURI S K, 1990, Journal of Communicable Diseases, V22, P98; Redmond AM, 2007, AIDS, V21, P763, DOI 10.1097/QAD.0b013e328031f41a; Robert Coatney G., 1971, PRIMATE MALARIAS, Vix; SCHMIDT LH, 1986, AM J TROP MED HYG, V35, P1077, DOI 10.4269/ajtmh.1986.35.1077; SHANKS GD, 1994, AM J TROP MED HYG, V50, P641, DOI 10.4269/ajtmh.1994.50.641; Skinner-Adams TS, 2004, J INFECT DIS, V190, P1998, DOI 10.1086/425584; Soyinka JO, 2010, BRIT J CLIN PHARMACO, V69, P262, DOI 10.1111/j.1365-2125.2009.03566.x; White NJ, 2007, LANCET INFECT DIS, V7, P549, DOI 10.1016/S1473-3099(07)70187-1; WHO, 1995, WHO MOD PERSCR INF D	49	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115506	10.1371/journal.pone.0115506	http://dx.doi.org/10.1371/journal.pone.0115506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541998	Green Submitted, gold, Green Published			2022-12-26	WOS:000347239900048
J	Li, YB; Zang, DW				Li, Yubo; Zang, Dawei			The Neuron Regrowth Is Associated with the Proliferation of Neural Precursor Cells after Leukemia Inhibitory Factor Administration following Spinal Cord Injury in Mice	PLOS ONE			English	Article							OLIGODENDROCYTE DIFFERENTIATION; STEM/PRECURSOR CELLS; MOUSE MODEL; STEM-CELLS; BRAIN; LIF; ASTROCYTES; DEMYELINATION; TRANSPORT; RECOVERY	Objectives: To explore whether LIF could promote the proliferation of neural precursor cells (NPCs) and to analyze the correlation between increased NPCs and FluoroGold (FG) labeled neurons in mice after spinal cord injury (SCI). Methods: Motor behavior was assessed using Rotarod and Platform Hang tests; neurons in the corticospinal and rubrospinal systems were labeled with FG, NPCs were immustained with nestin-FITC conjugate. The numbers of FG-labeled neurons and NPCs were estimated, and the correlation between FG-labeled neurons and NPCs was assessed. Results: Mice in the SCI group showed negligible recovery of locomotor behavior; in contrast, mice in the LIF group showed a statically significant improvement. Both FG-labeled neurons and NPCs were significantly increased in the LIF group compared to the SCI group, and this increase in FG-labeled neurons and NPCs showed a clear association above the lesion level. Conclusions: LIF could promote locomotive behaviors in mice post-SCI by encouraging the proliferation of NPCs; LIF may in fact be a potential cytokine for the induction of NPCs post-SCI.	[Li, Yubo] Capital Med Univ, Beijing 100069, Peoples R China; [Zang, Dawei] Tianjin Med Univ, Tianjin Ctr 1, Dept Neurol, Tianjin 300192, Peoples R China	Capital Medical University; Tianjin Medical University	Zang, DW (corresponding author), Tianjin Med Univ, Tianjin Ctr 1, Dept Neurol, Tianjin 300192, Peoples R China.	zangdawei@gmail.com			Tianjin Health Bureau [11KG104]	Tianjin Health Bureau	This work was supported by Tianjin Health Bureau (11KG104). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RK, 2009, NEUROSCI LETT, V464, P203, DOI 10.1016/j.neulet.2009.08.050; Asano H, 2009, STEM CELLS, V27, P2744, DOI 10.1002/stem.176; Azari MF, 2005, EUR J NEUROL, V12, P638, DOI 10.1111/j.1468-1331.2005.01066.x; Azari MF, 2006, J NEUROPATH EXP NEUR, V65, P914, DOI 10.1097/01.jnen.0000235855.77716.25; Bambakidis NC, 2009, J NEUROSURG-SPINE, V10, P171, DOI 10.3171/2008.10.SPI08231; Bazley FA, 2012, IEEE ENG MED BIO, P82, DOI 10.1109/EMBC.2012.6345876; Beatus P, 2011, DEV NEUROBIOL, V71, P619, DOI 10.1002/dneu.20871; Christie KJ, 2013, ADV EXP MED BIOL, V786, P129, DOI 10.1007/978-94-007-6621-1_8; Covey MV, 2011, ANN NEUROL, V70, P616, DOI 10.1002/ana.22473; Cusimano M, 2012, BRAIN, V135, P447, DOI 10.1093/brain/awr339; Daadi MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041120; Dooley D, 2014, PHARMACOL THERAPEUT, V141, P21, DOI 10.1016/j.pharmthera.2013.08.001; Gauthier MK, 2013, EUR J NEUROSCI, V38, P2693, DOI 10.1111/ejn.12268; Gresle MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047379; Guadagno J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.59; Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P2222, DOI 10.1089/scd.2011.0596; Jin Y, 2012, J NEUROSCI RES, V90, P2065, DOI 10.1002/jnr.23099; Juan L, 2007, NEUROL RES, V29, P204, DOI 10.1179/174313206X152519; Karimi-Abdolrezaee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037589; Kerr BJ, 2005, GLIA, V51, P73, DOI 10.1002/glia.20177; Kumamaru H, 2013, STEM CELLS, V31, P1535, DOI 10.1002/stem.1404; Laterza C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3597; Lee JW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00167; Liu J, 2009, NEUROL RES, V31, P681, DOI 10.1179/174313209X382368; Lopez-Arenas E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045018; Mathieu ME, 2012, STEM CELL REV REP, V8, P1, DOI 10.1007/s12015-011-9261-7; Moghadam FH, 2009, DIFFERENTIATION, V78, P59, DOI 10.1016/j.diff.2009.06.005; Mothe AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027079; Mutoh T, 2012, STEM CELLS, V30, P561, DOI 10.1002/stem.1019; Pan WH, 2008, CURR PHARM DESIGN, V14, P1620, DOI 10.2174/138161208784705450; Pan WH, 2006, J NEUROIMMUNOL, V174, P119, DOI 10.1016/j.jneuroim.2006.02.006; Suehiro K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04972; Tu J, 2010, SPINE, V35, P1116, DOI 10.1097/BRS.0b013e3181ba6ce4; Urayama S, 2013, CELL STRUCT FUNCT, V38, P55, DOI 10.1247/csf.12034; Wang YP, 2011, J NEUROSCI, V31, P6053, DOI 10.1523/JNEUROSCI.5524-09.2011; Weible MW, 2007, GLIA, V55, P1156, DOI 10.1002/glia.20539; Weinger J.G., 2013, CURR PROTOC STEM CEL, V26; White RE, 2011, J NEUROSCI, V31, P15173, DOI 10.1523/JNEUROSCI.3441-11.2011; Zang DW, 2003, J NEUROTRAUM, V20, P1215, DOI 10.1089/089771503770802880	39	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e116031	10.1371/journal.pone.0116031	http://dx.doi.org/10.1371/journal.pone.0116031			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542011	Green Published, gold, Green Submitted			2022-12-26	WOS:000347239900132
J	Flannigan, KL; Agbor, TA; Motta, JP; Ferraz, JGP; Wang, R; Buret, AG; Wallace, JL				Flannigan, Kyle L.; Agbor, Terence A.; Motta, Jean-Paul; Ferraz, Jose G. P.; Wang, Rui; Buret, Andre G.; Wallace, John L.			Proresolution effects of hydrogen sulfide during colitis are mediated through hypoxia-inducible factor-1 alpha	FASEB JOURNAL			English	Article						inflammation; healing; ulcer; inflammatory bowel disease; gasotransmitter	EPITHELIAL-CELLS; FACTOR-I; INFLAMMATION; H2S; RESOLUTION; MODEL; RAT; INHIBITOR; INDUCTION; CYCLOOXYGENASE-2	During a course of colitis, production of the gaseous mediator hydrogen sulfide (H2S) is markedly up-regulated at sites of mucosal damage and contributes significantly to healing and resolution of inflammation. The signaling mechanisms through which H2S promotes resolution of colitis are unknown. We hypothesized that the beneficial effects of H2S in experimental colitis are mediated via stabilization of hypoxia-inducible factor (HIF)-1 alpha. The hapten dinitrobenzene sulfonic acid was used to induce colitis in rats and mice. This resulted in an elevated expression of the H2S producing enzyme, cystathionine gamma-lyase (CSE), and HIF-1 alpha at sites of mucosal ulceration, and the expression of these 2 enzymes followed a similar pattern throughout the course of colitis. This represented a functionally important relationship because the loss of CSE-derived H2S production led to decreased HIF-1 alpha stabilization and exacerbation of colitis. Furthermore, application of an H2S-releasing molecule, diallyl disulfide (DADS), stabilized colonic HIF-1 alpha expression, up-regulated hypoxia-responsive genes, and reduced the severity of disease during peak inflammation. Importantly, the ability of DADS to promote the resolution of colitis was abolished when coadministered with an inhibitor of HIF-1 alpha in vivo (PX-478). DADS was also able to maintain HIF-1 alpha expression at a later point incolitis, when HIF-1 alpha levels would have normally returned to control levels, and to enhance resolution. Finally, we found that HIF-1 alpha stabilization inhibited colonic H2S production and may represent a negative feedback mechanism to prevent prolonged HIF-1 alpha stabilization. Our findings demonstrate an important link between H2S and HIF-1 alpha in the resolution of inflammation and injury during colitis and provide mechanistic insights into the therapeutic value ofH(2)S donors.	[Flannigan, Kyle L.; Agbor, Terence A.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Motta, Jean-Paul; Buret, Andre G.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Ferraz, Jose G. P.] Univ Calgary, Dept Med, Calgary, AB T2N 1N4, Canada; [Wallace, John L.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Wang, Rui] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada	McMaster University; University of Calgary; University of Calgary; University of Calgary; Lakehead University	Wallace, JL (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	altapharm@hotmail.com	Wang, Rui/C-7824-2012; Motta, Jean-Paul/A-8844-2014; Wallace, John/AAL-3763-2021	Wang, Rui/0000-0003-3825-3620; Motta, Jean-Paul/0000-0002-9464-0695; 	Canadian Institutes of Health Research; Crohn's and Colitis Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Crohn's and Colitis Canada	The authors thank Webb McKnight for his assistance. The work described in this paper was supported by grants to J.L.W. from the Canadian Institutes of Health Research and Crohn's and Colitis Canada.	Abe K, 1996, J NEUROSCI, V16, P1066; Ajuebor MN, 2000, AM J PHYSIOL-GASTR L, V279, pG238; Benavides GA, 2007, P NATL ACAD SCI USA, V104, P17977, DOI 10.1073/pnas.0705710104; BOUGHTONSMITH NK, 1988, AGENTS ACTIONS, V25, P115, DOI 10.1007/BF01969102; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Budde MW, 2010, MOL BIOL CELL, V21, P212, DOI 10.1091/mbc.E09-03-0199; Bynoe MS, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/260983; Cai ZQ, 2013, P NATL ACAD SCI USA, V110, P17462, DOI 10.1073/pnas.1317158110; Calvert JW, 2010, ANTIOXID REDOX SIGN, V12, P1203, DOI 10.1089/ars.2009.2882; Campbell EL, 2014, IMMUNITY, V40, P66, DOI 10.1016/j.immuni.2013.11.020; Chavez-Pina AE, 2008, BRIT J PHARMACOL, V155, P857, DOI 10.1038/bjp.2008.316; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Curtis VF, 2015, FASEB J, V29, P208, DOI 10.1096/fj.14-259663; Dufton N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00499; Fiorucci S, 2007, BRIT J PHARMACOL, V150, P996, DOI 10.1038/sj.bjp.0707193; Flannigan KL, 2014, P NATL ACAD SCI USA, V111, P13559, DOI 10.1073/pnas.1413390111; Flannigan KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071962; Flannigan KL, 2011, AM J PHYSIOL-GASTR L, V301, pG188, DOI 10.1152/ajpgi.00105.2011; Fu M, 2012, P NATL ACAD SCI USA, V109, P2943, DOI 10.1073/pnas.1115634109; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Glover LE, 2011, GASTROENTEROLOGY, V140, P1748, DOI 10.1053/j.gastro.2011.01.056; Jacoby JJ, 2010, J THORAC ONCOL, V5, P940, DOI 10.1097/JTO.0b013e3181dc211f; Kaidi A, 2006, CANCER RES, V66, P6683, DOI 10.1158/0008-5472.CAN-06-0425; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Keely S, 2009, FASEB J, V23, P1338, DOI 10.1096/fj.08-125344; Koh MY, 2008, MOL CANCER THER, V7, P90, DOI 10.1158/1535-7163.MCT-07-0463; Lagoutte E, 2010, BBA-BIOENERGETICS, V1797, P1500, DOI 10.1016/j.bbabio.2010.04.004; Lin F, 2004, J IMMUNOL, V172, P3836, DOI 10.4049/jimmunol.172.6.3836; Louis NA, 2005, FASEB J, V19, P950, DOI 10.1096/fj.04-3251com; Louis NA, 2008, J IMMUNOL, V180, P4246, DOI 10.4049/jimmunol.180.6.4246; Lowie BJ, 2011, AM J PHYSIOL-GASTR L, V301, pG835, DOI 10.1152/ajpgi.00077.2011; Mariggio MA, 1998, IMMUNOPHARM IMMUNOT, V20, P399, DOI 10.3109/08923979809034822; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; Mimoun S, 2012, ANTIOXID REDOX SIGN, V17, P1, DOI 10.1089/ars.2011.4186; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Motta J. P., 2014, INFLAMMATOR IN PRES; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Palinkas Z, 2015, BRIT J PHARMACOL, V172, P1516, DOI 10.1111/bph.12769; Peng YJ, 2010, P NATL ACAD SCI USA, V107, P10719, DOI 10.1073/pnas.1005866107; Predmore BL, 2012, AM J PHYSIOL-HEART C, V302, pH2410, DOI 10.1152/ajpheart.00044.2012; Reuter BK, 1996, J CLIN INVEST, V98, P2076, DOI 10.1172/JCI119013; Robinson A, 2008, GASTROENTEROLOGY, V134, P145, DOI 10.1053/j.gastro.2007.09.033; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Szabo C, 2011, BRIT J PHARMACOL, V164, P853, DOI 10.1111/j.1476-5381.2010.01191.x; Taupin DR, 2000, P NATL ACAD SCI USA, V97, P799, DOI 10.1073/pnas.97.2.799; Wallace JL, 2005, BRIT J PHARMACOL, V145, P275, DOI 10.1038/sj.bjp.0706201; WALLACE JL, 1995, J PHARMACOL TOXICOL, V33, P237, DOI 10.1016/1056-8719(95)00001-X; Wallace JL, 2007, FASEB J, V21, P4070, DOI 10.1096/fj.07-8669com; Wallace JL, 2015, ANTIOXID REDOX SIGN, V22, P398, DOI 10.1089/ars.2014.5901; Wallace JL, 2012, ANTIOXID REDOX SIGN, V17, P58, DOI 10.1089/ars.2011.4351; Wallace JL, 2010, ANTIOXID REDOX SIGN, V12, P1125, DOI 10.1089/ars.2009.2900; Wallace JL, 2009, GASTROENTEROLOGY, V137, P569, DOI 10.1053/j.gastro.2009.04.012; Welsh S, 2004, MOL CANCER THER, V3, P233; WRIGHT NA, 1993, GASTROENTEROLOGY, V104, P12, DOI 10.1016/0016-5085(93)90830-6; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	60	40	40	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1591	1602		10.1096/fj.14-266015	http://dx.doi.org/10.1096/fj.14-266015			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25550470				2022-12-26	WOS:000354115000042
J	Lopez-Pelegrin, M; Ksiazek, M; Karim, AY; Guevara, T; Arolas, JL; Potempa, J; Gomis-Ruth, FX				Lopez-Pelegrin, Mar; Ksiazek, Miroslaw; Karim, Abdulkarim Y.; Guevara, Tibisay; Arolas, Joan L.; Potempa, Jan; Xavier Gomis-Rueth, F.			A Novel Mechanism of Latency in Matrix Metalloproteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SNAKE-VENOM METALLOPROTEINASES; ALPHA-CONVERTING ENZYME; CATALYTIC DOMAIN; CYSTEINE SWITCH; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ACTIVATION MECHANISMS; ACTIVE-SITE; FAMILY; INHIBITORS	The matrix metalloproteinases (MMPs) are a family of secreted soluble or membrane-anchored multimodular peptidases regularly found in several paralogous copies in animals and plants, where they have multiple functions. The minimal consensus domain architecture comprises a signal peptide, a 60-90-residue globular prodomain with a conserved sequence motif including a cysteine engaged in "cysteine-switch" or "Velcro" mediated latency, and a catalytic domain. Karilysin, from the human periodontopathogen Tannerella forsythia, is the only bacterial MMP to have been characterized biochemically to date. It shares with eukaryotic forms the catalytic domain but none of the flanking domains. Instead of the consensus MMP prodomain, it features a 14-residue propeptide, the shortest reported for a metallopeptidase, which lacks cysteines. Here we determined the structure of a prokarilysin fragment encompassing the propeptide and the catalytic domain, and found that the former runs across the cleft in the opposite direction to a bound substrate and inhibits the latter through an "aspartate-switch" mechanism. This finding is reminiscent of latency maintenance in the otherwise unrelated astacin and fragilysin metallopeptidase families. In addition, in vivo and biochemical assays showed that the propeptide contributes to protein folding and stability. Our analysis of prokarilysin reveals a novel mechanism of latency and activation in MMPs. Finally, our findings support the view that the karilysin catalytic domain was co-opted by competent bacteria through horizontal gene transfer from a eukaryotic source, and later evolved in a specific bacterial environment.	[Xavier Gomis-Rueth, F.] CSIC, Proteolysis Lab, Dept Biol Struct, Mol Biol Inst Barcelona, E-08028 Barcelona, Catalonia, Spain; [Ksiazek, Miroslaw; Karim, Abdulkarim Y.; Potempa, Jan] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Potempa, Jan] Univ Louisville, Sch Dent, Louisville, KY 40202 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Jagiellonian University; University of Louisville		jlacri@ibmb.csic.es; jan.potempa@louisville.edu; fxgr@ibmb.csic.es	Karim, Abdulkarim/M-8690-2019; Potempa, Jan/AAA-6850-2021	Karim, Abdulkarim/0000-0002-8829-9769; Lopez Arolas, Joan/0000-0002-4198-5016; Potempa, Jan/0000-0002-3600-7461; Gomis-Ruth, F. Xavier/0000-0002-6848-6874; Guevara Puig, Tibisay/0000-0002-1366-8507	ESRF; European Union [POIG.02.01.00-12-064/08]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE009761, R01DE022597] Funding Source: NIH RePORTER	ESRF; European Union(European Commission); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We are grateful to the joint IBMB/IRB Automated Crystallography Platform for assistance during crystallization experiments and Robin Rycroft for very helpful contributions to the manuscript. We acknowledge the help provided by local contacts at the ESRF synchrotron. The clone for production of human rhinovirus 3C proteinase was a generous gift from Arie Gerlof (EMBL, Hamburg). Funding for data collection was provided in part by ESRF. The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of structural funds from the European Union (POIG.02.01.00-12-064/08).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Anderson MT, 2011, MBIO, V2, DOI 10.1128/mBio.00005-11; Angerer L, 2006, DEV BIOL, V300, P267, DOI 10.1016/j.ydbio.2006.07.046; Arolas J. L., 2013, ENCY METALLOPROTEINS, P2473, DOI DOI 10.1007/978-1-4614-1533-6_186; Baker D, 1993, CURR OPIN CELL BIOL, V5, P966, DOI 10.1016/0955-0674(93)90078-5; Balaban NP, 2012, BIOCHEMISTRY-MOSCOW+, V77, P119, DOI 10.1134/S0006297912020010; Batra J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075836; BECKER JW, 1995, PROTEIN SCI, V4, P1966, DOI 10.1002/pro.5560041002; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bode W, 2003, BIOL CHEM, V384, P863, DOI 10.1515/BC.2003.097; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; BODE W, 1979, NATURWISSENSCHAFTEN, V66, P251, DOI 10.1007/BF00571605; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cerda-Costa N, 2014, PROTEIN SCI, V23, P123, DOI 10.1002/pro.2400; Cerda-Costa N, 2011, MOL MICROBIOL, V79, P119, DOI 10.1111/j.1365-2958.2010.07434.x; Cha JH, 1996, BIOCHEMISTRY-US, V35, P15831, DOI 10.1021/bi962085f; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHOTHIA C, 1977, P NATL ACAD SCI USA, V74, P4130, DOI 10.1073/pnas.74.10.4130; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; Das S, 2003, MOL CELL BIOCHEM, V253, P31, DOI 10.1023/A:1026093016148; Debreczeni JE, 2012, ACTA CRYSTALLOGR D, V68, P425, DOI 10.1107/S0907444912000200; Demidyuk IV, 2010, J BIOL CHEM, V285, P2003, DOI 10.1074/jbc.M109.015396; DESOUZA SJ, 1993, J MOL EVOL, V36, P596, DOI 10.1007/BF00556364; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; FOTOUHI N, 1994, J BIOL CHEM, V269, P30227; Gao XA, 2010, P NATL ACAD SCI USA, V107, P17569, DOI 10.1073/pnas.1005681107; Gomis-Ruth FX, 1998, PROTEIN SCI, V7, P283; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; Gomis-Ruth FX., 2013, ENCY METALLOPROTEINS, P2345; GOMISRUTH FX, 1993, J MOL BIOL, V229, P945, DOI 10.1006/jmbi.1993.1098; GOMISRUTH FX, 1993, EMBO J, V12, P4151, DOI 10.1002/j.1460-2075.1993.tb06099.x; Gonzales PE, 2004, J BIOL CHEM, V279, P31638, DOI 10.1074/jbc.M401311200; Goulas T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112643; Goulas T, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P887, DOI 10.1016/B978-0-12-382219-2.00186-1; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; Graef C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043863; GRAMS F, 1995, EUR J BIOCHEM, V228, P830, DOI 10.1111/j.1432-1033.1995.tb20329.x; GRAMS F, 1993, FEBS LETT, V335, P76, DOI 10.1016/0014-5793(93)80443-X; Guevara T, 2013, ACTA CRYSTALLOGR F, V69, P472, DOI 10.1107/S1744309113007392; Guevara T, 2010, J BIOL CHEM, V285, P13958, DOI 10.1074/jbc.M109.097436; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016; Jackson Brian C., 2010, Human Genomics, V4, P345; JIANG WP, 1992, FEBS LETT, V312, P110, DOI 10.1016/0014-5793(92)80916-5; Jones S, 2000, PROTEIN ENG, V13, P77, DOI 10.1093/protein/13.2.77; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Jusko M, 2012, J IMMUNOL, V188, P2338, DOI 10.4049/jimmunol.1101240; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karim AY, 2010, BIOL CHEM, V391, P105, DOI 10.1515/BC.2010.009; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Keeling PJ, 2009, CURR OPIN GENET DEV, V19, P613, DOI 10.1016/j.gde.2009.10.001; Khan AR, 1998, PROTEIN SCI, V7, P815; Klein T, 2011, J PROTEOME RES, V10, P17, DOI 10.1021/pr100556z; Koziel J, 2010, J INNATE IMMUN, V2, P288, DOI 10.1159/000281881; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Leonard JD, 2005, BIOCHEM J, V387, P797, DOI 10.1042/BJ20041727; Loechel F, 1999, J BIOL CHEM, V274, P13427, DOI 10.1074/jbc.274.19.13427; Marino G, 2012, PHYSIOL PLANTARUM, V145, P196, DOI 10.1111/j.1399-3054.2011.01544.x; Massova I, 1998, FASEB J, V12, P1075, DOI 10.1096/fasebj.12.12.1075; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moncrief JS, 1998, INFECT IMMUN, V66, P1735, DOI 10.1128/IAI.66.4.1735-1739.1998; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; MURPHY GJP, 1991, FEBS LETT, V289, P4, DOI 10.1016/0014-5793(91)80895-A; NAGASE H, 1990, BIOCHEMISTRY-US, V29, P5783, DOI 10.1021/bi00476a020; Nagase H, 1997, BIOL CHEM, V378, P151; Ng N, 2013, ACTA CRYSTALLOGR F, V69, P912, DOI 10.1107/S1744309113018927; Ng NM, 2013, STRUCTURE, V21, P2003, DOI 10.1016/j.str.2013.08.024; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pomerantsev AP, 2011, PROTEIN EXPRES PURIF, V80, P80, DOI 10.1016/j.pep.2011.05.016; Potempa J, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P883, DOI 10.1016/B978-0-12-382219-2.00185-X; REINEMER P, 1994, FEBS LETT, V338, P227, DOI 10.1016/0014-5793(94)80370-6; Rosenblum G, 2007, J AM CHEM SOC, V129, P13566, DOI 10.1021/ja073941l; Sang QXA, 1996, J PROTEIN CHEM, V15, P137, DOI 10.1007/BF01887395; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Skottrup PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048537; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; STETLERSTEVENSON WG, 1991, AM J MED SCI, V302, P163, DOI 10.1097/00000441-199109000-00009; STOCKER W, 1995, CURR OPIN STRUC BIOL, V5, P383, DOI 10.1016/0959-440X(95)80101-4; STOCKER W, 1995, PROTEIN SCI, V4, P823; Stocker W., 2013, PROTEASES STRUCTURE, P235, DOI DOI 10.1007/978-3-7091-0885-7; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; Takeda S, 2012, BBA-PROTEINS PROTEOM, V1824, P164, DOI 10.1016/j.bbapap.2011.04.009; Tallant C, 2006, J BIOL CHEM, V281, P17920, DOI 10.1074/jbc.M600907200; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Vendrell J, 2000, BBA-PROTEIN STRUCT M, V1477, P284, DOI 10.1016/S0167-4838(99)00280-0; Waltersperger S, 2010, PROTEINS, V78, P2720, DOI 10.1002/prot.22777; Wetmore DR, 1996, BIOCHEMISTRY-US, V35, P6549, DOI 10.1021/bi9530752; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woessner J.F., 2000, PROTEIN PROFILE SER; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Gomis-Ruth FX, 2013, STRUCTURE, V21, P1909, DOI 10.1016/j.str.2013.10.004; Gomis-Ruth FX, 2012, BIOL CHEM, V393, P1027, DOI 10.1515/hsz-2012-0149; Gomis-Ruth FX, 2012, BBA-PROTEINS PROTEOM, V1824, P157, DOI 10.1016/j.bbapap.2011.04.014; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Yu ACY, 2012, STRUCTURE, V20, P707, DOI 10.1016/j.str.2012.02.015	109	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4728	4740		10.1074/jbc.M114.605956	http://dx.doi.org/10.1074/jbc.M114.605956			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25555916	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000350042000016
J	Zhao, NN; Nizzi, CP; Anderson, SA; Wang, JH; Ueno, A; Tsukamoto, H; Eisenstein, RS; Enns, CA; Zhang, AS				Zhao, Ningning; Nizzi, Christopher P.; Anderson, Sheila A.; Wang, Jiaohong; Ueno, Akiko; Tsukamoto, Hidekazu; Eisenstein, Richard S.; Enns, Caroline A.; Zhang, An-Sheng			Low Intracellular Iron Increases the Stability of Matriptase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE TMPRSS6; HEPCIDIN EXPRESSION; JUVENILE HEMOCHROMATOSIS; REGULATORY PROTEINS; CELL-SURFACE; MITOCHONDRIAL ACONITASE; DOWN-REGULATION; HUMAN LIVER; RAT-LIVER; HEMOJUVELIN	Matriptase-2 (MT2) is a type II transmembrane serine protease that is predominantly expressed in hepatocytes. It suppresses the expression of hepatic hepcidin, an iron regulatory hormone, by cleaving membrane hemojuvelin into an inactive form. Hemojuvelin is a bone morphogenetic protein (BMP) co-receptor. Here, we report that MT2 is up-regulated under iron deprivation. In HepG2 cells stably expressing the coding sequence of the MT2 gene, TMPRSS6, incubation with apotransferrin or the membrane-impermeable iron chelator, deferoxamine mesylate salt, was able to increase MT2 levels. This increase did not result from the inhibition of MT2 shedding from the cells. Rather, studies using a membrane-permeable iron chelator, salicylaldehyde isonicotinoyl hydrazone, revealed that depletion of cellular iron was able to decrease the degradation of MT2 independently of internalization. We found that lack of the putative endocytosis motif in its cytoplasmic domain largely abolished the sensitivity of MT2 to iron depletion. Neither acute nor chronic iron deficiency was able to alter the association of Tmprss6 mRNA with polyribosomes in the liver of rats indicating a lack of translational regulation by low iron levels. Studies in mice showed that Tmprss6 mRNA was not regulated by iron nor the BMP-mediated signaling with no evident correlation with either Bmp6 mRNA or Id1 mRNA, a target of BMP signaling. These results suggest that regulation of MT2 occurs at the level of protein degradation rather than by changes in the rate of internalization and translational or transcriptional mechanisms and that the cytoplasmic domain of MT2 is necessary for its regulation.	[Enns, Caroline A.; Zhang, An-Sheng] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Nizzi, Christopher P.; Anderson, Sheila A.; Eisenstein, Richard S.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Wang, Jiaohong; Ueno, Akiko; Tsukamoto, Hidekazu] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Tsukamoto, Hidekazu] Greater Los Angeles Healthcare Syst, Dept Vet Affairs, Los Angeles, CA 90073 USA	Oregon Health & Science University; University of Wisconsin System; University of Wisconsin Madison; University of Southern California	Zhang, AS (corresponding author), Oregon Hlth & Sci Univ, Dept Cell & Dev Biol L215, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	zhanga@ohsu.edu			National Institutes of Health [DK080765, DK102791, DK054488, K99DK104066, DK066600, P50AA11199, R24AA12885]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066600, R56DK066600, K99DK104066, R01DK102791, R01DK072166, R01DK054488, R01DK080765, R37DK054488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK080765 and DK102791 (to A. S. Z.), DK054488 (to C. A. E.), K99DK104066 (to N. Z.), DK066600 (to R. S. E.), P50AA11199 (to H. T.), and R24AA12885 (to H. T.).	Anderson SA, 2013, CELL METAB, V17, P282, DOI 10.1016/j.cmet.2013.01.007; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Anthony TG, 2001, J NUTR, V131, P1171, DOI 10.1093/jn/131.4.1171; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2011, SEMIN LIVER DIS, V31, P280, DOI 10.1055/s-0031-1286059; BAKER E, 1985, AM J PHYSIOL, V248, pG93, DOI 10.1152/ajpgi.1985.248.1.G93; Beliveau F, 2011, J BIOL CHEM, V286, P29035, DOI 10.1074/jbc.M111.223461; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; Chen OS, 1998, J NUTR, V128, P525, DOI 10.1093/jn/128.3.525; Chen W, 2011, BLOOD, V117, P6319, DOI 10.1182/blood-2010-12-327957; De Domenico I, 2008, CELL METAB, V8, P146, DOI 10.1016/j.cmet.2008.07.002; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Enns CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060534; Enns CA, 2012, J BIOL CHEM, V287, P35104, DOI 10.1074/jbc.M112.363937; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Finberg KE, 2010, BLOOD, V115, P3817, DOI 10.1182/blood-2009-05-224808; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Gkouvatsos K, 2011, HEPATOLOGY, V54, P1800, DOI 10.1002/hep.24547; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Larsen BR, 2013, EXP CELL RES, V319, P918, DOI 10.1016/j.yexcr.2013.01.008; Lee DH, 2010, BLOOD, V115, P3136, DOI 10.1182/blood-2009-11-251199; Li HH, 2010, NAT MED, V16, P177, DOI 10.1038/nm.2073; Maurer E, 2013, BIOCHEM J, V450, P583, DOI 10.1042/BJ20121518; Maxson JE, 2010, J BIOL CHEM, V285, P39021, DOI 10.1074/jbc.M110.183160; Meynard D, 2011, BLOOD, V118, P747, DOI 10.1182/blood-2011-04-348698; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nai A, 2010, BLOOD, V116, P851, DOI 10.1182/blood-2010-04-278655; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Parr C, 2010, ANTI-CANCER AGENT ME, V10, P47, DOI 10.2174/1871520611009010047; Ramsay AJ, 2009, HAEMATOL-HEMATOL J, V94, P840, DOI 10.3324/haematol.2008.001867; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Schalinske KL, 1996, J BIOL CHEM, V271, P7168, DOI 10.1074/jbc.271.12.7168; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Stirnberg M, 2010, BIOCHEM J, V430, P87, DOI 10.1042/BJ20091565; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Uhles S, 2007, FASEB J, V21, P1609, DOI 10.1096/fj.06-7589com; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; Young SP, 1997, FEBS LETT, V411, P93, DOI 10.1016/S0014-5793(97)00478-X; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292; Zhang AS, 2010, J BIOL CHEM, V285, P16416, DOI 10.1074/jbc.M110.109488; Zhang AS, 2009, J BIOL CHEM, V284, P22580, DOI 10.1074/jbc.M109.027318; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200; Zhao BY, 2013, J BIOL CHEM, V288, P11155, DOI 10.1074/jbc.M113.454611; Zhao NN, 2014, P NATL ACAD SCI USA, V111, P9175, DOI 10.1073/pnas.1405355111; Zhao NN, 2013, J CLIN INVEST, V123, P2337, DOI 10.1172/JCI67225; Zhao NN, 2010, J BIOL CHEM, V285, P32141, DOI 10.1074/jbc.M110.143248	53	39	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4432	4446		10.1074/jbc.M114.611913	http://dx.doi.org/10.1074/jbc.M114.611913			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25550162	Green Published, hybrid			2022-12-26	WOS:000349458400050
J	Chun, YH; Han, K; Park, SH; Park, KM; Yim, HW; Lee, WC; Park, YG; Park, YM				Chun, Yoon Hong; Han, Kyungdo; Park, Shin Hae; Park, Kyung-Min; Yim, Hyeon Woo; Lee, Won-Chul; Park, Yong Gyu; Park, Yong-Moon			Insulin Resistance Is Associated with Intraocular Pressure Elevation in a Non-Obese Korean Population	PLOS ONE			English	Article							METABOLIC SYNDROME; OBESITY; EYE; HYPERTENSION; STIMULATION; OSTEOCALCIN; GLAUCOMA; DISEASES	Based on reports of an association between elevated intraocular pressure (IOP) and metabolic syndrome (MetS), and the major role of insulin resistance (IR) in MetS pathogenesis, a positive association between IOP and IR has been hypothesized. Although Asian populations tend to have lower body mass indices (BMIs) than Western populations, they tend to have a higher risk of developing MetS. This study examined the hypothesis that the association between IOP and IR differs by obesity status in an Asian population, by examining a nationally representative sample of South Korean adults. Data collected from 4,621 South Korean adults regarding demographic, lifestyle, and laboratory parameters by the 2010 Korea National Health and Nutrition Examination Survey were subjected to linear regression analysis to evaluate the relationship between IOP and metabolic profiles. After adjusting for confounding factors, the data were subjected to multiple linear regression analysis to examine the association between IR, as measured by the homeostasis model assessment of insulin resistance (HOMA-IR), and IOP. Obesity was defined as BMI >= 27.5 kg/m(2), and the subjects were divided into obese vs. non-obese groups for investigation of the association between IR and IOP according to obesity status. IOP was found to correlate with fasting blood sugar, total cholesterol, insulin, and HOMA-IR values in non-obese men; and with BMI, waist circumference, triglycerides, total cholesterol, HOMA-IR, and low-density lipoprotein cholesterol values in non-obese women, whereas no association between IOP and IR was found in obese men or women. IOP was significantly associated with IR in non-obese men and women after adjusting for age, and in non-obese men after adjusting for age, BMI, and lifestyle and demographic factors. These findings indicate that a positive and independent relationship exists between IOP and IR in non-obese individuals only, suggesting that other factors likely contribute to IOP elevation in obese individuals.	[Chun, Yoon Hong] Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Dept Pediat, Seoul, South Korea; [Han, Kyungdo; Park, Yong Gyu] Catholic Univ Korea, Dept Biostat, Seoul, South Korea; [Park, Shin Hae] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Park, Kyung-Min] Catholic Univ Korea, Sch Med, Seoul, South Korea; [Yim, Hyeon Woo; Lee, Won-Chul; Park, Yong-Moon] Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Yong-Moon] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Park, YM (corresponding author), Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul, South Korea.	markYMpark@gmail.com	PARK, YONG-MOON ("MARK")/ABA-2765-2021	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879; Park, Yong Gyu/0000-0002-8721-3230; Chun, Yoon Hong/0000-0002-9871-5244				Chang YC, 2010, EYE, V24, P1037, DOI 10.1038/eye.2009.247; Cheung N, 2007, SURV OPHTHALMOL, V52, P180, DOI 10.1016/j.survophthal.2006.12.003; Choi YJ, 2011, DIABETES METAB J, V35, P587, DOI 10.4093/dmj.2011.35.6.587; Civan MM, 2004, EXP EYE RES, V78, P625, DOI 10.1016/j.exer.2003.09.021; dos Santos MG, 1998, OPHTHALMOLOGY, V105, P2260, DOI 10.1016/S0161-6420(98)91226-X; EAKINS KE, 1967, J PHARMACOL EXP THER, V157, P524; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Ferron M, 2014, ARCH BIOCHEM BIOPHYS, V561, P137, DOI 10.1016/j.abb.2014.05.022; GALLAR J, 1993, INVEST OPHTH VIS SCI, V34, P596; Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002; GREAVES DP, 1952, BRIT J OPHTHALMOL, V36, P258, DOI 10.1136/bjo.36.5.258; Imai K, 2010, INT J OBESITY, V34, P1209, DOI 10.1038/ijo.2010.32; Jain A, 2012, INVEST OPHTH VIS SCI, V53, P857, DOI 10.1167/iovs.11-8497; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kelley DE, 2000, AM J PHYSIOL-ENDOC M, V278, pE941, DOI 10.1152/ajpendo.2000.278.5.E941; Kim MK, 2014, CLIN ENDOCRINOL, V80, P214, DOI 10.1111/cen.12162; LANDSBERG L, 1994, J CARDIOVASC PHARM, V23, pS1, DOI 10.1097/00005344-199423001-00002; Lee MK, 2012, OPHTHALMOLOGY, V119, P450, DOI 10.1016/j.ophtha.2011.09.016; Lim SG, 2014, J CLIN PERIODONTOL, V41, P121, DOI 10.1111/jcpe.12196; Lin CP, 2012, EUR J INTERN MED, V23, P76, DOI 10.1016/j.ejim.2011.06.002; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Oh SW, 2005, DIABETES-METAB RES, V21, P434, DOI 10.1002/dmrr.529; Oh SW, 2004, OBES RES, V12, P2031, DOI 10.1038/oby.2004.254; Park BJ, 2013, MENOPAUSE, V20, P742, DOI [10.1097/gme.0b013e31827ce3c6, 10.1097/GME.0b013e31827ce3c6]; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Schlaich M, 2014, LANCET DIABETES ENDO; SHIOSE Y, 1990, SURV OPHTHALMOL, V34, P413, DOI 10.1016/0039-6257(90)90122-C; Silvestri C, 2013, J BIOL CHEM, V288, P23307, DOI 10.1074/jbc.M113.489906; Stevens GA, 2013, OPHTHALMOLOGY, V120, P2377, DOI 10.1016/j.ophtha.2013.05.025; Tan GS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1354, DOI 10.1001/archophthalmol.2009.268; Wallace TM, 2002, DIABETIC MED, V19, P527, DOI 10.1046/j.1464-5491.2002.00745.x; Westphal Sydney A, 2008, Clin Cornerstone, V9, P23, DOI 10.1016/S1098-3597(08)60025-3; WHO, 2004, LANCET, V363, P902; Wu SY, 1997, ARCH OPHTHALMOL-CHIC, V115, P1572, DOI 10.1001/archopht.1997.01100160742012; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	36	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2015	10	1							e112929	10.1371/journal.pone.0112929	http://dx.doi.org/10.1371/journal.pone.0112929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3BG	25559470	Green Published, gold, Green Submitted			2022-12-26	WOS:000348102200005
J	Derouet, MF; Liu, G; Darling, GE				Derouet, Mathieu Francois; Liu, Geoffrey; Darling, Gail Elizabeth			MiR-145 Expression Accelerates Esophageal Adenocarcinoma Progression by Enhancing Cell Invasion and Anoikis Resistance	PLOS ONE			English	Article							MICRORNA EXPRESSION; CANCER PROGRESSION; ALPHA-5-BETA-1; METASTASIS	Background: Carcinoma of the esophagus has a high case fatality ratio and is now the 6th most common cause of cancer deaths in the world. We previously conducted a study to profile the expression of miRNAs in esophageal adenocarcinoma (EAC) pre and post induction therapy. Of the miRNAs differentially expressed post induction chemoradiation, miR-145, a known tumor suppressor miRNA, was upregulated 8-fold following induction therapy, however, its expression was associated with shorter disease-free survival. This unexpected result was explored in this current study. Methods: In order to study the role of miR-145 in EAC, miRNA-145 was overexpressed in 3 EAC cell lines (OE33, FLO-1, SK-GT-4) and one ESCC cell line (KYSE-410). After validation of the expression of miR-145, hallmarks of cancer such as cell proliferation, resistance to chemotherapy drugs or anoikis, and cell invasion were analyzed. Results: There were no differences in cell proliferation and 5 FU resistance between miR145 cell lines and the control cell lines. miR-145 expression also had no effect on cisplatin resistance in two of three cell lines (OE33 and FLO-1), but miR-145 appeared to protect SK-GT-4 cells against cisplatin treatment. However, there was a significant difference in cell invasion, cell adhesion and resistance to anoikis. All three EAC miR-145 cell lines invaded more than their respective controls. Similarly, OE33 and SK-GT-4 miR-145 cell lines were able to survive longer in a suspension state. Discussion: While expression of miR-145 in ESCC stopped proliferation and invasion, expression of miR-145 in EAC cells enhanced invasion and anoikis resistance. Although more work is required to understand how miR-145 conveys these effects, expression of miR-145 appears to promote EAC progression by enhancing invasion and protection against anoikis, which could in turn facilitate distant metastasis.	[Derouet, Mathieu Francois] Univ Hlth Network, Latner Thorac Surg Res Labs, Toronto, ON, Canada; [Liu, Geoffrey] Univ Hlth Network Toronto, Princess Margaret Hosp, Dept Med Oncol, Toronto, ON, Canada; [Darling, Gail Elizabeth] Univ Hlth Network, Toronto Gen Hosp, Div Thorac Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Derouet, MF (corresponding author), Univ Hlth Network, Latner Thorac Surg Res Labs, Toronto Discovery Med Tower, Toronto, ON, Canada.	mderouet@uhnresearch.ca	Liu, Geoffrey/N-4421-2016	Liu, Geoffrey/0000-0002-2603-7296	Kress Family Chair in Esophageal Surgery	Kress Family Chair in Esophageal Surgery	This work was supported by the Kress Family Chair in Esophageal Surgery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir S, 2014, PLOS ONE, V8; Arndt GM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-374; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beausejour M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-53; BLOT WJ, 1994, SEMIN ONCOL, V21, P403; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen Z, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-151; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabbri M, 2007, EXPERT OPIN BIOL TH, V7, P1009, DOI 10.1517/14712598.7.7.1009; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Hvid-Jensen F, 2011, NEW ENGL J MED, V365, P1375, DOI 10.1056/NEJMoa1103042; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kano M, 2010, INT J CANC; Ko MA, 2012, ANN THORAC SURG, V94, P1094, DOI 10.1016/j.athoracsur.2012.04.145; Korah R, 2004, CANCER RES, V64, P4514, DOI 10.1158/0008-5472.CAN-03-3853; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Lin CW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2876; Liu D, 2014, BIOCHEM BIOPH RES CO, V446, P549, DOI 10.1016/j.bbrc.2014.03.002; Liu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033987; Mitra AK, 2011, ONCOGENE, V30, P1566, DOI 10.1038/onc.2010.532; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pagliuca A, 2013, ONCOGENE, V32, P4806, DOI 10.1038/onc.2012.495; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020341; Roman J, 2010, AM J RESP CELL MOL, V43, P684, DOI 10.1165/rcmb.2009-0375OC; Tang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035435; Valeri N, 2014, CANCER CELL, V25, P469, DOI 10.1016/j.ccr.2014.03.006; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Yin Y, 2013, BBA-GENE REGUL MECH, V1829, P239, DOI 10.1016/j.bbagrm.2012.11.006; Yuan W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102017	32	31	32	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115589	10.1371/journal.pone.0115589	http://dx.doi.org/10.1371/journal.pone.0115589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551563	gold, Green Submitted, Green Published			2022-12-26	WOS:000347119100046
J	Dudkina, E; Kayumov, A; Ulyanova, V; Ilinskaya, O				Dudkina, Elena; Kayumov, Airat; Ulyanova, Vera; Ilinskaya, Olga			New Insight into Secreted Ribonuclease Structure: Binase Is a Natural Dimer	PLOS ONE			English	Article							BOVINE SEMINAL RIBONUCLEASE; BACILLUS-INTERMEDIUS-RIBONUCLEASE; CRYSTAL-STRUCTURE; CELL-DEATH; RNASE; PROTEIN; BARNASE; BARSTAR; DOMAIN; CYTOTOXICITY	The biological effects of ribonucleases (RNases), such as the control of the blood vessels growth, the toxicity towards tumour cells and antiviral activity, require a detailed explanation. One of the most intriguing properties of RNases which can contribute to their biological effects is the ability to form dimers, which facilitates efficient RNA hydrolysis and the evasion of ribonuclease inhibitor. Dimeric forms of microbial RNase binase secreted by Bacillus pumilus (former B. intermedius) have only been found in crystals to date. Our study is the first report directly confirming the existence of binase dimers in solution and under natural conditions of enzyme biosynthesis and secretion by bacilli. Using different variants of gel electrophoresis, immunoblotting, size-exclusion chromatography and mass-spectrometry, we revealed that binase is a stable natural dimer with high catalytic activity.	[Dudkina, Elena; Kayumov, Airat; Ulyanova, Vera; Ilinskaya, Olga] Kazan Fed Volga Reg Univ, Inst Fundamental Med & Biol, Kazan, Russia	Kazan Federal University	Dudkina, E (corresponding author), Kazan Fed Volga Reg Univ, Inst Fundamental Med & Biol, Kazan, Russia.	lenatimonina@rambler.ru	Kayumov, Airat/M-6725-2013; Ulyanova, Vera/A-9427-2014; Ilinskaya, Olga N/A-7458-2014; Dudkina, Elena/G-4318-2016	Kayumov, Airat/0000-0001-7195-1557; Ulyanova, Vera/0000-0003-1768-3314; Ilinskaya, Olga N/0000-0001-6936-2032; Dudkina, Elena/0000-0002-2817-1384	Russian Research Foundation [14 -14-00522]	Russian Research Foundation	This work was performed in frames of the Russian Government Program for Competitive Growth of Kazan Federal University and supported by the Russian Research Foundation (project No 14 -14-00522). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababou A, 2007, BIOPHYS CHEM, V125, P221, DOI 10.1016/j.bpc.2006.08.003; APHANASENKO GA, 1979, FEBS LETT, V97, P77, DOI 10.1016/0014-5793(79)80056-3; Arnold U, 2011, FEBS J, V278, P331, DOI 10.1111/j.1742-4658.2010.07957.x; Bertram R, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00006; Boix E, 2013, BIOCHIMIE, V95, P1087, DOI 10.1016/j.biochi.2012.12.015; Cabrera-Fuentes HA, 2013, TOXICON, V69, P219, DOI 10.1016/j.toxicon.2013.03.015; CAFARO V, 1995, FEBS LETT, V359, P31, DOI 10.1016/0014-5793(94)01450-F; Cook GM, 2013, BBA-GENE REGUL MECH, V1829, P523, DOI 10.1016/j.bbagrm.2013.02.007; Cui ZH, 2005, BIOINFORMATION, V1, P28, DOI 10.6026/97320630001028; Ercole C, 2011, ARCH BIOCHEM BIOPHYS, V506, P123, DOI 10.1016/j.abb.2010.11.014; Ermakova E, 2007, BIOPHYS CHEM, V130, P26, DOI 10.1016/j.bpc.2007.06.012; Faizullin D. A., 1995, MOL BIOL, V29, P563; Fuentes H. A. Cabrera, 2012, Biomeditsinskaya Khimiya, V58, P272; Garvie CW, 2013, BBA-PROTEINS PROTEOM, V1834, P1562, DOI 10.1016/j.bbapap.2013.04.010; Gotte G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046804; Hahnen E, 2000, MOL GEN GENET, V263, P571; HARTLEY RW, 1988, J MOL BIOL, V202, P913, DOI 10.1016/0022-2836(88)90568-2; Ilinskaya ON, 2002, PROTEIN SCI, V11, P2522, DOI 10.1110/ps.0216702; Ilinskaya ON, 1996, MUTAT RES-FUND MOL M, V354, P203, DOI 10.1016/0027-5107(96)00012-7; Kayumov A, 2011, FEBS J, V278, P1779, DOI 10.1111/j.1742-4658.2011.08102.x; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JE, 2005, BIOCHEMISTRY-US, V44, P15760, DOI 10.1021/bi051668z; Lin RJ, 2013, NUCLEIC ACIDS RES, V41, P3314, DOI 10.1093/nar/gkt019; Liu YS, 1998, P NATL ACAD SCI USA, V95, P3437, DOI 10.1073/pnas.95.7.3437; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; MAKAROV AA, 1993, J BIOMOL STRUCT DYN, V10, P1047, DOI 10.1080/07391102.1993.10508695; MAZZARELLA L, 1993, ACTA CRYSTALLOGR D, V49, P389, DOI 10.1107/S0907444993003403; Merlino A, 2008, J MOL BIOL, V376, P427, DOI 10.1016/j.jmb.2007.11.008; Mitkevich VA, 2013, ACTA CRYSTALLOGR D, V69, P991, DOI 10.1107/S0907444913004046; Mitkevich VA, 2011, CELL CYCLE, V10, P4090, DOI 10.4161/cc.10.23.18210; Mitkevich VA, 2010, CELL CYCLE, V9, P2674, DOI 10.4161/cc.9.13.12150; Park C, 2000, PROTEIN SCI, V9, P2026, DOI 10.1110/ps.9.10.2026; PAVLOVSKII AG, 1989, KRISTALLOGRAFIYA+, V34, P137; PICCOLI R, 1992, P NATL ACAD SCI USA, V89, P1870, DOI 10.1073/pnas.89.5.1870; Poliakov K M, 2010, Mol Biol (Mosk), V44, P922; Polyakov KM, 2002, ACTA CRYSTALLOGR D, V58, P744, DOI 10.1107/S0907444902003207; Reibarkh MY, 1998, FEBS LETT, V431, P250, DOI 10.1016/S0014-5793(98)00765-0; Schulga A, 1998, PROTEIN ENG, V11, P775, DOI 10.1093/protein/11.9.775; SCHULGA AA, 1992, NUCLEIC ACIDS RES, V20, P2375, DOI 10.1093/nar/20.9.2375; Shah Mahmud R, 2013, ACTA NATURAE, V5, P44, DOI 10.32607/20758251-2013-5-4-44-51; Shirshikov FV, 2013, MED HYPOTHESES, V81, P328, DOI 10.1016/j.mehy.2013.04.006; Shlyakhovenko V. A., 2009, Experimental Oncology, V31, P127; Ulyanova V, 2011, FEBS J, V278, P3633, DOI 10.1111/j.1742-4658.2011.08294.x; VESCIA S, 1981, MOL CELL BIOCHEM, V36, P125, DOI 10.1007/BF02357027; Znamenskaya L. V., 1995, Mikrobiologiya, V64, P616; Zuo YH, 2002, J BIOL CHEM, V277, P50160, DOI 10.1074/jbc.M207707200	47	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115818	10.1371/journal.pone.0115818	http://dx.doi.org/10.1371/journal.pone.0115818			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551440	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100065
J	Lima, VD; Xavier, SCD; Maldonado, IFR; Roque, ALR; Vicente, ACP; Jansen, AM				Lima, Valdirene dos Santos; das Chagas Xavier, Samanta Cristina; Roman Maldonado, Irene Fabiola; Rodrigues Roque, Andre Luiz; Paulo Vicente, Ana Carolina; Jansen, Ana Maria			Expanding the Knowledge of the Geographic Distribution of Trypanosoma cruzi TcII and TcV/TcVI Genotypes in the Brazilian Amazon	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RIO-DE-JANEIRO; CHAGAS-DISEASE; MOLECULAR EPIDEMIOLOGY; CONSERVATION UNIT; DOMESTIC MAMMALS; WILD; TRANSMISSION; LINEAGES; INFECTION	Trypanosoma cruzi infection is a complex sylvatic enzooty involving a wide range of animal species. Six discrete typing units (DTUs) of T. cruzi, named TcI to TcVI, are currently recognized. One unanswered question concerning the epidemiology of T. cruzi is the distribution pattern of TcII and hybrid DTUs in nature, including their virtual absence in the Brazilian Amazon, the current endemic area of Chagas disease in Brazil. Herein, we characterized biological samples that were collected in previous epizootiological studies carried out in the Amazon Basin in Brazil. We performed T. cruzi genotyping using four polymorphic genes to identify T. cruzi DTUs: mini-exon, 1f8, histone 3 and gp72. This analysis was conducted in the following biological samples: (i) two T. cruzi isolates obtained by culturing of stools from the triatomine species Rhodnius picttipes and (ii) five serum samples from dogs in which trypomastigotes were observed during fresh blood examination. We report for the first time the presence of TcII and hybrid DTUs (TcV/TcVI) in the Amazon region in mixed infections with TcI. Furthermore, sequencing of the constitutive gene, gp72, demonstrated diversity in TcII even within the same forest fragment. These data show that TcII is distributed in the five main Brazilian biomes and is likely more prevalent than currently described. It is very probable that there is no biological or ecological barrier to the transmission and establishment of any DTU in any biome in Brazil.	[Lima, Valdirene dos Santos; das Chagas Xavier, Samanta Cristina; Roman Maldonado, Irene Fabiola; Rodrigues Roque, Andre Luiz; Jansen, Ana Maria] Fiocruz MS, Fundacao Oswaldo Cruz, Lab Biol Tripanosomatideos, BR-21045900 Rio De Janeiro, Brazil; [Paulo Vicente, Ana Carolina] Fiocruz MS, Lab Genet Mol Microorganismos, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Jansen, AM (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Lab Biol Tripanosomatideos, BR-21045900 Rio De Janeiro, Brazil.	jansen@ioc.fiocruz.br	Roque, André Luiz Rodrigues/W-7528-2019	Jansen, Ana Maria/0000-0001-5804-6210; Roman Maldonado, Irene Fabiola/0000-0001-5835-3560; Roque, Andre/0000-0002-8740-052X; Xavier, Samanta Cristina/0000-0002-3475-0075	Fundacao Oswaldo Cruz - FIOCRUZ; European Union [223034 - ChagasEpiNet]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Fundacao Oswaldo Cruz - FIOCRUZ; European Union(European Commission); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was funded by Fundacao Oswaldo Cruz - FIOCRUZ; the European Union Seventh Framework Program Grant 223034 - ChagasEpiNet; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). All isolates in the present study originated from ColTryp/IOC-FIOCRUZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliaga C, 2011, INFECT GENET EVOL, V11, P1155, DOI 10.1016/j.meegid.2010.11.013; Araujo CAC, 2011, EXP PARASITOL, V127, P308, DOI 10.1016/j.exppara.2010.07.013; Azambuja P, 2004, EXP PARASITOL, V107, P89, DOI 10.1016/j.exppara.2004.04.007; Barnabe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082269; Birky CW, 1996, GENETICS, V144, P427; Briones MRS, 1999, MOL BIOCHEM PARASIT, V104, P219, DOI 10.1016/S0166-6851(99)00155-3; Chagas C, 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; Coura JR, 2002, TRENDS PARASITOL, V18, P171, DOI 10.1016/S1471-4922(01)02200-0; Valente SADS, 2009, T ROY SOC TROP MED H, V103, P291, DOI 10.1016/j.trstmh.2008.10.047; Xavier SCD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001647; de Freitas JM, 2006, PLOS PATHOG, V2, P226, DOI 10.1371/journal.ppat.0020024; De Meeus T, 2006, INFECT GENET EVOL, V6, P163, DOI 10.1016/j.meegid.2005.02.004; Fernandes O, 2001, T ROY SOC TROP MED H, V95, P97, DOI 10.1016/S0035-9203(01)90350-5; Ferreira LF, 2000, ACTA TROP, V75, P79, DOI 10.1016/S0001-706X(99)00095-9; Breniere SF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001650; Guhl F, 2000, MEM I OSWALDO CRUZ, V95, P553, DOI 10.1590/S0074-02762000000400018; Herrera C, 2007, INFECT GENET EVOL, V7, P535, DOI 10.1016/j.meegid.2006.12.003; Herrera HM, 2008, T ROY SOC TROP MED H, V102, P1133, DOI 10.1016/j.trstmh.2008.04.041; JANSEN AM, 1991, EXP PARASITOL, V73, P249, DOI 10.1016/0014-4894(91)90096-F; Lewis MD, 2009, AM J TROP MED HYG, V81, P1041, DOI 10.4269/ajtmh.2009.09-0305; Lima VS, 2008, EMERG INFECT DIS, V14, P1001, DOI 10.3201/eid1406.070707; Lisboa CV, 2006, PARASITOLOGY, V133, P603, DOI 10.1017/S0031182006000722; Lisboa CV, 2009, VET PARASITOL, V165, P19, DOI 10.1016/j.vetpar.2009.07.002; Lisboa CV, 2000, MEM I OSWALDO CRUZ, V95, P445, DOI 10.1590/S0074-02762000000400002; Llewellyn MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000410; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; Marcili A, 2009, PARASITOLOGY, V136, P641, DOI 10.1017/S0031182009005861; Marcili A, 2009, INT J PARASITOL, V39, P615, DOI 10.1016/j.ijpara.2008.09.015; Mejia-Jaramillo AM, 2009, EXP PARASITOL, V121, P83, DOI 10.1016/j.exppara.2008.10.002; Mello CB, 1996, EXP PARASITOL, V82, P112, DOI 10.1006/expr.1996.0015; Miles MA, 2009, PARASITOLOGY, V136, P1509, DOI 10.1017/S0031182009990977; Monteiro WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041284; Pennington PM, 2009, AM J TROP MED HYG, V80, P239, DOI 10.4269/ajtmh.2009.80.239; Pinho AP, 2000, T ROY SOC TROP MED H, V94, P509, DOI 10.1016/S0035-9203(00)90069-5; Rocha FL, 2013, PARASITOLOGY, V140, P160, DOI 10.1017/S0031182012001539; Roque ALR, 2008, AM J TROP MED HYG, V79, P742, DOI 10.4269/ajtmh.2008.79.742; Roque ALR, 2013, VET PARASITOL, V193, P71, DOI 10.1016/j.vetpar.2012.11.028; Rozas M, 2007, J INFECT DIS, V195, P1381, DOI 10.1086/513440; Santos-Mallet JR, 2008, PARASITOL RES, V103, P1041, DOI 10.1007/s00436-008-1089-y; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TIBAYRENC M, 1986, P NATL ACAD SCI USA, V83, P115, DOI 10.1073/pnas.83.1.115; TIBAYRENC M, 1987, PARASITOL TODAY, V3, P189, DOI 10.1016/0169-4758(87)90179-7; Toledo A, 2013, AM J TROP MED HYG, V88, P285, DOI 10.4269/ajtmh.2012.12-0227; Vallejo GA, 1999, ACTA TROP, V72, P203, DOI 10.1016/S0001-706X(98)00085-0; Westenberger SJ, 2005, GENETICS, V171, P527, DOI 10.1534/genetics.104.038745; Xavier SCC, 2007, PARASITOL INT, V56, P119, DOI 10.1016/j.parint.2007.01.003; Yeo M, 2007, INT J PARASITOL, V37, P111, DOI 10.1016/j.ijpara.2006.08.002; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	48	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116137	10.1371/journal.pone.0116137	http://dx.doi.org/10.1371/journal.pone.0116137			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551227	Green Published, gold			2022-12-26	WOS:000347119100098
J	McGuire, LP; Jonasson, KA; Guglielmo, CG				McGuire, Liam P.; Jonasson, Kristin A.; Guglielmo, Christopher G.			Bats on a Budget: Torpor-Assisted Migration Saves Time and Energy	PLOS ONE			English	Article							BODY-COMPOSITION; TEMPERATURE; BIRDS; HYPOTHERMIA; SELECTION; STOPOVER	Bats and birds must balance time and energy budgets during migration. Migrating bats face similar physiological challenges to birds, but nocturnality creates special challenges for bats, such as a conflict between travelling and refueling, which many birds avoid by feeding in daylight and flying at night. As endothermic animals, bats and birds alike must expend substantial amounts of energy to maintain high body temperatures. For migratory birds refueling at stopovers, remaining euthermic during inactive periods reduces the net refuelling rate, thereby prolonging stopover duration and delaying subsequent movement. We hypothesized that bats could mitigate similar ambient-temperature dependent costs by using a torpor-assisted migration strategy. We studied silver-haired bats Lasionycteris noctivagans during autumn migration using a combination of respirometry and temperature-sensitive radiotelemetry to estimate energy costs incurred under ambient temperature conditions, and the energy that bats saved by using torpor during daytime roosting periods. All bats, regardless of sex, age, or body condition used torpor at stopover and saved up to 91% of the energy they would have expended to remain euthermic. Furthermore, bats modulated use of torpor depending on ambient temperature. By adjusting the time spent torpid, bats achieved a rate of energy expenditure independent of the ambient temperature encountered at stopover. By lowering body temperature during inactive periods, fuel stores are spared, reducing the need for refuelling. Optimal migration models consider trade-offs between time and energy. Heterothermy provides a physiological strategy that allows bats to conserve energy without paying a time penalty as they migrate. Although uncommon, some avian lineages are known to use heterothermy, and current theoretical models of migration may not be appropriate for these groups. We propose that thermoregulatory strategies should be an important consideration of future migration studies of both bats and birds.	[McGuire, Liam P.; Jonasson, Kristin A.; Guglielmo, Christopher G.] Univ Western Ontario, Dept Biol, Adv Facil Avian Res, London, ON, Canada	Western University (University of Western Ontario)	McGuire, LP (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	liam.mcguire@ttu.edu	McGuire, Liam/CAE-8434-2022		Discovery Grant from the Natural Sciences and Engineering Research Council of Canada; Leaders Opportunity Fund Grant from the Canada Foundation for Innovation; Ontario Research Fund [CFI 11826]; Canada Graduate Scholarships from the Natural Sciences and Engineering Research Council of Canada	Discovery Grant from the Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Leaders Opportunity Fund Grant from the Canada Foundation for Innovation; Ontario Research Fund; Canada Graduate Scholarships from the Natural Sciences and Engineering Research Council of Canada	Funding was provided to CGG by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada and a Leaders Opportunity Fund Grant from the Canada Foundation for Innovation and Ontario Research Fund (CFI 11826). LPM and KAJ were supported by Canada Graduate Scholarships from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 1990, BIRD MIGRATION PHYSL, P331, DOI [DOI 10.1007/978-3-642-74542-3_22., 10.1007/978-3-642-74542-3_22]; [Anonymous], 2020, ECONOMIST 0326; BAIRLEIN F, 1994, ANNU REV NUTR, V14, P187, DOI 10.1146/annurev.nu.14.070194.001155; Barclay RMR, 1996, J MAMMAL, V77, P1102, DOI 10.2307/1382791; BARCLAY RMR, 1988, J MAMMAL, V69, P821, DOI 10.2307/1381639; Butler PJ, 2001, J EXP BIOL, V204, P1361; CARPENTER FL, 1988, CONDOR, V90, P373, DOI 10.2307/1368565; Corman AM, 2014, BEHAV ECOL SOCIOBIOL, V68, P391, DOI 10.1007/s00265-013-1653-z; Cryan PM, 2003, J EXP BIOL, V206, P3381, DOI 10.1242/jeb.00574; Dietz C, 2007, BATS BRITAIN EUROPE; EWING WG, 1970, COMP BIOCHEM PHYSIOL, V36, P119, DOI 10.1016/0010-406X(70)90658-4; Geiser F, 2004, LIFE COLD EVOLUTION, P51; Geiser Fritz, 2012, P109; Giavi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085628; Hedenstrom A, 1997, J THEOR BIOL, V189, P227, DOI 10.1006/jtbi.1997.0505; Hedenstrom A, 2009, J MAMMAL, V90, P1298, DOI 10.1644/09-MAMM-S-075R2.1; Humphries MM, 2002, NATURE, V418, P313, DOI 10.1038/nature00828; Kerlinger P, 1989, CURRENT ORNITHOLOGY, V6; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; McGuire LP, 2012, J ANIM ECOL, V81, P377, DOI 10.1111/j.1365-2656.2011.01912.x; McGuire LP, 2010, J MAMMAL, V91, P1375, DOI 10.1644/10-MAMM-A-051.1; McKechnie AE, 2002, CONDOR, V104, P705, DOI 10.1650/0010-5422(2002)104[0705:AFHRAR]2.0.CO;2; McKechnie AE, 2007, J AVIAN BIOL, V38, P261, DOI 10.1111/j.2007.0908-8857.04116.x; McKechnie Andrew E., 2004, Biological Papers of the University of Alaska, V27, P63; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; R Core Team, 2020, R LANG ENV STAT COMP; Schaub M, 2001, ECOLOGY, V82, P852, DOI 10.2307/2680203; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Speakman JR, 2003, BAT ECOLOGY, P430; Speakman JR, 1999, P NUTR SOC, V58, P123, DOI 10.1079/PNS19990017; Stawski C, 2010, NATURWISSENSCHAFTEN, V97, P29, DOI 10.1007/s00114-009-0606-x; Taylor PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027054; Turbill C, 2008, J EXP BIOL, V211, P3871, DOI 10.1242/jeb.023101; Voigt CC, 2012, P ROY SOC B-BIOL SCI, V279, P3772, DOI 10.1098/rspb.2012.0902; Voigt CC, 2010, ECOLOGY, V91, P2908, DOI 10.1890/09-2232.1; Wang LCH, 1978, STRATEGIES COLD NATU, P109; Warnecke L, 2010, J COMP PHYSIOL B, V180, P437, DOI 10.1007/s00360-009-0417-6; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Willis C.K.R., 2008, HYPOMETABOLISM ANIMA, P373; Willis CKR, 2006, NATURWISSENSCHAFTEN, V93, P80, DOI 10.1007/s00114-005-0063-0; Wojciechowski MS, 2007, COMP BIOCHEM PHYS A, V147, P828, DOI 10.1016/j.cbpa.2006.06.039; Wojciechowski MS, 2009, J EXP BIOL, V212, P3068, DOI 10.1242/jeb.033001; Zuur Alain F., 2009, P1	43	46	46	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115724	10.1371/journal.pone.0115724	http://dx.doi.org/10.1371/journal.pone.0115724			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551615	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100054
J	Zhang, YJ; Wang, XJ; Wu, JX; Chen, SY; Chen, H; Chai, LJ; Yi, HL				Zhang, Ya-Jian; Wang, Xing-Jian; Wu, Ju-Xun; Chen, Shan-Yan; Chen, Hong; Chai, Li-Jun; Yi, Hua-Lin			Comparative Transcriptome Analyses between a Spontaneous Late-Ripening Sweet Orange Mutant and Its Wild Type Suggest the Functions of ABA, Sucrose and JA during Citrus Fruit Ripening	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; RNA-SEQ; PEACH FRUIT; EXPRESSION; GENES; SINENSIS; TOOL; L.; IDENTIFICATION; ANNOTATION	A spontaneous late-ripening mutant of 'Jincheng' (C. sinensis L. Osbeck) sweet orange exhibited a delay of fruit pigmentation and harvesting. In this work, we studied the processes of orange fruit ripening through the comparative analysis between the Jincheng mutant and its wild type. This study revealed that the fruit quality began to differ on 166th days after anthesis. At this stage, fruits were subjected to transcriptome analysis by RNA sequencing. 13,412 differentially expressed unigenes (DEGs) were found. Of these unigenes, 75.8% were down-regulated in the wild type, suggesting that the transcription level of wild type was lower than that of the mutant during this stage. These DEGs were mainly clustered into five pathways: metabolic pathways, plant-pathogen interaction, spliceosome, biosynthesis of plant hormones and biosynthesis of phenylpropanoids. Therefore, the expression profiles of the genes that are involved in abscisic acid, sucrose, and jasmonic acid metabolism and signal transduction pathways were analyzed during the six fruit ripening stages. The results revealed the regulation mechanism of sweet orange fruit ripening metabolism in the following four aspects: First, the more mature orange fruits were, the lower the transcription levels were. Second, the expression level of PME boosted with the maturity of the citrus fruit. Therefore, the expression level of PME might represent the degree of the orange fruit ripeness. Third, the interaction of PP2C, PYR/PYL, and SnRK2 was peculiar to the orange fruit ripening process. Fourth, abscisic acid, sucrose, and jasmonic acid all took part in orange fruit ripening process and might interact with each other. These findings provide an insight into the intricate process of sweet orange fruit ripening.	[Zhang, Ya-Jian; Wang, Xing-Jian; Wu, Ju-Xun; Chen, Shan-Yan; Chai, Li-Jun; Yi, Hua-Lin] Huazhong Agr Univ, Minist Educ, Key Lab Hort Plant Biol, Wuhan 430070, Peoples R China; [Zhang, Ya-Jian; Wang, Xing-Jian; Wu, Ju-Xun; Chen, Shan-Yan; Chai, Li-Jun; Yi, Hua-Lin] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China; [Chen, Shan-Yan] Kunming Acad Agr Sci, Kunming 650000, Peoples R China; [Chen, Hong] Huazhong Agr Univ, Engn Technol Coll, Wuhan 430070, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University	Chai, LJ (corresponding author), Huazhong Agr Univ, Minist Educ, Key Lab Hort Plant Biol, Wuhan 430070, Peoples R China.	chailijun@mail.hzau.edu.cn; yihualin@mail.hzau.edu.cn		Wu, Juxun/0000-0003-0785-1927	State Agriculture Research System (SARS) of China; National Natural Science Foundation of China [31301706, 31460507]; Fundamental Research Funds for the Central Universities [2013QC037]; Special Project on the Integration of Industry, Education and Research of Guangdong Province [2012B091100169]	State Agriculture Research System (SARS) of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Special Project on the Integration of Industry, Education and Research of Guangdong Province	This research was funded by the State Agriculture Research System (SARS) of China, the National Natural Science Foundation of China (nos. 31301706, 31460507), the Fundamental Research Funds for the Central Universities (2013QC037), and the Special Project on the Integration of Industry, Education and Research of Guangdong Province (2012B091100169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alos E, 2013, PHYSL PLANTARUM; Bartolozzi F, 1997, J CHROMATOGR A, V758, P99, DOI 10.1016/S0021-9673(96)00709-1; Bianco L, 2009, J PROTEOMICS, V72, P586, DOI 10.1016/j.jprot.2008.11.019; Camacho-Villasana YM, 2002, PLANT MOL BIOL REP, V20, P407, DOI 10.1007/BF02772128; Chai LJ, 2011, PLANT CELL TISS ORG, V104, P1, DOI 10.1007/s11240-010-9793-6; Chernys JT, 2000, PLANT PHYSIOL, V124, P343, DOI 10.1104/pp.124.1.343; Concha CM, 2013, PLANT PHYSIOL BIOCH, V70, P433, DOI 10.1016/j.plaphy.2013.06.008; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Distefano G, 2009, J AGR FOOD CHEM, V57, P7974, DOI 10.1021/jf900710v; Falchi R, 2013, J PLANT GROWTH REGUL, V32, P519, DOI 10.1007/s00344-013-9318-8; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Fortes AM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-149; Gambetta G, 2012, J PLANT GROWTH REGUL, V31, P273, DOI 10.1007/s00344-011-9237-5; Gambetta GA, 2010, PLANTA, V232, P219, DOI 10.1007/s00425-010-1165-2; Gmitter FG, 2012, TREE GENET GENOMES, V8, P611, DOI 10.1007/s11295-012-0499-2; Gouthu S, 2014, J EXP BOT, V65, P5889, DOI 10.1093/jxb/eru329; Guo SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-454; Hu ZY, 2007, J AM SOC HORTIC SCI, V132, P777, DOI 10.21273/JASHS.132.6.777; Huang GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107562; Irfan M, 2014, J EXP BOT, V65, P5835, DOI 10.1093/jxb/eru324; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jia H, 2013, NEW PHYTOLOGIST; Jia HF, 2011, PLANT PHYSIOL, V157, P188, DOI 10.1104/pp.111.177311; Jia HF, 2013, PAK J BOT, V45, P169; Karppinen K, 2013, PHYTOCHEMISTRY, V95, P127, DOI 10.1016/j.phytochem.2013.06.023; Kato M, 2004, PLANT PHYSIOL, V134, P824, DOI 10.1104/pp.103.031104; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liu LH, 2012, J EXP BOT, V63, P5751, DOI 10.1093/jxb/ers224; [LIU Yongzhong 刘永忠], 2006, [华中农业大学学报, Journal of Huazhong Agricultural University], V25, P300; Liu YL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-695; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicolas P, 2013, PLANT PHYSIOL; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Preuss A, 2014, J PLANT PHYSIOL, V171, P1315, DOI 10.1016/j.jplph.2014.06.004; Ren J, 2010, J PLANT PHYSIOL, V167, P1486, DOI 10.1016/j.jplph.2010.05.027; Rios G, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-276; Rodrigo MJ, 2013, SCI HORTIC-AMSTERDAM, V163, P46, DOI 10.1016/j.scienta.2013.08.014; Rodrigo MJ, 2013, J EXP BOT, V64, P4461, DOI 10.1093/jxb/ert260; Romero P, 2012, J EXP BOT, V63, P4931, DOI 10.1093/jxb/ers168; Ruiz KB, 2013, J PLANT GROWTH REGUL, V32, P852, DOI 10.1007/s00344-013-9351-7; Soto A, 2012, J PLANT PHYSIOL, V169, P1858, DOI 10.1016/j.jplph.2012.07.007; Sun L, 2011, J EXP BOT, V62, P5659, DOI 10.1093/jxb/err252; Teichert I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-511; Wang GY, 2013, PHILIPP AGRIC SCI, V96, P26; Wang SF, 2014, J EXP BOT, V65, P3005, DOI 10.1093/jxb/eru137; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu J, 2014, J EXP BOT; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Ye JL, 2010, J INTEGR PLANT BIOL, V52, P856, DOI 10.1111/j.1744-7909.2010.00952.x; Yin YX, 2012, PLANT MOL BIOL, V78, P617, DOI 10.1007/s11103-012-9890-5; Yu KQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-10; Zeng JW, 2012, SCI HORTIC-AMSTERDAM, V134, P32, DOI 10.1016/j.scienta.2011.10.018; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhang JZ, 2009, GENE, V430, P95, DOI 10.1016/j.gene.2008.09.023	56	31	40	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116056	10.1371/journal.pone.0116056	http://dx.doi.org/10.1371/journal.pone.0116056			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551568	Green Published, gold, Green Submitted			2022-12-26	WOS:000347119100094
J	Antonioli, L; Giron, MC; Colucci, R; Pellegrini, C; Sacco, D; Caputi, V; Orso, G; Tuccori, M; Scarpignato, C; Blandizzi, C; Fornai, M				Antonioli, Luca; Giron, Maria Cecilia; Colucci, Rocchina; Pellegrini, Carolina; Sacco, Deborah; Caputi, Valentina; Orso, Genny; Tuccori, Marco; Scarpignato, Carmelo; Blandizzi, Corrado; Fornai, Matteo			Involvement of the P2X7 Purinergic Receptor in Colonic Motor Dysfunction Associated with Bowel Inflammation in Rats	PLOS ONE			English	Article							P2X(7) RECEPTORS; IMMUNE-RESPONSE; ENTERIC NEURONS; ADENOSINE; CELLS; PATHOGENESIS; COMPARTMENTS; RECRUITMENT; ACTIVATION; BLOCKADE	Background and Purpose: Recent evidence indicates an involvement of P2X7 purinergic receptor (P2X7R) in the fine tuning of immune functions, as well as in driving enteric neuron apoptosis under intestinal inflammation. However, the participation of this receptor in the regulation of enteric neuromuscular functions remains undetermined. This study was aimed at investigating the role of P2X7Rs in the control of colonic motility in experimental colitis. Experimental Approach: Colitis was induced in rats by 2,4-dinitrobenzenesulfonic acid. P2X7R distribution was examined by immunofluorescence analysis. The effects of A804598 (selective P2X7R antagonist) and BzATP (P2X7R agonist) were tested on contractions of longitudinal smooth muscle evoked by electrical stimulation or by carbachol in the presence of tetrodotoxin. Key Results: P2X7Rs were predominantly located in myenteric neurons, but, in the presence of colitis, their expression increased in the neuromuscular layer. In normal preparations, A804598 elicited a negligible increase in electrically induced contractions, while a significant enhancement was recorded in inflamed tissues. In the presence of N-omega-propyl-L-arginine (NPA, neuronal nitric oxide synthase inhibitor) the A804598 effects were lost. P2X7R stimulation with BzATP did not significantly affect electrical-induced contractions in normal colon, while a marked reduction was recorded under inflammation. The inhibitory effect of BzATP was antagonized by A804598, and it was also markedly blunted by NPA. Both P2X7R ligands did not affect carbachol-induced contractions. Conclusions and Implications: The purinergic system contributes to functional neuromuscular changes associated with bowel inflammation via P2X7Rs, which modulate the activity of excitatory cholinergic nerves through a facilitatory control on inhibitory nitrergic pathways.	[Antonioli, Luca; Colucci, Rocchina; Pellegrini, Carolina; Sacco, Deborah; Tuccori, Marco; Blandizzi, Corrado; Fornai, Matteo] Univ Pisa, Dept Clin & Expt Med, Div Pharmacol & Chemotherapy, Pisa, Italy; [Giron, Maria Cecilia; Caputi, Valentina] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Orso, Genny] Conegliano, Sci Inst IRCCS Eugenio Medea, Treviso, Italy; [Scarpignato, Carmelo] Univ Parma, Lab Clin Pharmacol, I-43100 Parma, Italy	University of Pisa; University of Padua; IRCCS Eugenio Medea; University of Parma	Colucci, R (corresponding author), Univ Pisa, Dept Clin & Expt Med, Div Pharmacol & Chemotherapy, Pisa, Italy.	r.colucci@med.unipi.it	Scarpignato, Carmelo/ABC-1745-2021; Pellegrini, Carolina/ABE-3462-2021; Giron, Maria Cecilia/AAL-4438-2021; Blandizzi, Corrado/AAB-8736-2019	Scarpignato, Carmelo/0000-0001-5645-857X; Pellegrini, Carolina/0000-0003-2644-5430; Giron, Maria Cecilia/0000-0002-0825-7965; COLUCCI, ROCCHINA LUCIA/0000-0002-2593-5457; BLANDIZZI, CORRADO/0000-0001-9927-5386; FORNAI, MATTEO/0000-0002-0812-3959	Italian Ministry of Education, University and Research (COFIN) [2003052707_002]; University of Padova [CPDA095223]; Nexus Award in memory of Professor Marcello Tonini	Italian Ministry of Education, University and Research (COFIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); University of Padova; Nexus Award in memory of Professor Marcello Tonini	This research was supported by grants from the Italian Ministry of Education, University and Research (COFIN 2003, project no. 2003052707_002), grant from the University of Padova (CPDA095223), by the Nexus Award in memory of Professor Marcello Tonini. VC is supported by the Fondazione Cariparo Doctoral Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson SE, 2014, FEBS LETT; Alves LA, 2013, MOLECULES, V18, P10953, DOI 10.3390/molecules180910953; Antonioli L, 2014, BRIT J PHARMACOL, V171, P1314, DOI 10.1111/bph.12539; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Antonioli L, 2013, PHARMACOL THERAPEUT, V139, P157, DOI 10.1016/j.pharmthera.2013.04.002; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Antonioli L, 2011, BRIT J PHARMACOL, V164, P1577, DOI 10.1111/j.1476-5381.2011.01529.x; Antonioli L, 2011, EUR J PHARMACOL, V650, P639, DOI 10.1016/j.ejphar.2010.10.041; Antonioli L, 2010, J PHARMACOL EXP THER, V335, P434, DOI 10.1124/jpet.110.171223; Antonioli L, 2008, PHARMACOL THERAPEUT, V120, P233, DOI 10.1016/j.pharmthera.2008.08.010; Burnstock G, 2001, TRENDS PHARMACOL SCI, V22, P182, DOI 10.1016/S0165-6147(00)01643-6; Burnstock G, 2013, PURINERG SIGNAL, V9, P541, DOI 10.1007/s11302-013-9381-4; Chen LF, 2006, CRIT REV IMMUNOL, V26, P499, DOI 10.1615/CritRevImmunol.v26.i6.30; Cho YR, 2010, KOREAN J PHYSIOL PHA, V14, P311, DOI 10.4196/kjpp.2010.14.5.311; da Silva MV, 2014, HISTOCHEM CELL BIOL; de Campos NE, 2012, J INNATE IMMUN, V4, P529, DOI 10.1159/000336628; Gulbransen BD, 2012, NAT MED, V18, P600, DOI 10.1038/nm.2679; Hu HZ, 2001, J COMP NEUROL, V440, P299, DOI 10.1002/cne.1387; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kataoka A, 2009, J NEUROCHEM, V108, P115, DOI 10.1111/j.1471-4159.2008.05744.x; Kurashima Y, 2013, EUR J IMMUNOL, V43, P3108, DOI 10.1002/eji.201343782; Kurashima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2023; Lakhan SE, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-37; Marques CC, 2014, BBA-MOL BASIS DIS, V1842, P65, DOI 10.1016/j.bbadis.2013.10.012; Neves AR, 2014, INFLAMM BOWEL DIS, V20, P444, DOI 10.1097/01.MIB.0000441201.10454.06; Palombit K, 2013, DIGEST DIS SCI, V58, P3429, DOI 10.1007/s10620-013-2847-y; Shi XZ, 2011, AM J PHYSIOL-GASTR L, V300, pG41, DOI 10.1152/ajpgi.00358.2010; Vanderwinden JM, 2003, CELL TISSUE RES, V312, P149, DOI 10.1007/s00441-003-0716-2; Vieira C, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/254640; Volonte C, 2009, FEBS J, V276, P318, DOI 10.1111/j.1742-4658.2008.06793.x; Xu XR, 2014, WORLD J GASTROENTERO, V20, P3255, DOI 10.3748/wjg.v20.i12.3255	31	29	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116253	10.1371/journal.pone.0116253	http://dx.doi.org/10.1371/journal.pone.0116253			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549098	Green Published, gold, Green Submitted			2022-12-26	WOS:000347063500069
J	Behbahani, M				Behbahani, Mandana			Evaluation of In Vitro Anticancer Activity of Ocimum Basilicum, Alhagi Maurorum, Calendula Officinalis and Their Parasite Cuscuta Campestris	PLOS ONE			English	Article							CELLS; ANTIOXIDANT; EXPRESSION; APOPTOSIS; LUTEIN; BCL-2; VIVO; P53	The present investigation was carried out to study the relationship between presence of cytotoxic compounds in Ocimum basilicum, Alhagi maurorum, Calendula officinalis and their parasite Cuscuta campestris. The cytotoxic activity of the pure compounds was performed by MTT assay against breast cancer cell lines (MCF-7 and MDA-MB-231) and normal breast cell line (MCF 10A). The induction of apoptosis was measured by the expression levels of p53, bcl-2, bax and caspase-3 genes using quantitative Real Time PCR. Three active fractions were detected by nuclear magnetic resonance as lutein, lupeol and eugenol, respectively, in C. officinalis, A. maurorum and O. basilicum. These compounds and their epoxidized forms were also detected in their parasite C. campestris. The cytotoxic activity of lutein epoxide, lupeol epoxide and eugenol epoxide was significantly more than lutein, lupeol and eugenol. The mRNA expression level of p53, caspase-3 and bax genes were increased in both cancer cells treated with all pure compounds. However, bcl-2 gene expression decreased in treated breast cancer cells. In conclusion, all the data indicated that the epoxide forms of lupeol, lutein and eugenol are potential drug candidates for inducing apoptosis in human breast cancer cells.	Univ Isfahan, Fac Adv Sci & Technol, Dept Biotechnol, Esfahan 8174673441, Iran	University of Isfahan	Behbahani, M (corresponding author), Univ Isfahan, Fac Adv Sci & Technol, Dept Biotechnol, Esfahan 8174673441, Iran.	Ma_behbahani@yahoo.com			University of Isfahan, Isfahan, Iran	University of Isfahan, Isfahan, Iran	This study was financially supported by the University of Isfahan, Isfahan, Iran. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha AM, 1996, PHYTOTHER RES, V10, P117, DOI 10.1002/(SICI)1099-1573(199603)10:2&lt;117::AID-PTR782&gt;3.0.CO;2-X; Behbahani M, 2013, ANTIVIR RES, V97, P376, DOI 10.1016/j.antiviral.2013.01.001; Borole S. P., 2011, Research Journal of Pharmaceutical, Biological and Chemical Sciences, V2, P657; Dawson Jean H., 1994, Reviews of Weed Science, V6, P265; Deans S. G., 1995, Flavour and Fragrance Journal, V10, P323, DOI 10.1002/ffj.2730100507; Edelenbos M, 2001, J AGR FOOD CHEM, V49, P4768, DOI 10.1021/jf010569z; Fido Roger J., 1995, V49, P423; Finnegan NM, 2001, BRIT J CANCER, V85, P115, DOI 10.1054/bjoc.2001.1850; Ghule R.S., 2011, J ADV PHARM ED RES, V1, P45; Gilani Anwar-Ul Hassan, 1992, International Journal of Pharmacognosy, V30, P296; Humphries JM, 2003, J AGR FOOD CHEM, V51, P1322, DOI 10.1021/jf026073e; Jadhav RB, 2005, J PLANT INTERACT, V1, P171, DOI 10.1080/17429140600986161; Jimenez-Medina E, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-119; Kobayashi S, 1997, BREAST CANCER RES TR, V42, P173, DOI 10.1023/A:1005760013810; Laghari AH, 2012, NAT PROD RES, V26, P173, DOI 10.1080/14786419.2010.538846; Lakshminarayana R, 2013, CHEM-BIOL INTERACT, V203, P448, DOI 10.1016/j.cbi.2013.03.006; Matsuda T, 2013, JPN J CLIN ONCOL, V43, P449, DOI 10.1093/jjco/hyt045; MIYASHITA T, 1995, CELL, V80, P293; Ni IBP, 2006, TROP BIOMED, V23, P53; Qamar KA, 2010, LETT DRUG DES DISCOV, V7, P726; Rates SMK, 2001, TOXICON, V39, P603, DOI 10.1016/S0041-0101(00)00154-9; Saeed MA, 2002, FITOTERAPIA, V73, P417, DOI 10.1016/S0367-326X(02)00127-2; Saleem M, 2008, CLIN CANCER RES, V14, P2119, DOI 10.1158/1078-0432.CCR-07-4413; Shai LJ, 2008, J ETHNOPHARMACOL, V119, P238, DOI 10.1016/j.jep.2008.06.036; Siddique HR, 2011, LIFE SCI, V88, P285, DOI 10.1016/j.lfs.2010.11.020; Suzuki K, 1999, JPN J CLIN ONCOL, V29, P323, DOI 10.1093/jjco/29.7.323	26	33	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116049	10.1371/journal.pone.0116049	http://dx.doi.org/10.1371/journal.pone.0116049			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548920	Green Published, Green Submitted, gold			2022-12-26	WOS:000347063500048
J	Fiallos, E; Judkins, J; Matlaf, L; Prichard, M; Dittmer, D; Cobbs, C; Soroceanu, L				Fiallos, Estefania; Judkins, Jonathon; Matlaf, Lisa; Prichard, Mark; Dittmer, Dirk; Cobbs, Charles; Soroceanu, Liliana			Human Cytomegalovirus Gene Expression in Long-Term Infected Glioma Stem Cells	PLOS ONE			English	Article							VIRAL-DNA; GLIOBLASTOMA; GROWTH; IDENTIFICATION; REACTIVATION; ACTIVATION; PHENOTYPE; LATENCY; TUMORS; AXIS	The most common adult primary brain tumor, glioblastoma (GBM), is characterized by fifteen months median patient survival and has no clear etiology. We and others have identified the presence of human cytomegalovirus (HCMV) gene products endogenously expressed in GBM tissue and primary cells, with a subset of viral genes being consistently expressed in most samples. Among these viral genes, several have important oncomodulatory properties, regulating tumor stemness, proliferation, immune evasion, invasion and angiogenesis. These findings lead us to hypothesize that a specific HCMV gene signature may be associated with GBM pathogenesis. To investigate this hypothesis, we used glioma cell lines and primary glioma stem-like cells (GSC) infected with clinical and laboratory HCMV strains and measured relative viral gene expression levels along several time points up to 15 weeks post-infection. While HCMV gene expression was detected in several infected glioma lines through week 5 post-infection, only HCMV-infected GSC expressed viral gene products 15 weeks post-infection. Efficiency of infection across time was higher in GSC compared to cell lines. Importantly, HCMV-infected GSC outlived their uninfected counterparts, and this extended survival was paralleled by increased tumorsphere frequency and upregulation of stemness regulators, such as SOX2, p-STAT3, and BMX (a novel HCMV target identified in this study). Interleukin 6 (IL-6) treatment significantly upregulated HCMV gene expression in long-term infected glioma cultures, suggesting that pro-inflammatory signaling in the tumor milieu may further augment HCMV gene expression and subsequent tumor progression driven by viral-induced cellular signaling. Together, our data support a critical role for long-term, low-level HCMV infection in promoting survival, stemness, and proliferation of GSC that could significantly contribute to GBM pathogenesis.	[Fiallos, Estefania; Judkins, Jonathon; Matlaf, Lisa; Soroceanu, Liliana] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; [Prichard, Mark] Univ Alabama Birmingham, Dept Pediat & Infect Dis, Birmingham, AL USA; [Dittmer, Dirk] Univ N Carolina, Sch Med, Dept Virol, Chapel Hill, NC USA; [Cobbs, Charles] Swedish Neurosci Inst, Ben & Catherine Ivy Ctr Adv Brain Tumor Treatment, Seattle, WA 98122 USA; [Cobbs, Charles] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Swedish Medical Center; University of California System; University of California San Francisco	Cobbs, C (corresponding author), Swedish Neurosci Inst, Ben & Catherine Ivy Ctr Adv Brain Tumor Treatment, Seattle, WA 98122 USA.	charles.cobbs@gmail.com; sorocel@cpmcri.org	Dittmer, Dirk/AAH-3535-2021; Dittmer, Dirk/GPW-7423-2022	Dittmer, Dirk/0000-0003-4968-5656; Prichard, Mark/0000-0002-2720-6661; Judkins, Jonathon/0000-0002-6513-2501	National Institutes of Health [R01NS070289, R21NS067395]; American Cancer Society Research Scholar award; Accelerated Brain Cancer Cure; Flaming Foundations; NATIONAL CANCER INSTITUTE [P01CA019014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067395, R01NS070289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar award(American Cancer Society); Accelerated Brain Cancer Cure; Flaming Foundations; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health, R01NS070289 to CC and LS, R21NS067395 to LS, American Cancer Society Research Scholar award to CC and additional funds from the Accelerated Brain Cancer Cure and the Flaming Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belzile JP, 2014, J VIROL, V88, P4021, DOI 10.1128/JVI.03492-13; Bhattacharjee B, 2012, J VIROL, V86, P6815, DOI 10.1128/JVI.00015-12; Bianchi E, 2014, NEUROPATHOL APPL NEU; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cobbs C, 2014, ONCOTARGET, V5, P1091, DOI 10.18632/oncotarget.1787; Cobbs CS, 2008, CANCER RES, V68, P724, DOI 10.1158/0008-5472.CAN-07-2291; Cobbs CS, 2002, CANCER RES, V62, P3347; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dos Santos CJ, 2013, J MED VIROL; Duan YL, 2014, J VIROL, V88, P3861, DOI 10.1128/JVI.01166-13; Dziurzynski K, 2012, NEURO-ONCOLOGY, V14, P246, DOI 10.1093/neuonc/nor227; Ernst A, 2009, CLIN CANCER RES, V15, P6541, DOI 10.1158/1078-0432.CCR-09-0695; Fonseca RF, 2012, MEM I OSWALDO CRUZ, V107, P953, DOI 10.1590/S0074-02762012000700020; Gilbert CA, 2009, J CELL BIOCHEM, V108, P1031, DOI 10.1002/jcb.22350; Guryanova OA, 2011, CANCER CELL, V19, P498, DOI 10.1016/j.ccr.2011.03.004; Hargett D, 2010, P NATL ACAD SCI USA, V107, P20039, DOI 10.1073/pnas.1014509107; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Isomura H, 2011, J VIROL, V85, P6629, DOI 10.1128/JVI.00384-11; Johnsen JI, 2011, ONCOTARGET, V2, P1329; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Loveland AN, 2007, J VIROL, V81, P620, DOI 10.1128/JVI.01903-06; Lucas KG, 2011, J NEURO-ONCOL, V103, P231, DOI 10.1007/s11060-010-0383-6; Matlaf LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068176; Meissner CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025115; Milne RSB, 1998, J GEN VIROL, V79, P855, DOI 10.1099/0022-1317-79-4-855; Mitchell DA, 2008, NEURO-ONCOLOGY, V10, P10, DOI 10.1215/15228517-2007-035; Qian ZK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000814; Ranganathan P, 2012, J VIROL, V86, P854, DOI 10.1128/JVI.06097-11; Reeves MB, 2011, J VIROL, V85, P12750, DOI 10.1128/JVI.05878-11; Ryan KJ, 2010, SHERRIS MED MICROB E; Ryckman BJ, 2010, J VIROL, V84, P2597, DOI 10.1128/JVI.02256-09; Scheurer ME, 2008, ACTA NEUROPATHOL, V116, P79, DOI 10.1007/s00401-008-0359-1; Schmittgen Thomas D., 2008, V429, P89, DOI 10.1007/978-1-60327-040-3_7; Sherry MM, 2009, STEM CELLS, V27, P2383, DOI 10.1002/stem.185; Sinclair J, 2006, J GEN VIROL, V87, P1763, DOI 10.1099/vir.0.81891-0; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Slinger E, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001180; Soroceanu L, 2007, P NATL ACAD SCI USA, V104, P3466, DOI 10.1073/pnas.0611271104; Soroceanu L, 2011, CANCER RES, V71, P6643, DOI 10.1158/0008-5472.CAN-11-0744; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Yurochko AD, 1997, J VIROL, V71, P5051, DOI 10.1128/JVI.71.7.5051-5059.1997; Zhou MM, 2013, J VIROL, V87, P9680, DOI 10.1128/JVI.01167-13	43	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116178	10.1371/journal.pone.0116178	http://dx.doi.org/10.1371/journal.pone.0116178			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549333	gold, Green Published, Green Submitted			2022-12-26	WOS:000347063500056
J	Li, DL; Wang, X; Liu, B; Liu, YZ; Zeng, ZY; Lu, LL; Zheng, ZY; Li, B; Zheng, ZF				Li, DongLiang; Wang, Xiao; Liu, Bang; Liu, YuZheng; Zeng, ZhiYu; Lu, LingLing; Zheng, ZhiYong; Li, Bing; Zheng, ZongFu			Exercises in Hot and Humid Environment Caused Liver Injury in a Rat Model	PLOS ONE			English	Article							WHOLE-BODY HYPERTHERMIA; OXIDATIVE STRESS; HEAT-STROKE; NECROSIS; ALPHA; CELLS; MICE; DNA; HEATSTROKE; APOPTOSIS	Objective: To investigate injury pattern during intense exercises in hot and humid environment particularly on liver in a rat exertional heat stroke model. Methods: We randomly divided 30 rats into a control group (CG), a normal temperature (25 +/- 2 degrees C, 60% +/- 5% humidity) exercise group (NTEG) and a high temperature and high humidity (35 +/- 2 degrees C, 80% +/- 10% humidity) exercising group (HTEG), each comprising 10 animals. The NTEG and HTEG rats were forced to run in a treadmill for 1 hour maximum at 20 rpm. We analyzed liver cells of all three groups with JC-1 dye and flow cytometry for apoptosis rates in addition to liver tissue 8 - hydroxy deoxyguanosine (8 - OhdG) and blood serum IL-6, tumor necrosis factor alpha (TNF-alpha), alanine aminotransferase ALT, aspartate amino transferase (AST), serum creatinine (CREA), blood urea nitrogen (BUN), lactate dehydrogenase (LDH), creatine phosphate kinase (CK) concentrations. Result: Compared with NTEG rats, beside reduced exercise tolerance (60 +/- 5 vs. 15 +/- 3 minutes) (p = 0.002) the 8-OhdG liver tissue concentrations were significantly higher (p = 0.040) in the HTEG rats. The HTEG developed more organ tissue damage and cellular fragmentations of liver cells. In both exercise groups TNF-alpha and IL-6 serum concentrations were enhanced significantly (p < 0.001) being highest in the HTEG animals. Serum ALT, AST, LDH, CREA, BUN and CK concentrations were significantly enhance in both exercise groups. Conclusion: In our exertional heat stroke rat model, we found tissue damage particularly in livers during exercises in hot and humid environment that was related to inflammation, oxidative stress and apoptosis.	[Li, DongLiang; Wang, Xiao; Liu, Bang; Liu, YuZheng; Zeng, ZhiYu; Lu, LingLing; Li, Bing] Fuzhou PLA Gen Hosp, Dept Hepatobiliary Med, Fuzhou, Fujian, Peoples R China; [Zheng, ZhiYong] Fuzhou PLA Gen Hosp, Dept Pathol, Fuzhou, Fujian, Peoples R China; [Zheng, ZongFu] 476 Hosp PLA Fujian, Clin Lab, Fuzhou, Fujian, Peoples R China		Li, DL (corresponding author), Fuzhou PLA Gen Hosp, Dept Hepatobiliary Med, Fuzhou, Fujian, Peoples R China.	donglianglifz@163.com		Liu, Bang/0000-0003-3045-2019	Medical Science and Technology Innovation Foundation of Nanjing Military Command of Chinese PLA [10MA109]	Medical Science and Technology Innovation Foundation of Nanjing Military Command of Chinese PLA	This work was funded by The Medical Science and Technology Innovation Foundation of Nanjing Military Command of Chinese PLA, No. 10MA109 to DongLiang Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; CAMUS G, 1994, INTENS CARE MED, V20, P602, DOI 10.1007/BF01705731; Carter R, 2005, MED SCI SPORT EXER, V37, P1338, DOI 10.1249/01.mss.0000174895.19639.ed; de Souza-Pinto NC, 2001, CANCER RES, V61, P5378; DICKSON JA, 1979, J APPL PHYSIOL, V47, P712, DOI 10.1152/jappl.1979.47.4.712; Diesen DL, 2011, J SURG RES, V167, P96, DOI 10.1016/j.jss.2009.10.006; GATHIRAM P, 1987, CIRC SHOCK, V23, P157; Hall Philip, 2012, Ulster Med J, V81, P30; HARMON BV, 1990, INT J RADIAT BIOL, V58, P845, DOI 10.1080/09553009014552221; Hsieh YC, 2011, ACTA PHARMACOL SIN, V32, P167, DOI 10.1038/aps.2010.191; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Kravchenko J, 2013, AM J PREV MED, V44, P274, DOI 10.1016/j.amepre.2012.11.015; Leon LR, 2010, J APPL PHYSIOL, V109, P1980, DOI 10.1152/japplphysiol.00301.2010; Lim CL, 2007, AM J PHYSIOL-REG I, V292, pR186, DOI 10.1152/ajpregu.00921.2005; Lippi G, 2011, EUR J INTERN MED, V22, pE36, DOI 10.1016/j.ejim.2011.02.007; Miyake Yasufumi, 2013, Nihon Rinsho, V71, P1065; Ogonovszky H, 2005, CAN J APPL PHYSIOL, V30, P186, DOI 10.1139/h05-114; Pease S, 2009, INTENS CARE MED, V35, P1454, DOI 10.1007/s00134-009-1500-x; Ramos D, 2013, APPL PHYSIOL NUTR ME, V38, P507, DOI 10.1139/apnm-2012-0302; Rohe ST, 2012, JAAPA-J AM ACAD PHYS, V25, P36; Rohe Steven T, 2012, JAAPA, V25, P36; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Shah NG, 2012, INT J HYPERTHER, V28, P627, DOI 10.3109/02656736.2012.690547; Thakur V, 2006, J LEUKOCYTE BIOL, V79, P1348, DOI 10.1189/jlb.1005613; THRALL DE, 1986, CANCER RES, V46, P6229; Tukov FF, 2007, TOXICOL SCI, V100, P267, DOI 10.1093/toxsci/kfm209; van Wijck K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022366; Waskiewicz Z, 2012, EUR J APPL PHYSIOL, V112, P1679, DOI 10.1007/s00421-011-2135-5; Wilson MR, 2005, AM J PHYSIOL-LUNG C, V288, pL599, DOI 10.1152/ajplung.00304.2004; Xing JQ, 2013, INT J CLIN EXP MED, V6, P712	30	13	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e111741	10.1371/journal.pone.0111741	http://dx.doi.org/10.1371/journal.pone.0111741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548911	Green Published, Green Submitted, gold			2022-12-26	WOS:000347063500003
J	Joensen, O; Paff, T; Haarman, EG; Skovgaard, IM; Jensen, PO; Bjarnsholt, T; Nielsen, KG				Joensen, Odin; Paff, Tamara; Haarman, Eric G.; Skovgaard, Ib M.; Jensen, Peter O.; Bjarnsholt, Thomas; Nielsen, Kim G.			Exhaled Breath Analysis Using Electronic Nose in Cystic Fibrosis and Primary Ciliary Dyskinesia Patients with Chronic Pulmonary Infections	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA INFECTION; VOLATILE ORGANIC-COMPOUNDS; PNEUMONIA SCORE; EXACERBATIONS; COLONIZATION; METABOLOMICS; SIGNATURE; DIAGNOSIS	The current diagnostic work-up and monitoring of pulmonary infections may be perceived as invasive, is time consuming and expensive. In this explorative study, we investigated whether or not a non-invasive exhaled breath analysis using an electronic nose would discriminate between cystic fibrosis (CF) and primary ciliary dyskinesia (PCD) with or without various well characterized chronic pulmonary infections. We recruited 64 patients with CF and 21 with PCD based on known chronic infection status. 21 healthy volunteers served as controls. An electronic nose was employed to analyze exhaled breath samples. Principal component reduction and discriminant analysis were used to construct internally cross-validated receiver operator characteristic (ROC) curves. Breath profiles of CF and PCD patients differed significantly from healthy controls p=0.001 and p=0.005, respectively. Profiles of CF patients having a chronic P. aeruginosa infection differed significantly from to non-chronically infected CF patients p=0.044. We confirmed the previously established discriminative power of exhaled breath analysis in separation between healthy subjects and patients with CF or PCD. Furthermore, this method significantly discriminates CF patients suffering from a chronic pulmonary P. aeruginosa (PA) infection from CF patients without a chronic pulmonary infection. Further studies are needed for verification and to investigate the role of electronic nose technology in the very early diagnostic workup of pulmonary infections before the establishment of a chronic infection.	[Joensen, Odin; Bjarnsholt, Thomas] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Paff, Tamara; Haarman, Eric G.] Vrije Univ Amsterdam, Med Ctr Amsterdam, Dept Pulm Dis, Amsterdam, Netherlands; [Skovgaard, Ib M.] Univ Copenhagen, Dept Math Sci, Copenhagen, Denmark; [Jensen, Peter O.; Bjarnsholt, Thomas] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark; [Nielsen, Kim G.] Rigshosp, Danish Paediat Pulm Serv, DK-2100 Copenhagen, Denmark	University of Copenhagen; Vrije Universiteit Amsterdam; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Nielsen, KG (corresponding author), Rigshosp, Danish Paediat Pulm Serv, DK-2100 Copenhagen, Denmark.	kgn@dadlnet.dk	Jensen, Peter Ostrup/HGD-7725-2022; Bjarnsholt, Thomas/ABD-6178-2021; Nielsen, KG/AAE-6575-2020	Nielsen, KG/0000-0001-5906-9449; Bjarnsholt, Thomas/0000-0002-8003-7414; Jensen, Peter Ostrup/0000-0003-1648-7186	Danmarks lungeforening; A.P. Moller og Hustru Chastine Mc-Kinney Moller Fond; John and Birthe Meyer Foundation; European Union [8305404]	Danmarks lungeforening; A.P. Moller og Hustru Chastine Mc-Kinney Moller Fond; John and Birthe Meyer Foundation; European Union(European Commission)	Funding: Funding provided by the following: Danmarks lungeforening (https://www.lunge.dk/); no grant number; receiver OJ. A.P. Moller og Hustru Chastine Mc-Kinney Moller Fond til almene Formaal (http://www.apmollerfonde.dk/); no grant number; receiver OJ. The John and Birthe Meyer Foundation (no website); no grant number; receiver KGN. European Union Seventh, Framework Programme (FP7/2007-2013); (http://ec.europa.eu/research/fp7/index_en.cfm); grant agreement n8305404 (BESTCILIA); receiver KGN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allardyce RA, 2006, DIAGN MICR INFEC DIS, V55, P255, DOI 10.1016/j.diagmicrobio.2006.01.031; Amann A, 2010, EUR RESPIR MONOGR, P96, DOI 10.1183/1025448x.00018509; Amirav I, 2009, PAEDIATR RESPIR REV, V10, P58, DOI 10.1016/j.prrv.2008.11.003; Barker M, 2006, EUR RESPIR J, V27, P929, DOI 10.1183/09031936.06.00085105; Bos LDJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003311; Chambers ST, 2011, MED MYCOL, V49, pS54, DOI 10.3109/13693786.2010.508187; Dam JS, 2012, NAT PHOTONICS, V6, P788, DOI [10.1038/NPHOTON.2012.231, 10.1038/nphoton.2012.231]; de Heer K, 2013, J CLIN MICROBIOL, V51, P1490, DOI 10.1128/JCM.02838-12; Dragonieri S, 2007, J ALLERGY CLIN IMMUN, V120, P856, DOI 10.1016/j.jaci.2007.05.043; *DTU NAN, DEVICE FOR DIAGNOSIS; Frederiksen B, 1997, PEDIATR PULM, V23, P330, DOI 10.1002/(SICI)1099-0496(199705)23:5<330::AID-PPUL4>3.0.CO;2-O; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Gangell C, 2011, CLIN INFECT DIS, V53, P425, DOI 10.1093/cid/cir399; Gilchrist FJ, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/2/026010; Hansen CR, 2008, J CYST FIBROS, V7, P523, DOI 10.1016/j.jcf.2008.06.009; Hanson CW, 2005, ANESTHESIOLOGY, V102, P63, DOI 10.1097/00000542-200501000-00013; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Hockstein NG, 2005, ANN OTO RHINOL LARYN, V114, P504, DOI 10.1177/000348940511400702; Hockstein NG, 2004, LARYNGOSCOPE, V114, P1701, DOI 10.1097/00005537-200410000-00005; Hoiby N, 2005, J Cyst Fibros, V4 Suppl 2, P49, DOI 10.1016/j.jcf.2005.05.018; HOIBY N, 1977, SCAND J RESPIR DIS, V58, P65; Hoiby N, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-32; Kang NK, 2010, SENSOR ACTUAT B-CHEM, V147, P55, DOI 10.1016/j.snb.2010.03.025; Kharitonov SA, 2001, AM J RESP CRIT CARE, V163, P1693, DOI 10.1164/ajrccm.163.7.2009041; Kuehni CE, 2010, EUR RESPIR J, V36, P1248, DOI 10.1183/09031936.00001010; Lai SY, 2002, LARYNGOSCOPE, V112, P975, DOI 10.1097/00005537-200206000-00007; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Maglione M, 2014, PEDIATR PULM, V49, P1243, DOI 10.1002/ppul.22984; Marthin JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057262; McGrath LT, 2000, EUR RESPIR J, V16, P1065, DOI 10.1034/j.1399-3003.2000.16f08.x; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Paff T, 2013, J CYST FIBROS, V12, P454, DOI 10.1016/j.jcf.2012.12.010; Proesmans M, 2006, EUR RESPIR J, V27, P937, DOI 10.1183/09031936.06.00100805; Rabin HR, 2004, PEDIATR PULM, V37, P400, DOI 10.1002/ppul.20023; Robroeks CMHHT, 2010, PEDIATR RES, V68, P75, DOI 10.1203/00006450-201011001-00143; Rogers GB, 2010, J CLIN MICROBIOL, V48, P78, DOI 10.1128/JCM.01324-09; Savelev SU, 2011, LETT APPL MICROBIOL, V52, P610, DOI 10.1111/j.1472-765X.2011.03049.x; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; Scott-Thomas A, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/4/046002; Scott-Thomas AJ, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-56; Smith D, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/2/022001; Thorn RMS, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/2/024001	44	35	36	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115584	10.1371/journal.pone.0115584	http://dx.doi.org/10.1371/journal.pone.0115584			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542036	Green Published, Green Submitted, gold			2022-12-26	WOS:000347239900054
J	Levin, ML; Killmaster, LF; Zemtsova, GE; Ritter, JM; Langham, G				Levin, Michael L.; Killmaster, Lindsay F.; Zemtsova, Galina E.; Ritter, Jana M.; Langham, Gregory			Clinical Presentation, Convalescence, and Relapse of Rocky Mountain Spotted Fever in Dogs Experimentally Infected via Tick Bite	PLOS ONE			English	Article							RICKETTSIA-RICKETTSII; PATHOGENESIS; EFFICACY; IXODIDAE; ACARI	Rocky Mountain spotted fever (RMSF) is a tick-borne disease caused by R. rickettsii in North and South America. Domestic dogs are susceptible to infection and canine RMSF can be fatal without appropriate treatment. Although clinical signs of R. rickettsii infection in dogs have been described, published reports usually include descriptions of either advanced clinical cases or experimental infections caused by needle-inoculation of cultured pathogen rather than by tick bite. The natural progression of a tick-borne R. rickettsii infection has not been studied in sufficient detail. Here, we provide a detailed description of clinical, hematological, molecular, and serological dynamics of RMSF in domestic dogs from the day of experimental exposure to infected ticks through recovery. Presented data indicate that neither the height/duration of fever nor detection of rickettsial DNA in dogs' blood by PCR are good indicators for clinical prognosis. Only the apex and subsequent subsidence of neutrophilia seem to mark the beginning of recovery and allow predicting a favorable outcome in Rickettsia-infected dogs, even despite the continuing persistence of mucosal petechiae and skin rash. On the other hand the appropriate (doxycycline) antibiotic therapy of sufficient duration is crucial in prevention of RMSF relapses in dogs.	[Levin, Michael L.; Killmaster, Lindsay F.; Zemtsova, Galina E.] Ctr Dis Control & Prevent, Rickettsial Zoonoses Branch, Atlanta, GA 30333 USA; [Ritter, Jana M.] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Atlanta, GA USA; [Langham, Gregory] Ctr Dis Control & Prevent, Anim Resources Branch, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Levin, ML (corresponding author), Ctr Dis Control & Prevent, Rickettsial Zoonoses Branch, Atlanta, GA 30333 USA.	MLevin@cdc.gov			US Government within CDC budget	US Government within CDC budget	Funding: Funding for work was provided by the US Government within the CDC budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASH M, 1995, MED J AUSTRALIA, V163, P167, DOI 10.5694/j.1326-5377.1995.tb127987.x; Barreto MC, 2008, REV INST MED TROP SP, V50, P297, DOI 10.1590/S0036-46652008000500009; Beaty B., 1995, DIAGNOSTIC PROCEDURE; BOZEMAN FM, 1967, AM J TROP MED HYG, V16, P48, DOI 10.4269/ajtmh.1967.16.48; Breitschwerdt E. B., 2000, Textbook of veterinary internal medicine: diseases of the dog and cat, Volumes 1 and 2., P400; Breitschwerdt EB, 1999, ANTIMICROB AGENTS CH, V43, P813, DOI 10.1128/AAC.43.4.813; BREITSCHWERDT EB, 1988, AM J VET RES, V49, P70; BREITSCHWERDT EB, 1985, AM J VET RES, V46, P2124; BREITSCHWERDT EB, 1991, ANTIMICROB AGENTS CH, V35, P2375, DOI 10.1128/AAC.35.11.2375; Clark K. L., 1996, Journal of Agromedicine, V3, P45, DOI 10.1300/J096v03n04_05; DAVIDSON MG, 1989, J AM VET MED ASSOC, V194, P777; Demma LJ, 2005, NEW ENGL J MED, V353, P587, DOI 10.1056/NEJMoa050043; Elchos BN, 2003, J AM VET MED ASSOC, V223, P1450, DOI 10.2460/javma.2003.223.1450; Eremeeva ME, 2003, J CLIN MICROBIOL, V41, P5466, DOI 10.1128/JCM.41.12.5466-5472.2003; Figueiredo Luiz Tadeu Moraes, 1999, Revista da Sociedade Brasileira de Medicina Tropical, V32, P613, DOI 10.1590/S0037-86821999000600002; Folkema AM, 2012, AM J TROP MED HYG, V86, P152, DOI 10.4269/ajtmh.2012.11-0269; Gasser AM, 2001, J AM ANIM HOSP ASSOC, V37, P41, DOI 10.5326/15473317-37-1-41; GORDON JC, 1983, J INFECT DIS, V148, P1123, DOI 10.1093/infdis/148.6.1123; GREENE CE, 1987, J AM VET MED ASSOC, V191, P666; GREENE CE, 1985, J AM VET MED ASSOC, V186, P465; Greene CE., 2006, INFECT DIS DOG CAT, P232; Greene CE, 1998, INFECT DIS DOG CAT, P155; HILL GD, 1982, J AM VET MED ASSOC, V180, P26; Karpathy SE, 2007, J CLIN MICROBIOL, V45, P2545, DOI 10.1128/JCM.00367-07; KEENAN KP, 1977, J INFECT DIS, V135, P911, DOI 10.1093/infdis/135.6.911; KEENAN KP, 1977, AM J VET RES, V38, P851; KOCH HG, 1982, J MED ENTOMOL, V19, P293, DOI 10.1093/jmedent/19.3.293; Labruna MB, 2009, EMERG INFECT DIS, V15, P458, DOI 10.3201/eid1503.081227; McQuiston JH, 2011, ZOONOSES PUBLIC HLTH, V58, P85, DOI 10.1111/j.1863-2378.2009.01300.x; Morrison W.I, 2010, MERCK VET MANUAL, V10, P33; Ober CP, 2004, VET RADIOL ULTRASOUN, V45, P458, DOI 10.1111/j.1740-8261.2004.04079.x; Pacheco RC, 2011, MED VET ENTOMOL, V25, P148, DOI 10.1111/j.1365-2915.2010.00915.x; Paddock CD, 2008, CLIN INFECT DIS, V47, P1188, DOI 10.1086/592254; Piranda EM, 2008, MEM I OSWALDO CRUZ, V103, P696, DOI 10.1590/S0074-02762008000700012; Plumb D.C., 2011, PLUMBS VET DRUGS, V7e; RAOULT D, 1991, ANTIMICROB AGENTS CH, V35, P2457, DOI 10.1128/AAC.35.12.2457; Rodgers S J, 1989, J Vet Diagn Invest, V1, P154; SHAKED Y, 1989, J INFECTION, V18, P35, DOI 10.1016/S0163-4453(89)93567-6; Stiles J, 2000, VET CLIN N AM-SMALL, V30, P1135, DOI 10.1016/S0195-5616(00)05011-7; Troughton DR, 2007, J MED ENTOMOL, V44, P732, DOI 10.1603/0022-2585(2007)44[732:LCOSIT]2.0.CO;2; YAGUPSKY P, 1985, T ROY SOC TROP MED H, V79, P139, DOI 10.1016/0035-9203(85)90265-2; Zemtsova G, 2010, EXP APPL ACAROL, V52, P383, DOI 10.1007/s10493-010-9375-7	42	28	28	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115105	10.1371/journal.pone.0115105	http://dx.doi.org/10.1371/journal.pone.0115105			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25542001	gold, Green Published			2022-12-26	WOS:000347239900024
J	Tsukuda, S; Watashi, K; Iwamoto, M; Suzuki, R; Aizaki, H; Okada, M; Sugiyama, M; Kojima, S; Tanaka, Y; Mizokami, M; Li, JS; Tong, SP; Wakita, T				Tsukuda, Senko; Watashi, Koichi; Iwamoto, Masashi; Suzuki, Ryosuke; Aizaki, Hideki; Okada, Maiko; Sugiyama, Masaya; Kojima, Soichi; Tanaka, Yasuhito; Mizokami, Masashi; Li, Jisu; Tong, Shuping; Wakita, Takaji			Dysregulation of Retinoic Acid Receptor Diminishes Hepatocyte Permissiveness to Hepatitis B Virus Infection through Modulation of Sodium Taurocholate Cotransporting Polypeptide (NTCP) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENRICHED TRANSCRIPTION FACTORS; MEMBRANE TRANSPORTER; NUCLEAR RECEPTORS; HEPG2 CELLS; IN-VIVO; ENTRY; MOUSE; INHIBITORS; INTERFERON; PROTEIN	Sodium taurocholate cotransporting polypeptide (NTCP) is an entry receptor for hepatitis B virus (HBV) and is regarded as one of the determinants that confer HBV permissiveness to host cells. However, how host factors regulate the ability of NTCP to support HBV infection is largely unknown. We aimed to identify the host signaling that regulated NTCP expression and thereby permissiveness to HBV. Here, a cell-based chemical screening method identified that Ro41-5253 decreased host susceptibility to HBV infection. Pretreatment with Ro41-5253 inhibited the viral entry process without affecting HBV replication. Intriguingly, Ro41-5253 reduced expression of both NTCP mRNA and protein. We found that retinoic acid receptor (RAR) regulated the promoter activity of the human NTCP (hNTCP) gene and that Ro41-5253 repressed the hNTCP promoter by antagonizing RAR. RAR recruited to the hNTCP promoter region, and nucleotides 112 to 96 of the liNTCP was suggested to be critical for RAR-mediated transcriptional activation. HBV susceptibility was decreased in pharmacologically RAR-inactivated cells. CD2665 showed a stronger anti-HBV potential and disrupted the spread of HBV infection that was achieved by continuous reproduction of the whole HBV life cycle. In addition, this mechanism was significant for drug development, as antagonization of RAR blocked infection of multiple HBV genotypes and also a clinically relevant HBV mutant that was resistant to nucleoside analogs. Thus, RAR is crucial for regulating NTCP expression that determines permissiveness to HBV infection. This is the first demonstration showing host regulation of NTCP to support HBV infection.	[Tsukuda, Senko; Watashi, Koichi; Iwamoto, Masashi; Suzuki, Ryosuke; Aizaki, Hideki; Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo 1628640, Japan; [Tsukuda, Senko; Kojima, Soichi] RIKEN Ctr Life Sci Technol, Microsignaling Regulat Technol Unit, Wako, Saitama 3510198, Japan; [Okada, Maiko] St Marianna Univ, Sch Med, Dept Translat Oncol, Kawasaki, Kanagawa 2168511, Japan; [Sugiyama, Masaya; Mizokami, Masashi] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa 2728516, Japan; [Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi 4678601, Japan; [Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi 4678601, Japan; [Li, Jisu; Tong, Shuping] Brown Univ, Rhode Isl Hosp, Liver Res Ctr, Warren Alpert Sch Med, Providence, RI 02912 USA	National Institute of Infectious Diseases (NIID); RIKEN; Saint Marianna University; National Center for Global Health & Medicine - Japan; Nagoya City University; Nagoya City University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Watashi, K (corresponding author), Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	kwatashi@nih.go.jp	Kojima, Soichi/N-7104-2015	Kojima, Soichi/0000-0002-5252-1612; Iwamoto, Masashi/0000-0002-0419-4485; Tanaka, Yasuhito/0000-0002-2473-6966	Ministry of Health, Labor, and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Society for the Promotion of Science; Liver Forum in Kyoto	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Liver Forum in Kyoto	This work was supported in part by grants-in-aid from the Ministry of Health, Labor, and Welfare, Japan, from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and from Japan Society for the Promotion of Science, and by the incentive support from Liver Forum in Kyoto.	Aly HH, 2007, J HEPATOL, V46, P26, DOI 10.1016/j.jhep.2006.08.018; APFEL C, 1992, P NATL ACAD SCI USA, V89, P7129, DOI 10.1073/pnas.89.15.7129; Arbuthnot P, 2001, INT J EXP PATHOL, V82, P77, DOI 10.1111/j.1365-2613.2001.iep178.x; Bai JR, 2000, MOL THER, V1, P244, DOI 10.1006/mthe.2000.0038; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; CATTANEO R, 1984, EMBO J, V3, P2191, DOI 10.1002/j.1460-2075.1984.tb02113.x; Chen Li-Ping, 2012, World J Virol, V1, P174, DOI 10.5501/wjv.v1.i6.174; Denson LA, 2001, GASTROENTEROLOGY, V121, P140, DOI 10.1053/gast.2001.25503; Deuffic-Burban S, 2011, J CLIN VIROL, V52, P4, DOI 10.1016/j.jcv.2011.05.016; Dusheiko G, 2013, LIVER INT, V33, P137, DOI 10.1111/liv.12078; Geier A, 2008, AM J PHYSIOL-GASTR L, V295, pG226, DOI 10.1152/ajpgi.00012.2008; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; HIRSCH RC, 1990, NATURE, V344, P552, DOI 10.1038/344552a0; Ho RH, 2004, J BIOL CHEM, V279, P7213, DOI 10.1074/jbc.M305782200; HUAN BF, 1993, J HEPATOL, V17, pS20, DOI 10.1016/S0168-8278(05)80419-2; HUAN BF, 1992, P NATL ACAD SCI USA, V89, P9059, DOI 10.1073/pnas.89.19.9059; Ishida Y., 2013, INT M MOL BIOL HEP B, VP13; Iwamoto M, 2014, BIOCHEM BIOPH RES CO, V443, P808, DOI 10.1016/j.bbrc.2013.12.052; Jung D, 2004, AM J PHYSIOL-GASTR L, V286, pG752, DOI 10.1152/ajpgi.00456.2003; Kao JH, 2010, ADV CANCER RES, V108, P21, DOI 10.1016/S0065.230X(10)08003.6; Kotani N, 2012, MOL PHARMACEUT, V9, P3434, DOI 10.1021/mp300171p; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Liu F, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-59; Lok ASF, 2002, NEW ENGL J MED, V346, P1682, DOI 10.1056/NEJM200205303462202; Marusawa H, 2001, MICROBIOL IMMUNOL, V45, P483, DOI 10.1111/j.1348-0421.2001.tb02648.x; Newman M, 2003, J VIROL, V77, P12950, DOI 10.1128/JVI.77.24.12950-12960.2003; Ni Y, 2014, GASTROENTEROLOGY, V146, P1070, DOI 10.1053/j.gastro.2013.12.024; Nkongolo S, 2014, J HEPATOL, V60, P723, DOI 10.1016/j.jhep.2013.11.022; Ohishi W, 2012, HEPATOL RES, V42, P219, DOI 10.1111/j.1872-034X.2011.00921.x; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Pagliaccetti NE, 2010, VIROLOGY, V401, P197, DOI 10.1016/j.virol.2010.02.022; Pan W, 2011, XENOBIOTICA, V41, P501, DOI 10.3109/00498254.2011.555567; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Petersen J, 2008, NAT BIOTECHNOL, V26, P335, DOI 10.1038/nbt1389; Rippin SJ, 2001, HEPATOLOGY, V33, P776, DOI 10.1053/jhep.2001.23433; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Schulze A, 2007, HEPATOLOGY, V46, P1759, DOI 10.1002/hep.21896; Schulze A, 2010, J VIROL, V84, P1989, DOI 10.1128/JVI.01902-09; SELLS MA, 1988, J VIROL, V62, P2836, DOI 10.1128/JVI.62.8.2836-2844.1988; Shiao T, 2000, GENOMICS, V69, P203, DOI 10.1006/geno.2000.6329; Stieger B, 2011, HANDB EXP PHARMACOL, V201, P205, DOI 10.1007/978-3-642-14541-4_5; Sugiyama M, 2006, HEPATOLOGY, V44, P915, DOI 10.1002/hep.21345; Watashi K, 2003, MOL CELL BIOL, V23, P7498, DOI 10.1128/MCB.23.21.7498-7509.2003; Watashi K, 2008, J VIROL, V82, P9928, DOI 10.1128/JVI.01017-08; Watashi K, 2014, HEPATOLOGY, V59, P1726, DOI 10.1002/hep.26982; Watashi K, 2014, INT J MOL SCI, V15, P2892, DOI 10.3390/ijms15022892; Watashi Koichi, 2013, J Biol Chem, V288, P31715, DOI 10.1074/jbc.M113.501122; Yan H, 2014, J VIROL, V88, P3273, DOI 10.1128/JVI.03478-13; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; YEH CT, 1991, J VIROL, V65, P2327, DOI 10.1128/JVI.65.5.2327-2331.1991; Zollner G, 2005, AM J PHYSIOL-GASTR L, V289, pG798, DOI 10.1152/ajpgi.00319.2004; Zoulim F, 2013, LIVER INT, V33, P116, DOI 10.1111/liv.12069	53	47	49	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5673	5684		10.1074/jbc.M114.602540	http://dx.doi.org/10.1074/jbc.M114.602540			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25550158	hybrid, Green Published			2022-12-26	WOS:000350044200036
J	Goedken, ER; Argiriadi, MA; Banach, DL; Fiamengo, BA; Foley, SE; Frank, KE; George, JS; Harris, CM; Hobson, AD; Ihle, DC; Marcotte, D; Merta, PJ; Michalak, ME; Murdock, SE; Tomlinson, MJ; Voss, JW				Goedken, Eric R.; Argiriadi, Maria A.; Banach, David L.; Fiamengo, Bryan A.; Foley, Sage E.; Frank, Kristine E.; George, Jonathan S.; Harris, Christopher M.; Hobson, Adrian D.; Ihle, David C.; Marcotte, Douglas; Merta, Philip J.; Michalak, Mark E.; Murdock, Sara E.; Tomlinson, Medha J.; Voss, Jeffrey W.			Tricyclic Covalent Inhibitors Selectively Target Jak3 through an Active Site Thiol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MINIMUM SIGNIFICANT RATIO; JANUS KINASES; IRREVERSIBLE INHIBITORS; TOFACITINIB CP-690,550; RHEUMATOID-ARTHRITIS; INADEQUATE RESPONSE; ERBB FAMILY; ACTIVATION; DESIGN; POTENT	The action of Janus kinases (JAKs) is required for multiple cytokine signaling pathways, and as such, JAK inhibitors hold promise for treatment of autoimmune disorders, including rheumatoid arthritis, inflammatory bowel disease, and psoriasis. However, due to high similarity in the active sites of the four members (Jak1, Jak2, Jak3, and Tyk2), developing selective inhibitors within this family is challenging. We have designed and characterized substituted, tricyclic Jak3 inhibitors that selectively avoid inhibition of the other JAKs. This is accomplished through a covalent interaction between an inhibitor containing a terminal electrophile and an active site cysteine (Cys-909). We found that these ATP competitive compounds are irreversible inhibitors of Jak3 enzyme activity in vitro. They possess high selectivity against other kinases and can potently (IC50 < 100 nM) inhibit Jak3 activity in cell-based assays. These results suggest irreversible inhibitors of this class may be useful selective agents, both as tools to probe Jak3 biology and potentially as therapies for autoimmune diseases.	[Goedken, Eric R.; Argiriadi, Maria A.; Banach, David L.; Fiamengo, Bryan A.; Foley, Sage E.; Frank, Kristine E.; George, Jonathan S.; Harris, Christopher M.; Hobson, Adrian D.; Ihle, David C.; Marcotte, Douglas; Merta, Philip J.; Michalak, Mark E.; Murdock, Sara E.; Tomlinson, Medha J.; Voss, Jeffrey W.] AbbVie Biores Ctr, Worcester, MA 01605 USA	AbbVie	Goedken, ER (corresponding author), AbbVie Biores Ctr, 100 Res Dr, Worcester, MA 01605 USA.	eric.goedken@abbvie.com	Hobson, Adrian D/N-2308-2017	Hobson, Adrian D/0000-0003-3948-0577	Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; AbbVie	Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); AbbVie(AbbVie)	Use of the Industrial Macromolecular Crystallography Association-Collaborative Access Team beamline 17-ID (or 17-BM) at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. The authors are/were employees of AbbVie (or Abbott Laboratories prior to separation) and may own AbbVie/Abbott stocks or stock options. Financial support for this work was provided by AbbVie, who participated in the interpretation of data, review, and approval of the manuscript.	[Anonymous], 2004, AM J TRANSPLANT, V4, P51, DOI 10.1046/j.1600-6143.2003.00281.x; Argiriadi MA, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-22; Boggon TJ, 2005, BLOOD, V106, P996, DOI 10.1182/blood-2005-02-0707; Bricogne G., 2011, BUSTER VERSION 2 9 7; Changelian PS, 2008, BLOOD, V111, P2155, DOI 10.1182/blood-2007-09-115030; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Chen JJ, 2006, BIOORG MED CHEM LETT, V16, P5633, DOI 10.1016/j.bmcl.2006.08.022; Chrencik JE, 2010, J MOL BIOL, V400, P413, DOI 10.1016/j.jmb.2010.05.020; Clark MP, 2007, BIOORG MED CHEM LETT, V17, P1250, DOI 10.1016/j.bmcl.2006.12.018; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Denny WA, 2002, PHARMACOL THERAPEUT, V93, P253, DOI 10.1016/S0163-7258(02)00194-8; Eastwood BJ, 2006, J BIOMOL SCREEN, V11, P253, DOI 10.1177/1087057105285611; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans EK, 2013, J PHARMACOL EXP THER, V346, P219, DOI 10.1124/jpet.113.203489; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Fleischmann R, 2012, ARTHRITIS RHEUM-US, V64, P617, DOI 10.1002/art.33383; Fry DW, 1998, P NATL ACAD SCI USA, V95, P12022, DOI 10.1073/pnas.95.20.12022; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Gehringer M, 2014, CHEMMEDCHEM, V9, P277, DOI 10.1002/cmdc.201300520; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Goedken ER, 2012, J BIOMOL SCREEN, V17, P857, DOI 10.1177/1087057112447108; Haan C, 2011, CHEM BIOL, V18, P314, DOI 10.1016/j.chembiol.2011.01.012; HARPUR AG, 1992, ONCOGENE, V7, P1347; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; Hur W, 2008, BIOORG MED CHEM LETT, V18, P5916, DOI 10.1016/j.bmcl.2008.07.062; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAWAMURA M, 1994, P NATL ACAD SCI USA, V91, P6374, DOI 10.1073/pnas.91.14.6374; Kremer JM, 2012, ARTHRITIS RHEUM-US, V64, P970, DOI 10.1002/art.33419; Kulagowski JJ, 2012, J MED CHEM, V55, P5901, DOI 10.1021/jm300438j; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Liang J, 2013, EUR J MED CHEM, V67, P175, DOI 10.1016/j.ejmech.2013.03.070; Liu KD, 1997, CURR BIOL, V7, P817, DOI 10.1016/S0960-9822(06)00369-1; Liu QS, 2013, CHEM BIOL, V20, P146, DOI 10.1016/j.chembiol.2012.12.006; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; O'Shea JJ, 2013, ANN RHEUM DIS, V72, P111, DOI 10.1136/annrheumdis-2012-202576; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potashman MH, 2009, J MED CHEM, V52, P1231, DOI 10.1021/jm8008597; Quelle FW, 1996, MOL CELL BIOL, V16, P1622; Rankin AL, 2013, J IMMUNOL, V191, P4540, DOI 10.4049/jimmunol.1301553; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Scott LJ, 2013, DRUGS, V73, P857, DOI 10.1007/s40265-013-0065-8; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; Simmons DL, 2013, CURR OPIN PHARMACOL, V13, P426, DOI 10.1016/j.coph.2013.02.008; Singh J, 2010, CURR OPIN CHEM BIOL, V14, P475, DOI 10.1016/j.cbpa.2010.06.168; Solca F, 2012, J PHARMACOL EXP THER, V343, P342, DOI 10.1124/jpet.112.197756; Sonbol MB, 2013, THER ADV HEMATOL, V4, P15, DOI 10.1177/2040620712461047; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Styles M. L., 2005, International Patent, Patent No. [WO 2005066156 A1, 2005066156, WO2005066156 (A1)]; Thompson JE, 2005, DRUG NEWS PERSPECT, V18, P305, DOI 10.1358/dnp.2005.18.5.904198; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; Van Epps S, 2013, BIOORG MED CHEM LETT, V23, P693, DOI 10.1016/j.bmcl.2012.11.108; Verma A, 2003, CANCER METAST REV, V22, P423, DOI 10.1023/A:1023805715476; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; WILKS AF, 1991, MOL CELL BIOL, V11, P2057, DOI 10.1128/MCB.11.4.2057; Williams NK, 2009, J MOL BIOL, V387, P219, DOI 10.1016/j.jmb.2009.01.041; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhu K, 2014, J CHEM INF MODEL, V54, P1932, DOI 10.1021/ci500118s	64	71	77	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4573	4589		10.1074/jbc.M114.595181	http://dx.doi.org/10.1074/jbc.M114.595181			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25552479	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000350042000005
J	Fan, JD; Lei, PJ; Zheng, JY; Wang, X; Li, S; Liu, H; He, YL; Wang, ZN; Wei, G; Zhang, X; Li, LY; Wu, M				Fan, Jia-Dong; Lei, Pin-Ji; Zheng, Jun-Yi; Wang, Xiang; Li, Shangze; Liu, Huan; He, Yi-Lei; Wang, Zhao-Ning; Wei, Gang; Zhang, Xiaodong; Li, Lian-Yun; Wu, Min			The Selective Activation of p53 Target Genes Regulated by SMYD2 in BIX-01294 Induced Autophagy-Related Cell Death	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE; METHYLATION; PROLIFERATION; ACETYLATION; INHIBITOR; APOPTOSIS; G9A; DIFFERENTIATION; METABOLISM; PROTEINS	Transcription regulation emerged to be one of the key mechanisms in regulating autophagy. Inhibitors of H3K9 methylation activates the expression of LC3B, as well as other autophagy-related genes, and promotes autophagy process. However, the detailed mechanisms of autophagy regulated by nuclear factors remain elusive. In this study, we performed a drug screen of SMYD2(-/-)cells and discovered that SMYD2 deficiency enhanced the cell death induced by BIX01294, an inhibitor of histone H3K9 methylation. BIX-01294 induces accumulation of LC3 II and autophagy-related cell death, but not caspase-dependent apoptosis. We profiled the global gene expression pattern after treatment with BIX-01294, in comparison with rapamycin. BIX-01294 selectively activates the downstream genes of p53 signaling, such as p21 and DOR, but not PUMA, a typical p53 target gene inducing apoptosis. BIX-01294 also induces other autophagy-related genes, such as ATG4A and ATG9A. SMYD2 is a methyltransferase for p53 and regulates its transcription activity. Its deficiency enhances the BIX-01294-induced autophagy-related cell death through transcriptionally promoting the expression of p53 target genes. Taken together, our data suggest BIX-01294 induces autophagy-related cell death and selectively activates p53 target genes, which is repressed by SMYD2 methyltransferase.	[Fan, Jia-Dong; Lei, Pin-Ji; Zheng, Jun-Yi; Wang, Xiang; Liu, Huan; He, Yi-Lei; Wang, Zhao-Ning; Li, Lian-Yun; Wu, Min] Wuhan Univ, Coll Life Sci, Dept Biochem & Mol Biol, Wuhan 430072, Hubei, Peoples R China; [Li, Shangze; Zhang, Xiaodong] Wuhan Univ, Coll Life Sci, Dept Cell Biol & Dev Biol, Wuhan 430072, Hubei, Peoples R China; [Wei, Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai 200031, Peoples R China	Wuhan University; Wuhan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Li, LY (corresponding author), Wuhan Univ, Coll Life Sci, Dept Biochem & Mol Biol, Wuhan 430072, Hubei, Peoples R China.	lilianyun@whu.edu.cn; wumin@whu.edu.cn	Wu, Min/AAE-5066-2021; Wang, Zhaoning/AAB-5893-2021; Liu, Huan/CAA-2351-2022; Wang, Xiang/J-4036-2019; li, shangze/AAW-6317-2021	Wu, Min/0000-0003-1372-4764; Wang, Zhaoning/0000-0002-0290-4746; Wang, Xiang/0000-0002-7190-9233; 	National Basic Research Program of China (973 Program) [2011CB504206, 2012CB518700]; National Natural Science Foundation of China [30971502, 91019013, 31221061, 31200653, 31370866]; Program for New Century Excellent Talents in University [NCET-11-0410]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by grants from the National Basic Research Program of China (973 Program, 2011CB504206 and 2012CB518700), the National Natural Science Foundation of China to Min Wu (30971502 and 91019013) and Lian-Yun Li (31221061, 31200653 and 31370866), and Program for New Century Excellent Talents in University to Min Wu (NCET-11-0410). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Culmes M, 2013, EUR J CELL BIOL, V92, P70, DOI 10.1016/j.ejcb.2012.11.001; de Narvajas AAM, 2013, MOL CELL BIOL, V33, P3983, DOI 10.1128/MCB.00813-13; Diehl F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009748; Fullgrabe J, 2014, NAT REV MOL CELL BIO, V15, P65, DOI 10.1038/nrm3716; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Hamamoto R, 2014, CANCER LETT, V351, P126, DOI 10.1016/j.canlet.2014.05.014; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Kim Y, 2013, AUTOPHAGY, V9, P2126, DOI 10.4161/auto.26308; Komatsu S, 2009, CARCINOGENESIS, V30, P1139, DOI 10.1093/carcin/bgp116; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Leinhart K, 2011, GENES-BASEL, V2, P210, DOI 10.3390/genes2010210; Meijer AJ, 2009, AUTOPHAGY, V5, P3, DOI 10.4161/auto.5.1.7207; Mezentseva NV, 2013, STEM CELLS DEV, V22, P654, DOI 10.1089/scd.2012.0181; Munoz-Fontela C, 2011, CELL CYCLE, V10, P3701, DOI 10.4161/cc.10.21.17899; Piao L, 2014, NEOPLASIA, V16, DOI 10.1016/j.neo.2014.03.002; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Saddic LA, 2010, J BIOL CHEM, V285, P37733, DOI 10.1074/jbc.M110.137612; Sajjad A, 2014, BBA-MOL CELL RES, V1843, P2556, DOI 10.1016/j.bbamcr.2014.06.019; Savickiene J, 2014, LEUKEMIA RES, V38, P822, DOI 10.1016/j.leukres.2014.04.003; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Sakamoto LHT, 2014, LEUKEMIA RES, V38, P496, DOI 10.1016/j.leukres.2014.01.013; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Yang Q, 2012, CELL PROLIFERAT, V45, P335, DOI 10.1111/j.1365-2184.2012.00828.x; Zhang X, 2013, P NATL ACAD SCI USA, V110, P17284, DOI 10.1073/pnas.1307959110; Zhang XD, 2008, NAT METHODS, V5, P163, DOI [10.1038/nmeth1170, 10.1038/NMETH1170]; Zhao QY, 2012, SPRINGERPLUS, V1, DOI 10.1186/2193-1801-1-65	35	27	27	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2015	10	1							e0116782	10.1371/journal.pone.0116782	http://dx.doi.org/10.1371/journal.pone.0116782			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ3YO	25562686	Green Published, gold, Green Submitted			2022-12-26	WOS:000348160000003
J	Gorman, BR; Lu, JJ; Baccei, A; Lowry, NC; Purvis, JE; Mangoubi, RS; Lerou, PH				Gorman, Bryan R.; Lu, Junjie; Baccei, Anna; Lowry, Nathan C.; Purvis, Jeremy E.; Mangoubi, Rami S.; Lerou, Paul H.			Multi-Scale Imaging and Informatics Pipeline for In Situ Pluripotent Stem Cell Analysis	PLOS ONE			English	Article							DIFFERENTIATION; HESCS	Human pluripotent stem (hPS) cells are a potential source of cells for medical therapy and an ideal system to study fate decisions in early development. However, hPS cells cultured in vitro exhibit a high degree of heterogeneity, presenting an obstacle to clinical translation. hPS cells grow in spatially patterned colony structures, necessitating quantitative single-cell image analysis. We offer a tool for analyzing the spatial population context of hPS cells that integrates automated fluorescent microscopy with an analysis pipeline. It enables high-throughput detection of colonies at low resolution, with single-cellular and sub-cellular analysis at high resolutions, generating seamless in situ maps of single-cellular data organized by colony. We demonstrate the tool's utility by analyzing inter- and intra-colony heterogeneity of hPS cell cycle regulation and pluripotency marker expression. We measured the heterogeneity within individual colonies by analyzing cell cycle as a function of distance. Cells loosely associated with the outside of the colony are more likely to be in G1, reflecting a less pluripotent state, while cells within the first pluripotent layer are more likely to be in G2, possibly reflecting a G2/M block. Our multi-scale analysis tool groups colony regions into density classes, and cells belonging to those classes have distinct distributions of pluripotency markers and respond differently to DNA damage induction. Lastly, we demonstrate that our pipeline can robustly handle high-content, high-resolution single molecular mRNA FISH data by using novel image processing techniques. Overall, the imaging informatics pipeline presented offers a novel approach to the analysis of hPS cells that includes not only single cell features but also colony wide, and more generally, multi-scale spatial configuration.	[Gorman, Bryan R.; Lu, Junjie; Baccei, Anna; Lerou, Paul H.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pediat Newborn Med,Harvard Stem Cell Inst, Boston, MA 02115 USA; [Gorman, Bryan R.; Lu, Junjie; Baccei, Anna; Lerou, Paul H.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Genet,Harvard Stem Cell Inst, Boston, MA 02115 USA; [Gorman, Bryan R.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Gorman, Bryan R.; Lowry, Nathan C.; Mangoubi, Rami S.] Charles Stark Draper Lab, Cambridge, MA USA; [Purvis, Jeremy E.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); The Charles Stark Draper Laboratory, Inc.; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Lerou, PH (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pediat Newborn Med,Harvard Stem Cell Inst, Boston, MA 02115 USA.	plerou@partners.org	; Lu, Junjie/A-6611-2009	Eastman, Anna/0000-0002-1455-291X; Lu, Junjie/0000-0002-4175-1762	National Institutes of Health [R00 HD061981, P01 GM099117, NIH R00-GM102372, R01 EB006161-01A4]; National Institutes of Health from the National Human Genome Research Institute [T32 HG002295]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD061981] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM102372, P01GM099117] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from the National Human Genome Research Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (R00 HD061981 to P.H.L., Pilot Grant under P01 GM099117 to P.H.L., NIH R00-GM102372 to J.E.P., R01 EB006161-01A4 to R.S.M., T32 HG002295 from the National Human Genome Research Institute to B.G.) and an internal research and development grant to R.S.M. from the C.S. Draper Laboratory, Cambridge, MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbaric I, 2010, STEM CELL RES, V5, P104, DOI 10.1016/j.scr.2010.04.006; Blagovic K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022892; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Daley GQ, 2010, J CLIN INVEST, V120, P8, DOI 10.1172/JCI41801; Drukker M, 2012, NATURE BIOTECHNOLOGY; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Erb TM, 2011, STEM CELLS DEV, V20, P1601, DOI 10.1089/scd.2010.0281; Filipczyk AA, 2007, STEM CELL RES, V1, P45, DOI 10.1016/j.scr.2007.09.002; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Kamentsky L., 2011, BIOINFORMATICS; Lam AQ, 2014, J AM SOC NEPHROL, V25, P1211, DOI 10.1681/ASN.2013080831; Lerou PH, 2008, NAT BIOTECHNOL, V26, P212, DOI 10.1038/nbt1378; Lerou PH, 2005, BLOOD REV, V19, P321, DOI 10.1016/j.blre.2005.01.005; Liu JC, 2013, CELL STEM CELL, V13, P483, DOI 10.1016/j.stem.2013.07.018; Lowry N, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P194, DOI 10.1109/ISBI.2012.6235517; Maciorowski Z, 1997, CYTOMETRY, V28, P123, DOI 10.1002/(SICI)1097-0320(19970601)28:2<123::AID-CYTO4>3.3.CO;2-1; Martinez Arias A, 2011, CURRENT OPINION CELL; Moogk D, 2010, CYTOM PART A, V77A, P321, DOI 10.1002/cyto.a.20878; Narkilahti S, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-11; Nazareth EJP, 2013, NAT METHODS, V10, P1225, DOI [10.1038/nmeth.2684, 10.1038/NMETH.2684]; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Paduano V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080776; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sammak PJ, 2008, HIGH CONTENT SCREENI, P205; Scherf N, 2012, BIOINFORMATICS, V28, pI556, DOI 10.1093/bioinformatics/bts404; Snijder B, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.9; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Unachukwu UJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083906; Wang XF, 2009, J BIOL CHEM, V284, P34054, DOI 10.1074/jbc.M109.052290; Warmflash A, 2014, NAT METHODS, V11, P847, DOI [10.1038/nmeth.3016, 10.1038/NMETH.3016]; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wong RCB, 2008, STEM CELL REV, V4, P283, DOI 10.1007/s12015-008-9038-9	36	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116037	10.1371/journal.pone.0116037	http://dx.doi.org/10.1371/journal.pone.0116037			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551762	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100090
J	Habuka, M; Fagerberg, L; Hallstrom, BM; Kampf, C; Edlund, K; Sivertsson, A; Yamamoto, T; Ponten, F; Uhlen, M; Odeberg, J				Habuka, Masato; Fagerberg, Linn; Hallstrom, Bjorn M.; Kampf, Caroline; Edlund, Karolina; Sivertsson, Asa; Yamamoto, Tadashi; Ponten, Fredrik; Uhlen, Mathias; Odeberg, Jacob			The Kidney Transcriptome and Proteome Defined by Transcriptomics and Antibody-Based Profiling	PLOS ONE			English	Article							ALPHA-CRYSTALLIN; SLIT DIAPHRAGM; RNA-SEQ; GENE; NEPHRIN; EXPRESSION; DISEASE; BIOLOGY; TOOL; UROMODULIN	To understand renal functions and disease, it is important to define the molecular constituents of the various compartments of the kidney. Here, we used comparative transcriptomic analysis of all major organs and tissues in the human body, in combination with kidney tissue micro array based immunohistochemistry, to generate a comprehensive description of the kidney-specific transcriptome and proteome. A special emphasis was placed on the identification of genes and proteins that were elevated in specific kidney subcompartments. Our analysis identified close to 400 genes that had elevated expression in the kidney, as compared to the other analysed tissues, and these were further subdivided, depending on expression levels, into tissue enriched, group enriched or tissue enhanced. Immunohistochemistry allowed us to identify proteins with distinct localisation to the glomeruli (n=11), proximal tubules (n=120), distal tubules (n=9) or collecting ducts (n=8). Among the identified kidney elevated transcripts, we found several proteins not previously characterised or identified as elevated in kidney. This description of the kidney specific transcriptome and proteome provides a resource for basic and clinical research to facilitate studies to understand kidney biology and disease.	[Habuka, Masato; Fagerberg, Linn; Hallstrom, Bjorn M.; Sivertsson, Asa; Uhlen, Mathias; Odeberg, Jacob] KTH Royal Inst Technol, Sci Life Lab, Sch Biotechnol, Stockholm, Sweden; [Kampf, Caroline; Edlund, Karolina; Ponten, Fredrik] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Habuka, Masato; Yamamoto, Tadashi] Niigata Univ, Sch Med & Dent, Inst Nephrol, Dept Struct Pathol, Niigata, Japan; [Odeberg, Jacob] Karolinska Inst, Dept Med, Stockholm, Sweden; [Odeberg, Jacob] Karolinska Univ Hosp, Ctr Hematol, Stockholm, Sweden	Royal Institute of Technology; Uppsala University; Niigata University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Odeberg, J (corresponding author), KTH Royal Inst Technol, Sci Life Lab, Sch Biotechnol, Stockholm, Sweden.	Jacob.odeberg@scilifelab.se	Uhlen, Mathias/AAV-8746-2021; Uhlen, Mathias/B-3262-2016; Odeberg, Jacob/I-8314-2016	Uhlen, Mathias/0000-0002-4858-8056; Odeberg, Jacob/0000-0003-0996-1644; Fagerberg, Linn/0000-0003-0198-7137	Knut and Alice Wallenberg Foundation; Stockholm County Council	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Stockholm County Council(Stockholm County Council)	Funding was provided by the Knut and Alice Wallenberg Foundation (http://www.wallenberg.com/kaw/en) and by the Stockholm County Council (http://www.forskningsstod.sll.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson CMH, 2010, PHYSIOLOGY, V25, P364, DOI 10.1152/physiol.00027.2010; Andley UP, 2009, CURR MOL MED, V9, P887, DOI 10.2174/156652409789105598; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beall MH, 2005, J SOC GYNECOL INVEST, V12, P298, DOI 10.1016/j.jsgi.2005.02.009; Bleyer AJ, 2011, NEPHRON CLIN PRACT, V118, pC31, DOI 10.1159/000320889; Cui ZY, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-13; Curthoys NP, 2007, AM J PHYSIOL-RENAL, V292, pF140, DOI 10.1152/ajprenal.00217.2006; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eladari D, 2012, ANNU REV PHYSIOL, V74, P325, DOI 10.1146/annurev-physiol-020911-153225; Faber JJ, 2010, INT J DEV BIOL, V54, P391, DOI 10.1387/ijdb.082796jf; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Farrah T, 2014, J PROTEOME RES, V13, P60, DOI 10.1021/pr4010037; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Griffin NM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.000935; He Lei, 2009, Human Genomics, V3, P195; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; KUMAR R, 1994, AM J PHYSIOL, V266, pF477, DOI 10.1152/ajprenal.1994.266.3.F477; Lhotta K, 2010, KIDNEY BLOOD PRESS R, V33, P393, DOI 10.1159/000320681; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Miyamoto M, 2007, J PROTEOME RES, V6, P3680, DOI 10.1021/pr070203n; Morrissey KM, 2012, CLIN PHARMACOL THER, V92, P545, DOI 10.1038/clpt.2012.44; Moser M, 2003, LAB INVEST, V83, P571, DOI 10.1097/01.LAB.0000064703.92382.50; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Sato T, 2012, J CELL SCI, V125, P1544, DOI 10.1242/jcs.095273; Schafer J A, 1979, Physiologist, V22, P44; Schlessinger A, 2013, CLIN PHARMACOL THER, V94, P19, DOI 10.1038/clpt.2013.73; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Serafini-Cessi F, 2003, AM J KIDNEY DIS, V42, P658, DOI 10.1016/S0272-6386(03)00829-1; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Takemoto M, 2006, EMBO J, V25, P1160, DOI 10.1038/sj.emboj.7601014; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Usener D, 2003, J INVEST DERMATOL, V121, P198, DOI 10.1046/j.1523-1747.2003.12318.x; Walmsley SJ, 2010, AM J PHYSIOL-RENAL, V298, pF1323, DOI 10.1152/ajprenal.00711.2009; Yamamoto T, 1998, KIDNEY INT, V54, P1041, DOI 10.1046/j.1523-1755.1998.00123.x; Zhou Y, 2012, AM J PHYSIOL-RENAL, V302, pF316, DOI 10.1152/ajprenal.00464.2011	41	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e116125	10.1371/journal.pone.0116125	http://dx.doi.org/10.1371/journal.pone.0116125			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551756	Green Published, Green Submitted, gold			2022-12-26	WOS:000347119100096
J	Modi, K; Misra, HS				Modi, Kruti; Misra, Hari S.			Dr-FtsA, an Actin Homologue in Deinococcus radiodurans Differentially Affects Dr-FtsZ and Ec-FtsZ Functions In Vitro	PLOS ONE			English	Article							CELL-DIVISION PROTEIN; ESCHERICHIA-COLI FTSA; CRYSTAL-STRUCTURE; RADIORESISTANCE; MEMBRANE; SYSTEM; GENOME; KINASE; RING; LOCALIZATION	The Deinococcus radiodurans genome encodes homologues of divisome proteins including FtsZ and FtsA. FtsZ of this bacterium (Dr-FtsZ) has been recently characterized. In this paper, we study FtsA of D. radiodurans (Dr-FtsA) and its involvement in regulation of FtsZ function. Recombinant Dr-FtsA showed neither ATPase nor GTPase activity and its polymerization was ATP dependent. Interestingly, we observed that Dr-FtsA, when compared with E. coli FtsA (EcFtsA), has lower affinity for both Dr-FtsZ and Ec-FtsZ. Also, Dr-FtsA showed differential effects on GTPase activity and sedimentation characteristics of Dr-FtsZ and Ec-FtsZ. For instance, Dr-FtsA stimulated GTPase activity of Dr-FtsZ while GTPase activity of Ec-FtsZ was reduced in the presence of Dr-FtsA. Stimulation of GTPase activity of Dr-FtsZ by Dr-FtsA resulted in depolymerization of Dr-FtsZ. Dr-FtsA effects on GTPase activity and polymerization/depolymerisation characteristics of Dr-FtsZ did not change significantly in the presence of ATP. Recombinant E. coli expressing Dr-FtsA showed cell division inhibition in spite of in trans expression of Dr-FtsZ in these cells. These results suggested that Dr-FtsA, although it lacks ATPase activity, is still functional and differentially affects Dr-FtsZ and Ec-FtsZ function in vitro.	[Modi, Kruti; Misra, Hari S.] Bhabha Atom Res Ctr, Div Mol Biol, Bombay 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC)	Misra, HS (corresponding author), Bhabha Atom Res Ctr, Div Mol Biol, Bombay 400085, Maharashtra, India.	hsmisra@barc.gov.in		Misra, Hari/0000-0002-9349-1229	Department of Atomic Energy, Government of India	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE))	Authors are grateful to Dr. S. K. Apte for his constructive criticisms on the work and valuable suggestions. We thank Professor Dulal Panda, IIT Bombay for Ec-FtsZ expression plasmid and table top ultramicrocentrifuge facility while Professor P. Ajitkumar, IISc Bangalore for Ec-FtsZ antibodies, and Dr. B. Vishwanath, Material Science Division, BARC for his help in carrying out transmission electron microscopy. We sincerely acknowledge the help of Dr Manisha Banerjee and Dr Swathi Kota for the critical reading of the manuscript. KM is grateful to Department of Atomic Energy, Government of India for Senior Research Fellowship.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Barak I, 2007, FEMS MICROBIOL REV, V31, P311, DOI 10.1111/j.1574-6976.2007.00067.x; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; Battista JR, 2000, CURR BIOL, V10, pR204, DOI 10.1016/S0960-9822(00)00353-5; Battista JR, 2001, CRYOBIOLOGY, V43, P133, DOI 10.1006/cryo.2001.2357; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BEGG KJ, 1985, J BACTERIOL, V163, P615, DOI 10.1128/JB.163.2.615-622.1985; Beuria TK, 2003, J BIOL CHEM, V278, P3735, DOI 10.1074/jbc.M205760200; Blasius M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-69; Charaka VK, 2012, J BACTERIOL, V194, P5739, DOI 10.1128/JB.00610-12; DAI K, 1992, J BACTERIOL, V174, P6145, DOI 10.1128/JB.174.19.6145-6151.1992; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Feucht A, 2001, MOL MICROBIOL, V40, P115, DOI 10.1046/j.1365-2958.2001.02356.x; Fujita J, 2014, FEBS LETT, V588, P1879, DOI 10.1016/j.febslet.2014.04.008; Geissler B, 2007, MICROBIOL-SGM, V153, P814, DOI 10.1099/mic.0.2006/001834-0; Jonas K, 2014, CURR OPIN MICROBIOL, V18, P54, DOI 10.1016/j.mib.2014.02.006; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Karimova G, 2001, J MOL MICROB BIOTECH, V3, P73; Kota S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085288; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lara B, 2005, MOL MICROBIOL, V55, P699, DOI 10.1111/j.1365-2958.2004.04432.x; Lecointe F, 2004, GENE, V336, P25, DOI 10.1016/j.gene.2004.04.006; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Loose M, 2014, NAT CELL BIOL, V16, P38, DOI 10.1038/ncb2885; Lu CL, 1998, METHOD ENZYMOL, V298, P305, DOI 10.1016/S0076-6879(98)98027-2; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Martos A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039829; Misra HS, 2013, CURR SCI INDIA, V104, P194; Modi KM, 2014, INT J BIOCHEM CELL B, V50, P38, DOI 10.1016/j.biocel.2014.01.015; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Pichoff S, 2007, MOL MICROBIOL, V64, P1129, DOI 10.1111/j.1365-2958.2007.05735.x; Rajpurohit YS, 2013, INT J BIOCHEM CELL B, V45, P2541, DOI 10.1016/j.biocel.2013.08.011; Rajpurohit YS, 2010, MOL MICROBIOL, V77, P1470, DOI 10.1111/j.1365-2958.2010.07301.x; Rico AI, 2004, MOL MICROBIOL, V53, P1359, DOI 10.1111/j.1365-2958.2004.04245.x; Ringgaard S, 2014, P NATL ACAD SCI USA, V111, pE255, DOI 10.1073/pnas.1315722111; Sambrook J., 2001, MOL CLONING LAB MANU; Schafer M, 2000, PHOTOCHEM PHOTOBIOL, V71, P514, DOI 10.1562/0031-8655(2000)071<0514:SSOPIT>2.0.CO;2; Scheffers DJ, 2002, MOL MICROBIOL, V43, P1517, DOI 10.1046/j.1365-2958.2002.02828.x; Schultz C, 2009, MOL MICROBIOL, V74, P724, DOI 10.1111/j.1365-2958.2009.06897.x; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2000, EMBO J, V19, P5300, DOI 10.1093/emboj/19.20.5300; Wang XD, 1997, J BACTERIOL, V179, P5551, DOI 10.1128/jb.179.17.5551-5559.1997; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Yim L, 2000, J BACTERIOL, V182, P6366, DOI 10.1128/JB.182.22.6366-6373.2000	48	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115918	10.1371/journal.pone.0115918	http://dx.doi.org/10.1371/journal.pone.0115918			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551229	gold, Green Submitted, Green Published			2022-12-26	WOS:000347119100077
J	Rodriguez-Ruiz, J; de la Puente, J; Parejo, D; Valera, F; Calero-Torralbo, MA; Reyes-Gonzalez, JM; Zajkova, Z; Bermejo, A; Aviles, JM				Rodriguez-Ruiz, Juan; de la Puente, Javier; Parejo, Deseada; Valera, Francisco; Calero-Torralbo, Miguel A.; Reyes-Gonzalez, Jose M.; Zajkova, Zuzana; Bermejo, Ana; Aviles, Jesus M.			Disentangling Migratory Routes and Wintering Grounds of Iberian Near-Threatened European Rollers Coracias garrulus	PLOS ONE			English	Article							HOBBIES FALCO-SUBBUTEO; ANNUAL CYCLE; FLIGHT; AUTUMN	Long-distance migrants are suffering drastic declines in the last decades. Causes beneath this problem are complex due to the wide spatial and temporal scale involved. We aim to reveal migratory routes, stopover areas, wintering grounds, and migratory strategies for the most southwestern populations of the near-threatened European Roller Coracias garrulus in order to identify conservation key areas for the non-breeding stage of this species. To this end, we used tracking data from seven satellite transmitters fitted to birds breeding in different populations throughout the Iberian Peninsula and four geolocators fitted to individuals in a southeastern Iberian population. Precise satellite data were used to describe daily activity patterns and speed in relation to the main regions crossed during the migration. Individuals from the most southwestern Iberian populations made a detour towards the Atlantic African coast whereas those from northeastern populations followed a straight north-to-south route. We identified important stopover areas in the Sahel belt, mainly in the surroundings of the Lake Chad, and wintering grounds on southwestern Africa farther west than previously reported for the species. Concerning the migratory strategy, satellite data revealed: 1) a mainly nocturnal flying activity, 2) that migration speed depended on the type of crossed habitat, with higher average speed while crossing the desert; and 3) that the migration was slower and lasted longer in autumn than in spring. The studied populations showed weak migratory connectivity, suggesting the confluence of birds from a wide range of breeding grounds in a restricted wintering area. Therefore, we suggest to target on defining precisely key areas for this species and identifying specific threats in them in order to develop an appropriate global conservation programme for the European Roller.	[Rodriguez-Ruiz, Juan; Parejo, Deseada; Valera, Francisco; Calero-Torralbo, Miguel A.; Aviles, Jesus M.] CSIC, Estn Expt Zonas Aridas, Dept Ecol Func & Evolut, Almeria, Spain; [de la Puente, Javier; Bermejo, Ana] SEO BirdLife, Area Estudio & Seguimiento Aves, Madrid, Spain; [Parejo, Deseada] Univ Extremadura, Fac Ciencias, Dept Anat Biol Celular & Zool, Area Zool, Badajoz, Spain; [Reyes-Gonzalez, Jose M.; Zajkova, Zuzana] Univ Barcelona, Fac Biol, Dept Anim Biol Vertebrates, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Universidad de Extremadura; University of Barcelona	Rodriguez-Ruiz, J (corresponding author), CSIC, Estn Expt Zonas Aridas, Dept Ecol Func & Evolut, Almeria, Spain.	juanrodruiz@gmail.com	Avilés, Jesús/K-3332-2014; REYES-GONZÁLEZ, JOSÉ MANUEL/N-9182-2017; Parejo, Deseada/L-3953-2014; Valera, Francisco/J-5951-2014; Valera, Francisco/R-3437-2019	Avilés, Jesús/0000-0002-1463-8393; REYES-GONZÁLEZ, JOSÉ MANUEL/0000-0001-8311-3235; Parejo, Deseada/0000-0002-7368-2378; Valera, Francisco/0000-0003-2266-8899; Valera, Francisco/0000-0003-2266-8899; Zajkova, Zuzana/0000-0002-7540-3651; Rodriguez-Ruiz, Juan/0000-0002-3937-7900	Spanish Ministry of Education and Science/FEDER [CGL2008-00718, CGL2008-00562]; Government of Extremadura [TA13002]	Spanish Ministry of Education and Science/FEDER(Spanish Government); Government of Extremadura	Funding in the form of salaries and fieldwork expenses was provided by the Spanish Ministry of Education and Science/FEDER through the projects CGL2008-00718 to DP and JMA and CGL2008-00562 to FV and only in form of salary by the Government of Extremadura through the grant TA13002 to DP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T., 1990, P331; Alerstam T, 2001, J THEOR BIOL, V209, P319, DOI 10.1006/jtbi.2001.2266; Alerstam T, 1993, BIRD MIGRATION; Alerstam T, 2009, J THEOR BIOL, V258, P530, DOI 10.1016/j.jtbi.2009.01.020; Ambrosini R, 2009, J THEOR BIOL, V257, P203, DOI 10.1016/j.jtbi.2008.11.019; [Anonymous], 2014, R LANG ENV STAT COMP; Argos, 2007, ARG US MAN; Arlt D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082316; ASH J S, 1980, Bulletin of the British Ornithologists' Club, V100, P216; Austin D, 2003, MAR MAMMAL SCI, V19, P371, DOI 10.1111/j.1748-7692.2003.tb01115.x; Aviles Jesus M., 1998, Vogelwarte, V39, P242; Bachler E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009566; Barron DG, 2010, METHODS ECOL EVOL, V1, P180, DOI 10.1111/j.2041-210X.2010.00013.x; *BIRDLIFE BOTSW, 2014, SPEC FACTSH COR GARR; *BIRDLIFE INT, 2013, SPEC FACTSH COR GARR; Bowlin MS, 2010, METHODS ECOL EVOL, V1, P398, DOI 10.1111/j.2041-210X.2010.00043.x; *BRIT ANT SURV, 2010, GEOL MAN V8; Brown L.H., 1973, Bulletin Br Orn Club, V93, P126; Catry I, 2014, J ORNITHOL, V155, P1071, DOI 10.1007/s10336-014-1097-x; CRAMP S, 1998, COMPLETE BRIDS W PAL; Dorst J., 1962, LAPD JUNE 2021 SETUP; Emmenegger T, 2014, J ORNITHOL, V155, P427, DOI 10.1007/s10336-013-1023-7; Feare C.J., 1983, Bulletin of the British Ornithologists' Club, V103, P39; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; FRY CH, 2001, HDB BIRDS WORLD, V6, P342; Gao H, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034021; garcelon D.K., 1985, MOUNTING BACKPACK TE; Glutz Von Blotzheim U.N., 1980, HDB VOGEL MITTELEURO, V9; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; HEDENSTROM A, 1993, PHILOS T ROY SOC B, V342, P353, DOI 10.1098/rstb.1993.0164; Hill Roger D., 1994, P227; Kerlinger P., 1989, Current Ornithology, V6, P109; Liminana R, 2008, ARDEA, V96, P81, DOI 10.5253/078.096.0109; Liminana R, 2012, BIOL CONSERV, V145, P62, DOI 10.1016/j.biocon.2011.10.009; Lisovski S, 2012, METHODS ECOL EVOL, V3, P603, DOI 10.1111/j.2041-210X.2012.00185.x; Lopez-Lopez P, 2010, LANDSCAPE ECOL, V25, P803, DOI 10.1007/s10980-010-9460-7; Lopez-Lopez P, 2009, ZOOL STUD, V48, P485; MAYAUD N, 1985, Alauda, V53, P29; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; Mellone U, 2013, J AVIAN BIOL, V44, P417, DOI 10.1111/j.1600-048X.2013.00139.x; Meyburg B-U, 2009, POPULATIONSOKOLOGIE, V6, P311; Moreau R., 1972, PALAEARCTIC AFRICAN; MOREL G, 1973, IBIS, V115, P413, DOI 10.1111/j.1474-919X.1973.tb01979.x; Mulliu W.C., 2009, LIVING EDGE WETLANDS, P202; Newton I, 2004, IBIS, V146, P197, DOI 10.1111/j.1474-919X.2004.00293.x; PEPLER D, 2000, ESKOM RED DATA BOOK, P90; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Robinson WD, 2010, FRONT ECOL ENVIRON, V8, P354, DOI 10.1890/080179; Rodgers A. R., 2005, HRT HOME RANGE TOOLS; Rodriguez A, 2009, DIVERS DISTRIB, V15, P1010, DOI 10.1111/j.1472-4642.2009.00600.x; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Sauvage A., 1998, Malimbus, V20, P75; Scandolara C, 2014, J AVIAN BIOL, V45, P417, DOI 10.1111/jav.00412; Schmaljohann H, 2012, BEHAV ECOL SOCIOBIOL, V66, P915, DOI 10.1007/s00265-012-1340-5; Schwilch R, 2002, ARDEA, V90, P149; Searle SR., 1992, VARIANCE COMPONENTS; Strandberg R, 2009, P ROY SOC B-BIOL SCI, V276, P727, DOI 10.1098/rspb.2008.1202; Strandberg R, 2007, BEHAV ECOL SOCIOBIOL, V61, P1865, DOI 10.1007/s00265-007-0426-y; Strandberg R, 2009, ARDEA, V97, P287, DOI 10.5253/078.097.0304; Stresemann Erwin, 1944, ORNITHOL MONATSBER, V52, P132; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Tottrup AP, 2012, P ROY SOC B-BIOL SCI, V279, P1008, DOI 10.1098/rspb.2011.1323; Trierweiler C, 2013, J ANIM ECOL, V82, P107, DOI 10.1111/j.1365-2656.2012.02036.x; Vickery JA, 2014, IBIS, V156, P1, DOI 10.1111/ibi.12118; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Zwarts L., 2009, LIVING EDGE WETLANDS	67	18	21	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115615	10.1371/journal.pone.0115615	http://dx.doi.org/10.1371/journal.pone.0115615			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551212	Green Published, gold, Green Submitted			2022-12-26	WOS:000347119100050
J	Zelman, B; Kiszewski, A; Cotter, C; Liu, J				Zelman, Brittany; Kiszewski, Anthony; Cotter, Chris; Liu, Jenny			Costs of Eliminating Malaria and the Impact of the Global Fund in 34 Countries	PLOS ONE			English	Article								Background: International financing for malaria increased more than 18-fold between 2000 and 2011; the largest source came from The Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund). Countries have made substantial progress, but achieving elimination requires sustained finances to interrupt transmission and prevent reintroduction. Since 2011, global financing for malaria has declined, fueling concerns that further progress will be impeded, especially for current malaria-eliminating countries that may face resurgent malaria if programs are disrupted. Objectives: This study aims to 1) assess past total and Global Fund funding to the 34 current malaria-eliminating countries, and 2) estimate their future funding needs to achieve malaria elimination and prevent reintroduction through 2030. Methods: Historical funding is assessed against trends in country-level malaria annual parasite incidences (APIs) and income per capita. Following Kizewski et al. (2007), program costs to eliminate malaria and prevent reintroduction through 2030 are estimated using a deterministic model. The cost parameters are tailored to a package of interventions aimed at malaria elimination and prevention of reintroduction. Results: The majority of Global Fund-supported countries experiencing increases in total funding from 2005 to 2010 coincided with reductions in malaria APIs and also overall GNI per capita average annual growth. The total amount of projected funding needed for the current malaria-eliminating countries to achieve elimination and prevent reintroduction through 2030 is approximately US$8.5 billion, or about $1.84 per person at risk per year (PPY) (ranging from $2.51 PPY in 2014 to $1.43 PPY in 2030). Conclusions: Although external donor funding, particularly from the Global Fund, has been key for many malaria-eliminating countries, sustained and sufficient financing is critical for furthering global malaria elimination. Projected cost estimates for elimination provide policymakers with an indication of the level of financial resources that should be mobilized to achieve malaria elimination goals.	[Zelman, Brittany; Cotter, Chris; Liu, Jenny] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Kiszewski, Anthony] Bentley Univ, Waltham, MA USA	University of California System; University of California San Francisco; Bentley University	Zelman, B (corresponding author), Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA.	Brittany.Zelman@ucsf.edu			Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The University of California San Francisco Global Health Group's Malaria Elimination Initiative is supported by grants from the Bill & Melinda Gates Foundation. The authors declare that no funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ETH INT FRAM GLOB FU; [Anonymous], WHO COMM SRI LANK; [Anonymous], DET COST EFF MAL RAP; [Anonymous], DIAGN G6DP DEF; [Anonymous], MAL EL COUNTR BRIEF; [Anonymous], IND MEAS IMP MAL CON; [Anonymous], SOURC PRIC SEL MED C; [Anonymous], COART PRIC LIST; [Anonymous], INT J GEOINFORMATICS; [Anonymous], LONG LAST INS NETS L; [Anonymous], FINANCING MALARIA EL; [Anonymous], PROGR EL SRI LANK; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Hay SI, 2006, PLOS MED, V3, P2204, DOI 10.1371/journal.pmed.0030473; Kiszewski A, 2007, B WORLD HEALTH ORGAN, V85, P623, DOI 10.2471/BLT.06.039529; Oduro AR, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-96; Pigott DM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-246; WHO, 2012, WORLD MALARIA REPORT 2012, P1	21	16	16	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2014	9	12							e115714	10.1371/journal.pone.0115714	http://dx.doi.org/10.1371/journal.pone.0115714			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UC	25551454	gold, Green Submitted, Green Published			2022-12-26	WOS:000347119100052
J	Fei, P; Zaitoun, I; Farnoodian, M; Fisk, DL; Wang, SJ; Sorenson, CM; Sheibani, N				Fei, Ping; Zaitoun, Ismail; Farnoodian, Mitra; Fisk, Debra L.; Wang, Shoujian; Sorenson, Christine M.; Sheibani, Nader			Expression of Thrombospondin-1 Modulates the Angioinflammatory Phenotype of Choroidal Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; RETINAL VASCULAR DEVELOPMENT; GROWTH-FACTOR; VE-CADHERIN; IN-VITRO; ANGIOGENESIS; ENDOGLIN; GENE; NEOVASCULARIZATION; HETEROGENEITY	The choroidal circulation plays a central role in maintaining the health of outer retina and photoreceptor function. Alterations in this circulation contribute to pathogenesis of many eye diseases including exudative age-related macular degeneration. Unfortunately, very little is known about the choroidal circulation and its molecular and cellular regulation. This has been further hampered by the lack of methods for routine culturing of choroidal endothelial cells (ChEC), especially from wild type and transgenic mice. Here we describe a method for isolation and culturing of mouse ChEC. We show that expression of thrombospondin-1 (TSP1), an endogenous inhibitor of angiogenesis and inflammation, has a significant impact on phenotype of ChEC. ChEC from TSP1-deficient (TSP1-/-) mice were less proliferative and more apoptotic, less migratory and less adherent, and failed to undergo capillary morphogenesis in Matrigel. However, re-expression of TSP1 was sufficient to restore TSP1-/- ChEC migration and capillary morphogenesis. TSP1-/- ChEC expressed increased levels of TSP2, phosphorylated endothelial nitric oxide synthase (NOS) and inducible NOS (iNOS), a marker of inflammation, which was associated with significantly higher level of NO and oxidative stress in these cells. Wild type and TSP1-/- ChEC produced similar levels of VEGF, although TSP1-/- ChEC exhibited increased levels of VEGF-R1 and pSTAT3. Other signaling pathways including Src, Akt, and MAPKs were not dramatically affected by the lack of TSP1. Together our results demonstrate an important autocrine role for TSP1 in regulation of ChEC phenotype.	[Fei, Ping; Zaitoun, Ismail; Farnoodian, Mitra; Fisk, Debra L.; Wang, Shoujian; Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA; [Sorenson, Christine M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI USA; [Sorenson, Christine M.; Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, McPherson Eye Res Inst, Madison, WI USA; [Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomed Engn, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sheibani, N (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA.	nsheibanikar@wisc.edu	Sheibani, Nader/AAG-2379-2020	Sheibani, Nader/0000-0003-2723-9217	UW Paul P. Carbone Cancer Center Support Grant from the National Institutes of Health [EY023024, EY022883, P30 EY016665, P30 CA014520]; Research to Prevent Blindness; American Diabetes Association [1-10-BS-160]; Retina Research Foundation; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY016665, R24EY022883, R21EY023024] Funding Source: NIH RePORTER	UW Paul P. Carbone Cancer Center Support Grant from the National Institutes of Health; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); American Diabetes Association(American Diabetes Association); Retina Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants EY023024, EY022883, P30 EY016665 Core grant, and P30 CA014520 UW Paul P. Carbone Cancer Center Support Grant from the National Institutes of Health and an unrestricted departmental award from Research to Prevent Blindness. NS is a recipient of a Research Award from American Diabetes Association, 1-10-BS-160 and Retina Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 1997, OPHTHALMIC RES, V29, P354, DOI 10.1159/000268033; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Bhutto IA, 2008, ARCH OPHTHALMOL-CHIC, V126, P670, DOI 10.1001/archopht.126.5.670; Blanes MG, 2007, J BIOL CHEM, V282, P10660, DOI 10.1074/jbc.M609048200; Browning AC, 2005, BRIT J OPHTHALMOL, V89, P1343, DOI 10.1136/bjo.2004.063602; Browning AC, 2012, BRIT J OPHTHALMOL, V96, P128, DOI 10.1136/bjophthalmol-2011-300572; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; CERVERA R, 1994, ANN RHEUM DIS, V53, P265, DOI 10.1136/ard.53.4.265; Daufenbach DR, 1998, OPHTHALMOLOGY, V105, P1455, DOI 10.1016/S0161-6420(98)98028-9; Dejana E, 2012, CURRENT OPINION HEMA; FAJARDO LF, 1989, AM J CLIN PATHOL, V92, P241, DOI 10.1093/ajcp/92.2.241; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Green W Richard, 2005, Retina, V25, P180, DOI 10.1097/00006982-200507001-00005; GREENWOOD J, 1994, LAB INVEST, V70, P39; Grisanti S, 2004, EXP EYE RES, V78, P207, DOI 10.1016/j.exer.2003.11.008; Guyer DR, 1994, RETINA, P18; He Shikun, 2006, Yan Ke Xue Bao, V22, P265; He SK, 2005, INVEST OPHTH VIS SCI, V46, P4772, DOI 10.1167/iovs.05-0502; Hnasko R, 2006, CELL CYCLE, V5, P2021, DOI 10.4161/cc.5.17.3217; Hoffmann S, 1998, GRAEF ARCH CLIN EXP, V236, P779, DOI 10.1007/s004170050158; Ioannidou S, 2006, P NATL ACAD SCI USA, V103, P16770, DOI 10.1073/pnas.0603501103; Isenberg JS, 2005, P NATL ACAD SCI USA, V102, P13141, DOI 10.1073/pnas.0502977102; Jozkowicz A, 2004, GROWTH FACTORS, V22, P19, DOI 10.1080/0897719041682863; Kibbe M, 1999, CARDIOVASC RES, V43, P650, DOI 10.1016/S0008-6363(99)00130-3; Kobayashi S, 1998, JPN J PHARMACOL, V78, P471, DOI 10.1254/jjp.78.471; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; Leal EC, 2007, INVEST OPHTH VIS SCI, V48, P5257, DOI 10.1167/iovs.07-0112; Li RM, 2009, MICROCIRCULATION, V16, P640, DOI 10.1080/10739680903133185; Lidington EA, 2002, AM J PHYSIOL-CELL PH, V282, pC67, DOI 10.1152/ajpcell.2002.282.1.C67; LIU XP, 1993, EXP EYE RES, V57, P37, DOI 10.1006/exer.1993.1096; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Luo Y, 2005, J CELL BIOL, V169, P29, DOI 10.1083/jcb.200411127; Lutty G, 1999, MOL VIS, V5; MAJACK RA, 1988, J CELL BIOL, V106, P415, DOI 10.1083/jcb.106.2.415; McLeod DS, 2009, INVEST OPHTH VIS SCI, V50, P4982, DOI 10.1167/iovs.09-3639; Miller JW, 1997, AM J PATHOL, V151, P13; MORSE LS, 1990, CURR EYE RES, V9, P631, DOI 10.3109/02713689008999578; Nagareddy PR, 2005, AM J PHYSIOL-HEART C, V289, pH2144, DOI 10.1152/ajpheart.00591.2005; Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804; Park S, 2013, J CELL SCI, V126, P1392, DOI 10.1242/jcs.117275; Park S, 2010, AM J PHYSIOL-CELL PH, V299, pC1468, DOI 10.1152/ajpcell.00246.2010; SABET MD, 1989, BIOL CELL, V65, P171, DOI 10.1016/0248-4900(89)90025-7; SAKAMOTO T, 1995, CURR EYE RES, V14, P621, DOI 10.3109/02713689508998488; Scheef E, 2005, MOL VIS, V11, P613; Scheef EA, 2007, MOL VIS, V13, P1483; Scheef EA, 2009, AM J PHYSIOL-CELL PH, V296, pC724, DOI 10.1152/ajpcell.00409.2008; Sheibani N, 1999, HISTOL HISTOPATHOL, V14, P285, DOI 10.14670/HH-14.285; Steinle JJ, 2003, AUTON NEUROSCI-BASIC, V108, P57, DOI 10.1016/S1566-0702(03)00151-6; Stewart EA, 2011, EXP EYE RES, V93, P761, DOI 10.1016/j.exer.2011.09.010; Su XJ, 2003, MOL VIS, V9, P171; Tang YX, 2009, BLOOD, V113, P744, DOI 10.1182/blood-2008-03-145219; Thirunavukkarasu M, 2007, FREE RADICAL BIO MED, V42, P1487, DOI 10.1016/j.freeradbiomed.2007.02.011; TUCKER RP, 1991, DIFFERENTIATION, V48, P59, DOI 10.1111/j.1432-0436.1991.tb00243.x; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang S, 2012, ARCH OPHTHALMOLOGY; Wang SJ, 2012, ARCH OPHTHALMOL-CHIC, V130, P615, DOI 10.1001/archopthalmol.2011.1892; Wang SJ, 2003, DEV DYNAM, V228, P630, DOI 10.1002/dvdy.10412; Wang YJ, 2006, MICROVASC RES, V71, P143, DOI 10.1016/j.mvr.2006.02.004; Wu ZF, 2006, DEV DYNAM, V235, P1908, DOI 10.1002/dvdy.20837; Zamiri P, 2005, INVEST OPHTH VIS SCI, V46, P908, DOI 10.1167/iovs.04-0362; Zamora DO, 2007, MOL VIS, V13, P2058; Zubilewicz A, 2001, ONCOGENE, V20, P1403, DOI 10.1038/sj.onc.1204231	63	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116423	10.1371/journal.pone.0116423	http://dx.doi.org/10.1371/journal.pone.0116423			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25548916	Green Published, gold			2022-12-26	WOS:000347063500083
J	Karino, M; Nakatani, E; Hideshima, K; Nariai, Y; Tsunematsu, K; Ohira, K; Kanno, T; Asahina, I; Kagimura, T; Sekine, J				Karino, Masaaki; Nakatani, Eiji; Hideshima, Katsumi; Nariai, Yoshiki; Tsunematsu, Kohji; Ohira, Koichiro; Kanno, Takahiro; Asahina, Izumi; Kagimura, Tatsuo; Sekine, Joji			Applicability of Preoperative Nuclear Morphometry to Evaluating Risk for Cervical Lymph Node Metastasis in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							NECK DISSECTION; ELECTIVE NECK; CANCER; PREDICTION; BIOPSY; TONGUE; HEAD; LESIONS; FLOOR	Background: We previously reported the utility of preoperative nuclear morphometry for evaluating risk for cervical lymph node metastases in tongue squamous cell carcinoma. The risk for lymph node metastasis in oral squamous cell carcinoma, however, is known to differ depending on the anatomical site of the primary tumor, such as the tongue, gingiva, mouth floor, and buccal mucosa. In this study, we evaluated the applicability of this morphometric technique to evaluating the risk for cervical lymph node metastasis in oral squamous cell carcinoma. Methods: A digital image system was used to measure the mean nuclear area, mean nuclear perimeter, nuclear circular rate, ratio of nuclear length to width (aspect ratio), and nuclear area coefficient of variation (NACV). Relationships between these parameters and nodal status were evaluated by t-test and logistic regression analysis. Results: Eighty-eight cases of squamous cell carcinoma (52 of the tongue, 25 of the gingiva, 4 of the buccal mucosa, and 7 of the mouth floor) were included: 46 with positive node classification and 42 with negative node classification. Nuclear area and perimeter were significantly larger in node-positive cases than in node-negative cases; however, there were no significant differences in circular rate, aspect ratio, or NACV. We derived two risk models based on the results of multivariate analysis: Model 1, which identified age and mean nuclear area and Model 2, which identified age and mean nuclear perimeter. It should be noted that primary tumor site was not associated the pN-positive status. There were no significant differences in pathological nodal status by aspect ratio, NACV, or primary tumor site. Conclusion: Our method of preoperative nuclear morphometry may contribute valuable information to evaluations of the risk for lymph node metastasis in oral squamous cell carcinoma.	[Karino, Masaaki; Hideshima, Katsumi; Nariai, Yoshiki; Tsunematsu, Kohji; Ohira, Koichiro; Kanno, Takahiro; Sekine, Joji] Shimane Univ, Fac Med, Dept Oral & Maxillofacial Surg, Izumo, Shimane, Japan; [Nakatani, Eiji; Kagimura, Tatsuo] Translat Res Informat Ctr, Kobe, Hyogo, Japan; [Asahina, Izumi] Nagasaki Univ, Grad Sch Med Sci, Dept Regenerat Oral Surg, Nagasaki 852, Japan	Shimane University; Nagasaki University	Sekine, J (corresponding author), Shimane Univ, Fac Med, Dept Oral & Maxillofacial Surg, Izumo, Shimane, Japan.	georges@med.shimane-u.ac.jp	Nakatani, Eiji/O-2782-2013	Nakatani, Eiji/0000-0002-4876-446X				BRIGGS RJS, 1992, ARCH OTOLARYNGOL, V118, P531; Chone CT, 2013, EUR ARCH OTO-RHINO-L, V270, P313, DOI 10.1007/s00405-012-2032-5; Crile G, 1906, J AMER MED ASSOC, V47, P1780; Ferris RL, 2012, CLIN EXP METASTAS, V29, P693, DOI 10.1007/s10585-012-9492-2; Flach GB, 2013, ORAL ONCOL, V49, P157, DOI 10.1016/j.oraloncology.2012.08.006; Giardina C, 1996, ORAL ONCOL, V32B, P91, DOI 10.1016/0964-1955(95)00062-3; Giardina C, 1994, Boll Soc Ital Biol Sper, V70, P271; Harada H, 2006, J EXP CLIN CANC RES, V25, P351; Hoch S, 2012, AM J OTOLARYNG, V33, P505, DOI 10.1016/j.amjoto.2011.11.005; Unzurrunzaga EI, 2011, ACTA OTORRINOLAR ESP, V62, P443, DOI 10.1016/j.otorri.2011.06.004; Ishibashi N, 2012, ULTRASOUND MED BIOL, V38, P389, DOI 10.1016/j.ultrasmedbio.2011.12.004; Jerjes W, 2012, HEAD NECK ONCOL, V4, DOI 10.1186/1758-3284-4-5; Kang CJ, 2011, ORAL ONCOL, V47, P1085, DOI 10.1016/j.oraloncology.2011.07.018; Kawano K, 2006, HEAD NECK-J SCI SPEC, V28, P525, DOI 10.1002/hed.20349; Keereweer S, 2012, HEAD NECK-J SCI SPEC, V34, P1002, DOI 10.1002/hed.21861; Keiko U-N, 2013, ACTA OTO-LARYNGOL, V133, P544; Kim KY, 2011, ORAL ONCOL, V47, P1069, DOI 10.1016/j.oraloncology.2011.07.017; Liao CT, 2012, ORAL ONCOL, V48, P329, DOI 10.1016/j.oraloncology.2011.10.017; Lim SC, 2004, CLIN CANCER RES, V10, P166, DOI 10.1158/1078-0432.CCR-0533-3; Lim YC, 2006, LARYNGOSCOPE, V116, P1232, DOI 10.1097/01.mlg.0000224363.04459.8b; Lore JM, 1999, ATLAS HEAD NECK SURG, P645; MacCarthy Denise, 2011, J Ir Dent Assoc, V57, P195; Manola M, 2011, ACTA OTORHINOLARYNGO, V31, P130; Martano M, 2006, EUR J HISTOCHEM, V50, P125; Matsuzuka T, 2008, LARYNGOSCOPE, V118, P646, DOI 10.1097/MLG.0b013e3181613aa6; Montes DM, 2011, HEAD NECK-J SCI SPEC, V33, P1581, DOI 10.1002/hed.21631; Nagashima T, 2000, Breast Cancer, V7, P43, DOI 10.1007/BF02967187; Nandini D B, 2011, J Oral Maxillofac Pathol, V15, P177, DOI 10.4103/0973-029X.84488; Nariai Y, 2011, INT J ORAL MAX SURG, V40, P419, DOI 10.1016/j.ijom.2010.10.020; Natarajan S, 2010, INDIAN J CANCER, V47, P406, DOI 10.4103/0019-509X.73580; Nathanson SD, 2003, CANCER, V98, P413, DOI 10.1002/cncr.11464; Okura M, 2005, J ORAL PATHOL MED, V34, P214, DOI 10.1111/j.1600-0714.2005.00304.x; Pektas ZO, 2006, J ORAL MAXIL SURG, V64, P628, DOI 10.1016/j.joms.2005.12.010; Sekine J, 2011, CANC DETECT PREV, V27, P427; SHAH JP, 1990, CANCER, V66, P109, DOI 10.1002/1097-0142(19900701)66:1<109::AID-CNCR2820660120>3.0.CO;2-A; Smitha T, 2011, J Oral Maxillofac Pathol, V15, P26, DOI 10.4103/0973-029X.80034; Stoeckli SJ, 2012, CURR OPIN OTOLARYNGO, V20, P103, DOI 10.1097/MOO.0b013e32834ef6d3; Suzuki M, 2001, Breast Cancer, V8, P138, DOI 10.1007/BF02967493; van der Vorst JR, 2013, ORAL ONCOL, V49, P15, DOI 10.1016/j.oraloncology.2012.07.017; vandenBrekel MWM, 1996, LARYNGOSCOPE, V106, P987, DOI 10.1097/00005537-199608000-00014; VANDERWAL N, 1989, J ORAL PATHOL MED, V18, P8; Vazquez-Mahia I, 2012, J ORAL MAXIL SURG, V70, P1724, DOI 10.1016/j.joms.2011.06.228; Werner JA, 2003, HEAD NECK-J SCI SPEC, V25, P322, DOI 10.1002/hed.10257; White FH, 1997, HISTOL HISTOPATHOL, V12, P69; WYDNER KS, 1991, MODERN PATHOL, V4, P154; Yan M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-437	46	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116452	10.1371/journal.pone.0116452	http://dx.doi.org/10.1371/journal.pone.0116452			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549090	Green Published, gold, Green Submitted			2022-12-26	WOS:000347063500084
J	Karpievitch, YV; Nikolic, SB; Wilson, R; Sharman, JE; Edwards, LM				Karpievitch, Yuliya V.; Nikolic, Sonja B.; Wilson, Richard; Sharman, James E.; Edwards, Lindsay M.			Metabolomics Data Normalization with EigenMS	PLOS ONE			English	Article							HUMAN URINE; MS	Liquid chromatography mass spectrometry has become one of the analytical platforms of choice for metabolomics studies. However, LC-MS metabolomics data can suffer from the effects of various systematic biases. These include batch effects, day-to-day variations in instrument performance, signal intensity loss due to time-dependent effects of the LC column performance, accumulation of contaminants in the MS ion source and MS sensitivity among others. In this study we aimed to test a singular value decomposition-based method, called EigenMS, for normalization of metabolomics data. We analyzed a clinical human dataset where LC-MS serum metabolomics data and physiological measurements were collected from thirty nine healthy subjects and forty with type 2 diabetes and applied EigenMS to detect and correct for any systematic bias. EigenMS works in several stages. First, EigenMS preserves the treatment group differences in the metabolomics data by estimating treatment effects with an ANOVA model (multiple fixed effects can be estimated). Singular value decomposition of the residuals matrix is then used to determine bias trends in the data. The number of bias trends is then estimated via a permutation test and the effects of the bias trends are eliminated. EigenMS removed bias of unknown complexity from the LC-MS metabolomics data, allowing for increased sensitivity in differential analysis. Moreover, normalized samples better correlated with both other normalized samples and corresponding physiological data, such as blood glucose level, glycated haemoglobin, exercise central augmentation pressure normalized to heart rate of 75, and total cholesterol. We were able to report 2578 discriminatory metabolite peaks in the normalized data (p<0.05) as compared to only 1840 metabolite signals in the raw data. Our results support the use of singular value decomposition-based normalization for metabolomics data.	[Karpievitch, Yuliya V.] Univ Tasmania, Sch Math & Phys, Hobart, Tas, Australia; [Nikolic, Sonja B.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Wilson, Richard; Sharman, James E.] Univ Tasmania, Cent Sci Lab, Hobart, Tas, Australia; [Edwards, Lindsay M.] Kings Coll London, Ctr Human & Aerosp Physiol Sci, London, England; [Edwards, Lindsay M.] GlaxoSmithKline R&D, Fibrosis Discovery Performance Unit, Stevenage, Herts, England	University of Tasmania; University of Tasmania; University of Tasmania; University of London; King's College London; GlaxoSmithKline	Karpievitch, YV (corresponding author), Univ Tasmania, Sch Math & Phys, Hobart, Tas, Australia.	yuliya.karpievitch@utas.edu.au	Sharman, James/B-2755-2009; Wilson, Richard/H-8429-2012	Sharman, James/0000-0003-2792-0811; Wilson, Richard/0000-0003-0152-4394	GlaxoSmithKline RD	GlaxoSmithKline RD(GlaxoSmithKline)	GlaxoSmithKline R&D provided support in the form of salaries for authors [LME], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bordbar A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.21; Climie RED, 2013, ARTERY RES, V7, P194, DOI 10.1016/j.artres.2013.09.002; Gika HG, 2008, J CHROMATOGR A, V1189, P314, DOI 10.1016/j.chroma.2007.10.066; Guy PA, 2008, J CHROMATOGR B, V871, P253, DOI 10.1016/j.jchromb.2008.04.034; Kaiser BLD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067155; Karpievitch YV, 2009, BIOINFORMATICS, V25, P2573, DOI 10.1093/bioinformatics/btp426; Kim YM, 2013, MOL BIOSYST, V9, P1522, DOI 10.1039/c3mb25598k; Lai L, 2010, MOL BIOSYST, V6, P108, DOI 10.1039/b910482h; Leek J.T., 2007, PLOS GENETICS, V3; Metz TO, 2008, TRAC-TREND ANAL CHEM, V27, P205, DOI 10.1016/j.trac.2007.11.003; Nikolic SB, 2014, METABOLOMICS, V10, P105, DOI 10.1007/s11306-013-0557-2; Sangster T, 2006, ANALYST, V131, P1075, DOI 10.1039/b604498k; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; Zelena E, 2009, ANAL CHEM, V81, P1357, DOI 10.1021/ac8019366	15	74	73	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e116221	10.1371/journal.pone.0116221	http://dx.doi.org/10.1371/journal.pone.0116221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549083	Green Published, gold, Green Submitted			2022-12-26	WOS:000347063500064
J	Lu, J; Huang, CM; Zheng, CH; Li, P; Xie, JW; Wang, JB; Lin, JX; Chen, QY; Cao, LL; Lin, M				Lu, Jun; Huang, Chang-ming; Zheng, Chao-hui; Li, Ping; Xie, Jian-wei; Wang, Jia-bin; Lin, Jian-xian; Chen, Qi-yue; Cao, Long-long; Lin, Mi			Prognostic Value of Tumor Size in Patients with Remnant Gastric Cancer: Is the Seventh UICC Stage Sufficient for Predicting Prognosis?	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; STUMP CARCINOMA; DISTAL GASTRECTOMY; CLINICOPATHOLOGICAL FEATURES; SURGICAL OUTCOMES; CLASSIFICATION; INDICATOR; DIAMETER; STILL	Background: The 7th UICC N stage may be unsuitable for remnant gastric cancer (RGC) because the original disease and previous operation usually cause abnormal lymphatic drainage. However, the prognostic significance of the current TNM staging system in RGC has not been studied. Methods: Prospective data from 153 RGC patients who underwent curative gastrectomy from Jan 1995 to Aug 2009 were reviewed. All patients were classified according to tumor size (<3 cm as N0; 3>&&LE; 5 cm as N1; >5&&LE; 7 cm as N2; and >7 cm as N3). The overall survival was estimated using the Kaplan-Meier method, and hazard ratios (HRs) were calculated using the Cox proportional hazard model. Results: Tumor sizes ranged from 1.0 to 15.0 cm (median 5.0 cm). Tumor size, depth of invasion and lymph node (LN) metastasis were significant prognostic factors based on both the univariate and multivariate analyses (P<0.05). In the survival analysis, the seventh edition UICC-TNM classification provided a detailed classification; however, some subgroups of the UICC-TNM classification did not have significantly different survival rates. The combination of the seventh edition T classification and the suggested N classification, with ideal relative risk (RR) results and P value, was distinctive for subgrouping the survival rates except for the IA versus IB and II A versus IIB. A modified staging system based on tumor size, predicted survival more accurately than the conventional TNM staging system. Conclusions: In RGCs, tumor size is an independent prognostic factor and a modified TNM system based on tumor size accurately predicts survival.	[Lu, Jun; Huang, Chang-ming; Zheng, Chao-hui; Li, Ping; Xie, Jian-wei; Wang, Jia-bin; Lin, Jian-xian; Chen, Qi-yue; Cao, Long-long; Lin, Mi] Fujian Med Univ, Union Hosp, Dept Gastr Surg, Fuzhou, Peoples R China	Fujian Medical University	Huang, CM (corresponding author), Fujian Med Univ, Union Hosp, Dept Gastr Surg, Fuzhou, Peoples R China.	hcmlr2002@163.com	Zheng, Chao-hui/HGE-3348-2022; Li, Ping/GYV-4914-2022; Lu, Jun/AAP-1222-2021	Zheng, Chao-hui/0000-0001-8680-3127; 	National Key Clinical Specialty Discipline Construction program of China [[2012]649]	National Key Clinical Specialty Discipline Construction program of China	This work was sponsored by National Key Clinical Specialty Discipline Construction program of China (No.[2012]649). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of manuscript.	Adachi Y, 1997, ANN SURG ONCOL, V4, P137, DOI 10.1007/BF02303796; Ahn HS, 2008, ANN SURG ONCOL, V15, P1632, DOI 10.1245/s10434-008-9871-8; Aurello P, 2007, AM SURGEON, V73, P359; Campiglio M, 2014, ANN ONCOL, V25, P1073, DOI 10.1093/annonc/mdu058; Catarci M, 2011, UPDATES SURG-ITALY, V63, P83, DOI 10.1007/s13304-011-0065-8; Coburn NG, 2006, CANCER-AM CANCER SOC, V107, P2143, DOI 10.1002/cncr.22229; Czymek R, 2012, HEPATO-GASTROENTEROL, V59, P768, DOI 10.5754/hge10466; de Manzoni G, 2002, BRIT J CANCER, V87, P171, DOI 10.1038/sj.bjc.6600432; Deng JY, 2012, ANN SURG, V256, pE35, DOI 10.1097/SLA.0b013e3182769545; Deng JY, 2010, ANN SURG ONCOL, V17, P1259, DOI 10.1245/s10434-010-0939-x; Di Leo A, 2007, J GASTROINTEST SURG, V11, P1146, DOI 10.1007/s11605-006-0062-2; Di Leo A, 2014, ANN SURG ONCOL, V21, P2594, DOI 10.1245/s10434-014-3633-6; Giuliani A, 2003, J EXP CLIN CANC RES, V22, P531; Hu X, 2009, J SURG ONCOL, V100, P472, DOI 10.1002/jso.21370; Huang CM, 2014, SURG ONCOL, V23, P5, DOI 10.1016/j.suronc.2014.01.003; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; KAMINISHI M, 1995, CANCER, V75, P1490, DOI 10.1002/1097-0142(19950315)75:6+<1490::AID-CNCR2820751518>3.0.CO;2-3; Kunisaki C, 2008, ANN SURG ONCOL, V15, P1959, DOI 10.1245/s10434-008-9884-3; Kusano T, 2013, ANN SURG ONCOL, V20, P2290, DOI 10.1245/s10434-012-2839-8; Lee SB, 2010, J GASTRIC CANCER, V10, P219, DOI 10.5230/jgc.2010.10.4.219; Li FX, 2013, AM J CLIN ONCOL-CANC, V36, P244, DOI 10.1097/COC.0b013e3182467ebd; Li FX, 2012, J CANCER RES CLIN, V138, P111, DOI 10.1007/s00432-011-1034-9; Mezhir JJ, 2011, ANN SURG ONCOL, V18, P670, DOI 10.1245/s10434-010-1425-1; Ohashi M, 2007, BRIT J SURG, V94, P92, DOI 10.1002/bjs.5538; Ohyama S, 2009, GASTRIC CANCER, V12, P88, DOI 10.1007/s10120-009-0502-2; Rabin I, 2011, ISR MED ASSOC J, V13, P534; Saito H, 2006, AM J SURG, V192, P296, DOI 10.1016/j.amjsurg.2006.03.004; Sayegh Mazin E, 2004, Gastric Cancer, V7, P140; Schaefer N, 2000, ANN SURG, V231, P188; Schaefer N, 2007, AM J SURG, V194, P63, DOI 10.1016/j.amjsurg.2006.12.037; Sinning C, 2007, EJSO-EUR J SURG ONC, V33, P133, DOI 10.1016/j.ejso.2006.09.006; Sobin LH, 2009, TNM CLASSIFICATION M, P73; Son T, 2014, ANN SURG ONCOL, V21, P899, DOI 10.1245/s10434-013-3403-x; Tanigawa Nobuhiko, 2002, Gastric Cancer, V5, P23, DOI 10.1007/s101200200003; Tanigawa N, 2010, WORLD J SURG, V34, P1540, DOI 10.1007/s00268-010-0505-5; Thorban S, 2000, ANN SURG, V231, P188, DOI 10.1097/00000658-200002000-00006; Verlato G, 2009, ANN SURG ONCOL, V16, P594, DOI 10.1245/s10434-008-0271-x; Wang X, 2008, J SURG ONCOL, V97, P236, DOI 10.1002/jso.20951; Zhang JZ, 2013, ANN SURG, V257, P81, DOI 10.1097/SLA.0b013e31825eff3f; Zu HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054502	40	16	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2014	9	12							e115776	10.1371/journal.pone.0115776	http://dx.doi.org/10.1371/journal.pone.0115776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX6YH	25549339	Green Published, Green Submitted, gold			2022-12-26	WOS:000347063500026
J	Van der Goten, J; Vanhove, W; Lemaire, K; Van Lommel, L; Machiels, K; Wollants, WJ; De Preter, V; De Hertogh, G; Ferrante, M; Van Assche, G; Rutgeerts, P; Schuit, F; Vermeire, S; Arijs, I				Van der Goten, Jan; Vanhove, Wiebe; Lemaire, Katleen; Van Lommel, Leentje; Machiels, Kathleen; Wollants, Willem-Jan; De Preter, Vicky; De Hertogh, Gert; Ferrante, Marc; Van Assche, Gert; Rutgeerts, Paul; Schuit, Frans; Vermeire, Severine; Arijs, Ingrid			Integrated miRNA and mRNA Expression Profiling in Inflamed Colon of Patients with Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; MUCOSAL GENE-EXPRESSION; MESENCHYMAL TRANSITION; INTESTINAL FIBROSIS; MICRORNA EXPRESSION; MIR-200B; IDENTIFICATION; PATHOGENESIS; BIOMARKERS; VARIANT	Background: Ulcerative colitis (UC) is associated with differential colonic expression of genes involved in immune response (e. g. IL8) and barrier integrity (e. g. cadherins). MicroRNAs (miRNAs) are regulators of gene expression and are involved in various immune-related diseases. In this study, we investigated (1) if miRNA expression in UC mucosa is altered and (2) if any of these changes correlate with mucosal mRNA expression. Integration of mRNA and miRNA expression profiling may allow the identification of functional links between dysregulated miRNAs and their target mRNA. Methodology: Colonic mucosal biopsies were obtained from 17 UC (10 active and 7 inactive) patients and 10 normal controls. Total RNA was used to analyze miRNA and mRNA expression via Affymetrix miRNA 2.0 and Affymetrix Human Gene 1.0ST arrays, respectively. Both miRNA and gene expression profiles were integrated by correlation analysis to identify dysregulated miRNAs with their corresponding predicted target mRNA. Microarray data were validated with qRT-PCR. Regulation of IL8 and CDH11 expression by hsa-miR-200c-3p was determined by luciferase reporter assays. Results: When comparing active UC patients vs. controls, 51 miRNAs and 1543 gene probe sets gave significantly different signals. In contrast, in inactive UC vs. controls, no significant miRNA expression differences were found while 155 gene probe sets had significantly different signals. We then identified potential target genes of the significantly dysregulated miRNAs and genes in active UC vs. controls and found a highly significant inverse correlation between hsa-miR-200c-3p and IL8, an inflammatory marker, and between hsa-miR-200c-3p and CDH11, a gene related to intestinal epithelial barrier function. We could demonstrate that hsa-miR-200c-3p directly regulates IL8 and CDH11 expression. Conclusion: Differential expression of immune- and barrier-related genes in inflamed UC mucosa may be influenced by altered expression of miRNAs. Integrated analysis of miRNA and mRNA expression profiles revealed hsa-miR-200c-3p for use of miRNA mimics as therapeutics.	[Van der Goten, Jan; Vanhove, Wiebe; Machiels, Kathleen; Wollants, Willem-Jan; De Preter, Vicky; Ferrante, Marc; Van Assche, Gert; Rutgeerts, Paul; Vermeire, Severine; Arijs, Ingrid] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders TARGI, Dept Clin & Expt Med, Leuven, Belgium; [Van der Goten, Jan; Lemaire, Katleen; Van Lommel, Leentje; Schuit, Frans; Arijs, Ingrid] Katholieke Univ Leuven, Dept Cellular & Mol Med, Gene Express Unit, Leuven, Belgium; [De Hertogh, Gert] Katholieke Univ Leuven, Dept Imaging & Pathol, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven	Arijs, I (corresponding author), Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders TARGI, Dept Clin & Expt Med, Leuven, Belgium.	ingrid.arijs@med.kuleuven.be	Arijs, Ingrid/AAJ-3163-2020; De Preter, Vicky/P-6131-2019	Arijs, Ingrid/0000-0002-9415-083X; Vermeire, Severine/0000-0001-9942-3019	Fund for Scientific Research-Flanders (FWO-Flanders), Belgium (FWO project) [G.0582.08, G.0479.10]	Fund for Scientific Research-Flanders (FWO-Flanders), Belgium (FWO project)(FWO)	This work was supported by grants from the Fund for Scientific Research-Flanders (FWO-Flanders), Belgium (FWO project nr. G.0582.08 and nr. G.0479.10). IA is a postdoctoral fellow and SV is a clinical researcher of FWO-Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archanioti P, 2011, J CROHNS COLITIS, V5, P520, DOI 10.1016/j.crohns.2011.05.007; Arijs I, 2009, GUT, V58, P1612, DOI 10.1136/gut.2009.178665; Arijs I, 2011, AM J GASTROENTEROL, V106, P748, DOI 10.1038/ajg.2011.27; Arijs I, 2010, INFLAMM BOWEL DIS, V16, P2090, DOI 10.1002/ibd.21301; Arijs I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007984; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bengtsson H., 2008, 745 U CAL DEP STAT; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharyya S, 2011, J BIOL CHEM, V286, P11604, DOI 10.1074/jbc.M110.198390; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Borcherding F, 2010, AM J PATHOL, V176, P1816, DOI 10.2353/ajpath.2010.090461; Brenner MB, 2013, United States patent, Patent No. [US 13/702,018, 13702018]; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Breynaert C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068876; Chang SK, 2011, P NATL ACAD SCI USA, V108, P8402, DOI 10.1073/pnas.1019437108; Chen Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.22; Chen YW, 2012, INT J MOL MED, V29, P601, DOI 10.3892/ijmm.2012.894; Chuang TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095370; Clark PM, 2012, INFLAMM BOWEL DIS, V18, P2315, DOI 10.1002/ibd.22958; Coskun M, 2013, WORLD J GASTROENTERO, V19, P4289, DOI 10.3748/wjg.v19.i27.4289; Coskun M, 2012, WORLD J GASTROENTERO, V18, P4629, DOI 10.3748/wjg.v18.i34.4629; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; Dai Yang, 2010, Open Access Bioinformatics, V2, P29; Dalmasso G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019293, 10.1371/journal.pone.0023806]; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Fasseu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013160; Geboes K, 2000, GUT, V47, P404, DOI 10.1136/gut.47.3.404; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Iborra M, 2013, CLIN EXP IMMUNOL, V173, P250, DOI 10.1111/cei.12104; Iborra M, 2012, AUTOIMMUN REV, V11, P305, DOI 10.1016/j.autrev.2010.07.002; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Lin JM, 2014, MODERN PATHOL, V27, P602, DOI 10.1038/modpathol.2013.152; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo DY, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-57; Min M, 2014, INFLAMM BOWEL DIS, V20, P652, DOI 10.1097/MIB.0000000000000009; MITSUYAMA K, 1994, CLIN EXP IMMUNOL, V96, P432; Muzes G, 2012, WORLD J GASTROENTERO, V18, P5848, DOI 10.3748/wjg.v18.i41.5848; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Olaru AV, 2011, INFLAMM BOWEL DIS, V17, P221, DOI 10.1002/ibd.21359; Pekow JR, 2012, INFLAMM BOWEL DIS, V18, P187, DOI 10.1002/ibd.21691; Quinn SR, 2011, INT IMMUNOL, V23, P421, DOI 10.1093/intimm/dxr034; Rieder F, 2009, NAT REV GASTRO HEPAT, V6, P228, DOI 10.1038/nrgastro.2009.31; Ruike Y, 2008, J HUM GENET, V53, P515, DOI 10.1007/s10038-008-0279-x; Schaefer JS, 2011, J IMMUNOL, V187, P5834, DOI 10.4049/jimmunol.1100922; Schneider DJ, 2012, FASEB J, V26, P503, DOI 10.1096/fj.11-186098; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takagi T, 2010, J GASTROEN HEPATOL, V25, pS129, DOI 10.1111/j.1440-1746.2009.06216.x; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; Wendlandt EB, 2012, INNATE IMMUN-LONDON, V18, P846, DOI 10.1177/1753425912443903; Worm J, 2009, NUCLEIC ACIDS RES, V37, P5784, DOI 10.1093/nar/gkp577; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Wu F, 2010, INFLAMM BOWEL DIS, V16, P1729, DOI 10.1002/ibd.21267; Zahm AM, 2014, J CROHNS COLITIS, V8, P1108, DOI 10.1016/j.crohns.2014.02.012; Zwiers A, 2012, J IMMUNOL, V188, P1573, DOI 10.4049/jimmunol.1101494	66	56	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2014	9	12							e116117	10.1371/journal.pone.0116117	http://dx.doi.org/10.1371/journal.pone.0116117			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7UN	25546151	Green Published, gold, Green Submitted			2022-12-26	WOS:000347120200099
J	Huemer, P; Mutanen, M; Sefc, KM; Hebert, PDN				Huemer, Peter; Mutanen, Marko; Sefc, Kristina M.; Hebert, Paul D. N.			Testing DNA Barcode Performance in 1000 Species of European Lepidoptera: Large Geographic Distances Have Small Genetic Impacts	PLOS ONE			English	Article							BUTTERFLIES; WOLBACHIA; LIBRARY; FAUNA	This study examines the performance of DNA barcodes (mt cytochrome c oxidase 1 gene) in the identification of 1004 species of Lepidoptera shared by two localities (Finland, Austria) that are 1600 km apart. Maximum intraspecific distances for the pooled data were less than 2% for 880 species (87.6%), while deeper divergence was detected in 124 species. Despite such variation, the overall DNA barcode library possessed diagnostic COI sequences for 98.8% of the taxa. Because a reference library based on Finnish specimens was highly effective in identifying specimens from Austria, we conclude that barcode libraries based on regional sampling can often be effective for a much larger area. Moreover, dispersal ability (poor, good) and distribution patterns (disjunct, fragmented, continuous, migratory) had little impact on levels of intraspecific geographic divergence. Furthermore, the present study revealed that, despite the intensity of past taxonomic work on European Lepidoptera, nearly 20% of the species shared by Austria and Finland require further work to clarify their status. Particularly discordant BIN (Barcode Index Number) cases should be checked to ascertain possible explanatory factors such as incorrect taxonomy, hybridization, introgression, and Wolbachia infections.	[Huemer, Peter] Tiroler Landesmuseen Betriebsges mbH, Nat Wissenschaftl Sammlungen, Innsbruck, Austria; [Mutanen, Marko] Univ Oulu, Dept Biol, Biodivers Unit, Oulu, Finland; [Sefc, Kristina M.] Graz Univ, Inst Zool, A-8010 Graz, Austria; [Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	University of Oulu; University of Graz; University of Guelph	Huemer, P (corresponding author), Tiroler Landesmuseen Betriebsges mbH, Nat Wissenschaftl Sammlungen, Innsbruck, Austria.	p.huemer@tiroler-landesmuseen.at	Hebert, Paul DN/C-4161-2013	Hebert, Paul DN/0000-0002-3081-6700; Sefc, Kristina/0000-0001-8108-8339	Genome Canada; Ontario Genomics Institute; Ontario Ministry of Research and Innovation; Kone Foundation; Finnish Cultural Foundation; Erlebnis naturschau Dornbirn	Genome Canada(Genome Canada); Ontario Genomics Institute; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Kone Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Erlebnis naturschau Dornbirn	This work was supported by Genome Canada (PDNH) (www.genomecanada.ca/, Ontario Genomics Institute (PDNH) (www.ontariogenomics.ca/), Ontario Ministry of Research and Innovation (PDNH) (https://www.ontario.ca/ministry-research-innovation), Kone Foundation (MM) (www.koneensaatio,fi/en/), Finnish Cultural Foundation (MM) (https://www.skr.fi/en), and Erlebnis naturschau Dornbirn (PH) (http://www.inatura.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, DISTRIBUTION ATLAS B; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Buszko Jaroslaw, 2000, Polish Entomological Monographs, V1, P1; Candek K, 2015, MOL ECOL RESOUR, V15, P268, DOI 10.1111/1755-0998.12304; Dewaard JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018290; DeWaard Jeremy R., 2008, V410, P275; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gaedike R, 1999, ENTOMOLOGISCHE NACHR, V5, P1; Hausmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084518; Hausmann A, 2011, SPIXIANA, V34, P47; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Huemer P, 2013, SYSTEMATISCHE FAUNIS, V12; Ivinskis P, 2004, LEPIDOPTERA LITHUANI; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Kodandaramaiah U, 2013, ECOL EVOL, V3, P5167, DOI 10.1002/ece3.886; Kullberg J, 2008, CHECKLIST FINNISH LE; Lastuvka Z, 2011, ANNOTATED CHECKLIST; Leneveu J, 2009, BIOL J LINN SOC, V97, P346, DOI 10.1111/j.1095-8312.2009.01208.x; Lopez-Vaamonde Carlos, 2010, BioRisk, V4, P603; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; Mutanen M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02901; Mutanen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047214; Pentinsaari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108651; Pinheiro J, 2020, R PACKAGE VERSION 31; R Core Team, 2021, R LANGUAGE ENV STAT; Ratnasingham S., 2013, BOLD BARCODE LIFE DA; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Ritter S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078107; Savenkov N, 2010, LATVIAN LEPIDOPTERA; Schintlmeister A., 2008, Palaearctic Macrolepidoptera, Volume 1: Notodontidae; Sinev S.Yu., 2008, CATALOGUE LEPIDOPTER; Smith A, 2012, MOL ECOLOGY RESOURCE, V13, P168, DOI DOI 10.1111/1755-0998; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Zahiri R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092797; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	44	112	122	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115774	10.1371/journal.pone.0115774	http://dx.doi.org/10.1371/journal.pone.0115774			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	25541991	gold, Green Published, Green Submitted			2022-12-26	WOS:000347239900084
J	Yu, J; Yu, B; He, J; Zheng, P; Mao, XB; Han, GQ; Chen, DW				Yu, Jie; Yu, Bing; He, Jun; Zheng, Ping; Mao, Xiangbing; Han, Guoquan; Chen, Daiwen			Chronic Glucocorticoid Exposure-Induced Epididymal Adiposity Is Associated with Mitochondrial Dysfunction in White Adipose Tissue of Male C57BL/6J Mice	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; GROWTH-FACTOR 21; METABOLIC SYNDROME; CUSHINGS-SYNDROME; HUMAN ADIPOCYTES; PRIMARY SITE; LIPOLYSIS; CORTICOSTERONE; BIOGENESIS; ROSIGLITAZONE	Prolonged and excessive glucocorticoids (GC) exposure resulted from Cushing's syndrome or GC therapy develops central obesity. Moreover, mitochondria are crucial in adipose energy homeostasis. Thus, we tested the hypothesis that mitochondrial dysfunction may contribute to chronic GC exposure-induced epididymal adiposity in the present study. A total of thirty-six 5-week-old male C57BL/6J mice (similar to 20 g) were administrated with 100 mu g/ml corticosterone (CORT) or vehicle through drinking water for 4 weeks. Chronic CORT exposure mildly decreased body weight without altering food and water intake in mice. The epididymal fat accumulation was increased, but adipocyte size was decreased by CORT. CORT also increased plasma CORT, insulin, leptin, and fibroblast growth factor 21 concentrations as measured by RIA or ELISA. Interestingly, CORT increased plasma levels of triacylglycerols and nonesterified fatty acids, and up-regulated the expression of both lipolytic and lipogenic genes as determined by real-time RT-PCR. Furthermore, CORT impaired mitochondrial biogenesis and oxidative function in epididymal WAT. The reactive oxygen species production was increased and the activities of anti-oxidative enzymes were reduced by CORT treatment as well. Taken together, these findings reveal that chronic CORT administration-induced epididymal adiposity is, at least in part, associated with mitochondrial dysfunction in mouse epididymal white adipose tissue.	[Yu, Jie; Yu, Bing; He, Jun; Zheng, Ping; Mao, Xiangbing; Han, Guoquan; Chen, Daiwen] Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Peoples R China; [Yu, Jie; Yu, Bing; He, Jun; Zheng, Ping; Mao, Xiangbing; Chen, Daiwen] Sichuan Agr Univ, Key Lab Anim Dis Resistance Nutr, China Minist Educ, Chengdu 611130, Peoples R China; [Han, Guoquan] Sichuan Agr Univ, Coll Food Sci, Yaan 625014, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Chen, DW (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Peoples R China.	dwchen@sicau.edu.cn		Yu, Jiaojun/0000-0001-9400-5408	Sichuan Department of Education [13ZA0261]; Program for Changjiang Scholars and Innovative Research Team in University from Ministry of Education of China [IRT0555-5]	Sichuan Department of Education; Program for Changjiang Scholars and Innovative Research Team in University from Ministry of Education of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by Key Project (13ZA0261) from Sichuan Department of Education (JY) and Program for Changjiang Scholars and Innovative Research Team in University (IRT0555-5) from Ministry of Education of China (DC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany M, 2013, NUTR RES, V33, P1, DOI 10.1016/j.nutres.2012.11.013; Anagnostis P, 2009, J CLIN ENDOCR METAB, V94, P2692, DOI 10.1210/jc.2009-0370; Arnaldi G, 2003, J CLIN ENDOCR METAB, V88, P5593, DOI 10.1210/jc.2003-030871; BERDANIER CD, 1989, FASEB J, V3, P2179, DOI 10.1096/fasebj.3.10.2666232; Buttgereit F, 2005, LANCET, V365, P801; Campbell JE, 2011, AM J PHYSIOL-CELL PH, V300, pC198, DOI 10.1152/ajpcell.00045.2010; Cassano AE, 2012, COMPARATIVE MED, V62, P348; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; Davies NA, 2013, J ENDOCRINOL; DEMONACOS C, 1995, J STEROID BIOCHEM, V55, P43, DOI 10.1016/0960-0760(95)00159-W; DIVERTIE GD, 1991, DIABETES, V40, P1228, DOI 10.2337/diabetes.40.10.1228; Djurhuus CB, 2002, AM J PHYSIOL-ENDOC M, V283, pE172, DOI 10.1152/ajpendo.00544.2001; Galitzky J, 2013, CELL METAB, V18, P3, DOI 10.1016/j.cmet.2013.06.008; Gathercole LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026223; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hassan-Smith Z, 2014, LANCET, V383, P53; Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6; Karatsoreos IN, 2010, ENDOCRINOLOGY, V151, P2117, DOI 10.1210/en.2009-1436; Lee MJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE1126, DOI 10.1152/ajpendo.00228.2012; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Liu JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034835; Liu Y, 2008, PHYSIOL GENOMICS, V32, P343, DOI 10.1152/physiolgenomics.00067.2007; Lu RH, 2010, MOL BIOL REP, V37, P2173, DOI 10.1007/s11033-009-9695-z; Lundgren M, 2008, HORM METAB RES, V40, P854, DOI 10.1055/s-0028-1087168; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; MAYOSMITH W, 1989, RADIOLOGY, V170, P515, DOI 10.1148/radiology.170.2.2911678; Minami I, 2006, INTERNAL MED, V45, P1231, DOI 10.2169/internalmedicine.45.1809; Murphy MP, 2013, CELL METAB, V18, P145, DOI 10.1016/j.cmet.2013.07.006; Murray F, 2008, EUR J PHARMACOL, V583, P115, DOI 10.1016/j.ejphar.2008.01.014; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Yuji OA, 2007, EXP MOL PATHOL, V83, P73, DOI 10.1016/j.yexmp.2007.02.007; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Pezaro C, 2013, BRIT J CANCER, V109, P325, DOI 10.1038/bjc.2013.340; Rees SL, 2004, HORM BEHAV, V46, P411, DOI 10.1016/j.yhbeh.2004.03.010; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Schuff KG, 2003, PRIMARY CARE, V30, P791, DOI 10.1016/S0095-4543(03)00088-5; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; SLAVIN BG, 1994, J LIPID RES, V35, P1535; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Stewart PM, 2005, CLIN MED, V5, P142, DOI 10.7861/clinmedicine.5-2-142; Stewart PM, 2003, EUR J ENDOCRINOL, V149, P163, DOI 10.1530/eje.0.1490163; Tang VM, 2013, HORM METAB RES, V45, P709, DOI 10.1055/s-0033-1345119; Tedesco L, 2008, DIABETES, V57, P2028, DOI 10.2337/db07-1623; Tsiriyotis C, 1997, BIOCHEM BIOPH RES CO, V235, P349, DOI 10.1006/bbrc.1997.6787; Wang Minghan, 2005, Nutr Metab (Lond), V2, P3, DOI 10.1186/1743-7075-2-3; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Xu C, 2009, MOL ENDOCRINOL, V23, P1161, DOI 10.1210/me.2008-0464; Yu J, 2012, BRIT J NUTR, V107, P461, DOI 10.1017/S0007114511003205; Yu J, 2012, ENDOCRINOLOGY, V153, P750, DOI 10.1210/en.2011-1591	51	43	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112628	10.1371/journal.pone.0112628	http://dx.doi.org/10.1371/journal.pone.0112628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25551379	gold, Green Published, Green Submitted			2022-12-26	WOS:000349144400113
